
@article{ ISI:000321283600006,
Author = {Bustamante-Montes, L. P. and Hernandez-Valero, M. A. and
   Flores-Pimentel, D. and Garcia-Fabila, M. and Amaya-Chavez, A. and Barr,
   D. B. and Borja-Aburto, V. H.},
Title = {{Prenatal exposure to phthalates is associated with decreased anogenital
   distance and penile size in male newborns}},
Journal = {{JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE}},
Year = {{2013}},
Volume = {{4}},
Number = {{4}},
Pages = {{300-306}},
Month = {{AUG}},
Abstract = {{Reproductive effects from phthalate exposure have been documented mostly
   in animal studies. This study explored the association between prenatal
   exposure to phthalate metabolites, anogenital distance and penile
   measurements in male newborns in Toluca, State of Mexico. A total of 174
   pregnant women provided urine samples for phthalate analysis during
   their last prenatal visit, and the 73 who gave birth to male infants
   were included in the study. The 73 male newborns were weighed and
   measured using standardized methods after delivery. After adjusting for
   creatinine and supine length at birth, significant inverse associations
   were observed between an index of prenatal exposure to total phthalate
   exposure and the distance from the anus to anterior base of the penis
   (beta = -0.191 mm per 1 mu g/l, P = 0.037), penile width (beta =
   -0.0414, P = 0.050) and stretched length (beta = -0.2137, P = 0.034);
   prenatal exposure to mono-2-ethylhexyl phthalate exposure was associated
   with a reduction in the stretched length of the penis (beta = -0.2604, P
   = 0.050). Human exposure to phthalates is a public health concern, and
   the system most vulnerable to its potential effects seems to be the
   immature male reproductive tract.}},
Publisher = {{CAMBRIDGE UNIV PRESS}},
Address = {{EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Borja-Aburto, VH (Reprint Author), Coordinac Vigilancia Epidemiol Inst Mexicano Segu, Mier \& Pesado 120 Col Valle, Mexico City 03100, DF, Mexico.
   Bustamante-Montes, L. P., Univ Autonoma Estado Mexico, Fac Med, Unidad Invest Con Enfoque Ecosistem, Toluca 50180, Edo De Mexico, Mexico.
   Hernandez-Valero, M. A., Univ Texas MD Anderson Canc Ctr, Ctr Res Minor Hlth, Dept Hlth Dispar Res, Houston, TX 77030 USA.
   Flores-Pimentel, D., Univ Autonoma Estado Mexico, Fac Med, Ctr Invest \& Estudios Avanzados Salud Publ, Toluca 50180, Edo De Mexico, Mexico.
   Garcia-Fabila, M., Univ Autonoma Estado Mexico, Fac Quim, Lab Toxicol, Toluca 50180, Edo De Mexico, Mexico.
   Amaya-Chavez, A., Univ Autonoma Estado Mexico, Fac Quim, Lab Anal Instrumental, Toluca 50180, Edo De Mexico, Mexico.
   Barr, D. B., Emory Univ, Rollins Sch Publ Hlth, Dept Environm Hlth, Atlanta, GA 30322 USA.
   Borja-Aburto, V. H., Coordinac Vigilancia Epidemiol Inst Mexicano Segu, Mexico City 03100, DF, Mexico.}},
DOI = {{10.1017/S2040174413000172}},
ISSN = {{2040-1744}},
Keywords = {{phthalates; anogenital distance; penile measurements; prenatal exposure}},
Keywords-Plus = {{TEMPORAL VARIABILITY; MEXICAN WOMEN; URINE SAMPLES; MALE-RAT;
   METABOLITES; HEALTH; ESTERS; LENGTH; CELLS; AGE}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{victor.borja@imss.gob.mx}},
Funding-Acknowledgement = {{Universidad Autonoma del Estado de Mexico (UAEM) {[}2245, S81109];
   Fulbright-Garcia Robles Scholars Program; National Institutes of Health,
   National Center for Minority Health and Health Disparities {[}NCMHD
   P60-MD000503]}},
Funding-Text = {{The study was funded by the Universidad Autonoma del Estado de Mexico
   (UAEM) with Grant 2245/Contract 2006, and with `Fondos de Consolidacion
   2009' project number S81109. This study was also supported by the
   Fulbright-Garcia Robles Scholars Program through the scholarship
   provided to Dr Maria A. Hernandez-Valero to cover her travel expenses
   and research in Mexico, and through the research support provided to Dr
   Hernandez-Valero by the National Institutes of Health, National Center
   for Minority Health and Health Disparities (NCMHD P60-MD000503).}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   ALBRO PW, 1982, J CHROMATOGR, V244, P65, DOI 10.1016/S0021-9673(00)80123-5.
   Al-Herbish AS, 2002, SAUDI MED J, V23, P314.
   Anhalt H, 1996, Pediatr Rev, V17, P213, DOI 10.1542/pir.17-6-213.
   Anigstein Carlos R., 2005, Arch. argent. pediatr., V103, P401.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Bowman CJ, 2003, TOXICOL SCI, V74, P393, DOI 10.1093/toxsci/kfg128.
   CAPURRO H, 1978, J PEDIATR, V93, P120, DOI 10.1016/S0022-3476(78)80621-0.
   CARMUDAN AD, 2007, UROLOGY, V70, P572.
   Chen Guo-Rong, 2007, Zhonghua Nan Ke Xue, V13, P195.
   DAMON V, 1990, PEDIATRIE, V45, P519.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   Fok TF, 2005, BIOL NEONATE, V87, P242, DOI 10.1159/000083420.
   FUJIEDA K, 1987, PEDIATR INT, V29, P220, DOI 10.1111/j.1442-200X.1987.tb00036.x.
   GARCIA MA, 2002, METODOS ANALITICOS G.
   Ge RS, 2007, REPROD TOXICOL, V23, P366, DOI 10.1016/j.reprotox.2006.12.006.
   GRAY TJB, 1984, FOOD CHEM TOXICOL, V22, P123, DOI 10.1016/0278-6915(84)90092-9.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   LEE PA, 1980, JOHNS HOPKINS MED J, V146, P156.
   Masutomi N, 2003, TOXICOLOGY, V192, P149, DOI 10.1016/S0300-483X(03)00269-5.
   Mendiola J, 2011, ENVIRON HEALTH PERSP, V119, P958, DOI 10.1289/ehp.1103421.
   Nakahara Hiroyuki, 2003, Fukuoka Acta Medica, V94, P331.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Romano-Riquera SP, 2007, PAEDIATR PERINAT EP, V21, P219, DOI 10.1111/j.1365-3016.2007.00810.x.
   Romero-Franco M, 2011, ENVIRON INT, V37, P867, DOI 10.1016/j.envint.2011.02.014.
   SALAZARMARTINEZ E, 2005, ENV HLTH, V3, P8.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Suzuki Y, 2012, INT J ANDROL, V35, P236, DOI 10.1111/j.1365-2605.2011.01190.x.
   Svensson K, 2011, ENVIRON RES, V111, P792, DOI 10.1016/j.envres.2011.05.015.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}WHO, 2003, HLTH ENV CHILDR.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{0}},
Journal-ISO = {{J. Dev. Orig. Health Dis.}},
Doc-Delivery-Number = {{176DL}},
Wos-Id = {{ISI:000321283600006}},
}

@article{ ISI:000321032000012,
Author = {Tranfo, Giovanna and Papaleo, Bruno and Caporossi, Lidia and Capanna,
   Silvia and De Rosa, Mariangela and Pigini, Daniela and Corsetti,
   Federica and Paci, Enrico},
Title = {{Urinary metabolite concentrations of phthalate metabolites in Central
   Italy healthy volunteers determined by a validated HPLC/MS/MS analytical
   method}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2013}},
Volume = {{216}},
Number = {{4}},
Pages = {{481-485}},
Month = {{JUL}},
Abstract = {{The main objective of this study was to determine the average
   concentrations for the metabolites of the four more common phthalates,
   industrial chemicals widely used in commercial products and potential
   endocrine disruptors, in the urine of a control population living in
   Central Italy. The study population consisted of 157 healthy subjects,
   not occupationally exposed to phthalates (74 males and 83 females).
   Urinary levels of the analytes were determined by liquid chromatography
   tandem mass spectrometry (LC-MS/MS) with isotopic dilution.
   The reference values (geometric mean) for males and females were
   estimated for each metabolite:. Females: for MEP was 72.94 mu g/g
   creatinine (Cl 95\% 3.63-149.51), for MEHP was 3.37 mu g/g creatinine
   (Cl 95\% 1.85-4.89), for MEHHP was 12.74 mu g/g creatinine (CI 95\%
   9.45-22.19), for MnBP was 20.26 mu g/g creatinine (Cl 95\% 8.17-28.43)
   and for MBzP was 14.74 (CI 95\% 2.94-17.68). Males: for MEP was 56.35 mu
   g/g creatinine (Cl 95\% 2.32-110.39), for MEHP was 2.80 mu g/g
   creatinine (Cl 95\% 1.08-4.52), for MEHHP was 10.77 mu g/g creatinine
   (CI 95\% 6.18-16.95), for MnBP was 17.59 mu g/g creatinine (CI 95\%
   5.72-29.45) and for MBzP was 16.44 (Cl 95\% 7.90-29.45).
   To obtain reference values for these chemicals is without doubt an
   important topic for evaluate the exposure of population and their
   possible health effects. Information from different geographical areas
   are important to understand the real different background
   concentrations. (C) 2012 Elsevier GmbH. All rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Tranfo, G (Reprint Author), Res Ctr Monteporzio Catone, Dept Occupat Med, INAIL Res, Verificat Area, Via Fontana Candida 1, I-00040 Rome, Italy.
   Tranfo, Giovanna; Papaleo, Bruno; Caporossi, Lidia; Capanna, Silvia; De Rosa, Mariangela; Pigini, Daniela; Corsetti, Federica; Paci, Enrico, Res Ctr Monteporzio Catone, Dept Occupat Med, INAIL Res, Verificat Area, I-00040 Rome, Italy.}},
DOI = {{10.1016/j.ijheh.2012.11.003}},
ISSN = {{1438-4639}},
Keywords = {{Reference value; Phthalate metabolites; Urine; LC-MS/MS; Method
   validation}},
Keywords-Plus = {{RISK-ASSESSMENT; PREGNANT-WOMEN; EXPOSURE; POPULATION; CHILDREN; HUMANS}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{g.tranfo@inail.it}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012.
   Centers for Disease Control and Prevention - CDC, 2005, 3 CDCP.
   Colacino JA, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-40.
   David F., 2003, HDB ENV CHEM, V3.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hines CJ, 2009, ANN OCCUP HYG, V53, P1, DOI 10.1093/annhyg/men066.
   Jaffe M., 1886, Z PHYSL CHEM, V10, P391.
   Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Latini G, 2006, CURR MED CHEM, V13, P2527, DOI 10.2174/092986706778201666.
   Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073.
   Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091.
   Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091.
   Romero-Franco M, 2011, ENVIRON INT, V37, P867, DOI 10.1016/j.envint.2011.02.014.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Tranfo G, 2012, TOXICOL LETT, V213, P15, DOI 10.1016/j.toxlet.2011.11.033.
   YOUNG DS, 1975, CLIN CHEM, V21, pD1.}},
Number-of-Cited-References = {{23}},
Times-Cited = {{0}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{172VC}},
Wos-Id = {{ISI:000321032000012}},
}

@article{ ISI:000320586200007,
Author = {Sathyanarayana, Sheela and Alcedo, Garry and Saelens, Brian E. and Zhou,
   Chuan and Dills, Russell L. and Yu, Jianbo and Lanphear, Bruce},
Title = {{Unexpected results in a randomized dietary trial to reduce phthalate and
   bisphenol A exposures}},
Journal = {{JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY}},
Year = {{2013}},
Volume = {{23}},
Number = {{4}},
Pages = {{378-384}},
Month = {{JUL-AUG}},
Abstract = {{Diet is a primary source of exposure for high-molecular-weight
   phthalates and bisphenol A (BPA), but little is known about the efficacy
   of various interventions to reduce exposures. We conducted a randomized
   trial with 10 families to test the efficacy of a 5-day complete dietary
   replacement (Arm 1; n = 21) versus written recommendations to reduce
   phthalate and BPA exposures (Arm 2; n = 19). We measured phthalate and
   BPA concentrations in urine samples at baseline, intervention, and
   post-intervention periods. We used Wilcoxon paired signed-rank tests to
   assess change in concentrations across time and multi-level mixed
   effects regression models to assess differences between Arms 1 and 2.
   Urinary di(2-ethylhexyl) phthalate (DEHP) metabolite concentrations
   increased unexpectedly from a median of 283.7 nmol/g at baseline to
   7027.5 nmol/g during the intervention (P<0.0001) among Arm 1
   participants, and no significant changes were observed for Arm 2
   participants. We observed a statistically significant increase in total
   BPA concentration between baseline and intervention periods in Arm 1 but
   no significant changes in Arm 2. Arm 1 food ingredient testing for DEHP
   revealed concentrations of 21,400 ng/g in ground coriander and 673 ng/g
   in milk. Food contamination with DEHP led to unexpected increases in
   urinary phthalate concentrations in a trial intended to minimize
   exposure. In the absence of regulation to reduce phthalate and BPA
   concentrations in food production, it may be difficult to develop
   effective interventions that are feasible in the general population. An
   estimate of DEHP daily intake for children in the dietary replacement
   Arm was above the US Environmental Protection Agency oral reference dose
   and the European Food Safety Authority's tolerable daily intake,
   suggesting that food contamination can be a major source of DEHP
   exposure.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sathyanarayana, S (Reprint Author), Univ Washington, Seattle Childrens Res Inst, Dept Pediat, 2001 West 8th Ave, Seattle, WA 98121 USA.
   Sathyanarayana, Sheela; Saelens, Brian E.; Zhou, Chuan, Univ Washington, Dept Pediat, Seattle, WA 98121 USA.
   Sathyanarayana, Sheela; Alcedo, Garry; Saelens, Brian E.; Zhou, Chuan, Seattle Childrens Hosp Res Inst, Ctr Child Hlth Behav \& Dev, Seattle, WA USA.
   Dills, Russell L.; Yu, Jianbo, Univ Washington, Dept Environm \& Occupat Hlth Sci, Environm Hlth Lab, Seattle, WA 98121 USA.
   Lanphear, Bruce, BC Childrens Hosp, Child \& Family Res Inst, Vancouver, BC, Canada.
   Lanphear, Bruce, Simon Fraser Univ, Vancouver, BC, Canada.}},
DOI = {{10.1038/jes.2013.9}},
ISSN = {{1559-0631}},
Keywords = {{phthalate; bisphenol A; food; diet}},
Keywords-Plus = {{PERINATAL EXPOSURE; PRENATAL EXPOSURE; PRIMARY-CARE; HUMAN URINE; FOOD;
   INTERVENTION; PLASTICIZERS; METABOLITES; OVERWEIGHT; ENDOCRINE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{sheela.sathyanarayana@seattlechildrens.org}},
Funding-Acknowledgement = {{University of Washington Center for Ecogenetics and Environmental Health
   {[}ES007033]}},
Funding-Text = {{We thank the University of Washington Center for Ecogenetics and
   Environmental Health (grant number ES007033, NIEHS) who provided funding
   for this study. We thank the families that participated in this study.}},
Cited-References = {{American Academy of Pediatric Council on Environmental Health, 2010, PEDIATRICS, V127, P983.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979.
   Buckley JP, 2012, J EXPO SCI ENV EPID, V22, P468, DOI 10.1038/jes.2012.33.
   Carwile JL, 2011, JAMA-J AM MED ASSOC, V306, P2218, DOI 10.1001/jama.2011.1721.
   Centers for Disease Control and Prevention (CDC), 2012, 4 CDCP.
   Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Fierens T, 2012, FOOD CHEM TOXICOL, V50, P2575, DOI 10.1016/j.fct.2012.04.029.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Just AC, 2012, ENVIRON HEALTH PERSP, V120, P1475, DOI 10.1289/ehp.1104544.
   Kang JH, 2006, TOXICOLOGY, V226, P79, DOI 10.1016/j.tox.2006.06.009.
   Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Kueseng P, 2007, J ENVIRON SCI HEAL B, V42, P569, DOI 10.1080/03601230701389488.
   Lakind JS, 2008, J EXPO SCI ENV EPID, V21, P272.
   Liddy S, 2012, ENV HLTH PERSPECT, V119, P1170.
   PAGE BD, 1995, FOOD ADDIT CONTAM, V12, P129.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   President's Cancer Panel, 2010, RED ENV CANC RISK.
   Remer T, 2002, AM J CLIN NUTR, V75, P561.
   Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783.
   Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170.
   Saelens BE, 2002, OBES RES, V10, P22, DOI 10.1038/oby.2002.4.
   Sandel M, 2010, J PUBLIC HEALTH MAN, V16, pS24, DOI 10.1097/PHH.0b013e3181e3cc2a.
   Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Spanier AJ, 2012, ENVIRON HEALTH PERSP, V120, P916, DOI 10.1289/ehp.1104175.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   U.S. Environmental Protection Agency (EPA), 2011, EXP FACT HDB.
   von Goetz N, 2010, RISK ANAL, V30, P473, DOI 10.1111/j.1539-6924.2009.01345.x.
   Wadia PR, 2007, ENVIRON HEALTH PERSP, V115, P592, DOI 10.1289/ehp.9640.
   Wake M, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3308.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {[}Anonymous], 2008, CHECK KIND PLAST YOU.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{1}},
Journal-ISO = {{J. Expo. Sci. Environ. Epidemiol.}},
Doc-Delivery-Number = {{166VG}},
Wos-Id = {{ISI:000320586200007}},
}

@article{ ISI:000319848000004,
Author = {Servaes, K. and Voorspoels, S. and Lievens, J. and Noten, B. and
   Allaerts, K. and Van de Weghe, H. and Vanermen, G.},
Title = {{Direct analysis of phthalate ester biomarkers in urine without
   preconcentration: Method validation and monitoring}},
Journal = {{JOURNAL OF CHROMATOGRAPHY A}},
Year = {{2013}},
Volume = {{1294}},
Pages = {{25-32}},
Month = {{JUN 14}},
Abstract = {{Phthalates, which are ubiquitous in the environment, are readily
   metabolized in human bodies to their respective monoesters. These
   phthalate monoesters are non-persistent with short half-lives, which
   make them the ideal biomarkers of human exposure to phthalates. In this
   study a direct analysis method without preconcentration was developed
   and validated for the following phthalate ester metabolites in urine:
   mono-(2-ethylhexyl) phthalate, mono-(2-ethyl-5-hydroxyhexyl) phthalate,
   mono-(2-ethyl-5-oxohexyl)phthalate, monobenzyl phthalate,
   mono-isobutylphthalate, mono-n-butyl phthalate and monoethyl phthalate.
   The recovery of the phthalate ester metabolites varied between 97\% and
   104\%. The intraday precision for the replicate analysis (n = 10) of a
   urine sample did not exceed 5\% for most of the compounds. The
   coefficient of variance amounted to 2-3\%. The limit of quantification
   was set equal to 0.5 mu g/L for the majority of the compounds. A
   comparison between the direct analysis method and a foregoing solid
   phase extraction (SPE) of the urine sample was made. Finally, the
   applicability of the direct analysis method was tested in three
   interlaboratory comparisons. (C) 2013 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Servaes, K (Reprint Author), Flemish Inst Technol Res VITO, Boeretang 200, B-2400 Mol, Belgium.
   Servaes, K.; Voorspoels, S.; Lievens, J.; Noten, B.; Allaerts, K.; Van de Weghe, H.; Vanermen, G., Vlaamse Instelling Technol Onderzoek, Unit Environm Anal \& Technol, B-2400 Mol, Belgium.}},
DOI = {{10.1016/j.chroma.2013.03.054}},
ISSN = {{0021-9673}},
Keywords = {{Phthalate ester metabolites; Urine; Liquid chromatography; Direct
   analysis}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; METABOLITES; QUANTIFICATION; EXPOSURE; SAMPLES}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{kelly.servaes@vito.be}},
Cited-References = {{CDC, 2011, 4 CDC CDCP NAT CTR E.
   Chen M, 2012, J CHROMATOGR B, V904, P73, DOI 10.1016/j.jchromb.2012.07.022.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch H.M., 2008, MAK COLLECTION 4, V11, P73.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Monfort N, 2012, J CHROMATOGR B, V908, P113, DOI 10.1016/j.jchromb.2012.09.030.
   Schulz C, 2011, INT J HYG ENVIR HEAL, V215, P26, DOI 10.1016/j.ijheh.2011.06.007.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Silva MJ, 2008, J CHROMATOGR B, V873, P180, DOI 10.1016/j.jchromb.2008.08.017.
   Solymos E, 2011, ANAL BIOANAL CHEM, V401, P517, DOI 10.1007/s00216-010-4589-4.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Kasper-Sonnenberg M, 2012, INT J HYG ENVIR HEAL, V215, P373, DOI 10.1016/j.ijheh.2011.09.004.}},
Number-of-Cited-References = {{17}},
Times-Cited = {{0}},
Journal-ISO = {{J. Chromatogr. A}},
Doc-Delivery-Number = {{156TY}},
Wos-Id = {{ISI:000319848000004}},
}

@article{ ISI:000317873700002,
Author = {Casas, Maribel and Chevrier, Cecile and Den Hond, Elly and Fernandez,
   Mariana F. and Pierik, Frank and Philippat, Claire and Slama, Remy and
   Toft, Gunnar and Vandentorren, Stephanie and Wilhelm, Michael and
   Vrijheid, Martine},
Title = {{Exposure to brominated flame retardants, perfluorinated compounds,
   phthalates and phenols in European birth cohorts: ENRIECO evaluation,
   first human biomonitoring results, and recommendations}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2013}},
Volume = {{216}},
Number = {{3}},
Pages = {{230-242}},
Month = {{JUN}},
Abstract = {{There are emerging concerns about potential effects on child health and
   development of early-life exposure to substances such as brominated
   flame retardants (BFRs), perfluorinated compounds (PFCs), phthalates and
   phenols (including bisphenol A (BPA)); pregnancy and birth cohort
   studies are ideally designed to study such concerns prospectively. As
   part of the ENRIECO project, we evaluated existing human biomonitoring
   data for these substances in European birth cohorts and develop
   recommendations for more harmonized methods that will enable combination
   and comparison of cohort data in the future. The ENRIECO inventory shows
   that 20 European birth cohorts have measured or are measuring BFRs (N =
   10), PFCs (N = 11), phthalates (N = 16) or phenols (N = 8). Generally,
   samples were collected prenatally or at birth and measurements involved
   few subjects in each cohort (a few hundred maximum). Biological
   matrices, timing, and analytical methods of the measurements varied
   between cohorts. Few cohorts have measured at multiple time points or in
   children. In European cohorts, levels of BFRs were very low and at least
   10-fold lower than in US; levels of PFCs and phthalates have decreased
   over the last decade since the phasing out of certain of these
   compounds; concentrations of phenols are comparable to those in the US.
   Although there is little published data in the cohorts now, many
   measurements are ongoing and we recommend that cohorts start working
   towards combined and comparison studies. Specific recommendations for
   use of existing data include the development of conversion models for
   the different media used for measurement of persistent chemicals, and
   inter-laboratory comparisons and calibrations. Recommendations for
   further data collection include more evaluation of exposure to these
   chemicals in children; repeated measurements of non-persistent
   chemicals; validation and harmonisation of questionnaires; and the
   development of mechanisms for fast European birth cohort response for
   the detection and prioritisation of new chemicals of concern. (c) 2012
   Elsevier GmbH. All rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Casas, M (Reprint Author), Ctr Res Environm Epidemiol, Doctor Aiguader 88, Barcelona 08003, Spain.
   Casas, Maribel; Vrijheid, Martine, Ctr Res Environm Epidemiol CREAL, Barcelona, Spain.
   Casas, Maribel; Vrijheid, Martine, Hosp del Mar, Res Inst IMIM, Barcelona, Spain.
   Casas, Maribel; Fernandez, Mariana F.; Vrijheid, Martine, Spanish Consortium Res Epidemiol \& Publ Hlth CIBE, Barcelona, Spain.
   Chevrier, Cecile, Univ Rennes 1, French Natl Inst Hlth \& Med Res INSERM, IRSET, Rennes, France.
   Den Hond, Elly, Flemish Inst Technol Res Vito Environm Hlth \& Ris, Mol, Belgium.
   Fernandez, Mariana F., Univ Granada, Lab Med Invest, San Cecilio Univ Hosp, Biomed Res Ctr, Granada, Spain.
   Philippat, Claire; Slama, Remy, INSERM, F-38042 Grenoble, France.
   Philippat, Claire; Slama, Remy, Grenoble Univ, Team Environm Epidemiol Appl Reprod \& Resp Hlth, Inst Albert Bonniot U823, F-38042 Grenoble, France.
   Pierik, Frank, Netherlands Org Appl Sci Res TNO, Urban Environm \& Safety, Utrecht, Netherlands.
   Pierik, Frank, Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands.
   Toft, Gunnar, Aarhus Univ Hosp, Dept Occupat Med, DK-8000 Aarhus, Denmark.
   Vandentorren, Stephanie, Natl Inst Publ Hlth Surveillance InVS, St Maurice, France.
   Wilhelm, Michael, Ruhr Univ Bochum, Dept Hyg Social \& Environm Med, Bochum, Germany.}},
DOI = {{10.1016/j.ijheh.2012.05.009}},
ISSN = {{1438-4639}},
Keywords = {{Human biomonitoring; Brominated flame retardants; Perfluorinated
   compounds; Phthalates; Phenols; Bisphenol A; Birth cohorts; Europe}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; SOLID-PHASE EXTRACTION; PLACENTAL TISSUE
   SAMPLES; MOTHER-CHILD-PAIRS; TOTAL BISPHENOL-A; HUMAN URINE;
   PREGNANT-WOMEN; PRENATAL EXPOSURE; DIPHENYL ETHERS; HUMAN HEALTH}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{mcasas@creal.cat}},
ResearcherID-Numbers = {{Fernandez, Mariana/C-9877-2012}},
Funding-Acknowledgement = {{ENRIECO (Environmental Health Risks in European Birth Cohorts)
   {[}226285]}},
Funding-Text = {{This work was supported by ENRIECO (Environmental Health Risks in
   European Birth Cohorts), a project conducted within the European Union's
   7th Framework Programme (Theme 6, Environment (Including Climate
   Change)) {[}Grant agreement number: 226285].}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Antignac JP, 2008, MOL NUTR FOOD RES, V52, P258, DOI 10.1002/mnfr.200700077.
   Baird DD, 2010, J EXPO SCI ENV EPID, V20, P169, DOI 10.1038/jes.2009.17.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P1083, DOI 10.1289/ehp.7617.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Benson H A, 2000, Am J Clin Dermatol, V1, P217, DOI 10.2165/00128071-200001040-00003.
   Braun JM, 2011, PEDIATRICS, V128, P873, DOI 10.1542/peds.2011-1335.
   Brouwers MM, 2009, OCCUP ENVIRON MED, V66, P607, DOI 10.1136/oem.2008.042184.
   Calafat AM, 2008, INT J ANDROL, V31, P139, DOI 10.1111/j.1365-2605.2007.00826.x.
   Carrizo D, 2007, ENVIRON SCI TECHNOL, V41, P4907, DOI 10.1021/es070217u.
   Carwile JL, 2011, ENVIRON RES, V111, P825, DOI 10.1016/j.envres.2011.05.014.
   Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012.
   CDC-Centers for Disease Control Prevention, 2011, 4 CDCP.
   Chevrier C, 2011, ENVIRON HEALTH PERSP, V119, P1034, DOI 10.1289/ehp.1002775.
   Christensen KY, 2011, ENVIRON INT, V37, P129, DOI 10.1016/j.envint.2010.08.007.
   Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008.
   Drouillet P, 2009, PAEDIATR PERINAT EP, V23, P76, DOI 10.1111/j.1365-3016.2008.00982.x.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   EFSA, 2008, EFSA J, V653, P1.
   EFSA, 2008, EFSA J, V838, P1.
   EFSA, 2010, EFSA J, V8, P1789, DOI DOI 10.2903/J.EFSA.2010.1789.
   Eggesbo M, 2009, ENVIRON RES, V109, P559, DOI 10.1016/j.envres.2009.04.001.
   Ehresman DJ, 2007, ENVIRON RES, V103, P176, DOI 10.1016/j.envres.2006.06.008.
   Fei CY, 2007, ENVIRON HEALTH PERSP, V115, P1677, DOI 10.1289/ehp.10506.
   Frederiksen M, 2009, INT J HYG ENVIR HEAL, V212, P109, DOI 10.1016/j.ijheh.2008.04.005.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Fromme H, 2009, INT J HYG ENVIR HEAL, V212, P239, DOI 10.1016/j.ijheh.2008.04.007.
   Gascon M, 2011, ENVIRON INT, V37, P605, DOI 10.1016/j.envint.2010.12.005.
   Goen T, 2011, INT J HYG ENVIR HEAL, V215, P36, DOI 10.1016/j.ijheh.2011.07.011.
   Golding J, 2001, PAEDIATR PERINAT EP, V15, P74.
   Gomara B, 2007, ANAL CHIM ACTA, V597, P121, DOI 10.1016/j.aca.2007.06.037.
   Govarts E, 2012, ENVIRON HEALTH PERSP, V120, P162, DOI 10.1289/ehp.1103767.
   Grandjean P, 1997, NEUROTOXICOL TERATOL, V19, P417, DOI 10.1016/S0892-0362(97)00097-4.
   GRANDJEAN P, 1992, ARCH ENVIRON HEALTH, V47, P185.
   Grandjean P, 2008, BASIC CLIN PHARMACOL, V102, P73, DOI 10.1111/j.1742-7843.2007.00114.x.
   Gump BB, 2011, ENVIRON SCI TECHNOL, V45, P8151, DOI 10.1021/es103712g.
   Gutzkow KB, 2012, INT J HYG ENVIR HEAL, V215, P216, DOI 10.1016/j.ijheh.2011.08.011.
   Guxens M, 2011, INT J EPIDEMIOL.
   Hale RC, 2002, CHEMOSPHERE, V46, P729, DOI 10.1016/S0045-6535(01)00237-5.
   Hooper K, 2000, ENVIRON HEALTH PERSP, V108, P387, DOI 10.2307/3454377.
   Jaddoe VWV, 2008, EUR J EPIDEMIOL, V23, P801, DOI 10.1007/s10654-008-9309-4.
   Jedrychowski Wiesław, 2003, Int J Occup Med Environ Health, V16, P21.
   Jimenez-Diaz I, 2011, TALANTA, V84, P702, DOI 10.1016/j.talanta.2011.01.075.
   Jimenez-Diaz I, 2010, J CHROMATOGR B, V878, P3363, DOI 10.1016/j.jchromb.2010.10.021.
   Joas R, 2012, INT J HYG ENVIR HEAL, V215, P172, DOI 10.1016/j.ijheh.2011.08.010.
   Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2.
   Karrman A, 2007, ENVIRON HEALTH PERSP, V115, P226, DOI 10.1289/ehp.9491.
   Karrman A, 2010, ENVIRON SCI POLLUT R, V17, P750, DOI 10.1007/s11356-009-0178-5.
   Karvonen AM, 2009, PEDIATRICS, V124, pE329, DOI 10.1542/peds.2008-1590.
   Kasper-Sonnenberg M, 2012, J TOXICOL ENV HEAL A, V75, P429, DOI 10.1080/15287394.2012.674907.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2011, ENVIRON SCI TECHNOL, V45, P8037, DOI 10.1021/es1043613.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2001, J CHROMATOGR B, V759, P43, DOI 10.1016/S0378-4347(01)00209-2.
   Kuklenyik Z, 2004, ENVIRON SCI TECHNOL, V38, P3698, DOI 10.1021/es040332u.
   Kuklenyik Z, 2005, ANAL CHEM, V77, P6085, DOI 10.1021/ac050671l.
   Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170.
   Messer A, 2010, PHYSIOL BEHAV, V100, P245, DOI 10.1016/j.physbeh.2010.01.011.
   Mortamais M., 2012, ENV HLTH, V11.
   Mosch C, 2010, J CHROMATOGR B, V878, P2652, DOI 10.1016/j.jchromb.2010.01.015.
   Needham LL, 2011, ENVIRON SCI TECHNOL, V45, P1121, DOI 10.1021/es1019614.
   Nepomnaschy PA, 2009, ENVIRON RES, V109, P734, DOI 10.1016/j.envres.2009.04.004.
   Olsen GW, 2007, ENVIRON HEALTH PERSP, V115, P1298, DOI 10.1289/ehp.10009.
   Olsen J, 2001, SCAND J PUBLIC HEALT, V29, P300, DOI 10.1177/14034948010290040201.
   Philippat C, 2012, ENVIRON HEALTH PERSP, V120, P464, DOI 10.1289/ehp.1103634.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Richiardi L, 2007, EUR J EPIDEMIOL, V22, P831, DOI 10.1007/s10654-007-9194-2.
   Robins Jared C, 2011, Front Biosci (Elite Ed), V3, P690, DOI 10.2741/e279.
   Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025.
   Samandar E, 2009, ENVIRON RES, V109, P641, DOI 10.1016/j.envres.2009.02.004.
   Schoeters G., 2011, BIOMARKETS HUMAN BIO.
   Segev O, 2009, INT J ENV RES PUB HE, V6, P478, DOI 10.3390/ijerph6020478.
   Sekizawa J, 2008, J TOXICOL SCI, V33, P389, DOI 10.2131/jts.33.389.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Smolders R, 2010, INT J HYG ENVIR HEAL, V213, P395, DOI 10.1016/j.ijheh.2010.05.006.
   Sonneborn D, 2008, PAEDIATR PERINAT EP, V22, P202, DOI 10.1111/j.1365-3016.2008.00929.x.
   Tagliaferri S, 2010, TOXICOL IN VITRO, V24, P116, DOI 10.1016/j.tiv.2009.08.020.
   Thomsen C, 2010, ENVIRON INT, V36, P68, DOI 10.1016/j.envint.2009.10.002.
   Thomsen C, 2007, J CHROMATOGR B, V846, P252, DOI 10.1016/j.jchromb.2006.09.011.
   Toft Gunnar, 2005, Environ Health, V4, P26, DOI 10.1186/1476-069X-4-26.
   Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716.
   Vandentorren S, 2011, ENVIRON RES, V111, P761, DOI 10.1016/j.envres.2011.05.018.
   Vandentorren S, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-58.
   Vardavas CI, 2010, J EPIDEMIOL, V20, P355, DOI 10.2188/jea.JE20090156.
   Vela-Soria F, 2011, TALANTA, V85, P1848, DOI 10.1016/j.talanta.2011.07.030.
   Volkel W, 2008, TOXICOL LETT, V179, P155, DOI 10.1016/j.toxlet.2008.05.002.
   Völkel Wolfgang, 2002, Chem Res Toxicol, V15, P1281, DOI 10.1021/tx025548t.
   Volkel W, 2011, ENVIRON RES, V111, P143, DOI 10.1016/j.envres.2010.10.001.
   vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005.
   Vrijheid M, 2012, ENVIRON HEALTH PERSP, V120, P29, DOI 10.1289/ehp.1103823.
   Wang IJ, 2011, ENVIRON RES, V111, P785, DOI 10.1016/j.envres.2011.04.006.
   Whitworth KW, 2012, EPIDEMIOLOGY, V23, P257, DOI 10.1097/EDE.0b013e31823b5031.
   Wilhelm M, 2008, MUTAT RES-REV MUTAT, V659, P83, DOI 10.1016/j.mrrev.2007.11.002.
   Wilhelm M., 2012, HDB ENV CHEM, V17, P155.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Ye XB, 2009, INT J HYG ENVIR HEAL, V212, P481, DOI 10.1016/j.ijheh.2009.03.004.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.
   Ye XY, 2011, ENVIRON HEALTH PERSP, V119, P983, DOI 10.1289/ehp.1002701.
   Ye XY, 2007, J EXPO SCI ENV EPID, V17, P567, DOI 10.1038/sj.jes.7500566.
   Ye XY, 2005, ANAL BIOANAL CHEM, V383, P638, DOI 10.1007/s00216-005-0019-4.
   Ye XY, 2005, ANAL CHEM, V77, P5407, DOI 10.1021/ac050390d.
   Zuurbier Moniek, 2007, International Journal of Occupational Medicine and Environmental Health, V20, P291, DOI 10.2478/v10001-007-0022-4.
   Kasper-Sonnenberg M, 2012, INT J HYG ENVIR HEAL, V215, P373, DOI 10.1016/j.ijheh.2011.09.004.}},
Number-of-Cited-References = {{107}},
Times-Cited = {{0}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{129WC}},
Wos-Id = {{ISI:000317873700002}},
}

@article{ ISI:000317873700007,
Author = {Zeman, F. A. and Boudet, C. and Tack, K. and Barneaud, A. Floch and
   Brochot, C. and Pery, A. R. R. and Oleko, A. and Vandentorren, S.},
Title = {{Exposure assessment of phthalates in French pregnant women: Results of
   the ELFE pilot study}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2013}},
Volume = {{216}},
Number = {{3}},
Pages = {{271-279}},
Month = {{JUN}},
Abstract = {{The ubiquitous use of phthalate esters in plastics, building material,
   medical devices, personal care products and food packaging materials
   results in a widespread exposure of general population. This study
   reports measurement of urinary concentration of phthalate metabolites in
   France and provides a first assessment of the exposure of French
   pregnant women to this chemical class. For the majority of the phthalate
   metabolites, concentrations measured in urine were similar to those
   reported in previous studies except for two phthalates that were
   characterized by high concentrations of metabolites if compared to
   previous European and American studies: DiNP (Di-iso-nonylphthalate) and
   DEHP (Di(2-ethylhexyl)phthalate). In a second part of the study, a
   pharmacokinetic model was used in order to gain understanding on
   exposure to DEHP. A high concentration of the primary metabolite of
   DEHP, MEHP (Mono(2-ethylhexyl)phthalate), was thus identified probably
   because of a very recent exposure to perfusion materials at the
   hospital. Pharmacokinetics modelling highlighted that gathering data on
   the time gap between exposure and biomonitoring is an essential
   information requirement for reconstructing the dose of non persistent
   pollutants. Information about exposure pathway is also crucial for
   conducting effective reverse dosimetry. (c) 2013 Elsevier GmbH. All
   rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zeman, FA (Reprint Author), INERIS, Unite Modele Ecotoxicol \& Toxicol METO, BP2,Parc Alata, F-60550 Verneuil En Halatte, France.
   Zeman, F. A.; Boudet, C.; Tack, K.; Barneaud, A. Floch; Brochot, C.; Pery, A. R. R., Natl Inst Ind Environm \& Risks INERIS, Verneuil En Halatte, France.
   Oleko, A.; Vandentorren, S., Natl Inst Publ Hlth Surveillance InVS, St Maurice, France.}},
DOI = {{10.1016/j.ijheh.2012.12.005}},
ISSN = {{1438-4639}},
Keywords = {{Phthalates; DEHP; Toxicokinetics; Biomonitoring; Reverse dosimetry}},
Keywords-Plus = {{ISO-NONYLPHTHALATE DINP; DEUTERIUM-LABELED DEHP; N-BUTYL PHTHALATE;
   IN-UTERO EXPOSURE; HUMAN URINE; DI(2-ETHYLHEXYL)PHTHALATE DEHP;
   BIOMONITORING DATA; BISPHENOL-A; METABOLITES; POPULATION}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{florence.zeman@ineris.fr}},
Funding-Acknowledgement = {{French Ministry in charge of Ecology {[}190, 181]}},
Funding-Text = {{Our thanks to the ELFE team and to the midwives who participated in the
   recruitment phase and in the collection of biological samples. This
   study was supported by the French Ministry in charge of Ecology within
   the framework of program 190 and 181. We would like also to thank Enrico
   Mombelli and our English colleague Cleo Tebby for their help for English
   corrections. We are very grateful to the two anonymous reviewers for the
   helpful comments on this work.}},
Cited-References = {{Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Beaudouin R, 2010, REGUL TOXICOL PHARM, V57, P103, DOI 10.1016/j.yrtph.2010.01.005.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Bois F.Y., 1997, J STAT SOFTW, V2.
   Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   Clewell HJ, 2008, TOXICOL APPL PHARM, V231, P122, DOI 10.1016/j.taap.2008.04.021.
   CSTEE (Scientific Committee on Toxicity Ecotoxicity and the Environment), 2002, OP RES RISK ASS BIS.
   CSTEE (Scientific Committee on Toxicity Ecotoxicity and the Environment), 1998, 6 CSTEE PLEN M BRUSS.
   EFSA, 2005, EFSA J, V243, P1.
   EFSA (European Food Safety Authority), 2005, EFSA J, V241, P1.
   EFSA (European Food Safety Authority), 2005, EFSA J, V242, P1.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   European Chemicals Bureau European Chemicals Bureau (ECB), 2004, R0420402ENVHH46 ECB.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Helm D, 2007, SCI TOTAL ENVIRON, V388, P389, DOI 10.1016/j.scitotenv.2007.07.009.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   HEYMSFIELD SB, 1983, AM J CLIN NUTR, V37, P478.
   Houlihan J., 2002, NOT TOO PRETTY PHTHA.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013.
   Lorber M, 2010, J EXPO SCI ENV EPID, V20, P38, DOI 10.1038/jes.2008.74.
   Lorber Matthew, 2011, J Expo Sci Environ Epidemiol, V21, P576, DOI 10.1038/jes.2010.43.
   Mose T, 2007, REPROD TOXICOL, V23, P83, DOI 10.1016/j.reprotox.2006.08.006.
   NRC (National Research Council), 2006, HUM BIOM ENV CHEM.
   Peck J.D., 2009, J EXPO SCI ENV EPID, V20, P90.
   PERRONE RD, 1992, CLIN CHEM, V38, P1933.
   Philippat C., 2011, ENV HLTH PERSPECT.
   R Development Core Team, 2006, R LANG ENV STAT COMP.
   Steer PJ, 2005, HIGH RISK PREGNANCY.
   Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   US EPA, 2007, INT RISK INF SYST BU.
   US EPA, 2007, INT RISK INF SYST DI.
   Vandentorren S, 2011, ENVIRON RES, V111, P761, DOI 10.1016/j.envres.2011.05.018.
   Vandentorren S., 2009, BMC PEDIATR, V21, P9.
   Wittassek M., 2010, MOL NUTR FOOD RES, V55, P7.
   Wittassek M, 2009, INT J HYG ENVIR HEAL, V212, P492, DOI 10.1016/j.ijheh.2009.04.001.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Yan X, 2009, HUM ECOL RISK ASSESS, V15, P565, DOI 10.1080/10807030902892554.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{0}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{129WC}},
Wos-Id = {{ISI:000317873700007}},
}

@article{ ISI:000317254100001,
Author = {Hernandez-Diaz, Sonia and Su, Yung-Cheng and Mitchell, Allen A. and
   Kelley, Katherine E. and Calafat, Antonia M. and Hauser, Russ},
Title = {{Medications as a potential source of exposure to phthalates among women
   of childbearing age}},
Journal = {{REPRODUCTIVE TOXICOLOGY}},
Year = {{2013}},
Volume = {{37}},
Pages = {{1-5}},
Month = {{JUN}},
Abstract = {{Objective: To evaluate the association between the use of medications
   potentially containing phthalates and urinary concentrations of specific
   phthalate metabolites around conception.
   Methods: Women enrolled in the Environment and Reproductive Health
   project from 2006 to 2009 completed questionnaires about the use of
   medications and provided multiple urine samples before and after
   conception. We compared the mean urinary concentration of phthalate
   metabolites between users of phthalate containing medications and a
   matched unexposed control group.
   Results: One woman used Asacol (R) (mesalamine), which utilizes dibutyl
   phthalate (DBP) as a delayed release coating material, and had a mean
   urinary concentration of the main DBP metabolite 200 times higher than
   the controls (8176 mu g/L vs. 37.5 mu g/L). The three users of stool
   softeners had a higher concentration of the main diethyl phthalate (DEP)
   metabolite (8636 mu g/L vs. 714.2 mu g/L). Neither the three additional
   Prilosec (R) (omeprazole) users nor one cyclobenzaprine user had higher
   urinary concentration than controls.
   Conclusion: Selected medications may be important sources of DBP and DEP
   exposures around conception. (C) 2013 Elsevier Inc. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Su, YC (Reprint Author), Buddhist Tzu Chi Dalin Gen Hosp, Emergency Dept, 2 Minsheng Rd, Dalin Township 622, Chiayi County, Taiwan.
   Hernandez-Diaz, Sonia; Su, Yung-Cheng; Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   Su, Yung-Cheng, Buddhist Tzu Chi Dalin Gen Hosp, Emergency Dept, Dalin Township 622, Chiayi County, Taiwan.
   Mitchell, Allen A.; Kelley, Katherine E., Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth HSPH, Dept Environm Hlth Occupat \& Environm Med, Boston, MA 02115 USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth HSPH, Program Epidemiol, Boston, MA 02115 USA.
   Hauser, Russ, Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv, Boston, MA 02114 USA.}},
DOI = {{10.1016/j.reprotox.2013.01.001}},
ISSN = {{0890-6238}},
Keywords = {{Phthalate; Toxicology; Medications; Mesalamine; Male reproductive system}},
Keywords-Plus = {{N-BUTYL PHTHALATE; SEXUAL-DIFFERENTIATION; ANOGENITAL DISTANCE; MALE
   INFANTS; HUMAN URINE; MALE-RAT; METABOLITES; POPULATION}},
Research-Areas = {{Reproductive Biology; Toxicology}},
Web-of-Science-Categories  = {{Reproductive Biology; Toxicology}},
Author-Email = {{drsu119@gmail.com}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences (NIEHS) {[}ES009718,
   ES00002]; National Institute of Child Health and Human Development
   {[}RO1HD059861]; Pfizer; ASISA}},
Funding-Text = {{National Institute of Environmental Health Sciences (NIEHS) (grant
   numbers: ES009718 and ES00002) and by the National Institute of Child
   Health and Human Development (grant number RO1HD059861)The findings and
   conclusions in this report are those of the authors and do not
   necessarily represent the views of the U.S. Centers for Disease Control
   and Prevention. The Pharmacoepidemiology Program at the Harvard School
   of Public Health is supported by training grants from Pfizer and ASISA.
   The Slone Epidemiology Center receives unrelated research support from
   various pharmaceutical manufacturers, some of which may market products
   containing phthalates.}},
Cited-References = {{Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   Caudill SP, 2008, STAT MED, V27, P4094, DOI 10.1002/sim.3222.
   CDC, 2010, 4 CDCP.
   Gray JLE, 2000, TOXICOL SCI, V58, P350.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Hotchkiss AK, 2004, BIOL REPROD, V71, P1852, DOI 10.1095/biolreprod.104.031674.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch H, 2005, UMWELTMED FORSCH PRA, V10, P144.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Saillenfait AM, 1998, TOXICOL SCI, V45, P212, DOI 10.1093/toxsci/45.2.212.
   Seckin E, 2009, TOXICOL LETT, V188, P33, DOI 10.1016/j.toxlet.2009.03.002.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Silva MJ, 2007, ENVIRON SCI TECHNOL, V41, P7576, DOI 10.1021/es071142x.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Vo TTB, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-104.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{0}},
Journal-ISO = {{Reprod. Toxicol.}},
Doc-Delivery-Number = {{121OM}},
Wos-Id = {{ISI:000317254100001}},
}

@article{ ISI:000320637300025,
Author = {Chang, Yuan-Jhe and Lin, Keh-Liang and Chang, Yan-Zin},
Title = {{Determination of Di-(2-ethylhexyl)phthalate (DEHP) metabolites in human
   hair using liquid chromatography-tandem mass spectrometry}},
Journal = {{CLINICA CHIMICA ACTA}},
Year = {{2013}},
Volume = {{420}},
Number = {{SI}},
Pages = {{155-159}},
Month = {{MAY}},
Abstract = {{Background: Di-(2-ethylhexyl)phthalate (DEHP) is an endocrine disrupting
   chemical that is widely used as the major plasticizer for worldwide
   plastic products. It can cause several toxic effects to human with high
   dose exposure. In response to the need of human exposure assessment,
   different biological specimens are taken into account. Compared to
   blood, urine and other specimens, hair is unique in that it could
   determine the time period of chemical exposure after several months to
   years.
   Method: The developed method consists of solution incubation,
   liquid-liquid extraction and stable isotope dilution liquid
   chromatography-tandem mass spectrometry (LC-MS/MS) analysis.
   Results: A reliable and sensitive analytical method was developed and
   validated for the determination of 5 metabolites,
   mono-(2-ethylhexyl)phthalate (MEHP),
   mono-(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP),
   mono-(2-ethyl-5-oxy-hexyl)phthalate (MEOHP),
   mono-(2-ethyl-5-carboxypentyl)phthalate (5cx-MEPP) and
   mono-{[}2-(carboxymethyl)hexyl]phthalate (2cx-MMHP) in human hair. Ten
   authentic hair specimens were successfully determined and quantitated by
   the developed method.
   Conclusion: The developed LC-MS/MS method can successfully determine
   specific DEHP metabolites in human hair and has a great potential to
   assess the long term DEHP exposure of human. (c) 2012 Elsevier B.V. All
   rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chang, YZ (Reprint Author), Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan.
   Chang, Yuan-Jhe; Chang, Yan-Zin, Chung Shan Med Univ, Inst Med, Taichung 40201, Taiwan.
   Lin, Keh-Liang, Chung Shan Med Univ, Sch Med Lab \& Biotechnol, Taichung 40201, Taiwan.
   Chang, Yan-Zin, Chung Shan Med Univ Hosp, Dept Clin Lab, Drug Testing Ctr, Taichung 40201, Taiwan.}},
DOI = {{10.1016/j.cca.2012.10.009}},
ISSN = {{0009-8981}},
Keywords = {{Phthalate metabolites; Human hair; HPLC-MS/MS}},
Keywords-Plus = {{DEUTERIUM-LABELED DEHP; PHTHALATE METABOLITES; HUMAN URINE; QUANTITATIVE
   DETECTION; DI(2-ETHYLHEXYL)PHTHALATE DEHP; HUMAN EXPOSURE; SERUM;
   CONTAMINATION; BIOMARKERS; MONOESTERS}},
Research-Areas = {{Medical Laboratory Technology}},
Web-of-Science-Categories  = {{Medical Laboratory Technology}},
Author-Email = {{yzc@csmu.edu.tw}},
Funding-Acknowledgement = {{Food and Drug Administration, Department of Health, Executive Yuan,
   Republic of China (R.O.C.); National Science Council, Republic of China
   (R.O.C.) {[}NSC 100-2113-M-040-003]}},
Funding-Text = {{The authors thank the Food and Drug Administration, Department of
   Health, Executive Yuan, Republic of China (R.O.C.) and the National
   Science Council, Republic of China (R.O.C.) for the financial support of
   this research (NSC 100-2113-M-040-003).}},
Cited-References = {{AHRENS B, 1992, FRESEN J ANAL CHEM, V344, P559, DOI 10.1007/BF00324655.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Gaudin R, 2011, INT ARCH OCC ENV HEA, V84, P523, DOI 10.1007/s00420-010-0566-7.
   Hoppin JA, 2003, EPIDEMIOLOGY, V14, P259, DOI 10.1097/00001648-200305000-00002.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kintz P, 2007, ANAL BIOANAL CHEM, V388, P1467, DOI 10.1007/s00216-007-1209-z.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Kondo F, 2010, B ENVIRON CONTAM TOX, V85, P92, DOI 10.1007/s00128-010-0051-8.
   Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   MOELLER MR, 1993, FORENSIC SCI INT, V63, P185, DOI 10.1016/0379-0738(93)90273-D.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Pragst F, 2006, CLIN CHIM ACTA, V370, P17, DOI 10.1016/j.cca.2006.02.019.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2005, ARCH TOXICOL, V79, P647, DOI 10.1007/s00204-005-0674-4.
   SUZUKI S, 1989, J ANAL TOXICOL, V13, P176.
   Takatori S, 2004, J CHROMATOGR B, V804, P397, DOI 10.1016/j.jchromb.2004.01.056.
   Yen TH, 2011, J FORMOS MED ASSOC, V110, P671, DOI 10.1016/j.jfma.2011.09.002.
   Zhou Y, 2011, LANCET, V378, pE4, DOI 10.1016/S0140-6736(11)61700-5.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{0}},
Journal-ISO = {{Clin. Chim. Acta}},
Doc-Delivery-Number = {{167MY}},
Wos-Id = {{ISI:000320637300025}},
}

@article{ ISI:000320493500003,
Author = {Carbone, S. and Ponzo, O. J. and Gobetto, N. and Samaniego, Y. A. and
   Reynoso, R. and Scacchi, P. and Moguilevsky, J. A. and Cutrera, R.},
Title = {{Antiandrogenic effect of perinatal exposure to the endocrine disruptor
   di-(2-ethylhexyl) phthalate increases anxiety-like behavior in male rats
   during sexual maturation}},
Journal = {{HORMONES AND BEHAVIOR}},
Year = {{2013}},
Volume = {{63}},
Number = {{5}},
Pages = {{692-699}},
Month = {{MAY}},
Abstract = {{Di-2-ethylhexyl phthalate (DEHP) is the most widely used phthalate to
   convey flexibility and transparency to plastic products made of
   polyvinyl chloride. It has been recognized as endocrine disruptor and
   associated with reproductive toxic effects. We examined the effects of
   perinatal exposure to DEHP on anxiety-like behavior, using the Elevated
   Plus Maze (EPM) test, in male and female rats at different stages of
   sexual development. Anxiety-like behavior was expressed as a) frequency
   of open arm entries over the total arm entries (\% FEO); b) time spent
   in them compared with total time the animal stayed in the EPM (\% TSO)
   and c) time spent in closed arms (TSC). Because DEHP has anti-androgenic
   action we also tested control and exposed immature male rats pretreated
   with testosterone. We found sex differences in behavior induced by DEHP;
   while male rats of 45 and 60 days of age showed a significant decrease
   in FEO and TSO percentages, as well as an increase in TSC, no changes
   were observed in anxiety-like behavior in perinatal DEHP exposed females
   at these ages of sexual maturation. In 60-day-old male rats, DEHP
   exposure produced a significant decrease in serum testosterone levels.
   Testosterone replacement was able to antagonize the adverse effects of
   DEHP exposure on LH, activating the negative feed-back mechanism of this
   steroid on reproductive axis, as well as increasing FE and TSO
   percentages to similar values observed in the control group. These
   findings suggest that the anti-androgenic action of this chemical could
   be one possible mechanism underlie anxiogenic-like behavior produced by
   perinatal DEHP exposure in 60-day-old male rats. (C) 2013 Elsevier Inc.
   All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ponzo, OJ (Reprint Author), Univ Buenos Aires, Fac Med, Dept Fisiol, Paraguay 2155,7 P C1121ABG, RA-1425 Buenos Aires, DF, Argentina.
   Ponzo, O. J.; Gobetto, N.; Samaniego, Y. A.; Reynoso, R.; Cutrera, R., Univ Buenos Aires, Fac Med, Dept Fisiol, RA-1425 Buenos Aires, DF, Argentina.
   Carbone, S.; Scacchi, P.; Cutrera, R., Consejo Nacl Invest Cient \& Tecn, RA-1033 Buenos Aires, DF, Argentina.
   Carbone, S.; Moguilevsky, J. A., Univ Favaloro, Fac Postgrad, Buenos Aires, DF, Argentina.}},
DOI = {{10.1016/j.yhbeh.2013.01.006}},
ISSN = {{0018-506X}},
Keywords = {{Phthalate; Testosterone; LH; Male rats; Antiandrogenic effect; Anxiety;
   Behavior; Elevated Plus Maze}},
Keywords-Plus = {{ELEVATED PLUS-MAZE; IN-UTERO EXPOSURE; LACTATIONAL EXPOSURE;
   BIS(2-ETHYLHEXYL) PHTHALATE; OFFSPRING RATS; ANTI-ANXIETY; FEMALE RATS;
   5-ALPHA-REDUCED METABOLITES; NEUROBEHAVIORAL TOXICITY; DIETHYLHEXYL
   PHTHALATE}},
Research-Areas = {{Behavioral Sciences; Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Behavioral Sciences; Endocrinology \& Metabolism}},
Author-Email = {{oponzo@fmed.uba.ar}},
Funding-Acknowledgement = {{Universidad Buenos Aires {[}UBACYT 20020090200080]}},
Funding-Text = {{This work was supported by Grants from the Universidad Buenos Aires
   (UBACYT 20020090200080).}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Albro P.W., 1987, REV BIOCHEM TOXICOL, V8, P73.
   Andrade AJM, 2006, TOXICOLOGY, V228, P85, DOI 10.1016/j.tox.2006.08.020.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   Barkus C, 2010, EUR J PHARMACOL, V626, P49, DOI 10.1016/j.ejphar.2009.10.014.
   Bing O, 1998, EUR NEUROPSYCHOPHARM, V8, P321, DOI 10.1016/S0924-977X(97)00095-3.
   BITRAN D, 1993, HORM BEHAV, V27, P568, DOI 10.1006/hbeh.1993.1041.
   Borch J, 2005, REPROD TOXICOL, V19, P517, DOI 10.1016/j.reprotox.2004.11.004.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   Carbone S, 2012, NEUROTOXICOLOGY, V33, P78, DOI 10.1016/j.neuro.2011.11.009.
   Carbone S, 2010, NEUROTOXICOLOGY, V31, P747, DOI 10.1016/j.neuro.2010.06.006.
   Clement Y, 2002, BRAIN RES BULL, V57, P57, DOI 10.1016/S0361-9230(01)00637-2.
   Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649.
   Czerniczyniec A, 2011, FREE RADICAL BIO MED, V51, P1428, DOI 10.1016/j.freeradbiomed.2011.06.034.
   Dalsenter PR, 2006, HUM EXP TOXICOL, V25, P297, DOI 10.1191/0960327105ht624oa.
   David RM, 2000, TOXICOL SCI, V55, P433, DOI 10.1093/toxsci/55.2.433.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Debatin T, 2006, REV BRAS PSIQUIATR, V28, P18, DOI 10.1590/S1516-44462006000100005.
   Dickerson SM, 2011, ENDOCRINOLOGY, V152, P581, DOI 10.1210/en.2010-1103.
   DOHLER KD, 1975, ENDOCRINOLOGY, V97, P898.
   Edinger KL, 2004, BEHAV NEUROSCI, V118, P1352, DOI 10.1037/0735-7044.118.6.1352.
   Edinger KL, 2005, PSYCHONEUROENDOCRINO, V30, P418, DOI 10.1016/j.psyneuen.2004.11.001.
   Elliott BM, 2004, PHARMACOL BIOCHEM BE, V77, P21, DOI 10.1016/j.pbb.2003.09.016.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Estanislau C, 2006, INT J DEV NEUROSCI, V24, P255, DOI 10.1016/j.ijdevneu.2006.03.001.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Frye Cheryl A., 2001, Cognitive Affective and Behavioral Neuroscience, V1, P371, DOI 10.3758/CABN.1.4.371.
   Frye CA, 2004, PHARMACOL BIOCHEM BE, V78, P473, DOI 10.1016/j.pbb.2004.04.019.
   Gartner S, 2009, J AGR FOOD CHEM, V57, P10675, DOI 10.1021/jf902683m.
   Grande SW, 2007, TOXICOLOGY, V229, P114, DOI 10.1016/j.tox.2006.10.005.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009.
   IMHOF JT, 1993, BEHAV BRAIN RES, V56, P177, DOI 10.1016/0166-4328(93)90036-P.
   JOHNSTON AL, 1991, PHYSIOL BEHAV, V49, P245, DOI 10.1016/0031-9384(91)90039-Q.
   Jones BA, 2012, HORM BEHAV, V61, P605, DOI 10.1016/j.yhbeh.2012.02.011.
   JUSTO SN, 1989, NEUROENDOCRINOLOGY, V50, P382, DOI 10.1159/000125252.
   Kambia N., 2008, J ENZYM INHIB MED CH, V5, P611.
   Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034.
   Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Latini G, 2006, CURR MED CHEM, V13, P2527, DOI 10.2174/092986706778201666.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   Li YF, 2009, J APPL TOXICOL, V29, P603, DOI 10.1002/jat.1447.
   Liu T.L, 2013, J ATTEN DIS IN PRESS, DOI DOI 10.1177/1087054712439936.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Lynn D.A., 2009, ONTOGENY EXPLORATORY, DOI DOI 10.1002/CLEV.20386.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Marcondes FK, 2001, PHYSIOL BEHAV, V74, P435, DOI 10.1016/S0031-9384(01)00593-5.
   Martinez JC, 2002, BEHAV PROCESS, V60, P15, DOI 10.1016/S0376-6357(02)00102-X.
   Mccarthy MM, 2008, PHYSIOL REV, V88, P91, DOI 10.1152/physrev.00010.2007.
   MOGUILEVSKY JA, 1995, FRONT ENDOCRINOL, V10, P199.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   NISWENDE.GD, 1968, P SOC EXP BIOL MED, V128, P807.
   NTP-CERHR, 2006, NIH PUBL.
   Osborne DM, 2009, AGE, V31, P191, DOI 10.1007/s11357-009-9114-3.
   Pallares ME, 2007, PHYSIOL BEHAV, V92, P951, DOI 10.1016/j.physbeh.2007.06.021.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Patisaul HB, 2006, NEUROTOXICOL TERATOL, V28, P111, DOI 10.1016/j.ntt.2005.11.004.
   Patisaul HB, 2008, BRAIN RES REV, V57, P352, DOI 10.1016/j.brainresrev.2007.06.008.
   Pickard L, 2000, J NEUROSCI, V20, P7922.
   Rojas-Ortiz YA, 2006, HORM BEHAV, V49, P123, DOI 10.1016/j.yhbeh.2005.05.014.
   Roohbakhsh A, 2011, IRAN J BASIC MED SCI, V14, P376.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Tanaka T, 2002, FOOD CHEM TOXICOL, V40, P1499, DOI 10.1016/S0278-6915(02)00073-X.
   Tanaka T, 2005, FOOD CHEM TOXICOL, V43, P581, DOI 10.1016/j.fct.2005.01.001.
   Taylor TN, 2009, J NEUROSCI, V29, P8103, DOI 10.1523/JNEUROSCI.1495-09.2009.
   Tian YH, 2010, SYNAPSE, V64, P432, DOI 10.1002/syn.20746.
   Tirelli E, 2003, NEUROSCI BIOBEHAV R, V27, P163, DOI 10.1016/S0149-7634(03)00018-6.
   Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050.
   Walfi AA., 2007, NAT PROTOC, V2, P323.
   Weinstock M, 2001, PROG NEUROBIOL, V65, P427, DOI 10.1016/S0301-0082(01)00018-1.
   Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705.
   Xiang XJ, 2011, BEHAV BRAIN RES, V222, P326, DOI 10.1016/j.bbr.2011.03.068.
   Xu XH, 2012, HORM BEHAV, V62, P480, DOI 10.1016/j.yhbeh.2012.08.005.}},
Number-of-Cited-References = {{80}},
Times-Cited = {{0}},
Journal-ISO = {{Horm. Behav.}},
Doc-Delivery-Number = {{165OP}},
Wos-Id = {{ISI:000320493500003}},
}

@article{ ISI:000317643900043,
Author = {Wang, He-xing and Wang, Bin and Zhou, Ying and Jiang, Qing-wu},
Title = {{Rapid and sensitive analysis of phthalate metabolites, bisphenol A, and
   endogenous steroid hormones in human urine by mixed-mode solid-phase
   extraction, dansylation, and ultra-performance liquid chromatography
   coupled with triple quadrupole mass spectrometry}},
Journal = {{ANALYTICAL AND BIOANALYTICAL CHEMISTRY}},
Year = {{2013}},
Volume = {{405}},
Number = {{12}},
Pages = {{4313-4319}},
Month = {{MAY}},
Abstract = {{Steroid hormone levels in human urine are convenient and sensitive
   indicators for the impact of phthalates and/or bisphenol A (BPA)
   exposure on the human steroid hormone endocrine system. In this study, a
   rapid and sensitive method for determination of 14 phthalate
   metabolites, BPA, and ten endogenous steroid hormones in urine was
   developed and validated on the basis of ultra-performance liquid
   chromatography coupled with electrospray ionization triple quadrupole
   mass spectrometry. The optimized mixed-mode solid phase-extraction
   separated the weakly acidic or neutral BPA and steroid hormones from
   acidic phthalate metabolites in urine: the former were determined in
   positive ion mode with a methanol/water mobile phase containing 10 mM
   ammonium formate; the latter were determined in negative ion mode with a
   acetonitrile/water mobile phase containing 0.1 \% acetic acid, which
   significantly alleviated matrix effects for the analysis of BPA and
   steroid hormones. Dansylation of estrogens and BPA realized simultaneous
   and sensitive analysis of the endogenous steroid hormones and BPA in a
   single chromatographic run. The limits of detection were less than 0.84
   ng/mL for phthalate metabolites and less than 0.22 ng/mL for endogenous
   steroid hormones and BPA. This proposed method had satisfactory
   precision and accuracy, and was successfully applied to the analyses of
   human urine samples. This method could be valuable when investigating
   the associations among endocrine-disrupting chemicals, endogenous
   steroid hormones, and relevant adverse outcomes in epidemiological
   studies.}},
Publisher = {{SPRINGER HEIDELBERG}},
Address = {{TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zhou, Y (Reprint Author), Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Room 125,Bldg 8,130,Dongan Rd, Shanghai 200032, Peoples R China.
   Wang, He-xing; Wang, Bin; Zhou, Ying; Jiang, Qing-wu, Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200032, Peoples R China.}},
DOI = {{10.1007/s00216-013-6779-3}},
ISSN = {{1618-2642}},
Keywords = {{Phthalate metabolites; Bisphenol A; Endogenous steroid hormones;
   Mixed-mode solid-phase extraction; Liquid chromatography-tandem mass
   spectrometry; Urine}},
Keywords-Plus = {{ENDOCRINE-DISRUPTING CHEMICALS; US POPULATION; EXPOSURE; HEALTH; DRUGS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{yingchou@fudan.edu.cn}},
Funding-Acknowledgement = {{Key Laboratory of Public Health Safety of the Ministry of Education,
   School of Public Health, Fudan University, China; Young Foundation of
   Fudan University, China {[}EYF 201023]; Project 985 Innovation Platform
   for Superiority Subject, of the Ministry of Education, China}},
Funding-Text = {{This project was supported by the Key Laboratory of Public Health Safety
   of the Ministry of Education, School of Public Health, Fudan University,
   China. It was also funded by the Young Foundation of Fudan University,
   China (EYF 201023) and the Project 985 Innovation Platform for
   Superiority Subject, of the Ministry of Education, China.}},
Cited-References = {{Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Bushnik Tracey, 2010, Health Rep, V21, P7.
   Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753.
   Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200.
   Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012.
   Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Fedejko Barbara, 2011, Postepy Biochem, V57, P49.
   Gonzalez-Marino I, 2012, ANAL CHEM, V84, P1708, DOI 10.1021/ac202989e.
   Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m.
   Ho ENM, 2006, J CHROMATOGR A, V1120, P38, DOI 10.1016/j.chroma.2006.03.089.
   Hoffmann P, 2010, STEROIDS, V75, P1067, DOI 10.1016/j.steroids.2010.06.014.
   Lakind Judy S, 2011, J Expo Sci Environ Epidemiol, V21, P272, DOI 10.1038/jes.2010.9.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Palermo M, 1996, STEROIDS, V61, P583, DOI 10.1016/S0039-128X(96)00118-9.
   Ritter JK, 2000, CHEM-BIOL INTERACT, V129, P171, DOI 10.1016/S0009-2797(00)00198-8.
   Rubin BS, 2011, J STEROID BIOCHEM, V127, P27, DOI 10.1016/j.jsbmb.2011.05.002.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Wang HX, 2013, FOOD ADDIT CONTAM A, V30, P166, DOI 10.1080/19440049.2012.720036.
   Xu X, 2005, ANAL CHEM, V77, P6646, DOI 10.1021/ac050697c.
   {[}Anonymous], OFF J EUR COMMUNIT L, V221, P8.}},
Number-of-Cited-References = {{23}},
Times-Cited = {{0}},
Journal-ISO = {{Anal. Bioanal. Chem.}},
Doc-Delivery-Number = {{126TK}},
Wos-Id = {{ISI:000317643900043}},
}

@article{ ISI:000318008400184,
Author = {Beko, Gabriel and Weschler, Charles J. and Langer, Sarka and Callesen,
   Michael and Toftum, Jorn and Clausen, Geo},
Title = {{Children's Phthalate Intakes and Resultant Cumulative Exposures
   Estimated from Urine Compared with Estimates from Dust Ingestion,
   Inhalation and Dermal Absorption in Their Homes and Daycare Centers}},
Journal = {{PLOS ONE}},
Year = {{2013}},
Volume = {{8}},
Number = {{4}},
Month = {{APR 23}},
Abstract = {{Total daily intakes of diethyl phthalate (DEP), di(n-butyl) phthalate
   (DnBP), di(isobutyl) phthalate (DiBP), butyl benzyl phthalate (BBzP) and
   di(2-ethylhexyl) phthalate (DEHP) were calculated from phthalate
   metabolite levels measured in the urine of 431 Danish children between 3
   and 6 years of age. For each child the intake attributable to exposures
   in the indoor environment via dust ingestion, inhalation and dermal
   absorption were estimated from the phthalate levels in the dust
   collected from the child's home and daycare center. Based on the urine
   samples, DEHP had the highest total daily intake (median: 4.42 mu
   g/d/kg-bw) and BBzP the lowest (median: 0.49 mu g/d/kg-bw). For DEP,
   DnBP and DiBP, exposures to air and dust in the indoor environment
   accounted for approximately 100\%, 15\% and 50\% of the total intake,
   respectively, with dermal absorption from the gas-phase being the major
   exposure pathway. More than 90\% of the total intake of BBzP and DEHP
   came from sources other than indoor air and dust. Daily intake of DnBP
   and DiBP from all exposure pathways, based on levels of metabolites in
   urine samples, exceeded the Tolerable Daily Intake (TDI) for 22 and 23
   children, respectively. Indoor exposures resulted in an average daily
   DiBP intake that exceeded the TDI for 14 children. Using the concept of
   relative cumulative Tolerable Daily Intake (TDIcum), which is applicable
   for phthalates that have established TDIs based on the same health
   endpoint, we examined the cumulative total exposure to DnBP, DiBP and
   DEHP from all pathways; it exceeded the tolerable levels for 30\% of the
   children. From the three indoor pathways alone, several children had a
   cumulative intake that exceeded TDIcum. Exposures to phthalates present
   in the air and dust indoors meaningfully contribute to a child's total
   intake of certain phthalates. Such exposures, by themselves, may lead to
   intakes exceeding current limit values.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Beko, G (Reprint Author), Tech Univ Denmark, Dept Civil Engn, Int Ctr Indoor Environm \& Energy, DK-2800 Lyngby, Denmark.
   Beko, Gabriel; Weschler, Charles J.; Toftum, Jorn; Clausen, Geo, Tech Univ Denmark, Dept Civil Engn, Int Ctr Indoor Environm \& Energy, DK-2800 Lyngby, Denmark.
   Weschler, Charles J., Univ Med \& Dent New Jersey, Environm \& Occupat Hlth Sci Inst, Piscataway, NJ 08854 USA.
   Weschler, Charles J., Rutgers State Univ, Piscataway, NJ USA.
   Langer, Sarka, Swedish Environm Res Inst, S-40258 Gothenburg, Sweden.
   Callesen, Michael, Odense Univ Hosp, Hans Christian Andersen Childrens Hosp, Pediat Res Unit, DK-5000 Odense, Denmark.}},
DOI = {{10.1371/journal.pone.0062442}},
Article-Number = {{e62442}},
ISSN = {{1932-6203}},
Keywords-Plus = {{SEMIVOLATILE ORGANIC-COMPOUNDS; N-BUTYL PHTHALATE; BODY TOPICAL
   APPLICATION; DUPLICATE DIET SAMPLES; DEUTERIUM-LABELED DEHP;
   SPRAGUE-DAWLEY RAT; RISK-ASSESSMENT; DI(2-ETHYLHEXYL) PHTHALATE;
   INTERNAL EXPOSURE; REPRODUCTIVE DEVELOPMENT}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{gab@byg.dtu.dk}},
ResearcherID-Numbers = {{Beko, Gabriel/C-8684-2009}},
Funding-Acknowledgement = {{Danish VILLUM FOUNDATION {[}VKR020814]}},
Funding-Text = {{The Danish VILLUM FOUNDATION generously supported the study (Grant \#
   VKR020814). The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.}},
Cited-References = {{Abraham K, 2005, ARCH TOXICOL, V79, P63, DOI 10.1007/s00204-004-0599-3.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Aylward LL, 2011, J EXPO SCI ENV EPID, V21, P615, DOI 10.1038/jes.2011.28.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x.
   Bosgra S, 2005, REGUL TOXICOL PHARM, V43, P104, DOI 10.1016/j.yrtph.2005.06.008.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Buckley JP, 2012, J EXPO SCI ENV EPID, V22, P468, DOI 10.1038/jes.2012.33.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Carlstedt F, 2013, INDOOR AIR, V23, P32, DOI 10.1111/j.1600-0668.2012.00788.x.
   CDC, 2012, 4 CDCP.
   CDC, 2005, 3 CDCP.
   CHAN PKL, 1994, ENVIRON CARCIN ECO R, V12, P257.
   Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870.
   Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004.
   Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376.
   Christiansen S, 2009, ENVIRON HEALTH PERSP, V117, P1839, DOI 10.1289/ehp.0900689.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   Clark KE, 2011, HUM ECOL RISK ASSESS, V17, P923, DOI 10.1080/10807039.2011.588157.
   Clausen G, 2012, INDOOR AIR, V22, P467, DOI 10.1111/j.1600-0668.2012.00777.x.
   Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712.
   COT, 2011, COT STAT DIET EXP PH, P1.
   Deisinger PJ, 1998, FOOD CHEM TOXICOL, V36, P521, DOI 10.1016/S0278-6915(98)00015-5.
   Du Bois D, 1916, ARCH INTERN MED, V17, P863.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   EFSA, 2005, EFSA J, V3, P1.
   EFSA, 2005, EFSA J, V3, P241.
   EFSA, 2005, EFSA J, V3, P243.
   EFSA, 2005, EFSA J, V3, P242.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002.
   Franco A, 2007, ENVIRON INT, V33, P283, DOI 10.1016/j.envint.2006.10.001.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Frederiksen H, 2012, INT J ANDROL, V35, P216, DOI 10.1111/j.1365-2605.2012.01260.x.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Fromme H, 2005, INDOOR AIR, V15, P335, DOI 10.1111/j.1600-0668.2005.00377.x.
   Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1046/j.1600-0668.2003.00223.x.
   Gevao B, 2013, INDOOR AIR, V23, P126, DOI 10.1111/ina.12001.
   Goeen T, 2011, INT J HYG ENVIR HEAL, V215, P36.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005.
   Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3788, DOI 10.1021/es2002106.
   Guo Y, 2012, J AGR FOOD CHEM, V60, P6913, DOI 10.1021/jf3021128.
   HAGEDORNLEWEKE U, 1995, PHARMACEUT RES, V12, P1354.
   Hannas BR, 2011, TOXICOL SCI, V123, P206, DOI 10.1093/toxsci/kfr146.
   Hannas BR, 2011, TOXICOL SCI, V120, P184, DOI 10.1093/toxsci/kfq386.
   Hatch EE, 2010, INT J ANDROL, V33, P324, DOI 10.1111/j.1365-2605.2009.01035.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   HAWLEY JK, 1985, RISK ANAL, V5, P289, DOI 10.1111/j.1539-6924.1985.tb00185.x.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009.
   Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y.
   Jaakkola JJK, 2008, ENVIRON HEALTH PERSP, V116, P845, DOI 10.1289/ehp.10846.
   Jakubowski M, 2009, ENVIRON TOXICOL PHAR, V28, P311, DOI 10.1016/j.etap.2009.05.011.
   Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2.
   Just AC, 2012, ENVIRON HEALTH PERSP, V120, P1475, DOI 10.1289/ehp.1104544.
   Kanazawa A, 2010, INDOOR AIR, V20, P72, DOI 10.1111/j.1600-0668.2009.00629.x.
   Kang Y, 2012, ENVIRON SCI TECHNOL, V46, P8422, DOI 10.1021/es300379v.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178.
   Kimber I, 2010, TOXICOLOGY, V271, P73, DOI 10.1016/j.tox.2010.03.020.
   Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009.
   Koch HM, 2012, ARCH TOXICOL, V86, P1829, DOI 10.1007/s00204-012-0908-1.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2013, INT J HYGIE IN PRESS.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Kodavanti PRS, 2010, TOXICOL SCI, V116, P297, DOI 10.1093/toxsci/kfq105.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Koniecki D, 2011, ENVIRON RES, V111, P329, DOI 10.1016/j.envres.2011.01.013.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Kortenkamp A, 2010, INT J ANDROL, V33, P463, DOI 10.1111/j.1365-2605.2009.01047.x.
   Langer S, 2013, INT J HYGIENE UNPUB.
   Langer S, 2010, ATMOS ENVIRON, V44, P2294, DOI 10.1016/j.atmosenv.2010.04.001.
   Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079.
   Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073.
   Little JC, 2012, ENVIRON SCI TECHNOL, V46, P11171, DOI 10.1021/es301088a.
   Martino-Andrade AJ, 2010, MOL NUTR FOOD RES, V54, P148, DOI 10.1002/mnfr.200800312.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268.
   Mendiola J, 2011, INT J ANDROL, V34, P369, DOI 10.1111/j.1365-2605.2010.01095.x.
   Mielke H, 2011, TOXICOL LETT, V204, P190, DOI 10.1016/j.toxlet.2011.04.032.
   MILLER LA, 1989, J UROLOGY, V141, P918.
   Morgan MK, 2004, PILOT STUDY CHILDREN.
   Needham LL, 2007, INT J HYG ENVIR HEAL, V210, P229, DOI 10.1016/j.ijheh.2006.11.002.
   Nomiyama T, 2000, INT ARCH OCC ENV HEA, V73, P121, DOI 10.1007/s004200050017.
   Nomiyama T, 2001, INT ARCH OCC ENV HEA, V74, P224, DOI 10.1007/s004200000207.
   NRC (National Research Council), 2008, PHTHAL CUM RISK ASS.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Rider CV, 2010, INT J ANDROL, V33, P443, DOI 10.1111/j.1365-2605.2009.01049.x.
   Rider CV, 2009, TOXICOL PATHOL, V37, P100, DOI 10.1177/0192623308329478.
   Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x.
   Romero-Franco M, 2011, ENVIRON INT, V37, P867, DOI 10.1016/j.envint.2011.02.014.
   Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001.
   Schossler P, 2011, SCI TOTAL ENVIRON, V409, P4031, DOI 10.1016/j.scitotenv.2011.06.012.
   Seckin E, 2009, TOXICOL LETT, V188, P33, DOI 10.1016/j.toxlet.2009.03.002.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Soeborg T, 2012, INT J ANDROL, V35, P245, DOI 10.1111/j.1365-2605.2011.01240.x.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Svensson K, 2011, ENVIRON RES, V111, P792, DOI 10.1016/j.envres.2011.05.015.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   SZABO L, 1995, BRIT J UROL, V76, P16, DOI 10.1111/j.1464-410X.1995.tb07824.x.
   Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Testa C, 2012, ASN NEURO, V4, P223, DOI 10.1042/AN20120015.
   Teuschler LK, 1995, TOXICOLOGY, V105, P137, DOI 10.1016/0300-483X(95)03207-V.
   Toft G, 2012, ENVIRON HEALTH PERSP, V120, P458, DOI 10.1289/ehp.1103552.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474.
   US EPA, 2009, CHILD SPEC EXP FACT.
   US EPA, 1993, 85687 US EPA CASRN.
   US EPA, 1997, 117817 US EPA CASRN.
   Weschler CJ, 2012, INDOOR AIR, V22, P356, DOI 10.1111/j.1600-0668.2012.00772.x.
   Weschler CJ, 2010, ATMOS ENVIRON, V44, P3609, DOI 10.1016/j.atmosenv.2010.06.029.
   Weschler CJ, 2008, ATMOS ENVIRON, V42, P9018, DOI 10.1016/j.atmosenv.2008.09.052.
   Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705.
   WILLIAMS DT, 1975, J AGR FOOD CHEM, V23, P854, DOI 10.1021/jf60201a047.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Xu Y, 2009, ENVIRON SCI TECHNOL, V43, P2374, DOI 10.1021/es801354f.
   Xu Y, 2010, ENVIRON HEALTH PERSP, V118, P253, DOI 10.1289/ehp.0900559.
   Ye XB, 2009, INT J HYG ENVIR HEAL, V212, P481, DOI 10.1016/j.ijheh.2009.03.004.}},
Number-of-Cited-References = {{142}},
Times-Cited = {{0}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{131QH}},
Wos-Id = {{ISI:000318008400184}},
}

@article{ ISI:000317156100004,
Author = {Rastkari, Noushin and Ahmadkhaniha, Reza},
Title = {{Magnetic solid-phase extraction based on magnetic multi-walled carbon
   nanotubes for the determination of phthalate monoesters in urine samples}},
Journal = {{JOURNAL OF CHROMATOGRAPHY A}},
Year = {{2013}},
Volume = {{1286}},
Pages = {{22-28}},
Month = {{APR 19}},
Abstract = {{In this study, magnetic carbon nanotubes (MCNTs) were prepared by
   assembling magnetic nanoparticles onto the acid-treated multiwall carbon
   nanotubes (MWCNTs). Due to their excellent adsorption capability, the
   MCNTs were used as adsorbent of magnetic solid-phase extraction (MSPE)
   to extract phthalate monoesters (PMEs), the main biomarkers of phthalate
   exposure, from human urine. By coupling MSPE with gas
   chromatography-mass spectrometry (GC-MS), a reliable, sensitive and
   cost-effective method for the simultaneous determination of five main
   PMEs including monomethyl phthalate (MMP), monoethyl phthalate (MEP),
   mono n-butyl phthalate (MBP), mono-(2-ethylhexyl) phthalate (MEHP) and
   monobenzyl phthalate (MBzP) was developed. The factors that could
   influence the extraction, including the amount of magnetic
   nanoparticles, pH of sample solution, extraction and desorption time,
   the amount of salt addition, the type and volume of desorption solvent
   were investigated in detail. Under optimized conditions, the LODs and
   LOQs achieved were in the range of 0.025-0.050 and 0.125-0.250 ng mL(-1)
   respectively. And calibration curves were linear (r(2) >= 0.992) over
   the concentration ranges from 0.250 to 250 ng mL(-1). In addition, a
   satisfying reproducibility was achieved by evaluating the intra- and
   inter-day precisions with relative standard deviations (RSDs) less than
   11.2\% and 11.4\%, respectively. The recoveries of the five PMEs ranged
   from 92.6\% to 98.8\% with the RSDs less than 10.7\%. Finally, the
   established MSPE-GC-MS method was successfully applied to determine PMEs
   in human urine samples. MMP, MEP, MBP and MEHP were detected in most of
   the samples with the median concentration of 8.46, 9.26, 13.60, and 5.95
   ng mL(-1) respectively. MBzP was detected in 58.3\% of the samples with
   the median concentration of 3.05 ng mL(-1). Taken together, the
   MSPE-GC-MS method developed in current study provides a new option for
   the determination of PMEs in human urine. (C) 2013 Elsevier B.V. All
   rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ahmadkhaniha, R (Reprint Author), Univ Tehran Med Sci, Sch Publ Hlth, Tehran 1417614411, Iran.
   Rastkari, Noushin, Univ Tehran Med Sci, Inst Environm Res, Ctr Air Pollut Res, Tehran 1417614411, Iran.
   Rastkari, Noushin; Ahmadkhaniha, Reza, Univ Tehran Med Sci, Sch Publ Hlth, Tehran 1417614411, Iran.}},
DOI = {{10.1016/j.chroma.2013.02.070}},
ISSN = {{0021-9673}},
Keywords = {{Magnetic carbon nanotubes (MCNTs); Magnetic solid-phase extraction
   (MSPE); Phthalate; Phthalate monoesters (PMEs); Biomarker; MSPE-GC MS}},
Keywords-Plus = {{PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY;
   ENVIRONMENTAL WATER SAMPLES; QUANTITATIVE DETECTION; DI-(2-ETHYLHEXYL)
   PHTHALATE; HUMAN EXPOSURE; METABOLITES; ESTERS; ONLINE;
   DI(2-ETHYLHEXYL)PHTHALATE}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{nr\_rastkari@yahoo.com
   r-ahmadkhaniha@tums.ac.ir}},
Funding-Acknowledgement = {{Tehran University of Medical Sciences (TUMS); Health Services grant
   {[}89-03-46-11394]}},
Funding-Text = {{This research has been supported by Tehran University of Medical
   Sciences (TUMS) and Health Services grant (project no. 89-03-46-11394).
   Hereby, the cooperation of the University, School of public health and
   also the Institute for Environmental Research (IER) is highly
   appreciated.}},
Cited-References = {{ALBRO PW, 1982, J ENVIRON SCI HEAL B, V17, P701, DOI 10.1080/03601238209372351.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Cai YQ, 2003, ANAL CHIM ACTA, V494, P149, DOI 10.1016/j.aca.2003.08.006.
   Chang Y.J., 2012, CLIN CHIM ACTA.
   Deng YH, 2005, CHEM COMMUN, P5548, DOI 10.1039/b511683j.
   Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Fankhauser-Noti A, 2007, ANAL CHIM ACTA, V582, P353, DOI 10.1016/j.aca.2006.09.012.
   Garofolo F, 2004, ANALYTICAL METHOD VALIDATION AND INSTRUMENT PERFORMANCE VERIFICATION, P105, DOI 10.1002/0471463728.ch8.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Guan Y, 2010, TALANTA, V83, P337, DOI 10.1016/j.talanta.2010.09.023.
   Hoffmann E., 2007, MASS SPECTROMETRY PR.
   Inoue K, 2003, ANAL BIOANAL CHEM, V375, P527, DOI 10.1007/s00216-002-1709-9.
   Jessome LL, 2006, LC GC N AM, V24, P498.
   Jiao YN, 2012, ANAL METHODS-UK, V4, P291, DOI 10.1039/c1ay05433c.
   Jonsson S, 2002, J CHROMATOGR A, V963, P393, DOI 10.1016/S0021-9673(02)00647-7.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Kondo F, 2010, B ENVIRON CONTAM TOX, V85, P92, DOI 10.1007/s00128-010-0051-8.
   {[}赖莺 Lai Ying], 2012, {[}色谱, Chinese Journal of Chromatography], V30, P647.
   Li JD, 2008, TALANTA, V74, P498, DOI 10.1016/j.talanta.2007.06.008.
   Lin JH, 2010, ANAL METHODS-UK, V2, P1874, DOI 10.1039/c0ay00575d.
   Luo YB, 2012, TALANTA, V90, P123, DOI 10.1016/j.talanta.2012.01.015.
   Morales-Cid G, 2010, ANAL CHEM, V82, P2743, DOI 10.1021/ac902631h.
   Niu HY, 2007, J CHROMATOGR A, V1172, P113, DOI 10.1016/j.chroma.2007.10.014.
   Rastkari N, 2009, J CHROMATOGR B, V877, P1568, DOI 10.1016/j.jchromb.2009.04.002.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Sun L, 2009, ANAL CHIM ACTA, V638, P162, DOI 10.1016/j.aca.2009.02.039.
   Takatori S, 2004, J CHROMATOGR B, V804, P397, DOI 10.1016/j.jchromb.2004.01.056.
   Wang F, 2010, ENVIRON SCI TECHNOL, V44, P6985, DOI 10.1021/es101326j.
   Xiong Y, 2003, CHEM-EUR J, V9, P4991, DOI 10.1002/chem.200305118.
   Yang K, 2010, CHEM REV, V110, P5989, DOI 10.1021/cr100059s.
   Zhang SX, 2010, ANAL CHIM ACTA, V665, P167, DOI 10.1016/j.aca.2010.03.026.
   Zhao XL, 2008, J CHROMATOGR A, V1188, P140, DOI 10.1016/j.chroma.2008.02.069.
   Zhou QX, 2006, J CHROMATOGR A, V1125, P152, DOI 10.1016/j.chroma.2006.05.047.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{0}},
Journal-ISO = {{J. Chromatogr. A}},
Doc-Delivery-Number = {{120FL}},
Wos-Id = {{ISI:000317156100004}},
}

@article{ ISI:000319321700015,
Author = {Bradley, Emma L. and Burden, Richard A. and Bentayeb, Karim and
   Driffield, Malcolm and Harmer, Nick and Mortimer, David N. and Speck,
   Dennis R. and Ticha, Jana and Castle, Laurence},
Title = {{Exposure to phthalic acid, phthalate diesters and phthalate monoesters
   from foodstuffs: UK total diet study results}},
Journal = {{FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL
   EXPOSURE \& RISK ASSESSMENT}},
Year = {{2013}},
Volume = {{30}},
Number = {{4}},
Pages = {{735-742}},
Month = {{APR 1}},
Abstract = {{Phthalates are ubiquitous in the environment and thus exposure to these
   compounds can occur in various forms. Foods are one source of such
   exposure. There are only a limited number of studies that describe the
   levels of phthalates (diesters, monoesters and phthalic acid) in foods
   and assess the exposure from this source. In this study the levels of
   selected phthalate diesters, phthalate monoesters and phthalic acid in
   total diet study (TDS) samples are determined and the resulting exposure
   estimated. The methodology for the determination of phthalic acid and
   nine phthalate monoesters (mono-isopropyl phthalate, mono-n-butyl
   phthalate, mono-isobutyl phthalate, mono-benzyl phthalate,
   mono-cyclohexyl phthalate, mono-n-pentyl phthalate, mono-(2-ethylhexyl)
   phthalate, mono-n-octyl phthalate and mono-isononyl phthalate) in foods
   is described. In this method phthalate monoesters and phthalic acid are
   extracted from the foodstuffs with a mixture of acidified acetonitrile
   and dichloromethane. The method uses isotope-labelled phthalic acid and
   phthalate monoester internal standards and is appropriate for
   quantitative determination in the concentration range of 5100 mu gkg(1).
   The method was validated in-house and its broad applicability
   demonstrated by the analysis of high-fat, high-carbohydrate and
   high-protein foodstuffs as well as combinations of all three major food
   constituents. The methodology used for 15 major phthalate diesters has
   been reported elsewhere. Phthalic acid was the most prevalent phthalate,
   being detected in 17 food groups. The highest concentration measured was
   di-(2-ethylhexyl) phthalate in fish (789 mu gkg(1)). Low levels of
   mono-n-butyl phthalate and mono-(2-ethylhexyl) phthalate were detected
   in several of the TDS animal-based food groups and the highest
   concentrations measured corresponded with the most abundant diesters
   (di-n-butyl phthalate and di-(2-ethylhexyl) phthalate). The UK Committee
   on Toxicity of Chemicals in Food, Consumer Products and the Environment
   (COT) considered the levels found and concluded that they did not
   indicate a risk to human health from dietary exposure alone.}},
Publisher = {{TAYLOR \& FRANCIS LTD}},
Address = {{4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bradley, EL (Reprint Author), Food \& Environm Res Agcy, York, N Yorkshire, England.
   Bradley, Emma L.; Driffield, Malcolm; Harmer, Nick; Speck, Dennis R.; Ticha, Jana; Castle, Laurence, Food \& Environm Res Agcy, York, N Yorkshire, England.
   Burden, Richard A.; Mortimer, David N., Food Stand Agcy, London, England.
   Bentayeb, Karim, Univ Zaragoza, Dept Analyt Chem, Zaragoza, Spain.}},
DOI = {{10.1080/19440049.2013.781684}},
ISSN = {{1944-0049}},
Keywords = {{phthalate; total diet study; method validation; exposure}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; SOLID-PHASE EXTRACTION; HUMAN URINE;
   HUMAN-MILK; FOOD; METABOLITES; QUANTIFICATION; PRODUCTS; RATS; OIL}},
Research-Areas = {{Chemistry; Food Science \& Technology; Toxicology}},
Web-of-Science-Categories  = {{Chemistry, Applied; Food Science \& Technology; Toxicology}},
Author-Email = {{emma.bradley@fera.gsi.gov.uk}},
Cited-References = {{ALBRO PW, 1989, TOXICOL APPL PHARM, V100, P193, DOI 10.1016/0041-008X(89)90305-0.
   Anderson WAC, 2002, ANALYST, V127, P1193, DOI 10.1039/b200487a.
   Bradley EL, 2011, DETERMINATION PHTHAL.
   Bradley EL, 2013, FOOD ADDIT CONTAM A, V30, P722, DOI 10.1080/19440049.2013.781683.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Cao XL, 2010, COMPR REV FOOD SCI F, V9, P21, DOI 10.1111/j.1541-4337.2009.00093.x.
   Cavaliere B, 2008, J CHROMATOGR A, V1205, P137, DOI 10.1016/j.chroma.2008.08.009.
   Committee on Toxicity, 2011, CONS PROD ENV COT ST.
   EMA M, 1995, TOXICOL LETT, V78, P101, DOI 10.1016/0378-4274(94)03241-X.
   European Food Safety Authority, 2005, EFSA J, V241, P114.
   European Union, 2011, OFF J EUR UNION L, VL12, P1.
   Fierens T, 2012, FOOD CHEM TOXICOL, V50, P2575, DOI 10.1016/j.fct.2012.04.029.
   Finch S, 1998, NATL DIET NUTR SURVE, V1.
   Godwin A, 2010, USE PHTHALATES OTHER.
   Gregory JR, 1995, NATL DIET NUTR SURVE.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P116, DOI 10.1016/0041-008X(92)90374-2.
   Henderson L, 2002, NATL DIET NUTR SURVE, V1.
   Holm A, 2004, ANAL BIOANAL CHEM, V378, P1762, DOI 10.1007/s00216-003-2488-7.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Latini G, 2006, TOXICOLOGY, V226, P90, DOI 10.1016/j.tox.2006.07.011.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   PEATTIE ME, 1983, FOOD CHEM TOXICOL, V21, P503, DOI 10.1016/0278-6915(83)90110-2.
   Pedersen GA, 2008, FOOD ADDIT CONTAM, V25, P503, DOI 10.1080/02652030701519088.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   Petrovic M, 2004, ANAL BIOANAL CHEM, V378, P549, DOI 10.1007/s00216-003-2184-7.
   Sannino A, 2009, FOOD ADDIT CONTAM B, V2, P166, DOI 10.1080/02652030903148330.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Sioen I, 2012, ENVIRON INT, V48, P102, DOI 10.1016/j.envint.2012.07.004.
   Sorensen LK, 2006, RAPID COMMUN MASS SP, V20, P1135, DOI 10.1002/rcm.2425.
   VikelsOe J, 1999, 268 NERI MIN ENV EN.
   {[}EFSA] European Food Safety Authority, 2005, EFSA J, V243, P120.
   {[}EFSA] European Food Safety Authority, 2005, EFSA J, V245, P114.
   {[}EFSA] European Food Safety Authority, 2005, OP SCI COMM REQ EFSA.
   {[}EFSA] European Food Safety Authority, 2005, EFSA J, V244, P118.
   {[}EFSA] European Food Safety Authority, 2005, EFSA J, V242, P117.
   {[}WHO] World Health Organisation, 2003, 52 WHO.
   {[}WHO] World Health Organisation, 2000, IPCS ENV HLTH CRIT.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{1}},
Journal-ISO = {{Food Addit. Contam. Part A-Chem.}},
Doc-Delivery-Number = {{149LR}},
Wos-Id = {{ISI:000319321700015}},
}

@article{ ISI:000317454000009,
Author = {Song, Na Rae and On, Ji-won and Lee, Jeongae and Park, Jung-Duck and
   Kwon, Ho-Jang and Yoon, Hae Jung and Pyo, Heesoo},
Title = {{Biomonitoring of urinary di(2-ethylhexyl) phthalate metabolites of
   mother and child pairs in South Korea}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2013}},
Volume = {{54}},
Pages = {{65-73}},
Month = {{APR}},
Abstract = {{Di(2-ethylhexyl) phthalate (DEHP) is one of the common phthalate
   plasticizers used primarily in soft polyvinyl chloride, which is a
   plastic polymer that makes up the total weight of goods from 1\% up to
   40\% in many consumer products. The aims of this study were to examine
   the urinary DEHP metabolites in South Korean children and to investigate
   the correlation between mother and child DEHP urine excretion. Three
   kinds of urinary DEHP metabolites: mono(2-ethylhexyl) phthalate (MEHP),
   mono(2-ethyl-5-hydroxyhexyl) phthalate (5-OH-MEHP) and
   mono(2-ethyl-5-oxohexyl) phthalate (5-oxo-MEHP), were analyzed. The
   total of 954 samples (n(Children) = 392, n(Mothers) = 265, n(Aadults)=
   297), including 258 mother and child pairs, were analyzed using isotope
   dilution gas chromatography-mass spectrometry. Many studies present
   higher concentration of DEHP metabolites detected from adults in
   reproductive age than adults in other ages. Therefore, adults who are
   age-matched to mothers were evaluated to serve as a standard of
   comparison against mothers. All statistical analysis was made by
   adjusting detected volume concentrations (mu g/L) with respect to
   creatinine concentrations (mg/dL) since urinary DEHP metabolites were
   studied using human reference. The difference in median levels of sum of
   urinary DEHP metabolites was only significant when children were
   analyzed in relation to region (p-value <= 0.005). Among the three DEHP
   metabolites, only MEHP of children was significantly correlated to that
   of paired mothers (p-value <= 0.01). The present paper defines the
   relative metabolic rate (RMR) of DEHP metabolism for the first time in
   study on phthalates. Children had faster RMR than mothers and adults,
   specifically in the first step of DEHP metabolism (RMR1 MEHP
   hydroxylation to 5-OH-MEHP), and RMR1 of children between 1 and 24
   months was the fastest. The above results may be used to study and
   assess human health risk from DEHP exposures, especially among mothers
   and children in Korea. (C) 2013 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Pyo, H (Reprint Author), Korea Inst Sci \& Technol, Mol Recognit Res Ctr, Hwarangno 14 Gil 5, Seoul 136791, South Korea.
   Song, Na Rae; On, Ji-won; Lee, Jeongae; Pyo, Heesoo, Korea Inst Sci \& Technol, Mol Recognit Res Ctr, Seoul 136791, South Korea.
   Song, Na Rae, Univ Calif Los Angeles, Dept Chem \& Biochem, Los Angeles, CA 90095 USA.
   On, Ji-won, Korea Univ, Dept Chem, Seoul 136701, South Korea.
   Park, Jung-Duck, Chung Ang Univ, Coll Med, Dept Prevent Med, Seoul 156756, South Korea.
   Kwon, Ho-Jang, Dankook Univ, Coll Med, Dept Prevent Med, Cheonan, South Korea.
   Yoon, Hae Jung, Natl Inst Food \& Drug Safety Evaluat, Risk Anal \& Res Div, Cheongwon, South Korea.}},
DOI = {{10.1016/j.envint.2013.01.007}},
ISSN = {{0160-4120}},
Keywords = {{DEHP metabolites; Human exposure; Children; Biomonitoring}},
Keywords-Plus = {{GENERAL-POPULATION; PRENATAL EXPOSURE; INTERNAL EXPOSURE;
   RISK-ASSESSMENT; PREGNANT-WOMEN; US POPULATION; DEHP; ASSOCIATION;
   BIOMARKERS; GERMANY}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{pyo3692@kist.re.kr}},
Funding-Acknowledgement = {{Korea Food \& Drug Administration {[}10162KFDA994]; Intramural Research
   Program at the Korea Institute of Science and Technology}},
Funding-Text = {{This research was supported by a grant (10162KFDA994) from Korea Food \&
   Drug Administration in 2010 and a grant from the Intramural Research
   Program at the Korea Institute of Science and Technology.}},
Cited-References = {{Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809.
   Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012.
   CDC, 2012, BIOM SUMM PHTH OV.
   CDC, 2009, 4 CDCP.
   CPSC, REV EXP DAT ASS SEL.
   EFSA, STAT SCI PAN FOOD AD.
   EPA, DI 2 ETH PHTHAL DEHP.
   European Commission Joint Research Center, 2008, EUR UN RISK ASS REP, V80, P231.
   FDA. Center for Devices and Radiological Health, 2001, SAF ASS DI 2 ETH PHT.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Frederiksen MM, 2001, AM IND HYG ASSOC J, V62, P195.
   Fromme H, 2011, ENVIRON INT, V37, P715, DOI 10.1016/j.envint.2011.02.008.
   Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m.
   Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005.
   HCWH EPHA, 2005, ENV NETW WEIGHT EV D.
   HHS, TOX PROF DI 2 ETH PH.
   HHS, OCC SAF HLTH GUID DE.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   KFDA, 2010, PHTHAL RISK PROF.
   Kim HH, 2011, ENV HLTH TOXICOL, V26.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koo HJ, 2005, J TOXICOL ENV HEAL A, V68, P1379, DOI 10.1080/15287390590956506.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Latini G, 2009, ENVIRON INT, V35, P236, DOI 10.1016/j.envint.2008.06.002.
   Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073.
   Markey CN, 2006, PERS INDIV DIFFER, V41, P1503, DOI 10.1016/j.paid.2006.06.007.
   NTP-CERHR, NTP CERHR EXP PAN UP.
   Romero-Franco M, 2011, ENVIRON INT, V37, P867, DOI 10.1016/j.envint.2011.02.014.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Sathyanarayana S, 2008, ENVIRON RES, V108, P413, DOI 10.1016/j.envres.2008.07.002.
   SGS, 2011, WORLDW PHTHAL CRIS.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Suzuki Y, 2010, ENVIRON INT, V36, P699, DOI 10.1016/j.envint.2010.05.003.
   WHO, DI 2 ETH PHTHAL DRIN.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Kasper-Sonnenberg M, 2012, INT J HYG ENVIR HEAL, V215, P373, DOI 10.1016/j.ijheh.2011.09.004.
   {[}Anonymous], 2010, BULLETIN.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{0}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{124HI}},
Wos-Id = {{ISI:000317454000009}},
}

@article{ ISI:000317253500003,
Author = {Park, Hye Yin and Kim, Jin Hee and Lim, Youn-Hee and Bae, Sanghyuk and
   Hong, Yun-Chul},
Title = {{Influence of genetic polymorphisms on the association between phthalate
   exposure and pulmonary function in the elderly}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2013}},
Volume = {{122}},
Pages = {{18-24}},
Month = {{APR}},
Abstract = {{Background: Phthalates are prevalent environmental exposure chemicals
   with rising concern on various health effects, including pulmonary
   function. Meanwhile, elderly people are more susceptible to
   environmental exposure, and their decreasing lung function is an
   important health issue.
   Objectives: To investigate the association between urinary phthalate
   metabolite levels and indices for pulmonary function, and evaluate
   effect modification by genetic polymorphisms of oxidative-stress related
   genes, catalase (CAT), superoxide dismutase (SOD2), and myeloperoxidase
   (MPO) in elderly Koreans.
   Methods: We conducted a panel study on 418 individuals over 60 years old
   in Seoul, Korea, and repeatedly measured urinary phthalate metabolite
   levels and ran pulmonary function tests. Genetic polymorphisms of CAT
   (rs769218, rs769217), SOD2 (rs4880, rs2758331, rs5746136) and MPO
   (rs2071409, rs7208693) were determined. Mixed effect model was used to
   investigate association of phthalate levels with pulmonary function
   indices and to examine the effect of CAT, SOD2 and MPO polymorphisms on
   the association.
   Results: Inverse association was demonstrated between sum of
   mono-(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl)
   phthalate (Sigma DEHP) levels and FEV1/FVC (beta = -0.632, p = 0.0275)
   or FEF25-75 (beta = -0.077, p = 0.025) after adjusting for age, months
   after previous measurements, sex, body mass index, cotinine, mean
   temperature and dew point. The effect of Sigma DEHP on lung function was
   significant only in subjects with certain genotypes, and having all
   significant genotypes in three genes showed significant difference in
   the phthalate-pulmonary function association (FEV1/FVC: beta = -2.169, p
   = 0.0032; FEF25-75: beta = -0.155, p = 0.0103), while other combinations
   showed less estimate size without any significance.
   Conclusions: Urinary phthalate metabolites levels are associated with
   decreasing pulmonary function in elderly Koreans, and effect
   modification of certain CAT, SOD2 and MPO polymorphisms on the
   association is suggested. (C) 2012 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hong, YC (Reprint Author), Seoul Natl Univ, Med Res Ctr, Inst Environm Med, 103 Daehakro, Seoul 110799, South Korea.
   Park, Hye Yin; Bae, Sanghyuk; Hong, Yun-Chul, Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul 110799, South Korea.
   Kim, Jin Hee; Hong, Yun-Chul, Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul 110799, South Korea.
   Lim, Youn-Hee, Seoul Natl Univ, Sch Publ Hlth, Dept Epidemiol \& Biostat, Seoul 110799, South Korea.}},
DOI = {{10.1016/j.envres.2012.11.004}},
ISSN = {{0013-9351}},
Keywords = {{Phthalates; Pulmonary function; Genetic polymorphisms; Elderly;
   Oxidation}},
Keywords-Plus = {{OXIDATIVE STRESS; YOUNG-CHILDREN; BRONCHIAL OBSTRUCTION; MISSING DATA;
   BISPHENOL-A; RATS; INFLAMMATION; METABOLISM; DECLINE; INDOOR}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{ychong1@snu.ac.kr}},
Funding-Acknowledgement = {{Susceptible Population Research Program of the Ministry of Environment;
   Basic Science Research Program through the National Research Foundation
   of Korea (NRF); Ministry of Education, Science and Technology Republic
   of Korea {[}2011-0005907]}},
Funding-Text = {{This study was supported by the Susceptible Population Research Program
   (2008-2010) of the Ministry of Environment and the Basic Science
   Research Program through the National Research Foundation of Korea
   (NRF), funded by the Ministry of Education, Science and Technology
   (2011-0005907), Republic of Korea.}},
Cited-References = {{Bindhumol V, 2003, TOXICOLOGY, V188, P117, DOI 10.1016/S0300-483X(03)00056-8.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   CERUTTI P, 1994, ENVIRON HEALTH PERSP, V102, P123, DOI 10.2307/3432228.
   Chitra KC, 2003, TOXICOLOGY, V185, P119, DOI 10.1016/S0300-483X(02)00597-8.
   Drost EM, 2005, THORAX, V60, P293, DOI 10.1136/thx.2004.027946.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Hancock DB, 2010, NAT GENET, V42, P45, DOI 10.1038/ng.500.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hiroi S, 1999, BIOCHEM BIOPH RES CO, V261, P332, DOI 10.1006/bbrc.1999.1036.
   Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Huang PC, 2010, HUM REPROD, V25, P986, DOI 10.1093/humrep/deq015.
   Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797.
   Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188.
   Masuko H, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-97.
   McCracken J, 2010, ENVIRON HEALTH PERSP, V118, P1564, DOI 10.1289/ehp.0901831.
   Meeker JD, 2012, J EXPO SCI ENV EPID, V22, P376, DOI 10.1038/jes.2012.7.
   Obeidat M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019382.
   Oie L, 1999, EPIDEMIOLOGY, V10, P294, DOI 10.1097/00001648-199905000-00018.
   Perianayagam M.C., 2012, KIDNEY INT.
   Ponsonby AL, 2003, EPIDEMIOLOGY, V14, P37, DOI 10.1097/00001648-200301000-00012.
   Rakkestad KE, 2007, J ENVIRON MONITOR, V9, P1419, DOI 10.1039/b709947a.
   Repapi E, 2010, NAT GENET, V42, P36, DOI 10.1038/ng.501.
   Risher JF, 2010, REV ENVIRON CONTAM T, V207, P95, DOI 10.1007/978-1-4419-6406-9\_2.
   Roberts AM, 2011, CRIT CARE MED, V39, P2776, DOI 10.1097/CCM.0b013e31822b3a00.
   ROBINS JM, 1995, J AM STAT ASSOC, V90, P106, DOI 10.2307/2291134.
   RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581.
   Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025.
   Seagrave J, 2008, J TOXICOL ENV HEAL A, V71, P1352, DOI 10.1080/15287390802271566.
   Singh VK, 2008, CLIN BIOCHEM, V41, P152, DOI 10.1016/j.clinbiochem.2007.11.017.
   Sun Pin, 2007, Wei Sheng Yan Jiu, V36, P11.
   WARE JH, 1990, AM J EPIDEMIOL, V132, P685.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{0}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{121OG}},
Wos-Id = {{ISI:000317253500003}},
}

@article{ ISI:000316109500015,
Author = {Braun, Joseph M. and Sathyanarayana, Sheela and Hauser, Russ},
Title = {{Phthalate exposure and children's health}},
Journal = {{CURRENT OPINION IN PEDIATRICS}},
Year = {{2013}},
Volume = {{25}},
Number = {{2}},
Pages = {{247-254}},
Month = {{APR}},
Abstract = {{Purpose of review
   Phthalates are multifunctional chemicals used in personal care products,
   medications, and plastics. We reviewed the epidemiological literature
   examining the relationship between early life phthalate exposure and
   pediatric health outcomes.
   Recent findings
   Five studies from Asia, Europe, and the United States suggest that
   childhood exposure to di-2-ethylhexyl phthalate (DEHP) and butylbenzyl
   phthalate (BBzP) may increase the risk of allergic diseases including
   asthma and eczema. Six studies from four different prospective cohorts
   report that gestational BBzP, DEHP, di-butyl phthalate (DBP), and
   di-ethyl phthalate (DEP) exposures are associated with alterations in
   infant/toddler physical development as well as parent-reported
   externalizing, internalizing, and autistic-like child behavior. However,
   there are inconsistencies related to the specific phthalates and
   behavioral domains. Two small studies report shorter anogenital distance
   among male infants with higher gestational phthalate exposure.
   Summary
   Several epidemiological studies suggest fetal and childhood exposure to
   some phthalates may perturb normal development, with several studies
   consistently reporting increased risk of allergic diseases with DEHP and
   BBzP exposure. Although anticipatory guidance is not evidence-based at
   this time, providers can counsel concerned patients to reduce phthalate
   exposures in order to protect the developing fetus and child from
   potential adverse health outcomes.}},
Publisher = {{LIPPINCOTT WILLIAMS \& WILKINS}},
Address = {{530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Braun, JM (Reprint Author), Brown Univ, Dept Epidemiol, Box G-S121-2, Providence, RI 02912 USA.
   Braun, Joseph M., Brown Univ, Dept Epidemiol, Providence, RI 02912 USA.
   Sathyanarayana, Sheela, Univ Washington, Dept Pediat, Seattle Childrens Res Inst, Seattle, WA 98195 USA.
   Hauser, Russ, Harvard Univ, Massachusetts Gen Hosp, Sch Med,Fertil Ctr, Dept Obstet \& Gynecol,Div Reprod Endocrinol \& Inf, Boston, MA USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.}},
DOI = {{10.1097/MOP.0b013e32835e1eb6}},
ISSN = {{1040-8703}},
Keywords = {{children; endocrine disruption; epidemiology; phthalates}},
Keywords-Plus = {{IN-UTERO EXPOSURE; BODY TOPICAL APPLICATION; PERSONAL CARE PRODUCTS;
   SCHOOL-AGE-CHILDREN; NEW-YORK-CITY; URINARY CONCENTRATIONS; PRENATAL
   EXPOSURE; BISPHENOL-A; DIETHYLHEXYL PHTHALATE; DI(2-ETHYLHEXYL)PHTHALATE
   DEHP}},
Research-Areas = {{Pediatrics}},
Web-of-Science-Categories  = {{Pediatrics}},
Author-Email = {{joseph\_braun\_1@brown.edu}},
Funding-Acknowledgement = {{NIEHS {[}K99 ES020346, R01 ES021357, R01 ES009718]}},
Funding-Text = {{J.M.B. was supported by NIEHS grants K99 ES020346 and R01 ES021357. R.
   H. is supported by NIEHS grant R01 ES009718.}},
Cited-References = {{Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Benayoun L, 2001, AM J RESP CRIT CARE, V164, P1487.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139.
   Buckley JP, 2012, J EXPO SCI ENV EPID, V22, P468, DOI 10.1038/jes.2012.33.
   Carlstedt F, 2013, INDOOR AIR, V23, P32, DOI 10.1111/j.1600-0668.2012.00788.x.
   Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Frederiksen H, 2012, INT J ANDROL, V35, P216, DOI 10.1111/j.1365-2605.2012.01260.x.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Hannas BR, 2011, TOXICOL SCI, V123, P206, DOI 10.1093/toxsci/kfr146.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Hsu NY, 2012, INDOOR AIR, V22, P186, DOI 10.1111/j.1600-0668.2011.00753.x.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Hubinger JC, 2010, J COSMET SCI, V61, P457.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   Just AC, 2012, ENVIRON HEALTH PERSP, V120, P1475, DOI 10.1289/ehp.1104544.
   Just AC, 2010, J EXPO SCI ENV EPID, V20, P625, DOI 10.1038/jes.2010.13.
   Just AC, 2012, AM J RESP CRIT CARE, V186, P830, DOI 10.1164/rccm.201203-0398OC.
   Kelley KE, 2012, ENVIRON HEALTH PERSP, V120, P379, DOI 10.1289/ehp.1103998.
   Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034.
   Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2005, ARCH TOXICOL, V79, P689, DOI 10.1007/s00204-005-0004-x.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   Koniecki D, 2011, ENVIRON RES, V111, P329, DOI 10.1016/j.envres.2011.01.013.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Loff S, 2008, J PEDIATR GASTR NUTR, V47, P81, DOI 10.1097/MPG.0b013e318164d933.
   Lovekamp-Swan T, 2003, MOL CELL ENDOCRINOL, V201, P133, DOI 10.1016/S0303-7207(02)00423-9.
   MacLeod DJ, 2010, INT J ANDROL, V33, P279, DOI 10.1111/j.1365-2605.2009.01005.x.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522.
   Miodovnik A, 2011, NEUROTOXICOLOGY, V32, P261, DOI 10.1016/j.neuro.2010.12.009.
   Needham LL, 2005, NEUROTOXICOLOGY, V26, P547, DOI 10.1016/j.neuro.2004.09.006.
   Philippat C, 2012, ENVIRON HEALTH PERSP, V120, P464, DOI 10.1289/ehp.1103634.
   Romero-Franco M, 2011, ENVIRON INT, V37, P867, DOI 10.1016/j.envint.2011.02.014.
   Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Simmchen J, 2012, TRANSFUS MED REV, V26, P27, DOI 10.1016/j.tmrv.2011.06.001.
   Suzuki Y, 2012, INT J ANDROL, V35, P236, DOI 10.1111/j.1365-2605.2011.01190.x.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Teitelbaum SL, 2012, ENVIRON RES, V112, P186, DOI 10.1016/j.envres.2011.12.006.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Testa C, 2012, ASN NEURO, V4, P223, DOI 10.1042/AN20120015.
   Vandentorren S, 2011, ENVIRON RES, V111, P761, DOI 10.1016/j.envres.2011.05.018.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705.
   Whyatt RM, 2009, PEDIATRICS, V124, pE1213, DOI 10.1542/peds.2009-0325.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Wolff MS, 2010, ENVIRON HEALTH PERSP, V118, P1039, DOI 10.1289/ehp.0901690.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003.
   Zhang YH, 2009, J PEDIATR, V155, P500, DOI 10.1016/j.jpeds.2009.04.007.
   {[}Anonymous], 2011, RESOURCES HLTH PROFE.
   {[}Anonymous], 2002, FDA PUBLIC HLTH NOTI.}},
Number-of-Cited-References = {{75}},
Times-Cited = {{0}},
Journal-ISO = {{CURR. OPIN. PEDIATR.}},
Doc-Delivery-Number = {{105YV}},
Wos-Id = {{ISI:000316109500015}},
}

@article{ ISI:000316258800027,
Author = {Shiue, I.},
Title = {{Urine phthalate concentrations are higher in people with stroke: United
   States National Health and Nutrition Examination Surveys (NHANES),
   2001-2004}},
Journal = {{EUROPEAN JOURNAL OF NEUROLOGY}},
Year = {{2013}},
Volume = {{20}},
Number = {{4}},
Pages = {{728-731}},
Month = {{APR}},
Abstract = {{Background and purpose Associations between plastic-associated
   chemicals, such as bisphenol A, and cardiovascular disease have begun to
   emerge in the current century. However, the relationship between urine
   phthalates and risk of stroke is unclear. It was aimed to study the
   relationship between urine phthalate concentrations and risk of stroke
   in a national population-based cross-sectional study. Methods Data were
   retrieved from United States National Health and Nutrition Examination
   Surveys, 20012004, including demographics, self-reported medical
   conditions (stroke status) and urine phthalate concentrations. Analyses
   involved t-test and logistic regression models. Results Of 13 phthalate
   concentrations, the mean values of mono-n-butyl phthalate (20012002:
   131.27 +/- 685.62 and 43.02 +/- 117.70, P=0.0001; 20032004: 114.36 +/-
   555.41 and 49.48 +/- 153.53, P=0.008) and mono-(3-carboxypropyl)
   phthalate (20012002: 13.60 +/- 37.05 and 5.48 +/- 10.55, P<0.001;
   20032004: 10.56 +/- 38.37 and 5.94 +/- 14.76, P=0.038) concentrations
   were found significantly higher in people with stroke. It was also
   observed that low doses of mono-n-butyl phthalate (OR 1.0009, 95\%CI
   0.9991.003, P=0.266 in 20012002, and OR 1.0010, 95\%CI 1.00011.0019,
   P=0.028 in 20032004) and mono-(3-carboxypropyl) phthalate (OR 1.03,
   95\%CI 1.001.05, P=0.055 in 20012002, and OR 1.004, 95\% CI 1.001.01
   P=0.240 in 20032004) were associated with higher risk of stroke after
   full adjustments. Conclusions Urine phthalate concentrations are
   potentially associated with increased risk of stroke, although the
   causality cannot be established in the current cross-sectional study
   design. Future longitudinal cohort studies and/or clinical trials are
   warranted to understand the biological mechanism along the pathway
   before drawing a firm conclusion on the relationship between phthalates
   and risk of stroke in humans.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Shiue, I (Reprint Author), Univ Exeter, Royal Cornwall Hosp, European Ctr Environm \& Human Hlth, Knowledge Spa, Truro TR1 3HD, England.
   Shiue, I., Univ Exeter, European Ctr Environm \& Human Hlth, Exeter, Devon, England.
   Shiue, I., Univ Georgia, William A \& Barbara R Owens Inst Behav Res, Athens, GA 30602 USA.}},
DOI = {{10.1111/j.1468-1331.2012.03862.x}},
ISSN = {{1351-5101}},
Keywords = {{aetiology; environmental chemicals; molecular epidemiology; population
   health; stroke}},
Keywords-Plus = {{SUBARACHNOID HEMORRHAGE; POPULATION; CHEMICALS; RISK}},
Research-Areas = {{Neurosciences \& Neurology}},
Web-of-Science-Categories  = {{Clinical Neurology; Neurosciences}},
Author-Email = {{is262@exeter.ac.uk}},
Funding-Acknowledgement = {{European Regional Development Fund; European Social Fund Convergence
   Programme}},
Funding-Text = {{IS is supported by the European Regional Development Fund and the
   European Social Fund Convergence Programme.}},
Cited-References = {{Bisset KM, 2011, NEUROCHEM INT, V59, P706, DOI 10.1016/j.neuint.2011.06.019.
   Boas M, 2009, CURR OPIN ENDOCRINOL, V16, P385, DOI 10.1097/MED.0b013e3283305af7.
   BROTONS JA, 1995, ENVIRON HEALTH PERSP, V103, P608, DOI 10.2307/3432439.
   Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7.
   Lind L, 2012, J INTERN MED, V271, P537, DOI 10.1111/j.1365-2796.2012.02536.x.
   O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3.
   Osman AM, 2010, REPROD TOXICOL, V30, P322, DOI 10.1016/j.reprotox.2010.05.084.
   Ruigrok YM, 2001, STROKE, V32, P1173.
   Shiue I, 2012, J NEUROL SCI, V313, P92, DOI 10.1016/j.jns.2011.09.017.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   {[}Anonymous], 2012, NAT HLTH NUTR EX SUR.}},
Number-of-Cited-References = {{11}},
Times-Cited = {{0}},
Journal-ISO = {{Eur. J. Neurol.}},
Doc-Delivery-Number = {{107ZC}},
Wos-Id = {{ISI:000316258800027}},
}

@article{ ISI:000318690700027,
Author = {Ivell, Richard and Heng, Kee and Nicholson, Helen and Anand-Ivell,
   Ravinder},
Title = {{Brief maternal exposure of rats to the xenobiotics dibutyl phthalate or
   diethylstilbestrol alters adult-type Leydig cell development in male
   offspring}},
Journal = {{ASIAN JOURNAL OF ANDROLOGY}},
Year = {{2013}},
Volume = {{15}},
Number = {{2, SI}},
Pages = {{261-268}},
Month = {{MAR}},
Abstract = {{Maternal exposure to estrogenic xenobiotics or phthalates has been
   implicated in the distortion of early male reproductive development,
   referred to in humans as the testicular dysgenesis syndrome. It is not
   known, however, whether such early gestational and/or lactational
   exposure can influence the later adult-type Leydig cell phenotype. In
   this study, Sprague-Dawley rats were exposed to dibutyl phthalate (DBP;
   from gestational day (GD) 14.5 to postnatal day (PND) 6) or
   diethylstilbestrol (DES; from GD14.5 to GD16.5) during a short
   gestational/lactational window, and male offspring subsequently analysed
   for various postnatal testicular parameters. All offspring remained in
   good health throughout the study. Maternal xenobiotic treatment appeared
   to modify specific Leydig cell gene expression in male offspring,
   particularly during the dynamic phase of mid-puberty, with serum INSL3
   concentrations showing that these compounds led to a faster attainment
   of peak values, and a modest acceleration of the pubertal trajectory.
   Part of this effect appeared to be due to a treatment-specific impact on
   Leydig cell proliferation during puberty for both xenobiotics. Taken
   together, these results support the notion that maternal exposure to
   certain xenobiotics can also influence the development of the adult-type
   Leydig cell population, possibly through an effect on the Leydig stem
   cell population.}},
Publisher = {{ACTA PHARMACOLOGICA SINICA}},
Address = {{294 TAI-YUAN RD, SHANGHAI, 200031, PEOPLES R CHINA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Anand-Ivell, R (Reprint Author), FBN Leibniz Inst Farm Anim Biol, D-18196 Dummerstorf, Germany.
   Ivell, Richard; Heng, Kee, Univ Adelaide, Sch Mol \& Biomed Sci, Adelaide, SA 5005, Australia.
   Ivell, Richard; Anand-Ivell, Ravinder, FBN Leibniz Inst Farm Anim Biol, D-18196 Dummerstorf, Germany.
   Nicholson, Helen, Univ Otago, Otago Sch Med Sci, Ctr Reprod \& Genom, Dunedin 9054, New Zealand.
   Anand-Ivell, Ravinder, Univ S Australia, Sch Pharm \& Med Sci, Adelaide, SA 5000, Australia.}},
DOI = {{10.1038/aja.2012.138}},
ISSN = {{1008-682X}},
Keywords = {{diethylstilbestrol (DES); INSL3; Leydig cells; dibutyl phthalate (DBP);
   puberty; testis}},
Keywords-Plus = {{INSULIN-LIKE FACTOR-3; IN-UTERO EXPOSURE; DIMETHANE SULFONATE TREATMENT;
   N-BUTYL PHTHALATE; REPRODUCTIVE DEVELOPMENT; DI(N-BUTYL) PHTHALATE;
   TESTICULAR DYSGENESIS; TESTIS; EXPRESSION; NUMBER}},
Research-Areas = {{Endocrinology \& Metabolism; Urology \& Nephrology}},
Web-of-Science-Categories  = {{Andrology; Urology \& Nephrology}},
Author-Email = {{anand-ivell@fbn-dummerstorf.de}},
Funding-Acknowledgement = {{Laboratory Animal Services, University of Adelaide; Australian Research
   Council {[}DP 0773315]; University of Adelaide}},
Funding-Text = {{We gratefully acknowledge the help and support from Laboratory Animal
   Services, University of Adelaide. We also thank Professor Jeff Schwartz
   (Griffith University) for helpful advice, as well as to Ms Navdeep Mann,
   Ms Lee Ling Tan and Mr Damien Hunter for assistance with some of the
   animal experimentation, and the PCR analysis. We also wish to
   acknowledge the kind help and guidance of Dr Maree Gould and Dr Peter
   Hurst (University of Otago) in regard to the stereology. This work was
   funded in part through an Australian Research Council
   (http://www.arc.gov.au) project grant to RI (DP 0773315), and through
   scholarship support by the University of Adelaide to KH.}},
Cited-References = {{Anand-Ivell R, 2008, HUM REPROD, V23, P1180, DOI 10.1093/humrep/den038.
   Anand-Ivell R, 2009, BIOL REPROD, V81, P480, DOI 10.1095/biolreprod.109.077552.
   Anand-Ivell RJK, 2006, BIOL REPROD, V74, P945, DOI 10.1095/biolreprod.105.048165.
   Andersson AM, 2004, J CLIN ENDOCR METAB, V89, P3161, DOI 10.1210/jc.2003-031786.
   Ariyaratne HBS, 2000, BIOL REPROD, V63, P1115, DOI 10.1095/biolreprod63.4.1115.
   de Kretser DM, 2004, J CLIN ENDOCR METAB, V89, P3158, DOI 10.1210/jc.2004-0741.
   Emmen JMA, 2000, ENDOCRINOLOGY, V141, P846, DOI 10.1210/en.141.2.846.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Gould ML, 2007, REPRODUCTION, V134, P271, DOI 10.1530/REP-07-0025.
   GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3.
   GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219.
   HARDY MP, 1989, ENDOCRINOLOGY, V124, P762.
   Heng K, 2012, INT J ANDROL, V35, P353, DOI 10.1111/j.1365-2605.2011.01231.x.
   Howard V, 1998, UNBIASED STEREOLOGY.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Ivell R, 2009, HUM REPROD UPDATE, V15, P463, DOI 10.1093/humupd/dmp011.
   Kawaguchi H, 2009, J VET MED SCI, V71, P1309, DOI 10.1292/jvms.001309.
   Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802.
   Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671.
   McKinnell C, 2005, ENDOCRINOLOGY, V146, P4536, DOI 10.1210/en.2005-0676.
   Muller PY, 2002, BIOTECHNIQUES, V32, P1372.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Nanjappa MK, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.095349.
   Rasier G, 2007, BIOL REPROD, V77, P734, DOI 10.1095/biolreprod.106.059303.
   Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026.
   TEERDS KJ, 1989, J ANDROL, V10, P472.
   Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375.
   VELDHUIZENTSOERKAN MB, 1994, MOL CELL ENDOCRINOL, V105, P37, DOI 10.1016/0303-7207(94)90033-7.
   Wilson VS, 2007, TOXICOL LETT, V170, P177, DOI 10.1016/j.toxlet.2007.03.004.
   WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505.
   ZIRKIN BR, 1987, ANAT REC, V219, P157, DOI 10.1002/ar.1092190208.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{1}},
Journal-ISO = {{Asian J. Androl.}},
Doc-Delivery-Number = {{140XV}},
Wos-Id = {{ISI:000318690700027}},
}

@article{ ISI:000315126200013,
Author = {Parlett, Lauren E. and Calafat, Antonia M. and Swan, Shanna H.},
Title = {{Women's exposure to phthalates in relation to use of personal care
   products}},
Journal = {{JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY}},
Year = {{2013}},
Volume = {{23}},
Number = {{2}},
Pages = {{197-206}},
Month = {{MAR-APR}},
Abstract = {{Several phthalates, particularly diethyl phthalate (DEP) and di-n-butyl
   phthalate, can be used in personal care products (PCPs) to fix fragrance
   and hold color. We investigated associations between women's reported
   use of PCPs within the 24 h before urine collection and concentrations
   of several urinary phthalate metabolites. Between 2002 and 2005, 337
   women provided spot urine samples and answered questions regarding their
   use of 13 PCPs at a follow-up visit 3-36 months after pregnancy. We
   examined associations between urinary concentrations of several
   phthalate metabolites and use of PCPs using linear regression. Use of
   individual PCPs ranged from 7\% (nail polish) to 91\% (deodorant). After
   adjusting for age, education, and urinary creatinine, women reporting
   use of perfume had 2.92 times higher (95\% CI: 2.20-3.89) concentration
   of rnonoethyl phthalate (MEP; the primary metabolite of DEP) than other
   women. Other PCPs that were significantly associated with MEP
   concentrations included: hair spray, nail polish, and deodorant. MEP
   concentrations increased with the nurnber of PCPs used. PCP use was
   widespread in this group of recently pregnant women. Women's use of
   PCPs, particularly of perfumes and fragranced products, was positively
   associated with urinary concentration of multiple phthalate metabolites.
   Joumal of Exposure Science and Environmental Epidemiology (2013) 23,
   197-206; doi:10.1038/jes.2012.105; published online 21 November 2012}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Parlett, LE (Reprint Author), Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, Off Res Adm, 601 Elmwood Ave,Box 668, Rochester, NY 14642 USA.
   Parlett, Lauren E., Univ Rochester, Sch Med \& Dent, Dept Publ Hlth Sci, Rochester, NY 14642 USA.
   Parlett, Lauren E.; Swan, Shanna H., Univ Rochester, Med Ctr, Dept Obstet \& Gynecol, Rochester, NY 14642 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Swan, Shanna H., Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA.}},
DOI = {{10.1038/jes.2012.105}},
ISSN = {{1559-0631}},
Keywords = {{phthalates; epidemiology; personal exposure}},
Keywords-Plus = {{COSMETIC PRODUCTS; URINARY CONCENTRATIONS; DI(2-ETHYLHEXYL) PHTHALATE;
   OXIDATIVE METABOLITES; ANOGENITAL DISTANCE; DIETHYL PHTHALATE;
   PREGNANT-WOMEN; MEXICAN WOMEN; MALE INFANTS; ESTERS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{Lauren\_Parlett@urmc.rochester.edu}},
ResearcherID-Numbers = {{Parlett, Lauren/I-3309-2013}},
ORCID-Numbers = {{Parlett, Lauren/0000-0003-1240-4566}},
Funding-Acknowledgement = {{US Environmental Protection Agency; National Institutes of Health
   {[}R01-ES09916, MO1-RR00400, MO1-RR0425]; State of Iowa to the
   University of Iowa {[}18018278, 1RC2ES018736-02]}},
Funding-Text = {{This study was supported by grants from the US Environmental Protection
   Agency; National Institutes of Health Grants R01-ES09916 to the
   University of Missouri, MO1-RR00400 to the University of Minnesota, and
   MO1-RR0425 to Harbor-UCLA Medical Center; Grant 18018278 from the State
   of Iowa to the University of Iowa and 1RC2ES018736-02 to the University
   of Rochester. We gratefully acknowledge the technical assistance of
   Manori Silva, Jack Reidy, Ella Samandar, Tao Jia, and Jim Preau (Centers
   for Disease Control and Prevention, Atlanta, GA, USA) in measuring the
   urinary concentrations of phthalate metabolites. The findings and
   conclusions in this report are those of the authors and do not
   necessarily represent the views of the CDC.}},
Cited-References = {{Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Calafat AM, 2008, INT J ANDROL, V31, P139, DOI 10.1111/j.1365-2605.2007.00826.x.
   Centers for Disease Control and Prevention (CDC), 2012, 4 CDCP.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   DeGroot AC, 1997, CONTACT DERMATITIS, V36, P57.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Gervin D, 2008, J INTELL PROP L, V15, P315.
   Hall B, 2007, FOOD CHEM TOXICOL, V45, P2097, DOI 10.1016/j.fct.2007.06.017.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P48.
   Houlihan J, 2002, NOT TOO PRETTY.
   Hubinger JC, 2006, J COSMET SCI, V57, P127.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Jurek AM, 2008, INT J EPIDEMIOL, V37, P382, DOI 10.1093/ije/dym291.
   Just AC, 2010, J EXPO SCI ENV EPID, V20, P625, DOI 10.1038/jes.2010.13.
   KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kim SH, 2011, FERTIL STERIL, V95, P357, DOI 10.1016/j.fertnstert.2010.07.1059.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koniecki D, 2011, ENVIRON RES, V111, P329.
   Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091.
   Loretz L, 2006, FOOD CHEM TOXICOL, V44, P2008, DOI 10.1016/j.fct.2006.06.029.
   Loretz LJ, 2008, FOOD CHEM TOXICOL, V46, P1516, DOI 10.1016/j.fct.2007.12.011.
   Loretz LJ, 2005, FOOD CHEM TOXICOL, V43, P279, DOI 10.1016/j.fct.2004.09.016.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Maxwell N.I., 2000, SOCIAL DIFFERENCES W.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Nassar N, 2010, OCCUP ENVIRON MED, V67, P585, DOI 10.1136/oem.2009.048272.
   Ormond G, 2009, ENVIRON HEALTH PERSP, V117, P303, DOI 10.1289/ehp.11933.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Reddy BS, 2006, BJOG-INT J OBSTET GY, V113, P515, DOI 10.1111/j.1471-0528.2006.00925.x.
   Romero-Franco M, 2011, ENVIRON INT, V37, P867, DOI 10.1016/j.envint.2011.02.014.
   Sarantis H, 2010, NOT SO SEXY HLTH RIS.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Scheinman PL, 1999, J AM ACAD DERMATOL, V41, P1020, DOI 10.1016/S0190-9622(99)70265-3.
   Grandjean P, 2006, INT J ANDROL, V29, P181, DOI 10.1111/j.1365-2605.2005.00679.x.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Shen HY, 2007, J SEP SCI, V30, P48, DOI 10.1002/jssc.200600215.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Svensson K, 2011, ENVIRON RES, V111, P792, DOI 10.1016/j.envres.2011.05.015.
   Swan SH, 2006, ENVIRON HEALTH PERSP, V114, pA88.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Termini RB, 2008, FOOD DRUG LAW J, V63, P257.
   THOMAS JA, 1982, ENVIRON HEALTH PERSP, V45, P85, DOI 10.2307/3429388.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Wu XM, 2010, FOOD CHEM TOXICOL, V48, P3109, DOI 10.1016/j.fct.2010.08.004.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{0}},
Journal-ISO = {{J. Expo. Sci. Environ. Epidemiol.}},
Doc-Delivery-Number = {{092MH}},
Wos-Id = {{ISI:000315126200013}},
}

@article{ ISI:000315059500026,
Author = {Guerranti, Cristiana and Sbordoni, Ivana and Fanello, Emiliano Leonida
   and Borghini, Francesca and Corsi, Ilaria and Focardi, Silvano Ettore},
Title = {{Levels of phthalates in human milk samples from central Italy}},
Journal = {{MICROCHEMICAL JOURNAL}},
Year = {{2013}},
Volume = {{107}},
Number = {{SI}},
Pages = {{178-181}},
Month = {{MAR}},
Note = {{14th Hungarian-Italian Symposium on Spectrochemistry - Analytical
   Techniques and Preservation of Natural Resources, Sumeg, HUNGARY, OCT
   05-07, 2011}},
Organization = {{Hungarian Chem Soc; Hungarian Acad Sci; Eotvos Lorand Univ; Italian Natl
   Inst Hlth; Italian Branch Soc Environm Toxicol \& Chem}},
Abstract = {{This study concerns the presence and levels of phthalic acid diester
   DEHP and its metabolite MEHP in human biological samples; breast milk,
   as the only food given to infants in the first few months of life, is
   the chosen matrix and studying its DEHP and MEHP concentrations
   represents one of the most important ways to remove this kind of
   contaminants from the human body.
   The study was carried out on 32 samples of human milk, obtained from
   women living in Siena and its district, in central Italy. The
   contaminant's extraction was done using an ion-pairing extraction
   procedure, and then the concentrations were determined using high
   performance liquid chromatography (HPLC) with electrospray tandem mass
   spectrometry (ESI-MS).
   The results show the presence of MEHP in each sample (mean value 17.41
   ng/g w.w.), while DEHP has never been detected. Comparing the results of
   these analyses with a previous work, carried out on Italian breast milk
   samples, we have found a higher mean level of MEHP but a lower maximum
   level.
   In order to quantify the amount of the molecules of interest transmitted
   by mother to child during breast feeding, we estimated the daily intake
   of MEHP that resulted lower than safety limits. (C) 2012 Elsevier B.V.
   All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Guerranti, C (Reprint Author), Univ Siena, Dept Environm Sci, Via Mattioli 4, I-53100 Siena, Italy.
   Guerranti, Cristiana; Sbordoni, Ivana; Fanello, Emiliano Leonida; Borghini, Francesca; Corsi, Ilaria; Focardi, Silvano Ettore, Univ Siena, Dept Environm Sci, I-53100 Siena, Italy.}},
DOI = {{10.1016/j.microc.2012.06.014}},
ISSN = {{0026-265X}},
Keywords = {{Breast milk; Exposure; Environmental hazards; Human; Infant; Phthalate
   monoester}},
Keywords-Plus = {{HUMAN ADIPOSE-TISSUE; TANDEM MASS-SPECTROMETRY; HUMAN BREAST-MILK;
   POLYCHLORINATED-BIPHENYLS; EXPOSURE; METABOLITES; PESTICIDES; CONGENERS;
   TOXICITY; SERUM}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Author-Email = {{guerranticri@unisi.it}},
Cited-References = {{BARRON MG, 1989, TOXICOL APPL PHARM, V98, P49, DOI 10.1016/0041-008X(89)90133-6.
   Bellieni C.V., 2008, GRAVIDANZA ECOLOGICA, P93.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   CORSOLINI S, 1995, ARCH ENVIRON CON TOX, V29, P61.
   EFSA, 2005, EFSA J, V243, P1.
   FOCARDI S, 1987, CHEMOSPHERE, V16, P2315.
   FOCARDI S, 1986, B ENVIRON CONTAM TOX, V36, P644.
   FOCARDI S, 1984, RIV ITAL PED, V10, P286.
   Governini L, 2011, J ASSIST REPROD GEN, V28, P415, DOI 10.1007/s10815-011-9548-2.
   Governini L., 2009, SYST BIOL REPROD MED, V2, P41.
   Guerranti C, 2008, J FOOD LIPIDS, V15, P190, DOI 10.1111/j.1745-4522.2008.00111.x.
   Guerranti C., 2008, ORGANOHALOGEN COMPD, V70.
   Guerranti C., 2007, THESIS U SIENA SIENA.
   Guerranti C., 2011, ORGANOHALOGEN COMPD, V73, P84.
   Guerranti C., 2011, ISRN TOXICOL.
   Guerranti C., 2011, ORGANOHALOGEN COMPD, V73, P957.
   Guerranti C., 2011, ISRN TOXICOLOGY.
   Guerranti C., 2009, GIMT, V63, P397.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Latini G, 2004, REPROD TOXICOL, V19, P27, DOI 10.1016/j.reprotox.2004.05.011.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Latini G, 2009, ENVIRON INT, V35, P236, DOI 10.1016/j.envint.2008.06.002.
   Latini G, 2006, TOXICOLOGY, V226, P90, DOI 10.1016/j.tox.2006.07.011.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Mariottini M, 2000, MICROCHEM J, V67, P63, DOI 10.1016/S0026-265X(00)00100-4.
   Mariottini M, 2002, B ENVIRON CONTAM TOX, V68, P72.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   Riordan J, 2005, J HUM LACT, V21, P406, DOI 10.1177/0890334405281032.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019.
   Takatori S, 2004, J CHROMATOGR B, V804, P397, DOI 10.1016/j.jchromb.2004.01.056.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{0}},
Journal-ISO = {{Microchem J.}},
Doc-Delivery-Number = {{091OK}},
Wos-Id = {{ISI:000315059500026}},
}

@article{ ISI:000315184200166,
Author = {Wang, Hexing and Zhou, Ying and Tang, Chuanxi and He, Yanhong and Wu,
   Jingui and Chen, Yue and Jiang, Qingwu},
Title = {{Urinary Phthalate Metabolites Are Associated with Body Mass Index and
   Waist Circumference in Chinese School Children}},
Journal = {{PLOS ONE}},
Year = {{2013}},
Volume = {{8}},
Number = {{2}},
Month = {{FEB 20}},
Abstract = {{Background: Lab studies have suggested that ubiquitous phthalate
   exposures are related to obesity, but relevant epidemiological studies
   are scarce, especially for children.
   Objective: To investigate the association of phthalate exposures with
   body mass index (BMI) and waist circumference (WC) in Chinese school
   children.
   Methods: A cross-sectional study was conducted in three primary and
   three middle schools randomly selected from Changning District of
   Shanghai City of China in 2011-2012. According to the physical
   examination data in October, 2011, 124 normal weight, 53 overweight, and
   82 obese students 8-15 years of age were randomly chosen from these
   schools on the basis of BMI-based age- and sex-specific criterion. First
   morning urine was collected in January, 2012, and fourteen urine
   phthalate metabolites (free plus conjugated) were determined by
   ultra-performance liquid chromatography coupled to tandem mass
   spectrometry. Multiple linear regression was used to explore the
   associations between naturally log-transformed urine phthalate
   metabolites and BMI or WC.
   Results: The urine specific gravity-corrected concentrations of nine
   urine phthalate metabolites and five molar sums were positively
   associated with BMI or WC in Chinese school children after adjustment
   for age and sex. However, when other urine phthalate metabolites were
   included in the models together with age and sex as covariables, most of
   these significant associations disappeared except for mono
   (2-ethylhexyl) phthalate (MEHP) and monoethyl phthalate (MEP).
   Additionally, some associations showed sex- or age- specific
   differences.
   Conclusions: Some phthalate exposures were associated with BMI or WC in
   Chinese school children. Given the cross-sectional nature of this study
   and lack of some important obesity-related covariables, further studies
   are needed to confirm the associations.}},
Publisher = {{PUBLIC LIBRARY SCIENCE}},
Address = {{1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zhou, Y (Reprint Author), Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China.
   Wang, Hexing; Zhou, Ying; Jiang, Qingwu, Fudan Univ, Sch Publ Hlth, Minist Educ, Key Lab Publ Hlth Safety, Shanghai 200433, Peoples R China.
   Tang, Chuanxi; Wu, Jingui, Ctr Dis Control \& Prevent Changning Dist, Shanghai, Peoples R China.
   He, Yanhong, Anting Hosp, Dept Lab Med, Shanghai, Peoples R China.
   Chen, Yue, Univ Ottawa, Fac Med, Dept Epidemiol \& Community Med, Ottawa, ON, Canada.}},
DOI = {{10.1371/journal.pone.0056800}},
Article-Number = {{e56800}},
ISSN = {{1932-6203}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; ENDOCRINE DISRUPTORS; TEMPORAL VARIABILITY;
   US POPULATION; AGE-CHILDREN; EXPOSURE; OBESITY; ADOLESCENTS; RECEPTOR;
   HEALTH}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{yingchou@fudan.edu.cn}},
Funding-Acknowledgement = {{Ministry of Education of China {[}EZF201001]; National Health Research
   Program from the State Ministry of Health of China {[}201202012]}},
Funding-Text = {{This study was supported by project of 985 innovation platform for
   superiority subject of Ministry of Education of China (No. EZF201001)
   and grants of the National Health Research Program from the State
   Ministry of Health of China (No. 201202012). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.}},
Cited-References = {{Aylward LL, 2012, J EXPO SCI ENV EPID, V22, P398, DOI 10.1038/jes.2012.35.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2.
   Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139.
   Cameron N., 1978, HUMAN GROWTH, V2, P35.
   Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200.
   Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012.
   Centers for Disease Control and Prevention (CDC), 2012, 4 CDCP.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   Desdoits-Lethimonier C, 2012, HUM REPROD, V27, P1451, DOI 10.1093/humrep/des069.
   Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200.
   Gruen F, 2009, MOL CELL ENDOCRINOL, V304, P19.
   Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m.
   Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005.
   Guo Y, 2012, J AGR FOOD CHEM.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hatch EE, 2010, INT J ANDROL, V33, P324, DOI 10.1111/j.1365-2605.2009.01035.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610.
   Holtcamp W, 2012, ENVIRON HEALTH PERSP, V120, pA62, DOI 10.1289/ehp.120-a62.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Ji CY, 2010, BIOMED ENVIRON SCI, V23, P12, DOI 10.1016/S0895-3988(10)60026-8.
   Ji CY, 2005, BIOMED ENVIRON SCI, V18, P390.
   Kitahara CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034979.
   KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268.
   Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054.
   Pietrobelli A, 1998, J PEDIATR, V132, P204, DOI 10.1016/S0022-3476(98)70433-0.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Rajapakse N, 2002, ENVIRON HEALTH PERSP, V110, P917.
   Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x.
   Sargis RM, 2010, OBESITY, V18, P1283, DOI 10.1038/oby.2009.419.
   Shen OX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019159.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Takeuchi S, 2005, TOXICOLOGY, V210, P223, DOI 10.1016/j.tox.2005.02.002.
   Tanaka T, 2005, FOOD CHEM TOXICOL, V43, P581, DOI 10.1016/j.fct.2005.01.001.
   Teitelbaum SL, 2012, ENVIRON RES, V112, P186, DOI 10.1016/j.envres.2011.12.006.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597.
   Trasande L, 2012, JAMA-J AM MED ASSOC, V308, P1113, DOI 10.1001/2012.jama.11461.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   Wang HX, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-79.
   WINSHIP C, 1994, SOCIOL METHOD RES, V23, P230, DOI 10.1177/0049124194023002004.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Yen TH, 2011, J FORMOS MED ASSOC, V110, P671, DOI 10.1016/j.jfma.2011.09.002.
   Zhou Y, 2011, LANCET, V378, pE4, DOI 10.1016/S0140-6736(11)61700-5.}},
Number-of-Cited-References = {{57}},
Times-Cited = {{0}},
Journal-ISO = {{PLoS One}},
Doc-Delivery-Number = {{093IE}},
Wos-Id = {{ISI:000315184200166}},
}

@article{ ISI:000313610900004,
Author = {Kransler, Kevin M. and Bachman, Ammie N. and McKee, Richard H.},
Title = {{Estimates of daily di-isodecyl phthalate (DIDP) intake calculated from
   urinary biomonitoring data}},
Journal = {{REGULATORY TOXICOLOGY AND PHARMACOLOGY}},
Year = {{2013}},
Volume = {{65}},
Number = {{1}},
Pages = {{29-33}},
Month = {{FEB}},
Abstract = {{Biomonitoring of chemical species in biologic media can be a valuable
   tool in risk assessment since it informs directly on aggregate
   exposures. While advances in the analytical techniques required for
   biomonitoring have resulted in increased sensitivity for the detection
   of chemical species, the detection of a chemical substance in a
   biological medium (such as blood, urine or breast milk) does not mean
   that the chemical causes or is associated with an adverse health
   outcome. In this paper, intake estimates for di-isodecyl phthalate
   (DIDP), a high molecular weight general purpose plasticizer, were
   calculated from urinary biomonitoring data representing various
   population segments and geographic locales. From these data, intake
   estimates converge on a mean that is <1 mu g/kg/day (95th\% < 5 mu
   g/kg/day). This intake estimate is at least two orders of magnitude
   lower than the health-based exposure guidance values (38-150 mu
   g/kg/day) which have been proposed by regulatory authorities and other
   authoritative bodies as safe exposure levels. (C) 2012 Elsevier Inc. All
   rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kransler, KM (Reprint Author), ExxonMobil Biomed Sci Inc, 1545 Route 22 E, Annandale, NJ 08801 USA.
   Kransler, Kevin M.; Bachman, Ammie N.; McKee, Richard H., ExxonMobil Biomed Sci Inc, Annandale, NJ 08801 USA.}},
DOI = {{10.1016/j.yrtph.2012.11.004}},
ISSN = {{0273-2300}},
Keywords = {{Di-isodecyl phthalate; DIDP; Biomonitoring; Exposure estimates; Human;
   Urine}},
Keywords-Plus = {{ISO-NONYLPHTHALATE; PREGNANT-WOMEN; HUMAN EXPOSURE; METABOLITES; RATS;
   BIOMARKERS; EXCRETION; GERMANY; ESTERS}},
Research-Areas = {{Legal Medicine; Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Medicine, Legal; Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{kevin.kransler@exxonmobil.com
   ammie.n.bachman@exxonmobil.com
   richard.h.mckee@exxonmobil.com}},
Cited-References = {{Anderson WAC, 2011, FOOD CHEM TOXICOL, V49, P2022, DOI 10.1016/j.fct.2011.05.013.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Calafat AM, 2011, ENVIRON HEALTH PERSP, V119, P50, DOI 10.1289/ehp.1002316.
   California Office of Environmental Health Hazard Assessment, 2010, PROP 65 MAX ALL DOS.
   Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012.
   Cousins I, 2000, CHEMOSPHERE, V41, P1389, DOI 10.1016/S0045-6535(00)00005-9.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   European Chemicals Bureau, 2003, 68515491 CAS EUR CHE, V36.
   Hildenbrand S, 2009, INT J HYG ENVIR HEAL, V212, P679, DOI 10.1016/j.ijheh.2009.06.003.
   Hushka LJ, 2001, REPROD TOXICOL, V15, P153, DOI 10.1016/S0890-6238(01)00109-5.
   Kato K, 2007, TOXICOLOGY, V236, P114, DOI 10.1016/j.tox.2007.04.009.
   Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Remer T, 2002, AM J CLIN NUTR, V75, P561.
   Saravanabhavan G., 2012, J ENV PUB HLTH.
   Sears J.K., 1982, TECHNOLOGY PRASTICIZ.
   Silva MJ, 2007, BIOMARKERS, V12, P133, DOI 10.1080/13547500601066915.
   Tietz N.W., 2006, TIETZ TXB CLIN CHEM.
   United States Consumer Products Safety Commission, 2010, TOX REV DI IS PHTHAL.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Wittassek M., 2010, MOL NUTR FOOD RES, V54, P1.
   Kasper-Sonnenberg M, 2012, INT J HYG ENVIR HEAL, V215, P373, DOI 10.1016/j.ijheh.2011.09.004.
   <IT>European Food Safety Authority</IT>, 2005, EFSA J, V245, P1.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{0}},
Journal-ISO = {{Regul. Toxicol. Pharmacol.}},
Doc-Delivery-Number = {{071RC}},
Wos-Id = {{ISI:000313610900004}},
}

@article{ ISI:000313667400037,
Author = {Frederiksen, Hanne and Kranich, Selma K. and Jorgensen, Niels and
   Taboureau, Olivier and Petersen, Jorgen H. and Andersson, Anna-Maria},
Title = {{Temporal Variability in Urinary Phthalate Metabolite Excretion Based on
   Spot, Morning, and 24-h Urine Samples: Considerations for
   Epidemiological Studies}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2013}},
Volume = {{47}},
Number = {{2}},
Pages = {{958-967}},
Month = {{JAN 15}},
Abstract = {{Urinary phthalate excretion is used as marker of phthalate exposure in
   epidemiological studies. Here we examine the reliability of urinary
   phthalate levels in exposure classification by comparing the inter- and
   intrasubject variation of urinary phthalate metabolite levels.
   Thirty-three young healthy men each collected two spot, three
   first-morning, and three 24-h urine samples during a 3-month period.
   Samples were analyzed for the content of 12 urinary metabolites of 7
   different phthalates. Variability was assessed as intraclass correlation
   coefficients (ICC). For the metabolites of diethyl-, dibutyl-, and
   butylbenzyl-phthalates moderate ICCs were observed in all three sample
   types, albeit highest in 24-h urine (0.51-0.59). For the metabolites of
   di(2-ethylhexyl) phthalate and di-iso-nonyl phthlates lower ICCs
   (0.06-0.29) were found. These low ICCs indicate a high risk of
   misclassification of exposures for these two phthalates in population
   studies and hence an attenuation of the power to detect possible
   exposure-outcome associations. The only slightly higher ICCs for 24-h
   pools compared to first-morning and spot urine samples does not seem to
   justify the extra effort needed to collect 24-h pools.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Andersson, AM (Reprint Author), Copenhagen Univ Hosp, Rigshosp, Dept Growth \& Reprod, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
   Frederiksen, Hanne; Kranich, Selma K.; Jorgensen, Niels; Petersen, Jorgen H.; Andersson, Anna-Maria, Copenhagen Univ Hosp, Rigshosp, Dept Growth \& Reprod, DK-2100 Copenhagen, Denmark.
   Taboureau, Olivier, Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.}},
DOI = {{10.1021/es303640b}},
ISSN = {{0013-936X}},
Keywords-Plus = {{BISPHENOL-A CONCENTRATIONS; BODY-MASS INDEX; REPRODUCTIVE-TRACT;
   PREGNANT-WOMEN; SEMEN QUALITY; CARE PRODUCTS; EXPOSURE; MEN; POPULATION;
   BIOMARKERS}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{anna@rh.dk}},
ResearcherID-Numbers = {{Jorgensen, Niels/A-8148-2012}},
Funding-Acknowledgement = {{Velux Fonden; Danish Research Agency {[}2107-05-0006]; Lundbeck
   Foundation {[}124/05]; European Commission {[}FP7-212844]; Danish
   Environmental Protection Agency {[}MST-621-00013]}},
Funding-Text = {{We thank Ole Nielsen, Department of Growth and Reproduction, Copenhagen
   University Hospital, Denmark for skilled technical assistance. Prof.
   Jurgen Angerer and Mathias Wittassek, University of Erlangen-Nuremberg,
   Germany are thanked for supporting us with some of the internal
   standards. Velux Fonden financially supported the instrumental equipment
   and the Danish Research Agency (grant 2107-05-0006); the Lundbeck
   Foundation (j.nr. 124/05), the European Commission (FP7-212844, DEER),
   and the Danish Environmental Protection Agency (MST-621-00013) supported
   the present work. The findings and conclusions in the present study are
   those of the authors and do not necessarily represent the views of the
   supporters.}},
Cited-References = {{Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Baird DD, 2010, J EXPO SCI ENV EPID, V20, P169, DOI 10.1038/jes.2009.17.
   Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139.
   CDC, 2009, 4 CDCP.
   Christensen KLY, 2012, J EXPO SCI ENV EPID, V22, P632, DOI 10.1038/jes.2012.52.
   EIGENBERG DA, 1986, J TOXICOL ENV HEALTH, V17, P445.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Frederiksen H, 2012, INT J ANDROL, V35, P216, DOI 10.1111/j.1365-2605.2012.01260.x.
   Frederiksen H, 2010, J ANAL TOXICOL, V34, P400.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Herr C, 2009, INT J HYG ENVIR HEAL, V212, P648, DOI 10.1016/j.ijheh.2009.08.001.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Jorgensen N, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000990.
   Just AC, 2010, J EXPO SCI ENV EPID, V20, P625, DOI 10.1038/jes.2010.13.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Marcus Michele, 2010, Reviews on Environmental Health, V25, P359.
   Meeker JD, 2012, J EXPO SCI ENV EPID, V22, P376, DOI 10.1038/jes.2012.7.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522.
   Mortamais M, 2012, ENVIRON HEALTH-GLOB, V11, DOI 10.1186/1476-069X-11-29.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Ravnborg TL, 2011, HUM REPROD, V26, P1000, DOI 10.1093/humrep/der011.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Whyatt RM, 2009, PEDIATRICS, V124, pE1213, DOI 10.1542/peds.2009-0325.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{0}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{072JO}},
Wos-Id = {{ISI:000313667400037}},
}

@article{ ISI:000322100800004,
Author = {Zhang, Lian-Dong and Deng, Qian and Wang, Zi-Ming and Gao, Ming and
   Wang, Lei and Chong, Tie and Li, He-Cheng},
Title = {{Disruption of reproductive development in male rat offspring following
   gestational and lactational exposure to di-(2-ethylhexyl) phthalate and
   genistein}},
Journal = {{BIOLOGICAL RESEARCH}},
Year = {{2013}},
Volume = {{46}},
Number = {{2}},
Pages = {{139-146}},
Abstract = {{Studies of developmental effects of mixtures of endocrine disrupters on
   the male reproductive system are of great concern. In this study, the
   reproductive effects of the co-administration of di-2-(ethylhexyl)
   phthalate (DEHP) and genistein (GEN) during pregnancy and lactation were
   studied in male rat offspring. Pregnant Sprague-Dawley rats were gavaged
   from gestation day 3 to postnatal day 21 with vehicle control, DEHP 250
   mg/kg body weight (bw)/day, GEN 50 mg/kg bw/day, GEN 400 mg/kg bw/day,
   and two combinations of the two compounds (DEHP 250 mg/kg bw/day + GEN
   50 mg(kg bw/day, DEHP 250 mg/kg bw/day + GEN 400 mg/kg bw/day). The
   outcomes studied were general morphometry (weight, AGD), testicular
   histology, testosterone levels, and expression at the mRNA le-vel of
   genes involved in steroidogenesis. Organ coefficient, AGD / body
   weight(1 / 3), serum testosterone concentration and genes involved in
   steroidogenic pathway expression when exposed to DEHP (250mg/kg bw/day),
   GEN(50mg/kg bw/day) or GEN(400mg/kg bw/day) alone were not significantly
   different from the control group. When exposed to (DEHP 250mg/kg bw/day
   +GEN 50mg/kg bw/day) together during pregnancy and lactation, serum
   testosterone concentration, epididymis coefficient and Cypall7a1,Scarbl
   m RNA expression significantly decreased compared to the control and
   GEN(50mg /kg bw/day). When exposed to (DEHP 250mg /kg bw/day +GEN
   400mg/kg bw/day) together during pregnancy and lactation, AGD / body
   weightl 3, serum testosterone concentration, testis and epididymis
   coefficient and Star, Cypall7a1 mRNA expression appeared significantly
   decreased compared to the control and DEHP /GEN single exposure,
   together with developmental impairment of seminiferous tubules and
   seminiferous epithelium. Overall, co-administration of DEHP and GEN
   during gestation and lactation seem to acts in a cumulative manner to
   induce the most significant alterations in the neonate, especially with
   GEN at high dose, although the effect of the DEHP-GEN mixture on adult
   offspring should be observed further.}},
Publisher = {{SOC BIOLGIA CHILE}},
Address = {{CASILLA 16164, SANTIAGO 9, CHILE}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Li, HC (Reprint Author), Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 2, Sch Med, 157 Xiwu Rd, Xian 710004, Shaanxi, Peoples R China.
   Zhang, Lian-Dong; Deng, Qian; Wang, Zi-Ming; Wang, Lei; Chong, Tie; Li, He-Cheng, Xi An Jiao Tong Univ, Dept Urol, Affiliated Hosp 2, Sch Med, Xian 710004, Shaanxi, Peoples R China.
   Gao, Ming, Xian 4 Hosp, Dept Nephrol, Xian 710004, Shaanxi, Peoples R China.}},
ISSN = {{0716-9760}},
Keywords = {{Di-2-(ethylhexyl) phthalate; genistein; pregnancy; lactation;
   reproductive system}},
Keywords-Plus = {{TESTICULAR DYSGENESIS SYNDROME; SPRAGUE-DAWLEY RATS; IN-UTERO EXPOSURE;
   PHYTO-ESTROGENS; TESTOSTERONE PRODUCTION; ANTI-ANDROGENS; SOY;
   ENDOCRINE; MODEL; PHYTOESTROGEN}},
Research-Areas = {{Life Sciences \& Biomedicine - Other Topics}},
Web-of-Science-Categories  = {{Biology}},
Author-Email = {{lihecheng@yahoo.com.cn}},
Cited-References = {{Casals-Casas C, 2011, ANNU REV PHYSIOL, V73, P135, DOI 10.1146/annurev-physiol-012110-142200.
   Cederroth CR, 2010, INT J ANDROL, V33, P304, DOI 10.1111/j.1365-2605.2009.01011.x.
   Christiansen S, 2010, REPROD TOXICOL, V30, P313, DOI 10.1016/j.reprotox.2010.04.005.
   Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649.
   Duncan AM, 2003, BEST PRACT RES CL EN, V17, P253, DOI 10.1053/ybeem.2003.246.
   Eustache F, 2009, ENVIRON HEALTH PERSP, V117, P1272, DOI 10.1289/ehp.0800158.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Hass U, 2007, ENVIRON HEALTH PERSP, V115, P122, DOI 10.1289/ehp.9360.
   Hu GX, 2009, TRENDS ENDOCRIN MET, V20, P139, DOI 10.1016/j.tem.2008.12.001.
   Kamrin MA, 2009, J TOXICOL ENV HEAL B, V12, P157, DOI 10.1080/10937400902729226.
   Kortenkamp A, 2008, INT J ANDROL, V31, P233, DOI 10.1111/j.1365-2605.2007.00862.x.
   Kumi-Diaka J, 1999, BIOL CELL, V91, P515, DOI 10.1016/S0248-4900(00)88208-8.
   Lagos-Cabre R, 2012, BIOL RES, V45, P5, DOI 10.1590/S0716-97602012000100001.
   Lehraiki A, 2011, TOXICOL IN VITRO, V25, P1542, DOI 10.1016/j.tiv.2011.05.017.
   Lehraiki A, 2011, REPROD TOXICOL, V31, P424, DOI 10.1016/j.reprotox.2010.12.005.
   Main KM, 2010, BEST PRACT RES CL EN, V24, P279, DOI 10.1016/j.beem.2009.10.003.
   McClain RM, 2007, FOOD CHEM TOXICOL, V45, P1319, DOI 10.1016/j.fct.2007.01.009.
   MICHAEL MR, 2006, FOOD CHEM TOXICOL, V44, P56.
   Pocar P, 2012, ENDOCRINOLOGY, V153, P937, DOI 10.1210/en.2011-1450.
   Qian YS, 2012, NEUROCHEM INT, V60, P759, DOI 10.1016/j.neuint.2012.03.011.
   Rider CV, 2010, INT J ANDROL, V33, P443, DOI 10.1111/j.1365-2605.2009.01049.x.
   Rider CV, 2009, TOXICOL PATHOL, V37, P100, DOI 10.1177/0192623308329478.
   Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x.
   Roberts D, 2000, ENDOCRINE, V13, P281, DOI 10.1385/ENDO:13:3:281.
   ROSENBERG ZR, 2000, CLIN CHEM, V46, P887.
   Shirota Mariko, 2005, Journal of Toxicological Sciences, V30, P175, DOI 10.2131/jts.30.175.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Strom BL, 2001, JAMA-J AM MED ASSOC, V286, P807, DOI 10.1001/jama.286.7.807.
   TM E, 2006, INT J ANDROL, V29, P109.
   Toppari J, 2010, BIRTH DEFECTS RES A, V88, P910, DOI 10.1002/bdra.20707.
   Vo TTB, 2009, J REPROD DEVELOP, V55, P400.
   Wisniewski AB, 2003, J UROLOGY, V169, P1582, DOI 10.1097/01.ju.0000046780.23389.e0.
   Wisniewski AB, 2005, PHYSIOL BEHAV, V84, P327, DOI 10.1016/j.physbeh.2004.12.008.
   Yiee JH, 2010, J UROLOGY, V184, P34, DOI 10.1016/j.juro.2010.03.051.
   You L, 2002, TOXICOL SCI, V66, P91, DOI 10.1093/toxsci/66.1.91.
   Yousef MI, 2003, J ENVIRON SCI HEAL B, V38, P463, DOI 10.1081/PFC-120021666.
   {[}Anonymous], 2008, CURR UROL REP, V9, P137.
   {[}Anonymous], 2001, J ENDOCRINOL, V170, P591.
   {[}Anonymous], 1993, LANCET, V342, P1209.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{0}},
Journal-ISO = {{Biol. Res.}},
Doc-Delivery-Number = {{187EX}},
Wos-Id = {{ISI:000322100800004}},
}

@article{ ISI:000315508900008,
Author = {Sun, Jian-Nan and Shi, Yan-Ping and Chen, Juan},
Title = {{Simultaneous determination of plasticizer di(2-ethylhexyl)phthalate and
   its metabolite in human urine by temperature controlled ionic liquid
   dispersive liquid-liquid microextraction combined with high performance
   liquid chromatography}},
Journal = {{ANALYTICAL METHODS}},
Year = {{2013}},
Volume = {{5}},
Number = {{6}},
Pages = {{1427-1434}},
Abstract = {{Temperature controlled ionic liquid dispersive liquid-liquid
   microextraction (TC IL-DLLME) combined with high performance liquid
   chromatography (HPLC) has been developed for the simultaneous
   determination of di(2-ethylhexyl)phthalate (DEHP) and its metabolite
   mono(2-ethylhexyl) phthalate (MEHP) in human urine samples. Dibutyl
   phthalate (DBP) was employed as an internal standard. Some important
   parameters, such as the type of extraction solvent and dispersive
   solvent, the volume ratio of extraction to dispersive solvent, volume of
   a mixture of extraction solvent and dispersive solvent, temperature,
   sample pH, salt effect, cooling time and centrifugation time, were
   investigated and optimized to achieve a high extraction efficiency.
   Under the optimized extraction conditions, the method showed 115- and
   164-fold enrichment factors for MEHP and DEHP in urine samples,
   respectively. It also exhibited high sensitivity with the limits of
   detection at 0.96 mu g L-1 and 3.2 mu g L-1 for MEHP and DEHP,
   respectively. The calibration curves were linear in the concentration
   range of 20-1920 mu g L-1 for MEHP and 60-1920 mu g L-1 for DEHP, with
   the correlation coefficients higher than 0.9990. The proposed method can
   be expected to monitor the human exposure to the plasticizer agent by
   determining its metabolites in human urine samples.}},
Publisher = {{ROYAL SOC CHEMISTRY}},
Address = {{THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chen, J (Reprint Author), Chinese Acad Sci, Lanzhou Inst Chem Phys, Key Lab Chem Northwestern Plant Resources, Lanzhou 730000, Peoples R China.
   Sun, Jian-Nan; Shi, Yan-Ping; Chen, Juan, Chinese Acad Sci, Lanzhou Inst Chem Phys, Key Lab Chem Northwestern Plant Resources, Lanzhou 730000, Peoples R China.
   Sun, Jian-Nan; Shi, Yan-Ping; Chen, Juan, Chinese Acad Sci, Lanzhou Inst Chem Phys, Key Lab Nat Med Gansu Prov, Lanzhou 730000, Peoples R China.
   Sun, Jian-Nan, Chinese Acad Sci, Grad Univ, Beijing 100039, Peoples R China.}},
DOI = {{10.1039/c3ay26367c}},
ISSN = {{1759-9660}},
Keywords-Plus = {{SOLID-PHASE MICROEXTRACTION; TANDEM MASS-SPECTROMETRY; PHTHALATE
   EXPOSURE; WATER SAMPLES; DIETHYL PHTHALATE; DIBUTYL PHTHALATE; ESTERS;
   EXTRACTION; MONO(2-ETHYLHEXYL)PHTHALATE; PESTICIDES}},
Research-Areas = {{Chemistry; Food Science \& Technology; Spectroscopy}},
Web-of-Science-Categories  = {{Chemistry, Analytical; Food Science \& Technology; Spectroscopy}},
Author-Email = {{chenjuan@licp.cas.cn}},
Funding-Acknowledgement = {{National Nature Science Foundation of China {[}21075127, 21105106];
   Nature Science Foundation of Gansu Province {[}1107RJZA146]}},
Funding-Text = {{The work was supported by the National Nature Science Foundation of
   China (no. 21075127 and 21105106) and Nature Science Foundation of Gansu
   Province (no. 1107RJZA146).}},
Cited-References = {{Asensio-Ramos M, 2011, J CHROMATOGR A, V1218, P4808, DOI 10.1016/j.chroma.2010.11.030.
   Bai HH, 2009, ANAL CHIM ACTA, V651, P64, DOI 10.1016/j.aca.2009.08.011.
   Balafas D, 1999, FOOD CHEM, V65, P279, DOI 10.1016/S0308-8146(98)00240-4.
   Berton P, 2012, ANAL CHIM ACTA, V713, P56, DOI 10.1016/j.aca.2011.11.024.
   Bidari A, 2011, FOOD CHEM, V126, P1840, DOI 10.1016/j.foodchem.2010.11.142.
   Blair JD, 2009, ENVIRON SCI TECHNOL, V43, P6262, DOI 10.1021/es9013135.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376.
   Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m.
   Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   He LJ, 2009, ANAL CHIM ACTA, V655, P52, DOI 10.1016/j.aca.2009.09.044.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Higuchi TT, 1999, BIOL REPROD, V60, P153.
   Ito R, 2006, J PHARMACEUT BIOMED, V41, P455, DOI 10.1016/j.jpba.2005.12.021.
   Itoh H, 2009, SCI TOTAL ENVIRON, V408, P37, DOI 10.1016/j.scitotenv.2009.09.012.
   Itoh H, 2005, INT J HYG ENVIR HEAL, V208, P237, DOI 10.1016/j.ijheh.2005.02.004.
   Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755.
   Kamarei F, 2010, TALANTA, V83, P36, DOI 10.1016/j.talanta.2010.08.035.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091.
   Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x.
   Mao T, 2009, J SEP SCI, V32, P3029, DOI 10.1002/jssc.200900337.
   Mazzeo P, 2007, BIOMED CHROMATOGR, V21, P1166, DOI 10.1002/bmc.870.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Pena MT, 2009, J CHROMATOGR A, V1216, P6356, DOI 10.1016/j.chroma.2009.07.032.
   Pereiro AB, 2007, J CHEM THERMODYN, V39, P1168, DOI 10.1016/j.jct.2006.12.005.
   Pietrogrande MC, 2003, ANAL CHIM ACTA, V480, P1, DOI 10.1016/S0003-2670(02)01652-5.
   Pizzolato TM, 2007, TRAC-TREND ANAL CHEM, V26, P609, DOI 10.1016/j.trac.2007.04.005.
   Brossa L, 2002, J CHROMATOGR A, V963, P287, DOI 10.1016/S0021-9673(02)00224-8.
   Polo M, 2005, J CHROMATOGR A, V1072, P63, DOI 10.1016/j.chroma.2004.12.040.
   Psillakis E, 2004, CHEMOSPHERE, V54, P849, DOI 10.1016/j.chemosphere.2003.09.039.
   Rezaee M, 2006, J CHROMATOGR A, V1116, P1, DOI 10.1016/j.chroma.2006.03.007.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Sun JN, 2011, J CHROMATOGR B, V879, P3429, DOI 10.1016/j.jchromb.2011.09.019.
   Suzuki T, 2001, ENVIRON SCI TECHNOL, V35, P3757, DOI 10.1021/es001860i.
   Takatori S, 2004, J CHROMATOGR B, V804, P397, DOI 10.1016/j.jchromb.2004.01.056.
   Vitali M, 1997, ENVIRON INT, V23, P337, DOI 10.1016/S0160-4120(97)00035-4.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Yan HY, 2011, J PHARMACEUT BIOMED, V54, P53, DOI 10.1016/j.jpba.2010.08.007.
   Zhang HF, 2010, TALANTA, V82, P1010, DOI 10.1016/j.talanta.2010.06.008.
   Zhang JH, 2011, J CHROMATOGR A, V1218, P6621, DOI 10.1016/j.chroma.2011.07.102.
   Zhou Qingxiang, 2008, J Chromatogr A, V1188, P148, DOI 10.1016/j.chroma.2008.02.094.
   Zhou QX, 2011, ANAL METHODS-UK, V3, P1815, DOI 10.1039/c1ay05137g.
   Zhou QX, 2011, TALANTA, V85, P1598, DOI 10.1016/j.talanta.2011.06.050.
   Zhou QX, 2008, J CHROMATOGR A, V1177, P43, DOI 10.1016/j.chroma.2007.10.103.
   Zhou QX, 2009, J CHROMATOGR A, V1216, P4361, DOI 10.1016/j.chroma.2009.03.046.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{0}},
Journal-ISO = {{Anal. Methods}},
Doc-Delivery-Number = {{097YH}},
Wos-Id = {{ISI:000315508900008}},
}

@article{ ISI:000313474200011,
Author = {Arguelles, D. B. Martinez and McIntosh, M. and Rohlicek, C. V. and
   Culty, M. and Zirkin, B. R. and Papadopoulos, V.},
Title = {{Maternal in utero exposure to the endocrine disruptor di-(2-ethylhexyl)
   phthalate affects the blood pressure of adult male offspring}},
Journal = {{TOXICOLOGY AND APPLIED PHARMACOLOGY}},
Year = {{2013}},
Volume = {{266}},
Number = {{1}},
Pages = {{95-100}},
Month = {{JAN 1}},
Abstract = {{Di-(2-ethylhexyl) phthalate (DEHP) is used industrially to add
   flexibility to polyvinyl chloride (PVC) polymers and is ubiquitously
   found in the environment, with evidence of prenatal, perinatal and early
   infant exposure in humans. In utero exposure to DEHP decreases
   circulating testosterone levels in the adult rat. In addition, DEHP
   reduces the expression of the angiotensin II receptors in the adrenal
   gland, resulting in decreased circulating aldosterone levels. The latter
   may have important effects on water and electrolyte balance as well as
   systemic arterial blood pressure. Therefore, we determined the effects
   of in utero exposure to DEHP on systemic arterial blood pressure in the
   young (2 month-old) and older (6.5 month-old) adult rats. Sprague-Dawley
   pregnant dams were exposed from gestational day 14 until birth to 300 mg
   DEHP/kg/day. Blood pressure, heart rate, and activity data were
   collected using an intra-aortal transmitter in the male offspring at
   postnatal day (PND) 60 and PND200. A low (0.01\%) and high-salt (8\%)
   diet was used to challenge the animals at PND200. In utero exposure to
   DEHP resulted in reduced activity at PND60. At PND200, systolic and
   diastolic systemic arterial pressures as well as activity were reduced
   in response to DEHP exposure. This is the first evidence showing that in
   utero exposure to DEHP has cardiovascular and behavioral effects in the
   adult male offspring. (c) 2012 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Papadopoulos, V (Reprint Author), McGill Univ, Montreal Gen Hosp, Ctr Hlth, Res Inst, 1650 Cedar Ave,Room C10-148, Montreal, PQ H3G 1A4, Canada.
   Arguelles, D. B. Martinez; McIntosh, M.; Rohlicek, C. V.; Culty, M.; Papadopoulos, V., McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3G 1A4, Canada.
   Arguelles, D. B. Martinez; Culty, M.; Papadopoulos, V., McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada.
   McIntosh, M.; Rohlicek, C. V., McGill Univ, Dept Pediat, Montreal, PQ H3G 1A4, Canada.
   Zirkin, B. R.; Papadopoulos, V., Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem \& Mol Biol, Baltimore, MD 21205 USA.}},
DOI = {{10.1016/j.taap.2012.10.027}},
ISSN = {{0041-008X}},
Keywords = {{Adrenal gland; Phthalate; Aldosterone; Systolic pressure; Activity}},
Keywords-Plus = {{CARE-UNIT INFANTS; TESTOSTERONE PRODUCTION; RISK-ASSESSMENT; MALE RATS;
   METABOLITES; DI(2-ETHYLHEXYL)PHTHALATE; MONOESTERS; NEURONS; BRAIN;
   CELLS}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{vassilios.papadopoulos@mcgill.ca}},
Funding-Acknowledgement = {{Canadian Institutes of Health Research (CIHR) {[}MOP-111131]; Canada
   Research Chair in Biochemical Pharmacology; Fonds de la Recherche Quebec
   - Sante}},
Funding-Text = {{We gratefully acknowledge Mr. Charles Essagian for his assistance.
   Supported by grant MOP-111131 from the Canadian Institutes of Health
   Research (CIHR) and a Canada Research Chair in Biochemical Pharmacology
   (to V.P.) The Research Institute of McGill University Health Centre is
   supported in part by a center grant from Fonds de la Recherche Quebec -
   Sante.}},
Cited-References = {{Calafat AM, 2004, PEDIATRICS, V113, P429.
   Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649.
   Desdoits-Lethimonier C, 2012, HUM REPROD, V27, P1451, DOI 10.1093/humrep/des069.
   Dhanya C. R., 2003, Indian Journal of Experimental Biology, V41, P814.
   Dobrzynska MM, 2012, ANN AGR ENV MED, V19, P31.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Ge RS, 2005, MOL CELL ENDOCRINOL, V243, P35, DOI 10.1016/j.mce.2005.08.004.
   Giribabu N., ENV TOXICOL.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Huang LP, 2011, FERTIL STERIL, V96, P90, DOI 10.1016/j.fertnstert.2011.04.093.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Jiang JT, 2007, TOXICOLOGY, V232, P286, DOI 10.1016/j.tox.2007.01.018.
   Kim TS, 2010, J TOXICOL ENV HEAL A, V73, P1544, DOI 10.1080/15287394.2010.511579.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Kwack SJ, 2009, J TOXICOL ENV HEAL A, V72, P1446, DOI 10.1080/15287390903212923.
   Latini Giuseppe, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P37, DOI 10.2174/1568008043340017.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lim CK, 2009, TOXICOLOGY, V264, P145, DOI 10.1016/j.tox.2009.08.015.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   Martinez-Arguelles DB, 2011, BIOL REPROD, V85, P51, DOI 10.1095/biolreprod.110.089920.
   Martinez-Arguelles DB, 2009, ENDOCRINOLOGY, V150, P5575, DOI 10.1210/en.2009-0847.
   Masuo Y, 2004, REGUL PEPTIDES, V123, P225, DOI 10.1016/j.regpep.2004.05.010.
   McKee RH, 2004, REPROD TOXICOL, V18, P1, DOI 10.1016/j.reprotox.2003.09.002.
   Phillips KP, 2008, J TOXICOL ENV HEAL B, V11, P188, DOI 10.1080/10937400701873472.
   Pocar P, 2012, ENDOCRINOLOGY, V153, P937, DOI 10.1210/en.2011-1450.
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF.
   Ross B, 2010, AM J HYPERTENS, V23, P1228, DOI 10.1038/ajh.2010.160.
   Shelby M. D., 2006, NTP CERHR MON, Vv, pvii.
   Silva MJ, 2005, ARCH TOXICOL, V79, P647, DOI 10.1007/s00204-005-0674-4.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Tanida T, 2009, TOXICOL LETT, V189, P40, DOI 10.1016/j.toxlet.2009.04.005.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   Xu Y, 2007, ARCH TOXICOL, V81, P57, DOI 10.1007/s00204-006-0143-8.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{0}},
Journal-ISO = {{Toxicol. Appl. Pharmacol.}},
Doc-Delivery-Number = {{069YY}},
Wos-Id = {{ISI:000313474200011}},
}

@article{ ISI:000313116100017,
Author = {Martine, Blanchard and Marie-Jeanne, Teil and Cendrine, Dargnat and
   Fabrice, Alliot and Marc, Chevreuil},
Title = {{Assessment of Adult Human Exposure to Phthalate Esters in the Urban
   Centre of Paris (France)}},
Journal = {{BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY}},
Year = {{2013}},
Volume = {{90}},
Number = {{1}},
Pages = {{91-96}},
Month = {{JAN}},
Abstract = {{Human exposure to phthalates was assessed through digestive and
   respiratory intakes. Six phthalates (DMP, DEP, DnBP, BBP, DEHP, DnOP)
   were investigated in drinking water, in current foodstuff and in ambient
   air. Digestive intake was prevailing (92 \%) with a major contribution
   of food (95.5 \%). Phthalate intake from water was mainly due to bottled
   water (60 \%) in spite of the minor volume absorbed daily. From the
   respiratory tract, it was dominated by DEP: 30.3 ng kg(-1) bw day(-1)
   and the part played by indoor air prevailed. Total intake were as ng
   kg(-1) bw day(-1), for DEHP: 1458, DnBP: 191.8, BBP: 164.3, DEP: 107.7,
   DMP: 79.1.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Martine, B (Reprint Author), Univ Paris 06, Ecole Prat Hautes Etud, Lab Hydrol Environm, UMR Sisyphe 7619, BC 105,Tour 56,4 PL Jussieu, F-75252 Paris 05, France.
   Martine, Blanchard; Marie-Jeanne, Teil; Cendrine, Dargnat; Fabrice, Alliot; Marc, Chevreuil, Univ Paris 06, Ecole Prat Hautes Etud, Lab Hydrol Environm, UMR Sisyphe 7619, F-75252 Paris 05, France.}},
DOI = {{10.1007/s00128-012-0859-5}},
ISSN = {{0007-4861}},
Keywords = {{Phthalate; Digestive intake; Respiratory intake}},
Keywords-Plus = {{ENDOCRINE-DISRUPTING COMPOUNDS; DI(2-ETHYLHEXYL)PHTHALATE DEHP; PHASE
   MICROEXTRACTION; DIET SAMPLES; ACID ESTERS; INDOOR AIR; WATER;
   ALKYLPHENOLS; PESTICIDES; URINE}},
Research-Areas = {{Environmental Sciences \& Ecology; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Toxicology}},
Author-Email = {{martine.blanchard@upmc.fr}},
Funding-Acknowledgement = {{Agence de l'Eau Seine-Normandie (AESN)}},
Funding-Text = {{This study was financially supported by the Agence de l'Eau
   Seine-Normandie (AESN). The authors wish to thank Mesdames A. Desportes
   and C. Bourges for their technical assistance. Last, we are grateful to
   Monsieur Le Cacheux and the staff from the restaurant of the University
   P\&M Curie for providing the food samples.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Amiridou Diana, 2011, J Hazard Mater, V185, P281, DOI 10.1016/j.jhazmat.2010.09.031.
   Dean JR, 2007, CHEMOSPHERE, V68, P1399, DOI 10.1016/j.chemosphere.2007.03.054.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1046/j.1600-0668.2003.00223.x.
   Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019.
   Koch HM, 2005, INT J HYG ENVIR HEAL, V208, P489, DOI 10.1016/j.ijheh.2005.07.001.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Muncke J, 2009, SCI TOTAL ENVIRON, V407, P4549, DOI 10.1016/j.scitotenv.2009.05.006.
   Peters RJB, 2006, R2006095 TNO.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   Prokupkova G, 2002, ANAL CHIM ACTA, V457, P211, DOI 10.1016/S0003-2670(02)00020-X.
   Regueiro J, 2008, J CHROMATOGR A, V1190, P27, DOI 10.1016/j.chroma.2008.02.091.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Rudel RA, 2009, ATMOS ENVIRON, V43, P170, DOI 10.1016/j.atmosenv.2008.09.025.
   Rundell KW, 2007, INHAL TOXICOL, V19, P133, DOI 10.1080/08958370601051727.
   Serodio P, 2006, WATER RES, V40, P2572, DOI 10.1016/j.watres.2006.05.002.
   Wang GH, 2007, ATMOS ENVIRON, V41, P407, DOI 10.1016/j.atmosenv.2006.07.033.
   Wang P, 2008, CHEMOSPHERE, V72, P1572.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Xie ZY, 2006, ANAL CHIM ACTA, V565, P198, DOI 10.1016/j.aca.2006.02.027.
   Xu J, 2007, ANAL CHIM ACTA, V597, P1, DOI 10.1016/j.aca.2007.06.047.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{0}},
Journal-ISO = {{Bull. Environ. Contam. Toxicol.}},
Doc-Delivery-Number = {{064ZS}},
Wos-Id = {{ISI:000313116100017}},
}

@article{ ISI:000313534900001,
Author = {Huang, Po-Chin and Liou, Saou-Hsing and Ho, Ing-Kan and Chiang, Hung-Che
   and Huang, Hsin-I and Wang, Shu-Li},
Title = {{Phthalates Exposure and Endocrinal Effects: An Epidemiological Review}},
Journal = {{JOURNAL OF FOOD AND DRUG ANALYSIS}},
Year = {{2012}},
Volume = {{20}},
Number = {{4}},
Pages = {{719-733}},
Month = {{DEC}},
Abstract = {{Phthalates are ubiquitous endocrine disruptors which may cause potential
   health effects in general populations. We explored 3 scientific
   databases (PubMed, Medline, and ScienceDirect) to search epidemiological
   studies focused on phthalates exposure and the important health effects
   including endocrine, hormonal regulation of thyroid and steroid,
   reproductive effects, pregnancy, precocious puberty, obesity, and
   infertility in human. Some studies demonstrated negative association
   between phthalate levels and sex steroid hormones (testosterone, LH),
   thyroid hormones (thyroxine), sperm quality, anogenital distance,
   gestational age and neurodevelopment (cognitive function and
   intelligence quotient), although most of them have some limitations. A
   few studies showed positive association between phthalate levels and
   precocious puberty, pregnancy loss, obesity, leiomyoma, although results
   of some studies were not consistent. In summary, phthalates may affect
   reproductive and sex hormones, thyroid function and development.
   Although large-scale cohort studies are needed to clarify the
   association, it is necessary to reduce the phthalates exposure in
   pregnant women and young children to prevent unexpected consequences of
   reproductive and development effects in the offspring.}},
Publisher = {{FOOD \& DRUG ADMINSTRATION}},
Address = {{161-2 KUNYANG STREET, NANGANG, TAIPEI, 00000, TAIWAN}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Wang, SL (Reprint Author), Natl Hlth Res Inst, Div Environm Hlth \& Occupat Med, Miaoli, Taiwan.
   Huang, Po-Chin; Chiang, Hung-Che, Natl Hlth Res Inst, NEHRC, Miaoli, Taiwan.
   Liou, Saou-Hsing; Chiang, Hung-Che; Huang, Hsin-I; Wang, Shu-Li, Natl Hlth Res Inst, Div Environm Hlth \& Occupat Med, Miaoli, Taiwan.
   Ho, Ing-Kan, Natl Hlth Res Inst, Div Mental Hlth \& Subst Abuse Res, Miaoli, Taiwan.}},
DOI = {{10.6227/jfda.2012200401}},
ISSN = {{1021-9498}},
Keywords = {{phthalate; endocrine; reproduction; thyroid function; neurodevelopment;
   infertility}},
Keywords-Plus = {{MALE REPRODUCTIVE DEVELOPMENT; HIGH PLASMA-CONCENTRATIONS;
   SCHOOL-AGE-CHILDREN; N-BUTYL PHTHALATE; URINARY PHTHALATE; ANOGENITAL
   DISTANCE; SEMEN QUALITY; DI(N-BUTYL) PHTHALATE; DI(2-ETHYLHEXYL)
   PHTHALATE; LACTATIONAL EXPOSURE}},
Research-Areas = {{Food Science \& Technology; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Food Science \& Technology; Pharmacology \& Pharmacy}},
Author-Email = {{slwang@nhri.org.tw}},
ResearcherID-Numbers = {{Huang, Po-Chin/I-5844-2012
   Chiang, Hung-Che/D-5154-2009
   Wang, Shu-Li/C-1367-2010
   Liou, Saou-Hsing /B-2667-2010}},
Funding-Acknowledgement = {{National Health Research Institutes {[}EO-100-PP05, EO-101-PP05]; Taiwan
   National Science Council {[}NSC98-2314-B-400-001-MY3,
   NSC100-3114-Y-043-005]}},
Funding-Text = {{We are grateful for the financial support from National Health Research
   Institutes (grants no.: EO-100-PP05, EO-101-PP05) and Taiwan National
   Science Council (NSC98-2314-B-400-001-MY3, NSC100-3114-Y-043-005).}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Al-Hendy A, 2006, HUM REPROD UPDATE, V12, P385, DOI 10.1093/humupd/dm1015.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Bustamante-Montes LP, 2008, EPIDEMIOLOGY, V19, pS270.
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   Chevrier C, 2012, EPIDEMIOLOGY, V23, P353, DOI 10.1097/EDE.0b013e318246073e.
   Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376.
   Chou YY, 2009, J PEDIATR ENDOCR MET, V22, P69.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Devlieger R, 2003, HUM REPROD UPDATE, V9, P139, DOI 10.1093/humupd/dmg010.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   Durmaz E, 2010, PEDIATRICS, V125, pE122, DOI 10.1542/peds.2009-0724.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   Ema M, 2001, REPROD TOXICOL, V15, P261, DOI 10.1016/S0890-6238(01)00131-9.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   FABER KA, 1992, BIOL REPROD, V46, P101, DOI 10.1095/biolreprod46.1.101.
   Gallavan RH, 1999, REPROD TOXICOL, V13, P383, DOI 10.1016/S0890-6238(99)00036-2.
   Grande SW, 2007, TOXICOLOGY, V229, P114, DOI 10.1016/j.tox.2006.10.005.
   Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88.
   Guo SW, 2005, MOL HUM REPROD, V11, P729, DOI 10.1093/molehr/gah206.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   Hatch EE, 2010, INT J ANDROL, V33, P324, DOI 10.1111/j.1365-2605.2009.01035.x.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Houlihan J., 2002, NOT PRETTY PHTHALATE.
   Huang LP, 2011, FERTIL STERIL, V96, P90, DOI 10.1016/j.fertnstert.2011.04.093.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Huang PC, 2010, HUM REPROD, V25, P986, DOI 10.1093/humrep/deq015.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Itoh H, 2009, SCI TOTAL ENVIRON, V408, P37, DOI 10.1016/j.scitotenv.2009.09.012.
   Jin Q., 2008, FRONT MED CHINA, V2, P303, DOI 10.1007/s11684-008-0058-2.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Key T J, 2001, Lancet Oncol, V2, P133, DOI 10.1016/S1470-2045(00)00254-0.
   Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034.
   Kim Y, 2011, ENVIRON HEALTH PERSP, V119, P1495, DOI 10.1289/ehp.1003178.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013.
   Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079.
   Liu LP, 2012, ENVIRON INT, V42, P78, DOI 10.1016/j.envint.2011.04.005.
   Lomenick JP, 2010, J PEDIATR-US, V156, P221, DOI 10.1016/j.jpeds.2009.09.047.
   Luisi S, 2006, GYNECOL ENDOCRINOL, V22, P92, DOI 10.1080/09513590600551312.
   Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Marin P, 1996, J CLIN ENDOCR METAB, V81, P1018, DOI 10.1210/jc.81.3.1018.
   MARIN P, 1992, INT J OBESITY, V16, P991.
   Marin P, 1995, OBES RES, V3, pS609.
   Mårin P, 1993, Obes Res, V1, P245.
   Martino-Andrade AJ, 2010, MOL NUTR FOOD RES, V54, P148, DOI 10.1002/mnfr.200800312.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582.
   Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522.
   Mendiola J, 2011, INT J ANDROL, V34, P369, DOI 10.1111/j.1365-2605.2010.01095.x.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Okubo T, 2003, BIOL PHARM BULL, V26, P1219.
   PALANZA P, 1995, PHYSIOL BEHAV, V58, P827, DOI 10.1016/0031-9384(95)00107-T.
   Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001.
   Qiao Lili, 2007, Wei Sheng Yan Jiu, V36, P93.
   Reddy BS, 2006, FERTIL STERIL, V85, P775, DOI 10.1016/j.fertnstert.2005.08.037.
   Reddy BS, 2006, BJOG-INT J OBSTET GY, V113, P515, DOI 10.1111/j.1471-0528.2006.00925.x.
   Risk Assessment Forum US Environmental Protection Agency, 1996, FED REG, V61, P56274.
   Roya R, 2009, INDIAN J MED RES, V129, P395.
   Rozati R, 2008, INT J FERTIL STERIL, V1, P165.
   Samandar E, 2009, ENVIRON RES, V109, P641, DOI 10.1016/j.envres.2009.02.004.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Sugiyama S, 2005, TOXICOL SCI, V88, P367, DOI 10.1093/toxsci/kfi330.
   Suzuki Y, 2012, INT J ANDROL, V35, P236, DOI 10.1111/j.1365-2605.2011.01190.x.
   Suzuki Y, 2010, ENVIRON INT, V36, P699, DOI 10.1016/j.envint.2010.05.003.
   Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Tellez-Rojo M.M., 2011, ISEE 2011 C BARC SPA.
   Toft G, 2012, ENVIRON HEALTH PERSP, V120, P458, DOI 10.1289/ehp.1103552.
   Weuve J, 2010, ENVIRON HEALTH PERSP, V118, P825, DOI 10.1289/ehp.0901543.
   Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705.
   Wirth JJ, 2008, SYST BIOL REPROD MEC, V54, P143, DOI 10.1080/19396360802055921.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Wolff MS, 2010, ENVIRON HEALTH PERSP, V118, P1039, DOI 10.1289/ehp.0901690.
   Yen TH, 2011, J FORMOS MED ASSOC, V110, P671, DOI 10.1016/j.jfma.2011.09.002.
   Zhang YH, 2006, BIOMED ENVIRON SCI, V19, P205.
   Zoeller RT, 2007, THYROID, V17, P811, DOI 10.1089/thy.2007.0107.}},
Number-of-Cited-References = {{98}},
Times-Cited = {{0}},
Journal-ISO = {{J. Food Drug Anal.}},
Doc-Delivery-Number = {{070TT}},
Wos-Id = {{ISI:000313534900001}},
}

@article{ ISI:000312427600015,
Author = {Rylee Phuong Do and Stahlhut, Richard W. and Ponzi, Davide and vom Saal,
   Frederick S. and Taylor, Julia A.},
Title = {{Non-monotonic dose effects of in utero exposure to di(2-ethylhexyl)
   phthalate (DEHP) on testicular and serum testosterone and anogenital
   distance in male mouse fetuses}},
Journal = {{REPRODUCTIVE TOXICOLOGY}},
Year = {{2012}},
Volume = {{34}},
Number = {{4}},
Pages = {{614-621}},
Month = {{DEC}},
Abstract = {{Di(2-ethylhexyl) phthalate (DEHP) is a ubiquitous environmental
   contaminant. Epidemiological studies suggest that DEHP decreases
   masculinization of male fetuses. Numerous rat studies report DEHP
   reduces fetal testosterone production at doses greatly exceeding human
   exposure. We fed pregnant CD-1 mice 0.5-500,000 mu g/kg/day DEHP from
   gestation day (CD) 9-18 and examined mothers and male fetuses on GD 18.
   We assessed non-monotonic dose-response by adding a quadratic term to a
   simple linear regression model. Except at the 500,000 mu g/kg/day dose,
   DEHP stimulated an increase in maternal and fetal serum testosterone and
   increased anogenital distance (AGD). Non-monotonic dose-response curves
   were noted for AGD and maternal, and testis testosterone (P values
   0.013-0.021). Because data from our highest dose (500,000 mu g/kg/day)
   did not differ significantly from controls, this dose could have been
   incorrectly assumed to be the NOAEL had we only tested very high doses,
   as is typical in studies for regulatory agencies. (C) 2012 Elsevier Inc.
   All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Taylor, JA (Reprint Author), Univ Missouri, Div Biol Sci, 114 Lefevre Hall, Columbia, MO 65211 USA.
   Rylee Phuong Do; Ponzi, Davide; vom Saal, Frederick S.; Taylor, Julia A., Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.
   Stahlhut, Richard W., Univ Rochester, Dept Obstet \& Gynecol, Med Ctr, Rochester, NY 14642 USA.}},
DOI = {{10.1016/j.reprotox.2012.09.006}},
ISSN = {{0890-6238}},
Keywords = {{Phthalates; DEHP; MEHP; Testosterone; Anogenital distance; Non-monotonic
   dose-response}},
Keywords-Plus = {{ENDOCRINE-DISRUPTING CHEMICALS; DYSGENESIS SYNDROME; DI-(2-ETHYLHEXYL)
   PHTHALATE; REPRODUCTIVE DEVELOPMENT; DIETHYLHEXYL PHTHALATE; LACTATIONAL
   EXPOSURE; MALE-RAT; SEXUAL-DIFFERENTIATION; AMNIOTIC-FLUID; MALE INFANTS}},
Research-Areas = {{Reproductive Biology; Toxicology}},
Web-of-Science-Categories  = {{Reproductive Biology; Toxicology}},
Author-Email = {{pbd6v8@mail.missouri.edu
   richard\_stahlhut@urmc.rochester.edu
   depr29@mail.missouri.edu
   vomsaalf@missouri.edu
   taylorja@missouri.edu}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Andrade AJM, 2006, TOXICOLOGY, V225, P64, DOI 10.1016/j.tox.2006.05.007.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Bay K, 2006, BEST PRACT RES CL EN, V20, P77, DOI 10.1016/j.beem.2005.09.004.
   Blystone CR, 2010, TOXICOL SCI, V116, P640, DOI 10.1093/toxsci/kfq147.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   CDC Prevention CfDCa, 2012, 4 CDC PREV CFDCA.
   Cederroth CR, 2007, ENVIRON HEALTH PERSP, V115, P1467, DOI 10.1289/ehp.10413.
   Diamond M, 2009, HORM BEHAV, V55, P621, DOI 10.1016/j.yhbeh.2009.03.007.
   EVEN MD, 1992, J REPROD FERTIL, V96, P709.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Gaido KW, 2007, TOXICOL SCI, V97, P491, DOI 10.1093/toxsci/kfm049.
   Gallavan RH, 1999, REPROD TOXICOL, V13, P383, DOI 10.1016/S0890-6238(99)00036-2.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Hannas BR, 2011, TOXICOL SCI, V123, P206, DOI 10.1093/toxsci/kfr146.
   Hayashi Y, 2012, ARCH TOXICOL, V86, P563, DOI 10.1007/s00204-011-0790-2.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009.
   Latini Giuseppe, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P37, DOI 10.2174/1568008043340017.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Latini G, 2003, ENV HLTH PERSPECTIVE, P111.
   Lin H, 2008, P NATL ACAD SCI USA, V105, P7218, DOI 10.1073/pnas.0709260105.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Rhomberg LR, 2012, REGUL TOXICOL PHARM, V64, P130, DOI 10.1016/j.yrtph.2012.06.015.
   Ruhlen RL, 2008, ENVIRON HEALTH PERSP, V116, P322, DOI 10.1289/ehp.10448.
   SCHMITZER JL, 1988, J AGR FOOD CHEM, V36, P210, DOI 10.1021/jf00079a053.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   SOARES MJ, 1982, J ENDOCRINOL, V95, P29, DOI 10.1677/joe.0.0950029.
   Sonne SB, 2008, INT J ANDROL, V31, P275, DOI 10.1111/j.1365-2605.2007.00855.x.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Takatori S, 2004, J CHROMATOGR B, V804, P397, DOI 10.1016/j.jchromb.2004.01.056.
   THOMAS JA, 1984, CRC CR REV TOXICOL, V13, P283, DOI 10.3109/10408448409023761.
   Vandenberg LN, 2012, ENDOCR REV, V33, P378, DOI 10.1210/er.2011-1050.
   VANDENBERGH JG, 1995, LAB ANIM SCI, V45, P567.
   vom Saal FS, 1998, FORUM APPL RES PUBLI, V1, P1.
   Vom Saal F S, 1992, Physiol Behav, V52, P163, DOI 10.1016/0031-9384(92)90447-A.
   vom Saal F S, 1989, J Anim Sci, V67, P1824.
   VOMSAAL FS, 1978, BIOL REPROD, V19, P842, DOI 10.1095/biolreprod19.4.842.
   VOMSAAL FS, 1990, BIOL REPROD, V43, P751, DOI 10.1095/biolreprod43.5.751.
   Welshons WV, 2003, ENV HLTH PERSPECTIVE, P111.
   Wilson VS, 2007, TOXICOL LETT, V170, P177, DOI 10.1016/j.toxlet.2007.03.004.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Zoeller RT, 2012, ENDOCRINOLOGY, V153, P4097, DOI 10.1210/en.2012-1422.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{1}},
Journal-ISO = {{Reprod. Toxicol.}},
Doc-Delivery-Number = {{055OZ}},
Wos-Id = {{ISI:000312427600015}},
}

@article{ ISI:000310393600003,
Author = {Banerjee, Ranjan and Pathmasiri, Wimal and Snyder, Rodney and McRitchie,
   Susan and Sumner, Susan},
Title = {{Metabolomics of brain and reproductive organs: characterizing the impact
   of gestational exposure to butylbenzyl phthalate on dams and resultant
   offspring}},
Journal = {{METABOLOMICS}},
Year = {{2012}},
Volume = {{8}},
Number = {{6}},
Pages = {{1012-1025}},
Month = {{DEC}},
Abstract = {{Phthalates are plasticizers finding wide spread use in industrial and
   household products, with measureable levels of phthalate-derived
   metabolites in the general US population. Phthalates have endocrine
   disruption potential and have been implicated as obesogens. Our
   exploratory investigation to reveal the impact of in utero exposure to a
   phthalate on the biochemical profiles of the brain, testes, and uterus
   of prepubertal offspring, and of tissues from dams administered
   butylbenzyl phthalate (BBP). Pregnant rats (three per group) were
   administered (on gestation day 14-21) corn oil (control), or 25
   mg/kg/day or 750 mg/kg/day BBP in corn oil. Tissues were collected from
   each of the dams on postnatal day (pnd) 21 (similar to 3 weeks after the
   end of BBP administration), and from each of the pups on pnd 26 (similar
   to 4 weeks after birth to dams administered vehicle or BBP during
   gestation) and processed for metabolomics analysis. Multivariate data
   analyses revealed metabolites that best distinguished the exposed and
   control groups. The metabolites most important to distinguishing the
   study groups were tested for significance using the exact Wilcoxon
   rank-sum test. Male pups had significant differences (control versus BBP
   dose groups) in levels of metabolites for both the brain and testes even
   at the P < 0.01 level. However, female pups and dams had significant
   testing for the uterus only at the P = 0.1 level tested. Female pups
   also had some significant differences for the brain with P values
   between 0.5 and 0.1. Amino acid metabolism (male and female pups) and
   phospholipid metabolism (male pups) were perturbed for the brain. Amino
   acid metabolism, purine metabolism, and TCA cycle were perturbed for
   tests and uterus. This study demonstrated the use of metabolomics to
   reveal metabolic perturbations in tissues of offspring following in
   utero exposures, and suggests the use of this approach for determining
   the impact of exposure past the time of the presence of the parent
   compound and metabolites derived from the parent compound.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sumner, S (Reprint Author), RTI Int, Discovery \& Analyt Sci, Res Triangle Pk, Res Triangle Pk, NC 27709 USA.
   Banerjee, Ranjan; Pathmasiri, Wimal; Snyder, Rodney; Sumner, Susan, RTI Int, Discovery \& Analyt Sci, Res Triangle Pk, NC 27709 USA.
   Banerjee, Ranjan, Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.
   Banerjee, Ranjan, Univ N Carolina, Dept Phys, Chapel Hill, NC 27599 USA.
   McRitchie, Susan, RTI Int, Stat \& Epidemiol, Res Triangle Pk, NC 27709 USA.}},
DOI = {{10.1007/s11306-011-0396-y}},
ISSN = {{1573-3882}},
Keywords = {{Metabolomics; NMR; Phthalates; BBP; Gestational exposure; Brain; Testes;
   Uterus}},
Keywords-Plus = {{BUTYL BENZYL PHTHALATE; CULTURED SERTOLI-CELLS; CENTRAL NERVOUS-SYSTEM;
   BLOOD-TESTIS BARRIER; IN-UTERO; URINARY CREATINE; SPRAGUE-DAWLEY;
   SEXUAL-DIFFERENTIATION; DI(N-BUTYL) PHTHALATE; LACTATIONAL EXPOSURE}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Endocrinology \& Metabolism}},
Author-Email = {{ssumner@rti.org}},
Funding-Acknowledgement = {{NIGMS {[}5R21GM75903]; North Carolina Biotechnology Center}},
Funding-Text = {{Dr. Rochelle Tyl is appreciated for review and comment on this
   manuscript. The North Carolina Biotechnology Center is acknowledged for
   supporting laboratory supplies and an internship stipend for Mr. Ranjan
   Banerjee. Dr. Kevin Knagge of DHMRI is acknowledged for technical
   support. NIGMS Grant 5R21GM75903 provided funding for development of
   methods used in this investigation. The authors appreciate the review
   and suggestions by the journal referee, which has strengthened this
   manuscript.}},
Cited-References = {{Anway M. D., 2005, SCIENCE, V308, P1391.
   Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376.
   Bergh A, 1996, INT J ANDROL, V19, P229, DOI 10.1111/j.1365-2605.1996.tb00467.x.
   Blount B. C., 2000, ENV HLTH PERSPECT, V108, P972.
   CROCKER JFS, 1988, J TOXICOL ENV HEALTH, V23, P433.
   {[}丁瑜 DING Yu], 2010, {[}中华预防医学杂志, Chinese Journal of Preventive Medicine], V44, P150.
   Draper RP, 1996, REPROD TOXICOL, V10, P79, DOI 10.1016/0890-6238(95)02021-7.
   Dym M, 1970, Biology Reprod., V3, P308.
   Ebesunun M O, 2004, West Afr J Med, V23, P290.
   Eriksson L., 2006, MULTIVARIATE MEGA 11.
   FABIAN RH, 1989, J NEUROIMMUNOL, V24, P183, DOI 10.1016/0165-5728(89)90116-1.
   Fan LQ, 1998, J ENDOCRINOL, V158, P237, DOI 10.1677/joe.0.1580237.
   FUKUOKA M, 1989, J APPL TOXICOL, V9, P277, DOI 10.1002/jat.2550090413.
   FUKUOKA M, 1990, J APPL TOXICOL, V10, P285, DOI 10.1002/jat.2550100410.
   Govindaraju V, 2000, NMR BIOMED, V13, P129, DOI 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.3.CO;2-M.
   Grande SW, 2006, TOXICOL SCI, V91, P247, DOI 10.1093/toxsci/kfj128.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Griesmaier E, 2012, PHARMACOL BIOCHEM BE, V100, P835, DOI 10.1016/j.pbb.2011.04.011.
   Griffin JL, 2000, FEBS LETT, V486, P225, DOI 10.1016/S0014-5793(00)02307-3.
   Guerra MT, 2010, REPROD TOXICOL, V29, P99, DOI 10.1016/j.reprotox.2009.10.005.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009.
   Jouannet P, 2001, APMIS, V109, P333, DOI 10.1034/j.1600-0463.2001.090502.x.
   Kalantaridou S, 2007, FRONT BIOSCI, V12, P572, DOI 10.2741/2083.
   Kato R, 2006, AM J PHYSIOL-ENDOC M, V290, pE968, DOI 10.1152/ajpendo.00160.2005.
   Kato R, 2005, J PHARMACOL EXP THER, V312, P601, DOI 10.1124/jpet.104.073387.
   Kavlock R, 2002, REPROD TOXICOL, V16, P453, DOI 10.1016/S0890-6238(02)00029-1.
   Kunz N, 2011, INT J DEV NEUROSCI, V29, P37, DOI 10.1016/j.ijdevneu.2010.09.009.
   Kuramori C, 2009, TOXICOL SCI, V109, P143, DOI 10.1093/toxsci/kfp041.
   Kwack SJ, 2009, J TOXICOL ENV HEAL A, V72, P1446, DOI 10.1080/15287390903212923.
   Lehninger A. L., 1997, PRINCIPLES BIOCH.
   LINDGREN A, 1982, TOXICOLOGY, V23, P149, DOI 10.1016/0300-483X(82)90094-4.
   Liu PS, 2003, NEUROTOXICOLOGY, V24, P97, DOI 10.1016/S0161-813X(02)00154-7.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211.
   Maness SC, 1998, TOXICOL APPL PHARM, V151, P135, DOI 10.1006/taap.1998.8431.
   Mazzei P., 2010, NMR BIOMED, V23, P1.
   Moore NP, 1998, J REPROD FERTIL, V112, P331.
   MOORE NP, 1992, ARCH TOXICOL, V66, P435, DOI 10.1007/BF02035135.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   MURATURE DA, 1987, BIOMED ENVIRON MASS, V14, P473, DOI 10.1002/bms.1200140815.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Naftolin F, 1975, Adv Biosci, V15, P105.
   Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2.
   NAHAS K, 1993, HUM EXP TOXICOL, V12, P173.
   NICHOLSON JK, 1989, MOL PHARMACOL, V36, P398.
   Parkhie M. R., 1982, ENVIRON HEALTH PERSP, V45, P85.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Pathmasiri W., 2011, HDB SYSTEMS TOXICOLO, P299.
   PHARIKAL K, 1988, INT J VITAM NUTR RES, V58, P306.
   Ravenzwaay B., 2010, TOXICOL LETT, V198, P159.
   RAWCLIFFE L, 1989, REPROD TOXICOL, V3, P269, DOI 10.1016/0890-6238(89)90021-X.
   Rosner B., 2000, FUNDAMENTALS BIOSTAT, P343.
   Saillenfait AM, 1998, TOXICOL SCI, V45, P212, DOI 10.1093/toxsci/45.2.212.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   Slupsky CM, 2007, ANAL CHEM, V79, P6995, DOI 10.1021/ac0708588.
   Sumner S, 2009, J APPL TOXICOL, V29, P703, DOI 10.1002/jat.1462.
   Sumner S., 2010, REPROD TOXICOL.
   Sumner SCJ, 2010, J APPL TOXICOL, V30, P354, DOI 10.1002/jat.1503.
   Sumner SJ, 2010, METABOLOMICS, V6, P238, DOI 10.1007/s11306-010-0197-8.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Tabacova S, 1999, EPIDEMIOLOGY, V10, pS127.
   Timbrell John A., 2000, Arhiv za Higijenu Rada i Toksikologiju, V51, P295.
   Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   Vitale R, 1973, Anat Rec, V176, P331.
   Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   Wilson VS, 2007, TOXICOL LETT, V170, P177, DOI 10.1016/j.toxlet.2007.03.004.
   Wold S., 2006, MULTIVARIATE MEGAV 1.
   Xu Y, 2007, ARCH TOXICOL, V81, P57, DOI 10.1007/s00204-006-0143-8.
   Yamamoto Toshinori, 2007, Journal of Toxicological Sciences, V32, P515, DOI 10.2131/jts.32.515.}},
Number-of-Cited-References = {{74}},
Times-Cited = {{0}},
Journal-ISO = {{Metabolomics}},
Doc-Delivery-Number = {{027ZW}},
Wos-Id = {{ISI:000310393600003}},
}

@article{ ISI:000313463400028,
Author = {Li, Na and Liu, Te and Zhou, Liting and He, Jun and Ye, Lin},
Title = {{Di-(2-ethylhcxyl) phthalate reduces progesterone levels and induces
   apoptosis of ovarian granulosa cell in adult female ICR mice}},
Journal = {{ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY}},
Year = {{2012}},
Volume = {{34}},
Number = {{3}},
Pages = {{869-875}},
Month = {{NOV}},
Abstract = {{Di-(2-ethylhexyl) phthalate (DEHP) as an environmental endocrine
   disruptor is a known reproductive toxicant and carcinogen. The purpose
   of this study was to evaluate the female reproductive toxicity of DEHP.
   Sixty ICR female mice were randomized into four groups dosed with 0,
   125, 500, or 2 000 mg/kg DEHP by gavage for 16 weeks, 6 days/week. DEHP
   treatment prolonged duration of the estrous cycle in mice at 500 and
   2000 mg/kg DEHP, but no significant effects on estrus phase of the cycle
   in each group were detected. Exposure to DEHP inhibited secretion of
   serum progesterone. DEHP arrested granulosa cells at G(0)/G(1) phases
   and increased proportion of apoptosis cells at 500 and 2000 mg/kg DEHP.
   There was no significant difference in P450arom mRNA expression among
   groups. Results demonstrate that DEHP can produce toxicity in female
   reproductive system. (C) 2012 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ye, L (Reprint Author), Jilin Univ, Sch Publ Hlth, Dept Occupat \& Environm Hlth, 1163 Xin Min St, Changchun 130021, Jilin, Peoples R China.
   Li, Na; Liu, Te; Zhou, Liting; He, Jun; Ye, Lin, Jilin Univ, Sch Publ Hlth, Dept Occupat \& Environm Hlth, Changchun 130021, Jilin, Peoples R China.}},
DOI = {{10.1016/j.etap.2012.08.013}},
ISSN = {{1382-6689}},
Keywords = {{Endocrine disruptors; Di-(2-ethylhcxyl)phthalate; Estrous cycle; Sex
   hormone; Apoptosis; Reproductive toxicity}},
Keywords-Plus = {{SPRAGUE-DAWLEY RATS; ESTRADIOL PRODUCTION; TESTOSTERONE PRODUCTION;
   SUPPRESSES ESTRADIOL; IN-VITRO; RECEPTOR; EXPOSURE; AROMATASE; DEHP;
   STEROIDOGENESIS}},
Research-Areas = {{Environmental Sciences \& Ecology; Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{jlyelin@163.com}},
Cited-References = {{Andrade AJM, 2006, TOXICOLOGY, V228, P85, DOI 10.1016/j.tox.2006.08.020.
   Borch J, 2005, REPROD TOXICOL, V19, P517, DOI 10.1016/j.reprotox.2004.11.004.
   Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Drevnick PE, 2006, AQUAT TOXICOL, V79, P49, DOI 10.1016/j.aquatox.2006.05.007.
   Erkekoglu P., 2011, ARCH ENV CONTAM TOXI.
   Friberg PA, 2009, BIOL REPROD, V80, P1160, DOI 10.1095/biolreprod.108.073932.
   Ghosh D, 2009, NATURE, V457, P219, DOI 10.1038/nature07614.
   Giammona CJ, 2002, TOXICOL APPL PHARM, V185, P119, DOI 10.1006/taap.2002.9536.
   Gray LE, 2009, TOXICOL SCI, V110, P411, DOI 10.1093/toxsci/kfp109.
   Gupta RK, 2010, TOXICOL APPL PHARM, V242, P224, DOI 10.1016/j.taap.2009.10.011.
   Henson MC, 2004, EXP BIOL MED, V229, P383.
   Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610.
   Hirosawa N, 2006, PROTEOMICS, V6, P958, DOI 10.1002/pmic.200401344.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   HSUEH AJW, 1994, ENDOCR REV, V15, P707, DOI 10.1210/er.15.6.707.
   Hussein MR, 2005, HUM REPROD UPDATE, V11, P162, DOI 10.1093/humupd/dmi001.
   Karim BO, 2003, COMPARATIVE MED, V53, P532.
   Kijima K, 2004, TOXICOL APPL PHARM, V200, P103, DOI 10.1016/j.taap.2004.03.015.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Mizuta T, 2007, ENDOCRINOLOGY, V148, P3554, DOI 10.1210/en.2007-0109.
   Mousavi SH, 2009, FOOD CHEM TOXICOL, V47, P855, DOI 10.1016/j.fct.2009.01.018.
   Noriega NC, 2009, TOXICOL SCI, V111, P163, DOI 10.1093/toxsci/kfp129.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   Peluso JJ, 2008, ENDOCRINOLOGY, V149, P534, DOI 10.1210/en.2007-1050.
   Reinsberg J, 2009, TOXICOL APPL PHARM, V239, P116, DOI 10.1016/j.taap.2009.05.022.
   Rouillier P, 1998, MOL REPROD DEV, V50, P170, DOI 10.1002/(SICI)1098-2795(199806)50:2<170::AID-MRD7>3.0.CO;2-H.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Song Xiao-feng, 2006, Zhonghua Nan Ke Xue, V12, P775.
   Sriraman V, 2006, MOL ENDOCRINOL, V20, P348, DOI 10.1210/me.2005-0317.
   Svechnikov K, 2008, REPROD TOXICOL, V25, P485, DOI 10.1016/j.reprotox.2008.05.057.
   Svechnikova I, 2007, J ENDOCRINOL, V194, P603, DOI 10.1677/JOE-07-0238.
   Tayarani-Najaran Z., 2009, EVID-BASED COMPL ALT, P1.
   Xu CA, 2010, TOXICOL LETT, V199, P323, DOI 10.1016/j.toxlet.2010.09.015.
   Zhu JP, 2006, ENVIRON SCI TECHNOL, V40, P5276, DOI 10.1021/es060356w.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{1}},
Journal-ISO = {{Environ. Toxicol. Pharmacol.}},
Doc-Delivery-Number = {{069UU}},
Wos-Id = {{ISI:000313463400028}},
}

@article{ ISI:000311128300009,
Author = {Just, Allan C. and Whyatt, Robin M. and Miller, Rachel L. and Rundle,
   Andrew G. and Chen, Qixuan and Calafat, Antonia M. and Divjan, Adnan and
   Rosa, Maria J. and Zhang, Hanjie and Perera, Frederica P. and Goldstein,
   Inge F. and Perzanowski, Matthew S.},
Title = {{Children's Urinary Phthalate Metabolites and Fractional Exhaled Nitric
   Oxide in an Urban Cohort}},
Journal = {{AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE}},
Year = {{2012}},
Volume = {{186}},
Number = {{9}},
Pages = {{830-837}},
Month = {{NOV 1}},
Abstract = {{Rationale: Phthalates are used widely in consumer products. Exposure to
   several phthalates has been associated with respiratory symptoms and
   decreased lung function. Associations between children's phthalate
   exposures and fractional exhaled nitric oxide (FENO), a biomarker of
   airway inflammation, have not been examined.
   Objectives: We hypothesized that urinary concentrations of four
   phthalate metabolites would be positively associated with FENO and that
   these associations would be stronger among children with seroatopy or
   wheeze.
   Methods: In an urban ongoing birth cohort, 244 children had phthalate
   metabolites determined in urine collected on the same day as FENO
   measurement. Repeated sampling gathered 313 observations between ages
   4.9 and 9.1 years. Seroatopy was assessed by specific IgE. Wheeze in the
   past year was assessed by validated questionnaire. Regression models
   used generalized estimating equations.
   Measurements and Main Results: Log-unit increases in urinary
   concentrations of metabolites of diethyl phthalate (DEP) and butylbenzyl
   phthalate (BBzP) were associated with a 6.6\% (95\% confidence interval
   {[}CI] 0.5-13.1\%) and 8.7\% (95\% CI, 1.9-16.0\%) increase in FENO,
   respectively, adjusting for other phthalate metabolites and potential
   covariates/confounders. There was no association between concentrations
   of metabolites of di(2-ethylhexyl) phthalate or di-n-butyl phthalate and
   FENO. There was no significant interaction by seroatopy. The BBzP
   metabolite association was significantly stronger among children who
   wheeze (P = 0.016).
   Conclusions: Independent associations between exposures to DEP and BBzP
   and FENO in a cohort of inner-city children were observed. These results
   suggest that these two ubiquitous phthalates, previously shown to have
   substantial contributions from inhalation, are positively associated
   with airway inflammation in children.}},
Publisher = {{AMER THORACIC SOC}},
Address = {{61 BROADWAY, FL 4, NEW YORK, NY 10006 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Just, AC (Reprint Author), 722 W 168th St,11th Floor, New York, NY 10032 USA.
   Just, Allan C.; Whyatt, Robin M.; Miller, Rachel L.; Rundle, Andrew G.; Divjan, Adnan; Rosa, Maria J.; Perera, Frederica P.; Goldstein, Inge F.; Perzanowski, Matthew S., Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, New York, NY USA.
   Just, Allan C.; Whyatt, Robin M.; Miller, Rachel L.; Divjan, Adnan; Rosa, Maria J.; Perera, Frederica P.; Perzanowski, Matthew S., Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA.
   Rundle, Andrew G.; Goldstein, Inge F., Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA.
   Chen, Qixuan, Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY USA.
   Miller, Rachel L.; Zhang, Hanjie, Columbia Univ Coll Phys \& Surg, Dept Med, Div Pulm Allergy \& Crit Care, New York, NY 10032 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.}},
DOI = {{10.1164/rccm.201203-0398OC}},
ISSN = {{1073-449X}},
Keywords = {{airway inflammation; asthma; diethyl phthalate; butylbenzyl phthalate;
   fractional exhaled nitric oxide}},
Keywords-Plus = {{INNER-CITY CHILDREN; NEW-YORK-CITY; HEALTHY-CHILDREN; PREGNANT-WOMEN;
   AIR-POLLUTION; US POPULATION; EXPOSURE; ASTHMA; VARIABILITY; CHILDHOOD}},
Research-Areas = {{General \& Internal Medicine; Respiratory System}},
Web-of-Science-Categories  = {{Critical Care Medicine; Respiratory System}},
Author-Email = {{acj2109@columbia.edu}},
ResearcherID-Numbers = {{Rundle, Andrew/A-5282-2009}},
ORCID-Numbers = {{Rundle, Andrew/0000-0003-0211-7707}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences {[}R01 ES014393, R01
   ES013163, P01 ES09600, R01 ES008977, P30 ES009089]; U.S. Environmental
   Protection Agency {[}R827027, RD832141, RD834509]; EPA STAR graduate
   fellowship {[}FP-91712001]; John and Wendy Neu Family Foundation;
   Blanchette Hooker Rockefeller Fund; New York Community Trust;
   Educational Foundation of America; Millstream Fund}},
Funding-Text = {{Supported by the National Institute of Environmental Health Sciences
   grants R01 ES014393, R01 ES013163, P01 ES09600, R01 ES008977, and P30
   ES009089; the U.S. Environmental Protection Agency grants R827027,
   RD832141, RD834509, and EPA STAR graduate fellowship FP-91712001
   (A.C.J.); the John and Wendy Neu Family Foundation; Blanchette Hooker
   Rockefeller Fund; New York Community Trust; Educational Foundation of
   America; and the Millstream Fund.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x.
   American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483.
   Barnes PJ, 2010, CHEST, V138, P682, DOI 10.1378/chest.09-2090.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Bastain TM, 2011, EUR RESPIR J, V37, P523, DOI 10.1183/09031936.00021210.
   Benayoun L, 2001, AM J RESP CRIT CARE, V164, P1487.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x.
   Carey V.J., 2011, GEE GEN ESTIMATION E.
   Caudri D, 2010, THORAX, V65, P801, DOI 10.1136/thx.2009.126912.
   {[}Centers for Disease Control and Prevention National Center for Health Statistics], NAT HLTH NUTR EX SUR.
   Chen Q, 2012, ANN ALLERG ASTHMA IM, V108.
   Cornell AG, 2012, J EXPO SCI ENV EPID, V22, P258, DOI 10.1038/jes.2012.3.
   Delfino RJ, 2006, ENVIRON HEALTH PERSP, V114, P1736, DOI 10.1289/ehp.9141.
   Donohue KM, 2008, J ALLERGY CLIN IMMUN, V122, P914, DOI 10.1016/j.jaci.2008.08.034.
   Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI {[}10.1164/rccm.9120-11ST, 10.1164/rccm.912011ST].
   Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002.
   Franklin P, 2000, AM J RESP CRIT CARE, V161, P1757.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Garg R., 2003, ASTHMA FACTS.
   Holguin F, 2007, AM J RESP CRIT CARE, V176, P1236, DOI 10.1164/rccm.200611-1616OC.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Just AC, 2010, J EXPO SCI ENV EPID, V20, P625, DOI 10.1038/jes.2010.13.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kolarik B, 2009, INDOOR AIR, V19, P145, DOI 10.1111/j.1600-0668.2008.00572.x.
   Mattes J, 2002, PEDIATR RES, V51, P190, DOI 10.1203/00006450-200202000-00011.
   McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535.
   Olin AC, 2010, AM J RESP CRIT CARE, V181, P324, DOI 10.1164/rccm.200907-1079OC.
   Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742.
   Perzanowski MS, 2010, J ASTHMA, V47, P1015, DOI 10.3109/02770903.2010.513075.
   Perzanowski MS, 2008, J ALLERGY CLIN IMMUN, V122, P213, DOI 10.1016/j.jaci.2008.03.030.
   Pijnenburg MW, 2005, THORAX, V60, P215, DOI 10.1136/thx.2004.023374.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP.
   Rauh VA, 2004, NEUROTOXICOL TERATOL, V26, P373, DOI 10.1016/j.ntt.2004.01.002.
   Rosa MJ, 2011, PEDIATR PULM, V46, P83, DOI 10.1002/ppul.21328.
   Rudel RA, 2010, ENVIRON SCI TECHNOL, V44, P6583, DOI 10.1021/es100159c.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stern G, 2011, J ALLERGY CLIN IMMUN, V128, P293, DOI 10.1016/j.jaci.2011.03.010.
   Swan SH, 2009, INT J ANDROL, V33, P259.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Szefler SJ, 2008, J ALLERGY CLIN IMMUN, V121, P598, DOI 10.1016/j.jaci.2007.12.1192.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Tuomainen A, 2006, ENVIRON HEALTH PERSP, V114, P1409, DOI 10.1289/ehp.8965.
   Van Amsterdam JGC, 2000, ARCH ENVIRON HEALTH, V55, P418.
   Whyatt RM, 2012, ENVIRON HEALTH PERSP, V120, P290, DOI 10.1289/ehp.1103705.
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3\_1.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{4}},
Journal-ISO = {{Am. J. Respir. Crit. Care Med.}},
Doc-Delivery-Number = {{037TB}},
Wos-Id = {{ISI:000311128300009}},
}

@article{ ISI:000311195100016,
Author = {Monfort, Nuria and Ventura, Rosa and Balcells, Georgina and Segura,
   Jordi},
Title = {{Determination of five di-(2-ethylhexyl)phthalate metabolites in urine by
   UPLC-MS/MS, markers of blood transfusion misuse in sports}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES}},
Year = {{2012}},
Volume = {{908}},
Pages = {{113-121}},
Month = {{NOV 1}},
Abstract = {{Di-(2-ethylhexyl)phthalate (DEHP) is the most commonly used plasticizer
   for polyvinyl chloride. which is found in a large variety of products,
   including most of the bags used for blood storage because of its
   protective role on erythrocytes survival. DEHP metabolites have been
   recently proposed as markers of the misuse of blood transfusion in
   athletes. In this study, a method to quantify the main five DEHP
   metabolites in urine has been developed: mono-(2-ethylhexyl)phthalate
   (MEHP), mono-(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP),
   mono-(2-ethyl-5-oxohexyl)phthalate (MEOHP),
   mono-(2-ethyl-5-carboxypentyl)phthalate (5cx-MEPP), and
   mono-(2-carboxymethylhexyl)phthalate (2cx-MMHP). The method involved an
   enzymatic hydrolysis with beta-glucuronidase from Escherichia coil
   followed by an acidic extraction with ethyl acetate. The hydrolysed
   extracts were analysed by ultraperformance liquid chromatography tandem
   mass spectrometry. Isotope labelled MEHP, MEOHP and 5cx-MEPP were used
   as internal standards. Analysis of all the metabolites was achieved in a
   total run time of 10 min, using a C-18 column and a mobile phase
   containing deionized water and acetonitrile with formic acid, with
   gradient elution at a flow-rate of 0.6 mL min(-1). Detection of the
   compounds was performed by multiple reaction monitoring, using
   electrospray ionization in positive and negative ion modes. The method
   was validated for quantitative purposes. Extraction recoveries were
   greater than 90\% and the limits of quantitation ranged from 1.2 to 2.6
   ng mL(-1). Intra-day precisions were better than 8\% for all metabolites
   while inter-assay precisions were better than 12\%. Concentrations of
   DEHP metabolites were measured in a control group (n = 30. subjects
   reflecting the common environmental DEHP exposure), and in sportsmen (n
   = 464), to evaluate population distribution exposure to DEHP.
   Additionally, threshold concentrations indicating outliers of common
   exposure for DEHP metabolites are proposed. (C) 2012 Elsevier B.V. All
   rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Segura, J (Reprint Author), Inst Hosp Mar Invest Med, Grp Recerca Bioanal, Dr Aiguader 88, Barcelona 08003, Spain.
   Monfort, Nuria; Ventura, Rosa; Balcells, Georgina; Segura, Jordi, Inst Hosp Mar Invest Med, Grp Recerca Bioanal, Barcelona 08003, Spain.
   Monfort, Nuria; Ventura, Rosa; Balcells, Georgina; Segura, Jordi, Inst Hosp Mar Invest Med, Serv Analit, Programa Recerca Neurociencies, Barcelona 08003, Spain.
   Monfort, Nuria; Ventura, Rosa; Segura, Jordi, UPF, Dept Ciencies Expt \& Salut, Barcelona, Spain.}},
DOI = {{10.1016/j.jchromb.2012.09.030}},
ISSN = {{1570-0232}},
Keywords = {{Blood doping; Transfusion; Di-(2-ethylhexyl)phthalate (DEHP);
   Plasticizers; Ultraperformance liquid chromatography coupled to tandem
   mass spectrometry (UPLC-MS/MS); Doping control}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; HUMAN EXPOSURE ASSESSMENT; PHTHALATE
   METABOLITES; DI(2-ETHYLHEXYL) PHTHALATE; INTERNAL EXPOSURE; DEHP; SERUM;
   PLASTICIZER; BIOMARKERS; QUANTIFICATION}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{jsegura@imim.es}},
Funding-Acknowledgement = {{DIUE Generalitat de Catalunya {[}2009 SGR 492]; World Antidoping Agency
   {[}06A6JS]; Consell Catala de l'Esport (Generalitat de Catalunya)}},
Funding-Text = {{This work was supported by grants from DIUE Generalitat de Catalunya
   (2009 SGR 492) and the World Antidoping Agency (Research Grant 06A6JS).
   Financial support from Consell Catala de l'Esport (Generalitat de
   Catalunya) is also acknowledged. The background support of IMIM-Hospital
   del Mar is acknowledged. The authors thank the collaboration of Dr. M.
   Farre, E. Menoyo and M. Bosch for sample collection, Mr. S. Mojal for
   statistical analysis and to Pieter Van Renterghem for providing the
   RefVal program.}},
Cited-References = {{ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   Arndt PA, 2008, AM J HEMATOL, V83, P657, DOI 10.1002/ajh.21196.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Blystone CR, 2010, TOXICOL SCI, V116, P640, DOI 10.1093/toxsci/kfq147.
   Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x.
   Calafat AM, 2004, PEDIATRICS, V113, P429.
   Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712.
   European Commission Opinion on Medical Devices Containing DEHP plasticised PVC, 2002, EUR COMM OP MED DEV.
   FDA Public Health Notification PVC Devices Containing Plasticizer DEHP US Food and Drug Administration Center of Devices and Radiological Health, FDA PUBL HLTH NOT PV.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Frederiksen H, 2010, J ANAL TOXICOL, V34, P400.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Giraud S, 2008, FORENSIC SCI INT, V179, P23, DOI 10.1016/j.forsciint.2008.04.007.
   Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005.
   HOROWITZ B, 1985, VOX SANG, V48, P150.
   Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2005, J CHROMATOGR B, V814, P355, DOI 10.1016/j.jchromb.2004.10.056.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Latini Giuseppe, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P37, DOI 10.2174/1568008043340017.
   Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x.
   Monfort N, 2012, TRANSFUSION, V52, P647, DOI 10.1111/j.1537-2995.2011.03331.x.
   Monfort N, 2012, TRANSFUSION, V52, P680, DOI 10.1111/j.1537-2995.2011.03456.x.
   Monfort N, 2010, TRANSFUSION, V50, P145, DOI 10.1111/j.1537-2995.2009.02352.x.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Segura J., 2012, DRUG TEST ANAL.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Simmchen J, 2012, TRANSFUS MED REV, V26, P27, DOI 10.1016/j.tmrv.2011.06.001.
   Solberg HE, 1995, COMPUT METH PROG BIO, V48, P247, DOI 10.1016/0169-2607(95)01697-X.
   Solymos E, 2011, ANAL BIOANAL CHEM, V401, P517, DOI 10.1007/s00216-010-4589-4.
   Solymos E, 2011, ANAL BIOANAL CHEM, V401, P579, DOI 10.1007/s00216-011-4841-6.
   Solymos E, 2011, DRUG TEST ANAL, V3, P892, DOI 10.1002/dta.377.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   World Anti-doping Agency, 2004, TD2004EAAS WORLD ANT.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{2}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{038ST}},
Wos-Id = {{ISI:000311195100016}},
}

@article{ ISI:000311195100018,
Author = {Gries, Wolfgang and Ellrich, Dietmar and Kuepper, Katja and Ladermann,
   Birgit and Leng, Gabriele},
Title = {{Analytical method for the sensitive determination of major
   di-(2-propylheptyl)-phthalate metabolites in human urine}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES}},
Year = {{2012}},
Volume = {{908}},
Pages = {{128-136}},
Month = {{NOV 1}},
Abstract = {{Di-(2-propylheptyl)-phthalate (DPHP) is a specific phthalic acid ester
   of isomeric C10 alcohols. It is classified as high molecular weight
   phthalate and marketed as plasticizer for polyvinyl chloride (PVC). The
   increase of its production volume and its wide field of application
   suggest a possible background exposure of the human population as found
   for other phthalates, making suitable analytical methods necessary. The
   aim of the presented analytical report is the sensitive and selective
   determination of the three major DPHP metabolites
   mono-2-(propyl-6-hydroxy-heptyl)-phthalate (OH-MPHP),
   mono-2-(propyl-6-oxoheptyl)-phthalate (oxo-MPHP) and
   mono-2-(propyl-6-carboxy-hexyl)-phthalate (cx-MPHxP) in human urine.
   Most of the published analytical methods for phthalate metabolites use
   high pressure liquid chromatography tandem mass spectrometry
   (HPLC-MS/MS). The methods presented here allow a comparison of
   chromatographic separation between HPLC-MS/MS and gas chromatography
   high resolution mass spectrometry (GC-HRMS), which is useful to
   distinguish between DPHP and DIDP. The enhanced detection limits range
   between 0.05-0.1 mu g/L for GC-HRMS and 0.1-0.2 mu g/L for HPLC-MS/MS.
   (C) 2012 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gries, W (Reprint Author), Currenta GmbH \& Co OHG, Hlth Protect, Inst Biomonitoring, D-51368 Leverkusen, Germany.
   Gries, Wolfgang; Ellrich, Dietmar; Kuepper, Katja; Ladermann, Birgit; Leng, Gabriele, Currenta GmbH \& Co OHG, Hlth Protect, Inst Biomonitoring, D-51368 Leverkusen, Germany.}},
DOI = {{10.1016/j.jchromb.2012.09.019}},
ISSN = {{1570-0232}},
Keywords = {{Biomonitoring; DPHP metabolites; Phthalates; Urine; GC-MS; LC-MS/MS}},
Keywords-Plus = {{ISO-NONYLPHTHALATE DINP; PHTHALATE EXPOSURE; MASS-SPECTROMETRY;
   SECONDARY}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{wolfgang.gries@currenta.de}},
Funding-Acknowledgement = {{German Chemical Industry Association (VCI)}},
Funding-Text = {{We thank the German Chemical Industry Association (VCI) for sponsoring
   this method development and the syntheses of the necessary calibration
   and internal standards. This method development is part of the human
   biomonitoring project of German Chemical Industry Association and German
   Federal Ministry for the Environmental (BMU). We also thank Dr. Holger
   Koch for fruitful discussion and providing us with urine samples of
   persons who were exposed against DINP and DIDP.}},
Cited-References = {{Albro P., 1986, ENV HLTH PERSPECT, V65, P393.
   BASF, 2008, TECHN LEAFL PAL 10 P, P0117.
   Centers for Disease Control and Prevention, 2005, 3 CDCP NAT CTR ENV H.
   Centers for Disease Control and Prevention, 2009, 4 CDCP NAT CTR ENV H.
   Kato K, 2007, TOXICOLOGY, V236, P114, DOI 10.1016/j.tox.2007.04.009.
   Koch HM, 2012, TOXICOL LETT, V213, P100, DOI 10.1016/j.toxlet.2011.06.010.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Leng G, 2005, J CHROMATOGR B, V814, P285, DOI 10.1016/j.jchromb.2004.10.044.
   National Industrial Chemicals Notification and Assessment Scheme, 2003, NATL IND CHEMICAL NO.
   Silva M., 2007, BIOMARKERS, V12, P122.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Wittassek M., 2010, MOL NUTR FOOD RES, V54, P1.
   {[}Anonymous], 2005, EFSA J, V245, P1.
   {[}Anonymous], 2003, EUROPEAN UNION RISK.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{0}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{038ST}},
Wos-Id = {{ISI:000311195100018}},
}

@article{ ISI:000310795100017,
Author = {Su, Pen-Hua and Chang, Yan-Zin and Chang, Hua-Pin and Wang, Shu-Li and
   Haung, Hsin-I and Huang, Po-Chin and Chen, Jia-Yuh},
Title = {{Exposure to di(2-ethylhexyl) phthalate in premature neonates in a
   neonatal intensive care unit in Taiwan}},
Journal = {{PEDIATRIC CRITICAL CARE MEDICINE}},
Year = {{2012}},
Volume = {{13}},
Number = {{6}},
Pages = {{671-677}},
Month = {{NOV}},
Abstract = {{Objective: Neonates are exposed to high levels of di(2-ethylhexyl)
   phthalate through numerous medical procedures in the neonatal intensive
   care unit. Our aim was to assess the contribution of specific medical
   devices to the di(2-ethylhexyl) phthalate exposure of neonates.
   Design: Prospective.
   Setting: University hospital.
   Patients: We recruited 32 premature neonates, 20 with very low birth
   weight (<1500 g) and 12 with low birth weight (<2500 g), and 31 controls
   at a neonatal intensive care unit from a medical center in central
   Taiwan. Interventions:
   Interventions were based on a clinical need and used standard materials
   and devices, including endotracheal tubes, continuous positive airway
   pressure, oxygen hood, intravenous injection, intralipid injection,
   blood transfusion, orogastric tubes, nasogastric tubes, umbilical venous
   catheterization, umbilical arterial catheterization, chest tube, and
   isolate.
   Measurements and Main Results: We recorded the medical procedures of
   each subject, collected their urine samples, and determined the urinary
   concentration of three metabolites of di(2-ethylhexyl) phthalate using
   reversed-phase high-performance liquid chromatography-atmospheric
   pressure chemical ionization-tandem mass spectrometry. Median levels of
   di(2-ethylhexyl) phthalate metabolites in premature neonates treated
   with an endotracheal tube and orogastric tube or nasogastric tube were
   significantly higher than those not treated with an endotracheal tube,
   orogastric tube, or nasogastric tube. Median levels of di(2-ethylhexyl)
   phthalate metabolites in premature neonates treated with intravenous
   injection were >= 2-fold higher than those of healthy controls who
   received intravenous injections (p = .01). Median levels of three
   di(2-ethylhexyl) phthalate metabolites were similar in
   very-low-birth-weight and low-birth-weight neonates.
   Conclusions: These data suggest that polyvinyl chloride-containing
   devices are the major defining factor in di(2-ethylhexyl) phthalate
   exposure levels in neonates in the neonatal intensive care unit. We urge
   the use of polyvinyl chloride-free or alternative materials in medical
   devices, especially for endotracheal tubes, orogastric tubes,
   nasogastric tubes, and intravenous tubing in the neonatal intensive care
   unit. The health effects of high di(2-ethylhexyl) phthalate exposure on
   premature neonates in the neonatal intensive care unit is worthy of
   further investigation. (Pediatr Crit Care Med 2012; 13:671-677)}},
Publisher = {{LIPPINCOTT WILLIAMS \& WILKINS}},
Address = {{530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chen, JY (Reprint Author), Chung Shan Med Univ, Chung Shan Med Univ Hosp, Div Genet, Taichung, Taiwan.
   Su, Pen-Hua; Chen, Jia-Yuh, Chung Shan Med Univ, Chung Shan Med Univ Hosp, Div Genet, Taichung, Taiwan.
   Su, Pen-Hua; Chang, Hua-Pin; Chen, Jia-Yuh, Chung Shan Med Univ, Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan.
   Chang, Yan-Zin, Chung Shan Med Univ, Dept Toxicol, Taichung, Taiwan.
   Wang, Shu-Li, Chung Shan Med Univ, Dept Publ Hlth, Taichung, Taiwan.
   Su, Pen-Hua; Chen, Jia-Yuh, Chung Shan Med Univ, Sch Med, Taichung, Taiwan.
   Wang, Shu-Li; Huang, Po-Chin, Natl Environm Hlth Res Ctr, Zhunan, Taiwan.
   Wang, Shu-Li; Haung, Hsin-I; Huang, Po-Chin, Natl Hlth Res Inst, Div Environm Hlth \& Occupat Med, Zhunan, Taiwan.}},
DOI = {{10.1097/PCC.0b013e3182455558}},
ISSN = {{1529-7535}},
Keywords = {{di(2-ethylhexyl) phthalates metabolites; medical device; neonatal
   intensive care unit; polyvinyl chloride; premature neonates}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; DEUTERIUM-LABELED DEHP; HUMAN URINE; INTERNAL
   EXPOSURE; QUANTITATIVE DETECTION; GENERAL-POPULATION; US POPULATION;
   METABOLITES; INFANTS; PLASTICIZERS}},
Research-Areas = {{General \& Internal Medicine; Pediatrics}},
Web-of-Science-Categories  = {{Critical Care Medicine; Pediatrics}},
Author-Email = {{pchuang@nhri.org.tw
   jen@csh.org.tw}},
ResearcherID-Numbers = {{Wang, Shu-Li/C-1367-2010
   Huang, Po-Chin/I-5844-2012}},
Funding-Acknowledgement = {{Chung Shan Medical University Hospital, Taichung, Taiwan {[}CSH-96-23,
   CSH-97-A-10]}},
Funding-Text = {{Supported, in part, by a research grant of the Chung Shan Medical
   University Hospital (CSH-96-23, CSH-97-A-10), Taichung, Taiwan.}},
Cited-References = {{ATSDR, 2002, TOX PROF DI 2 ETH PH.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Chiellini F, 2011, INT J PHARMACEUT, V409, P57, DOI 10.1016/j.ijpharm.2011.02.024.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Jaeger Rudolph J, 2005, J Infus Nurs, V28, P54, DOI 10.1097/00129804-200501000-00007.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2005, INT J HYG ENVIR HEAL, V208, P489, DOI 10.1016/j.ijheh.2005.07.001.
   Koch HM, 2006, INT J ANDROL, V29, P181.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, ARCH TOXICOL, V79, P689, DOI 10.1007/s00204-005-0004-x.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Krumbiegel P, 1997, ACTA PAEDIATR, V86, P1236, DOI 10.1111/j.1651-2227.1997.tb14853.x.
   Latini G, 2009, NEONATOLOGY, V95, P317, DOI 10.1159/000181161.
   Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   National Toxicology Program, 2006, NTP BRIEF POT HUM RE.
   Pak VM, 2007, MCN-AM J MATERN-CHIL, V32, P244, DOI 10.1097/01.NMC.0000281965.45905.c0.
   Parke DV, 1984, TOXICOLOGY NEWBORN, P1.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Rais-Bahrami K, 2004, ENVIRON HEALTH PERSP, V112, P1339, DOI 10.1289/ehp.6901.
   Scientific Committee for Toxicity Ecotoxicity and the Environment, 2004, OP RES 2 RISK ASS BI.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Subotic U, 2007, J PEDIATR GASTR NUTR, V44, P71, DOI 10.1097/01.mpg.0000237939.50791.4b.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   U.S. Environmental Protection Agency, 1999, INT RISK INF SYST DI.
   Van Vliet EDS, 2011, J PERINATOL, V31, P551, DOI 10.1038/jp.2010.208.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   Whyatt RM, 2009, PEDIATRICS, V124, pE1213, DOI 10.1542/peds.2009-0325.
   World Medical Association, 2000, DECL HELS ETH PRINC.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{0}},
Journal-ISO = {{Pediatr. Crit. Care Med.}},
Doc-Delivery-Number = {{033KP}},
Wos-Id = {{ISI:000310795100017}},
}

@article{ ISI:000309989900011,
Author = {Liu, Liangpo and Xia, Tongwei and Guo, Lihua and Cao, Lanyu and Zhao,
   Benhua and Zhang, Jie and Dong, Sijun and Shen, Heqing},
Title = {{Expressing urine from a gel disposable diaper for biomonitoring using
   phthalates as an example}},
Journal = {{JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY}},
Year = {{2012}},
Volume = {{22}},
Number = {{6}},
Pages = {{625-631}},
Month = {{NOV-DEC}},
Abstract = {{The urinary metabolites of phthalates are well-accepted exposure
   biomarkers for adults and children older than 6 years but are not
   commonly used for infants owing to non-convenient sampling. In the light
   of this situation, a novel sampling method based on monitoring the urine
   expressed from the gel diaper was developed. The urine was expressed
   from the gel absorbent after mixing the absorbent with CaCl2 and then
   collected by a laboratory-made device; the urinary phthalate metabolites
   were extracted and cleaned using a solid-phase extraction (SPE) column
   and analyzed with high-performance liquid chromatography-electrospray
   ionization-tandem mass spectrometry / mass spectrometry. To evaluate the
   method's feasibility, the following factors were investigated: the
   proportion of CaCl2 to gel absorbent, the urination volume variation and
   the target compounds' deposition bias in the diaper, the matrix blank of
   the different diaper brands, the storage stabilities and the recoveries
   of creatinine and phthalate metabolites in the expressed urine.
   Mono-methyl phthalate, mono-ethyl phthalate, mono-butyl phthalate,
   mono-benzyl phthalate, mono-2-ethylhexyl phthalate and
   mono-2-ethyl-5-oxohexyl phthalate were involved. 70-80\% of the urine
   can be expressed from the diaper, and the expressed spiking recoveries
   and the limit of detection of mono-phthalates ranged from 88.5-115\% and
   0.21-0.50 ng/ml. The method was applied to measure phthalate metabolites
   in 65 gel diaper samples from 15 infants, and the pilot data suggests
   the infants are commonly exposed to phthalates. In summary, the method
   for monitoring of infant exposure to phthalates is sound and validated,
   and the potential health effects from the vulnerable infants' exposure
   to phthalates should be concerned.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Shen, HQ (Reprint Author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm \& Hlth, Xiamen 361021, Peoples R China.
   Liu, Liangpo; Xia, Tongwei; Zhang, Jie; Dong, Sijun; Shen, Heqing, Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm \& Hlth, Xiamen 361021, Peoples R China.
   Xia, Tongwei, China Univ Geosci, Sch Environm Studies, Wuhan 430074, Peoples R China.
   Guo, Lihua; Cao, Lanyu; Zhao, Benhua, Xiamen Univ, Sch Publ Hlth, Xiamen 361005, Peoples R China.}},
DOI = {{10.1038/jes.2012.51}},
ISSN = {{1559-0631}},
Keywords = {{biomonitoring; infant exposure; phthalates; gel diaper}},
Keywords-Plus = {{COLLECTION PADS; YOUNG-CHILDREN; EXPOSURE; METABOLITES; SAMPLES;
   BIOMARKERS; CHEMICALS; INFANTS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{hqshen@iue.ac.cn}},
ResearcherID-Numbers = {{Shen, Heqing/H-9338-2013}},
Funding-Acknowledgement = {{39th Scientific Research Foundation for the Returned Overseas Chinese
   Scholars (SRF for ROCS); Hundred Talent Program of Chinese Academy of
   Sciences (CAS); CAS/SAFEA International Partnership Program for Creative
   Research Teams {[}KZCX2-YW-T08]}},
Funding-Text = {{We sincerely thank the participant parents of this study for providing
   their infants' diaper samples, as well as others who gave us assistance.
   The present work was sponsored by the 39th Scientific Research
   Foundation for the Returned Overseas Chinese Scholars (SRF for ROCS)
   form the State Education Ministry (SEM) of China, Hundred Talent Program
   of Chinese Academy of Sciences (CAS) for 2010 on Human Exposure to
   Environmental Pollutants and Health Effects, CAS/SAFEA International
   Partnership Program for Creative Research Teams (KZCX2-YW-T08).}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   ATSDR, 2001, TOX PROF DI N BUT PH.
   ATSDR, 2002, TOX PROF DI 2 ETH PH.
   Daston G, 2004, ENVIRON HEALTH PERSP, V112, P238, DOI 10.1289/ehp.6182.
   Farrell M, 2002, J ADV NURS, V37, P387, DOI 10.1046/j.1365-2648.2002.02097.x.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Hu V.A., 2000, J EXPO ANAL ENV EPID, V10, P703.
   Hu Y, 2004, J EXPO ANAL ENV EPID, V14, P378, DOI 10.1038/sj.jea.7500334.
   Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y.
   Lambrot R, 2009, ENVIRON HEALTH PERSP, V117, P32, DOI 10.1289/ehp.11146.
   Lee EJ, 2009, J EXPO SCI ENV EPID, V19, P625, DOI 10.1038/jes.2009.36.
   Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073.
   Liu LP, 2012, ENVIRON INT, V42, P78, DOI 10.1016/j.envint.2011.04.005.
   Lorber M., 2009, J EXPO SCI ENV EPID, V20, P38.
   Macfarlane PI, 2005, PEDIATR NEPHROL, V20, P170, DOI 10.1007/s00467-004-1709-4.
   Masuyama H, 2000, MOL ENDOCRINOL, V14, P421, DOI 10.1210/me.14.3.421.
   Mukerjee M, 2000, SCI AM, V283, P100.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Shvartzman P, 2004, J AM BOARD FAM PRACT, V17, P91.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Wolff MS, 2007, ENVIRON HEALTH PERSP, V115, P116, DOI 10.1289/ehp.9488.
   World Health Organization, 2006, ENV HLTH CRIT, V237.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{0}},
Journal-ISO = {{J. Expo. Sci. Environ. Epidemiol.}},
Doc-Delivery-Number = {{022US}},
Wos-Id = {{ISI:000309989900011}},
}

@article{ ISI:000309989900012,
Author = {Christensen, Krista L. Yorita and Lorber, Matthew and Koch, Holger M.
   and Kolossa-Gehring, Marike and Morgan, Marsha K.},
Title = {{Population variability of phthalate metabolites and bisphenol A
   concentrations in spot urine samples versus 24-or 48-h collections}},
Journal = {{JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY}},
Year = {{2012}},
Volume = {{22}},
Number = {{6}},
Pages = {{632-640}},
Month = {{NOV-DEC}},
Abstract = {{Human exposure to phthalates and bisphenol A (BPA) can be assessed
   through urinary biomonitoring, but methods to infer daily intakes assume
   that spot sample concentrations are comparable to daily average
   concentrations. We evaluate this assumption using human biomonitoring
   data from Germany and the United States (US). The German data comprised
   three regional studies with spot samples and one with full-day samples
   analyzed for phthalate metabolites. The US data included: a study on
   DEHP metabolites and BPA involving eight persons supplying all urine
   voids (from which 24-h samples were constructed) for seven consecutive
   days; NHANES spot sample data on DEHP metabolites and BPA; and a
   regional study of children with 48-h samples analyzed for BPA. In the
   German data, measures of central tendency differed, but spot and 24-h
   samples showed generally comparable variance including 95th percentiles
   and maxima equidistant from central tendency measures. In contrast, the
   US adult data from the eight-person study showed similar central
   tendencies for phthalate metabolites and BPA, but generally greater
   variability for the spot samples, including higher 95th percentiles and
   maxima. When comparing children's BPA concentrations in NHANES spot and
   48-h samples, distributions showed similar central tendency and
   variability. Overall, spot urinary concentrations of DEHP metabolites
   and BPA have variability roughly comparable with corresponding 24-h
   average concentrations obtained from a comparable population, suggesting
   that spot samples can be used to characterize population distributions
   of intakes. However, the analysis also suggests that caution should be
   exercised when interpreting the high end of spot sample data sets.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Christensen, KLY (Reprint Author), US EPA, Natl Ctr Environm Assessment, Off Res \& Dev, Mailstop 8623P,1200 Penn Ave NW, Washington, DC 20460 USA.
   Christensen, Krista L. Yorita; Lorber, Matthew, US EPA, Natl Ctr Environm Assessment, Off Res \& Dev, Washington, DC 20460 USA.
   Koch, Holger M., Inst Ruhr Univ Bochum IPA, Inst Prevent \& Occupat Med, German Social Accid Insurance, Bochum, Germany.
   Kolossa-Gehring, Marike, Umweltbundesamt Fed Environm Agcy, Berlin, Germany.
   Morgan, Marsha K., US EPA, Natl Exposure Res Lab, Off Res \& Dev, Res Triangle Pk, NC 27711 USA.}},
DOI = {{10.1038/jes.2012.52}},
ISSN = {{1559-0631}},
Keywords = {{phthalate; bisphenol A; metabolite; urine; variability}},
Keywords-Plus = {{GENERAL-POPULATION; DI(2-ETHYLHEXYL)PHTHALATE DEHP; TEMPORAL
   VARIABILITY; RISK-ASSESSMENT; EXPOSURE; CHILDREN; PHARMACOKINETICS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{Christensen.Krista@epa.gov}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{Aylward L.L., 2011, INTRAINDIVIDUAL VARI, P20002.
   Davison AC, 1997, BOOTSTRAP METHODS TH.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P3, DOI 10.2307/3429377.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Kutting B, 2009, INT J HYG ENVIR HEAL, V212, P470, DOI 10.1016/j.ijheh.2009.01.002.
   Li Z, 2010, J EXPO SCI ENV EPID, V20, P526, DOI 10.1038/jes.2009.41.
   Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605.
   Morgan MK, 2011, ENVIRON SCI TECHNOL, V45, P5309, DOI 10.1021/es200537u.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   SAS, 2008, SAS STAT 9 2 US GUID.
   Scher DP, 2007, J EXPO SCI ENV EPID, V17, P350, DOI 10.1038/sj.jes.7500505.
   Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   USEPA, 1992, GUID EXP ASS.
   Volkel W, 2005, DRUG METAB DISPOS, V33, P1748, DOI 10.1124/dmd.105.005454.
   Völkel Wolfgang, 2002, Chem Res Toxicol, V15, P1281, DOI 10.1021/tx025548t.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.}},
Number-of-Cited-References = {{22}},
Times-Cited = {{1}},
Journal-ISO = {{J. Expo. Sci. Environ. Epidemiol.}},
Doc-Delivery-Number = {{022US}},
Wos-Id = {{ISI:000309989900012}},
}

@article{ ISI:000309568700007,
Author = {Pradeep, S. and Benjamin, Sailas},
Title = {{Mycelial fungi completely remediate di(2-ethylhexyl)phthalate, the
   hazardous plasticizer in PVC blood storage bag}},
Journal = {{JOURNAL OF HAZARDOUS MATERIALS}},
Year = {{2012}},
Volume = {{235}},
Pages = {{69-77}},
Month = {{OCT 15}},
Abstract = {{This pioneering work describes how simply, inexpensively and efficiently
   novel fungi utilize the alarming plasticizer, di(2-ethylhexyl)phthalate
   (DEHP) blended in PVC blood storage bags (BB). In order to quantify
   total DEHP (33.5\%, w/w) present in BB, it was extracted using n-hexane
   and confirmed by GC-MS. Three mycelial fungi, viz., Aspergillus
   parasiticus, Fusarium subglutinans and Penicillium funiculosum isolated
   in our laboratory form heavily plastics-contaminated soil - either
   singly or in consortium - completely consumed intact DEHP physically
   bound to BB by static submerged growth (28 degrees C) in simple basal
   salt medium (BSM). A two-stage cultivation strategy was adopted for the
   complete removal of DEHP from BB in situ. During the first growth stage,
   almost 70\% DEHP contained in the BB was consumed in 2 weeks,
   accompanied by increased fungal biomass (similar to 0.15-0.35 g/g BB; OD
   similar to 7 at 600 nm) and a sharp declining (3.3) of initial pH (7.2).
   Spent BSM was replaced at this stagnant growth state (low pH), thus in
   the second stage, remaining DEHP bound to BB utilized completely (over
   99\%). Furthermore, A. parasiticus and F. subglutinans also grew well on
   scrapes of PVC water pipes in BSM. F. subglutinans was as efficient
   independently as consortium in completely utilizing the DEHP bound to
   BB, and these fungi offer great potentials for the inexpensive and
   eco-friendly bioremediation of phthalates in medical and allied PVC
   wastes on a large scale through a batch process in alleviating the
   plactics waste management issue. (c) 2012 Elsevier B.V. All rights
   reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Benjamin, S (Reprint Author), Univ Calicut, Dept Bot, Div Biotechnol, Enzyme Technol Lab, Calicut 673635, Kerala, India.
   Pradeep, S.; Benjamin, Sailas, Univ Calicut, Dept Bot, Div Biotechnol, Enzyme Technol Lab, Calicut 673635, Kerala, India.}},
DOI = {{10.1016/j.jhazmat.2012.06.064}},
ISSN = {{0304-3894}},
Keywords = {{Bioremediation; Mycoremediation; Blood storage bag; PVC medical device;
   DEHP}},
Keywords-Plus = {{POLYVINYL-CHLORIDE; DI-2-ETHYLHEXYL PHTHALATE; MICROBIAL-DEGRADATION;
   MEDICAL DEVICES; BIODEGRADATION; DEHP; HEALTH; ESTERS; METABOLITES;
   ENVIRONMENT}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Engineering, Civil; Environmental Sciences}},
Author-Email = {{sailasben@yahoo.co.in}},
Funding-Acknowledgement = {{Ministry of Environment and Forests, Government of India
   {[}19/62/2005-RE]}},
Funding-Text = {{The authors would like to thank the Ministry of Environment and Forests,
   Government of India for a research grant no. 19/62/2005-RE.}},
Cited-References = {{Ali MI, 2009, INT J AGRIC BIOL, V11, P577.
   Al-Salem SM, 2009, WASTE MANAGE, V29, P2625, DOI 10.1016/j.wasman.2009.06.004.
   Baek JH, 2009, J TOXICOL ENV HEAL A, V72, P1388, DOI 10.1080/15287390903212733.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Chang BV, 2004, CHEMOSPHERE, V55, P533, DOI 10.1016/j.chemphere.2003.11.057.
   Chen CY, 2004, APPL SURF SCI, V231, P447, DOI 10.1016/j.apsusc.2004.03.168.
   Chen JA, 2007, APPL MICROBIOL BIOT, V74, P676, DOI 10.1007/s00253-006-0700-3.
   Florence T.A., 2009, INTRO CLIN PHARM.
   Ganji Shobha H., 1995, Biodegradation, V6, P61, DOI 10.1007/BF00702300.
   Graham P R, 1973, Environ Health Perspect, V3, P3, DOI 10.2307/3428023.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hill SS, 2001, CLIN CHIM ACTA, V304, P1, DOI 10.1016/S0009-8981(00)00411-3.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019.
   Jameton A, 2001, CAN MED ASSOC J, V164, P365.
   Jenke Dennis, 2006, PDA J Pharm Sci Technol, V60, P191.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Latini G, 2010, CURR MED CHEM, V17, P2979.
   Latini Giuseppe, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P37, DOI 10.2174/1568008043340017.
   Lee SM, 2004, ENZYME MICROB TECH, V35, P417, DOI 10.1016/j.enzmictec.2004.06.001.
   Lee SM, 2007, BIOTECHNOL BIOENG, V97, P1516, DOI 10.1002/bit.21333.
   Liang DW, 2008, APPL MICROBIOL BIOT, V80, P183, DOI 10.1007/s00253-008-1548-5.
   Luo ZH, 2009, MAR POLLUT BULL, V58, P765, DOI 10.1016/j.marpolbul.2009.03.005.
   Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004.
   Nair IC, 2009, APPL BIOCHEM BIOTECH, V159, P545, DOI 10.1007/s12010-008-8454-2.
   Nakamiya K, 2005, J BIOSCI BIOENG, V99, P115, DOI 10.1263/jbb.99.115.
   Quan CS, 2005, APPL MICROBIOL BIOT, V66, P702, DOI 10.1007/s00253-004-1683-6.
   Reynolds TB, 2001, SCIENCE, V291, P878, DOI 10.1126/science.291.5505.878.
   Roslev P, 2007, WATER RES, V41, P969, DOI 10.1016/j.watres.2006.11.049.
   Ruzickova K, 2004, PREVENTING HARM PHTH.
   Sabev HA, 2006, MICROBIOL-SGM, V152, P1731, DOI 10.1099/mic.0.28569-0.
   Sampson J, 2011, TRANSFUSION MED, V21, P73, DOI 10.1111/j.1365-3148.2010.01056.x.
   Shaz BH, 2011, TRANSFUSION, V51, P2510, DOI 10.1111/j.1537-2995.2011.03164.x.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Webb JS, 1999, APPL ENVIRON MICROB, V65, P3575.
   Yuan SY, 2002, CHEMOSPHERE, V49, P1295, DOI 10.1016/S0045-6535(02)00495-2.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{1}},
Journal-ISO = {{J. Hazard. Mater.}},
Doc-Delivery-Number = {{017CW}},
Wos-Id = {{ISI:000309568700007}},
}

@article{ ISI:000309849900015,
Author = {Kessler, Winfried and Numtip, Wanwiwa and Voelkel, Wolfgang and Seckin,
   Elcim and Csanady, Gyorgy A. and Puetz, Christian and Klein, Dominik and
   Fromme, Hermann and Filser, Johannes G.},
Title = {{Kinetics of di(2-ethylhexyl) phthalate (DEHP) and mono(2-ethylhexyl)
   phthalate in blood and of DEHP metabolites in urine of male volunteers
   after single ingestion of ring-deuterated DEHP}},
Journal = {{TOXICOLOGY AND APPLIED PHARMACOLOGY}},
Year = {{2012}},
Volume = {{264}},
Number = {{2}},
Pages = {{284-291}},
Month = {{OCT 15}},
Abstract = {{The plasticizer di(2-ethylhexyl) phthalate (DEHP) is suspected to induce
   antiandrogenic effects in men via its metabolite mono(2-ethylhexyl)
   phthalate (MEHP). However, there is only little information on the
   kinetic behavior of DEHP and its metabolites in humans. The
   toxikokinetics of DEHP was investigated in four male volunteers (28-61
   y) who ingested a single dose (645 +/- 20 mu g/kg body weight) of
   ring-deuterated DEHP (DEHP-D-4). Concentrations of DEHP-D-4, of free
   ring-deuterated MEHP (MEHP-D-4), and the sum of free and glucuronidated
   MEHP-D-4 were measured in blood for up to 24 h; amounts of the
   monoesters MEHP-D-4, ring-deuterated mono(2-ethyl-5-hydroxyhexyl)
   phthalate and ring-deuterated mono(2-ethyl-5-oxohexyl) phthalate were
   determined in urine for up to 46 h after ingestion. The bioavailability
   of DEHP-D-4 was surprisingly high with an area under the
   concentration-time curve until 24 h (AUC) amounting to 50\% of that of
   free MEHP-D-4. The AUC of free MEHP-D-4 normalized to DEHP-D-4 dose and
   body weight (AUC/D) was 2.1 and 8.1 times, that of DEHP-D-4 even 50 and
   100 times higher than the corresponding AUC/D values obtained earlier in
   rat and marmoset, respectively. Time courses of the compounds in blood
   and urine of the volunteers oscillated widely. Terminal elimination
   half-lives were short (4.3-6.6 h). Total amounts of metabolites in 22-h
   urine are correlated linearly with the AUC of free MEHP-D-4 in blood,
   the parameter regarded as relevant for risk assessment. (C) 2012
   Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kessler, W (Reprint Author), Helmholtz Zentrum Munchen, Inst Mol Toxicol \& Pharmacol, German Res Ctr Environm Hlth, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
   Kessler, Winfried; Numtip, Wanwiwa; Csanady, Gyorgy A.; Puetz, Christian; Klein, Dominik; Filser, Johannes G., Helmholtz Zentrum Munchen, Inst Mol Toxicol \& Pharmacol, German Res Ctr Environm Hlth, D-85764 Neuherberg, Germany.
   Voelkel, Wolfgang; Seckin, Elcim; Fromme, Hermann, Bavarian Hlth \& Food Safety Author, Dept Chem Safety \& Toxicol, D-80538 Munich, Germany.
   Csanady, Gyorgy A.; Klein, Dominik; Filser, Johannes G., Tech Univ Munich, Inst Toxikol \& Umwelthyg, Munich, Germany.}},
DOI = {{10.1016/j.taap.2012.08.009}},
ISSN = {{0041-008X}},
Keywords = {{Di(2-ethylhexyl) phthalate (DEHP); Mono(2-ethylhexyl) phthalate (MEHP);
   Monoesters human; Blood; Urine}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; DEUTERIUM-LABELED DEHP; N-BUTYL PHTHALATE;
   MONO-(2-ETHYLHEXYL) PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; EXPOSURE
   ASSESSMENT; COMMON MARMOSETS; RISK-ASSESSMENT; SERUM; RAT}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{kessler@helmholtz-muenchen.de}},
Funding-Acknowledgement = {{German ``Umweltbundesamt{''} (UFOPLAN) {[}3707 61 201]}},
Funding-Text = {{This work was financially supported by the German ``Umweltbundesamt{''}
   (UFOPLAN Ref-No. 3707 61 201).}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   Anderson WAC, 2011, FOOD CHEM TOXICOL, V49, P2022, DOI 10.1016/j.fct.2011.05.013.
   Brown RP, 1997, TOXICOL IND HEALTH, V13, P407.
   CARRIERE F, 1993, GASTROENTEROLOGY, V105, P876.
   Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870.
   Desdoits-Lethimonier C, 2012, HUM REPROD, V27, P1451, DOI 10.1093/humrep/des069.
   ECB (European Chemicals Bureau), 2008, 2 PRIOR LIST, V80.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P345, DOI 10.1016/j.ijheh.2007.01.026.
   Gentry PR, 2011, CRIT REV TOXICOL, V41, P1, DOI 10.3109/10408444.2011.599366.
   GRIFFITHS WC, 1988, ENVIRON HEALTH PERSP, V77, P151, DOI 10.2307/3430640.
   Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m.
   Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005.
   Hines CJ, 2011, J EXPO SCI ENV EPID, V21, P133, DOI 10.1038/jes.2009.62.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Ito Y, 2005, ARCH TOXICOL, V79, P147, DOI 10.1007/s00204-004-0615-7.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kessler W, 2004, TOXICOL APPL PHARM, V195, P142, DOI 10.1016/j.taap.2003.11.014.
   Kessler W, 2001, ARCH TOXICOL, V75, P62, DOI 10.1007/s002040000198.
   Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Kurata Y, 2012, J TOXICOL SCI, V37, P401.
   Kurata Y, 1998, TOXICOL SCI, V42, P49, DOI 10.1093/toxsci/42.1.49.
   Lague E, 2008, ENDOCRINOLOGY, V149, P4688, DOI 10.1210/en.2008-0310.
   Li H, 2003, BIOL REPROD, V69, P1964, DOI 10.1095/biolreprod.103.018895.
   Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073.
   LINDENA J, 1986, J CLIN CHEM CLIN BIO, V24, P19.
   Lorber M, 2011, J EXPO SCI ENV EPID, V21, P576, DOI 10.1038/jes.2010.43.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Samandar E, 2009, ENVIRON RES, V109, P641, DOI 10.1016/j.envres.2009.02.004.
   Seckin E, 2009, TOXICOL LETT, V188, P33, DOI 10.1016/j.toxlet.2009.03.002.
   Silva MJ, 2008, J CHROMATOGR B, V873, P180, DOI 10.1016/j.jchromb.2008.08.017.
   Takatori S, 2004, J CHROMATOGR B, V804, P397, DOI 10.1016/j.jchromb.2004.01.056.
   Thews G., 1991, ANATOMIE PHYSL PATHO.
   Tomonari Y, 2006, J TOXICOL ENV HEAL A, V69, P1651, DOI 10.1080/15287390600630054.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{0}},
Journal-ISO = {{Toxicol. Appl. Pharmacol.}},
Doc-Delivery-Number = {{020XM}},
Wos-Id = {{ISI:000309849900015}},
}

@article{ ISI:000309692600021,
Author = {Joensen, Ulla Nordstrom and Frederiksen, Hanne and Jensen, Martin
   Blomberg and Lauritsen, Mette Petri and Olesen, Inge Ahlmann and Lassen,
   Tina Harmer and Andersson, Anna-Maria and Jorgensen, Niels},
Title = {{Phthalate Excretion Pattern and Testicular Function: A Study of 881
   Healthy Danish Men}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2012}},
Volume = {{120}},
Number = {{10}},
Pages = {{1397-1403}},
Month = {{OCT}},
Abstract = {{BACKGROUND: In animals, some phthalates impair male reproductive
   development and function. Epidemiological studies have reported
   inconsistent evidence of associations between phthalates and markers of
   human testicular function.
   OBJECTIVES: We aimed to provide estimates of the effects of phthalate
   exposure on reproductive hormone levels and semen quality in healthy
   men.
   METHODS: A total of 881 men gave urine, serum, and semen samples. Serum
   levels of testosterone, estradiol (E-2), sex hormone-binding globulin
   (SHBG), luteinizing hormone (LH), follicle-stimulating hormone (FSH),
   and inhibin-B; semen quality; and urinary concentrations of 14 phthalate
   metabolites, including metabolites of di(2-ethylhexyl) phthalate (DEHP)
   and diisononyl phthalate (DiNP), were assessed. The proportions of DEHP
   and DiNP excreted as their respective primary metabolites
   {[}mono(2-ethylhexyl) phthalate (MEHP) and mono-isononyl phthalate
   (MiNP)] were calculated and expressed as percentages (\%MEHP and \%MiNP,
   respectively).
   RESULTS: The free androgen index was 15\% lower {[}95\% confidence
   interval (CI): -23, -8\%] for men in the highest \%MiNP quartile
   compared to the lowest quartile (p < 0.001) after adjusting for
   confounders, and 9\% lower (95\% CI: -16, -1\%) in the highest \%MEHP
   quartile (p = 0.02). \%MEHP and \%MiNP were negatively associated with
   the ratio of testosterone/LH and testosterone/FSH. \%MEHP was negatively
   associated with total testosterone, free testosterone, and ratio of
   testosterone/E-2. \%MiNP was positively associated with SHBG. There was
   little evidence of associations between urinary phthalate metabolites or
   sums of phthalates with reproductive hormones or semen quality
   CONCLUSION: Our data suggest that both testosterone production and
   pituitary hypothalamic feedback may be compromised in individuals
   excreting a high proportion of primary metabolites of long-chained
   phthalates relative to the proportion of secondary metabolites.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Joensen, UN (Reprint Author), Copenhagen Univ Hosp, Dept Growth \& Reprod, Sect 5064, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
   Joensen, Ulla Nordstrom, Copenhagen Univ Hosp, Dept Growth \& Reprod, Sect 5064, DK-2100 Copenhagen, Denmark.
   Lauritsen, Mette Petri, Copenhagen Univ Hosp, Fertil Dept, DK-2100 Copenhagen, Denmark.}},
DOI = {{10.1289/ehp.1205113}},
ISSN = {{0091-6765}},
Keywords = {{DEHP; DiNP; male reproduction; phthalates; semen quality; testosterone;
   \%MEHP; \%MiNP}},
Keywords-Plus = {{HORMONE BINDING GLOBULIN; SEMEN QUALITY; REPRODUCTIVE HORMONES;
   OXIDATIVE METABOLITES; FREE TESTOSTERONE; EXPOSURE; SERUM; ASSOCIATIONS;
   POPULATION; MONOESTER}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{ulla.nordstroem.joensen@rh.regionh.dk}},
ResearcherID-Numbers = {{Jorgensen, Niels/A-8148-2012}},
Funding-Acknowledgement = {{European Commission {[}FP7-2007-212844]; Danish Agency for Science,
   Technology and Innovation {[}27107068, 09-067180]; University Hospital
   of Copenhagen {[}961506336]; University of Copenhagen; Danish Ministry
   of Health; Danish Environmental Protection Agency {[}MST-621-00013];
   Kirsten and Freddy Johansen Foundation {[}95-103-72087]}},
Funding-Text = {{The authors received financial support from the European Commission
   (DEER, FP7-2007-212844), the Danish Agency for Science, Technology and
   Innovation (grants 27107068 and 09-067180), the University Hospital of
   Copenhagen (grant 961506336), the University of Copenhagen, the Danish
   Ministry of Health, the Danish Environmental Protection Agency
   (MST-621-00013), and the Kirsten and Freddy Johansen Foundation (grant
   95-103-72087). Instrumental equipment was supported financially by the
   Velux Foundation.}},
Cited-References = {{Andersson AM, 2007, J CLIN ENDOCR METAB, V92, P4696, DOI 10.1210/jc.2006-2633.
   BELGOROSKY A, 1985, ACTA ENDOCRINOL-COP, V109, P130.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   Boberg J, 2011, REPROD TOXICOL, V31, P200, DOI 10.1016/j.reprotox.2010.11.001.
   Buteau-Lozano H, 2008, J ENDOCRINOL, V196, P399, DOI 10.1677/JOE-07-0198.
   CARLSEN E, 1992, BRIT MED J, V305, P609.
   Centers for Disease Control and Prevention, 2012, 4 CDCP.
   Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870.
   Department of Growth and Reproduction Copenhagen University Hospital, 2012, NORM RANG REPR HORM.
   Desdoits-Lethimonier C, 2012, HUM REPROD, V27, P1451, DOI 10.1093/humrep/des069.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Frederiksen H, 2010, J ANAL TOXICOL, V34, P400.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hammond GL, 2008, CLIMACTERIC, V11, P41, DOI 10.1080/13697130701851814.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Herr C, 2009, INT J HYG ENVIR HEAL, V212, P648, DOI 10.1016/j.ijheh.2009.08.001.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Jorgensen N, 2011, INT J ANDROL, V34, pE37, DOI 10.1111/j.1365-2605.2010.01133.x.
   Jorgensen N, 2002, HUM REPROD, V17, P2199, DOI 10.1093/humrep/17.8.2199.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Mendiola J, 2011, INT J ANDROL, V34, P369, DOI 10.1111/j.1365-2605.2010.01095.x.
   MENKVELD R, 1990, HUM REPROD, V5, P586.
   Pan G, 2011, INT J ANDROL, V34, pE397, DOI 10.1111/j.1365-2605.2011.01201.x.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Ravnborg TL, 2011, HUM REPROD, V26, P1000, DOI 10.1093/humrep/der011.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Suzuki Y, 2012, INT J ANDROL, V35, P236, DOI 10.1111/j.1365-2605.2011.01190.x.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wolff MS, 2010, ENVIRON HEALTH PERSP, V118, P1039, DOI 10.1289/ehp.0901690.
   World Health Organization, 2010, WHO LAB MAN EX PROC.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{3}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{018US}},
Wos-Id = {{ISI:000309692600021}},
}

@article{ ISI:000309692600033,
Author = {Just, Allan C. and Whyatt, Robin M. and Perzanowski, Matthew S. and
   Calafat, Antonia M. and Perera, Frederica P. and Goldstein, Inge F. and
   Chen, Qixuan and Rundle, Andrew G. and Miller, Rachel L.},
Title = {{Prenatal Exposure to Butylbenzyl Phthalate and Early Eczema in an Urban
   Cohort}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2012}},
Volume = {{120}},
Number = {{10}},
Pages = {{1475-1480}},
Month = {{OCT}},
Abstract = {{BACKGROUND: Recent cross-sectional studies suggest a link between
   butylbenzyl phthalate (BBzP) in house dust and childhood eczema.
   OBJECTIVES: We aimed to evaluate whether concentrations of monobenzyl
   phthalate (MBzP), the main BBzP metabolite in urine, during pregnancy
   are associated prospectively with eczema in young children, and whether
   this association varies by the child's sensitization to indoor allergens
   or serological evidence of any allergies.
   METHoDs: MBzP was measured in spot urine samples during the third
   trimester of pregnancy from 407 African-American and Dominican women
   residing in New York City in 1999-2006. Repeated questionnaires asked
   mothers whether their doctor ever said their child had eczema. Child
   blood samples at 24, 36, and 60 months of age were analyzed for total,
   anti-cockroach, dust mite, and mouse IgE. Relative risks (RR) were
   estimated with multivariable modified Poisson regression. Analyses
   included a multinomial logistic regression model for early- and
   late-onset eczema versus no eczema through 60 months of age.
   RESULTS: MBzP was detected in > 99\% of samples (geometric mean = 13.6;
   interquartile range: 5.7-31.1 ng/mL). By 24 months, 30\% of children
   developed eczema, with the proportion higher among African Americans
   (48\%) than among Dominicans (21\%) (p < 0.001). An interquartile range
   increase in log MBzP concentration was associated positively with
   early-onset eczema (RR = 1.52 for eczema by 24 months; 95\% confidence
   interval: 1.21, 1.91, p = 0.0003, n = 113 reporting eczema/376 total
   sample), adjusting for urine specific gravity, sex, and race/ethnicity.
   MBzP was not associated with allergic sensitization, nor did seroatopy
   modify consistently the MBzP and eczema association.
   CONCLUSIONS: Prenatal exposure to BBzP may influence the risk of
   developing eczema in early childhood.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Just, AC (Reprint Author), Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, Dept Environm Hlth Sci, 722 W 168th St,12th Floor, New York, NY 10032 USA.
   Just, Allan C.; Whyatt, Robin M.; Perzanowski, Matthew S.; Perera, Frederica P.; Goldstein, Inge F.; Rundle, Andrew G.; Miller, Rachel L., Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, Dept Environm Hlth Sci, New York, NY 10032 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Goldstein, Inge F.; Rundle, Andrew G., Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA.
   Chen, Qixuan, Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA.
   Miller, Rachel L., Columbia Univ Coll Phys \& Surg, Dept Med, Div Pulm, New York, NY 10032 USA.}},
DOI = {{10.1289/ehp.1104544}},
ISSN = {{0091-6765}},
Keywords = {{butylbenzyl phthalate; eczema; plasticizers}},
Keywords-Plus = {{ATOPIC-DERMATITIS; US POPULATION; ASSOCIATION; CHILDREN; DUST;
   METABOLITES; PREVALENCE; CHILDHOOD; HEALTH; ASTHMA}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{acj2109@columbia.edu}},
ResearcherID-Numbers = {{Rundle, Andrew/A-5282-2009}},
ORCID-Numbers = {{Rundle, Andrew/0000-0003-0211-7707}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences {[}R01 ES014393, R01
   ES013163, P01 ES09600, R01 ES008977, P30 ES009089]; U.S. Environmental
   Protection Agency (EPA) {[}R827027, RD832141, RD834509]; EPA STAR
   graduate fellowship {[}FP-91712001]; John and Wendy Neu Family
   Foundation; Blanchette Hooker Rockefeller Fund; New York Community
   Trust; Educational Foundation of America; Millstream Fund}},
Funding-Text = {{This work was supported by the National Institute of Environmental
   Health Sciences (grants R01 ES014393, R01 ES013163, P01 ES09600, R01
   ES008977, and P30 ES009089), the U.S. Environmental Protection Agency
   (EPA; grants R827027, RD832141, and RD834509, and EPA STAR graduate
   fellowship FP-91712001 for A.C.J.), the John and Wendy Neu Family
   Foundation, Blanchette Hooker Rockefeller Fund, New York Community
   Trust, Educational Foundation of America, and Millstream Fund.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Centers for Disease Control and Prevention (CDC), 2012, 4 CDCP.
   Chang Carolyn, 2010, Clin Mol Allergy, V8, P11, DOI 10.1186/1476-7961-8-11.
   Choi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013423.
   Dillon SR, 2004, NAT IMMUNOL, V5, P752, DOI 10.1038/ni1084.
   Donohue KM, 2008, J ALLERGY CLIN IMMUN, V122, P914, DOI 10.1016/j.jaci.2008.08.034.
   Flohr C, 2004, J ALLERGY CLIN IMMUN, V114, P150, DOI 10.1016/j.jaci.2004.04.027.
   Herbarth O, 2006, INT J HYG ENVIR HEAL, V209, P241, DOI 10.1016/j.ijheh.2006.01.003.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Jepsen KF, 2004, TOXICOL IN VITRO, V18, P265, DOI 10.1016/j.tiv.2003.09.008.
   Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Knol MJ, 2007, INT J EPIDEMIOL, V36, P1111, DOI 10.1093/ije/dym157.
   Kolarik B, 2008, ATMOS ENVIRON, V42, P8553, DOI 10.1016/j.atmosenv.2008.08.028.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   Kramer U, 2004, BRIT J DERMATOL, V150, P111, DOI 10.1111/j.1365-2133.2004.05710.x.
   Kusel MMH, 2005, J ALLERGY CLIN IMMUN, V116, P1067, DOI 10.1016/j.jaci.2005.06.038.
   Kwak ES, 2009, OPEN ALLERGY J, V2, P45.
   Larson RP, 2010, J IMMUNOL, V184, P2974, DOI 10.4049/jimmunol.0803478.
   Laughter D, 2000, J AM ACAD DERMATOL, V43, P649, DOI 10.1067/mjd.2000.107773.
   Leung DYM, 2004, J CLIN INVEST, V113, P651, DOI 10.1172/JCI200421060.
   National Center for Health Statistics, 2008, 2005 2006 DAT DOC CO.
   Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742.
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P3.
   Schulz F, 2007, J ALLERGY CLIN IMMUN, V120, P1097, DOI 10.1016/j.jaci.2007.07.065.
   Shaw TE, 2011, J INVEST DERMATOL, V131, P67, DOI 10.1038/jid.2010.251.
   Shigeno T, 2009, IMMUNOLOGY, V128, pe849, DOI 10.1111/j.1365-2567.2009.03094.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Staumont-Salle D, 2008, J ALLERGY CLIN IMMUN, V121, P962, DOI 10.1016/j.jaci.2007.12.1165.
   Wittassek M, 2009, INT J HYG ENVIR HEAL, V212, P492, DOI 10.1016/j.ijheh.2009.04.001.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Yanagisawa R, 2008, ENVIRON HEALTH PERSP, V116, P1136, DOI 10.1289/ehp.11191.
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{6}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{018US}},
Wos-Id = {{ISI:000309692600033}},
}

@article{ ISI:000308786900030,
Author = {James-Todd, Tamarra and Stahlhut, Richard and Meeker, John D. and
   Powell, Sheena-Gail and Hauser, Russ and Huang, Tianyi and Rich-Edwards,
   Janet},
Title = {{Urinary Phthalate Metabolite Concentrations and Diabetes among Women in
   the National Health and Nutrition Examination Survey (NHANES) 2001-2008}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2012}},
Volume = {{120}},
Number = {{9}},
Pages = {{1307-1313}},
Month = {{SEP}},
Abstract = {{BACKGROUND: Previous studies have shown that women have higher urinary
   concentrations of several phthalate metabolites than do men, possibly
   because of a higher use of personal care products. Few studies have
   evaluated the association between phthalate metabolites, diabetes, and
   diabetes-related risk factors among women.
   OBJECTIVE: We explored the association between urinary phthalate
   metabolite concentrations and diabetes among women who participated in a
   cross-sectional study.
   METHODS: We used urinary concentrations of phthalate metabolites,
   analyzed by the Centers for Disease Control and Prevention, and
   self-reported diabetes of 2,350 women between 20 and 79 years of age who
   participated in the NHANES (2001-2008). We used multiple logistic
   regression to estimate odds ratios (ORs) and 95\% confidence intervals
   (CIs) and adjusted for urinary creatinine, sociodemographic
   characteristics, dietary factors, and body size. A secondary analysis
   was conducted for women who did not have diabetes to evaluate the
   association between phthalate metabolite concentrations and fasting
   blood glucose (FBG), homeostasis model assessment estimated insulin
   resistance, and glycosylated hemoglobin A1c.
   RESULTS: After adjusting for potential confounders, women with higher
   levels of mono-n-butyl phthalate (MnBP), mono-isobutyl phthalate (MiBP),
   monobenzyl phthalate (MBzP), mono-(3-carboxypropyl) phthalate (MCPP),
   and three di-(2-ethylhexyl) phthalate metabolites (Sigma DEHP) had an
   increased odds of diabetes compared with women with the lowest levels of
   these phthalates. Women in the highest quartile for MBzP and MiBP had
   almost twice the odds of diabetes {[}OR = 1.96 (95\% Cl: 1.11, 3.47) and
   OR = 1.95 (95\% CI: 0.99, 3.85), respectively] compared with women in
   the lowest quartile. Nonmonotonic, positive associations were found for
   MnBP and Sigma DEHP, whereas MCPP appeared to have a threshold effect.
   Certain phthalate metabolites were positively associated with FBG and
   insulin resistance.
   DISCUSSION: Urinary levels of several phthalates were associated with
   prevalent diabetes. Future prospective studies are needed to further
   explore these associations to determine whether phthalate exposure can
   alter glucose metabolism and increase the risk of insulin resistance and
   diabetes.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{James-Todd, T (Reprint Author), Brigham \& Womens Hosp, Div Womens Hlth, Dept Med, Connors Ctr Womens Hlth \& Gender Biol, 1620 Tremont St,3rd Floor, Boston, MA 02120 USA.
   James-Todd, Tamarra; Powell, Sheena-Gail; Huang, Tianyi; Rich-Edwards, Janet, Brigham \& Womens Hosp, Div Womens Hlth, Dept Med, Connors Ctr Womens Hlth \& Gender Biol, Boston, MA 02120 USA.
   James-Todd, Tamarra, Harvard Univ, Sch Med, Div Womens Hlth, Boston, MA USA.
   Stahlhut, Richard, Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, Rochester, NY 14642 USA.
   Meeker, John D., Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   Hauser, Russ; Rich-Edwards, Janet, Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.}},
DOI = {{10.1289/ehp.1104717}},
ISSN = {{0091-6765}},
Keywords = {{diabetes; di(2-ethylhexyl) phthalate; monobenzyl phthalate;
   mono-(3-carboxypropyl) phthalate; monoethyl phthalate; mono-isobutyl
   phthalate; mono-n-butyl phthalate; women}},
Keywords-Plus = {{HOMEOSTASIS MODEL ASSESSMENT; PPAR-ALPHA; INSULIN SENSITIVITY;
   GLUCOSE-TOLERANCE; MEXICAN WOMEN; US POPULATION; EXPOSURE; OBESITY;
   MEDICATIONS; RESISTANCE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{tjames-todd@bics.bwh.harvard.edu}},
Funding-Acknowledgement = {{American Diabetes Association Mentor-based Minority Postdoctoral
   Fellowship Award {[}7-09-MI-06]; National Institute of Environmental
   Health Sciences {[}R0 1ES018872]}},
Funding-Text = {{This research was funded by the American Diabetes Association
   Mentor-based Minority Postdoctoral Fellowship Award (7-09-MI-06) and the
   National Institute of Environmental Health Sciences (grant R0
   1ES018872).}},
Cited-References = {{Ali MK, 2011, DIABETES CARE, V34, P1998, DOI 10.2337/dc11-0792.
   Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57.
   Burgette LF, 2011, EPIDEMIOLOGY, V22, P859, DOI 10.1097/EDE.0b013e31822908b3.
   Casals-Casas C, 2008, INT J OBESITY, V32, pS53, DOI 10.1038/ijo.2008.207.
   CDC, 2011, NAT HLTH NUTR EX SUR.
   CDC (Centers for Disease Control and Prevention), 2011, NHANES AN COURS.
   CDC (Centers for Disease Control and Prevention), 2011, 4 CDC.
   CDC (Centers for Disease Control and Prevention), 2011, DAT TRENDS AG ADJ PE.
   COLDITZ GA, 1995, ANN INTERN MED, V122, P481.
   Crinnion WJ, 2010, ALTERN MED REV, V15, P190.
   Danaei Goodarz, 2009, Popul Health Metr, V7, P16, DOI 10.1186/1478-7954-7-16.
   Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017.
   Emoto M, 1999, DIABETES CARE, V22, P818, DOI 10.2337/diacare.22.5.818.
   Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217.
   Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Gayathri NS, 2004, INDIAN J MED RES, V119, P139.
   GRAS F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI DOI 10.1186/1476-069X-7-27.
   HARRIS MI, 1995, DIABETES AM, P15.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hermans MP, 1999, DIABETOLOGIA, V42, P678, DOI 10.1007/s001250051215.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Kelley KE, 2012, ENVIRON HEALTH PERSP, V120, P379, DOI 10.1289/ehp.1103998.
   KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166.
   Lapinskas PJ, 2005, TOXICOLOGY, V207, P149, DOI 10.1016/j.tox.2004.09.008.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Latini G, 2009, ENVIRON INT, V35, P987, DOI 10.1016/j.envint.2009.03.008.
   Mokdad AH, 2000, DIABETES CARE, V23, P1278, DOI 10.2337/diacare.23.9.1278.
   Newbold RR, 2010, HORM-INT J ENDOCRINO, V9, P206.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Rengarajan S, 2007, TOXICOL IN VITRO, V21, P99, DOI 10.1016/j.tiv.2006.07.005.
   Romero-Franco M, 2011, ENVIRON INT, V37, P867, DOI 10.1016/j.envint.2011.02.014.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Svensson K, 2011, ENVIRON RES, V111, P792, DOI 10.1016/j.envres.2011.05.015.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Thayer KA, 2012, ENVIRON HEALTH PERSP, V120, P779, DOI 10.1289/ehp.1104597.
   Tordjman K, 2002, J LIPID RES, V43, P936.
   Tsatsoulis A, 2009, CONTEMP DIABETES, P83, DOI 10.1007/978-1-60327-250-6\_5.
   {*}CDC, 2011, TASK 3A ID OUTL EV T.
   {*}SAS I, 2011, QUANTREG PROC EXP, DOI DOI 10.1016/J.ENVINT.2011.02.014.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{2}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{005YV}},
Wos-Id = {{ISI:000308786900030}},
}

@article{ ISI:000308734400009,
Author = {Chen, Mei and Tao, Lin and Collins, Erin M. and Austin, Christine and
   Lu, Chensheng},
Title = {{Simultaneous determination of multiple phthalate metabolites and
   bisphenol-A in human urine by liquid chromatography-tandem mass
   spectrometry}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES}},
Year = {{2012}},
Volume = {{904}},
Pages = {{73-80}},
Month = {{SEP 1}},
Abstract = {{Phthalates and bisphenol A are environmental endocrine-disrupting
   chemicals used widely in common consumer products. There is increasing
   concern about human exposure to phthalates and bisphenol A due to the
   potential adverse effects related to the anti-androgenic activity of
   phthalates and estrogenic activity of bisphenol A. In assessing
   environmental exposure to phthalates and bisphenol A, it is essential to
   have a validated analytical method that can quantify trace
   concentrations of phthalate metabolites and bisphenol A in humans. In
   this study, we developed and validated an accurate, sensitive, and
   robust LC-MS/MS method to simultaneously quantify 5 phthalate monoester
   metabolites, including mono-methyl phthalate, mono-ethyl phthalate,
   mono-butyl phthalate, mono-benzyl phthalate, mono-2-ethylhexyl
   phthalate, and bisphenol A in human urine. In this method, the phthalate
   metabolites and bisphenol A, along with their isotope labeled internal
   standards, were extracted from 200 mu l of human urine using automated
   off-line solid phase extraction. The analytes were quantitatively
   determined using LC-MS/MS operated in negative electrospray ionization
   multiple reaction-monitoring mode. The limit of quantification was 0.3
   ng/ml for mono-methyl phthalate, mono-ethyl phthalate, mono-benzyl
   phthalate and bisphenol A. and 1 ng/ml for mono-butyl phthalate and
   mono-2-ethylhexyl phthalate. The precision and accuracy were well within
   the acceptable 15\% range. This validated method has been used
   successfully in assessing exposure to phthalates and bisphenol A in
   humans. (C) 2012 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lu, CS (Reprint Author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, 677 Huntington Ave, Boston, MA 02115 USA.
   Chen, Mei; Tao, Lin; Collins, Erin M.; Austin, Christine; Lu, Chensheng, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.}},
DOI = {{10.1016/j.jchromb.2012.07.022}},
ISSN = {{1570-0232}},
Keywords = {{Phthalate metabolite; Bisphenol A; SPE; LC-MS/MS}},
Keywords-Plus = {{QUANTITATIVE DETECTION; SAMPLES; QUANTIFICATION; POPULATION; EXTRACTION;
   EXPOSURE; PHENOLS; HEALTH; ADULTS; MS/MS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{cslu@hsph.harvard.edu}},
Funding-Acknowledgement = {{Harvard-NIEHS Center for Environmental Health {[}ES000002]; NIEHS
   {[}5R21ES019773-02]; NIOSH {[}5R210H009831-02]}},
Funding-Text = {{This project was primarily supported by the Harvard-NIEHS Center for
   Environmental Health (ES000002), and by research funding from NIEHS
   (5R21ES019773-02) and NIOSH (5R210H009831-02).}},
Cited-References = {{Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Braun JM, 2012, ENVIRON HEALTH PERSP, V120, P739, DOI 10.1289/ehp.1104139.
   Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753.
   Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012.
   CDC (Centers for Disease Control and Prevention), 2012, 4 NAT REP HUM EXP EN.
   Chen M, 2011, J SEP SCI, V34, P1648, DOI 10.1002/jssc.201100152.
   Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395.
   Geens T, 2009, J CHROMATOGR B, V877, P4042, DOI 10.1016/j.jchromb.2009.10.017.
   Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714.
   Inoue K, 2003, J CHROMATOGR B, V798, P17, DOI 10.1016/j.jchromb.2003.08.042.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kondo F, 2010, B ENVIRON CONTAM TOX, V85, P92, DOI 10.1007/s00128-010-0051-8.
   Krotz S.P., 2012, J ASSIST REPROD GEN, P27.
   Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303.
   Markham DA, 2010, J ANAL TOXICOL, V34, P293.
   Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582.
   Roy JR, 2009, MED SCI MONITOR, V15, pRA137.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Silva MJ, 2008, J CHROMATOGR B, V873, P180, DOI 10.1016/j.jchromb.2008.08.017.
   Takashima K, 2008, J OCCUP HEALTH, V50, P169, DOI 10.1539/joh.L7105.
   Vandentorren S, 2011, ENVIRON RES, V111, P761, DOI 10.1016/j.envres.2011.05.018.
   Volkel W, 2005, DRUG METAB DISPOS, V33, P1748, DOI 10.1124/dmd.105.005454.
   Ye XY, 2005, ANAL CHEM, V77, P5407, DOI 10.1021/ac050390d.
   Yolton K, 2011, NEUROTOXICOL TERATOL, V33, P558, DOI 10.1016/j.ntt.2011.08.003.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{1}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{005EX}},
Wos-Id = {{ISI:000308734400009}},
}

@article{ ISI:000307934000006,
Author = {Buckley, Jessie P. and Palmieri, Rachel T. and Matuszewski, Jeanine M.
   and Herring, Amy H. and Baird, Donna D. and Hartmann, Katherine E. and
   Hoppin, Jane A.},
Title = {{Consumer product exposures associated with urinary phthalate levels in
   pregnant women}},
Journal = {{JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY}},
Year = {{2012}},
Volume = {{22}},
Number = {{5}},
Pages = {{468-475}},
Month = {{SEP-OCT}},
Abstract = {{Human phthalate exposure is ubiquitous, but little is known regarding
   predictors of urinary phthalate levels. To explore this, 50 pregnant
   women aged 18-38 years completed two questionnaires on potential
   phthalate exposures and provided a first morning void. Urine samples
   were analyzed for 12 phthalate metabolites. Associations with
   questionnaire items were evaluated via Wilcoxon tests and t-tests, and
   r-squared values were calculated in multiple linear regression models.
   Few measured factors were statistically significantly associated with
   phthalate levels. Individuals who used nail polish had higher levels of
   mono-butyl phthalate (P=0.048) than non-users. Mono-benzyl phthalate
   levels were higher among women who used eye makeup (P=0.034) or used
   makeup on a regular basis (P=0.004). Women who used cologne or perfume
   had higher levels of di-(2-ethylhexyl) phthalate metabolites. Household
   products, home flooring or paneling, and other personal care products
   were also associated with urinary phthalates. The proportion of variance
   in metabolite concentrations explained by questionnaire items ranged
   between 0.31 for mono-ethyl phthalate and 0.42 for mono-n-methyl
   phthalate. Although personal care product use may be an important
   predictor of urinary phthalate levels, most of the variability in
   phthalate exposure was not captured by our relatively comprehensive set
   of questionnaire items.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hoppin, JA (Reprint Author), NIEHS, Epidemiol Branch, NIH, MD A3-05,POB 12233, Res Triangle Pk, NC 27709 USA.
   Baird, Donna D.; Hoppin, Jane A., NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA.
   Buckley, Jessie P.; Palmieri, Rachel T.; Hartmann, Katherine E., Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.
   Matuszewski, Jeanine M.; Herring, Amy H., Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.
   Herring, Amy H., Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA.
   Hartmann, Katherine E., Vanderbilt Univ, Inst Med \& Publ Hlth, Nashville, TN USA.}},
DOI = {{10.1038/jes.2012.33}},
ISSN = {{1559-0631}},
Keywords = {{phthalates; pregnancy; biomonitoring; urine; personal care products}},
Keywords-Plus = {{NEW-YORK-CITY; DI-(2-ETHYLHEXYL) PHTHALATE; METABOLITE CONCENTRATIONS;
   WAIST CIRCUMFERENCE; US POPULATION; CARE PRODUCTS; MONOESTERS;
   VARIABILITY; OUTCOMES; SAMPLES}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{hoppin1@niehs.nih.gov}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences {[}T32 ES007018];
   American Water Works Association Research Foundation {[}2579]; National
   Institute of Environmental Health Sciences, NIH, DHHS {[}Z01ES049003]}},
Funding-Text = {{Jessie P. Buckley and Jeanine M. Matuszewski were supported by a
   National Institute of Environmental Health Sciences training grant (T32
   ES007018). Amy H. Herring and Katherine E. Hartmann were supported by
   the American Water Works Association Research Foundation under Contract
   \#2579. This work was supported in part by the Intramural Research
   Program of the National Institute of Environmental Health Sciences, NIH,
   DHHS (Z01ES049003). We thank CDC for the analysis of these samples.}},
Cited-References = {{Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809.
   Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x.
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Centers for Disease Control and Prevention, 1974, 4 CDCP NAT CTR ENV H.
   Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Hines CJ, 2009, ANN OCCUP HYG, V53, P1, DOI 10.1093/annhyg/men066.
   Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610.
   Hoffman CS, 2008, EPIDEMIOLOGY, V19, P729, DOI 10.1097/EDE.0b013e3181812bd4.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Just AC, 2010, J EXPO SCI ENV EPID, V20, P625, DOI 10.1038/jes.2010.13.
   Kato K, 2006, ANAL CHEM, V78, P6651, DOI 10.1021/ac0608220.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Kwapniewski R, 2008, J OCCUP ENVIRON MED, V50, P705, DOI 10.1097/JOM.0b013e3181651571.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091.
   Marcus Michele, 2010, Reviews on Environmental Health, V25, P359.
   Mose T, 2007, REPROD TOXICOL, V23, P83, DOI 10.1016/j.reprotox.2006.08.006.
   Promislow JHE, 2004, PAEDIATR PERINAT EP, V18, P143, DOI 10.1111/j.1365-3016.2003.00546.x.
   Romero-Franco M, 2011, ENVIRON INT, V37, P867, DOI 10.1016/j.envint.2011.02.014.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Savitz DA, 2006, AM J EPIDEMIOL, V164, P1043, DOI 10.1093/aje/kwj300.
   Grandjean P, 2006, INT J ANDROL, V29, P181, DOI 10.1111/j.1365-2605.2005.00679.x.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Whyatt RM, 2009, PEDIATRICS, V124, pE1213, DOI 10.1542/peds.2009-0325.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Ye XB, 2009, INT J HYG ENVIR HEAL, V212, P481, DOI 10.1016/j.ijheh.2009.03.004.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{3}},
Journal-ISO = {{J. Expo. Sci. Environ. Epidemiol.}},
Doc-Delivery-Number = {{994MD}},
Wos-Id = {{ISI:000307934000006}},
}

@article{ ISI:000307528900004,
Author = {Tranfo, Giovanna and Caporossi, Lidia and Paci, Enrico and Aragona,
   Cesare and Romanzi, Daniela and De Carolis, Caterina and De Rosa,
   Mariangela and Capanna, Silvia and Papaleo, Bruno and Pera, Alessandra},
Title = {{Urinary phthalate monoesters concentration in couples with infertility
   problems}},
Journal = {{TOXICOLOGY LETTERS}},
Year = {{2012}},
Volume = {{213}},
Number = {{1, SI}},
Pages = {{15-20}},
Month = {{AUG 13}},
Abstract = {{The widespread use of phthalates results in human exposure: phthalates
   are rapidly metabolized to their respective monoesters and other
   oxidative products, which are glucuronidated and excreted through the
   urine and feces. Several in vivo studies showed that some phthalates, in
   particular diethyl-hexyl phthalate (DEHP), diethyl phthalate (DEP),
   di(n-butyl)phthalate (DnBP) and n-butylbenzylphthalate (BBzP), are able
   to interact with the human endocrine system, interfering with the
   reproduction ability. In this study, 56 couples were recruited from a
   centre of assisted reproduction. Spot urine samples were collected and
   five urinary metabolites of the above phthalates were determined using
   an HPLC/MS/MS analytical method with isotopic dilution.
   The results were compared with those of 56 couples of parents of one or
   more children and the statistical analysis revealed a significant
   difference between the two groups in terms of urinary concentrations of
   phthalates metabolites. A further step will be the correlation of these
   results with information on the life styles and working conditions
   collected through a specifically designed questionnaire. (C) 2011
   Elsevier Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Tranfo, G (Reprint Author), INAIL Res, Dept Occupat Med, Via Fontana Candida 1, I-00040 Rome, Italy.
   Tranfo, Giovanna; Caporossi, Lidia; Paci, Enrico; De Rosa, Mariangela; Capanna, Silvia; Papaleo, Bruno; Pera, Alessandra, INAIL Res, Dept Occupat Med, I-00040 Rome, Italy.
   Aragona, Cesare; Romanzi, Daniela, Univ Roma La Sapienza, Assisted Reprod Ctr, Rome, Italy.
   De Carolis, Caterina, Azienda Osped San Giovanni Addolorata, I-00184 Rome, Italy.}},
DOI = {{10.1016/j.toxlet.2011.11.033}},
ISSN = {{0378-4274}},
Keywords = {{Endocrine interferent; Phthalates; Biological monitoring; Infertility;
   Environmental exposure; Case control study}},
Keywords-Plus = {{HIGH PLASMA-CONCENTRATIONS; N-BUTYL PHTHALATE; INTERNAL EXPOSURE;
   METABOLITES; WOMEN; DEHP; ENDOMETRIOSIS; SERUM; POPULATION; ESTERS}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{giovanna.tranfo@ispesl.it
   caterina.decarolis@fastwebnet.it
   bruno.papaleo@ispesl.it
   alessandra.pera@ispesl.it}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   ATSDR, 1995, TOX PROF DIETH.
   ATSDR, 2001, TOX PROF N BUT.
   ATSDR, 1997, TOX PROF N OCT.
   ATSDR, 2002, TOX PROF DI 2 ETH PH.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   Drbohlav P, 2005, Ceska Gynekol, V70, P377.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Gerhard I, 1998, HUM REPROD UPDATE, V4, P301, DOI 10.1093/humupd/4.3.301.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hoppin JA, 2003, EPIDEMIOLOGY, V14, P259, DOI 10.1097/00001648-200305000-00002.
   Itoh H, 2009, SCI TOTAL ENVIRON, V408, P37, DOI 10.1016/j.scitotenv.2009.09.012.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Lorz P.M., 2003, ULLMANNS ENCY IND CH, DOI {[}10.1002/14356007.A20\_181, DOI 10.1002/14356007.A20\_181].
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Mc Neal T.P., 1998, ANN M AM CHEM SOC AU.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Reddy BS, 2006, FERTIL STERIL, V85, P775, DOI 10.1016/j.fertnstert.2005.08.037.
   Reddy BS, 2006, BJOG-INT J OBSTET GY, V113, P515, DOI 10.1111/j.1471-0528.2006.00925.x.
   Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Soto B.D., 1995, ENVIRON HEALTH PER S, V103, P113.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Younglai EV, 2002, ARCH ENVIRON CON TOX, V43, P121, DOI 10.1007/s00244-001-0048-8.
   Zegers-Hochschild F., 2009, HUM REPROD, V24, P1.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{4}},
Journal-ISO = {{Toxicol. Lett.}},
Doc-Delivery-Number = {{988ZB}},
Wos-Id = {{ISI:000307528900004}},
}

@article{ ISI:000307528900017,
Author = {Koch, Holger Martin and Haller, Andreas and Weiss, Tobias and
   Kaefferlein, Heiko-Udo and Stork, Joachim and Bruening, Thomas},
Title = {{Phthalate exposure during cold plastisol application-a human
   biomonitoring study}},
Journal = {{TOXICOLOGY LETTERS}},
Year = {{2012}},
Volume = {{213}},
Number = {{1, SI}},
Pages = {{100-106}},
Month = {{AUG 13}},
Abstract = {{The phthalates DEHP (Diethylhexyl phthalate), DiNP (Diisononyl
   phthalate) and DiDP (Diisodecyl phthalate) are constituents of
   plastisols. We sought to obtain first data on occupational exposures to
   the above phthalates by analyzing their metabolites in pre- and
   post-shift urine samples from 5 workers in a car manufacturing plant
   engaged in seam sealing with a DINP based plastisol. Pre-shift samples
   were collected after a work-free period of at least 2 days. As a
   comparison group we investigated 10 employees from the same plant.
   The comparison group had phthalate exposures in the range of the general
   German population. All plastisol workers had post shift values of DiNP
   and DiDP metabolites that were approx. 20-times higher, and pre-shift
   values that were approx. 5-10 times higher than those of the general
   background exposure. Post-shift values of DiNP metabolites were (median
   {[}maximum]: OH-MiNP: 117 {[}442] mu g/L; oxo-MiNP: 44.3 {[}175] mu g/L;
   carboxy-MiNP: 57.8 {[}286] mu g/L), pre shift values were (OH-MiNP: 26
   {[}164] mu g/L; oxo-MiNP 12.9 {[}68.6] mu g/L: carboxy-MiNP: 32.3
   {[}103] mu g/L), compared to the comparison group (OH-MiNP: 6.2 {[}33]
   mu g/L; oxo-MiNP: 2.8 {[}16] mu g/L; carboxy-MiNP: 6.5 {[}31] mu g/L).
   DiDP values were generally lower. Regarding DEHP we found no significant
   work related exposure. The dermal exposure route might play an important
   role for phthalates in plastisols, with possible influences on
   distribution and elimination kinetics and therefore data interpretation.
   (C) 2011 Elsevier Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Koch, HM (Reprint Author), Ruhr Univ Bochum, IPA, Inst Prevent \& Occupat Med German Social Accid In, Burkle Camp Pl 1, D-44789 Bochum, Germany.
   Koch, Holger Martin; Weiss, Tobias; Kaefferlein, Heiko-Udo; Bruening, Thomas, Ruhr Univ Bochum, IPA, Inst Prevent \& Occupat Med German Social Accid In, D-44789 Bochum, Germany.
   Haller, Andreas; Stork, Joachim, Audi AG, AUDI AG Werk Ingolstadt, D-85045 Ingolstadt, Germany.}},
DOI = {{10.1016/j.toxlet.2011.06.010}},
ISSN = {{0378-4274}},
Keywords = {{Phthalates; Plastisol; Human biomonitoring; Exposure; Metabolites; Urine}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; ISO-NONYLPHTHALATE DINP; N-OCTYL PHTHALATE;
   HUMAN URINE; DI(2-ETHYLHEXYL) PHTHALATE; METABOLITE CONCENTRATIONS;
   BUTYL PHTHALATE; TOBACCO-SMOKE; WORKERS; DEHP}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{koch@ipa-dguv.de
   Andreas.Haller@audi.de
   weiss@ipa-dguv.de
   kaefferlein@ipa-dguv.de
   Joachim.Stork@audi.de
   bruening@ipa-dguv.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011
   Kafferlein, Heiko/E-2114-2012
   Bruning, Thomas/D-3690-2013}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837
   }},
Cited-References = {{ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   Angerer J, 2007, INT J HYG ENVIR HEAL, V210, P201, DOI 10.1016/j.ijheh.2007.01.024.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blagoev M., 2009, CHEM EC HDB MARKETIN.
   Boberg J, 2011, REPROD TOXICOL, V31, P200, DOI 10.1016/j.reprotox.2010.11.001.
   Calafat AM, 2011, ENVIRON HEALTH PERSP, V119, P50, DOI 10.1289/ehp.1002316.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   CDC, 2005, 3 NAT REP HUM EXP EN.
   DFG, 2002, BIOL MON PROSP OCC E.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395.
   Gaudin R, 2008, INT ARCH OCC ENV HEA, V81, P959, DOI 10.1007/s00420-007-0289-6.
   Gaudin R., 2010, INT ARCH OCCUP ENV H.
   Gray E.L, 2008, PHTHALATES BISPHENOL.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Greim H, 2002, GES ARB TOX ARB BEG, V35.
   Hannas BR, 2011, TOXICOL SCI, V123, P206, DOI 10.1093/toxsci/kfr146.
   Haufroid V, 1998, INT ARCH OCC ENV HEA, V71, P162, DOI 10.1007/s004200050266.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hines CJ, 2008, EPIDEMIOLOGY, V19, pS104.
   Hines CJ, 2009, ANN OCCUP HYG, V53, P1, DOI 10.1093/annhyg/men066.
   Hines CJ, 2011, J EXPO SCI ENV EPID, V21, P133, DOI 10.1038/jes.2009.62.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   RIBOLI E, 1990, CANCER CAUSE CONTROL, V1, P243, DOI 10.1007/BF00117476.
   Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x.
   Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2005, TOXICOLOGY, V210, P123, DOI 10.1016/j.tox2005.01.012.
   Silva MJ, 2007, ENVIRON SCI TECHNOL, V41, P7576, DOI 10.1021/es071142x.
   TANAKA A, 1978, TOXICOLOGY, V9, P109, DOI 10.1016/0300-483X(78)90036-7.
   TAUSSKY HH, 1954, J BIOL CHEM, V208, P853.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Xu X, 2004, CLIN CHEM, V50, P2323, DOI 10.1373/clinchem.2004.038489.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{3}},
Journal-ISO = {{Toxicol. Lett.}},
Doc-Delivery-Number = {{988ZB}},
Wos-Id = {{ISI:000307528900017}},
}

@article{ ISI:000308253700001,
Author = {Shao Min and Chen Yong-Heng and Li Xiao-Yu},
Title = {{Consecutive Online Separation and Determination of Polybrominated
   Diphenyl Ethers, Phthalate Esters and Bisphenol A in Human Serum by Gas
   Chromatography-Mass Spectrometry}},
Journal = {{CHINESE JOURNAL OF ANALYTICAL CHEMISTRY}},
Year = {{2012}},
Volume = {{40}},
Number = {{8}},
Pages = {{1139-1145}},
Month = {{AUG}},
Abstract = {{A method was developed for the consecutive online separation of several
   environmental estrogens, polybrominated diphenyl ethers (PBDEs),
   phthalate esters (PAEs) and bisphenol A (BPA), in human serum by gas
   chromatography-mass spectrometry (GC-MS). After denaturation of protein
   by concentrated hydrochloride acid, extraction by ether, separation by
   silica flash chromatograph, several group components including PBDEs,
   PAEs and BPA in human serum were separated and purified. Then these
   group components were detected by GC-MS in selected ion monitoring mode.
   The standard calibration curves of PBDEs, PAEs and BPA were linear over
   the assayed range with correlation coefficients equal or higher than
   0.99. The detection limitations of the targeted compounds ranged from
   0.005 to 0.048 mu g L-1 for PBDEs, 0.103-0.833 mu g L-1 for PAEs, and
   0.035 mu g L-1 for BPA. In standard duplicated samples, the relative
   standard deviations were 2.8\%-10.9\% for PBDEs, 5.6\%-9.9\% for PAEs,
   and 3.0\% for BPA. The surrogate recoveries in these 7 samples ranged
   from 74.8\% to 88.5\% for PCB-209 (polychloride diphenyl ether 209) in
   PBDEs, from 78.7\% to 97.0\% for DBP-D4 (dibutyl phthalate-deutorium 4)
   in PAEs, and from 76.3 \% to 93.1\% for BPA-D16 (Bisphenol A-Deutorium
   16) in BPA, respectively. This method for detecting multiple
   environmental estrogens in human serum is sensitive, high reproducible
   with satisfied recoveries.}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chen, YH (Reprint Author), Guangzhou Univ, Environm Sci \& Engn Inst, Guangzhou 510006, Guangdong, Peoples R China.
   Shao Min; Chen Yong-Heng; Li Xiao-Yu, Guangzhou Univ, Environm Sci \& Engn Inst, Guangzhou 510006, Guangdong, Peoples R China.}},
DOI = {{10.1016/S1872-2040(11)60569-0}},
ISSN = {{0253-3820}},
Keywords = {{Human serum; Polybrominated diphenyl ethers; Phthalate esters; Bisphenol
   A; Gas chromatography-mass spectrometry}},
Keywords-Plus = {{PERFORMANCE LIQUID-CHROMATOGRAPHY; WILDLIFE; WATER}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Author-Email = {{chenyong\_heng@163.com}},
Funding-Acknowledgement = {{Scientific Special project of Public Benefit Sector of National
   Environment Protection Department, China {[}201109001-08]}},
Funding-Text = {{This work was supported by the Scientific Special project of Public
   Benefit Sector of National Environment Protection Department, China
   (No.201109001-08).}},
Cited-References = {{COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890.
   Dai X B, 2008, J ENV HLTH, V6, P503.
   Darnerud PO, 2003, ENVIRON INT, V29, P841, DOI 10.1016/S0160-4120(03)00107-7.
   Huang XiaoQun, 2007, China Tropical Medicine, V7, P1443.
   Wang YW, 2007, ENVIRON INT, V33, P963, DOI 10.1016/j.envint.2007.03.016.
   Li Y, 2008, CHEM J CHINESE U, V29, P2142.
   Li Z Y, 2011, SCI TECHNOLOGY ENG, V11, P97.
   Liang ChunYing, 2009, Journal of Environment and Health, V26, P996.
   {[}吕怡兵 LU Yibing], 2007, {[}中国环境监测, Environmental Monitoring in China], V23, P66.
   Luo XJ, 2009, PROG CHEM, V21, P359.
   Qu WY, 2007, CHINESE J ANAL CHEM, V35, P1015.
   Shi J L, 2004, J ENV OCCUP MED, V21, P190.
   Wang Z F, 2001, HYPHENATED CHROMATOG, P78.
   Wu SY, 2010, CHINESE J ANAL CHEM, V38, P503, DOI 10.3724/SP.J.1096.2010.00503.
   Xiao G B, 2005, J ENV OCCUP MED, V22, P295.
   {[}杨再福 Yang Zaifu], 2005, {[}生态环境, Ecology and Environment], V14, P108.
   {[}曾锋 Zeng Feng], 2005, {[}分析化学, Chinese Journal of Analytical Chemistry], V33, P1063.
   Zhao Z W, 2004, CHINESE J CLIN REHAB, V8, P1724.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{0}},
Journal-ISO = {{Chin. J. Anal. Chem.}},
Doc-Delivery-Number = {{998PU}},
Wos-Id = {{ISI:000308253700001}},
}

@article{ ISI:000306401600008,
Author = {Sun, Yongkun and Takahashi, Kumiko and Hosokawa, Toshiyuki and Saito,
   Takeshi and Kurasaki, Masaaki},
Title = {{Diethyl Phthalate Enhances Apoptosis Induced by Serum Deprivation in
   PC12 Cells}},
Journal = {{BASIC \& CLINICAL PHARMACOLOGY \& TOXICOLOGY}},
Year = {{2012}},
Volume = {{111}},
Number = {{2}},
Pages = {{113-119}},
Month = {{AUG}},
Abstract = {{In this study, to examine the mechanism of diethyl phthalate toxicity to
   cells, the effects of diethyl phthalate on apoptosis in a PC12 cell
   system were investigated by assaying apoptotic factors such as
   caspase-3, Bax, cytochrome c and DNA damage. Diethyl phthalate was shown
   to enhance the apoptosis induced by serum deprivation according to the
   results of DNA electrophoresis and TUNEL signal assays, although it
   could not induce apoptosis itself in the cells. This enhancement was
   thought to be because of an increase in caspase-3-like activity. In
   addition, the expression of bax and contents of cytochrome c in the
   cytosol showed a tendency to increase the cells exposed to diethyl
   phthalate. These results indicated that diethyl phthalate, a potential
   endocrine disrupter, affects the apoptotic system in PC12 cells. Diethyl
   phthalate may enhance oxidative stress such as that induced by reactive
   oxygen species in PC12 cells.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kurasaki, M (Reprint Author), Hokkaido Univ, Fac Environm Earth Sci, Grad Sch Environm Sci, Div Environm Sci Dev, Sapporo, Hokkaido 0600810, Japan.
   Kurasaki, Masaaki, Hokkaido Univ, Fac Environm Earth Sci, Grad Sch Environm Sci, Div Environm Sci Dev, Sapporo, Hokkaido 0600810, Japan.
   Hosokawa, Toshiyuki, Hokkaido Univ, Inst Adv Higher Educ, Div Higher Educ Res \& Dev, Sapporo, Hokkaido 0600810, Japan.
   Saito, Takeshi, Hokkaido Univ, Environm Hlth Sci Lab, Fac Hlth Sci, Sapporo, Hokkaido 0600810, Japan.
   Kurasaki, Masaaki, Hokkaido Univ, Grp Environm Adaptat Sci, Fac Environm Earth Sci, Sapporo, Hokkaido 0600810, Japan.}},
DOI = {{10.1111/j.1742-7843.2012.00869.x}},
ISSN = {{1742-7835}},
Keywords-Plus = {{MALE WISTAR RATS; CHRONIC TOXICITY; DOSE-RESPONSE; BCL-2 FAMILY;
   EXPOSURE; DEATH; PLASTICIZERS; MITOCHONDRIA; EXPRESSION; PROTEINS}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{kura@ees.hokudai.ac.jp}},
ResearcherID-Numbers = {{Hosokawa, Toshiyuki/A-3851-2012
   Kurasaki, Masaaki/B-8207-2012}},
ORCID-Numbers = {{Kurasaki, Masaaki/0000-0003-2125-095X}},
Funding-Acknowledgement = {{Japan Society for the Promotion of Science {[}23655139]}},
Funding-Text = {{This research was supported by grants-in-aid from the Japan Society for
   the Promotion of Science (No. 23655139 for Kurasaki). The authors also
   appreciate the technical assistance of Ms. Miyako Komori.}},
Cited-References = {{Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0.
   Alam MS, 2010, REPRODUCTION, V139, P427, DOI 10.1530/REP-09-0226.
   Al-Saleh I, 2011, J TOXICOL SCI, V36, P469.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Aoki M, 2004, LIFE SCI, V74, P2301, DOI 10.1016/j.lfs.2003.09.066.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Aravind L, 1999, TRENDS BIOCHEM SCI, V24, P47, DOI 10.1016/S0968-0004(98)01341-3.
   Awal MA, 2004, INT J TOXICOL, V23, P349, DOI 10.1080/10915810490901985.
   BATISTATOU A, 1993, J CELL BIOL, V122, P523, DOI 10.1083/jcb.122.3.523.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032.
   Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002.
   Gollapudi L, 1999, J NEUROSCI RES, V56, P99, DOI 10.1002/(SICI)1097-4547(19990401)56:1<99::AID-JNR13>3.0.CO;2-G.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hosokawa O, 2000, Pharmacol Toxicol, V86, P276.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Kawakami M, 2008, FOOD CHEM TOXICOL, V46, P2157, DOI 10.1016/j.fct.2008.02.014.
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33.
   Kurasaki M, 2001, ANAL SCI           S, V17, pi1547.
   Lin CH, 2011, TOXICOL LETT, V206, P245, DOI 10.1016/j.toxlet.2011.08.002.
   Maroto R, 1997, J NEUROCHEM, V69, P514.
   Matsunaga T, 2008, FREE RADICAL BIO MED, V44, P1191, DOI 10.1016/j.freeradbiomed.2007.12.024.
   Pereira C, 2006, REGUL TOXICOL PHARM, V45, P169, DOI 10.1016/j.yrtph.2006.04.006.
   Pereira C, 2007, ENVIRON TOXICOL PHAR, V23, P319, DOI 10.1016/j.etap.2006.12.005.
   Pereira C, 2007, ECOTOX ENVIRON SAFE, V68, P118, DOI 10.1016/j.ecoenv.2006.04.007.
   Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867.
   Spanos S, 2002, REPRODUCTION, V124, P353, DOI 10.1530/rep.0.1240353.
   Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907.
   Tsujimoto Y, 1998, GENES CELLS, V3, P697, DOI 10.1046/j.1365-2443.1998.00223.x.
   Tujimoto Y, 2000, FEBS LETT, V466, P6.
   Wang Xin, 2010, Zhonghua Fu Chan Ke Za Zhi, V45, P411.
   Wensing M, 2005, SCI TOTAL ENVIRON, V339, P19, DOI 10.1016/j.scitotenv.2004.10.028.
   Woodgate A, 1999, MOL BRAIN RES, V69, P84, DOI 10.1016/S0169-328X(99)00103-5.
   Wu SD, 2010, BASIC CLIN PHARMACOL, V106, P118, DOI 10.1111/j.1742-7843.2009.00483.x.
   Xia XH, 2011, J ENVIRON QUAL, V40, P1643, DOI 10.2134/jeq2011.0032.
   Yamanoshita O, 2001, LIFE SCI, V69, P403, DOI 10.1016/S0024-3205(01)01132-8.
   Yamanoshita O, 2000, BIOCHEM BIOPH RES CO, V272, P557, DOI 10.1006/bbrc.2000.2810.
   Zhu JP, 2006, ENVIRON SCI TECHNOL, V40, P5276, DOI 10.1021/es060356w.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{1}},
Journal-ISO = {{Basic Clin. Pharmacol. Toxicol.}},
Doc-Delivery-Number = {{974AH}},
Wos-Id = {{ISI:000306401600008}},
}

@article{ ISI:000306679900015,
Author = {Wei, Zhengzheng and Song, Liqiong and Wei, Jie and Chen, Tian and Chen,
   Jun and Lin, Yi and Xia, Wei and Xu, Bing and Li, Xuguang and Chen, Xi
   and Li, Yuanyuan and Xu, Shunqing},
Title = {{Maternal exposure to di-(2-ethylhexyl)phthalate alters kidney
   development through the renin-angiotensin system in offspring}},
Journal = {{TOXICOLOGY LETTERS}},
Year = {{2012}},
Volume = {{212}},
Number = {{2}},
Pages = {{212-221}},
Month = {{JUL 20}},
Abstract = {{Di-(2-ethylhexyl)phthalate (DEHP) is a widely used industrial
   plasticizer to which humans are widely exposed. We investigated the
   consequences of maternal exposure to DEHP on nephron formation, examined
   the programming of renal function and blood pressure and explored the
   mechanism in offspring. Maternal rats were treated with vehicle, 0.25
   and 6.25 mg/kg body weight/day DEHP respectively from gestation day 0 to
   postnatal day 21. Maternal DEHP exposure resulted in lower number of
   nephrons, higher glomerular volume and smaller Bowman's capsule in the
   DEHP-treated offspring at weaning, as well as glomerulosclerosis,
   interstitial fibrosis and effacement of podocyte foot processes in
   adulthood. In the DEHP-treated offspring, the renal function was lower
   and the blood pressure was higher. The renal protein expression of renin
   and angiotensin II was reduced at birth day and increased at weaning.
   Maternal DEHP exposure also led to reduced mRNA expression of some renal
   development involved genes at birth day, including Foxd1, Gdnf, Pax2 and
   Wnt11. While, the mRNA expression of some genes was raised, including
   Bmp4, Cdh11, Calm1 and Ywhab. These data show that maternal DEHP
   exposure impairs the offspring renal development, resulting in a nephron
   deficit, and subsequently elevated blood pressure later in life. Our
   findings suggest that DEHP exposure in developmental periods may affect
   the development of nephrons and adult renal disease through inhibition
   of the renin-angiotensin system. (C) 2012 Elsevier Ireland Ltd. All
   rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Li, YY (Reprint Author), Huazhong Univ Sci \& Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm \& Hlth,Minist Educ, Wuhan 430030, Peoples R China.
   Wei, Zhengzheng; Song, Liqiong; Wei, Jie; Chen, Tian; Chen, Jun; Lin, Yi; Xia, Wei; Xu, Bing; Chen, Xi; Li, Yuanyuan; Xu, Shunqing, Huazhong Univ Sci \& Technol, Tongji Med Coll, Sch Publ Hlth, Key Lab Environm \& Hlth,Minist Educ, Wuhan 430030, Peoples R China.
   Li, Xuguang, Huazhong Univ Sci \& Technol, Tongji Med Coll, Tongji Hosp, Inst Hypertens, Wuhan 430030, Peoples R China.
   Li, Xuguang, Huazhong Univ Sci \& Technol, Tongji Med Coll, Tongji Hosp, Dept Internal Med, Wuhan 430030, Peoples R China.}},
DOI = {{10.1016/j.toxlet.2012.05.023}},
ISSN = {{0378-4274}},
Keywords = {{Early development; Nephron numbers; Renal dysfunction; RAS;
   Di-(2-ethylhexyl)phthalate}},
Keywords-Plus = {{ACTIVATED-RECEPTOR-GAMMA; DI(2-ETHYLHEXYL) PHTHALATE; ADULT
   HYPERTENSION; NEPHRON NUMBER; NEONATAL EXPOSURE; GENE-EXPRESSION; AT(2)
   RECEPTOR; BLOOD-VESSELS; PPAR-GAMMA; RATS}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{tjliyuanyuan@yahoo.com.cn
   xuscience@hotmail.com}},
Funding-Acknowledgement = {{National Program on Key Basic Research Project of China (973 Program)
   {[}2012CB722401]; National Natural Science Foundation of China
   {[}81030051, 21177046]; R\&D Special Fund for Public Welfare Industry
   (Environment) {[}200909102]; National Basic Research Development Program
   of China {[}2008CB418206]; Doctoral Fund of Ministry of Education of
   China {[}20080487087]; Fundamental Research Funds for the Central
   Universities, HUST {[}2012QN240, 2012TS072]}},
Funding-Text = {{This work was supported by the National Program on Key Basic Research
   Project of China (973 Program) (2012CB722401), the National Natural
   Science Foundation of China (81030051, 21177046), the R\&D Special Fund
   for Public Welfare Industry (Environment) (200909102), the National
   Basic Research Development Program of China (2008CB418206), the Doctoral
   Fund of Ministry of Education of China (20080487087), and the
   Fundamental Research Funds for the Central Universities, HUST
   (2012QN240, 2012TS072).}},
Cited-References = {{Bagby SP, 2007, J NUTR, V137, P1066.
   Barker DJP, 2002, J HYPERTENS, V20, P1951, DOI 10.1097/00004872-200210000-00013.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Benkirane K, 2006, HYPERTENSION, V47, P102, DOI 10.1161/01.HYP.0000196728.05488.c3.
   Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698.
   Brophy PD, 2001, DEVELOPMENT, V128, P4747.
   Bruin JE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003371.
   Bruin JE, 2008, TOXICOL SCI, V103, P362, DOI 10.1093/toxsci/kfn012.
   Cain JE, 2008, DIFFERENTIATION, V76, P831, DOI 10.1111/j.1432-0436.2008.00265.x.
   Casals-Casas C., 2008, INT J OBESITY LON S6, V32.
   Cheng JL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000427.
   Cho EA, 1998, DEVELOPMENT, V125, P803.
   CPSC U.S., 2010, TOX REV DI 2 ETH PHT.
   Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56.
   David RM, 2000, TOXICOL SCI, V55, P433, DOI 10.1093/toxsci/55.2.433.
   Diep QN, 2002, CIRCULATION, V105, P2296, DOI 10.1161/01.CIR.0000016049.86468.23.
   DOSTAL LA, 1987, TOXICOL APPL PHARM, V87, P81, DOI 10.1016/0041-008X(87)90086-X.
   ECB, 2008, SUMM RISK ASS REP BI.
   Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217.
   Gartner S, 2009, J AGR FOOD CHEM, V57, P10675, DOI 10.1021/jf902683m.
   Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473.
   Griffin KA, 2000, J AM SOC NEPHROL, V11, P497.
   Guron G, 2000, J HYPERTENS, V18, P123, DOI 10.1097/00004872-200018020-00001.
   Hao XQ, 2010, HYPERTENS RES, V33, P76, DOI 10.1038/hr.2009.185.
   Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467.
   Hayashi Y, 2011, TOXICOLOGY, V289, P1, DOI 10.1016/j.tox.2011.02.007.
   Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005.
   Ji YY, 2009, LAB INVEST, V89, P887, DOI 10.1038/labinvest.2009.45.
   Kamijo Y, 2007, J AM SOC NEPHROL, V18, P176, DOI 10.1681/ASN.2006060597.
   Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549.
   Lackland DT, 2000, ARCH INTERN MED, V160, P1472, DOI 10.1001/archinte.160.10.1472.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   Le Menuet D, 2001, J BIOL CHEM, V276, P38911, DOI 10.1074/jbc.M103984200.
   Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0.
   Lin Y, 2011, AM J PHYSIOL-ENDOC M, V301, pE527, DOI 10.1152/ajpendo.00233.2011.
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262.
   Luers GH, 2002, MECH DEVELOP, V118, P229, DOI 10.1016/S0925-4773(02)00253-8.
   Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520.
   Manalich R, 2000, KIDNEY INT, V58, P770, DOI 10.1046/j.1523-1755.2000.00225.x.
   NTP, 1982, 214 NTP, P1.
   NTP-CERHR, 2000, NTP CERHR EXP PAN RE.
   Osmond C, 2000, ENVIRON HEALTH PERSP, V108, P545, DOI 10.2307/3454545.
   PACHNIS V, 1993, DEVELOPMENT, V119, P1005.
   Pak VM, 2007, MCN-AM J MATERN-CHIL, V32, P244, DOI 10.1097/01.NMC.0000281965.45905.c0.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Porteous S, 2000, HUM MOL GENET, V9, P1, DOI 10.1093/hmg/9.1.1.
   Iosipiv IV, 2003, AM J PHYSIOL-RENAL, V285, pF199, DOI 10.1152/ajprenal.00401.2002.
   Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610.
   Song RF, 2010, AM J PHYSIOL-RENAL, V298, pF807, DOI 10.1152/ajprenal.00147.2009.
   Sugawara A, 2010, ENDOCR J, V57, P847.
   Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125.
   TOMASZEWSKI KE, 1990, TOXICOLOGY, V65, P49, DOI 10.1016/0300-483X(90)90078-U.
   Vallon V, 2003, NEWS PHYSIOL SCI, V18, P169, DOI 10.1152/nips.01442.2003.
   Vanden Heuvel John P., 1999, Journal of Nutrition, V129, p575S.
   Warner MJ, 2010, BIOCHEM J, V427, P333, DOI 10.1042/BJ20091861.
   Wei J, 2011, ENDOCRINOLOGY, V152, P3049, DOI 10.1210/en.2011-0045.
   Woods LL, 2000, CURR OPIN NEPHROL HY, V9, P419, DOI 10.1097/00041552-200007000-00014.
   Woods LL, 2001, PEDIATR RES, V49, P460, DOI 10.1203/00006450-200104000-00005.
   Yasuno K, 2010, J VET MED SCI, V72, P1319, DOI 10.1292/jvms.10-0094.
   Yosypiv IV, 2008, KIDNEY INT, V74, P1287, DOI 10.1038/ki.2008.378.
   Zandi-Nejad K, 2006, HYPERTENSION, V47, P502, DOI 10.1161/01.HYP.0000198544.09909.1a.
   Zhang SL, 2004, J AM SOC NEPHROL, V15, P1452, DOI 10.1097/01.ASN.0000130567.}},
Number-of-Cited-References = {{62}},
Times-Cited = {{0}},
Journal-ISO = {{Toxicol. Lett.}},
Doc-Delivery-Number = {{977QQ}},
Wos-Id = {{ISI:000306679900015}},
}

@article{ ISI:000306297800032,
Author = {Guo, Ying and Zhang, Zifeng and Liu, Liyan and Li, Yifan and Ren, Nanqi
   and Kannan, Kurunthachalam},
Title = {{Occurrence and Profiles of Phthalates in Foodstuffs from China and Their
   Implications for Human Exposure}},
Journal = {{JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY}},
Year = {{2012}},
Volume = {{60}},
Number = {{27, SI}},
Pages = {{6913-6919}},
Month = {{JUL 11}},
Abstract = {{Phthalate esters are used in a wide variety of consumer products, and
   human exposure to this class of compounds is widespread. Nevertheless,
   studies on dietary exposure of humans to phthalates are limited. In this
   study, nine phthalate esters were analyzed in eight categories of
   foodstuffs (n = 78) collected from Harbin and Shanghai, China, in 2011.
   Dimethyl phthalate (DMP), diethyl phthalate (DEP), dibutyl phthalate
   (DBP), diisobutyl phthalate (DIBP), benzyl butyl phthalate (BzBP), and
   diethylhexyl phthalate (DEHP) were frequently detected in food samples.
   DEHP was the major compound found in most of the food samples, with
   concentrations that ranged from below the limit of quantification (LOQ)
   to 762 ng/g wet weight (wt). The concentrations of phthalates in food
   samples from China were comparable to concentrations reported for
   several other countries, but the profiles were different; DMP was found
   more frequently in Chinese foods than in foods from other countries. The
   estimated daily dietary intake of phthalates (EDIdiet) was calculated
   based on the concentrations measured and the daily ingestion rates of
   food items. The EDIdiet values for DMP, DEP, DIBP, DBP, BzBP, and DEHP
   (based on mean concentrations) were 0.092, 0.051, 0.505, 0.703, 0.022,
   and 1.60 mu g/kg-bw/d, respectively, for Chinese adults. The EDIdiet
   values calculated for phthalates were below the reference closes
   suggested by the United States Environmental Protection Agency (EPA).
   Comparison of total daily intakes, reported previously based on a
   biomonitoring study, with the current dietary intake estimates suggests
   that diet is the main source of DEHP exposure in China. Nevertheless,
   diet accounted for only <10\% of the total exposure to DMP, DEP, DBP,
   and DIBP, which suggested the existence of other sources of exposure to
   these phthalates.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kannan, K (Reprint Author), SUNY Albany, New York State Dept Hlth, Wadsworth Ctr, Empire State Plaza,POB 509, Albany, NY 12201 USA.
   Guo, Ying; Kannan, Kurunthachalam, SUNY Albany, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.
   Guo, Ying; Kannan, Kurunthachalam, SUNY Albany, Dept Environm Hlth Sci, Sch Publ Hlth, Albany, NY 12201 USA.
   Zhang, Zifeng; Liu, Liyan; Li, Yifan; Ren, Nanqi; Kannan, Kurunthachalam, Harbin Inst Technol, Int Joint Res Ctr Persistent Toxic Subst IJRC PTS, State Key Lab Urban Water Resource \& Environm, Harbin 150090, Peoples R China.}},
DOI = {{10.1021/jf3021128}},
ISSN = {{0021-8561}},
Keywords = {{phthalate esters; dietary intake; DEHP; foodstuffs; total diet survey}},
Keywords-Plus = {{ACID ESTERS; URINARY LEVELS; BISPHENOL-A; HEALTH; PLASTICIZERS;
   METABOLITES; PATHWAYS; ADIPATE; SAMPLES; DIET}},
Research-Areas = {{Agriculture; Chemistry; Food Science \& Technology}},
Web-of-Science-Categories  = {{Agriculture, Multidisciplinary; Chemistry, Applied; Food Science \&
   Technology}},
Author-Email = {{kkannan@wadsworth.org}},
Funding-Acknowledgement = {{State Key Laboratory of Urban Water and Environmental Resources, Harbin
   Institute of Technology, Harbin, China; Centers for Disease Control and
   Prevention (CDC), Atlanta, GA, USA {[}1U38EH000464-01]}},
Funding-Text = {{This study was funded by a grant from the State Key Laboratory of Urban
   Water and Environmental Resources, Harbin Institute of Technology,
   Harbin, China, and partly by a biomonitoring grant (1U38EH000464-01)
   from the Centers for Disease Control and Prevention (CDC), Atlanta, GA,
   USA. This study's contents are the sole responsibility of the authors
   and do not necessarily represent the official views of the CDC.}},
Cited-References = {{Antian J., 1973, ENV HLTH PERSPECT, P1.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Cao XL, 2010, COMPR REV FOOD SCI F, V9, P21, DOI 10.1111/j.1541-4337.2009.00093.x.
   Casajuana N, 2004, J AGR FOOD CHEM, V52, P3702, DOI 10.1021/jf040027s.
   Cirillo T, 2011, J AGR FOOD CHEM, V59, P10532, DOI 10.1021/jf2020446.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   Clark KE, 2011, HUM ECOL RISK ASSESS, V17, P923, DOI 10.1080/10807039.2011.588157.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m.
   Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005.
   Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3788, DOI 10.1021/es2002106.
   Houlihan J., 2010, NOT TOO PRETTY PHTHA.
   Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y.
   Itoh H, 2009, SCI TOTAL ENVIRON, V408, P37, DOI 10.1016/j.scitotenv.2009.09.012.
   Ji K, 2010, ENVIRON RES, V110, P375, DOI 10.1016/j.envres.2010.02.008.
   Kamrin MA, 2009, J TOXICOL ENV HEAL B, V12, P157, DOI 10.1080/10937400902729226.
   Latini G, 2009, ENVIRON INT, V35, P236, DOI 10.1016/j.envint.2008.06.002.
   Martino-Andrade AJ, 2010, MOL NUTR FOOD RES, V54, P148, DOI 10.1002/mnfr.200800312.
   Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004.
   Mo CH, 2009, ARCH ENVIRON CON TOX, V56, P181, DOI 10.1007/s00244-008-9177-7.
   PAGE BD, 1995, FOOD ADDIT CONTAM, V12, P129.
   Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Spillmann M, 2009, RISK ANAL, V29, P1170.
   Tsumura Y, 2002, J HEALTH SCI, V48, P493, DOI 10.1248/jhs.48.493.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474.
   US EPA, PHTHAL TEACH CHEM SU.
   Wenzl T., 2009, METHODS DETERMINATIO.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Yano K, 2002, B ENVIRON CONTAM TOX, V68, P463, DOI 10.1007/s00128-001-0277-6.
   {[}翟凤英 Zhai Fengying], 2005, {[}中华流行病学杂志, Chinese Journal of Epidemiology], V26, P485.
   {[}张兵 Zhang Bing], 2011, {[}中华预防医学杂志, Chinese Journal of Preventive Medicine], V45, P330.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{3}},
Journal-ISO = {{J. Agric. Food Chem.}},
Doc-Delivery-Number = {{972RO}},
Wos-Id = {{ISI:000306297800032}},
}

@article{ ISI:000306371900007,
Author = {Josh, M. K. Sarath and Pradeep, S. and Balachandran, S. and Devi, R.
   Sudha and Amma, K. S. Vijayalakshmi and Benjamin, Sailas},
Title = {{Temperature- and solvent-dependent migrations of di(2-ethylhexyl)
   phthalate, the hazardous plasticizer from commercial PVC blood storage
   bag}},
Journal = {{JOURNAL OF POLYMER RESEARCH}},
Year = {{2012}},
Volume = {{19}},
Number = {{7}},
Month = {{JUL}},
Abstract = {{Towards a process development for the bioremediation of phthalic acid
   esters (PAE) blended in various plastics, we explored the type of PAE in
   commercially available PVC blood storage bags (BB), its solvent-and
   temperature-dependent migrations and coefficient of diffusion (D)
   behaviors at static condition by solvent extraction method. The PAE
   {[}about 34 \% (w/w)] in BB was confirmed as DEHP by UV, TLC and GC-MS
   analyses. When effects of five solvents on the rate of migration of
   intact DEHP from BB tested (40 degrees C), order of migration during the
   initial hrs was: n-hexane>methanol>t-butyl alcohol>isopropyl
   alcohol>ethanol. At 40 C, about 60 \% (of total) DEHP in BB migrated
   into n-hexane, which rose to 80 \% at 60 degrees C and almost 95 \% at
   boiling (69 degrees C) in the first h. DEHP diffusion from BB was
   dependent on its concentration and nature of surrounding medium and
   temperature. Fickian approximation was used to calculate D values for
   DEHP migration, and in n-hexane average values were: 1.26x10(-7), 1.92x
   10(-7) and 2.18x10(-7)cm(2) sec-1 at 40, 50 and 60 degrees C,
   respectively. This study shows that n-hexane is the preferred solvent to
   extract DEHP from used or waste medical and allied PVC products for
   small scale, especially screening studies. Briefly, DEHP and solvent
   were separated individually upon distillation of the extract; thus DEHP,
   microporous PVC BB sheet and solvent were recovered for reuse
   inexpensively without environmental contamination.}},
Publisher = {{SPRINGER}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Benjamin, S (Reprint Author), Univ Calicut, Dept Bot, Div Biotechnol, Enzyme Technol Lab, Malappuram 673635, Kerala, India.
   Josh, M. K. Sarath; Pradeep, S.; Benjamin, Sailas, Univ Calicut, Dept Bot, Div Biotechnol, Enzyme Technol Lab, Malappuram 673635, Kerala, India.
   Balachandran, S.; Devi, R. Sudha, Univ Kerala, Mahatma Gandhi Coll, Dept Chem, Thiruvananthapuram 695004, Kerala, India.
   Amma, K. S. Vijayalakshmi, Univ Calicut, Sri Vyasa NSS Coll Wadakkanchery, Dept Chem, Trichur 680582, Kerala, India.}},
DOI = {{10.1007/s10965-012-9915-4}},
Article-Number = {{9915}},
ISSN = {{1022-9760}},
Keywords = {{PVC blood bag; DEHP migration; TLC; GC-MS; SEM; AFM}},
Keywords-Plus = {{POLYVINYL-CHLORIDE) SHEETS; MEDICAL DEVICES; PETROLEUM OILS; HEALTH;
   BEHAVIOR; ESTERS; DEHP}},
Research-Areas = {{Polymer Science}},
Web-of-Science-Categories  = {{Polymer Science}},
Author-Email = {{sailasben@yahoo.co.in}},
Funding-Acknowledgement = {{Ministry of Environment and Forests, Government of India
   {[}19/62/2005-RE]}},
Funding-Text = {{The authors would like to thank the Ministry of Environment and Forests,
   Government of India for a research Grant No. 19/62/2005-RE.}},
Cited-References = {{Akovali G, 2007, PLASTIC RUBBER HLTH.
   Cano JM, 2002, J CHROMATOGR A, V963, P401, DOI 10.1016/S0021-9673(02)00642-8.
   Chen CY, 2004, APPL SURF SCI, V231, P447, DOI 10.1016/j.apsusc.2004.03.168.
   David RM, 2001, PATTYS TOXICOLOGY.
   DUVIS T, 1991, J APPL POLYM SCI, V42, P191, DOI 10.1002/app.1991.070420123.
   Florence AT, 2009, INTRO CLIN PHARM.
   Haishima Y, 2005, INT J PHARM, V298, P126, DOI 10.1016/j.ijpharm.2005.04.009.
   Haishima Y, 2004, INT J PHARM, V274, P119, DOI 10.1016/j.ijpharm.2004.01.009.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019.
   Jenke Dennis, 2006, PDA J Pharm Sci Technol, V60, P191.
   Kim JH, 2003, B KOR CHEM SOC, V24, P345.
   Latini Giuseppe, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P37, DOI 10.2174/1568008043340017.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004.
   PAPASPYRIDES CD, 1989, J APPL POLYM SCI, V38, P1573, DOI 10.1002/app.1989.070380901.
   PAPASPYRIDES CD, 1986, J APPL POLYM SCI, V32, P6025, DOI 10.1002/app.1986.070320730.
   Ruzickova K, 2004, PREVENTING HARM PHTH.
   Sampson J, 2011, TRANSFUSION MED, V21.
   Sastri VR, 2009, PLASTICS MED DEVICES.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   Shaz BH, 2011, TRANSFUSION, V51, P2510, DOI 10.1111/j.1537-2995.2011.03164.x.
   Shieh YT, 1996, J APPL POLYM SCI, V59, P695, DOI 10.1002/(SICI)1097-4628(19960124)59:4<695::AID-APP15>3.0.CO;2-P.
   Takehisa H, 2005, INT J PHARM, V297, P30, DOI 10.1016/j.ijpharm.2005.02.015.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Tikka HK, 2004, J COLLOID INTERF SCI, V273, P388, DOI 10.1016/j.jcis.2004.02.013.
   Yang Z, 2006, POLYVINYL CHLORIDE, V2.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{2}},
Journal-ISO = {{J. Polym. Res.}},
Doc-Delivery-Number = {{973PJ}},
Wos-Id = {{ISI:000306371900007}},
}

@article{ ISI:000305548900021,
Author = {Lind, P. Monica and Zethelius, Bjorn and Lind, Lars},
Title = {{Circulating Levels of Phthalate Metabolites Are Associated With
   Prevalent Diabetes in the Elderly}},
Journal = {{DIABETES CARE}},
Year = {{2012}},
Volume = {{35}},
Number = {{7}},
Pages = {{1519-1524}},
Month = {{JUL}},
Abstract = {{OBJECTIVE-Phthalates are ubiquitous industrial high-volume chemicals
   known as ligands to peroxisome proliferator activated receptors (PPARs).
   Because PPAR-gamma agonists modulate insulin sensitivity and are used to
   treat type 2 diabetes, we investigated whether circulating levels of
   phthalate metabolites are related to prevalent type 2 diabetes.
   RESEARCH DESIGN AND METHODS-A total of 1,016 subjects, aged 70 years,
   were investigated in the Prospective Investigation of the Vasculature in
   Uppsala Seniors Study. Four phthalate metabolites were detected in
   almost all participant sera by an API 4000 liquid chromatograph/tandem
   mass spectrometer. Type 2 diabetes was defined as the use of
   pharmacological hypoglycemic agents or a fasting plasma glucose >7.0
   mmol/L.
   RESULTS-A total of 114 subjects were shown to have diabetes. Following
   adjustment for sex, BMI, serum cholesterol and triglycerides,
   educational level, and smoking and exercise habits, high levels of the
   phthalate metabolites monomethyl phthalate (MMP) (P < 0.01),
   monoisobutyl phthalate (MiBP) (P < 0.05), and monoethyl phthalate (MEP)
   (P < 0.05), but not mono(2-ethylhexyl) phthalate, were associated with
   an increased prevalence of diabetes. Using the fasting proinsulin to
   insulin ratio as a marker of insulin secretion and the homeostasis model
   assessment-insulin resistance index as a marker of insulin resistance,
   MiBP was mainly related to poor insulin secretion, whereas MEP and MMP
   mainly were related to insulin resistance.
   CONCLUSIONS-The findings in this cross-sectional study showed that
   several phthalate metabolites are related to diabetes prevalence, as
   well as to markers of insulin secretion and resistance. These findings
   support the view that these commonly used chemicals might influence
   major factors that are regulating glucose metabolism in humans at the
   level of exposure of phthalate metabolites seen in the general elderly
   population.}},
Publisher = {{AMER DIABETES ASSOC}},
Address = {{1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lind, PM (Reprint Author), Uppsala Univ, Dept Occupat \& Environm Med, Uppsala, Sweden.
   Lind, P. Monica, Uppsala Univ, Dept Occupat \& Environm Med, Uppsala, Sweden.
   Zethelius, Bjorn, Uppsala Univ, Dept Publ Hlth Geriatr, Uppsala, Sweden.
   Zethelius, Bjorn, Med Prod Agcy, Uppsala, Sweden.
   Lind, Lars, Univ Uppsala Hosp, Dept Med, Uppsala, Sweden.}},
DOI = {{10.2337/dc11-2396}},
ISSN = {{0149-5992}},
Keywords-Plus = {{ACTIVATED-RECEPTOR-GAMMA; INSULIN-RESISTANCE; DI(2-ETHYLHEXYL)PHTHALATE
   DEHP; WAIST CIRCUMFERENCE; CELL FUNCTION; BISPHENOL-A; PPAR-GAMMA;
   EXPOSURE; ALPHA; PROINSULIN}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Endocrinology \& Metabolism}},
Author-Email = {{monica.lind@medsci.uu.se}},
Funding-Acknowledgement = {{Swedish Research Council; Swedish Research Council for Environment,
   Agricultural Sciences, and Spatial Planning}},
Funding-Text = {{This study was supported by the Swedish Research Council and the Swedish
   Research Council for Environment, Agricultural Sciences, and Spatial
   Planning. B.Z. is employed by the Medical Products Agency, Uppsala,
   Sweden.}},
Cited-References = {{Arnlov J, 2011, DIABETES CARE, V34, P61, DOI 10.2337/dc10-0955.
   Boberg J, 2008, TOXICOLOGY, V250, P75, DOI 10.1016/j.tox.2008.05.020.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   DAVIES MJ, 1993, DIABETIC MED, V10, P313.
   Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217.
   Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714.
   Hastie T, 1995, Stat Methods Med Res, V4, P187, DOI 10.1177/096228029500400302.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P116, DOI 10.1016/0041-008X(92)90374-2.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Kahn SE, 1997, DIABETES, V46, P1725, DOI 10.2337/diabetes.46.11.1725.
   Kaya T, 2006, CHEM RES TOXICOL, V19, P999, DOI 10.1021/tx050301s.
   Soo-Kyung K, 2007, EUR J ENDOCRINOL, V157, P167, DOI 10.1530/EJE-07-0043.
   Koch HM, 2006, INT J ANDROL, V29, P181.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Lapinskas PJ, 2005, TOXICOLOGY, V207, P149, DOI 10.1016/j.tox.2004.09.008.
   Lebovitz HE, 2001, RECENT PROG HORM RES, V56, P265, DOI 10.1210/rp.56.1.265.
   Lind PM, 2011, ATHEROSCLEROSIS, V218, P207, DOI 10.1016/j.atherosclerosis.2011.05.001.
   Lupi R, 2004, AM J PHYSIOL-ENDOC M, V286, pE560, DOI 10.1152/ajpendo.00561.2002.
   Martino-Andrade AJ, 2010, MOL NUTR FOOD RES, V54, P148, DOI 10.1002/mnfr.200800312.
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883.
   Moon JH, 2011, METABOLISM, V60, P165, DOI 10.1016/j.metabol.2009.12.007.
   Olsen L, 2012, ECOTOX ENVIRON SAFE, V75, P242, DOI 10.1016/j.ecoenv.2011.09.004.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Svensson K, 2011, ENVIRON RES, V111, P792, DOI 10.1016/j.envres.2011.05.015.
   Thomas E Louise, 2007, Atherosclerosis, V195, pe181, DOI 10.1016/j.atherosclerosis.2007.03.043.
   Venkata NG, 2006, TOXICOL LETT, V163, P224, DOI 10.1016/j.toxlet.2005.11.001.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{2}},
Journal-ISO = {{Diabetes Care}},
Doc-Delivery-Number = {{962MJ}},
Wos-Id = {{ISI:000305548900021}},
}

@article{ ISI:000305694000010,
Author = {Meeker, John D. and Calafat, Antonia M. and Hauser, Russ},
Title = {{Urinary phthalate metabolites and their biotransformation products:
   predictors and temporal variability among men and women}},
Journal = {{JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY}},
Year = {{2012}},
Volume = {{22}},
Number = {{4}},
Pages = {{376-385}},
Month = {{JUL-AUG}},
Abstract = {{Most epidemiology studies investigating the potential adverse health
   effects in relation to phthalates measure the urinary concentration of
   the free plus glucuronidated species of phthalate metabolites (i.e.,
   total concentration) to estimate exposure. However, the free species may
   represent the biologically relevant dose. In this study, we collected
   943 urine samples from 112 men and 157 women and assessed the
   between-and within-person variability and predictors of (1) the free and
   total urinary concentrations of phthalate metabolites, and (2) the
   percentage of free phthalate metabolites (a potential phenotypic
   indicator of individual susceptibility). We also explored the proportion
   of urinary di-(2-ethylhexyl) phthalate (DEHP) metabolites contributed to
   by the bioactive mono-2-ethylhexyl phthalate (MEHP), considered a
   possible indicator of susceptibility to phthalate exposure. The
   percentage of phthalate metabolites present in the free form was less
   stable over time than the total metabolite concentration, and,
   therefore, it is not likely a useful indicator of metabolic
   susceptibility. Thus, the added costs and effort involved in the
   measurement of free in addition to total metabolite concentrations in
   large-scale studies may not be justified. Conversely, the proportion of
   DEHP metabolites contributed to by MEHP was more stable within
   individuals over time and may be a promising indicator of susceptibility
   if time of day of sample collection is carefully considered.}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Meeker, JD (Reprint Author), Univ Michigan, Dept Environm Hlth Sci, Sch Publ Hlth, 6635 SPH Tower,109 S Observ St, Ann Arbor, MI 48109 USA.
   Meeker, John D., Univ Michigan, Dept Environm Hlth Sci, Sch Publ Hlth, Ann Arbor, MI 48109 USA.
   Calafat, Antonia M., Ctr Dis \& Control \& Prevent, Atlanta, GA USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Hauser, Russ, Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv, Androl Lab, Boston, MA 02114 USA.
   Hauser, Russ, Massachusetts Gen Hosp, Vitro Fertilizat Unit, Boston, MA 02114 USA.}},
DOI = {{10.1038/jes.2012.7}},
ISSN = {{1559-0631}},
Keywords = {{biomarker; environment; metabolism}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; QUANTITATIVE DETECTION; DIETHYL PHTHALATE;
   MASS-SPECTROMETRY; PREGNANT-WOMEN; HUMAN EXPOSURE; HORMONE LEVELS;
   HUMANS; HEALTH; REPRODUCIBILITY}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{meekerj@umich.edu}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences (NIEHS)
   {[}P30ES000002, R01ES009718, R01ES018872, P20ES018171, P42ES017198,
   P30ES017885]; US Environmental Protection Agency (USEPA) {[}RD83480001]}},
Funding-Text = {{This work was supported by grants P30ES000002, R01ES009718, R01ES018872,
   P20ES018171, P42ES017198, and P30ES017885 from the National Institute of
   Environmental Health Sciences (NIEHS), and RD83480001 from the US
   Environmental Protection Agency (USEPA). We acknowledge Manori Silva,
   Ella Samandar, and Jim Preau for measuring the urinary concentrations of
   phthalate metabolites.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   CDC, 2011, 4 CDCP.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Just AC, 2010, J EXPO SCI ENV EPID, V20, P625, DOI 10.1038/jes.2010.13.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch HM, 2006, INT J ANDROL, V29, P181.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Lorber M., 2010, J EXPO SCI ENV EPID, V111, P718.
   Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{2}},
Journal-ISO = {{J. Expo. Sci. Environ. Epidemiol.}},
Doc-Delivery-Number = {{964KR}},
Wos-Id = {{ISI:000305694000010}},
}

@article{ ISI:000303685200010,
Author = {Marcella, Ferri and Federica, Chiellini and Giorgio, Pili and Luca,
   Grimaldi and Florio, Elena Tiziana and Stefania, Pili and Francesco,
   Cucci and Giuseppe, Latini},
Title = {{Di-(2-ethylhexyl)-phthalate migration from irradiated poly(vinyl
   chloride) blood bags for graft-vs-host disease prevention}},
Journal = {{INTERNATIONAL JOURNAL OF PHARMACEUTICS}},
Year = {{2012}},
Volume = {{430}},
Number = {{1-2}},
Pages = {{86-88}},
Month = {{JUL 1}},
Abstract = {{Irradiation with 20-25 kGy is a process commonly used for sterilizing
   poly(vinyl chloride) (PVC) medical devices. Moreover, whole blood and
   blood components undergo additional irradiation with 25-50 Gy to inhibit
   the proliferative capacity of lymphocytes and reduce the risk of
   transfusion-associated graft-vs-host disease (GVHD).
   Di-(2-ethylhexyl)-phthalate (DEHP) plasticized PVC is extensively used
   for the production of flexible medical devices including blood bags, but
   since DEHP is not covalently bound to PVC, it tends to migrate and leach
   out of the medical device, with harmful consequences for the patients.
   In this study, the effects of different doses of gamma irradiation on
   DEHP migration from PVC blood bags was investigated using differential
   scanning calorimetry (DSC) analysis.
   Our findings indicate that irradiation with 25-100 Gy reduces the
   ability of DEHP to migrate from the blood bags, and in the case of a
   primary container a correlation between the doses of gamma ray
   irradiation was also observed. In particular, a decrease in DEHP
   leachability was obtained by increasing the dose of gamma ray
   irradiation. (C) 2012 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Federica, C (Reprint Author), Univ Pisa, Dept Chem \& Ind Chem, Lab Bioact Polymer Mat Biomed \& Environm Applicat, Pisa, Italy.
   Marcella, Ferri; Federica, Chiellini, Univ Pisa, Dept Chem \& Ind Chem, Lab Bioact Polymer Mat Biomed \& Environm Applicat, Pisa, Italy.
   Giorgio, Pili; Luca, Grimaldi; Florio, Elena Tiziana, Perrino Hosp, Dept Med Phys, Brindisi, Italy.
   Stefania, Pili, Univ Cattolica Sacro Cuore, Sch Med, Rome, Italy.
   Francesco, Cucci; Giuseppe, Latini, Perrino Hosp, Div Neonatol, Brindisi, Italy.
   Giuseppe, Latini, Natl Res Council Italy IFC CNR, Inst Clin Physiol, Pisa, Italy.}},
DOI = {{10.1016/j.ijpharm.2012.03.039}},
ISSN = {{0378-5173}},
Keywords = {{Di-(2-ethylhexyl)-phthalate; Differential scanning calorimetry;
   Graft-vs-host disease; Poly(vinyl chloride); Glass transition
   temperature}},
Keywords-Plus = {{PHTHALATE METABOLITES; EXPOSURE; CHILDREN}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Author-Email = {{federica@dcci.unipi.it}},
Cited-References = {{Butson M.J., 2000, PHYS MED BIOL, V45, P139.
   Center for Devices and Radiological Health, 2001, USFDA SAF ASS DI 2 E.
   Fearon T, 2005, TRANSFUSION, V45, P1658, DOI 10.1111/j.1537-2995.2005.00573.x.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   Goes EG, 2004, VOX SANG, V86, P105, DOI 10.1111/j.0042-9007.2004.00400.x.
   Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3788, DOI 10.1021/es2002106.
   International Organization for Standardization 1995. International Standard ISO 11137, 1995, 11137 ISO.
   Ito R., 2006, J PHARM BIOMED ANAL, V41, P198.
   Ito R, 2009, INT J PHARMACEUT, V376, P213, DOI 10.1016/j.ijpharm.2009.04.019.
   Ito R, 2008, J LIQ CHROMATOGR R T, V31, P198, DOI 10.1080/10826070701738811.
   Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2.
   KERC J, 1995, THERMOCHIM ACTA, V248, P81, DOI 10.1016/0040-6031(94)01949-H.
   Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Latini G, 2010, CURR MED CHEM, V17, P2979.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Luban NLC, 1996, TRANSFUSION, V36, P101, DOI 10.1046/j.1537-2995.1996.36296181918.x.
   PELSZYNSKI MM, 1994, BLOOD, V83, P1683.
   Romero-Franco M, 2011, ENVIRON INT, V37, P867, DOI 10.1016/j.envint.2011.02.014.
   Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   {[}Anonymous], 1995, US PHARM 23.}},
Number-of-Cited-References = {{22}},
Times-Cited = {{0}},
Journal-ISO = {{Int. J. Pharm.}},
Doc-Delivery-Number = {{937US}},
Wos-Id = {{ISI:000303685200010}},
}

@article{ ISI:000303226500011,
Author = {Liu, Liangpo and Bao, Huaqiong and Liu, Feng and Zhang, Jie and Shen,
   Heqing},
Title = {{Phthalates exposure of Chinese reproductive age couples and its effect
   on male semen quality, a primary study}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2012}},
Volume = {{42}},
Number = {{SI}},
Pages = {{78-83}},
Month = {{JUL}},
Abstract = {{Phthalates are suspected of having adverse effects on androgen-regulated
   reproductive development in animals and may be toxic for human sperm.
   The purposes of our study were to investigate the general exposure of a
   Chinese reproductive age cohort to these ubiquitous pollutants and to
   assess their potential effect on semen quality.
   Six phthalate metabolites, monomethyl phthalate (MMP), monoethyl
   phthalate (MEP), monobutyl phthalate (MBP), monobenzyl phthalate (MBzP).
   mono-2-ethylhexyl phthalate (MEHP), and mono-2-ethyl-5-oxohexyl
   phthalate (MEOHP) were measured ill spot urines of 150 individuals
   recruited from a Chongqing, China, reproductive institute. The
   questionnaire and clinical data were evaluated, and the correlations of
   phthalate exposure and semen qualities like semen volume, sperm
   concentration, motility and sperm motion parameters, were determined by
   multiple logistic regression analysis.
   The creatinine adjusted average concentrations for MMP, MEP, MBP, MBzP,
   MEHP and MEOHP were 41.3, 300, 41.0, 0.78, 2.99 and 3.90 mu g/g,
   respectively. After adjustment for age, body mass index (BMI),
   abstinence, smoking, drinking, and education, there was a
   borderline-significant dose-response relationship between MBP and sperm
   concentration, with odd ratios (ORs) 1.0, 6.8 and 12.0 for increasing
   exposure tertiles (p = 0.05). Although the dose-response relationships
   for MMP and MEP versus sperm concentration were not significant, a
   significant positive correlation between MEP and straight-line velocity
   of sperm motion was observed.
   The present data may imply some effects of phthalate exposure on semen.
   However, due to the small sample size, our finding needs to be confirmed
   on a larger population. (C) 2011 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Shen, HQ (Reprint Author), 1799 Jimei Da Dao, Xiamen 361021, Peoples R China.
   Liu, Liangpo; Liu, Feng; Zhang, Jie; Shen, Heqing, Chinese Acad Sci, Key Lab Urban Environm \& Hlth, Inst Urban Environm, Xiamen 361021, Peoples R China.
   Bao, Huaqiong, Chongqing Inst Sci \& Technol Populat \& Family Pla, Chongqing 400020, Peoples R China.}},
DOI = {{10.1016/j.envint.2011.04.005}},
ISSN = {{0160-4120}},
Keywords = {{Phthalate exposure; Urinary metabolite; Semen quality; Male fertility;
   Endocrine disruption}},
Keywords-Plus = {{MONO-(2-ETHYLHEXYL) PHTHALATE; HUMAN URINE; DI(2-ETHYLHEXYL)PHTHALATE
   DEHP; POLYCHLORINATED-BIPHENYLS; MALE-INFERTILITY; SERTOLI-CELLS;
   FERTILE MEN; METABOLITES; SERUM; HEALTH}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{hqshen@iue.ac.cn}},
ResearcherID-Numbers = {{Shen, Heqing/H-9338-2013}},
Funding-Acknowledgement = {{Chinese Academy of Sciences (CAS); CAS/SAFEA {[}KZCX2-YW-T08]; MOST for
   Combined Pollution and Ecosystem Health in Urban Agglomeration
   {[}2009DFB90120]}},
Funding-Text = {{We sincerely thank the participants of this study for providing urine
   samples and semen samples, as well as others who gave their assistance.
   The present work was funded by Chinese Academy of Sciences' (CAS) 100
   Talents Program for Human Exposure to Environmental Pollutant and Health
   Effect, CAS/SAFEA International Partnership Program for Creative
   Research Teams (KZCX2-YW-T08) and MOST for Combined Pollution and
   Ecosystem Health in Urban Agglomeration (2009DFB90120).}},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   AUGER J, 1995, NEW ENGL J MED, V332, P281, DOI 10.1056/NEJM199502023320501.
   Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335.
   CARLSEN E, 1992, BRIT MED J, V305, P609.
   Centers for Disease Control and Prevention, 4 CDCP.
   CREASY DM, 1988, TOXICOL IN VITRO, V2, P83, DOI 10.1016/0887-2333(88)90018-5.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hamilton BE, 2006, INT J ANDROL, V29, P34, DOI 10.1111/j-1365-2605.2005.00638.x.
   Hansen C, 2010, ENVIRON HEALTH PERSP, V118, P203, DOI 10.1289/ehp.0901022.
   Hauser R, 2003, ENVIRON HEALTH PERSP, V111, P1505, DOI 10.1289/ehp.6175.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hauser R, 2005, ENVIRON HEALTH PERSP, V113, P425, DOI 10.1289/ehp.7305.
   Herr C, 2009, INT J HYG ENVIR HEAL, V212, P648, DOI 10.1016/j.ijheh.2009.08.001.
   Irvine DS, 1998, HUM REPROD, V13, P33.
   Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y.
   Itoh H, 2009, SCI TOTAL ENVIRON, V408, P37, DOI 10.1016/j.scitotenv.2009.09.012.
   Joensen UN, 2009, ENVIRON HEALTH PERSP, V117, P923, DOI 10.1289/ehp.0800517.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   JOUANNET P, 1988, INT J ANDROL, V11, P379, DOI 10.1111/j.1365-2605.1988.tb01011.x.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P689, DOI 10.1007/s00204-005-0004-x.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   KRUGER TF, 1988, FERTIL STERIL, V49, P112.
   Li H, 2003, BIOL REPROD, V69, P1964, DOI 10.1095/biolreprod.103.018895.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Lorber M., 2009, J EXPO SCI ENV EPID, V20, P38.
   Meeker JD, 2008, ENVIRON HEALTH PERSP, V116, P1473, DOI 10.1289/ehp.11490.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2004, ENVIRON HEALTH PERSP, V112, P1665, DOI 10.1289/ehp.7234.
   Mendiola J, 2010, INT J ANDROL, V14, P1.
   Mendiola J, 2010, ENVIRON HEALTH PERSP, V118, P1286, DOI 10.1289/ehp.1002037.
   Mocarelli P, 2008, ENVIRON HEALTH PERSP, V116, P70, DOI 10.1289/ehp.10399.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Sokol RZ, 2006, ENVIRON HEALTH PERSP, V114, P360, DOI 10.1289/ehp.8232.
   SRIVASTAVA SP, 1990, ARCH TOXICOL, V64, P148, DOI 10.1007/BF01974401.
   Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P1478, DOI 10.1289/ehp.6417.
   Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Toft G, 2007, ENVIRON HEALTH PERSP, V115, P15, DOI 10.1289/ehp.9352.
   Toft G, 2006, EPIDEMIOLOGY, V17, P450, DOI 10.1097/01.ede.0000221769.41028.d2.
   Wirth JJ, 2008, SYST BIOL REPROD MEC, V54, P143, DOI 10.1080/19396360802055921.
   World Health Organization, 1999, LAB MAN EX HUM SEM S.
   Xia YK, 2009, HUM REPROD, V24, P1067, DOI 10.1093/humrep/dep006.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{4}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{931NL}},
Wos-Id = {{ISI:000303226500011}},
}

@article{ ISI:000304337300025,
Author = {Olsen, Lena and Lind, Lars and Lind, P. Monica},
Title = {{Associations between circulating levels of bisphenol A and phthalate
   metabolites and coronary risk in the elderly}},
Journal = {{ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY}},
Year = {{2012}},
Volume = {{80}},
Pages = {{179-183}},
Month = {{JUN 1}},
Abstract = {{Studies have pointed out associations between various chemicals with
   estrogenic activity and cardiovascular disease. Being ubiquitous, the
   plastic additive substances bisphenol A (BPA), and phthalates have been
   detected in almost all types of analyzed human samples. The aim of this
   study was to investigate whether circulating levels of BPA and/or four
   selected phthalate metabolites are associated to coronary risk in an
   elderly population. In the Prospective Investigation of the Vasculature
   in Uppsala Seniors (PIVUS) study, coronary risk was assessed by the
   Framingham Risk Score (FRS) together with circulating serum levels of
   BPA and the four phthalate metabolites monoisobutyl phthalate (MiBP),
   monomethyl phthalate (MMP), monoethyl phthalate (MEP),
   mono-(2-ethylhexyl) phthalate (MEHP) in 1016 subjects aged 70 years.
   BPA, MEHP, and MMP were associated to LDL-cholesterol and MEHP to
   HDL-cholesterol, MEP to diastolic blood pressure and MiBP to fasting
   glucose when the compounds were investigated one by one. After
   Bonferronni correction, only the relations for MMP to LDL-cholesterol
   (p<0.0001), MEP to diastolic blood pressure (p<0.0002), and MiBP to
   fasting glucose (p<0.0001) remained significant. MMP was associated to
   the FRS (p=0.02), but after Bonferronni correction, this association was
   not significant. In conclusion, associations were found between MMP and
   LDL-cholesterol, MEP and diastolic blood pressure, and MiBP and fasting
   glucose. We did not observe any strong associations between BPA nor any
   of the four phthalate metabolites and Framingham Risk Score in this
   elderly population. (C) 2012 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lind, PM (Reprint Author), Uppsala Univ, Dept Med Sci Occupat \& Environm Med, Uppsala, Sweden.
   Olsen, Lena; Lind, P. Monica, Uppsala Univ, Dept Med Sci Occupat \& Environm Med, Uppsala, Sweden.
   Lind, Lars, Uppsala Univ, Dept Med Sci Acute \& Internal Med, Uppsala, Sweden.}},
DOI = {{10.1016/j.ecoenv.2012.02.023}},
ISSN = {{0147-6513}},
Keywords = {{Serum levels; Bisphenol A (BPA); Phthalate metabolites; Elderly;
   Coronary risk}},
Keywords-Plus = {{UPPSALA SENIORS PIVUS; WAIST CIRCUMFERENCE; RECEPTORS PPARS; HUMAN
   HEALTH; EXPOSURE; CHEMICALS; VASCULATURE; POPULATION; ACTIVATION;
   MONOESTERS}},
Research-Areas = {{Environmental Sciences \& Ecology; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Toxicology}},
Author-Email = {{Lena.olsen@medsci.uu.se
   lars.lind@medsci.uu.se
   Monica.Lind@medsci.uu.se}},
Funding-Acknowledgement = {{Swedish Council for Environment, Agricultural Sciences and Spatial
   Planning (FORMAS); Swedish Research Council (VR)}},
Funding-Text = {{The work was supported by funds from the Swedish Council for
   Environment, Agricultural Sciences and Spatial Planning (FORMAS) and the
   Swedish Research Council (VR).}},
Cited-References = {{Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253.
   Carlsson L, 2010, GERONTOLOGY, V56, P259, DOI 10.1159/000251722.
   Dirinck E., 2010, OBESITY SILVER SPRIN.
   Fernandez MF, 2007, REPROD TOXICOL, V24, P259, DOI 10.1016/j.reprotox.2007.06.007.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   GRIFFITHS WC, 1988, ENVIRON HEALTH PERSP, V77, P151, DOI 10.2307/3430640.
   Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   KREISS K, 1981, JAMA-J AM MED ASSOC, V245, P2505, DOI 10.1001/jama.245.24.2505.
   Lampen A, 2003, TOXICOL APPL PHARM, V188, P14, DOI 10.1016/S0041-008X(03)00014-0.
   Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303.
   Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da.
   Lind PM, 2011, ATHEROSCLEROSIS, V218, P207, DOI 10.1016/j.atherosclerosis.2011.05.001.
   Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809.
   Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673.
   Olsen L, 2012, ECOTOX ENVIRON SAFE, V75, P242, DOI 10.1016/j.ecoenv.2011.09.004.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Schug TT, 2011, J STEROID BIOCHEM, V127, P204, DOI 10.1016/j.jsbmb.2011.08.007.
   Sergeev AV, 2010, INT J OCCUP MED ENV, V23, P5, DOI 10.2478/v10001-010-0010-y.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281.
   Uemura H, 2009, ENVIRON HEALTH PERSP, V117, P568, DOI 10.1289/ehp.0800012.
   vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005.
   Wilson PWF, 1998, CIRCULATION, V97, P1837.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Wolstenholme J.T., 2010, HORM BEHAV.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{0}},
Journal-ISO = {{Ecotox. Environ. Safe.}},
Doc-Delivery-Number = {{946FQ}},
Wos-Id = {{ISI:000304337300025}},
}

@article{ ISI:000304343800002,
Author = {Frederiksen, H. and Sorensen, K. and Mouritsen, A. and Aksglaede, L. and
   Hagen, C. P. and Petersen, J. H. and Skakkebaek, N. E. and Andersson, A.
   -M. and Juul, A.},
Title = {{High urinary phthalate concentration associated with delayed pubarche in
   girls}},
Journal = {{INTERNATIONAL JOURNAL OF ANDROLOGY}},
Year = {{2012}},
Volume = {{35}},
Number = {{3}},
Pages = {{216-226}},
Month = {{JUN}},
Abstract = {{Phthalates are a group of chemicals present in numerous consumer
   products. They have anti-androgenic properties in experimental studies
   and are suspected to be involved in human male reproductive health
   problems. A few studies have shown associations between phthalate
   exposure and changes in pubertal timing among girls, although
   controversies exist. We determined the concentration of 12 phthalate
   metabolites in first morning urine samples from 725 healthy Danish girls
   (aged 5.619.1 years) in relation to age, pubertal development (breast
   and pubic hair stage) and reproductive hormone levels (luteinizing
   hormone, oestradiol and testosterone). Furthermore, urinary phthalates
   were determined in 25 girls with precocious puberty (PP). In general,
   the youngest girls with less advanced pubertal development had the
   highest first morning urinary concentration of the monobutyl phthalate
   isoforms (?MBP(i+n)), monobenzyl phthalate (MBzP), metabolites of
   di-(2-ethylhexyl) phthalate (?DEHPm) and of di-iso-nonyl phthalate
   (?DINPm). After stratification of the urinary phthalate excretion into
   quartiles, we found that the age at pubarche was increasing with
   increasing phthalate metabolite quartiles (except for MEP). This trend
   was statistically significant when all phthalate metabolites (except
   MEP) were summarized and expressed as quartiles. No association between
   phthalates and breast development was observed. In addition, there were
   no differences in urinary phthalate metabolite levels between girls with
   PP and controls. We demonstrated that delayed pubarche, but not
   thelarche, was associated with high phthalate excretion in urine samples
   from 725 healthy school girls, which may suggest anti-androgenic actions
   of phthalates in our study group of girls.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Frederiksen, H (Reprint Author), Copenhagen Univ Hosp, Rigshosp, Dept Growth \& Reprod, Sect 5064, DK-2100 Copenhagen, Denmark.
   Frederiksen, H., Copenhagen Univ Hosp, Rigshosp, Dept Growth \& Reprod, Sect 5064, DK-2100 Copenhagen, Denmark.}},
DOI = {{10.1111/j.1365-2605.2012.01260.x}},
ISSN = {{0105-6263}},
Keywords = {{breast development; endocrine disruptor; LC-MS; MS; precocious puberty;
   pubic hair development; urinary phthalate excretion}},
Keywords-Plus = {{IN-UTERO EXPOSURE; PRECOCIOUS PUBERTY; REPRODUCTIVE DEVELOPMENT;
   MALE-RAT; DIETHYLHEXYL PHTHALATE; ENDOCRINE DISRUPTORS; DIISOBUTYL
   PHTHALATE; BREAST DEVELOPMENT; SEXUAL-MATURATION; AGE}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{hanne.01.frederiksen@rh.regionh.dk}},
ResearcherID-Numbers = {{Juul, Anders /F-5864-2013}},
Funding-Acknowledgement = {{Aase and Ejnar Danielsens Foundation; Kirsten and Freddy Johansen
   Foundation; EU (DEER) {[}212844]; Danish Council for Strategic Research
   (DAN-ED) {[}2107-05-0006]; Danish Center on Endocrine Disrupters; Velux
   Fondene}},
Funding-Text = {{This study was supported by Aase and Ejnar Danielsens Foundation, the
   Kirsten and Freddy Johansen Foundation, EU FP7 (DEER; grant agreement
   no. 212844), Danish Council for Strategic Research 2009 (DAN-ED; grant
   agreement no. 2107-05-0006) and the Danish Center on Endocrine
   Disrupters. The instrumental equipment was financially supported by
   Velux Fondene. We thank Ole Nielsen for skilled technical assistance.
   Finally, we are grateful to all the participating girls from the
   following schools: Bronshoj Skole, Hanssted Skole, Hyltebjerg Skole,
   Kongevejens Skole, Rodkilde Skole, Sankt Annae Gymnasium, Vibenhus Skole
   and Oster Farimagsgade Skole.}},
Cited-References = {{Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Biro FM, 2006, INT J ANDROL, V29, P272, DOI 10.1111/j.1365-2605.2005.00602.x.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   Boberg J, 2010, REPROD TOXICOL, V31, P200.
   Calafat AM, 2011, ENVIRON HEALTH PERSP, V119, P50, DOI 10.1289/ehp.1002316.
   Carel JC, 2009, PEDIATRICS, V123, pE752, DOI 10.1542/peds.2008-1783.
   Carel JC, 2008, NEW ENGL J MED, V358, P2366, DOI 10.1056/NEJMcp0800459.
   CDC, 2009, 4 CDC.
   Chou YY, 2009, J PEDIATR ENDOCR MET, V22, P69.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Dickson-Spillmann M, 2009, RISK ANAL, V29, P1170, DOI 10.1111/j.1539-6924.2009.01233.x.
   Durmaz E, 2010, PEDIATRICS, V125, pE122, DOI 10.1542/peds.2009-0724.
   Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714.
   Elks CE, 2011, BRIEF FUNCT GENOMICS, V10, P91, DOI 10.1093/bfgp/elq030.
   Ellis BJ, 2007, CHILD DEV, V78, P1799, DOI 10.1111/j.1467-8624.2007.01092.x.
   EPA, 2011, IN INGR PEST PROD.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Frederiksen H, 2010, J ANAL TOXICOL, V34, P400.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Hannas BR, 2011, TOXICOL SCI, V123, P206, DOI 10.1093/toxsci/kfr146.
   HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Kanno J, 2003, ENVIRON HEALTH PERSP, V111, P1550, DOI 10.1289/ehp.5870.
   Kristensen DM, 2011, ENVIRON HEALTH PERSP, V119, P534, DOI 10.1289/ehp.1002635.
   Lomenick JP, 2010, J PEDIATR-US, V156, P221, DOI 10.1016/j.jpeds.2009.09.047.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Marcus Michele, 2010, Reviews on Environmental Health, V25, P359.
   MARSHALL WA, 1969, ARCH DIS CHILD, V44, P291.
   Massart F, 2008, J PEDIATR, V152, P690, DOI 10.1016/j.jpeds.2007.10.020.
   Massart F, 2010, INT J ANDROL, V33, P369, DOI 10.1111/j.1365-2605.2009.01009.x.
   McKee RH, 2004, ENVIRON HEALTH PERSP, V112, pA541.
   Morris DH, 2011, PAEDIATR PERINAT EP, V25, P306, DOI 10.1111/j.1365-3016.2010.01183.x.
   Mouritsen A, 2010, INT J ANDROL, V33, P346, DOI 10.1111/j.1365-2605.2010.01051.x.
   Ohtani Yoshimi, 2005, Environ Sci, V12, P207.
   Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382.
   Ormond G, 2009, ENVIRON HEALTH PERSP, V117, P303, DOI 10.1289/ehp.11933.
   Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Petersen JH, 2010, FOOD ADDIT CONTAM A, V27, P1608, DOI 10.1080/19440049.2010.501825.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Qiao Lili, 2007, Wei Sheng Yan Jiu, V36, P93.
   Rubin C, 2009, PAEDIATR PERINAT EP, V23, P492, DOI 10.1111/j.1365-3016.2009.01055.x.
   Saillenfait AM, 2008, REPROD TOXICOL, V26, P107, DOI 10.1016/j.reprotox.2008.07.006.
   Sathyanarayana S, 2008, ENVIRON RES, V108, P413, DOI 10.1016/j.envres.2008.07.002.
   Schlumpf M, 2010, CHEMOSPHERE, V81, P1171, DOI 10.1016/j.chemosphere.2010.09.079.
   Sorensen K, 2010, J CLIN ENDOCR METAB, V95, P263, DOI 10.1210/jc.2009-1478.
   Sorensen K, 2010, J CLIN ENDOCR METAB, V95, P3736, DOI 10.1210/jc.2010-0731.
   SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.2307/3432519.
   Sun SMS, 2002, PEDIATRICS, V110, P911, DOI 10.1542/peds.110.5.911.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Toppari J, 2010, MOL CELL ENDOCRINOL, V324, P39, DOI 10.1016/j.mce.2010.03.011.
   van den Driesche S, 2011, INT J ANDROL, V34, pE578, DOI 10.1111/j.1365-2605.2011.01175.x.
   Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241.
   Wittassek M., 2010, MOL NUTR FOOD RES, V55, P7.
   Wolff MS, 2007, ENVIRON HEALTH PERSP, V115, P116, DOI 10.1289/ehp.9488.
   Wolff MS, 2010, ENVIRON HEALTH PERSP, V118, P1039, DOI 10.1289/ehp.0901690.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Zhang ZB, 2011, TOXICOL LETT, V207, P7, DOI 10.1016/j.toxlet.2011.08.017.}},
Number-of-Cited-References = {{65}},
Times-Cited = {{6}},
Journal-ISO = {{Int. J. Androl.}},
Doc-Delivery-Number = {{946IB}},
Wos-Id = {{ISI:000304343800002}},
}

@article{ ISI:000304343800003,
Author = {Mieritz, Mikkel G. and Frederiksen, Hanne and Sorensen, Kaspar and
   Aksglaede, Lise and Mouritsen, Annette and Hagen, Casper P. and
   Skakkebaek, Niels E. and Andersson, Anna-Maria and Juul, Anders},
Title = {{Urinary phthalate excretion in 555 healthy Danish boys with and without
   pubertal gynaecomastia}},
Journal = {{INTERNATIONAL JOURNAL OF ANDROLOGY}},
Year = {{2012}},
Volume = {{35}},
Number = {{3}},
Pages = {{227-235}},
Month = {{JUN}},
Abstract = {{Pubertal gynaecomastia is a clinical sign of an oestrogen-androgen
   imbalance, which occurs in 4060\% of adolescent Caucasian boys. In most
   cases no underlying endocrinopathy can be identified. A recent study
   reports higher plasma phthalate levels in Turkish boys with pubertal
   gynaecomastia. Therefore, we asked whether there was an association
   between concurrent measures of urinary phthalate metabolites and
   pubertal timing as well as the presence of gynaecomastia in otherwise
   healthy boys. We studied a total of 555 healthy boys (age 6.0719.83
   years) as part of the COPENHAGEN Puberty Study. Anthropometry and
   pubertal stages (PH1-6 and G1-5) were evaluated, and the presence of
   gynaecomastia was assessed. Non-fasting blood samples were analysed for
   serum testosterone and morning urine samples were analysed for the total
   content of 12 phthalate metabolites (MEP, MnBP, MiBP, MBzP, MEHP, MEHHP,
   MEOHP, MECPP, MiNP, MHiNP, MiONP and MCiOP) by LC-MS/MS. A statistically
   significant negative correlation was observed between chronological age
   and the urinary concentration of the sum of measured metabolites DEHP
   (?DEHPm) (r = -0.164) and DiNP (?DiNPm) (r = -0.224), respectively, and
   the sum of monobutyl phthalate (MBP) isomers (?MBP(i+n)) (r = -0.139)
   (all with p < 0.01). In contrast urinary monoethyl phthalate
   concentration was positively correlated to age (r = 0.187, p < 0.01).
   The urinary levels of phthalate metabolites were not associated with age
   at pubertal onset, serum testosterone levels or presence of
   gynaecomastia. In conclusion, we did not find evidence of
   anti-androgenic effects of phthalates in our healthy boys. Thus, current
   phthalate exposure was not associated with pubertal timing, testosterone
   levels or with the presence of pubertal gynaecomastia in this
   cross-sectional study. However, longitudinal studies are needed to
   evaluate possible perinatal or long-term postnatal effects of phthalates
   on healthy boys.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mieritz, MG (Reprint Author), Univ Copenhagen, Rigshosp, Dept Growth \& Reprod, Fac Healthy Sci,Sect 5064, DK-2100 Copenhagen, Denmark.
   Mieritz, Mikkel G., Univ Copenhagen, Rigshosp, Dept Growth \& Reprod, Fac Healthy Sci,Sect 5064, DK-2100 Copenhagen, Denmark.}},
DOI = {{10.1111/j.1365-2605.2012.01279.x}},
ISSN = {{0105-6263}},
Keywords = {{gynaecomastia; healthy boys; LC-MS; MS; phthalates; puberty}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; IN-UTERO EXPOSURE; ADOLESCENT GYNECOMASTIA;
   SOMATOMETRIC PARAMETERS; BREAST DEVELOPMENT; HORMONE EXCRETION; ESTERS;
   RATS; ASSOCIATIONS; GIRLS}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{mikkel.grunnet.mieritz@rh.regionh.dk}},
ResearcherID-Numbers = {{Juul, Anders /F-5864-2013}},
Funding-Acknowledgement = {{Aase og Einar Danielsen Foundation; Kirsten and Freddy Johansen
   Foundation; EU (DEER) {[}212844]; Danish Council for Strategic Research
   (DAN-ED) {[}2107-05-0006]; Danish Agency for Science, Technology and
   Innovation {[}09-067180]; Danish Center of Endocrine Disrupters; Velux
   Fondene}},
Funding-Text = {{This study was supported by the Aase og Einar Danielsen Foundation,
   Kirsten and Freddy Johansen Foundation, EU FP7 (DEER; grant agreement
   no. 212844), Danish Council for Strategic Research 2009 (DAN-ED; grant
   agreement no. 2107-05-0006), Danish Agency for Science, Technology and
   Innovation 09-067180 and the Danish Center of Endocrine Disrupters. The
   instrumental equipment was financially supported by Velux Fondene. Ole
   Nielsen is thanked for his skilled technical assistance. Finally, we
   thank all participating boys from the following schools: Bronshoj Skole,
   Hanssted Skole, Hyltebjerg Skole, Kongevejens Skole, Rodkilde Skole,
   Sankt Annae Gymnasium, Vibenhus Skole and Oster Farimagsgade Skole.}},
Cited-References = {{Aksglaede L, 2009, PEDIATRICS, V123, pE932, DOI 10.1542/peds.2008-2491.
   Bandak M, 2011, EUR J CANCER, V47, P2585, DOI 10.1016/j.ejca.2011.05.026.
   BIRO FM, 1990, J PEDIATR, V116, P450, DOI 10.1016/S0022-3476(05)82843-4.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011.
   Borch J, 2005, REPROD TOXICOL, V19, P517, DOI 10.1016/j.reprotox.2004.11.004.
   Braunstein GD, 2007, NEW ENGL J MED, V357, P1229, DOI 10.1056/NEJMcp070677.
   BULARD J, 1987, J CLIN ENDOCR METAB, V64, P618.
   Chou YY, 2009, J PEDIATR ENDOCR MET, V22, P69.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Courant F, 2010, J CLIN ENDOCR METAB, V95, P82, DOI 10.1210/jc.2009-1140.
   Durmaz E, 2010, PEDIATRICS, V125, pE122, DOI 10.1542/peds.2009-0724.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Frederiksen H, 2012, INT J ANDROL, V35, P216, DOI 10.1111/j.1365-2605.2012.01260.x.
   Frederiksen H, 2010, J ANAL TOXICOL, V34, P400.
   GEORGIADIS E, 1994, ANN HUM BIOL, V21, P579, DOI 10.1080/03014469400003582.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hellmann P, 2012, ARCH DIS CHILD.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009.
   Ismail AAA, 2001, ANN CLIN BIOCHEM, V38, P596, DOI 10.1258/0004563011900993.
   JULL JW, 1964, BRIT MED J, V2, P797.
   JULL JW, 1964, BRIT MED J, V2, P795.
   Kinsella C, 2012, PLAST RECONSTR SURG, V129, P1, DOI 10.1097/PRS.0b013e3182361efd.
   Kumanov P, 2007, J ADOLESCENT HEALTH, V41, P126, DOI 10.1016/j.jadohealth.2007.03.010.
   Lomenick JP, 2010, J PEDIATR-US, V156, P221, DOI 10.1016/j.jpeds.2009.09.047.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13.
   Moral R, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-5.
   NYDICK M, 1961, JAMA-J AM MED ASSOC, V178, P449.
   Prader A, 1966, Triangle, V7, P240.
   Qiao Lili, 2007, Wei Sheng Yan Jiu, V36, P93.
   Sorensen K, 2010, J CLIN ENDOCR METAB, V95, P263, DOI 10.1210/jc.2009-1478.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Teitelbaum SL, 2012, ENVIRON RES, V112, P186, DOI 10.1016/j.envres.2011.12.006.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Wolff MS, 2010, ENVIRON HEALTH PERSP, V118, P1039, DOI 10.1289/ehp.0901690.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   ZACHMANN M, 1974, HELV PAEDIATR ACTA, V29, P61.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{0}},
Journal-ISO = {{Int. J. Androl.}},
Doc-Delivery-Number = {{946IB}},
Wos-Id = {{ISI:000304343800003}},
}

@article{ ISI:000304343800004,
Author = {Suzuki, Y. and Yoshinaga, J. and Mizumoto, Y. and Serizawa, S. and
   Shiraishi, H.},
Title = {{Foetal exposure to phthalate esters and anogenital distance in male
   newborns}},
Journal = {{INTERNATIONAL JOURNAL OF ANDROLOGY}},
Year = {{2012}},
Volume = {{35}},
Number = {{3}},
Pages = {{236-244}},
Month = {{JUN}},
Abstract = {{Phthalate esters, commonly used as plasticizers, show anti-androgenic
   activity and cause male reproductive malformation in experimental
   animals. However, the effects of prenatal exposure to phthalate esters
   in humans have not been extensively studied. The purpose of this study
   was to examine the relationship between prenatal exposure to phthalate
   esters and the anogenital distance (AGD) as a reproductive endpoint in
   human male newborns. Spot urine samples were collected from 111 Japanese
   pregnant women after obtaining their informed consent. Seven urinary
   phthalate ester metabolites were determined by high performance liquid
   chromatographytandem mass spectrometry. Urinary isoflavones
   concentrations were measured as possible covariates because their
   oestrogenicities and high exposure levels among Japanese have the
   potential to affect male genital development. Birth outcomes and AGD,
   the distance from the centre of the anus to external genitalia, were
   measured for their male newborns. In a multiple regression model, the
   log-transformed mono-2-ethylhexyl phthalate concentration (specific
   gravity-corrected) was negatively significant, and maternal smoking
   status was positively significant, in explaining anogenital index (AGI)
   when potential covariates were controlled for. Urinary isoflavones did
   not significantly contribute to AGI in any models. Our results suggest
   that prenatal exposure to di(2-ethylhexyl) phthalate affects
   reproductive development in human males.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Suzuki, Y (Reprint Author), Univ Tokyo, Dept Environm Studies, Kashiwanoha 5-1-5, Kashiwa, Chiba 2708563, Japan.
   Suzuki, Y.; Yoshinaga, J., Univ Tokyo, Dept Environm Studies, Kashiwa, Chiba 2708563, Japan.
   Mizumoto, Y., Cent Hosp Self Def Force, Dept Obstet \& Gynecol, Tokyo, Japan.
   Serizawa, S.; Shiraishi, H., Natl Inst Environm Studies, Ibaraki, Japan.}},
DOI = {{10.1111/j.1365-2605.2011.01190.x}},
ISSN = {{0105-6263}},
Keywords = {{anogenital distance; fetal development; phthalates; urinary metabolites}},
Keywords-Plus = {{MALE RATS; PROGRAMMING WINDOW; REPRODUCTIVE-TRACT; PRENATAL EXPOSURE;
   SOY ISOFLAVONES; IN-VITRO; TESTIS; URINE; INFANTS; DEHP}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{yayoi-suzuki@umin.ac.jp}},
Funding-Acknowledgement = {{Japan Society for the Promotion of Science {[}22310040, 22-5950]}},
Funding-Text = {{We thank the study subjects for donation of urine samples and clinical
   staff of the Central Hospital of Self-Defense Force for urine sampling
   and measurement of newborns. This study was supported by Grants-in-aid
   for scientific research from the Japan Society for the Promotion of
   Science (project numbers 22310040 and 22-5950).}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   C. D. C. Centers for Disease Control and Prevention, 2009, 4 CDCP.
   Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870.
   Christiansen S, 2010, REPROD TOXICOL, V30, P313, DOI 10.1016/j.reprotox.2010.04.005.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Ganmaa D, 2001, MED HYPOTHESES, V57, P510, DOI 10.1054/mehy.2001.1380.
   Ge RS, 2007, REPROD TOXICOL, V23, P366, DOI 10.1016/j.reprotox.2006.12.006.
   Grace PB, 2003, ANAL BIOCHEM, V315, P114, DOI 10.1016/S0003-2697(02)00707-8.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hallmark N, 2007, ENVIRON HEALTH PERSP, V115, P390, DOI 10.1289/ehp.9490.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009.
   Hsieh Michael H, 2008, Curr Urol Rep, V9, P137, DOI 10.1007/s11934-008-0025-0.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Japanese Ministry of Health Labor and Welfare, 2010, POP SURV REP.
   Japanese Ministry of Health Labor and Welfare, 2006, NAT HLTH NUTR SURV J.
   Johnson KJ, 2011, TOXICOL SCI, V120, P460, DOI 10.1093/toxsci/kfr020.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863.
   Lambrot R, 2009, ENVIRON HEALTH PERSP, V117, P32, DOI 10.1289/ehp.11146.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Mivazaki T., 1998, REPORTS GRANTS HLTH.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Nagata C, 2006, CANCER CAUSE CONTROL, V17, P1107, DOI 10.1007/s10552-006-0044-4.
   NTP (National Toxicology Program), 2008, NIH PUBLICATION, V08-5976.
   Ogata M, 1991, BIOL MONITORING, P87.
   Romano-Riquera SP, 2007, PAEDIATR PERINAT EP, V21, P219, DOI 10.1111/j.1365-3016.2007.00810.x.
   Rowland IR, 2000, NUTR CANCER, V36, P27, DOI 10.1207/S15327914NC3601\_5.
   Salazar-Martinez Eduardo, 2004, Environ Health, V3, P8, DOI 10.1186/1476-069X-3-8.
   Santell RC, 1997, J NUTR, V127, P263.
   Sathyanarayana S, 2010, INT J ANDROL, V33, P317, DOI 10.1111/j.1365-2605.2009.01044.x.
   Scott HM, 2008, ENDOCRINOLOGY, V149, P5280, DOI 10.1210/en.2008-0413.
   Sharpe RM, 2002, HUM REPROD, V17, P1692, DOI 10.1093/humrep/17.7.1692.
   Sharpe RM, 2008, FERTIL STERIL, V89, P33, DOI DOI 10.1016/J.FERTNSTERT.2007.12.026.
   Sherrill JD, 2010, BIOL REPROD, V83, P488, DOI 10.1095/biolreprod.109.082685.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Suzuki Y, 2010, ENVIRON INT, V36, P699, DOI 10.1016/j.envint.2010.05.003.
   Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Thankamony A, 2009, ENVIRON HEALTH PERSP, V117, P1786, DOI 10.1289/ehp.0900881.
   Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241.
   Wisniewski AB, 2003, J UROLOGY, V169, P1582, DOI 10.1097/01.ju.0000046780.23389.e0.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{15}},
Journal-ISO = {{Int. J. Androl.}},
Doc-Delivery-Number = {{946IB}},
Wos-Id = {{ISI:000304343800004}},
}

@article{ ISI:000304343800005,
Author = {Soeborg, T. and Frederiksen, H. and Andersson, A. M.},
Title = {{Cumulative risk assessment of phthalate exposure of Danish children and
   adolescents using the hazard index approach}},
Journal = {{INTERNATIONAL JOURNAL OF ANDROLOGY}},
Year = {{2012}},
Volume = {{35}},
Number = {{3}},
Pages = {{245-252}},
Month = {{JUN}},
Abstract = {{Human risk assessment of chemicals is traditionally presented as the
   ratio between the actual level of exposure and an acceptable level of
   exposure, with the acceptable level of exposure most often being
   estimated by appropriate authorities. This approach is generally sound
   when assessing the risk of individual chemicals. However, several
   chemicals may concurrently target the same receptor, work through the
   same mechanism or in other ways induce the same effect(s) in the body.
   In these cases, cumulative risk assessment should be applied. The
   present study uses biomonitoring data from 129 Danish children and
   adolescents and resulting estimated daily intakes of four different
   phthalates. These daily intake estimates are used for a cumulative risk
   assessment with anti-androgenic effects as the endpoint using Tolerable
   Daily Intake (TDI) values determined by the European Food Safety
   Authorities (EFSA) or Reference Doses for Anti-Androgenicity (RfD AA)
   determined by Kortenkamp and Faust {[}Int J Androl 33 (2010) 463] as
   acceptable levels of exposure. United States Environmental Protection
   Agency Reference Doses (US EPA RfD) could not be used as none of them
   identifies anti-androgenic effects as the most sensitive endpoint for
   the phthalates included in this article. Using the EFSA TDI values, 12
   children exceeded the hazard quotient for the sum of di-n-butyl
   phthalate and di-iso-butyl phthalate (?DBP(i+n)) and one child exceeded
   the hazard quotient for di-(2-ethylhexyl)phthalate (DEHP). Nineteen
   children exceeded the cumulated hazard index for three phthalates. Using
   the RfD AA values, one child exceeded the hazard quotient for DEHP and
   the same child exceeded the cumulated hazard index for four phthalates.
   The EFSA TDI approach thus is more restrictive and identifies ?DBP(i+n)
   as the compound(s) associated with the greatest risk, while DEHP is the
   compound associated with the greatest risk when using the RfD AA
   approach.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Soeborg, T (Reprint Author), Copenhagen Univ Hosp, Rigshosp, Dept Growth \& Reprod, Sect 5064, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
   Soeborg, T.; Frederiksen, H.; Andersson, A. M., Copenhagen Univ Hosp, Rigshosp, Dept Growth \& Reprod, Sect 5064, DK-2100 Copenhagen, Denmark.}},
DOI = {{10.1111/j.1365-2605.2011.01240.x}},
ISSN = {{0105-6263}},
Keywords = {{endocrine disruptors; human exposure; reference doses for
   anti-androgenicity; tolerable daily intake}},
Keywords-Plus = {{DI-ISO-NONYLPHTHALATE; TESTOSTERONE PRODUCTION; SEXUAL-DIFFERENTIATION;
   URINARY-EXCRETION; MALE-RATS; METABOLITES; TOXICITY; FETAL; DEHP; HUMANS}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{tue.soeborg@rh.regionh.dk}},
ResearcherID-Numbers = {{Soeborg, Tue/E-6498-2011}},
ORCID-Numbers = {{Soeborg, Tue/0000-0001-7643-1833}},
Funding-Acknowledgement = {{European Union {[}212844]; Danish Ministry of Interior and Health;
   Research Center for Environmental Health {[}J. 7-302-02-9/7]; National
   Center on Endocrine Disruptors; Velux Fondene}},
Funding-Text = {{The authors thank Ole Nielsen, Department of Growth and Reproduction,
   Rigshospitalet, Copenhagen University Hospital, Denmark for skilled
   technical assistance and Susanne Hougaard, Danish Environmental
   Protection Agency for comments and suggestions to the manuscript. This
   study was supported by 212844 (DEER: Developmental effects of
   environment on reproductive health) from the European Union, Danish
   Ministry of Interior and Health, the Research Center for Environmental
   Health's fund (J. 7-302-02-9/7) and the National Center on Endocrine
   Disruptors. The instrumental equipment was financially supported by the
   Velux Fondene.}},
Cited-References = {{Anderson WAC, 2011, FOOD CHEM TOXICOL, V49, P2022, DOI 10.1016/j.fct.2011.05.013.
   Auharek SA, 2010, ENDOCRINOLOGY, V151, P2868, DOI 10.1210/en.2010-0108.
   Benson R, 2009, REGUL TOXICOL PHARM, V53, P90, DOI 10.1016/j.yrtph.2008.11.005.
   Boberg J, 2011, REPROD TOXICOL, V31, P200, DOI 10.1016/j.reprotox.2010.11.001.
   Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011.
   CARPENTER CP, 1953, AMA ARCH IND HYG OCC, V8, P219.
   Christiansen S, 2009, ENVIRON HEALTH PERSP, V117, P1839, DOI 10.1289/ehp.0900689.
   CLARK RL, 1990, TERATOLOGY, V42, P91, DOI 10.1002/tera.1420420111.
   EFSA, 2005, EFSA J, V243, P1.
   EFSA, 2005, EFSA J, V242, P1.
   EFSA, 2005, EFSA J, V245, P1.
   EFSA, 2005, EFSA J, V244, P1.
   Frederiksen H, 2010, J ANAL TOXICOL, V34, P1.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P48, DOI 10.1191/074823399678846646.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hannas BR, 2011, TOXICOL SCI, V123, P206, DOI 10.1093/toxsci/kfr146.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Hsieh Michael H, 2008, Curr Urol Rep, V9, P137, DOI 10.1007/s11934-008-0025-0.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Kortenkamp A, 2010, INT J ANDROL, V33, P463, DOI 10.1111/j.1365-2605.2009.01047.x.
   Kortenkamp A, 2009, STATE ART REPORT MIX.
   Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013.
   Lhuguenot JC, 2009, MOL NUTR FOOD RES, V53, P1063, DOI 10.1002/mnfr.200800076.
   Luccio-Camelo DC, 2011, J STEROID BIOCHEM, V127, P74, DOI 10.1016/j.jsbmb.2011.04.004.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   National Research Council, 2008, PHTH CUM RISK ASS TA.
   OECD, 2011, OECD GUID TEST CHEM.
   Orton F, 2011, ENVIRON HEALTH PERSP, V119, P794, DOI {[}10.1289/ehp.1002895, 10.1289/ehp.1002897].
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   SMITH CC, 1953, AMA ARCH IND HYG OCC, V7, P310.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Teuschler LK, 1995, TOXICOLOGY, V105, P137, DOI 10.1016/0300-483X(95)03207-V.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   US Environmental Protection Agency, 1993, BUT BENZ PHTH.
   US FDA, 2001, SAF ASS 2 ETH PHTHAL.
   Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{2}},
Journal-ISO = {{Int. J. Androl.}},
Doc-Delivery-Number = {{946IB}},
Wos-Id = {{ISI:000304343800005}},
}

@article{ ISI:000303113800003,
Author = {Hsu, N. -Y. and Lee, C. -C. and Wang, J. -Y. and Li, Y. -C. and Chang,
   H. -W. and Chen, C. -Y. and Bornehag, C. -G. and Wu, P. -C. and Sundell,
   J. and Su, H. -J.},
Title = {{Predicted risk of childhood allergy, asthma, and reported symptoms using
   measured phthalate exposure in dust and urine}},
Journal = {{INDOOR AIR}},
Year = {{2012}},
Volume = {{22}},
Number = {{3}},
Pages = {{186-199}},
Month = {{JUN}},
Abstract = {{The associated risk of phthalate exposure, both parent compounds in the
   home and their metabolites in urine, to childhood allergic and
   respiratory morbidity, after adjusting for exposures of indoor
   pollutants, especially bioaerosols, was comprehensively assessed. Levels
   of five phthalates in settled dust from the homes of 101 children (39
   years old) were measured, along with their corresponding urinary
   metabolites. Other environmental risk factors, including indoor CO2,
   PM2.5, formaldehyde, 1,3-beta-d-glucan, endotoxin, allergen and fungal
   levels, were concomitantly examined. Subjects health status was verified
   by pediatricians, and parents recorded observed daily symptoms of their
   children for the week that the home investigation visit took place.
   Significantly increased level of benzylbutyl phthalate, in settled dust,
   was associated with test case subjects (allergic or asthmatic children).
   Higher levels of dibutyl phthalate and its metabolites, mono-n-butyl
   phthalate, and mono-2-ethylhexyl phthalate were found to be the
   potential risk factors for the health outcomes of interest. Similarly,
   indoor fungal exposure remained a significant risk factor, especially
   for reported respiratory symptoms. The relative contribution from
   exposure to phthalates and indoor biocontaminants in childhood allergic
   and respiratory morbidity is, for the first time, quantitatively
   assessed and characterized. Practical Implications For asthmatic and
   allergic children living in subtropical and highly developed
   environments like homes in Taiwan, controlling environmental exposure of
   phthalates may be viewed as equally important as avoiding indoor
   microbial burdens, for the management of allergy-related diseases. It is
   also recognized that multidisciplinary efforts will be critical in
   realizing the true underlying mechanisms associated with these
   observations.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Su, HJ (Reprint Author), Natl Cheng Kung Univ, Coll Med, Dept Environm \& Occupat Hlth, 138 Sheng Li Rd, Tainan 70403, Taiwan.
   Hsu, N. -Y.; Lee, C. -C.; Li, Y. -C.; Chang, H. -W.; Chen, C. -Y.; Wu, P. -C.; Su, H. -J., Natl Cheng Kung Univ, Coll Med, Dept Environm \& Occupat Hlth, Tainan 70403, Taiwan.
   Wang, J. -Y., Natl Cheng Kung Univ, Coll Med, Dept Pediat, Tainan 70403, Taiwan.
   Bornehag, C. -G., Karlstad Univ, Karlstad, Sweden.
   Wu, P. -C., Chang Jung Christian Univ, Dept Occupat Safety \& Hlth, Tainan, Taiwan.
   Sundell, J., Tech Univ Denmark, Int Ctr Indoor Environm \& Energy, DK-2800 Lyngby, Denmark.}},
DOI = {{10.1111/j.1600-0668.2011.00753.x}},
ISSN = {{0905-6947}},
Keywords = {{Phthalates; Benzylbutyl phthalate; Children; Asthma; Allergy; Fungi}},
Keywords-Plus = {{ENVIRONMENTAL ENDOTOXIN MEASUREMENT; IN-HOUSE DUST; SOUTHERN TAIWAN;
   YOUNG-CHILDREN; LIMULUS ASSAY; IGE LEVELS; PHASE-III; ASSOCIATION;
   PREVALENCE; HEALTH}},
Research-Areas = {{Construction \& Building Technology; Engineering}},
Web-of-Science-Categories  = {{Construction \& Building Technology; Engineering, Environmental}},
Author-Email = {{hjsu@mail.ncku.edu.tw}},
Funding-Acknowledgement = {{Taiwan National Science Council {[}NSC 96-2621-Z-006-015, NSC
   97-2621-M-006-002]}},
Funding-Text = {{The authors are in great debt to all participants, and the entire team
   of field and laboratory technicians for their most dedicated and
   professional contributions, including Chien-Cheng Jung, Ya-Huei Chang,
   Che-Wei Hsu, Pei-Yu Chen, Hsiu-Hao Liang, Chian-Chiau Lin and Fang-Jin
   Lee. Our utmost appreciations go to Dr. Chih-Ching Chang for his most
   valuable contributions in rectifying the study design and data analysis.
   Dr. Chao-Yu Guo and Ms. Mu-Jean Chen assisted with the statistical
   examination. This study was supported by Taiwan National Science Council
   (NSC 96-2621-Z-006-015 and NSC 97-2621-M-006-002). The authors declare
   they have no conflicting financial interests.}},
Cited-References = {{Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x.
   Bornehag CG, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00306.x.
   Bornehag CG, 2004, INDOOR AIR, V14, P59, DOI 10.1111/j.1600-0668.2004.00274.x.
   Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805.
   Butala JH, 2004, TOXICOLOGY, V201, P77, DOI 10.1016/j.tox.2004.04.004.
   CDC, 2009, 4 CDC CDCP.
   Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004.
   Chen YL, 2005, CLIN EXP ALLERGY, V35, P926, DOI 10.1111/j.1365-2222.2005.02278.x.
   Chou Tzn-Yu, 2002, Acta Paediatrica Taiwanica, V43, P35.
   Chou YY, 2009, J PEDIATR ENDOCR MET, V22, P69.
   Dearman RJ, 2009, J APPL TOXICOL, V29, P118, DOI 10.1002/jat.1388.
   Dodig S, 2011, CLIN CHEM LAB MED, V49, P587, DOI 10.1515/CCLM.2011.094.
   Douwes J, 2000, AM J RESP CRIT CARE, V162, P1348.
   EFSA, 2005, EFSA J, V243, P1.
   Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002.
   Holme J, 2010, INDOOR AIR, V20, P329, DOI 10.1111/j.1600-0668.2010.00658.x.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Hsu NY, 2010, INDOOR AIR, V20, P392, DOI 10.1111/j.1600-0668.2010.00663.x.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Imai Y, 2006, CLIN EXP ALLERGY, V36, P1462, DOI 10.1111/j.1365-2222.2006.02574.x.
   Jaakkola JJK, 2008, ENVIRON HEALTH PERSP, V116, P845, DOI 10.1289/ehp.10846.
   Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797.
   Kimber I, 2010, TOXICOLOGY, V271, P73, DOI 10.1016/j.tox.2010.03.020.
   Kobayashi T, 2009, J IMMUNOL, V182, P2502, DOI 10.4049/jimmunol.0802773.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Kolarik B, 2008, ATMOS ENVIRON, V42, P8553, DOI 10.1016/j.atmosenv.2008.08.028.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   Larsen ST, 2003, FOOD CHEM TOXICOL, V41, P439, DOI 10.1016/S0278-6915(02)00248-X.
   Larsson M, 2010, INDOOR AIR, V20, P494, DOI 10.1111/j.1600-0668.2010.00671.x.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Lee YL, 2007, PEDIATR ALLERGY IMMU, V18, P188, DOI 10.1111/j.1399-3038.2006.00504.x.
   Liao PF, 2009, PEDIATR NEONATOL, V50, P18, DOI 10.1016/S1875-9572(09)60025-5.
   London SJ, 2009, ANNU REV PUBL HEALTH, V30, P55, DOI 10.1146/annurev.publhealth.031308.100151.
   Malo JL, 2009, J ALLERGY CLIN IMMUN, V123, P545, DOI 10.1016/j.jaci.2008.09.010.
   Matsuda T, 2010, FOOD CHEM TOXICOL, V48, P1704, DOI 10.1016/j.fct.2010.03.049.
   McGwin G, 2010, ENVIRON HEALTH PERSP, V118, P313, DOI 10.1289/ehp.0901143.
   Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x.
   MILTON DK, 1992, ENVIRON RES, V57, P212, DOI 10.1016/S0013-9351(05)80081-7.
   Milton DK, 1997, AM IND HYG ASSOC J, V58, P861, DOI 10.1202/0002-8894(1997)058<0861:EEMIAS>2.0.CO;2.
   Murphy K., 2008, JANEWAYS IMMUNOBIOLO, P585.
   Oie L, 1999, EPIDEMIOLOGY, V10, P294, DOI 10.1097/00001648-199905000-00018.
   Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169.
   PEARCE N, 1993, EUR RESPIR J, V6, P1455.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Shigeno T, 2009, IMMUNOLOGY, V128, pe849, DOI 10.1111/j.1365-2567.2009.03094.x.
   Shyur SD, 2010, PEDIAT ALLERG IMM-UK, V21, P623, DOI 10.1111/j.1399-3038.2009.00956.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Su HJ, 2001, ENVIRON RES, V85, P135, DOI 10.1006/enrs.2000.4113.
   Su HJJ, 2005, MEDIAT INFLAMM, P167, DOI 10.1155/MI.2005.167.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Tsuang HA, 2003, PAEDIATR PERINAT EP, V17, P3, DOI 10.1046/j.1365-3016.2003.00466.x.
   Vetrano AM, 2010, PEDIATR RES, V68, P134, DOI 10.1203/00006450-201011001-00260.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Zeldin DC, 2006, ENVIRON HEALTH PERSP, V114, P620, DOI 10.1289/ehp.8379.}},
Number-of-Cited-References = {{62}},
Times-Cited = {{8}},
Journal-ISO = {{Indoor Air}},
Doc-Delivery-Number = {{930CL}},
Wos-Id = {{ISI:000303113800003}},
}

@article{ ISI:000305308700025,
Author = {Mendiola, Jaime and Meeker, John D. and Jorgensen, Niels and Andersson,
   Anna-Maria and Liu, Fan and Calafat, Antonia M. and Redmon, J. Bruce and
   Drobnis, Erma Z. and Sparks, Amy E. and Wang, Christina and Hauser, Russ
   and Swan, Shanna H.},
Title = {{Urinary Concentrations of Di(2-ethylhexyl) Phthalate Metabolites and
   Serum Reproductive Hormones: Pooled Analysis of Fertile and Infertile
   Men}},
Journal = {{JOURNAL OF ANDROLOGY}},
Year = {{2012}},
Volume = {{33}},
Number = {{3}},
Pages = {{488-498}},
Month = {{MAY-JUN}},
Abstract = {{Urinary concentrations of metabolites of the anti-androgenic xenobiotic
   di-(2-ethylhexyl) phthalate (DEHP) were previously shown to be weakly
   associated with serum levels of several hormones in 2 disparate US
   populations: partners of pregnant women participating in the Study for
   Future Families and partners in infertile couples from Massachusetts
   General Hospital infertility clinic. The observed associations between
   phthalate metabolites and reproductive hormones were robust and
   insensitive to the characteristics of the subpopulation or the
   laboratory in which the hormones were measured, despite the fact that
   these 2 populations span a range of fertility, urinary phthalate
   metabolites, and reproductive hormone levels. We therefore examined
   associations between urinary metabolites of DEHP and reproductive
   hormones follicle-stimulating hormone, luteinizing hormone, testosterone
   (T), inhibin B, and estradiol (E-2) and sex hormone binding globulin
   (SHBG) in the pooled population. The magnitude of the associations seen
   were similar to those reported for each population separately, but
   effect estimates were more precise because of the increased sample size
   and the greater range of phthalate metabolite concentrations and hormone
   levels. Urinary concentrations of 3 metabolites of DEHP
   {[}mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-hydroxyhexyl)
   phthalate (MEHHP), and mono(2-ethyl-5-oxohexyl) phthalate (MEOHP)] were
   inversely associated with the free androgen index (FAI = T/SHBG) and
   calculated free testosterone. Urinary concentrations of MEHHP and MEOHP
   were positively associated with SHBG, and MEHP was inversely associated
   with E2. No other phthalate metabolites were associated with serum
   hormones, consistent with results in each population. Our results in
   this diverse population suggest that DEHP exposure is robustly
   associated with some male sex steroid hormones.}},
Publisher = {{AMER SOC ANDROLOGY, INC}},
Address = {{C/O ALLEN PRESS, INC PO BOX 368, LAWRENCE, KS 66044 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Swan, SH (Reprint Author), Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, 601 Elmwood Ave,Box 668, Rochester, NY 14642 USA.
   Mendiola, Jaime; Liu, Fan; Hauser, Russ; Swan, Shanna H., Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, Rochester, NY 14642 USA.
   Meeker, John D., Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   Jorgensen, Niels; Andersson, Anna-Maria, Univ Copenhagen, Rigshosp, Univ Dept Growth \& Reprod, DK-2100 Copenhagen, Denmark.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Redmon, J. Bruce, Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.
   Redmon, J. Bruce, Univ Minnesota, Sch Med, Dept Urol Surg, Minneapolis, MN 55455 USA.
   Drobnis, Erma Z., Univ Missouri, Sch Med, Dept Obstet Gynecol \& Womens Hlth, Columbia, MO USA.
   Sparks, Amy E., Univ Iowa, Dept Obstet \& Gynecol, Iowa City, IA 52242 USA.
   Wang, Christina, Harbor UCLA Med Ctr, Dept Med, Div Endocrinol, Torrance, CA 90509 USA.
   Wang, Christina, Los Angeles Biomed Res Inst, Torrance, CA USA.
   Hauser, Russ, Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv, Androl Lab, Vitro Fertilizat Unit, Boston, MA 02114 USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Swan, Shanna H., Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA.}},
DOI = {{10.2164/jandrol.111.013557}},
ISSN = {{0196-3635}},
Keywords = {{Anti-androgens; DEHP metabolites; endocrine disruptor; male hormones}},
Keywords-Plus = {{FOLLICLE-STIMULATING-HORMONE; RAT GRANULOSA-CELLS; MONO-(2-ETHYLHEXYL)
   PHTHALATE; NEONATAL-RATS; SEMEN QUALITY; YOUNG MEN; DIETHYLHEXYL
   PHTHALATE; SEXUAL-DIFFERENTIATION; TEMPORAL VARIABILITY; ESTRADIOL
   PRODUCTION}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{shanna\_swan@urmc.rochester.edu}},
ResearcherID-Numbers = {{Jorgensen, Niels/A-8148-2012}},
Funding-Acknowledgement = {{Danish Agency for Science, Technology, and Innovation {[}271070678];
   University of Iowa Center for Health Effects of Environmental
   Contamination cooperative project grant; General Clinical Research
   Center at Harbor UCLA Medical Center {[}MO1 RR00425]; NIEHS {[}ES009718]}},
Funding-Text = {{This study is supported by The Danish Agency for Science, Technology,
   and Innovation, grant 271070678 to N.J.; a University of Iowa Center for
   Health Effects of Environmental Contamination cooperative project grant
   to A.E.S.; the General Clinical Research Center at Harbor UCLA Medical
   Center (MO1 RR00425); and NIEHS grant ES009718 to R.H.}},
Cited-References = {{Agency for Toxic Substances and Disease Registry, 2002, TOX PROF DI2ETHYLHEX.
   Andersson AM, 2007, J CLIN ENDOCR METAB, V92, P4696, DOI 10.1210/jc.2006-2633.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Asklund C, 2007, HUM REPROD, V22, P2639, DOI 10.1093/humrep/dem217.
   Bang AK, 2005, HUM REPROD, V20, P3109, DOI 10.1093/humrep/dei170.
   Bjornerem A, 2006, J CLIN ENDOCR METAB, V91, P3798, DOI 10.1210/jc.2006-0866.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   BOX GEP, 1962, TECHNOMETRICS, V4, P531, DOI 10.2307/1266288.
   CARLSEN E, 1992, BRIT MED J, V305, P609.
   Centers for Disease Control and Prevention (CDC), 2011, 4 CDCP NAT CTR ENV H.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   HEINDEL JJ, 1989, FUND APPL TOXICOL, V12, P508, DOI 10.1016/0272-0590(89)90024-9.
   Higuchi TT, 2003, TOXICOL SCI, V72, P301, DOI 10.1093/toxsci/kfg036.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P48.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Jorgensen N, 2010, INT J ANDROL, V33, P298, DOI 10.1111/j.1365-2605.2009.01050.x.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Mendiola J, 2011, INT J ANDROL, V34, P369, DOI 10.1111/j.1365-2605.2010.01095.x.
   National Research Council, 1999, HORM ACT AG ENV.
   Noda M, 2007, MOL CELL ENDOCRINOL, V274, P8, DOI 10.1016/j.mce.2007.05.004.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PARMAR D, 1986, TOXICOLOGY, V42, P47, DOI 10.1016/0300-483X(86)90091-0.
   Pentikainen V, 2000, J CLIN ENDOCR METAB, V85, P2057, DOI 10.1210/jc.85.5.2057.
   Pitteloud N, 2008, J CLIN ENDOCR METAB, V93, P2686, DOI 10.1210/jc.2007-2548.
   Rosner W, 2007, J CLIN ENDOCR METAB, V92, P405, DOI 10.1210/jc.2006-1864.
   Sharpe RM, 2008, FERTIL STERIL, V89, P33, DOI DOI 10.1016/J.FERTNSTERT.2007.12.026.
   Sikaris K, 2005, J CLIN ENDOCR METAB, V90, P5928, DOI 10.1210/jc.2005-0962.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   SRIVASTAVA SP, 1990, ARCH TOXICOL, V64, P148, DOI 10.1007/BF01974401.
   Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P414, DOI 10.1289/ehp.5927.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228, DOI 10.1289/ehp.971051228.
   Taieb J, 2003, CLIN CHEM, V49, P1381, DOI 10.1373/49.8.1381.
   Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Thompson RC, 2009, PHILOS T R SOC B, V364, P2153, DOI 10.1098/rstb.2009.0053.
   Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375.
   Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666.
   Wang C, 2004, J CLIN ENDOCR METAB, V89, P534, DOI 10.1210/jc.2003-031287.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{5}},
Journal-ISO = {{J. Androl.}},
Doc-Delivery-Number = {{959JM}},
Wos-Id = {{ISI:000305308700025}},
}

@article{ ISI:000303546000040,
Author = {Braun, Joe M. and Smith, Kristen W. and Williams, Paige L. and Calafat,
   Antonia M. and Berry, Katharine and Ehrlich, Shelley and Hauser, Russ},
Title = {{Variability of Urinary Phthalate Metabolite and Bisphenol A
   Concentrations before and during Pregnancy}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2012}},
Volume = {{120}},
Number = {{5}},
Pages = {{739-745}},
Month = {{MAY}},
Abstract = {{BACKGROUND: Gestational phthalate and bisphenol A (BPA) exposure may
   increase the risk of adverse maternal/child health outcomes, but there
   are few data on the variability of urinary biomarkers before and during
   pregnancy.
   OBJECTIVE: We characterized the variability of urinary phthalate
   metabolite and BPA concentrations before and during pregnancy and the
   ability of a single spot urine sample to classify average gestational
   exposure.
   METHODS: We collected 1,001 urine samples before and during pregnancy
   from 137 women who were partners in couples attending a Boston fertility
   clinic and who had a live birth. Women provided spot urine samples
   before (n >= 2) and during (n >= 2) pregnancy. We measured urinary
   concentrations of monoethyl phthalate (MEP), mono-n-butyl phthalate
   (MBP), mono-iso-butyl phthalate, monobenzyl phthalate (MBzP), four
   metabolites of di-(2-ethylhexyl) phthalate (DEHP), and BPA. After
   adjusting for specific gravity, we characterized biomarker variability
   using intraclass correlation coefficients (ICCs) and conducted several
   surrogate category analyses to determine whether a single spot urine
   sample could adequately classify average gestational exposure.
   RESULTS: Absolute concentrations of phthalate metabolites and BPA were
   similar before and during pregnancy. Variability was higher during
   pregnancy than before pregnancy for BPA and MBzP, but similar during and
   before pregnancy for MBP, MEP, and Sigma DEHP. During pregnancy, MEP
   (ICC = 0.50) and MBP (ICC = 0.45) were less variable than BPA (ICC =
   0.12), MBzP (ICC = 0.25), and Sigma DEHP metabolites (ICC = 0.08).
   Surrogate analyses suggested that a single spot urine sample may
   reasonably classify MEP and MBP concentrations during pregnancy, but
   more than one sample may be necessary for MBzP, DEHP, and BPA.
   CONCLUSIONS: Urinary phthalate metabolites and BPA concentrations were
   variable before and during pregnancy, but the magnitude of variability
   was biomarker specific. A single spot urine sample adequately classified
   MBP and MEP concentrations during pregnancy. The present results may be
   related to unique features of the women studied, and replication in
   other pregnancy cohorts is recommended.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hauser, R (Reprint Author), 665 Huntington Ave,Bldg 1,14th Floor, Boston, MA 02115 USA.
   Braun, Joe M.; Smith, Kristen W.; Berry, Katharine; Ehrlich, Shelley; Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Williams, Paige L., Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Berry, Katharine, Brigham \& Womens Hosp, Div Reprod Med, Dept Obstet Gynecol \& Reprod Biol, Boston, MA 02115 USA.}},
DOI = {{10.1289/ehp.1104139}},
ISSN = {{0091-6765}},
Keywords = {{bisphenol A; endocrine disruptors; epidemiology; phthalates; pregnancy;
   variability}},
Keywords-Plus = {{CARE PRODUCT USE; TEMPORAL VARIABILITY; US POPULATION; EXPOSURE; WOMEN;
   MEN; PREDICTORS; TOXICITY; PHENOLS; SAMPLES}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{rhauser@hohp.harvard.edu}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences {[}T32 ES007069, R01
   ES009718, P30 ES000002]; Leaves of Grass Fund}},
Funding-Text = {{This work was supported by grants T32 ES007069, R01 ES009718, and P30
   ES000002 from the National Institute of Environmental Health Sciences,
   and by the Leaves of Grass Fund.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Baird DD, 2010, J EXPO SCI ENV EPID, V20, P169, DOI 10.1038/jes.2009.17.
   Biedermann S, 2010, ANAL BIOANAL CHEM, V398, P571, DOI 10.1007/s00216-010-3936-9.
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2.
   Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979.
   Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366.
   Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753.
   Chapin RE, 2008, BIRTH DEFECTS RES B, V83, P157, DOI 10.1002/bdrb.20147.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Ge RS, 2007, REPROD TOXICOL, V23, P366, DOI 10.1016/j.reprotox.2006.12.006.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Irvin EA, 2010, CHEMOSPHERE, V80, P1301, DOI 10.1016/j.chemosphere.2010.06.048.
   Jackson W, 1985, U.S. Patent, Patent No. {[}4507256, 4,507,256].
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Liao CY, 2011, ENVIRON SCI TECHNOL, V45, P6761, DOI 10.1021/es200977t.
   Lopez-Cervantes J, 2003, FOOD ADDIT CONTAM, V20, P596, DOI 10.1080/0265203031000109495.
   Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605.
   Meeker JD, 2005, J EXPO ANAL ENV EPID, V15, P271, DOI 10.1038/sj.jea.7500402.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Miodovnik A, 2011, NEUROTOXICOLOGY, V32, P261, DOI 10.1016/j.neuro.2010.12.009.
   NRC (National Research Council), 2008, PHTHAL CUM RISK ASS.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Petersen JH, 2010, FOOD ADDIT CONTAM A, V27, P1608, DOI 10.1080/19440049.2010.501825.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Romero-Franco M, 2011, ENVIRON INT, V37, P867, DOI 10.1016/j.envint.2011.02.014.
   Rosner B, 2000, FUNDAMENTALS BIOSTAT.
   Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P914, DOI 10.1289/ehp.1003170.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   von Goetz N, 2010, RISK ANAL, V30, P473, DOI 10.1111/j.1539-6924.2009.01345.x.
   Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727.
   Ye XY, 2011, ENVIRON HEALTH PERSP, V119, P983, DOI 10.1289/ehp.1002701.
   Ye XY, 2008, ANAL CHIM ACTA, V622, P150, DOI 10.1016/j.aca.2008.05.068.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{14}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{935UF}},
Wos-Id = {{ISI:000303546000040}},
}

@article{ ISI:000303973700002,
Author = {Kobrosly, Roni W. and Parlett, Lauren E. and Stahlhut, Richard W. and
   Barrett, Emily S. and Swan, Shanna H.},
Title = {{Socioeconomic factors and phthalate metabolite concentrations among
   United States women of reproductive age}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2012}},
Volume = {{115}},
Pages = {{11-17}},
Month = {{MAY}},
Abstract = {{Introduction: Relatively little is known about the socioeconomic
   correlates of phthalate metabolite urine concentrations among the
   general population, exposures of increasing public health concern,
   particularly for women of reproductive age. Methods: We pooled data from
   the 2001-2008 cycles of the National Health and Nutrition Examination
   Survey to examine the associations between phthalate metabolite
   concentrations (including the molar sum of four di-2-ethylhexyl
   phthalate (DEHP) metabolites, the molar sum of two dibutyl phthalate
   (DBP) metabolites, and metabolites of benzylbutyl phthalate (BzBP) and
   diethyl phthalate (DEP)) with socioeconomic indicators (including
   ethnicity, education, income, and food security status) among women 20
   to 39 years age. We also derived a socioeconomic status summary measure
   using factor analysis and investigated its associations with metabolite
   concentrations. Results: In fully adjusted models, the lowest quartile
   of overall socioeconomic status was associated with 1.83 (95\%
   CI=1.54-2.17) times the concentrations of mono-benzyl phthalate (MBzP),
   and 0.72 (95\% CI=0.54-0.98) times the concentrations of (molar sum)
   DEHP metabolites compared with the highest quartile of overall
   socioeconomic status. This latter association was driven primarily by
   educational attainment. All Non-White ethnicities combined had 1.24
   (95\% CI=1.09-1.40) times the concentrations of (molar sum) DBP
   metabolites, 1.32 (95\% CI=1.12-1.56) times the mono-ethyl phthalate
   (MEP) concentrations, and 0.82 (95\% CI=0.71-0.96) the concentrations of
   MBzP of Non-Hispanic Whites. Conclusions: Biomarkers of phthalate
   exposure vary with socioeconomic factors in women of reproductive age in
   the United States. Given the public health concern surrounding phthalate
   exposure, more research is needed to elucidate the reasons for these
   differences. (C) 2012 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kobrosly, RW (Reprint Author), Univ Rochester, Sch Med \& Dent, Dept Community \& Prevent Med, Med Ctr, 601 Elmwood Ave,Box 644, Rochester, NY 14642 USA.
   Kobrosly, Roni W., Univ Rochester, Sch Med \& Dent, Dept Community \& Prevent Med, Med Ctr, Rochester, NY 14642 USA.
   Kobrosly, Roni W.; Parlett, Lauren E.; Stahlhut, Richard W.; Barrett, Emily S.; Swan, Shanna H., Univ Rochester, Ctr Reprod Epidemiol, Med Ctr, Rochester, NY 14642 USA.
   Swan, Shanna H., Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA.}},
DOI = {{10.1016/j.envres.2012.03.008}},
ISSN = {{0013-9351}},
Keywords = {{Phthalates; Environmental Epidemiology; Biomarkers; Population health;
   National Health and Nutrition Examination Survey (NHANES)}},
Keywords-Plus = {{LIFE-STYLE FACTORS; US POPULATION; QUANTITATIVE DETECTION; URINARY
   METABOLITES; HUMAN EXPOSURE; FOOD; HEALTH; PREGNANCY; OUTCOMES;
   PLASTICIZERS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{Roni\_Kobrosly@URMC.Rochester.edu}},
ResearcherID-Numbers = {{Parlett, Lauren/I-3309-2013}},
ORCID-Numbers = {{Parlett, Lauren/0000-0003-1240-4566}},
Cited-References = {{Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   Anderson WAC, 2011, FOOD CHEM TOXICOL, V49, P2022, DOI 10.1016/j.fct.2011.05.013.
   Aylward L.L, 2010, URINARY DEHP METABOL.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   CDC. Centers for Disease Control and Prevention, 2011, NHANES NAT HLTH NUTR.
   Centers for Disease Control and Prevention, 2009, CONT NHANES WEB TUT.
   Centers for Disease Control and Prevention, 2009, NAT HLTH NUTR EX SUR.
   Cesaroni G, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-41.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P125.
   Cobaugh DJ, 2008, AM J HEALTH-SYST PH, V65, P2137, DOI 10.2146/ajhp080062.
   Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712.
   Cullen K, 2007, J AM DIET ASSOC, V107, P1747, DOI 10.1016/j.jada.2007.07.007.
   Deshmukh-Taskar P, 2007, J AM DIET ASSOC, V107, P223, DOI {[}10.1016/j.jada.2006.11.004, 10.1016/j.jada.20.06.11.004].
   Dickson-Spillmann M, 2009, RISK ANAL, V29, P1170, DOI 10.1111/j.1539-6924.2009.01233.x.
   Diez-Roux A V, 2001, Ann Epidemiol, V11, P395, DOI 10.1016/S1047-2797(01)00221-6.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hines CJ, 2009, ANN OCCUP HYG, V53, P1, DOI 10.1093/annhyg/men066.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   JACKSON S, 1966, HEALTH PHYS, V12, P843, DOI 10.1097/00004032-196606000-00014.
   Kaplan D, 2004, SAGE HDB QUANTITATIV.
   Kim J., 1978, FACTOR ANAL STAT MET.
   Kim J.O., 1978, INTRO FACTOR ANAL WH.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P3, DOI 10.2307/3429377.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koniecki D, 2011, ENVIRON RES, V111, P329, DOI 10.1016/j.envres.2011.01.013.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   Kwapniewski R, 2008, J OCCUP ENVIRON MED, V50, P705, DOI 10.1097/JOM.0b013e3181651571.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lumley T., 2004, J STAT SOFTW, V9, p{[}1, 41].
   Lumley Thomas, 2010, SURVEY ANAL COMPLEX, P23.
   Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268.
   Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522.
   Morland K, 2007, PUBLIC HEALTH NUTR, V10, P1481, DOI 10.1017/S1368980007000079.
   Mose T, 2007, INT J TOXICOL, V26, P221, DOI 10.1080/1091581070135721.
   Northstone K, 2008, EUR J CLIN NUTR, V62, P471, DOI 10.1038/sj.ejcn.1602741.
   NRC. National Research Council (U.S.). Committee on the Health Risks of Phthalates. National Academies Press (U.S.), 2008, PHTHAL CUM RISK ASS.
   Ormond G, 2009, ENVIRON HEALTH PERSP, V117, P303, DOI 10.1289/ehp.11933.
   PAGE BD, 1995, FOOD ADDIT CONTAM, V12, P129.
   Rao CR, 2008, EPIDEMIOLOGY MED STA.
   Robinson SM, 2004, EUR J CLIN NUTR, V58, P1174, DOI 10.1038/sj.ejcn.1601946.
   Rudel R.A, 2011, ENV HLTH PERSPECT.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Thomson G. H., 1951, FACTORIAL ANAL HUMAN.
   USDA. United States Department of Agriculture, 2004, EC RES REP, V11.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Yoo S, 2006, PUBLIC HEALTH NUTR, V9, P384, DOI 10.1079/PHN2006864.
   Zhang YH, 2009, J PEDIATR, V155, P500, DOI 10.1016/j.jpeds.2009.04.007.}},
Number-of-Cited-References = {{56}},
Times-Cited = {{0}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{941OY}},
Wos-Id = {{ISI:000303973700002}},
}

@article{ ISI:000303088300007,
Author = {Langlois, Eric and LeBlanc, Alain and Simard, Yves and Thellen, Claude},
Title = {{Accuracy Investigation of Phthalate Metabolite Standards}},
Journal = {{JOURNAL OF ANALYTICAL TOXICOLOGY}},
Year = {{2012}},
Volume = {{36}},
Number = {{4}},
Pages = {{270-279}},
Month = {{MAY}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Langlois, E (Reprint Author), INSPQ, CTQ, Quebec City, PQ G1V 5B3, Canada.
   Langlois, Eric; LeBlanc, Alain; Simard, Yves; Thellen, Claude, INSPQ, CTQ, Quebec City, PQ G1V 5B3, Canada.}},
DOI = {{10.1093/jat/bks016}},
ISSN = {{0146-4760}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; NUTRITION EXAMINATION SURVEY; HUMAN EXPOSURE
   ASSESSMENT; ISO-NONYLPHTHALATE DINP; HUMAN URINE; QUANTITATIVE
   DETECTION; DI(2-ETHYLHEXYL)PHTHALATE DEHP; WAIST CIRCUMFERENCE;
   NATIONAL-HEALTH; BIOMARKERS}},
Research-Areas = {{Chemistry; Toxicology}},
Web-of-Science-Categories  = {{Chemistry, Analytical; Toxicology}},
Author-Email = {{eric.langlois@inspq.qc.ca}},
Funding-Acknowledgement = {{Centre de Toxicologie du Quebec (Institut National de Sante Publique du
   Quebec)}},
Funding-Text = {{This research was supported by internal funds from the Centre de
   Toxicologie du Quebec (Institut National de Sante Publique du Quebec)}},
Cited-References = {{Baird DD, 2010, J EXPO SCI ENV EPID, V20, P169, DOI 10.1038/jes.2009.17.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Calafat AM, 2011, ENVIRON HEALTH PERSP, V119, P50, DOI 10.1289/ehp.1002316.
   Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   Frederiksen H, 2010, J ANAL TOXICOL, V34, P400.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Martens E., 2002, ACTA CLIN BELG     S, V1, P16.
   National Center for Environmental Health Division of Laboratory Sciences. Centers for Disease Control and Prevention, 2009, 4 NAT CTR ENV HLTH D, P258.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Samandar E, 2009, ENVIRON RES, V109, P641, DOI 10.1016/j.envres.2009.02.004.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Silva M.J., 2008, J CHROMATOGR B, V873, P189.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Silva MJ, 2007, ENVIRON SCI TECHNOL, V41, P7576, DOI 10.1021/es071142x.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Weuve J, 2010, ENVIRON HEALTH PERSP, V118, P825, DOI 10.1289/ehp.0901543.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Ye XB, 2009, INT J HYG ENVIR HEAL, V212, P481, DOI 10.1016/j.ijheh.2009.03.004.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{0}},
Journal-ISO = {{J. Anal. Toxicol.}},
Doc-Delivery-Number = {{929TJ}},
Wos-Id = {{ISI:000303088300007}},
}

@article{ ISI:000313336300001,
Author = {Mortamais, Marion and Chevrier, Cecile and Philippat, Claire and Petit,
   Claire and Calafat, Antonia M. and Ye, Xiaoyun and Silva, Manori J. and
   Brambilla, Christian and Eijkemans, Marinus J. C. and Charles,
   Marie-Aline and Cordier, Sylvaine and Slama, Remy},
Title = {{Correcting for the influence of sampling conditions on biomarkers of
   exposure to phenols and phthalates: a 2-step standardization method
   based on regression residuals}},
Journal = {{ENVIRONMENTAL HEALTH}},
Year = {{2012}},
Volume = {{11}},
Month = {{APR 26}},
Abstract = {{Background: Environmental epidemiology and biomonitoring studies
   typically rely on biological samples to assay the concentration of
   non-persistent exposure biomarkers. Between-participant variations in
   sampling conditions of these biological samples constitute a potential
   source of exposure misclassification. Few studies attempted to correct
   biomarker levels for this error. We aimed to assess the influence of
   sampling conditions on concentrations of urinary biomarkers of select
   phenols and phthalates, two widely-produced families of chemicals, and
   to standardize biomarker concentrations on sampling conditions.
   Methods: Urine samples were collected between 2002 and 2006 among 287
   pregnant women from Eden and Pelagie cohorts, from which phthalates and
   phenols metabolites levels were assayed. We applied a 2-step
   standardization method based on regression residuals. First, the
   influence of sampling conditions (including sampling hour, duration of
   storage before freezing) and of creatinine levels on biomarker
   concentrations were characterized using adjusted linear regression
   models. In the second step, the model estimates were used to remove the
   variability in biomarker concentrations due to sampling conditions and
   to standardize concentrations as if all samples had been collected under
   the same conditions (e. g., same hour of urine collection).
   Results: Sampling hour was associated with concentrations of several
   exposure biomarkers. After standardization for sampling conditions,
   median concentrations differed by - 38 \% for 2,5-dichlorophenol to +80
   \% for a metabolite of diisodecyl phthalate. However, at the individual
   level, standardized biomarker levels were strongly correlated
   (correlation coefficients above 0.80) with unstandardized measures.
   Conclusions: Sampling conditions, such as sampling hour, should be
   systematically collected in biomarker-based studies, in particular when
   the biomarker half-life is short. The 2-step standardization method
   based on regression residuals that we proposed in order to limit the
   impact of heterogeneity in sampling conditions could be further tested
   in studies describing levels of biomarkers or their influence on health.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Slama, R (Reprint Author), INSERM, Team Environm Epidemiol Appl Reprod \& Resp Hlth, Inst Albert Bonniot, U823, Grenoble, France.
   Mortamais, Marion; Philippat, Claire; Slama, Remy, INSERM, Team Environm Epidemiol Appl Reprod \& Resp Hlth, Inst Albert Bonniot, U823, Grenoble, France.
   Mortamais, Marion, INSERM, U1061, Montpellier, France.
   Chevrier, Cecile; Petit, Claire; Cordier, Sylvaine, INSERM, U625, Rennes, France.
   Philippat, Claire; Brambilla, Christian; Slama, Remy, Grenoble Univ, Inst Albert Bonniot, U823, Grenoble, France.
   Calafat, Antonia M.; Ye, Xiaoyun; Silva, Manori J., Ctr Dis Control \& Prevent, Atlanta, GA USA.
   Eijkemans, Marinus J. C., UMC, Julius Ctr Hlth Sci \& Primary Care, Utrecht, Netherlands.
   Charles, Marie-Aline, Inserm \& INED Joint Res Grp, Paris, France.
   Charles, Marie-Aline, INSERM, CESP, U1018, Villejuif, France.}},
DOI = {{10.1186/1476-069X-11-29}},
Article-Number = {{29}},
ISSN = {{1476-069X}},
Keywords = {{Biomarker; Endocrine Disruptor; Phenols; Phthalate esters; Pregnancy;
   Sampling conditions}},
Keywords-Plus = {{BISPHENOL-A; URINARY CONCENTRATIONS; PREGNANT-WOMEN; DIETHYL PHTHALATE;
   MEASUREMENT ERROR; US POPULATION; METABOLITES; VARIABILITY; SERUM;
   OUTCOMES}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{remy.slama@ujf-grenoble.fr}},
Funding-Acknowledgement = {{French Agency for Environmental and Occupational Health Safety (ANSES);
   Foundation for medical research (FRM); Eden cohort is funded by the
   Foundation for medical research (FRM), Inserm; IReSP; Nestle; French
   Ministry of health; National Research Agency (ANR); Univ. Paris-Sud;
   Institute of health monitoring (InVS); AFSSET; MGEN; AFSSA (ANSES);
   ANSES; Ministry of Health, Ministry of Labor; ANR; InVS; Inserm;
   Regional Council of Brittany; AVENIR grant from Inserm}},
Funding-Text = {{This work was supported by the French Agency for Environmental and
   Occupational Health Safety (ANSES). Eden cohort is funded by the
   Foundation for medical research (FRM), Inserm, IReSP, Nestle, French
   Ministry of health, National Research Agency (ANR), Univ. Paris-Sud,
   Institute of health monitoring (InVS), AFSSET, MGEN, AFSSA (ANSES).
   Pelagie cohort was funded by ANSES, Ministry of Health, Ministry of
   Labor, ANR, InVS, Inserm, and the Regional Council of Brittany. The team
   of Environmental Epidemiology (Inserm U823) is supported by an AVENIR
   grant from Inserm. The findings and conclusion in this report are those
   of the authors and do not necessarily represent the views of the Centers
   for Disease Control and Prevention.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Armstrong B, 2003, EXPOSURE ASSESSMENT.
   Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366.
   Buonaccorsi JP, 2010, INTERD STAT, P1, DOI 10.1201/9781420066586.
   Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P303, DOI 10.1289/ehp.10768.
   Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012.
   Centers for Disease Control and Prevention (CDC), 2012, 4 CDCP.
   Chevrier C, 2012, EPIDEMIOLOGY, V23, P353, DOI 10.1097/EDE.0b013e318246073e.
   Dempsey D, 2002, J PHARMACOL EXP THER, V301, P594, DOI 10.1124/jpet.301.2.594.
   Drouillet P, 2008, PAEDIATR PERINAT EP, V17, P1.
   Engel SM, ENV HLTH PERSPECT, V118, P565.
   Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165.
   Fisher JW, 2011, TOXICOL APPL PHARM, V257, P122, DOI 10.1016/j.taap.2011.08.026.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Garlantezec R, 2009, OCCUP ENVIRON MED, V66, P456, DOI 10.1136/oem.2008.041772.
   Guldner L, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-33.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Lorber M, 2010, J EXPO SCI ENV EPID, V20, P38, DOI 10.1038/jes.2008.74.
   Pereira C, 2007, ACTA HISTOCHEM, V109, P29, DOI 10.1016/j.acthis.2006.09.008.
   Philippat C, 2012, ENVIRON HEALTH PERSP, V120, P464, DOI 10.1289/ehp.1103634.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Preis SR, 2011, AM J EPIDEMIOL, V173, P683, DOI 10.1093/aje/kwq415.
   Richardson DB, 2007, EPIDEMIOLOGY, V18, P441, DOI 10.1097/EDE.0b013e318060d25c.
   Samandar E, 2009, ENVIRON RES, V109, P641, DOI 10.1016/j.envres.2009.02.004.
   Grandjean P, 2006, INT J ANDROL, V29, P181, DOI 10.1111/j.1365-2605.2005.00679.x.
   Schisterman EF, 2006, AM J EPIDEMIOL, V163, P374, DOI 10.1093/aje/kwj039.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Slama R, 2009, ENVIRON HEALTH PERSP, V117, P1313, DOI 10.1289/ehp.0800465.
   Teeguarden JG, 2011, TOXICOL SCI, V123, P48, DOI 10.1093/toxsci/kfr160.
   Tworoger SS, 2006, CANCER CAUSE CONTROL, V17, P889, DOI 10.1007/s10552-006-0035-5.
   Völkel Wolfgang, 2002, Chem Res Toxicol, V15, P1281, DOI 10.1021/tx025548t.
   vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005.
   Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Ye XB, 2009, INT J HYG ENVIR HEAL, V212, P481, DOI 10.1016/j.ijheh.2009.03.004.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.
   Ye XY, 2011, ENVIRON HEALTH PERSP, V119, P983, DOI 10.1289/ehp.1002701.
   Ye XY, 2005, ANAL BIOANAL CHEM, V383, P638, DOI 10.1007/s00216-005-0019-4.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{2}},
Journal-ISO = {{Environ. Health}},
Doc-Delivery-Number = {{068AG}},
Wos-Id = {{ISI:000313336300001}},
}

@article{ ISI:000305458200001,
Author = {Lind, P. Monica and Roos, Vendela and Ronn, Monika and Johansson, Lars
   and Ahlstrom, Hakan and Kullberg, Joel and Lind, Lars},
Title = {{Serum concentrations of phthalate metabolites are related to abdominal
   fat distribution two years later in elderly women}},
Journal = {{ENVIRONMENTAL HEALTH}},
Year = {{2012}},
Volume = {{11}},
Month = {{APR 2}},
Abstract = {{Background: Phthalates, commonly used to soften plastic goods, are known
   PPAR-agonists affecting lipid metabolism and adipocytes in the
   experimental setting. We evaluated if circulating concentrations of
   phthalates were related to different indices of obesity using data from
   the Prospective Investigation of the Vasculature in Uppsala Seniors
   (PIVUS) study. Data from both dual-energy X-ray absorptiometry (DXA) and
   abdominal magnetic resonance imaging (MRI) were used.
   Methods: 1,016 subjects aged 70 years were investigated in the PIVUS
   study. Four phthalate metabolites were detected in the serum of almost
   all subjects (> 96\%) by an API 4000 liquid chromatograph/tandem mass
   spectrometer. Abdominal MRI was performed in a representative subsample
   of 287 subjects (28\%), and a dual-energy X-ray absorptiometry
   (DXA)-scan was obtained in 890 (88\%) of the subjects two year following
   the phthalate measurements.
   Results: In women, circulating concentrations of mono-isobutyl phthalate
   (MiBP) were positively related to waist circumference, total fat mass
   and trunk fat mass by DXA, as well as to subcutaneous adipose tissue by
   MRI following adjustment for serum cholesterol and triglycerides,
   education, smoking and exercise habits (all p < 0.008). Mono-methyl
   phthalate (MMP) concentrations were related to trunk fat mass and the
   trunk/leg-ratio by DXA, but less powerful than MiBP. However, no such
   statistically significant relationships were seen in men.
   Conclusions: The present evaluation shows that especially the phthalate
   metabolite MiBP was related to increased fat amount in the subcutaneous
   abdominal region in women measured by DXA and MRI two years later.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lind, PM (Reprint Author), Uppsala Univ, Dept Radiol Oncol \& Radiat Sci, Uppsala, Sweden.
   Lind, P. Monica; Johansson, Lars; Ahlstrom, Hakan; Kullberg, Joel, Uppsala Univ, Dept Radiol Oncol \& Radiat Sci, Uppsala, Sweden.
   Lind, Lars, Uppsala Univ, Dept Med, Uppsala, Sweden.}},
DOI = {{10.1186/1476-069X-11-21}},
Article-Number = {{21}},
ISSN = {{1476-069X}},
Keywords = {{Phthalates; Obesity; Mono-isobutyl phthalate; DXA; Abdominal MRI; PIVUS;
   Fat distribution; PPAR agonist}},
Keywords-Plus = {{PROLIFERATOR-ACTIVATED-RECEPTOR; IN-UTERO EXPOSURE; PPAR-GAMMA;
   CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; ADIPOSE-TISSUE; OBESITY;
   ADIPOGENESIS; INHIBITION; DISRUPTION}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{monica.lind@medsci.uu.se}},
Funding-Acknowledgement = {{Swedish Research Council (VR); Swedish Research Council for Environment,
   Agricultural Sciences, and Spatial Planning (Formas)}},
Funding-Text = {{This study was financially supported by the Swedish Research Council
   (VR) and the Swedish Research Council for Environment, Agricultural
   Sciences, and Spatial Planning (Formas).}},
Cited-References = {{Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017.
   Ellero-Simatos S, 2011, J PROTEOME RES, V10, P5493, DOI 10.1021/pr200765v.
   Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Ingelsson E, 2009, ATHEROSCLEROSIS, V206, P239, DOI 10.1016/j.atherosclerosis.2009.02.029.
   Jeong S, 2011, ACTA PHARMACOL SIN, V32, P230, DOI 10.1038/aps.2010.198.
   Jeong S, 2007, OBESITY, V15, P1430, DOI 10.1038/oby.2007.171.
   Kim BH, 2009, BMB REP, V42, P91.
   Koch HM, 2006, INT J ANDROL, V29, P181.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Kullberg J, 2007, CLIN PHYSIOL FUNCT I, V27, P148, DOI 10.1111/j.1475-097X.2007.00728.x.
   LARSSON B, 1984, BRIT MED J, V288, P1401.
   Lee DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015977.
   Lee DH, 2010, ENVIRON HEALTH PERSP, V118, P1235, DOI 10.1289/ehp.0901480.
   Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026.
   Neel BA, 2011, DIABETES, V60, P1838, DOI 10.2337/db11-0153.
   Newbold RR, 2010, HORM-INT J ENDOCRINO, V9, P206.
   Olsen L, ECOTOXICOLOGY ENV SA.
   Olsen L, 2012, ECOTOX ENVIRON SAFE, V75, P242, DOI 10.1016/j.ecoenv.2011.09.004.
   Schwartz S, 1998, NEW ENGL J MED, V338, P861, DOI 10.1056/NEJM199803263381302.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Teitelbaum SL, 2012, ENVIRON RES, V112, P186, DOI 10.1016/j.envres.2011.12.006.
   Wang ZM, 2010, PHYS MED BIOL, V55, P2619, DOI 10.1088/0031-9155/55/9/013.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{4}},
Journal-ISO = {{Environ. Health}},
Doc-Delivery-Number = {{961IN}},
Wos-Id = {{ISI:000305458200001}},
}

@article{ ISI:000303960900016,
Author = {Kasper-Sonnenberg, Monika and Koch, Holger M. and Wittsiepe, Juergen and
   Wilhelm, Michael},
Title = {{Levels of phthalate metabolites in urine among mother-child-pairs -
   Results from the Duisburg birth cohort study, Germany}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2012}},
Volume = {{215}},
Number = {{3}},
Pages = {{373-382}},
Month = {{APR}},
Abstract = {{Phthalates are used ubiquitously and human exposure is widespread. Some
   phthalates are anti-androgens and have to be regarded as reproductive
   and developmental toxicants. In the Duisburg birth cohort study we
   examine the associations between hormonally active environmental agents
   and child development. Here we report the concentrations of 21 primary
   and secondary phthalate metabolites from seven low molecular weight
   (LMW) phthalates (DMP, DEP, BBzP, DiBP, DnBP, DCHP, DnPeP) and five
   high-molecular weight (HMW) phthalates (DEHP, DiNP, DiDP, DPHP, DnOP) in
   208 urine samples from 104 mothers and their school-aged children.
   Analysis was performed by multidimensional liquid chromatography coupled
   to tandem mass spectrometry (LC/LC-MS/MS), using internal
   isotope-labeled standards. In both children and mothers, 18 out of 21
   phthalate metabolites were detected above the limits of quantification
   (between 0.2 and 1.0 mu g/l) in nearly all urine samples. Among the LMW
   phthalates, the excretion level (geometric mean) of the EDiBP
   metabolites was most prominent in children (103.91 mu g/l), followed by
   Sigma DnBP (56.5 mu g/l), and MEP (39.1 mu g/l). In mothers EDiBP (66.6
   mu g/l) was highest, followed by MEP (50.5 mu g/l), and Sigma DnBP (36.0
   mu g/l). Among the HMW phthalates, Sigma DEHP was highest in children
   and mothers (55.7/28.9 mu g/l). Compared to reference values derived
   from the German Human Biomonitoring Commission, children's metabolite
   concentrations were within background levels, whereas for mothers
   considerably higher exposure to the LMW phthalates DnBP and DiBP, and
   the HMW phthalate DEHP was detected (MiBP: 10.7\%; MnBP: 11.7\%; Sigma
   DEHP: 23.3\% of the samples were above the reference values). The LMW
   metabolites from DMP, DiBP, and DnBP, and the HMW metabolites from DEHP
   and DiNP were correlated between the mothers and children, probably
   indicating shared exposure in the immediate surrounding environment.
   Children showed higher excretion levels for most of the secondary
   metabolites than mothers, confirming previous findings on higher
   oxidized metabolite levels in children. The LMW metabolites Sigma DiBP,
   Sigma DnBP, and MMP, and the HMW metabolites Sigma DEHP were negatively
   associated with children's age. The LMW inetabolites Sigma DiBP, Sigma
   DnBP, and MBzP were inversely associated with body mass index of the
   children. The LMW Sigma DiBP metabolites revealed a significant
   association with nicotine metabolites in urine from both children and
   mothers. Further analyses are ongoing to study long-term phthalate
   exposure and the associations with puberty outcome in these children.
   (C) 2011 Elsevier GmbH. All rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kasper-Sonnenberg, M (Reprint Author), Ruhr Univ Bochum, Dept Hyg Social \& Environm Med, Univ Str 150, Bochum, Germany.
   Kasper-Sonnenberg, Monika; Wittsiepe, Juergen; Wilhelm, Michael, Ruhr Univ Bochum, Dept Hyg Social \& Environm Med, Bochum, Germany.
   Koch, Holger M., Inst Ruhr Univ Bochum IPA, Inst Prevent \& Occupat Med German Social Accid In, Bochum, Germany.}},
DOI = {{10.1016/j.ijheh.2011.09.004}},
ISSN = {{1438-4639}},
Keywords = {{Children, Duisburg birth cohort study; Human biomonitoring; Mother-child
   pairs; Phthalates; Phthalate metabolites; Women}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; DI-N-BUTYLPHTHALATE; DI(2-ETHYLHEXYL)PHTHALATE
   DEHP; EXPOSURE; BUTYLBENZYLPHTHALATE; POPULATION; SECONDARY; NICOTINE;
   NEWBORNS}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{kasper-sonnenberg@hygiene.rub.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Funding-Acknowledgement = {{Federal Environment Agency of Germany; North Rhine-Westphalia State
   Agency for Nature, Environment, and Consumer Protection (LANUV-NRW)}},
Funding-Text = {{We thank the mothers and children who participated in the study and
   Michaela Greshake for her outstanding engagement, preparation of the
   study protocol and her field work carried out between 2007 and 2008. We
   are also grateful for the financial support from the Federal Environment
   Agency of Germany. Furthermore, we acknowledge the North
   Rhine-Westphalia State Agency for Nature, Environment, and Consumer
   Protection (LANUV-NRW), which supported the initial period of the study.}},
Cited-References = {{Angerer J, 2007, INT J HYG ENVIR HEAL, V210, P201, DOI 10.1016/j.ijheh.2007.01.024.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K., 2002, 102 UMW, VIII.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Bizzari S., 2009, CHEM EC HDB.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366.
   Cao YG, 2008, INT J HYG ENVIR HEAL, V211, P30, DOI 10.1016/j.ijheh.2007.04.005.
   Casas L, 2011, ENVIRON INT, V37, P858, DOI 10.1016/j.envint.2011.02.012.
   CDC-Centers for Disease Control Prevention, 2011, 4 CDCP.
   He YH, 2009, ENVIRON RES, V109, P629, DOI 10.1016/j.envres.2009.04.003.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Johnson C.E., 1998, 52 TOB SCI RES C 14.
   Jurewicz J, 2011, INT J OCCUP MED ENV, V24, P115, DOI 10.2478/s13382-011-0022-2.
   Kamrin MA, 2009, J TOXICOL ENV HEAL B, V12, P157, DOI 10.1080/10937400902729226.
   Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Lin S., 2011, CHEMOSPHERE, V82, P655.
   Lorber M, 2010, J EXPO SCI ENV EPID, V20, P38, DOI 10.1038/jes.2008.74.
   Milford E.C., 1991, CIGARETTE PAPER WRAP.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Sathyanarayana S, 2008, ENVIRON RES, V108, P413, DOI 10.1016/j.envres.2008.07.002.
   Schulz C., 2011, INT J HYG ENVIR HEAL, DOI {[}10.1016/j.ijheh.2011.06.007, DOI 10.1016/J.ITHEH.2011.06.007].
   Tuomi T, 1999, CLIN CHEM, V45, P2164.
   Wilhelm M, 2008, MUTAT RES-REV MUTAT, V659, P83, DOI 10.1016/j.mrrev.2007.11.002.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   Wittsiepe J, 2007, CHEMOSPHERE, V67, pS286, DOI 10.1016/j.chemosphere.2006.05.118.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Xu X, 2004, CLIN CHEM, V50, P2323, DOI 10.1373/clinchem.2004.038489.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{10}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{941KA}},
Wos-Id = {{ISI:000303960900016}},
}

@article{ ISI:000302835900009,
Author = {Crago, Jordan and Klaper, Rebecca},
Title = {{A mixture of an environmentally realistic concentration of a phthalate
   and herbicide reduces testosterone in male fathead minnow (Pimephales
   promelas) through a novel mechanism of action}},
Journal = {{AQUATIC TOXICOLOGY}},
Year = {{2012}},
Volume = {{110}},
Pages = {{74-83}},
Month = {{APR}},
Abstract = {{Several chemicals that are used by humans, such as pesticides and
   plastics, are released into the aquatic environment through wastewater
   and runoff and have been shown to be potent disruptors of androgen
   synthesis at high concentrations. Although many of these chemicals have
   been studied in isolation, a large amount of uncertainty remains over
   how fish respond to low concentrations of anti-androgenic mixtures,
   which more accurately reflects how such chemicals are present in the
   aquatic environment. In this study male fathead minnows (FHM)(Pimephales
   promelas) were exposed to environmentally relevant concentrations of two
   anti-androgens, the herbicide linuron, and the plasticizer
   di(2-ethylhexyl) phthalate (DEHP) individually and as part of a mixture
   of the two for a 28-day period. At the end of this period there was a
   reduction in plasma testosterone (T) concentrations in male FHM exposed
   to the mixture, but not in FHM exposed individually to linuron or DEHP
   or the control FHM. There was also a significant reduction in 17
   beta-estradiol (E2) in the DEHP-only and mixture exposed groups as
   compared to the control. Contrary to what has been previously published
   for these two chemicals in mammals, the lower plasma T concentrations in
   male FHM exposed to the mixture was not a result of the inhibition of
   genes involved in steroidogenesis: nor due to an increase in the
   expression of genes associated with peroxisome proliferation. Rather, an
   increase in relative transcript abundance for CYP3A4 in the liver and
   androgen- and estrogen-specific SULT2A1 and SULT1st2 in the testes
   provides evidence that the decrease in plasma T and E2 may be linked to
   increased steroid catabolism. Feedback from the pituitary is not
   repressed as the relative expression of follicle stimulating hormone
   beta-subunit mRNA transcript levels in the brain was significantly
   higher in both DEHP and mixture exposed FHM. In addition, luteinizing
   hormone beta-subunit mRNA transcript levels increased but were not
   significant in the mixture as compared to the control. Hormone receptor
   mRNA transcript levels in the liver and testes were not significantly
   different across all four exposure groups. This study highlights the
   importance of assessing environmentally relevant concentrations of
   mixtures when determining risk to aquatic organisms. (C) 2012 Elsevier
   B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Klaper, R (Reprint Author), Univ Wisconsin Milwaukee, Sch Freshwater Sci, 600 E Greenfield Ave, Milwaukee, WI 53204 USA.
   Klaper, Rebecca, Univ Wisconsin Milwaukee, Sch Freshwater Sci, Milwaukee, WI 53204 USA.
   Crago, Jordan, Univ Wisconsin Milwaukee, Dept Biol Sci, Milwaukee, WI 53204 USA.}},
DOI = {{10.1016/j.aquatox.2011.12.021}},
ISSN = {{0166-445X}},
Keywords = {{Phthalates; Herbicides; Anti-androgen; Fathead minnow; Endocrine
   disruption; Low-dose}},
Keywords-Plus = {{PREGNANE-X-RECEPTOR; ALTERS SEXUAL-DIFFERENTIATION; IN-VITRO EXPRESSION;
   MOLECULAR-CLONING; MALE-RAT; REPRODUCTIVE MALFORMATIONS; ESTROGENIC
   CHEMICALS; METABOLIZING ENZYMES; UTERO EXPOSURE; ANDROGEN}},
Research-Areas = {{Marine \& Freshwater Biology; Toxicology}},
Web-of-Science-Categories  = {{Marine \& Freshwater Biology; Toxicology}},
Author-Email = {{jcrago@uwm.edu
   rklaper@uwm.edu}},
Funding-Acknowledgement = {{NIH {[}P30ES004184-24]}},
Funding-Text = {{This research was funded by NIH grant. (No. P30ES004184-24).}},
Cited-References = {{Ankley GT, 2007, ENVIRON TOXICOL CHEM, V26, P1214, DOI 10.1897/06-428R.1.
   Ankley GT, 2009, TOXICOL SCI, V112, P344, DOI 10.1093/toxsci/kfp227.
   Ankley GT, 2009, AQUAT TOXICOL, V92, P168, DOI 10.1016/j.aquatox.2009.01.013.
   Aoki KAA, 2011, ENVIRON TOXICOL CHEM, V30, P1338, DOI 10.1002/etc.502.
   Belanger A, 1998, J STEROID BIOCHEM, V65, P301, DOI 10.1016/S0960-0760(97)00183-0.
   Brian JV, 2005, ENVIRON HEALTH PERSP, V113, P721, DOI 10.1289/ehp.7598.
   CHATTERJEE B, 1987, J BIOL CHEM, V262, P822.
   CHATTERJEE B, 1994, CHEM-BIOL INTERACT, V92, P273, DOI 10.1016/0009-2797(94)90069-8.
   Clewell H.J., 2011, TOXICOL SCI      JUL.
   Cooper BW, 2008, TOXICOL SCI, V103, P268, DOI 10.1093/toxsci/kfn047.
   Correia AD, 2007, ENVIRON HEALTH PERSP, V115, P115, DOI 10.1289/ehp.9359.
   Corton JC, 1997, BIOCHIMIE, V79, P151, DOI 10.1016/S0300-9084(97)81508-8.
   EAGON PK, 1994, INT J CANCER, V58, P736, DOI 10.1002/ijc.2910580519.
   Fan LQ, 2004, TOXICOLOGY, V204, P109, DOI 10.1016/j.tox.2004.06.018.
   Filby AL, 2007, AQUAT TOXICOL, V81, P219, DOI 10.1016/j.aquatox.2006.12.003.
   Finne EF, 2007, AQUAT TOXICOL, V81, P293, DOI 10.1016/j.aquatox.2006.12.010.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Fromme H, 2002, WATER RES, V36, P1429, DOI 10.1016/S0043-1354(01)00367-0.
   Gentry PR, 2010, ENVIRON MOL MUTAGEN, V51, P1, DOI 10.1002/em.20505.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hill EM, 2010, ENVIRON SCI TECHNOL, V44, P1137, DOI 10.1021/es901837n.
   Hockley SL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-260.
   Hotchkiss AK, 2004, BIOL REPROD, V71, P1852, DOI 10.1095/biolreprod.104.031674.
   Huang H, 2010, PLOS ONE, V5, P9144, DOI DOI 10.1371/J0URNAL.P0NE.0009144.
   Hurst CH, 2004, TOXICOL APPL PHARM, V199, P266, DOI 10.1016/j.taap.2003.11.028.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Lambright C, 2000, TOXICOL SCI, V56, P389, DOI 10.1093/toxsci/56.2.389.
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404.
   Martinovic D, 2008, ENVIRON TOXICOL CHEM, V27, P478, DOI 10.1897/07-206R.1.
   Onorato TM, 2008, J ANDROL, V29, P293, DOI 10.2164/jandrol.107.003335.
   Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x.
   Sonoda J, 2002, P NATL ACAD SCI USA, V99, P13801, DOI 10.1073/pnas.212494599.
   Strott CA, 2002, ENDOCR REV, V23, P703, DOI 10.1210/er.2001.0040.
   Sugahara T, 2003, BIOCHEM J, V375, P785, DOI 10.1042/BJ20031050.
   Takeuchi S, 2008, CHEMOSPHERE, V74, P155, DOI 10.1016/j.chemosphere.2008.08.015.
   Thibaut R, 2004, J STEROID BIOCHEM, V92, P485, DOI 10.1016/j.jsbmb.2004.10.008.
   Uren-Webster TM, 2010, AQUAT TOXICOL, V99, P360, DOI 10.1016/j.aquatox.2010.05.015.
   Wilson VS, 2009, TOXICOL LETT, V186, P73, DOI {[}10.1016/j.toxlet.2008.12.017, 10.1016/j.toxiet.2008.12.017].
   Wilson VS, 2004, ENVIRON SCI TECHNOL, V38, P6314, DOI 10.1021/es049771j.
   Woudneh MB, 2009, J ENVIRON QUAL, V38, P940, DOI 10.2134/jeq2007.0524.
   Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V346, P161, DOI 10.1006/abbi.1997.0302.
   You L, 2004, CHEM-BIOL INTERACT, V147, P233, DOI 10.1016/j.cbi.2004.01.006.
   Zhang B, 2010, ENDOCRINOLOGY, V151, P5721, DOI 10.1210/en.2010-0708.
   Zhang H, 2009, ENVIRON TOXICOL, V24, P484, DOI 10.1002/tox.20453.
   Zhao S, 2005, J COMPUT BIOL, V12, p1045 1062, DOI DOI 10.1089/CMB.2005.12.1047.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{2}},
Journal-ISO = {{Aquat. Toxicol.}},
Doc-Delivery-Number = {{926MT}},
Wos-Id = {{ISI:000302835900009}},
}

@article{ ISI:000301573400009,
Author = {Hines, Cynthia J. and Hopf, Nancy B. and Deddens, James A. and Silva,
   Manori J. and Calafat, Antonia M.},
Title = {{Occupational exposure to diisononyl phthalate (DiNP) in polyvinyl
   chloride processing operations}},
Journal = {{INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH}},
Year = {{2012}},
Volume = {{85}},
Number = {{3}},
Pages = {{317-325}},
Month = {{APR}},
Abstract = {{Diisononyl phthalate (DiNP) is primarily used as a plasticizer in
   polyvinyl chloride (PVC) materials. While information is available on
   general population exposure to DiNP, occupational exposure data are
   lacking. We present DiNP metabolite urinary concentrations in PVC
   processing workers, estimate DiNP daily intake for these workers, and
   compare worker estimates to other populations.
   We assessed DiNP exposure in participants from two companies that
   manufactured PVC materials, a PVC film manufacturer (n = 25) and a PVC
   custom compounder (n = 12). A mid-shift and end-shift urine sample was
   collected from each participant and analyzed for the DiNP metabolite
   mono(carboxy-isooctyl) phthalate (MCiOP). Mixed models were used to
   assess the effect on MCiOP concentrations of a worker being assigned to
   (1) a task using DiNP and (2) a shift where DiNP was used. A simple
   pharmacokinetic model was used to estimate DiNP daily intake from the
   MCiOP concentrations.
   Creatinine-adjusted MCiOP urinary concentrations ranged from 0.42-80 mu
   g/g in PVC film and from 1.11-13.4 mu g/g in PVC compounding. PVC film
   participants who worked on a task using DiNP (n = 7) had the highest
   MCiOP geometric mean (GM) end-shift concentration (25.2 mu g/g),
   followed by participants who worked on a shift where DiNP was used (n =
   11) (17.7 mu g/g) as compared to participants with no task (2.92 mu g/g)
   or shift (2.08 mu g/g) exposure to DiNP. The GM end-shift MCiOP
   concentration in PVC compounding participants (4.80 mu g/g) was
   comparable to PVC film participants with no task or shift exposure to
   DiNP. Because no PVC compounding participants were assigned to tasks
   using DINP on the day sampled, DiNP exposure in this company may be
   underestimated. The highest DiNP intake estimate was 26 mu g/kg/day.
   Occupational exposure to DiNP associated with PVC film manufacturing
   tasks were substantially higher (sixfold to tenfold) than adult general
   population exposures; however, all daily intake estimates were less than
   25\% of current United States or European acceptable or tolerable daily
   intake estimates. Further characterization of DiNP occupational
   exposures in other industries is recommended.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hines, CJ (Reprint Author), NIOSH, Ctr Dis Control \& Prevent, 4676 Columbia Pkwy,R-14, Cincinnati, OH 45226 USA.
   Hines, Cynthia J.; Hopf, Nancy B.; Deddens, James A., NIOSH, Ctr Dis Control \& Prevent, Cincinnati, OH 45226 USA.
   Hopf, Nancy B., Inst Work \& Hlth IST, Lausanne, Switzerland.
   Deddens, James A., Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA.
   Silva, Manori J.; Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.}},
DOI = {{10.1007/s00420-011-0674-z}},
ISSN = {{0340-0131}},
Keywords = {{Diisononyl phthalate; Occupational; Exposure assessment; Biological
   monitoring; Intake estimates; Polyvinyl chloride}},
Keywords-Plus = {{ISO-NONYLPHTHALATE DINP; ISONONYL PHTHALATE; HUMAN URINE; METABOLITE
   CONCENTRATIONS; DEVELOPMENTAL TOXICITY; RATS; ESTERS; REPRODUCTION;
   POPULATION; ABSORPTION}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{chines@cdc.gov}},
Funding-Acknowledgement = {{Centers for Disease Control and Prevention, National Institute for
   Occupational Safety and Health; National Center for Environmental Health}},
Funding-Text = {{This work was supported by intramural research funds from the Centers
   for Disease Control and Prevention, National Institute for Occupational
   Safety and Health and National Center for Environmental Health.}},
Cited-References = {{Adamsson A, 2009, REPROD TOXICOL, V28, P66, DOI 10.1016/j.reprotox.2009.03.002.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Boberg J, 2011, REPROD TOXICOL, V31, P200, DOI 10.1016/j.reprotox.2010.11.001.
   Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011.
   Calafat AM, 2010, ENV HLTH PERPSECT, DOI {[}10.1289/ehp.1002316, DOI 10.1289/EHP.1002316].
   Centers for Disease Control and Prevention (CDC), 2009, 4 NAT REP HUM EXP EN.
   CPSC (Consumer Product Safety Commission), 2001, REP US CONS PROD SAF.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   EFSA, 2005, EFSA J, V244, P1.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Garrod ANI, 2001, ANN OCCUP HYG, V45, P55, DOI 10.1016/S0003-4878(00)00013-2.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hall Michael, 1999, Journal of Toxicological Sciences, V24, P237.
   Harper HA, 1977, REV PHYSIOLOGICAL CH.
   Hellwig J, 1997, FOOD CHEM TOXICOL, V35, P501, DOI 10.1016/S0278-6915(97)00008-2.
   Hines CJ, 2009, ANN OCCUP HYG, V53, P1, DOI 10.1093/annhyg/men066.
   Hines CJ, 2001, ANN OCCUP HYG, V45, P227, DOI 10.1016/S0003-4878(00)00062-4.
   Hines CJ, 2011, J EXPO SCI ENV EPID, V21, P133, DOI 10.1038/jes.2009.62.
   Kaufmann W, 2002, REGUL TOXICOL PHARM, V36, P175, DOI 10.1066/rtph.2002.1575.
   Kavlock R, 2002, REPROD TOXICOL, V16, P679, DOI 10.1016/S0890-6238(02)00034-5.
   Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/10408440390250154.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Latini G, 2009, ENVIRON INT, V35, P236, DOI 10.1016/j.envint.2008.06.002.
   Lington AW, 1997, FUND APPL TOXICOL, V36, P79, DOI 10.1006/faat.1997.2286.
   Masutomi N, 2003, TOXICOLOGY, V192, P149, DOI 10.1016/S0300-483X(03)00269-5.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   Pugh G, 2000, TOXICOL SCI, V56, P181, DOI 10.1093/toxsci/56.1.181.
   Rawson BV, 2005, ANN OCCUP HYG, V49, P535, DOI 10.1093/annhyg/mei015.
   SCOTT RC, 1987, ENVIRON HEALTH PERSP, V74, P223, DOI 10.2307/3430452.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1.
   TURI, 2006, MASS TOX US RED I 5.
   Wallach J., 2000, INTERPRETATION DIAGN.
   Waterman SJ, 1999, REPROD TOXICOL, V13, P131, DOI 10.1016/S0890-6238(99)00002-7.
   Waterman SJ, 2000, REPROD TOXICOL, V14, P21, DOI 10.1016/S0890-6238(99)00067-2.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{0}},
Journal-ISO = {{Int. Arch. Occup. Environ. Health}},
Doc-Delivery-Number = {{909OG}},
Wos-Id = {{ISI:000301573400009}},
}

@article{ ISI:000301125600008,
Author = {Kao, Mark L. and Ruoff, Bruce and Bower, Nancy and Aoki, Toyohiko and
   Smart, Clair and Mannens, Geert},
Title = {{Pharmacokinetics, metabolism and excretion of C-14-monoethyl phthalate
   (MEP) and C-14-diethyl phthalate (DEP) after single oral and IV
   administration in the juvenile dog}},
Journal = {{XENOBIOTICA}},
Year = {{2012}},
Volume = {{42}},
Number = {{4}},
Pages = {{389-397}},
Month = {{APR}},
Abstract = {{1. The pharmacokinetics, metabolism and excretion of monoethyl phthalate
   (MEP) and diethyl phthalate (DEP) were compared after intravenous or
   oral administration of {[}C-14] MEP or {[}C-14] DEP in juvenile beagle
   dogs. Four male juvenile beagle dogs were treated with a single oral or
   bolus intravenous dose of either {[}C-14] MEP or {[}C-14] DEP (164 mu
   g/kg).
   2. The absorption, metabolism, excretion and pharmacokinetics of
   {[}C-14] MEP and {[}C-14] DEP were nearly identical. {[}C-14] DEP was
   rapidly and nearly completely metabolized to {[}C-14] MEP following
   either intravenous or oral administration. {[}C-14] MEP and{[}C-14] DEP
   were rapidly absorbed, the elimination half-life was estimated to be 1
   hour. Approximately 90\%-96\% of the dose was excreted in urine with
   2\%-3\% of the dose in faeces. MEP accounted for the majority of the
   dose in plasma and urine; in addition, three minor metabolites (M1, M2
   and M3) were detected. The minor metabolites were neither phthalic acid
   nor glucuronide/sulfate conjugates.
   3. The nearly identical metabolism and pharmacokinetics of MEP and DEP
   in juvenile dogs justifies the use of DEP toxicity data in the risk
   assessment of MEP exposure.}},
Publisher = {{INFORMA HEALTHCARE}},
Address = {{TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kao, ML (Reprint Author), Janssen R\&D, Drug Safety Sci, 1000 Route 202 South, Raritan, NJ 08869 USA.
   Kao, Mark L.; Ruoff, Bruce, Janssen R\&D, Drug Safety Sci, Raritan, NJ 08869 USA.
   Bower, Nancy, Eisai Inc, Regulatory Affairs, Woodcliff Lake, NJ USA.
   Aoki, Toyohiko, Eisai \& Co Ltd, Drug Safety, Kakamighara, Japan.
   Smart, Clair, Huntingdon Life Sci, Drug Metab, Huntingdon, Cambs, England.
   Mannens, Geert, Janssen R\&D, Drug Metab Farmacokinetiek, Turnhoutseweg, Beerse, Belgium.}},
DOI = {{10.3109/00498254.2011.627478}},
ISSN = {{0049-8254}},
Keywords = {{Diethyl phthalate; monoethyl phthalate; metabolism; pharmacokinetics;
   safety assessment; paediatric}},
Keywords-Plus = {{DIETHYL PHTHALATE; EXPOSURE}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{mkao@its.jnj.com}},
Cited-References = {{Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Blau K, 1977, HDB DERIVATIVES CHRO.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Ioku T, 1976, YAKURI TO CHIRYO, V4, P510.
   Laroute V, 2005, RES VET SCI, V79, P161, DOI 10.1016/j.rvsc.2004.11.011.
   National Institute of Environmental Health Sciences (NIEHS), 2006, CHEM INF PROF DIETH.
   National Research Council (NCR) Committee on the health risks of phthalates, 2008, PHTHAL CUM RISK ASS, P43.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.}},
Number-of-Cited-References = {{11}},
Times-Cited = {{0}},
Journal-ISO = {{Xenobiotica}},
Doc-Delivery-Number = {{903OA}},
Wos-Id = {{ISI:000301125600008}},
}

@article{ ISI:000301627400005,
Author = {Liu, Shi-Bo and Ma, Zheng and Sun, Wen-Lan and Sun, Xiao-Wen and Hong,
   Yan and Ma, Long and Qin, Chao and Stratton, Harrison J. and Liu, Qiang
   and Jiang, Jun-Tao},
Title = {{The role of androgen-induced growth factor (FGF8) on genital tubercle
   development in a hypospadiac male rat model of prenatal exposure to
   di-n-butyl phthalate}},
Journal = {{TOXICOLOGY}},
Year = {{2012}},
Volume = {{293}},
Number = {{1-3}},
Pages = {{53-58}},
Month = {{MAR 11}},
Abstract = {{Fibroblast growth factor 8 (FGF8) is an androgen-induced growth factor
   (AIGF) that is crucial for embryonic development. This study was
   developed to investigate the role of FGF8 in developmental abnormalities
   of the genital tubercle (GT) in hypospadiac male rats when prenatally
   exposed to din-butyl phthalate (DBP). DBP was administered to
   timed-pregnant rats to establish the hypospadiac rat model where the
   incidence of hypospadias in male offspring was 43.6\%. On postnatal day
   (PND) 7, decreased mRNA and protein expression levels for androgen
   receptor (AR) and FGF8 were observed in the GT of hypospadiac rats.
   Decreased serum testosterone (T) levels were observed in groups
   displaying hypospadias, which was confirmed using histological analysis.
   Further anatomical examination using digital photography helped to
   reveal visualized expression of dysplasia in organs strongly associated
   with hypospadias. In addition, changes in body weight (BW) and
   anogenital distance (AGD) were recorded, showing definitive decreases.
   Collectively, these data clearly demonstrate an interaction between
   androgen and FGF8, which might play an important role in the occurrence
   of hypospadias and abnormal organ development induced by DBP. (c) 2011
   Elsevier Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jiang, JT (Reprint Author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Urol, 85 Wujin Rd, Shanghai 200080, Peoples R China.
   Liu, Shi-Bo; Sun, Xiao-Wen; Jiang, Jun-Tao, Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200080, Peoples R China.
   Ma, Zheng, Nantong Univ, Wujiang City People Hosp 1, Dept Urol, Wujiang 215200, Jiangsu, Peoples R China.
   Sun, Wen-Lan, Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Geriatr, Shanghai 200080, Peoples R China.
   Hong, Yan, Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Expt Res Ctr, Shanghai 200080, Peoples R China.
   Ma, Long, Jiangsu Prov Hosp Tcm, Dept Urol, Nanjing 210029, Jiangsu, Peoples R China.
   Qin, Chao, Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing 210029, Jiangsu, Peoples R China.
   Stratton, Harrison J.; Liu, Qiang, St Josephs Hosp, Barrow Neurol Inst, Div Neurol \& Neurobiol, Phoenix, AZ 85013 USA.
   Stratton, Harrison J., Arizona State Univ, Sch Life Sci, Tempe, AZ 85285 USA.}},
DOI = {{10.1016/j.tox.2011.12.010}},
ISSN = {{0300-483X}},
Keywords = {{Di-n-butyl phthalate; Hypospadias; Androgen receptor; Fibroblast growth
   factor 8; Testoterone}},
Keywords-Plus = {{IN-UTERO EXPOSURE; MALE REPRODUCTIVE DEVELOPMENT; SPRAGUE-DAWLEY RATS;
   DI(N-BUTYL) PHTHALATE; LATE PREGNANCY; LATE-GESTATION; MOUSE; TOXICITY;
   DBP; MALFORMATIONS}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{jjturologist@26.com}},
Funding-Acknowledgement = {{National Science Foundation for Young Scientists of China {[}81000243]}},
Funding-Text = {{This work was supported by the National Science Foundation for Young
   Scientists of China (Grant No. 81000243).}},
Cited-References = {{Abu-Issa R, 2002, DEVELOPMENT, V129, P4613.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   Baskin LS, 2000, J UROLOGY, V163, P951, DOI 10.1016/S0022-5347(05)67861-5.
   Canning D A, 1999, J Urol, V161, P366.
   CROSSLEY PH, 1995, DEVELOPMENT, V121, P439.
   Ema M, 1997, J APPL TOXICOL, V17, P223, DOI 10.1002/(SICI)1099-1263(199707)17:4<223::AID-JAT433>3.0.CO;2-H.
   Ema M, 1998, TOXICOL LETT, V98, P87, DOI 10.1016/S0378-4274(98)00107-6.
   EMA M, 1993, TOXICOL LETT, V69, P197.
   Ema M, 2000, TOXICOL LETT, V111, P271, DOI 10.1016/S0378-4274(99)00192-7.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Gnanapragasam VJ, 2002, ONCOGENE, V21, P5069, DOI 10.1038/sj.onc.12056630.
   Jiang JT, 2007, TOXICOLOGY, V232, P286, DOI 10.1016/j.tox.2007.01.018.
   Jung JN, 1999, SCIENCE, V284, P1998, DOI 10.1126/science.284.5422.1998.
   Kim TS, 2010, J TOXICOL ENV HEAL A, V73, P1544, DOI 10.1080/15287394.2010.511579.
   Kurzrock EA, 1999, CELLS TISSUES ORGANS, V164, P125, DOI 10.1159/000016650.
   Morgan EA, 2003, DEVELOPMENT, V130, P3095, DOI 10.1242/dev.00530.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   Steinhardt GF, 2004, ADV EXP MED BIOL, V545, P203.
   TANAKA A, 1992, P NATL ACAD SCI USA, V89, P8928, DOI 10.1073/pnas.89.19.8928.
   Wang MH, 2008, J ANDROL, V29, P499, DOI 10.2164/jandrol.108.004945.
   Wine RN, 1997, ENVIRON HEALTH PERSP, V105, P102, DOI 10.1289/ehp.97105102.
   Yu SB, 2010, DEV BIOL, V347, P92, DOI 10.1016/j.ydbio.2010.08.013.
   Zhang YH, 2004, REPROD TOXICOL, V18, P669, DOI 10.1016/j.reprotox.2004.04.009.
   Zhu YJ, 2009, TOXICOLOGY, V260, P120, DOI 10.1016/j.tox.2009.03.017.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{0}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{910HI}},
Wos-Id = {{ISI:000301627400005}},
}

@article{ ISI:000301229200008,
Author = {Sheffield, William P. and Bhakta, Varsha and Mastronardi, Cherie and
   Ramirez-Arcos, Sandra and Howe, David and Jenkins, Craig},
Title = {{Changes in coagulation factor activity and content of
   di(2-ethylhexyl)phthalate in frozen plasma units during refrigerated
   storage for up to five days after thawing}},
Journal = {{TRANSFUSION}},
Year = {{2012}},
Volume = {{52}},
Number = {{3}},
Pages = {{493-502}},
Month = {{MAR}},
Abstract = {{BACKGROUND: Thawed plasma is typically transfused to supply coagulation
   factors but factor activity declines during refrigerated storage.
   Refrigerating thawed plasma for longer than 24 hours could reduce plasma
   wastage and make plasma more readily available for emergency
   transfusions. We measured coagulation factor activity and
   di(2-ethylhexyl)phthalate (DEHP) concentration in frozen plasma (FP)
   thawed and stored at 1 to 6 degrees C for up to 5 days.
   STUDY DESIGN AND METHODS: FP units prepared using ``top-and-bottom{''}
   collection sets were thawed, refrigerated, and sampled aseptically at 0,
   24, 72, and 120 hours after thawing (n = 54). Clotting factor activities
   and prothrombin times (PTs) were measured using an automated coagulation
   factor analyzer. DEHP was measured by high-performance liquid
   chromatography after hexane extraction (n = 11). Unit sterility was
   confirmed using an automated microbial detection system.
   RESULTS: Factor (F) V and FVIII, but not FVII, declined significantly
   within 24 hours. By Day 5, mean losses were 20, 14, and 41\%, in FV,
   FVII, and FVIII, respectively; fibrinogen activity did not change. PT
   values were prolonged by 9\% on Day 5. Mean DEHP levels increased from
   22 ppm at thaw to 66 ppm on Day 5.
   CONCLUSIONS: The bulk of coagulation factor activity losses during
   storage occurred in the first 24 hours. Coagulation factor activities
   remaining in FP after 5 days did not differ from those previously
   reported in similar products frozen within 24 hours of phlebotomy. While
   DEHP levels in 5-day-thawed FP are not of concern for adult patients,
   for infants, DEHP levels can be minimized by using FP refrigerated for
   no more than 24 hours.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sheffield, WP (Reprint Author), McMaster Univ, Dept Pathol \& Mol Med, HSC 4N66,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.
   Sheffield, William P., McMaster Univ, Dept Pathol \& Mol Med, Hamilton, ON L8N 3Z5, Canada.
   Canadian Blood Serv, Res \& Dev Serv, Hamilton, ON, Canada.
   Canadian Blood Serv, Prod \& Hosp Serv, Hamilton, ON, Canada.
   Canadian Blood Serv, Res \& Dev Serv, Ottawa, ON, Canada.
   Canadian Blood Serv, Prod \& Hosp Serv, Ottawa, ON, Canada.
   Canadian Blood Serv, Res \& Dev Serv, Vancouver, BC, Canada.
   Canadian Blood Serv, Prod \& Hosp Serv, Vancouver, BC, Canada.}},
DOI = {{10.1111/j.1537-2995.2011.03300.x}},
ISSN = {{0041-1132}},
Keywords-Plus = {{CLOTTING FACTORS; ROOM-TEMPERATURE; PHTHALATE DEHP; CRYOPRECIPITATE;
   STABILITY; QUALITY; IMPLEMENTATION; 6-DEGREES-C; GUIDELINES; PLATELETS}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Author-Email = {{sheffiel@mcmaster.ca}},
Cited-References = {{Alhumaidan H, 2010, TRANSFUSION, V50, P1934, DOI 10.1111/j.1537-2995.2010.02648.x.
   BCSH, 2004, BR J HAEMATOL, V126, P11.
   BOOMGAARD MN, 1994, VOX SANG, V66, P18.
   Canada H, 2002, HLTH CAN EXP ADV PAN.
   Canadian Blood Services, 2005, CIRC INF AM 1 2 MAY, P61.
   Calder L, 1997, CAN MED ASSOC J, V156, pS1.
   Downes KA, 2001, TRANSFUSION, V41, P570, DOI 10.1046/j.1537-2995.2001.41040570.x.
   Eder A F, 2007, Immunohematology, V23, P150.
   European Commission, 2008, OP SAF MED DEV CONT.
   Hellstern P, 2002, THROMB RES, V107, pS3, DOI 10.1016/S0049-3848(02)00145-7.
   KAKAIYA RM, 1984, VOX SANG, V46, P44.
   Kotitschke R, 2000, INFUS THER TRANSFUS, V27, P174.
   Lamboo M, 2007, TRANSFUSION MED, V17, P182, DOI 10.1111/j.1365-3148.2007.00729.x.
   Levin E, 2008, TRANSFUSION, V48, P2331, DOI 10.1111/j.1537-2995.2008.01836.x.
   Mastronardi C, 2010, CLIN CHEM LAB MED, V48, P1179, DOI 10.1515/CCLM.2010.240.
   Nakazawa H, 2009, TRANSFUSION, V49, P2434, DOI 10.1111/j.1537-2995.2009.02321.x.
   Nascimento B, 2010, CRIT CARE, V14, DOI 10.1186/cc8205.
   Norda R, 2007, VOX SANG, V93, P223, DOI 10.1111/j.1423-0410.2007.00963..
   O'Neill EM, 1999, TRANSFUSION, V39, P488, DOI 10.1046/j.1537-2995.1999.39050488.x.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Pugh G, 2000, TOXICOL SCI, V56, P181, DOI 10.1093/toxsci/56.1.181.
   Rais-Bahrami K, 2004, ENVIRON HEALTH PERSP, V112, P1339, DOI 10.1289/ehp.6901.
   ROCK GA, 1991, NEW ENGL J MED, V325, P393, DOI 10.1056/NEJM199108083250604.
   Scott E, 2009, TRANSFUSION, V49, P1584, DOI 10.1111/j.1537-2995.2009.02198.x.
   Serrano K, 2010, TRANSFUSION, V50, P344, DOI 10.1111/j.1537-2995.2009.02441.x.
   Sheffield WP, 2010, TRANSFUSION, V50, P1043, DOI 10.1111/j.1537-2995.2009.02555.x.
   Sidhu RS, 2006, J CLIN APHERESIS, V21, P224, DOI 10.1002/jca.20095.
   SJOBERG P, 1985, ACTA PHARMACOL TOX, V56, P30.
   Stanworth Simon J, 2007, Hematology Am Soc Hematol Educ Program, P179.
   Tomonari Y, 2006, J TOXICOL ENV HEAL A, V69, P1651, DOI 10.1080/15287390600630054.
   von Heymann C, 2009, TRANSFUSION, V49, P913, DOI 10.1111/j.1537-2995.2008.02063.x.
   Wolfe GW, 2003, MULTIGENERATIONAL RE, P7244.
   Woodhams B, 2001, BLOOD COAGUL FIBRIN, V12, P229, DOI 10.1097/00001721-200106000-00002.
   Yazer MH, 2008, TRANSFUSION, V48, P2525, DOI 10.1111/j.1537-2995.2008.01913.x.
   {[}Anonymous], 2004, CANCSAZ90203, P82.
   {[}Anonymous], 1994, JAMA, V271, P777.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{1}},
Journal-ISO = {{Transfusion}},
Doc-Delivery-Number = {{904WI}},
Wos-Id = {{ISI:000301229200008}},
}

@article{ ISI:000301394700037,
Author = {Toft, Gunnar and Jonsson, Bo A. G. and Lindh, Christian H. and Jensen,
   Tina Kold and Hjollund, Niels H. and Vested, Anne and Bonde, Jens Peter},
Title = {{Association between Pregnancy Loss and Urinary Phthalate Levels around
   the Time of Conception}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2012}},
Volume = {{120}},
Number = {{3}},
Pages = {{458-463}},
Month = {{MAR}},
Abstract = {{BACKGROUND: Animal studies indicate that some phthalate metabolites may
   harm female reproductive function. OBJECTIVES: We assessed the
   associations between exposure to phthalate metabolites and pregnancy
   loss.
   METHODS: Using a previously established cohort of couples planning their
   first pregnancy, we analyzed four primary and two oxidized secondary
   phthalate metabolites in urine samples collected on day 10 after the
   first day of the last menstrual period before conception occurred (n =
   128) and during the previous cycle (if any, is = 111). Subclinical
   embryonal loss was identified by repeated measurement of urinary human
   chorionic gonadotropin, and information on clinical spontaneous
   abortions was obtained by telephone interview with the mother.
   RESULTS: Pregnancy loss (n = 48) was increased among women with urinary
   concentration of monoethylhexyl phthalate (MEHP) in the upper tertile in
   the conception sample compared with women in the lowest tertile
   {[}adjusted odds ratio (OR) = 2.9; 95\% confidence interval (CI): 1.1,
   7.6]. The corresponding OR for subclinical embryonal loss (n = 32) was
   40.7 (95\% Cl: 4.5, 369.5).
   CONCLUSIONS: The phthalate metabolite MEHP was associated with higher
   occurrence of pregnancy loss. Because this is the first human study to
   show this association and the sample size is small, the findings need to
   be corroborated in independent studies.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Toft, G (Reprint Author), Aarhus Univ Hosp, Dept Occupat Med, Danish Ramazzini Ctr, Norrebrogade 44,Bldg 2C, DK-8000 Aarhus, Denmark.
   Toft, Gunnar; Vested, Anne, Aarhus Univ Hosp, Dept Occupat Med, Danish Ramazzini Ctr, DK-8000 Aarhus, Denmark.
   Jonsson, Bo A. G.; Lindh, Christian H., Univ Lund Hosp, Dept Lab Med, Div Occupat \& Environm Med, S-22185 Lund, Sweden.
   Jensen, Tina Kold, Univ So Denmark, Dept Environm Med, Odense, Denmark.
   Hjollund, Niels H., Herning Reg Hosp, Dept Occupat Med, Herning, Denmark.
   Hjollund, Niels H., Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark.
   Bonde, Jens Peter, Univ Copenhagen, Bispebjerg Hosp, Dept Occupat \& Environm Med, Copenhagen, Denmark.}},
DOI = {{10.1289/ehp.1103552}},
ISSN = {{0091-6765}},
Keywords = {{abortion; MEHP; phthalates; pregnancy loss}},
Keywords-Plus = {{SPONTANEOUS-ABORTION; DI-(2-ETHYLHEXYL) PHTHALATE; 1ST-PREGNANCY
   PLANNERS; INTERNAL EXPOSURE; ACID ESTERS; METABOLITES; RATS; POPULATION;
   FERTILITY; EXCRETION}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{guntof@rm.dk}},
Funding-Acknowledgement = {{Aarhus University Research Foundation; Danish Medical Research Council;
   Danish Medical Health Insurance Foundation; Danish Ministry of
   Environment; Lundbeck Foundation; AFA (Swedish Labor Market Insurance
   Company); Swedish Research Council}},
Funding-Text = {{The original data for the study were collected as part of the First
   Pregnancy Planner study supported by the Aarhus University Research
   Foundation, the Danish Medical Research Council, and the Danish Medical
   Health Insurance Foundation. Phthalate and data analyses were funded by
   the Danish Ministry of Environment and the Lundbeck Foundation, AFA
   (Swedish Labor Market Insurance Company), and the Swedish Research
   Council.}},
Cited-References = {{Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Baird DD, 2010, J EXPO SCI ENV EPID, V20, P169, DOI 10.1038/jes.2009.17.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2.
   Bonde JPE, 1998, REPROD TOXICOL, V12, P19, DOI 10.1016/S0890-6238(97)00096-8.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Gray LE, 2006, TOXICOL SCI, V93, P189, DOI 10.1093/toxsci/kfl035.
   Henriksen TB, 2004, AM J EPIDEMIOL, V160, P661, DOI 10.1093/aje/kwh259.
   Hjollund NHI, 2000, SCAND J WORK ENV HEA, V26, P187.
   Hjollund NHI, 2000, EPIDEMIOLOGY, V11, P18, DOI 10.1097/00001648-200001000-00006.
   Hoppin JA, 2006, J EXPO SCI ENV EPID, V16, P39, DOI 10.1038/sj.jea.7500435.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Schindler AE, 2004, GYNECOL ENDOCRINOL, V18, P51, DOI 10.1080/09513590310001651795.
   SELEVAN SG, 1987, J OCCUP ENVIRON MED, V29, P451.
   Svechnikova I, 2007, J ENDOCRINOL, V194, P603, DOI 10.1677/JOE-07-0238.
   Venners SA, 2005, AM J EPIDEMIOL, V162, P709, DOI 10.1093/aje/kwi275.
   WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{4}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{907CF}},
Wos-Id = {{ISI:000301394700037}},
}

@article{ ISI:000301394700038,
Author = {Philippat, Claire and Mortamais, Marion and Chevrier, Cecile and Petit,
   Claire and Calafat, Antonia M. and Ye, Xiaoyun and Silva, Manori J. and
   Brambilla, Christian and Pin, Isabelle and Charles, Marie-Aline and
   Cordier, Sylvaine and Slama, Remy},
Title = {{Exposure to Phthalates and Phenols during Pregnancy and Offspring Size
   at Birth}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2012}},
Volume = {{120}},
Number = {{3}},
Pages = {{464-470}},
Month = {{MAR}},
Abstract = {{BACKGROUND: Data concerning the effects of prenatal exposures to
   phthalates and phenols on fetal growth are limited in humans. Previous
   findings suggest possible effects of some phenols on male birth weight.
   OBJECTIVE: Our aim was to assess the relationships between prenatal
   exposures to phthalates and phenols and fetal growth among male
   newborns.
   METHODS: We conducted a case control study on male malformations of the
   genitalia nested in two French mother child cohorts with recruitment
   between 2002 and 2006. We measured, in maternal urinary samples
   collected between 6 and 30 gestational weeks, the concentrations
   (micrograms per liter) of 9 phenol (n = 191 pregnant women) and 11
   phthalate metabolites (a = 287). Weight, length, and head circumference
   at birth were collected from maternity records. Statistical analyses
   were corrected for the oversampling of malformation cases.
   RESULTS: Adjusted birth weight decreased by 77 g {[}95\% confidence
   interval (CI): 129, 25] and by 49 g (95\% CI: 86, 13) in association
   with a 1-unit increase in In-transformed 2,4-dichlorophenol (DCP) and
   2,5-DCP urinary concentrations, respectively. Benzophenone-3 (BP3)
   In-transformed concentrations were positively associated with weight (26
   g; 95\% CI: 2, 54) and head circumference at birth (0.1 cm; 95\% Cl:
   0.0, 0.2). Head circumference increased by 0.3 cm (95\% CI: 0.0, 0.7) in
   association with a 1-unit increase in In-transformed BPA concentration.
   For phthalate metabolites there was no evidence of monotonic
   associations with birth weight.
   CONCLUSIONS: Consistent with findings of a previous study, we observed
   evidence of an inverse association of 2,5-DCP and a positive association
   of BP3 with male birth weight.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Philippat, C (Reprint Author), Inst Albert Bonniot, INSERM, Ctr Rech, UJF U823, UJF Site Sante,BP 170 La Tronche Grenoble, F-38042 Grenoble 9, France.
   Philippat, Claire; Mortamais, Marion; Pin, Isabelle; Slama, Remy, Inst Albert Bonniot U823, INSERM, Team Environm Epidemiol Appl Reprod \& Resp Hlth, Grenoble, France.
   Philippat, Claire; Brambilla, Christian; Slama, Remy, Grenoble Univ, Inst Albert Bonniot, Grenoble, France.
   Mortamais, Marion, CNRS, INSERM, U1061, Montpellier, France.
   Chevrier, Cecile; Petit, Claire; Cordier, Sylvaine, Univ Rennes 1, INSERM, IFR140, U625, Rennes, France.
   Calafat, Antonia M.; Ye, Xiaoyun; Silva, Manori J., Ctr Res Dis Prevent, Atlanta, GA USA.
   Brambilla, Christian, Grenoble Univ, Inst Albert Bonniot U823, Grenoble, France.
   Pin, Isabelle, Univ Grenoble, Ctr Hosp, Serv Pediat, Grenoble, France.
   Charles, Marie-Aline, Ctr Rech Epidemiol \& Sante Populat CESP, INSERM, U1018, Team Epidemiol Diabetes Obes \& Renal Dis Lifelong, Villejuif, France.}},
DOI = {{10.1289/ehp.1103634}},
ISSN = {{0091-6765}},
Keywords = {{birth outcomes; fetal growth; phenols; phthalates; pregnancy exposure;
   urinary biomarkers}},
Keywords-Plus = {{BISPHENOL-A CONCENTRATIONS; GENERAL-POPULATION; WOMEN;
   2,5-DICHLOROPHENOL; QUANTIFICATION; VARIABILITY; METABOLITES;
   PREDICTORS; OUTCOMES; HEALTH}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{Claire.Philippat@e.ujf-grenoble.fr}},
Funding-Acknowledgement = {{French Agency for Food, Environmental and Occupational Health and Safety
   (ANSES); la Fondation pour la Recherche Medicale; INSERM; l'Institut de
   Recherche en Sante Publique; Nestle; French Ministry of Health; l'Agence
   Nationale de la Recherche (ANR); l'Universite Paris-Sud; l'Institut de
   veille sanitaire (InVS); ANSES; Mutuelle Generale de l'Education
   Nationale; Regional Council of Brittany}},
Funding-Text = {{This work was supported by the French Agency for Food, Environmental and
   Occupational Health and Safety (ANSES). The EDEN cohort is funded by la
   Fondation pour la Recherche Medicale, INSERM, l'Institut de Recherche en
   Sante Publique, Nestle, French Ministry of Health, l'Agence Nationale de
   la Recherche (ANR), l'Universite Paris-Sud, l'Institut de veille
   sanitaire (InVS), ANSES, and Mutuelle Generale de l'Education Nationale.
   The PELAGIE cohort is funded by ANR, InVS, INSERM, and the Regional
   Council of Brittany.}},
Cited-References = {{ABRAHAMSSON K, 1983, J CHROMATOGR, V279, P199, DOI 10.1016/S0021-9673(01)93618-0.
   Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Agency for Toxic Substances and Disease Registry, 2006, TOX PROF DICHL.
   Balakrishnan B, 2010, AM J OBSTET GYNECOL, V202.
   Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366.
   Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P893, DOI 10.1289/ehp.11269.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   Cantonwine D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-62.
   Drouillet P, 2009, BRIT J NUTR, V101, P583, DOI 10.1017/S0007114508025038.
   Garlantezec R, 2009, OCCUP ENVIRON MED, V66, P456, DOI 10.1136/oem.2008.041772.
   Harrell FE, 2001, REGRESSION MODELING.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605.
   Mose T, 2007, REPROD TOXICOL, V23, P83, DOI 10.1016/j.reprotox.2006.08.006.
   Richardson DB, 2007, EPIDEMIOLOGY, V18, P441, DOI 10.1097/EDE.0b013e318060d25c.
   Rothman KJ, 2008, MODERN EPIDEMIOLOGY, P3.
   Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783.
   Rubin BS, 2009, MOL CELL ENDOCRINOL, V304, P55, DOI 10.1016/j.mce.2009.02.023.
   Samandar E, 2009, ENVIRON RES, V109, P641, DOI 10.1016/j.envres.2009.02.004.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Slama R, 2005, REV EPIDEMIOL SANTE, V53, p2S65.
   Slama R, 2008, ENVIRON HEALTH PERSP, V116, pA284, DOI 10.1289/ehp.11105.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Yang J, 2010, J HAZARD MATER, V184, P782, DOI 10.1016/j.jhazmat.2010.08.109.
   Ye XB, 2009, INT J HYG ENVIR HEAL, V212, P481, DOI 10.1016/j.ijheh.2009.03.004.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.
   Ye XY, 2005, ANAL BIOANAL CHEM, V383, P638, DOI 10.1007/s00216-005-0019-4.
   Yoshida T, 2002, ARCH ENVIRON CON TOX, V43, P481, DOI 10.1007/s00244-002-1228-x.
   Zhang YH, 2009, J PEDIATR, V155, P500, DOI 10.1016/j.jpeds.2009.04.007.
   Zona R, 2002, WATER RES, V36, P1369, DOI 10.1016/S0043-1354(01)00323-2.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{9}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{907CF}},
Wos-Id = {{ISI:000301394700038}},
}

@article{ ISI:000301229600003,
Author = {Mitchell, R. T. and Childs, A. J. and Anderson, R. A. and van den
   Driesche, S. and Saunders, P. T. K. and McKinnell, C. and Wallace, W. H.
   B. and Kelnar, C. J. H. and Sharpe, R. M.},
Title = {{Do Phthalates Affect Steroidogenesis by the Human Fetal Testis? Exposure
   of Human Fetal Testis Xenografts to Di-n-Butyl Phthalate}},
Journal = {{JOURNAL OF CLINICAL ENDOCRINOLOGY \& METABOLISM}},
Year = {{2012}},
Volume = {{97}},
Number = {{3}},
Pages = {{E341-E348}},
Month = {{MAR}},
Abstract = {{Context: Phthalates are ubiquitous environmental chemicals. Fetal
   exposure to certain phthalates {[}e. g. di-n-butyl phthalate (DBP)]
   causes masculinization disorders in rats, raising concern for similar
   effects in humans. We investigated whether DBP exposure impairs
   steroidogenesis by the human fetal testis.
   Objective: The aim of the study was to determine effects of DBP exposure
   on testosterone production by normally growing human fetal testis
   xenografts.
   Design: Humanfetal testes (14-20wkgestation; n = 12) were xenografted
   into castrate male nude mice that were treated for 4-21 dwith vehicle,
   or 500 mg/kg.dDBP, or monobutyl phthalate (active metabolite of DBP);
   all mice were treated with human chorionic gonadotropin to mimic normal
   human pregnancy. Rat fetal testis xenografts were exposed for 4 d to DBP
   as a positive control.
   Main Outcome Measures: Testosterone production was assessed by measuring
   host serum testosterone and seminal vesicle (SV) weights at termination,
   plus testis gene expression (rats).
   Results: Human fetal testis xenografts showed similar survival (similar
   to 80\%) and total graft weight (8.6 vs. 10.1 mg) in vehicle and
   DBP-exposed hosts, respectively. Serum testosterone (0.56 vs. 0.64
   ng/ml; P > 0.05) and SV weight (67.2 vs. 81.9 mg; P > 0.05) also did not
   differ. Exposure to monobutyl phthalate gave similar results. In
   contrast, exposure of rat fetal xenografts to DBP significantly reduced
   SV weight and testis Cyp11a1/StAR mRNA expression and lowered
   testosterone levels, confirming that DBP exposure can inhibit
   steroidogenesis in xenografts, further validating the negative findings
   on testosterone production in the human.
   Conclusions: Exposure of human fetal testes to DBP is unlikely to impair
   testosterone production as it does in rats. This has important safety
   and regulatory implications. (J Clin Endocrinol Metab 97: E341-E348,
   2012)}},
Publisher = {{ENDOCRINE SOC}},
Address = {{8401 CONNECTICUT AVE, SUITE 900, CHEVY CHASE, MD 20815-5817 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mitchell, RT (Reprint Author), Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Reprod Hlth, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.
   Mitchell, R. T.; Childs, A. J.; Anderson, R. A.; van den Driesche, S.; Saunders, P. T. K.; McKinnell, C.; Sharpe, R. M., Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Reprod Hlth, Edinburgh EH16 4TJ, Midlothian, Scotland.
   Mitchell, R. T.; Wallace, W. H. B.; Kelnar, C. J. H., Edinburgh Royal Hosp Sick Children, Edinburgh EH9 1LF, Midlothian, Scotland.}},
DOI = {{10.1210/jc.2011-2411}},
ISSN = {{0021-972X}},
Keywords-Plus = {{IN-UTERO EXPOSURE; TESTICULAR DEVELOPMENTAL PROBLEMS; GERM-CELL
   DIFFERENTIATION; DI(N-BUTYL) PHTHALATE; SEXUAL-DIFFERENTIATION;
   REPRODUCTIVE HORMONES; ANOGENITAL DISTANCE; DYSGENESIS SYNDROME;
   PROGRAMMING WINDOW; GENE-EXPRESSION}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Endocrinology \& Metabolism}},
Author-Email = {{Rod.Mitchell@ed.ac.uk}},
ResearcherID-Numbers = {{Sharpe, Richard/D-2725-2013}},
Funding-Acknowledgement = {{Medical Research Council {[}G33253, G1100357]; British Society for
   Paediatric Endocrinology and Diabetes; Medical Research Scotland
   {[}354FRG]}},
Funding-Text = {{This work was supported in part by Grants G33253 (to R.M.S.) and
   G1100357 (to R.A.A.) from the Medical Research Council and a research
   award from the British Society for Paediatric Endocrinology and Diabetes
   (to R.T.M.). A.J.C. is supported by Medical Research Scotland (Grant
   354FRG).}},
Cited-References = {{Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   Clewell RA, 2010, TOXICOL IN VITRO, V24, P327, DOI 10.1016/j.tiv.2009.08.003.
   Clewell RA, 2009, TOXICOLOGY, V255, P80, DOI 10.1016/j.tox.2008.10.010.
   Eisenberg ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018973.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Gaido KW, 2007, TOXICOL SCI, V97, P491, DOI 10.1093/toxsci/kfm049.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hallmark N, 2007, ENVIRON HEALTH PERSP, V115, P390, DOI 10.1289/ehp.9490.
   Hileman B., 2007, CALIFORNIA BANS PHTH, P12.
   Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009.
   Hsieh Michael H, 2008, Curr Urol Rep, V9, P137, DOI 10.1007/s11934-008-0025-0.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Jobling MS, 2011, INT J ANDROL, V34, pE386, DOI 10.1111/j.1365-2605.2010.01140.x.
   Kamrin MA, 2009, J TOXICOL ENV HEAL B, V12, P157, DOI 10.1080/10937400902729226.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Lambrot R, 2009, ENVIRON HEALTH PERSP, V117, P32, DOI 10.1289/ehp.11146.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Grigor KM, 2007, INT J ANDROL, V30, P204.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   McKinnell C, 2009, HUM REPROD, V24, P2244, DOI 10.1093/humrep/dep200.
   Mendiola J, 2011, INT J ANDROL, V34, P369, DOI 10.1111/j.1365-2605.2010.01095.x.
   Mitchell RT, 2008, HUM REPROD, V23, P2755, DOI 10.1093/humrep/den295.
   Mitchell RT, 2010, HUM REPROD, V25, P2405, DOI 10.1093/humrep/deq183.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Plummer S, 2007, TOXICOL SCI, V97, P520, DOI 10.1093/toxsci/kfm062.
   Polkinghorne J, 1989, REV GUIDANCE RES USE.
   Scott HM, 2008, ENDOCRINOLOGY, V149, P5280, DOI 10.1210/en.2008-0413.
   Scott HM, 2009, ENDOCR REV, V30, P883, DOI 10.1210/er.2009-0016.
   Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Skakkebek NE, 2007, INT J ANDROL, V30, P198, DOI 10.1111/j.1365-2605.2007.00776.x.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Thompson CJ, 2005, BIOL REPROD, V73, P908, DOI 10.1095/biolreprod.105.042382.
   Van Eyck AS, 2010, FERTIL STERIL, V93, P1676, DOI 10.1016/j.fertnstert.2009.04.048.
   Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{15}},
Journal-ISO = {{J. Clin. Endocrinol. Metab.}},
Doc-Delivery-Number = {{904WM}},
Wos-Id = {{ISI:000301229600003}},
}

@article{ ISI:000301030000004,
Author = {Kransler, Kevin M. and Bachman, Ammie N. and McKee, Richard H.},
Title = {{A comprehensive review of intake estimates of di-isononyl phthalate
   (DINP) based on indirect exposure models and urinary biomonitoring data}},
Journal = {{REGULATORY TOXICOLOGY AND PHARMACOLOGY}},
Year = {{2012}},
Volume = {{62}},
Number = {{2}},
Pages = {{248-256}},
Month = {{MAR}},
Abstract = {{Di-isononyl phthalate (DINP) is a high molecular weight general purpose
   plasticizer used principally in the manufacture of flexible polyvinyl
   chloride (PVC) articles. DINP metabolites can be measured in biological
   media such as blood and urine. However, measurement of a substance in
   the blood or urine does not by itself mean that the chemical causes or
   is associated with adverse health outcomes. This is particularly
   pertinent given the advances in modern analytical techniques whereby
   ever diminishing trace amounts of substances can be detected. Therefore,
   it is a scientific necessity that risk assessors understand the
   relationship of biomonitoring data to estimation of exposure so that
   appropriate comparisons can be made to the no observed adverse effects
   levels (NOAELs) or other points of departure from toxicological studies
   in animals. In this paper, estimates of daily DINP intake are calculated
   for various population segments based on urinary biomonitoring data and
   are compared to estimates of exposure based on indirect methods and to
   health-based exposure guidance values. In general, intake estimates
   converge on a mean of 1-2 mu g/kg/day regardless of source of exposure
   or population cluster; a value 2-orders of magnitude lower than
   health-based exposure guidance values, ranging from 120 to 290 mu
   g/kg/day, which have been established by regulatory authorities and
   other authoritative bodies as representing acceptable levels. (C) 2012
   Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kransler, KM (Reprint Author), ExxonMobil Biomed Sci Inc, 1545 Route 22 E, Annandale, NJ 08801 USA.
   Kransler, Kevin M.; Bachman, Ammie N.; McKee, Richard H., ExxonMobil Biomed Sci Inc, Annandale, NJ 08801 USA.}},
DOI = {{10.1016/j.yrtph.2012.01.001}},
ISSN = {{0273-2300}},
Keywords = {{Di-isononyl phthalate; DINP; Biomonitoring; Exposure estimates; Human;
   Urine}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; DIISONONYL PHTHALATE; RISK-ASSESSMENT;
   DEVELOPMENTAL TOXICITY; ISO-NONYLPHTHALATE; PREGNANT-WOMEN;
   ORAL-EXPOSURE; BREAST-MILK; METABOLITES; ESTERS}},
Research-Areas = {{Legal Medicine; Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Medicine, Legal; Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{kevin.kransler@exxonmobil.com
   ammie.n.bachman@exxonmobil.com
   richard.h.mckee@exxonmobil.com}},
Cited-References = {{Anderson WAC, 2011, FOOD CHEM TOXICOL, V49, P2022, DOI 10.1016/j.fct.2011.05.013.
   Babich MA, 2004, REGUL TOXICOL PHARM, V40, P151, DOI 10.1016/j.yrtph.2004.06.005.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   Butala J., 1996, TOXICOLOGIST, V30, P202.
   Butala J, 1997, TOXICOLOGIST, V36, P173.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Calafat AM, 2011, ENVIRON HEALTH PERSP, V119, P50, DOI 10.1289/ehp.1002316.
   Chronic Health Advisory Panel, 2001, REP US CONS PROD SAF.
   Clark KE, 2011, HUM ECOL RISK ASSESS, V17, P923, DOI 10.1080/10807039.2011.588157.
   Cousins I, 2000, CHEMOSPHERE, V41, P1389, DOI 10.1016/S0045-6535(00)00005-9.
   CSTEE, 1998, OP EXPR CSTEE 3 PLEN.
   CSTEE, 2001, EU SCI COMM TOX EC E.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   ECETOC, 2001, TR079 ECETOC.
   European Chemicals Bureau, 2003, RISK ASSESSMENT REPO, V35.
   European Food Safety Authority, 2005, EFSAQ2003194.
   Frederiksen H, 2010, J ANAL TOXICOL, V34, P400.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   Fromme H, 2011, ENVIRON INT, V37, P715, DOI 10.1016/j.envint.2011.02.008.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Gill US, 2001, REV ENVIRON CONTAM T, V172, P87.
   Goen T, 2011, INT J HYG ENVIR HEAL, V215, P36, DOI 10.1016/j.ijheh.2011.07.011.
   Guo Y, 2011, ENVIRON SCI TECHNOL, V45, P3138, DOI 10.1021/es103879m.
   Guo Y, 2011, ENVIRON INT, V37, P893, DOI 10.1016/j.envint.2011.03.005.
   Health Canada, 1998, CONS PROD DIV.
   Hellwig J, 1997, FOOD CHEM TOXICOL, V35, P501, DOI 10.1016/S0278-6915(97)00008-2.
   Hildenbrand S, 2009, INT J HYG ENVIR HEAL, V212, P679, DOI 10.1016/j.ijheh.2009.06.003.
   Karbe E, 2002, TOXICOL PATHOL, V30, P216, DOI 10.1080/019262302753559551.
   Kavlock R, 2002, REPROD TOXICOL, V16, P679, DOI 10.1016/S0890-6238(02)00034-5.
   Koch HM, 2011, INT J HYG ENVIR HEAL, V214, P188, DOI 10.1016/j.ijheh.2011.01.009.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Kondo F, 2010, B ENVIRON CONTAM TOX, V85, P92, DOI 10.1007/s00128-010-0051-8.
   Konemann W.H, 1998, 613320002 RIVM.
   Latini G, 2009, ENVIRON INT, V35, P236, DOI 10.1016/j.envint.2008.06.002.
   Lin S, 2011, CHEMOSPHERE, V82, P947, DOI 10.1016/j.chemosphere.2010.10.073.
   Lington AW, 1997, FUND APPL TOXICOL, V36, P79, DOI 10.1006/faat.1997.2286.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   NTP-CERHR, 2003, NTP CERHR MON POT HU.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Remer T, 2002, AM J CLIN NUTR, V75, P561.
   RIVM Rijksinstituut voor Volksgesondheid en Milieu (National Institute of Public Health and Environment), 1998, 613320002 RIVM.
   Sears J. K., 1982, TECHNOLOGY PLASTICIZ.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Sugita T, 2003, J FOOD HYG SOC JPN, V44, P96.
   Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9.
   Tietz N.W., 2006, TIETZ TXB CLIN CHEM.
   Tsumura Y, 2003, FOOD ADDIT CONTAM, V20, P317, DOI 10.1080/0265203031000122021.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474.
   United States Consumer Products Safety Commission, 2003, YOUNG CHILDREN PLAST, V8, P3.
   United States Consumer Products Safety Commission, 2002, 991 HP US CONS PROD.
   United States Consumer Products Safety Commission, 1998, RISK CHRON TOX ASS E.
   United States Environmental Protection Agency, 1997, EXP FACT HDB.
   United States Environmental Protection Agency, 2008, CHILD SPEC EXP FACT.
   Waterman SJ, 1999, REPROD TOXICOL, V13, P131, DOI 10.1016/S0890-6238(99)00002-7.
   Waterman SJ, 2000, REPROD TOXICOL, V14, P21, DOI 10.1016/S0890-6238(99)00067-2.
   Witorsch RJ, 2010, CRIT REV TOXICOL, V40, P1, DOI 10.3109/10408444.2010.515563.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wittassek M., 2010, MOL NUTR FOOD RES, V54, P1.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Ye CW, 2009, ANAL CHIM ACTA, V641, P64, DOI 10.1016/j.aca.2009.02.052.
   Ye XB, 2009, INT J HYG ENVIR HEAL, V212, P481, DOI 10.1016/j.ijheh.2009.03.004.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.
   Kasper-Sonnenberg M, 2012, INT J HYG ENVIR HEAL, V215, P373, DOI 10.1016/j.ijheh.2011.09.004.}},
Number-of-Cited-References = {{71}},
Times-Cited = {{1}},
Journal-ISO = {{Regul. Toxicol. Pharmacol.}},
Doc-Delivery-Number = {{902HU}},
Wos-Id = {{ISI:000301030000004}},
}

@article{ ISI:000301329800004,
Author = {Christen, Verena and Crettaz, Pierre and Oberli-Schraemmli, Aurelia and
   Fent, Karl},
Title = {{Antiandrogenic activity of phthalate mixtures: Validity of concentration
   addition}},
Journal = {{TOXICOLOGY AND APPLIED PHARMACOLOGY}},
Year = {{2012}},
Volume = {{259}},
Number = {{2}},
Pages = {{169-176}},
Month = {{MAR 1}},
Abstract = {{Phthalates and bisphenol A have very widespread use leading to
   significant exposure of humans. They are suspected to interfere with the
   endocrine system, including the androgen, estrogen and the thyroid
   hormone system. Here we analyzed the antiandrogenic activity of six
   binary, and one ternary mixture of phthalates exhibiting complete
   antiandrogenic dose-response curves, and binary mixtures of phthalates
   and bisphenol A at equi-effective concentrations of EC10, EC25 and EC50
   in MDA-kb2 cells. Mixture activity followed the concentration addition
   (CA) model with a tendency to synergism at high and antagonism at low
   concentrations. Isoboles and the toxic unit approach (TUA) confirmed the
   additive to synergistic activity of the binary mixtures BBP + DBP, DBP +
   DEP and DEP + BPA at high concentrations. Both methods indicate a
   tendency to antagonism for the EC10 mixtures BBP + DBP, BBP + DEP and
   DBP + DEP, and the EC25 mixture of DBP + BPA. A ternary mixture revealed
   synergism at the EC50, and weak antagonistic activity at the EC25 level
   by the TUA. A mixture of five phthalates representing a human urine
   composition and reflecting exposure to corresponding parent compounds
   showed no antiandrogenic activity. Our study demonstrates that CA is an
   appropriate concept to account for mixture effects of antiandrogenic
   phthalates and bisphenol A. The interaction indicates a departure from
   additivity to antagonism at low concentrations, probably due to
   interaction with the androgen receptor and/or cofactors. This study
   emphasizes that a risk assessment of phthalates should account for
   mixture effects by applying the CA concept. (C) 2012 Elsevier Inc. All
   rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fent, K (Reprint Author), Univ Appl Sci NW Switzerland, Sch Life Sci, Grundenstr 40, CH-4132 Muttenz, Switzerland.
   Christen, Verena; Fent, Karl, Univ Appl Sci NW Switzerland, Sch Life Sci, CH-4132 Muttenz, Switzerland.
   Crettaz, Pierre; Oberli-Schraemmli, Aurelia, Swiss Fed Off Publ Hlth, Div Chem Prod, CH-3003 Bern, Switzerland.
   Fent, Karl, Swiss Fed Inst Technol Zurich ETH Zurich, Dept Environm Sci, CH-8092 Zurich, Switzerland.}},
DOI = {{10.1016/j.taap.2011.12.021}},
ISSN = {{0041-008X}},
Keywords = {{Phthalates; Benzylbutylphthalate (BBP); Dibutyl phthalate (DBP);
   Diethylphthalate (DEP); Dimethyl phthalate (DMP); Di-2-ethylhexyl
   phthalate (DEHP); Bisphenol A; Mixture activity; Antiandrogenicity;
   Concentration addition; Toxic unit approach; Isobole method}},
Keywords-Plus = {{UV FILTER MIXTURES; FETAL-RAT TESTIS; IN-VITRO ASSAYS; REPRODUCTIVE
   DEVELOPMENT; TESTOSTERONE PRODUCTION; DIETHYLHEXYL PHTHALATE; ESTROGENIC
   ACTIVITY; ANTI-ANDROGENS; CELL-LINE; CHEMICALS}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{karl.fent@bluewin.ch}},
Funding-Acknowledgement = {{Swiss Federal Office of Public Health {[}08.004889df]; Ecotoxicology
   Centre, Diibendorf}},
Funding-Text = {{We thank Petra Kunz, Ecotoxicology Centre, Diibendorf, for helpful
   discussion and support. The study was funded by the Swiss Federal Office
   of Public Health (Project No. 08.004889df to K.F.).}},
Cited-References = {{Ahn KC, 2008, ENVIRON HEALTH PERSP, V116, P1203, DOI 10.1289/ehp.11200.
   Ait-Aissa S, 2010, TOXICOL IN VITRO, V24, P1979, DOI 10.1016/j.tiv.2010.08.014.
   Andersen HR, 1999, ENVIRON HEALTH PERSP, V107, P89, DOI 10.2307/3434476.
   Benson R, 2009, REGUL TOXICOL PHARM, V53, P90, DOI 10.1016/j.yrtph.2008.11.005.
   BERENBAUM MC, 1989, PHARMACOL REV, V41, P93.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   Chang CY, 2005, TRENDS PHARMACOL SCI, V26, P225, DOI 10.1016/j.tips.2005.03.002.
   Christen V, 2010, CHEMOSPHERE, V81, P1245, DOI 10.1016/j.chemosphere.2010.09.031.
   Christiansen S, 2009, ENVIRON HEALTH PERSP, V117, P1839, DOI 10.1289/ehp.0900689.
   Ermler S, 2011, TOXICOL APPL PHARM, V257, P189, DOI 10.1016/j.taap.2011.09.005.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   Stoker TE, 2005, TOXICOL APPL PHARM, V207, P78, DOI 10.1016/j.taap.2005.05.010.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Korner W, 2004, ENVIRON HEALTH PERSP, V112, P695, DOI 10.1289/ehp.6715.
   Kortenkamp A, 2010, INT J ANDROL, V33, P463, DOI 10.1111/j.1365-2605.2009.01047.x.
   Kortenkamp A, 1998, SCI TOTAL ENVIRON, V221, P59, DOI 10.1016/S0048-9697(98)00261-7.
   Kunz PY, 2009, TOXICOL APPL PHARM, V234, P77, DOI 10.1016/j.taap.2008.09.032.
   Kunz PY, 2006, TOXICOL APPL PHARM, V217, P86, DOI 10.1016/j.taap.2006.07.014.
   Lambrot R, 2009, ENVIRON HEALTH PERSP, V117, P32, DOI 10.1289/ehp.11146.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Martino-Andrade AJ, 2009, INT J ANDROL, V32, P704, DOI 10.1111/j.1365-2605.2008.00939.x.
   NRC (National Research Council), 2008, PHTHAL CUM RISK ASS.
   Rider CV, 2010, INT J ANDROL, V33, P443, DOI 10.1111/j.1365-2605.2009.01049.x.
   Rider CV, 2009, TOXICOL PATHOL, V37, P100, DOI 10.1177/0192623308329478.
   Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x.
   Schlumpf M, 2010, CHEMOSPHERE, V81, P1171, DOI 10.1016/j.chemosphere.2010.09.079.
   Sharpe R.M., 2005, ENV HLTH PERSPECT, V113, P504.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Terouanne B, 2000, MOL CELL ENDOCRINOL, V160, P39, DOI 10.1016/S0303-7207(99)00251-8.
   Wilson VS, 2002, TOXICOL SCI, V66, P69, DOI 10.1093/toxsci/66.1.69.
   Zacharewski T, 1998, ENVIRON HEALTH PERSP, V106, P577, DOI 10.2307/3433808.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{3}},
Journal-ISO = {{Toxicol. Appl. Pharmacol.}},
Doc-Delivery-Number = {{906FH}},
Wos-Id = {{ISI:000301329800004}},
}

@article{ ISI:000300459100011,
Author = {Silva, Manori J. and Furr, Johnathan and Preau, Jr., James L. and
   Samandar, Ella and Gray, L. Earl and Calafat, Antonia M.},
Title = {{Identification of potential biomarkers of exposure to
   di(isononyl)cyclohexane-1,2-dicarboxylate (DINCH), an alternative for
   phthalate plasticizers}},
Journal = {{JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY}},
Year = {{2012}},
Volume = {{22}},
Number = {{2}},
Pages = {{204-211}},
Month = {{MAR-APR}},
Abstract = {{Di(isononyl)cyclohexane-1,2-dicarboxylate (DINCH) is used as an
   alternative for some phthalate plasticizers. In rats, DINCH mostly
   eliminates in feces as cyclohexane-1,2-dicarboxylic acid (CHDA), mono
   isononyl ester (MINCH) or in urine as CHDA. However, CHDA is not a
   specific biomarker of DINCH and measuring MINCH in feces is impractical.
   To identify additional potential biomarkers, we administered DINCH (500
   mg/kg body weight) in a single subcutaneous (SC) or oral dose to four
   adult female Sprague Dawley rats. We collected 24-h urine samples before
   dosing (to be used as controls) and 24-h and 48-h after dosing, and
   serum at necropsy after 48 h. We positively identified and accurately
   quantified CHDA and cyclohexane-1,4-dicarboxylic acid, mono
   hydroxyisononyl ester (MHNCH) using authentic standards. Moreover, we
   tentatively identified MINCH and 12 oxidative metabolites, including 4
   cyclohexane ring oxidation products, based on their mass
   spectrometric-fragmentation patterns. CHDA and MHNCH levels were higher
   in the urine collected 24 h after oral than SC administration. By
   contrast, 48-h after dosing, CHDA urinary levels were similar regardless
   of the exposure route. We detected all but two of the urine metabolites
   also in serum. Levels of CHDA and MHNCH in serum were lower than in the
   two post-dose urine collections. Our results suggest that several
   urinary oxidative metabolites, specifically CHDA, mono oxoisononyl ester
   and MHNCH may be used as specific biomarkers of DINCH exposure in
   humans. Journal of Exposure Science and Environmental Epidemiology
   (2012) 22, 204-211; doi:10.1038/jes.2011.43; published online 18 January
   2012}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Mailstop F53,4770 Buford Highway, Chamblee, GA 30341 USA.
   Silva, Manori J.; Preau, James L., Jr.; Samandar, Ella; Calafat, Antonia M., Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Furr, Johnathan; Gray, L. Earl, US EPA, Reprod Toxicol Branch, Tox Assessment Div, Natl Hlth \& Environm Effects Res Lab,Off Res \& De, Res Triangle Pk, NC 27711 USA.}},
DOI = {{10.1038/jes.2011.43}},
ISSN = {{1559-0631}},
Keywords = {{DINCH; biomonitoring; plasticizer; biomarkers; exposure assessment;
   oxidative metabolism}},
Keywords-Plus = {{ISO-NONYLPHTHALATE DINP; HUMAN URINE; DI(ISONONYL)
   CYCLOHEXANE-1,2-DICARBOXYLATE; ENVIRONMENTAL CHEMICALS;
   MECHANICAL-PROPERTIES; ISONONYL PHTHALATE; MASS-SPECTROMETRY;
   METABOLITES; RATS; MORPHOLOGY}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{zca2@cdc.gov}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   Biedermann-Brem S, 2008, CHROMATOGRAPHIA, V68, P227, DOI 10.1365/s10337-008-0672-9.
   Calafat AM, 2006, INT J ANDROL, V29, P166, DOI 10.1111/j.1365-2605.2005.00570.x.
   CPSC, 2010, REV EXP TOX DAT PHTH.
   Crespo JE, 2009, J ELASTOM PLAST, V41, P145, DOI 10.1177/0095244308092438.
   Crespo JE, 2007, J APPL POLYM SCI, V104, P1215, DOI 10.1002/app.25760.
   Doerge DR, 2010, TOXICOL APPL PHARM, V247, P158, DOI 10.1016/j.taap.2010.06.008.
   EFSA, 2006, EFSA J, P395.
   Egestad B, 1996, J CHROMATOGR B, V677, P99, DOI 10.1016/0378-4347(95)00439-4.
   Kato K, 2007, TOXICOLOGY, V236, P114, DOI 10.1016/j.tox.2007.04.009.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   Nativelle C, 1999, FOOD CHEM TOXICOL, V37, P905, DOI 10.1016/S0278-6915(99)00071-X.
   Needham LL, 2004, NEUROTOXICOLOGY, V25, P666.
   Rothenbacher T, 2009, RAPID COMMUN MASS SP, V23, P2829, DOI 10.1002/rcm.4194.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Sexton K, 2004, AM SCI, V92, P38, DOI 10.1511/2004.45.921.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Silva MJ, 2007, ENVIRON SCI TECHNOL, V41, P7576, DOI 10.1021/es071142x.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Silva MJ, 2011, CHEMOSPHERE, V82, P431, DOI 10.1016/j.chemosphere.2010.09.052.
   Tukova J, 2009, CLIN EXP RHEUMATOL, V27, P1047.
   Wadey BL, 2003, J VINYL ADDIT TECHN, V9, P172, DOI 10.1002/vnl.10080.
   Wang RY, 2009, POLYM ENG SCI, V49, P2414, DOI 10.1002/pen.21490.
   {[}Anonymous], 2006, Official Journal of the European Union, Patent No. {[}9932427, 99/32427].}},
Number-of-Cited-References = {{27}},
Times-Cited = {{3}},
Journal-ISO = {{J. Expo. Sci. Environ. Epidemiol.}},
Doc-Delivery-Number = {{894WV}},
Wos-Id = {{ISI:000300459100011}},
}

@article{ ISI:000300462500036,
Author = {Zhou, Xi-Min and Lue, Wen-Juan and Su, Li and Shan, Zhi-Jie and Chen,
   Xing-Guo},
Title = {{Binding of Phthalate Plasticizers to Human Serum Albumin in Vitro: A
   Multispectroscopic Approach and Molecular Modeling}},
Journal = {{JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY}},
Year = {{2012}},
Volume = {{60}},
Number = {{4}},
Pages = {{1135-1145}},
Month = {{FEB 1}},
Abstract = {{As endocrine-disrupting chemicals, a few frequently used phthalate
   plasticizers were banned or restricted for use as additives in food in
   some countries. The interaction mechanisms between three phthalate
   plasticizers with human serum albumin (HSA) were studied by fluorescence
   (quenching, synchronous, and three-dimensional), UV-vis absorption,
   circular dichroism (CD), and Fourier transform infrared (FT-IR)
   spectroscopy, in combination with molecular modeling under simulative
   physiological conditions, respectively. The results obtained from
   fluorescence quenching data revealed that the plasticizers-HSA
   interaction altered the conformational strcture of HSA. Meanwhile, the
   alterations of HSA secondary structure in the presence of phthalate
   plasticizers were investigated. The binding distances for the
   plasticizers-HSA system were provided by the efficiency of fluorescence
   resonance energy transfer. Furthermore, the thermodynamic analysis
   implied that hydrophobic forces were the main interaction for the
   plasticizers-HSA system, which agreed well with the results from the
   molecular modeling study.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chen, XG (Reprint Author), Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.
   Zhou, Xi-Min; Lue, Wen-Juan; Su, Li; Shan, Zhi-Jie; Chen, Xing-Guo, Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.
   Zhou, Xi-Min; Lue, Wen-Juan; Su, Li; Shan, Zhi-Jie; Chen, Xing-Guo, Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China.
   Chen, Xing-Guo, Key Lab Nonferrous Met Chem \& Resources Utilizat, Lanzhou 730000, Peoples R China.}},
DOI = {{10.1021/jf204380r}},
ISSN = {{0021-8561}},
Keywords = {{phthalate plasticizers; human serum albumin (HSA); fluorescence
   quenching; circular dichroism (CD); Fourier transform infrared (FT-IR)}},
Keywords-Plus = {{BISPHENOL-A; PROTEIN; BOVINE; FLUORESCENCE; ESTERS; DRUGS; SPECTROSCOPY;
   DOCKING; WATER}},
Research-Areas = {{Agriculture; Chemistry; Food Science \& Technology}},
Web-of-Science-Categories  = {{Agriculture, Multidisciplinary; Chemistry, Applied; Food Science \&
   Technology}},
Author-Email = {{chenxg@lzu.edu.cn}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}21075056, J0730425];
   Fundamental Research Funds for the Central Universities
   {[}lzujbky-2010-40]}},
Funding-Text = {{We are grateful for financial support from the National Natural Science
   Foundation of China (No. 21075056, J0730425) and the Fundamental
   Research Funds for the Central Universities (lzujbky-2010-40).}},
Cited-References = {{Boberg J, 2008, TOXICOLOGY, V250, P75, DOI 10.1016/j.tox.2008.05.020.
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153.
   Casajuana N, 2004, J AGR FOOD CHEM, V52, P3702, DOI 10.1021/jf040027s.
   DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022.
   Epps DE, 1999, J PHARM PHARMACOL, V51, P41, DOI 10.1211/0022357991772079.
   Gong AQ, 2007, TALANTA, V73, P668, DOI 10.1016/j.talanta.2007.04.041.
   HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0.
   Hu YJ, 2004, J PHARMACEUT BIOMED, V36, P915, DOI 10.1016/j.jpba.2004.08.021.
   Khan MA, 2002, INT J BIOL MACROMOL, V30, P243, DOI 10.1016/S0141-8130(02)00038-7.
   Kuo PL, 2011, J AGR FOOD CHEM, V59, P3429, DOI 10.1021/jf1049485.
   Lakowicz J., 1983, PRINCIPLES FLUORESCE, P258.
   Lu SY, 2010, J MOL GRAPH MODEL, V28, P766, DOI 10.1016/j.jmgm.2010.02.001.
   Mallick A, 2005, J PHYS CHEM B, V109, P14683, DOI 10.1021/jp051367z.
   Matei Iulia, 2011, J LUMIN, V131, P1629.
   Miller J. N., 1979, P ANAL DIV CHEM SOC, V16, P203.
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B.
   RAHMAN MH, 1993, BIOCHEM PHARMACOL, V46, P1721, DOI 10.1016/0006-2952(93)90576-I.
   Robert B, 2009, REGUL TOXICOL PHARM, V53, P90.
   ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017.
   Sirotkin VA, 2001, BBA-PROTEIN STRUCT M, V1547, P359, DOI 10.1016/S0167-4838(01)00201-1.
   SJOHOLM I, 1979, MOL PHARMACOL, V16, P767.
   SKLAR LA, 1977, BIOCHEMISTRY-US, V16, P5100, DOI 10.1021/bi00642a024.
   Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1.
   Sulkowska A, 2002, J MOL STRUCT, V614, P227, DOI 10.1016/S0022-2860(02)00256-9.
   Wang YQ, 2009, J PHOTOCH PHOTOBIO B, V94, P183, DOI 10.1016/j.jphotobiol.2008.11.013.
   Xiao JB, 2010, J HAZARD MATER, V182, P696, DOI 10.1016/j.jhazmat.2010.06.088.
   Xie XY, 2011, J HAZARD MATER, V192, P1291, DOI 10.1016/j.jhazmat.2011.06.038.
   Yang XZ, 2009, J AGR FOOD CHEM, V57, P3431, DOI 10.1021/jf803671s.
   Yue Y, 2008, J PHOTOCH PHOTOBIO B, V90, P26, DOI 10.1016/j.jphotobiol.2007.10.003.
   Zhang YZ, 2008, LUMINESCENCE, V23, P150, DOI 10.1002/bio.1025.
   Zhang ZB, 2011, TOXICOL LETT, V207, P7, DOI 10.1016/j.toxlet.2011.08.017.
   Zhang ZH, 2011, J LUMIN, V131, P1386, DOI 10.1016/j.jlumin.2011.03.013.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{7}},
Journal-ISO = {{J. Agric. Food Chem.}},
Doc-Delivery-Number = {{894YD}},
Wos-Id = {{ISI:000300462500036}},
}

@article{ ISI:000299915400036,
Author = {Whyatt, Robin M. and Liu, Xinhua and Rauh, Virginia A. and Calafat,
   Antonia M. and Just, Allan C. and Hoepner, Lori and Diaz, Diurka and
   Quinn, James and Adibi, Jennifer and Perera, Frederica P. and
   Factor-Litvak, Pam},
Title = {{Maternal Prenatal Urinary Phthalate Metabolite Concentrations and Child
   Mental, Psychomotor, and Behavioral Development at 3 Years of Age}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2012}},
Volume = {{120}},
Number = {{2}},
Pages = {{290-295}},
Month = {{FEB}},
Abstract = {{BACKGROUND: Research suggests that prenatal phthalate exposures affect
   child executive function and behavior.
   OBJECTIVE: We evaluated associations between phthalate metabolite
   concentrations in maternal prenatal urine and mental, motor, and
   behavioral development in children at 3 years of age.
   METHODS: Mono-n-butyl phthalate (MnBP), monobenzyl phthalate (MBzP),
   monoisobutyl phthalate (MiBP), and four di-2-ethylhexyl phthalate
   metabolites were measured in a spot urine sample collected from 319
   women during the third trimester. When children were 3 years of age, the
   Mental Development Index (MDI) and Psychomotor Development Index (PDI)
   were measured using the Bayley Scales of Infant Development II, and
   behavior problems were assessed by maternal report on the Child Behavior
   Checklist.
   RESULTS: Child PDI scores decreased with increasing log(e) MnBP
   {[}estimated adjusted beta-coefficient = -2.81; 95\% confidence interval
   (CI): -4.63, -1.0] and log(e) MiBP (beta = -2.28; 95\% CI: -3.90,
   -0.67); odds of motor delay increased significantly {[}per log(e) MnBP:
   estimated adjusted odds ratio (OR) = 1.64; 95\% CI: 1.10, 2.44; per
   log(e) MiBP: adjusted OR =1.82; 95\% CI: 1.24, 2.66]. In girls, MDI
   scores decreased with increasing log(e) MnBP (beta = -2.67; 95\% CI:
   -4.70, -0.65); the child sex difference in odds of mental delay was
   significant (p = 0.037). The ORs for clinically withdrawn behavior were
   2.23 (95\% CI: 1.27, 3.92) and 1.57 (95\% CI: 1.07, 2.31) per log(e)
   unit increase in MnBP and MBzP, respectively; for clinically
   internalizing behaviors, the OR was 1.43 (95\% CI: 1.01, 1.90) per
   log(e) unit increase in MBzP. Significant child sex differences were
   seen in associations between MnBP and MBzP and behaviors in
   internalizing domains (p < 0.05).
   CONCLUSION: Certain prenatal phthalate exposures may decrease child
   mental and motor development and increase internalizing behaviors.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Whyatt, RM (Reprint Author), Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, Dept Environm Hlth Sci, 722 W 168th St, New York, NY 10032 USA.
   Whyatt, Robin M.; Just, Allan C.; Hoepner, Lori; Diaz, Diurka; Perera, Frederica P., Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, Dept Environm Hlth Sci, New York, NY 10032 USA.
   Liu, Xinhua, Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, New York, NY 10032 USA.
   Rauh, Virginia A., Columbia Univ, Mailman Sch Publ Hlth, Dept Populat \& Family Hlth, New York, NY 10032 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Quinn, James, Columbia Univ, Inst Social \& Econ Res \& Policy, New York, NY 10032 USA.
   Adibi, Jennifer, Univ Calif San Francisco, Dept Obstet Gynecol \& Reprod Sci, San Francisco, CA USA.
   Factor-Litvak, Pam, Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA.}},
DOI = {{10.1289/ehp.1103705}},
ISSN = {{0091-6765}},
Keywords = {{behavior; child; mental; phthalates; prenatal; psychomotor}},
Keywords-Plus = {{BIS(2-ETHYLHEXYL) PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE;
   DI(2-ETHYLHEXYL) PHTHALATE; NEUROBEHAVIORAL TOXICITY; LACTATIONAL
   EXPOSURE; THYROID-HORMONES; ORAL TOXICITY; MALE RATS; IN-UTERO; SYSTEM}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{rmw5@columbia.edu}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences (NIEHS)
   {[}R01ES013543, R01ES014393, R01ES08977]; NIEHS/U.S. Environmental
   Protection Agency {[}P50 ES09600/RD 83214101]}},
Funding-Text = {{This work was supported by National Institute of Environmental Health
   Sciences (NIEHS) grants R01ES013543, R01ES014393, and R01ES08977 and by
   NIEHS/U.S. Environmental Protection Agency grant P50 ES09600/RD
   83214101. The findings expressed in this article are the opinions of the
   authors and do not necessarily reflect the official opinion of the
   Centers for Disease Control and Prevention.}},
Cited-References = {{Achenbach TM, 2000, MANUAL ASEBA PRESCHO.
   Adibi JJ, 2010, ENVIRON HEALTH PERSP, V118, P291, DOI 10.1289/ehp.0900788.
   Andrade AJM, 2006, TOXICOLOGY, V228, P85, DOI 10.1016/j.tox.2006.08.020.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   ATTREE E A, 1992, Medical Science Research, V20, P197.
   Bakker J, 2010, J NEUROENDOCRINOL, V22, P728, DOI 10.1111/j.1365-2826.2010.02016.x.
   Bayley N, 1993, BAYLEY SCALES INFANT.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   Breous E, 2005, MOL CELL ENDOCRINOL, V244, P75, DOI 10.1016/j.mce.2005.06.009.
   Brown L., 1990, TEST NONVERBAL INTEL, V2.
   Burchinal MR, 2000, CHILD DEV, V71, P339, DOI 10.1111/1467-8624.00149.
   Caldwell BM, 1979, HOME OBSERVATION MEA.
   CDC-Centers for Disease Control Prevention, 2011, 4 CDCP.
   Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376.
   DOHRENWEND BS, 1978, J HEALTH SOC BEHAV, V19, P205, DOI 10.2307/2136536.
   Doyle A, 1997, J CLIN CHILD PSYCHOL, V26, P276, DOI 10.1207/s15374424jccp2603\_6.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Eskenazi B, 2007, ENVIRON HEALTH PERSP, V115, P792, DOI 10.1289/ehp.9828.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   HENDRICH CE, 1984, NEUROENDOCRINOLOGY, V38, P429, DOI 10.1159/000123931.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356.
   Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034.
   Li YF, 2009, J APPL TOXICOL, V29, P603, DOI 10.1002/jat.1447.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Lundy SM, 2010, OPEN PEDIAT MED J, V4, P1.
   McCarthy MM, 2009, NEUROSCIENTIST, V15, P599, DOI 10.1177/1073858409340924.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P1396, DOI 10.1289/ehp.1103582.
   Miodovnik A, 2011, NEUROTOXICOLOGY, V32, P261, DOI 10.1016/j.neuro.2010.12.009.
   O'Connor JC, 2002, TOXICOL SCI, V69, P92, DOI 10.1093/toxsci/69.1.92.
   Pereira C, 2007, ACTA HISTOCHEM, V109, P29, DOI 10.1016/j.acthis.2006.09.008.
   Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94.
   PRICE SC, 1988, TOXICOL LETT, V40, P37, DOI 10.1016/0378-4274(88)90181-6.
   Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338.
   Reynolds CR, 1992, BEHAV ASSESSMENT SYS.
   Roselli CE, 2009, SEMIN REPROD MED, V27, P207, DOI 10.1055/s-0029-1216274.
   Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001.
   Sternberg RJ, 2011, MERRILLPALMER Q, V47, P1.
   Sugiyama S, 2005, TOXICOL SCI, V88, P367, DOI 10.1093/toxsci/kfi330.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Tanaka T, 2002, FOOD CHEM TOXICOL, V40, P1499, DOI 10.1016/S0278-6915(02)00073-X.
   Tanaka T, 2005, FOOD CHEM TOXICOL, V43, P581, DOI 10.1016/j.fct.2005.01.001.
   Wasserman GA, 2003, CHILD NEUROPSYCHOL, V9, P22, DOI 10.1076/chin.9.1.22.14497.
   Whyatt RM, 2009, PEDIATRICS, V124, pE1213, DOI 10.1542/peds.2009-0325.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Woodruff TJ, 2011, ENVIRON HEALTH PERSP, V119, P878, DOI 10.1289/ehp.1002727.
   Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036.
   Xu Y, 2008, PLACENTA, V29, P962, DOI 10.1016/j.placenta.2008.08.011.
   Xu Y, 2007, ARCH TOXICOL, V81, P57, DOI 10.1007/s00204-006-0143-8.
   Ye XY, 2005, ANAL CHEM, V77, P5407, DOI 10.1021/ac050390d.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{8}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{887GR}},
Wos-Id = {{ISI:000299915400036}},
}

@article{ ISI:000298597900008,
Author = {Ito, Tomohiro and Inoue, Ken-ichiro and Nishimura, Noriko and Takano,
   Hirohisa},
Title = {{Phthalate esters modulate the differentiation and maturation of mouse
   peripheral blood mononuclear cell-derived dendritic cells}},
Journal = {{JOURNAL OF APPLIED TOXICOLOGY}},
Year = {{2012}},
Volume = {{32}},
Number = {{2}},
Pages = {{142-148}},
Month = {{FEB}},
Abstract = {{Phthalate esters, such as di-(2-ethylhexyl) phthalate (DEHP), are
   widespread environmental contaminants. Previously, we have observed that
   DEHP exacerbates dermatitis elicited by mite antigen in NC/Nga mice.
   Also, DEHP enhances the functions of bone marrow-derived dendritic cells
   (DCs) in vitro. The present study sought to investigate whether
   phthalate esters affect peripheral blood mononuclear cell (PBMC)-derived
   DCs of NC/Nga mice. First, we studied the time course of DC generation
   from PBMCs and the dose dependency of granulocyte macrophage
   colony-stimulating factor and interleukin-4, and then determined the
   conditions under which DC differentiation and maturation are moderately
   induced from PBMCs. Under the conditions determined above, DEHP at 10 mu
   m significantly inhibited the expression of DC differentiation and
   maturation markers, such as CD11c, CD40, CD80, CD86 and CD205, whereas
   mono-(2-ethylhexyl) phthalate, a metabolite of DEHP, did not.
   Furthermore, the effects of DEHP on PBMC-derived DCs were partially
   rescued by treatment with ICI 182,780, an estrogen receptor antagonist.
   Taken together, these results suggest that DEHP can modulate the
   differentiation and maturation of mouse PBMC-derived DCs at least
   partially through activation of the estrogen receptor under our
   experimental conditions. Copyright (C) 2011 John Wiley \& Sons, Ltd.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ito, T (Reprint Author), Natl Inst Environm Studies, Environm Hlth Sci Div, 16-2 Onogawa, Tsukuba, Ibaraki 3058506, Japan.
   Ito, Tomohiro; Inoue, Ken-ichiro; Takano, Hirohisa, Natl Inst Environm Studies, Environm Hlth Sci Div, Tsukuba, Ibaraki 3058506, Japan.
   Nishimura, Noriko, Natl Inst Environm Studies, Res Ctr Environm Risk, Tsukuba, Ibaraki 3058506, Japan.}},
DOI = {{10.1002/jat.1652}},
ISSN = {{0260-437X}},
Keywords = {{dendritic cells; differentiation; maturation; NC; Nga mice; peripheral
   blood mononuclear cells; phthalate ester}},
Keywords-Plus = {{IN-VITRO; MALE RATS; MICE; DI(2-ETHYLHEXYL)PHTHALATE; PROGENITORS;
   APOPTOSIS; CYTOKINE; EXPOSURE; MODEL}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{itotomo@nies.go.jp}},
Funding-Acknowledgement = {{Ministry of the Environment; National Institute for Environmental
   Studies}},
Funding-Text = {{This study was supported by the Environmental Technology Development
   Fund from the Ministry of the Environment to H. T. and National
   Institute for Environmental Studies grants to T. I. The authors would
   like to thank Drs J. Yonemoto, Y. Aoki, M. Matsumoto, H. Sone, E. Koike
   and R. Yanagisawa (National Institute for Environmental Studies) for
   their useful discussions. We also thank Mrs R. Shibahara and K. Taki for
   their secretarial assistance.}},
Cited-References = {{Alam MS, 2010, REPRODUCTION, V139, P427, DOI 10.1530/REP-09-0226.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0.
   Butler M, 2007, IMMUNOLOGY, V120, P362, DOI 10.1111/j.1365-2567.2006.02512.x.
   Carreras E, 2008, J IMMUNOL, V180, P727.
   CROCKER JFS, 1988, J TOXICOL ENV HEALTH, V23, P433.
   Douin-Echinard V, 2008, J IMMUNOL, V180, P3661.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   Koike E, 2009, TOXICOLOGY, V259, P54, DOI 10.1016/j.tox.2009.02.002.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   Larsen ST, 2001, TOXICOL LETT, V125, P11.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Manome H, 1999, IMMUNOLOGY, V98, P481, DOI 10.1046/j.1365-2567.1999.00916.x.
   Mao A, 2005, J IMMUNOL, V175, P5146.
   Masurier C, 1999, IMMUNOLOGY, V96, P569.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Okubo T, 2003, BIOL PHARM BULL, V26, P1219.
   Pepin E, 2007, TOXICOL LETT, V175, P89, DOI 10.1016/j.toxiet.2007.09.012.
   ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83.
   Schreurs MWJ, 1999, EUR J IMMUNOL, V29, P2835, DOI 10.1002/(SICI)1521-4141(199909)29:09<2835::AID-IMMU2835>3.0.CO;2-Q.
   Siracusa MC, 2008, J IMMUNOL, V180, P1423.
   SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9.
   Takano H, 2006, ENVIRON HEALTH PERSP, V114, P1266, DOI 10.1289/ehp.8985.
   von Bubnoff D, 2001, J ALLERGY CLIN IMMUN, V108, P329, DOI 10.1067/mai.2001.117457.
   Yang Q, 2000, CLIN EXP IMMUNOL, V122, P219, DOI 10.1046/j.1365-2249.2000.01367.x.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{0}},
Journal-ISO = {{J. Appl. Toxicol.}},
Doc-Delivery-Number = {{869KX}},
Wos-Id = {{ISI:000298597900008}},
}

@article{ ISI:000298762900064,
Author = {Ferguson, Kelly K. and Loch-Caruso, Rita and Meeker, John D.},
Title = {{Exploration of Oxidative Stress and Inflammatory Markers in Relation to
   Urinary Phthalate Metabolites: NHANES 1999-2006}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2012}},
Volume = {{46}},
Number = {{1}},
Pages = {{477-485}},
Month = {{JAN 3}},
Abstract = {{Phthalate exposure has been associated with a wide range of adverse
   health outcomes in limited epidemiologic studies, and inflammation and
   oxidative stress have been hypothesized as potential mechanisms
   involved. In the present study we investigated associations between
   urinary concentrations of phthalate metabolites and potential blood
   markers of oxidative stress (bilirubin) and inflammation (alkaline
   phosphatase {[}ALP], absolute neutrophil count {[}ANC], ferritin
   {[}adjusted for iron status], and fibrinogen), using data from 10,026
   participants in the National Health and Nutrition Examination Survey
   (NHANES) recruited between 1999 and 2006. After adjustment for
   covariates we found that bilirubin was inversely associated with several
   phthalate metabolites (all p-values <0.0001), including the metabolites
   of di-2-ethylhexyl phthalate (DEHP) and dibutyl phthalate (DBP), in
   addition to monobenzyl phthalate (MBzP) and mono-(3-carboxypropyl)
   phthalate (MCPP). Since bilirubin is a potent antioxidant these
   relationships suggest that phthalates may be associated with increased
   oxidative stress. Many of the same metabolites were also significantly
   and positively related with ANC, ALP, and ferritin, suggesting
   phthalates may be associated with increased inflammation. These markers
   may be useful in other studies of low-dose exposure to environmental
   contaminants.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Meeker, JD (Reprint Author), Univ Michigan, Dept Environm Hlth Sci, Sch Publ Hlth, 1415 Washington Hts, Ann Arbor, MI 48109 USA.
   Ferguson, Kelly K.; Loch-Caruso, Rita; Meeker, John D., Univ Michigan, Dept Environm Hlth Sci, Sch Publ Hlth, Ann Arbor, MI 48109 USA.}},
DOI = {{10.1021/es202340b}},
ISSN = {{0013-936X}},
Keywords-Plus = {{C-REACTIVE PROTEIN; BISPHENOL-A CONCENTRATION; CORONARY-ARTERY-DISEASE;
   ALKALINE-PHOSPHATASE; SEMEN QUALITY; TEMPORAL VARIABILITY; SERUM
   BILIRUBIN; NATIONAL-HEALTH; UNITED-STATES; US POPULATION}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{meekerj@umich.edu}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences (NIEHS)
   {[}R01ES018872, P42ES017198, P20ES018171]; US Environmental Protection
   Agency (USEPA) {[}RD83480001]}},
Funding-Text = {{Work supported by grants R01ES018872, P42ES017198, and P20ES018171 from
   the National Institute of Environmental Health Sciences (NIEHS) and
   RD83480001 from the US Environmental Protection Agency (USEPA).}},
Cited-References = {{Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Bremner WF, 2000, AM HEART J, V139, P164, DOI 10.1016/S0002-8703(00)90324-7.
   BRIDGES AB, 1992, FREE RADICAL RES COM, V16, P89, DOI 10.3109/10715769209049162.
   Huang SS, 2010, HEART, V96, P1227, DOI 10.1136/hrt.2009.192393.
   Cheung BMY, 2008, CLIN CHEM LAB MED, V46, P523, DOI 10.1515/CCLM.2008.111.
   Ferguson KK, 2011, ENVIRON RES, V111, P718, DOI 10.1016/j.envres.2011.02.002.
   Frost-Pineda K, 2011, NICOTINE TOB RES, V13, P182, DOI 10.1093/ntr/ntq235.
   Giral P, 2010, ATHEROSCLEROSIS, V210, P607, DOI 10.1016/j.atherosclerosis.2009.12.026.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001.
   Hopkins PN, 1996, ARTERIOSCL THROM VAS, V16, P250.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Ito Y, 2007, J OCCUP HEALTH, V49, P172, DOI 10.1539/joh.49.172.
   Jepsen KF, 2004, TOXICOL IN VITRO, V18, P265, DOI 10.1016/j.tiv.2003.09.008.
   Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254.
   Kerner A, 2005, ARTERIOSCL THROM VAS, V25, P193, DOI 10.1161/01.ATV.0000148324.63685.6a.
   KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166.
   Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303.
   Lazo M, 2008, ANN INTERN MED, V148, P348.
   Liao DP, 2005, J EXPO ANAL ENV EPID, V15, P319, DOI 10.1038/sj.jea.7500408.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2010, MATURITAS, V66, P236, DOI 10.1016/j.maturitas.2010.03.001.
   Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522.
   Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673.
   Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742.
   Nayeem F, 2010, BIOMARKERS, V15, P663, DOI 10.3109/1354750X.2010.509811.
   NCHS, NHANES 2005 2006 LAB.
   NCHS (National Center for Health and Statistics), DOC COD FREQ UR PHTH.
   NCHS (National Center for Health and Statistics), INTR NHANES.
   NCHS (National Center for Health and Statistics), 2005 2006 DAT DOC CO.
   Northrop-Clewes CA, 2008, ANN CLIN BIOCHEM, V45, P18, DOI 10.1258/acb.2007.007167.
   Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001.
   Rael LT, 2009, OXID MED CELL LONGEV, V2, P166.
   Rakkestad KE, 2010, INHAL TOXICOL, V22, P140, DOI 10.3109/08958370903019885.
   Rusyn I, 2001, MOL PHARMACOL, V59, P744.
   SCHWERTNER HA, 1994, CLIN CHEM, V40, P18.
   Seo KW, 2004, FOOD CHEM TOXICOL, V42, P107, DOI 10.1016/j.fct.2003.08.010.
   Shekeeb Sahab M., 2008, MOL CELL BIOCHEM, V317, P51.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Skinner AC, 2010, PEDIATRICS, V125, pE801, DOI 10.1542/peds.2009-2182.
   STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864.
   Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Tell G, 2009, CURR PHARM DESIGN, V15, P2908.
   Thompson AMS, 2010, ENVIRON HEALTH PERSP, V118, P120, DOI 10.1289/ehp.0900550.
   Venn A, 2007, CIRCULATION, V115, P990, DOI 10.1161/CIRCULATIONAHA.106.648469.
   Webber M, 2010, CLIN CHEM LAB MED, V48, P167, DOI 10.1515/CCLM.2010.052.
   Weuve J, 2010, ENVIRON HEALTH PERSP, V118, P825, DOI 10.1289/ehp.0901543.
   YAMAGUCHI T, 1994, J BIOCHEM-TOKYO, V116, P298.
   Yang YJ, 2009, ENVIRON RES, V109, P797, DOI 10.1016/j.envres.2009.04.014.
   Zhou DX, 2010, SYST BIOL REPROD MED, V56, P413, DOI 10.3109/19396368.2010.509902.}},
Number-of-Cited-References = {{56}},
Times-Cited = {{2}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{871UJ}},
Wos-Id = {{ISI:000298762900064}},
}

@article{ ISI:000311211300001,
Author = {Genuis, Stephen J. and Beesoon, Sanjay and Lobo, Rebecca A. and
   Birkholz, Detlef},
Title = {{Human Elimination of Phthalate Compounds: Blood, Urine, and Sweat (BUS)
   Study}},
Journal = {{SCIENTIFIC WORLD JOURNAL}},
Year = {{2012}},
Abstract = {{Background. Individual members of the phthalate family of chemical
   compounds are components of innumerable everyday consumer products,
   resulting in a high exposure scenario for some individuals and
   population groups. Multiple epidemiological studies have demonstrated
   statistically significant exposure-disease relationships involving
   phthalates and toxicological studies have shown estrogenic effects in
   vitro. Data is lacking in the medical literature, however, on effective
   means to facilitate phthalate excretion. Methods. Blood, urine, and
   sweat were collected from 20 individuals (10 healthy participants and 10
   participants with assorted health problems) and analyzed for parent
   phthalate compounds as well as phthalate metabolites using high
   performance liquid chromatography-tandem mass spectrometry. Results.
   Some parent phthalates as well as their metabolites were excreted into
   sweat. All patients had MEHP (mono(2-ethylhexyl) phthalate) in their
   blood, sweat, and urine samples, suggesting widespread phthalate
   exposure. In several individuals, DEHP (di (2-ethylhexl) phthalate) was
   found in sweat but not in serum, suggesting the possibility of phthalate
   retention and bioaccumulation. On average, MEHP concentration in sweat
   was more than twice as high as urine levels. Conclusions. Induced
   perspiration may be useful to facilitate elimination of some potentially
   toxic phthalate compounds including DEHP and MEHP. Sweat analysis may be
   helpful in establishing the existence of accrued DEHP in the human body.}},
Publisher = {{HINDAWI PUBLISHING CORPORATION}},
Address = {{410 PARK AVENUE, 15TH FLOOR, \#287 PMB, NEW YORK, NY 10022 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Genuis, SJ (Reprint Author), Univ Alberta, Fac Med, 2935-66 St, Edmonton, AB T6K 4C1, Canada.
   Genuis, Stephen J., Univ Alberta, Fac Med, Edmonton, AB T6K 4C1, Canada.
   Beesoon, Sanjay, Univ Alberta, Dept Lab Med, Edmonton, AB T6G 2B7, Canada.
   Lobo, Rebecca A., Univ Alberta, Dept Family Med, Edmonton, AB T6G 2C8, Canada.
   Birkholz, Detlef, ALS Lab Grp, Environm Div, Edmonton, AB T6E 5C1, Canada.}},
DOI = {{10.1100/2012/615068}},
Article-Number = {{615068}},
ISSN = {{1537-744X}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; SOLID-PHASE EXTRACTION; GERM-CELL APOPTOSIS;
   N-BUTYL PHTHALATE; CARE-UNIT INFANTS; IN-UTERO EXPOSURE; MALE-RAT;
   DI(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL PHTHALATE;
   SEXUAL-DIFFERENTIATION}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Author-Email = {{sgenuis@ualberta.ca}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Agency for Toxic Substances and Disease Registry, 2001, TOX PROF DI N BUT PH.
   Agency for Toxic Substances and Disease Registry, 1995, TOX PROF DIETH PHTH.
   Agency for Toxic Substances and Disease Registry, 2002, TOX PROF DI2 ETH PHT.
   Agency for Toxic Substances and Disease Registry, 2004, TOX PROF POL BIPH PO.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Andrade AJM, 2006, TOXICOLOGY, V225, P64, DOI 10.1016/j.tox.2006.05.007.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Bornehag CG, 2004, INDOOR AIR, V14, P243, DOI 10.1111/j.1600-0668.2004.00240.x.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Cadogan D. F., 1996, KIRK OTHMER ENCY CHE, V19.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Clark K., 2003, HDB ENV CHEM, V3.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   COHN WJ, 1978, NEW ENGL J MED, V298, P243, DOI 10.1056/NEJM197802022980504.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Crinnion WJ, 2010, ALTERN MED REV, V15, P101.
   Crinnion WJ, 2011, ALTERN MED REV, V16, P215.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   E. Commission, 2005, OFFICIAL J EUROPEA L, VL344, P40.
   Forster P. M. D., 1981, CHEMICOBIOLOGICAL IN, V34, P233.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387.
   Genuis S. J., 2012, J ENV PUBLIC HLTH, V2012.
   Genuis SJ, 2011, ARCH ENVIRON CON TOX, V61, P344, DOI 10.1007/s00244-010-9611-5.
   Genuis SJ, 2011, HUM EXP TOXICOL, V30, P3, DOI 10.1177/0960327110368417.
   Grande SW, 2006, TOXICOL SCI, V91, P247, DOI 10.1093/toxsci/kfj128.
   Grande SW, 2007, TOXICOLOGY, V229, P114, DOI 10.1016/j.tox.2006.10.005.
   Gray LE, 2006, TOXICOL SCI, V93, P189, DOI 10.1093/toxsci/kfl035.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Huang LP, 2011, FERTIL STERIL, V96, P90, DOI 10.1016/j.fertnstert.2011.04.093.
   Jaakkola JJK, 2008, ENVIRON HEALTH PERSP, V116, P845, DOI 10.1289/ehp.10846.
   Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797.
   Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188.
   Jandacek RJ, 2001, LIPIDS, V36, P1289, DOI 10.1007/s11745-001-0844-z.
   JONES HB, 1993, EXP MOL PATHOL, V58, P179, DOI 10.1006/exmp.1993.1016.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Koch HM, 2006, EPIDEMIOLOGY, V17, pS300, DOI 10.1097/00001648-200611001-00785.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   Kwak ES, 2009, OPEN ALLERGY J, V2, P45.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lee J, 1999, ENDOCRINOLOGY, V140, P852, DOI 10.1210/en.140.2.852.
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169.
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404.
   Lorz P. M., 2006, ULLMANNS ENCY IND CH, V7, P1.
   Mahood IK, 2006, INT J ANDROL, V29, P148, DOI 10.1111/j.1365-2605.2005.00574.x.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Martino-Andrade AJ, 2010, MOL NUTR FOOD RES, V54, P148, DOI 10.1002/mnfr.200800312.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   Moser GA, 1999, CHEMOSPHERE, V39, P1513, DOI 10.1016/S0045-6535(99)00219-2.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   Reddy BS, 2006, BJOG-INT J OBSTET GY, V113, P515, DOI 10.1111/j.1471-0528.2006.00925.x.
   Redgrave TG, 2005, J NUTR BIOCHEM, V16, P383, DOI 10.1016/j.jnutbio.2004.12.014.
   Richburg JH, 1996, TOXICOL APPL PHARM, V137, P42, DOI 10.1006/taap.1996.0055.
   Ross GH, 2012, TOXICOL IND HEALTH, V28, P758, DOI 10.1177/0748233711425070.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Salam MT, 2004, ENVIRON HEALTH PERSP, V112, P760, DOI 10.1289/ehp.6662.
   SCHNARE DW, 1984, AMBIO, V13, P378.
   SHAFFER CB, 1945, J IND HYG TOXICOL, V27, P130.
   Shelby M.D., 2006, NTP CERHR MON, V18, p{[}vii, II].
   Silva MJ, 2005, J ANAL TOXICOL, V29, P819.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   TYL RW, 1988, FUND APPL TOXICOL, V10, P395, DOI 10.1016/0272-0590(88)90286-2.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   WHO, 2002, GLOB ASS STAT OF THE.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wittassek M, 2009, INT J HYG ENVIR HEAL, V212, P492, DOI 10.1016/j.ijheh.2009.04.001.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   WYSS PA, 1982, DRUG METAB DISPOS, V10, P657.
   Zhu JP, 2006, ENVIRON SCI TECHNOL, V40, P5276, DOI 10.1021/es060356w.
   {[}Anonymous], 2005, EFSA J, V243, P1.}},
Number-of-Cited-References = {{92}},
Times-Cited = {{0}},
Journal-ISO = {{Sci. World J.}},
Doc-Delivery-Number = {{038YZ}},
Wos-Id = {{ISI:000311211300001}},
}

@article{ ISI:000300519500010,
Author = {Carbone, S. and Samaniego, Y. A. and Cutrera, R. and Reynoso, R. and
   Cardoso, N. and Scacchi, P. and Moguilevsky, J. A. and Ponzo, O. J.},
Title = {{Different effects by sex on hypothalamic-pituitary axis of prepubertal
   offspring rats produced by in utero and lactational exposure to
   di-(2-ethylhexyl) phthalate (DEHP)}},
Journal = {{NEUROTOXICOLOGY}},
Year = {{2012}},
Volume = {{33}},
Number = {{1}},
Pages = {{78-84}},
Month = {{JAN}},
Abstract = {{This study investigated the effect of pre and perinatal exposure to
   di-(2-ethylhexyl) phthalate (DEHP) on the neuroendocrine parameters that
   regulate reproduction in prepubertal male and female rats. DEHP at doses
   of 3 and 30 mg/kg bw/day was administered orally in the drinking water
   to dam rats since pregnancy onset until the moment of pups sacrifice at
   15 days of age. In these animals gonadotropin serum level and the
   hypothalamic contents of the amino acids aspartate, glutamate and
   gamma-aminobutyric acid were determined. No changes in gonadotropin
   levels and amino acid neurotransmitters were detected at the low dose in
   both sexes. However, DEHP administered at high dose (30 mg/kg bw/day) to
   dams produced a significant decrease in the inhibitory neurotransmitter
   GABA and an increase in the stimulatory neurotransmitter aspartate in
   prepubertal male offspring rats. These modifications were accompanied by
   gonadotropin serum levels increase. On the contrary, in treated female
   rats this chemical increased both, aspartate and GABA, which exert a
   characteristic stimulatory action on gonadotropin in 15-day-old normal
   females. This study provides new data about changes produced by DEHP on
   the hypothalamic amino acid neurotransmitters involved in the
   neuroendocrine reproductive regulation, in prepubertal male and female
   rat offspring from dams exposed during gestational and lactational
   periods. These alterations induced by DEHP exposure could be related to
   the gonadotropin modifications also described in this work, and with
   changes in the production of sexual hormones previously reported by
   other authors. (C) 2011 Elsevier Inc. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ponzo, OJ (Reprint Author), Univ Buenos Aires, Fac Med, Dept Fisiol, Paraguay 2155,7 P-C1121ABG, RA-1425 Buenos Aires, DF, Argentina.
   Carbone, S.; Samaniego, Y. A.; Cutrera, R.; Reynoso, R.; Cardoso, N.; Scacchi, P.; Ponzo, O. J., Univ Buenos Aires, Fac Med, Dept Fisiol, RA-1425 Buenos Aires, DF, Argentina.
   Carbone, S.; Cutrera, R.; Scacchi, P., Consejo Nacl Invest Cient \& Tecn, RA-1033 Buenos Aires, DF, Argentina.
   Carbone, S.; Moguilevsky, J. A., Univ Favaloro, Fac Postgrado, Buenos Aires, DF, Argentina.
   Scacchi, P., Pontificia Univ Catolica Argentina, Fac Med, Buenos Aires, DF, Argentina.}},
DOI = {{10.1016/j.neuro.2011.11.009}},
ISSN = {{0161-813X}},
Keywords = {{Phthalate; Prepubertal; Rats; Gestational; Lactational; Gonadotropin;
   Aspartate; GABA}},
Keywords-Plus = {{REPRODUCTIVE-TRACT DEVELOPMENT; D-ASPARTATE RECEPTORS;
   METHYL-D-ASPARTATE; FEMALE RATS; DIETHYLHEXYL PHTHALATE;
   GONADOTROPIN-SECRETION; LUTEINIZING-HORMONE; POSITIVE FEEDBACK;
   GABAERGIC CONTROL; GRANULOSA-CELLS}},
Research-Areas = {{Neurosciences \& Neurology; Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Neurosciences; Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{oponzo@fmed.uba.ar}},
Funding-Acknowledgement = {{Agencia de Promocion Cientifica y Tecnica {[}1728]; Universidad Buenos
   Aires {[}UBACYT 20020090200080, UBACYT M006]}},
Funding-Text = {{This work was supported by Grants from Agencia de Promocion Cientifica y
   Tecnica BID 1728 PIC 2003 and the Universidad Buenos Aires (UBACYT
   20020090200080 and UBACYT M006). We thank Angela Ciocca for the
   manuscript revision.}},
Cited-References = {{Adams MM, 1999, ENDOCRINOLOGY, V140, P2288, DOI 10.1210/en.140.5.2288.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Akingbemi BT, 2001, ANN MED, V33, P391, DOI 10.3109/07853890108995952.
   Albro P.W., 1987, REV BIOCHEM TOXICOL, V8, P73.
   Andrade AJM, 2006, TOXICOLOGY, V225, P64, DOI 10.1016/j.tox.2006.05.007.
   ANDREWS WW, 1981, ENDOCRINOLOGY, V109, P1404.
   Bonefeld-Jorgensen EC, 2001, TOXICOLOGY, V158, P141, DOI 10.1016/S0300-483X(00)00368-1.
   Borch J, 2005, REPROD TOXICOL, V19, P517, DOI 10.1016/j.reprotox.2004.11.004.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   Brann WD, 1994, FRONT NEUROENDOCRIN, V15, P3.
   Calafat AM, 2006, ENV HLTH PERSPECT, V114, P783.
   Calafat AM, 2004, PEDIATRICS, V113, P429.
   Caligaris L, 1972, J ENDOCRINOL, V57, P97.
   Carbone S, 1996, BRAIN RES, V707, P139, DOI 10.1016/0006-8993(95)01216-8.
   Carbone S, 2010, NEUROTOXICOLOGY, V31, P747, DOI 10.1016/j.neuro.2010.06.006.
   Dalsenter PR, 2006, HUM EXP TOXICOL, V25, P297, DOI 10.1191/0960327105ht624oa.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P27.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Faouzi MA, 1999, INT J PHARMACEUT, V80, P13.
   Feleder C, 1996, NEUROENDOCRINOLOGY, V64, P305, DOI 10.1159/000127133.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Gartner S, 2009, J AGR FOOD CHEM, V57, P10675, DOI 10.1021/jf902683m.
   Ge RS, 2007, REPROD TOXICOL, V23, P366, DOI 10.1016/j.reprotox.2006.12.006.
   Grande SW, 2007, TOXICOLOGY, V229, P114, DOI 10.1016/j.tox.2006.10.005.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gupta RK, 2010, TOXICOL APPL PHARM, V242, P224, DOI 10.1016/j.taap.2009.10.011.
   Heudorf J, 2007, INT J HYG ENVIR HEAL, V210, P623.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Hu GX, 2009, TRENDS ENDOCRIN MET, V20, P139, DOI 10.1016/j.tem.2008.12.001.
   JARRY H, 1992, NEUROENDOCRINOLOGY, V56, P133, DOI 10.1159/000126220.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   MOGUILEVSKY JA, 1991, BRAIN RES, V563, P12, DOI 10.1016/0006-8993(91)91508-X.
   Moguilevsky JA, 2001, EXP CLIN ENDOCR DIAB, V109, P188, DOI 10.1055/s-2001-15105.
   MOGUILEVSKY JA, 1995, J STEROID BIOCHEM, V53, P337, DOI 10.1016/0960-0760(95)00079-F.
   NISWENDE.GD, 1968, P SOC EXP BIOL MED, V128, P807.
   NTP-CERHR, 2006, NIH PUBL.
   Pak VMM, 2007, MCN-AM J MATERN-CHIL, V332, P244.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   SCACCHI P, 1973, EXPERIENTIA, V29, P877, DOI 10.1007/BF01946340.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610.
   Shinji T, 2005, TOXICOLOGY, V210, P223.
   SJOBERG P, 1985, ARCH TOXICOL, V58, P72, DOI 10.1007/BF00348312.
   SJOBERG P, 1986, ENVIRON HEALTH PERSP, V65, P237, DOI 10.2307/3430188.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Svechnikova I, 2007, J ENDOCRINOL, V194, P603, DOI 10.1677/JOE-07-0238.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   SZWARCFARB B, 1994, BRAIN RES, V646, P351, DOI 10.1016/0006-8993(94)90105-8.
   Wilson VS, 2008, INT J ANDROL, V31, P178, DOI 10.1111/j.1365-2605.2007.00861.x.}},
Number-of-Cited-References = {{61}},
Times-Cited = {{2}},
Journal-ISO = {{Neurotoxicology}},
Doc-Delivery-Number = {{895TO}},
Wos-Id = {{ISI:000300519500010}},
}

@article{ ISI:000299804800024,
Author = {Teitelbaum, Susan L. and Mervish, Nancy and Moshier, Erin L. and
   Vangeepuram, Nita and Galvez, Maida P. and Calafat, Antonia M. and
   Silva, Manori J. and Brenner, Barbara L. and Wolff, Mary S.},
Title = {{Associations between phthalate metabolite urinary concentrations and
   body size measures in New York City children}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2012}},
Volume = {{112}},
Pages = {{186-193}},
Month = {{JAN}},
Abstract = {{Objective: To examine prospectively associations between urinary
   phthalate metabolite concentrations and body size measures in children.
   Methods: Urinary concentrations of nine phthalate metabolites: monoethyl
   (MEP); mono-n-butyl (MBP); mono-(3-carboxypropyl) (MCPP); monobenzyl
   (MBzP); mono-isobutyl (MiBP); mono-(2-ethylhexyl) (MEHP);
   mono-(2-ethyl-5-oxohexyl) (MEOHP); mono-(2-ethyl-5-carboxypentyl)
   (MECPP); and mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) and the
   molar sum of the low molecular-weight phthalate metabolites (low MWP:
   MEP, MBP and MiBP) and high molecular-weight phthalate metabolites (high
   MWP: MECPP, MEHHP, MEOHP, MEHP and MBzP) and of four di-(2-ethylhexyl)
   phthalate (DEHP) metabolites (Sigma DEHP: MEHP, MEHHP, MEOHP, MECPP) and
   anthropometry, including body mass index and waist circumference were
   measured among 387 Hispanic and Black, New York City children who were
   between six and eight years at cohort enrollment (2004-2007).
   Relationships between baseline metabolite concentrations and body size
   characteristics obtained one year later were examined using
   multivariate-adjusted geometric means for each body size characteristic
   by continuous and categories of phthalate metabolite concentrations.
   Stratified analyses by body size (age/sex specific) were conducted.
   Results: No significant associations are reported among all girls or
   boys. Dose response relationships were seen with monoethyl phthalate and
   the sum of low molecular-weight phthalates and body mass index and waist
   circumference among overweight children; for increasing monoethyl
   phthalate concentration quartiles among girls, adjusted mean body mass
   indexes were as follows: 21.3, 21.7, 23.8, 23.5 and adjusted mean waist
   circumference (cm) were as follows: 73.4, 73.5, 79.2, 78.8 (p-trend <
   0.001 for both).
   Conclusion: In this prospective analysis we identified positive
   relationships between urinary concentrations of monoethyl phthalate and
   the sum of low molecular-weight phthalates and body size measures in
   overweight children. These are metabolites with concentrations above 1
   mu M. (C) 2011 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Teitelbaum, SL (Reprint Author), Mt Sinai Sch Med, Dept Prevent Med, 1 Gustave L Levy Pl,Box 1057, New York, NY 10029 USA.
   Teitelbaum, Susan L.; Mervish, Nancy; Moshier, Erin L.; Vangeepuram, Nita; Galvez, Maida P.; Brenner, Barbara L.; Wolff, Mary S., Mt Sinai Sch Med, Dept Prevent Med, New York, NY 10029 USA.
   Vangeepuram, Nita; Galvez, Maida P., Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA.
   Calafat, Antonia M.; Silva, Manori J., Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA.}},
DOI = {{10.1016/j.envres.2011.12.006}},
ISSN = {{0013-9351}},
Keywords = {{Body mass index; Children; Obesity; Phthalates; Waist circumference}},
Keywords-Plus = {{WAIST CIRCUMFERENCE; MASS INDEX; DI(2-ETHYLHEXYL) PHTHALATE;
   RISK-FACTORS; OBESITY; TESTOSTERONE; ADOLESCENTS; PERFORMANCE;
   POPULATION; ACTIVATION}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{Susan.Teitelbaum@mssm.edu}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences (NIEHS)/National
   Cancer Institute {[}ES012771]; NIEHS {[}ES12645]; NIEHS/U.S.
   Environmental Protection Agency Children's Center {[}ES09584, R827039];
   Agency for Toxic Substances and Disease Registry ATSDR {[}ATU 300014,
   HD049311]; National Center for Research Resources (NCRR)
   {[}MO1-RR-00071]}},
Funding-Text = {{This research was supported by National Institute of Environmental
   Health Sciences (NIEHS)/National Cancer Institute ES012771; NIEHS
   ES12645; NIEHS/U.S. Environmental Protection Agency Children's Center
   grants ES09584 and R827039; the Agency for Toxic Substances and Disease
   Registry ATSDR Grant \#ATU 300014 the Pediatric Environmental Health
   Fellowship HD049311 and National Center for Research Resources (NCRR)
   MO1-RR-00071.}},
Cited-References = {{Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009.
   Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253.
   Black JL, 2010, AM J EPIDEMIOL, V171, P765, DOI 10.1093/aje/kwp458.
   Boas M., 2010, ENV HLTH PERSPECT.
   Boberg J, 2008, TOXICOLOGY, V250, P75, DOI 10.1016/j.tox.2008.05.020.
   Botelho GGK, 2009, ARCH ENVIRON CON TOX, V57, P777, DOI 10.1007/s00244-009-9317-8.
   C. D. C. Centers for Disease Control and Prevention, 2009, 4 CDCP.
   Carrieri M, 2001, INT ARCH OCC ENV HEA, V74, P63.
   Casals-Casas C, 2008, INT J OBESITY, V32, pS53, DOI 10.1038/ijo.2008.207.
   Centers for Disease Control and Prevention, 2005, REF MAN REP CDCP.
   DOSTAL LA, 1987, TOXICOL APPL PHARM, V87, P81, DOI 10.1016/0041-008X(87)90086-X.
   Engel SM, 2007, AM J EPIDEMIOL, V165, P1397, DOI 10.1093/aje/kwm029.
   Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200.
   Freedman DS, 2007, AM J CLIN NUTR, V86, P33.
   Goran M.I., 1999, AM J CLIN NUTR, V70, p149S.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Janssen I, 2002, AM J CLIN NUTR, V75, P683.
   Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610.
   Hotchkiss AK, 2008, TOXICOL SCI, V105, P235, DOI 10.1093/toxsci/kfn030.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   Lorber M, 2007, RISK ANAL, V27, P1203, DOI 10.1111/j.1539-6924.2007.00956.x.
   Maffeis C, 2003, EUR J CLIN NUTR, V57, P566, DOI 10.1038/sj.ejcn.1601573.
   Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x.
   McDowell Margaret A, 2005, Adv Data, P1.
   MCLACHLAN JA, 1993, ENVIRON HEALTH PERSP, V101, P386, DOI 10.2307/3431891.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   National Academy of Sciences, 2008, PHTH CUM RISK ASS.
   Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x.
   Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401.
   Olson E., 2006, TAKE CARE E HARL.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Pasquali R, 2006, FERTIL STERIL, V85, P1319, DOI 10.1016/j.fertnstert.2005.10.054.
   Skinner AM, 1996, EUR J PEDIATR, V155, P596, DOI 10.1007/BF01957912.
   SNODGRASS WR, 1992, SIMILARITIES AND DIFFERENCES BETWEEN CHILDREN AND ADULTS : IMPLICATIONS FOR RISK ASSESSMENT, P35.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   U.S. Department of Health \& Human Services, 2000, PRACT GUID ID EV TRE.
   US Food and Drug Administration, 2010, PHTHALATES COSMETIC.
   Wajchenberg BL, 2000, ENDOCR REV, V21, P697, DOI 10.1210/er.21.6.697.
   Willett W., 1998, NUTR EPIDEMIOLOGY.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{5}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{885TX}},
Wos-Id = {{ISI:000299804800024}},
}

@article{ ISI:000298448300003,
Author = {Simmchen, Juliane and Ventura, Rosa and Segura, Jordi},
Title = {{Progress in the Removal of Di-{[}2-Ethylhexyl]-Phthalate as Plasticizer
   in Blood Bags}},
Journal = {{TRANSFUSION MEDICINE REVIEWS}},
Year = {{2012}},
Volume = {{26}},
Number = {{1}},
Pages = {{27-37}},
Month = {{JAN}},
Abstract = {{Polyvinylchloride (PVC) is used in blood component containers as well as
   in many other medical devices because it shows optimal inertness,
   durability, and resistance to heat and chemicals. However, the polymer
   itself does not provide good handling characteristics or the necessary
   properties for red blood cell (RBC) survival. PVC thus needs to be
   plasticized, and di-(2-ethylhexyl)phthalate (DEHP) has been the most
   common plasticizer to produce the required flexibility to PVC. However,
   DEHP has been found to leach out from the containers, causing toxic
   effects, as demonstrated mainly in rodents. It is considered to be a
   possible carcinogen and suspected to also produce endocrine effects
   especially in young males. Although controversial, it is commonly
   accepted that in vulnerable patients such as newborns, trauma patients,
   or pregnant women, high exposure to DEHP should be avoided.
   The replacement of the common PVC + DEHP blood bags poses technical
   challenges due to the positive influence of the DEHP molecules on the
   red blood cell (RBC) membrane, and thus it has been shown to affect RBC
   storage and survival after transfusion. Different approaches are thus
   being taken to find a suitable alternative to DEHP for blood components
   bags. Environmentalists even favor the substitution of the PVC to avoid
   not only the plasticizers but even the other residues contained in the
   polymer material. Consequently, whereas the simplest solution is the
   substitution of the DEHP by other plasticizers, alternative
   plasticizer-free materials are becoming explored. Even modifications of
   existing materials are being presented by some research groups, ranging
   from covering of the DEHP-containing materials to alloys or special
   additive solutions. Different strategies as well as the most promising
   approaches are presented in this review. In any case, the degree of
   stabilization of RBCs undergoing prolonged storage will dictate the
   final acceptance for such alternatives. (C) 2012 Elsevier Inc. All
   rights reserved.}},
Publisher = {{W B SAUNDERS CO-ELSEVIER INC}},
Address = {{1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Segura, J (Reprint Author), Hosp del Mar, Bioanal \& Analyt Serv Res Grp, Res Inst, IMIM, Carrer Dr Aiguader 88, Barcelona 08003, Spain.
   Simmchen, Juliane; Ventura, Rosa; Segura, Jordi, Hosp del Mar, Bioanal \& Analyt Serv Res Grp, Res Inst, IMIM, Barcelona 08003, Spain.}},
DOI = {{10.1016/j.tmrv.2011.06.001}},
ISSN = {{0887-7963}},
Keywords-Plus = {{DI-(2-ETHYLHEXYL) PHTHALATE; POLYVINYL-CHLORIDE; STORAGE; CELLS; PVC;
   SURVIVAL; RBCS}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Author-Email = {{jsegura@imim.es}},
Funding-Acknowledgement = {{European Commission; IMIM Foundation; DIUE Generalitat de Catalunya
   {[}2009 SGR 492]}},
Funding-Text = {{The authors thank Dr. Otter of BASF for helpful information on the
   legislative status and Dr. L. Puig of the Banc de Sang i Teixits for
   providing some interesting insights. J Simmchen thanks the European
   Commission for a Leonardo da Vinci fellowship. The IMIM Foundation and
   the DIUE Generalitat de Catalunya (2009 SGR 492) partially supported the
   publication of this article.}},
Cited-References = {{Ajili SH, 2003, J APPL POLYM SCI, V89, P2496, DOI 10.1002/app.12180.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   All Business, 2008, Plastic Technology, Patent No. 3200264.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   ASTM International, COMPL STAND TERM REL.
   AUBUCHON JP, 1988, BLOOD, V71, P448.
   Blais P, 1989, J VINYL TECHNOL, V11, P71, DOI 10.1002/vnl.730110206.
   Brass CR, 2001, ROLE POLY VINYL CHLO.
   Carraher CE, 2006, INTRO POLYM CHEM.
   Center for Devices and Radiological Health, SAF ASS DI 2 ETH PHT.
   Codan, 2009, PROD INF NO DEHP TUB.
   Draper CJ, 2002, TRANSFUSION, V42, P830, DOI 10.1046/j.1537-2995.2002.00138.x.
   Du Pont, COMP IMPR VAL BLEND.
   ESTEP TN, 1984, BLOOD, V64, P1270.
   GREENWALT TJ, 1993, VOX SANG, V65, P87.
   Greening DW, 2010, J PROTEOMICS, V73, P386, DOI 10.1016/j.jprot.2009.07.011.
   Hess JR, 2002, TRANSFUS MED REV, V16, P283, DOI 10.1053/tmrv.2002.35213.
   Hill HR, 2001, VOX SANG, V81, P161, DOI 10.1046/j.1423-0410.2001.00097.x.
   Hmel PJ, 2002, TRANSFUSION, V42, P836, DOI 10.1046/j.1537-2995.2002.00135.x.
   Hogman CF, 1999, TRANSFUS MED REV, V13, P275, DOI 10.1016/S0887-7963(99)80058-3.
   Kelch R, NEW FAMILY HF WELDAB.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P3, DOI 10.2307/3429377.
   Labow S, 1987, BLOOD, V70, P319.
   Lee JH, 1999, J BIOMED MATER RES, V48, P328, DOI 10.1002/(SICI)1097-4636(1999)48:3<328::AID-JBM18>3.0.CO;2-L.
   MERYMAN HT, 1986, TRANSFUSION, V26, P500, DOI 10.1046/j.1537-2995.1986.26687043613.x.
   Messori M, 2004, POLYMER, V45, P805, DOI 10.1016/j.polymer.2003.12.006.
   Navarro R, 2010, MACROMOLECULES, V43, P2377, DOI 10.1021/ma902740t.
   Ortega JA, 2002, MEDIDAS PREVENTIVAS, V58, P251.
   Otter Dr., COMMUNICATION.
   PAN Pesticide Database, POL.
   Plastemart, ALT PVC MED APPL DEV.
   Rahman M, 2004, PROG POLYM SCI, V29, P1223, DOI 10.1016/j.progpolymsci.2004.10.001.
   Romero-Bastida C. A., 2004, Ciencia y Tecnologia Alimentaria, V4, P251.
   Rossi M, 2000, SETT HEALTHC ENV AG.
   Sampson J, 2011, TRANSFUSION MED, V21, P73, DOI 10.1111/j.1365-3148.2010.01056.x.
   Science Daily, 2008, ALL BUSINESS PVC HEA.
   Scott KL, 2005, TRANSFUS MED REV, V19, P127, DOI 10.1016/j.tmrv.2004.11.004.
   Shah TM, POLYURETHANE THIN FI.
   Slater M, HIST BLOOD BANKS.
   Stein H, 2005, TRANSFUS APHER SCI, V3, P55.
   Swedish Chemicals Agency, EUR UN RISK ASS REP.
   Tendero PMR, 2006, EUR POLYM J, V42, P961, DOI 10.1016/j.eurpolymj.2005.10.006.
   Tickner AJ, 2001, AM J IND MED, V39, P100.
   Usha KC, BLOOD BAGS SLIDES LE.
   Van Vliet EDS, 2011, J PERINATOL, V31, P551, DOI 10.1038/jp.2010.208.
   Varma R, NEW TPES PROVIDE MAT.
   {[}Anonymous], HIGH PROD VOL CHEM C.
   {[}Anonymous], SCI DAILY.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{8}},
Journal-ISO = {{Transf. Med. Rev.}},
Doc-Delivery-Number = {{867IO}},
Wos-Id = {{ISI:000298448300003}},
}

@article{ ISI:000297088500030,
Author = {Olsen, Lena and Lampa, Erik and Birkholz, Detlef A. and Lind, Lars and
   Lind, P. Monica},
Title = {{Circulating levels of bisphenol A (BPA) and phthalates in an elderly
   population in Sweden, based on the Prospective Investigation of the
   Vasculature in Uppsala Seniors (PIVUS)}},
Journal = {{ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY}},
Year = {{2012}},
Volume = {{75}},
Pages = {{242-248}},
Month = {{JAN 1}},
Abstract = {{The plastic manufacture compounds, bisphenol A (BPA) and phthalates, are
   ubiquitous and have therefore been detected in virtually all types of
   analyzed human samples. The aim of this study was: (1) to investigate
   concentrations of serum levels of BPA and phthalate metabolites in
   seniors residing in the city of Uppsala, Sweden (2) to evaluate gender
   differences in relation to serum levels of BPA and phthalate metabolites
   in the subjects.
   In the population-based Prospective Investigation of the Vasculature in
   Uppsala Seniors (PIVUS), encompassing 1016 subjects, all aged 70, serum
   levels of BPA and phthalate metabolites were measured by Isotope
   Dilution-High Performance Liquid Chromatography-Tandem Mass
   Spectrometry.
   BPA and four out of ten phthalate metabolites, namely, Monoisobutyl
   phthalate (MiBP), Monomethyl phthalate (MMP), Monoethyl phthalate (MEP),
   Mono-(2-ethylhexyl) phthalate (MEHP), were detectable in almost all
   subjects. Of the remaining phthalate metabolites. Monobenzyl phthalate
   (MBzP), Mono-(2-ethyl-5-hydroxyhexyl) phthalate (MeHHP), and
   Mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) were seen in some 300-700 of
   the subjects, whereas Monoisononyl phthalate (MINP) and Mono-n-octyl
   phthalate (MOP) were found in only a few and Monocyclohexyl phthalate
   (MCHP) was not detected in any subject. Neither the circulation levels
   of BPA nor those of phthalate metabolites differ between the genders in
   this elderly population of residents in Uppsala, Sweden. (C) 2011
   Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lind, PM (Reprint Author), Uppsala Univ, Dept Med Sci Occupat \& Environm Med, S-75185 Uppsala, Sweden.
   Olsen, Lena; Lampa, Erik; Lind, P. Monica, Uppsala Univ, Dept Med Sci Occupat \& Environm Med, S-75185 Uppsala, Sweden.
   Birkholz, Detlef A., ALS Environm Div, Edmonton, AB, Canada.
   Lind, Lars, Uppsala Univ, Dept Med Sci Acute \& Internal Med, S-75185 Uppsala, Sweden.}},
DOI = {{10.1016/j.ecoenv.2011.09.004}},
ISSN = {{0147-6513}},
Keywords = {{Serum levels; Bisphenol A (Bpa); Phthalate metabolites; Elderly}},
Keywords-Plus = {{SOLID-PHASE EXTRACTION; PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM
   MASS-SPECTROMETRY; HUMAN SERUM; GENDER-DIFFERENCES; HUMAN EXPOSURE;
   NORMAL WOMEN; METABOLITES; URINARY; HEALTH}},
Research-Areas = {{Environmental Sciences \& Ecology; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Toxicology}},
Author-Email = {{lena.olsen@medsci.uu.se
   erik.lampa@medsci.uu.se
   Deib.Birkholz@ALSGlobal.com
   lars.lind@medsci.uu.se
   monica.lind@medsci.uu.se}},
Funding-Acknowledgement = {{Swedish Research Council (VR); Swedish Research Council for Environment,
   Agricultural Sciences and Spatial Planning (FORMAS)}},
Funding-Text = {{This study was supported by the Swedish Research Council (VR) and the
   Swedish Research Council for Environment, Agricultural Sciences and
   Spatial Planning (FORMAS).}},
Cited-References = {{Beronius A, 2009, REGUL TOXICOL PHARM, V55, P111, DOI 10.1016/j.yrtph.2009.05.019.
   Bushnik Tracey, 2010, Health Rep, V21, P7.
   Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391.
   Cobellis L, 2009, BIOMED CHROMATOGR, V23, P1186, DOI 10.1002/bmc.1241.
   Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008.
   Dirtu AC, 2008, ANAL BIOANAL CHEM, V391, P1175, DOI 10.1007/s00216-007-1807-9.
   Fernandez MF, 2007, REPROD TOXICOL, V24, P259, DOI 10.1016/j.reprotox.2007.06.007.
   Fernandez SV, 2010, TOXICOL PATHOL, V38, P110, DOI {[}10.1177/0192623309354108, 10.1177/019263309354108].
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Frederiksen H, 2010, J ANAL TOXICOL, V34, P400.
   Fung EYK, 2000, J AM DENT ASSOC, V131, P51.
   GOLLAMUDI R, 1983, J TOXICOL ENV HEALTH, V12, P623.
   Guo ZY, 2010, BIOMED CHROMATOGR, V24, P1094, DOI 10.1002/bmc.1410.
   Halden RU, 2010, ANNU REV PUBL HEALTH, V31, P179, DOI 10.1146/annurev.publhealth.012809.103714.
   He YH, 2009, ENVIRON RES, V109, P629, DOI 10.1016/j.envres.2009.04.003.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P116, DOI 10.1016/0041-008X(92)90374-2.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610.
   Hiroi H, 2004, ENDOCR J, V51, P595, DOI 10.1507/endocrj.51.595.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   HOLM S, 1979, SCAND J STAT, V6, P65.
   Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839.
   Inoue K, 2000, J CHROMATOGR B, V749, P17, DOI 10.1016/S0378-4347(00)00351-0.
   Kandaraki E, 2011, J CLIN ENDOCR METAB, V96, pE480, DOI 10.1210/jc.2010-1658.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kim YH, 2003, BIOCHEM BIOPH RES CO, V312, P441, DOI 10.1016/j.bbrc.2003.10.135.
   Kimber I, 2010, TOXICOLOGY, V271, P73, DOI 10.1016/j.tox.2010.03.020.
   Koch HM, 2006, INT J ANDROL, V29, P181.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch H.M., 2005, ARCH TOXICOL, V79, P367.
   Kuroda N, 2003, J PHARMACEUT BIOMED, V30, P1743, DOI 10.1016/S0731-7085(02)00516-2.
   Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303.
   Lee YJ, 2008, REPROD TOXICOL, V25, P413, DOI 10.1016/j.reprotox.2008.05.058.
   Liu M, 2006, J CHROMATOGR A, V1133, P142, DOI 10.1016/j.chroma.2006.08.009.
   Meeker JD, 2010, MATURITAS, V66, P236, DOI 10.1016/j.maturitas.2010.03.001.
   Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673.
   Newbold RR, 2010, HORM-INT J ENDOCRINO, V9, P206.
   Rudel R.A, 2011, ENV HLTH PERSPECT.
   Sajiki J, 1999, J CHROMATOGR B, V736, P255, DOI 10.1016/S0378-4347(99)00471-5.
   Silva MJ, 2005, J ANAL TOXICOL, V29, P819.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2011, CHEMOSPHERE, V82, P431, DOI 10.1016/j.chemosphere.2010.09.052.
   Sugiura-Ogasawara M, 2005, HUM REPROD, V20, P2325, DOI 10.1093/humrep/deh888.
   Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165.
   Takeuchi T, 2004, BIOCHEM BIOPH RES CO, V325, P549, DOI 10.1016/j.bbrc.2004.10.073.
   Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V291, P76, DOI 10.1006/bbrc.2002.6407.
   Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281.
   Vandenberg LN, 2010, ENVIRON HEALTH PERSP, V118, P1055, DOI 10.1289/ehp.0901716.
   Wan Y, 2010, ENVIRON SCI TECHNOL, V44, P5233, DOI 10.1021/es1002764.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Yamada H, 2002, REPROD TOXICOL, V16, P735, DOI 10.1016/S0890-6238(02)00051-5.
   Yang C.Z., 2011, ENV HLTH PERSPECT.
   Ye XY, 2009, ENVIRON INT, V35, P1160, DOI 10.1016/j.envint.2009.07.011.
   Yoshimura Y, 2002, ANAL CHIM ACTA, V458, P331, DOI 10.1016/S0003-2670(02)00077-6.
   Zimmerman-Downs Joyce M, 2010, J Dent Hyg, V84, P145.}},
Number-of-Cited-References = {{59}},
Times-Cited = {{5}},
Journal-ISO = {{Ecotox. Environ. Safe.}},
Doc-Delivery-Number = {{848XN}},
Wos-Id = {{ISI:000297088500030}},
}

@article{ ISI:000298534700095,
Author = {Jiang, Jun-Tao and Sun, Wen-Lan and Jing, Yi-Feng and Liu, Shi-Bo and
   Ma, Zheng and Hong, Yan and Ma, Long and Qin, Chao and Liu, Qiang and
   Stratton, Harrison J. and Xia, Shu-Jie},
Title = {{Prenatal exposure to di-n-butyl phthalate induces anorectal
   malformations in male rat offspring}},
Journal = {{TOXICOLOGY}},
Year = {{2011}},
Volume = {{290}},
Number = {{2-3}},
Pages = {{322-326}},
Month = {{DEC 18}},
Abstract = {{The objectives of this study were to investigate the dysplasia,
   histological malformations, and genetic abnormalities in male rats
   induced by maternal exposure to di-n-butyl phthalate (DBP). Here we
   report novel findings concerning developmental abnormalities resulting
   from prenatal exposure to DBP, which leads to significant anorectal
   malformations (ARMs) in male rat offspring. The incidence of ARMs was
   39.5\% in male offspring and all abnormal pups were complicated with
   secondary megacolon. General images, histological analysis and anatomy
   examination confirmed the malformation. The development abnormalities
   such as decreased bodyweight (BW) and anogenital distance (AGD),
   shortened body lengths (with tail removed), as well as increased
   abdominal circumference were observed at different developmental stages
   of ARMs in male rat. The developmental abnormalities in both solid
   organs (brain, heart, liver, spleen, lung and kidney) and reproductive
   organs (testes and epididymis) of abnormal pubs on PND35 were also
   investigated. In addition, the serum testosterone (T) level of ARMs in
   male rats on PND1 was significantly lower than that of controls with
   accompanying reduced expression of androgen receptor (AR), sonic
   hedgehog (Shh) and bone morphogenetic protein 4 (Bmp4) mRNA from tissues
   of the terminal rectum. These results conclusively demonstrate for the
   first time that in utero exposure to DBP leads to an increased
   likelihood for the development of ARMs and subsequent complicating
   megacolon in male rat offspring. (C) 2011 Elsevier Ireland Ltd. All
   rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Xia, SJ (Reprint Author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Urol, 85 Wujin Rd, Shanghai 200080, Peoples R China.
   Jiang, Jun-Tao; Jing, Yi-Feng; Liu, Shi-Bo; Xia, Shu-Jie, Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200080, Peoples R China.
   Sun, Wen-Lan, Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Geriatr, Shanghai 200080, Peoples R China.
   Ma, Zheng, Nantong Univ, Wujiang City Peoples Hosp 1, Dept Urol, Wujiang 215200, Jiangsu, Peoples R China.
   Hong, Yan, Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Expt Res Ctr, Shanghai 200080, Peoples R China.
   Ma, Long, Jiangsu Prov Hosp TCM, Dept Urol, Nanjing 210029, Jiangsu, Peoples R China.
   Qin, Chao, Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing 210029, Jiangsu, Peoples R China.
   Liu, Qiang, St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ 85013 USA.
   Stratton, Harrison J., Arizona State Univ, Interdisciplinary Dept Neurosci, Tempe, AZ 85287 USA.}},
DOI = {{10.1016/j.tox.2011.10.008}},
ISSN = {{0300-483X}},
Keywords = {{Di-n-butyl phthalate; Anorectal malformations; Secondary megacolon;
   Testosterone; Terminal rectum}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{xsjurologist@126.com}},
Funding-Acknowledgement = {{National Science Foundation for Young Scientists of China {[}81000243]}},
Funding-Text = {{This work was supported by the National Science Foundation for Young
   Scientists of China (Grant No. 81000243).}},
Cited-References = {{Andersen Alan, 2006, Int J Toxicol, V25 Suppl 1, P129.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   Baskin LS, 2001, ENVIRON HEALTH PERSP, V109, P1175, DOI 10.1289/ehp.011091175.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   Falcone RA, 2007, J PEDIATR SURG, V42, P124, DOI 10.1016/j.jpedsurg.2006.09.012.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Grano C, 2010, PEDIATR SURG INT, V26, P151, DOI 10.1007/s00383-009-2541-5.
   Hartman EE, 2011, ARCH DIS CHILD, V96, P398, DOI 10.1136/adc.2007.118133.
   Hsieh Michael H, 2008, Curr Urol Rep, V9, P137, DOI 10.1007/s11934-008-0025-0.
   Jiang JT, 2007, TOXICOLOGY, V232, P286, DOI 10.1016/j.tox.2007.01.018.
   Kalfa N, 2009, INT J ANDROL, V32, P187, DOI 10.1111/j.1365-2605.2008.00899.x.
   Kavlock R, 2002, REPROD TOXICOL, V16, P489, DOI 10.1016/S0890-6238(02)00033-3.
   Kim HS, 2004, J TOXICOL ENV HEAL A, V67, P2045, DOI 10.1080/15287390490514859.
   Le B.A.G., 2010, J RADIOL, V91, P475.
   Levitt M.A., 2007, J. Pediatr. Surg., V42, P127.
   Levitt MA, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-33.
   Macedo M, 2004, BJU INT, V94, P893, DOI 10.1111/j.1464-410X.2004.05053.x.
   Mandhan P, 2006, J PEDIATR SURG, V41, P2041, DOI 10.1016/j.jpedsurg.2006.08.035.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Norgil D.I., 2002, BEST PRACTICE RES CL, V16, P289.
   NTP-CERHR, 2003, NTP CERHR MON, V4, pi.
   Oettling G, 1998, EUR J OBSTET GYN R B, V77, P211, DOI 10.1016/S0301-2115(97)00212-1.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Patisaul HB, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.010.2009.
   Sasaki Y, 2004, J PEDIATR SURG, V39, P170, DOI 10.1016/j.jpedsurg.2003.10.009.
   Grandjean P, 2006, INT J ANDROL, V29, P181, DOI 10.1111/j.1365-2605.2005.00679.x.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Steinhardt GF, 2004, ADV EXP MED BIOL, V545, P203.
   Wang MH, 2008, J ANDROL, V29, P499, DOI 10.2164/jandrol.108.004945.
   Zhang J, 2009, J INT MED RES, V37, P1842.
   Zhang YH, 2004, REPROD TOXICOL, V18, P669, DOI 10.1016/j.reprotox.2004.04.009.
   Zhu YJ, 2009, TOXICOLOGY, V260, P120, DOI 10.1016/j.tox.2009.03.017.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{4}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{868PH}},
Wos-Id = {{ISI:000298534700095}},
}

@article{ ISI:000299134600004,
Author = {Goeen, Thomas and Dobler, Lorenz and Koschorreck, Jan and Mueller,
   Johannes and Wiesmueller, Gerhard Andreas and Drexler, Hans and
   Kolossa-Gehring, Marike},
Title = {{Trends of the internal phthalate exposure of young adults in
   Germany-Follow-up of a retrospective human biomonitoring study}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2011}},
Volume = {{215}},
Number = {{1}},
Pages = {{36-45}},
Month = {{DEC}},
Abstract = {{The exposure of the general population to phthalates is of increasing
   public health concern. Variations in the internal exposure of the
   population are likely, because the amounts, distribution and application
   characters of the phthalate use change over time. Estimating the
   chronological sequences of the phthalate exposure, we performed a
   retrospective human biomonitoring study by investigating the metabolites
   of the five most prominent phthalates in urine. Therefore, 24 h-urine
   samples from the German Environmental Specimen Bank (ESB) collected from
   240 subjects (predominantly students, age range 19-29 years, 120
   females, 120 males) in the years 2002, 2004, 2006 and 2008 (60
   individuals each), were analysed for the concentrations of mono-n-butyl
   phthalate (MnBP) as metabolite of di-n-butyl phthalate (DnBP),
   mono-iso-butyl phthalate (MiBP) as metabolite of di-iso-butyl phthalate
   (DiBP), monobenzyl phthalate (MBzP) as metabolite of butylbenzyl
   phthalate (BBzP), mono-(2-ethylhexyl) phthalate (MEHP),
   mono-(2-ethyl-5-hydroxyhexyl) phthalate (5OH-MEHP),
   mono-(2-ethyl-5-oxohexyl) phthalate (5oxo-MEHP),
   mono-(2-ethyl-5-carboxypentyl) phthalate (5cx-MEPP) and
   mono-(2-carboxymethyl hexyl) phthalate (2cx-MMHxP) as metabolites of
   di(2-ethylhexyl) phthalate (DEHP), monohydroxylated (OH-MiNP),
   monooxidated (oxo-MiNP) and monocarboxylated (cx-MiNP)
   mono-iso-nonylphthalates as metabolites of di-iso-nonyl phthalates
   (DiNP). Based on the urinary metabolite excretion, together with results
   of a previous study, which covered the years 1988-2003, we investigated
   the chronological sequences of the phthalate exposure over two decades.
   In more than 98\% of the urine samples metabolites of all five
   phthalates were detectable indicating a ubiquitous exposure of people
   living in Germany to all five phthalates throughout the period
   investigated. The medians in samples from the different years
   investigated are 65.4 (2002), 38.5 (2004), 29.3 (2006) and 19.6 mu g/l
   (2008) for MnBP, 31.4 (2002), 25.4 (2004), 31.8 (2006) and 25.5 mu g/l
   (2008) for MiBP, 7.8 (2002), 6.3 (2004), 3.6 (2006) and 3.8 mu g/l
   (2008) for MBzP, 7.0 (2002), 5.6 (2004), 4.1 (2006) and 3.3 mu g/l
   (2008) for MEHP, 19.6 (2002), 16.2 (2004), 13.2 (2006) and 9.6 mu g/l
   (2008) for 5OH-MEHP, 13.9 (2002), 11.8 (2004), 8.3 (2006) and 6.4 mu g/l
   (2008) for 5oxo-MEHP, 18.7 (2002), 16.5 (2004), 13.8 (2006) and 10.2 mu
   g/l (2008) for 5cx-MEPP, 7.2 (2002), 6.5 (2004), 5.1 (2006) and 4.6 mu
   g/l (2008) for 2cx-MMHxP, 3.3 (2002), 2.8 (2004), 3.5 (2006) and 3.6 mu
   g/l (2008) for OH-MiNP, 2.1 (2002), 2.1 (2004), 2.2 (2006) and 2.3 mu
   g/l (2008) for oxo-MiNP and 4.1 (2002), 3.2 (2004), 4.1 (2006) and 3.6
   mu g/l (2008) for cx-MiNP. The investigation of the time series
   1988-2008 indicates a decrease of the internal exposure to DnBP by the
   factor of 7-8 and to DEHP and BzBP by the factor of 2-3. In contrast, an
   increase of the internal exposure by the factor of 4 was observed for
   DiNP over the study period. The exposure to DiBP was found to be stable.
   In summary, we found decreases of the internal human exposure for
   legally restricted phthalates whereas the exposure to their substitutes
   increased. Future investigations should verify these trends. This is of
   increasing importance since the European Commission decided to require
   ban or authorization from 1.1.2015 for DEHP, DnBP, DiBP and BzBP
   according to REACh Annex XIV. (C) 2011 Elsevier GmbH. All rights
   reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Goen, T (Reprint Author), Univ Erlangen Nurnberg, Inst Occupat Social \& Environm Med, Schillerstr 25-29, D-91054 Erlangen, Germany.
   Goeen, Thomas; Mueller, Johannes; Drexler, Hans, Univ Erlangen Nurnberg, Inst Occupat Social \& Environm Med, D-91054 Erlangen, Germany.
   Goeen, Thomas; Mueller, Johannes; Drexler, Hans, Univ Erlangen Nurnberg, Outpatient Clin Occupat Social \& Environm Med, D-91054 Erlangen, Germany.
   Dobler, Lorenz; Wiesmueller, Gerhard Andreas, German Environm Specimen Bank Human Tissues ESB, Munster, Germany.
   Koschorreck, Jan; Kolossa-Gehring, Marike, Fed Environm Agcy Umweltbundesamt, Dessau, Germany.}},
DOI = {{10.1016/j.ijheh.2011.07.011}},
ISSN = {{1438-4639}},
Keywords = {{Biomarkers; Bimonitoring; General population; Phthalates; Retrospective
   study}},
Keywords-Plus = {{N-BUTYL PHTHALATE; TANDEM MASS-SPECTROMETRY; MALE REPRODUCTIVE
   DEVELOPMENT; ISO-NONYLPHTHALATE DINP; HUMAN URINE; DI(2-ETHYLHEXYL)
   PHTHALATE; DEVELOPMENTAL TOXICITY; PREGNANT-WOMEN; MALE-RAT;
   DIETHYLHEXYL PHTHALATE}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{Thomas.Goeen@ipasum.med.uni-erlangen.de}},
Funding-Acknowledgement = {{Federal Environment Agency (UBA); Deutsche Forschungsgemeinschaft {[}AN
   107/16-4]}},
Funding-Text = {{We especially thank the Fund of the Federal Environment Agency (UBA) for
   its financial support of this study.The syntheses of the reference
   substances for calibration and internal standardizing were supported by
   the Deutsche Forschungsgemeinschaft (AN 107/16-4).}},
Cited-References = {{Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blystone CR, 2010, TOXICOL SCI, V116, P640, DOI 10.1093/toxsci/kfq147.
   Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   CDC, 2009, 4 CDC DEP HLTH HUM S.
   Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017.
   EC (European Commission), 2003, EUR UN RISK ASS REP, V35.
   EC (European Commission), 1999, OFF J EUR COMMUN L, V315.
   ECPI (European council for plasticisers and intermediates), 2010, PLAST HIGH PHTHAL.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   EU (European Union), 2005, OFF J EUR UNION L, V344.
   European Chemicals Agency (ECHA), 2009, DAT MAN IMP EXP US R.
   Fabjan E, 2006, CRIT REV TOXICOL, V36, P695, DOI 10.1080/10408440600894914.
   Foster PMD, 2000, FOOD CHEM TOXICOL, V38, pS97, DOI 10.1016/S0278-6915(99)00128-3.
   Frederiksen H, 2010, J ANAL TOXICOL, V34, P400.
   Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Fromme H, 2002, WATER RES, V36, P1429, DOI 10.1016/S0043-1354(01)00367-0.
   G-EQUAS (German External Quality Assessment Scheme), 2011, PROF TESTS HUM BIOM.
   Goen T., 2011, INT J HYG E IN PRESS, DOI {[}10.1016/j.ijheh.2011.08.012, DOI 10.1016/J.IJHEH.2011.08.012].
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R., 2006, EPIDEMIOLOGY, V17, P430.
   Hermandez-Diaz S., 2009, ENV HLTH PERSPECT, V117, P185.
   Hildenbrand S, 2009, INT J HYG ENVIR HEAL, V212, P679, DOI 10.1016/j.ijheh.2009.06.003.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Kissel JC, 2005, J EXPO ANAL ENV EPID, V15, P164, DOI 10.1038/sj.jea.7500384.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Kommission Human-Biomonitoring, 2007, BUNDESGESUNDHEITSBLA, V50, P249.
   Kommission Human-Biomonitoring, 2007, BUNDESGESUNDHEITSBLA, V50, P251.
   Kommission Human-Biomonitoring, 2007, BUNDESGESUNDHEITSBLA, V50, P255.
   LARSEN K, 1972, CLIN CHIM ACTA, V41, P209, DOI 10.1016/0009-8981(72)90513-X.
   Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013.
   Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2.
   National Research Council, 2008, PHTHAL CUM RISK ASS.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   PlasticsEurope, 2006, PLAST PHTHAL.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Rider CV, 2010, INT J ANDROL, V33, P443, DOI 10.1111/j.1365-2605.2009.01049.x.
   Saillenfait AM, 2006, TOXICOL LETT, V165, P39, DOI 10.1016/j.toxlet.2006.01.013.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan S.H., 2005, ENV HLTH PERSPECT, V113, P1057.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   Wiesmuller GA, 2007, INT J HYG ENVIR HEAL, V210, P299, DOI 10.1016/j.ijheh.2007.01.036.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.
   Zhang YH, 2009, J PEDIATR, V155, P500, DOI 10.1016/j.jpeds.2009.04.007.}},
Number-of-Cited-References = {{69}},
Times-Cited = {{6}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{876VA}},
Wos-Id = {{ISI:000299134600004}},
}

@article{ ISI:000296830200052,
Author = {Hsu, Jing-Fang and Peng, Li-Wen and Li, Yu-Jang and Lin, Lung-Cheng and
   Liao, Pao-Chi},
Title = {{Identification of Di-isononyl Phthalate Metabolites for Exposure Marker
   Discovery Using In Vitro/In Vivo Metabolism and Signal Mining Strategy
   with LC-MS Data}},
Journal = {{ANALYTICAL CHEMISTRY}},
Year = {{2011}},
Volume = {{83}},
Number = {{22}},
Pages = {{8725-8731}},
Month = {{NOV 15}},
Abstract = {{Di-isononyl phthalate esters (DINPs) are endocrine-disrupting chemicals
   and have replaced di(2-ethylhexyl) phthalate (DEHP) as the major
   plasticizer for poly(vinyl chloride) (PVC) products in recent years.
   Exposure marker discovery of DINPs is crucial, because of their high
   potential for human exposure and toxicity. Here, we propose an
   alternative approach for tracing signals derived from stable
   isotope-labeled precursors with varied labeling ratios to efficiently
   filter probable metabolite signals. The statistical process, which
   involves a signal mining algorithm with isotope tracing (SMAIT), has
   effectively filtered 13 probable DINP metabolite signals out of the 8867
   peaks in the LC-MS data obtained from incubated stable isotope-labeled
   precursors with liver enzymes. Seven of the 13 probable metabolite
   signals were confirmed as DINP structure-related metabolites by
   preliminary MS/MS analyses. These 7 structure-related metabolite signals
   were validated as effective DINP exposure markers, using urine samples
   collected from DINP-administered rats without time-consuming
   comprehensive structure identification. We propose that the 7 identified
   possible DINP metabolite signals of m/z 279.1, 293.1, 305.1, 307.1,
   321.1, 365.1, and 375.1 are potential markers for DINP exposure and
   should be investigated further. The integrated approach described here
   can efficiently, and systematically, filter probable metabolite signals
   from a complex LC-MS dataset for toxic exposure marker discovery. It is
   a relatively low-cost/rapid workflow for exposure marker discovery.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Liao, PC (Reprint Author), Natl Cheng Kung Univ, Dept Environm \& Occupat Hlth, Coll Med, 138 Sheng Li Rd, Tainan 704, Taiwan.
   Hsu, Jing-Fang; Peng, Li-Wen; Lin, Lung-Cheng; Liao, Pao-Chi, Natl Cheng Kung Univ, Dept Environm \& Occupat Hlth, Coll Med, Tainan 704, Taiwan.
   Li, Yu-Jang, Natl Chiayi Univ, Dept Appl Chem, Chiayi 600, Taiwan.
   Liao, Pao-Chi, Natl Cheng Kung Univ, Ctr Micro Nano Sci \& Technol, Tainan 701, Taiwan.}},
DOI = {{10.1021/ac202034k}},
ISSN = {{0003-2700}},
Keywords-Plus = {{NUTRITION EXAMINATION SURVEY; TANDEM MASS-SPECTROMETRY;
   ISO-NONYLPHTHALATE DINP; DRUG-METABOLISM; DEVELOPMENTAL TOXICITY;
   NATIONAL-HEALTH; HUMAN URINE; MALE-RAT; BIOMARKERS; DIISONONYL}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Author-Email = {{liaopc@mail.ncku.edu.tw}},
Funding-Acknowledgement = {{National Science Council of Taiwan {[}NSC93-2113-M006-017,
   NSC97-2113-M-006-005-MY3, NSC100-2113-M-006-002-MY3]; Ministry of
   Education, Taiwan, ROC}},
Funding-Text = {{This work was supported by grants from the National Science Council of
   Taiwan (NSC93-2113-M006-017, NSC97-2113-M-006-005-MY3, and
   NSC100-2113-M-006-002-MY3) and Ministry of Education, Taiwan, ROC, under
   the NCKU Project of Promoting Academic Excellence \& Developing World
   Class Research Centers.}},
Cited-References = {{Anari MR, 2004, ANAL CHEM, V76, P823, DOI 10.1021/ac034980s.
   Calafat AM, 2011, ENVIRON HEALTH PERSP, V119, P50, DOI 10.1289/ehp.1002316.
   Chen C, 2007, DRUG METAB REV, V39, P581, DOI 10.1080/03602530701497804.
   Clarke N, 2001, ANAL CHEM, V73, p430A, DOI 10.1021/ac012480y.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Glue P, 1999, CELL MOL NEUROBIOL, V19, P309, DOI 10.1023/A:1006993631057.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hellwig J, 1997, FOOD CHEM TOXICOL, V35, P501, DOI 10.1016/S0278-6915(97)00008-2.
   JACKSON PJ, 1995, J MASS SPECTROM, V30, P446, DOI 10.1002/jms.1190300308.
   JUAN YY, 2011, TAIPEI TIMES, P2.
   Kavlock R, 2002, REPROD TOXICOL, V16, P679, DOI 10.1016/S0890-6238(02)00034-5.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Lin LC, 2010, J AM SOC MASS SPECTR, V21, P232, DOI 10.1016/j.jasms.2009.10.002.
   Lin LC, 2011, CHEMOSPHERE, V83, P1192, DOI 10.1016/j.chemosphere.2010.12.079.
   Ma SG, 2011, ANAL CHEM, V83, P5028, DOI 10.1021/ac200349g.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Mounicou S, 2009, CHEM SOC REV, V38, P1119, DOI 10.1039/b713633c.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   Waterman SJ, 1999, REPROD TOXICOL, V13, P131, DOI 10.1016/S0890-6238(99)00002-7.
   Yan ZY, 2004, ANAL CHEM, V76, P6835, DOI 10.1021/ac040159k.
   Zhang HY, 2003, J MASS SPECTROM, V38, P1110, DOI 10.1002/jms.521.
   Zhang HY, 2009, J MASS SPECTROM, V44, P999, DOI 10.1002/jms.1610.
   Zhu PJ, 2009, ANAL CHEM, V81, P5910, DOI 10.1021/ac900626d.
   {*}AGPU, 2006, PLAST MATK DAT, P34905.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{0}},
Journal-ISO = {{Anal. Chem.}},
Doc-Delivery-Number = {{845NQ}},
Wos-Id = {{ISI:000296830200052}},
}

@article{ ISI:000298599900019,
Author = {Solymos, E. and Guddat, S. and Geyer, H. and Thomas, A. and Thevis, M.
   and Schaenzer, W.},
Title = {{Di(2-ethylhexyl)phthalate metabolites as markers for blood transfusion
   in doping control: Intra-individual variability of urinary
   concentrations}},
Journal = {{DRUG TESTING AND ANALYSIS}},
Year = {{2011}},
Volume = {{3}},
Number = {{11-12}},
Pages = {{892-895}},
Month = {{NOV-DEC}},
Abstract = {{To indicate homologous or autologous blood transfusion in sports drug
   testing, quantification of increased urinary concentrations of
   di(2-ethylhexyl) phthalate (DEHP) metabolites presents a promising
   approach; however, the possible intra-individual variation of the
   metabolite concentrations over time has not been well characterized.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Guddat, S (Reprint Author), German Sport Univ Cologne, Inst Biochem, Sportpk 6, D-50933 Cologne, Germany.
   Guddat, S.; Geyer, H.; Thomas, A.; Thevis, M.; Schaenzer, W., German Sport Univ Cologne, Inst Biochem, D-50933 Cologne, Germany.
   Guddat, S.; Geyer, H.; Thomas, A.; Thevis, M.; Schaenzer, W., German Sport Univ Cologne, Ctr Prevent Doping Res, D-50933 Cologne, Germany.
   Solymos, E., Eotvos Lorand Univ, Joint Res \& Training Lab Separat Tech, Budapest, Hungary.}},
DOI = {{10.1002/dta.377}},
ISSN = {{1942-7603}},
Keywords = {{DEHP metabolites; sports drug testing; liquid chromatography mass
   spectrometry; blood transfusion}},
Keywords-Plus = {{PHTHALATE METABOLITES; EXPOSURE; SAMPLES; SERUM; DEHP}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical; Pharmacology \&
   Pharmacy}},
Author-Email = {{s.guddat@biochem.dshs-koeln.de}},
Funding-Acknowledgement = {{Antidoping Switzerland (Bern, Switzerland); Manfred Donike Institute for
   Doping Analysis e.V. (Cologne, Germany)}},
Funding-Text = {{The study was carried out with the financial support of the Antidoping
   Switzerland (Bern, Switzerland) and the Manfred Donike Institute for
   Doping Analysis e.V. (Cologne, Germany).}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ATSDR, 2002, TOX PROF DI 2 ETH PH.
   CDC, 2009, 4 CDC US CDCP NAT CT.
   CDC, 2010, 4 CDC US CDCP NAT CT.
   Fromme H., 2007, INT J HYG ENVIR HEAL, V210, P1.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Monfort N, 2010, TRANSFUSION, V50, P145, DOI 10.1111/j.1537-2995.2009.02352.x.
   Park M. S., 2010, J PREV MED PUBLIC HL, V1043, P301.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Solymos E, 2011, ANAL BIOANAL CHEM, V401, P517, DOI 10.1007/s00216-010-4589-4.}},
Number-of-Cited-References = {{15}},
Times-Cited = {{6}},
Journal-ISO = {{Drug Test. Anal.}},
Doc-Delivery-Number = {{869LQ}},
Wos-Id = {{ISI:000298599900019}},
}

@article{ ISI:000295402400023,
Author = {Meeker, John D. and Ferguson, Kelly K.},
Title = {{Relationship between Urinary Phthalate and Bisphenol A Concentrations
   and Serum Thyroid Measures in US Adults and Adolescents from the
   National Health and Nutrition Examination Survey (NHANES) 2007-2008}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2011}},
Volume = {{119}},
Number = {{10}},
Pages = {{1396-1402}},
Month = {{OCT}},
Abstract = {{Background: Limited animal, in vitro, and human studies have reported
   that exposure to phthalates or bisphenol A (BPA) may affect thyroid
   signaling.
   Objective: We explored the cross-sectional relationship between urinary
   concentrations of metabolites of di(2-ethylhexyl) phthalate (DEHP),
   dibutyl phthalate (DBP), and BPA with a panel of serum thyroid measures
   among a representative sample of U. S. adults and adolescents.
   Methods: We analyzed data on urinary biomarkers of exposure to
   phthalates and BPA, serum thyroid measures, and important covariates
   from 1,346 adults (ages >= 20 years) and 329 adolescents (ages 12-19
   years) from the National Health and Nutrition Examination Survey
   (NHANES) 2007-2008 using multivariable linear regression.
   Results: Among adults, we observed significant inverse relationships
   between urinary DEHP metabolites and total thyroxine (T(4)), free T(4),
   total triiodo-thyronine (T(3)), and thyroglobulin, and positive
   relationships with thyroid-stimulating hormone (TSH). The strongest and
   most consistent relationships involved total T(4), where adjusted
   regression coefficients for quintiles of oxidative DEHP metabolites
   displayed monotonic dose-dependent decreases in total T(4) (p-value for
   trend < 0.0001). Suggestive inverse relationships between urinary BPA
   and total T(4) and TSH were also observed. Conversely, among
   adolescents, we observed significant positive relationships between DEHP
   metabolites and total T(3). Mono(3-carboxypropyl) phthalate, a secondary
   metabolite of both DBP and di-n-octyl phthalate, was associated with
   several thyroid measures in both age groups, whereas other DBP
   metabolites were not associated with thyroid measures.
   Conclusions: These results support previous reports of associations
   between phthalates-and possibly BPA-and altered thyroid hormones. More
   detailed studies are needed to determine the temporal relationships and
   potential clinical and public health implications of these associations.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Meeker, JD (Reprint Author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, 6635 SPH Tower,109 S Observ St, Ann Arbor, MI 48109 USA.
   Meeker, John D.; Ferguson, Kelly K., Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.}},
DOI = {{10.1289/ehp.1103582}},
ISSN = {{0091-6765}},
Keywords = {{biomarkers; epidemiology; exposure; population; risk}},
Keywords-Plus = {{SCHOOL-AGE-CHILDREN; TEMPORAL VARIABILITY; HORMONE-LEVELS;
   DI-(2-ETHYLHEXYL) PHTHALATE; DI(2-ETHYLHEXYL) PHTHALATE; ENVIRONMENTAL
   CHEMICALS; CHILDHOOD BEHAVIOR; MALE RATS; EXPOSURE; POPULATION}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{meekerj@umich.edu}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences {[}R01ES018872,
   P42ES017198, P20ES018171]; U.S. Environmental Protection Agency
   {[}RD83480001]}},
Funding-Text = {{This work was supported by grants R01ES018872, P42ES017198, and
   P20ES018171 from the National Institute of Environmental Health
   Sciences, and grant RD83480001 from the U.S. Environmental Protection
   Agency.}},
Cited-References = {{Andersen S, 2002, J CLIN ENDOCR METAB, V87, P1068, DOI 10.1210/jc.87.3.1068.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979.
   Breous E, 2005, MOL CELL ENDOCRINOL, V244, P75, DOI 10.1016/j.mce.2005.06.009.
   Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753.
   Centers for Disease Control and Prevention, 2010, 4 NAT REP HUM EXP EN.
   Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376.
   CORCORAN JM, 1977, ARCH DIS CHILD, V52, P716.
   Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Gaitan E, 1983, Ecol Dis, V2, P295.
   Galloway T, 2010, ENVIRON HEALTH PERSP, V118, P1603, DOI 10.1289/ehp.1002367.
   Ghisari M, 2009, TOXICOL LETT, V189, P67, DOI 10.1016/j.toxlet.2009.05.004.
   Hatch EE, 2010, INT J ANDROL, V33, P324, DOI 10.1111/j.1365-2605.2009.01035.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Heimeier RA, 2009, ENDOCRINOLOGY, V150, P2964, DOI 10.1210/en.2008-1503.
   HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Kaneko M, 2008, GEN COMP ENDOCR, V155, P574, DOI 10.1016/j.ygcen.2007.09.009.
   Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034.
   KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166.
   Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303.
   Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2010, ENVIRON SCI TECHNOL, V44, P1458, DOI 10.1021/es9028292.
   Meeker JD, 2011, ENVIRON HEALTH PERSP, V119, P252, DOI 10.1289/ehp.1002238.
   Miller MD, 2009, ENVIRON HEALTH PERSP, V117, P1033, DOI 10.1289/ehp.0800247.
   Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209.
   NCHS, 2010, NAT HLTH NUTR EX SUR.
   O'Connor JC, 2002, TOXICOL SCI, V69, P92, DOI 10.1093/toxsci/69.1.92.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   PRICE SC, 1988, TOXICOL LETT, V40, P37, DOI 10.1016/0378-4274(88)90181-6.
   Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019.
   Shi W, 2011, ENVIRON POLLUT, V159, P441, DOI 10.1016/j.envpol.2010.10.023.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Wenzel A, 2005, MOL CELL ENDOCRINOL, V244, P63, DOI 10.1016/j.mce.2005.02.008.
   WESTGARD JO, 1981, CLIN CHEM, V27, P493.
   Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010.
   Ye XY, 2005, ANAL CHEM, V77, P5407, DOI 10.1021/ac050390d.
   Zoeller RT, 2007, THYROID, V17, P811, DOI 10.1089/thy.2007.0107.
   {*}NCHS, 2009, 2007 2008 DOC COD FR.
   {*}NCHS, 2010, 2007 2008 DAT DOC CO.
   {*}NCHS, 2010, CONT NHANES WEB TUT.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{21}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{827CA}},
Wos-Id = {{ISI:000295402400023}},
}

@article{ ISI:000295402400039,
Author = {Kim, Yeni and Ha, Eun-Hee and Kim, Eui-Jung and Park, Hyesook and Ha,
   Mina and Kim, Ja-Hyeong and Hong, Yun-Chul and Chang, Namsoo and Kim,
   Bung-Nyun},
Title = {{Prenatal Exposure to Phthalates and Infant Development at 6 Months:
   Prospective Mothers and Children's Environmental Health (MOCEH) Study}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2011}},
Volume = {{119}},
Number = {{10}},
Pages = {{1495-1500}},
Month = {{OCT}},
Abstract = {{BACKGROUND: There are increasing concerns over adverse effects of
   prenatal phthalate exposure on the neurodevelopment of infants.
   OBJECTIVES: Our goal was to explore the association between prenatal
   di(2-ethylhexyl) phthalate and dibutyl phthalate exposure and the Mental
   and Psychomotor Developmental Indices (MDI and PDI, respectively) of the
   Bayley Scales of Infant Development at 6 months, as part of the Mothers
   and Children's Environmental Health Study.
   METHODS: Between 2006 and 2009, 460 mother-infant pairs from Seoul,
   Cheonan, and Ulsan, Korea, participated. Prenatal
   mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl)
   phthalate (MEOHP), and mono-n-butyl phthalate (MBP) were measured in one
   urine sample acquired from each mother during the third trimester of
   pregnancy. Associations with log-transformed creatinine-corrected
   phthalate concentrations were estimated using linear regression models
   adjusted for potential confounders.
   RESULTS: MDI was inversely associated with the natural log
   concentrations (micrograms per gram creatinine) of MEHHP {[}beta =
   -0.97; confidence interval (CI), -1.85 to -0.08] and MEOHP (beta =
   -0.95; CI, -1.87 to -0.03), and PDI was inversely associated with MEHHP
   (beta = -1.20; CI, -2.33 to -0.08). In males, MDI was inversely
   associated with MEHHP (beta = -1.46; CI, -2.70 to -0.22), MEOHP (beta =
   -1.57; CI, -2.87 to -0.28), and MBP (beta = -0.93; CI, -1.82 to -0.05);
   PDI was inversely associated with MEHHP (beta = -2.36; CI, -3.94 to
   -0.79), MEOHP (beta = -2.05; CI, -3.71 to -0.39), and MBP (beta = -1.25;
   CI, -2.40 to -0.11). No significant linear associations were observed
   for females.
   CONCLUSIONS: The results suggest that prenatal exposure to phthalates
   may be inversely associated with the MDI and PDI of infants,
   particularly males, at 6 months.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kim, BN (Reprint Author), Seoul Natl Univ Hosp, Div Child \& Adolescent Psychiat, Dept Neuropsychiat, 28 Yongon Dong, Seoul 110744, South Korea.
   Kim, Yeni, Seoul Natl Univ Hosp, Dept Adolescent Psychiat, Natl Ctr Child \& Adolescent Psychiat, Seoul 110744, South Korea.
   Ha, Eun-Hee; Park, Hyesook, Ewha Womans Univ, Dept Prevent Med, Coll Med, Seoul, South Korea.
   Kim, Eui-Jung, Ewha Womans Univ, Dept Psychiat, Coll Med, Seoul, South Korea.
   Ha, Mina, Dankook Univ, Dept Prevent Med, Coll Med, Cheonan, South Korea.
   Kim, Ja-Hyeong, Univ Ulsan, Coll Med, Dept Pediat, Ulsan 680749, South Korea.
   Hong, Yun-Chul, Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.
   Chang, Namsoo, Ewha Womans Univ, Dept Nutr Sci \& Food Management, Coll Hlth Sci, Seoul, South Korea.
   Kim, Bung-Nyun, Seoul Natl Univ, Div Child \& Adolescent Psychiat, Dept Psychiat, Coll Med, Seoul, South Korea.}},
DOI = {{10.1289/ehp.1003178}},
ISSN = {{0091-6765}},
Keywords = {{development; dibutyl phthalate; di(2-ethylhexyl) phthalate; infant;
   prenatal}},
Keywords-Plus = {{TYROSINE-HYDROXYLASE IMMUNOREACTIVITY; SCHOOL-AGE-CHILDREN; CAUSES
   HYPERACTIVITY; THYROID-HORMONES; PREGNANT-WOMEN; BISPHENOL-A; RAT; LEAD;
   ASSOCIATION; IMPAIRMENT}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{kbn1@snu.ac.kr}},
ResearcherID-Numbers = {{Kim, Boong Nyun/J-5397-2012
   Hong, Yun-Chul/J-5725-2012}},
Funding-Acknowledgement = {{Mothers and Children's Environmental Health (MOCEH) study of the
   Ministry of the Environment, Republic of Korea}},
Funding-Text = {{This study was supported by the Mothers and Children's Environmental
   Health (MOCEH) study of the Ministry of the Environment, Republic of
   Korea.}},
Cited-References = {{{[}American Educational Research Association American Psychological Association National Council on Measurement in Education], 1999, STAND ED PSYCH TEST.
   Bayley N, 1993, BAYLEY SCALES INFANT.
   Bellinger DC, 2008, CURR OPIN PEDIATR, V20, P172, DOI 10.1097/MOP.0b013e3282f4f97b.
   Berbel P, 2010, CEREB CORTEX, V20, P1462, DOI 10.1093/cercor/bhp212.
   BOQUE R, 2009, LCGC EUROPE, V22.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809.
   Braun JM, 2006, ENVIRON HEALTH PERSP, V114, P1904, DOI 10.1289/ehp.9478.
   Canfield RL, 2003, NEW ENGL J MED, V348, P1517, DOI 10.1056/NEJMoa022848.
   Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376.
   Colborn T, 2004, ENVIRON HEALTH PERSP, V112, P944, DOI 10.1289/ehp.6601.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Ghisari M, 2009, TOXICOL LETT, V189, P67, DOI 10.1016/j.toxlet.2009.05.004.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Ishido M, 2004, J NEUROSCI RES, V76, P423, DOI 10.1002/jnr.20050.
   Ishido M, 2004, J NEUROCHEM, V91, P69, DOI 10.1111/j.1471-4159.2004.02696.x.
   Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034.
   Kim Bong Soo, 2009, Korean Journal of Internal Medicine, V24, P24, DOI 10.3904/kjim.2009.24.1.24.
   Kim Y, 2009, NEUROTOXICOLOGY, V30, P564, DOI 10.1016/j.neuro.2009.03.012.
   Kim Y, 2010, SCI TOTAL ENVIRON, V408, P5737, DOI 10.1016/j.scitotenv.2010.07.070.
   LEE JH, 2008, 3 NATL SURVEY HUMAN.
   Lim YR, 2000, KOREAN J CLIN PSYCHO, V19, P563.
   Masuo Y, 2004, REGUL PEPTIDES, V123, P225, DOI 10.1016/j.regpep.2004.05.010.
   Mink PJ, 2004, EPIDEMIOLOGY, V15, P385, DOI 10.1097/01.ede.0000128402.86336.7e.
   Miodovnik A, 2011, NEUROTOXICOLOGY, V32, P261, DOI 10.1016/j.neuro.2010.12.009.
   Park HW, 2006, KOREAN BAYLEY SCALES.
   SILVERSTEIN AB, 1990, J CLIN PSYCHOL, V46, P333, DOI 10.1002/1097-4679(199005)46:3<333::AID-JCLP2270460314>3.0.CO;2-X.
   Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Tanida T, 2009, TOXICOL LETT, V189, P40, DOI 10.1016/j.toxlet.2009.04.005.
   UM TH, 1992, MANUAL KOREAN WECHSL.
   Wittassek M, 2009, INT J HYG ENVIR HEAL, V212, P492, DOI 10.1016/j.ijheh.2009.04.001.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Xu Y, 2007, ARCH TOXICOL, V81, P57, DOI 10.1007/s00204-006-0143-8.
   Ye XB, 2009, INT J HYG ENVIR HEAL, V212, P481, DOI 10.1016/j.ijheh.2009.03.004.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.
   {*}CDCP, 2009, LAB PROC MAN CTR DIS.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{9}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{827CA}},
Wos-Id = {{ISI:000295402400039}},
}

@article{ ISI:000295236800047,
Author = {Xie, Xiaoyun and Wang, Zhaowei and Zhou, Ximin and Wang, Xiaoru and
   Chen, Xingguo},
Title = {{Study on the interaction of phthalate esters to human serum albumin by
   steady-state and time-resolved fluorescence and circular dichroism
   spectroscopy}},
Journal = {{JOURNAL OF HAZARDOUS MATERIALS}},
Year = {{2011}},
Volume = {{192}},
Number = {{3}},
Pages = {{1291-1298}},
Month = {{SEP 15}},
Abstract = {{Phthalate esters (PAEs) are globally pervasive contaminants that are
   considered to be endocrine disruptor chemicals and toxic environmental
   priority pollutants. In this paper, the interactions between PAEs and
   human serum albumin (HSA) were examined by molecular modelling, steady
   state and time-resolved fluorescence, ultraviolet-visible spectroscopy
   (UV-vis) and circular dichroism spectroscopy (CD). The association
   constants between PAEs and HSA were determined using the Stern-Volmer
   and Scatchard equations. The binding of dimethyl phthalate (DMP) to HSA
   has a single class of binding site and its binding constants (K) are
   4.08 x 10(3), 3.97 x 10(3), 3.45 x 10(3), and 3.20 x 10(3) L mol(-1) at
   289, 296, 303, and 310 K, respectively. The Stern-Volmer and Scatchard
   plots both had two regression curves for HSA-butylbenzyl phthalate (BBP)
   and HSA-di-2-ethylhexyl phthalate (DEHP), which indicated that these
   bindings were via two types of binding sites: the numbers of binding
   site for the first type were lower than for the second type. The binding
   constants of the first type binding site were higher than those of the
   second type binding site at corresponding temperatures, the results
   suggesting that the first type of binding site had high affinity and the
   second binding site involved other sites with lower binding affinity and
   selectivity. The thermodynamic parameters of the binding reactions
   (Delta G degrees, Delta H degrees and Delta S degrees) were measured,
   and they indicated the presences of hydrophobic forces and hydrogen
   interactions in the PAEs-HSA interactions, which agreed well with the
   results from molecular modelling. The alterations of protein secondary
   structure in the presence of PAEs were confirmed by UV-vis and CD
   spectroscopy. The time-resolved fluorescence study showed that the
   lifetime of Trp residue of HSA decreased after the addition of PAEs,
   which implied that the Trp residue of HSA was the main binding site. (C)
   2011 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chen, XG (Reprint Author), Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China.
   Chen, Xingguo, Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China.
   Xie, Xiaoyun; Zhou, Ximin; Wang, Xiaoru; Chen, Xingguo, Lanzhou Univ, Natl Key Lab Organ Chem, Lanzhou 730000, Peoples R China.
   Xie, Xiaoyun; Wang, Zhaowei, Lanzhou Univ, Coll Earth \& Environm Sci, Lanzhou 730000, Peoples R China.}},
DOI = {{10.1016/j.jhazmat.2011.06.038}},
ISSN = {{0304-3894}},
Keywords = {{Phthalate esters; Human serum albumin; Fluorescence; Molecular
   modelling; Circular dichroism}},
Keywords-Plus = {{BINDING; DEGRADATION; BOVINE; DRUGS; SPECTRA; WATER}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Engineering, Civil; Environmental Sciences}},
Author-Email = {{chenxg@lzu.edu.cn}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}20875040, J0730425]}},
Funding-Text = {{This work was kindly supported by the National Natural Science
   Foundation of China (No. 20875040, J0730425).}},
Cited-References = {{Ambrosetti R, 1996, CHEM-EUR J, V2, P149, DOI 10.1002/chem.19960020206.
   Bertucci C, 2002, CURR MED CHEM, V9, P1463.
   Blair JD, 2009, ENVIRON SCI TECHNOL, V43, P6262, DOI 10.1021/es9013135.
   Chen GZ, 1990, METHODS FLUORESCENCE.
   Divsalar A, 2009, J PHYS CHEM B, V113, P14035, DOI 10.1021/jp904822n.
   Flora K, 1998, BIOPHYS J, V75, P1084.
   Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119.
   Hirshfield KM, 1996, BIOPHYS CHEM, V62, P25, DOI 10.1016/S0301-4622(96)00027-0.
   Hu YJ, 2009, BIOMACROMOLECULES, V10, P517, DOI 10.1021/bm801120k.
   Kabdasli I, 2009, J HAZARD MATER, V171, P932, DOI 10.1016/j.jhazmat.2009.06.093.
   Lakowicz J. R., 1999, PRINCIPLES FLUORESCE.
   Mackintosh CE, 2006, ENVIRON SCI TECHNOL, V40, P3481, DOI 10.1021/es0519637.
   MORRIS G, 2002, SYBYL SOFTW VERS 6 9.
   Papadopoulou A, 2005, J AGR FOOD CHEM, V53, P158, DOI 10.1021/jf048693g.
   Petitpas I, 2001, J BIOL CHEM, V276, P22804, DOI 10.1074/jbc.M100575200.
   RAHMAN MH, 1993, BIOCHEM PHARMACOL, V46, P1721, DOI 10.1016/0006-2952(93)90576-I.
   ROSS PD, 1981, BIOCHEMISTRY-US, V20, P3096, DOI 10.1021/bi00514a017.
   Salim CJ, 2010, CARBOHYD POLYM, V81, P640, DOI 10.1016/j.carbpol.2010.03.024.
   SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x.
   SJOHOLM I, 1979, MOL PHARMACOL, V16, P767.
   Soares S, 2007, J AGR FOOD CHEM, V55, P6726, DOI 10.1021/jf070905x.
   Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1.
   Sulkowska A, 2002, J MOL STRUCT, V614, P227, DOI 10.1016/S0022-2860(02)00256-9.
   Suzuki T, 2001, ENVIRON SCI TECHNOL, V35, P3757, DOI 10.1021/es001860i.
   US EPA, 1981, EPA440481020.
   WOLFBEIS OS, 1984, BER BUNSEN PHYS CHEM, V88, P759.
   Xu B, 2009, J HAZARD MATER, V162, P954, DOI 10.1016/j.jhazmat.2008.05.122.
   Xu ZW, 2010, ENVIRON SCI TECHNOL, V44, P3130, DOI 10.1021/es100058j.
   Yang P., 2002, PRINCIPLE BIOINORGAN, P349.
   Yuan SY, 2010, J HAZARD MATER, V184, P826, DOI 10.1016/j.jhazmat.2010.08.116.
   Zeng F, 2009, J HAZARD MATER, V169, P719, DOI 10.1016/j.jhazmat.2009.04.006.
   Zolese G, 2000, PROTEINS, V40, P39, DOI 10.1002/(SICI)1097-0134(20000701)40:1<39::AID-PROT60>3.0.CO;2-N.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{6}},
Journal-ISO = {{J. Hazard. Mater.}},
Doc-Delivery-Number = {{824XZ}},
Wos-Id = {{ISI:000295236800047}},
}

@article{ ISI:000296544500005,
Author = {Yolton, Kimberly and Xu, Yingying and Strauss, Donna and Altaye, Mekibib
   and Calafat, Antonia M. and Khoury, Jane},
Title = {{Prenatal exposure to bisphenol A and phthalates and infant neurobehavior}},
Journal = {{NEUROTOXICOLOGY AND TERATOLOGY}},
Year = {{2011}},
Volume = {{33}},
Number = {{5}},
Pages = {{558-566}},
Month = {{SEP-OCT}},
Abstract = {{Objective: To examine the association of prenatal exposure to bisphenol
   A and select common phthalates with infant neurobehavior measured at 5
   weeks.
   Methods: We compared the concentration of maternal urinary metabolites
   of bisphenol A and phthalates at two distinct time points in pregnancy
   (16w, 26w) with scores on the NICU Network Neurobehavioral Scale (NNNS)
   at 5 weeks of age in a cohort of 350 mother/infant pairs.
   Results: Prenatal exposure to BPA was not significantly associated with
   neurobehavioral outcomes at 5 weeks. Significant associations between
   prenatal exposure to measured phthalates and infant neurobehavioral
   outcomes differed by type of phthalate and were only seen with exposure
   measured at 26 weeks. Higher total di-butyl phthalate (DBP) metabolites
   at 26w were associated with improved behavioral organization evidenced
   by decreased arousal (p = .04), increased self-regulation (p = .052),
   and decreased handling (p = .02). In males, higher total di-2-ethylhexyl
   phthalate (DEHP) metabolites at 26w were associated with more nonoptimal
   reflexes (p = .02).
   Conclusion: The association between prenatal phthalate exposure and
   infant neurobehavior differed by type of phthalate and was evident only
   with exposure measured at 26w. Prenatal exposure to DBP was associated
   with improved behavioral organization in 5-week-old infants. Prenatal
   exposure to DEHP was associated with nonoptimal reflexes in male
   infants. There was no evidence of an association between prenatal BPA
   exposure and infant neurobehavior. (C) 2011 Elsevier Inc. All rights
   reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Yolton, K (Reprint Author), Cincinnati Childrens Hosp Med Ctr, Div Gen \& Community Pediat, Dept Pediat, 3333 Burnet Ave,ML 7035, Cincinnati, OH 45229 USA.
   Yolton, Kimberly; Xu, Yingying; Strauss, Donna; Altaye, Mekibib; Khoury, Jane, Cincinnati Childrens Hosp Med Ctr, Div Gen \& Community Pediat, Dept Pediat, Cincinnati, OH 45229 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Atlanta, GA 30341 USA.}},
DOI = {{10.1016/j.ntt.2011.08.003}},
ISSN = {{0892-0362}},
Keywords = {{Bisphenol A; Infant neurobehavior; Phthalates; Prenatal exposure}},
Keywords-Plus = {{OXIDATIVE METABOLITES; MICE; PREGNANCY; MONOESTER; TOXICITY; CHILDREN;
   DEHP; LIFE; RAT}},
Research-Areas = {{Neurosciences \& Neurology; Toxicology}},
Web-of-Science-Categories  = {{Neurosciences; Toxicology}},
Author-Email = {{kimberly.yolton@cchmc.org}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences {[}R01 ES015517, P01
   ES11261]}},
Funding-Text = {{This work was partially supported by grants from the National Institute
   of Environmental Health Sciences (R01 ES015517, P01 ES11261). The study
   sponsors made no contributions to study design, data collection,
   analysis, interpretation, authorship, or decisions to submit for
   publication. We appreciate the support and guidance of Dr. Bruce
   Lanphear. We acknowledge the technical assistance of X. Ye, A. Bishop,
   M. Silva, E. Samandar, J. Preau, T. Jia, P. Olive and T. Bernert
   (Centers for Disease Control and Prevention, Atlanta, GA) in measuring
   the urinary concentrations of BPA, phthalate metabolites, creatinine,
   and of serum cotinine.}},
Cited-References = {{ADEWALE HB, 2010, NEUROTOXICOLOGY.
   ADIBI J, 2009, AM J EPIDEMIOL, V8, P1015.
   AKINGBEMI B, 2004, ENDOCRINOLOGY, V2, P592.
   ANDRADE A, 2006, TOXICOLOGY, V1, P85.
   BARR D, 2005, ENV HLTH PERSPECT, V2, P192.
   BARROS MCD, 2006, J PEDIAT, V6, P781.
   Bearer CF, 2000, NEUROTOXICOLOGY, V21, P925.
   Beck A. T., 1996, MANUAL BECK DEPRESSI, P1.
   BERMAN T, 2009, ENVIRON INT, V2, P353.
   BIEDERMANN S, 2010, ANAL BIOANAL CHEM, P1.
   BRAUN J, 2009, PRENATAL BISPHENOL E.
   BRAUN JM, 2010, ENV HLTH PERSPECT.
   Brazelton T. B., 1995, NEONATAL BEHAV ASSES.
   CALAFAT A, 2008, ENV HLTH PERSPECT, V1, P39.
   CANTONWINE D, 2010, ENV HLTH, V1, P62.
   Centers for Disease Control and Prevention, 2009, NCEH PUBL.
   CHO SC, 2010, ENV HLTH PERSPECT.
   DALSENTER P, 2006, HUM EXP TOXICOL, V6, P297.
   ENGEL SM, 2009, NEUROTOXICOLOGY, V4, P522.
   ENGEL SM, 2010, ENV HLTH PERSPECT, V4, P565.
   GERAGHTY SR, 2008, BREASTFEED MED, V4, P207.
   GRAY L, 2000, TOXICOL SCI, V2, P350.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   HORNUNG R, 1991, APPL OCCUP ENV HYG, P516.
   HOSHI H, 2009, B ENVIRON CONTAM TOX, V1, P62.
   IRVIN E, 2010, CHEMOSPHERE.
   Ishido M, 2004, J NEUROCHEM, V91, P69, DOI 10.1111/j.1471-4159.2004.02696.x.
   JOHN E, 1994, EPIDEMIOLOGY, V2, P147.
   JUST A, 2010, J EXPO SCI ENV EPIDE.
   KIM B, 2009, BIOL PSYCHIAT, V10, P958.
   LAGASSE LL, 2010, NEUROTOXICOL TERATOL.
   Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688.
   Law KL, 2003, PEDIATRICS, V111, P1318, DOI 10.1542/peds.111.6.1318.
   LEE H, 2003, TOXICOL SCI, V1, P40.
   LEE H, 2006, J REPROD DEVELOP.
   LESTER B, 2004, PEDIATRICS, V3, P668.
   LESTER B, 2004, USING NNNS TM NICU N, P13.
   Lester BM, 2002, PEDIATRICS, V110, P1182, DOI 10.1542/peds.110.6.1182.
   LI D, 2010, HUM REPROD, V2, P519.
   LI Y, 2009, J APPL TOXICOL, V7, P603.
   LIN EM, 2010, INT J ANDROL, V2, P385.
   Lottrup G, 2006, INT J ANDROL, V29, P181.
   Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x.
   MA M, 2006, TOXICOL SCI, V1, P164.
   Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605.
   MCKEE R, 2006, REPROD TOXICOL, V3, P241.
   MEEKER J, 2009, ENV HLTH PERSPECT, V10, P1587.
   MEEKER J, 2010, REPROD TOXICOL.
   MEEKER J, 2007, ENV HLTH PERSPECT, V7, P1029.
   Meeker J.D., 2009, J ANDROL, V3, P287.
   MENDIOLA J, 2010, ENV HLTH PERSPECT, V9, P1286.
   MIODOVNIK A, 2010, NEUROTOXICOLOGY.
   MOORE R, 2001, ENV HLTH PERSPECT, V3, P229.
   NORIEGA N, 2009, TOXICOL SCI.
   PALANZA P, 2008, ENVIRON RES, V2, P150.
   Palanza P, 2002, ENVIRON HEALTH PERSP, V110, P415.
   PANT N, 2008, TOXICOL APPL PHARM, V1, P112.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PAZ MS, 2009, NEUROTOXICOL TERATOL, V3, P177.
   PECK J, 2009, J EXPO SCI ENV EPID, V1, P90.
   POIMENOVA A, 2010, NEUROSCIENCE.
   PREAU J, 2010, ENV HLTH PERSPECT.
   SALIAN S, 2009, LIFE SCI, V21, P742.
   SILVA M, 2008, J CHROMATOGR B, V2, P180.
   SOMM E, 2009, PERINATAL EXPOSURE B.
   STROUD LR, 2009, J PEDIAT, V1, P10.
   SWAN SH, 2010, INT J ANDROL, V2, P259.
   Tanaka T, 2002, FOOD CHEM TOXICOL, V40, P1499, DOI 10.1016/S0278-6915(02)00073-X.
   Tanaka T, 2005, FOOD CHEM TOXICOL, V43, P581, DOI 10.1016/j.fct.2005.01.001.
   TIAN Y, 2010, SYNAPSE, V6, P432.
   TRONICK E, 2004, PEDIATRICS, V3, P676.
   VOLKEL W, 2010, ENV RES.
   VONGOETZ N, 2010, RISK ANAL, V3, P473.
   VORHEES C, 1986, HDB TERATOLOGY.
   WHYATT R, 2009, PEDIATRICS, V6, pE1213.
   WOLFF M, 2010, ENV HLTH PERSPECT, V7, P1039.
   WOLFF MS, 2008, ENV HLTH PERSPECT, V8, P1092.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   XU X, 2010, HORM BEHAV.
   YE X, 2008, ENVIRON RES, V2, P260.
   YE X, 2005, ANAL CHEM, V16, P5407.
   Yolton K, 2005, ENVIRON HEALTH PERSP, V113, P98.
   YOLTON K, 2009, NEUROTOXICOL TERATOL, V6, P356.}},
Number-of-Cited-References = {{84}},
Times-Cited = {{10}},
Journal-ISO = {{Neurotoxicol. Teratol.}},
Doc-Delivery-Number = {{841VY}},
Wos-Id = {{ISI:000296544500005}},
}

@article{ ISI:000294493800016,
Author = {Bao, Ai-Mei and Man, Xiao-Ming and Guo, Xue-Jiang and Dong, Hui-Bin and
   Wang, Fu-Qiang and Sun, Hong and Wang, Yu-Bang and Zhou, Zuo-Min and
   Sha, Jia-Hao},
Title = {{Effects of di-n-butyl phthalate on male rat reproduction following
   pubertal exposure}},
Journal = {{ASIAN JOURNAL OF ANDROLOGY}},
Year = {{2011}},
Volume = {{13}},
Number = {{5}},
Pages = {{702-709}},
Month = {{SEP}},
Abstract = {{Di-n-butyl phthalate (DBP) is an endocrine-disrupting chemical that has
   the potential to affect male reproduction. However, the reproductive
   effects of low-dose DBP are still not well known, especially at the
   molecular level. In the present study, pubertal male Sprague-Dawley rats
   were orally administered DBP at a wide range of doses (0.1, 1.0, 10, 100
   and 500 mg kg(-1) day(-1)) for 30 days. The selected end points included
   reproductive organ weights, testicular histopathology and serum hormonal
   levels. Additionally, proteomic analysis was performed to identify
   proteins that are differentially expressed as a result of exposure to
   DBP at low doses (0.1, 1.0 and 10 mg kg(-1) day(-1)). Toxic effects were
   observed in the high-dose groups, including anomalous development of
   testes and epididymides, severe atrophy of seminiferous tubules, loss of
   spermatogenesis and abnormal levels of serum hormones. Treatment with
   low doses of DBP seemed to exert a `stimulative effect' on the serum
   hormones. Proteomics analysis of rat testes showed 20 differentially
   expressed proteins. Among these proteins, alterations in the expression
   of HnRNPA2/B1, vimentin and superoxide dismutase 1 (SOD1) were further
   confirmed by Western blot and immunohistochemistry. Taken together, we
   conclude that high doses of DBP led to testicular toxicity, and low
   doses of DBP led to changes in the expression of proteins involved in
   spermatogenesis as well as changes in the number and function of Sertoli
   and Leydig cells, although no obvious morphological changes appeared.
   The identification of these differentially expressed proteins provides
   important information about the mechanisms underlying the effects of DBP
   on male rat reproduction. Asian Journal of Andrology (2011) 13, 702-709;
   doi:10.1038/aja.2011.76; published online 15 August 2011}},
Publisher = {{SHANGHAI INST MATERIA MEDICA}},
Address = {{555 ZU CHONG ZHI RD, ZHANG JIANG HI-TECH PARK, SHANGHAI, PUDONG 201203,
   PEOPLES R CHINA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wang, YB (Reprint Author), Nanjing Med Univ, Key Lab Reprod Med, Inst Toxicol, Nanjing 210029, Peoples R China.
   Man, Xiao-Ming; Dong, Hui-Bin; Wang, Yu-Bang, Nanjing Med Univ, Key Lab Reprod Med, Inst Toxicol, Nanjing 210029, Peoples R China.
   Bao, Ai-Mei; Guo, Xue-Jiang; Wang, Fu-Qiang; Zhou, Zuo-Min; Sha, Jia-Hao, Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Peoples R China.
   Sun, Hong, Jiangsu Prov Ctr Dis Control \& Prevent, Nanjing 210009, Peoples R China.}},
DOI = {{10.1038/aja.2011.76}},
ISSN = {{1008-682X}},
Keywords = {{di-n-butyl phthalate; hormones; proteomics; spermatogenesis; testis}},
Keywords-Plus = {{DI(N-BUTYL) PHTHALATE; DIETHYLHEXYL PHTHALATE; SUPEROXIDE-DISMUTASE;
   LEYDIG-CELLS; TESTICULAR AROMATIZATION; SEXUAL-DIFFERENTIATION;
   DEVELOPMENTAL TOXICITY; TESTOSTERONE SYNTHESIS; LACTATIONAL EXPOSURE;
   OXIDATIVE STRESS}},
Research-Areas = {{Endocrinology \& Metabolism; Urology \& Nephrology}},
Web-of-Science-Categories  = {{Andrology; Urology \& Nephrology}},
Author-Email = {{ncsa@njmu.edu.cn
   zhouzm@njmu.edu.cn}},
Funding-Acknowledgement = {{National Basic Research Program of China (973 Program) {[}2009CB941703];
   Jiangsu Provincial Natural Science Funds {[}BK2007235]; National Natural
   Science Foundation of China {[}30901222]}},
Funding-Text = {{We gratefully acknowledge the assistance of Feng Chen with the
   statistical analysis. The study was supported by grants from the
   National Basic Research Program of China (973 Program) (No.
   2009CB941703), Jiangsu Provincial Natural Science Funds (No. BK2007235)
   and the National Natural Science Foundation of China (No. 30901222).}},
Cited-References = {{Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Alam MS, 2010, ANAT HISTOL EMBRYOL, V39, P186, DOI 10.1111/j.1439-0264.2010.00993.x.
   AMLANI S, 1988, ANAT REC, V220, P143, DOI 10.1002/ar.1092200206.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Andrade AJM, 2006, TOXICOLOGY, V228, P85, DOI 10.1016/j.tox.2006.08.020.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Boettger-Tong H, 1998, ENVIRON HEALTH PERSP, V106, P369, DOI 10.1289/ehp.98106369.
   Bonilla E, 2010, REPROD TOXICOL, V30, P387, DOI 10.1016/j.reprotox.2010.04.008.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   Bosnir J, 2003, COLLEGIUM ANTROPOL, V27, P23.
   CANICK JA, 1979, ENDOCRINOLOGY, V104, P285.
   Chen HL, 2001, EXP GERONTOL, V36, P1361, DOI 10.1016/S0531-5565(01)00118-8.
   DORRINGTON JH, 1978, BIOL REPROD, V18, P55, DOI 10.1095/biolreprod18.1.55.
   Eliasson R, 2010, ASIAN J ANDROL, V12, P26, DOI 10.1038/aja.2008.58.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Hales DB, 1999, ENDOCRINE, V10, P201, DOI 10.1007/BF02738619.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   HIKIM APS, 1988, BIOL REPROD, V39, P1225.
   Huang XY, 2008, J PROTEOME RES, V7, P3435, DOI 10.1021/pr800179h.
   Kamma H, 1999, EXP CELL RES, V246, P399, DOI 10.1006/excr.1998.4323.
   Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P3, DOI 10.2307/3429377.
   Kopecky M, 2005, ACTA HISTOCHEM, V107, P279, DOI 10.1016/j.acthis.2005.06.007.
   Kurahashi N, 2005, J OCCUP HEALTH, V47, P437, DOI 10.1539/joh.47.437.
   Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013.
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169.
   Luo LD, 2006, J ANDROL, V27, P240, DOI 10.2164/jandrol.05075.
   Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68.
   Manna I, 2003, ACTA PHYSIOL SCAND, V178, P33, DOI 10.1046/j.1365-201X.2003.01095.x.
   Merzenich H, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-24.
   Murugesan P, 2008, REPROD TOXICOL, V25, P447, DOI 10.1016/j.reprotox.2008.04.003.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Narayana K, 2005, Folia Morphol (Warsz), V64, P65.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Ryu JY, 2007, TOXICOLOGY, V234, P103, DOI 10.1016/j.tox.2007.02.003.
   SASAKI J, 1994, HISTOCHEMISTRY, V102, P173, DOI 10.1007/BF00268893.
   Takemura S, 2006, J NEUROSURG, V104, P129, DOI 10.3171/jns.2006.104.1.129.
   Thompson CJ, 2004, ENDOCRINOLOGY, V145, P1227, DOI 10.1210/en.2003-1475.
   Thompson CJ, 2005, BIOL REPROD, V73, P908, DOI 10.1095/biolreprod.105.042382.
   VALLADARES LE, 1979, ENDOCRINOLOGY, V105, P431.
   VALLADARES LE, 1981, BIOL REPROD, V25, P752, DOI 10.1095/biolreprod25.4.752.
   VANDEKERCKHOVE P, 2007, COCHRANE DB SYST REV.
   Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4\_11.
   Wang YB, 2006, CHEM-BIOL INTERACT, V164, P15, DOI 10.1016/j.cbi.2006.08.022.
   Wang YB, 2004, NATL J ANDROL, V10, P729.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   Wolff MS, 2010, ENVIRON HEALTH PERSP, V118, P1039, DOI 10.1289/ehp.0901690.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{2}},
Journal-ISO = {{Asian J. Androl.}},
Doc-Delivery-Number = {{814YS}},
Wos-Id = {{ISI:000294493800016}},
}

@article{ ISI:000294475600035,
Author = {Lind, P. Monica and Lind, Lars},
Title = {{Circulating levels of bisphenol A and phthalates are related to carotid
   atherosclerosis in the elderly}},
Journal = {{ATHEROSCLEROSIS}},
Year = {{2011}},
Volume = {{218}},
Number = {{1}},
Pages = {{207-213}},
Month = {{SEP}},
Abstract = {{Background and objective: Bisphenol A (BPA) levels have previously been
   associated with coronary heart disease (CHD). Since CHD is an
   atherosclerotic disease, we investigated if circulating levels of BPA
   and phthalate metabolites are related to atherosclerosis in a
   cross-sectional study.
   Methods: In the population-based Prospective Investigation of the
   Vasculature in Uppsala Seniors (PIVUS) study (1016 subjects all aged
   70), the prevalence of overt plaques and echogenectity (grey scale
   median, GSM) of carotid artery plaques were recorded by ultrasound in
   both of the carotid arteries. The thickness (IMT) and echogenicity
   (IM-GSM) of the intima-media complex were also measured. Bisphenol A
   (BPA) and 10 phthalate metabolites were analyzed in serum by a API 4000
   liquid chromatograph/tandem mass spectrometer.
   Results: Mono-methyl phthalate (MMP) was related to carotid plaques in
   an inverted U-shaped manner. This pattern was significant after
   adjustment for gender, body mass index, blood glucose, blood pressure,
   HDL and LDL-cholesterol, serum triglycerides, smoking, antihypertensive
   treatment and statin use (p = 0.004). High levels of BPA, mono-isobutyl
   phthalate (MiBP) and MMP were associated with an echogenic IM-GSM and
   plaque GSM, while high levels of mono-2-ethylhexyl phthalate (MEHP) were
   associated with an echolucent IM-GSM and plaque GSM (p < 0.0001 after
   adjustment).
   Conclusion: The phthalate metabolite MMP was related to atherosclerotic
   plaques in an inverted U-shaped manner independently of CV risk factors.
   Some phthalates and BPA were also related to the echogenicity of the
   plaques, suggesting a role for plaque-associated chemicals in
   atherosclerosis. (C) 2011 Published by Elsevier Ireland Ltd.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lind, L (Reprint Author), Univ Uppsala Hosp, Dept Med, S-75185 Uppsala, Sweden.
   Lind, Lars, Univ Uppsala Hosp, Dept Med, S-75185 Uppsala, Sweden.
   Lind, P. Monica, Uppsala Univ, Uppsala, Sweden.}},
DOI = {{10.1016/j.atherosclerosis.2011.05.001}},
ISSN = {{0021-9150}},
Keywords = {{Phthalate metabolites; Bisphenol A; Elderly; Serum levels;
   Atherosclerosis}},
Keywords-Plus = {{PERSISTENT ORGANIC POLLUTANTS; NUTRITION EXAMINATION SURVEY; SOLID-PHASE
   EXTRACTION; CORONARY-HEART-DISEASE; INTIMA-MEDIA COMPLEX;
   POLYCHLORINATED-BIPHENYLS; NATIONAL-HEALTH; CARDIOVASCULAR-DISEASE;
   MYOCARDIAL-INFARCTION; SERUM CONCENTRATIONS}},
Research-Areas = {{Cardiovascular System \& Cardiology}},
Web-of-Science-Categories  = {{Peripheral Vascular Disease}},
Author-Email = {{lars.lind@medsci.uu.se}},
Funding-Acknowledgement = {{Swedish Research Council (VR); Swedish Research Council for Environment,
   Agricultural Sciences and Spatial Planning (FORMAS)}},
Funding-Text = {{This study was supported by the Swedish Research Council (VR) and the
   Swedish Research Council for Environment, Agricultural Sciences and
   Spatial Planning (FORMAS).}},
Cited-References = {{Bertazzi PA, 1998, ENVIRON HEALTH PERSP, V106, P625, DOI 10.2307/3433813.
   CABATON NJ, 2010, ENV HLTH PERSPECT, P119.
   Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391.
   CHASE KH, 1982, J OCCUP ENVIRON MED, V24, P109.
   Dalton T P, 2001, Cardiovasc Toxicol, V1, P285, DOI 10.1385/CT:1:4:285.
   Davidsson L, 2010, ATHEROSCLEROSIS, V209, P469, DOI 10.1016/j.atherosclerosis.2009.10.016.
   Dirinck E, 2011, OBESITY, V19, P709, DOI 10.1038/oby.2010.133.
   Duft M, 2003, AQUAT TOXICOL, V64, P437, DOI 10.1016/S0166-445X(03)00102-4.
   ElBarghouty NM, 1996, EUR J VASC ENDOVASC, V11, P414, DOI 10.1016/S1078-5884(96)80172-9.
   Everett CJ, 2008, ENVIRON RES, V108, P94, DOI 10.1016/j.envres.2008.05.006.
   Fernandez MF, 2007, REPROD TOXICOL, V24, P259, DOI 10.1016/j.reprotox.2007.06.007.
   FLESCHJANYS D, 1995, AM J EPIDEMIOL, V142, P1165.
   Goncharov A, 2008, ENVIRON RES, V106, P226, DOI 10.1016/j.envres.2007.10.006.
   Ha MH, 2007, ENVIRON HEALTH PERSP, V115, P1204, DOI 10.1289/ehp.10184.
   Hennig B, 2002, TOXICOL APPL PHARM, V181, P174, DOI 10.1006/taap.2002.9408.
   Hulthe J, 1997, STROKE, V28, P1189.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Kratz M, 2005, HANDB EXP PHARM, V170, P195.
   KREISS K, 1981, JAMA-J AM MED ASSOC, V245, P2505, DOI 10.1001/jama.245.24.2505.
   Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303.
   Lee DH, 2010, ENVIRON HEALTH PERSP, V118, P1235, DOI 10.1289/ehp.0901480.
   Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4.
   Lind L, 2005, ARTERIOSCL THROM VAS, V25, P2368, DOI 10.1161/01.ATV.0000184769.22061.da.
   Lind L, 2007, ATHEROSCLEROSIS, V195, P411, DOI 10.1016/j.atherosclerosis.2007.03.029.
   Melzer D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008673.
   O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103.
   Quan Liang, 2000, IEEE Transactions on Medical Imaging, V19, DOI 10.1109/42.836372.
   Sergeev AV, 2005, ENVIRON HEALTH PERSP, V113, P756, DOI 10.1289/ehp.7595.
   Sergeev AV, 2010, INT J OCCUP MED ENV, V23, P5, DOI 10.2478/v10001-010-0010-y.
   Silva MJ, 2005, J ANAL TOXICOL, V29, P819.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281.
   Uemura H, 2009, ENVIRON HEALTH PERSP, V117, P568, DOI 10.1289/ehp.0800012.
   Vandenberg LN, 2009, ENDOCR REV, V30, P75, DOI 10.1210/er.2008-0021.
   Vena J, 1998, ENVIRON HEALTH PERSP, V106, P645, DOI 10.2307/3433815.
   vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005.
   Witorsch RJ, 2002, FOOD CHEM TOXICOL, V40, P905, DOI 10.1016/S0278-6915(02)00069-8.
   Wohlin M, 2009, ATHEROSCLEROSIS, V205, P486, DOI 10.1016/j.atherosclerosis.2009.01.032.
   Wolstenholme JT, 2011, HORM BEHAV, V59, P296, DOI 10.1016/j.yhbeh.2010.10.001.
   {*}N R C COMM HLTH R, 2008, PHTHAL CUM RISK ASS.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{12}},
Journal-ISO = {{Atherosclerosis}},
Doc-Delivery-Number = {{814RU}},
Wos-Id = {{ISI:000294475600035}},
}

@article{ ISI:000294211500012,
Author = {Lin, Yi and Wei, Jie and Li, Yuanyuan and Chen, Jun and Zhou, Zhao and
   Song, Liqiong and Wei, Zhengzheng and Lv, Ziquan and Chen, Xi and Xia,
   Wei and Xu, Shunqing},
Title = {{Developmental exposure to di(2-ethylhexyl) phthalate impairs endocrine
   pancreas and leads to long-term adverse effects on glucose homeostasis
   in the rat}},
Journal = {{AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM}},
Year = {{2011}},
Volume = {{301}},
Number = {{3}},
Pages = {{E527-E538}},
Month = {{SEP}},
Abstract = {{Lin Y, Wei J, Li Y, Chen J, Zhou Z, Song L, Wei Z, Lv Z, Chen X, Xia W,
   Xu S. Developmental exposure to di(2-ethylhexyl) phthalate impairs
   endocrine pancreas and leads to long-term adverse effects on glucose
   homeostasis in the rat. Am J Physiol Endocrinol Metab 301: E527-E538,
   2011. First published June 14, 2011;
   doi:10.1152/ajpendo.00233.2011.-Di(2-ethylhexyl) phthalate (DEHP), a
   typical endocrine-disrupting chemical (EDC), is widely used as
   plasticizer. DEHP exposure in humans is virtually ubiquitous, and those
   undergoing certain medical procedures can be especially high. In this
   study, we investigated whether developmental DEHP exposure disrupted
   glucose homeostasis in the rat and whether this was associated with the
   early impairment in endocrine pancreas. Pregnant Wistar rats were
   administered DEHP (1.25 and 6.25 mg.kg(-1).day(-1)) or corn oil
   throughout gestation and lactation by oral gavage. Body weight, glucose
   and insulin tolerance, and beta-cell morphometry and function were
   examined in offspring during the growth. In this study, developmental
   DEHP exposure led to abnormal beta-cell ultrastructure, reduced
   beta-cell mass, and pancreatic insulin content as well as alterations in
   the expression of genes involved in pancreas development and beta-cell
   function in offspring at weaning. At adulthood, female DEHP-exposed
   offspring exhibited elevated blood glucose, reduced serum insulin,
   impaired glucose tolerance, and insulin secretion. Male DEHP-exposed
   offspring had increased serum insulin, although there were no
   significant differences in blood glucose at fasting and during glucose
   tolerance test. In addition, both male and female DEHP-exposed offspring
   had significantly lower birth weight and maintained relatively lower
   body weight up to 27 wk of age. These results suggest that developmental
   exposure to DEHP gives rise to beta-cell dysfunction and the whole body
   glucometabolic abnormalities in the rat. DEHP exposure in critical
   periods of development can be a potential risk factor, at least in part,
   for developing diabetes.}},
Publisher = {{AMER PHYSIOLOGICAL SOC}},
Address = {{9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Xu, SQ (Reprint Author), Huazhong Univ Sci \& Technol, Minist Educ, Key Lab Environm \& Hlth, Sch Publ Hlth,Tongji Med Coll, Wuhan 430030, Peoples R China.
   Lin, Yi; Wei, Jie; Li, Yuanyuan; Chen, Jun; Zhou, Zhao; Song, Liqiong; Wei, Zhengzheng; Lv, Ziquan; Chen, Xi; Xia, Wei; Xu, Shunqing, Huazhong Univ Sci \& Technol, Minist Educ, Key Lab Environm \& Hlth, Sch Publ Hlth,Tongji Med Coll, Wuhan 430030, Peoples R China.}},
DOI = {{10.1152/ajpendo.00233.2011}},
ISSN = {{0193-1849}},
Keywords = {{beta-cells; insulin secretion}},
Keywords-Plus = {{ENDOPLASMIC-RETICULUM STRESS; STIMULATED INSULIN-SECRETION;
   INTENSIVE-CARE-UNIT; BETA-CELL; DI-(2-ETHYLHEXYL) PHTHALATE; UNCOUPLING
   PROTEIN-2; NEONATAL EXPOSURE; DIABETES-MELLITUS; NATIONAL-HEALTH;
   URINARY LEVELS}},
Research-Areas = {{Endocrinology \& Metabolism; Physiology}},
Web-of-Science-Categories  = {{Endocrinology \& Metabolism; Physiology}},
Author-Email = {{xuscience@hotmail.com}},
Funding-Acknowledgement = {{National Natural Science Foundation of China {[}81030051, 20807017];
   National High Technology Research and Program of China {[}2008AA062504];
   R \& D Special Fund for Public Welfare Industry (Environment)
   {[}200909102]}},
Funding-Text = {{This work was supported by the National Natural Science Foundation of
   China (81030051, 20807017), the National High Technology Research and
   Program of China (2008AA062504), and the R \& D Special Fund for Public
   Welfare Industry (Environment) (200909102).}},
Cited-References = {{Alonso-Magdalena P, 2010, ENVIRON HEALTH PERSP, V118, P1243, DOI 10.1289/ehp.1001993.
   BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095.
   Brissova M, 2002, J BIOL CHEM, V277, P11225, DOI 10.1074/jbc.M111272200.
   Bruin JE, 2008, TOXICOL SCI, V103, P362, DOI 10.1093/toxsci/kfn012.
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0.
   CASALSCASAS C, 2010, ANNU REV PHYSIOL, V73, P135.
   Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302.
   Chan CB, 2004, DIABETES, V53, pS136, DOI 10.2337/diabetes.53.2007.S136.
   Chen SQ, 2010, J PERINAT MED, V38, P515, DOI 10.1515/JPM.2010.083.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Fonseca SG, 2010, ISLETS, V2, P1, DOI 10.4161/isl.2.1.10456.
   Garofano A, 1998, DIABETOLOGIA, V41, P1114, DOI 10.1007/s001250051038.
   Gauthier BR, 2004, J BIOL CHEM, V279, P31121, DOI 10.1074/jbc.M405030200.
   Gayathri NS, 2004, INDIAN J MED RES, V119, P139.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455.
   Hectors TLM, 2011, DIABETOLOGIA, V54, P1273, DOI 10.1007/s00125-011-2109-5.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   Martinelli MI, 2006, HUM EXP TOXICOL, V25, P531, DOI 10.1191/0960327106het651oa.
   MUSHTAQ M, 1980, TOXICOLOGY, V16, P153, DOI 10.1016/0300-483X(80)90045-1.
   Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877.
   Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160.
   Park Sun Kyun, 2010, J Prev Med Public Health, V43, P1, DOI 10.3961/jpmph.2010.43.1.1.
   Rich-Edwards JW, 1999, ANN INTERN MED, V130, P278.
   Selvin E, 2007, DIABETES CARE, V30, P234, DOI 10.2337/dc06-1579.
   Seo HY, 2008, ENDOCRINOLOGY, V149, P3832, DOI 10.1210/en.2008-0015.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   Somm E, 2008, ENDOCRINOLOGY, V149, P6289, DOI 10.1210/en.2008-0361.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Tanida T, 2009, TOXICOL LETT, V189, P40, DOI 10.1016/j.toxlet.2009.04.005.
   Uemura H, 2008, ENVIRON RES, V108, P63, DOI 10.1016/j.envres.2008.06.002.
   Ukropec J, 2010, DIABETOLOGIA, V53, P899, DOI 10.1007/s00125-010-1683-2.
   US Environmental Protection Agency, 1999, INT RISK INF SYST IR.
   VALTAT B, 2010, DIABETOLOGIA, V54, P350.
   Wang SL, 2008, DIABETES CARE, V31, P1574, DOI 10.2337/dc07-2449.
   {*}RARE, 2005, EU RISK ASS BIS 2 ET.
   {*}SCI COMM EM NEWL, 2008, OP EU SCI COMM EM NE.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{6}},
Journal-ISO = {{Am. J. Physiol.-Endocrinol. Metab.}},
Doc-Delivery-Number = {{811LJ}},
Wos-Id = {{ISI:000294211500012}},
}

@article{ ISI:000293671300005,
Author = {Vandentorren, Stephanie and Zeman, Florence and Morin, Lise and Sarter,
   Helene and Bidondo, Marie-Laure and Oleko, Amivi and Leridon, Henri},
Title = {{Bisphenol-A and phthalates contamination of urine samples by catheters
   in the Elfe pilot study: Implications for large-scale biomonitoring
   studies}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2011}},
Volume = {{111}},
Number = {{6}},
Pages = {{761-764}},
Month = {{AUG}},
Abstract = {{Exposure to phthalates and Bisphenol A could cause developmental and
   reproductive toxicity. This study provides a first assessment of these
   exposures for more than 250 French pregnant women. The median
   concentrations of total and free Bisphenol A in urine were similar to
   those in other studies except the highest concentrations (5\% of women
   had total and free Bisphenol A > 50 mu g/L). Our study highlights high
   levels of Di-(2-ethylhexyl)-phthalate metabolites in pregnant women,
   suggesting recent exposure, probably in hospital. Differences between
   types of delivery (caesarean vs. natural) support this hypothesis. This
   is a significant implication for large-scale biomonitoring studies among
   this population. (C) 2011 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Vandentorren, S (Reprint Author), Natl Inst Publ Hlth Surveillance InVS, St Maurice, France.
   Vandentorren, Stephanie; Morin, Lise; Sarter, Helene; Bidondo, Marie-Laure; Oleko, Amivi, Natl Inst Publ Hlth Surveillance InVS, St Maurice, France.
   Zeman, Florence, Natl Inst Ind Environm \& Risks INERIS, Nancy, France.
   Leridon, Henri, Inst Demog, Paris, France.}},
DOI = {{10.1016/j.envres.2011.05.018}},
ISSN = {{0013-9351}},
Keywords = {{Bisphenol A; Phtalates; Biomonitoring; Pregnancy; Maternal exposure;
   Epidemiology}},
Keywords-Plus = {{HUMAN EXPOSURE; RISK-ASSESSMENT; METABOLITES; POPULATION; PREGNANCY;
   OUTCOMES; INFANTS; SERUM}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{s.vandentorren@invs.sante.fr}},
Cited-References = {{Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   AMANTIKANDARAKI.E, 2009, ENDOCR REV, V30, P293.
   Booker SM, 2001, ENVIRON HEALTH PERSP, V109, pA260, DOI 10.1289/ehp.109-a260.
   Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Kortenkamp A, 2010, INT J ANDROL, V33, P463, DOI 10.1111/j.1365-2605.2009.01047.x.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   LI DK, 2010, J ANDROL.
   Markham DA, 2010, J ANAL TOXICOL, V34, P293.
   Matsumoto A, 2003, ENVIRON HEALTH PERSP, V111, P101, DOI 10.1289/ehp.5512.
   Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Twaddle NC, 2010, RAPID COMMUN MASS SP, V24, P3011, DOI 10.1002/rcm.4733.
   Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010.
   Volkel W, 2008, TOXICOL LETT, V179, P155, DOI 10.1016/j.toxlet.2008.05.002.
   Volkel W, 2011, ENVIRON RES, V111, P143, DOI 10.1016/j.envres.2010.10.001.
   vom Saal FS, 2008, JAMA-J AM MED ASSOC, V300, P1353, DOI 10.1001/jama.300.11.1353.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Yan X, 2009, HUM ECOL RISK ASSESS, V15, P565, DOI 10.1080/10807030902892554.
   Ye X, 2008, TALANTA, V76, P865, DOI 10.1016/j.talanta.2008.04.034.
   Ye XY, 2011, ANAL BIOANAL CHEM, V399, P1071, DOI 10.1007/s00216-010-4344-x.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{15}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{804RI}},
Wos-Id = {{ISI:000293671300005}},
}

@article{ ISI:000293671300009,
Author = {Svensson, Katherine and Hernandez-Ramirez, Raul U. and Burguete-Garcia,
   Ana and Cebrian, Mariano E. and Calafat, Antonia M. and Needham, Larry
   L. and Claudio, Luz and Lopez-Carrillo, Lizbeth},
Title = {{Phthalate exposure associated with self-reported diabetes among Mexican
   women}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2011}},
Volume = {{111}},
Number = {{6}},
Pages = {{792-796}},
Month = {{AUG}},
Abstract = {{Background: Phthalates are ubiquitous industrial chemicals used as
   plasticizers in plastics made of polyvinyl chloride (PVC) to confer
   flexibility and durability. They are also present in products used for
   personal-care, industry and in medical devices. Phthalates have been
   associated with several adverse health effects, and recently it has been
   proposed that exposure to phthalates, could have an effect on metabolic
   homeostasis. This exploratory cross-sectional study evaluated the
   possible association between phthalate exposure and self-reported
   diabetes among adult Mexican women.
   Methods: As part of an on-going case-control study for breast cancer,
   only controls were selected, which constituted 221 healthy women matched
   by age (+/- 5 years) and place of residence with the cases. Women with
   diabetes were identified by self-report. Urinary concentrations of nine
   phthalate metabolites were measured by online solid phase extraction
   coupled to high performance liquid chromatography-isotope-dilution
   tandem mass spectrometry.
   Results: Participants with diabetes had significantly higher
   concentrations of di(2-ethylhexyl) pththalate (DEHP) metabolites:
   mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), mono(2-ethyl-5-oxohexyl)
   phthalate (MEOHP) and mono(2-ethy1-5-carboxypentyl) phthalate (MECPP)
   but lower levels of monobenzyl phthalate (MBzP) a metabolite of
   benzylbutyl phthalate, compared to participants without diabetes. A
   marginally significant positive associations with diabetes status were
   observed over tertiles with MEHHP (OR(T3) vs. (T1) = 266; 95\% CI:
   0.97-7.33: p for trend = 0.063) and MEOHP (OR(T3) vs. (T1) = 2.27; 95\%
   CI; 0.90-5.75; P for trend = 0.079) even after adjusting for important
   confounders.
   Conclusions: The results suggest that levels of some phthalates may play
   a role in the genesis of diabetes. (C) 2011 Elsevier Inc. All rights
   reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lopez-Carrillo, L (Reprint Author), Natl Inst Publ Hlth, Univ 655, Cuernavaca 62100, Morelos, Mexico.
   Svensson, Katherine; Hernandez-Ramirez, Raul U.; Burguete-Garcia, Ana; Lopez-Carrillo, Lizbeth, Natl Inst Publ Hlth, Cuernavaca 62100, Morelos, Mexico.
   Svensson, Katherine, Univ Puerto Rico, Grad Sch Publ Hlth, San Juan, PR 00936 USA.
   Cebrian, Mariano E., Inst Politecn Nacl, Ctr Invest \& Estudios Avanzados, Dept Toxicol, Mexico City, DF, Mexico.
   Calafat, Antonia M.; Needham, Larry L., Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Claudio, Luz, Mt Sinai Sch Med, Dept Prevent Med, Div Int Hlth, New York, NY USA.}},
DOI = {{10.1016/j.envres.2011.05.015}},
ISSN = {{0013-9351}},
Keywords = {{Diabetes; Phthalates; Urinary metabolites; Environmental health; Mexico}},
Keywords-Plus = {{URINARY CONCENTRATIONS; TEMPORAL VARIABILITY; INSULIN-RESISTANCE;
   PPAR-GAMMA; METABOLITES; TESTOSTERONE; ACTIVATION; MONOESTERS; HORMONES;
   SAMPLES}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{lizbeth@insp.mx}},
Funding-Acknowledgement = {{Fondo Sectorial de Investigacion en Salud y Seguridad Social
   {[}2005-C02-14373, 2009-01-111384]; Fondo Sectorial de Investigacion
   para la Educacion {[}79912]; Fogarty International Center {[}TW000640,
   D43TW000640]; National Center of Minority Health and Health Disparities
   {[}MD001452]}},
Funding-Text = {{The study was supported by Fondo Sectorial de Investigacion en Salud y
   Seguridad Social 2005-C02-14373, 2009-01-111384. Additional partial
   funds were obtained from: Fondo Sectorial de Investigacion para la
   Educacion 79912 and the ITREOH program of the Fogarty International
   Center (TW000640) the MIRT program of the National Center of Minority
   Health and Health Disparities (MD001452).Authors gratefully acknowledge
   B.Sc. Veronica Lopez for the overall coordination of field work and,
   Manori Silva, Tao Jia, Ella Samandar and Jim Preau for their technical
   assistance in measuring the urinary concentrations of phthalate
   metabolites. The study was supported by Fondo Sectorial de Investigacion
   en Salud y Seguridad Social 2005-C02-14373, 2009-01-111384 Additional
   partial funds were obtained from Fondo Sectorial de Investigacion para
   la Educacion 79912. Katherine Svensson is a Mount Sinai International
   Exchange Program Minority Student participant. Her work was supported by
   grant MD001452 from the National Center on Minority Health and Health
   Disparities of the National Institutes of Health. Additional support for
   this project was provided in part by the Mount Sinai International
   Training Program in Environmental and Occupational Health (D43TW000640)
   from the Fogarty International Center.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   American Diabetes Association, 2008, DIABETES CARE S1, V31, pS55, DOI DOI 10.2337/DC08-S055.
   Aschner Pablo, 2010, Expert Rev Cardiovasc Ther, V8, P407, DOI 10.1586/erc.10.13.
   ATSDR, 2001, TOX PROF DI N BUT PH.
   ATSDR, 2002, TOX PROF DI 2 ETH PH.
   Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268.
   Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253.
   Boberg J, 2008, TOXICOLOGY, V250, P75, DOI 10.1016/j.tox.2008.05.020.
   Casals-Casas C, 2008, INT J OBESITY, V32, pS53, DOI 10.1038/ijo.2008.207.
   Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017.
   Feige JN, 2010, ENVIRON HEALTH PERSP, V118, P234, DOI 10.1289/ehp.0901217.
   Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Gayathri NS, 2004, INDIAN J MED RES, V119, P139.
   Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x.
   HATCH EE, 2008, ENV HLTH, V3, P27.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Holemans K, 2003, J PHYSIOL-LONDON, V547, P11, DOI 10.1113/jphysiol.2002.036582.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Kapoor D, 2006, EUR J ENDOCRINOL, V154, P899, DOI 10.1530/eje.1.02166.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Olaiz-Fernandez G, 2006, ENCUESTA NACL SALUD.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Rengarajan S, 2007, TOXICOL IN VITRO, V21, P99, DOI 10.1016/j.tiv.2006.07.005.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   StataCorp, 2005, STAT STAT SOFTW REL.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Tapia-Conyer R, 1992, Salud Publica Mex, V34, P124.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   {*}ATSDR, 1997, TOX PROF DIN PHTHAL.
   {*}SSA, 2005, ENC NAC ENF CRON.
   {*}US DEP HHS, 2003, NTP CERHR MONGR POT.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{7}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{804RI}},
Wos-Id = {{ISI:000293671300009}},
}

@article{ ISI:000292889200010,
Author = {Mendiola, J. and Jorgensen, N. and Andersson, A. -M. and Calafat, A. M.
   and Silva, M. J. and Redmon, J. B. and Sparks, A. and Drobnis, E. Z. and
   Wang, C. and Liu, F. and Swan, S. H.},
Title = {{Associations between urinary metabolites of di(2-ethylhexyl) phthalate
   and reproductive hormones in fertile men}},
Journal = {{INTERNATIONAL JOURNAL OF ANDROLOGY}},
Year = {{2011}},
Volume = {{34}},
Number = {{4, 1}},
Pages = {{369-378}},
Month = {{AUG}},
Abstract = {{Widely used man-made chemicals, including phthalates, can induce
   hormonal alterations through a variety of cellular and molecular
   mechanisms. A number of rodent and observational studies have
   consistently demonstrated the antiandrogenic effect of several
   phthalates. However, there are only limited data on the relationship
   between exposure to these chemicals and reproductive hormone levels in
   men. All men (n = 425) were partners of pregnant women who participated
   in the Study for Future Families in five US cities and provided urine
   and serum samples on the same day. Eleven phthalate metabolites were
   measured in urine and serum samples were analysed for reproductive
   hormones, including follicle-stimulating hormone, luteinizing hormone,
   testosterone, inhibin B and oestradiol and sex hormone-binding globulin
   (SHBG). Pearson correlations and parametric tests were used for
   unadjusted analyses, and multiple linear regression analysis was
   performed controlling for appropriate covariates. We observed weak or no
   associations with urinary phthalates other than di(2-ethylhexyl)
   phthalate (DEHP). All measures of testosterone {[}total, calculated free
   testosterone and the free androgen index (FAI)] were inversely
   correlated with the urinary concentrations of four DEHP metabolites.
   After adjustment by appropriate covariates, there was no longer an
   association between urinary DEHP metabolite concentrations and total
   testosterone levels; however, FAI was significantly associated with the
   urinary concentrations of several DEHP metabolites. SHBG was positively
   related to the urinary concentrations of mono(2-ethylhexyl) phthalate,
   but not with other DEHP metabolites, an association that was attenuated
   after adjustment. Our results suggest that DEHP exposure of fertile men
   is associated with minor alterations of markers of free testosterone.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Swan, SH (Reprint Author), Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, 601 Elmwood Ave,Box 668, Rochester, NY 14642 USA.
   Mendiola, J.; Liu, F.; Swan, S. H., Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, Rochester, NY 14642 USA.
   Jorgensen, N.; Andersson, A. -M., Univ Copenhagen, Rigshosp, Univ Dept Growth \& Reprod, DK-2100 Copenhagen, Denmark.
   Calafat, A. M.; Silva, M. J., Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Redmon, J. B., Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.
   Redmon, J. B., Univ Minnesota, Sch Med, Dept Urol Surg, Minneapolis, MN 55455 USA.
   Sparks, A., Univ Iowa, Dept Obstet \& Gynecol, Iowa City, IA 52242 USA.
   Drobnis, E. Z., Univ Missouri, Sch Med, Dept Obstet Gynecol \& Womens Hlth, Columbia, MO USA.
   Wang, C., Harbor UCLA Med Ctr, Div Endocrinol, Dept Med, Torrance, CA 90509 USA.
   Wang, C., Los Angeles Biomed Res Inst, Torrance, CA USA.}},
DOI = {{10.1111/j.1365-2605.2010.01095.x}},
ISSN = {{0105-6263}},
Keywords = {{anti-androgens; di(2-ethylhexyl) phthalate metabolites; endocrine
   disruptors; male hormones; phthalates}},
Keywords-Plus = {{N-BUTYL PHTHALATE; TESTICULAR DYSGENESIS SYNDROME; SEMEN QUALITY;
   MALE-RAT; DIETHYLHEXYL PHTHALATE; SEXUAL-DIFFERENTIATION; TEMPORAL
   VARIABILITY; DANISH POPULATION; FREE TESTOSTERONE; NEONATAL-RATS}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{shanna\_swan@urmc.rochester.edu}},
ResearcherID-Numbers = {{Perez , Claudio Alejandro/F-8310-2010
   Jorgensen, Niels/A-8148-2012}},
ORCID-Numbers = {{Perez , Claudio Alejandro/0000-0001-9688-184X
   }},
Funding-Acknowledgement = {{Danish Agency for Science, Technology and Innovation {[}271070678];
   University of Iowa Center for Health Effects of Environmental
   Contamination; General Clinical Research Center at Harbor-UCLA Medical
   Center {[}MO1 RR00425]}},
Funding-Text = {{The findings and conclusions in this report are those of the author and
   do not necessarily represent the official position of the CDC. The
   authors gratefully acknowledge Ella Samandar, James Preau and Jack Reidy
   (CDC, Atlanta, GA) for measuring the urinary concentrations of the
   phthalate metabolites. This study is supported by the following grants:
   the Danish Agency for Science, Technology and Innovation, grant no.
   271070678 to N. Jorgensen; University of Iowa Center for Health Effects
   of Environmental Contamination cooperative project grant to A. Sparks;
   and the General Clinical Research Center at Harbor-UCLA Medical Center
   (MO1 RR00425) to C. Wang.}},
Cited-References = {{Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Andersson AM, 2007, J CLIN ENDOCR METAB, V92, P4696, DOI 10.1210/jc.2006-2633.
   Asklund C, 2007, HUM REPROD, V22, P2639, DOI 10.1093/humrep/dem217.
   ATSDR, 2002, TOX PROF DI 2 ETH PH.
   Bang AK, 2005, HUM REPROD, V20, P3109, DOI 10.1093/humrep/dei170.
   BELGOROSKY A, 1985, ACTA ENDOCRINOL-COP, V109, P130.
   Bjornerem A, 2006, J CLIN ENDOCR METAB, V91, P3798, DOI 10.1210/jc.2006-0866.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   CARLSEN E, 1992, BRIT MED J, V305, P609.
   CDC, 2009, 4 CDC.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Eveillard A, 2009, TOXICOL APPL PHARM, V236, P282, DOI 10.1016/j.taap.2009.02.008.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   HEINDEL JJ, 1989, FUND APPL TOXICOL, V12, P508, DOI 10.1016/0272-0590(89)90024-9.
   Higuchi TT, 2003, TOXICOL SCI, V72, P301, DOI 10.1093/toxsci/kfg036.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Jorgensen N, 2010, INT J ANDROL, V33, P298, DOI 10.1111/j.1365-2605.2009.01050.x.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Lambrot R, 2009, ENVIRON HEALTH PERSP, V117, P32, DOI 10.1289/ehp.11146.
   Lapinskas PJ, 2005, TOXICOLOGY, V207, P149, DOI 10.1016/j.tox.2004.09.008.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972.
   Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PARMAR D, 1986, TOXICOLOGY, V42, P47, DOI 10.1016/0300-483X(86)90091-0.
   Sharpe RM, 2008, FERTIL STERIL, V89, P33, DOI DOI 10.1016/J.FERTNSTERT.2007.12.026.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   SRIVASTAVA SP, 1990, ARCH TOXICOL, V64, P148, DOI 10.1007/BF01974401.
   Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P414, DOI 10.1289/ehp.5927.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228, DOI 10.1289/ehp.971051228.
   Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Thompson RC, 2009, PHILOS T R SOC B, V364, P2153, DOI 10.1098/rstb.2009.0053.
   Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375.
   Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666.
   Wang C, 2007, J CLIN ENDOCR METAB, V92, P2433, DOI 10.1210/jc.2007-1085.
   Wyde ME, 2005, TOXICOL SCI, V86, P281, DOI 10.1093/toxsci/kfi204.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{7}},
Journal-ISO = {{Int. J. Androl.}},
Doc-Delivery-Number = {{794IP}},
Wos-Id = {{ISI:000292889200010}},
}

@article{ ISI:000292550900011,
Author = {Solymos, E. and Guddat, S. and Geyer, H. and Flenker, U. and Thomas, A.
   and Segura, J. and Ventura, R. and Platen, P. and Schulte-Mattler, M.
   and Thevis, M. and Schaenzer, W.},
Title = {{Rapid determination of urinary di(2-ethylhexyl) phthalate metabolites
   based on liquid chromatography/tandem mass spectrometry as a marker for
   blood transfusion in sports drug testing}},
Journal = {{ANALYTICAL AND BIOANALYTICAL CHEMISTRY}},
Year = {{2011}},
Volume = {{401}},
Number = {{2}},
Pages = {{517-528}},
Month = {{AUG}},
Abstract = {{Methods of blood doping such as autologous and homologous blood
   transfusion are one of the main challenging doping practices in
   competitive sport. Whereas homologous blood transfusion is detectable
   via minor blood antigens, the detection of autologous blood transfusion
   is still not feasible. A promising approach to indicate homologous or
   autologous blood transfusion is the quantification of increased urinary
   levels of di(2-ethylhexyl) phthalate (DEHP) metabolites found after
   blood transfusion. The commonly used plasticizer for flexible PVC
   products, such as blood bags, is DEHP which is known to diffuse into the
   stored blood. Therefore, a straight forward, rapid and reliable assay is
   presented for the quantification of the main metabolites
   mono(2-ethyl-5-oxohexyl) phthalate, mono(2-ethyl-5-hydroxyhexyl)
   phthalate and mono(2-ethylhexyl) phthalate that can easily be
   implemented into existing multi-target methods used for sports drug
   testing. Quantification of the DEHP metabolites was accomplished after
   enzymatic hydrolysis of urinary glucuronide conjugates and direct
   injection using isotope-dilution liquid chromatography/tandem mass
   spectrometry. The method was fully validated for quantitative purposes
   considering the parameters specificity, linearity (1-250 ng/mL), inter-
   (2.4\%-4.3\%) and intra-day precision (0.7\%-6.1\%), accuracy
   (85\%-105\%), limit of detection (0.2-0.3 ng/mL), limit of
   quantification (1 ng/mL), stability and ion suppression effects. Urinary
   DEHP metabolites were measured in a control group without special
   exposure to DEHP (n = 100), in hospitalized patients receiving blood
   transfusion (n = 10), and in athletes (n = 468) being subject of routine
   doping controls. The investigation demonstrates that significantly
   increased levels of secondary DEHP metabolites were found in urine
   samples of transfused patients, strongly indicating blood transfusion.}},
Publisher = {{SPRINGER HEIDELBERG}},
Address = {{TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Guddat, S (Reprint Author), German Sport Univ Cologne, Inst Biochem, Sportpk 6, D-50933 Cologne, Germany.
   Guddat, S.; Geyer, H.; Flenker, U.; Schaenzer, W., German Sport Univ Cologne, Inst Biochem, D-50933 Cologne, Germany.
   Solymos, E., Eotvos Lorand Univ, Joint Res \& Training Lab Separat Tech, H-1117 Budapest, Hungary.
   Thomas, A.; Thevis, M., German Sport Univ Cologne, Ctr Prevent Doping Res, D-50933 Cologne, Germany.
   Segura, J.; Ventura, R., IMIM Hosp del Mar, PRBB, Municipal Inst Med Res, Bioanal Res Grp,Neuropsychopharmacol Program, Barcelona 08003, Spain.
   Segura, J.; Ventura, R., Pompeu Fabra Univ, Dept Expt \& Hlth Sci, Barcelona 08002, Spain.
   Schulte-Mattler, M., Surface Zentrum Orthopadie, D-41460 Neuss, Germany.
   Platen, P., Ruhr Univ Bochum, Lehrstuhl Sportmed \& Sporternahrung, D-44801 Bochum, Germany.}},
DOI = {{10.1007/s00216-010-4589-4}},
ISSN = {{1618-2642}},
Keywords = {{DEHP metabolites; Sport drug testing; Urine; Liquid chromatography mass
   spectrometry; Blood transfusion}},
Keywords-Plus = {{SOLID-PHASE EXTRACTION; DI-(2-ETHYLHEXYL) PHTHALATE; QUANTITATIVE
   DETECTION; GENERAL-POPULATION; HUMAN EXPOSURE; HUMAN-MILK; DEHP; ONLINE;
   MONOESTERS; SERUM}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{s.guddat@biochem.dshs-koeln.de}},
Funding-Acknowledgement = {{Antidoping Switzerland (Bern, Switzerland); Eotvos Lorand University
   (Budapest, Hungary); Federal Ministry of the Interior of the Federal
   Republic of Germany; Manfred Donike Institute for Doping Analysis e.V.}},
Funding-Text = {{The study was carried out with the financial support of the Antidoping
   Switzerland (Bern, Switzerland), the Fund for Chemist Education of the
   Eotvos Lorand University (Budapest, Hungary), the Federal Ministry of
   the Interior of the Federal Republic of Germany, and the Manfred Donike
   Institute for Doping Analysis e.V.}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   Annesley TM, 2003, CLIN CHEM, V49, P1041, DOI 10.1373/49.7.1041.
   ATSDR, 2002, TOX PROF DI 2 ETH PH.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   GERLAI I, 1987, CHROMATOGRAPHIA, V24, P403, DOI 10.1007/BF02688515.
   Giraud S, 2008, FORENSIC SCI INT, V179, P23, DOI 10.1016/j.forsciint.2008.04.007.
   Hill SS, 2001, CLIN CHIM ACTA, V304, P1, DOI 10.1016/S0009-8981(00)00411-3.
   Inoue K, 2002, CLIN CHIM ACTA, V325, P157, DOI 10.1016/S0009-8981(02)00291-7.
   Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019.
   Inoue K, 2003, ANAL BIOANAL CHEM, V375, P527, DOI 10.1007/s00216-002-1709-9.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2006, ANAL CHEM, V78, P6651, DOI 10.1021/ac0608220.
   Kato K, 2003, J CHROMATOGR B, V788, P407, DOI 10.1016/S1570-0232(03)00041-2.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   MS P, 2010, J PREV MED PUBLIC HL, V43, P301.
   Nelson M, 2002, HAEMATOLOGICA, V87, P881.
   NR M, 2010, TRANSFUSION PARIS, V50, P145, DOI DOI 10.1111/J.1537-2995.2009.02352.X.
   PA A, 2008, AM J HEMATOL, V83, P657.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Pialoux V, 2009, INT J HEMATOL, V89, P714, DOI 10.1007/s12185-009-0330-5.
   Pottgiesser T, 2007, MED SCI SPORT EXER, V39, P1748, DOI 10.1249/mss.0b013e318123e8a6.
   PREAU JL, 2010, ENV HLTH PERSPECT.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   R Development Core Team, 2010, R LANG ENV STAT COMP.
   Samandar E, 2009, ENVIRON RES, V109, P641, DOI 10.1016/j.envres.2009.02.004.
   Scientific Committee on Emerging and Newly-Identified Health Risks SCENIHR, 2008, OP SAF MED DEV CONT.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   SILVA MJ, 2004, ENV HLTH PERSPECT, V112, P1999.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   SJOBERG P, 1985, J CHROMATOGR, V344, P167, DOI 10.1016/S0378-4347(00)82017-4.
   Takatori S, 2004, J CHROMATOGR B, V804, P397, DOI 10.1016/j.jchromb.2004.01.056.
   Venables W. N., 2002, MODERN APPL STAT S.
   Voss SC, 2007, INT J SPORTS MED, V28, P633, DOI 10.1055/s-2007-965076.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   {*}CDRH, 2001, SAF ASS DI 2 ETH PHT.
   {*}IARC, 2000, DI 2 ETH PHTH.
   {*}SCMPMD, 2002, MED DEV CONT DEHP PL.
   2009, VALIDATION ANAL PROC.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{15}},
Journal-ISO = {{Anal. Bioanal. Chem.}},
Doc-Delivery-Number = {{789WX}},
Wos-Id = {{ISI:000292550900011}},
}

@article{ ISI:000292552400016,
Author = {Wang, Qian and Wang, Li and Chen, Xi and Rao, Kai Min and Lu, Shao You
   and Ma, Sheng Tao and Jiang, Pu and Zheng, Dan and Xu, Shun Qing and
   Zheng, Hong Yan and Wang, Jian Shu and Yu, Zhi Qiang and Zhang, Rong and
   Tao, Yong and Yuan, Jing},
Title = {{Increased urinary 8-hydroxy-2 `-deoxyguanosine levels in workers exposed
   to di-(2-ethylhexyl) phthalate in a waste plastic recycling site in
   China}},
Journal = {{ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH}},
Year = {{2011}},
Volume = {{18}},
Number = {{6}},
Pages = {{987-996}},
Month = {{JUL}},
Abstract = {{Background Di-(2-ethylhexyl) phthalate (DEHP) is a common plasticizer
   used in industrial and diverse consumer products. Animal studies
   indicate DEHP caused developmental, reproductive, and hepatic
   toxicities. However, human studies of the potential effects of DEHP are
   limited.
   Methods The exposed site with a history of over 20 years of waste
   plastic recycling was located in Hunan Province, China. The reference
   site without known DEHP pollution source was about 50 km far away from
   the exposed site. In this study, 181 workers working in plastic waste
   recycling and 160 gender-age matched farmers were recruited. DEHP
   concentrations in water and cultivated soil samples, serum
   thyroid-stimulating hormone, malondialdehyde (MDA), superoxide dismutase
   (SOD), urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG), and micronuclei
   frequency in human capillary blood lymphocytes were analyzed.
   Results Mean levels of DEHP were greater in environment at the recycling
   site than at reference site (industry wastewater for the exposed: 42.43
   mu g/l; well water: 14.20 vs. 0.79 mu g/l, pond water: 135.68 vs. 0.37
   mu g/l, cultivated soil: 13.07 vs. 0.81 mg/kg, p < 0.05 for all). The
   workers had higher median levels of MDA (3.80 vs. 3.14 nmol/ml) and
   urinary 8-OHdG (340.37 vs. 268.18 mu mol/mol creatinine) and decreased
   SOD activities (112.15 vs. 123.82 U/ml) than the reference group (p <
   0.01 for all). Multivariate analysis revealed that the history of
   working in waste plastic recycling was an independent risk factor for
   the increased urinary 8-OHdG levels in the male workers (p < 0.01).
   Conclusions The occupational DEHP exposure might contribute to oxidative
   deoxyribonucleic acid damage in the male workers.}},
Publisher = {{SPRINGER HEIDELBERG}},
Address = {{TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Yuan, J (Reprint Author), Huazhong Univ Sci \& Technol, Dept Occupat \& Environm Hlth, Sch Publ Hlth, Tongji Med Coll, 13 Hongkong Rd, Wuhan 430030, Hubei, Peoples R China.
   Wang, Qian; Chen, Xi; Rao, Kai Min; Wang, Jian Shu; Yuan, Jing, Huazhong Univ Sci \& Technol, Dept Occupat \& Environm Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China.
   Wang, Qian; Chen, Xi; Rao, Kai Min; Jiang, Pu; Zheng, Dan; Xu, Shun Qing; Zheng, Hong Yan; Wang, Jian Shu; Yuan, Jing, Huazhong Univ Sci \& Technol, MOE Key Lab Environm \& Hlth, Sch Publ Hlth, Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China.
   Wang, Li; Zhang, Rong; Tao, Yong, Chinese Ctr Dis Control \& Prevent, Natl Ctr Rural Water Supply Tech Guidance, Beijing 102200, Peoples R China.
   Lu, Shao You; Ma, Sheng Tao; Yu, Zhi Qiang, Chinese Acad Sci, State Key Lab Organ Geochem, Guangzhou Inst Geochem, Guangzhou 510640, Peoples R China.
   Lu, Shao You; Ma, Sheng Tao; Yu, Zhi Qiang, Chinese Acad Sci, Guangdong Key Lab Environm Protect \& Resource Uti, Guangzhou Inst Geochem, Guangzhou 510640, Peoples R China.}},
DOI = {{10.1007/s11356-010-0420-1}},
ISSN = {{0944-1344}},
Keywords = {{Waste plastic; DEHP; Oxidative stress; 8-OHdG; TSH}},
Keywords-Plus = {{POLYBROMINATED DIPHENYL ETHERS; OXIDATIVE STRESS; SPECIAL EMPHASIS;
   DNA-DAMAGE; ENVIRONMENTAL CHEMICALS; SUBTROPICAL CITY; PPAR-ALPHA;
   ESTERS; METABOLITES; LIVER}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{zhiqiang@gig.ac.cn
   rzhang@crwstc.org
   jyuan@tjh.tjmu.edu.cn}},
ResearcherID-Numbers = {{yu, zhiqiang/F-7862-2012}},
Funding-Acknowledgement = {{National Natural Science Foundation of China (NNSFC) {[}40590390]}},
Funding-Text = {{The authors are grateful to Professor Qingyi Wei (The University of
   Texas M. D. Anderson Cancer Center, USA) for his critical review and
   Prof. Tangchun Wu (Huazhong University of Science and Technology,
   People's Republic of China) for the constructional suggestions, and
   thank all of the volunteers who participated in this study. This work
   was partially supported by funding provided by the key funding from the
   National Natural Science Foundation of China (NNSFC, grant no.
   40590390).}},
Cited-References = {{Andersen HR, 1997, CLIN CHEM, V43, P562.
   Bernal CA, 2002, FOOD ADDIT CONTAM, V19, P1091, DOI 10.1080/02652030210157709.
   Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128.
   Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870.
   Grande SW, 2007, TOXICOLOGY, V229, P114, DOI 10.1016/j.tox.2006.10.005.
   Hashizume K, 2002, BIOL PHARM BULL, V25, P209, DOI 10.1248/bpb.25.209.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610.
   Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7.
   Hu XY, 2003, J ENVIRON MONITOR, V5, P649, DOI 10.1039/b304669a.
   Isenberg JS, 2000, TOXICOL SCI, V56, P73, DOI 10.1093/toxsci/56.1.73.
   Ito Y, 2008, PPAR RES, DOI 10.1155/2008/759716.
   Ito Y, 2007, J OCCUP HEALTH, V49, P172, DOI 10.1539/joh.49.172.
   Kerksick C, 2008, MED SCI SPORT EXER, V40, P1772, DOI 10.1249/MSS.0b013e31817d1cce.
   Lapinskas PJ, 2005, TOXICOLOGY, V207, P149, DOI 10.1016/j.tox.2004.09.008.
   Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809.
   Marnett LJ, 2000, CARCINOGENESIS, V21, P361, DOI 10.1093/carcin/21.3.361.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Moore CJ, 2008, ENVIRON RES, V108, P131, DOI 10.1016/j.envres.2008.07.025.
   Nielsen F, 1997, CLIN CHEM, V43, P1209.
   Oehlmann J, 2008, ENVIRON RES, V108, P140, DOI 10.1016/j.envres.2008.07.016.
   Olusi SO, 2002, INT J OBESITY, V26, P1159, DOI 10.1038/sj.ijo.0802066.
   Palleschi S, 2009, TOXICOL LETT, V187, P52, DOI 10.1016/j.toxlet.2009.01.031.
   Palmer CNA, 1998, MOL PHARMACOL, V53, P14.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Peijnenburg WJGM, 2006, ECOTOX ENVIRON SAFE, V63, P204, DOI 10.1016/j.ecoenv.2005.07.023.
   Piconi L, 2003, CLIN CHEM LAB MED, V41, P1144, DOI 10.1515/CCLM.2003.177.
   REDDY JK, 1989, MUTAT RES, V214, P63, DOI 10.1016/0027-5107(89)90198-X.
   Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065.
   Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001.
   Seitz HK, 2006, BIOL CHEM, V387, P349, DOI 10.1515/BC.2006.047.
   Seo KW, 2004, FOOD CHEM TOXICOL, V42, P107, DOI 10.1016/j.fct.2003.08.010.
   TAKAGI A, 1990, JPN J CANCER RES, V81, P213.
   Talsness CE, 2008, ENVIRON RES, V108, P158, DOI 10.1016/j.envres.2008.08.008.
   Tian Y, 2003, J OCCUP HEALTH, V45, P408, DOI 10.1539/joh.45.408.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   van Wezel AP, 2000, ECOTOX ENVIRON SAFE, V46, P305, DOI 10.1006/eesa.2000.1930.
   Vikelsoe J, 2002, SCI TOTAL ENVIRON, V296, P105, DOI 10.1016/S0048-9697(02)00063-3.
   Wang F, 2008, J HAZARD MATER, V154, P317, DOI 10.1016/j.jhazmat.2007.10.028.
   Wang YQ, 2005, ANAL BIOANAL CHEM, V383, P857, DOI 10.1007/s00216-005-0082-x.
   Wenzel A, 2005, MOL CELL ENDOCRINOL, V244, P63, DOI 10.1016/j.mce.2005.02.008.
   Xu G, 2008, SCI TOTAL ENVIRON, V393, P333, DOI 10.1016/j.scitotenv.2008.01.001.
   Yuan J, 2008, ENVIRON SCI TECHNOL, V42, P2195, DOI 10.1021/es702295f.
   Zeng F, 2008, ENVIRON INT, V34, P372, DOI 10.1016/j.envint.2007.09.002.
   Zeng F, 2009, J HAZARD MATER, V164, P1171, DOI 10.1016/j.jhazmat.2008.09.029.
   Zhu JP, 2006, ENVIRON SCI TECHNOL, V40, P5276, DOI 10.1021/es060356w.
   {*}EUR CHEM BUR, 2008, BIS 2 ETH PHTHAL DEH.
   2009, 9 PLAST EXH C TAIZH.
   2009, DAILY METROPOLIS NAN.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{0}},
Journal-ISO = {{Environ. Sci. Pollut. Res.}},
Doc-Delivery-Number = {{789XK}},
Wos-Id = {{ISI:000292552400016}},
}

@article{ ISI:000292026800009,
Author = {Martinez-Arguelles, Daniel B. and Guichard, Theodore and Culty, Martine
   and Zirkin, Barry R. and Papadopoulos, Vassilios},
Title = {{In Utero Exposure to the Antiandrogen Di-(2-Ethylhexyl) Phthalate
   Decreases Adrenal Aldosterone Production in the Adult Rat}},
Journal = {{BIOLOGY OF REPRODUCTION}},
Year = {{2011}},
Volume = {{85}},
Number = {{1}},
Pages = {{51-61}},
Month = {{JUL}},
Abstract = {{We previously reported that in utero exposure of the male fetus to the
   plasticizer di-(2-ethylhexyl) phthalate (DEHP) resulted in decreased
   circulating levels of testosterone in the adult without affecting Leydig
   cell numbers, luteinizing hormone levels, or steroidogenic enzyme
   expression. Fetal exposure to DEHP resulted in reduced mineralocorticoid
   receptor (MR; NR3C2) expression in adult Leydig cells. In the present
   studies, treatment of pregnant Sprague-Dawley dams from Gestational Day
   14 until birth with 20, 50, 100, 300, or 750 mg kg(-1) day(-1) of DEHP
   resulted in significant sex-specific decreases in serum aldosterone but
   not corticosterone levels at Postnatal Day 60 (PND60) but not at PND21.
   There was no effect on circulating levels of potassium, angiotensin II
   or adrenocorticotropin hormone (ACTH). However, there was reduced
   expression of AT receptor Agtr1a, Agtr1b, and Agtr2 mRNAs. The mRNA
   levels of proteins and enzymes implicated in aldosterone biosynthesis
   were not affected by in utero DEHP treatment except for Cyp11b2, which
   was decreased at high (>= 500 mg kg(-1) day(-1)) doses. The data
   presented herein, together with our previous observation that
   aldosterone stimulates testosterone production via an MR-mediated
   mechanism, suggest that in utero exposure to DEHP causes reduction in
   both adrenal aldosterone synthesis and MR expression in Leydig cells,
   leading to reduced testosterone production in the adult. Moreover, these
   results suggest the existence of a DEHP-sensitive adrenal-testis axis
   regulating androgen formation.}},
Publisher = {{SOC STUDY REPRODUCTION}},
Address = {{1603 MONROE ST, MADISON, WI 53711-2021 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Papadopoulos, V (Reprint Author), McGill Univ, Res Inst, Ctr Hlth, Montreal Gen Hosp, 1650 Cedar Ave,Room C10-148, Montreal, PQ H3G 1A4, Canada.
   Martinez-Arguelles, Daniel B.; Guichard, Theodore; Culty, Martine; Papadopoulos, Vassilios, McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ H3G 1A4, Canada.
   Culty, Martine; Papadopoulos, Vassilios, McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada.
   Culty, Martine; Papadopoulos, Vassilios, McGill Univ, Dept Pharmacol \& Therapeut, Montreal, PQ H3G 1A4, Canada.
   Martinez-Arguelles, Daniel B.; Culty, Martine; Papadopoulos, Vassilios, Georgetown Univ, Med Ctr, Dept Biochem \& Mol \& Cellular Biol, Washington, DC 20007 USA.
   Zirkin, Barry R., Johns Hopkins Univ, Dept Biochem \& Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD USA.}},
DOI = {{10.1095/biolreprod.110.089920}},
ISSN = {{0006-3363}},
Keywords = {{adrenal cortex; endocrine disruptors; Leydig cells; phthalates; steroid
   hormones/steroid hormone receptors; testosterone formation; toxicology}},
Keywords-Plus = {{DENSITY-LIPOPROTEIN CHOLESTEROL; RECEPTOR-ASSOCIATED PROTEIN;
   ANGIOTENSIN-II; TESTOSTERONE PRODUCTION; ADRENOCORTICAL-CELLS;
   DI(N-BUTYL) PHTHALATE; TESTICULAR DYSGENESIS; GENE-EXPRESSION; SEMEN
   QUALITY; CLASS-B}},
Research-Areas = {{Reproductive Biology}},
Web-of-Science-Categories  = {{Reproductive Biology}},
Author-Email = {{vassilios.papadopoulos@mcgill.ca}},
Funding-Acknowledgement = {{National Institutes of Health {[}R01 ES013495]; Canada Research Chair in
   Biochemical Pharmacology; Royal Victoria Hospital; Georgetown
   University-Consejo Nacional de Ciencia y Tecnologia; Fonds de la
   Recherche en Sante Quebec}},
Funding-Text = {{Supported by grant R01 ES013495 from the National Institutes of Health,
   a Canada Research Chair in Biochemical Pharmacology (to V. P.), the
   Royal Victoria Hospital Centennial Fund (to M. C.), and a Georgetown
   University-Consejo Nacional de Ciencia y Tecnologia fellowship (to D. B.
   M.-A.). The Research Institute of McGill University Health Centre is
   supported in part by a center grant from Fonds de la Recherche en Sante
   Quebec.}},
Cited-References = {{Bassett MH, 2004, MOL CELL ENDOCRINOL, V217, P67, DOI 10.1016/j.mce.2003.10.011.
   BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311.
   BRUN HP, 1991, TOXICOL APPL PHARM, V108, P307, DOI 10.1016/0041-008X(91)90120-4.
   BURSON JM, 1994, AM J PHYSIOL, V267, P260.
   Calafat AM, 2004, PEDIATRICS, V113, P429.
   Cherradi N, 2003, ENDOCRINOLOGY, V144, P4905, DOI 10.1210/en.2003-0325.
   Cherradi N, 2001, ENDOCRINOLOGY, V142, P4540, DOI 10.1210/en.142.10.4540.
   Christiansen S, 2009, ENVIRON HEALTH PERSP, V117, P1839, DOI 10.1289/ehp.0900689.
   Cui TX, 2000, BIOCHEM BIOPH RES CO, V279, P938, DOI 10.1006/bbrc.2000.4055.
   Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   GASC JM, 1994, HYPERTENSION, V24, P531.
   Ge RS, 2005, MOL CELL ENDOCRINOL, V243, P35, DOI 10.1016/j.mce.2005.08.004.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GWYNNE JT, 1976, P NATL ACAD SCI USA, V73, P4329, DOI 10.1073/pnas.73.12.4329.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Jiang JT, 2007, TOXICOLOGY, V232, P286, DOI 10.1016/j.tox.2007.01.018.
   JONES HB, 1993, EXP MOL PATHOL, V58, P179, DOI 10.1006/exmp.1993.1016.
   Koo HJ, 2007, J TOXICOL ENV HEAL A, V70, P383, DOI 10.1080/15287390600882150.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   LEHOUX JG, 1994, ENDOCRINOLOGY, V134, P776, DOI 10.1210/en.134.2.776.
   LEITERSDORF E, 1985, BIOCHIM BIOPHYS ACTA, V835, P183, DOI 10.1016/0005-2760(85)90272-3.
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   Lopez-Ilasaca M, 2003, MOL BIOL CELL, V14, P5038, DOI 10.1091/mbc.E03-06-0383.
   Martinez-Arguelles DB, 2009, ENDOCRINOLOGY, V150, P5575, DOI 10.1210/en.2009-0847.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   Nogueira EF, 2009, MOL CELL ENDOCRINOL, V302, P230, DOI 10.1016/j.mce.2008.08.024.
   Nogueira EF, 2007, J MOL ENDOCRINOL, V39, P365, DOI 10.1677/JME-07-0094.
   OISHI S, 1980, TOXICOL LETT, V5, P413.
   Pak Victoria M, 2006, Neonatal Netw, V25, P447.
   Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001.
   Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030.
   Phillips KP, 2008, J TOXICOL ENV HEAL B, V11, P188, DOI 10.1080/10937400701873472.
   Pilon A, 2003, BBA-MOL CELL BIOL L, V1631, P218, DOI 10.1016/S1388-1981(03)00020-9.
   RAINEY WE, 1992, STEROIDS, V57, P167, DOI 10.1016/0039-128X(92)90003-R.
   Rider CV, 2009, TOXICOL PATHOL, V37, P100, DOI 10.1177/0192623308329478.
   SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   Stewart PM, 1995, J STEROID BIOCHEM, V55, P465, DOI 10.1016/0960-0760(95)00195-6.
   Subotic U, 2007, J PEDIATR GASTR NUTR, V44, P71, DOI 10.1097/01.mpg.0000237939.50791.4b.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Takai Daiya, 2003, In Silico Biology, V3, P235.
   Temel RE, 1997, P NATL ACAD SCI USA, V94, P13600, DOI 10.1073/pnas.94.25.13600.
   Thompson CJ, 2005, BIOL REPROD, V73, P908, DOI 10.1095/biolreprod.105.042382.
   Wakamiya R, 1994, Blood Press Suppl, V5, P109.
   Williams G, 2005, HEART FAIL REV, V10, P7, DOI 10.1007/s10741-005-2343-3.
   Zhang LQ, 2009, PEPTIDES, V30, P913, DOI 10.1016/j.peptides.2009.01.024.
   {*}NAT CTR ENV HLTH, 2005, 3 DEP HLTH HUM SERV, P269.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{2}},
Journal-ISO = {{Biol. Reprod.}},
Doc-Delivery-Number = {{782RE}},
Wos-Id = {{ISI:000292026800009}},
}

@article{ ISI:000292012100004,
Author = {Casas, Lidia and Fernandez, Mariana F. and Llop, Sabrina and Guxens,
   Monica and Ballester, Ferran and Olea, Nicolas and Basterrechea Irurzun,
   Mikel and Santa Marina Rodriguez, Loreto and Riano, Isolina and Tardon,
   Adonina and Vrijheid, Martine and Calafat, Antonia M. and Sunyer, Jordi
   and INMA Project},
Title = {{Urinary concentrations of phthalates and phenols in a population of
   Spanish pregnant women and children}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2011}},
Volume = {{37}},
Number = {{5}},
Pages = {{858-866}},
Month = {{JUL}},
Abstract = {{Background: Phthalate and phenol exposure is prevalent among the general
   population and of potential concern for pregnant women and children
   because of their suspected susceptibility to endocrine effects.
   Objectives: To evaluate the extent of exposure to several phthalates and
   phenols in a sample of Spanish pregnant women - according to their
   individual characteristics (age, social class, education, and body mass
   index) - and children who participated in the INMA - Infancia y Medio
   Ambiente (Environment and Childhood) project.
   Methods: One spot urine sample was taken during the third trimester of
   pregnancy from 120 pregnant women and from 30 4-year old children
   belonging to 5 Spanish birth cohorts, and analyzed for 11 phthalate
   metabolites and 9 phenols.
   Results: Three metabolites of di(2-ethylhexyl) phthalate,
   mono-2-ethyl-5-carboxypentyl phthalate, mono-2-ethyl-5-hydroxyhexyl
   phthalate, and mono-2-ethyl-5-oxohexyl phthalate; two metabolites of
   dibutyl phthalates, mono-isobutyl phthalate and mono-n-butyl phthalate;
   monoethyl phthalate (MEP), the main metabolite of diethyl phthalate; and
   two phenols, methyl paraben (M-PB) and 2,5-dichlorophenol were detected
   in the urine samples of all women. The highest urinary concentrations
   were for MEP and M-PB. Urinary concentrations of all phthalate
   metabolites and of 2,4-dichlorophenol, 2,5-dichlorophenol, and bisphenol
   A were lower in the pregnant women than in the children. Among women, a
   positive relationship with social class and education was shown for most
   of the phthalate metabolites and phenols. Almost all phthalate
   metabolites varied by region even after adjusting for social class and
   education.
   Conclusions: Phthalate and phenol exposures are prevalent in a group of
   pregnant women and young children, two susceptible populations, and
   these exposures might be positively related to social class. (C) 2011
   Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Casas, L (Reprint Author), Ctr Res Environm Epidemiol, Dr Aiguader 88, Barcelona 08003, Catalonia, Spain.
   Casas, Lidia; Guxens, Monica; Vrijheid, Martine; Sunyer, Jordi, Ctr Res Environm Epidemiol, Barcelona 08003, Catalonia, Spain.
   Casas, Lidia; Guxens, Monica; Vrijheid, Martine; Sunyer, Jordi, Hosp del Mar Res Inst IMIM, Barcelona 08003, Catalonia, Spain.
   Fernandez, Mariana F.; Olea, Nicolas, Univ Granada, San Cecilio Univ Hosp, Lab Med Invest, Granada, Spain.
   Llop, Sabrina; Ballester, Ferran, Inst Salud Carlos III, Madrid, Spain.
   Llop, Sabrina, Ctr Publ Hlth Res CSISP, Valencia, Spain.
   Ballester, Ferran, Univ Valencia, Valencia, Spain.
   Basterrechea Irurzun, Mikel; Santa Marina Rodriguez, Loreto, Dept Sanidad, Subdirecc Salud Publ Gipuzkoa, San Sebastian, Spain.
   Basterrechea Irurzun, Mikel; Santa Marina Rodriguez, Loreto, Inst Invest Sanitaria BIODONOSTIA, San Sebastian, Spain.
   Riano, Isolina, Hosp San Agustin, Aviles, Spain.
   Tardon, Adonina, Univ Oviedo, Oviedo, Spain.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.
   Sunyer, Jordi, Pompeu Fabra Univ, Barcelona, Catalonia, Spain.}},
DOI = {{10.1016/j.envint.2011.02.012}},
ISSN = {{0160-4120}},
Keywords = {{Phthalate; Phenol; Pregnancy; Children; Social class; Exposure}},
Keywords-Plus = {{BISPHENOL-A CONCENTRATIONS; DI-N-BUTYLPHTHALATE; ENVIRONMENTAL PHENOLS;
   OXIDATIVE METABOLITES; TESTICULAR TOXICITY; HUMAN SPERM; DNA-DAMAGE;
   IN-UTERO; EXPOSURE; HEALTH}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{lcasas@creal.cat}},
ResearcherID-Numbers = {{Fernandez, Mariana/C-9877-2012}},
Funding-Acknowledgement = {{Instituto de Salud Carlos III {[}Red INMA G03/176 CB06/02/0041,
   FIS-FEDER 03/1615, 04/1509, 04/1112, 04/1931, 05/1079, 05/1052, 06/1213,
   07/0314, 09/02647]; Spanish Ministry of Health {[}FIS-PI041436,
   FIS-PI081151, FIS-PI06/0867, FIS-PS09/00090, FISS-PI042018,
   FISS-PI09/02311]; Generalitat de Catalunya-CIRIT {[}1999SGR 00241]; Obra
   Social Cajastur; Universidad de Oviedo; Department of Health of the
   Basque Government {[}2005111093, 2009111069]; Provincial Government of
   Gipuzkoa {[}DFG06/004, DFG08/001]; Conselleria de Sanitat Generalitat
   Valenciana, and Fundacion Roger Tome}},
Funding-Text = {{This study was funded by grants from Instituto de Salud Carlos III (Red
   INMA G03/176 CB06/02/0041, FIS-FEDER 03/1615, 04/1509, 04/1112, 04/1931,
   05/1079, 05/1052, 06/1213, 07/0314 and 09/02647), Spanish Ministry of
   Health (FIS-PI041436, FIS-PI081151, FIS-PI06/0867, FIS-PS09/00090
   FISS-PI042018, FISS-PI09/02311), Generalitat de Catalunya-CIRIT 1999SGR
   00241, Obra Social Cajastur, Universidad de Oviedo, Department of Health
   of the Basque Government (2005111093 and 2009111069), the Provincial
   Government of Gipuzkoa (DFG06/004 and DFG08/001), Conselleria de Sanitat
   Generalitat Valenciana, and Fundacion Roger Tome.}},
Cited-References = {{Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   Adibi JJ, 2010, ENVIRON HEALTH PERSP, V118, P291, DOI 10.1289/ehp.0900788.
   Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Braun JM, 2009, ENVIRON HEALTH PERSP, V117, P1945, DOI 10.1289/ehp.0900979.
   Braun JM, 2011, ENVIRON HEALTH PERSP, V119, P131, DOI 10.1289/ehp.1002366.
   Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753.
   Castorina R, 2010, ENVIRON HEALTH PERSP, V118, P856, DOI 10.1289/ehp.0901568.
   Centers for Disease Control and Prevention (CDC), 2010, NAT REP HUM EXP ENV.
   Domingo-Salvany A, 2000, Aten Primaria, V25, P350.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lin H, 2008, P NATL ACAD SCI USA, V105, P7218, DOI 10.1073/pnas.0709260105.
   Lomenick JP, 2010, J PEDIATR-US, V156, P221, DOI 10.1016/j.jpeds.2009.09.047.
   Meeker JD, 2010, ENVIRON SCI TECHNOL, V44, P1458, DOI 10.1021/es9028292.
   Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268.
   Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522.
   MENDIOLA J, 2010, ENV HLTH PERSPECT.
   Mok-Lin E, 2010, INT J ANDROL, V33, P385, DOI 10.1111/j.1365-2605.2009.01014.x.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Ribas-Fito N, 2006, PAEDIATR PERINAT EP, V20, P403, DOI 10.1111/j.1365-3016.2006.00745.x.
   Samandar E, 2009, ENVIRON RES, V109, P641, DOI 10.1016/j.envres.2009.02.004.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165.
   Talsness CE, 2009, PHILOS T R SOC B, V364, P2079, DOI 10.1098/rstb.2008.0281.
   Weuve J, 2010, ENVIRON HEALTH PERSP, V118, P825, DOI 10.1289/ehp.0901543.
   WHYATT RM, 2009, PEDIATRICS, V124, P1213.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Wolff MS, 2010, ENVIRON HEALTH PERSP, V118, P1039, DOI 10.1289/ehp.0901690.
   Ye XB, 2009, INT J HYG ENVIR HEAL, V212, P481, DOI 10.1016/j.ijheh.2009.03.004.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.
   Ye XY, 2007, J EXPO SCI ENV EPID, V17, P567, DOI 10.1038/sj.jes.7500566.
   Ye XY, 2005, ANAL CHEM, V77, P5407, DOI 10.1021/ac050390d.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{24}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{782LV}},
Wos-Id = {{ISI:000292012100004}},
}

@article{ ISI:000292012100005,
Author = {Romero-Franco, Michelle and Hernandez-Ramirez, Raill U. and Calafat,
   Antonia M. and Cebrian, Mariano E. and Needham, Larry L. and Teitelbaum,
   Susan and Wolff, Mary S. and Lopez-Carrillo, Lizbeth},
Title = {{Personal care product use and urinary levels of phthalate metabolites in
   Mexican women}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2011}},
Volume = {{37}},
Number = {{5}},
Pages = {{867-871}},
Month = {{JUL}},
Abstract = {{Sources of phthalates other than Polyvinyl chloride (PVC) related
   products are scarcely documented in Mexico. The objective of our study
   was to explore the association between urinary levels of nine phthalate
   metabolites and the use of personal care products.
   Subjects included 108 women who participated as controls in an ongoing
   population-based case-control study of environmental factors and genetic
   susceptibility to breast cancer in northern Mexico. Direct interviews
   were performed to inquire about sociodemographic characteristics,
   reproductive history, use of personal care products, and diet. Phthalate
   metabolites measured in urine by high performance liquid
   chromatography-isotope dilution tandem mass spectrometry were monoethyl
   phthalate (MEP), monobenzyl phthalate (MBzP), mono-n-butyl phthalate
   (MBP), mono-isobutyl phthalate (MiBP), mono-3-carboxypropyl phthalate
   (MCPP) as well as mono-2-ethylhexyl phthalate (MEHP),
   mono-2-ethyl-5-oxohexyl phthalate (MEOHP), mono-2-ethyl-5-hydroxyhexyl
   phthalate (MEHHP), mono-2-ethyl-5-carboxypentyl phthalate (MECPP) that
   are metabolites of di-ethylhexyl phthalate (DEHP). Detectable urinary
   concentrations of phthalate metabolites varied from 75\% (MEHP) to 100\%
   (MEP, MBP, MEOHP, MEHHP and MECPP).
   Medians of urinary concentrations of some phthalate metabolites were
   significantly higher among users of the following personal care products
   compared to nonusers: body lotion (MEHHP, MECPP and sum of DEHP
   metabolites (Sigma DEHP)), deodorant (MEHP and Sigma DEHP), perfume
   (MiBP), anti-aging facial cream (MEP, MBP and MCPP) and bottled water
   (MCPP, MEHHP and MEOHP). Urinary concentrations of MEP showed a positive
   relationship with the number of personal care products used.
   Our results suggest that the use of some personal care products
   contributes to phthalate body burden that deserves attention due to its
   potential health impact. (C) 2011 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lopez-Carrillo, L (Reprint Author), Natl Inst Publ Hlth, Ctr Populat Hlth Res, Ave Univ 655,Col Santa Maria Ahuacatitlan,Cerrada, Cuernavaca 62100, Morelos, Mexico.
   Romero-Franco, Michelle; Hernandez-Ramirez, Raill U.; Lopez-Carrillo, Lizbeth, Natl Inst Publ Hlth, Ctr Populat Hlth Res, Cuernavaca 62100, Morelos, Mexico.
   Calafat, Antonia M.; Needham, Larry L., Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Cebrian, Mariano E., CINVESTAV, Inst Politecn Nacl, Ctr Invest \& Estudios Avanzados, Dept Toxicol, San Pedro Zacatenco 07360, DF, Mexico.
   Teitelbaum, Susan; Wolff, Mary S., Mt Sinai Sch Med, Ctr Childrens Environm Hlth \& Dis Prevent Res, New York, NY 10029 USA.}},
DOI = {{10.1016/j.envint.2011.02.014}},
ISSN = {{0160-4120}},
Keywords = {{Phthalates; Personal care products; Mexican women}},
Keywords-Plus = {{ASSESSING HUMAN EXPOSURE; PREGNANT-WOMEN; COSMETIC PRODUCTS; INTERNAL
   EXPOSURE; MONOESTERS; PERFORMANCE; POPULATION; BIOMARKERS; CHEMICALS;
   HUMANS}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{michelle.romerof@gmail.com
   ruhernandez@gmail.com
   aic7@cdc.gov
   mcebrian@cinvestav.mx
   LNeedham@cdc.gov
   susan.teitelbaum@mssm.edu
   mary.wolff@mssm.edu
   lizbeth@insp.mx}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Funding-Acknowledgement = {{CONACYT {[}2005-C02-14373, FOSISS 2009-01-111384]; SEP-CONACYT
   {[}2008-79912]; Fogarty International Center {[}D43TW000640]}},
Funding-Text = {{Authors gratefully acknowledge B.Sc. Veronica Lopez for the overall
   coordination of field work, and Manori Silva, Tao Jia, Ella Samandar and
   Jim Preau for their technical assistance in measuring the urinary
   concentrations of phthalate metabolites. The study was supported by
   CONACYT Fondo Sectorial de Investigacion en Salud y Seguridad Social
   (FOSISS) 2005-C02-14373, FOSISS 2009-01-111384 and SEP-CONACYT
   2008-79912. Michelle Romero-Franco is an Irving J. Selikoff
   International Scholar of the Mount Sinai School of Medicine. Her work
   was supported in part by Award Number D43TW000640 from the Fogarty
   International Center. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   Fogarty International Center or the National Institutes of Health. The
   findings expressed in this paper are the opinions of the authors and do
   not necessarily reflect the official opinion of the Centers for Disease
   Control and Prevention.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   BUSTAMANTEMONTE.LP, 2007, SALUD PUBLICA MEX, V49.
   Bustamante-Montes LP, 2004, SALUD PUBLICA MEXICO, V46, P501, DOI 10.1590/S0036-36342004000600004.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   DIGANGI J, 2002, HLTH CARE HARM.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Finkelstein MM, 2001, AIHAJ, V62, P195, DOI 10.1080/15298660108984622.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   HATCH EE, 2008, MOL NUTR FOOD RES, V7, P27, DOI DOI 10.1002/MNFR.20060243.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   HOULIHAN J, 2002, NOT TOO PRETTY PHTHA, DOI DOI 10.1016/J.IJHEH.2007.07.011.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Hwang HM, 2008, SCI TOTAL ENVIRON, V404, P26, DOI 10.1016/j.scitotenv.2008.05.031.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2006, INT J ANDROL, V29, P181.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091.
   Loretz L, 2006, FOOD CHEM TOXICOL, V44, P2008, DOI 10.1016/j.fct.2006.06.029.
   Loretz LJ, 2008, FOOD CHEM TOXICOL, V46, P1516, DOI 10.1016/j.fct.2007.12.011.
   Loretz LJ, 2005, FOOD CHEM TOXICOL, V43, P279, DOI 10.1016/j.fct.2004.09.016.
   Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522.
   MONTES LPB, 2005, REV INT CONTAM AMBIE, V21, P63.
   Montuori P, 2008, FOOD ADDIT CONTAM, V25, P511, DOI 10.1080/02652030701551800.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Tapia-Conyer R, 1992, Salud Publica Mex, V34, P124.
   Teitelbaum S, 2007, EPIDEMIOLOGY, V18, pS79.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}CIR, 2003, DIB PHTHAL DIETH PHT.
   {*}NRC, 2008, PHTHAL CUM RISK ASS, DOI DOI 10.1080/02652030701551800.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{12}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{782LV}},
Wos-Id = {{ISI:000292012100005}},
}

@article{ ISI:000292012100009,
Author = {Guo, Ying and Wu, Qian and Kannan, Kurunthachalam},
Title = {{Phthalate metabolites in urine from China, and implications for human
   exposures}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2011}},
Volume = {{37}},
Number = {{5}},
Pages = {{893-898}},
Month = {{JUL}},
Abstract = {{Phthalates are esters of phthalic acid and are mainly used as
   plasticizers (added to plastics to increase their flexibility,
   transparency, durability, and longevity). Humans are exposed to
   phthalates through several routes. Urinary phthalate metabolites can be
   used as biomarkers of human exposures to phthalates. In this study, 14
   phthalate metabolites were analyzed in 183 urine samples collected in
   2010 from Shanghai, Guangzhou, and Qiqihaer, China. Phthalate
   metabolites were found in all urine samples and their total
   concentrations ranged from 18.6 to 3160 ng/mL (median: 331 ng/mL).
   Mono-n-butyl phthalate (mBP) and mono-2-isobutyl phthalate (miBP) were
   the major metabolites found in urine, and their respective median
   concentrations were 61.2 and 51.7 ng/mL; concentrations of miBP were
   higher than the concentrations reported for other countries, to date.
   Based on the urinary concentrations of phthalate metabolites, we
   estimated the daily intake rates in the Chinese population. The
   estimated daily intakes of dibutyl phthalate (DBP), diethyl phthalate
   (DEP), and di-(2-ethylhexyl) phthalate (DEHP) in China were 12.2, 3.8,
   and similar to 5 mu g/kg bw/day, respectively. Thirty nine percent of
   the samples exceeded the tolerable daily intake of 10 mu g/kg bw/day,
   proposed for DBP, by the European Food Safety Authority, but none of the
   estimated daily intake values exceeded the reference dose recommended by
   the U.S. Environmental Protection Agency. (C) 2011 Elsevier Ltd. All
   rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kannan, K (Reprint Author), New York State Dept Hlth, Wadsworth Ctr, Empire State Plaza,POB 509, Albany, NY 12201 USA.
   Guo, Ying; Wu, Qian; Kannan, Kurunthachalam, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.
   Wu, Qian; Kannan, Kurunthachalam, SUNY Albany, Dept Environm Hlth Sci, Sch Publ Hlth, Albany, NY 12201 USA.
   Kannan, Kurunthachalam, Harbin Inst Technol, State Key Lab Urban Water Resource \& Environm, Int Joint Res Ctr Persistent Tox Subst IJRC PTS, Harbin 150090, Peoples R China.}},
DOI = {{10.1016/j.envint.2011.03.005}},
ISSN = {{0160-4120}},
Keywords = {{Phthalate metabolites; DEHP; Human urine; Phthalate exposure;
   Biomonitoring; China}},
Keywords-Plus = {{N-BUTYL PHTHALATE; DEUTERIUM-LABELED DEHP; DI(2-ETHYLHEXYL)PHTHALATE
   DEHP; RISK-ASSESSMENT; US POPULATION; SERUM; BIOMARKERS; WOMEN;
   DIESTERS; MILK}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{kkannan@wadsworth.org}},
Funding-Acknowledgement = {{Center for Disease Control and Prevention (CDC), Atlanta, GA
   {[}1U38EH000464-01]}},
Funding-Text = {{This research (method development and analysis) is supported by a
   biomonitoring grant (1U38EH000464-01) from the Center for Disease
   Control and Prevention (CDC), Atlanta, GA. Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the CDC. We thank Dr. Jing Ma, Shanghai University,
   and Dr. Bao-Zhong Zhang, Guangzhou Institute of Geochemistry, Chinese
   Academy of Sciences, for sample collection.}},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Aylward LL, 2009, REGUL TOXICOL PHARM, V55, P259, DOI 10.1016/j.yrtph.2009.09.003.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Boberg J, 2008, TOXICOLOGY, V250, P75, DOI 10.1016/j.tox.2008.05.020.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Chen JA, 2008, ENVIRON POLLUT, V156, P849, DOI 10.1016/j.envpol.2008.05.019.
   Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712.
   Foster PMD, 2000, FOOD CHEM TOXICOL, V38, pS97, DOI 10.1016/S0278-6915(99)00128-3.
   Gray LE, 2006, TOXICOL SCI, V93, P189, DOI 10.1093/toxsci/kfl035.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   HAUSER R, 2005, OCCUP ENV MED, V62.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y.
   Itoh H, 2009, SCI TOTAL ENVIRON, V408, P37, DOI 10.1016/j.scitotenv.2009.09.012.
   Ji K, 2010, ENVIRON RES, V110, P375, DOI 10.1016/j.envres.2010.02.008.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2008, J CHROMATOGR B, V873, P180, DOI 10.1016/j.jchromb.2008.08.017.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   TANG DB, 2005, PLASTICIZER, V1, P24.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.
   Zhang X., 2004, POLYM ADDITIVES, V211, P6.
   {*}SPORTS BUR BEIJ, 2005, MON REP NAT PHYS.
   {*}SPORTS BUR GUANGD, 2005, MON REP NAT PHYS.
   {*}SPORTS BUR SHANGH, 2005, MON REP NAT PHYS.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{15}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{782LV}},
Wos-Id = {{ISI:000292012100009}},
}

@article{ ISI:000292299300021,
Author = {Rudel, Ruthann A. and Gray, Janet M. and Engel, Connie L. and
   Rawsthorne, Teresa W. and Dodson, Robin E. and Ackerman, Janet M. and
   Rizzo, Jeanne and Nudelman, Janet L. and Brody, Julia Green},
Title = {{Food Packaging and Bisphenol A and Bis(2-Ethyhexyl) Phthalate Exposure:
   Findings from a Dietary Intervention}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2011}},
Volume = {{119}},
Number = {{7}},
Pages = {{914-920}},
Month = {{JUL}},
Abstract = {{BACKGROUND: Bisphenol A (BPA) and bis(2-ethylhexyl) phthalate (DEHP) are
   high-production-volume chemicals used in plastics and resins for food
   packaging. They have been associated with endocrine disruption in
   animals and in some human studies. Human exposure sources have been
   estimated, but the relative contribution of dietary exposure to total
   intake has not been studied empirically.
   OBJECTIVES: To evaluate the contribution of food packaging to exposure,
   we measured urinary BPA and phthalate metabolites before, during, and
   after a ``fresh foods{''} dietary intervention.
   METHODS: We selected 20 participants in five families based on
   self-reported use of canned and packaged foods. Participants ate their
   usual diet, followed by 3 days of ``fresh foods{''} that were not canned
   or packaged in plastic, and then returned to their usual diet. We
   collected evening urine samples over 8 days in January 2010 and
   composited them into pre-intervention, during intervention, and
   post-intervention samples. We used mixed-effects models for repeated
   measures and Wilcoxon signed-rank tests to assess change in urinary
   levels across time.
   RESULTS: Urine levels of BPA and DEHP metabolites decreased
   significantly during the fresh foods intervention {[}e.g., BPA geometric
   mean (GM), 3.7 ng/mL pre-intervention vs. 1.2 ng/mL during intervention;
   mono-(2-ethyl-5-hydroxy hexyl) phthalate GM, 57 ng/mL vs. 25 ng/mL]. The
   intervention reduced GM concentrations of BPA by 66\% and DEHP
   metabolites by 53-56\%. Maxima were reduced by 76\% for BPA and 93-96\%
   for DEHP metabolites.
   CONCLUSIONS: BPA and DEHP exposures were substantially reduced when
   participants' diets were restricted to food with limited packaging.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rudel, RA (Reprint Author), Silent Spring Inst, 29 Crafts St, Newton, MA 02458 USA.
   Rudel, Ruthann A.; Dodson, Robin E.; Ackerman, Janet M.; Brody, Julia Green, Silent Spring Inst, Newton, MA 02458 USA.
   Gray, Janet M.; Engel, Connie L.; Rizzo, Jeanne; Nudelman, Janet L., Breast Canc Fund, San Francisco, CA USA.
   Gray, Janet M., Vassar Coll, Poughkeepsie, NY 12601 USA.
   Rawsthorne, Teresa W., AXYS Analyt Serv, Sidney, BC, Canada.}},
DOI = {{10.1289/ehp.1003170}},
ISSN = {{0091-6765}},
Keywords = {{canned foods; diet; endocrine disruptor; exposure; food packaging;
   intervention design; pharmacokinetics; phthalates; plastics}},
Keywords-Plus = {{ENDOCRINE-DISRUPTING COMPOUNDS; URINARY CREATININE EXCRETION;
   MASS-SPECTROMETRY; PROTEIN INTAKE; US POPULATION; METABOLITES;
   CHROMATOGRAPHY; PESTICIDES; INDOOR; ESTERS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{rudel@silentspring.org}},
Funding-Acknowledgement = {{Passport Foundation (Charlotte, NC, USA); Silent Spring Institute;
   Breast Cancer Fund (BCF)}},
Funding-Text = {{This research was supported by the Passport Foundation (Charlotte, NC,
   USA) and the Susan S. Bailis Breast Cancer Research Fund at Silent
   Spring Institute.R.A.R., J.G.B., R.E.D., and J.M.A. are employed at
   Silent Spring Institute, a scientific research organization dedicated to
   studying environmental factors in women's health. The institute is a
   501(c)3 public charity funded by federal grants and contracts,
   foundation grants, and private donations, including from breast cancer
   organizations. J.L.N., J.R., and C.L.E. are employed by the Breast
   Cancer Fund (BCF), and J.M.G. voluntarily serves on the BCF Board of
   Directors and as a science advisor. BCF advocates for increased funding
   for research into the environmental causes of breast cancer and stricter
   regulation of chemicals, including bisphenol A (BPA). J.L.N. also serves
   as the coordinator of a national campaign to secure stricter regulation
   of food-based exposures to BPA. T.W.R. is employed by AXYS Analytical
   Services Ltd, an analytical chemistry laboratory that is accredited to
   ISO 17025 standards. The authors declare they have no competing
   financial interests.}},
Cited-References = {{Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753.
   Carwile JL, 2009, ENVIRON HEALTH PERSP, V117, P1368, DOI 10.1289/ehp.0900604.
   CDC, 2009, 4 CDC.
   Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712.
   Doerge DR, 2010, TOXICOL APPL PHARM, V248, P1, DOI 10.1016/j.taap.2010.07.009.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   FDA, 2010, UPD BISPH US FOOD CO.
   Feng YL, 2005, ANAL CHIM ACTA, V538, P41, DOI 10.1016/j.aca.2005.02.020.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x.
   Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y.
   Ji K, 2010, ENVIRON RES, V110, P375, DOI 10.1016/j.envres.2010.02.008.
   KESTELOOT HE, 1993, J AM COLL NUTR, V12, P42.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Lakind Judy S, 2011, J Expo Sci Environ Epidemiol, V21, P272, DOI 10.1038/jes.2010.9.
   Lopez-Cervantes J, 2003, FOOD ADDIT CONTAM, V20, P596, DOI 10.1080/0265203031000109495.
   Lu CS, 2006, ENVIRON HEALTH PERSP, V114, P260, DOI 10.1289/ehp.8418.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Neubert A, 1998, J PEDIATR, V133, P655, DOI 10.1016/S0022-3476(98)70107-6.
   NTP-CERHR, 2003, NTP CERHR MON POT HU.
   Petersen JH, 2010, FOOD ADDIT CONTAM A, V27, P1608, DOI 10.1080/19440049.2010.501825.
   R Development Core Team, 2010, R LANG ENV STAT COMP.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Rudel RA, 2010, ENVIRON SCI TECHNOL, V44, P6583, DOI 10.1021/es100159c.
   Schecter A, 2010, ENVIRON SCI TECHNOL, V44, P9425, DOI 10.1021/es102785d.
   Shao B, 2007, J CHROMATOGR B, V850, P412, DOI 10.1016/j.jchromb.2006.12.033.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Taylor JA, 2011, ENVIRON HEALTH PERSP, V119, P422, DOI 10.1289/ehp.1002514.
   Willhite CC, 2008, J TOXICOL ENV HEAL B, V11, P69, DOI 10.1080/10937400701724303.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {[}Anonymous], 2005, EFSA J, V243, P1.
   {*}NTP CERHR, 2006, NTP CERHR MON POT HU.
   {*}NTP CERHR, 2008, NTP CERHR MON POT HU.
   {*}UN FAO, 2010, JOINT FAO WHO EXP M.
   {*}US EPA, 2006, EPAQAG9S.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{41}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{786IT}},
Wos-Id = {{ISI:000292299300021}},
}

@article{ ISI:000291906000006,
Author = {Frederiksen, Hanne and Aksglaede, Lise and Sorensen, Kaspar and
   Skakkebaek, Niels E. and Juul, Anders and Andersson, Anna-Maria},
Title = {{Urinary excretion of phthalate metabolites in 129 healthy Danish
   children and adolescents: Estimation of daily phthalate intake}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2011}},
Volume = {{111}},
Number = {{5}},
Pages = {{656-663}},
Month = {{JUL}},
Abstract = {{Background: Phthalates are a group of chemicals with widespread use in
   the industrial production of numerous consumer products. They are
   suspected to be involved in male reproductive health problems and have
   also been associated with several other health problems in children
   including obesity and asthma.
   Objectives: To study the urinary excretion of phthalate metabolites in
   Danish children recruited from the general population, and to estimate
   the daily intake of phthalates in this segment of the population.
   Method: One 24 h urine sample and to consecutive first morning urine
   samples were collected from 129 healthy Danish children and adolescents
   (range 6-21 yrs). The concentrations of 11 phthalate metabolites of 5
   different phthalate diesters were analyzed by liquid
   chromatography-tandem mass spectrometry.
   Results: The analyzed metabolites were detectable in almost all 24 h
   urine samples. The median concentrations of monoethyl phthalate (MEP),
   monobenzyl phthalate (MBzP) and the sums of the two monobutyl phthalate
   isoforms (Sigma MBP(i+n)), metabolites of di-(2-ethylhexyl) phthalate
   (Sigma DEHPm) and of di-iso-nonyl phthalate (Sigma DiNPm) were 29, 17,
   111, 107 and 31 ng/mL, respectively. The youngest children were
   generally more exposed to phthalates than older children and adolescents
   (except diethyl phthalate (DEP)). Boys were more exposed than girls. The
   median estimated daily intake of phthalate diesters was: 4.29 (dibutyl
   phthalate isoforms (DBP(i+n))), 4.04 (DEHP), 1.70 (DiNP), 1.09 (DEP) and
   0.62 (butylbenzyl phthalate (BBzP)), all calculated as mu g/kg body
   weight/24 h. Between 40\% and 48\% of the absolute amount of phthalate
   metabolites excreted over 24 h were excreted in first morning urine
   voids.
   Conclusion: Danish children are exposed simultaneously to multiple
   phthalates. The highest exposure levels were found for DBP(i+n) and
   DEHP, which in animal models are the known most potent antiandrogenic
   phthalates. The combined exposure to the two isoforms of DBP, which have
   similar endocrine-disrupting potencies in animal models, exceeded the
   TDI for di-n-butyl phthalate (DnBP) in several of the younger children.
   (C) 2011 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Frederiksen, H (Reprint Author), Copenhagen Univ Hosp, Rigshosp, Dept Growth \& Reprod, Sect 5064, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
   Frederiksen, Hanne; Aksglaede, Lise; Sorensen, Kaspar; Skakkebaek, Niels E.; Juul, Anders; Andersson, Anna-Maria, Copenhagen Univ Hosp, Rigshosp, Dept Growth \& Reprod, Sect 5064, DK-2100 Copenhagen, Denmark.}},
DOI = {{10.1016/j.envres.2011.03.005}},
ISSN = {{0013-9351}},
Keywords = {{Phthalate metabolite; Endocrine disruptor; Human exposure; Urinary
   excretion; Puberty; LC-MS/MS; Estimated daily intake}},
Keywords-Plus = {{FOOD-CONTACT MATERIALS; DI-N-BUTYLPHTHALATE; SCHOOL-AGE-CHILDREN;
   IN-UTERO EXPOSURE; DI(2-ETHYLHEXYL) PHTHALATE; DIISOBUTYL PHTHALATE;
   REPRODUCTIVE DEVELOPMENT; OXIDATIVE METABOLITES; BUTYL PHTHALATE; MALE
   RATS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{hanne.01.frederiksen@rh.regionh.dk}},
ResearcherID-Numbers = {{Juul, Anders /F-5864-2013}},
Funding-Acknowledgement = {{Kirsten and Freddy Johansen Foundation; Danish Ministry of Interior and
   Health; Research Center for Environmental Health {[}J.7-302-02-9/7];
   National Center on Endocrine Disrupters; Velux Fondene}},
Funding-Text = {{For skilled technical assistance, the authors thank Ole Nielsen and
   Astrid Reinhold, the Department of Growth and Reproduction,
   Rigshospitalet, the Copenhagen University Hospital, Denmark. Prof.
   Jurgen Angerer, Institute of the Ruhr-Universit at Bochum (IPA), Bochum,
   Germany and Dr. Mathias Wittassek, University of Erlangen-Nuremberg,
   Germany are thanked for supporting us with some of the internal
   standards. This study was supported by the Kirsten and Freddy Johansen
   Foundation, the Danish Ministry of Interior and Health, the Research
   Center for Environmental Health's fund (J. 7-302-02-9/7), the National
   Center on Endocrine Disrupters and the instrumental equipment was
   financially supported by the Velux Fondene.}},
Cited-References = {{Aksglaede L, 2009, PEDIATRICS, V123, pE932.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   Boberg J, 2011, REPROD TOXICOL, V31, P200, DOI 10.1016/j.reprotox.2010.11.001.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x.
   Centers for Disease Control, 2009, 4 NAT REP HUM EXP EN, P1.
   Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376.
   Dickson-Spillmann M, 2009, RISK ANAL, V29, P1170, DOI 10.1111/j.1539-6924.2009.01233.x.
   Durmaz E, 2010, PEDIATRICS, V125, pE122, DOI 10.1542/peds.2009-0724.
   EFSA, 2005, EFSA J, V243, P1.
   EFSA, 2005, EFSA J, V242, P1.
   EFSA, 2005, EFSA J, V244, P1.
   EFSA, 2005, EFSA J, V241, P1.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Frederiksen H, 2010, J ANAL TOXICOL, V34, P400.
   HATCH EE, 2008, ENV HLTH, V7, P1.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hubal EAC, 2000, ENVIRON HEALTH PERSP, V108, P475, DOI 10.2307/3454607.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005.
   Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Lhuguenot JC, 2009, MOL NUTR FOOD RES, V53, P1063, DOI 10.1002/mnfr.200800076.
   Lomenick JP, 2010, J PEDIATR-US, V156, P221, DOI 10.1016/j.jpeds.2009.09.047.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   McKee RH, 2004, REPROD TOXICOL, V18, P1, DOI 10.1016/j.reprotox.2003.09.002.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Ormond G, 2009, ENVIRON HEALTH PERSP, V117, P303, DOI 10.1289/ehp.11933.
   Petersen JH, 2010, FOOD ADDIT CONTAM A, V27, P1608, DOI 10.1080/19440049.2010.501825.
   Preau JL, 2010, ENVIRON HEALTH PERSP, V118, P1748, DOI 10.1289/ehp.1002231.
   Saillenfait AM, 2006, TOXICOL LETT, V165, P39, DOI 10.1016/j.toxlet.2006.01.013.
   Saillenfait AM, 2008, REPROD TOXICOL, V26, P107, DOI 10.1016/j.reprotox.2008.07.006.
   Samandar E, 2009, ENVIRON RES, V109, P641, DOI 10.1016/j.envres.2009.02.004.
   Sathyanarayana S, 2008, ENVIRON RES, V108, P413, DOI 10.1016/j.envres.2008.07.002.
   Schlumpf M, 2010, CHEMOSPHERE, V81, P1171, DOI 10.1016/j.chemosphere.2010.09.079.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Sorensen K, 2010, J CLIN ENDOCR METAB, V95, P263, DOI 10.1210/jc.2009-1478.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   WITTASSEK M, 2010, MOL NUTR FOOD RES, DOI DOI 10.1002/MNFR.20100012.
   Wolff MS, 2007, ENVIRON HEALTH PERSP, V115, P116, DOI 10.1289/ehp.9488.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}CDC, 2005, 3 NAT REP HUM EXP EN, P1.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{19}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{781BQ}},
Wos-Id = {{ISI:000291906000006}},
}

@article{ ISI:000291906000014,
Author = {Ferguson, Kelly K. and Loch-Caruso, Rita and Meeker, John D.},
Title = {{Urinary phthalate metabolites in relation to biomarkers of inflammation
   and oxidative stress: NHANES 1999-2006}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2011}},
Volume = {{111}},
Number = {{5}},
Pages = {{718-726}},
Month = {{JUL}},
Abstract = {{Phthalate esters are a class of compounds utilized extensively in
   widely-distributed consumer goods, and have been associated with various
   adverse health outcomes in previous epidemiologic research. Some of
   these health outcomes may be the result of phthalate-induced increases
   in oxidative stress or inflammation, which have been demonstrated in
   animal studies. The aim of this study was to explore the relationship
   between urinary phthalate metabolite concentrations and serum markers of
   inflammation and oxidative stress (C-reactive protein (CRP) and gamma
   glutamyltransferase (GGT), respectively). Subjects were participants in
   the National Health and Nutrition Examination Survey (NHANES) between
   the years 1999 and 2006. In multivariable linear regression models, we
   observed significant positive associations between CRP and mono-benzyl
   phthalate (MBzP) and mono-isobutyl phthalate (MiBP). There were CRP
   elevations of 6.0\% (95\% confidence interval (CI) 1.7-10.8\%) and 8.3\%
   (95\% CI 2.9-14.0\%) in relation to interquartile range (IQR) increases
   in urinary MBzP and MiBP, respectively. GGT was positively associated
   with mono(2-ethylhexyl) phthalate (MEHP) and an MEHP\% variable
   calculated from the proportion of MEHP in comparison to other
   di(2-ethylhexyl) phthalate (DEHP) metabolites. IQR increases in MEHP and
   MEHP\% were associated with 2.5\% (95\% CI 0.2-4.8\%) and 3.7\% (95\% CI
   1.7-5.7\%) increases in GGT, respectively. CRP and GGT were also
   inversely related to several phthalate metabolites, primarily oxidized
   metabolites. In conclusion, several phthalate monoester metabolites that
   are detected in a high proportion of urine samples from the US general
   population are associated with increased serum markers of inflammation
   and oxidative stress. On the other hand, several oxidized phthalate
   metabolites were inversely associated with these markers. These
   relationships deserve further exploration in both experimental and
   observational studies. (C) 2011 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Meeker, JD (Reprint Author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, 6635 SPH Tower,109 S Observ St, Ann Arbor, MI 48109 USA.
   Ferguson, Kelly K.; Loch-Caruso, Rita; Meeker, John D., Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.}},
DOI = {{10.1016/j.envres.2011.02.002}},
ISSN = {{0013-9351}},
Keywords = {{Biomarkers; Exposure; Epidemiology; Population; Risk}},
Keywords-Plus = {{GAMMA-GLUTAMYL-TRANSFERASE; C-REACTIVE PROTEIN; DNA-DAMAGE; SEMEN
   QUALITY; TEMPORAL VARIABILITY; WAIST CIRCUMFERENCE; SPRAGUE-DAWLEY;
   PREGNANT-WOMEN; US POPULATION; HUMAN SPERM}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{meekerj@umich.edu}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences (NIEHS) {[}R01
   ES018872, P42ES017198, P20ES018171]; US Environmental Protection Agency
   (USEPA) {[}RD83480001]}},
Funding-Text = {{Work supported by Grants R01 ES018872, P42ES017198, and P20ES018171 from
   the National Institute of Environmental Health Sciences (NIEHS), and
   RD83480001 from the US Environmental Protection Agency (USEPA).}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Agency for Toxic Substances and Disease Registry (ATSDR), 1996, DIETH PHTHAL TOXFAQS.
   Agency for Toxic Substances and Disease Registry (ATSDR), 2002, DI 2 ETH PHTHAL DEHP.
   Aitken RJ, 2010, MOL HUM REPROD, V16, P3, DOI 10.1093/molehr/gap059.
   Aitken RJ, 2009, INT J ANDROL, V32, P46, DOI 10.1111/j.1365-2605.2008.00943.x.
   ATSDR, 2001, TOX PROF DI N BUT PH.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253.
   Boas M, 2010, ENVIRON HEALTH PERSP, V118, P1458, DOI 10.1289/ehp.0901331.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Bornehag CG, 2010, INT J ANDROL, V33, P333, DOI 10.1111/j.1365-2605.2009.01023.x.
   Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305.
   Centers for Disease Control and Prevention (CDC), 2010, CHEM INF BENZ PHTHAL.
   CHU I, 1978, DRUG METAB DISPOS, V6, P146.
   Clark BJ, 2007, DRUG METAB REV, V39, P353, DOI 10.1080/03602530701519151.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Erkekoglu P, 2010, TOXICOL APPL PHARM, V248, P52, DOI 10.1016/j.taap.2010.07.016.
   Everett CJ, 2010, ENVIRON RES, V110, P79, DOI 10.1016/j.envres.2009.09.010.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Gourlay T, 2003, ARTIF ORGANS, V27, P256, DOI 10.1046/j.1525-1594.2003.07107.x.
   Gu Y, 2009, CYTOKINE, V45, P44, DOI 10.1016/j.cyto.2008.10.014.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Higuchi TT, 2003, TOXICOL SCI, V72, P301, DOI 10.1093/toxsci/kfg036.
   Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Ito Y, 2007, J OCCUP HEALTH, V49, P172, DOI 10.1539/joh.49.172.
   Jepsen KF, 2004, TOXICOL IN VITRO, V18, P265, DOI 10.1016/j.tiv.2003.09.008.
   Ji K, 2010, ENVIRON RES, V110, P375, DOI 10.1016/j.envres.2010.02.008.
   Kang JC, 2010, ECOTOX ENVIRON SAFE, V73, P1449, DOI 10.1016/j.ecoenv.2010.07.025.
   Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lazo M, 2008, ANN INTERN MED, V148, P348.
   Lee DH, 2009, FREE RADICAL RES, V43, P533, DOI 10.1080/10715760902893324.
   Lee DH, 2009, J EPIDEMIOL COMMUN H, V63, P884, DOI 10.1136/jech.2008.083592.
   Lorber M, 2011, J EXPO SCI ENV EPID, V21, P576, DOI 10.1038/jes.2010.43.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Marnell L, 2005, CLIN IMMUNOL, V117, P104, DOI 10.1016/j.clim.2005.08.04.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522.
   Meier-Ewert HK, 2001, CLIN CHEM, V47, P426.
   Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2.
   NCHS, 2010, NAT HLTH NUTR EX SUR.
   NCHS (National Center for Health and Statistics), 2010, 2005 2006 DAT DOC CO.
   NCHS (National Center for Health and Statistics), 2009, DOC COD FREQ UR PHTH.
   Noriega NC, 2009, TOXICOL SCI, V111, P163, DOI 10.1093/toxsci/kfp129.
   Pauley CJ, 2002, CELL SIGNAL, V14, P351, DOI 10.1016/S0898-6568(01)00260-1.
   Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45.
   Rael LT, 2009, OXID MED CELL LONGEV, V2, P166.
   Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773.
   Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065.
   Santhosh A, 1998, INDIAN J MED RES, V108, P17.
   Seo KW, 2004, FOOD CHEM TOXICOL, V42, P107, DOI 10.1016/j.fct.2003.08.010.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Wellejus A, 2002, J TOXICOL ENV HEAL A, V65, P813, DOI 10.1080/00984100290071126.
   Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263.
   Whitfield JB, 2007, CLIN CHEM, V53, P1, DOI 10.1373/clinchem.2006.080432.
   Whyatt RM, 2009, PEDIATRICS, V124, pE1213, DOI 10.1542/peds.2009-0325.
   Yao PL, 2007, J BIOL CHEM, V282, P5420, DOI 10.1074/jbc.M609068200.
   Zhang YH, 2006, BIOMED ENVIRON SCI, V19, P205.
   Zhou D., 2010, TOXICOL IND HLTH.
   {*}NCHS, 2010, CONT NHANES WEB TUT.}},
Number-of-Cited-References = {{75}},
Times-Cited = {{11}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{781BQ}},
Wos-Id = {{ISI:000291906000014}},
}

@article{ ISI:000292283000038,
Author = {Huang, Li-Ping and Lee, Ching-Chang and Hsu, Ping-Chi and Shih,
   Tung-Sheng},
Title = {{The association between semen quality in workers and the concentration
   of di(2-ethylhexyl) phthalate in polyvinyl chloride pellet plant air}},
Journal = {{FERTILITY AND STERILITY}},
Year = {{2011}},
Volume = {{96}},
Number = {{1}},
Pages = {{90-94}},
Month = {{JUL}},
Abstract = {{Objective: To investigate potential associations between semen quality
   in workers and the concentrations of di(2-ethylhexyl) phthalate (DEHP)
   in personal air collected from polyvinyl chloride (PVC) plants.
   Design: Cross-sectional study.
   Setting: PVC plants in Taiwan.
   Patient(s): Forty-five male workers employed in two PVC pellet plants.
   Intervention(s): None.
   Main Outcome Measurement(s): Sperm concentration, motility, morphology,
   and chromatin DNA integrity were accessed.
   Result(s): The workers were divided into low-and high-DEHP-exposed
   groups in accordance with the median levels of DEHP (23.7 mu g/m(3)) in
   personal air. In the high-DEHP-exposed group, significant increases were
   found in the tendency for sperm DNA denaturation (alpha T) induction,
   the DNA fragmentation index (DFI), and propensity for coffee drinking.
   After adjusting for coffee drinking, cigarette smoking, and age,
   personal air concentrations of DEHP showed positive associations with
   alpha T (beta = 0.038) and DFI (beta = 0.140) and negative associations
   with sperm motility (beta = -0.227).
   Conclusion(s): This is the first study to demonstrate a link between
   DEHP concentration in ambient air and the adverse effects in sperm
   motility and chromatin DNA integrity. Given the current wide use of
   these PVC products, the implications for phthalates toxicity and
   occupational health could be considerable. (Fertil Steril (R)
   2011;96:90-4. (C)2011 by American Society for Reproductive Medicine.)}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hsu, PC (Reprint Author), Natl Kaohsiung First Univ Sci \& Technol, Dept Safety Hlth \& Environm Engn, 2 Jhuoyue Rd, Kaohsiung 811, Taiwan.
   Huang, Li-Ping; Hsu, Ping-Chi, Natl Kaohsiung First Univ Sci \& Technol, Dept Safety Hlth \& Environm Engn, Kaohsiung 811, Taiwan.
   Huang, Li-Ping, Chung Jen Coll Nursing Hlth Sci \& Management, Dept Nursing, Chiayi, Taiwan.
   Lee, Ching-Chang, Natl Cheng Kung Univ, Dept Environm \& Occupat Hlth, Tainan 70101, Taiwan.
   Shih, Tung-Sheng, Council Labor Affairs, Inst Occupat Safety \& Hlth, Taipei, Taiwan.
   Shih, Tung-Sheng, China Med Univ, Coll Publ Hlth, Grad Inst Environm Hlth, Taichung, Taiwan.}},
DOI = {{10.1016/j.fertnstert.2011.04.093}},
ISSN = {{0015-0282}},
Keywords = {{di(2-ethylhexyl) phthalate (DEHP); polyvinyl chloride (PVC);
   occupational exposure; ambient air; semen quality; sperm chromatin DNA}},
Keywords-Plus = {{DNA-DAMAGE; OXIDATIVE METABOLITES; URINE SAMPLES; COMET ASSAY; HUMAN
   SPERM; EXPOSURE; FRAGMENTATION; MONOESTER; DEHP}},
Research-Areas = {{Obstetrics \& Gynecology; Reproductive Biology}},
Web-of-Science-Categories  = {{Obstetrics \& Gynecology; Reproductive Biology}},
Author-Email = {{pchsu@nkfust.edu.tw}},
Funding-Acknowledgement = {{Institute of Occupational Safety and Health {[}IOSH98-M306]; National
   Science Council (NSC) of Taiwan {[}97-2221-E-327-009-MY3]}},
Funding-Text = {{Supported in part by grants from the Institute of Occupational Safety
   and Health (IOSH98-M306) and the National Science Council (NSC
   97-2221-E-327-009-MY3) of Taiwan.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Anderson D, 1999, TERATOGEN CARCIN MUT, V19, P275, DOI 10.1002/(SICI)1520-6866(1999)19:4<275::AID-TCM4>3.0.CO;2-1.
   ATSDR, 2002, TOX PROF DI 2 ETH PH.
   Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Evenson Donald, 2000, Methods in Cell Science, V22, P169, DOI 10.1023/A:1009844109023.
   Evenson DP, 2002, J ANDROL, V23, P25.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   Ichimura T, 2003, TOXICOLOGY, V194, P35, DOI 10.1016/j.tox.2003.07.003.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381.
   Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001.
   PARMAR D, 1986, TOXICOLOGY, V42, P47, DOI 10.1016/0300-483X(86)90091-0.
   Schmid TE, 2007, HUM REPROD, V22, P180, DOI 10.1093/humrep/del338.
   Spjuth L, 2006, INT J ANDROL, V29, P534, DOI 10.1111/j.1365-2605.2006.00693.x.
   World Health Organization, 1999, LAB MAN EX HUM SEM S.
   {*}NIOSH, 1979, HLTH HAZ EV DET REP.
   {*}OSHA, CHEM SAMPL AN DEHP.
   {*}OSHA, 2006, TOX HAZ SUBST DEHP.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{11}},
Journal-ISO = {{Fertil. Steril.}},
Doc-Delivery-Number = {{786DH}},
Wos-Id = {{ISI:000292283000038}},
}

@article{ ISI:000293814600002,
Author = {Koch, Holger M. and Wittassek, Matthias and Bruening, Thomas and
   Angerer, Juergen and Heudorf, Ursel},
Title = {{Exposure to phthalates in 5-6 years old primary school starters in
   Germany-A human biomonitoring study and a cumulative risk assessment}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2011}},
Volume = {{214}},
Number = {{3}},
Pages = {{188-195}},
Month = {{JUN}},
Abstract = {{We determined the internal exposure of 111 German primary school
   starters by analyzing urinary metabolites of six phthalates: butyl
   benzyl phthalate (BBzP), di-iso-butyl phthalate (DiBP), di-n-butyl
   phthalate (DnBP), di (2-ethylhexyl) phthalate (DEHP), di-iso-nonyl
   phthalate (DiNP) and di-iso-decylphthalate (DiDP). From the urinary
   metabolite levels, we calculated daily intakes and related these values
   to Tolerable Daily Intake (TDI) values. By introducing the concept of a
   relative cumulative Tolerable Daily Intake (TDIcum) value, we tried to
   account for the cumulative exposure to several of the above-mentioned
   phthalates. The TDIcum was derived as follows: the daily intake (DI)
   calculated from the metabolite level was divided by the TDI for each
   phthalate; this ratio was multiplied by 100\% indicating the TDI
   percentage for which the DI accounted. Finally the \%TDIs of the
   different phthalates were totalled to get the TDIcum. A TDIcum above
   100\% is a potential cause for concern. We confirmed the ubiquitous
   exposure of the children to all phthalates investigated. Exposures were
   within range of levels previously reported for GerES, albeit slightly
   lower. Regarding daily intakes, two children exceeded the TDI for DnBP,
   whereas one child closely approached the TDI for DEHP. 24\% of the
   children exceeded the TDIcum for the three most critical phthalates:
   DEHP, DnBP and DiBP. Furthermore, 54\% of the children had total
   exposures that used up more than 50\% the TDIcum. Therefore, the overall
   exposure to a number of phthalates, and the knowledge that these
   phthalates (and other anti-androgens) act in a dose-additive manner,
   urgently warrants a cumulative risk assessment approach. (C) 2011
   Elsevier GmbH. All rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Koch, HM (Reprint Author), Inst Ruhr Univ Bochum IPA, Inst Prevent \& Occupat Med German Social Accid In, Burkle de la Camp Pl 1, D-44789 Bochum, Germany.
   Koch, Holger M.; Bruening, Thomas; Angerer, Juergen, Inst Ruhr Univ Bochum IPA, Inst Prevent \& Occupat Med German Social Accid In, D-44789 Bochum, Germany.
   Wittassek, Matthias, Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, D-91054 Erlangen, Germany.
   Heudorf, Ursel, Dept Publ Hlth, D-60313 Frankfurt, Germany.}},
DOI = {{10.1016/j.ijheh.2011.01.009}},
ISSN = {{1438-4639}},
Keywords = {{Children; Phthalate; Metabolites; Urine; Daily intake; Cumulative
   tolerable daily intake}},
Keywords-Plus = {{REPRODUCTIVE-TRACT DEVELOPMENT; N-BUTYL PHTHALATE; TANDEM
   MASS-SPECTROMETRY; ISO-NONYLPHTHALATE DINP; FETAL-RAT TESTIS; HUMAN
   URINE; DI(2-ETHYLHEXYL)PHTHALATE DEHP; ENVIRONMENTAL CHEMICALS;
   TESTOSTERONE PRODUCTION; OXIDATIVE METABOLITES}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{koch@ipa-dguv.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011
   Bruning, Thomas/D-3690-2013}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837
   }},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P1083, DOI 10.1289/ehp.7617.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   Calafat AM, 2011, ENVIRON HEALTH PERSP, V119, P50, DOI 10.1289/ehp.1002316.
   CDC Centers for Disease Control and Prevention, 2009, 4 CDCP DEP HLTH HUM.
   Christiansen S, 2009, ENVIRON HEALTH PERSP, V117, P1839, DOI 10.1289/ehp.0900689.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   EFSA, 2005, EFSA J, V243, P1.
   EFSA, 2005, EFSA J, V244, P77.
   EFSA, 2005, EFSA J, V245, P1.
   EFSA, 2005, EFSA J, V241, P1.
   EFSA (European Food Safety Authority), 2005, EFSA J, V242, P1.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hatch EE, 2010, INT J ANDROL, V33, P324, DOI 10.1111/j.1365-2605.2009.01035.x.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Heudorf U, 2001, ENVIRON RES, V86, P80, DOI 10.1006/enrs.2001.4237.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Kato K, 2007, TOXICOLOGY, V236, P114, DOI 10.1016/j.tox.2007.04.009.
   Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Kortenkamp A, 2010, INT J ANDROL, V33, P463, DOI 10.1111/j.1365-2605.2009.01047.x.
   LARSEN K, 1972, CLIN CHIM ACTA, V41, P209, DOI 10.1016/0009-8981(72)90513-X.
   Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013.
   National Research Council of the National Academies (NRC) Committee on the Health Risks of Phthalates, 2008, PHTHAL CUM RISK ASS.
   Noriega NC, 2009, TOXICOL SCI, V111, P163, DOI 10.1093/toxsci/kfp129.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Remer T, 2002, AM J CLIN NUTR, V75, P561.
   Rider CV, 2010, INT J ANDROL, V33, P443, DOI 10.1111/j.1365-2605.2009.01049.x.
   Rider CV, 2009, TOXICOL PATHOL, V37, P100, DOI 10.1177/0192623308329478.
   Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x.
   Sharpe RM, 2003, PURE APPL CHEM, V75, P2023, DOI 10.1351/pac200375112023.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2007, ENVIRON SCI TECHNOL, V41, P7576, DOI 10.1021/es071142x.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan SH, 2010, INT J ANDROL, V33, P259, DOI 10.1111/j.1365-2605.2009.01019.x.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Teuschler LK, 1995, TOXICOLOGY, V105, P137, DOI 10.1016/0300-483X(95)03207-V.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   UBA, 2005, GESUNDHEITSSCHUTZ, V48, P616.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   Wilson VS, 2008, INT J ANDROL, V31, P178, DOI 10.1111/j.1365-2605.2007.00861.x.
   Wittassek M, 2011, MOL NUTR FOOD RES, V55, P7, DOI 10.1002/mnfr.201000121.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   World Health Organization, 1996, BIOL MON CHEM EXP WO, V1.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.}},
Number-of-Cited-References = {{63}},
Times-Cited = {{14}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{806NJ}},
Wos-Id = {{ISI:000293814600002}},
}

@article{ ISI:000290679700006,
Author = {Gaudin, R. and Marsan, P. and Ndaw, S. and Robert, A. and Ducos, P.},
Title = {{Biological monitoring of exposure to di(2-ethylhexyl) phthalate in six
   French factories: a field study}},
Journal = {{INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH}},
Year = {{2011}},
Volume = {{84}},
Number = {{5}},
Pages = {{523-531}},
Month = {{JUN}},
Abstract = {{Objective The aim of this study was to assess, by biological monitoring,
   workers' exposure to di(2-ethylhexyl) phthalate (DEHP) in the
   flexible-PVC industry in France to provide additional occupational
   exposure data, which are particularly scarce.
   Method Over 5 days of pre-and post-shift sampling, three urinary
   metabolites of DEHP, mono (2-ethylhexyl) phthalate (MEHP), mono
   (5-carboxy-2-ethylpentyl) phthalate (5cx-MEPP) and 2-ethylhexanoic acid
   (2-EHA) were quantified in 62 workers and 29 controls from six
   factories. Analyses were performed by high-performance liquid
   chromatography with tandem mass spectrometry (HPLC-MS/MS) after on-line
   extraction.
   Results Median concentrations of the pre- and post-shift urinary samples
   in the exposed workers were 12.6 and 28.7 mu g/l for MEHP, 38.6 and 84.4
   mu g/l for 5cx-MEPP and 20.4 and 70.6 mu g/l for 2-EHA, respectively. In
   the controls, the corresponding values were 4.8 and 4.7 mu g/l for MEHP,
   15.1 and 12.4 mu g/l for 5cx-MEPP and 21.8 and 20.5 mu g/l for 2-EHA,
   respectively. There was a significant increase (Mann-Whitney U-test, P <
   0.05) of post-shift excretion in the exposed workers versus the
   unexposed controls and in the post-shift versus pre-shift concentrations
   only in the exposed workers. Values of 250 and 500 mu g/l (100 and 280
   mu/g creatinine) for MEHP and 5cx-MEPP, respectively, are proposed as
   guidance values.
   Conclusion There is clear evidence of occupational exposure of workers
   in these factories. The guideline values proposed should prevent high
   exposures in the soft PVC industry, particularly in factories where DEHP
   compounds or plastisols are employed. An epidemiological survey is
   needed to complete the DEHP risk assessment.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gaudin, R (Reprint Author), Inst Natl Rech \& Secur, Dept Polluants \& Sante, CS 60027, F-54519 Vandoeuvre Les Nancy, France.
   Gaudin, R.; Marsan, P.; Ndaw, S.; Robert, A.; Ducos, P., Inst Natl Rech \& Secur, Dept Polluants \& Sante, F-54519 Vandoeuvre Les Nancy, France.}},
DOI = {{10.1007/s00420-010-0566-7}},
ISSN = {{0340-0131}},
Keywords = {{DEHP; Biological monitoring; Metabolites; Occupational exposure}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; DEUTERIUM-LABELED DEHP; HUMAN BREAST-MILK;
   HUMAN URINE; DI-(2-ETHYLHEXYL) PHTHALATE; METABOLITES; BIOMARKERS;
   WORKERS; SERUM; POPULATION}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{rene.gaudin@inrs.fr}},
Cited-References = {{ALBRO PW, 1981, DRUG METAB DISPOS, V9, P223.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Aylward LL, 2009, REGUL TOXICOL PHARM, V55, P249, DOI 10.1016/j.yrtph.2009.09.001.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   CADOGAN D, 2006, EUROPEAN COUNCIL PLA.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   DOELMAN CJA, 1990, LANCET, V335, P725, DOI 10.1016/0140-6736(90)90839-W.
   Gaudin R, 2008, INT ARCH OCC ENV HEA, V81, P959, DOI 10.1007/s00420-007-0289-6.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hines CJ, 2009, ANN OCCUP HYG, V53, P1, DOI 10.1093/annhyg/men066.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Lambrot R, 2009, ENVIRON HEALTH PERSP, V117, P32, DOI 10.1289/ehp.11146.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Melnick RL, 2001, ENVIRON HEALTH PERSP, V109, P437, DOI 10.2307/3454700.
   Milkov L E, 1973, Environ Health Perspect, V3, P175, DOI 10.2307/3428045.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   NIELSEN J, 1985, AM IND HYG ASSOC J, V46, P643, DOI 10.1202/0002-8894(1985)046<0643:PEEALA>2.3.CO;2.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   THIESS AM, 1978, ZBL ARBEITSMED, V12, P351.
   Vermeulen R, 2005, INT ARCH OCC ENV HEA, V78, P663, DOI 10.1007/s00420-005-0017-z.
   Wahl HG, 2001, J CHROMATOGR B, V758, P213.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wittassek M, 2009, INT J HYG ENVIR HEAL, V212, P492, DOI 10.1016/j.ijheh.2009.04.001.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   WOLFE GW, 2003, 7244200 TRC.
   {[}Anonymous], 2002, ULLMANNS ENCY IND CH.
   {*}CSTEE, 2000, 469 CSTEE.
   {*}EU, 2001, RISK ASS BIS 2 ETH P.
   {*}EU, 2008, EUR CHEM BUR 2 PRIOR, V80.
   {*}IARC, 2000, MON EV CARC RISKS HU, P41.
   {*}NTP CERHR, 2000, EXP PAN REP DI 2 ETH.
   2007, BUNDESGESUNDHEITSBL, V50, P249.}},
Number-of-Cited-References = {{53}},
Times-Cited = {{1}},
Journal-ISO = {{Int. Arch. Occup. Environ. Health}},
Doc-Delivery-Number = {{765BZ}},
Wos-Id = {{ISI:000290679700006}},
}

@article{ ISI:000291559500001,
Author = {Colacino, Justin A. and Soliman, Amr S. and Calafat, Antonia M. and
   Nahar, Muna S. and Van Zomeren-Dohm, Adrienne and Hablas, Ahmed and
   Seifeldin, Ibrahim A. and Rozek, Laura S. and Dolinoy, Dana C.},
Title = {{Exposure to phthalates among premenstrual girls from rural and urban
   Gharbiah, Egypt: A pilot exposure assessment study}},
Journal = {{ENVIRONMENTAL HEALTH}},
Year = {{2011}},
Volume = {{10}},
Month = {{MAY 16}},
Abstract = {{Background: Phthalates have been identified as endocrine active
   compounds associated with developmental and reproductive toxicity. The
   exposure to phthalates in premenstrual Egyptian females remains unknown.
   The objective of this study was to characterize phthalate exposure of a
   potentially vulnerable population of premenstrual girls from urban and
   rural Egypt.
   Materials and methods: We collected one spot urine sample from 60 10-13
   year old females, 30 from rural Egypt, and 30 from urban Egypt from July
   to October 2009. Samples were analyzed for 11 phthalate metabolites.
   Additionally, we collected anthropometrics as well as questionnaire data
   concerning food storage behaviors, cooking practices, and cosmetic use.
   Phthalate metabolite concentrations were compared between urban and
   rural Egyptians as well as to age and gender matched Americans.
   Results: Monoethyl phthalate (MEP), was detected at the highest
   concentration in urine of Egyptian girls (median: 43.2 ng/mL in rural,
   98.8 ng/mL in urban). Concentrations of urinary metabolites of
   di-(2-ethylhexyl) phthalate and dibutyl phthalate were comparable
   between Egyptians and age matched US girls. Storage of food in plastic
   containers was a statistically significant predictor of urinary
   mono-isobutyl phthalate (MiBP) concentrations when comparing covariate
   adjusted means.
   Conclusions: Urinary concentrations of phthalate metabolites were
   similar in Egyptian and US populations, suggesting that phthalate
   exposure also occurs in developing nations. Dietary intake is likely an
   important route of exposure to phthalates in both urban and rural
   populations.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dolinoy, DC (Reprint Author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   Colacino, Justin A.; Nahar, Muna S.; Van Zomeren-Dohm, Adrienne; Rozek, Laura S.; Dolinoy, Dana C., Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   Colacino, Justin A.; Soliman, Amr S., Univ Michigan, Ctr Global Hlth, Ann Arbor, MI 48109 USA.
   Soliman, Amr S., Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Hablas, Ahmed; Seifeldin, Ibrahim A., Tanta Canc Ctr, Gharbiah, Egypt.
   Hablas, Ahmed; Seifeldin, Ibrahim A., Gharbiah Canc Soc, Gharbiah, Egypt.}},
DOI = {{10.1186/1476-069X-10-40}},
Article-Number = {{40}},
ISSN = {{1476-069X}},
Keywords-Plus = {{PREGNANT-WOMEN; URINARY LEVELS; PVC GLOVES; METABOLITES; POPULATION;
   PRODUCTS; QUALITY; RATS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{ddolinoy@umich.edu}},
Funding-Acknowledgement = {{University of Michigan NIEHS P30 Core Center {[}P30 ES017885]; NIH
   {[}ES017524]; National Institute of Environmental Health Sciences
   (NIEHS), NIH {[}T32 ES07062]; University of Michigan Cancer {[}R25
   CA112383]}},
Funding-Text = {{This work was supported the University of Michigan NIEHS P30 Core Center
   (P30 ES017885), with generous support from the UM School of Public
   Health (SPH) and the SPH Department of Environmental Health Sciences.
   Support for DCD and LSR was provided by NIH grant ES017524. Support for
   JAC and MN was provided by an Institutional Training Grant from the
   National Institute of Environmental Health Sciences (NIEHS), NIH (T32
   ES07062) and the University of Michigan Cancer Epidemiology Education in
   Special Populations Program (R25 CA112383). We acknowledge Manori Silva,
   Ella Samandar, and Jim Preau for measuring the urinary concentrations of
   phthalate metabolites and Stacy Endres at NIEHS for her effort in part
   of the data collection.}},
Cited-References = {{Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Caudill SP, 2008, STAT MED, V27, P4094, DOI 10.1002/sim.3222.
   CDC, 2010, 4 CDC.
   CDC, 2005, 3 CDC.
   CDC, 2009, 4 CDC.
   {[}Centers for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS) Centers for Disease Control and Prevention (CDC)], 2003, NAT HLTH NUTR EX SUR.
   Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   DEY S, 2009, BJOG, V117, P348.
   Dey S, 2010, BREAST CANCER RES TR, V120, P149, DOI 10.1007/s10549-009-0427-9.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Fromme H, 2007, ENVIRON SCI TECHNOL, V41, P7928, DOI 10.1021/es071244n.
   Gray LE, 2006, TOXICOL SCI, V93, P189, DOI 10.1093/toxsci/kfl035.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Irvin EA, 2010, CHEMOSPHERE, V80, P1301, DOI 10.1016/j.chemosphere.2010.06.048.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091.
   Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522.
   Mohamed M.A., 2008, AM J FOOD TECHNOLOGY, V3, P341.
   Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001.
   Grandjean P, 2006, INT J ANDROL, V29, P181, DOI 10.1111/j.1365-2605.2005.00679.x.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P569, DOI 10.1080/02652030010028344.
   Tsumura Y, 2003, FOOD ADDIT CONTAM, V20, P317, DOI 10.1080/0265203031000122021.
   Wolff MS, 2010, ENVIRON HEALTH PERSP, V118, P1039, DOI 10.1289/ehp.0901690.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{4}},
Journal-ISO = {{Environ. Health}},
Doc-Delivery-Number = {{776SZ}},
Wos-Id = {{ISI:000291559500001}},
}

@article{ ISI:000291120400020,
Author = {Lin, Lung-Cheng and Wang, Shu-Li and Chang, Yu-Chen and Huang, Po-Chin
   and Cheng, Joan-Tin and Su, Pen-Hua and Liao, Pao-Chi},
Title = {{Associations between maternal phthalate exposure and cord sex hormones
   in human infants}},
Journal = {{CHEMOSPHERE}},
Year = {{2011}},
Volume = {{83}},
Number = {{8}},
Pages = {{1192-1199}},
Month = {{MAY}},
Abstract = {{It has been speculated that maternal phthalate exposure may affect
   reproductive development in human newborns. However, the mechanism
   awaits further investigation. The aim is to evaluate the association
   between maternal phthalate exposure and cord sex steroid hormones in
   pregnant women and their newborns from the general population. A total
   of 155 maternal and infant pair were recruited and analyzed. Levels of
   urinary phthalate metabolites and sex steroid hormones were determined
   using liquid chromatography/electrospray tandem mass spectrometry
   (LC-ESI-MS/MS) and radioimmunoassay (RIA), respectively. No significant
   correlation was found between each steroid hormones and phthalate
   metabolites for male newborns, except MMP was marginally significantly
   correlated with E(2). After adjusting for maternal age, estradiol (E(2))
   levels in cord serum from male newborns were not correlated with
   maternal urinary phthalate metabolites. In female newborns, the maternal
   urinary levels of mono-(2-ethylhexyl) phthalate (MEHP) and
   mono-(2-ethyl-5-hydroxyhexyl) phthalate (5OH-MEHP) were negatively
   correlated with the free testosterone (fT) and fT/E(2) levels in cord
   serum with Pearson correlation coefficients ranging between -0.24 and
   -0.29 (p < 0.05). Additionally, after gestational age was adjusted, the
   maternal urinary level of DEHP was negatively correlated with the free
   testosterone (IT) and fT/E(2) levels in cord serum. We suggest that
   maternal exposure to phthalates may affect sex steroid hormones status
   in fetal and newborn stage. (C) 2011 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Liao, PC (Reprint Author), Natl Cheng Kung Univ, Coll Med, Dept Environm \& Occupat Hlth, 138 Sheng Li Rd, Tainan 704, Taiwan.
   Lin, Lung-Cheng; Chang, Yu-Chen; Cheng, Joan-Tin; Liao, Pao-Chi, Natl Cheng Kung Univ, Coll Med, Dept Environm \& Occupat Hlth, Tainan 704, Taiwan.
   Wang, Shu-Li; Huang, Po-Chin, Natl Hlth Res Inst, Div Environm Hlth \& Occupat Med, Miaoli 350, Taiwan.
   Wang, Shu-Li, China Med Univ \& Hosp, Coll Publ Hlth, Inst Environm Med, Taichung, Taiwan.
   Su, Pen-Hua, Chung Shan Med Univ Hosp, Div Genet, Dept Pediat, Taichung 402, Taiwan.
   Su, Pen-Hua, Chung Shan Med Univ, Sch Med, Taichung 402, Taiwan.
   Liao, Pao-Chi, Natl Cheng Kung Univ, Sustainable Environm Res Ctr, Tainan 701, Taiwan.}},
DOI = {{10.1016/j.chemosphere.2010.12.079}},
ISSN = {{0045-6535}},
Keywords = {{Sex steroid hormones; Maternal exposure; Phthalate; Umbilical cord blood}},
Keywords-Plus = {{IN-UTERO EXPOSURE; BUTYL BENZYL PHTHALATE; CORONARY-ARTERY-DISEASE;
   FETAL-RAT TESTIS; DI(N-BUTYL) PHTHALATE; LACTATIONAL EXPOSURE;
   REPRODUCTIVE-SYSTEM; POLYCHLORINATED-BIPHENYLS; MASS-SPECTROMETRY;
   SPRAGUE-DAWLEY}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{liaopc@mail.ncku.edu.tw}},
ResearcherID-Numbers = {{Wang, Shu-Li/C-1367-2010
   Huang, Po-Chin/I-5844-2012}},
Funding-Acknowledgement = {{National Science Council, Taiwan {[}NSC94-2113-M006-06,
   NSC97-2113-M-006-005-MY3]; National Health Research Institutes, Taiwan
   {[}EO-097-PP-05, EO-098-PP-03]}},
Funding-Text = {{This work was supported by Grants NSC94-2113-M006-06 and
   NSC97-2113-M-006-005-MY3 from National Science Council, Taiwan, and
   Grants EO-097-PP-05 and EO-098-PP-03 from National Health Research
   Institutes, Taiwan.}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Barlow NJ, 2004, TOXICOL PATHOL, V32, P79, DOI 10.1080/01926230490265894.
   BECK W, 1981, EUR J PEDIATR, V137, P41, DOI 10.1007/BF00441168.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   Cao YG, 2008, INT J HYG ENVIR HEAL, V211, P30, DOI 10.1016/j.ijheh.2007.04.005.
   Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004.
   Chou YY, 2009, J PEDIATR ENDOCR MET, V22, P69.
   Dalsenter PR, 2006, HUM EXP TOXICOL, V25, P297, DOI 10.1191/0960327105ht624oa.
   DAWOOD MY, 1977, AM J OBSTET GYNECOL, V129, P37.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Ema M, 2000, TOXICOL LETT, V111, P271, DOI 10.1016/S0378-4274(99)00192-7.
   Ema M, 2002, REPROD TOXICOL, V16, P71, DOI 10.1016/S0890-6238(01)00200-3.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Grande SW, 2007, TOXICOLOGY, V229, P114, DOI 10.1016/j.tox.2006.10.005.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   He H, 2007, MENOPAUSE, V14, P385, DOI 10.1097/01.gme.0000235369.24479.dd.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Huang PC, 2010, HUM REPROD, V25, P986, DOI 10.1093/humrep/deq015.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Kai H, 2005, J PEDIATR SURG, V40, P429, DOI 10.1016/j.jpedsurg.2004.10.009.
   Kajinami K, 2004, CORONARY ARTERY DIS, V15, P199.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   LATINI G, 2003, ENV HLTH PERSPECT, V1111, P783.
   Latini G, 2006, TOXICOLOGY, V226, P90, DOI 10.1016/j.tox.2006.07.011.
   Lin LC, 2004, RAPID COMMUN MASS SP, V18, P1310, DOI 10.1002/rcm.1488.
   Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Mahood IK, 2007, ENVIRON HEALTH PERSP, V115, P55, DOI 10.1289/ehp.9366.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   MENDIOLA J, 2010, INT J ANDROL, P1, DOI 10.1109/FUZZY.2010.5584727.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Savarese TM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1674.
   Scott HM, 2007, ENDOCRINOLOGY, V148, P2027, DOI 10.1210/en.2006-1622.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Tanaka K, 2000, CANCER RES, V60, P5106.
   Thompson CJ, 2004, ENDOCRINOLOGY, V145, P1227, DOI 10.1210/en.2003-1475.
   Troisi R, 2003, CANCER EPIDEM BIOMAR, V12, P452.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   Wang SL, 2005, ENVIRON HEALTH PERSP, V113, P1645, DOI 10.1289/ehp.7994.
   Wang SL, 2004, CHEMOSPHERE, V54, P1459, DOI 10.1016/j.chemosphere.2003.08.012.
   Wilson VS, 2007, TOXICOL LETT, V170, P177, DOI 10.1016/j.toxlet.2007.03.004.
   {*}WORK MED ASS, 2000, B MED ETH, V162, P8.}},
Number-of-Cited-References = {{49}},
Times-Cited = {{11}},
Journal-ISO = {{Chemosphere}},
Doc-Delivery-Number = {{770WY}},
Wos-Id = {{ISI:000291120400020}},
}

@article{ ISI:000290637300005,
Author = {Pak, Victoria M. and McCauley, Linda A. and Pinto-Martin, Jennifer},
Title = {{Phthalate Exposures and Human Health Concerns A Review and Implications
   for Practice}},
Journal = {{AAOHN JOURNAL}},
Year = {{2011}},
Volume = {{59}},
Number = {{5}},
Pages = {{228-233}},
Month = {{MAY}},
Abstract = {{High levels of exposure to phthalates have been associated with an
   increased risk for adverse male fetal reproductive development: Although
   animal studies have consistently demonstrated reproductive health
   effects, additional human epidemiological. studies are needed to fully
   understand the potential harm to humans. Recent findings reported for
   humans have demonstrated endocrine-disrupting action similar to that
   associated with phthalate exposures in animals. As a result, phthalate
   exposure is an emerging public health concern that warrants further
   review. This article explores the state of the science on phthalate
   exposure, reviews the literature, and provides recommendations
   occupational health nurses can use to optimize the health of susceptible
   populations.}},
Publisher = {{SLACK INC}},
Address = {{6900 GROVE RD, THOROFARE, NJ 08086 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Pak, VM (Reprint Author), Univ Penn, Sch Nursing, 420 Gaurdian Dr, Philadelphia, PA 19104 USA.
   Pak, Victoria M., Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA.
   McCauley, Linda A., Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA.
   Pinto-Martin, Jennifer, Univ Penn, Biobehav \& Hlth Sci Div, Philadelphia, PA 19104 USA.}},
DOI = {{10.3928/08910162-20110426-01}},
ISSN = {{0891-0162}},
Keywords-Plus = {{N-BUTYL PHTHALATE; EXTRACORPOREAL MEMBRANE-OXYGENATION; IN-UTERO
   EXPOSURE; REPRODUCTIVE DEVELOPMENT; EXCHANGE-TRANSFUSION; ANOGENITAL
   DISTANCE; NEWBORN-INFANTS; RISK-ASSESSMENT; URINARY LEVELS; PLASTICIZERS}},
Research-Areas = {{Public, Environmental \& Occupational Health; Nursing}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Nursing}},
Author-Email = {{vicpak1@yahoo.com}},
Cited-References = {{Betit P, 2009, RESP CARE, V54, P1244.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050.
   Centers for Disease Control and Prevention - CDC, 2005, 3 CDCP.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Foster PMD, 2000, FOOD CHEM TOXICOL, V38, pS97, DOI 10.1016/S0278-6915(99)00128-3.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Kwapniewski R, 2008, J OCCUP ENVIRON MED, V50, P705, DOI 10.1097/JOM.0b013e3181651571.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   National Research Council, 1999, HORM ACT AG ENV.
   Pak Victoria M, 2007, AAOHN J, V55, P12.
   Pak VM, 2007, MCN-AM J MATERN-CHIL, V32, P244, DOI 10.1097/01.NMC.0000281965.45905.c0.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   Rais-Bahrami K, 2004, ENVIRON HEALTH PERSP, V112, P1339, DOI 10.1289/ehp.6901.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}ENV WORK GROUP, 2006, IND SPIN FACT.
   {*}ENV WORK GROUP, 2000, RES WARN CONS HAZ IN.
   {*}US EPA, DIB PHTHAL.
   {*}US EPA, 2002, PVC DEV CONT PLAST D.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{5}},
Journal-ISO = {{AAOHN J.}},
Doc-Delivery-Number = {{764NM}},
Wos-Id = {{ISI:000290637300005}},
}

@article{ ISI:000290085000008,
Author = {Fromme, H. and Gruber, L. and Seckin, E. and Raab, U. and Zimmermann, S.
   and Kiranoglu, M. and Schlummer, M. and Schwegler, U. and Smolic, S. and
   Voelkel, W. and HBMnet},
Title = {{Phthalates and their metabolites in breast milk - Results from the
   Bavarian Monitoring of Breast Milk (BAMBI)}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2011}},
Volume = {{37}},
Number = {{4}},
Pages = {{715-722}},
Month = {{MAY}},
Abstract = {{Phthalates have long been used as plasticizers to soften plastic
   products and, thus, are ubiquitous in modern life. As part of the
   Bavarian Monitoring of Breast Milk (BAMBI), we aimed to characterize the
   exposure of infants to phthalates in Germany. Overall, 15 phthalates,
   including di-2-ethylhexyl phthalate (DEHP), di-n-butyl phthalate (DnBP),
   di-isobutyl phthalate (DiBP), di-isononyl phthalate (DiNP), three
   primary metabolites of DEHP {[}mono(2-ethylhexyl) phthalate (MEHP),
   mono-isobutyl phthalate (MiBP), and mono-n-butyl phthalate (MnBP)], and
   two secondary metabolites of DEHP were analyzed in 78 breast milk
   samples.
   We found median concentrations of 3.9 ng/g for DEHP, 0.8 ng/g for DnBP,
   and 1.2 ng/g for DiBP, while other parent phthalates were found in only
   some or none of the samples at levels above the limit of quantitation.
   In infant formula (n = 4) we observed mean values of 19.7 ng/g (DEHP),
   3.8 ng/g (DnBP), and 3.6 ng/g (DiBP). For MEHP, MiBP, and MnBP, the
   median values in breast milk were 2.3 mu g/l, 11.8 mu g/l, and 2.1 mu
   g/l, respectively. The secondary metabolites were not detected in any
   samples.
   Using median and 95th percentile values, we estimated an ``average{''}
   and ``high{''} daily intake for an exclusively breast-fed infant of 0.6
   mu g/kg body weight (b.w.) and 2.1 mu g/kg b.w., respectively, for DEHP,
   0.1 mu g/kg b.w. and 0.5 mu g/kg b.w. for DnBP, and 0.2 mu g/kg b.w. and
   0.7 mu g/kg b.w. for DiBP. For DiNP, intake values were 3.2 mu g/kg b.
   w. and 6.4 mu g/kg b.w., respectively, if all values in milk were set
   half of the detection limit or the detection limit. The above-mentioned
   ``average{''} and ``high{''} intake values corresponded to only about
   2\% to 7\%, respectively, of the recommended tolerable daily intake.
   Thus, it is not likely that an infant's exposure to phthalates from
   breast milk poses any significant health risk. Nevertheless, other
   sources of phthalates in this vulnerable phase have to be considered.
   Moreover, it should be noted that for infants nourished with formula,
   phthalate intake is of the same magnitude or slightly higher (DEHP) than
   for exclusively breast-fed infants. (C) 2011 Published by Elsevier Ltd.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fromme, H (Reprint Author), Dept Chem Safety \& Toxicol, Bavarian Hlth \& Food Safety Author, D-80538 Munich, Germany.
   Fromme, H.; Seckin, E.; Raab, U.; Kiranoglu, M.; Schwegler, U.; Voelkel, W., Dept Chem Safety \& Toxicol, Bavarian Hlth \& Food Safety Author, D-80538 Munich, Germany.
   Gruber, L.; Zimmermann, S.; Schlummer, M.; Smolic, S., Fraunhofer Inst Proc Engn \& Packaging, Dept Prod Safety \& Anal, D-85354 Freising Weihenstephan, Germany.}},
DOI = {{10.1016/j.envint.2011.02.008}},
ISSN = {{0160-4120}},
Keywords = {{Phthalates; DEHP; DBP; DINP; MEHP; Breast milk}},
Keywords-Plus = {{N-BUTYL PHTHALATE; PRENATAL EXPOSURE; BIRTH OUTCOMES; DIET SAMPLES;
   MOTHERS MILK; HUMAN URINE; BABY FOOD; POPULATION; GERMANY; HEALTH}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{hermann.fromme@lgl.bayern.de}},
ResearcherID-Numbers = {{Gruber, Ludwig/G-1310-2010
   Schlummer, Martin/B-1101-2013}},
ORCID-Numbers = {{Gruber, Ludwig/0000-0001-9198-4786
   }},
Funding-Acknowledgement = {{Bavarian State Ministry of Environment and Public Health; Bayerische
   Forschungsstiftung}},
Funding-Text = {{We thank all participants of the BAMBI study for their generous support.
   Additional thanks go to the Bavarian Midwife Society. This project was
   funded in part by a grant from the Bavarian State Ministry of
   Environment and Public Health and in part by a grant of the ``Bayerische
   Forschungsstiftung{''}.}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ATSDR, 2002, TOX PROF DI 2 ETH PH.
   Australian Government Department of Health and Ageing (NICNAS), 2008, EX CHEM HAZ ASS REP.
   Benson R, 2009, REGUL TOXICOL PHARM, V53, P90, DOI 10.1016/j.yrtph.2008.11.005.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Bruns-Weller Elke, 2000, Umweltwissenschaften und Schadstoff-Forschung, V12, P125.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Chen JA, 2008, ENVIRON POLLUT, V156, P849, DOI 10.1016/j.envpol.2008.05.019.
   Christiansen S, 2010, REPROD TOXICOL, V30, P313, DOI 10.1016/j.reprotox.2010.04.005.
   ECB (European Chemicals Bureau), 2008, EUR UN RISK ASS REP.
   EFSA, 2005, STAT SCI PAN FOOD AD.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P345, DOI 10.1016/j.ijheh.2007.01.026.
   Fromme H, 2011, Gesundheitswesen, V73, pe27, DOI 10.1055/s-0030-1268452.
   Gruber L, 1998, DEUT LEBENSM-RUNDSCH, V94, P177.
   Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Kamrin MA, 2009, J TOXICOL ENV HEAL B, V12, P157, DOI 10.1080/10937400902729226.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Kohlhuber M, 2008, BRIT J NUTR, V99, P1127, DOI 10.1017/S0007114508864835.
   Kwack SJ, 2009, J TOXICOL ENV HEAL A, V72, P1446, DOI 10.1080/15287390903212923.
   LaKind JS, 2009, ENVIRON INT, V35, P994, DOI 10.1016/j.envint.2009.03.013.
   Latini G, 2009, ENVIRON INT, V35, P236, DOI 10.1016/j.envint.2008.06.002.
   Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   NCEH, 2005, 3 NCEH.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   Pfordt J, 2004, DEUT LEBENSM-RUNDSCH, V100, P431.
   Raab U, 2008, CHEMOSPHERE, V72, P87, DOI 10.1016/j.chemosphere.2008.01.053.
   Rider CV, 2009, TOXICOL PATHOL, V37, P100, DOI 10.1177/0192623308329478.
   Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x.
   Seckin E, 2009, TOXICOL LETT, V188, P33, DOI 10.1016/j.toxlet.2009.03.002.
   Sievers E, 2003, BIOL NEONATE, V83, P246, DOI 10.1159/000069485.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Suzuki Y, 2010, ENVIRON INT, V36, P699, DOI 10.1016/j.envint.2010.05.003.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   TAKATORI S, 2008, INT J PHARMACEUT, V20, P139.
   Whyatt RM, 2009, PEDIATRICS, V124, pE1213, DOI 10.1542/peds.2009-0325.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Yano K, 2005, B ENVIRON CONTAM TOX, V74, P373, DOI 10.1007/s00128-004-0594-7.
   Zhu JP, 2006, ENVIRON SCI TECHNOL, V40, P5276, DOI 10.1021/es060356w.
   ZIMMERMANN G, J CHROMATOGR B UNPUB.
   {*}CERHR, 2000, DI N BUT PHTHAL DBP.
   {*}CERHR, 2006, DI 2 ETH PHTH DEHP E.
   {*}ECB, 2003, DIB PHTH, V29.
   {*}ECB, 2003, EUR UN RISK ASS REP, V30.
   {*}MAFF, 1996, 83 MIN AGR FISH FOOD.}},
Number-of-Cited-References = {{53}},
Times-Cited = {{10}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{757KX}},
Wos-Id = {{ISI:000290085000008}},
}

@article{ ISI:000289997900018,
Author = {Kambia, Nicolas and Dine, Thierry and Gressier, Bernard and Frimat,
   Bruno and Cazin, Jean-Louis and Luyckx, Michel and Brunet, Claude and
   Michaud, Laurent and Gottrand, Frederic},
Title = {{Correlation Between Exposure to Phthalates and Concentrations of
   Malondialdehyde in Infants and Children Undergoing Cyclic Parenteral
   Nutrition}},
Journal = {{JOURNAL OF PARENTERAL AND ENTERAL NUTRITION}},
Year = {{2011}},
Volume = {{35}},
Number = {{3}},
Pages = {{395-401}},
Month = {{MAY}},
Abstract = {{Background: Plasticizers such as di(2-ethylhexyl) phthalate (DEHP) are
   added to polyvinyl chloride (PVC) to confer flexibility. However, DEHP
   is associated with reproductive disorders in humans. Because of its
   noncovalent bond to the PVC matrix, this plasticizer tends to leach
   easily. Infants and children undergoing cyclic, long-term parenteral
   nutrition (PN) could be particularly at risk of potential toxicity from
   DEHP due to regular exposure. Malondialdehyde (MDA) is one of the most
   commonly used markers of free radical activity. The purpose of this
   study was to investigate how long-term exposure to phthalate affects the
   plasmatic rate of MDA. Methods: Studies were performed on 7 randomized
   infants and children on regular cyclic, long-term PN, and the results
   were compared with those of 5 nontreated infants. The circulating
   concentrations of DEHP in children and infants during the PN therapy
   were measured by high-performance liquid chromatography. The
   concentrations were assessed before and after the PN session. In the
   same way, plasma MDA concentrations were measured. Results: The
   circulating concentrations of DEHP before and after a 10-to 11-hour
   cyclic PN treatment in 7 infants and children under regular perfusion
   ranged widely, showing a significant increase after the treatment among
   all the patients. The same phenomenon observed with the rate of MDA
   showed that the 2 events are closely dependent. Therefore, long-term
   exposure to DEHP during cyclic PN raised plasma MDA levels, indicating
   increased oxidative stress. Conclusion: Long-term exposure to DEHP
   during PN increased free radical activity in vivo. (JPEN J Parenter
   Enteral Nutr. 2011; 35: 395-401)}},
Publisher = {{SAGE PUBLICATIONS INC}},
Address = {{2455 TELLER RD, THOUSAND OAKS, CA 91320 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kambia, N (Reprint Author), Univ Lille 2, Lab Pharmacol Pharmacokinet \& Clin Pharm, 3 Rue Prof Laguesse, F-59006 Lille, France.
   Kambia, Nicolas; Dine, Thierry; Gressier, Bernard; Frimat, Bruno; Cazin, Jean-Louis; Luyckx, Michel; Brunet, Claude, Univ Lille 2, Lab Pharmacol Pharmacokinet \& Clin Pharm, F-59006 Lille, France.
   Michaud, Laurent; Gottrand, Frederic, Jeanne de Flandre Hosp, Dept Pediat, Div Gastroenterol Hepatol \& Nutr, Lille, France.}},
DOI = {{10.1177/0148607110381769}},
ISSN = {{0148-6071}},
Keywords = {{di(2-ethylhexyl) phthalate; malondialdehyde; long-term parenteral
   nutrition; infants and children; high-performance liquid chromatography}},
Keywords-Plus = {{PERFORMANCE LIQUID-CHROMATOGRAPHY; SPRAGUE-DAWLEY RATS; DI(2-ETHYLHEXYL)
   PHTHALATE; DI-2-ETHYLHEXYL PHTHALATE; LIPID-PEROXIDATION;
   POLYVINYL-CHLORIDE; OXIDATIVE STRESS; PLASTICIZERS; PLASMA; TOXICITY}},
Research-Areas = {{Nutrition \& Dietetics}},
Web-of-Science-Categories  = {{Nutrition \& Dietetics}},
Author-Email = {{nicolas.kambia@univ-lille2.fr}},
Cited-References = {{Akigbemi BT, 2001, BIOL REPROD, V65, P1252.
   ALLWOOD MC, 1986, INT J PHARM, V29, P233, DOI 10.1016/0378-5173(86)90120-1.
   BARRY YA, 1989, J THORAC CARDIOV SUR, V97, P900.
   Bassiouny MR, 2009, J PEDIATR GASTR NUTR, V48, P363.
   Basu R, 1999, J PEDIATR SURG, V34, P1091, DOI 10.1016/S0022-3468(99)90573-0.
   Bhattacharya N, 2005, BIOL REPROD, V72, P745, DOI 10.1095/biolreprod.104.031583.
   Chen ZY, 2007, BURNS, V33, P708, DOI 10.1016/j.burns.2006.10.380.
   CHRISTENSSON A, 1991, INT J ARTIF ORGANS, V14, P407.
   Cordis GA, 1998, J CHROMATOGR A, V798, P117, DOI 10.1016/S0021-9673(97)01161-8.
   DINE T, 1991, BIOMED CHROMATOGR, V5, P94, DOI 10.1002/bmc.1130050211.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   Fenaille F, 2001, J CHROMATOGR A, V921, P237, DOI 10.1016/S0021-9673(01)00883-4.
   Gourlay T, 2003, ARTIF ORGANS, V27, P256, DOI 10.1046/j.1525-1594.2003.07107.x.
   Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030.
   Hasanoglu A, 2005, PROSTAG LEUKOTR ESS, V73, P99, DOI 10.1016/j.plefa.2005.04.015.
   Kambia K, 2001, J CHROMATOGR B, V755, P297, DOI 10.1016/S0378-4347(01)00125-6.
   Kambia K, 2001, INT J PHARM, V229, P139, DOI 10.1016/S0378-5173(01)00840-7.
   Kambia K, 2003, INT J PHARM, V262, P83, DOI 10.1016/S0378-5173(03)00335-1.
   Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254.
   LAKE BG, 1995, ANNU REV PHARMACOL, V35, P483, DOI 10.1146/annurev.pharmtox.35.1.483.
   Latini G, 2004, REPROD TOXICOL, V19, P27, DOI 10.1016/j.reprotox.2004.05.011.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   Mateos R, 2005, J CHROMATOGR B, V27, P76.
   MAZUR HI, 1989, JPEN-PARENTER ENTER, V13, P59, DOI 10.1177/014860718901300159.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   Rusyn I, 2001, MOL PHARMACOL, V59, P744.
   Ryu JY, 2007, J TOXICOL ENV HEAL A, V70, P1296, DOI 10.1080/15287390701432160.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Tanaka T, 2002, FOOD CHEM TOXICOL, V40, P1499, DOI 10.1016/S0278-6915(02)00073-X.
   Templar J, 1999, NEPHROL DIAL TRANSPL, V14, P946, DOI 10.1093/ndt/14.4.946.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{1}},
Journal-ISO = {{J. Parenter. Enter. Nutr.}},
Doc-Delivery-Number = {{756FU}},
Wos-Id = {{ISI:000289997900018}},
}

@article{ ISI:000289341300084,
Author = {Guo, Ying and Kannan, Kurunthachalam},
Title = {{Comparative Assessment of Human Exposure to Phthalate Esters from House
   Dust in China and the United States}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2011}},
Volume = {{45}},
Number = {{8}},
Pages = {{3788-3794}},
Month = {{APR 15}},
Abstract = {{Because of volatilization and leaching from their application in
   consumer and personal care products, phthalate esters are ubiquitous
   contaminants in the indoor environment. In this study, we measured
   concentrations and profiles of 9 phthalate esters in indoor dust samples
   collected from six cities in China (n = 75). For comparison, we also
   analyzed samples collected from Albany, New York, USA (n = 33). The
   results indicated that concentrations, except for dicyclohexyl phthalate
   (DCHP) and bis(2-ethylhexyl) phthalate (DEHP), and profiles of phthalate
   esters varied significantly between the two countries. Concentrations of
   diethyl phthalate (DEP), di-n-hexyl phthalate (DNHP), and benzyl butyl
   phthalate (BzBP) were 5 to 10 times higher in dust samples collected
   from Albany than those from the Chinese cities. In contrast,
   concentrations of di-iso-butyl phthalate (DIBP) in dust samples from
   Albany were 5 times lower than those from the Chinese cities. We
   estimated the daily intake (DI) of phthalate esters through the routes
   of dust ingestion and dermal dust absorption. The extent of contribution
   of indoor dust to human exposures varied, depending on the type of
   phthalate esters. The contribution of dust to DEHP exposure was 2-5\%
   and 10-58\% of the estimated total DIs in China and the USA,
   respectively. On the basis of the estimates of total DIs of phthalates,
   extrapolated from urinary metabolite concentrations, the contributions
   of inhalation, dermal absorption, and dietary intake to total DIs were
   estimated. The results indicated that dietary intake is the main source
   of exposure to DEHP (especially in China), whereas dermal exposure was a
   major source for DEP. This is the first study to elucidate sources of
   human exposure to phthalates among the general population in China.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kannan, K (Reprint Author), New York State Dept Hlth, Wadsworth Ctr, Empire State Plaza,POB 509, Albany, NY 12201 USA.
   Guo, Ying; Kannan, Kurunthachalam, New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA.
   Guo, Ying; Kannan, Kurunthachalam, SUNY Albany, Sch Publ Hlth, Dept Environm Hlth Sci, Albany, NY 12201 USA.
   Kannan, Kurunthachalam, Harbin Inst Technol, State Key Lab Urban Water Resource \& Environm, IJRC PTS, Harbin 150090, Peoples R China.}},
DOI = {{10.1021/es2002106}},
ISSN = {{0013-936X}},
Keywords-Plus = {{N-BUTYL PHTHALATE; ENDOCRINE-DISRUPTING CHEMICALS; DI(2-ETHYLHEXYL)
   PHTHALATE; CONSUMER PRODUCTS; MUSK FRAGRANCES; RISK-ASSESSMENT; URINARY
   LEVELS; SETTLED DUST; INDOOR DUST; DEHP}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{kkannan@wadsworth.org}},
ResearcherID-Numbers = {{GUO, YING/B-2819-2011}},
Funding-Acknowledgement = {{Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
   {[}1U38EH000464-01]}},
Funding-Text = {{This research is supported by a biomonitoring grant (1U38EH000464-01)
   from the Centers for Disease Control and Prevention (CDC), Atlanta, GA,
   USA. Its contents are solely the responsibility of the authors and do
   not necessarily represent the official views of the Centers for Disease
   Control and Prevention. We thank Dr. Jing Ma, Shanghai University, Dr.
   Bao-Zhong Zhang, Guangzhou Institute of Geochemistry, Chinese Academy of
   Sciences, and Mr. Qian Wu, Wadsworth Center, for sample collection.}},
Cited-References = {{Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Boberg J, 2008, TOXICOLOGY, V250, P75, DOI 10.1016/j.tox.2008.05.020.
   Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809.
   Butte W, 2001, GEFAHRST REINHALT L, V61, P19.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Chen JA, 2008, ENVIRON POLLUT, V156, P849, DOI 10.1016/j.envpol.2008.05.019.
   Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376.
   Clausen PA, 2003, J CHROMATOGR A, V986, P179, DOI 10.1016/S0021-9673(02)02007-1.
   Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Foster PMD, 2000, FOOD CHEM TOXICOL, V38, pS97, DOI 10.1016/S0278-6915(99)00128-3.
   Franco A, 2007, ENVIRON INT, V33, P283, DOI 10.1016/j.envint.2006.10.001.
   Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1046/j.1600-0668.2003.00223.x.
   Fujii M, 2003, ATMOS ENVIRON, V37, P5495, DOI 10.1016/j.atmosenv.2003.09.026.
   Gray LE, 2006, TOXICOL SCI, V93, P189, DOI 10.1093/toxsci/kfl035.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GUO Y, ENV INT IN PRESS.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Houlihan J., 2010, NOT TOO PRETTY PHTHA.
   Hwang HM, 2008, SCI TOTAL ENVIRON, V404, P26, DOI 10.1016/j.scitotenv.2008.05.031.
   Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y.
   Ji K, 2010, ENVIRON RES, V110, P375, DOI 10.1016/j.envres.2010.02.008.
   Johnson-Restrepo B, 2009, CHEMOSPHERE, V76, P542, DOI 10.1016/j.chemosphere.2009.02.068.
   Kolarik B, 2008, ATMOS ENVIRON, V42, P8553, DOI 10.1016/j.atmosenv.2008.08.028.
   Langer S, 2010, ATMOS ENVIRON, V44, P2294, DOI 10.1016/j.atmosenv.2010.04.001.
   Li XH, 2006, B ENVIRON CONTAM TOX, V77, P252, DOI 10.1007/s00128-006-1057-0.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Rudel RA, 2010, ENVIRON SCI TECHNOL, V44, P6583, DOI 10.1021/es100159c.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Wang GH, 2006, ENVIRON SCI TECHNOL, V40, P4619, DOI 10.1021/es060291x.
   Weschler CJ, 2008, ATMOS ENVIRON, V42, P1449, DOI 10.1016/j.atmosenv.2007.11.014.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Wormuth M, 2005, J IND ECOL, V9, P237, DOI 10.1162/1088198054084626.
   Xu G, 2008, SCI TOTAL ENVIRON, V393, P333, DOI 10.1016/j.scitotenv.2008.01.001.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.
   Zeng F, 2009, J HAZARD MATER, V164, P1171, DOI 10.1016/j.jhazmat.2008.09.029.
   Zhang X., 2004, POLYM ADDITIVES, V211, P6.
   {*}US CONS PROD SAF, REV EXP DAT ASS SEL.
   {*}US EPA, UR PHTH LEV.
   {*}USEPA, EXP FACT HDB.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{17}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{747SZ}},
Wos-Id = {{ISI:000289341300084}},
}

@article{ ISI:000288841500093,
Author = {Guo, Ying and Alomirah, Husam and Cho, Hyeon-Seo and Tu Binh Minh and
   Mohd, Mustafa Ali and Nakata, Haruhiko and Kannan, Kurunthachalam},
Title = {{Occurrence of Phthalate Metabolites in Human Urine from Several Asian
   Countries}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2011}},
Volume = {{45}},
Number = {{7}},
Pages = {{3138-3144}},
Month = {{APR 1}},
Abstract = {{The occurrence of 14 phthalate metabolites was found in human urine
   samples collected from seven Asian countries: China, India, Japan,
   Korea, Kuwait, Malaysia, and Vietnam. Phthalate metabolites were found
   in all samples, indicating widespread exposure of humans to phthalates
   in these Asian countries. The highest total (the sum of 14 phthalates)
   phthalate metabolite concentrations were found mL), China (234 ng/mL),
   Vietnam (133 ng/mL), Japan (120 in samples collected from Kuwait
   (median: 1050 ng/mL), followed in decreasing order by samples from India
   (389 ng/mL), China (234 ng/mL), Vietnam (133 ng/mL), Japan (120 ng/mL),
   Korea (117 ng/mL), and Malaysia (94.9 ng/mL). The creatinine,
   respectively. Monomethyl phthalate (mMP), Korea, and Malaysia were 692,
   506, 289, 119, 103, 104, and 169 creatinine-adjusted median
   concentrations of total phthalates ng/mL), Korea (117 ng/mL), and
   Malaysia (94.9 ng/mL). The for urine samples from Kuwait, India, China,
   Vietnam, Japan, monoethyl phthalate (mEP), mono (2-isobutyl phthalate)
   (miBP), mono-n-butyl phthalate (mEP), and metabolites of
   di-(2-ethylhexyl) phthalate (DEHP) were the dominant compounds,
   collectively accounting for > 95\% of the total concentrations in the
   samples from the seven countries. The profiles of urinary phthalate
   metabolite concentrations varied among the samples collected from the
   seven countries. Urine samples from Kuwait contained the highest
   concentrations of mEP (median: 391 ng/mL), mBP (94.1 ng/mL), and the
   metabolites of DEHP (202 ng/mL), whereas samples from China and Japan
   contained the highest concentrations of miBP (50.8 ng/mL) and niMP (17.5
   ng/mL), respectively. mEP was the predominant metabolite in urine
   samples from India and Kuwait (accounting for 49\% of the total), mBP
   and miBP were the predominant compounds in samples from China (52\%),
   and DEHP metabolites were the predominant compounds in samples from
   Korea (46\%) and Vietnam (52\%). Based on the urinary concentrations of
   mEP, mBP, miBP, and DEHP metabolites of the samples from the seven Asian
   countries, we estimated daily intake rates of diethyl phthalate (DEP),
   dibutyl phthalate (DBP), and DEHP. The results indicated that people in
   the seven Asian countries are exposed to DEP, DBP, and DEHP at levels
   well below the reference doses (RfD) suggested as unsafe by the U.S.
   Environmental Protection Agency (EPA). The estimated exposure doses to
   DEHP in Kuwait, however, were above the RID recommended by the EPA.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kannan, K (Reprint Author), SUNY Albany, Sch Publ Hlth, Wadsworth Ctr, New York State Dept Hlth,Dept Environm Hlth Sci, Empire State Plaza,POB 509, Albany, NY 12201 USA.
   Guo, Ying; Kannan, Kurunthachalam, SUNY Albany, Sch Publ Hlth, Wadsworth Ctr, New York State Dept Hlth,Dept Environm Hlth Sci, Albany, NY 12201 USA.
   Alomirah, Husam, Kuwait Inst Sci Res, Dept Biotechnol, Safat 13109, Kuwait.
   Cho, Hyeon-Seo, Chonnam Natl Univ, Coll Fishery \& Ocean Sci, Yeosu 550749, South Korea.
   Tu Binh Minh, Vietnam Environm Adm, Hanoi, Vietnam.
   Mohd, Mustafa Ali, Univ Malaya, Fac Med, Kuala Lumpur, Malaysia.
   Nakata, Haruhiko, Kumamoto Univ, Grad Sch Sci \& Technol, Kumamoto 8608555, Japan.
   Kannan, Kurunthachalam, Harbin Inst Technol, Int Joint Res Ctr Persistent Toxic Subst, State Key Lab Urban Water Resource \& Environm, Harbin 150090, Peoples R China.}},
DOI = {{10.1021/es103879m}},
ISSN = {{0013-936X}},
Keywords-Plus = {{DEUTERIUM-LABELED DEHP; DI(2-ETHYLHEXYL) PHTHALATE; RISK-ASSESSMENT;
   PREGNANT-WOMEN; HUMAN EXPOSURE; HUMAN SPERM; DNA-DAMAGE; SERUM;
   POPULATION; BIOMARKERS}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{kkannan@wadsworth.org}},
ResearcherID-Numbers = {{GUO, YING/B-2819-2011
   ALI MOHD, Mustafa/B-9184-2010}},
ORCID-Numbers = {{ALI MOHD, Mustafa/0000-0002-4220-5384}},
Funding-Acknowledgement = {{Centers for Disease Control and Prevention (CDC), Atlanta, GA
   {[}1U38EH000464-01]}},
Funding-Text = {{We thank all the donors for kindly providing the samples. We thank Madam
   Suad Al-Hooti (Biotechnology Department, KISR) for providing the Kuwaiti
   urine samples, Dr. Nguyen Hung Minh (VEA) and Dr. Vu Due Loi (VAST) for
   collection of samples in Hanoi, and Mr. Perianna Gounder Kurunthachalam
   for collection of samples from India. This research (analytical method
   development) was supported by a biomonitoring grant (1U38EH000464-01)
   from the Centers for Disease Control and Prevention (CDC), Atlanta, GA.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Boberg J, 2008, TOXICOLOGY, V250, P75, DOI 10.1016/j.tox.2008.05.020.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376.
   Colacino JA, 2010, ENVIRON HEALTH PERSP, V118, P998, DOI 10.1289/ehp.0901712.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Foster PMD, 2000, FOOD CHEM TOXICOL, V38, pS97, DOI 10.1016/S0278-6915(99)00128-3.
   Gray LE, 2006, TOXICOL SCI, V93, P189, DOI 10.1093/toxsci/kfl035.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y.
   Itoh H, 2009, SCI TOTAL ENVIRON, V408, P37, DOI 10.1016/j.scitotenv.2009.09.012.
   Ji K, 2010, ENVIRON RES, V110, P375, DOI 10.1016/j.envres.2010.02.008.
   Johnson-Restrepo B, 2009, CHEMOSPHERE, V76, P542, DOI 10.1016/j.chemosphere.2009.02.068.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Perucca J, 2007, AM J PHYSIOL-REG I, V292, pR700, DOI 10.1152/ajpregu.00500.2006.
   Remer T, 2002, AM J CLIN NUTR, V75, P561.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Weuve J, 2010, ENVIRON HEALTH PERSP, V118, P825, DOI 10.1289/ehp.0901543.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.
   {*}US EPA, UR PHTHAL LEV.
   {*}US EPA, PHTHAL ACT PLAN.
   {*}USEPA, EXP FACT HDB.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{13}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{741CU}},
Wos-Id = {{ISI:000288841500093}},
}

@article{ ISI:000288054700005,
Author = {Hines, Cynthia J. and Hopf, Nancy B. N. and Deddens, James A. and Silva,
   Manori J. and Calafat, Antonia M.},
Title = {{Estimated daily intake of phthalates in occupationally exposed groups}},
Journal = {{JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY}},
Year = {{2011}},
Volume = {{21}},
Number = {{2}},
Pages = {{133-141}},
Month = {{MAR-APR}},
Abstract = {{Improved analytical methods for measuring urinary phthalate metabolites
   have resulted in biomarker-based estimates of phthalate daily intake for
   the general population, but not for occupationally exposed groups. In
   2003-2005, we recruited 156 workers from eight industries where
   materials containing diethyl phthalate (DEP), dibutyl phthalate (DBP),
   and/or di(2-ethylhexyl) phthalate (DEHP) were used as part of the
   worker's regular job duties. Phthalate metabolite concentrations
   measured in the workers' end-shift urine samples were used in a simple
   pharmacokinetic model to estimate phthalate daily intake. DEHP intake
   estimates based on three DEHP metabolites combined were 0.6-850 mu
   g/kg/day, with the two highest geometric mean (GM) intakes in polyvinyl
   chloride (PVC) film manufacturing (17 mu g/kg/day) and PVC compounding
   (12 mu g/kg/day). All industries, except phthalate manufacturing, had
   some workers whose DEHP exposure exceeded the U.S. reference dose (RfD)
   of 20 mu g/kg/day. A few workers also exceeded the DEHP European
   tolerable daily intake (TDI) of 50 mu g/kg/day. DEP intake estimates
   were 0.5-170 mu g/kg/day, with the highest GM in phthalate manufacturing
   (27 mu g/kg/day). DBP intake estimates were 0.1-76 mu g/kg/day, with the
   highest GMs in rubber gasket and in phthalate manufacturing (17 mu
   g/kg/day, each). No DEP or DBP intake estimates exceeded their
   respective RfDs. The DBP TDI (10 mu g/kg/day) was exceeded in three
   rubber industries and in phthalate manufacturing. These intake estimates
   are subject to several uncertainties; however, an occupational
   contribution to phthalate daily intake is clearly indicated in some
   industries. Journal of Exposure Science and Environmental Epidemiology
   (2011) 21, 133-141; doi:10.1038/jes.2009.62; published online 16
   December 2009}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hines, CJ (Reprint Author), NIOSH, Ctr Dis Control \& Prevent, 4676 Columbia Pkwy,R-14, Cincinnati, OH 45230 USA.
   Hines, Cynthia J.; Hopf, Nancy B. N.; Deddens, James A., NIOSH, Ctr Dis Control \& Prevent, Cincinnati, OH 45230 USA.
   Deddens, James A., Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA.
   Silva, Manori J.; Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.}},
DOI = {{10.1038/jes.2009.62}},
ISSN = {{1559-0631}},
Keywords = {{phthalates; biomonitoring; personal exposure}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; DEUTERIUM-LABELED DEHP; HUMAN URINE;
   DI(2-ETHYLHEXYL)PHTHALATE DEHP; METABOLITE LEVELS; TEMPORAL VARIABILITY;
   BIOMARKER APPROACH; DIETHYL PHTHALATE; INTERNAL EXPOSURE;
   RISK-ASSESSMENT}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{cjh8@cdc.gov}},
ResearcherID-Numbers = {{Wu, Qian/A-3289-2011}},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   EFSA, 2005, EFSA J, V243, P1.
   EFSA, 2005, EFSA J, V242, P1.
   EFSA, 2005, EFSA J, V241, P1.
   Franco A, 2007, ENVIRON INT, V33, P283, DOI 10.1016/j.envint.2006.10.001.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   HARPER HA, 1977, REV PHYSL CHEM, P625.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hines CJ, 2009, ANN OCCUP HYG, V53, P1, DOI 10.1093/annhyg/men066.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y.
   Itoh H, 2005, INT J HYG ENVIR HEAL, V208, P237, DOI 10.1016/j.ijheh.2005.02.004.
   Jaakkola JJK, 2008, ENVIRON HEALTH PERSP, V116, P845, DOI 10.1289/ehp.10846.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kawasaki T, 1991, Nihon Koshu Eisei Zasshi, V38, P567.
   Koch HM, 2005, INT J HYG ENVIR HEAL, V208, P489, DOI 10.1016/j.ijheh.2005.07.001.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   Koo HJ, 2005, J TOXICOL ENV HEAL A, V68, P1379, DOI 10.1080/15287390590956506.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   STANLEY MK, 2003, PHTHALATE ESTERS, P1.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   US EPA, 2007, INT RISK INF SYST DI.
   VAINIOTALO S, 1990, ANN OCCUP HYG, V34, P585, DOI 10.1093/annhyg/34.6.585.
   WALLACH J, 2000, INTERPRETATION DIAGN, P87.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   WYPYCH G, 2004, HDB PLASTICIZERS, P1.
   {*}NIOSH, 1979, HETA7891621 NIOSH US.}},
Number-of-Cited-References = {{56}},
Times-Cited = {{6}},
Journal-ISO = {{J. Expo. Sci. Environ. Epidemiol.}},
Doc-Delivery-Number = {{730SN}},
Wos-Id = {{ISI:000288054700005}},
}

@article{ ISI:000288639700004,
Author = {Li ShuGuang and Dai JiCan and Zhang LiQian and Zhang Jing and Zhang
   ZiQiang and Chen Bo},
Title = {{An Association of Elevated Serum Prolactin with Phthalate Exposure in
   Adult Men}},
Journal = {{BIOMEDICAL AND ENVIRONMENTAL SCIENCES}},
Year = {{2011}},
Volume = {{24}},
Number = {{1}},
Pages = {{31-39}},
Month = {{FEB}},
Abstract = {{Objective To investigate the associations of hormone circulation with
   phthalate exposure in adult men.
   Methods Semen and serum samples were collected from 118 men who were
   suspected of infertility. Phthalate diesters including dibutyl phthalate
   (DBP) and diethylhexyl phthalate (DEHP) in both semen and serum samples
   were measured, along with serum levels of follicle stimulating hormone
   (FSH), luteinizing hormone (LH), testosterone (T), estradiol (E(2)) and
   prolactin (PRL).
   Results Serum PRL was positively associated with serum DBP and DEHP and
   semen DEHP in all models of Spearman correlation, linear regression and
   binary logistic regression. In linear regression models adjusted for
   potential confounders and excluding subjects with undetectable
   phthalates, a 10-fold increase in semen DEHP was associated with a 23\%
   increase in serum PRL, as well as a 26\% increase in serum DBP and a
   20\% increase in serum DEHP. In logistic regression models all subjects
   demonstrated a dose-response relationship between above reference value
   PRL and semen DEHP (odds ratio per tertile adjusted for potential
   confounders = 1.0, 1.70, 3.50; Pfor trend = 0.01), and serum DBP (1.0,
   1.10, 2.62; Pfor trend = 0.04), and serum DEHP (1.0, 1.46, 4.69; P for
   trend < 0.01). A positive correlation between serum estradiol and semen
   DEHP (linear regression), and an inverse correlation between semen DBP
   and serum testosterone and T:E(2) ratio (Spearman correlation) were also
   established.
   Conclusions Serum PRL is suggested to be positively associated with both
   DBP and DEHP exposure in adult men.}},
Publisher = {{CHINESE CENTER DISEASE CONTROL \& PREVENTION}},
Address = {{155 CHANGBAI RD, CHANGPING DISTRICT, BEIJING, 102206, PEOPLES R CHINA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chen, B (Reprint Author), Fudan Univ, Sch Publ Hlth, Shanghai 200032, Peoples R China.
   Li ShuGuang; Zhang LiQian; Chen Bo, Fudan Univ, Sch Publ Hlth, Shanghai 200032, Peoples R China.
   Dai JiCan, Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Urol, Shanghai 200001, Peoples R China.
   Zhang Jing; Zhang ZiQiang, Tongji Univ, Sch Med, Shanghai 200092, Peoples R China.}},
DOI = {{10.3967/0895-3988.2011.01.004}},
ISSN = {{0895-3988}},
Keywords = {{Phthalate diesters; Prolactin; Testosterone; Estradiol; Male
   reproduction}},
Keywords-Plus = {{EXPERT PANEL REPORT; SEMEN QUALITY; DI(2-ETHYLHEXYL) PHTHALATE;
   DEVELOPMENTAL TOXICITY; URINARY CONCENTRATIONS; REPRODUCTIVE HORMONES;
   NTP CENTER; FETAL-RAT; IN-UTERO; METABOLITES}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{chenb@fudan.edu.cn}},
Funding-Acknowledgement = {{Shanghai Municipal Health Bureau {[}08GWQ003]; Shanghai Population and
   Family Planning Commission {[}2007JG05]}},
Funding-Text = {{This work was supported by a grant (08GWQ003) from the Shanghai
   Municipal Health Bureau, and by a grant (2007JG05) from the Shanghai
   Population and Family Planning Commission.}},
Cited-References = {{Alessio L, 2006, ENVIRON HEALTH PERSP, V114, pA573.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   CAI Z, 2006, PHYS TEST CHEM ANA B, V42, P115.
   CAI Z, 2006, PHYS TEST CHEM ANA B, V42, P119.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   CHAUVIGNE F, 2009, ENVIRON HEALTH PERSP, V117.
   Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   FENTON SE, 2006, ENDOCRINOLOGY, V147, pS18, DOI DOI 10.1210/EN.2005-1131.
   Hallmark N, 2007, ENVIRON HEALTH PERSP, V115, P390, DOI 10.1289/ehp.9490.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, ENVIRON HEALTH PERSP, V113, P425, DOI 10.1289/ehp.7305.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hess-Wilson JK, 2006, CANCER LETT, V241, P1, DOI 10.1016/j.canlet.2005.10.006.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Higuchi TT, 2003, TOXICOL SCI, V72, P301, DOI 10.1093/toxsci/kfg036.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kavlock R, 2002, REPROD TOXICOL, V16, P679, DOI 10.1016/S0890-6238(02)00034-5.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kruger THC, 2003, J ENDOCRINOL, V177, P57, DOI 10.1677/joe.0.1770057.
   Lafuente A, 2003, BIOMETALS, V16, P243, DOI 10.1023/A:1020658128413.
   LI Z, 2003, PLAST ADDIT, V1, P3.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Nussey S.S, 2001, ENDOCRINOLOGY INTEGR.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001.
   PARMAR D, 1986, TOXICOLOGY, V42, P47, DOI 10.1016/0300-483X(86)90091-0.
   Saillenfait AM, 2008, REPROD TOXICOL, V26, P107, DOI 10.1016/j.reprotox.2008.07.006.
   Takeuchi S, 2005, TOXICOLOGY, V210, P223, DOI 10.1016/j.tox.2005.02.002.
   Wirth JJ, 2008, SYST BIOL REPROD MEC, V54, P143, DOI 10.1080/19396360802055921.
   Zhang YH, 2006, BIOMED ENVIRON SCI, V19, P205.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{3}},
Journal-ISO = {{Biomed. Environ. Sci.}},
Doc-Delivery-Number = {{738KW}},
Wos-Id = {{ISI:000288639700004}},
}

@article{ ISI:000287563800002,
Author = {Lin, Susana and Ku, Hsiu-Ying and Su, Pen-Hua and Chen, Jein-Wen and
   Huang, Po-Chin and Angerer, Juergen and Wang, Shu-Li},
Title = {{Phthalate exposure in pregnant women and their children in central
   Taiwan}},
Journal = {{CHEMOSPHERE}},
Year = {{2011}},
Volume = {{82}},
Number = {{7}},
Pages = {{947-955}},
Month = {{FEB}},
Abstract = {{Phthalate exposure was found to be associated with endocrine disruption,
   respiratory effects, reproductive and developmental toxicity. The
   intensive use of plastics may be increasing the exposure to phthalates
   in Taiwanese population, particularly for young children.
   We studied phthalate metabolites in pregnant women and their newborns in
   a prospective cohort from a medical center in Central Taiwan. One
   hundred maternal urine samples and 30 paired cord blood and milk samples
   were randomly selected from all of participants (430 pregnant women).
   Eleven phthalate metabolites (MEHP, 5OH-MEHP, 2cx-MEHP, 5cx-MEPP,
   5oxo-MEHP, MiBP, MnBP, MBzP, OH-MiNP, oxo-MiNP, and cx-MiNP)
   representing the exposure to five commonly used phthalates (DEHP,
   di-isobutyl phthalate (DiBP), DnBP, BBP, DiNP) were measured in urine of
   pregnant women, cord serum and breast milk after delivery, and in urine
   of their children. Exposure was estimated with excretion factors and
   correlation among metabolites of the same parent compound. Thirty and 59
   urinary samples from 2 and 5 years-old children were randomly selected
   from 185 children successfully followed.
   Total urinary phthalate metabolite concentration (geometric mean, 14
   L(-1)) was found to be higher in 2years-olds (398.6) and 5-years-olds
   (333.7) than pregnant women (205.2). Metabolites in urine are mainly
   from DEHP. The proportion of DiNP metabolites was higher in children
   urine (4.39 and 8.31\%, ages 2 and 5) than in adults (0.83\%) (p <
   0.01). Compared to urinary levels, phthalate metabolite levels are low
   in cord blood (37.45) and milk (14.90). DEHP metabolite levels in
   women's urine and their corresponding cord blood are significantly
   correlated. Compared to other populations in the world, DEHP derived
   metabolites in maternal urine were higher, while phthalate metabolite
   levels in milk and cord blood were similar. The level of phthalate
   metabolites in milk and cord blood were comparable to those found in
   other populations. Further studies of health effects related to DEHP and
   DiNP exposure are necessary for the children. (C) 2010 Elsevier Ltd. All
   rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wang, SL (Reprint Author), Natl Hlth Res Inst, Div Environm Hlth \& Occupat Med, Miaoli, Taiwan.
   Lin, Susana; Chen, Jein-Wen; Huang, Po-Chin; Wang, Shu-Li, Natl Hlth Res Inst, Div Environm Hlth \& Occupat Med, Miaoli, Taiwan.
   Ku, Hsiu-Ying, Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.
   Su, Pen-Hua, Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan.
   Su, Pen-Hua, Chung Shan Med Univ, Sch Med, Taichung, Taiwan.
   Angerer, Juergen, Ruhr Univ Bochum, Inst Prevent \& Occupat Med German Social Accid In, Bochum, Germany.
   Wang, Shu-Li, China Med Univ Hosp, Coll Publ Hlth, Inst Environm Med, Taichung, Taiwan.}},
DOI = {{10.1016/j.chemosphere.2010.10.073}},
ISSN = {{0045-6535}},
Keywords = {{Phthalate; Environmental exposure; Taiwan; Cord blood; Urinary levels;
   Children}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; NURSERY-SCHOOL CHILDREN; HUMAN BREAST-MILK;
   IN-VITRO; MALE-RAT; MONO-(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL
   PHTHALATE; SEXUAL-DIFFERENTIATION; ANOGENITAL DISTANCE; ESTROGENIC
   ACTIVITY}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{susanalin@nhri.org.tw
   shiuo@nhri.org.tw
   jen@csh.org.tw
   jwchen@nhri.org.tw
   pchuang@nhri.org.tw
   juergen.angerer@ipasum.imed.uni-erlangen.de
   slwang@nhri.org.tw}},
ResearcherID-Numbers = {{Wang, Shu-Li/C-1367-2010
   Huang, Po-Chin/I-5844-2012}},
Funding-Acknowledgement = {{National Health Research Institutes, Taiwan {[}EO-97-PP-05, EO-98-PP-03]}},
Funding-Text = {{We greatly appreciate the excellent assistance of Ms. Hsiao-Yen Chen for
   the various specimen collections. This work was supported by National
   Health Research Institutes, Taiwan (EO-97-PP-05 and EO-98-PP-03).}},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138.
   BOLTE RG, 2002, SYNOPSIS PEDIAT EMER, P249.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004.
   Coldham NG, 1997, ENVIRON HEALTH PERSP, V105, P734, DOI 10.1289/ehp.97105734.
   Cooper BW, 2008, TOXICOL SCI, V103, P268, DOI 10.1093/toxsci/kfn047.
   Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017.
   Duty SM, 2004, J ANDROL, V25, P293.
   EFSA, 2005, EFSA J, V243, P1.
   EFSA, 2005, EFSA J, V242, P1.
   EFSA, 2005, EFSA J, V245, P1.
   EFSA, 2005, EFSA J, V241, P1.
   EFSA, 2005, EFSA J, V244, P1.
   Eveillard A, 2009, BIOCHEM PHARMACOL, V77, P1735, DOI 10.1016/j.bcp.2009.02.023.
   Fay M, 1999, TOXICOL IND HEALTH, V15, P651, DOI 10.1177/074823379901500801.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   Hashimoto Y, 2000, J MATER SCI-MATER M, V11, P465, DOI 10.1023/A:1013009006522.
   Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Hurst CH, 2004, TOXICOL APPL PHARM, V199, P266, DOI 10.1016/j.taap.2003.11.028.
   Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797.
   Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188.
   Jahnke GD, 2005, BIRTH DEFECTS RES B, V74, P1, DOI 10.1002/bdrb.20028.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Korner W, 1998, CHEMOSPHERE, V37, P2395, DOI 10.1016/S0045-6535(98)00297-5.
   Kruger T, 2008, TOXICOLOGY, V246, P112, DOI 10.1016/j.tox.2007.12.028.
   Latini G, 2009, ENVIRON INT, V35, P236, DOI 10.1016/j.envint.2008.06.002.
   Lee SK, 2005, J TOXICOL ENV HEAL A, V68, P763, DOI 10.1080/15287390590930243.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Lovekamp-Swan T, 2003, MOL CELL ENDOCRINOL, V201, P133, DOI 10.1016/S0303-7207(02)00423-9.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Matthews J, 2000, J STEROID BIOCHEM, V74, P223, DOI 10.1016/S0960-0760(00)00126-6.
   McKee RH, 2004, ENVIRON HEALTH PERSP, V112, pA541.
   Moorman WJ, 2000, REPROD TOXICOL, V14, P293, DOI 10.1016/S0890-6238(00)00089-7.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   Mose T, 2007, REPROD TOXICOL, V23, P83, DOI 10.1016/j.reprotox.2006.08.006.
   Nishihara E, 2000, ENDOCRINOLOGY, V141, P615, DOI 10.1210/en.141.2.615.
   NTP-CERHR, 2006, NIH PUBL.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001.
   Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019.
   Singletary K, 1997, CARCINOGENESIS, V18, P1669, DOI 10.1093/carcin/18.8.1669.
   Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327.
   Soto AM, 1997, ENVIRON HEALTH PERSP, V105, P647, DOI 10.2307/3433384.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9.
   Swan SH, 2006, ENVIRON HEALTH PERSP, V114, pA88.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Tran DQ, 1996, BIOCHEM BIOPH RES CO, V229, P518, DOI 10.1006/bbrc.1996.1836.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Zacharewski TR, 1998, TOXICOL SCI, V46, P282, DOI 10.1093/toxsci/46.2.282.
   {*}DOH, 2000, NUTR HLTH SURV TAIW.
   {*}NTP CERHR, 2003, NTP CERHR MON, pR1.
   {*}USCDC, 2003, 3 USCDC.}},
Number-of-Cited-References = {{67}},
Times-Cited = {{16}},
Journal-ISO = {{Chemosphere}},
Doc-Delivery-Number = {{724GJ}},
Wos-Id = {{ISI:000287563800002}},
}

@article{ ISI:000288506200011,
Author = {Lee, Maw-Rong and Lai, Feng-Ying and Dou, Jianpeng and Lin, Keh-Liang
   and Chung, Li-Wen},
Title = {{DETERMINATION OF TRACE LEACHING PHTHALATE ESTERS IN WATER AND URINE FROM
   PLASTIC CONTAINERS BY SOLID-PHASE MICROEXTRACTION AND GAS
   CHROMATOGRAPHY-MASS SPECTROMETRY}},
Journal = {{ANALYTICAL LETTERS}},
Year = {{2011}},
Volume = {{44}},
Number = {{4}},
Pages = {{676-686}},
Abstract = {{A sensitive method has been developed for determination of trace
   leaching phthalate esters (PAEs) in water and urine from plastic
   containers by direct immersion solid-phase micro-extraction (DI-SPME)
   coupled to gas chromatography-mass spectrometry (GC-MS). The limits of
   detection (LODs) for PAEs in water and urine had values between 0.2-8 ng
   L(-1) and 4-70 ng L(-1), respectively. The proposed method was
   successfully used for quantification of trace PAEs in water in
   microwavable polypropylene containers heated by microwave irradiation
   and in the urine of patients treated with a glucose injection using
   polyvinyl chloride tubing.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lee, MR (Reprint Author), Natl Chung Hsing Univ, Dept Chem, 250 Kuo Kuang Rd, Taichung 402, Taiwan.
   Lee, Maw-Rong; Lai, Feng-Ying; Dou, Jianpeng; Chung, Li-Wen, Natl Chung Hsing Univ, Dept Chem, Taichung 402, Taiwan.
   Dou, Jianpeng, Jilin Univ, Coll Biol \& Agr Engn, Changchun 130023, Peoples R China.
   Lin, Keh-Liang, Chung Shan Med Univ, Sch Med Lab \& Biotechnol, Taichung, Taiwan.}},
DOI = {{10.1080/00032711003783077}},
ISSN = {{0003-2719}},
Keywords = {{Direct immersion solid-phase microextraction; Gas chromatography-mass
   spectrometry; Medical devices; Microwavable polypropylene container;
   Phthalate esters; Polyvinyl chloride}},
Keywords-Plus = {{ENDOCRINE-DISRUPTING COMPOUNDS; ACID ESTERS; EXTRACTION; FIBER;
   MONOESTERS; SEDIMENTS; SAMPLES; MILK; WINE}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Author-Email = {{mrlee@dragon.nchu.edu.tw}},
Funding-Acknowledgement = {{National Science Council of the Republic of China
   {[}NSC92-2113-M-005-024]}},
Funding-Text = {{The authors would like to thank the National Science Council of the
   Republic of China for financially supporting this research under
   contract No. NSC92-2113-M-005-024.}},
Cited-References = {{Bartolome L, 2005, J CHROMATOGR A, V1068, P229, DOI 10.1016/j.chroma.2005.02.003.
   Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Cao XL, 2008, J CHROMATOGR A, V1178, P231, DOI 10.1016/j.chroma.2007.11.095.
   Carrillo JD, 2007, J CHROMATOGR A, V1164, P248, DOI 10.1016/j.chroma.2007.06.059.
   Chang CM, 2005, ANAL CHIM ACTA, V539, P41, DOI 10.1016/j.aca.2005.03.051.
   Del Carlo M, 2008, FOOD CHEM, V111, P771, DOI 10.1016/j.foodchem.2008.04.065.
   FAWELL JK, 2004, GUIDELINES DRINKING, V1.
   Feas CP, 2008, TALANTA, V75, P1184, DOI 10.1016/j.talanta.2008.01.019.
   Feng YL, 2005, ANAL CHIM ACTA, V538, P41, DOI 10.1016/j.aca.2005.02.020.
   HOEGBERG J, 2008, ENV HLTH PERSPECT, V116, P334.
   Holadova K, 2007, ANAL CHIM ACTA, V582, P24, DOI 10.1016/j.aca.2006.09.005.
   HOLADOVA K, 1995, INT J ENVIRON AN CH, V59, P43, DOI 10.1080/03067319508027635.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Inoue K, 2003, J PHARMACEUT BIOMED, V31, P1145, DOI 10.1016/S0731-7085(03)00019-0.
   Kotowska U, 2006, ANAL CHIM ACTA, V560, P110, DOI 10.1016/j.aca.2005.12.022.
   Lopez-Jimenez FJ, 2005, ANAL CHIM ACTA, V551, P142, DOI 10.1016/j.aca.2005.07.032.
   Ma LL, 2003, J ENVIRON MONITOR, V5, P786, DOI 10.1039/b305901d.
   Petrovic M, 2001, TRAC-TREND ANAL CHEM, V20, P637, DOI 10.1016/S0165-9936(01)00118-2.
   Polo M, 2005, J CHROMATOGR A, V1072, P63, DOI 10.1016/j.chroma.2004.12.040.
   Psillakis E, 2003, J CHROMATOGR A, V999, P145, DOI 10.1016/S0021-9673(03)00390-X.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   SHELTON DR, 1984, ENVIRON SCI TECHNOL, V18, P93, DOI 10.1021/es00120a008.
   Stales C A, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1.
   Staples CA, 2000, CHEMOSPHERE, V40, P885, DOI 10.1016/S0045-6535(99)00315-X.
   Tienpont B, 2005, CHROMATOGRAPHIA, V61, P365, DOI 10.1365/s10337-005-0516-9.
   Wang YY, 2004, INT BIODETER BIODEGR, V53, P93, DOI 10.1016/j.ibiod.2003.10.005.
   Zhao RS, 2008, J CHROMATOGR A, V1183, P15, DOI 10.1016/j.chroma.2008.01.021.
   Zhu JP, 2006, ENVIRON SCI TECHNOL, V40, P5276, DOI 10.1021/es060356w.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{4}},
Journal-ISO = {{Anal. Lett.}},
Doc-Delivery-Number = {{736PI}},
Wos-Id = {{ISI:000288506200011}},
}

@article{ ISI:000286493800018,
Author = {Silva, Manori J. and Furr, Johnathan and Samandar, Ella and Preau, Jr.,
   James L. and Gray, L. Earl and Needham, Larry L. and Calafat, Antonia M.},
Title = {{Urinary and serum metabolites of di-n-pentyl phthalate in rats}},
Journal = {{CHEMOSPHERE}},
Year = {{2011}},
Volume = {{82}},
Number = {{3}},
Pages = {{431-436}},
Month = {{JAN}},
Abstract = {{Di-n-pentyl phthalate (DPP) is used mainly as a plasticizer in
   nitrocellulose. At high doses. DPP acts as a potent testicular toxicant
   in rats. We administered a single oral dose of 500 mg kg(-1) bw of DPP
   to adult female Sprague-Dawley rats (N = 9) and collected 24-h urine
   samples 1 d before and 24- and 48-h after DPP was administered to
   tentatively identify DPP metabolites that could be used as exposure
   biomarkers. At necropsy, 48 h after dosing, we also collected serum. The
   metabolites were extracted from urine or serum, resolved with high
   performance liquid chromatography, and detected by mass spectrometry.
   Two DPP metabolites, phthalic acid (PA) and mono(3-carboxypropyl)
   phthalate (MCPP), were identified by using authentic standards, whereas
   mono-n-pentyl phthalate (MPP), mono(4-oxopentyl) phthalate (MOPP),
   mono(4-hydroxypentyl) phthalate (MHPP), mono(4-carboxybutyl) phthalate
   (MCBP), mono(2-carboxyethyl) phthalate (MCEP), and mono-n-pentenyl
   phthalate (MPeP) were identified based on their full scan mass
   spectrometric fragmentation pattern. The omega - 1 oxidation product,
   MHPP, was the predominant urinary metabolite of DPP. The median urinary
   concentrations (mu g mL(-1)) of the metabolites in the first 24 h urine
   collection after DPP administration were 993 (MHPP), 168 (MCBP), 0.2
   (MCEP), 222 (MPP), 47 (MOPP), 26 (PA), 16 (MPeP), and 9 (MCPP): the
   concentrations of metabolites in the second 24 h urine collection after
   DPP administration were significantly lower than in the first
   collection. We identified some urinary metabolic products in the serum,
   but at much lower levels than in urine. Because of the similarities in
   metabolism of phthalates between rats and humans, based on our results
   and the fact that MHPP can only be formed from the metabolism of DPP,
   MHPP would be the most adequate DPP exposure biomarker for human
   exposure assessment. Nonetheless, based on the urinary levels of MHPP,
   our preliminary data suggest that human exposure to DPP in the United
   States is rather limited. Published by Elsevier Ltd.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, 4770 Buford Highway,Mailstop F53, Chamblee, GA 30341 USA.
   Silva, Manori J.; Samandar, Ella; Preau, James L., Jr.; Needham, Larry L.; Calafat, Antonia M., Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Furr, Johnathan; Gray, L. Earl, US EPA, Reprod Toxicol Branch, Toxic Assessment Div, Natl Hlth \& Environm Effects Res Lab,Off Res \& De, Res Triangle Pk, NC 27711 USA.}},
DOI = {{10.1016/j.chemosphere.2010.09.052}},
ISSN = {{0045-6535}},
Keywords = {{Di-n-pentyl phthalate (DPP); Mono-n-pentyl phthalate (MPP); MHPP;
   Biomarkers; Exposure assessment; Oxidative metabolism}},
Keywords-Plus = {{DEUTERIUM-LABELED DEHP; DI(2-ETHYLHEXYL)PHTHALATE DEHP; OXIDATIVE
   METABOLITES; MASS-SPECTROMETRY; BUTYL PHTHALATE; OCTYL PHTHALATE; HUMAN
   EXPOSURE; BIOMARKERS; ESTERS; EXCRETION}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{zca2@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   Anderson WAC, 2002, ANALYST, V127, P1193, DOI 10.1039/b200487a.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   CREASY DM, 1987, EXP MOL PATHOL, V46, P357, DOI 10.1016/0014-4800(87)90056-6.
   CREASY DM, 1988, TOXICOL IN VITRO, V2, P83, DOI 10.1016/0887-2333(88)90018-5.
   CREASY DM, 1983, J PATHOL, V139, P309, DOI 10.1002/path.1711390307.
   Egestad B, 1996, J CHROMATOGR B, V677, P99, DOI 10.1016/0378-4347(95)00439-4.
   FOSTER PMD, 1983, TOXICOL LETT, V15, P265, DOI 10.1016/0378-4274(83)90226-6.
   GRANHOLM T, 1992, J REPROD IMMUNOL, V21, P1, DOI 10.1016/0165-0378(92)90036-4.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   JONES HB, 1993, EXP MOL PATHOL, V58, P179, DOI 10.1006/exmp.1993.1016.
   Kato K, 2007, TOXICOLOGY, V236, P114, DOI 10.1016/j.tox.2007.04.009.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404.
   Nativelle C, 1999, FOOD CHEM TOXICOL, V37, P905, DOI 10.1016/S0278-6915(99)00071-X.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Silva MJ, 2005, TOXICOLOGY, V210, P123, DOI 10.1016/j.tox2005.01.012.
   Silva MJ, 2006, ABSTR PAP AM CHEM S, V231.
   Silva MJ, 2007, ENVIRON SCI TECHNOL, V41, P7576, DOI 10.1021/es071142x.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2007, BIOMARKERS, V12, P133, DOI 10.1080/13547500601066915.
   WILSON AS, 1997, RAPRA REV REPORTS, V88.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{3}},
Journal-ISO = {{Chemosphere}},
Doc-Delivery-Number = {{710EN}},
Wos-Id = {{ISI:000286493800018}},
}

@article{ ISI:000285788900023,
Author = {Calafat, Antonia M. and Wong, Lee-Yang and Silva, Manori J. and
   Samandar, Ella and Preau, Jr., James L. and Jia, Lily T. and Needham,
   Larry L.},
Title = {{Selecting Adequate Exposure Biomarkers of Diisononyl and Diisodecyl
   Phthalates: Data from the 2005-2006 National Health and Nutrition
   Examination Survey}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2011}},
Volume = {{119}},
Number = {{1}},
Pages = {{50-55}},
Month = {{JAN}},
Abstract = {{BACKGROUND: High-molecular-weight phthalates, such as diisononyl
   phthalate (DINP) and diisodecyl phthalate (DIDP), are used primarily as
   polyvinyl chloride plasticizers.
   OBJECTIVES: We assessed exposure to DINP and DIDP in a representative
   sample of persons >= 6 years of age in the U.S. general population from
   the 2005-2006 National Health and Nutrition Examination Survey (NHANES).
   METHODS: We analyzed 2,548 urine samples by using online solid-phase
   extraction coupled to isotope dilution high-performance liquid
   chromatography-tandem mass spectrometry.
   RESULTS: We detected monocarboxyisooctyl phthalate (MCOP), a metabolite
   of DINP, and monocarboxyisononyl phthalate (MCNP), a metabolite of DIDP,
   in 95.2\% and 89.9\% of the samples, respectively. We detected
   monoisononyl phthalate (MNP), a minor metabolite of DINP, much less
   frequently (12.9\%) and at concentration ranges (> 0.8 mu g/L-148.1 mu
   g/L) much lower than MCOP (> 0.7 mu g/L-4,961 mu g/L). Adjusted
   geometric mean concentrations of MCOP and MCNP were significantly higher
   (p < 0.01) among children than among adolescents and adults.
   CONCLUSIONS: The general U.S. population, including children, was
   exposed to DINP and DIDP. In previous NHANES cycles, the occurrence of
   human exposure to DINP by using MNP as the sole urinary biomarker has
   been underestimated, thus illustrating the importance of selecting the
   most adequate biomarkers for exposure assessment.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, 4770 Buford Hwy,NE,Mailstop F53, Atlanta, GA 30341 USA.
   Calafat, Antonia M.; Wong, Lee-Yang; Silva, Manori J.; Samandar, Ella; Preau, James L., Jr.; Jia, Lily T.; Needham, Larry L., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.}},
DOI = {{10.1289/ehp.1002316}},
ISSN = {{0091-6765}},
Keywords = {{biomonitoring; DIDP; DINP; exposure; human; NHANES; urine}},
Keywords-Plus = {{DI-ISONONYL PHTHALATE; ISO-NONYLPHTHALATE DINP; EXPERT PANEL REPORT;
   N-BUTYL PHTHALATE; ENVIRONMENTAL CHEMICALS; DEVELOPMENTAL TOXICITY;
   ISODECYL PHTHALATE; HUMAN-REPRODUCTION; HUMAN URINE; NTP CENTER}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{Acalafat@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{Adamsson A, 2009, REPROD TOXICOL, V28, P66, DOI 10.1016/j.reprotox.2009.03.002.
   Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Angerer J, 2007, INT J HYG ENVIR HEAL, V210, P201, DOI 10.1016/j.ijheh.2007.01.024.
   Angerer J, 2006, TOXICOL SCI, V93, P3, DOI 10.1093/toxsci/kfl042.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   Calafat AM, 2009, ENVIRON HEALTH PERSP, V117, P1481, DOI 10.1289/ehp.0901108.
   Calafat AM, 2008, INT J ANDROL, V31, P139, DOI 10.1111/j.1365-2605.2007.00826.x.
   Calafat AM, 2006, INT J ANDROL, V29, P166, DOI 10.1111/j.1365-2605.2005.00570.x.
   David RM, 2001, PATTYS TOXICOLOGY, V6, P635.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Hushka LJ, 2001, REPROD TOXICOL, V15, P153, DOI 10.1016/S0890-6238(01)00109-5.
   Kato K, 2007, TOXICOLOGY, V236, P114, DOI 10.1016/j.tox.2007.04.009.
   Kavlock R, 2002, REPROD TOXICOL, V16, P679, DOI 10.1016/S0890-6238(02)00034-5.
   Kavlock R, 2002, REPROD TOXICOL, V16, P655, DOI 10.1016/S0890-6238(02)00068-0.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013.
   Masutomi N, 2003, TOXICOLOGY, V192, P149, DOI 10.1016/S0300-483X(03)00269-5.
   McKee RH, 2004, REPROD TOXICOL, V18, P1, DOI 10.1016/j.reprotox.2003.09.002.
   Meeker JD, 2009, PHILOS T R SOC B, V364, P2097, DOI 10.1098/rstb.2008.0268.
   Needham LL, 2005, ANAL BIOANAL CHEM, V381, P397, DOI 10.1007/s00216-004-2975-5.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Silva MJ, 2007, BIOMARKERS, V12, P133, DOI 10.1080/13547500601066915.
   SILVA MJ, 2004, ENV HLTH PERSPECT, V112, P231.
   Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1.
   Taylor J. K., 1987, QUALITY ASSURANCE CH.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   Waterman SJ, 2000, REPROD TOXICOL, V14, P21, DOI 10.1016/S0890-6238(99)00067-2.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   {*}CDCP, 2009, 5 DCCP.
   {*}EUR COMM, 2003, 1 2 BENZ AC DI C9 11.
   {*}EUR COMM, 2003, RISK ASS REP SUMM, V35.
   {*}NRC, 2008, PHTH CUM RISK ASS TA.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{10}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{701BI}},
Wos-Id = {{ISI:000285788900023}},
}

@article{ ISI:000298959400015,
Author = {Clark, Kathryn E. and David, Raymond M. and Guinn, Richard and Kramarz,
   Kurt W. and Lampi, Mark A. and Staples, Charles A.},
Title = {{Modeling Human Exposure to Phthalate Esters: A Comparison of Indirect
   and Biomonitoring Estimation Methods}},
Journal = {{HUMAN AND ECOLOGICAL RISK ASSESSMENT}},
Year = {{2011}},
Volume = {{17}},
Number = {{4}},
Pages = {{923-965}},
Abstract = {{Humans are potentially exposed to phthalate esters (PEs) through
   ingestion, inhalation, and dermal contact. Studies quantifying exposure
   to PEs include ``biomarker studies{''} and ``indirect studies.{''}
   Biomarker studies use measurements of PE metabolites in urine to
   back-calculate exposure to the parent diester, while indirect studies
   use the concentration of the PE in each medium of exposure and the rate
   of intake of that medium to quantify intake of the PE. In this review,
   exposure estimates from biomarker and indirect studies are compiled and
   compared for seven PEs to determine if there are regional differences
   and if there is a preferred approach. The indirect and biomarker methods
   generally agree with each other within an order of magnitude and
   discrepancies are explained by difficulties in accounting for use of
   consumer products, uncertainty concerning absorption, regional
   differences, and temporal changes. No single method is preferred for
   estimating intake of all PEs; it is suggested that biomarker estimates
   be used for low molecular weight PEs for which it is difficult to
   quantify all sources of exposure and either indirect or biomarker
   methods be used for higher molecular weight PEs. The indirect methods
   are useful in identifying sources of exposure while the biomarker
   methods quantify exposure.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Clark, KE (Reprint Author), 61 Catherine Ave, Aurora, ON, Canada.
   Clark, Kathryn E., BEC Technol Inc, Aurora, ON, Canada.
   David, Raymond M., BASF Corp, Florham Pk, NJ USA.
   Kramarz, Kurt W., BASF Corp, Pasadena, TX USA.
   Guinn, Richard, Eastman Chem Co, Kingsport, TN 37662 USA.
   Lampi, Mark A., ExxonMobil Biomed Sci Inc, Annandale, NJ USA.
   Staples, Charles A., Assessment Technol Inc, Keswick, VA USA.}},
DOI = {{10.1080/10807039.2011.588157}},
ISSN = {{1080-7039}},
Keywords = {{phthalate ester; human exposure; biomarker}},
Keywords-Plus = {{DUPLICATE DIET SAMPLES; PERSISTENT ORGANIC POLLUTANTS; DEUTERIUM-LABELED
   DEHP; DI(2-ETHYLHEXYL)PHTHALATE DEHP; HUMAN URINE; DIISONONYL PHTHALATE;
   GENERAL-POPULATION; INTERNAL EXPOSURE; RISK-ASSESSMENT; UNITED-STATES}},
Research-Areas = {{Biodiversity \& Conservation; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Biodiversity Conservation; Environmental Sciences}},
Author-Email = {{kclark@pathcom.com}},
Funding-Acknowledgement = {{Phthalate Esters Panel of the American Chemistry Council, Washington,
   DC, USA}},
Funding-Text = {{This study was funded by the Phthalate Esters Panel of the American
   Chemistry Council, Washington, DC, USA.}},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   BARR DB, 2003, ENV HLTH PERSPECT, V111, P1164.
   Bauer MJ, 1997, SCI TOTAL ENVIRON, V208, P49, DOI 10.1016/S0048-9697(97)00272-6.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   CDC, 2009, 4 CDC DEP HLTH HUM S.
   CDC (Center for Disease Control), 2003, 2 CDC DEP HLTH HUM S.
   Centers for Disease Control and Prevention ( CDC), 2001, NAT REP HUM EXP ENV.
   Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   CLARK K, 2008, REPORT UPDATE PHTHAL.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P125.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   Franco A, 2007, ENVIRON INT, V33, P283, DOI 10.1016/j.envint.2006.10.001.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Fujimaki Kayumi, 2006, Nihon Eiseigaku Zasshi, V61, P340.
   Gill US, 2001, REV ENVIRON CONTAM T, V172, P87.
   Helm D, 2007, SCI TOTAL ENVIRON, V388, P389, DOI 10.1016/j.scitotenv.2007.07.009.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Huang PC, 2006, EPIDEMIOLOGY, V17, pS195, DOI 10.1097/00001648-200611001-00494.
   Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y.
   JENSEN AA, 2006, DANISH ENV PROTECTIO, V75.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Koo HJ, 2005, J TOXICOL ENV HEAL A, V68, P1379, DOI 10.1080/15287390590956506.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   MICHAEL PR, 1984, ENVIRON TOXICOL CHEM, V3, P377, DOI 10.1897/1552-8618(1984)3{[}377:SOPEIS]2.0.CO;2.
   PAGE BD, 1995, FOOD ADDIT CONTAM, V12, P129.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   Shen HY, 2007, J SEP SCI, V30, P48, DOI 10.1002/jssc.200600215.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Stanley MK, 2003, HANDB ENVIRON CHEM, V3, P1.
   TABOR MW, 1985, INT J ENVIRON AN CH, V19, P281, DOI 10.1080/03067318508077039.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P569, DOI 10.1080/02652030010028344.
   Tsumura Y, 2003, FOOD ADDIT CONTAM, V20, P317, DOI 10.1080/0265203031000122021.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474.
   Wilson NK, 2003, J EXPO ANAL ENV EPID, V13, P187, DOI 10.1038/sj.jea.7500270.
   Wilson NK, 2001, J EXPO ANAL ENV EPID, V11, P449, DOI 10.1038/sj.jea.7500190.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Zhu JP, 2006, ENVIRON SCI TECHNOL, V40, P5276, DOI 10.1021/es060356w.
   {*}CDC, 2005, 3 CDC DEP HLTH HUM S.
   {*}HLTH CAN, 1995, PROB ASS 24 HOUR BRE.
   {*}HLTH WELF CAN, 1993, REF VAL CAN POP.}},
Number-of-Cited-References = {{57}},
Times-Cited = {{7}},
Journal-ISO = {{Hum. Ecol. Risk Assess.}},
Doc-Delivery-Number = {{874LQ}},
Wos-Id = {{ISI:000298959400015}},
}

@article{ ISI:000293979300001,
Author = {Jurewicz, Joanna and Hanke, Wojciech},
Title = {{EXPOSURE TO PHTHALATES: REPRODUCTIVE OUTCOME AND CHILDREN HEALTH. A
   REVIEW OF EPIDEMIOLOGICAL STUDIES}},
Journal = {{INTERNATIONAL JOURNAL OF OCCUPATIONAL MEDICINE AND ENVIRONMENTAL HEALTH}},
Year = {{2011}},
Volume = {{24}},
Number = {{2}},
Pages = {{115-141}},
Abstract = {{Phthalates are a family of industrial chemicals that have been used for
   a variety of purposes. As the potential consequences of human exposure
   to phthalates have raised concerns in the general population, they have
   been studied in susceptible subjects such as pregnant women, infants and
   children. This article aims at evaluating the impact of exposure to
   phthalates on reproductive outcomes and children health by reviewing
   most recent published literature. Epidemiological studies focusing on
   exposure to phthalates and pregnancy outcome, genital development, semen
   quality, precocious puberty, thyroid function, respiratory symptoms and
   neurodevelopment in children for the last ten years were identified by a
   search of the PubMed, Medline, Ebsco, Agricola and Toxnet literature
   bases. The results from the presented studies suggest that there are
   strong and rather consistent indications that phthalates increase the
   risk of allergy and asthma and have an adverse impact on children's
   neurodevelopment reflected by quality of alertness among girls,
   decreased (less masculine) composite score in boys and attention deficit
   hyperactivity disorder. Results of few studies demonstrate negative
   associations between phthalate levels commonly experienced by the public
   and impaired sperm quality (concentration, morphology, motility).
   Phthalates negatively impact also on gestational age and head
   circumference; however, the results of the studies were not consistent.
   In all the reviewed studies, exposure to phthalates adversely affected
   the level of reproductive hormones (luteinizing hormone, free
   testosterone, sex hormone-binding globulin), anogenital distance and
   thyroid function. The urinary levels of phthalates were significantly
   higher in the pubertal gynecomastia group, in serum in girls with
   premature thelarche and in girls with precocious puberty.
   Epidemiological studies, in spite of their limitations, suggest that
   phthalates may affect reproductive outcome and children health.
   Considering the suggested health effects, more epidemiologic data is
   urgently needed and, in the meantime, precautionary policies must be
   implemented.}},
Publisher = {{VERSITA}},
Address = {{SOLIPSKA 14A-1, 02-482 WARSAW, POLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Jurewicz, J (Reprint Author), Nofer Inst Occupat Med, Dept Environm Epidemiol, Sw Teresy 8, PL-91348 Lodz, Poland.
   Jurewicz, Joanna; Hanke, Wojciech, Nofer Inst Occupat Med, Dept Environm Epidemiol, PL-91348 Lodz, Poland.}},
DOI = {{10.2478/s13382-011-0022-2}},
ISSN = {{1232-1087}},
Keywords = {{Exposure to phthalates; Children health; Reproductive outcome}},
Keywords-Plus = {{IN-UTERO EXPOSURE; SCHOOL-AGE-CHILDREN; N-BUTYL PHTHALATE; ANOGENITAL
   DISTANCE; SEMEN QUALITY; DI(2-ETHYLHEXYL) PHTHALATE; URINARY
   CONCENTRATIONS; ENDOCRINE DISRUPTORS; BIS(2-ETHYLHEXYL) PHTHALATE;
   ENVIRONMENTAL CHEMICALS}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{joannaj@imp.lodz.pl}},
ResearcherID-Numbers = {{Jurewicz, Joanna/F-7598-2010
   Hanke, Wojciech/F-7604-2010}},
Funding-Acknowledgement = {{Norwegian Financial Mechanism within the Polish-Norwegian Research Fund,
   Norway {[}PNRF-218-AI-1/07]}},
Funding-Text = {{This study was performed under the project ``Prenatal and postnatal
   exposure to tobacco smoke, PAHs and heavy metals and the risk of
   respiratory diseases, allergy and poor mental and physical
   development{''} supported by the grant PNRF-218-AI-1/07 from Norway
   through the Norwegian Financial Mechanism within the Polish-Norwegian
   Research Fund.}},
Cited-References = {{Ablake M, 2004, INT J ANDROL, V27, P274, DOI 10.1111/j.1365-2605.2004.00482.x.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Bornehag CG, 2005, INDOOR AIR, V15, P48, DOI 10.1111/j.1600-0668.2005.00306.x.
   Brasche S, 2005, INT J HYG ENVIR HEAL, V208, P247, DOI 10.1016/j.ijheh.2005.03.003.
   Brown JS, 2009, SCHIZOPHRENIA BULL, V35, P256, DOI 10.1093/schbul/sbm147.
   BUSTAMENTEMONTE.LP, 2008, EPIDEMIOLOGY, V19, P270.
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   Chalubinski M, 2006, ALLERGY, V61, P1326, DOI 10.1111/j.1398-9995.2006.01135.x.
   Cho SC, 2010, ENVIRON HEALTH PERSP, V118, P1027, DOI 10.1289/ehp.0901376.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Dallaire F, 2003, ENVIRON HEALTH PERSP, V111, P1660, DOI 10.1289/ehp.6269.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   Durmaz E., 2010, PEDIATRICS, V125, P122.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Engel SM, 2010, ENVIRON HEALTH PERSP, V118, P565, DOI 10.1289/ehp.0901470.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Engman LH, 2007, SCAND J PUBLIC HEALT, V35, P125, DOI 10.1080/14034940600975658.
   FABER KA, 1992, BIOL REPROD, V46, P101, DOI 10.1095/biolreprod46.1.101.
   FOSTER PM, 2001, HUM REPROD UPDATE, P231.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Gallavan RH, 1999, REPROD TOXICOL, V13, P383, DOI 10.1016/S0890-6238(99)00036-2.
   Ge RS, 2007, REPROD TOXICOL, V23, P366, DOI 10.1016/j.reprotox.2006.12.006.
   Gladen BC, 1999, REPROD TOXICOL, V13, P41, DOI 10.1016/S0890-6238(98)00054-9.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P560, DOI 10.2105/AJPH.94.4.560.
   Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797.
   Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188.
   JONSSON AG, 2005, EPIDEMIOLOGY, V16, P487.
   Kamrin MA, 2009, J TOXICOL ENV HEAL B, V12, P157, DOI 10.1080/10937400902729226.
   Kavlock R, 2002, REPROD TOXICOL, V16, P721, DOI 10.1016/S0890-6238(02)00031-X.
   Kavlock RJ, 1996, ENVIRON HEALTH PERSP, V104, P715, DOI 10.2307/3432708.
   Key T J, 2001, Lancet Oncol, V2, P133, DOI 10.1016/S1470-2045(00)00254-0.
   Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   Larsson M, 2010, INDOOR AIR, V20, P494, DOI 10.1111/j.1600-0668.2010.00671.x.
   Latini G, 2004, REPROD TOXICOL, V19, P27, DOI 10.1016/j.reprotox.2004.05.011.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   LEWIS M, 1992, PEDIATRICS, V89, P1010.
   LIWNICZ BH, 1989, CLIN CHEM THEORY ANA, P607.
   Lomenick JP, 2010, J PEDIATR-US, V156, P221, DOI 10.1016/j.jpeds.2009.09.047.
   Longnecker MP, 2007, AM J EPIDEMIOL, V165, P1015, DOI 10.1093/aje/kwk109.
   Lopez-Carrillo L, 2010, ENVIRON HEALTH PERSP, V118, P539, DOI 10.1289/ehp.0901091.
   LOTTRUP AM, 2006, INT J ANDROL, V29, P172.
   Masuo Y, 2004, REGUL PEPTIDES, V123, P225, DOI 10.1016/j.regpep.2004.05.010.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   MEIN KM, 2006, ENV HLTH PERSPECT, V114, P270.
   MOORE KL, 1998, DEVELOPING HUMAN CLI, P157.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   NYDICK M, 1961, JAMA-J AM MED ASSOC, V178, P449.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   PALANZA P, 1995, PHYSIOL BEHAV, V58, P827, DOI 10.1016/0031-9384(95)00107-T.
   Pant N, 2008, TOXICOL APPL PHARM, V231, P112, DOI 10.1016/j.taap.2008.04.001.
   Partsch CJ, 2001, HUM REPROD UPDATE, V7, P292, DOI 10.1093/humupd/7.3.292.
   Qiao Lili, 2007, Wei Sheng Yan Jiu, V36, P93.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Selgrade MK, 2006, ENVIRON HEALTH PERSP, V114, P615, DOI 10.1289/ehp.8376.
   SHAPE RM, 1995, ENV HLTH PERSPECT, V103, P1136.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Steer PJ, 2005, HIGH RISK PREGNANCY.
   Swan SH, 2009, INT J ANDROL, V32, P1.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Tabacova S, 1997, ARCH ENVIRON HEALTH, V52, P341.
   Tanaka T, 2005, FOOD CHEM TOXICOL, V43, P581, DOI 10.1016/j.fct.2005.01.001.
   TANDON R, 1991, Indian Journal of Experimental Biology, V29, P1044.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Wang SL, 2005, ENVIRON HEALTH PERSP, V113, P1645, DOI 10.1289/ehp.7994.
   Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241.
   Wirth JJ, 2008, SYST BIOL REPROD MEC, V54, P143, DOI 10.1080/19396360802055921.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Zhang YH, 2006, BIOMED ENVIRON SCI, V19, P205.
   {*}NAT RES COUNC COM, 2008, PHTH CUM RISK ASS TA.}},
Number-of-Cited-References = {{90}},
Times-Cited = {{23}},
Journal-ISO = {{Int. J. Occup. Med. Environ. Health}},
Doc-Delivery-Number = {{808LN}},
Wos-Id = {{ISI:000293979300001}},
}

@article{ ISI:000285325200016,
Author = {Xu, Chuan and Chen, Ji-An and Qiu, Zhiqun and Zhao, Qing and Luo,
   Jiaohua and Yang, Lan and Zeng, Hui and Huang, Yujing and Zhang, Liang
   and Cao, Jia and Shu, Weiqun},
Title = {{Ovotoxicity and PPAR-mediated aromatase downregulation in female
   Sprague-Dawley rats following combined oral exposure to benzo{[}a]pyrene
   and di-(2-ethylhexyl) phthalate}},
Journal = {{TOXICOLOGY LETTERS}},
Year = {{2010}},
Volume = {{199}},
Number = {{3}},
Pages = {{323-332}},
Month = {{DEC 15}},
Abstract = {{The aim of the present study was to determine the ovotoxicity of female
   Sprague-Dawley (SD) rats exposed to benzo{[}a]pyrene (B{[}a]P) and
   di-(2-ethylhexyl) phthalate (DEHP), either alone or in combination; the
   molecular mechanism and the combined effects were also evaluated. Female
   rats were given intragastric administration of control (corn oil),
   B{[}a]P (5 and 10 mg/kg), DEHP (300 and 600 mg/kg) and B{[}a]P + DEHP
   (at 5 mg/kg and 300 mg/kg respectively, or at 10 mg/kg and 600 mg/kg
   respectively) on alternate days for 60 days. Relative ovary weight,
   estrous cycle, 17 beta-estradiol blood level, ovarian follicle
   populations, granulosa cell apoptosis, and gene and protein expression
   of P450Arom and PPAR were investigated. Our study demonstrated that the
   combination of B{[}a]P and DEHP exerts ovotoxicity in female rats and
   suppression of sex hormone secretion and homeostasis, which is
   associated with prolonged estrous cycles, decreases in ovarian follicle
   populations and granulosa cell apoptosis involving a PPAR-mediated
   signaling pathway of action of the two chemicals. In addition, based on
   qualitative assessment of the combined toxicity, no interaction effects
   were observed following combined B{[}a]P and DEHP administration. (C)
   2010 Elsevier Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Shu, WQ (Reprint Author), Third Mil Med Univ, Dept Environm Hyg, Coll Prevent Med, Chongqing 400038, Peoples R China.
   Xu, Chuan; Chen, Ji-An; Qiu, Zhiqun; Zhao, Qing; Luo, Jiaohua; Yang, Lan; Zeng, Hui; Huang, Yujing; Zhang, Liang; Shu, Weiqun, Third Mil Med Univ, Dept Environm Hyg, Coll Prevent Med, Chongqing 400038, Peoples R China.
   Xu, Chuan, Gen Hosp Chengdu Mil Reg, Div Sci Res \& Training, Chengdu 610083, Sichuan Prov, Peoples R China.}},
DOI = {{10.1016/j.toxlet.2010.09.015}},
ISSN = {{0378-4274}},
Keywords = {{Benzo{[}a]pyrene (B{[}a]P); Di-(2-ethylhexyl) phthalate (DEHP);
   Combination; Ovotoxicity; Granulosa cells; Mechanism}},
Keywords-Plus = {{OVARIAN GRANULOSA-CELLS; HUMAN FETAL TESTIS; LACTATIONAL EXPOSURE;
   IN-UTERO; MONO-(2-ETHYLHEXYL) PHTHALATE; SUPPRESSES ESTRADIOL;
   FOLLICULAR ATRESIA; DOSE-RESPONSE; YANGTZE-RIVER; WUHAN SECTION}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{xm0630@sina.com}},
ResearcherID-Numbers = {{Xu, C/A-5551-2013}},
Funding-Acknowledgement = {{National Natural Science Foundations of China {[}30630056, 30800900];
   Program of S\&T (Chongqing) Project {[}CSTC2006AA7003]}},
Funding-Text = {{This work was supported by grants from National Natural Science
   Foundations of China (Grant No. 30630056; Grant No. 30800900) and
   Program of S\&T (Chongqing) Project (Grant No. CSTC2006AA7003). The
   authors would thank Fei Wan (Center of Clinical Epidemiology and
   Biostatistics and Department of Biostatistics University of
   Pennsylvania, USA) for providing assistance in data analysis.}},
Cited-References = {{Archibong AE, 2002, REPROD TOXICOL, V16, P801, DOI 10.1016/S0890-6238(02)00058-8.
   Bocher V, 2002, ANN NY ACAD SCI, V967, P7.
   Bolon B, 1997, FUND APPL TOXICOL, V39, P1, DOI 10.1006/faat.1997.2338.
   Borman SM, 2000, TOXICOL APPL PHARM, V167, P191, DOI 10.1006/taap.2000.9006.
   BRAISSANT, 1996, ENDOCRINOLOGY, V137, P354.
   BRODERIUS SJ, 1995, ENVIRON TOXICOL CHEM, V14, P1591, DOI 10.1897/1552-8618(1995)14{[}1591:UOJTRT]2.0.CO;2.
   Cooper R. L., 1993, METHODS TOXICOLOGY B, V3, P45.
   Coutts SM, 2007, HUM REPROD, V22, P2912, DOI 10.1093/humrep/dem300.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Devine PJ, 2000, BIOL REPROD, V63, P1245, DOI 10.1095/biolreprod63.5.1245.
   Devine PJ, 2004, REPROD TOXICOL, V19, P71, DOI 10.1016/j.reprotox.2004.06.002.
   Feng CL, 2007, ENVIRON MONIT ASSESS, V133, P447, DOI 10.1007/s10661-006-9599-5.
   Feron VJ, 2002, FOOD CHEM TOXICOL, V40, P825, DOI 10.1016/S0278-6915(02)00021-2.
   FORTUNE JE, 1994, BIOL REPROD, V50, P225, DOI 10.1095/biolreprod50.2.225.
   Gaskell TL, 2004, BIOL REPROD, V71, P2012, DOI 10.1095/biolreprod.104028381.
   Grande SW, 2006, TOXICOL SCI, V91, P247, DOI 10.1093/toxsci/kfj128.
   Grande SW, 2007, TOXICOLOGY, V229, P114, DOI 10.1016/j.tox.2006.10.005.
   GURTOO HL, 1983, INT J CANCER, V31, P29, DOI 10.1002/ijc.2910310106.
   HATTEMERFREY HA, 1991, TOXICOL IND HEALTH, V7, P141.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   HICKEY GJ, 1990, MOL ENDOCRINOL, V4, P3.
   HUGHES FM, 1991, ENDOCRINOLOGY, V129, P2415.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Kim JH, 2005, TOXICOL SCI, V85, P585, DOI 10.1093/toxsci/kfi118.
   Li GC, 2006, ENVIRON POLLUT, V144, P985, DOI 10.1016/j.envpol.2006.01.047.
   Lovekamp-Swan T, 2003, MOL CELL ENDOCRINOL, V201, P133, DOI 10.1016/S0303-7207(02)00423-9.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Matikainen TM, 2002, ENDOCRINOLOGY, V143, P615, DOI 10.1210/en.143.2.615.
   MILLER MM, 1992, AM J OBSTET GYNECOL, V166, P1535.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Neal MS, 2008, REPROD TOXICOL, V25, P100, DOI 10.1016/j.reprotox.2007.10.012.
   Patel MR, 2006, AQUAT TOXICOL, V77, P267, DOI 10.1016/j.aquatox.2005.12.009.
   Presibella KM, 2005, REPROD TOXICOL, V20, P95, DOI 10.1016/j.reprotox.2004.11.007.
   Scheuplein R, 2002, REGUL TOXICOL PHARM, V35, P429, DOI 10.1006/trph.2002.1558.
   Sha YJ, 2007, ENVIRON MONIT ASSESS, V124, P277, DOI 10.1007/s10661-006-9225-6.
   THOMAS P, 1995, MAR ENVIRON RES, V39, P147, DOI 10.1016/0141-1136(94)00072-W.
   TILLY JL, 1991, ENDOCRINOLOGY, V129, P2799.
   Wang F, 2008, J HAZARD MATER, V154, P317, DOI 10.1016/j.jhazmat.2007.10.028.
   Wang Q, 2002, PLACENTA, V23, P661, DOI 10.1053/plac.2002.0855.
   Xu C, 2010, BIRTH DEFECTS RES B, V89, P26, DOI 10.1002/bdrb.20219.
   Zenzes MT, 2000, HUM REPROD UPDATE, V6, P122, DOI 10.1093/humupd/6.2.122.
   {*}CERHR, 2000, NTP CERHR EXP PAN RE.
   {*}US CDC, 1995, TOX PROF POL HYDR PA.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{4}},
Journal-ISO = {{Toxicol. Lett.}},
Doc-Delivery-Number = {{694UT}},
Wos-Id = {{ISI:000285325200016}},
}

@article{ ISI:000285190700031,
Author = {Preau, Jr., James L. and Wong, Lee-Yang and Silva, Manori J. and
   Needham, Larry L. and Calafat, Antonia M.},
Title = {{Variability over 1 Week in the Urinary Concentrations of Metabolites of
   Diethyl Phthalate and Di(2-Ethylhexyl) Phthalate among Eight Adults: An
   Observational Study}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2010}},
Volume = {{118}},
Number = {{12}},
Pages = {{1748-1754}},
Month = {{DEC}},
Abstract = {{BACKGROUND: Phthalates are metabolized and eliminated in urine within
   hours after exposure. Several reports suggest that concentrations of
   phthalate metabolites in a spot urine sample can provide a reliable
   estimation of exposure to phthalates for up to several months.
   OBJECTIVES: We examined inter-and intraperson and inter- and intraday
   variability in the concentrations of monoethyl phthalate (MEP), the
   major metabolite of diethyl phthalate, commonly used in personal care
   products, and mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP), a
   metabolite of di(2-ethylhexyl) phthalate (DEHP), a polyvinyl chloride
   plasticizer of which diet is the principal exposure source, among eight
   adults who collected all urine voids (average, 7.6 samples/person/ day)
   for 1 week.
   METHODS: We analyzed the urine samples using online solid-phase
   extraction coupled to isotope dilution-high-performance liquid
   chromatography-tandem mass spectrometry.
   RESULTS: Regardless of the type of void (spot, first morning, 24-hr
   collection), for MEP, interperson variability in concentrations
   accounted for > 75\% of the total variance. By contrast, for MEHHP,
   within-person variability was the main contributor (69-83\%) of the
   total variance. Furthermore, we observed considerable intraday
   variability in the concentrations of spot samples for MEHHP (51\%) and
   MEP (21\%).
   CONCLUSIONS: MEP and MEHHP urinary concentrations varied considerably
   during 1 week, but the main contributors to the total variance differed
   (interday variability, MEHHP; interperson variability, MEP) regardless
   of the sampling strategy (spot, first morning, 24-hr collection). The
   nature of the exposure (diet vs. other lifestyle factors) and timing of
   urine sampling to evaluate exposure to phthalates should be considered.
   For DEHP and phthalates to which people are mostly exposed through diet,
   collecting 24-hr voids for only 1 day may not be advantageous compared
   with multiple spot collections. When collecting multiple spot urine
   samples, changing the time of collection may provide the most complete
   approach to assess exposure to diverse phthalates.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, 4770 Buford Hwy NE,Mailstop F-53, Atlanta, GA 30341 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.}},
DOI = {{10.1289/ehp.1002231}},
ISSN = {{0091-6765}},
Keywords = {{biomonitoring; DEHP; DEP; exposure; human; phthalates; urine;
   variability}},
Keywords-Plus = {{TEMPORAL VARIABILITY; PREGNANT-WOMEN; US POPULATION; EXPOSURE; PRODUCTS;
   CHILDREN; SAMPLES; AGE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{Acalafat@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Caudill SP, 2008, STAT MED, V27, P4094, DOI 10.1002/sim.3222.
   David RM, 2001, PATTYS TOXICOLOGY, V6, P635.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Houlihan J., 2002, NOT TOO PRETTY PHTHA.
   Hubinger JC, 2006, J COSMET SCI, V57, P127.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Li Z, 2010, J EXPO SCI ENV EPID, V20, P526, DOI 10.1038/jes.2009.41.
   Pearson MA, 2009, J EXPO SCI ENV EPID, V19, P336, DOI 10.1038/jes.2008.48.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   {*}CDC, 2010, 4 CDC NAT CTR ENV HL.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{34}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{692YB}},
Wos-Id = {{ISI:000285190700031}},
}

@article{ ISI:000284199800016,
Author = {Carbone, Silvia and Szwarcfarb, Berta and Ponzo, Osvaldo and Reynoso,
   Roxana and Cardoso, Nancy and Deguiz, Laura and Moguilevsky, Jaime A.
   and Scacchi, Pablo},
Title = {{Impact of gestational and lactational phthalate exposure on hypothalamic
   content of amino acid neurotransmitters and FSH secretion in
   peripubertal male rats}},
Journal = {{NEUROTOXICOLOGY}},
Year = {{2010}},
Volume = {{31}},
Number = {{6}},
Pages = {{747-751}},
Month = {{DEC}},
Abstract = {{This study investigated the effect of the pre- and perinatal exposure to
   di-(2-ethylhexyl) phthalate (DEHP) on the neuroendocrine parameters that
   regulate reproduction in peripubertal male rats. DEHP at dose of 3 and
   30 mg/kg bw/day was administered orally to female rat since pregnancy
   onset until weaning. The male litters were sacrificed at 30 days of age
   to determine gonadotropin serum level and the hypothalamic contents of
   the amino acids aspartate and gamma-aminobutyric acid. No changes in
   gonadotropin, aspartate and gamma-aminobutyric acid levels were detected
   at the low dose. DEHP 30 mg/kg bw/day reduced testis weight and serum
   FSH, in correlation with a significant increase in the inhibitory
   GABAergic tone and a reduction in the stimulatory effect of aspartate on
   gonadotropin level. This study provides unknown data regarding changes
   in the hypothalamic contents of the amino acid neurotransmitters, which
   are involved in the neuroendocrine regulation of reproductive axis, in
   peripubertal male rat offspring from dams exposed to DEHP during
   gestational and lactational periods. This could be related with the
   gonadotropin modifications also here described. (C) 2010 Elsevier Inc.
   All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ponzo, O (Reprint Author), Univ Buenos Aires, Fac Med, Dept Fisiol, Paraguay 2155,7 P C1121 CABG, RA-2155 Buenos Aires, DF, Argentina.
   Carbone, Silvia; Ponzo, Osvaldo; Reynoso, Roxana; Cardoso, Nancy; Deguiz, Laura; Moguilevsky, Jaime A.; Scacchi, Pablo, Univ Buenos Aires, Fac Med, Dept Fisiol, RA-2155 Buenos Aires, DF, Argentina.
   Carbone, Silvia; Szwarcfarb, Berta; Scacchi, Pablo, Consejo Nacl Invest Cient \& Tecn, RA-1033 Buenos Aires, DF, Argentina.
   Moguilevsky, Jaime A., Univ Favaloro, Fac Postgrad, Buenos Aires, DF, Argentina.}},
DOI = {{10.1016/j.neuro.2010.06.006}},
ISSN = {{0161-813X}},
Keywords = {{Phtalate; Rats; Gestational; Lactational; Gonadotropin; Aspartate; GABA}},
Keywords-Plus = {{REPRODUCTIVE-TRACT DEVELOPMENT; DIETHYLHEXYL PHTHALATE; IN-UTERO;
   DI-(2-ETHYLHEXYL) PHTHALATE; SEXUAL-DIFFERENTIATION;
   LUTEINIZING-HORMONE; PERINATAL EXPOSURE; ESTER TOXICITY; LH; DEHP}},
Research-Areas = {{Neurosciences \& Neurology; Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Neurosciences; Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{oponzo@fmed.uba.ar}},
Funding-Acknowledgement = {{Agencia de Promocion Cientifica y Tecnica {[}BID 1728 PIC 2003];
   Universidad Buenos Aires {[}UBACYT M816, UBACYT M006]}},
Funding-Text = {{This work was supported by Grants from Agencia de Promocion Cientifica y
   Tecnica BID 1728 PIC 2003 and the Universidad Buenos Aires (UBACYT M816
   and UBACYT M006). We thanks Angela Ciocca for the manuscript revision.}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Albro P.W., 1987, REV BIOCHEM TOXICOL, V8, P73.
   Andrade AJM, 2006, TOXICOLOGY, V225, P64, DOI 10.1016/j.tox.2006.05.007.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   Bonefeld-Jorgensen EC, 2001, TOXICOLOGY, V158, P141, DOI 10.1016/S0300-483X(00)00368-1.
   Borch J, 2005, REPROD TOXICOL, V19, P517, DOI 10.1016/j.reprotox.2004.11.004.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   Brann WD, 1994, FRONT NEUROENDOCRIN, V15, P3.
   Calafat AM, 2006, ENV HLTH PERSPECT, V114, P783.
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Carbone S, 1996, BRAIN RES, V707, P139, DOI 10.1016/0006-8993(95)01216-8.
   Dalsenter PR, 2006, HUM EXP TOXICOL, V25, P297, DOI 10.1191/0960327105ht624oa.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   Feleder C, 1996, NEUROENDOCRINOLOGY, V64, P305, DOI 10.1159/000127133.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Ge RS, 2007, REPROD TOXICOL, V23, P366, DOI 10.1016/j.reprotox.2006.12.006.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Hu GX, 2009, TRENDS ENDOCRIN MET, V20, P139, DOI 10.1016/j.tem.2008.12.001.
   JARRY H, 1992, NEUROENDOCRINOLOGY, V56, P133, DOI 10.1159/000126220.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Moguilevsky JA, 2001, EXP CLIN ENDOCR DIAB, V109, P188, DOI 10.1055/s-2001-15105.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   NISWENDE.GD, 1968, P SOC EXP BIOL MED, V128, P807.
   NTP-CERHR, 2006, NIH PUBL.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Rubin BS, 2001, ENVIRON HEALTH PERSP, V109, P675, DOI 10.2307/3454783.
   Shinji T, 2005, TOXICOLOGY, V210, P223.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   SZWARCFARB B, 1994, BRAIN RES, V646, P351, DOI 10.1016/0006-8993(94)90105-8.
   Urbanski HF, 1994, PHYSL REPRODUCTION, V2, P363.
   WILSON VS, 2004, TOXICOL LETT, V146, P2107.
   Wilson VS, 2008, INT J ANDROL, V31, P178, DOI 10.1111/j.1365-2605.2007.00861.x.
   {*}NTP CERHR, 2000, NTPCERHRDEHP00.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{5}},
Journal-ISO = {{Neurotoxicology}},
Doc-Delivery-Number = {{679ZR}},
Wos-Id = {{ISI:000284199800016}},
}

@article{ ISI:000284670900001,
Author = {Schlumpf, Margret and Kypke, Karin and Wittassek, Matthias and Angerer,
   Juergen and Mascher, Hermann and Mascher, Daniel and Vokt, Cora and
   Birchler, Monika and Lichtensteiger, Walter},
Title = {{Exposure patterns of UV filters, fragrances, parabens, phthalates,
   organochlor pesticides, PBDEs, and PCBs in human milk Correlation of UV
   filters with use of cosmetics}},
Journal = {{CHEMOSPHERE}},
Year = {{2010}},
Volume = {{81}},
Number = {{10}},
Pages = {{1171-1183}},
Month = {{NOV}},
Abstract = {{In order to assess potential risks of exposure to environmental
   chemicals more information on concomitant exposure to different
   chemicals is needed We present data on chemicals in human milk of a
   cohort study (2004 2005 2006) of 54 mother/child pairs where for the
   first time cosmetic UV filters synthetic musks parabens and phthalate
   metabolites were analyzed in the same sample along with persistent
   organochlor pollutants (POPs) i e organochlor pesticides and metabolites
   polybrominated diphenylethers and polychlorinated biphenyls (PCBs) The
   two groups of chemicals exhibited different exposure patterns Six out of
   seven PCB congeners and a majority of pesticides were present in all
   milk samples with significant correlations between certain PCB congener
   and pesticide levels whereas the cosmetic derived compounds UV filters
   parabens and synthetic musks exhibited a more variable exposure pat tern
   with Inter individual differences UV filters were present in 85 2\% of
   milk samples in the range of PCB levels Comparison with a questionnaire
   revealed a significant correlation between use of products containing UV
   filters and their presence in milk for two frequently used and detected
   UV filters 4-methylbenzylidene camphor and octocrylene and for the whole
   group of UV filters Concentrations of PCBs and organochlor pesticides
   were within ranges seen in Western and Southern European countries For
   several POPs mean and/or maximum daily intake calculated from individual
   concentrations was above recent US EPA reference dose values Our data
   emphasize the need for analyses of complex mixtures to obtain more
   information on inter-individual and temporal variability of human
   exposure to different types of chemicals (C) 2010 Elsevier Ltd All
   rights reserved}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Schlumpf, M (Reprint Author), GREEN Tox, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
   Schlumpf, Margret; Lichtensteiger, Walter, GREEN Tox, CH-8057 Zurich, Switzerland.
   Schlumpf, Margret; Lichtensteiger, Walter, Univ Zurich, Inst Anat, Zurich, Switzerland.
   Kypke, Karin, State Inst Chem \& Vet Anal Food, Freiburg, Germany.
   Univ Erlangen Nurnberg, Occupat Toxicol \& Food Chem Inst, Erlangen, Germany.
   Univ Erlangen Nurnberg, Outpatient Clin Occupat Social \& Environm Med, Erlangen, Germany.
   Mascher, Hermann; Mascher, Daniel, Pharm Analyt Lab, Baden, Austria.
   Vokt, Cora; Birchler, Monika, Univ Womens Hosp, Basel, Switzerland.}},
DOI = {{10.1016/j.chemosphere.2010.09.079}},
ISSN = {{0045-6535}},
Keywords = {{Human milk; Cosmetic use; UV filters; Parabens; Phthalates; Persistent
   organic pollutants (POPs)}},
Keywords-Plus = {{HUMAN BREAST-MILK; TANDEM MASS-SPECTROMETRY; POLYBROMINATED DIPHENYL
   ETHERS; POLYCHLORINATED-BIPHENYLS; MOTHERS MILK; HUMAN URINE;
   4-METHYLBENZYLIDENE CAMPHOR; DEVELOPMENTAL TOXICITY; ESTROGENIC
   ACTIVITY; POSTNATAL EXPOSURE}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Funding-Acknowledgement = {{Swiss National Research Programme (NRP) {[}50]; Swiss Enviromental
   Protection Agency (BAFU)}},
Funding-Text = {{The study was supported by the Swiss National Research Programme (NRP)
   50 and the Swiss Enviromental Protection Agency (BAFU) We thank Prof
   Valentin Rousson (Institut Universitaire de Medecine Sociale et
   Preventive Centre Hospitalier Universitaire Lausanne Switzerland) for
   statistical analyses Ina Wegert and Monika Golz for technical support in
   analytical methods and quality control and Ralf Brandstetter for running
   the GC analyses (State Institute for Chemical and Veterinary Analysis of
   Food Freiburg Germany)}},
Cited-References = {{Abballe A, 2008, CHEMOSPHERE, V73, pS220, DOI 10.1016/j.chemosphere.2007.12.036.
   Andersson AM, 2008, INT J ANDROL, V31, P74, DOI 10.1111/j.1365-2605.2007.00853.x.
   Balmer ME, 2005, ENVIRON SCI TECHNOL, V39, P953, DOI 10.1021/es040055r.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Campoy C, 2001, EARLY HUM DEV, V65, pS183, DOI 10.1016/S0378-3782(01)00221-3.
   Chen JG, 2007, TOXICOL APPL PHARM, V221, P278, DOI 10.1016/j.taap.2007.03.015.
   Colles A, 2008, CHEMOSPHERE, V73, P907, DOI 10.1016/j.chemosphere.2008.07.002.
   Darbre PD, 2003, J APPL TOXICOL, V23, P43, DOI 10.1002/jat.886.
   Durrer S, 2007, ENVIRON HEALTH PERSP, V115, P42, DOI 10.1289/ehp.9134.
   Ennaceur S, 2008, ENVIRON RES, V108, P86, DOI 10.1016/j.envres.2008.05.005.
   ESCHLE HD, 1995, HUMANFETT MUTTERMILC, V92, P375.
   Faass O, 2009, NEUROTOXICOLOGY, V30, P249, DOI 10.1016/j.neuro.2008.12.008.
   Fent K, 2010, ENVIRON POLLUT, V158, P1817, DOI 10.1016/j.envpol.2009.11.005.
   Fromme H., 2009, Umweltmedizin in Forschung und Praxis, V14, P307.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Hoover SM, 1999, RISK ANAL, V19, P527, DOI 10.1023/A:1007065032101.
   Hui LL, 2008, CHEMOSPHERE, V73, P50, DOI 10.1016/j.chemosphere.2008.05.045.
   KANDARAKIS ED, 2009, ENDOCR REV, V30, P293.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Latini G, 2009, ENVIRON INT, V35, P236, DOI 10.1016/j.envint.2008.06.002.
   Lignell S, 2008, ENVIRON SCI TECHNOL, V42, P6743, DOI 10.1021/es800626n.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Malisch R., 2006, ORGANOHALOGEN COMPD, V68, P1627.
   Mascher HJ, 2008, J CHROMATOGR B, V869, P84, DOI 10.1016/j.jchromb.2008.05.015.
   Matsumoto H, 2005, YAKUGAKU ZASSHI, V125, P643, DOI 10.1248/yakushi.125.643.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   NEVILLE MC, 1988, AM J CLIN NUTR, V48, P1375.
   OLESEN LD, 2005, CHEMOSPHERE, V61, P422.
   Polder A, 2009, SCI TOTAL ENVIRON, V407, P4584, DOI 10.1016/j.scitotenv.2009.04.032.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Raab U, 2008, CHEMOSPHERE, V72, P87, DOI 10.1016/j.chemosphere.2008.01.053.
   Reiner JL, 2007, ENVIRON SCI TECHNOL, V41, P3815, DOI 10.1021/es063088a.
   ROGAN WJ, 1986, AM J PUBLIC HEALTH, V76, P172, DOI 10.2105/AJPH.76.2.172.
   Routledge EJ, 1998, TOXICOL APPL PHARM, V153, P12, DOI 10.1006/taap.1998.8544.
   Schauer UMD, 2006, TOXICOL APPL PHARM, V216, P339, DOI 10.1016/j.taap.2006.05.011.
   Schecter A, 2003, ENVIRON HEALTH PERSP, V111, P1723, DOI 10.1289/ehp.6466.
   Schlumpf M, 2008, CHIMIA, V62, P345, DOI 10.2533/chimia.2008.345.
   Schlumpf M, 2008, INT J ANDROL, V31, P144, DOI 10.1111/j.1365-2605.2007.00856.x.
   Seidlova-Wuttke D, 2006, TOXICOL APPL PHARM, V214, P1, DOI 10.1016/j.taap.2005.11.002.
   Sudaryanto A, 2006, ENVIRON POLLUT, V139, P107, DOI 10.1016/j.envpol.2005.04.028.
   Toms LML, 2009, ENVIRON INT, V35, P864, DOI 10.1016/j.envint.2009.03.001.
   Tsydenova OV, 2007, ENVIRON POLLUT, V146, P225, DOI 10.1016/j.envpol.2006.04.036.
   TUE NM, 2009, INTERDISCIPLINARY ST, P91.
   Ye XY, 2009, ENVIRON INT, V35, P1160, DOI 10.1016/j.envint.2009.07.011.
   Ye XY, 2008, ANAL CHIM ACTA, V622, P150, DOI 10.1016/j.aca.2008.05.068.
   ZEHRINGER M, 2001, EUR FOOD RES TECHNOL, V21, P2247.
   Zhao GF, 2007, SCI TOTAL ENVIRON, V378, P281, DOI 10.1016/j.scitotenv.2007.03.008.
   Zietz BP, 2008, INT J HYG ENVIR HEAL, V211, P624, DOI 10.1016/j.ijheh.2008.04.001.}},
Number-of-Cited-References = {{49}},
Times-Cited = {{37}},
Journal-ISO = {{Chemosphere}},
Doc-Delivery-Number = {{686BD}},
Wos-Id = {{ISI:000284670900001}},
}

@article{ ISI:000283170400009,
Author = {Just, Allan C. and Adibi, Jennifer J. and Rundle, Andrew G. and Calafat,
   Antonia M. and Camann, Davide. and Hauser, Russ and Silva, Manori J. and
   Whyatt, Robin M.},
Title = {{Urinary and air phthalate concentrations and self-reported use of
   personal care products among minority pregnant women in New York city}},
Journal = {{JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY}},
Year = {{2010}},
Volume = {{20}},
Number = {{7}},
Pages = {{625-633}},
Month = {{NOV-DEC}},
Abstract = {{Diethyl phthalate (DEP) and di-n-butyl phthalate (DnBP) are used
   extensively in personal care products, including fragrances (DEP) and
   nail polish (DnBP). Between May 2003 and July 2006, we gathered
   questionnaire data on the use of seven product categories (deodorant,
   perfume, hair spray, hair gel, nail polish/polish remover, liquid
   soap/body wash, and lotion/mist) over 48 h during the third trimester of
   pregnancy from 186 inner-city women. A 48-h personal air sample was
   collected and analyzed for DEP and DnBP; a maternal spot urine sample
   was collected and analyzed for their monoester metabolites, monoethyl
   phthalate (MEP) and mono-n-butyl phthalate (MnBP), respectively. In all,
   97\% of air samples and 84\% of urine samples were collected within +/-
   2 days of the questionnaire. During the 48 h, 41\% of women reported
   perfume use and 10\% reported nail polish/polish remover use. In
   adjusted analyses, no association was seen between nail product use and
   air DnBP or urine MnBP concentrations. Women reporting perfume use had
   2.3 times higher (95\% CI 1.6, 3.3) urinary MEP concentrations. Personal
   air DEP increased by 7\% for each 25\% increase in a composite indicator
   of the six other product categories (P<0.05), but was not associated
   with perfume use. Air DEP was correlated with urine MEP concentrations
   only among non-perfume users (r = 0.51, P<0.001). Results suggest that
   perfume use is a significant source of DEP exposure. Journal of Exposure
   Science and Environmental Epidemiology (2010) 20, 625-633;
   doi:10.1038/jes.2010.13; published online 31 March 2010}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Just, AC (Reprint Author), Columbia Univ, Joseph L Mailman Sch Publ Hlth, Dept Environm Hlth Sci, 60 Haven Ave,B-109, New York, NY 10032 USA.
   Just, Allan C.; Rundle, Andrew G.; Whyatt, Robin M., Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, New York, NY 10032 USA.
   Adibi, Jennifer J., Univ Calif San Francisco, Dept Obstet Gynecol \& Reprod Sci, San Francisco, CA 94143 USA.
   Calafat, Antonia M.; Silva, Manori J., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Camann, Davide., SW Res Inst, San Antonio, TX USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Hauser, Russ, Harvard Univ, Massachusetts Gen Hosp, Sch Med, Vincent Mem Obstet \& Gynecol Serv, Boston, MA USA.}},
DOI = {{10.1038/jes.2010.13}},
ISSN = {{1559-0631}},
Keywords = {{DEP; DnBP; human biomonitoring; personal care products}},
Keywords-Plus = {{COSMETIC PRODUCTS; CONSUMER PRODUCTS; EXPOSURE; METABOLITES; HUMANS;
   INGREDIENTS; POPULATION; OUTCOMES; SAMPLES; HEALTH}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{acj2109@columbia.edu}},
ResearcherID-Numbers = {{Rundle, Andrew/A-5282-2009}},
ORCID-Numbers = {{Rundle, Andrew/0000-0003-0211-7707}},
Funding-Acknowledgement = {{National Institutes of Environmental Health Sciences (NIEHS) {[}R01
   ES013543, R01 ES014393, R01 ES008977];  {[}P01 ES09600/EPA RD-8321]}},
Funding-Text = {{The authors gratefully acknowledge the contributions of many staff and
   participants at the Columbia Center for Children's Environmental Health
   and the technical assistance of Ella Samandar, James Preau, Jack Reidy,
   and others at the Centers for Disease Control and Prevention (CDC) in
   measuring the urinary concentrations of phthalate metabolites. This work
   was supported by Grants R01 ES013543, R01 ES014393, and R01 ES008977
   from the National Institutes of Environmental Health Sciences (NIEHS),
   as well as P01 ES09600/EPA RD-8321. Doctoral training support for ACJ
   came from T32 ES07322 and TL1 RR024158.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Gelman Andrew, 2007, DATA ANAL USING REGR.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hines CJ, 2009, ANN OCCUP HYG, V53, P1, DOI 10.1093/annhyg/men066.
   Houlihan J., 2002, NOT TOO PRETTY PHTHA.
   Hubinger JC, 2006, J COSMET SCI, V57, P127.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Kwapniewski R, 2008, J OCCUP ENVIRON MED, V50, P705, DOI 10.1097/JOM.0b013e3181651571.
   Loretz L, 2006, FOOD CHEM TOXICOL, V44, P2008, DOI 10.1016/j.fct.2006.06.029.
   Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742.
   PETERS RJB, 2005, PHTHALATES ARTIFICIA.
   R Development Core Team, 2009, R LANG ENV STAT COMP.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Grandjean P, 2006, INT J ANDROL, V29, P181, DOI 10.1111/j.1365-2605.2005.00679.x.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Shen HY, 2007, J SEP SCI, V30, P48, DOI 10.1002/jssc.200600215.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Steinemann AC, 2009, ENVIRON IMPACT ASSES, V29, P32, DOI 10.1016/j.eiar.2008.05.002.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   TEASS AW, 1998, NIOSH MANUAL ANAL ME, P52.
   Whyatt RM, 2003, ENVIRON HEALTH PERSP, V111, P749, DOI 10.1289/ehp.5768.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{7}},
Journal-ISO = {{J. Expo. Sci. Environ. Epidemiol.}},
Doc-Delivery-Number = {{667CO}},
Wos-Id = {{ISI:000283170400009}},
}

@article{ ISI:000281942800010,
Author = {van Ravenzwaay, B. and Cunha, G. Coelho-Palermo and Strauss, V. and
   Wiemer, J. and Leibold, E. and Kamp, H. and Walk, T. and Mellert, W. and
   Looser, R. and Prokoudine, A. and Fabian, E. and Krennrich, G. and
   Herold, M.},
Title = {{The individual and combined metabolite profiles (metabolomics) of
   dibutylphthalate and di(2-ethylhexyl)phthalate following a 28-day
   dietary exposure in rats}},
Journal = {{TOXICOLOGY LETTERS}},
Year = {{2010}},
Volume = {{198}},
Number = {{2}},
Pages = {{159-170}},
Month = {{OCT 5}},
Abstract = {{Metabolite profiles (metabolomics) of plasma samples of Wistar rats
   dosed with di(2-ethylhexyl)phthalate (DEHP - 3000 ppm) and
   dibutylphthalate (DBP - 150, 1000 and 7000 ppm) were individually
   determined in 28 days dietary studies. In addition, profiles of combined
   exposure to 3000 ppm DEHP and either 150, 1000 or 7000 ppm DBP were
   determined.
   High dose levels induced more profound metabolite changes in males than
   in females for both compounds. At 150 ppm DBP (NOEL for toxicity) there
   were very few (<false positives rate), inconsistent changes,
   demonstrating a metabolomic NOEL A part of the total metabolite profile
   was consistent with a pattern of changes indicative of peroxisome
   proliferation, confirmed by increased cyanide-insensitive Palmitoyl-CoA
   oxidation.
   Simultaneous administration of 3000 ppm DEHP and 150 ppm DBP did not
   result in relevant changes when compared to the metabolite profile of
   3000 ppm DEHP alone. Co-administration of 1000 ppm DBP induced marginal
   additional changes relative to the profile of 3000 ppm DEHP alone.
   Simultaneous exposure to high dose levels of DEHP and DBP resulted in a
   profile that was significantly different compared to the individual
   compounds. A quantitative statistical analysis of the data revealed that
   the effect of combined treatment on the metabolites was less than
   additive. (C) 2010 Elsevier Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{van Ravenzwaay, B (Reprint Author), BASF SE, Expt Toxicol \& Ecol, Z 470, D-67056 Ludwigshafen, Germany.
   van Ravenzwaay, B.; Cunha, G. Coelho-Palermo; Strauss, V.; Leibold, E.; Kamp, H.; Mellert, W.; Fabian, E.; Krennrich, G., BASF SE, Expt Toxicol \& Ecol, D-67056 Ludwigshafen, Germany.
   Wiemer, J.; Walk, T.; Looser, R.; Prokoudine, A.; Herold, M., Metanomics GmbH, D-10589 Berlin, Germany.}},
DOI = {{10.1016/j.toxlet.2010.06.009}},
ISSN = {{0378-4274}},
Keywords = {{Metabolomics; Metabolite profiling; Dibutylphthalate;
   Di(2-ethylhexyl)phthalate; Mode of action; Combination toxicity}},
Keywords-Plus = {{SPECIES-DIFFERENCES; MAGNETIC-RESONANCE; MASS-SPECTROMETRY;
   PHTHALATE-ESTERS; TOXICITY; CHEMICALS; METABONOMICS; COMBINATION;
   MIXTURES; GENDER}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{bennard.ravenzwaay@basf.com}},
Cited-References = {{ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   ANDERSON W, 2001, FOOD ADDIT CONTAM, V12, P1068.
   CHARTURVED AK, 1993, J APPL TOXICOL, V13, P183.
   David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195.
   Fernie A. R., 2004, NAT REV MOL CELL BIO, V5, P1.
   FERON VJ, 1995, TOXICOL LETT, V76, P47, DOI 10.1016/0378-4274(94)03193-2.
   Feron VJ, 1995, TOXICOL LETT, V82-3, P505, DOI 10.1016/0378-4274(95)03580-X.
   GRAY TJB, 1983, TOXICOLOGY, V28, P167, DOI 10.1016/0300-483X(83)90115-4.
   GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9.
   Groten JP, 1997, FUND APPL TOXICOL, V36, P15, DOI 10.1006/faat.1996.2281.
   HEINDEL JJ, 1994, FUND APPL TOXICOL, V22, P605, DOI 10.1006/faat.1994.1067.
   ITO N, 1995, FOOD CHEM TOXICOL, V33, P159, DOI 10.1016/0278-6915(94)00118-8.
   JANSEN EHJ, 1993, 618902013 TOX INV D.
   JONKER D, 1993, FOOD CHEM TOXICOL, V31, P125, DOI 10.1016/0278-6915(93)90126-J.
   KAWASHIMA Y, 1990, J BIOL CHEM, V265, P9170.
   Kochhar S, 2006, ANAL BIOCHEM, V352, P274, DOI 10.1016/j.ab.2006.02.033.
   Krishnan K, 1991, ARCH COMPLEX ENV STU, V3, P1.
   Lazarow P B, 1981, Methods Enzymol, V72, P315.
   Lindon JC, 2004, PROG NUCL MAG RES SP, V45, P109, DOI 10.1016/j.pnmrs.2004.05.001.
   Looser R, 2005, METABOLOME ANALYSES: STRATEGIES FOR SYSTEMS BIOLOGY, P103, DOI 10.1007/0-387-25240-1\_7.
   Mumtaz M. M., 1994, P565.
   OISHI S, 1980, TOXICOL APPL PHARM, V53, P35, DOI 10.1016/0041-008X(80)90378-6.
   PLACKETT RL, 1952, J ROY STAT SOC B, V14, P141.
   Plumb RS, 2005, ANALYST, V130, P844, DOI 10.1039/b501767j.
   Roessner U, 2000, PLANT J, V23, P131, DOI 10.1046/j.1365-313x.2000.00774.x.
   SCHILLING K, 1992, CONFIDENTIAL REPORT.
   SRIVASTAVA SP, 1990, ARCH TOXICOL, V64, P148, DOI 10.1007/BF01974401.
   STRAUSS V, 2009, TOXICOL LETT, V191, P85.
   van Ravenzwaay B, 2010, OMICS PERSPECTIVE ON CANCER RESEARCH, P141, DOI 10.1007/978-90-481-2675-0\_8.
   van Ravenzwaay B, 2007, TOXICOL LETT, V172, P21, DOI 10.1016/j.toxlet.2007.05.021.
   Walk T.B., 2003, Patent application, Patent No. {[}PCT/EP2003/001274, 2003001274].
   Walk T.B., 2003, Mass spectrometry method for analysing mixtures of substances, Patent No. 2003073464.
   Weckwerth W, 2005, DRUG DISCOV TODAY, V10, P1551, DOI 10.1016/S1359-6446(05)03609-3.
   Yamada H, 2002, J ANAL TOXICOL, V26, P17.
   Yang Raymond S. H., 1994, P99.
   {*}ECETOC, 2007, WORKSH APPL OM TECHN.
   {*}NTP, 1995, TOX REP SER NTP, V30.
   {*}NTP, 1995, NIH PUBL.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{0}},
Journal-ISO = {{Toxicol. Lett.}},
Doc-Delivery-Number = {{651QS}},
Wos-Id = {{ISI:000281942800010}},
}

@article{ ISI:000282841800009,
Author = {Guo, Zhi-Yong and Gai, Pan-Pan and Duan, Jing and Zhai, Jin-Xia and
   Zhao, Sha-Sha and Wanga, Sui and Wei, Dan-Yi},
Title = {{Simultaneous determination of phthalates and adipates in human serum
   using gas chromatography-mass spectrometry with solid-phase extraction}},
Journal = {{BIOMEDICAL CHROMATOGRAPHY}},
Year = {{2010}},
Volume = {{24}},
Number = {{10}},
Pages = {{1094-1099}},
Month = {{OCT}},
Abstract = {{A gas chromatography-mass spectrometry assay was developed and validated
   for the simultaneous determination of phthalates and adipates in human
   serum. The phthalates and adipates studied were dimethyl phthalate,
   diethyl phthalate, dibutyl phthalate, benzylbutyl phthalate,
   di-2-ethylhexyl phthalate, di-n-octyl phthalate, diethyl adipate,
   dibutyl adipate, diisobutyl adipate, bis(2-butoxyethyl) adipate and
   di-2-ethylhexyl adipate, with diisooctyl phthalate as internal standard.
   The extraction and cleaning up procedure was carried out with
   solid-phase extraction cartridges containing dimethyl butylamine groups,
   which showed extraction efficiencies over 88\% for each analyte and the
   internal standard. The calibration curves obtained were linear with
   correlation coefficients greater than 0.98. For all analytes, the assay
   gave CV\% values for intra-day precision from 4.9 to 13.3\% and mean
   accuracy values from 91.4 to 108.4\%, while inter-day precision was
   5.2-13.4\% and mean accuracy 91.0-110.2\%. The limits of detection for
   the assay of phthalates and adipates were in the range 0.7-4.5 ng/mL.
   The method is simple, sensitive and accurate, and allows for
   simultaneous determination of nanogram levels of phthalates and adipates
   in human serum. It was successfully applied to an investigation on the
   level of phthalates and adipates in a non-occupationally exposed
   population. Copyright (C) 2010 John Wiley \& Sons, Ltd.}},
Publisher = {{JOHN WILEY \& SONS LTD}},
Address = {{THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Guo, ZY (Reprint Author), Ningbo Univ, Fac Mat Sci \& Chem Engn, State Key Lab Base Novel Funct Mat \& Preparat Sc, Ningbo 315211, Zhejiang, Peoples R China.
   Guo, Zhi-Yong; Gai, Pan-Pan; Duan, Jing; Wanga, Sui; Wei, Dan-Yi, Ningbo Univ, Fac Mat Sci \& Chem Engn, State Key Lab Base Novel Funct Mat \& Preparat Sc, Ningbo 315211, Zhejiang, Peoples R China.
   Zhai, Jin-Xia, Anhui Med Univ, Sch Publ Hlth, Hefei 230032, Anhui, Peoples R China.
   Zhao, Sha-Sha, Anhui Res Inst Family Planning, Hefei 230021, Anhui, Peoples R China.}},
DOI = {{10.1002/bmc.1410}},
ISSN = {{0269-3879}},
Keywords = {{phthalates; adipates; human serum; GC-MS; solid-phase extraction;
   simultaneous determination}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; ESTERS; PLASMA; METABOLITES; EXPOSURE; RATS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Biochemistry \& Molecular Biology;
   Chemistry, Analytical; Pharmacology \& Pharmacy}},
Author-Email = {{gzy98618@sina.com}},
Funding-Acknowledgement = {{Science and Technology Department of Zhejiang Province of China
   {[}2007F70009, 2007R40G2070022]; Ningbo University}},
Funding-Text = {{Financial support from the Science and Technology Department of Zhejiang
   Province of China (2007F70009, 2007R40G2070022) is gratefully
   acknowledged. This work was also sponsored by K.C. Wong Magna Fund in
   Ningbo University.}},
Cited-References = {{BERGMAN K, 1987, FOOD CHEM TOXICOL, V25, P309, DOI 10.1016/0278-6915(87)90128-1.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Cao XL, 2008, J CHROMATOGR A, V1178, P231, DOI 10.1016/j.chroma.2007.11.095.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Dalgaard M, 2003, REPROD TOXICOL, V17, P163, DOI 10.1016/S0890-6238(02)00149-1.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   HIRAYAMA K, 2001, KIKAN KAGAKU SOSETSU, V50, P117.
   Kambia K, 2001, J CHROMATOGR B, V755, P297, DOI 10.1016/S0378-4347(01)00125-6.
   Kato K, 2002, J AOAC INT, V85, P719.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   KOTSUKA Y, 1997, KAWASAKI SHI KOGAI K, V23, P10.
   Kueseng P, 2007, J ENVIRON SCI HEAL B, V42, P569, DOI 10.1080/03601230701389488.
   Lake BG, 1997, TOXICOLOGY, V123, P217, DOI 10.1016/S0300-483X(97)00125-X.
   Niino T, 2002, J CHROMATOGR B, V780, P35, DOI 10.1016/S1570-0232(02)00413-0.
   OKA H, 2004, JPN J FOOD CHEM, V11, P106.
   Pietrogrande MC, 2003, ANAL CHIM ACTA, V480, P1, DOI 10.1016/S0003-2670(02)01652-5.
   Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1.
   Takatori S, 2004, J CHROMATOGR B, V804, P397, DOI 10.1016/j.jchromb.2004.01.056.
   TEIRLYNCK OA, 1985, J CHROMATOGR, V342, P399, DOI 10.1016/S0378-4347(00)84534-X.
   TONG B, 2006, J SAFETY ENV, V6, P25.
   Tsumura Y, 2000, J FOOD HYG SOC JPN, V41, P254, DOI 10.3358/shokueishi.41.254.
   WEI DY, 2009, J FOOD SCI, V74, P392.
   {*}EUR FOOD SAF AUTH, 2005, EFSA J, V244, P1.
   <IT>European Food Safety Authority</IT>, 2005, EFSA J, V245, P1.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{1}},
Journal-ISO = {{Biomed. Chromatogr.}},
Doc-Delivery-Number = {{662VH}},
Wos-Id = {{ISI:000282841800009}},
}

@article{ ISI:000280886700007,
Author = {Suzuki, Yayoi and Niwa, Mayu and Yoshinaga, Jun and Mizumoto, Yoshifumi
   and Serizawa, Shigeko and Shiraishi, Hiroaki},
Title = {{Prenatal exposure to phthalate esters and PAHs and birth outcomes}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2010}},
Volume = {{36}},
Number = {{7}},
Pages = {{699-704}},
Month = {{OCT}},
Abstract = {{The purpose of this study was to investigate the relationship between
   the levels of prenatal exposure to phthalate ester and PAHs and birth
   outcomes among 149 Japanese pregnant women.
   Urinary concentrations of 9 phthalate ester metabolites, mono methyl
   phthalate (MMP), mono ethyl phthalate (MEP), mono-n-butyl phthalate
   (MnBP), mono benzyl phthalate (MBzP), mono-2-ethylhexyl phthalate
   (MEHP), mono-2-ethyl-5-hydroxyhexyl phthalate (MEHHP),
   mono-2-ethyl-5-oxohexyl phthalate (MEOHP), mono-iso-nonyl phthalate
   (MINP) and mono-n-octyl phthalate (MnOP) and PAHs metabolite
   (1-hydroxypyrene, 1-OHP) were analyzed in spot urine samples collected
   from pregnant women. Correlation analysis and multiple regression
   analysis were conducted between the concentrations of maternal urinary
   metabolites and birth outcomes such as birth weight, birth length, head
   circumference and gestational age. Creatinine-corrected concentration
   (geometric mean; mu g/g cre) was 9.14 (MMP), 9.76 (MEP), 51.6 (MnBP),
   5.62 (MBzP), 5.45 (MEHP), 10.6 (MEHHP), 11.3 (MEOHP). 0.031 (MINP),
   0.025 (MnOP) and 0.121 (1-OHP). These concentrations are comparable with
   literature value. The relationships between prenatal exposure to
   phthalate esters and birth outcomes were not significant. Statistically
   significant negative correlation was observed between 1-OHP and birth
   weight, birth length and head circumstances although the correlation was
   insignificant when only non-smokers were included in multiple regression
   analysis. In conclusion, we found that prenatal exposure to phthalate
   esters or PAHs did not affect birth outcomes at the exposure level of
   the present subjects. (C) 2010 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Suzuki, Y (Reprint Author), Univ Tokyo, Dept Environm Studies, Kashiwanoha 5-1-5, Chiba 2708563, Japan.
   Suzuki, Yayoi; Niwa, Mayu; Yoshinaga, Jun, Univ Tokyo, Dept Environm Studies, Chiba 2708563, Japan.
   Mizumoto, Yoshifumi, Cent Hosp Self Defense Force, Dept Obstet \& Gynecol, Tokyo, Japan.
   Serizawa, Shigeko; Shiraishi, Hiroaki, Natl Inst Environm Studies, Ibaraki, Japan.}},
DOI = {{10.1016/j.envint.2010.05.003}},
ISSN = {{0160-4120}},
Keywords = {{Phthalate esters; Polycyclic aromatic hydrocarbons; Prenatal exposure;
   Urinary metabolites; Birth size; Gestational age}},
Keywords-Plus = {{POLYCYCLIC AROMATIC-HYDROCARBONS; TEMPORAL VARIABILITY; HUMAN URINE;
   METABOLITES; PREGNANCY; 1-HYDROXYPYRENE; POPULATION;
   DI(2-ETHYLHEXYL)PHTHALATE; TOXICITY; RATS}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{y\_suzuki@envhlth.k.u-tokyo.ac.jp}},
Funding-Acknowledgement = {{Japan Society for the Promotion of Science {[}22310040, 22-5950]}},
Funding-Text = {{We sincerely appreciate the subjects of this study for supplying urine
   samples and the technical staffs and clinical staffs of the Central
   Hospital of Self-Defense Force for sampling and for measurement of birth
   outcomes. Part of this study was financially supported by Grants-in-aid
   for scientific research from Japan Society for the Promotion of Science
   (Project number 22310040 and 22-5950).}},
Cited-References = {{Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   C. D. C. Centers for Disease Control and Prevention, 2009, 4 CDCP.
   Chetiyanukornkul T, 2002, J CHROMATOGR A, V961, P107, DOI 10.1016/S0021-9673(02)00363-1.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   DAVISON JM, 1980, BRIT J OBSTET GYNAEC, V87, P106, DOI 10.1111/j.1471-0528.1980.tb04501.x.
   Dejmek J, 2000, ENVIRON HEALTH PERSP, V108, P1159, DOI 10.2307/3434828.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Jacob R, 2002, J CHROMATOGR B, V778, P31.
   JAN LL, 2009, J TOXICAL ENV HLTH B, V12, P225.
   Japanese Ministry of Health Labor and Welfare, 2010, POP SURV REP.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lau Christopher, 2004, Birth Defects Res C Embryo Today, V72, P300, DOI 10.1002/bdrc.20029.
   Li Z, 2008, ENVIRON RES, V107, P320, DOI 10.1016/j.envres.2008.01.013.
   Meeker JD, 2009, ENVIRON HEALTH PERSP, V117, P1587, DOI 10.1289/ehp.0800522.
   NIWA M, BIOL MONITORIN UNPUB.
   Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742.
   Phillips DH, 1999, MUTAT RES-GEN TOX EN, V443, P139, DOI 10.1016/S1383-5742(99)00016-2.
   Shenkin SD, 2004, PSYCHOL BULL, V130, P989, DOI 10.1037/0033-2909.130.6.989.
   Suzuki K, 2007, INT ARCH OCC ENV HEA, V81, P115, DOI 10.1007/s00420-007-0188-x.
   Suzuki Yayoi, 2009, Environmental Health and Preventive Medicine, V14, P180, DOI 10.1007/s12199-009-0078-9.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   TYL RW, 1988, FUND APPL TOXICOL, V10, P395, DOI 10.1016/0272-0590(88)90286-2.
   VANROOIJ JGM, 1994, INT ARCH OCC ENV HEA, V66, P55.
   Wine RN, 1997, ENVIRON HEALTH PERSP, V105, P102, DOI 10.1289/ehp.97105102.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Zhang YH, 2009, J PEDIATR, V155, P500, DOI 10.1016/j.jpeds.2009.04.007.
   {*}IPCS, 2006, PRINC EV HLTH CHILDR, V237.
   1999, ASAHIKASEI AMIDAS ED.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{14}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{638II}},
Wos-Id = {{ISI:000280886700007}},
}

@article{ ISI:000282376900041,
Author = {Boas, Malene and Frederiksen, Hanne and Feldt-Rasmussen, Ulla and
   Skakkebaek, Niels E. and Hegedus, Laszlo and Hilsted, Linda and Juul,
   Anders and Main, Katharina M.},
Title = {{Childhood Exposure to Phthalates: Associations with Thyroid Function,
   Insulin-like Growth Factor I, and Growth}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2010}},
Volume = {{118}},
Number = {{10}},
Pages = {{1458-1464}},
Month = {{OCT}},
Abstract = {{BACKGROUND: Phthalates are widely used chemicals, and human exposure is
   extensive. Recent studies have indicated that phthalates may have
   thyroid-disrupting properties.
   OBJECTIVE: We aimed to assess concentrations of phthalate metabolites in
   urine samples from Danish children and to investigate the associations
   with thyroid function, insulin-like growth factor I (IGF-I), and growth.
   METHODS: In 845 children 4-9 years of age, we determined urinary
   concentrations of 12 phthalate metabolites and serum levels of
   thyroid-stimulating hormone, thyroid hormones, and IGF-I.
   RESULTS: Phthalate metabolites were detected in all urine samples, of
   which monobutyl phthalate was present in highest concentration.
   Phthalate metabolites were negatively associated with serum levels of
   free and total triiodothyronine, although statistically significant
   primarily in girls. Metabolites of di(2-ethylhexyl) phthalate and
   diisononyl phthalate were negatively associated with IGF-I in boys. Most
   phthalate metabolites were negatively associated with height, weight,
   body surface, and height gain in both sexes.
   CONCLUSIONS: Our study showed negative associations between urinary
   phthalate concentrations and thyroid hormones, IGF-I, and growth in
   children. Although our study was not designed to reveal the mechanism of
   action, the overall coherent negative associations between urine
   phthalate and thyroid and growth parameters may suggest causative
   negative roles of phthalate exposures for child health.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Boas, M (Reprint Author), Rigshosp, Univ Copenhagen Hosp, Dept Growth \& Reprod GR 5064, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
   Boas, Malene; Frederiksen, Hanne; Skakkebaek, Niels E.; Juul, Anders; Main, Katharina M., Rigshosp, Univ Copenhagen Hosp, Dept Growth \& Reprod, DK-2100 Copenhagen, Denmark.
   Feldt-Rasmussen, Ulla, Rigshosp, Univ Copenhagen Hosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark.
   Hegedus, Laszlo, Odense Univ Hosp, Dept Endocrinol \& Metab, DK-5000 Odense, Denmark.
   Hilsted, Linda, Rigshosp, Univ Copenhagen Hosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark.}},
DOI = {{10.1289/ehp.0901331}},
ISSN = {{0091-6765}},
Keywords = {{growth; insulin-like growth factor I; phthalate; thyroid}},
Keywords-Plus = {{ENDOCRINE-DISRUPTING CHEMICALS; IGF-BINDING PROTEIN-3; ACID ESTERS;
   BIS(2-ETHYLHEXYL) PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE;
   DI(2-ETHYLHEXYL) PHTHALATE; TEMPORAL VARIABILITY; URINARY-EXCRETION;
   METABOLITE LEVELS; ORAL TOXICITY}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{maleneboas@dadlnet.dk}},
ResearcherID-Numbers = {{Juul, Anders /F-5864-2013}},
Funding-Acknowledgement = {{Novo Nordisk Foundation; Velux Foundation; Lundbeck Foundation; Danish
   Medical Research Council {[}9700909]; Danish Ministry of Science
   Technology and Innovation {[}2107-05-0006]}},
Funding-Text = {{Financial support was provided by the Novo Nordisk Foundation, the Velux
   Foundation, the Lundbeck Foundation (journal no. 124/05), the Danish
   Medical Research Council (9700909), and the Danish Ministry of Science
   Technology and Innovation (2107-05-0006).K.M.M. was supported by a
   senior researcher grant from the Novo Nordisk Foundation, a research
   foundation independent of the pharmaceutical company. M.B. and N.E.S.
   were supported by a research grant from the Lundbeck Foundation, a
   research foundation independent from the pharmaceutical company. The
   other authors declare they have no actual or potential competing
   financial interests.}},
Cited-References = {{Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   Andersen E, 1982, Ugeskr Laeger, V144, P1760.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128.
   Boas M, 2009, J CLIN ENDOCR METAB, V94, P4031, DOI 10.1210/jc.2009-0939.
   Bowman CJ, 2005, TOXICOL SCI, V86, P161, DOI 10.1093/toxsci/kfi172.
   Chellakooty M, 2006, J CLIN ENDOCR METAB, V91, P820, DOI 10.1210/jc.2005-0950.
   Feld S, 1996, TRENDS ENDOCRIN MET, V7, P85, DOI 10.1016/1043-2760(96)00009-4.
   Fukuwatari T, 2002, BIOSCI BIOTECH BIOCH, V66, P705.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hansen PS, 2004, J CLIN ENDOCR METAB, V89, P2071, DOI 10.1210/jc.2003-031999.
   Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356.
   Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Hussain MA, 1996, EUR J ENDOCRINOL, V134, P563.
   Iglesias P, 2009, EUR J ENDOCRINOL, V160, P503, DOI 10.1530/EJE-08-0837.
   Ishihara A, 2003, MOL CELL ENDOCRINOL, V199, P105, DOI 10.1016/S0303-7207(02)00302-7.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   JORGENSEN JOL, 1989, J CLIN ENDOCR METAB, V69, P1127.
   JUUL A, 1995, J CLIN ENDOCR METAB, V80, P3059, DOI 10.1210/jc.80.10.3059.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   Lin H, 2008, P NATL ACAD SCI USA, V105, P7218, DOI 10.1073/pnas.0709260105.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Nysom K, 2001, INT J OBESITY, V25, P177, DOI 10.1038/sj.ijo.0801515.
   O'Connor JC, 2002, TOXICOL SCI, V69, P92, DOI 10.1093/toxsci/69.1.92.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610.
   Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019.
   Shimada N, 2004, J ENDOCRINOL, V183, P627, DOI 10.1677/joe.1.05893.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Skinner AM, 1996, EUR J PEDIATR, V155, P596, DOI 10.1007/BF01957912.
   Tanaka T, 2005, FOOD CHEM TOXICOL, V43, P581, DOI 10.1016/j.fct.2005.01.001.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   WHO UNICEF International Council for the Control of Iodine Deficiency Disorders, 2007, ASS IOD DEF DIS MON.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Wolff MS, 2007, ENVIRON HEALTH PERSP, V115, P116, DOI 10.1289/ehp.9488.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{28}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{656YL}},
Wos-Id = {{ISI:000282376900041}},
}

@article{ ISI:000282137700009,
Author = {Irvin, Elizabeth Ann and Calafat, Antonia M. and Silva, Manori J. and
   Aguilar-Villalobos, Manuel and Needham, Larry L. and Hall, Daniel B. and
   Cassidy, Brandon and Naeher, Luke P.},
Title = {{An estimate of phthalate exposure among pregnant women living in
   Trujillo, Peru}},
Journal = {{CHEMOSPHERE}},
Year = {{2010}},
Volume = {{80}},
Number = {{11}},
Pages = {{1301-1307}},
Month = {{SEP}},
Abstract = {{Phthalates are a group of phthalic acid esters which are used as
   plasticizers and additives. In laboratory animals, several phthalates
   are known endocrine disruptors. Several studies have described phthalate
   exposure in the United States and developed countries but little is
   known about phthalate exposure in the developing world, particularly
   during pregnancy. To assess exposure to six different phthalates, we
   measured the concentrations of nine phthalate metabolites in spot urine
   samples collected during the first, second, and third trimester of
   pregnancy from a group of 72 women living in Trujillo, Peru.
   Additionally, women completed questionnaires to provide demographic
   characteristics. Statistical analysis via linear models was used to
   evaluate potential differences in the concentrations of phthalate
   metabolites by trimester, cooking fuel type, socioeconomic status, and
   education. All metabolites were detected in >40\% of samples analyzed,
   and mono-n-butyl phthalate, mono (2-ethyl-5-carboxypentyl) phthalate,
   and monoethyl phthalate were found in >90\% of samples. Five of nine
   unadjusted urinary metabolites and four of nine creatinine-adjusted
   urinary metabolites were significantly lower in this group of pregnant
   women living in Peru compared to pregnant women in the US general
   population. (C) 2010 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Naeher, LP (Reprint Author), Univ Georgia, Coll Publ Hlth, Dept Environm Hlth Sci, Athens, GA 30602 USA.
   Irvin, Elizabeth Ann; Cassidy, Brandon; Naeher, Luke P., Univ Georgia, Coll Publ Hlth, Dept Environm Hlth Sci, Athens, GA 30602 USA.
   Calafat, Antonia M.; Silva, Manori J.; Needham, Larry L., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Aguilar-Villalobos, Manuel, Asociac Aire Ambiental, Lima, Peru.
   Hall, Daniel B., Univ Georgia, Dept Stat, Franklin Coll Arts \& Sci, Athens, GA 30602 USA.}},
DOI = {{10.1016/j.chemosphere.2010.06.048}},
ISSN = {{0045-6535}},
Keywords = {{Phthalates; Developing world; Indoor air pollution; Pregnant women}},
Keywords-Plus = {{HUMAN URINE; DEVELOPMENTAL TOXICITY; HUMAN PLACENTA; METABOLITES;
   DI(2-ETHYLHEXYL)PHTHALATE; POPULATION; MONOESTERS; SAMPLES; ESTERS; DEHP}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{LNaeher@uga.edu}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Funding-Acknowledgement = {{International Society of Exposure Science (ISES); American Chemistry
   Council (ACC)}},
Funding-Text = {{The authors would like to thank Ella Samandar, James Preau and John A.
   Reidy (CDC, Atlanta, GA) for technical assistance in measuring the
   concentrations of phthalate metabolites, and Charles Dodson (CDC) for
   assistance in sample collection. We also thank Ing. Jorge Murgia and
   Trujillo City Hall for their invaluable support and assistance with this
   study. We also thank the International Society of Exposure Science
   (ISES) {[}formerly International Society of Exposure Assessment (ISEA)]
   and the American Chemistry Council (ACC) for funding support for this
   study through Luke P. Naeher's ISEA Young Investigator Award. Finally,
   we thank the women from Trujillo who participated in this study.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   BERMAN T, 2008, ENVIRON INT, V35, P353.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Chen ML, 2008, ENVIRON INT, V34, P79, DOI 10.1016/j.envint.2007.07.004.
   Chou YY, 2009, J PEDIATR ENDOCR MET, V22, P69.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P48.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kavlock R, 2002, REPROD TOXICOL, V16, P489, DOI 10.1016/S0890-6238(02)00033-3.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Mose T, 2007, INT J TOXICOL, V26, P221, DOI 10.1080/1091581070135721.
   POOLE CF, 1977, J CHROMATOGR, V132, P511, DOI 10.1016/S0021-9673(00)82915-5.
   Rosner B, 2000, FUNDAMENTALS BIOSTAT.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Williams J, 2005, WILLIAMS OBSTET.
   WITRASEK M, 2008, INT J ANDROL, V31, P131.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   YE X, 2008, ENVIRON RES, V180, P260.
   {*}CDCP, 2003, NAT CTR HLTH STAT NA.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{4}},
Journal-ISO = {{Chemosphere}},
Doc-Delivery-Number = {{653ZK}},
Wos-Id = {{ISI:000282137700009}},
}

@article{ ISI:000280895000007,
Author = {Frederiksen, Hanne and Jorgensen, Niels and Andersson, Anna-Maria},
Title = {{Correlations Between Phthalate Metabolites in Urine, Serum, and Seminal
   Plasma from Young Danish Men Determined by Isotope Dilution Liquid
   Chromatography Tandem Mass Spectrometry}},
Journal = {{JOURNAL OF ANALYTICAL TOXICOLOGY}},
Year = {{2010}},
Volume = {{34}},
Number = {{7}},
Pages = {{400-410}},
Month = {{SEP}},
Publisher = {{PRESTON PUBL INC}},
Address = {{6600 W TOUHY AVE, NILES, IL 60714-4588 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Frederiksen, H (Reprint Author), Copenhagen Univ Hosp, Dept Growth \& Reprod, Rigshosp, Blegdamsvej 9, DK-2100 Copenhagen, Denmark.
   Frederiksen, Hanne; Jorgensen, Niels; Andersson, Anna-Maria, Copenhagen Univ Hosp, Dept Growth \& Reprod, Rigshosp, DK-2100 Copenhagen, Denmark.}},
ISSN = {{0146-4760}},
Keywords-Plus = {{SOLID-PHASE EXTRACTION; IN-UTERO EXPOSURE; HUMAN BREAST-MILK; OXIDATIVE
   METABOLITES; SEMEN QUALITY; DI(2-ETHYLHEXYL) PHTHALATE; QUANTITATIVE
   DETECTION; PREGNANT-WOMEN; MALE RATS; BIOMARKERS}},
Research-Areas = {{Chemistry; Toxicology}},
Web-of-Science-Categories  = {{Chemistry, Analytical; Toxicology}},
Author-Email = {{hanne.01.frederiksen@rh.regionh.dk}},
ResearcherID-Numbers = {{Jorgensen, Niels/A-8148-2012}},
Funding-Acknowledgement = {{Velux Fonden; Danish Research Agency {[}2107-05-0006]; Lundbeck
   Foundation {[}124/05]; European Commission {[}FP7-212844]; Danish
   Environmental Protection Agency {[}MST-621-00013]}},
Funding-Text = {{The authors thank Ole Nielsen, Department of Growth and Reproduction,
   Rigshospitalet, Copenhagen University Hospital, Denmark for skilled
   technical assistance. Velux Fonden financially supported the
   instrumental equipment and the Danish Research Agency (grant no.
   2107-05-0006), the Lundbeck Foundation (j.nr. 124/05), the European
   Commission (FP7-212844, DEER), and the Danish Environmental Protection
   Agency (MST-621-00013) supported the present work.}},
Cited-References = {{Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   CDC-Centers for Disease Control and Prevention, 2009, 4 CDCP, P1.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005.
   Joensen UN, 2009, NAT CLIN PRACT ENDOC, V5, P144, DOI 10.1038/ncpendmet1077.
   Jorgensen N, 2006, INT J ANDROL, V29, P54, DOI 10.1111/j.1365-2605.2005.00635.x.
   Jorgensen N, 2002, HUM REPROD, V17, P2199, DOI 10.1093/humrep/17.8.2199.
   Kato K, 2006, ANAL CHEM, V78, P6651, DOI 10.1021/ac0608220.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   MEEKER JD, 2008, J ANDROL, V30, P287.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Ormond G, 2009, ENVIRON HEALTH PERSP, V117, P303, DOI 10.1289/ehp.11933.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Sathyanarayana S, 2008, ENVIRON RES, V108, P413, DOI 10.1016/j.envres.2008.07.002.
   Sharpe Richard M, 2008, Fertil Steril, V89, pe33, DOI 10.1016/j.fertnstert.2007.12.026.
   SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E.
   Silva MJ, 2005, J ANAL TOXICOL, V29, P819.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Skakkebaek NE, 2006, INT J ANDROL, V29, P2, DOI 10.1111/j.1365-2605.2005.00573.x.
   SKAKKEBAEK NE, 2005, INT J ANDROL, V29, P2.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Ye XB, 2009, INT J HYG ENVIR HEAL, V212, P481, DOI 10.1016/j.ijheh.2009.03.004.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{15}},
Journal-ISO = {{J. Anal. Toxicol.}},
Doc-Delivery-Number = {{638KY}},
Wos-Id = {{ISI:000280895000007}},
}

@article{ ISI:000279580900019,
Author = {Kondo, Fumio and Ikai, Yoshitomo and Hayashi, Rumiko and Okumura,
   Masanao and Takatori, Satoshi and Nakazawa, Hiroyuki and Izumi,
   Shun-ichiro and Makino, Tsunehisa},
Title = {{Determination of Five Phthalate Monoesters in Human Urine Using Gas
   Chromatography-Mass Spectrometry}},
Journal = {{BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY}},
Year = {{2010}},
Volume = {{85}},
Number = {{1}},
Pages = {{92-96}},
Month = {{JUL}},
Abstract = {{We have developed a gas chromatography-mass spectrometry (GC-MS) method
   to determine five phthalate monoesters (monoethyl phthalate (MEP),
   mono-n-butyl phthalate (MBP), mono-(2-ethylhexyl) phthalate (MEHP),
   monoisononyl phthalate (MINP) and monobenzyl phthalate (MBz)) in human
   urine. Human urine samples were subjected to enzymatic deconjugation of
   the glucuronides followed by extraction with hexane. The extracted
   phthalate monoesters were methylated with diazomethane, purified on a
   Florisil column and then subjected to GC-MS analysis. The recoveries
   from urine spiked with five phthalate monoesters were 86.3\%-119\% with
   coefficients of variation of 0.6\%-6.1\%. We measured phthalate
   monoester levels in human urine by analyzing 36 samples from volunteers.
   MBP and MEP were detected in all samples, and their median
   concentrations were 60.0 and 10.7 ng/mL, respectively. MBzP and MEHP
   were found in 75\% and 56\% of samples, and their median concentrations
   were 10.9 and 5.75 ng/mL, respectively. MINPs were not detected in most
   samples (6\% detectable). Women had significantly (p < 0.05) higher mean
   concentrations of MBP and MEP than men. The estimated daily exposure
   levels for the four parent phthalates excluding diisononyl phthalate
   ranged from 0.27 to 5.69 mu g/kg/day (median).}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kondo, F (Reprint Author), Aichi Med Univ, Sch Med, Dept Pharmacol, Aichi 4801195, Japan.
   Izumi, Shun-ichiro; Makino, Tsunehisa, Tokai Univ, Sch Med, Dept Obstet \& Gynecol, Isehara, Kanagawa 251193, Japan.
   Nakazawa, Hiroyuki, Hoshi Univ, Dept Analyt Chem, Shinagawa Ku, Tokyo 1428501, Japan.
   Takatori, Satoshi, Osaka Prefectural Inst Publ Hlth, Div Food Chem, Higashinari Ku, Osaka 5370025, Japan.
   Kondo, Fumio; Ikai, Yoshitomo; Hayashi, Rumiko; Okumura, Masanao, Aichi Prefectural Inst Publ Hlth, Dept Toxicol, Nagoya, Aichi 4628576, Japan.}},
DOI = {{10.1007/s00128-010-0051-8}},
ISSN = {{0007-4861}},
Keywords = {{Phthalate monoesters; Exposure; Urine; Gas chromatography-mass
   spectrometry}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; MONOBUTYL PHTHALATE; HUMAN EXPOSURE;
   METABOLITES; POPULATION; RATS; MALFORMATIONS; BIOMARKER; INFANTS}},
Research-Areas = {{Environmental Sciences \& Ecology; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Toxicology}},
Author-Email = {{fumio@ipc-tokai.or.jp}},
Funding-Acknowledgement = {{Ministry of Health, Labor, and Welfare, Japan}},
Funding-Text = {{This study was supported by a grant from the Ministry of Health, Labor,
   and Welfare, Japan.}},
Cited-References = {{Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Calafat AM, 2004, PEDIATRICS, V113, P429.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   Ema M, 2001, REPROD TOXICOL, V15, P261, DOI 10.1016/S0890-6238(01)00131-9.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x.
   Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019.
   Itoh H, 2005, INT J HYG ENVIR HEAL, V208, P237, DOI 10.1016/j.ijheh.2005.02.004.
   KAWASAKI T, 1991, JAP J PUBLIC HLTH, V38, P567.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{12}},
Journal-ISO = {{Bull. Environ. Contam. Toxicol.}},
Doc-Delivery-Number = {{621LS}},
Wos-Id = {{ISI:000279580900019}},
}

@article{ ISI:000279435400036,
Author = {Cho, Soo-Churl and Bhang, Soo-Young and Hong, Yun-Chul and Shin, Min-Sup
   and Kim, Boong-Nyun and Kim, Jae-Won and Yoo, Hee-Jung and Cho, In Hee
   and Kim, Hyo-Won},
Title = {{Relationship between Environmental Phthalate Exposure and the
   Intelligence of School-Age Children}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2010}},
Volume = {{118}},
Number = {{7}},
Pages = {{1027-1032}},
Month = {{JUL}},
Abstract = {{BACKGROUND: Concern over phthalates has emerged because of their
   potential toxicity to humans.
   OBJECTIVE: We investigated the relationship between the urinary
   concentrations of phthalate metabolites and children's intellectual
   functioning.
   METHODS: This study enrolled 667 children at nine elementary schools in
   five South Korean cities. A cross-sectional examination of urine
   phthalate concentrations was performed, and scores on
   neuro-psychological tests were obtained from both the children and their
   mothers.
   RESULTS: We measured mono-2-ethylhexyl phthalate (MEHP) and
   mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), both metabolites of
   di(2-ethylhexyl)phthalate (DEHP), and mono-n-butyl phthalate (MBP), a
   metabolite of dibutyl phthalate (DBP), in urine samples. The geometric
   mean (ln) concentrations of MEHP, MEOHP, and MBP were 21.3 mu g/L
   {[}geometric SD (GSD) = 2.2 mu g/L; range, 0.5-445.4], 18.0 mu g/L (GSD
   = 2.4; range, 0.07-291.1), and 48.9 mu g/L (GSD = 2.2; range,
   2.1-1645.5), respectively. After adjusting for demographic and
   developmental covariates, the Full Scale IQ and Verbal IQ scores were
   negatively associated with DEHP metabolites but not with DBP
   metabolites. We also found a significant negative relationship between
   the urine concentrations of the metabolites of DEHP and DBP and
   children's vocabulary subscores. After controlling for maternal IQ, a
   significant inverse relationship between DEHP metabolites and vocabulary
   subscale score remained. Among boys, we found a negative association
   between increasing MEHP phthalate concentrations and the sum of DEHP
   metabolite concentrations and Wechsler Intelligence Scale for Children
   vocabulary score; however, among girls, we found no significant
   association between these variables.
   CONCLUSION: Controlling for maternal IQ and other covariates, the
   results show an inverse relationship between phthalate metabolites and
   IQ scores; however, given the limitations in cross-sectional
   epidemiology, prospective studies are needed to fully explore these
   associations.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bhang, SY (Reprint Author), Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Psychiat, 290-3 Jeonha Dong, Ulsan 682714, South Korea.
   Bhang, Soo-Young, Univ Ulsan, Coll Med, Ulsan Univ Hosp, Dept Psychiat, Ulsan 682714, South Korea.
   Cho, Soo-Churl; Shin, Min-Sup; Kim, Boong-Nyun; Kim, Jae-Won, Seoul Natl Univ, Coll Med, Div Child \& Adolescent Psychiat, Dept Psychiat, Seoul, South Korea.
   Cho, Soo-Churl; Shin, Min-Sup; Kim, Boong-Nyun; Kim, Jae-Won, Seoul Natl Univ, Coll Med, Inst Human Behav Med, Seoul, South Korea.
   Hong, Yun-Chul, Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.
   Hong, Yun-Chul, Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea.
   Yoo, Hee-Jung, Seoul Natl Univ, Bundang Hosp, Dept Psychiat, Songnam, South Korea.
   Cho, In Hee, Gachon Univ Med \& Sci, Dept Psychiat, Gil Med Ctr, Inchon, South Korea.
   Kim, Hyo-Won, Dongguk Univ, Int Hosp, Coll Med, Dept Neuropsychiat, Goyang, South Korea.}},
DOI = {{10.1289/ehp.0901376}},
ISSN = {{0091-6765}},
Keywords = {{children; cognition; dibutyl phthalate (DBP); di(2-ethylhexyl)phthalate
   (DEHP); IQ; mono-2-ethylhexyl phthalate (MEHP); mono(2-ethyl-5-oxohexyl)
   phthalate (MEOHP); mono-n-butyl phthalate (MBP); phthalate; sex}},
Keywords-Plus = {{ACTIVATED RECEPTOR-ALPHA; THYROID-HORMONE LEVELS; SUBCLINICAL
   HYPOTHYROIDISM; NEUROTOXICANT EXPOSURES; DIETHYL PHTHALATE; PPAR-ALPHA;
   SHORT FORM; RAT-BRAIN; METABOLITES; PLASTICIZERS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{dresme@dreamwiz.com}},
ResearcherID-Numbers = {{Kim, Hyo-Won /F-3483-2010
   Kim, Jae Won/J-5430-2012
   Kim, Boong Nyun/J-5397-2012
   Cho, Soo Churl/J-5667-2012
   Yoo, Hee Jeong/J-5555-2012
   Shin, Min Sup/J-5521-2012}},
Funding-Acknowledgement = {{Korea Institute of Environmental Science and Technology {[}091-081-059];
   Janssen; Eli-Lilly; Otsuka; Korea Health Industry Development Institute
   {[}A080651, A080054]}},
Funding-Text = {{This work was funded by the Eco-Technopia 21 project of Korea Institute
   of Environmental Science and Technology (091-081-059).S.-C.C. receives
   research funding from Janssen, Eli-Lilly, and Otsuka and is supported by
   the Korea Health Industry Development Institute (A080651 and A080054).
   The remaining authors declare they have no actual or potential competing
   financial interests.}},
Cited-References = {{Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Baldini IM, 1997, PROG NEURO-PSYCHOPH, V21, P925, DOI 10.1016/S0278-5846(97)00089-4.
   Barnett JH, 2009, AM J PSYCHIAT, V166, P909, DOI 10.1176/appi.ajp.2009.08081251.
   Bellinger DC, 2000, NEUROTOXICOL TERATOL, V22, P133, DOI 10.1016/S0892-0362(99)00053-7.
   Bellinger DC, 2008, NEUROTOXICOLOGY, V29, P828, DOI 10.1016/j.neuro.2008.04.005.
   Bellinger DC, 2004, EPIDEMIOLOGY, V15, P383, DOI 10.1097/01.ede.0000129525.15064.a4.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748.
   Breous E, 2005, MOL CELL ENDOCRINOL, V244, P75, DOI 10.1016/j.mce.2005.06.009.
   Brown JS, 2009, SCHIZOPHRENIA BULL, V35, P256, DOI 10.1093/schbul/sbm147.
   Cho SC, 2010, J CHILD PSYCHOL PSYC, V51, P1050, DOI 10.1111/j.1469-7610.2010.02250.x.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Ghisari M, 2009, TOXICOL LETT, V189, P67, DOI 10.1016/j.toxlet.2009.05.004.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hays T, 2005, CARCINOGENESIS, V26, P219, DOI 10.1093/carcin/bgh285.
   HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Ishido M, 2004, J NEUROCHEM, V91, P69, DOI 10.1111/j.1471-4159.2004.02696.x.
   Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755.
   Kamrin MA, 2009, J TOXICOL ENV HEAL B, V12, P157, DOI 10.1080/10937400902729226.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   KAUFMAN AS, 1976, CONTEMP EDUC PSYCHOL, V1, P180, DOI 10.1016/0361-476X(76)90022-9.
   KHO YL, 2008, J ENV HLTH SCI, V34, P271.
   Kim BN, 2009, BIOL PSYCHIAT, V66, P958, DOI 10.1016/j.biopsych.2009.07.034.
   Kim M. K., 1986, SEOUL J PSYCHIAT, V11, P194.
   Kim Y, 2009, NEUROTOXICOLOGY, V30, P564, DOI 10.1016/j.neuro.2009.03.012.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   Kota BP, 2005, PHARMACOL RES, V51, P85, DOI 10.1016/j.phrs.2004.07.012.
   Lim YR, 2000, KOREAN J CLIN PSYCHO, V19, P563.
   Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Mink PJ, 2004, EPIDEMIOLOGY, V15, P385, DOI 10.1097/01.ede.0000128402.86336.7e.
   MONZANI F, 1993, CLIN INVESTIGATOR, V71, P367.
   Park K. S., 1996, DEV KEDI WISC INDIVI.
   Pereira C, 2007, ACTA HISTOCHEM, V109, P29, DOI 10.1016/j.acthis.2006.09.008.
   Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029.
   Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543.
   Roberts RA, 1997, FUND APPL TOXICOL, V38, P107, DOI 10.1006/faat.1997.2331.
   Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001.
   Sattler J. M., 2001, ASSESSMENT CHILDREN.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   SILVERSTEIN AB, 1990, J CLIN PSYCHOL, V46, P333, DOI 10.1002/1097-4679(199005)46:3<333::AID-JCLP2270460314>3.0.CO;2-X.
   Tanaka T, 2002, FOOD CHEM TOXICOL, V40, P1499, DOI 10.1016/S0278-6915(02)00073-X.
   Tanaka T, 2005, FOOD CHEM TOXICOL, V43, P581, DOI 10.1016/j.fct.2005.01.001.
   Tanida T, 2009, TOXICOL LETT, V189, P40, DOI 10.1016/j.toxlet.2009.04.005.
   van Neerven S, 2008, PROG NEUROBIOL, V85, P433, DOI 10.1016/j.pneurobio.2008.04.006.
   Wenzel A, 2005, MOL CELL ENDOCRINOL, V244, P63, DOI 10.1016/j.mce.2005.02.008.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Xu Y, 2007, ARCH TOXICOL, V81, P57, DOI 10.1007/s00204-006-0143-8.
   Zevalkink J, 2008, J GENET PSYCHOL, V169, P72, DOI 10.3200/GNTP.169.1.72-91.
   Zhu DF, 2006, BRAIN, V129, P2923, DOI 10.1093/brain/awl215.}},
Number-of-Cited-References = {{56}},
Times-Cited = {{26}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{619MX}},
Wos-Id = {{ISI:000279435400036}},
}

@article{ ISI:000279435400038,
Author = {Wolff, Mary S. and Teitelbaum, Susan L. and Pinney, Susan M. and
   Windham, Gayle and Liao, Laura and Biro, Frank and Kushi, Lawrence H.
   and Erdmann, Chris and Hiatt, Robert A. and Rybak, Michael E. and
   Calafat, Antonia M. and Breast Canc Ctr and Environm Res Ctr},
Title = {{Investigation of Relationships between Urinary Biomarkers of
   Phytoestrogens, Phthalates, and Phenols and Pubertal Stages in Girls}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2010}},
Volume = {{118}},
Number = {{7}},
Pages = {{1039-1046}},
Month = {{JUL}},
Abstract = {{BACKGROUND: Hormonally active environmental agents may alter the course
   of pubertal development in girls, which is controlled by steroids and
   gonadotropins.
   OBJECTIVES: We investigated associations of concurrent exposures from
   three chemical classes (phenols, phthalates, and phytoestrogens) with
   pubertal stages in a multiethnic longitudinal study of 1,151 girls from
   New York City, New York, greater Cincinnati, Ohio, and northern
   California who were 6-8 years of age at enrollment (2004-2007).
   METHODS: We measured urinary exposure biomarkers at visit 1 and examined
   associations with breast and pubic hair development (present or absent,
   assessed 1 year later) using multivariate adjusted prevalence ratios
   (PR) and 95\% confidence intervals (CIs). Modification of biomarker
   associations by age-specific body mass index percentile (BMI\%) was
   investigated, because adipose tissue is a source of peripubertal
   hormones.
   RESULTS: Breast development was present in 30\% of girls, and 22\% had
   pubic hair. High-molecular-weight phthalate (high MWP) metabolites were
   weakly associated with pubic hair development {[}adjusted PR, 0.94 (95\%
   CI, 0.88-1.00), fifth vs. first quintile]. Small inverse associations
   were seen for daidzein with breast stage and for triclosan and high MWP
   with pubic hair stage; a positive trend was observed for
   low-molecular-weight phthalate biomarkers with breast and pubic hair
   development. Enterolactone attenuated BMI associations with breast
   development. In the first enterolactone quintile, for the association of
   high BMI with any development, the PR was 1.34 (95\% CI, 1.23-1.45 vs.
   low BMI). There was no BMI association in the fifth, highest quintile of
   enterolactone.
   CONCLUSIONS: Weak hormonally active xenobiotic agents investigated in
   this study had small associations with pubertal development, mainly
   among those agents detected at highest concentrations.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wolff, MS (Reprint Author), Mt Sinai Sch Med, 1 Gustave L Levy Pl,Box 1057, New York, NY 10029 USA.
   Wolff, Mary S.; Teitelbaum, Susan L.; Liao, Laura, Mt Sinai Sch Med, New York, NY 10029 USA.
   Pinney, Susan M., Univ Cincinnati, Coll Med, Cincinnati, OH USA.
   Windham, Gayle, Calif Dept Publ Hlth, Richmond, CA USA.
   Biro, Frank, Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA.
   Kushi, Lawrence H., Kaiser Permanente Div Res, Oakland, CA USA.
   Erdmann, Chris, Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   Hiatt, Robert A., Univ Calif San Francisco, Dept Epidemiol \& Biostat, San Francisco, CA 94143 USA.
   Rybak, Michael E.; Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.}},
DOI = {{10.1289/ehp.0901690}},
ISSN = {{0091-6765}},
Keywords = {{biomarkers; phenols; phthalates; phytoestrogens; puberty}},
Keywords-Plus = {{MASS-SPECTROMETRY; SEXUAL-MATURATION; BREAST-CANCER; HPLC-MS/MS;
   EXPOSURE; METABOLITES; CREATININE; GRAVITY}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{mary.wolff@mssm.edu}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences (NIEHS)
   {[}ES/CA012770, 012771, 012800, 012801, ES009584, ES012645]; National
   Cancer Institute (NCI) {[}CA93447]; U.S. Environmental Protection Agency
   {[}R827039, RD831711]; Agency for Toxic Substances and Disease Registry
   {[}ATU 300014]; National Center for Research Resources {[}MO1-RR-00071,
   UL1-RR024131]}},
Funding-Text = {{Financial support was provided by grants ES/CA012770, 012771, 012800,
   012801 from the National Institute of Environmental Health Sciences
   (NIEHS) and the National Cancer Institute (NCI); NIEHS (ES009584,
   ES012645); U.S. Environmental Protection Agency (R827039, RD831711);
   Agency for Toxic Substances and Disease Registry (ATU 300014); NCI
   (CA93447); and National Center for Research Resources (MO1-RR-00071,
   UL1-RR024131).}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Adlercreutz H, 2002, J STEROID BIOCHEM, V83, P113, DOI 10.1016/S0960-0760(02)00273-X.
   BIRO FM, PEDIATRICS IN PRESS.
   Cederroth CR, 2007, ENVIRON HEALTH PERSP, V115, P1467, DOI 10.1289/ehp.10413.
   Centers for Disease Control and Prevention, 2000, CDC GROWTH CHARTS US.
   Centers for Disease Control and Prevention (CDC), 2005, NAT REP HUM EXP ENV.
   Chou YY, 2009, J PEDIATR ENDOCR MET, V22, P69.
   Fang H, 2000, ENVIRON HEALTH PERSP, V108, P723, DOI 10.1289/ehp.00108723.
   Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Heavner DL, 2006, J PHARMACEUT BIOMED, V40, P928, DOI 10.1016/j.jpba.2005.08.008.
   HORNROSS PL, 1995, CANCER CAUSE CONTROL, V6, P567, DOI 10.1007/BF00054166.
   Jacobson-Dickman E, 2009, CURR OPIN ENDOCRINOL, V16, P25, DOI 10.1097/MED.0b013e328320d560.
   Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292.
   Rasier G, 2006, MOL CELL ENDOCRINOL, V254, P187, DOI 10.1016/j.mce.2006.04.002.
   Rybak ME, 2008, J CHROMATOGR B, V861, P145, DOI 10.1016/j.jchromb.2007.11.013.
   Schoeters G, 2008, BASIC CLIN PHARMACOL, V102, P168, DOI 10.1111/j.1742-7843.2007.00180.x.
   Selevan SG, 2003, NEW ENGL J MED, V348, P1527, DOI 10.1056/NEJMoa020880.
   Shen OX, 2009, TOXICOL LETT, V191, P9, DOI 10.1016/j.toxlet.2009.07.019.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   van Wieringen J C, 1985, Tijdschr Kindergeneeskd, V53, P147.
   WEINBERG CR, 1993, AM J EPIDEMIOL, V137, P1.
   Wolff MS, 2007, ENVIRON HEALTH PERSP, V115, P116, DOI 10.1289/ehp.9488.
   Wolff MS, 2008, ENVIRON RES, V107, P393, DOI 10.1016/j.envres.2008.03.006.
   Wu TJ, 2003, ENVIRON HEALTH PERSP, V111, P737, DOI 10.1289/ehp.6008.
   Ye XY, 2006, J CHROMATOGR B, V844, P53, DOI 10.1016/j.jchromb.2006.06.037.
   Ye XY, 2005, ANAL CHEM, V77, P5407, DOI 10.1021/ac050390d.
   Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090.
   {*}NAT SCI FDN, 2008, PHTHAL CUM RISK ASS.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{33}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{619MX}},
Wos-Id = {{ISI:000279435400038}},
}

@article{ ISI:000278591300028,
Author = {Weuve, Jennifer and Hauser, Russ and Calafat, Antonia M. and Missmer,
   Stacey A. and Wise, Lauren A.},
Title = {{Association of Exposure to Phthalates with Endometriosis and Uterine
   Leiomyomata: Findings from NHANES, 1999-2004}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2010}},
Volume = {{118}},
Number = {{6}},
Pages = {{825-832}},
Month = {{JUN}},
Abstract = {{BACKGROUND: Phthalates are ubiquitous chemicals used in consumer
   products. Some phthalates are reproductive toxicants in experimental
   animals, but human data are limited.
   OBJECTIVE: We conducted a cross-sectional study of urinary phthalate
   metabolite concentrations in relation to self-reported history of
   endometriosis and uterine leiomyomata among 1,227 women 20-54 years of
   age from three cycles of the National Health and Nutrition Examination
   Survey (NHANES), 1999-2004.
   METHODS: We examined four phthalate metabolites: mono(2-ethylhexyl)
   phthalate (MEHP), monobutyl phthalate (MBP), monoethyl phthalate (MEP),
   and monobenzyl phthalate (MBzP). From the last two NHANES cycles, we
   also examined mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) and
   mono(2-ethyl-5-oxohexyl) phthalate (MEOHP). We used logistic regression
   to estimate odds ratios (ORs) and 95\% confidence intervals (CIs),
   adjusting for potential confounders.
   RESULTS: Eighty-seven (7\%) and 151 (12\%) women reported diagnoses of
   endometriosis and leiomyomata, respectively. The ORs comparing the
   highest versus lowest three quartiles of urinary MBP were 1.36 (95\% CI,
   0.77-2.41) for endometriosis, 1.56 (95\% CI, 0.93-2.61) for leiomyomata,
   and 1.71 (95\% CI, 1.07-2.75) for both conditions combined. The
   corresponding ORs for MEHP were 0.44 (95\% CI, 0.19-1.02) for
   endometriosis, 0.63 (95\% CI, 0.35-1.12) for leiomyomata, and 0.59 (95\%
   CI, 0.37-0.95) for both conditions combined. Findings for MEHHP and
   MEOHP agreed with findings for MEHP with respect to endometriosis only.
   We observed Mill associations for MEP and MBzP. Associations were
   similar when we excluded women diagnosed > 7 years before their NHANES
   evaluation.
   CONCLUSION: The positive associations for MBP and inverse associations
   for MEHP in relation to endometriosis and leiomyomata warrant
   investigation in prospective studies.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Weuve, J (Reprint Author), Rush Univ, Med Ctr, Dept Internal Med, Rush Inst Healthy Aging, 645 W Jackson Blvd,Suite 675, Chicago, IL 60612 USA.
   Weuve, Jennifer, Rush Univ, Med Ctr, Dept Internal Med, Rush Inst Healthy Aging, Chicago, IL 60612 USA.
   Weuve, Jennifer; Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Hauser, Russ, Massachusetts Gen Hosp, Androl Lab, Vincent Mem Obstet \& Gynecol Serv, Boston, MA 02114 USA.
   Hauser, Russ, Massachusetts Gen Hosp, Vitro Fertilizat Unit, Boston, MA 02114 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Atlanta, GA USA.
   Missmer, Stacey A., Harvard Univ, Brigham \& Womens Hosp, Sch Med, Dept Obstet Gynecol \& Reprod Med, Boston, MA 02115 USA.
   Missmer, Stacey A., Harvard Univ, Brigham \& Womens Hosp, Sch Med, Dept Med,Channing Lab, Boston, MA 02115 USA.
   Missmer, Stacey A., Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   Wise, Lauren A., Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA.}},
DOI = {{10.1289/ehp.0901543}},
ISSN = {{0091-6765}},
Keywords = {{dibutyl phthalate; di(2-ethylhexyl) phthalate; endometriosis;
   leiomyomata; monobenzyl phthalate; monobutyl phthalate; monoethyl
   phthalate; mono(2-ethyl-5-hydroxyhexyl) phthalate;
   mono(2-ethyl-5-oxohexyl) phthalate; mono(2-ethylhexyl) phthalate}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; BUTYL BENZYL PHTHALATE; RAT GRANULOSA-CELLS;
   UNITED-STATES; QUANTITATIVE DETECTION; PREMENOPAUSAL WOMEN; CYCLING
   RATS; DI-(2-ETHYLHEXYL) PHTHALATE; SUPPRESSES ESTRADIOL; PSEUDOPREGNANT
   RATS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{Jennifer\_Weuve@rush.edu}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   AGARWAL DK, 1989, J TOXICOL ENV HEALTH, V26, P39.
   AGARWAL DK, 1985, J TOXICOL ENV HEALTH, V16, P71.
   Andersen J, 1998, BAILLIERE CLIN OB GY, V12, P225.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   Attia GR, 2000, J CLIN ENDOCR METAB, V85, P2897, DOI 10.1210/jc.85.8.2897.
   Baird DD, 2010, J EXPO SCI ENV EPID, V20, P169, DOI 10.1038/jes.2009.17.
   Baird DD, 2003, AM J OBSTET GYNECOL, V188, P100, DOI 10.1067/mob.2003.99.
   BERMAN E, 1993, REPROD TOXICOL, V7, P349, DOI 10.1016/0890-6238(93)90024-2.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Breslow NE, 1987, IARC SCI PUBL, V82, P1.
   CDC, 2009, NAT HLTH NUTR EX SUR.
   CDC; National Center for Health Statistics, 2005, AN REP GUID NAT HLTH.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   DIZEREGA GS, 1980, FERTIL STERIL, V33, P649.
   Ema M, 2000, REPROD TOXICOL, V14, P13, DOI 10.1016/S0890-6238(99)00066-0.
   Ema M, 1998, REPROD TOXICOL, V12, P127, DOI 10.1016/S0890-6238(97)00127-5.
   Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8.
   Farquhar CM, 2002, OBSTET GYNECOL, V99, P229, DOI 10.1016/S0029-7844(01)01723-9.
   Flynn M, 2006, AM J OBSTET GYNECOL, V195, P955, DOI 10.1016/j.ajog.2006.02.020.
   FRIEDMAN AJ, 1990, AM J OBSTET GYNECOL, V163, P1114.
   Gurates B, 2003, SEMIN REPROD MED, V21, P125.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   HOUSTON DE, 1984, EPIDEMIOL REV, V6, P167.
   Itoh H, 2009, SCI TOTAL ENVIRON, V408, P37, DOI 10.1016/j.scitotenv.2009.09.012.
   JACKSON S, 1966, HEALTH PHYS, V12, P843, DOI 10.1097/00004032-196606000-00014.
   Jung BH, 2004, INT J GYNECOL OBSTET, V84, P55, DOI 10.1016/S0020-7292(03)00336-9.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   LASKEY JW, 1993, REPROD TOXICOL, V7, P25, DOI 10.1016/0890-6238(93)90006-S.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Luisi S, 2006, GYNECOL ENDOCRINOL, V22, P92, DOI 10.1080/09513590600551312.
   Marshall LM, 1997, OBSTET GYNECOL, V90, P967, DOI 10.1016/S0029-7844(97)00534-6.
   Missmer SA, 2004, AM J EPIDEMIOL, V160, P784, DOI 10.1093/aje/kwh275.
   Missmer Stacey A, 2003, Obstet Gynecol Clin North Am, V30, P1, DOI 10.1016/S0889-8545(02)00050-5.
   MISSMER SA, 2008, ENDOMETRIOSIS 2008.
   Missmer SA, 2004, OBSTET GYNECOL, V104, P965, DOI 10.1097/01.AOG.0000142714.54857.f8.
   Picard K, 2001, TOXICOL APPL PHARM, V172, P108, DOI 10.1006/taap.2001.9141.
   Potgieter HC, 1995, E AFR MED J, V72, P510.
   Reddy BS, 2006, BJOG-INT J OBSTET GY, V113, P515, DOI 10.1111/j.1471-0528.2006.00925.x.
   REIN MS, 1992, SEMIN REPROD ENDOCR, V10, P310, DOI 10.1055/s-2007-1018888.
   Rein MS, 2000, ENVIRON HEALTH PERSP, V108, P791, DOI 10.2307/3454308.
   REIN MS, 1995, AM J OBSTET GYNECOL, V172, P14, DOI 10.1016/0002-9378(95)90077-2.
   Schwartz SM, 2000, WOMEN HLTH, P240, DOI 10.1016/B978-012288145-9/50022-X.
   Schwartz SM, 2000, ENVIRON HEALTH PERSP, V108, P821, DOI 10.2307/3454313.
   Schwartz SM, 2001, CLIN OBSTET GYNECOL, V44, P316, DOI 10.1097/00003081-200106000-00018.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010.
   STRAUSS J, 1999, REPROD ENDOCRINOLOGY, P218.
   Taylor RN, 2009, YEN JAFFES REPROD EN, P577, DOI 10.1016/B978-1-4160-4907-4.00024-3.
   U.S. Food and Drug Administration, 2002, SAF ASS DI 2 ETH PHT.
   VELEBIL P, 1995, OBSTET GYNECOL, V86, P764, DOI 10.1016/0029-7844(95)00252-M.
   WILCOX LS, 1994, OBSTET GYNECOL, V83, P549.
   Wise LA, 2004, AM J EPIDEMIOL, V159, P113, DOI 10.1093/aje/kwh016.
   Wise LA, 2005, OBSTET GYNECOL, V105, P563, DOI 10.1097/01.AOG.0000154161.03418.e3.
   Zondervan KT, 2002, HUM REPROD, V17, P1415, DOI 10.1093/humrep/17.6.1415.}},
Number-of-Cited-References = {{67}},
Times-Cited = {{18}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{608NP}},
Wos-Id = {{ISI:000278591300028}},
}

@article{ ISI:000277191700009,
Author = {Ji, Kyunghee and Kho, Young Lim and Park, Yoonsuk and Choi, Kyungho},
Title = {{Influence of a five-day vegetarian diet on urinary levels of antibiotics
   and phthalate metabolites: A pilot study with ``Temple Stay{''}
   participants}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2010}},
Volume = {{110}},
Number = {{4}},
Pages = {{375-382}},
Month = {{MAY}},
Abstract = {{Diet is purported to be means of exposure to many environmental
   contaminants. The purpose of this study is to understand the influence
   of dietary change on the levels of exposure to several environmental
   chemicals - in particular, antibiotics and phthalates. For this purpose,
   we examined the extent to which short-term changes in diet influenced
   the inadvertent exposure levels to these chemicals in an adult
   population. We recruited participants (n=25) of a five-day `Temple Stay'
   program in Korea and collected urine samples before and after the
   program. We also conducted a questionnaire survey on participants'
   dietary patterns prior to their participation. During the program,
   participants followed the daily routines of Buddhist monks and
   maintained a vegetarian diet. Urinary levels of three antibiotics and
   their major metabolites, metabolites of four major phthalates, and
   malondialdehyde (MDA) as an oxidative stress biomarker were analyzed.
   The frequency and levels of detection for antibiotics and phthalates
   noticeably decreased during the program. Urinary MDA levels were
   significantly lower than before program participation (0.16 versus 0.27
   mg/g creatinine). Although the exposure to target compounds might be
   influenced by other behavioral patterns, these results suggest that even
   short-term changes in dietary behavior may significantly decrease
   inadvertent exposure to antibiotics and phthalates and hence may reduce
   oxidative stress levels. (C) 2010 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Choi, K (Reprint Author), Seoul Natl Univ, Dept Environm Hlth, Sch Publ Hlth, Seoul 110799, South Korea.
   Ji, Kyunghee; Park, Yoonsuk; Choi, Kyungho, Seoul Natl Univ, Dept Environm Hlth, Sch Publ Hlth, Seoul 110799, South Korea.
   Kho, Young Lim, Eulji Univ, Sch Human \& Environm Sci, Songnam 461713, Gyeonggi, South Korea.}},
DOI = {{10.1016/j.envres.2010.02.008}},
ISSN = {{0013-9351}},
Keywords = {{Dietary; Intake; Malondialdehyde; Pharmaceutical; Phthalate metabolites}},
Keywords-Plus = {{HUMAN EXPOSURE; LIPID-PEROXIDATION; MASS-SPECTROMETRY; OXIDATIVE STRESS;
   RISK-ASSESSMENT; US POPULATION; SHORT-TERM; DEHP; PHARMACEUTICALS;
   ENVIRONMENT}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{kyungho@snu.ac.kr}},
ResearcherID-Numbers = {{choi, kyungho/D-5732-2012}},
ORCID-Numbers = {{choi, kyungho/0000-0001-7460-792X}},
Funding-Acknowledgement = {{Korea Food and Drug Administration {[}07162KFDA663]}},
Funding-Text = {{This research was partly supported by Korea Food and Drug Administration
   (07162KFDA663). Authors are grateful for kind supports of Won-Haeng and
   II-Gam sunim of Geumsan Temple which were crucial for the study.}},
Cited-References = {{Alonso V, 2009, REPROD TOXICOL, V27, P35, DOI 10.1016/j.reprotox.2008.10.007.
   Ankley GT, 2007, ENVIRON SCI TECHNOL, V41, P8211, DOI 10.1021/es072658j.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Becerra MC, 2006, MOL CELL BIOCHEM, V285, P29, DOI 10.1007/s11010-005-9051-0.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Bevilacqua L, 2004, AM J PHYSIOL-ENDOC M, V286, pE852, DOI 10.1152/ajpendo.00367.2003.
   Boothe Dawn Merton, 2002, Vet Ther, V3, P409.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Chung YH, 2005, FOOD SCI BIOTECHNOL, V14, P216.
   CSTEE (Scientific Committee on Toxicity Ecotoxicity and the Environment), 1998, 6 CSTEE PLEN M BRUSS.
   Cunningham VL, 2009, REGUL TOXICOL PHARM, V53, P39, DOI 10.1016/j.yrtph.2008.10.006.
   Farombi EO, 2008, EXP TOXICOL PATHOL, V60, P77, DOI 10.1016/j.etp.2008.02.002.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   HARDMAN JG, 2001, GOODMAN GILLMANS PHA.
   Hernandez-Diaz S, 2009, ENVIRON HEALTH PERSP, V117, P185, DOI 10.1289/ehp.11766.
   Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001.
   Kandimalla VB, 2007, VET MED-CZECH, V52, P445.
   Kang WH, 1998, KOREAN J NEPHROL, V17, P866.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kemper N, 2008, ECOL INDIC, V8, P1, DOI 10.1016/j.ecolind.2007.06.002.
   KHO YL, 2008, J ENV HLTH SCI, V34, P271.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Lee KH, 2006, CARCINOGENESIS, V27, P1398, DOI 10.1093/carcin/bgi337.
   MacIntosh DL, 1996, ENVIRON HEALTH PERSP, V104, P202, DOI 10.2307/3432790.
   Martinez M, 2006, VET J, V172, P10, DOI 10.1016/j.tvjl.2005.07.010.
   National Research Council, 1993, PEST DIETS INF CHILD.
   NOUWS JFM, 1986, AM J VET RES, V47, P642.
   Prescott John F., 2008, Animal Health Research Reviews, V9, P127, DOI 10.1017/S1466252308001473.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Salehzadeh F., 2007, Pakistan Journal of Nutrition, V6, P409.
   Santhosh A, 1998, INDIAN J MED RES, V108, P17.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Varma R, 2003, J VET PHARMACOL THER, V26, P303, DOI 10.1046/j.1365-2885.2003.00480.x.
   Vidaver AK, 2002, CLIN INFECT DIS, V34, pS107, DOI 10.1086/340247.
   Webb S, 2003, TOXICOL LETT, V142, P157, DOI 10.1016/S0378-4274(03)00071-7.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   {*}CSTEE, 2004, CSTEE 43 PLEN M 28 M.
   {*}JECFA, 2007, 1 68 M JOINT FOOD AG.
   {*}NAT CTR ENV HLTH, 3 NAT REP HUM EXP EN.
   {*}NVRQS, 2009, RISK ASS RES VET PHA.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{13}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{589ZC}},
Wos-Id = {{ISI:000277191700009}},
}

@article{ ISI:000277730900009,
Author = {Choi, Seonyoung and Park, So-Young and Jeong, Ji and Cho, Eunkyung and
   Phark, Sohee and Lee, Min and Kwak, Dongsub and Lim, Ji-Youn and Jung,
   Woon-Won and Sul, Donggeun},
Title = {{Identification of toxicological biomarkers of di(2-ethylhexyl) phthalate
   in proteins secreted by HepG2 cells using proteomic analysis}},
Journal = {{PROTEOMICS}},
Year = {{2010}},
Volume = {{10}},
Number = {{9}},
Pages = {{1831-1846}},
Month = {{MAY}},
Abstract = {{The effects of di(2-ethylhexyl) phthalate (DEHP) on proteins secreted by
   HepG2 cells were studied using a proteomic approach. HepG2 cells were
   exposed to various concentrations of DEHP (0, 2.5, 5, 10, 25, 50, 100,
   and 250 mu M) for 24 or 48h. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
   tetrazolium bromide (MTT) and comet assays were then conducted to
   determine the cytotoxicity and genotoxicity of DEHP, respectively. The
   MIT assay showed that 10 mu M DEHP was the maximum concentration that
   did not cause cell death. In addition, the DNA damage in HepG2 cells
   exposed to DEHP was found to increase in a dose- and time-dependent
   fashion. Proteomic analysis using two different pI ranges (4-7 and 6-9)
   and large size 2-DE revealed the presence of 2776 protein spots. A total
   of 35 (19 up- and 16 down-regulated) proteins were identified as
   biomarkers of DEHP by ESI-MS/MS. Several differentiated protein groups
   were also found. Proteins involved in apoptosis, transportation,
   signaling, energy metabolism, and cell structure and motility were found
   to be up- or down-regulated. Among these, the identities of cystatin C,
   Rho GDP inhibitor, retinol binding protein 4, gelsolin, DEK protein, Raf
   kinase inhibitory protein, triose phosphate isomerase, cofilin-1, and
   haptoglobin-related protein were confirmed by Western blot assay.
   Therefore, these proteins could be used as potential biomarkers of DEHP
   and human disease associated with DEHP.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sul, D (Reprint Author), Korea Univ, Grad Sch Med, 126-1 Anam Dong 5 Ka, Seoul 136705, South Korea.
   Choi, Seonyoung; Jeong, Ji; Cho, Eunkyung; Phark, Sohee; Lee, Min; Kwak, Dongsub; Sul, Donggeun, Korea Univ, Grad Sch Med, Seoul 136705, South Korea.
   Park, So-Young, Coll Adv Sci, Dept Nanobiomed Sci, Cheonan, Chungnam, South Korea.
   Lim, Ji-Youn; Sul, Donggeun, Korea Univ, Coll Med, Environm Toxicogenom \& Prote Ctr, Seoul 136705, South Korea.
   Jung, Woon-Won, Korea Univ, Coll Hlth Sci, Seoul 136705, South Korea.}},
DOI = {{10.1002/pmic.200900674}},
ISSN = {{1615-9853}},
Keywords = {{Animal proteomics; Biomarkers; Di(2-ethylhexyl) phthalate; HepG2;
   Secreted proteins; Two-dimensional polyacrylamide gel electrophoresis}},
Keywords-Plus = {{2-DIMENSIONAL GEL-ELECTROPHORESIS; CHEMICALLY-INDUCED CHANGES;
   RETINOL-BINDING-PROTEIN; COMET ASSAY; CYSTATIN-C; PLASMA-PROTEINS;
   DI-(2-ETHYLHEXYL) PHTHALATE; PEROXISOME PROLIFERATION;
   ALZHEIMERS-DISEASE; OXIDATIVE STRESS}},
Research-Areas = {{Biochemistry \& Molecular Biology}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Biochemistry \& Molecular Biology}},
Author-Email = {{dsul@korea.ac.kr}},
Funding-Acknowledgement = {{Ministry of Environment {[}2009-09001-0075-0]; Korean Ministry of
   Education, Science and Technology (MEST) {[}2009-009-1414]}},
Funding-Text = {{This work was supported by the Ministry of Environment as ``The
   Eco-Technopia 21 project{''} (No. 2009-09001-0075-0) and by the ACE
   program through the National Research Foundation of Korea(NRF) grant
   funded by the Korean Ministry of Education, Science and Technology
   (MEST) (No. 2009-009-1414).}},
Cited-References = {{Akaishi J, 2006, ANTICANCER RES, V26, P4437.
   Al-Mulla F, 2006, J CLIN ONCOL, V24, P5672, DOI 10.1200/JCO.2006.07.5499.
   Anderson D, 1999, TERATOGEN CARCIN MUT, V19, P275, DOI 10.1002/(SICI)1520-6866(1999)19:4<275::AID-TCM4>3.0.CO;2-1.
   Balasubramanian K, 2006, J PROTEOME RES, V5, P1133, DOI 10.1021/pr050445s.
   Bandara LR, 2002, DRUG DISCOV TODAY, V7, P411, DOI 10.1016/S1359-6446(02)02211-0.
   Benninghoff AD, 2007, TOXICOL SCI, V95, P1, DOI 10.1093/toxsci/kfl157.
   Candiano G, 2005, AM J RESP CRIT CARE, V172, P1090, DOI 10.1164/rccm.200409-1185OC.
   CATTLEY RC, 1987, CANCER LETT, V38, P15, DOI 10.1016/0304-3835(87)90195-9.
   Chauvigne F, 2009, ENVIRON HEALTH PERSP, V117, P515, DOI 10.1289/ehp.11870.
   CHO HJ, 2009, CLIN CANCER RES, V75, P2612.
   Crowley MR, 2000, DEV BIOL, V225, P407, DOI 10.1006/dbio.2000.9844.
   Deutschle T, 2008, ENVIRON HEALTH PERSP, V116, P1487, DOI 10.1289/ehp.11474.
   Dowling VA, 2006, PROTEOMICS, V6, P5597, DOI 10.1002/pmic.200600274.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Fella K, 2005, PROTEOMICS, V5, P1914, DOI 10.1002/pmic.200401067.
   Fu Z, 2006, PROSTATE, V66, P248, DOI 10.1002/pros.20319.
   Goede DL, 2009, SWISS MED WKLY, V139, P339, DOI smw-12654.
   Goodman D S, 1980, Ann N Y Acad Sci, V348, P378, DOI 10.1111/j.1749-6632.1980.tb21314.x.
   Guerreiro N, 1997, MOL PLANT MICROBE IN, V10, P506, DOI 10.1094/MPMI.1997.10.4.506.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hirosawa N, 2006, PROTEOMICS, V6, P958, DOI 10.1002/pmic.200401344.
   HUAUX F, 1995, TOXICOL APPL PHARM, V132, P53, DOI 10.1006/taap.1995.1086.
   Im H, 2006, J PROTEOME RES, V5, P1354, DOI 10.1021/pr050437b.
   IWASA F, 1988, BIOCHEM J, V253, P927.
   Ji LN, 2009, J ALZHEIMERS DIS, V18, P105, DOI 10.3233/JAD-2009-1127.
   Johnson JL, 2009, J BIOL CHEM, V284, P23860, DOI 10.1074/jbc.M109.031815.
   Joo WA, 2003, PROTEOMICS, V3, P2402, DOI 10.1002/pmic.200300616.
   Joo WA, 2004, MUTAT RES-GEN TOX EN, V558, P35, DOI 10.1016/j.mrgentox.2003.10.015.
   Kang MJ, 2005, J PROTEOME RES, V4, P1248, DOI 10.1021/pr049756d.
   Kappes F, 2008, MOL CELL BIOL, V28, P3245, DOI 10.1128/MCB.01921-07.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Kennedy S, 2002, BIOMARKERS, V7, P269, DOI 10.1080/13547500210127318.
   Kim CS, 2007, ENDOCRINOLOGY, V148, P1306, DOI 10.1210/en.2006-0923.
   Kim DW, 2009, J CELL BIOCHEM, V106, P1048, DOI 10.1002/jcb.22083.
   Kim M, 2009, ANIM REPROD SCI, V112, P172, DOI 10.1016/j.anireprosci.2008.04.029.
   Kleinsasser NH, 2004, TOXICOL LETT, V148, P83, DOI 10.1016/j.toxlet.2003.12.013.
   Knasmuller S, 2004, TOXICOLOGY, V198, P315, DOI 10.1016/j.tox.2004.02.008.
   KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Lee HC, 2006, GASTROENTEROLOGY, V131, P1208, DOI 10.1053/j.gastro.2006.07.012.
   LEE HJ, 2004, PROTEOMICS, V3, P498.
   Lee SE, 2006, PROTEOMICS, V6, P945, DOI 10.1002/pmic.200401349.
   Lee SH, 2005, J PROTEOME RES, V4, P335, DOI 10.1021/pr049830s.
   Li GH, 2009, CIRC RES, V104, P896, DOI 10.1161/CIRCRESAHA.108.172882.
   Li HZ, 2009, MOL CANCER RES, V7, P832, DOI 10.1158/1541-7786.MCR-08-0403.
   Link AJ, 1999, NAT BIOTECHNOL, V17, P676.
   Liu H, 2008, CHINESE MED J-PEKING, V121, P355.
   Maciver SK, 1998, CURR OPIN CELL BIOL, V10, P140, DOI 10.1016/S0955-0674(98)80097-5.
   Moffit JS, 2007, J ANDROL, V28, P883, DOI 10.2164/jandrol.107.002964.
   Moissoglu K, 2009, CANCER RES, V69, P2838, DOI 10.1158/0008-5472.CAN-08-1397.
   MOSMAM T, 1983, J IMMUNOL METHODS, V1, P55.
   Naruse H, 2009, AM J MED, V122, P566, DOI 10.1016/j.amjmed.2008.10.042.
   Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327.
   Nishio R, 2009, CIRC RES, V104, P829, DOI 10.1161/CIRCRESAHA.109.196329.
   Nishiyama K, 2005, BRAIN RES BULL, V67, P94, DOI 10.1016/j.brainresbull.2005.05.020.
   Noske A, 2005, EUR J CANCER, V41, P461, DOI 10.1016/j.ejca.2004.10.025.
   Oh S, 2004, PROTEOMICS, V4, P3514, DOI 10.1002/pmic.200400981.
   Orosz F, 2006, IUBMB LIFE, V58, P703, DOI 10.1080/15216540601115960.
   Park S, 2005, ONCOGENE, V24, P3535, DOI 10.1038/sj.onc.1208435.
   Park SY, 2007, ENVIRON INT, V33, P817, DOI 10.1016/j.envint.2007.03.014.
   Phillips David H., 2009, V99, P87.
   Pretsch W, 2009, GENET RES, V91, P1, DOI 10.1017/S0016672308009944.
   Randic M, 2001, MED CHEM RES, V10, P456.
   Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065.
   Seo KW, 2004, FOOD CHEM TOXICOL, V42, P107, DOI 10.1016/j.fct.2003.08.010.
   Singh N, 2009, BIOMATERIALS, V30, P3891, DOI 10.1016/j.biomaterials.2009.04.009.
   SON KS, 2004, PROTEOMICS, V4, P3505.
   Son WK, 2003, PROTEOMICS, V3, P2393, DOI 10.1002/pmic.200300605.
   Spencer TE, 2007, REPROD FERT DEVELOP, V19, P65, DOI 10.1071/RD06102.
   Spinardi L., 2007, V45, P55.
   Svechnikova I, 2007, J ENDOCRINOL, V194, P603, DOI 10.1677/JOE-07-0238.
   TAKAGI A, 1990, CANCER LETT, V53, P33, DOI 10.1016/0304-3835(90)90007-K.
   Thome-Kromer B, 2003, PROTEOMICS, V3, P1835, DOI 10.1002/pmic.200300552.
   Togawa A, 1999, ONCOGENE, V18, P5373, DOI 10.1038/sj.onc.1202921.
   Tsuji-Akimoto S, 2009, NEUROSCI LETT, V452, P52, DOI 10.1016/j.neulet.2009.01.026.
   TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805.
   Wang H, 2009, J BIOL CHEM, V284, P21265, DOI 10.1074/jbc.M109.019760.
   Wetmore BA, 2004, TOXICOL PATHOL, V32, P619, DOI 10.1080/01926230490518244.
   Witte I, 2007, TOXICOL SCI, V97, P21, DOI 10.1093/toxsci/kfl192.
   Yan B, 2010, ACTA HISTOCHEM, V112, P101, DOI 10.1016/j.acthis.2008.07.007.
   Yang M, 2008, ENVIRON MOL MUTAGEN, V49, P368, DOI 10.1002/em.20394.
   YASHIRO M, 2009, CLIN EXP NE IN PRESS.
   Yokoyama Y, 2003, TOXICOL LETT, V144, P371, DOI 10.1016/S0378-4274(03)00256-X.
   Zerovnik E, 2009, BIOESSAYS, V31, P597, DOI 10.1002/bies.200900012.
   Zhang BL, 2006, DRUG RESIST UPDATE, V9, P134, DOI 10.1016/j.drup.2006.06.001.
   Zwickl H, 2005, ELECTROPHORESIS, V26, P2779, DOI 10.1002/elps.200410387.
   {*}NTP, 1982, TECH REP SER, V217.}},
Number-of-Cited-References = {{87}},
Times-Cited = {{6}},
Journal-ISO = {{Proteomics}},
Doc-Delivery-Number = {{597BO}},
Wos-Id = {{ISI:000277730900009}},
}

@article{ ISI:000276454800028,
Author = {Lopez-Carrillo, Lizbeth and Hernandez-Ramirez, Raul U. and Calafat,
   Antonia M. and Torres-Sanchez, Luisa and Galvan-Portillo, Marcia and
   Needham, Larry L. and Ruiz-Ramos, Ruben and Cebrian, Mariano E.},
Title = {{Exposure to Phthalates and Breast Cancer Risk in Northern Mexico}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2010}},
Volume = {{118}},
Number = {{4}},
Pages = {{539-544}},
Month = {{APR}},
Abstract = {{BACKGROUND: Phthalates, ubiquitous environmental pollutants that may
   disturb the endocrine system, are used primarily as plasticizers of
   polyvinyl chloride and as additives in consumer and personal care
   products.
   OBJECTIVES: In this study, we examined the association between urinary
   concentrations of nine phthalate metabolites and breast cancer (BC) in
   Mexican women.
   METHODS: We age-matched 233 BC cases to 221 women residing in northern
   Mexico. Sociodemographic and reproductive characteristics were obtained
   by direct interviews. Phthalates were determined in urine samples
   (collected pretreatment from the cases) by isotope
   dilution/high-performance liquid chromatography coupled to tandem mass
   spectrometry.
   RESULTS: Phthalate metabolites were detected in at least 82\% of women.
   The geometric mean concentrations of monoethyl phthalate (MEP) were
   higher in cases than in controls (169.58 vs. 106.78 mu g/g creatinine).
   Controls showed significantly higher concentrations of mono-n-butyl
   phthalate, mono(2-ethyl-5-oxohexyl) phthalate, and mono(3-carboxypropyl)
   phthalate (MCPP) than did the cases. After adjusting for risk factors
   and other phthalates, MEP urinary concentrations were positively
   associated with BC {[}odds ratio (OR), highest vs. lowest tertile =
   2.20; 95\% confidence interval (CI), 1.33-3.63; p for trend < 0.01].
   This association became stronger when estimated for premenopausal women
   (OR, highest vs. lowest tertile = 4.13; 95\% CI, 1.60-10.70; p for trend
   < 0.01). In contrast, we observed significant negative associations for
   monobenzyl phthalate (MBzP) and MCPP.
   CONCLUSIONS: We show for the first time that exposure to diethyl
   phthalate, the parent compound of MEP, may be associated with increased
   risk of BC, whereas exposure to the parent phthalates of MBzP and MCPP
   might be negatively associated. These findings require confirmation.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lopez-Carrillo, L (Reprint Author), Natl Inst Publ Hlth, Univ 655, Cuernavaca 62100, Morelos, Mexico.
   Lopez-Carrillo, Lizbeth; Hernandez-Ramirez, Raul U.; Torres-Sanchez, Luisa; Galvan-Portillo, Marcia, Natl Inst Publ Hlth, Cuernavaca 62100, Morelos, Mexico.
   Calafat, Antonia M.; Needham, Larry L., Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Ruiz-Ramos, Ruben; Cebrian, Mariano E., Inst Politecn Nacl, Ctr Invest \& Estudios Avanzados, Dept Toxicol, Mexico City, DF, Mexico.}},
DOI = {{10.1289/ehp.0901091}},
ISSN = {{0091-6765}},
Keywords = {{breast cancer; case-control study; endocrine disruptors; environment;
   Mexico; phthalates; risk assessment; urinary metabolites}},
Keywords-Plus = {{ACTIVATED-RECEPTOR-GAMMA; HIGH PLASMA-CONCENTRATIONS; BODY TOPICAL
   APPLICATION; THYROID-HORMONE LEVELS; DIETHYL PHTHALATE; PREGNANT-WOMEN;
   COMET ASSAY; HUMAN SPERM; DNA-DAMAGE; PPAR-GAMMA}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{lizbeth@insp.mx}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Funding-Acknowledgement = {{CONACYT (Consejo Nacional de Ciencia y Tecnologia) Fondo Sectorial de
   Investigacion en Salud y Seguridad Social (FOSISS) {[}2005-C02-14373,
   FOSISS 2009-01-11384, SEP-CONACYT 2008-79912]}},
Funding-Text = {{The study was supported by CONACYT (Consejo Nacional de Ciencia y
   Tecnologia) Fondo Sectorial de Investigacion en Salud y Seguridad Social
   (FOSISS) 2005-C02-14373, FOSISS 2009-01-11384, and SEP-CONACYT
   2008-79912.}},
Cited-References = {{Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Anderson D, 1999, TERATOGEN CARCIN MUT, V19, P275, DOI 10.1002/(SICI)1520-6866(1999)19:4<275::AID-TCM4>3.0.CO;2-1.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Berman T, 2009, ENVIRON INT, V35, P353, DOI 10.1016/j.envint.2008.08.010.
   Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   Cao XL, 2008, J CHROMATOGR A, V1178, P231, DOI 10.1016/j.chroma.2007.11.095.
   CDC, 2005, 3 CDCP.
   Chingin K, 2009, ANAL CHEM, V81, P2414, DOI 10.1021/ac900270f.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   Corton JC, 2005, TOXICOL SCI, V83, P4, DOI 10.1093/toxsci/kfi011.
   David RM, 2003, HANDB ENVIRON CHEM, V3, P299.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Elstner E, 1998, P NATL ACAD SCI USA, V95, P8806, DOI 10.1073/pnas.95.15.8806.
   Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hines EP, 2009, ENVIRON HEALTH PERSP, V117, P86, DOI 10.1289/ehp.11610.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Houlihan J., 2002, NOT TOO PRETTY PHTHA.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   Kang SC, 2005, J TOXICOL ENV HEAL A, V68, P1995, DOI 10.1080/15287390491008913.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kleinsasser NH, 2000, ENVIRON MOL MUTAGEN, V35, P9, DOI 10.1002/(SICI)1098-2280(2000)35:1<9::AID-EM2>3.0.CO;2-1.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   MINT A, 1994, TOXICOL IN VITRO, V8, P251, DOI 10.1016/0887-2333(94)90190-2.
   Mueller E, 1998, MOL CELL, V1, P465, DOI 10.1016/S1097-2765(00)80047-7.
   National Research Council, 2008, PHTHAL CUM RISK ASS.
   Peck Jennifer David, 2010, J Expo Sci Environ Epidemiol, V20, P90, DOI 10.1038/jes.2009.4.
   Reddy BS, 2006, FERTIL STERIL, V85, P775, DOI 10.1016/j.fertnstert.2005.08.037.
   Reddy BS, 2006, BJOG-INT J OBSTET GY, V113, P515, DOI 10.1111/j.1471-0528.2006.00925.x.
   Rockhill B, 1998, AM J EPIDEMIOL, V147, P826.
   SCOTT RC, 1987, ENVIRON HEALTH PERSP, V74, P223, DOI 10.2307/3430452.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Tapia-Conyer R, 1992, Salud Publica Mex, V34, P124.
   Venkata NG, 2006, TOXICOL LETT, V163, P224, DOI 10.1016/j.toxlet.2005.11.001.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}AG TOX SUBST DIS, 1995, TOX PROF DIETH PHTHA.
   {*}COSM INGR REV, 2003, SCI LIT REV DIB PHTH.
   {*}HLTH CAR HARM, 2002, PRETT NAST PHTHAL EU.
   {*}SCI COMM COSM PRO, 2002, OP SCI COMM COSM PRO.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{29}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{580NA}},
Wos-Id = {{ISI:000276454800028}},
}

@article{ ISI:000275818200023,
Author = {Huang, Po-Chin and Tsai, Eing-Mei and Li, Wan-Fen and Liao, Pao-Chi and
   Chung, Meng-Chu and Wang, Ya-Hui and Wang, Shu-Li},
Title = {{Association between phthalate exposure and glutathione S-transferase M1
   polymorphism in adenomyosis, leiomyoma and endometriosis}},
Journal = {{HUMAN REPRODUCTION}},
Year = {{2010}},
Volume = {{25}},
Number = {{4}},
Pages = {{986-994}},
Month = {{APR}},
Abstract = {{Phthalates are known to have estrogenic effects in cell models and
   experimental animals. However, the evidence regarding the effects of
   phthalates on human reproduction is still limited. We conducted a
   case-control study to determine whether estrogen-dependent diseases are
   associated with phthalate exposure and how the glutathione S-transferase
   M1 (GSTM1; a major detoxification enzyme) genotype modulates the risk.
   We recruited subjects who underwent laparotomy and had pathologic
   confirmation of endometriosis (EN) (n = 28), adenomyosis (AD) (n = 16)
   and leiomyoma (LEI) (n = 36) from the Department of Obstetrics and
   Gynecology at a medical center in Taiwan between 2005 and 2007. Controls
   (n = 29) were patients without any of the three aforementioned
   gynecologic conditions. Urine samples were collected before surgery and
   analyzed for seven phthalate metabolites using liquid
   chromatography-tandem mass spectrometry. Peripheral lymphocytes were
   used for GSTM1 genotype determination.
   Patients with LEIs had significantly higher levels of total urinary
   mono-ethylhexyl phthalate (Sigma MEHP; 52.1 versus 18.9 mu g/g
   creatinine, P < 0.05) than the controls, whereas patients with EN had an
   increased level of urinary mono-n-butyl phthalate (94.1 versus 58.0 mu
   g/g creatinine, P < 0.05). Subjects with GSTM1 null genotype had
   significantly increased odds for AD relative to those with GSTM1 wild
   genotype {[}odds ratio (OR) = 5.30; 95\% CI, 1.22-23.1], even after
   adjustment for age and phthalate exposure. Subjects who carried the
   GSTM1 null genotype and had a high urinary level of Sigma MEHP showed a
   significantly increased risk for AD (OR = 10.4; 95\% CI, 1.26-85.0) and
   LEIs (OR = 5.93; 95\% CI, 1.10-31.9) after adjustment for age, compared
   with those with GSTM1 wild-type and low urinary level of Sigma MEHP.
   These results suggest that both GSTM1 null and phthalate exposure are
   associated with AD and LEI. Larger studies are warranted to investigate
   potential interaction between GSTM1 null and phthalate exposure in the
   etiology of estrogen-dependent gynecologic conditions.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wang, SL (Reprint Author), Natl Hlth Res Inst, Div Environm Hlth \& Occupat Med, 35 Keyan Rd, Zhunan 350, Miaoli County, Taiwan.
   Huang, Po-Chin; Li, Wan-Fen; Chung, Meng-Chu; Wang, Ya-Hui; Wang, Shu-Li, Natl Hlth Res Inst, Div Environm Hlth \& Occupat Med, Zhunan 350, Miaoli County, Taiwan.
   Tsai, Eing-Mei, Kaohsiung Med Univ Hosp, Dept Obstet \& Gynecol, Kaohsiung, Taiwan.
   Liao, Pao-Chi, Natl Cheng Kung Univ, Dept Environm \& Occupat Hlth, Coll Med, Tainan 70101, Taiwan.
   Wang, Shu-Li, China Med Univ \& Hosp, Coll Publ Hlth, Inst Environm Med, Taichung, Taiwan.
   Tsai, Eing-Mei; Wang, Shu-Li, Kaohsiung Med Univ, Ctr Excellence Environm Med, Kaohsiung, Taiwan.}},
DOI = {{10.1093/humrep/deq015}},
ISSN = {{0268-1161}},
Keywords = {{adenomyosis; leiomyoma; endometriosis; phthalate monoester; glutathione
   S-transferase M1}},
Keywords-Plus = {{HIGH PLASMA-CONCENTRATIONS; IN-VITRO; ESTROGENIC ACTIVITY; GENE
   POLYMORPHISMS; MASS-SPECTROMETRY; INDIAN WOMEN; BISPHENOL-A; GSTM1;
   ESTERS; CYP1A1}},
Research-Areas = {{Obstetrics \& Gynecology; Reproductive Biology}},
Web-of-Science-Categories  = {{Obstetrics \& Gynecology; Reproductive Biology}},
Author-Email = {{slwang@nhri.org.tw}},
ResearcherID-Numbers = {{Tsai, Eing-Mei/A-1414-2010
   Wang, Shu-Li/C-1367-2010
   Huang, Po-Chin/I-5844-2012}},
Funding-Acknowledgement = {{National Health Research Institutes {[}EO-095-PP-09, EO-096-PP-09]}},
Funding-Text = {{We are grateful for the financial support from the National Health
   Research Institutes (grant nos: EO-095-PP-09 and EO-096-PP-09).}},
Cited-References = {{Al-Hendy A, 2006, HUM REPROD UPDATE, V12, P385, DOI 10.1093/humupd/dm1015.
   Arvanitis DA, 2003, FERTIL STERIL, V79, P702, DOI 10.1016/S0015-0282(02)04817-3.
   Babu KA, 2005, PHARMACOGENET GENOM, V15, P167, DOI 10.1097/01213011-200503000-00005.
   Baranova H, 1997, MOL HUM REPROD, V3, P775, DOI 10.1093/molehr/3.9.775.
   Baranova H, 1999, MOL HUM REPROD, V5, P636, DOI 10.1093/molehr/5.7.636.
   Becker K, 2009, INT J HYG ENVIR HEAL, V212, P685, DOI 10.1016/j.ijheh.2009.08.002.
   BULUN SE, 2009, NEW ENGL J MED, V15, P268.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   Cramer DW, 2002, ANN NY ACAD SCI, V955, P11.
   Devlieger R, 2003, HUM REPROD UPDATE, V9, P139, DOI 10.1093/humupd/dmg010.
   DIGANGI J, 2002, AGGREGATE EXPOSURES.
   DIGANGI J, 2002, PRETTY NASTY PHTHALA.
   Ding Yan, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P101.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5.
   Guo SW, 2005, MOL HUM REPROD, V11, P729, DOI 10.1093/molehr/gah206.
   Hadfield RM, 2001, MOL HUM REPROD, V7, P1073, DOI 10.1093/molehr/7.11.1073.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   Hong EJ, 2005, J REPROD DEVELOP, V51, P253, DOI 10.1262/jrd.16075.
   Houlihan J., 2002, NOT TOO PRETTY PHTHA.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Hur SE, 2005, MOL HUM REPROD, V11, P15, DOI 10.1093/molehr/gah127.
   HUSEBY RA, 1982, AM J OBSTET GYNECOL, V15, P939.
   Jin Q., 2008, FRONT MED CHINA, V2, P303, DOI 10.1007/s11684-008-0058-2.
   Juo SH, 2006, HUM REPROD, V21, P1498, DOI 10.1093/humrep/de1033.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Lin J, 2003, CHINESE MED J-PEKING, V116, P777.
   Lin LC, 2004, RAPID COMMUN MASS SP, V18, P1310, DOI 10.1002/rcm.1488.
   Ma MY, 2006, TOXICOL SCI, V93, P164, DOI 10.1093/toxsci/kfl036.
   Moore NP, 2000, REPROD TOXICOL, V14, P183, DOI 10.1016/S0890-6238(00)00068-X.
   Morizane Mayumi, 2004, J Soc Gynecol Investig, V11, P118, DOI 10.1016/j.jsgi.2003.07.009.
   Newbold RR, 2007, REPROD TOXICOL, V24, P253, DOI 10.1016/j.reprotox.2007.07.006.
   Okubo T, 2003, BIOL PHARM BULL, V26, P1219.
   Rebbeck TR, 1997, CANCER EPIDEM BIOMAR, V6, P733.
   Reddy BS, 2006, FERTIL STERIL, V85, P775, DOI 10.1016/j.fertnstert.2005.08.037.
   Reddy BS, 2006, BJOG-INT J OBSTET GY, V113, P515, DOI 10.1111/j.1471-0528.2006.00925.x.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Shinka T, 1998, J UROLOGY, V159, P380, DOI 10.1016/S0022-5347(01)63924-7.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   van Dartel DAM, 2009, REPROD TOXICOL, V27, P93, DOI 10.1016/j.reprotox.2008.12.009.
   Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010.
   Vercellini P, 2006, BEST PRACT RES CL OB, V20, P465, DOI 10.1016/j.bpobgyn.2006.01.017.
   Wolff MS, 2007, ENVIRON HEALTH PERSP, V115, P116, DOI 10.1289/ehp.9488.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{18}},
Journal-ISO = {{Hum. Reprod.}},
Doc-Delivery-Number = {{572HH}},
Wos-Id = {{ISI:000275818200023}},
}

@article{ ISI:000275636400004,
Author = {Swan, S. H. and Liu, F. and Hines, M. and Kruse, R. L. and Wang, C. and
   Redmon, J. B. and Sparks, A. and Weiss, B.},
Title = {{Prenatal phthalate exposure and reduced masculine play in boys}},
Journal = {{INTERNATIONAL JOURNAL OF ANDROLOGY}},
Year = {{2010}},
Volume = {{33}},
Number = {{2}},
Pages = {{259-267}},
Month = {{APR}},
Note = {{5th Copenhagen Workshop on Endocrine Disruptgers - Ubiquitous Endocrine
   Disrupters and Possible Human Health Effects, Copenhagen, DENMARK, MAY
   20-22, 2009}},
Abstract = {{P>Foetal exposure to antiandrogens alters androgen-sensitive development
   in male rodents, resulting in less male-typical behaviour. Foetal
   phthalate exposure is also associated with male reproductive development
   in humans, but neurodevelopmental outcomes have seldom been examined in
   relation to phthalate exposure. To assess play behaviour in relation to
   phthalate metabolite concentration in prenatal urine samples, we
   recontacted participants in the Study for Future Families whose
   phthalate metabolites had been measured in mid-pregnancy urine samples.
   Mothers completed a questionnaire including the Pre-School Activities
   Inventory, a validated instrument used to assess sexually dimorphic play
   behaviour. We examined play behaviour scores (masculine, feminine and
   composite) in relationship to (log(10)) phthalate metabolite
   concentrations in mother's urine separately for boys (N = 74) and girls
   (N = 71). Covariates (child's age, mother's age and education and
   parental attitude towards atypical play choices) were controlled using
   multivariate regression models. Concentrations of dibutyl phthalate
   metabolites, mono-n-butyl phthalate (MnBP) and mono-isobutyl phthalate
   (MiBP) and their sum, were associated with a decreased (less masculine)
   composite score in boys (regression coefficients -4.53,-3.61 and -4.20,
   p = 0.01, 0.07 and 0.04 for MnBP, MiBP and their sum respectively).
   Concentrations of two urinary metabolites of di(2-ethylhexyl) phthalate
   (DEHP), mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP) and
   mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) and the sum of these
   DEHP metabolites plus mono(2-ethylhexyl) phthalate were associated with
   a decreased masculine score (regression coefficients -3.29,-2.94 and
   -3.18, p = 0.02, 0.04 and 0.04) for MEHHP, MEOHP and the sum
   respectively. No strong associations were seen between behaviour and
   urinary concentrations of any other phthalate metabolites in boys, or
   between girls' scores and any metabolites. These data, although based on
   a small sample, suggest that prenatal exposure to antiandrogenic
   phthalates may be associated with less male-typical play behaviour in
   boys. Our findings suggest that these ubiquitous environmental chemicals
   have the potential to alter androgen-responsive brain development in
   humans.}},
Publisher = {{WILEY-BLACKWELL PUBLISHING, INC}},
Address = {{COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Swan, SH (Reprint Author), Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, 601 Elmwood Ave,Box 668, Rochester, NY 14624 USA.
   Swan, S. H., Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, Rochester, NY 14624 USA.
   Kruse, R. L., Univ Missouri, Dept Family \& Community Med, Columbia, MO USA.
   Wang, C., Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Los Angeles, CA USA.
   Redmon, J. B., Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.
   Sparks, A., Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.
   Weiss, B., Univ Rochester, Dept Environm Med, Rochester, NY USA.
   Hines, M., Univ Cambridge, Dept Social \& Dev Psychol, Cambridge, England.}},
DOI = {{10.1111/j.1365-2605.2009.01019.x}},
ISSN = {{0105-6263}},
Keywords = {{di(2-ethylhexyl) phthalate; dibutyl phthalate; play behaviour; prenatal
   exposure phthalates; Pre-School Activities Inventory; sex-dimorphism}},
Keywords-Plus = {{GENDER-ROLE BEHAVIOR; SEX-DIFFERENCES; PRESCHOOL-CHILDREN;
   NONHUMAN-PRIMATES; RATS; TESTOSTERONE; INFANTS; AGE; POPULATION;
   DISRUPTION}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{shanna\_swan@urmc.rochester.edu}},
Cited-References = {{Alexander GM, 2002, EVOL HUM BEHAV, V23, P467, DOI 10.1016/S1090-5138(02)00107-1.
   Alexander GM, 2009, ARCH SEX BEHAV, V38, P427, DOI 10.1007/s10508-008-9430-1.
   Auyeung B, 2009, PSYCHOL SCI, V20, P144, DOI 10.1111/j.1467-9280.2009.02279.x.
   Brothers KB, 2008, CLIN PEDIATR, V47, P271, DOI 10.1177/0009922807309419.
   Casto JM, 2003, PHYSIOL BEHAV, V79, P633, DOI 10.1016/S0031-9384(03)00120-3.
   COLBERT NKP, 2005, ENVIRON HEALTH PERSP, V13, P700.
   Engel SM, 2009, NEUROTOXICOLOGY, V30, P522, DOI 10.1016/j.neuro.2009.04.001.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Golombok S, 2008, CHILD DEV, V79, P1583, DOI 10.1111/j.1467-8624.2008.01207.x.
   GOLOMBOK S, 1993, J CHILD PSYCHOL PSYC, V34, P805, DOI 10.1111/j.1469-7610.1993.tb01072.x.
   Hassett JM, 2008, HORM BEHAV, V54, P359, DOI 10.1016/j.yhbeh.2008.03.008.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hines M, 2002, CHILD DEV, V73, P1678, DOI 10.1111/1467-8624.00498.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Hotchkiss AK, 2003, PHYSIOL BEHAV, V79, P151, DOI 10.1016/S0031-9384(03)00093-3.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Kamrin MA, 2009, J TOXICOL ENV HEAL B, V12, P157, DOI 10.1080/10937400902729226.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Pellis SM, 2002, ARCH SEX BEHAV, V31, P17, DOI 10.1023/A:1014070916047.
   REYES FI, 1973, J CLIN ENDOCR METAB, V37, P74.
   Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x.
   SAS, 1999, SAS SYST WIND VERS 8.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Servin A, 1999, SCAND J PSYCHOL, V40, P43, DOI 10.1111/1467-9450.00096.
   Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   SMAIL PJ, 1981, PEDIAT ANDROLOGY.
   Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313.
   Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P414, DOI 10.1289/ehp.5927.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   van de Beek C, 2009, ARCH SEX BEHAV, V38, P6, DOI 10.1007/s10508-007-9291-z.
   Vreugdenhil HJI, 2002, ENVIRON HEALTH PERSP, V110, pA593.
   Wallen K, 2005, FRONT NEUROENDOCRIN, V26, P7, DOI 10.1016/j.yfrne.2005.02.001.
   Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241.
   {*}CDC, 2005, 3 CDC US DEP HLTH HU.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{42}},
Journal-ISO = {{Int. J. Androl.}},
Doc-Delivery-Number = {{569XO}},
Wos-Id = {{ISI:000275636400004}},
}

@article{ ISI:000274649700008,
Author = {Baird, Donna Day and Saldana, Tina M. and Nepomnaschy, Pablo A. and
   Hoppin, Jane A. and Longnecker, Matthew P. and Weinberg, Clarice R. and
   Wilcox, Allen J.},
Title = {{Within-person variability in urinary phthalate metabolite
   concentrations: measurements from specimens after long-term frozen
   storage}},
Journal = {{JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY}},
Year = {{2010}},
Volume = {{20}},
Number = {{2}},
Pages = {{169-175}},
Month = {{MAR-APR}},
Abstract = {{Laboratory studies show that exposure to phthalates during development
   can cause adverse effects, especially for males. Studies in humans would
   be facilitated by collection of urine during pregnancy, long-term
   storage, and measurement of phthalate metabolites at the time that
   offspring health is assessed. Our aims were to measure urinary phthalate
   metabolites after long-term freezer storage, to use those measurements
   to evaluate within-woman variability over 2- and 4-week intervals, and
   to determine whether the phases of the menstrual cycle affect metabolite
   levels. Samples were selected from daily first-morning urine specimens
   collected by 60 women and stored frozen since 1983-1985. Three specimens
   per woman were selected at approximately 2-week intervals to include
   both follicular and luteal phase samples. Seven metabolites of five
   phthalates were measured by mass spectrometry. Statistical analyses were
   conducted with correlation, mixed model regression, and the Wilcoxon
   signed rank test. Creatinine-corrected urinary phthalate metabolite
   concentrations measured in samples after long-term storage tended to
   have a similar right-skewed distribution, though with somewhat higher
   concentrations than those reported for recently collected US samples.
   The concentrations of three metabolites of di(2-ethylhexyl) phthalate in
   the same specimen were very highly correlated (Pearson r=0.85-0.97).
   Reproducibility over a 4-week interval was moderate for the metabolites
   of diethyl phthalate and benzylbutyl phthalate (intraclass correlation
   coefficients, ICCs, 0.48 and 0.53, respectively), whereas five other
   metabolites had lower ICCs (0.21-0.37). Menstrual phase was not related
   to metabolite concentrations. Although the same samples have not been
   measured both before and after long-term storage, results suggest that
   the measurement of phthalate metabolites after long-term sample storage
   yield generally similar distributions and temporal reliability as those
   reported for recently collected specimens. These findings support the
   use of stored urine specimens collected during the relevant stage of
   human pregnancy to investigate the influence of phthalate exposures on
   later outcomes. Journal of Exposure Science and Environmental
   Epidemiology (2010) 20, 169-175; doi: 10.1038/jes.2009.17; published
   online 11 March 2009}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Baird, DD (Reprint Author), NIEHS, Epidemiol Branch, NIH, MD A3-05 NIEHS,POB 12233, Res Triangle Pk, NC 27709 USA.
   Baird, Donna Day; Hoppin, Jane A.; Longnecker, Matthew P.; Wilcox, Allen J., NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA.
   Saldana, Tina M., Social \& Sci Syst Inc, Durham, NC USA.
   Nepomnaschy, Pablo A., Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.
   Weinberg, Clarice R., NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA.}},
DOI = {{10.1038/jes.2009.17}},
ISSN = {{1559-0631}},
Keywords = {{biomarker; phthalate; reproducibility; menstrual cycle; temporal
   variability}},
Keywords-Plus = {{TEMPORAL VARIABILITY; PREGNANT-WOMEN; MALE-RAT; EXPOSURE; POPULATION;
   HEALTH; ESTERS; DEHP; MONOESTERS; CHILDREN}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{baird@niehs.nih.gov}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences, National Institutes
   of Health, HHS}},
Funding-Text = {{The field manager of the North Carolina Early Pregnancy Study was Joy
   Pierce, and D. Robert McConnaughey manages the study data files. This
   research was funded by the intramural program at the National Institute
   of Environmental Health Sciences, National Institutes of Health, HHS. We
   thank AXYS Analytical Services Ltd from Sidney, BC Canada, for their
   assistance with this project including their detailed description of the
   analytic methods. An earlier version of the manuscript was reviewed by
   Drs. Freya Kamel and Yang Cao.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   BAIRD DD, 1991, STAT MED, V10, P255, DOI 10.1002/sim.4780100209.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P1083, DOI 10.1289/ehp.7617.
   BIZZARI S, 2000, PLASTICIZERS CHEM EC.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Helm D, 2007, SCI TOTAL ENVIRON, V388, P389, DOI 10.1016/j.scitotenv.2007.07.009.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hoppin JA, 2006, J EXPO SCI ENV EPID, V16, P39, DOI 10.1038/sj.jea.7500435.
   HORMUNG R, 1990, APPL OCCUP ENV HYG, V5, P46.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Main KM, 2008, GESUNDHEITSWESEN, V70, pS46, DOI 10.1055/s-2008-1042431.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037//0033-2909.86.2.420.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   TAUSSKY HH, 1954, J BIOL CHEM, V208, P853.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   {*}CDC, 2005, NAT REP HUM EXP ENV.
   {*}NTP CERHR EXPR PA, 2000, NTPCERHRBBP00.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{9}},
Journal-ISO = {{J. Expo. Sci. Environ. Epidemiol.}},
Doc-Delivery-Number = {{557DQ}},
Wos-Id = {{ISI:000274649700008}},
}

@article{ ISI:000274482400033,
Author = {Adibi, Jennifer J. and Whyatt, Robin M. and Hauser, Russ and Bhat, Hari
   K. and Davis, Barbara J. and Calafat, Antonia M. and Hoepner, Lori A.
   and Perera, Frederica P. and Tang, Deliang and Williams, Paige L.},
Title = {{Transcriptional Biomarkers of Steroidogenesis and Trophoblast
   Differentiation in the Placenta in Relation to Prenatal Phthalate
   Exposure}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2010}},
Volume = {{118}},
Number = {{2}},
Pages = {{291-296}},
Month = {{FEB}},
Abstract = {{BACKGROUND: Phthalates can alter steroidogenesis and peroxisome
   proliferator-activated receptor gamma (PPAR gamma)-mediated
   transcription in rodent tissues. The placenta offers a rich source of
   biomarkers to study these relationships in humans.
   OBJECTIVE: We evaluated whether gestational phthalate exposures in
   humans were associated with altered human placental steroidogenesis and
   trophoblast differentiation as measured by markers of mRNA
   transcription.
   METHODS: We measured seven target genes in placentas collected from 54
   Dominican and African-American women at delivery in New York City using
   quantitative real-time polymerase chain reaction (qPCR), normalized to
   18S rRNA. qPCR results for the target genes were log-transformed,
   converted to Z-scores, and grouped into two functional pathways:
   steroidogenesis (aromatase, cholesterol side chain cleavage enzyme, 17
   beta-hydroxysteroid dehydrogenase type 1, and cytochrome P450 1B1) and
   trophoblast differentiation (PPAR gamma, aryl hydrocarbon receptor, and
   human chorionic gonadotropin). Repeated measures models were used to
   evaluate the association of phthalate metabolites measured in
   third-trimester urine samples with each group of target genes,
   accounting for correlation among the genes within a pathway.
   RESULTS: Higher urinary concentrations of five phthalate metabolites
   were associated with lower expression of the target genes reflecting
   trophoblast differentiation. Results were less consistent for genes in
   the steroidogenesis pathway and suggested a nonlinear dose-response
   pattern for some phthalate metabolites.
   CONCLUSIONS: We observed a significant association between prenatal
   exposure to phthalates and placental gene expression within two
   pathways. Further studies are warranted to understand the significance
   of this association with respect to fetal development and placental
   function.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Adibi, JJ (Reprint Author), Univ Calif San Francisco, Dept Obstet Gynecol \& Reprod Sci, 513 Parnassus Ave,Box 0556, San Francisco, CA 94143 USA.
   Adibi, Jennifer J.; Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Whyatt, Robin M.; Bhat, Hari K.; Hoepner, Lori A.; Perera, Frederica P.; Tang, Deliang, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, New York, NY USA.
   Davis, Barbara J., Millennium Pharmaceut Inc, Cambridge, MA USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Williams, Paige L., Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.}},
DOI = {{10.1289/ehp.0900788}},
ISSN = {{0091-6765}},
Keywords = {{epidemiology; gene expression; phthalates; placenta; pregnancy;
   prenatal; steroidogenesis; trophoblast differentiation}},
Keywords-Plus = {{HUMAN CHORIONIC-GONADOTROPIN; NONMONOTONIC DOSE-RESPONSE; RAT
   GRANULOSA-CELLS; IN-UTERO EXPOSURE; GENE-EXPRESSION; MONO-(2-ETHYLHEXYL)
   PHTHALATE; DI(N-BUTYL) PHTHALATE; PPAR-GAMMA; FETAL-RAT;
   DI-(2-ETHYLHEXYL) PHTHALATE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{adibij@obgyn.ucsf.edu}},
Funding-Acknowledgement = {{National Institute of Environniental Health {[}P50 LS09600, R01
   ES013543, R01 ES08977, R01 ES11158]; U.S. Environmental Protection
   Agency {[}R827027, R8286090]}},
Funding-Text = {{This work was supported by National Institute of Environniental Health
   Sciences grants P50 LS09600, R01 ES013543, R01 ES08977, and R01 ES11158
   and by U.S. Environmental Protection Agency grants R827027 and R8286090}},
Cited-References = {{Adibi JJ, 2009, ENVIRON HEALTH-GLOB, V8, DOI 10.1186/1476-069X-8-20.
   Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Akre O, 2008, ENVIRON HEALTH PERSP, V116, P1071, DOI 10.1289/ehp.10791.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   Bhat HK, 2004, J BIOCHEM MOL TOXIC, V18, P180, DOI 10.1002/jbt.20024.
   Boberg J, 2008, TOXICOLOGY, V250, P75, DOI 10.1016/j.tox.2008.05.020.
   Borel V, 2008, PPAR RES, DOI 10.1155/2008/758562.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Detmar J, 2008, AM J PHYSIOL-ENDOC M, V295, pE519, DOI 10.1152/ajpendo.90436.2008.
   Ema M, 2000, REPROD TOXICOL, V14, P13, DOI 10.1016/S0890-6238(99)00066-0.
   Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200.
   Fitzmaurice GM, 2004, APPL LONGITUDINAL AN.
   Fournier T, 2007, PLACENTA, V28, P65, DOI 10.1016/j.placenta.2006.04.009.
   Froment P, 2006, J ENDOCRINOL, V189, P199, DOI 10.1677/joe.1.06667.
   Hallmark N, 2007, ENVIRON HEALTH PERSP, V115, P390, DOI 10.1289/ehp.9490.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Huuskonen P, 2008, CLIN PHARMACOL THER, V83, P542, DOI 10.1038/sj.clpt.6100376.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Lambrot R, 2009, ENVIRON HEALTH PERSP, V117, P32, DOI 10.1289/ehp.11146.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lepage N, 2003, AM J OBSTET GYNECOL, V188, P1354, DOI 10.1067/mob.2003.278.
   Li L, 2007, J MOL ENDOCRINOL, V38, P569, DOI 10.1677/JME-07-0003.
   Lin PP, 2003, TOXICOL SCI, V71, P20, DOI 10.1093/toxsci/71.1.20.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Lovekamp-Swan T, 2003, MOL CELL ENDOCRINOL, V201, P133, DOI 10.1016/S0303-7207(02)00423-9.
   Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809.
   McKinnell C, 2005, ENDOCRINOLOGY, V146, P4536, DOI 10.1210/en.2005-0676.
   Miyoshi Y, 2001, INT J CANCER, V94, P685, DOI 10.1002/ijc.1525.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Nishimura M, 2002, YAKUGAKU ZASSHI, V122, P339, DOI 10.1248/yakushi.122.339.
   Perera F, 2006, ANN NY ACAD SCI, V1076, P15, DOI 10.1196/annals.1371.018.
   Pidoux G, 2004, PLACENTA, V25, P469, DOI 10.1016/j.placenta.2003.10.016.
   Rauh VA, 2004, NEUROTOXICOL TERATOL, V26, P373, DOI 10.1016/j.ntt.2004.01.002.
   Rodie VA, 2005, J SOC GYNECOL INVEST, V12, P320, DOI 10.1016/j.jsgi.2005.03.004.
   Rozen S, 2000, BIOINFORMATICS METHO, P365, DOI DOI 10.1385/1-59259-192-2:365.
   Saillenfait AM, 2008, REPROD TOXICOL, V26, P107, DOI 10.1016/j.reprotox.2008.07.006.
   Schaiff WT, 2006, MOL CELL ENDOCRINOL, V249, P10, DOI 10.1016/j.mce.2006.02.009.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Tarrade A, 2001, ENDOCRINOLOGY, V142, P4504, DOI 10.1210/en.142.10.4504.
   Verbeke G., 2000, LINEAR MIXED MODELS.
   Vissac-Sabatier Cecile, 2003, Cancer Research, V63, P6607.
   Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494.
   Whyatt RM, 2009, PEDIATRICS, V124, pE1213, DOI 10.1542/peds.2009-0325.
   Whyatt RM, 2003, ENVIRON HEALTH PERSP, V111, P749, DOI 10.1289/ehp.5768.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Xu Y, 2008, PLACENTA, V29, P962, DOI 10.1016/j.placenta.2008.08.011.
   Yang M, 2003, ENDOCRINOLOGY, V144, P1108, DOI 10.1210/en.2002-220922.
   Yu L, 2002, MOL CELL ENDOCRINOL, V190, P9, DOI 10.1016/S0303-7207(02)00041-2.}},
Number-of-Cited-References = {{55}},
Times-Cited = {{5}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{555BQ}},
Wos-Id = {{ISI:000274482400033}},
}

@article{ ISI:000274051500014,
Author = {Lomenick, Jefferson P. and Calafat, Antonia M. and Castro, Maria S.
   Melguizo and Mier, Richard and Stenger, Peggy and Foster, Michael B. and
   Wintergerst, Kupper A.},
Title = {{Phthalate Exposure and Precocious Puberty in Females}},
Journal = {{JOURNAL OF PEDIATRICS}},
Year = {{2010}},
Volume = {{156}},
Number = {{2}},
Pages = {{221-225}},
Month = {{FEB}},
Abstract = {{Objective To determine whether phthalate exposure is associated with
   precocious puberty in girls.
   Study design This was a multicenter cross-sectional study in which 28
   girls with central precocious puberty (CPP) and 28 age- and race-matched
   prepubertal females were enrolled. Nine phthalate metabolites and
   creatinine were measured in spot urine samples from these 56 children.
   Results Levels of 8 of the 9 phthalate metabolites were above the limit
   of detection (LOD) in all 56 subjects. Mono (2-ethylhexyl) phthalate
   (MEHP) was below the LOD in 25/56 samples (14 subjects with precocious
   puberty and 11 controls). No significant differences between the
   children with CPP and the controls in either absolute or
   creatinine-normalized concentrations of any of the 9 phthalate
   metabolites were measured.
   Conclusions Although phthalates may be associated with certain other
   toxicities in humans, our study suggests that their exposure is not
   associated with precocious puberty in female children. (J Pediatr
   2010;156:221-5).}},
Publisher = {{MOSBY-ELSEVIER}},
Address = {{360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lomenick, JP (Reprint Author), Vanderbilt Univ, Div Endocrinol, Sch Med, 11136 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA.
   Lomenick, Jefferson P.; Castro, Maria S. Melguizo; Mier, Richard, Univ Kentucky, Coll Med, Dept Pediat, Lexington, KY USA.
   Lomenick, Jefferson P., Univ Kentucky, Coll Med, Div Endocrinol, Lexington, KY USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Atlanta, GA USA.
   Stenger, Peggy, Cincinnati Childrens Hosp Med Ctr, Div Pediat Endocrinol, Cincinnati, OH USA.
   Foster, Michael B.; Wintergerst, Kupper A., Univ Louisville, Sch Med, Div Pediat Endocrinol, Louisville, KY 40292 USA.}},
DOI = {{10.1016/j.jpeds.2009.09.047}},
ISSN = {{0022-3476}},
Keywords-Plus = {{IN-VITRO; ESTROGENIC ACTIVITY; HUMAN URINE; US GIRLS; AGE; MENARCHE;
   METABOLITES; ESTERS; RACE; PHYTOESTROGENS}},
Research-Areas = {{Pediatrics}},
Web-of-Science-Categories  = {{Pediatrics}},
Author-Email = {{jefferson.lomenick@vanderbilt.edu}},
Cited-References = {{Anderson SE, 2003, PEDIATRICS, V111, P844, DOI 10.1542/peds.111.4.844.
   Barlow NJ, 2004, TOXICOL PATHOL, V32, P79, DOI 10.1080/01926230490265894.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Louis GMB, 2008, PEDIATRICS, V121, pS192, DOI 10.1542/peds.1813E.
   Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050.
   Center for Disease Control and Prevention (CDC), 3 CDCP.
   Chou YY, 2009, J PEDIATR ENDOCR MET, V22, P69.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Euling SY, 2008, PEDIATRICS, V121, pS172, DOI 10.1542/peds.2007-1813D.
   Freedman DS, 2002, PEDIATRICS, V110, DOI 10.1542/peds.110.4.e43.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Henley DV, 2007, NEW ENGL J MED, V356, P479, DOI 10.1056/NEJMoa064725.
   HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505.
   Kaplowitz PB, 2001, PEDIATRICS, V108, P347, DOI 10.1542/peds.108.2.347.
   LEE PA, 2002, MANUAL ENDOCRINOLOGY, P210.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Massart F, 2008, J PEDIATR, V152, P690, DOI 10.1016/j.jpeds.2007.10.020.
   McKee RH, 2004, ENVIRON HEALTH PERSP, V112, pA541.
   NEELY EK, 1995, J PEDIATR, V127, P47, DOI 10.1016/S0022-3476(95)70255-5.
   Picard K, 2001, TOXICOL APPL PHARM, V172, P108, DOI 10.1006/taap.2001.9141.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Wolff MS, 2007, ENVIRON HEALTH PERSP, V115, P116, DOI 10.1289/ehp.9488.
   Wu TJ, 2002, PEDIATRICS, V110, P752, DOI 10.1542/peds.110.4.752.
   WYSHAK G, 1982, NEW ENGL J MED, V306, P1033, DOI 10.1056/NEJM198204293061707.
   Zacharewski TR, 1998, TOXICOL SCI, V46, P282, DOI 10.1093/toxsci/46.2.282.
   ZACHARIA.L, 1969, NEW ENGL J MED, V280, P868, DOI 10.1056/NEJM196904172801606.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{15}},
Journal-ISO = {{J. Pediatr.}},
Doc-Delivery-Number = {{549LW}},
Wos-Id = {{ISI:000274051500014}},
}

@article{ ISI:000276750000001,
Author = {Herreros, M. A. and Gonzalez-Bulnes, A. and Inigo-Nunez, S. and
   Letelier, C. and Contreras-Solis, I. and Ros-Rodriguez, J. M. and
   Encinas, T.},
Title = {{Pregnancy-associated changes in plasma concentration of the endocrine
   disruptor di(2-ethylhexyl) phthalate in a sheep model}},
Journal = {{THERIOGENOLOGY}},
Year = {{2010}},
Volume = {{73}},
Number = {{2}},
Pages = {{141-146}},
Month = {{JAN 15}},
Abstract = {{The plasticizer di(2-ethylhexyl)phthalate (DEHP), used for producing
   polyvinyl chloride (PVC), acts as an endocrine disruptor with toxic
   effects on reproductive and developmental processes. Exposure to DEHP in
   humans is mainly by environment and food. Thus, our aim was to determine
   plasma levels in livestock animals using the ewe (Ovis aries) as a
   model. In a first trial, 150 samples from ewes of different ages (2 to 7
   yr) and reproductive status (pregnant and nonpregnant) were analyzed by
   high-performance liquid chromatography (HPLC). DEHP was detected in
   34.7\% of the samples, with a mean level of 0.45 +/- 0.01 mu g/mL
   (range, 0.05 to 2.81 mu g/mL). The percentage of nonpregnant animals
   with DEHP traces was higher in animals older than 4 yr (n = 66, 37.9\%)
   than in younger animals (n = 69, 17.4\%; P < 0.05), although the mean
   levels in ewes with residues were similar (0.16 +/- 0.01 vs. 0.16 +/-
   0.02 mu g/mL). All the pregnant ewes (n = 15) showed presence of DEHP,
   with higher plasma levels than that in nonpregnant females (1.42 +/-
   0.18 vs. 0.16 +/- 0.01 mu g/mL; P <0.0001). For confirming the effect of
   pregnancy on mobilization of DEHP from body fat, 101 ewes of the same
   age were sampled in a second trial at a different farm. The percentage
   of animals with DEHP traces was higher in pregnant ewes (n = 32, 71.9\%;
   P < 0.005) than in nonpregnant ewes (n = 37, 35.1\%) or in ewes that
   recently gave birth (n = 32, 21.9\%), although mean levels were similar
   (0.42 +/- 0.02, 0.33 +/- 0.02, and 0.34 +/- 0.05 mu g/mL, respectively).
   In conclusion, current results indicate a high incidence of ewes reared
   in the field showing accumulation of phthalates; percentage of animals
   with presence of DEHP increases with age, due to an extended period of
   exposure, but mainly during pregnancy, due to the mobilization of body
   reserves. (C) 2010 Elsevier Inc. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Encinas, T (Reprint Author), Univ Complutense Madrid, Fac Vet, Dept Pharmacol \& Toxicol, Madrid, Spain.
   Gonzalez-Bulnes, A.; Ros-Rodriguez, J. M.; Encinas, T., Univ Complutense Madrid, Fac Vet, Dept Pharmacol \& Toxicol, Madrid, Spain.
   Herreros, M. A.; Inigo-Nunez, S., Comunidad Madrid, Consejeria Sanidad, Madrid, Spain.
   Gonzalez-Bulnes, A.; Letelier, C.; Contreras-Solis, I., Inst Nacl Invest Agr, Dept Anim Reprod, Madrid, Spain.}},
DOI = {{10.1016/j.theriogenology.2009.07.029}},
ISSN = {{0093-691X}},
Keywords = {{DEHP; Endocrine disruptors; Ewe; Exposure; Phthalate; Pregnancy}},
Keywords-Plus = {{DIETHYLHEXYL PHTHALATE; RELEASE BEHAVIOR; RISK-ASSESSMENT;
   AMNIOTIC-FLUID; EXPOSURE; METABOLITES; URINE; POPULATION; DIESTERS;
   HEALTH}},
Research-Areas = {{Reproductive Biology; Veterinary Sciences}},
Web-of-Science-Categories  = {{Reproductive Biology; Veterinary Sciences}},
Author-Email = {{tencinas@vet.ucm.es}},
Funding-Acknowledgement = {{SANTANDER/UCM {[}PR41/06-1500053]}},
Funding-Text = {{This work was supported by funds from SANTANDER/UCM (project
   PR41/06-1500053). This work is part of the first author's doctoral
   thesis, and the authors declare that there is no conflict of interest
   that would prejudice the impartiality of this scientific work.}},
Cited-References = {{Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Bigsby RM, 1997, CANCER RES, V57, P865.
   Bloch M, 2005, J CLIN ENDOCR METAB, V90, P695, DOI 10.1210/jc.2004-1388.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Boerjan ML, 2002, ANIM SCI, V74, P3.
   Bordes A, 2005, HUM REPROD, V20, P2745, DOI 10.1093/humrep/dei155.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   Campbell B K, 2003, Reprod Suppl, V61, P429.
   Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067.
   Denschlag D, 2005, FERTIL STERIL, V83, P501, DOI 10.1016/j.fertnstert.2004.07.958.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Gore AC, 2008, FRONT NEUROENDOCRIN, V29, P358, DOI 10.1016/j.yfrne.2008.02.002.
   Hanawa T, 2000, INT J PHARM, V210, P109, DOI 10.1016/S0378-5173(00)00578-0.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Ireland JJ, 2008, J ANIM SCI, V86, P2797, DOI 10.2527/jas.2008-1088.
   Kambia K, 2001, J CHROMATOGR B, V755, P297, DOI 10.1016/S0378-4347(01)00125-6.
   Koo HJ, 2005, J TOXICOL ENV HEAL A, V68, P1379, DOI 10.1080/15287390590956506.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Liang DW, 2008, APPL MICROBIOL BIOT, V80, P183, DOI 10.1007/s00253-008-1548-5.
   Ljungvall K, 2005, THERIOGENOLOGY, V64, P1170, DOI 10.1016/j.theriogenology.2005.02.003.
   Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   RHIND SM, 2005, ENV HLTH PERSPECT, V113, P3447.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   SYMONDS ME, 2003, NUTR EARLY LIFE CONC, P91.
   Takehisa H, 2005, INT J PHARM, V297, P30, DOI 10.1016/j.ijpharm.2005.02.015.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   WIDDOWSON EM, 1950, NATURE, V166, P626, DOI 10.1038/166626a0.
   Xu Y, 2008, PLACENTA, V29, P962, DOI 10.1016/j.placenta.2008.08.011.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{0}},
Journal-ISO = {{Theriogenology}},
Doc-Delivery-Number = {{584KG}},
Wos-Id = {{ISI:000276750000001}},
}

@article{ ISI:000273513800012,
Author = {Gupta, Rupesh K. and Singh, Jeffery M. and Leslie, Tracie C. and
   Meachum, Sharon and Flaws, Jodi A. and Yao, Humphrey H-C},
Title = {{Di-(2-ethylhexyl) phthalate and mono- (2-ethylhexyl) phthalate inhibit
   growth and reduce estradiol levels of antral follicles in vitro}},
Journal = {{TOXICOLOGY AND APPLIED PHARMACOLOGY}},
Year = {{2010}},
Volume = {{242}},
Number = {{2}},
Pages = {{224-230}},
Month = {{JAN 15}},
Abstract = {{Any insult that affects survival of ovarian antral follicles can cause
   abnormal estradiol production and fertility problems. Phthalate esters
   (PEs) are plasticizers used in a wide range of consumer and industrial
   products. Exposure to these chemicals has been linked to reduced
   fertility in humans and animal models. Di-(2-ethylhexyl) phthalate
   (DEHP) and mono-(2-ethylhexyl) phthalate (MEHP) decrease serum estradiol
   levels and aromatase (Arom) expression, prolong estrous cycles, and
   cause anovulation in animal and culture models. These observations
   suggest PEs directly target antral follicles. We therefore tested the
   hypothesis that DEHP (1-100 mu g/ml) and MEHP (0.1-10 mu g/ml) directly
   inhibit antral follicular growth and estradiol production. Antral
   follicles from adult mice were cultured with DEHP or MEHP, and/or
   estradiol for 96 h. During culture, follicle size was measured every 24
   h as a measurement of follicle growth. After culture, media were
   collected for measurement of estradiol levels and follicles were
   subjected to measurement of cylin-D-2 (Ccnd2), cyclin-dependant-kinase-4
   (Cdk4), and Arom. We found that DEHP and MEHP inhibited growth of
   follicles and decreased estradiol production compared to controls at the
   highest doses. DEHP and MEHP also decreased mRNA expression of Ccnd2,
   Cdk4, and Arom at the highest dose. Addition of estradiol to the culture
   medium prevented the follicles from DEHP- and MEHP-induced inhibition of
   growth, reduction in estradiol levels, and decreased Ccnd2 and Cdk4
   expression. Collectively, our results indicate that DEHP and MEHP may
   directly inhibit antral follicle growth via a mechanism that partially
   includes reduction in levels of estradiol production and decreased
   expression of cell cycle regulators. (C) 2009 Elsevier Inc. All rights
   reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Yao, HHC (Reprint Author), Univ Illinois, Dept Vet Biosci, Div Toxicol, 2001 S Lincoln Ave, Urbana, IL 61801 USA.
   Gupta, Rupesh K.; Singh, Jeffery M.; Leslie, Tracie C.; Meachum, Sharon; Flaws, Jodi A.; Yao, Humphrey H-C, Univ Illinois, Dept Vet Biosci, Div Toxicol, Urbana, IL 61801 USA.}},
DOI = {{10.1016/j.taap.2009.10.011}},
ISSN = {{0041-008X}},
Keywords = {{Phthalates; DEHP; MEHP; Ovary; Antral follicles; Cell cycle}},
Keywords-Plus = {{RAT GRANULOSA-CELLS; CYCLIN D2 EXPRESSION; MONO-(2-ETHYLHEXYL)
   PHTHALATE; SUPPRESSES ESTRADIOL; DISRUPTING COMPOUNDS; GENE-EXPRESSION;
   ER-ALPHA; ESTROGEN; METHOXYCHLOR; AROMATASE}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{drrupesh@illinois.edu
   jsingh20@illinois.edu
   tleslie2@illinois.edu
   smeachum@illinois.edu
   jflaws@illinois.edu
   hhyao@illinois.edu}},
ResearcherID-Numbers = {{Yao, Humphrey/B-4795-2010}},
Funding-Acknowledgement = {{NIH {[}R01 HD 046861, R01 ES012893-01A2]; NIEHS {[}T32 ES07326]}},
Funding-Text = {{This work was supported by NIH R01 HD 046861, NIH R01 ES012893-01A2, and
   NIEHS T32 ES07326}},
Cited-References = {{Agency for Toxic Substances and Disease Registry (ATSDR), 1993, NTIS PUBL.
   Aldyreva MV, 1975, GIG TR PROF ZABOL, V19, P25.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Bourguiba S, 2003, J MOL ENDOCRINOL, V31, P83, DOI 10.1677/jme.0.0310083.
   Britt KL, 2004, BIOL REPROD, V71, P1712, DOI 10.1095/biolreprod.104.028175.
   CONTI M, 1984, ENDOCRINOLOGY, V114, P2361.
   Cortvrindt RG, 2002, HUM REPROD UPDATE, V8, P243, DOI 10.1093/humupd/8.3.243.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Deroo BJ, 2009, MOL ENDOCRINOL, V23, P955, DOI 10.1210/me.2008-0213.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Fujita M, 2002, BIOCHEM BIOPH RES CO, V299, P222, DOI 10.1016/S0006-291X(02)02640-2.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   Gillum N, 2009, TOXICOL APPL PHARM, V236, P25, DOI 10.1016/j.taap.2008.12.027.
   Grande SW, 2007, TOXICOLOGY, V229, P114, DOI 10.1016/j.tox.2006.10.005.
   Gupta RK, 2006, TOXICOL SCI, V93, P382, DOI 10.1093/toxsci/kfl052.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   HIRSHFIELD AN, 1991, INT REV CYTOL, V124, P43, DOI 10.1016/S0074-7696(08)61524-7.
   Iliakis G, 1997, SEMIN ONCOL, V24, P602.
   Kanda N, 2004, J INVEST DERMATOL, V123, P319, DOI 10.1111/j.0022-202X.2004.12645.x.
   Kumar P, 2009, MOL ENDOCRINOL, V23, P784, DOI 10.1210/me.2008-0371.
   Lenie S, 2009, TOXICOL LETT, V185, P143, DOI 10.1016/j.toxlet.2008.12.015.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Lovekamp-Swan T, 2003, MOL CELL ENDOCRINOL, V201, P133, DOI 10.1016/S0303-7207(02)00423-9.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Miller KP, 2005, TOXICOL SCI, V88, P213, DOI 10.1093/toxsci/kfi276.
   Miller KR, 2006, TOXICOL SCI, V93, P180, DOI 10.1093/toxsci/kfl034.
   Mlynarcikova A, 2009, TOXICOL IN VITRO, V23, P371, DOI 10.1016/j.tiv.2008.12.017.
   MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0.
   Muncke J, 2009, SCI TOTAL ENVIRON, V407, P4549, DOI 10.1016/j.scitotenv.2009.05.006.
   Nakamura J, 1999, J CLIN ENDOCR METAB, V84, P1432, DOI 10.1210/jc.84.4.1432.
   NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603.
   de Castro I. Perez, 1999, Carcinogenesis (Oxford), V20, P1675, DOI 10.1093/carcin/20.9.1675.
   Piatelli MJ, 2002, J BIOL CHEM, V277, P12144, DOI 10.1074/jbc.M200102200.
   Reinsberg J, 2009, TOXICOL APPL PHARM, V239, P116, DOI 10.1016/j.taap.2009.05.022.
   Symonds DA, 2006, TOXICOL SCI, V89, P510, DOI 10.1093/toxsci/kfj044.
   TABACOVA S, 1999, EPIDEMIOLOGY S, V10.
   TANAKA A, 1975, TOXICOLOGY, V4, P253, DOI 10.1016/0300-483X(75)90105-5.
   TREINEN KA, 1990, TOXICOL APPL PHARM, V106, P334, DOI 10.1016/0041-008X(90)90252-P.
   Zhang WH, 2000, P NATL ACAD SCI USA, V97, P5936, DOI 10.1073/pnas.97.11.5936.
   {*}CERHR, 2000, NTP CERHR EXP PAN RE.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{12}},
Journal-ISO = {{Toxicol. Appl. Pharmacol.}},
Doc-Delivery-Number = {{542RX}},
Wos-Id = {{ISI:000273513800012}},
}

@article{ ISI:000272867900006,
Author = {Lorber, Matthew and Angerer, Juergen and Koch, Holger M.},
Title = {{A simple pharmacokinetic model to characterize exposure of Americans to
   Di-2-ethylhexyl phthalate}},
Journal = {{JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY}},
Year = {{2010}},
Volume = {{20}},
Number = {{1}},
Pages = {{38-53}},
Month = {{JAN-FEB}},
Abstract = {{A simple pharmacokinetic model to predict concentrations of metabolites
   of di-2-ethylhexyl phthalate, DEHP, in humans starting from intakes of
   DEHP was developed and applied. This model predicts serum and urine
   concentrations of five DEHP metabolites: MEHP, 5oxo-MEHP, 5OH-MEHP,
   5cx-MEPP, and 2cx-MMHP. The model was calibrated using data from an
   individual who dosed himself with 48.5mg DEHP, and then took blood and
   urine samples over a 44-h period. The calibrated model was then used in
   two applications: one on a second set of individuals whose exposure to
   DEHP was through PVC medical devices in a blood platelet donation
   procedure, and one on background exposures in the United States (US).
   Based on 2001/02 NHANES data, median US background urine concentrations
   of MEHP, 5OH-MEHP, and 5oxo-MEHP are 4.1, 20.1, and 14.0 mg/l,
   respectively. Creatine and urine volume-correction approaches were used
   to backcalculate an average daily dose of DEHP in the range of 0.6-2.2
   mg/kg per day. A ``background cohort{''} including 8 individuals and 57
   complete days of urination were assumed to be exposed to 1.5 mu g/kg per
   day, spread out in equal doses of 0.3 mu g/kg per day at 0900, 1200,
   1500, 1800, and 2100 h. The average predicted urine concentrations were
   4.6, 15.9, and 9.4 mu g/l for MEHP, 5OH-MEHP, and 5oxo-MEHP. These are
   similar, but the two secondary metabolites are slightly lower than
   medians found in NHANES. This slight difference between the NHANES
   results and the background simulations could have been due to
   differences in metabolism between the individual who provided the
   calibration data (61-year-old Caucasian male) and the general US
   population. Another explanation evaluated was that urine concentrations
   further from the time of exposure may have larger disparities between
   MEHP and the two secondary metabolites as compared with concentrations
   measured closer to the time of exposure. Journal of Exposure Science and
   Environmental Epidemiology (2010) 20, 38-53; doi:10.1038/jes.2008.74;
   published online 7 January 2009}},
Publisher = {{NATURE PUBLISHING GROUP}},
Address = {{75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lorber, M (Reprint Author), US EPA, Off Res \& Dev, 1200 Penn Ave,NW, Washington, DC 20460 USA.
   Lorber, Matthew, US EPA, Off Res \& Dev, Washington, DC 20460 USA.
   Angerer, Juergen; Koch, Holger M., Ruhr Univ Bochum, German Social Accid Insurance DGUV, Res Inst Occupat Med BGFA, D-44789 Bochum, Germany.}},
DOI = {{10.1038/jes.2008.74}},
ISSN = {{1559-0631}},
Keywords = {{phthalates; PBPK modeling; exposure modeling}},
Keywords-Plus = {{DI(2-ETHYLHEXYL)PHTHALATE DEHP; INTERNAL EXPOSURE; HUMAN URINE;
   METABOLITES; POPULATION; BIOMARKERS; FETAL; DISPOSITION; CHILDREN;
   UPDATE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{lorber.matthew@epa.gov}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{Aylward LL, 2005, J EXPO ANAL ENV EPID, V15, P51, DOI 10.1038/sj.jea.7500370.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Cahill TM, 2003, ENVIRON TOXICOL CHEM, V22, P26, DOI 10.1897/1551-5028(2003)022<0026:DAAOAG>2.0.CO;2.
   DAVID RM, 2000, 108 EHP, pA440.
   EPA, 1997, EXP FACT HDB.
   Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   KARARA AH, 1984, AQUAT TOXICOL, V5, P181, DOI 10.1016/0166-445X(84)90019-5.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Keys DA, 1999, TOXICOL SCI, V49, P172, DOI 10.1093/toxsci/49.2.172.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2005, INT J HYG ENVIR HEAL, V208, P489, DOI 10.1016/j.ijheh.2005.07.001.
   Koch HM, 2006, INT J ANDROL, V29, P181.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   KOCH HM, 2003, J HYG ENV HLTH, V206, P77.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Lorber M, 2008, J EXPO SCI ENV EPID, V18, P2, DOI 10.1038/sj.jes.7500572.
   Lorber M, 2002, SCI TOTAL ENVIRON, V288, P81, DOI 10.1016/S0048-9697(01)01119-6.
   Lorber M, 2009, J EXPO SCI ENV EPID, V19, P260, DOI 10.1038/jes.2008.8.
   Mahood IK, 2007, ENVIRON HEALTH PERSP, V115, P55, DOI 10.1289/ehp.9366.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Silva MJ, 2007, BIOMARKERS, V12, P133, DOI 10.1080/13547500601066915.
   Trudel D, 2008, RISK ANAL, V28, P251, DOI 10.1111/j.1539-6924.2008.01017.x.
   van Haarst EP, 2004, BJU INT, V93, P1257, DOI 10.1111/j.1464-410X.2004.04821.x.
   Washburn ST, 2005, ENVIRON SCI TECHNOL, V39, P3904, DOI 10.1021/es048353b.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}CDC, 2005, NCEH PUB, P30341.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{13}},
Journal-ISO = {{J. Expo. Sci. Environ. Epidemiol.}},
Doc-Delivery-Number = {{534AM}},
Wos-Id = {{ISI:000272867900006}},
}

@article{ ISI:000273348000044,
Author = {Durmaz, Erdem and Ozmert, Elif N. and Erkekoglu, Pinar and Giray, Belma
   and Derman, Orhan and Hincal, Filiz and Yurdakok, Kadriye},
Title = {{Plasma Phthalate Levels in Pubertal Gynecomastia}},
Journal = {{PEDIATRICS}},
Year = {{2010}},
Volume = {{125}},
Number = {{1}},
Pages = {{E122-E129}},
Month = {{JAN}},
Abstract = {{OBJECTIVE: Several untoward health effects of phthalates, which are a
   group of industrial chemicals with many commercial uses including
   personal-care products and plastic materials, have been defined. The
   most commonly used, di-(2-ethylhexyl)-phthalate (DEHP), is known to have
   antiandrogenic or estrogenic effects or both.
   Mono-(2-ethylhexyl)-phthalate (MEHP) is the main metabolite of DEHP. In
   this study, we aimed to determine the plasma DEHP and MEHP levels in
   pubertal gynecomastia cases.
   PATIENTS AND METHODS: The study group comprised 40 newly diagnosed
   pubertal gynecomastia cases who were admitted to Hacettepe University
   Ihsan Dogramaci Children's Hospital. The control group comprised 21
   age-matched children without gynecomastia or other endocrinologic
   disorder. Plasma DEHP and MEHP levels were measured by using
   high-performance liquid chromatography. Serum hormone levels were
   determined in some pubertal gynecomastia cases according to the
   physician's evaluation.
   RESULTS: Plasma DEHP and MEHP levels were found to be statistically
   significantly higher in the pubertal gynecomastia group compared with
   the control group (P<.001) (DEHP, 4.66 +/- 1.58 and 3.09 +/- 0.90 mu
   g/mL, respectively {[}odds ratio: 2.77 (95\% confidence interval:
   1.48-5.21)]; MEHP, 3.19 +/- 1.41 and 1.37 +/- 0.36 mu g/mL {[}odds
   ratio: 24.76 (95\% confidence interval: 3.5-172.6)]). There was a
   statistically significant correlation between plasma DEHP and MEHP
   levels (r: 0.58; P < .001). In the pubertal gynecomastia group, no
   correlation could be determined between plasma DEHP and MEHP levels and
   any of the hormone levels.
   CONCLUSIONS: DEHP, which has antiandrogenic or estrogenic effects, may
   be an etiologic factor in pubertal gynecomastia. These results may
   pioneer larger-scale studies on the etiologic role of DEHP in pubertal
   gynecomastia. Pediatrics 2010; 125: e122-e129}},
Publisher = {{AMER ACAD PEDIATRICS}},
Address = {{141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ozmert, EN (Reprint Author), Hacettepe Univ, Fac Med, Dept Pediat, Social Pediat Unit, TR-06100 Ankara, Turkey.
   Ozmert, Elif N., Hacettepe Univ, Fac Med, Dept Pediat, Social Pediat Unit, TR-06100 Ankara, Turkey.
   Erkekoglu, Pinar; Giray, Belma; Hincal, Filiz, Hacettepe Univ, Dept Toxicol, TR-06100 Ankara, Turkey.}},
DOI = {{10.1542/peds.2009-0724}},
ISSN = {{0031-4005}},
Keywords = {{phthalate; di-(2-ethylhexyl)-phthalate; mono-(2-ethylhexyl)-phthalate;
   endocrine disrupter; puberty; gynecomastia}},
Keywords-Plus = {{N-BUTYL PHTHALATE; SEXUAL-DIFFERENTIATION; TESTOSTERONE SYNTHESIS;
   GENE-EXPRESSION; MALE-RAT; EXPOSURE; DI-(2-ETHYLHEXYL)-PHTHALATE;
   TAMOXIFEN; DEHP; DI(2-ETHYLHEXYL)PHTHALATE}},
Research-Areas = {{Pediatrics}},
Web-of-Science-Categories  = {{Pediatrics}},
Author-Email = {{nozmert@hacettepe.edu.tr}},
Funding-Acknowledgement = {{Hacettepe University Scientific Research {[}07 D06 103 001]}},
Funding-Text = {{This study was funded by Hacettepe University Scientific Research Unit
   grant 07 D06 103 001.}},
Cited-References = {{Blom A, 1998, ARCH ENVIRON CON TOX, V34, P306.
   Braunstein GD, 2007, NEW ENGL J MED, V357, P1229, DOI 10.1056/NEJMcp070677.
   Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Derman O, 2008, J PEDIATR ENDOCR MET, V21, P449.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hokanson R, 2006, HUM EXP TOXICOL, V25, P687, DOI 10.1177/0960327106071977.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   Kai H, 2005, J PEDIATR SURG, V40, P429, DOI 10.1016/j.jpedsurg.2004.10.009.
   Kim IY, 2004, J TOXICOL ENV HEAL A, V67, P2025, DOI 10.1080/15287390490514750.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Kruger T, 2008, TOXICOLOGY, V246, P112, DOI 10.1016/j.tox.2007.12.028.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169.
   Moore NP, 2000, REPROD TOXICOL, V14, P183, DOI 10.1016/S0890-6238(00)00068-X.
   Narula HS, 2007, ENDOCRIN METAB CLIN, V36, P497, DOI 10.1016/j.ecl.2007.03.013.
   NYDICK M, 1961, JAMA-J AM MED ASSOC, V178, P449.
   PARIS I, 2003, ANAL LETT, V36, P2645.
   PARKER LN, 1986, METABOLISM, V35, P705, DOI 10.1016/0026-0495(86)90237-4.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   Qiao YJ, 2007, RARE METAL MAT ENG, V36, P95.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Thompson CJ, 2004, ENDOCRINOLOGY, V145, P1227, DOI 10.1210/en.2003-1475.
   U.S. Department of Health and Human Services, 2006, NIH PUBL, V06-3879.
   Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666.
   Voss C, 2005, TOXICOLOGY, V206, P359, DOI 10.1016/j.tox.2004.07.016.
   {*}AG TOX SUBST DIS, 2002, TOX PROF DI 2 ETH PH.
   {*}AG TOX SUBST DIS, 2001, TOX PROF DI N BUT PH.
   {*}AG TOX SUBST DIS, 1993, TOX PROF DI 2 ETH PH.
   {*}AG TOX SUBST DIS, 1995, TOX PROF DIETH.
   {*}AG TOX SUBST DIS, 1997, TOX PROF DI N OCT.
   {*}CTR EV RISKS HUM, 2000, EXP PAN REP DI 2 ETH.
   {*}EUR COMM HLTH CON, 2002, OP MED DEV CONT DEHP.
   {*}U HOSP GHENT, FREE BIO.
   {*}US DEP HHS, 2002, TOX PROF DI 2 ETH PH.
   {*}US FDA, 2002, SAF ASS DI 2 ETH PHT.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{20}},
Journal-ISO = {{Pediatrics}},
Doc-Delivery-Number = {{540PR}},
Wos-Id = {{ISI:000273348000044}},
}

@article{ ISI:000273171000022,
Author = {Monfort, Nuria and Ventura, Rosa and Latorre, Ana and Belalcazar,
   Viviana and Lopez, Merce and Segura, Jordi},
Title = {{Urinary di-(2-ethylhexyl)phthalate metabolites in athletes as screening
   measure for illicit blood doping: a comparison study with patients
   receiving blood transfusion}},
Journal = {{TRANSFUSION}},
Year = {{2010}},
Volume = {{50}},
Number = {{1}},
Pages = {{145-149}},
Month = {{JAN}},
Abstract = {{BACKGROUND:
   Subjects submitted to intravenous (IV) blood transfusions for medical
   reasons or blood doping to increase athletic performance are potentially
   exposed to the plasticizer di-(2-ethylhexyl)phthalate (DEHP) found in IV
   bags. Exposure to DEHP has been evaluated by measuring DEHP metabolites
   in selected groups of subjects.
   STUDY DESIGN AND METHODS:
   Urinary DEHP metabolites, mono-(2-ethylhexyl)phthalate,
   mono-(2-ethyl-5-hydroxyhexyl)phthalate (MEHHP), and
   mono-(2-ethyl-5-oxohexyl)phthalate (MEOHP) were measured in a control
   group with no explicit known exposure to DEHP (n = 30), hospitalized
   patients receiving blood transfusions (n = 25), nontransfused
   hospitalized patients receiving other medical care involving plastic
   materials (n = 39), and athletes (n = 127). Patients were tested in the
   periods 0 to 24 and 24 to 48 hours after exposition.
   RESULTS:
   Urinary concentrations of all three DEHP metabolites were significantly
   higher in patients receiving blood transfusion than in nontransfused
   patients and the control group, except for MEHHP and MEOHP in the period
   24 to 48 hours. Samples from four athletes showed increased
   concentrations of DEHP metabolites comparable to urinary concentrations
   of patients receiving blood transfusion.
   CONCLUSION:
   Elevated concentrations of urinary DEHP metabolites represent increased
   exposure to DEHP. High concentrations of DEHP metabolites present in
   urine collected from athletes may suggest illegal blood transfusion and
   can be used as a qualitative screening measure for blood doping.}},
Publisher = {{WILEY-BLACKWELL PUBLISHING, INC}},
Address = {{COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Segura, J (Reprint Author), IMIM Hosp Mar, Bioanal Res Grp, Dr Aiguader 88, Barcelona 08003, Spain.
   Segura, Jordi, IMIM Hosp Mar, Bioanal Res Grp, Barcelona 08003, Spain.
   Univ Pompeu Fabra, Dept Expt \& Hlth Sci, Barcelona, Spain.
   Hosp Mar, Blood Transfus Serv, Barcelona, Spain.}},
DOI = {{10.1111/j.1537-2995.2009.02352.x}},
ISSN = {{0041-1132}},
Keywords-Plus = {{DI(2-ETHYLHEXYL)PHTHALATE DEHP; PHTHALATE METABOLITES; EXPOSURE;
   POPULATION; SERUM}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Author-Email = {{jsegura@imim.es}},
ResearcherID-Numbers = {{ventura, rosa/A-6121-2011}},
Funding-Acknowledgement = {{World Antidoping Agency {[}06A6JS]; Consell Catal de l'Esport;
   Generalitat de Catalunya (Spain)}},
Funding-Text = {{The financial support received from World Antidoping Agency (Research
   Grant 06A6JS) and Consell Catal de l'Esport, Generalitat de Catalunya
   (Spain) is acknowledged. The authors thank the collaboration of Dr M.
   Farre, E. Menoyo, and M. Bosch for sample collection; Dr I. Mazzoni for
   useful comments; and Mr S. Mojal for statistical analysis.}},
Cited-References = {{Arndt PA, 2008, AM J HEMATOL, V83, P657, DOI 10.1002/ajh.21196.
   BELALCAZAR V, 2008, AM J HEMATOL, V83, P237.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Girard AL, 2008, J INTERPERS VIOLENCE, V23, P3, DOI 10.1177/0886260507307648.
   HOLGER M, 2003, ENVIRON RES, V93, P177.
   Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Koch HM, 2005, INT J HYG ENVIR HEAL, V208, P489, DOI 10.1016/j.ijheh.2005.07.001.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Mallorqui J, 2008, HAEMATOL-HEMATOL J, V93, P313, DOI 10.3324/haematol.12059.
   MORJEBERG J, 2008, TRANSFUSION, V48, P1524.
   Nelson M, 2002, HAEMATOLOGICA, V87, P881.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Prommer N, 2008, MED SCI SPORT EXER, V40, P2112, DOI 10.1249/MSS.0b013e3181820942.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   {*}EUR COMM HLTH CON, SCI COMM EM NEWL ID.
   {*}US FDA, FDA PUBL HLTH NOT MO.}},
Number-of-Cited-References = {{20}},
Times-Cited = {{13}},
Journal-ISO = {{Transfusion}},
Doc-Delivery-Number = {{538FX}},
Wos-Id = {{ISI:000273171000022}},
}

@article{ ISI:000272329700004,
Author = {Itoh, Hiroaki and Iwasaki, Motoki and Hanaoka, Tomoyuki and Sasaki,
   Hiroshi and Tanaka, Tadao and Tsugane, Shoichiro},
Title = {{Urinary phthalate monoesters and endometriosis in infertile Japanese
   women}},
Journal = {{SCIENCE OF THE TOTAL ENVIRONMENT}},
Year = {{2009}},
Volume = {{408}},
Number = {{1}},
Pages = {{37-42}},
Month = {{DEC 15}},
Abstract = {{Phthalates may act as an estrogen and are a potential risk factor for
   estrogen-related diseases such as endometriosis, We assessed the
   association between phthalate exposure and endometriosis in 166
   consecutive women who presented at a university hospital for
   consultation regarding infertility. The subjects were interviewed and
   provided a urine specimen prior to a laparoscopic diagnosis of
   endometriosis. They were then categorized by the severity of
   endometriosis as controls (stages 0-1) and cases (stages II-IV). Urinary
   concentrations of the phthalate metabolites monoethyl phthalate.
   mono-n-butyl phthalate, monobenzyl phthalate, mono (2-ethyl hexyl)
   phthalate (MEHP), mono (2-ethyl-5-oxohexyl) phthalate, and mono
   (2-ethyl-5-hydroxyhexyl) phthalate were measured in 57 cases and 80
   controls using high-performance liquid chromatography isotope-dilution
   tandem mass spectrometry. Adjusted odds ratios for endometriosis in
   relation to dichotomized individual phthalate metabolites (standardized
   for creatinine) were calculated. No significant association between
   endometriosis and any urinary creatinine-adjusted phthalate monoester
   was seen. Adjusted odds ratio (95\% confidence interval) for higher
   dichotomized MEHP by endometriosis was 1.57 (0.74-3.30). No monotonic
   trend was seen in urinary creatinine-adjusted concentration of phthalate
   metabolites by endometriosis stage (p = 0.23-0.90). Our results do not
   support the hypothesis that higher urinary concentrations of phthalate
   metabolites are associated with the risk of endometriosis in infertile
   Japanese women. (C) 2009 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Iwasaki, M (Reprint Author), Natl Canc Ctr, Res Ctr Canc Prevent \& Screening, Epidemiol \& Prevent Div, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.
   Itoh, Hiroaki; Iwasaki, Motoki; Hanaoka, Tomoyuki; Tsugane, Shoichiro, Natl Canc Ctr, Res Ctr Canc Prevent \& Screening, Epidemiol \& Prevent Div, Chuo Ku, Tokyo 1040045, Japan.
   Sasaki, Hiroshi; Tanaka, Tadao, Jikei Univ, Sch Med, Dept Obstet \& Gynecol, Minato Ku, Tokyo 1058461, Japan.}},
DOI = {{10.1016/j.scitotenv.2009.09.012}},
ISSN = {{0048-9697}},
Keywords = {{Epidemiology; Urine; Estrogenic; Phthalate; Endocrine disrupter}},
Keywords-Plus = {{HIGH PLASMA-CONCENTRATIONS; OXIDATIVE METABOLITES; TEMPORAL VARIABILITY;
   WAIST CIRCUMFERENCE; SERUM-LEVELS; HUMAN SPERM; DNA-DAMAGE; EXPOSURE;
   MEN; EPIDEMIOLOGY}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{moiwasak@ncc.go.jp}},
Funding-Acknowledgement = {{Ministry of Health, Labour, and Welfare of Japan; Japan Food Hygiene
   Association for Research on the Risk of Chemical Substances}},
Funding-Text = {{The present study was supported by Health and Labour Sciences Research
   Grants for Research on the Risk of Chemical Substances from the Ministry
   of Health, Labour, and Welfare of Japan. Hiroaki Itoh, one of the
   authors, is an awardee of a Research Resident Fellowship from the Japan
   Food Hygiene Association for Research on the Risk of Chemical
   Substances, which is also supported by the above Health and Labour
   Sciences Research Grants for Research on the Risk of Chemical Substances
   from the Ministry of Health, Labour, and Welfare of Japan.}},
Cited-References = {{Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   Cramer DW, 2002, ANN NY ACAD SCI, V955, P11.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Fujimaki Kayumi, 2006, Nihon Eiseigaku Zasshi, V61, P340.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Hosmer D. W., 1989, APPL LOGISTIC REGRES.
   Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Missmer Stacey A, 2003, Obstet Gynecol Clin North Am, V30, P1, DOI 10.1016/S0889-8545(02)00050-5.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Reddy BS, 2006, FERTIL STERIL, V85, P775, DOI 10.1016/j.fertnstert.2005.08.037.
   Reddy BS, 2006, BJOG-INT J OBSTET GY, V113, P515, DOI 10.1111/j.1471-0528.2006.00925.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.2307/3432519.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   The American Fertility Society, 1985, FERTIL STERIL, V43, P351.
   Tsuchiya M, 2007, EPIDEMIOLOGY, V18, P402, DOI 10.1097/01.ede.0000257571.01358.f9.
   Tsukino H, 2006, SCI TOTAL ENVIRON, V359, P90, DOI 10.1016/j.scitotenv.2005.04.014.
   Tsukino H, 2005, ENVIRON RES, V99, P118, DOI 10.1016/j.envres.2005.04.003.
   U.S. Environmental Protection Agency (USEPA), 1992, FED REG, V57, P22888.
   Vigano P, 2004, BEST PRACT RES CL OB, V18, P177, DOI 10.1016/j.bpobgyn.2004.01.007.
   Yoshimura M, 2006, BUNSEKI KAGAKU, V55, P661, DOI 10.2116/bunsekikagaku.55.661.
   {[}Anonymous], 1992, ENV HLTH CRIT.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}MIN HLTH WELF, 2000, JOINT M TOX GROUP TO.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{14}},
Journal-ISO = {{Sci. Total Environ.}},
Doc-Delivery-Number = {{526XP}},
Wos-Id = {{ISI:000272329700004}},
}

@article{ ISI:000272162400050,
Author = {Whyatt, Robin M. and Adibi, Jennifer J. and Calafat, Antonia M. and
   Camann, David E. and Rauh, Virgina and Bhat, Hari K. and Perera,
   Frederica P. and Andrews, Howard and Just, Allan C. and Hoepner, Lori
   and Tang, Deliang and Hauser, Russ},
Title = {{Prenatal Di(2-ethylhexyl)Phthalate Exposure and Length of Gestation
   Among an Inner-City Cohort}},
Journal = {{PEDIATRICS}},
Year = {{2009}},
Volume = {{124}},
Number = {{6}},
Pages = {{E1213-E1220}},
Month = {{DEC}},
Abstract = {{OBJECTIVE: Our objective was to assess the relationship between
   di(2-ethylhexyl)phthalate (DEHP) exposure during pregnancy and
   gestational age at delivery among 311 African American or Dominican
   women from New York City.
   METHODS: Forty-eight-hour personal air and/or spot urine samples were
   collected during the third trimester. DEHP levels were measured in air
   samples and 4 DEHP metabolite levels were measured in urine. Specific
   gravity was used to adjust for urinary dilution. Gestational age was
   abstracted from newborn medical records (n = 289) or calculated from the
   expected date of delivery (n = 42). Multivariate linear regression
   models controlled for potential confounders.
   RESULTS: DEHP was detected in 100\% of personal air samples (geometric
   mean: 0.20 mu g/m(3) {[}95\% confidence interval {[}CI]: 0.18-0.21 mu
   g/m(3)]); natural logarithms of air concentrations were inversely but
   not significantly associated with gestational age. Two or more of the
   DEHP metabolites were detected in 100\% of urine samples (geometric
   mean: 4.8-38.9 ng/mL {[}95\% CI: 4.1-44.3 ng/mL]). Controlling for
   potential confounders, gestational age was shorter by 1.1 days (95\% CI:
   0.2-1.8 days) for each 1-logarithmic unit increase in specific
   gravity-adjusted mono(2-ethylhexyl) phthalate concentrations (P = .01)
   and averaged 5.0 days (95\% CI: 2.1-8.0 days) less among subjects with
   the highest versus lowest quartile concentrations (P =. 001). Results
   were similar and statistically significant for the other DEHP
   metabolites.
   CONCLUSIONS: Prenatal DEHP exposure was associated with shorter
   gestation but, given inconsistencies with previous findings for other
   study populations, results should be interpreted with caution, and
   additional research is warranted. Pediatrics 2009; 124: e1213-e1220}},
Publisher = {{AMER ACAD PEDIATRICS}},
Address = {{141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Whyatt, RM (Reprint Author), Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, 60 Haven Ave,B-1, New York, NY 10032 USA.
   Whyatt, Robin M.; Rauh, Virgina; Bhat, Hari K.; Perera, Frederica P.; Andrews, Howard; Just, Allan C.; Hoepner, Lori; Tang, Deliang, Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, New York, NY 10032 USA.
   Adibi, Jennifer J., Univ Calif San Francisco, Dept Obstet Gynecol \& Reprod Sci, San Francisco, CA 94143 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Camann, David E., SW Res Inst, San Antonio, TX USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.}},
DOI = {{10.1542/peds.2009-0325}},
ISSN = {{0031-4005}},
Keywords = {{di(2-ethylhexyl)phthalate; gestational age; pregnancy; inner city}},
Keywords-Plus = {{PHTHALATE METABOLITES; PPAR-GAMMA; DI-(2-ETHYLHEXYL)-PHTHALATE DEHP;
   MONO-(2-ETHYLHEXYL) PHTHALATE; DEVELOPMENTAL TOXICITY; BIRTH OUTCOMES;
   HUMAN URINE; IN-UTERO; RAT; AGE}},
Research-Areas = {{Pediatrics}},
Web-of-Science-Categories  = {{Pediatrics}},
Author-Email = {{rmw5@columbia.edu}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences {[}P50 ES09600, RO1
   ES013543, RO1 ES08977, RO1 ES11158]; US Environmental Protection Agency
   {[}R827027, R82860901]; Irving General Clinical Research Center
   {[}RR00645]; Bauman Family Foundation; Gladys and Roland Harriman
   Foundation; Hansen Foundation; W. Alton Jones Foundation; New York
   Community Trust; Educational Foundation of America; New York Times
   Company Foundation; Rockefeller Financial Services; Horace W. Smith
   Foundation; Beldon Fund; John Merck Fund; V. Kann Rasmussen Foundation}},
Funding-Text = {{This work was supported by the National Institute of Environmental
   Health Sciences (grants P50 ES09600, RO1 ES013543, RO1 ES08977, and RO1
   ES11158), US Environmental Protection Agency (grants R827027 and
   R82860901), Irving General Clinical Research Center (grant RR00645),
   Bauman Family Foundation, Gladys and Roland Harriman Foundation, Hansen
   Foundation, W. Alton Jones Foundation, New York Community Trust,
   Educational Foundation of America, New York Times Company Foundation,
   Rockefeller Financial Services, Horace W. Smith Foundation, Beldon Fund,
   John Merck Fund, New York Community Trust, and V. Kann Rasmussen
   Foundation.}},
Cited-References = {{Adibi JJ, 2009, AM J EPIDEMIOL, V169, P1015, DOI 10.1093/aje/kwp001.
   Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Borel V, 2008, PPAR RES, DOI 10.1155/2008/758562.
   Davidoff MJ, 2006, SEMIN PERINATOL, V30, P8, DOI 10.1053/j.semperi.2006.01.009.
   Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200.
   Ge RS, 2007, J ANDROL, V28, P513, DOI 10.2164/jandrol.106.001909.
   Gourlay T, 2003, ARTIF ORGANS, V27, P256, DOI 10.1046/j.1525-1594.2003.07107.x.
   Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Institute of Medicine, 2007, PRET BIRTH CAUS CONS.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Kirkegaard I, 2006, PEDIATRICS, V118, P1600, DOI 10.1542/peds.2005-2700.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koupil I, 2005, J EPIDEMIOL COMMUN H, V59, P473, DOI 10.1136/jech.2004.026518.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Latini G, 2006, CURR MED CHEM, V13, P2527, DOI 10.2174/092986706778201666.
   Latini G, 2005, TOXICOL SCI, V85, P743, DOI 10.1093/toxsci/kfi131.
   Lovekamp-Swan T, 2003, MOL CELL ENDOCRINOL, V201, P133, DOI 10.1016/S0303-7207(02)00423-9.
   Meade EA, 1999, J BIOL CHEM, V274, P8328, DOI 10.1074/jbc.274.12.8328.
   Mose T, 2007, INT J TOXICOL, V26, P221, DOI 10.1080/1091581070135721.
   Onorato TM, 2008, J ANDROL, V29, P293, DOI 10.2164/jandrol.107.003335.
   Perera FP, 2003, ENVIRON HEALTH PERSP, V111, P201, DOI 10.1289/ehp.5742.
   Raikkonen K, 2007, BRIT J PSYCHIAT, V190, P469, DOI 10.1192/bjp.bp.106.022145.
   Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001.
   Schaiff WT, 2006, MOL CELL ENDOCRINOL, V249, P10, DOI 10.1016/j.mce.2006.02.009.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   Viswanathan M, 2008, EDUC ASIA PAC REG-IS, V12, P1, DOI 10.1007/978-1-4020-5769-4.
   Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494.
   Whyatt RM, 2003, ENVIRON HEALTH PERSP, V111, P749, DOI 10.1289/ehp.5768.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Xu Y, 2005, TOXICOL SCI, V84, P287, DOI 10.1093/toxsci/kfi083.
   {*}AG TOX SUBST DIS, 2002, TOX PROF DI 2 ETH PH.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{22}},
Journal-ISO = {{Pediatrics}},
Doc-Delivery-Number = {{524SE}},
Wos-Id = {{ISI:000272162400050}},
}

@article{ ISI:000271497400009,
Author = {Kim, Bung-Nyun and Cho, Soo-Churl and Kim, Yeni and Shin, Min-Sup and
   Yoo, Hee-Jeong and Kim, Jae-Won and Yang, Young Hee and Kim, Hyo-Won and
   Bhang, Soo-Young and Hong, Yun-Chul},
Title = {{Phthalates Exposure and Attention-Deficit/Hyperactivity Disorder in
   School-Age Children}},
Journal = {{BIOLOGICAL PSYCHIATRY}},
Year = {{2009}},
Volume = {{66}},
Number = {{10}},
Pages = {{958-963}},
Month = {{NOV 15}},
Abstract = {{Background: Very few studies have examined the association between
   attention-deficit/hyperactivity disorder (ADHD) and phthalate exposure
   in humans. The aim of this study was to investigate the impact of
   phthalates on symptoms of ADHD in school-age children.
   Methods: A cross-sectional examination of urine phthalate concentrations
   was performed, and scores on measures of ADHD symptoms and
   neuropsychological dysfunction with regard to attention and impulsivity
   were obtained from 261 Korean children, age 8-11 years.
   Results: Mono-2-ethylheyl phthalate (MEHP) and
   mono-2-ethyl-5-oxohexylphthalate (MEOP) for metabolites of
   Di-2-ethylhexylphthalate (DEHP) and mono-n-butyl phthalate (MNBP) for
   metabolites of dibutyl phthalate (DBP) were measured in urine samples.
   The mean concentrations of MEHP, MEOP, and MNBP were 34.0 mu g/dL (SD =
   36.3; range: 2.1-386.7),23.4 mu g/dL (SD = 23.0; range:.75-244.8), and
   46.7 mu g/L (SD = 21.4; range: 13.2-159.3), respectively. After
   adjustment for covariates, teacher-rated ADHD scores were significantly
   associated with DEHP metabolites but not with DBP metabolites. We also
   found significant relationships between the urine concentrations of
   metabolites for DBP and the number of omission and commission errors in
   continuous performance tests (CPT) after adjustment for covariates.
   Conclusion: The present study showed a strong positive association
   between phthalate metabolites in urine and symptoms of ADHD among
   school-age children.}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hong, YC (Reprint Author), Seoul Natl Univ, Coll Med, Dept Prevent Med, 28 Yongon Dong, Seoul 110744, South Korea.
   Hong, Yun-Chul, Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul 110744, South Korea.
   Kim, Bung-Nyun; Cho, Soo-Churl; Kim, Yeni; Shin, Min-Sup; Kim, Jae-Won; Yang, Young Hee; Kim, Hyo-Won, Seoul Natl Univ, Coll Med, Div Child \& Adolescent Psychiat, Dept Psychiat, Seoul 110744, South Korea.
   Kim, Bung-Nyun; Cho, Soo-Churl; Kim, Yeni; Shin, Min-Sup; Kim, Jae-Won; Yang, Young Hee; Kim, Hyo-Won, Seoul Natl Univ, Coll Med, Inst Human Behav Med, Seoul 110744, South Korea.
   Yoo, Hee-Jeong, Seoul Natl Univ, Bundang Hosp, Dept Psychiat, Songnam, South Korea.
   Hong, Yun-Chul, SNUMRC, Inst Environm Med, Seoul, South Korea.
   Bhang, Soo-Young, Ulsan Univ Hosp, Dept Psychiat, Ulsan, South Korea.}},
DOI = {{10.1016/j.biopsych.2009.07.034}},
ISSN = {{0006-3223}},
Keywords = {{ADHD; neuropsychology; phthalate}},
Keywords-Plus = {{DEFICIT-HYPERACTIVITY DISORDER; DOPAMINE TRANSPORTER DENSITY;
   CASE-CONTROL ASSOCIATION; EXPERT PANEL REPORT; DEVELOPMENTAL TOXICITY;
   HUMAN-REPRODUCTION; RECEPTOR GENE; NTP CENTER; POLYMORPHISM; BRAIN}},
Research-Areas = {{Neurosciences \& Neurology; Psychiatry}},
Web-of-Science-Categories  = {{Neurosciences; Psychiatry}},
Author-Email = {{ychong1@snu.ac.kr}},
ResearcherID-Numbers = {{Kim, Hyo-Won /F-3483-2010
   Kim, Jae Won/J-5430-2012
   Kim, Boong Nyun/J-5397-2012
   Hong, Yun-Chul/J-5725-2012
   Cho, Soo Churl/J-5667-2012
   Yoo, Hee Jeong/J-5555-2012
   Shin, Min Sup/J-5521-2012}},
Funding-Acknowledgement = {{Korea Institute of Environmental Science and Technology}},
Funding-Text = {{Soo-Churl Cho, M.D., Ph.D., and Yun-Chul Hong, M.D., Ph.D., received a
   research grant from the Korea Institute of Environmental Science and
   Technology (Eco-Technopia 21 Project). The other authors reported no
   biomedical financial interests or potential conflicts of interest.}},
Cited-References = {{Adams J, 2000, ENVIRON HEALTH PERSP, V108, P535.
   Adriani W, 2009, NEUROSCIENCE, V159, P47, DOI 10.1016/j.neuroscience.2008.11.042.
   Barr CL, 2000, AM J MED GENET, V96, P262, DOI 10.1002/1096-8628(20000612)96:3<262::AID-AJMG5>3.0.CO;2-8.
   Bellinger DC, 2008, BASIC CLIN PHARMACOL, V102, P237, DOI 10.1111/j.1742-7843.2007.00164.x.
   Cheon KA, 2003, EUR J NUCL MED MOL I, V30, P306, DOI 10.1007/s00259-002-1047-3.
   Cheon KA, 2007, NEUROPSYCHOPHARMACOL, V32, P1377, DOI 10.1038/sj.npp.1301244.
   COOK EH, 1995, AM J HUM GENET, V56, P993.
   Corton JC, 2005, TOXICOL SCI, V83, P4, DOI 10.1093/toxsci/kfi011.
   Curran S, 2001, MOL PSYCHIATR, V6, P425, DOI 10.1038/sj.mp.4000914.
   Dougherty DD, 1999, LANCET, V354, P2132, DOI 10.1016/S0140-6736(99)04030-1.
   DuPaul G. J., 1998, ADHD RATING SCALE 4.
   Fennell TR, 2004, TOXICOL SCI, V82, P407, DOI 10.1093/toxsci/kfh294.
   Gladen BC, 1999, REPROD TOXICOL, V13, P41, DOI 10.1016/S0890-6238(98)00054-9.
   GREENBERG LM, 1993, J CHILD PSYCHOL PSYC, V34, P1019, DOI 10.1111/j.1469-7610.1993.tb01105.x.
   Ishido M, 2004, J NEUROCHEM, V91, P69, DOI 10.1111/j.1471-4159.2004.02696.x.
   Jacobson JL, 2003, J PEDIATR, V143, P780, DOI 10.1067/S0022-3476(03)00577-8.
   KAUFMAN AS, 1976, CONTEMP EDUC PSYCHOL, V1, P180, DOI 10.1016/0361-476X(76)90022-9.
   Kavlock R, 2002, REPROD TOXICOL, V16, P721, DOI 10.1016/S0890-6238(02)00031-X.
   Kavlock R, 2002, REPROD TOXICOL, V16, P709, DOI 10.1016/S0890-6238(02)00030-8.
   Kim JW, 2006, J PSYCHIAT RES, V40, P730, DOI 10.1016/j.jpsychires.2005.11.002.
   Kim Y, 2009, HUM PSYCHOPHARM CLIN, V24, P95, DOI 10.1002/hup.1010.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Levitt P, 1998, DRUG ALCOHOL DEPEN, V51, P109, DOI 10.1016/S0376-8716(98)00070-2.
   Lidsky TI, 2003, BRAIN, V126, P5, DOI 10.1093/brain/awg014.
   Masuo Y, 2004, REGUL PEPTIDES, V123, P225, DOI 10.1016/j.regpep.2004.05.010.
   Masuo Yoshinori, 2004, Neural Plasticity, V11, P59, DOI 10.1155/NP.2004.59.
   Mendola P, 2002, MENT RETARD DEV D R, V8, P188, DOI 10.1002/mrdd.10033.
   MILLER MW, 1993, ALCOHOL CLIN EXP RES, V17, P304, DOI 10.1111/j.1530-0277.1993.tb00768.x.
   Park K. S., 1996, DEV KEDI WISC INDIVI.
   PETIT TL, 1983, NEUROTOXICOLOGY, V4, P79.
   Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543.
   Seidman LJ, 2005, BIOL PSYCHIAT, V57, P1263, DOI 10.1016/j.biopsych.2004.11.019.
   SHAYWITZ BA, 1976, SCIENCE, V191, P305, DOI 10.1126/science.942800.
   Shin M S, 2000, KOREAN J CHILD ADOLE, V11, P91.
   So YK, 2002, J KOREAN NEUROPSYCHI, V41, P283.
   Stewart PW, 2003, NEUROTOXICOL TERATOL, V25, P11, DOI 10.1016/S0892-0362(02)00320-3.
   SWANSON JM, 1998, MOL PSYCHIATR, V3, P370.
   Tabacova S, 1997, ARCH ENVIRON HEALTH, V52, P341.
   VORHEES CV, 1994, ENVIRON HEALTH PERSP, V102, P145, DOI 10.2307/3431832.
   White LD, 2007, TOXICOL APPL PHARM, V225, P1, DOI 10.1016/j.taap.2007.08.001.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Yang JW, 2008, PROG NEURO-PSYCHOPH, V32, P243, DOI 10.1016/j.pnpbp.2007.08.016.
   YANG YH, 2008, J KOREAN NEUROPSYCHA, V47, P292.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{41}},
Journal-ISO = {{Biol. Psychiatry}},
Doc-Delivery-Number = {{515UC}},
Wos-Id = {{ISI:000271497400009}},
}

@article{ ISI:000270983600016,
Author = {Botelho, Giuliana G. K. and Golin, Munisa and Bufalo, Aedra C. and
   Morais, Rosana N. and Dalsenter, Paulo R. and Martino-Andrade, Anderson
   J.},
Title = {{Reproductive Effects of Di(2-ethylhexyl)phthalate in Immature Male Rats
   and Its Relation to Cholesterol, Testosterone, and Thyroxin Levels}},
Journal = {{ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY}},
Year = {{2009}},
Volume = {{57}},
Number = {{4}},
Pages = {{777-784}},
Month = {{NOV}},
Abstract = {{Phthalates are chemicals employed in several industrial products and
   there is a growing body of evidence demonstrating that they induce
   numerous adverse effects on the reproductive system. This study was
   carried out to assess possible alterations induced by the plasticizer
   di(2-ethylhexyl phthalate (DEHP) on cholesterol, testosterone, and
   thyroxine (total T4) levels, as well as to discuss the significance of
   these data in global changes observed in the reproductive tract of
   pubertal animals. Wistar rats aged 21 days received DEHP orally at 0,
   250, 500, and 750 mg/kg/day for 30 days and were examined for different
   reproductive endpoints. At the end of the treatment, significant
   decreases in relative weight of testosterone-dependent organs, delayed
   preputial separation, and low serum testosterone were observed at the
   highest DEHP dose. The plot of the relationship between DEHP dose and
   serum cholesterol revealed a biphasic effect. The concentration of
   cholesterol in serum was significantly reduced at 250 mg/kg/day DEHP but
   returned to control values at 750 mg/kg/day. Cholesterol levels measured
   in testicular tissue increased with DEHP treatment. Serum T4 levels were
   not affected by DEHP at any dose, indicating the absence of a link
   between total thyroxin concentration and phthalate effects on
   cholesterol levels. Taken together these results indicate that effects
   observed in serum and testicular cholesterol levels may reflect distinct
   effects of DEHP on cholesterol synthesis and usage. These results
   confirm and extend previously reported findings showing that alterations
   in cholesterol balance may play a role in the suppression of
   steroidogenesis induced by DEHP in rats.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Botelho, GGK (Reprint Author), Univ Fed Parana, Dept Pharmacol, Caixa Postal 19031, BR-81531990 Curitiba, Parana, Brazil.
   Botelho, Giuliana G. K.; Golin, Munisa; Dalsenter, Paulo R., Univ Fed Parana, Dept Pharmacol, BR-81531990 Curitiba, Parana, Brazil.
   Bufalo, Aedra C., UNIPAR, Dept Biomed, Francisco Beltrao, PR, Brazil.
   Morais, Rosana N.; Martino-Andrade, Anderson J., Univ Fed Parana, Dept Physiol, BR-81531990 Curitiba, Parana, Brazil.}},
DOI = {{10.1007/s00244-009-9317-8}},
ISSN = {{0090-4341}},
Keywords-Plus = {{IN-UTERO EXPOSURE; DI-(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL PHTHALATE;
   GENE-EXPRESSION; TESTICULAR DYSGENESIS; LACTATIONAL EXPOSURE;
   DOSE-RESPONSE; FEMALE RATS; TOXICITY; TESTIS}},
Research-Areas = {{Environmental Sciences \& Ecology; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Toxicology}},
Author-Email = {{giu\_kasecker@uol.com.br}},
Funding-Acknowledgement = {{CNPq; FUNPAR}},
Funding-Text = {{We are grateful to CNPq and FUNPAR for financial support and to Ana C.
   Boareto, Juliane C Muller, Nelson Marques, Margarete K. Falbo, and the
   Clinical Hospital of Federal University of Parana for technical support.}},
Cited-References = {{AGARWAL DK, 1986, ENVIRON HEALTH PERSP, V65, P343, DOI 10.2307/3430202.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Andrade AJM, 2006, TOXICOLOGY, V228, P85, DOI 10.1016/j.tox.2006.08.020.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   BELL FP, 1982, ENVIRON HEALTH PERSP, V45, P41, DOI 10.2307/3429382.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   Clode SA, 2006, BEST PRACT RES CL EN, V20, P35, DOI 10.1016/j.beem.2005.09.011.
   Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649.
   DOSTAL LA, 1987, TOXICOL APPL PHARM, V87, P81, DOI 10.1016/0041-008X(87)90086-X.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Gayathri NS, 2004, INDIAN J MED RES, V119, P139.
   Ge RS, 2007, J ANDROL, V28, P513, DOI 10.2164/jandrol.106.001909.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Gunnarsson D, 2008, REPRODUCTION, V135, P693, DOI 10.1530/REP-07-0460.
   Hess RA, 2001, REPROD FERT DEVELOP, V13, P273, DOI 10.1071/RD00100.
   Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7.
   Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336.
   Itsuki-Yoneda A, 2007, BIOSCI BIOTECH BIOCH, V71, P414, DOI 10.1271/bbb.60478.
   JAMES JT, 2004, SPACECRAFT WATER EXP, V1.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404.
   Ma MY, 2006, TOXICOL SCI, V93, P164, DOI 10.1093/toxsci/kfl036.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Mocchiutti NO, 1997, FOOD CHEM TOXICOL, V35, P1017, DOI 10.1016/S0278-6915(97)87270-5.
   NAIR N, 1986, BIOCHEM PHARMACOL, V35, P3441, DOI 10.1016/0006-2952(86)90610-6.
   OISHI S, 1984, TOXICOL LETT, V23, P67.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   RHODES C, 1986, ENVIRON HEALTH PERSP, V65, P299, DOI 10.2307/3430197.
   Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065.
   SARADHA B, 2006, ENVIRON TOXICOL PHAR, V21, P31, DOI DOI 10.1016/J.ETAP.2005.06.004.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   SHIROTA M, 2005, J TOXICOL SCI, V30, P75, DOI DOI 10.2131/JTS.30.175.
   Sikka SC, 2008, ASIAN J ANDROL, V10, P134, DOI 10.1111/j.1745-7262.2008.00370.x.
   Stoker TE, 2000, CRIT REV TOXICOL, V30, P197, DOI 10.1080/10408440091159194.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Svechnikova I, 2007, J ENDOCRINOL, V194, P603, DOI 10.1677/JOE-07-0238.
   SWAN SH, 2005, DECREASE ANOGENITAL.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   Xu Y, 2007, ARCH TOXICOL, V81, P57, DOI 10.1007/s00204-006-0143-8.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{7}},
Journal-ISO = {{Arch. Environ. Contam. Toxicol.}},
Doc-Delivery-Number = {{509AP}},
Wos-Id = {{ISI:000270983600016}},
}

@article{ ISI:000272295300008,
Author = {Herr, Caroline and zur Nieden, Anja and Koch, Holger M. and Schuppe,
   Hans-Christian and Fieber, Christian and Angerer, Juergen and Eikmann,
   Thomas and Stilianakis, Nikolaos I.},
Title = {{Urinary di(2-ethylhexyl)phthalate (DEHP)-Metabolites and male human
   markers of reproductive function}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2009}},
Volume = {{212}},
Number = {{6}},
Pages = {{648-653}},
Month = {{NOV}},
Abstract = {{Introduction: Phthalates are suspected to act as endocrine modulators in
   humans and exert reproductive toxicity. The general population is
   exposed to phthalates through nutrition, consumer products, medications
   and medical devices. The aim of the present study is to explore whether
   internal phthalate exposure represented by metabolites of
   di(2-ethylhexyl)phthalate (DEHP) can be related to human markets of
   reproductive function (i.e. semen concentration, motility and
   morphology).
   Methods: We recruited 349 men who were part of subfertile couples and
   were referred for fertility work-up between April 2004 and November
   2005. Semen analysis was performed according to recommendations of the
   World Health Organization (WHO). Parameters were dichotomized based on
   1999 WHO reference values for sperm concentration (<20 million/ml) and
   motility (<50\% sperm with progressive motility), as well as Tygerberg
   strict criteria for morphology (<4\% normal forms). We analyzed internal
   DEHP exposure in single spot urine samples by determining its secondary
   metabolites mono(2-ethyl-5-oxo-hexyl)phthalate (5oxo-MEHP).
   mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP) and
   5carboxy-mono(2-ethylhexyl)phthalate (5cx-MEPP) next to the monoester
   metabolite mono(2-ethylhexyl) phthalate (MEHP). Logistic regression was
   performed for the three semen parameters (concentration, motility, and
   normal morphology) to estimate their dependence on the sum of the four
   DEHP metabolites (DEHP-4) under consideration. Adjustment was performed
   for age, duration of abstinence, and smoking status.
   Results: DEHP metabolites of n = 349 men (age: median = 34ys) were
   analysed. Median concentrations {[}mu g/l] were MEHP (n = 337) 4.35,
   5OH-MEHP (n = 341) 12.66, 5oxo-MEHP (n = 341) 9.02, and 5cx-MEPP (n =
   292) 14.53. Semen parameters of n = 349 men were analysed by logistic
   regression. Semen concentration (< 20 mio/ml: 35\%) or sperm motility
   (WHO A+B < 50\% = 20\%) were not found to be associated statistically
   significantly with the sum the DEHP metabolites (DEHP-4).
   Discussion: Metabolites of DEHP and other phthalates analyzed in urine
   are very specific for determining recent internal phthalate exposure.
   According to our evaluation human reproductive parameters from semen
   analyses do not show significant associations with concentrations of
   DEHP metabolites determined in spot urine sampled at the day of
   andrological examination. (C) 2009 Elsevier GmbH. All rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{zur Nieden, A (Reprint Author), Univ Giessen, Inst Hyg \& Umweltmed, Med Ctr, Fac Med, Friedrichstr 16, D-35385 Giessen, Germany.
   Herr, Caroline; zur Nieden, Anja; Fieber, Christian; Eikmann, Thomas, Univ Giessen, Inst Hyg \& Umweltmed, Med Ctr, Fac Med, D-35385 Giessen, Germany.
   Herr, Caroline, Bavarian Hlth \& Food Safety Author, Oberschleissheim, Germany.
   Koch, Holger M.; Angerer, Juergen, Inst Ruhr Univ Bochum, BGFA, Res Inst Occupat Med, Bochum, Germany.
   Schuppe, Hans-Christian, Univ Giessen, Ctr Dermatol \& Androl, Med Ctr, Fac Med, D-35390 Giessen, Germany.
   Stilianakis, Nikolaos I., Univ Erlangen Nurnberg, Dept Biometry \& Epidemiol, Erlangen, Germany.
   Stilianakis, Nikolaos I., European Commiss, Joint Res Ctr, Ispra, VA, Italy.}},
DOI = {{10.1016/j.ijheh.2009.08.001}},
ISSN = {{1438-4639}},
Keywords = {{DEHP metabolites; Biomarker; Human semen quality; Phthalate exposure;
   Male fertility; Endocrine disruption}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; PHTHALATE METABOLITES; SEMEN QUALITY;
   GENERAL-POPULATION; INTERNAL EXPOSURE; SPERM MORPHOLOGY; DEHP;
   BIOMARKERS; PARAMETERS; SECONDARY}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{anja.zur.nieden@hygiene.med.uni-giessen.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   FURUYA S, 1978, ARCH ANDROLOGY, V1, P211.
   Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005.
   HAIDL G, 2006, ANDROLOGY CLIN, P555.
   Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x.
   Hauser R, 2005, ENVIRON HEALTH PERSP, V113, P425, DOI 10.1289/ehp.7305.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Helm D, 2007, SCI TOTAL ENVIRON, V388, P389, DOI 10.1016/j.scitotenv.2007.07.009.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2006, INT J ANDROL, V29, P181.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Latini G, 2004, REPROD TOXICOL, V19, P27, DOI 10.1016/j.reprotox.2004.05.011.
   Latini Giuseppe, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P37, DOI 10.2174/1568008043340017.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Nallella KP, 2006, FERTIL STERIL, V85, P629, DOI 10.1016/j.fertnstert.2005.08.024.
   Ombelet W, 1997, HUM REPROD, V12, P987.
   Phillips KP, 2008, J TOXICOL ENV HEAL B, V11, P188, DOI 10.1080/10937400701873472.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Ritter L, 2007, TOXICOL SCI, V97, P241, DOI 10.1093/toxsci/kfm005.
   Sharpe RM, 2005, ENVIRON HEALTH PERSP, V113, pA504.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Van Waart J, 2001, HUM REPROD UPDATE, V7, P495, DOI 10.1093/humupd/7.5.495.
   Wirth JJ, 2008, SYST BIOL REPROD MEC, V54, P143, DOI 10.1080/19396360802055921.
   World Health Organization, 1999, WHO LAB MAN EX HUM S.
   {*}COMM HLTH RISKS P, 2008, PHTH CUM RISK ASS TA.
   {*}ECB, 2008, 80 ECB, P588.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{10}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{526MX}},
Wos-Id = {{ISI:000272295300008}},
}

@article{ ISI:000272295300012,
Author = {Hildenbrand, Sibylle and Wodarz, Roman and Gabrio, Thomas and Volland,
   Gerhard},
Title = {{Biomonitoring of the di(2-ethylhexyl) phthalate metabolites
   mono(2-ethyl-5-hydroxyhexyl) phthalate and mono(2-ethyl-5-oxohexyl)
   phthalate in children and adults during the course of time and seasons}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2009}},
Volume = {{212}},
Number = {{6}},
Pages = {{679-684}},
Month = {{NOV}},
Abstract = {{Di(2-ethylhexyl) phthalate (DEHP) is a commonly used plasticizer with
   ubiquitous spread. Its metabolites are suspected to impair endocrine
   functions and fertility in man. This Study is aimed to assess the DEHP
   exposure in children and adults, to evaluate the intraindividual
   variability, the influence of seasons and to identify potential routes
   of intake. Urine samples were collected from 6 people (age 4-58) over 7
   consecutive days 4-times during a year to test for seasonal factors.
   5-OH-MEHP and 5-oxo-MEHP were quantified by GC-MS. Urine concentrations
   of both metabolites were highly correlated with each other. Both female
   subjects showed remarkably low and stable 5-OH-MEHP concentrations
   throughout the year (median <= 64.1 and <= 78.5 mu g/l). Also both male
   adults exhibited a low burden during most measurements (median <= 50.0
   and <= 52.5 mu g/l) except in January For the 19 year old (median: 141.4
   mu g/l) and two single high events for the 58 year old male. In
   contrast, both examined boys reached weekly median concentrations as
   high as 171.0 mu g/l accompanied by a high degree of variability. Five
   peak events were identified, 3 of which are suspected to be caused by
   particular meals. During the 28 days of monitoring one adult male and
   two male children exceeded the tolerable metabolite concentration for
   the sum of 5-oxo-MEHP and 5-OH-MEHP (HBM I value) 4 times. Two of the
   children contributed one transgression event each, exceeding the HBM I
   value by a factor of 2-4. Across the 6 studied individuals we found a
   weak seasonal trend towards higher levels of exposure during the winter.
   (C) 2009 Elsevier GmbH. All rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hildenbrand, S (Reprint Author), Univ Tubingen Hosp, Inst Occupat \& Social Med, Wilhelmstr 27, D-72074 Tubingen, Germany.
   Hildenbrand, Sibylle; Wodarz, Roman, Univ Tubingen Hosp, Inst Occupat \& Social Med, D-72074 Tubingen, Germany.
   Gabrio, Thomas, State Hlth Off Baden Wuerttemberg, D-70191 Stuttgart, Germany.
   Volland, Gerhard, Univ Stuttgart, Mat Prufungsanstalt Otto Graf Inst, D-70569 Stuttgart, Germany.}},
DOI = {{10.1016/j.ijheh.2009.06.003}},
ISSN = {{1438-4639}},
Keywords = {{5-OH-MEHP; 5-oxo-MEHP; DEHP; Biomonitoring; Phthalates; Seasonal effects}},
Keywords-Plus = {{DEHP METABOLITES; URINARY LEVELS; POPULATION; MONOESTER; EXPOSURE}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{sibylle.hildenbrand@med.uni-tuebingen.de}},
Funding-Acknowledgement = {{Institute of Occupational and Social Medicine; employers' association of
   the metal and electric industry Baden-Wuerttemberg (Suedwestmetall)}},
Funding-Text = {{We thank Isolde Wodarz for her chemical-analytical work, Prof. Anna
   Maria Papini and Francesca Nuti, University of Florence, for the
   phthalate metabolites and Dr. Albrecht Kossel for providing helpful
   comments on the manuscript. For their financial Support our gratitude to
   the Landesstiftung foundation of the State of Baden-Wuerttemberg. The
   work of the Institute of Occupational and Social Medicine is supported
   by an unrestricted grant of the employers' association of the metal and
   electric industry Baden-Wuerttemberg (Suedwestmetall).}},
Cited-References = {{Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   European Chemicals Bureau European Chemicals Bureau (ECB), 2004, R0420402ENVHH46 ECB.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Kommission Human-Biomonitoring, 2007, BUNDESGESUNDHEITSBLA, V50, P255.
   Mettang T, 1999, ADV PERIT D, V15, P229.
   Mettang T, 1996, NEPHROL DIAL TRANSPL, V11, P2439.
   Nuti F, 2005, BIOORGAN MED CHEM, V13, P3461, DOI 10.1016/j.bmc.2005.03.005.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   WAMS TJ, 1987, SCI TOTAL ENVIRON, V66, P1, DOI 10.1016/0048-9697(87)90072-6.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   {*}KOMM HUM BIOM, 2005, BUNDESGESUNDHEITSBLA, V48, P706.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{6}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{526MX}},
Wos-Id = {{ISI:000272295300012}},
}

@article{ ISI:000272295300013,
Author = {Becker, Kerstin and Goeen, Thomas and Seiwert, Margarete and Conrad,
   Andre and Pick-Fuss, Helga and Mueller, Johannes and Wittassek, Matthias
   and Schulz, Christine and Kolossa-Gehring, Marike},
Title = {{GerES IV: Phthalate metabolites and bisphenol A in urine of German
   children}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2009}},
Volume = {{212}},
Number = {{6}},
Pages = {{685-692}},
Month = {{NOV}},
Abstract = {{Urine samples from GerES IV were analysed for concentrations of the
   metabolites of DEHP (MEHP 5OH-MEHP, 5oxo-MEHP, 5cx-MEPP, and 2cx-MMHP),
   DnBP and DiBP (MnBP and MiBP), BBzP (MBzP), DiNP (7OH-MMeOP, 7oxo-MMeOP
   and 7cx-MMeHP), and bisphenol A (BPA) to assess the exposure of German
   children on a representative basis. 600 morning urine samples had been
   randomly chosen from stored 1800 GerES IV samples originating from 3 to
   14 year old children living in Germany.
   All metabolites could be detected in nearly all urine samples (N = 599).
   Descriptive data analysis leads to mean concentrations of 5-OH-MEHP and
   5-oxo-MEHP of 48 mu g/l and 37 mu g/l, respectively. The mean
   concentration of 7OH-MMeCP was 11 mu g/l. MnBP, MiNP, MBzP showed mean
   levels of 96 mu g/l, 94 mu g/l, and 18 mu g/l, respectively. The
   concentrations of the phthalate metabolites decreased with increasing
   age. Compared to German adults all children showed three to five fold
   higher urine concentrations than adults analysed in the same decade.
   For some children the levels of the sum of 5OH-MEHP and 5oxo-MEHP in
   urine were higher than the German human biomonitoring value (HBM I) of
   500 mu g/l, which indicates that adverse health effects cannot be
   excluded for these subjects with Sufficient certainty.
   The mean concentration of BPA in urine was 2.7 mu g/l. A rough
   calculation of the daily intakes on the basis of the measured
   concentrations in urine resulted in daily intakes two orders of
   magnitude lower than the Current EFSA reference dose of 50 mu g/kg bw/d.
   (C) 2009 Elsevier GmbH. All rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Becker, K (Reprint Author), UBA, Fed Environm Agcy, Dessau Rosslau Berlin, Germany.
   Becker, Kerstin; Seiwert, Margarete; Conrad, Andre; Pick-Fuss, Helga; Schulz, Christine; Kolossa-Gehring, Marike, UBA, Fed Environm Agcy, Dessau Rosslau Berlin, Germany.
   Goeen, Thomas; Mueller, Johannes; Wittassek, Matthias, Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, Erlangen, Germany.}},
DOI = {{10.1016/j.ijheh.2009.08.002}},
ISSN = {{1438-4639}},
Keywords = {{Phthalates; Bisphenol A; Children; Urine}},
Keywords-Plus = {{IN-HOUSE DUST; HUMAN EXPOSURE; DI(2-ETHYLHEXYL)PHTHALATE DEHP;
   RISK-ASSESSMENT; UNITED-STATES; POPULATION; BIOMARKERS; HEALTH;
   VARIABILITY; MONOESTERS}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{Kerstin.Becker@uba.de}},
Funding-Acknowledgement = {{Federal Ministry for the Environment, Nature Conservation and Nuclear
   Safety; Federal Ministry of Education and Research}},
Funding-Text = {{We are highly indebted to the study participants and to the
   participating regional health and environmental offices supporting our
   work at the local level. The financial support of the Federal Ministry
   for the Environment, Nature Conservation and Nuclear Safety and the
   Federal Ministry of Education and Research is gratefully acknowledged.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Arakawa Chikako, 2004, Environ Health Prev Med, V9, P22, DOI 10.1265/ehpm.9.22.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K., 2005, POLLUTION ATMOSPHERI, V188, P475.
   BECKER K, 2008, LEVELS SELECTED SUBS.
   BECKER K, 2009, GERMAN ENV SURVEY CH.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Becker K, 2002, INT J HYG ENVIR HEAL, V205, P297, DOI 10.1078/1438-4639-00155.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   EFSA, 2008, EFSA J, V838, P1.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   GEIGY AG, 1977, WISSENSCHAFTLICHE TA.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Itoh H, 2007, ENVIRON SCI TECHNOL, V41, P4542, DOI 10.1021/es062926y.
   Jaakkola JJK, 2008, ENVIRON HEALTH PERSP, V116, P845, DOI 10.1289/ehp.10846.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Joskow R, 2006, J AM DENT ASSOC, V137, P353.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   KOCH HM, 2003, J CHROMOTOGR B, V784, P168.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   KURTH BM, 2008, BMC PUBLIC HEALTH, V8, P198.
   Lakind JS, 2008, J EXPO SCI ENV EPID, V18, P608, DOI 10.1038/jes.2008.20.
   Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x.
   Miyamoto Ken-ichi, 2006, Environmental Sciences, V13, P15.
   Myers JP, 2009, ENVIRON HEALTH PERSP, V117, P309, DOI 10.1289/ehp.0800173.
   Remer T, 2002, AM J CLIN NUTR, V75, P561.
   Schulz C, 2007, INT J HYG ENVIR HEAL, V210, P271, DOI 10.1016/j.ijheh.2007.01.034.
   Seifert B, 2000, J EXPO ANAL ENV EPID, V10, P103, DOI 10.1038/sj.jea.7500075.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Tsai WT, 2006, J ENVIRON SCI HEAL C, V24, P225, DOI 10.1080/10590500600936482.
   Volkel W, 2008, TOXICOL LETT, V179, P155, DOI 10.1016/j.toxlet.2008.05.002.
   vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}CDC, 2003, 2 NAT REP HUM EXP EN.
   {*}CERHR, 2007, NPT CERHR EXP PAN RE.
   {*}ECB, 2008, BIS 2 ETH DEHP EUR U, V80.
   {*}ECB, 2003, BISPH EUR UN RISK AS, V37.
   {*}EFSA, 2006, EFSA J, P428.
   {*}HUM BIOM COMM, 2007, BUNDESGESUNDHEITSBLA, V50, P255.
   {*}NRC, 2008, PHTH CUM RISK ASS CO.
   {*}SCHER, 2008, OP PHTH SCH SUPP.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{55}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{526MX}},
Wos-Id = {{ISI:000272295300013}},
}

@article{ ISI:000270529800035,
Author = {Meeker, John D. and Hu, Howard and Cantonwine, David E. and
   Lamadrid-Figueroa, Hector and Calafat, Antonia M. and Ettinger, Adrienne
   S. and Hernandez-Avila, Mauricio and Loch-Caruso, Rita and Maria
   Tellez-Rojo, Martha},
Title = {{Urinary Phthalate Metabolites in Relation to Preterm Birth in Mexico
   City}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2009}},
Volume = {{117}},
Number = {{10}},
Pages = {{1587-1592}},
Month = {{OCT}},
Abstract = {{BACKGROUND: Rates of preterm birth have been rising over the past
   several decades. Factors contributing to this trend remain largely
   unclear, and exposure to environmental contaminants may play a role.
   OBJECTIVE: We investigated the relationship between phthalate exposure
   and preterm birth.
   METHODS: Within a large Mexican birth cohort study, we compared
   third-trimester urinary phthalate metabolite concentrations in 30 women
   who delivered preterm (< 37 weeks of gestation) with those of 30
   controls (>= 37 weeks of gestation).
   RESULTS: Concentrations of most of the metabolites were similar to those
   reported among U.S. females, although in the present study mono-n-butyl
   phthalate (MBP) concentrations were higher and monobenzyl phthalate
   (MBzP) concentrations lower. In a crude comparison before correcting for
   urinary dilution, geometric mean urinary concentrations were higher for
   the phthalate metabolites MBP, MBzP, mono(3-carboxylpropyl)phthalate,
   and four metabolites of di(2-ethylhexyl) phthalate among women who
   subsequently delivered preterm. These differences remained, but were
   somewhat lessened, after correction by specific gravity or creatinine.
   In multivariate logistic regression analysis adjusted for potential
   confounders, elevated odds of having phthalate metabolite concentrations
   above the median level were found.
   CONCLUSIONS: We found that phthalate exposure is prevalent among this
   group of pregnant women in Mexico and that some phthalates may be
   associated with preterm birth.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Meeker, JD (Reprint Author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, 6635 SPH Tower,109 S Observ St, Ann Arbor, MI 48109 USA.
   Meeker, John D.; Hu, Howard; Cantonwine, David E.; Ettinger, Adrienne S.; Loch-Caruso, Rita, Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   Lamadrid-Figueroa, Hector; Maria Tellez-Rojo, Martha, Natl Inst Publ Hlth, Ctr Evaluat Res \& Surveys, Div Stat, Cuernavaca, Morelos, Mexico.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Atlanta, GA USA.
   Ettinger, Adrienne S., Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Hernandez-Avila, Mauricio, Minist Hlth, Mexico City, DF, Mexico.}},
DOI = {{10.1289/ehp.0800522}},
ISSN = {{0091-6765}},
Keywords = {{case-control; environment; epidemiology; exposure; pregnancy;
   prematurity}},
Keywords-Plus = {{24-HOUR CREATININE CLEARANCE; ENVIRONMENTAL TOBACCO-SMOKE; SERTOLI-CELL
   INJURY; N-BUTYL PHTHALATE; IN-UTERO EXPOSURE; MONO-(2-ETHYLHEXYL)
   PHTHALATE; PEROXISOME PROLIFERATORS; PRENATAL EXPOSURE; OXIDATIVE
   STRESS; GESTATIONAL-AGE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{meekerj@umich.edu}},
Funding-Acknowledgement = {{Department of Environmental Health Sciences {[}R01 ES 007821, P42 ES
   05947]; University of Michigan School of Public Health}},
Funding-Text = {{This work was supported by R01 ES 007821, P42 ES 05947 Project 1, and a
   pilot project grant from the Department of Environmental Health
   Sciences, University of Michigan School of Public Health.}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   ANDREWS KW, 1994, AM J IND MED, V26, P13, DOI 10.1002/ajim.4700260103.
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   DAVISON JM, 1980, BRIT J OBSTET GYNAEC, V87, P106, DOI 10.1111/j.1471-0528.1980.tb04501.x.
   DAVISON JM, 1981, BRIT J OBSTET GYNAEC, V88, P10, DOI 10.1111/j.1471-0528.1981.tb00930.x.
   Ettinger AS, 2009, ENVIRON HEALTH PERSP, V117, P26, DOI 10.1289/ehp.11868.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4.
   Gray LE, 2006, TOXICOL SCI, V93, P189, DOI 10.1093/toxsci/kfl035.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Institute of Medicine, 2006, PRET BIRTH CAUS CONS.
   Jaakkola JJK, 2001, ENVIRON HEALTH PERSP, V109, P557, DOI 10.2307/3455027.
   Jepsen KF, 2004, TOXICOL IN VITRO, V18, P265, DOI 10.1016/j.tiv.2003.09.008.
   Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254.
   Kataoka S, 2002, PLACENTA, V23, P224, DOI 10.1053/plac.2001.0776.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kharrazi M, 2004, EPIDEMIOLOGY, V15, P660, DOI 10.1097/01.ede.0000142137.39619.60.
   Kim SH, 2002, J TOXICOL ENV HEAL A, V65, P461, DOI 10.1080/15287390252808118.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Latini G, 2006, CURR MED CHEM, V13, P2527, DOI 10.2174/092986706778201666.
   Latini G, 2005, TOXICOL SCI, V85, P743, DOI 10.1093/toxsci/kfi131.
   Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5.
   Ledwith BJ, 1997, J BIOL CHEM, V272, P3707.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Lohsiriwat S, 2008, J OBSTET GYNAECOL RE, V34, P337, DOI 10.1111/j.1447-0756.2007.00694.x.
   Longnecker MP, 2001, LANCET, V358, P110, DOI 10.1016/S0140-6736(01)05329-6.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Martin JA, 2008, PEDIATRICS, V121, P788, DOI 10.1542/peds.2007-3753.
   Mathews T J, 2004, Natl Vital Stat Rep, V53, P1.
   MEEKER JD, 2008, J ANDROL, V30, P287.
   Nesin M, 2007, FRONT BIOSCI, V12, P115, DOI 10.2741/2052.
   Pauley CJ, 2002, CELL SIGNAL, V14, P351, DOI 10.1016/S0898-6568(01)00260-1.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Reti NG, 2007, AM J OBSTET GYNECOL, V196, p{[}484, e481].
   Richburg JH, 1996, TOXICOL APPL PHARM, V137, P42, DOI 10.1006/taap.1996.0055.
   Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   SIMS EAH, 1958, J CLIN INVEST, V37, P1764, DOI 10.1172/JCI103769.
   Slattery MM, 2002, LANCET, V360, P1489, DOI 10.1016/S0140-6736(02)11476-0.
   Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   TREINEN KA, 1990, TOXICOL APPL PHARM, V106, P334, DOI 10.1016/0041-008X(90)90252-P.
   Vina J, 2006, FREE RADICAL RES, V40, P1359, DOI 10.1080/10715760600952851.
   Wellejus A, 2002, J TOXICOL ENV HEAL A, V65, P813, DOI 10.1080/00984100290071126.
   WHYATT RM, 2008, EPIDEMIOLOGY, V16, pS220.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Xu Y, 2005, TOXICOL SCI, V84, P287, DOI 10.1093/toxsci/kfi083.
   Yao PL, 2007, J BIOL CHEM, V282, P5420, DOI 10.1074/jbc.M609068200.
   Yao PL, 2009, BIOL REPROD, V80, P581, DOI 10.1095/biolreprod.108.073122.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{29}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{503JI}},
Wos-Id = {{ISI:000270529800035}},
}

@article{ ISI:000270497800012,
Author = {Zhang, Yunhui and Lin, Ling and Cao, Yang and Chen, Bingheng and Zheng,
   Lixing and Ge, Ren-Shan},
Title = {{Phthalate Levels and Low Birth Weight: A Nested Case-Control Study of
   Chinese Newborns}},
Journal = {{JOURNAL OF PEDIATRICS}},
Year = {{2009}},
Volume = {{155}},
Number = {{4}},
Pages = {{500-504}},
Month = {{OCT}},
Abstract = {{Objective To assess maternal-fetal exposure to phthalates and
   investigate whether in utero phthalate exposure is associated with low
   birth weight (LBW).
   Study design A total of 201 newborn-mother pairs (88 LBW cases and 113
   controls) residing in Shanghai were enrolled in this nested case-control
   study during 2005-2006. Maternal blood, cord blood, and meconium
   specimens were collected and analyzed for phthalates by high-performance
   liquid chromatography-mass spectrometry. Nonparametric tests were used
   to compare demographic characteristics in cases and controls.
   Conditional logistic regression and Spearman correlation were used to
   analyze the association between phthalate exposure and LBW.
   Results No significant differences in gestational age, prepregnancy body
   mass index, prenatal care, vitamin supplementation, or socioeconomic
   levels were found between the LBW and control infants. More than 70\% of
   the biosamples had quantifiable levels of phthalates, with higher levels
   in the LBW infants compared with the controls. Prenatal di-n-butyl
   phthalate (DBP) exposure was associated with LBW, and di-2-ethylhexyl
   phthalate (DEHP) was negatively associated with birth length. After
   adjusting for the potential confounders, DBP concentrations in the
   highest quartile were associated with an increased risk of LBW.
   Conclusions Newborns in China are ubiquitously exposed to phthalates;
   significantly higher phthalate levels were detected in LBW cases
   compared with controls. In utero DBP and DEHP exposures were associated
   with LBW in a dose-dependent manner. Prenatal phthalate exposure may be
   a risk factor for LBW. (J Pediatr 2009,155:500-4).}},
Publisher = {{MOSBY-ELSEVIER}},
Address = {{360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ge, RS (Reprint Author), Populat Council, Ctr Biomed Res, Box 273,1230 York Ave, New York, NY 10021 USA.
   Zhang, Yunhui; Ge, Ren-Shan, Populat Council, Ctr Biomed Res, New York, NY 10021 USA.
   Zhang, Yunhui; Ge, Ren-Shan, Rockefeller Univ, New York, NY 10021 USA.
   Cao, Yang, Mil Med Coll 2, Dept Hlth Stat, Shanghai, Peoples R China.
   Zheng, Lixing, Fudan Univ, Key Lab, Minist Educ Publ Hlth, Shanghai 200433, Peoples R China.
   Zhang, Yunhui; Lin, Ling; Chen, Bingheng, Fudan Univ, Dept Environm Hlth, Sch Publ Hlth, Shanghai 200433, Peoples R China.}},
DOI = {{10.1016/j.jpeds.2009.04.007}},
ISSN = {{0022-3476}},
Keywords-Plus = {{PERFLUORINATED CHEMICALS; EXPOSURE; INFANTS; AGE; CONTAMINATION;
   METABOLITES; PREGNANCY; MECONIUM; URINARY; UPDATE}},
Research-Areas = {{Pediatrics}},
Web-of-Science-Categories  = {{Pediatrics}},
Author-Email = {{rge@popcbr.rockefeller.edu}},
Funding-Acknowledgement = {{Population Council; Natural Science Foundation of China {[}30500397]}},
Funding-Text = {{Supported in part by the Population Council (Fred H. Bixby Fellowship
   {[}2007-2009], to YZ) and the Natural Science Foundation of China (Grant
   30500397, to YZ). The authors declare no conflicts of interest.}},
Cited-References = {{Apelberg BJ, 2007, ENVIRON HEALTH PERSP, V115, P1670, DOI 10.1289/ehp.10334.
   Calafat AM, 2006, CHEMOSPHERE, V63, P490, DOI 10.1016/j.chemosphere.2005.08.028.
   Calafat AM, 2004, PEDIATRICS, V113, P429.
   Curtin S C, 2000, Natl Vital Stat Rep, V48, P1.
   de Bernabe JV, 2004, EUR J OBSTET GYN R B, V116, P3, DOI 10.1016/j.ejogrb.2004.03.007.
   Fei CY, 2007, ENVIRON HEALTH PERSP, V115, P1677, DOI 10.1289/ehp.10506.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Givens ML, 2007, CHEMOSPHERE, V69, P1295, DOI 10.1016/j.chemosphere.2007.05.031.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hubal EAC, 2000, ENVIRON HEALTH PERSP, V108, P475, DOI 10.2307/3454607.
   Kato K, 2006, ANAL CHEM, V78, P6651, DOI 10.1021/ac0608220.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Khanjani N, 2006, ENVIRON RES, V101, P373, DOI 10.1016/j.envres.2005.10.003.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   MARSMAN D, 1995, TOXIC REP SER, V30.
   McKee RH, 2004, REPROD TOXICOL, V18, P1, DOI 10.1016/j.reprotox.2003.09.002.
   {[}米杰 Mi Jie], 2002, {[}中华预防医学杂志, Chinese Journal of Preventive Medicine], V36, P154.
   Nahar N, 1998, Bangladesh Med Res Counc Bull, V24, P49.
   Norman M, 2008, ACTA PAEDIATR, V97, P1165, DOI 10.1111/j.1651-2227.2008.00904.x.
   Ostrea EM, 2008, ENVIRON RES, V106, P277, DOI 10.1016/j.envres.2007.08.014.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Smith LM, 2006, PEDIATRICS, V118, P1149, DOI 10.1542/peds.2005-2564.
   Suzuki K, 2008, J EPIDEMIOL, V18, P89, DOI 10.2188/jea.JE2007415.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   VANDIVERE S, 2007, STATES RANKED BASIS.
   Virtanen HE, 2008, HUM REPROD UPDATE, V14, P49, DOI 10.1093/humupd/dmm027.
   {*}WHO, 2004, INH WORLD ATL CHILDR.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{30}},
Journal-ISO = {{J. Pediatr.}},
Doc-Delivery-Number = {{502YT}},
Wos-Id = {{ISI:000270497800012}},
}

@article{ ISI:000269037000003,
Author = {Ye, Xibiao and Pierik, Frank H. and Angerer, Juergen and Meltzer, Helle
   Margrete and Jaddoe, Vincent W. V. and Tiemeier, Henning and Hoppin,
   Jane A. and Longnecker, Matthew P.},
Title = {{Levels of metabolites of organophosphate pesticides, phthalates, and
   bisphenol A in pooled urine specimens from pregnant women participating
   in the Norwegian Mother and Child Cohort Study (MoBa)}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2009}},
Volume = {{212}},
Number = {{5}},
Pages = {{481-491}},
Month = {{SEP}},
Abstract = {{Concerns about reproductive and developmental health risks of exposure
   to organophosphate (OP) pesticides, phthalates, and bisphenol A (BPA)
   among the general population are increasing. Six dialkyl phosphate (DAP)
   metabolites, 3,5,6-trichloro-2-pyridinol (TCPy), BPA, and fourteen
   phthalate metabolites were measured in 10 pooled urine samples
   representing 110 pregnant women who participated in the Norwegian Mother
   and Child Birth Cohort (MoBa) study in 2004. Daily intakes were
   estimated from urinary data and compared with reference doses (RfDs) and
   daily tolerable intakes (TDIs). The MoBa women had a higher mean BPA
   concentration (4.50 mu g/L) than the pregnant women in the Generation R
   Study (Generation R) in the Netherlands and the National Health and
   Nutrition Examination Survey (NHANES) in the United States. The mean
   concentration of total DAP metabolites (24.20 mu g/L) in MoBa women was
   higher than that in NHANES women but lower than that in Generation R
   women. The diethyl phthalate metabolite mono-ethyl phthalate (MEP) was
   the dominant phthalate metabolite in all three studies, with the mean
   concentrations of greater than 300 mu g/L. The MoBa and Generation R
   women had higher mean concentrations of mono-n-butyl phthalate (MnBP)
   and mono-isobutyl phthalate (MiBP) than the NHANES women. The estimated
   average daily intakes of BPA, chlorpyrifos/chlorpyrifos-methyl and
   phthalates in MoBa (and the other two studies) were below the RfDs and
   TDIs. The higher levels of metabolites in the MoBa participants may have
   been from intake via pesticide residues in food (organophosphates),
   consumption of canned food, especially fish/seafood (BPA), and use of
   personal care products (selected phthalates). Published by Elsevier
   GmbH.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Longnecker, MP (Reprint Author), NIEHS, Epidemiol Branch, NIH, DHHS, MD A3-05,POB 12233, Res Triangle Pk, NC 27709 USA.
   Ye, Xibiao; Hoppin, Jane A.; Longnecker, Matthew P., NIEHS, Epidemiol Branch, NIH, DHHS, Res Triangle Pk, NC 27709 USA.
   Pierik, Frank H., Netherlands Org Appl Sci Res, TNO, Dept Environm \& Hlth, NL-2600 AA Delft, Netherlands.
   Pierik, Frank H., Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands.
   Angerer, Juergen, Ruhr Univ Bochum, BGFA, Forschungsinst Arbeitsmed, Deutsch Gesetzlichen Unfallversicherung Inst, D-44789 Bochum, Germany.
   Meltzer, Helle Margrete, Norwegian Inst Publ Hlth, Dept Food Safety \& Nutr, Div Environm Med, Oslo, Norway.
   Jaddoe, Vincent W. V., Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands.
   Jaddoe, Vincent W. V., Univ Med Ctr Rotterdam, Erasmus MC, Generat Study Grp R, NL-3000 CA Rotterdam, Netherlands.
   Jaddoe, Vincent W. V., Univ Med Ctr Rotterdam, Erasmus MC, Dept Pediat, NL-3000 CA Rotterdam, Netherlands.
   Tiemeier, Henning, Univ Med Ctr Rotterdam, Erasmus MC, Dept Child \& Adolescent Psychiat, NL-3000 CA Rotterdam, Netherlands.}},
DOI = {{10.1016/j.ijheh.2009.03.004}},
ISSN = {{1438-4639}},
Keywords = {{Organophosphate (OP) pesticides; Bisphenol A (BPA); Phthalates;
   Biological monitoring; Environmental exposure}},
Keywords-Plus = {{EXPERT PANEL REPORT; DEVELOPMENTAL TOXICITY; ANOGENITAL DISTANCE;
   EXPOSURE ASSESSMENT; GENERAL-POPULATION; MALE INFANTS; CHLORPYRIFOS;
   3,5,6-TRICHLORO-2-PYRIDINOL; NEURODEVELOPMENT; BIOMARKERS}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{longnec1@niehs.nih.gov}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences (NIEHS); National
   Institutes of Health (NIH); Norwegian Ministry of Health, NIH/NIEHS
   {[}N01-ES-85433]; NIH/NINDS {[}1 UO1 NS 047537-01]; Norwegian Research
   Council/FUGE {[}151918/S10]; Erasmus MC, University Medical Center,
   Rotterdam; Law and Faculty of Social Sciences of the Erasmus University
   Rotterdam; Municipal Health Service Rotterdam; Rotterdam Homecare
   Foundation; Stichting Trombosedienst \& Artsenlaboratorium Rijnmond
   (STAR), Rotterdam}},
Funding-Text = {{This study was supported by the Intramural Research Program of the
   National Institute of Environmental Health Sciences (NIEHS), the
   National Institutes of Health (NIH). The Norwegian Mother and Child
   Cohort Study is supported by the Norwegian Ministry of Health, NIH/NIEHS
   (grant no N01-ES-85433), NIH/NINDS (grant no.1 UO1 NS 047537-01), and
   the Norwegian Research Council/FUGE (grant no. 151918/S10). The
   Generation R study is conducted by the Erasmus MC, University Medical
   Center, Rotterdam, the Netherlands in close collaboration with the
   School of Law and Faculty of Social Sciences of the Erasmus University
   Rotterdam, the Municipal Health Service Rotterdam area, the Rotterdam
   Homecare Foundation and the Stichting Trombosedienst \&
   Artsenlaboratorium Rijnmond (STAR), Rotterdam. The first phase of the
   Generation R study is made possible by financial support from the
   Erasmus MC, Rotterdam, the Erasmus University Rotterdam and the
   Netherlands Organization for Health Research and Development (ZonMw). We
   gratefully acknowledge the contribution of general practitioners,
   hospitals, midwives and pharmacies in Rotterdam, the Netherlands, and in
   Norway. We are grateful for Clare Weinberg's help with the modified
   t-test.}},
Cited-References = {{Agency for Toxic Substances and Disease Registry (ATSDR), 1997, TOX PROF CHLORP.
   Barr DB, 2005, ENVIRON RES, V99, P314, DOI 10.1016/j.envres.2005.03.012.
   Barr DB, 2002, J CHROMATOGR B, V778, P5, DOI 10.1016/S1570-0232(02)00035-1.
   Brantsaeter AL, 2009, EUR J CLIN NUTR, V63, P347, DOI 10.1038/sj.ejcn.1602952.
   Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391.
   Caudill SP, 2007, CHEMOSPHERE, V69, P371, DOI 10.1016/j.chemosphere.2007.05.061.
   CDC National Center for Health Statistics (NCHS), 2008, NAT HLTH NUTR EX SUR.
   Chapin RE, 2008, BIRTH DEFECTS RES B, V83, P157, DOI 10.1002/bdrb.20147.
   DIGANGI J, 2002, P NASTY PHTHALATES E.
   Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802272158 .
   Engel SM, 2007, AM J EPIDEMIOL, V165, P1397, DOI 10.1093/aje/kwm029.
   EPA United States Environmental Protection Agency, 2008, INT RISK INF SYST.
   Eskenazi B, 2007, ENVIRON HEALTH PERSP, V115, P792, DOI 10.1289/ehp.9828.
   Faraggi D, 2003, STAT MED, V22, P2515, DOI 10.1002/sim.1418.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   HAVERKAMP JB, 2008, EUR J PHARM BIOPHARM.
   Herrman JL, 1999, REGUL TOXICOL PHARM, V30, pS109, DOI 10.1006/rtph.1999.1335.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0.
   Jerardo A., 2008, WHAT SHARE US CONSUM.
   Kavlock R, 2002, REPROD TOXICOL, V16, P721, DOI 10.1016/S0890-6238(02)00031-X.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2001, INT J HYG ENVIR HEAL, V204, P175, DOI 10.1078/1438-4639-00082.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   LAKIND JS, 2008, J EXPO SCI ENV EPIDE.
   Landrigan PJ, 1999, ENVIRON HEALTH PERSP, V107, P431.
   Lang IA, 2008, JAMA-J AM MED ASSOC, V300, P1303, DOI 10.1001/jama.300.11.1303.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Magnus P, 2006, INT J EPIDEMIOL, V35, P1146, DOI 10.1093/ije/dyl170.
   MAIKRANZ P, 1989, KIDNEY INT, V36, P108, DOI 10.1038/ki.1989.168.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Matsumoto A, 2003, ENVIRON HEALTH PERSP, V111, P101, DOI 10.1289/ehp.5512.
   Miyamoto Ken-ichi, 2006, Environmental Sciences, V13, P15.
   Morgan MK, 2005, J EXPO ANAL ENV EPID, V15, P297, DOI 10.1038/sj.jea.7500406.
   Needham LL, 2005, ENVIRON HEALTH PERSP, V113, P494, DOI 10.1289/ehp.7490.
   Ronningen KS, 2006, EUR J EPIDEMIOL, V21, P619, DOI 10.1007/s10654-006-9041-x.
   Schisterman EF, 2008, PAEDIATR PERINAT EP, V22, P486, DOI 10.1111/j.1365-3016.2008.00956.x.
   Selevan SG, 2000, ENVIRON HEALTH PERSP, V108, P451, DOI 10.2307/3454536.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Skates SJ, 2007, CANCER EPIDEM BIOMAR, V16, P334, DOI 10.1158/1055-9965.EPI-06-0681.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Thomson BM, 2005, FOOD ADDIT CONTAM, V22, P65, DOI 10.1080/02652030400027920.
   US Environmental Protection Agency (USEPA), 1993, REF DOS RFD DESCR US.
   Weinberg CR, 1999, BIOMETRICS, V55, P718, DOI 10.1111/j.0006-341X.1999.00718.x.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   Ye XB, 2008, ENVIRON RES, V108, P260, DOI 10.1016/j.envres.2008.07.014.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.
   {*}EFSA, 2008, EFSA REEV SAF BISPH.
   {*}EUR COMM, 2007, ANN EU WID PEST RES.
   {*}EUR COMM, 2008, UPD EUR RISK ASS REP.
   {*}EUR INT, 2008, CONS CANN FOOD US.
   {*}FDA, 2005, PEST RES MON PROGR 2.
   {*}FED INT TRAD ASS, 2008, COUNT PROF RES NORW.
   {*}NAT TOX PROGR, 2008, NTP CERHR MONOGRAPH.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{35}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{484IE}},
Wos-Id = {{ISI:000269037000003}},
}

@article{ ISI:000269037000004,
Author = {Wittassek, Matthias and Angerer, Juergen and Kolossa-Gehring, Marike and
   Schaefer, Sebastian Daniel and Klockenbusch, Walter and Dobler, Lorenz
   and Guensel, Andreas K. and Mueller, Antje and Wiesmueller, Gerhard
   Andreas},
Title = {{Fetal exposure to phthalates - a pilot study}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2009}},
Volume = {{212}},
Number = {{5}},
Pages = {{492-498}},
Month = {{SEP}},
Abstract = {{The fetus is considered to be the most sensitive stage of life to the
   potential developmental and reproductive toxicity of the phthalates.
   But, data on human fetal exposure to phthalates is still scarce. In this
   pilot study we collected 11 pairs of amniotic fluid (AF) and
   corresponding maternal urine (MU) samples during Caesarean section and
   analysed them for several phthalate metabolites by LC-MS/MS. In all AF
   samples, metabolites of di-n-butyl phthalate (DnBP), diisobutyl
   phthalate (DiBP), butylbenzyl phthalate (BBzP), di(2-ethylhexyl)
   phthalate (DEHP) were detectable. For the first time, we were able to
   detect also oxidative phthalate metabolites in AF, with two carboxy
   metabolites of DEHP showing the highest abundance. In the MU samples,
   the concentrations of the phthalate metabolites were generally much
   higher than in the AF samples. There was a statistically significant
   linear correlation for the DiBP monoester (MiBP) (r = 0.93; p<0.001) in
   the AF and MU samples. We also found a significant correlation for the
   DEHP monoester (MEHP) (r = 0.91; p<0.001), although there was a most
   likely external contamination with MEHP in the MU samples. Our results
   suggest that several phthalates or their metabolites, respectively,
   reach the human fetus, which might be able to affect fetal health.
   Further research is needed to elucidate fetal metabolism of phthalates
   and to evaluate the in Utero phthalate exposure and the potential
   effects on fetal reproductive development. Due to the continuous turn
   over of AF, urinary levels may be most appropriate for assessing both
   maternal and fetal phthalate exposure. (C) 2009 Elsevier GmbH. All
   rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wiesmuller, GA (Reprint Author), Univ Munster, German Environm Specimen Bank Human Tissues, Umweltprobenbank Humanproben \& Datenbank, Domagkstr 11, D-48149 Munster, Germany.
   Guensel, Andreas K.; Mueller, Antje; Wiesmueller, Gerhard Andreas, Univ Munster, German Environm Specimen Bank Human Tissues, Umweltprobenbank Humanproben \& Datenbank, D-48149 Munster, Germany.
   Wittassek, Matthias; Angerer, Juergen, Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, D-91054 Erlangen, Germany.
   Kolossa-Gehring, Marike, Fed Environm Agcy, D-06844 Dessau Rosslau, Germany.
   Schaefer, Sebastian Daniel; Klockenbusch, Walter, Univ Hosp Munster, Clin \& Polyclin Gynaecol \& Obstet, D-48149 Munster, Germany.}},
DOI = {{10.1016/j.ijheh.2009.04.001}},
ISSN = {{1438-4639}},
Keywords = {{Phthalates; Biomonitoring; Amniotic fluid; Maternal urine; Fetal
   exposure}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; N-BUTYL PHTHALATE; REPRODUCTIVE-TRACT
   DEVELOPMENT; HUMAN URINE; MALE-RAT; DI(2-ETHYLHEXYL) PHTHALATE;
   DIETHYLHEXYL PHTHALATE; SEXUAL-DIFFERENTIATION; OXIDATIVE METABOLITES;
   INTERNAL EXPOSURE}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{GA.Wiesmueller@uni-muenster.de}},
Cited-References = {{ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Bay K, 2006, BEST PRACT RES CL EN, V20, P77, DOI 10.1016/j.beem.2005.09.004.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395.
   Gray Jr L. E., 2006, INT J ANDROL, V29, P105.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Howdeshell KL, 2008, TOXICOL SCI, V105, P153, DOI 10.1093/toxsci/kfn077.
   Huang PC, 2009, ENVIRON INT, V35, P14, DOI 10.1016/j.envint.2008.05.012.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   KOCH HM, EXPOSURE GE IN PRESS.
   Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Rider CV, 2008, INT J ANDROL, V31, P249, DOI 10.1111/j.1365-2605.2007.00859.x.
   ROSS MG, 2007, OBSTETRICS, P33.
   Scientific Committee on Emerging and Newly-Identified Health Risks SCENIHR, 2008, OP SAF MED DEV CONT.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Skakkebaek NE, 2006, INT J ANDROL, V29, P2, DOI 10.1111/j.1365-2605.2005.00573.x.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   {*}BMU GERM FED MIN, 2008, GERM ENV SPEC BANK C.
   {*}HLTH CAN, 2002, DEHP MED DEV EXP TOX.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{26}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{484IE}},
Wos-Id = {{ISI:000269037000004}},
}

@article{ ISI:000269287700006,
Author = {Scarano, Wellerson Rodrigo and de Toledo, Fabiola Choqueta and Guerra,
   Marina Trevizan and Pegorin de Campos, Silvana Gisele and Justulin
   Junior, Luis Antonio and Felisbino, Sergio Luis and Anselmo-Franci,
   Janete A. and Taboga, Sebastiao Roberto and Kempinas, Wilma De Grava},
Title = {{Long-term effects of developmental exposure to di-n-butyl-phthalate
   (DBP) on rat prostate: Proliferative and inflammatory disorders and a
   possible role of androgens}},
Journal = {{TOXICOLOGY}},
Year = {{2009}},
Volume = {{262}},
Number = {{3}},
Pages = {{215-223}},
Month = {{AUG 21}},
Abstract = {{In the present study we evaluated the toxic effects on the male adult
   rat prostate of DBP exposure during fetal and lactational periods,
   because although many studies have addressed the influence of phthalates
   on the male reproductive system, only a few have discussed their
   possible effects on prostate development. Pregnant females were
   distributed into two experimental groups: Control (C) and Treated (T).
   The females of the T group received DBP (100 mg/kg, by gavage) from
   gestation day 12 to postnatal day 21, while C rats received the vehicle
   (corn oil). In adulthood (90 days old), the animals were euthanized. The
   serum and testicular testosterone levels were measured. Ventral prostate
   was removed and weighed. Distal segment fragments of the ventral
   prostate were fixed and processed for histochemistry and
   immunohistochemistry to detect androgen receptor (AR) and Ki67 antigens.
   Protein extraction from ventral prostate fragments was performed for AR
   immunoblotting and Gelatin zymography for MMP-2 and MMP-9 (MMP,
   metalloproteinase). Stereological and histopathological analyses were
   also performed. Serum and testicular testosterone levels and prostate
   weight were comparable between groups. In the T group the relative
   proportions (\%) of epithelial (C=32.86; T=42.04{*}) and stromal
   (C=21.61; T=27.88{*}) compartments were increased, while the luminal
   compartment was decreased (C=45.54; T=30.08{*}), {*}p < 0.05. In T,
   disseminated inflammatory infiltrate in the stroma, associated or not
   with epithelial dysplasia and PIN (Prostatic Intraepithelial Neoplasia),
   was observed. Increases in AR expression, proliferation index and
   metalloproteinase 9 (MMP-9) activity were noted in T animals. In some T
   animals, collagen fibrils accumulated adjacent to the epithelium. As far
   as we are aware, this is the first report in the literature showing that
   phthalates could play a role in proliferative and inflammatory disorders
   of the rat prostate. (C) 2009 Elsevier Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Scarano, WR (Reprint Author), UNESP, Dept Morfol, Inst Biosci, Distrito Rubiao Jr S-N, BR-18618000 Botucatu, SP, Brazil.
   Scarano, Wellerson Rodrigo; Guerra, Marina Trevizan; Felisbino, Sergio Luis; Kempinas, Wilma De Grava, UNESP, Dept Morfol, Inst Biosci, BR-18618000 Botucatu, SP, Brazil.
   de Toledo, Fabiola Choqueta; Justulin Junior, Luis Antonio, Univ Estadual Campinas, Grad Program Cellular \& Struct Biol, Inst Biol, UNICAMP, BR-13083970 Campinas, SP, Brazil.
   Pegorin de Campos, Silvana Gisele; Taboga, Sebastiao Roberto, UNESP, Dept Biol, Inst Biosci Humanities \& Exact Sci IBILCE, BR-15100000 Sao Jose Do Rio Preto, SP, Brazil.
   Anselmo-Franci, Janete A., Univ Sao Paulo, Dept Morphol Stomatol \& Physiol, Sch Dent, BR-14049 Ribeirao Preto, SP, Brazil.}},
DOI = {{10.1016/j.tox.2009.06.011}},
ISSN = {{0300-483X}},
Keywords = {{DBP; Prostate; Inflammation; AR expression; Epithelial proliferation}},
Keywords-Plus = {{MALE REPRODUCTIVE DEVELOPMENT; IN-UTERO EXPOSURE; MATRIX
   METALLOPROTEINASES; DI(N-BUTYL) PHTHALATE; DI(2-ETHYLHEXYL) PHTHALATE;
   NONBACTERIAL PROSTATITIS; SEXUAL-DIFFERENTIATION; LACTATIONAL EXPOSURE;
   PERINATAL EXPOSURE; VENTRAL PROSTATE}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{wrscarano@yahoo.com}},
ResearcherID-Numbers = {{Kempinas, Wilma/E-4671-2012
   Taboga, Sebastiao/C-4937-2013
   Felisbino, Sergio/K-7641-2012
   6, INCT/H-4795-2013
   Infabic, Inct/I-2128-2013
   Justulin Jr, Luis /I-5734-2013}},
ORCID-Numbers = {{Kempinas, Wilma/0000-0002-2112-5123
   }},
Funding-Acknowledgement = {{State of Sao Paulo Research Foundation (FAPESP) {[}2006/59783-0]}},
Funding-Text = {{This work was supported by the State of Sao Paulo Research Foundation as
   a Postdoctoral scholarship (FAPESP, Grant 2006/59783-0). This paper
   represents part of the Postdoctoral Program developed for W.R.S. at the
   Sao Paulo State University, UNESP, Brazil. The authors are grateful to
   Jose Eduardo Bozano, from the Department of Morphology, institute of
   Biosciences, UNESP, Botucatu, SP, Brazil, for excellent technical
   assistance.}},
Cited-References = {{Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258.
   Andrade AJM, 2006, TOXICOLOGY, V228, P85, DOI 10.1016/j.tox.2006.08.020.
   Barlow NJ, 2004, TOXICOL PATHOL, V32, P79, DOI 10.1080/01926230490265894.
   Borch J, 2005, REPROD TOXICOL, V19, P517, DOI 10.1016/j.reprotox.2004.11.004.
   Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322.
   Cowin PA, 2008, ENVIRON HEALTH PERSP, V116, P923, DOI 10.1289/ehp.11239.
   CUNHA GR, 1992, J ANDROL, V13, P465.
   DELLELA FK, 2007, CELL BIOL INT, V31, P229.
   De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090.
   De Marzo AM, 2004, J CELL BIOCHEM, V91, P459, DOI 10.1002/jcb.10747.
   Droller MJ, 1997, BRIT J UROL, V79, P42.
   Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Ge RS, 2007, J ANDROL, V28, P513, DOI 10.2164/jandrol.106.001909.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005.
   Jiang JT, 2007, TOXICOLOGY, V232, P286, DOI 10.1016/j.tox.2007.01.018.
   LASKEY JW, 1994, BIOL REPROD, V50, P1151, DOI 10.1095/biolreprod50.5.1151.
   Ljungvall K, 2005, THERIOGENOLOGY, V64, P1170, DOI 10.1016/j.theriogenology.2005.02.003.
   Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x.
   Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3.
   MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q.
   McIntyre BS, 2002, TOXICOL SCI, V65, P62, DOI 10.1093/toxsci/65.1.62.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Naber KG, 2000, J ANTIMICROB CHEMOTH, V46, P157, DOI 10.1093/jac/46.2.157.
   Nagle RB, 2004, J CELL BIOCHEM, V91, P36, DOI 10.1002/jcb.10692.
   NASLUND MJ, 1988, J UROLOGY, V140, P1049.
   Palapattu GS, 2005, CARCINOGENESIS, V26, P1170, DOI 10.1093/carcin/bgh317.
   Parker S. L., 1996, CA CANC J CLIN, V65, P5.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   POTOSKY AL, 1995, JAMA-J AM MED ASSOC, V273, P548, DOI 10.1001/jama.273.7.548.
   Roberts RO, 1997, UROLOGY, V49, P809, DOI 10.1016/S0090-4295(97)00235-5.
   Scarano WR, 2006, ANAT REC PART A, V288A, P1190, DOI 10.1002/ar.a.20391.
   Scarano WR, 2008, INT J EXP PATHOL, V89, P25, DOI 10.1111/j.1365-2613.2007.00559.x.
   Sciarra A, 2008, J STEROID BIOCHEM, V108, P254, DOI 10.1016/j.jsbmb.2007.09.013.
   Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946.
   Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463.
   Stoker TE, 1999, REPROD TOXICOL, V13, P463, DOI 10.1016/S0890-6238(99)00049-0.
   Untergasser G, 2005, EXP GERONTOL, V40, P121, DOI 10.1016/j.exeger.2004.12.008.
   Vilamaior PSL, 2006, ANAT REC PART A, V288A, P885, DOI 10.1002/ar.a.20363.
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D.
   WEIBEL ER, 1963, LAB INVEST, V12, P131.
   Wilson MJ, 2004, EXP MOL PATHOL, V77, P7, DOI 10.1016/j.yexmp.2004.02.004.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   Wolf CJ, 2002, TOXICOL SCI, V65, P71, DOI 10.1093/toxsci/65.1.71.
   Wong YC, 2000, INT REV CYTOL, V199, P65, DOI 10.1016/S0074-7696(00)99002-8.
   Zhang YH, 2004, REPROD TOXICOL, V18, P669, DOI 10.1016/j.reprotox.2004.04.009.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{8}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{487PR}},
Wos-Id = {{ISI:000269287700006}},
}

@article{ ISI:000268907700028,
Author = {Blair, Joel D. and Ikonomou, Michael G. and Kelly, Barry C. and
   Surridge, Blair and Gobas, Frank A. P. C.},
Title = {{Ultra-Trace Determination of Phthalate Ester Metabolites in Seawater,
   Sediments, and Biota from an Urbanized Marine Inlet by LC/ESI-MS/MS}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2009}},
Volume = {{43}},
Number = {{16}},
Pages = {{6262-6268}},
Month = {{AUG 15}},
Abstract = {{This study presents results of an analytical method developed for the
   quantification of monoalkyl phthalate esters (MPEs) in seawater,
   sediments, and biota. The method uses accelerated solvent extraction,
   solid-phase extraction, and liquid chromatography electrospray
   ionization tandem mass spectrometry (LC/ESI-MS/MS). Results show the
   method is robust and can provide trace measurement of several MPE
   analytes at low parts per trillion levels in water and low parts per
   billion levels in sediments and biological tissues. Analyte recoveries
   varied between 70\% and 110\%. Method detection limits NOW varied
   between 0.19 and 3.98 ng/L in seawater and between 0.024 and 0.99 ng/g
   in sediment and biota, which is approximately 10-50 times lower than
   previously reported MDLs using gas chromatography mass spectrometry. We
   applied the method to field collected samples of seawater, sediments,
   and tissues of mussels, crabs, and fish from False Creek, an urbanized
   marine inlet near Vancouver, Canada. The results indicate residues of
   several MPEs can be found in surface waters, sediments, and organism
   tissues of this marine system. Monoethyl phthalate (MEP), mono-n-butyl
   phthalate (MnBP), and mono-(2-ethylhexyl)phthalate (MEHP) were
   frequently detected in all matrices. MnBP generally exhibited the
   highest concentrations among MPEs analyzed. Detectable concentrations of
   MPEs varied from 1 to 600 ng/L in seawater, 0.1 to 20 ng/g dry wt in
   sediments, and 0.1 to 600 ng/g wet wt in biota. Observed concentrations
   of low molecular weight MPEs in mussels were found to be significantly
   higher(P < 0.05)than those of corresponding parent DPEs (e.g,, MnBP >
   DBP). Mono-iso-nonyl-phthalate (MoC9) and mono-iso-decyl phthalate
   (MoC10), which were routinely detected in water and sediments, were not
   detected in False Creek biota, indicating negligible uptake and/or in
   vivo bioformation of these high molecular weight MPEs. The ability to
   measure MPEs in complex environmental samples provided by this
   LC/ESI-MS/MS method expands the capability for future biomonitoring and
   risk assessment of phthalate plasticizers.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ikonomou, MG (Reprint Author), Inst Ocean Sci, Fisheries \& Oceans Canada, Ocean Sci Div, 9860 W Saanich Rd, Sidney, BC V8L 4B2, Canada.
   Ikonomou, Michael G.; Kelly, Barry C.; Surridge, Blair, Inst Ocean Sci, Fisheries \& Oceans Canada, Ocean Sci Div, Sidney, BC V8L 4B2, Canada.
   Blair, Joel D.; Gobas, Frank A. P. C., Simon Fraser Univ, Sch Resource \& Environm Management, Burnaby, BC V5A 1S6, Canada.}},
DOI = {{10.1021/es9013135}},
ISSN = {{0013-936X}},
Keywords-Plus = {{SOLID-PHASE EXTRACTION; TANDEM MASS-SPECTROMETRY; GAS-CHROMATOGRAPHY;
   DI(2-ETHYLHEXYL) PHTHALATE; QUANTITATIVE DETECTION; ENVIRONMENTAL FATE;
   BREAST-MILK; HUMAN URINE; EXPOSURE; SERUM}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{Michael.Ikonomou@dfo-mpo.gc}},
Cited-References = {{ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   Alzaga R, 2003, J SEP SCI, V26, P87, DOI 10.1002/jssc.200390020.
   ARBIN A, 1980, J CHROMATOGR, V193, P405, DOI 10.1016/S0021-9673(00)87740-7.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   DANIEL JW, 1978, CLIN TOXICOL, V13, P257.
   Ejlertsson J, 1996, BIODEGRADATION, V7, P345, DOI 10.1007/BF00115748.
   Gavala HN, 2003, CHEMOSPHERE, V52, P673, DOI 10.1016/S0045-6535(03)00126-7.
   Gray LE, 2006, TOXICOL SCI, V93, P189, DOI 10.1093/toxsci/kfl035.
   GROUP EF, 1986, ENVIRON HEALTH PERSP, V65, P337, DOI 10.2307/3430201.
   Hashimoto S, 2005, ARCH ENVIRON CON TOX, V48, P209, DOI 10.1007/s00244-003-0205-3.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   Lee Yong-Ju, 2007, Integr Environ Assess Manag, V3, P508, DOI 10.1897/IEAM\_2007-008.1.
   Lin ZP, 2003, ENVIRON SCI TECHNOL, V37, P2100, DOI 10.1021/es026361r.
   Mackintosh CE, 2004, ENVIRON SCI TECHNOL, V38, P2011, DOI 10.1021/es034745r.
   Niino T, 2002, J CHROMATOGR B, V780, P35, DOI 10.1016/S1570-0232(02)00413-0.
   Otton SV, 2008, CHEMOSPHERE, V71, P2011, DOI 10.1016/j.chemosphere.2008.01.059.
   Prah J, 2004, TOXICOL SCI, V77, P195, DOI 10.1093/toxsci/kfh009.
   Psillakis E, 2003, J CHROMATOGR A, V999, P145, DOI 10.1016/S0021-9673(03)00390-X.
   Renfrew MJ, 2008, PAEDIATR PERINAT EP, V22, P72, DOI 10.1111/j.1365-3016.2007.00893.x.
   Schou JS, 2003, PHARMACOL TOXICOL, V92, P1.
   Schulz C O, 1973, Environ Health Perspect, V3, P123, DOI 10.2307/3428038.
   SHINTANI H, 1985, J CHROMATOGR, V337, P279, DOI 10.1016/0378-4347(85)80041-4.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   SNELL RP, 1993, J AOAC INT, V76, P531.
   Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1.
   Staples CA, 2000, CHEMOSPHERE, V40, P885, DOI 10.1016/S0045-6535(99)00315-X.
   Suzuki T, 2001, ENVIRON SCI TECHNOL, V35, P3757, DOI 10.1021/es001860i.
   TANAKA A, 1975, TOXICOLOGY, V4, P253, DOI 10.1016/0300-483X(75)90105-5.
   TEIRLYNCK O, 1988, TOXICOL LETT, V40, P85, DOI 10.1016/0378-4274(88)90186-5.
   Uriu-Adams JY, 2001, TOXICOLOGY, V159, P55, DOI 10.1016/S0300-483X(00)00403-0.
   {*}ARB PVC UMW E V, 2006, PLAST MARK DAT.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{16}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{482RZ}},
Wos-Id = {{ISI:000268907700028}},
}

@article{ ISI:000269592500003,
Author = {Struve, Melanie F. and Gaido, Kevin W. and Hensley, Janan B. and
   Lehmann, Kim P. and Ross, Susan M. and Sochaski, Mark A. and Willson,
   Gabrielle A. and Dorman, David C.},
Title = {{Reproductive Toxicity and Pharmacokinetics of di-n-butyl Phthalate (DBP)
   Following Dietary Exposure of Pregnant Rats}},
Journal = {{BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY}},
Year = {{2009}},
Volume = {{86}},
Number = {{4}},
Pages = {{345-354}},
Month = {{AUG}},
Abstract = {{Most rodent developmental toxicity studies of dibutylphthalate (DBP)
   have relied on bolus gavage closing. This study characterized the
   developmental toxicity of dietary DBP. Pregnant CD rats were given
   nominal doses of 0, 100, or 500 mg DBP/kg/day in diet (actual intake 0,
   112, and 582 mg/kg/day) from gestational day (GD) 12 through the morning
   of GD 19. Rats were killed 4 or 24 hr thereafter. DBP dietary exposure
   resulted in significant dose-dependent reductions in testicular mRNA
   concentration of scavenger receptor class B, member 1; steroidogenic
   acute regulatory protein; cytochrome P450, family 11, subfamily a,
   polypeptide 1; and cytochrome P450 family 17, subfamily a, polypeptide
   1. These effects were most pronounced 4 hr after the end of exposure.
   Testicular testosterone was reduced 24 hr post-exposure in both DBP dose
   groups and 4 hr after termination of the 500-mg DBP/kg/day exposure.
   Maternal exposure to 500mg DBP/kg/day induced a significant reduction in
   male offspring's anogenital distance indicating in utero disruption of
   androgen function. Leydig cell aggregates, increased cord diameters, and
   multinucleated gonocytes; were present in DBP-treated rats. Monobutyl
   phthalate, the developmentally toxic metabolite of DBP and its
   glucuronide conjugate were found in maternal and fetal plasma, amniotic
   fluid, and maternal urine. Our results, when compared to previously
   conducted gavage studies, indicate that approximately equal doses of
   oral DBP exposure of pregnant rats, from diet or gavage, result in
   similar responses in male offspring. Birth Defects Res (Part B)
   86:345-354, 2009. (C) 2009 Wiley-Liss, Inc.}},
Publisher = {{WILEY-LISS}},
Address = {{DIV JOHN WILEY \& SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dorman, DC (Reprint Author), N Carolina State Univ, Coll Vet Med, 4700 Hillsborough St,Box 8401, Raleigh, NC 27606 USA.
   Struve, Melanie F.; Gaido, Kevin W.; Hensley, Janan B.; Lehmann, Kim P.; Ross, Susan M.; Sochaski, Mark A.; Dorman, David C., Hamner Inst Hlth Sci, CIIT, Res Triangle Pk, NC 27709 USA.
   Willson, Gabrielle A., EPL Inc, Res Triangle Pk, NC 27709 USA.}},
DOI = {{10.1002/bdrb.20199}},
ISSN = {{1542-9733}},
Keywords = {{anti-androgen; endocrine disruptor; phthalate}},
Keywords-Plus = {{IN-UTERO EXPOSURE; DI(N-BUTYL) PHTHALATE; GENE-EXPRESSION; DEVELOPMENTAL
   TOXICITY; DIBUTYL PHTHALATE; LATE-GESTATION; FETAL; ESTERS; TESTES;
   BUTYLPHTHALATE}},
Research-Areas = {{Oncology; Genetics \& Heredity; Toxicology}},
Web-of-Science-Categories  = {{Oncology; Genetics \& Heredity; Toxicology}},
Author-Email = {{david\_dorman@ncsu.edu}},
Funding-Acknowledgement = {{American Chemistry Council}},
Funding-Text = {{This study was supported by the American Chemistry Council through their
   Long Range Research Initiative.}},
Cited-References = {{Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335.
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   CLARO F, 1994, PHYSIOL BEHAV, V56, P1069, DOI 10.1016/0031-9384(94)90345-X.
   Clewell RA, 2008, TOXICOL SCI, V103, P241, DOI 10.1093/toxsci/kfn054.
   CLEWELL RA, 2009, TOXICOLOGY, V255, P8.
   Ema M, 1996, ARCH ENVIRON CON TOX, V31, P170.
   EMA M, 1995, TOXICOL LETT, V78, P101, DOI 10.1016/0378-4274(94)03241-X.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   Ema M, 1998, TOXICOL LETT, V98, P87, DOI 10.1016/S0378-4274(98)00107-6.
   Fennell TR, 2004, TOXICOL SCI, V82, P407, DOI 10.1093/toxsci/kfh294.
   FOSTER PM, 1982, DRUG METAB DISPOS, V11, P59.
   FOSTER PMD, 1981, CHEM-BIOL INTERACT, V34, P233, DOI 10.1016/0009-2797(81)90134-4.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRIZZLE T, 1995, TOXICOKINETICS METAB, P48.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Howdeshell KL, 2008, ENVIRON RES, V108, P168, DOI 10.1016/j.envres.2008.08.009.
   Kremer JJ, 2005, TOXICOL LETT, V159, P144, DOI 10.1016/j.toxlet.2005.05.006.
   Lahousse SA, 2006, TOXICOL SCI, V93, P369, DOI 10.1093/toxsci/kfl049.
   LEHMANN KF, 2004, TOXICOL SCI, V80, P1.
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404.
   MEGUID MM, 1990, PHYSIOL BEHAV, V48, P759, DOI 10.1016/0031-9384(90)90222-P.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   OISHI S, 1980, TOXICOL LETT, V6, P239.
   Payan JP, 2001, DRUG METAB DISPOS, V29, P843.
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45.
   REYNOLDS F, 1989, OXFORD REV REPROD B, V11, P389.
   ROWLAND IR, 1977, FOOD COSMET TOXICOL, V15, P17, DOI 10.1016/S0015-6264(77)80257-5.
   Saillenfait AM, 2001, PHARMACOL TOXICOL, V89, P104, DOI 10.1034/j.1600-0773.2001.d01-143.x.
   Saillenfait AM, 1998, TOXICOL SCI, V45, P212, DOI 10.1093/toxsci/45.2.212.
   Shono T, 2000, BJU INT, V86, P121, DOI 10.1046/j.1464-410x.2000.00710.x.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Stasko SE, 2001, DEV DYNAM, V220, P49, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1086>3.0.CO;2-5.
   STUCCO DM, 2001, ANNU REV PHYSIOL, V63, P193.
   TANAKA A, 1978, TOXICOLOGY, V9, P109, DOI 10.1016/0300-483X(78)90036-7.
   Thompson CJ, 2005, BIOL REPROD, V73, P908, DOI 10.1095/biolreprod.105.042382.
   VOMSAAL FS, 1990, BIOL REPROD, V43, P751, DOI 10.1095/biolreprod43.5.751.
   West LA, 2001, ENDOCRINOLOGY, V142, P502, DOI 10.1210/en.142.1.502.
   {*}NTP CERHR, 2003, NTP CERIIR MON POT H.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{6}},
Journal-ISO = {{Birth Defects Res. Part B-Dev. Reprod. Toxicol.}},
Doc-Delivery-Number = {{491PX}},
Wos-Id = {{ISI:000269592500003}},
}

@article{ ISI:000267281600011,
Author = {Meeker, John D. and Sathyanarayana, Sheela and Swan, Shanna H.},
Title = {{Phthalates and other additives in plastics: human exposure and
   associated health outcomes}},
Journal = {{PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES}},
Year = {{2009}},
Volume = {{364}},
Number = {{1526}},
Pages = {{2097-2113}},
Month = {{JUL 27}},
Abstract = {{Concern exists over whether additives in plastics to which most people
   are exposed, such as phthalates, bisphenol A or polybrominated diphenyl
   ethers, may cause harm to human health by altering endocrine function or
   through other biological mechanisms. Human data are limited compared
   with the large body of experimental evidence documenting reproductive or
   developmental toxicity in relation to these compounds. Here, we discuss
   the current state of human evidence, as well as future research trends
   and needs.
   Because exposure assessment is often a major weakness in epidemiological
   studies, and in utero exposures to reproductive or developmental
   toxicants are important, we also provide original data on maternal
   exposure to phthalates during and after pregnancy (n = 242). Phthalate
   metabolite concentrations in urine showed weak correlations between pre-
   and post-natal samples, though the strength of the relationship
   increased when duration between the two samples decreased. Phthalate
   metabolite levels also tended to be higher in post-natal samples.
   In conclusion, there is a great need for more human studies of adverse
   health effects associated with plastic additives. Recent advances in the
   measurement of exposure biomarkers hold much promise in improving the
   epidemiological data, but their utility must be understood to facilitate
   appropriate study design.}},
Publisher = {{ROYAL SOC}},
Address = {{6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Meeker, JD (Reprint Author), Univ Michigan, Sch Publ Hlth, Dept Environm \& Ind Hlth, 6635 SPH Tower,109 S Observ St, Ann Arbor, MI 48109 USA.
   Meeker, John D., Univ Michigan, Sch Publ Hlth, Dept Environm \& Ind Hlth, Ann Arbor, MI 48109 USA.
   Sathyanarayana, Sheela, Univ Washington, Dept Pediat, Seattle, WA 98101 USA.
   Swan, Shanna H., Univ Rochester, Dept Obstet \& Gynecol, Sch Med \& Dent, Rochester, NY 14642 USA.}},
DOI = {{10.1098/rstb.2008.0268}},
ISSN = {{0962-8436}},
Keywords = {{bisphenol A; endocrine disruption; epidemiology; phthalate;
   polybrominated; diphenyl ether; reproductive health}},
Keywords-Plus = {{POLYBROMINATED DIPHENYL ETHERS; BISPHENOL-A CONCENTRATIONS; IN-UTERO
   EXPOSURE; HUMAN BREAST-MILK; FEMALE REPRODUCTIVE-SYSTEM; THYROID-HORMONE
   LEVELS; CARE-UNIT INFANTS; SEMEN QUALITY; URINARY CONCENTRATIONS;
   DEVELOPMENTAL EXPOSURE}},
Research-Areas = {{Life Sciences \& Biomedicine - Other Topics}},
Web-of-Science-Categories  = {{Biology}},
Author-Email = {{meekerj@umich.edu}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Aksglaede L, 2006, HUM REPROD UPDATE, V12, P341, DOI 10.1093/humupd/dml018.
   Allen JG, 2007, ENVIRON SCI TECHNOL, V41, P4574, DOI 10.1021/es0703170.
   Andrady AL, 2009, PHILOS T R SOC B, V364, P1977, DOI 10.1098/rstb.2008.0304.
   Armstrong B, 2003, EXPOSURE ASSESSMENT.
   ATSDR (Agency for Toxic Substances Disease Registry), 2004, TOX PROF POL BIPH PO.
   Bae B, 2002, WATER SCI TECHNOL, V46, P381.
   BAHN AK, 1980, NEW ENGL J MED, V302, P31, DOI 10.1056/NEJM198001033020105.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Birnbaum LS, 2006, ENVIRON HEALTH PERSP, V114, P1770, DOI 10.1289/ehp.9061.
   Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Brede C, 2003, FOOD ADDIT CONTAM, V20, P684, DOI 10.1080/02652030210134236.
   Bretveld RW, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-30.
   BROTONS JA, 1995, ENVIRON HEALTH PERSP, V103, P608, DOI 10.2307/3432439.
   Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   Chao HR, 2007, ENVIRON INT, V33, P239, DOI 10.1016/j.envint.2006.09.013.
   Colborn T, 2004, ENVIRON HEALTH PERSP, V112, P944, DOI 10.1289/ehp.6601.
   Colborn T, 2006, ENVIRON HEALTH PERSP, V114, P10, DOI 10.1289/ehp.7940.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Costa LG, 2007, NEUROTOXICOLOGY, V28, P1047, DOI 10.1016/j.neuro.2007.08.007.
   Damgaard IN, 2002, BEST PRACT RES CL EN, V16, P289, DOI 10.1053/beem.2002.0205.
   David R. M., 2001, PATTYS TOXICOLOGY, P635.
   Dhooge W, 2007, J ANDROL, V28, P435, DOI 10.2164/jandrol.106.001644.
   Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288.
   DODDS E. C, 1936, NATURE {[}LONDON], V137, P996, DOI 10.1038/137996a0.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   FACTOR A, 1998, ADV CHEM SER, V249, P59.
   Fleming LE, 1999, J OCCUP ENVIRON MED, V41, P279, DOI 10.1097/00043764-199904000-00010.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Gomara B, 2007, ENVIRON SCI TECHNOL, V41, P6961, DOI 10.1021/es0714484.
   Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473.
   Stoker TE, 2005, TOXICOL APPL PHARM, V207, P78, DOI 10.1016/j.taap.2005.05.010.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Hagmar L, 2001, ARCH ENVIRON HEALTH, V56, P138.
   Hanaoka T, 2002, OCCUP ENVIRON MED, V59, P625, DOI 10.1136/oem.59.9.625.
   Hardell L, 2006, INT J ANDROL, V29, P228, DOI 10.1111/j.1365-2605.2005.00622.x.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hauser R, 2005, ENVIRON HEALTH PERSP, V113, P425, DOI 10.1289/ehp.7305.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hill SS, 2003, BIOMED CHROMATOGR, V17, P250, DOI 10.1002/bmc.231.
   Hill SS, 2001, CLIN CHIM ACTA, V304, P1, DOI 10.1016/S0009-8981(00)00411-3.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839.
   Jensen TK, 1997, J CLIN ENDOCR METAB, V82, P4059, DOI 10.1210/jc.82.12.4059.
   Schecter A, 2007, J TOXICOL ENV HEAL A, V70, P1, DOI 10.1080/15287390600748369.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Joskow R, 2006, J AM DENT ASSOC, V137, P353.
   Julander A, 2005, INT ARCH OCC ENV HEA, V78, P584, DOI 10.1007/s00420-005-0627-5.
   Kang JH, 2003, J FOOD PROTECT, V66, P1444.
   Kang JH, 2006, TOXICOLOGY, V226, P79, DOI 10.1016/j.tox.2006.06.009.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch HM, 2009, PHILOS T R SOC B, V364, P2063, DOI 10.1098/rstb.2008.0208.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   Kuriyama SN, 2007, TOXICOLOGY, V242, P80, DOI 10.1016/j.tox.2007.09.011.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lilienthal H, 2006, ENVIRON HEALTH PERSP, V114, P194, DOI 10.1289/ehp.8391.
   Lopez-Cervantes J, 2003, FOOD ADDIT CONTAM, V20, P596, DOI 10.1080/0265203031000109495.
   Lorber M, 2008, J EXPO SCI ENV EPID, V18, P2, DOI 10.1038/sj.jes.7500572.
   Mabeck LM, 2005, HUM REPROD, V20, P2909, DOI 10.1093/humrep/dei141.
   Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605.
   Main KM, 2007, ENVIRON HEALTH PERSP, V115, P1519, DOI 10.1289/ehp.9924.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Main KM, 2006, EUR J ENDOCRINOL, V155, pS51, DOI 10.1530/eje.1.02237.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2007, J ANDROL, V28, P397, DOI 10.2164/jandrol.106.001545.
   MURATURE DA, 1987, BIOMED ENVIRON MASS, V14, P473, DOI 10.1002/bms.1200140815.
   National Research Council (NRC), 1999, HORM ACT AG ENV.
   Nicolopoulou-Stamati P, 2001, HUM REPROD UPDATE, V7, P323, DOI 10.1093/humupd/7.3.323.
   Oehlmann J, 2009, PHILOS T R SOC B, V364, P2047, DOI 10.1098/rstb.2008.0242.
   Olesen IA, 2007, BEST PRACT RES CL EN, V21, P462, DOI 10.1016/j.beem.2007.04.002.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Pflieger-Bruss S, 2004, ANDROLOGIA, V36, P337, DOI 10.1111/j.1439-0272.2004.00641.x.
   Pocar P, 2003, REPRODUCTION, V125, P313, DOI 10.1530/rep.0.1250313.
   Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004.
   ROTH B, 1988, EUR J PEDIATR, V147, P41, DOI 10.1007/BF00442609.
   Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Salazar-Martinez Eduardo, 2004, Environ Health, V3, P8, DOI 10.1186/1476-069X-3-8.
   Samuelsen M, 2001, CELL BIOL TOXICOL, V17, P139, DOI 10.1023/A:1011974012602.
   Sasaki N, 2005, J MATER SCI-MATER M, V16, P297, DOI 10.1007/s10856-005-0627-8.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001.
   Schecter A, 2005, J OCCUP ENVIRON MED, V47, P199, DOI 10.1097/01.jom.0000158704.27536.d2.
   Schecter A, 2003, ENVIRON HEALTH PERSP, V111, P1723, DOI 10.1289/ehp.6466.
   Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703.
   Selvin E, 2007, DIABETES CARE, V30, P234, DOI 10.2337/dc06-1579.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Sjodin A, 2008, ENVIRON SCI TECHNOL, V42, P1377, DOI 10.1021/es702451p.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Sugiura-Ogasawara M, 2005, HUM REPROD, V20, P2325, DOI 10.1093/humrep/deh888.
   Sun Y, 2004, BIOMED CHROMATOGR, V18, P501, DOI 10.1002/bmc.345.
   Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P1478, DOI 10.1289/ehp.6417.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Swan SH, 2008, ENVIRON RES, V108, P177, DOI 10.1016/j.envres.2008.08.007.
   Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165.
   Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V291, P76, DOI 10.1006/bbrc.2002.6407.
   Teilmann G, 2002, BEST PRACT RES CL EN, V16, P105, DOI 10.1053/beem.2002.0184.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Thompson RC, 2009, PHILOS T R SOC B, V364, P2153, DOI 10.1098/rstb.2009.0053.
   Thompson RC, 2009, PHILOS T R SOC B, V364, P1973, DOI 10.1098/rstb.2009.0054.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Tilson HA, 1998, ENVIRON HEALTH PERSP, V106, P807, DOI 10.2307/3434193.
   Toft G, 2004, REPROD TOXICOL, V19, P5, DOI 10.1016/j.reprotox.2004.05.006.
   Toppari J, 1998, BAILLIERE CLIN ENDOC, V12, P143, DOI 10.1016/S0950-351X(98)80529-6.
   Tseng LH, 2008, CHEMOSPHERE, V70, P640, DOI 10.1016/j.chemosphere.2007.06.078.
   Uhler ML, 2003, FERTIL STERIL, V79, P1535, DOI 10.1016/S0015-0282(03).
   Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010.
   Völkel Wolfgang, 2002, Chem Res Toxicol, V15, P1281, DOI 10.1021/tx025548t.
   Webster T., 2005, ORGANOHALOGEN COMPD, V67, P505.
   Wetherill YB, 2007, REPROD TOXICOL, V24, P178, DOI 10.1016/j.reprotox.2007.05.010.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   Windham GC, 2005, EPIDEMIOLOGY, V16, P182, DOI 10.1097/01.ede.0000152527.24339.17.
   Yamada H, 2002, REPROD TOXICOL, V16, P735, DOI 10.1016/S0890-6238(02)00051-5.
   Yang M, 2006, ENVIRON MOL MUTAGEN, V47, P571, DOI 10.1002/em.20230.
   Zhang YH, 2006, BIOMED ENVIRON SCI, V19, P205.
   Zhou T, 2002, TOXICOL SCI, V66, P105, DOI 10.1093/toxsci/66.1.105.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.
   {*}ATSDR, 2001, TOX PROF DINB PHTH D.
   {*}EU, 2001, DIPH PENT DER PENT E, P1.
   {*}NRC, 2006, HUM BIOM ENV CHEM, P167.}},
Number-of-Cited-References = {{136}},
Times-Cited = {{46}},
Journal-ISO = {{Philos. Trans. R. Soc. B-Biol. Sci.}},
Doc-Delivery-Number = {{461PU}},
Wos-Id = {{ISI:000267281600011}},
}

@article{ ISI:000266734300005,
Author = {Seckin, Elcim and Fromme, Hermann and Voelkel, Wolfgang},
Title = {{Determination of total and free mono-n-butyl phthalate in human urine
   samples after medication of a di-n-butyl phthalate containing capsule}},
Journal = {{TOXICOLOGY LETTERS}},
Year = {{2009}},
Volume = {{188}},
Number = {{1}},
Pages = {{33-37}},
Month = {{JUL 10}},
Abstract = {{Phthalates like di-n-butyl phthalate (DnBP) and diisobutyl phthalate
   (DiBP) are commonly used as plasticisers, enteric coatings in
   medications and their metabolites (MnBP respectively MiBP) are suspect
   of adverse endocrine activities. The aim of this study was to determine
   kinetical data in humans after the application of a drug containing 3600
   mu g of DnBP and to quantify main metabolites of DnBP and DiBP with and
   without glucuronidase treatment. Since commonly glucuronides do not
   exhibit endocrine activity it is of interest to determine the
   potentially active metabolite like free MnBP and MiBP for a valid risk
   assessment. After the application of one capsule containing 3600 mu g of
   DnBP to 17 volunteers 78\% (median of 2248 mu g of total MnBP) of
   administered DnBP was found within 24 h in urine. After 24 h the levels
   of MnBP in urine were comparable to concentrations before administration
   showing a fast elimination. In contrast to controls in all urine samples
   collected within 24 h after the administration of the drug free MnBP was
   observed with a median of 4\% of total MnBP. In controls total MnBP and
   MiBP were found in median concentration of 23 mu g/24 h and about 50 mu
   g/24 h, respectively and therefore environmental exposure to DnBP is
   only 1\% compared to medication. Since an uptake of 3600 mu g in only
   one capsule is already above the tolerable daily intake (TDI) for DnBP
   of 10 mu g/kg b.w. from a preventive health protection DnBP should be
   replaced in medical drugs. (C) 2009 Elsevier Ireland Ltd. All rights
   reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Volkel, W (Reprint Author), Bavarian Hlth \& Food Safety Author, Environm Med Biomonitoring, Pfarrstr 3, D-80538 Munich, Germany.
   Seckin, Elcim; Fromme, Hermann; Voelkel, Wolfgang, Bavarian Hlth \& Food Safety Author, Environm Med Biomonitoring, D-80538 Munich, Germany.}},
DOI = {{10.1016/j.toxlet.2009.03.002}},
ISSN = {{0378-4274}},
Keywords = {{Di-n-butyl phthalate; Diisobutyl phthalate; Exposure; Urine;
   Biomonitoring; Risk assessment}},
Keywords-Plus = {{BISPHENOL-A; IN-VITRO; EXPOSURE; METABOLITES; RATS; POPULATION;
   TOXICITY; VIVO}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{Wolfgang.Voelkel@lgl.bayern.de}},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Clewell RA, 2008, TOXICOL SCI, V103, P241, DOI 10.1093/toxsci/kfn054.
   EFSA (European Food Safety Authority), 2005, EFSA J, V242, P1.
   Fennell TR, 2004, TOXICOL SCI, V82, P407, DOI 10.1093/toxsci/kfh294.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hoyer PB, 2001, BIOCHEM PHARMACOL, V62, P1557, DOI 10.1016/S0006-2952(01)00814-0.
   Janjua NR, 2008, INT J ANDROL, V31, P118, DOI 10.1111/j.1365-2605.2007.00841.x.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Matthews JB, 2001, CHEM RES TOXICOL, V14, P149, DOI 10.1021/tx0001833.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Payan JP, 2001, DRUG METAB DISPOS, V29, P843.
   Pottenger LH, 2000, TOXICOL SCI, V54, P3, DOI 10.1093/toxsci/54.1.3.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2007, ENVIRON SCI TECHNOL, V41, P7576, DOI 10.1021/es071142x.
   Volkel W, 2008, INT J HYG ENVIR HEAL, V211, P440, DOI 10.1016/j.ijheh.2007.07.024.
   Volkel W, 2008, TOXICOL LETT, V179, P155, DOI 10.1016/j.toxlet.2008.05.002.
   Völkel Wolfgang, 2002, Chem Res Toxicol, V15, P1281, DOI 10.1021/tx025548t.
   Waechter J, 2007, TOXICOL MECH METHOD, V17, P13, DOI 10.1080/15376510600803581.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Ye XY, 2007, J EXPO SCI ENV EPID, V17, P567, DOI 10.1038/sj.jes.7500566.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{11}},
Journal-ISO = {{Toxicol. Lett.}},
Doc-Delivery-Number = {{455CN}},
Wos-Id = {{ISI:000266734300005}},
}

@article{ ISI:000267277600020,
Author = {Samandar, Ella and Silva, Manori J. and Reidy, John A. and Needham,
   Larry L. and Calafat, Antonia M.},
Title = {{Temporal stability of eight phthalate metabolites and their glucuronide
   conjugates in human urine}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2009}},
Volume = {{109}},
Number = {{5}},
Pages = {{641-646}},
Month = {{JUL}},
Abstract = {{Humans are exposed to phthalates due to the ubiquitous use of these
   chemicals in consumer products. In the body, phthalates metabolize
   quickly to form hydrolytic and oxidative monoesters which, in turn, can
   be glucuronidated before urinary excretion. Exposure assessment studies
   typically report the total urinary concentrations of phthalate
   metabolites (i.e., free plus glucuronidated species). Nevertheless,
   because conjugation may potentially reduce the bioactivity of the
   metabolites by reducing their bioavailability, measuring the
   concentrations of free species may be of interest. An accurate,
   quantitative measurement of phthalate monoesters and their conjugated
   species requires data on the stability of these species in urine after
   sample collection and before analysis. We studied the stability of eight
   phthalate metabolites and their glucuronide conjugates at 25, 4, and -70
   degrees C. Interestingly, the total concentrations of phthalate
   metabolites decreased over time at 25 and 4 degrees C, but not at -70
   degrees C for up to 1 year and despite several freeze-thaw cycles. We
   further observed a considerable decrease in the concentrations of the
   glucuronides of some phthalate metabolites 1 day and 3 days after
   collection when the samples were stored at 25 and 4 degrees C,
   respectively. By contrast, the concentrations of the glucuronide
   conjugates at -70 degrees C remained unchanged for the whole duration of
   the study (1 year). Based on these findings, we recommend transferring
   urine specimens to a cooler or a refrigerator immediately after
   collection followed by permanent storage at subfreezing temperatures
   within hours of sample collection. Published by Elsevier Inc}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, 4770 Buford Hwy,Mailstop F-53, Atlanta, GA 30341 USA.
   Samandar, Ella; Silva, Manori J.; Reidy, John A.; Needham, Larry L.; Calafat, Antonia M., Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.}},
DOI = {{10.1016/j.envres.2009.02.004}},
ISSN = {{0013-9351}},
Keywords = {{Biomonitoring; Glucuronidation; Phthalate metabolites; Exposure;
   Phthalate stability}},
Keywords-Plus = {{HUMAN EXPOSURE ASSESSMENT; OXIDATIVE METABOLITES; DI-(2-ETHYLHEXYL)
   PHTHALATE; QUANTIFICATION; BIOMARKERS; MONOESTER; CHILDREN}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{Acalafat@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{ALBRO PW, 1983, BIOCHIM BIOPHYS ACTA, V760, P283, DOI 10.1016/0304-4165(83)90175-7.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   David RM, 2001, PATTYS TOXICOLOGY, V6, P635.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hoppin JA, 2006, J EXPO SCI ENV EPID, V16, P39, DOI 10.1038/sj.jea.7500435.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch H, 2005, UMWELTMED FORSCH PRA, V10, P144.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Silva MJ, 2007, ENVIRON SCI TECHNOL, V41, P7576, DOI 10.1021/es071142x.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2008, J CHROMATOGR B, V873, P180, DOI 10.1016/j.jchromb.2008.08.017.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.}},
Number-of-Cited-References = {{20}},
Times-Cited = {{12}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{461OO}},
Wos-Id = {{ISI:000267277600020}},
}

@article{ ISI:000268834700003,
Author = {Engel, Stephanie M. and Zhu, Chenbo and Berkowitz, Gertrud S. and
   Calafat, Antonia M. and Silva, Manori J. and Miodovnik, Amir and Wolff,
   Mary S.},
Title = {{Prenatal phthalate exposure and performance on the Neonatal Behavioral
   Assessment Scale in a multiethnic birth cohort}},
Journal = {{NEUROTOXICOLOGY}},
Year = {{2009}},
Volume = {{30}},
Number = {{4}},
Pages = {{522-528}},
Month = {{JUL}},
Abstract = {{We investigated the relationship between prenatal maternal urinary
   concentrations of phthalate metabolites and neonatal behavior in their
   295 children enrolled in a multiethnic birth cohort between 1998 and
   2002 at the Mount Sinai School of Medicine in New York City. Trained
   examiners administered the Brazelton Neonatal Behavioral Assessment
   Scale (BNBAS) to children within 5 days of delivery. We measured
   metabolites of 7 phthalate esters in maternal urine that was collected
   between 25 and 40 weeks' gestation. All but two phthalate metabolites
   were over 95\% detectable. We summed metabolites on a molar basis into
   low and high molecular weight phthalates. We hypothesized the existence
   of sex-specific effects from phthalate exposure a priori given the
   hormonal activity of these chemicals. Overall we found few associations
   between individual phthalate metabolites or their molar sums and most of
   the BNBAS domains. However, we observed significant sex-phthalate
   metabolite interactions (p < 0.10) for the Orientation and Motor domains
   and the overall Quality of Alertness score. Among girls, there was a
   significant linear decline in adjusted mean Orientation score with
   increasing urinary concentrations of high molecular weight phthalate
   metabolites (B = -0.37, p = 0.02). Likewise, there was a strong linear
   decline in their adjusted mean Quality of Alertness score (B = -0.48, p
   < 0.01). In addition, boys and girls demonstrated opposite patterns of
   association between low and high molecular weight phthalate metabolite
   concentrations and motor performance, with some indication of improved
   motor performance with increasing concentration of low molecular weight
   phthalate metabolites among boys. This is the first study to report an
   association between prenatal phthalate exposure and neurological effects
   in humans or animals, and as such requires replication. (C) 2009
   Elsevier Inc. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Engel, SM (Reprint Author), Mt Sinai Sch Med, Dept Community \& Prevent Med, 1 Gustave L Levy Pl,Box 1057, New York, NY 10029 USA.
   Engel, Stephanie M.; Zhu, Chenbo; Berkowitz, Gertrud S.; Miodovnik, Amir; Wolff, Mary S., Mt Sinai Sch Med, Dept Community \& Prevent Med, New York, NY 10029 USA.
   Calafat, Antonia M.; Silva, Manori J., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.}},
DOI = {{10.1016/j.neuro.2009.04.001}},
ISSN = {{0161-813X}},
Keywords = {{Phthalates; Behavior; Neonatal; Neurodevelopment}},
Keywords-Plus = {{ACTIVATED RECEPTOR-ALPHA; IN-UTERO; DI(2-ETHYLHEXYL) PHTHALATE; URINARY
   CONCENTRATIONS; OXIDATIVE METABOLITES; TEMPORAL VARIABILITY; WAIST
   CIRCUMFERENCE; PESTICIDE EXPOSURE; THYROID-HORMONE; SEMEN QUALITY}},
Research-Areas = {{Neurosciences \& Neurology; Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Neurosciences; Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{Stephanie.Engel@mssm.edu}},
Funding-Acknowledgement = {{NIEHS/EPA Children's Center {[}ES09584, R827039]; New York Community
   Trust; ATSDR/CDC/ATPM; NICHD {[}5T32HD049311]}},
Funding-Text = {{This research was supported by NIEHS/EPA Children's Center grants
   ES09584 and R827039, The New York Community Trust. and ATSDR/CDC/ATPM.
   Dr. Miodovnik was supported by NICHD 5T32HD049311. The authors would
   like to thank Ella Samandar, James Preau and John A. Reidy (CDC,
   Atlanta, GA) for technical assistance in measuring the concentrations of
   phthalate metabolites, and Martha Lievano and Stefanie Meisel for
   recruiting and following the birth cohort.}},
Cited-References = {{Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Berkowitz GS, 2003, ENVIRON HEALTH PERSP, V111, P79, DOI 10.1289/ehp.5619.
   Berkowitz GS, 2004, ENVIRON HEALTH PERSP, V112, P388, DOI 10.1289/ehp.6414.
   Braissant O, 1998, ENDOCRINOLOGY, V139, P2748, DOI 10.1210/en.139.6.2748.
   Brazelton T. B., 1995, NEONATAL BEHAV ASSES.
   Breous E, 2005, MOL CELL ENDOCRINOL, V244, P75, DOI 10.1016/j.mce.2005.06.009.
   Canals J, 2006, ACTA PAEDIATR, V95, P1412, DOI 10.1080/0803250600760790.
   Colciago A, 2006, REPROD TOXICOL, V22, P738, DOI 10.1016/j.reprotox.2006.07.002.
   Committee on the Health Risks of Phthalates N. R. C., 2008, PHTHAL CUM RISK ASS.
   Corton JC, 2005, TOXICOL SCI, V83, P4, DOI 10.1093/toxsci/kfi011.
   Datta-Bhutada S, 1998, J Perinatol, V18, P183.
   Engel SM, 2007, AM J EPIDEMIOL, V165, P1397, DOI 10.1093/aje/kwm029.
   Fenster L, 2007, NEUROTOXICOLOGY, V28, P471, DOI 10.1016/j.neuro.2006.12.009.
   Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hays T, 2005, CARCINOGENESIS, V26, P219, DOI 10.1093/carcin/bgh285.
   HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   JACOBSON JL, 1984, DEV PSYCHOL, V20, P523, DOI 10.1037//0012-1649.20.4.523.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Latini G, 2008, PPAR RES, DOI 10.1155/2008/359267.
   LESTER BM, 1982, CHILD DEV, V53, P687, DOI 10.1111/j.1467-8624.1982.tb03442.x.
   Lonky E, 1996, J GREAT LAKES RES, V22, P198.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   de Escobar GM, 2004, EUR J ENDOCRINOL, V151, pU25.
   Morreale de Escobar G, 2001, J PEDIAT ENDOCRINOL, V14, P1453.
   Myers BJ, 2003, SUBST USE MISUSE, V38, P2065, DOI 10.1081/JA-120025126.
   Ohara Noriyuki, 2004, J Obstet Gynaecol Can, V26, P982.
   Ohgi S, 2003, CLIN PEDIATR, V42, P679, DOI 10.1177/000992280304200803.
   Ohgi S, 2003, BRAIN DEV-JPN, V25, P313, DOI 10.1016/S0387-7604(02)00233-4.
   Pereira C, 2007, ACTA HISTOCHEM, V109, P29, DOI 10.1016/j.acthis.2006.09.008.
   Peters JM, 1997, CARCINOGENESIS, V18, P2029, DOI 10.1093/carcin/18.11.2029.
   Peters JM, 2000, MOL CELL BIOL, V20, P5119, DOI 10.1128/MCB.20.14.5119-5128.2000.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x.
   PRICE SC, 1988, TOXICOL LETT, V40, P37, DOI 10.1016/0378-4274(88)90181-6.
   Richardson GA, 1996, NEUROTOXICOL TERATOL, V18, P519, DOI 10.1016/0892-0362(96)00062-1.
   ROGAN WJ, 1986, J PEDIATR, V109, P335, DOI 10.1016/S0022-3476(86)80397-3.
   Sagiv SK, 2008, ENVIRON HEALTH PERSP, V116, P666, DOI 10.1289/ehp.10553.
   Shearer BG, 2003, CURR MED CHEM, V10, P267.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2008, J CHROMATOGR B, V873, P180, DOI 10.1016/j.jchromb.2008.08.017.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Stewart P, 2000, NEUROTOXICOL TERATOL, V22, P21, DOI 10.1016/S0892-0362(99)00056-2.
   Sugiyama S, 2005, TOXICOL SCI, V88, P367, DOI 10.1093/toxsci/kfi330.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   TIROSH E, 1992, ACTA PAEDIATR, V81, P829, DOI 10.1111/j.1651-2227.1992.tb12112.x.
   Wolff MS, 2007, PEDIATR RES, V61, P243, DOI 10.1203/pdr.0b013e31802d77f0.
   Wolff MS, 2008, ENVIRON HEALTH PERSP, V116, P1092, DOI 10.1289/ehp.11007.
   Xu Y, 2007, ARCH TOXICOL, V81, P57, DOI 10.1007/s00204-006-0143-8.
   Young JG, 2005, NEUROTOXICOLOGY, V26, P199, DOI 10.1016/j.neuro.2004.10.004.
   Zhang YH, 2006, BIOMED ENVIRON SCI, V19, P205.}},
Number-of-Cited-References = {{56}},
Times-Cited = {{35}},
Journal-ISO = {{Neurotoxicology}},
Doc-Delivery-Number = {{481TM}},
Wos-Id = {{ISI:000268834700003}},
}

@article{ ISI:000271898400008,
Author = {Rael, Leonard T. and Bar-Or, Raphael and Ambruso, Daniel R. and Mains,
   Charles W. and Slone, Denetta S. and Craun, Michael L. and Bar-Or, David},
Title = {{Phthalate esters used as plasticizers in packed red blood cell storage
   bags may lead to progressive toxin exposure and the release of
   pro-inflammatory cytokines}},
Journal = {{OXIDATIVE MEDICINE AND CELLULAR LONGEVITY}},
Year = {{2009}},
Volume = {{2}},
Number = {{3}},
Pages = {{166-171}},
Month = {{JUL-AUG}},
Abstract = {{Phthalate esters (PE's) are plasticizers used to soften PVC-based
   medical devices. PE's are the most abundant man-made pollutants and
   increase the risk of developing an allergic respiratory disease or a
   malignancy. The leaching of PE's in donated packed red blood cells
   (PRBC) during storage was assessed. PRBC transfusion bags containing
   CPD/AS-1 (ADSOL) buffer were analyzed. Samples were collected on storage
   day I and day 42. Two PE's, di-(2-ethythexyl) phthalate (DEHP) and
   mono-(2-ethythexyl) phthalate (MEHP), were measured by liquid
   chromatography coupled to mass spectrometry (LCMS). Interleukin-8 (IL-8)
   was measured by standard ELISA techniques. DEHP significantly increased
   from 34.3 mu M (+/-20.0 SD) on day 1 to 433.2 mu M (+/-131.2 SD) on day
   42, a 12.6-fold increase. Similarly, MEHP significantly increased from
   3.7 mu M (+/-2.8 SD) on day I to 74.0 mu M (+/-19.1 SD) on day 42, a
   20.2-fold increase. Also, DEHP and MEHP increased the release of IL-8
   from human umbilical vein endothelial cells (HUVEC). The transfusion of
   older units of PRBC could lead to an accumulation of PE's possibly
   resulting in inflammation and other effects. This accumulation could be
   exacerbated due to the decreased metabolism of PE's since trauma
   patients have a lower esterase activity, the enzymes responsible for
   metabolizing PE's. The effect of oxidative stress caused by PE's is
   discussed as a potential mechanism for increases in inflammation caused
   by older units of PRBC.}},
Publisher = {{LANDES BIOSCIENCE}},
Address = {{1002 WEST AVENUE, 2ND FLOOR, AUSTIN, TX 78701 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Bar-Or, D (Reprint Author), Swedish Med Ctr, Trauma Res Lab, 501 E Hampden Ave Rm 4-454, Englewood, CO 80113 USA.
   Rael, Leonard T.; Bar-Or, Raphael; Bar-Or, David, Swedish Med Ctr, Trauma Res Lab, Englewood, CO 80113 USA.
   Ambruso, Daniel R., Bonfils Blood Ctr, Denver, CO USA.
   Mains, Charles W., St Anthonoy Cent Hosp, Trauma Serv, Denver, CO USA.
   Slone, Denetta S., Swedish Med Ctr, Trauma Serv, Englewood, CO 80110 USA.
   Craun, Michael L., Scott \& White Mem Hosp \& Clin, Trauma Serv, Temple, TX 76508 USA.
   Bar-Or, David, Swedish Med Ctr, Emergency Dept, Englewood, CO 80110 USA.}},
ISSN = {{1942-0900}},
Keywords = {{packed red blood cells; plasticizers; inflammation; blood transfusion;
   endothelial cells; oxidative stress; trauma}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS;
   PPAR-ALPHA; IL-8; HEMODIALYSIS; PRODUCTS; BINDING; LIVER; SERUM}},
Research-Areas = {{Cell Biology}},
Web-of-Science-Categories  = {{Cell Biology}},
Author-Email = {{dbaror@dmibio.com}},
Cited-References = {{Bar-Or D, 2005, CRIT CARE MED, V33, P1638, DOI 10.1097/01.CCM.0000169876.14858.91.
   CHU I, 1978, DRUG METAB DISPOS, V6, P146.
   DIRVEN HAAM, 1990, TOXICOLOGY, V65, P199, DOI 10.1016/0300-483X(90)90089-Y.
   GRIFFITHS WC, 1988, ENVIRON HEALTH PERSP, V77, P151, DOI 10.2307/3430640.
   Hillman RS, 2005, HEMATOLOGY CLIN PRAC.
   Hong YC, 2009, TOXICOL LETT, V184, P139, DOI 10.1016/j.toxlet.2008.11.001.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019.
   Jepsen KF, 2004, TOXICOL IN VITRO, V18, P265, DOI 10.1016/j.tiv.2003.09.008.
   Jozkowicz A, 2008, ANTIOXID REDOX SIGN, V10, P2035, DOI 10.1089/ars.2008.2032.
   Kambia K, 2001, INT J PHARM, V229, P139, DOI 10.1016/S0378-5173(01)00840-7.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Larsen ST, 2007, TOXICOL LETT, V170, P223, DOI 10.1016/j.toxlet.2007.03.009.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   Rael LT, 2009, J TRAUMA, V66, P76, DOI 10.1097/TA.0b013e318191bfe0.
   Rael LT, 2007, BIOCHEM BIOPH RES CO, V357, P543, DOI 10.1016/j.bbrc.2007.03.182.
   Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078.
   ROCK G, 1986, ENVIRON HEALTH PERSP, V65, P309, DOI 10.2307/3430198.
   ROCK G, 1984, TRANSFUSION, V24, P493, DOI 10.1046/j.1537-2995.1984.24685066808.x.
   Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065.
   Seo KW, 2004, FOOD CHEM TOXICOL, V42, P107, DOI 10.1016/j.fct.2003.08.010.
   Silliman CC, 1998, J CLIN INVEST, V101, P1458, DOI 10.1172/JCI1841.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{9}},
Journal-ISO = {{Oxidative Med. Cell. Longev.}},
Doc-Delivery-Number = {{521CY}},
Wos-Id = {{ISI:000271898400008}},
}

@article{ ISI:000265581800004,
Author = {Lin, Han and Lian, Qing-Quan and Hu, Guo-Xin and Jin, Yuan and Zhang,
   Yunhui and Hardy, Dianne O. and Chen, Guo-Rong and Lu, Zhong-Qiu and
   Sottas, Chantal M. and Hardy, Matthew P. and Ge, Ren-Shan},
Title = {{In Utero and Lactational Exposures to Diethylhexyl-Phthalate Affect Two
   Populations of Leydig Cells in Male Long-Evans Rats}},
Journal = {{BIOLOGY OF REPRODUCTION}},
Year = {{2009}},
Volume = {{80}},
Number = {{5}},
Pages = {{882-888}},
Month = {{MAY}},
Abstract = {{Diethylhexylphthalate (DEHP) has been classified as an antiandrogen.
   However, whether in utero and lactational exposures of DEHP affect
   Leydig cells has not been well established. In the present study, the
   effects of DEHP exposures on fetal Leydig cells (FLCs) and adult Leydig
   cells (ALCs) were assessed. Pregnant dams of Long-Evans rats were
   treated with 0, 10, and 750 mg/kg body weight DEHP from Gestational Day
   12.5 to Postnatal Day (PND) 21.5. Fetal Leydig cell clustering and
   FLC-specific gene expression were examined. Anogenital distances (AGDs)
   of male pups were assessed at PND 2. Serum testosterone levels of male
   pups and mRNA levels of ALC-specific genes were measured at PNDs 21 and
   49. The AGDs of male pups were significantly shorter in the group
   treated with 750 mg/kg DEHP (mean +/- SEM, 3.68 +/- 0.16 mm) compared
   with control (4.62 +/- 0.13 mm). The FLCs were aggregated after 10 and
   750 mg/kg DEHP exposures. Several FLC-specific genes, including
   luteinizing hormone receptor (Lhcgr) and steroidogenic enzyme genes,
   were downregulated at both doses. Serum testosterone levels were
   significantly lower compared with control at PND 21 after treatment of
   10 or 750 mg/kg DEHP, and continued to be lower even up to 49 days
   postpartum at the higher dose. The mRNA levels for Lhcgr and
   steroidogenic enzyme genes were significantly lower at both doses of
   DEHP at PND 21, whereas there were no significant differences for these
   genes at PND 49. In conclusion, in utero and continued lactational
   exposures to DEHP exert long-term disruption of steroidogenesis of ALCs.}},
Publisher = {{SOC STUDY REPRODUCTION}},
Address = {{1603 MONROE ST, MADISON, WI 53711-2021 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ge, RS (Reprint Author), Populat Council, 1230 York Ave, New York, NY 10065 USA.
   Lin, Han; Zhang, Yunhui; Hardy, Dianne O.; Sottas, Chantal M.; Hardy, Matthew P.; Ge, Ren-Shan, Populat Council, New York, NY 10065 USA.
   Lin, Han; Zhang, Yunhui; Hardy, Dianne O.; Sottas, Chantal M.; Hardy, Matthew P.; Ge, Ren-Shan, Rockefeller Univ, New York, NY 10021 USA.
   Lin, Han; Lian, Qing-Quan; Jin, Yuan; Ge, Ren-Shan, 2nd Affiliated Hosp, Dept Anesthesiol, Wenzhou, Peoples R China.
   Chen, Guo-Rong; Lu, Zhong-Qiu, Affiliated Hosp 1, Dept Pathol, Wenzhou, Peoples R China.
   Hu, Guo-Xin, Wenzhou Med Coll, Sch Pharm, Dept Pharmacol, Wenzhou, Peoples R China.}},
DOI = {{10.1095/biolreprod.108.072975}},
ISSN = {{0006-3363}},
Keywords = {{diethylhexyl-phthalate; Leydig cells; luteinizing hormone;
   steroidogenesis; toxicology}},
Keywords-Plus = {{N-BUTYL PHTHALATE; MALE REPRODUCTIVE HEALTH; DI(N-BUTYL) PHTHALATE;
   TESTICULAR DYSGENESIS; TESTOSTERONE PRODUCTION; DIMETHANE SULFONATE;
   TESTIS; FETAL; EXPRESSION; DI(2-ETHYLHEXYL)PHTHALATE}},
Research-Areas = {{Reproductive Biology}},
Web-of-Science-Categories  = {{Reproductive Biology}},
Author-Email = {{rge@popcbr.rockefeller.edu}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences {[}R01 ES10233]}},
Funding-Text = {{Supported in part by National Institute of Environmental Health Sciences
   grant R01 ES10233 to M. P. H. and R.-S.G.}},
Cited-References = {{Adham IM, 2000, MOL CELL ENDOCRINOL, V160, P11, DOI 10.1016/S0303-7207(99)00188-4.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Akingbemi BT, 2001, ANN MED, V33, P391, DOI 10.3109/07853890108995952.
   Akingbemi BT, 2000, BIOL REPROD, V62, P571, DOI 10.1095/biolreprod62.3.571.
   Andrade AJM, 2006, TOXICOLOGY, V228, P85, DOI 10.1016/j.tox.2006.08.020.
   Barlow NJ, 2004, TOXICOL PATHOL, V32, P79, DOI 10.1080/01926230490265894.
   Culty M, 2008, BIOL REPROD, V78, P1018, DOI 10.1095/biolreprod.107.065649.
   Ema M, 1998, TOXICOL LETT, V98, P87, DOI 10.1016/S0378-4274(98)00107-6.
   Emmen JMA, 2000, ENDOCRINOLOGY, V141, P846, DOI 10.1210/en.141.2.846.
   ESKOLA V, 1994, MOL CELL ENDOCRINOL, V102, P63, DOI 10.1016/0303-7207(94)90098-1.
   Ferrara D, 2006, ENDOCRINOLOGY, V147, P5352, DOI 10.1210/en.2006-0527.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Ge RS, 2007, REPROD TOXICOL, V23, P366, DOI 10.1016/j.reprotox.2006.12.006.
   Ge RS, 1998, ENDOCRINOLOGY, V139, P3787, DOI 10.1210/en.139.9.3787.
   Ge RS, 2007, J ANDROL, V28, P513, DOI 10.2164/jandrol.106.001909.
   GEORGIOU M, 1987, ENDOCRINOLOGY, V121, P1390.
   HABERT R, 1991, ARCH ANDROLOGY, V27, P65.
   Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6.
   HARDY MP, 1992, J EXP ZOOL, V261, P161, DOI 10.1002/jez.1402610207.
   HARDY MP, 1989, ENDOCRINOLOGY, V124, P762.
   HUHTANIEMI I, 1992, P SOC EXP BIOL MED, V201, P125.
   Ivell R, 2002, BIOL REPROD, V67, P699, DOI 10.1095/biolreprod.102.005199.
   Kobayashi K, 2006, IND HEALTH, V44, P652, DOI 10.2486/indhealth.44.652.
   Lin H, 2008, P NATL ACAD SCI USA, V105, P7218, DOI 10.1073/pnas.0709260105.
   Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671.
   Mahood IK, 2006, INT J ANDROL, V29, P148, DOI 10.1111/j.1365-2605.2005.00574.x.
   Mahood IK, 2007, ENVIRON HEALTH PERSP, V115, P55, DOI 10.1289/ehp.9366.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   McKinnell C, 2005, ENDOCRINOLOGY, V146, P4536, DOI 10.1210/en.2005-0676.
   Mendis-Handagama SMLC, 2007, REPRODUCTION, V133, P479, DOI 10.1530/REP-06-0238.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Reyes EM, 1997, J ANDROL, V18, P372.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   TenaSempere M, 1997, ENDOCRINOLOGY, V138, P3340, DOI 10.1210/en.138.8.3340.
   WARREN DW, 1984, ENDOCRINOLOGY, V114, P470.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   Yuen T, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e48.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{6}},
Journal-ISO = {{Biol. Reprod.}},
Doc-Delivery-Number = {{438UU}},
Wos-Id = {{ISI:000265581800004}},
}

@article{ ISI:000265479000017,
Author = {Keller, Bernd O. and Davidson, A. George F. and Innis, Sheila M.},
Title = {{Phthalate metabolites in urine of CF patients are associated with use of
   enteric-coated pancreatic enzymes}},
Journal = {{ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY}},
Year = {{2009}},
Volume = {{27}},
Number = {{3}},
Pages = {{424-427}},
Month = {{MAY}},
Abstract = {{In metabolomic studies using liquid chromatography mass spectrometry of
   urine from children with cystic fibrosis (CF), high levels of
   metabolites of low molecular weight phthalates were found. Phthalate
   metabolite excretion was explained by therapy with enteric-coated
   pancreatic enzyme replacements. Phthalate metabolite identity was
   confirmed by tandem mass spectrometry. Pancreatic insufficient CF
   children taking Cotazynn ECS (R), which is formulated with diethyl
   phthalate (DEP), had urinary metabolites of DEP. Children taking Creon
   (R), which has dibutyl phthalate (DEIP), excreted DBP metabolites. The
   estimated concentrations of free MEP were 2-3 orders of magnitude higher
   than reported from environmental phthalate exposure. Enteric-coated
   pancreatic enzymes can expose individuals with CF to incessant, high
   oral intakes of phthalates. Although adverse effects have neither been
   shown to be present nor absent, we raise the need to consider that
   individuals requiring life-long therapy with some current pancreatic
   enzyme replacements chronically ingest high amounts of phthalates. (C)
   2009 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Innis, SM (Reprint Author), Univ British Columbia, Nutr Res Program, Dept Paediat, Child \& Family Res Inst, 950 W 28th Ave, Vancouver, BC V5Z 4H4, Canada.
   Davidson, A. George F.; Innis, Sheila M., Univ British Columbia, Nutr Res Program, Dept Paediat, Child \& Family Res Inst, Vancouver, BC V5Z 4H4, Canada.
   Keller, Bernd O., Univ British Columbia, Dept Pathol \& Lab Med, Child \& Family Res Inst, Vancouver, BC V5Z 4H4, Canada.
   Davidson, A. George F., British Columbia Childrens Hosp, Cyst Fibrosis Clin, Vancouver, BC V6H 3V4, Canada.}},
DOI = {{10.1016/j.etap.2008.12.005}},
ISSN = {{1382-6689}},
Keywords = {{Cystic fibrosis; Enteric coating; Pancreatic enzymes; Phthalates}},
Keywords-Plus = {{MALE WISTAR RATS; CYSTIC-FIBROSIS; DIETHYL PHTHALATE; CHRONIC TOXICITY;
   HOMOCYSTEINE; EXPOSURE; CHILDREN; PLASMA; GLUTATHIONE; METHIONINE}},
Research-Areas = {{Environmental Sciences \& Ecology; Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{sinnis@interchange.ubc.ca}},
Funding-Acknowledgement = {{Cystic Fibrosis Foundation; Michael Smith Foundation for Health Research}},
Funding-Text = {{We acknowledge funding provided by a grant from the Cystic Fibrosis
   Foundation and a Research Unit Award from the Michael Smith Foundation
   for Health Research. We particularly thank Penny J. Slack for assistance
   with subject enrollment and data management. Vanessa McMahon also
   provided invaluable help with subject enrollment in the CF clinic.
   Funding for the mass spectrometric equipment is provided by the Canada
   Foundation for Innovation (CFI). BOK thanks the UBC Child \& Family
   Research Institute for an Establishment Award.}},
Cited-References = {{Centers for Disease Control and Prevention, 2005, 3 NAT REP HUM EXP EN.
   Domínguez-Muñoz J Enrique, 2007, Curr Gastroenterol Rep, V9, P116, DOI 10.1007/s11894-007-0005-4.
   Ferrone M, 2007, PHARMACOTHERAPY, V27, P910, DOI 10.1592/phco.27.6.910.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   HULTCRANTZ R, 1986, HEPATOLOGY, V6, P881, DOI 10.1002/hep.1840060513.
   Innis SM, 2008, ANNU REV NUTR, V28, P55, DOI 10.1146/annurev.nutr.27.061406.093625.
   Innis SM, 2007, AM J CLIN NUTR, V85, P702.
   Innis SM, 2003, J PEDIATR, V143, P351, DOI 10.1067/S0022-3476(03)00326-3.
   Innis SM, 2006, J NUTR, V136, P2226.
   Mapuskar K, 2007, PESTIC BIOCHEM PHYS, V87, P156, DOI 10.1016/j.pestbp.2006.07.005.
   Pereira C, 2006, REGUL TOXICOL PHARM, V45, P169, DOI 10.1016/j.yrtph.2006.04.006.
   Pereira C, 2007, ENVIRON TOXICOL PHAR, V23, P319, DOI 10.1016/j.etap.2006.12.005.
   Rosenfeld M, 2001, PEDIATR PULM, V32, P356, DOI 10.1002/ppul.1144.
   ROUM JH, 1993, J APPL PHYSIOL, V75, P2419.
   Sathyanarayana Sheela, 2008, Curr Probl Pediatr Adolesc Health Care, V38, P34, DOI 10.1016/j.cppeds.2007.11.001.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2007, ENVIRON SCI TECHNOL, V41, P7576, DOI 10.1021/es071142x.
   Wolff MS, 2007, ENVIRON HEALTH PERSP, V115, P116, DOI 10.1289/ehp.9488.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{3}},
Journal-ISO = {{Environ. Toxicol. Pharmacol.}},
Doc-Delivery-Number = {{437HZ}},
Wos-Id = {{ISI:000265479000017}},
}

@article{ ISI:000265621000011,
Author = {Meeker, John D. and Calafat, Antonia M. and Hauser, Russ},
Title = {{Urinary Metabolites of Di(2-ethylhexyl) Phthalate Are Associated With
   Decreased Steroid Hormone Levels in Adult Men}},
Journal = {{JOURNAL OF ANDROLOGY}},
Year = {{2009}},
Volume = {{30}},
Number = {{3}},
Pages = {{287-297}},
Month = {{MAY-JUN}},
Abstract = {{Experimental animal studies have demonstrated that exposure to some
   phthalates may be associated with altered endocrine function and adverse
   effects on male reproductive development and function, but human studies
   are limited. In the present study, urine and serum samples were
   collected from 425 men recruited through a US infertility clinic.
   Urinary concentrations of mono(2-ethylhexyl) phthalate (MEHP), the
   hydrolytic metabolite of di(2-ethylhexyl) phthalate (DEHP), and other
   phthalate monoester metabolites were measured, along with serum levels
   of testosterone, estradiol, sex hormone-binding globulin (SHBG),
   follicle-stimulating hormone, luteinizing hormone, inhibin B, and
   prolactin. Two oxidized urinary metabolites of DEHP were also measured
   in urine from 221 of the men. In multiple regression models adjusted for
   potential confounders, MEHP was inversely associated with testosterone,
   estradiol, and free androgen index (FAI). An interquartile range
   increase in MEHP was associated with 3.7\% (95\% confidence interval
   {[}CI], -6.8\% to -0.5\%) and 6.8\% (95\% Cl, -11.2\% to -2.4\%)
   declines in testosterone and estradiol, respectively, relative to the
   population median hormone levels. There was limited evidence for effect
   modification of the inverse association between MEHP and FAI by the
   proportion of DEHP metabolites in the urine measured as MEHP (MEHP\%),
   which is considered a phenotypic marker of less efficient metabolism of
   DEHP to its oxidized metabolites. Finally, the ratio of testosterone to
   estradiol was positively associated with MEHP (P = .07) and MEHP\% (P =
   .007), suggesting potential relationships with aromatase suppression. In
   conclusion, these results suggest that urinary metabolites of DEHP are
   inversely associated with circulating steroid hormone levels in adult
   men. However, additional research is needed to confirm these findings.}},
Publisher = {{AMER SOC ANDROLOGY, INC}},
Address = {{C/O ALLEN PRESS, INC PO BOX 368, LAWRENCE, KS 66044 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Meeker, JD (Reprint Author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, 6635 SPH Tower,109 S Observ St, Ann Arbor, MI 48109 USA.
   Meeker, John D., Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Atlanta, GA USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Hauser, Russ, Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv, Androl Lab, Boston, MA 02114 USA.
   Hauser, Russ, Massachusetts Gen Hosp, Vitro Fertilizat Unit, Boston, MA 02114 USA.}},
DOI = {{10.2164/jandrol.108.006403}},
ISSN = {{0196-3635}},
Keywords = {{Androgen; biomarker; endocrine; environment; human; estrogen; male
   reproduction; testosterone}},
Keywords-Plus = {{MALE REPRODUCTIVE-SYSTEM; RAT GRANULOSA-CELLS; MONO-(2-ETHYLHEXYL)
   PHTHALATE; QUANTITATIVE DETECTION; OXIDATIVE METABOLITES; TEMPORAL
   VARIABILITY; ESTRADIOL PRODUCTION; MALE-INFERTILITY; DNA-DAMAGE;
   IN-UTERO}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{meekerj@umich.edu}},
ResearcherID-Numbers = {{Perez , Claudio Alejandro/F-8310-2010}},
ORCID-Numbers = {{Perez , Claudio Alejandro/0000-0001-9688-184X}},
Funding-Acknowledgement = {{National Institute of Environmental Health Sciences (NIEHS) {[}ES009718,
   ES00002]; National Institutes of Health (NIH)}},
Funding-Text = {{Supported by grants ES009718 and ES00002 from the National Institute of
   Environmental Health Sciences (NIEHS), National Institutes of Health
   (NIH).}},
Cited-References = {{Andersson AM, 2007, J CLIN ENDOCR METAB, V92, P4696, DOI 10.1210/jc.2006-2633.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   BAIN J, 1988, FERTIL STERIL, V49, P123.
   Bjornerem A, 2006, J CLIN ENDOCR METAB, V91, P3798, DOI 10.1210/jc.2006-0866.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   Carreau S, 2006, MOL CELL ENDOCRINOL, V246, P65, DOI 10.1016/j.mce.2005.11.021.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   Corton JC, 1997, BIOCHIMIE, V79, P151, DOI 10.1016/S0300-9084(97)81508-8.
   David R. M., 2001, PATTYS TOXICOLOGY, P635.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Fleming LE, 1999, J OCCUP ENVIRON MED, V41, P279, DOI 10.1097/00043764-199904000-00010.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Ge RS, 2007, J ANDROL, V28, P513, DOI 10.2164/jandrol.106.001909.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hess RA, 1997, NATURE, V390, P509, DOI 10.1038/37352.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kim MM, 2003, RES HIGH EDUC, V44, P51, DOI 10.1023/A:1021365528640.
   KLEINBAUM DG, 1998, SELECTING BEST REGRE.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Liu PY, 2003, HUM REPROD UPDATE, V9, P9, DOI 10.1093/humupd/dmg002.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Meeker JD, 2008, J ANDROL, V29, P379, DOI 10.2164/jandrol.107.004416.
   Noda M, 2007, MOL CELL ENDOCRINOL, V274, P8, DOI 10.1016/j.mce.2007.05.004.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Pentikainen V, 2000, J CLIN ENDOCR METAB, V85, P2057, DOI 10.1210/jc.85.5.2057.
   Pflieger-Bruss S, 2004, ANDROLOGIA, V36, P337, DOI 10.1111/j.1439-0272.2004.00641.x.
   Grandjean P, 2006, INT J ANDROL, V29, P181, DOI 10.1111/j.1365-2605.2005.00679.x.
   Schiff JD, 2007, ENDOCRIN METAB CLIN, V36, P313, DOI 10.1016/j.ecl.2007.03.003.
   SCHRADER SM, 1993, J OCCUP ENVIRON MED, V35, P574, DOI 10.1097/00043764-199306000-00013.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   TEASS AW, 1998, NIOSH MANUAL ANAL ME, P52.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   Toft G, 2004, REPROD TOXICOL, V19, P5, DOI 10.1016/j.reprotox.2004.05.006.
   Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375.
   VERMEULEN A, 1992, J CLIN ENDOCR METAB, V74, P939, DOI 10.1210/jc.74.4.939.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.
   {*}ATSDR, 2001, TOX PROF DI N BUTYL.
   {*}CDC, 2008, NHANES 2003 2004 LAB.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{33}},
Journal-ISO = {{J. Androl.}},
Doc-Delivery-Number = {{439IO}},
Wos-Id = {{ISI:000265621000011}},
}

@article{ ISI:000265430100004,
Author = {Eveillard, Alexandre and Lasserre, Frederic and de Tayrac, Marie and
   Polizzi, Arnaud and Claus, Sandrine and Canlet, Cecile and
   Mselli-Lakhal, Laila and Gotardi, Gaelle and Paris, Alain and Guillou,
   Herve and Martin, Pascal G. P. and Pineau, Thierry},
Title = {{Identification of potential mechanisms of toxicity after
   di-(2-ethylhexyl)-phthalate (DEHP) adult exposure in the liver using a
   systems biology approach}},
Journal = {{TOXICOLOGY AND APPLIED PHARMACOLOGY}},
Year = {{2009}},
Volume = {{236}},
Number = {{3}},
Pages = {{282-292}},
Month = {{MAY 1}},
Abstract = {{Phthalates are industrial additives widely used as plasticizers. In
   addition to deleterious effects on male genital development. population
   studies have documented correlations between phthalates exposure and
   impacts on reproductive tract development and on the metabolic syndrome
   in male adults. In this work we investigated potential mechanisms
   underlying the impact of DEHP on adult mouse liver in vivo.
   A parallel analysis of hepatic transcript and metabolic profiles from
   adult mice exposed to varying DEHP doses was performed. Hepatic genes
   modulated by DEHP are predominantly PPAR alpha targets. However, the
   induction of prototypic cytochrome P450 genes strongly supports the
   activation of additional NR pathways, including Constitutive Androstane
   Receptor (CAR). Integration of transcriptomic and metabonomic profiles
   revealed a correlation between the impacts of DEHP on genes and
   metabolites related to heme synthesis and to the Rev-erb alpha pathway
   that senses endogenous heme level. We further confirmed the combined
   impact of DEHP on the hepatic expression of Alas1, a critical enzyme in
   heme synthesis and on the expression of Rev-erb alpha target genes
   involved in the cellular clock and in energy metabolism.
   This work shows that DEHP interferes with hepatic CAR and Rev-erb alpha
   pathways which are both involved in the control of metabolism. The
   identification of these new hepatic pathways targeted by DEHP could
   contribute to metabolic and endocrine disruption associated with
   phthalate exposure. Gene expression profiles performed on microdissected
   testis territories displayed a differential responsiveness to DEHR
   Altogether, this suggests that impacts of DEHP on adult organs,
   including testis, could be documented and deserve further
   investigations. (C) 2009 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Pineau, T (Reprint Author), INRA, Lab Pharmacol \& Toxicol, UR66, 180 Chemin Tournefeuille, F-31027 Toulouse 3, France.
   Eveillard, Alexandre; Lasserre, Frederic; Polizzi, Arnaud; Mselli-Lakhal, Laila; Guillou, Herve; Martin, Pascal G. P.; Pineau, Thierry, INRA, Lab Pharmacol \& Toxicol, UR66, F-31027 Toulouse 3, France.
   de Tayrac, Marie, Fac Med Rennes, CNRS UMR 6061, GFAS IFR140, Rennes, France.
   Claus, Sandrine, Univ London Imperial Coll Sci Technol \& Med, Div Surg Oncol, Reprod Biol \& Anaesthet Dept, London SW7 2AZ, England.
   Canlet, Cecile; Gotardi, Gaelle; Paris, Alain, INRA, Lan Xenobiot, UMR1089, F-31027 Toulouse 3, France.}},
DOI = {{10.1016/j.taap.2009.02.008}},
ISSN = {{0041-008X}},
Keywords = {{Rev-erb alpha; CAR; DEHP; Testis; Endocrine disruptor; Systems biology}},
Keywords-Plus = {{PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; REV-ERB-ALPHA;
   URINARY PHTHALATE METABOLITES; PPAR-ALPHA; WAIST CIRCUMFERENCE;
   ANOGENITAL DISTANCE; NMR-SPECTROSCOPY; MALE INFANTS; NUCLEAR}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{Thierry.Pineau@toulouse.inra.fr}},
ResearcherID-Numbers = {{Kransler, Kevin/A-9662-2009}},
Funding-Acknowledgement = {{ANR (PNRA-PlastImpact program); MESR}},
Funding-Text = {{We acknowledge the excellent technical assistance of Colette Betoulieres
   and Gerard Galy. We are grateful to Dr Talal Al Saati and Florence
   Capilla (Histopathology core facility of IFR30, Toulouse) for their help
   in laser-capture microdissection. We thank DrJean Mosser, Amandine
   Etcheverry and Regis Bouvet (Transcriptomic Facility, Ouest-Genopole,
   Rennes) for their advices concerning gene expression profiling. This
   work was supported by a grant from ANR (PNRA-PlastImpact program). A.E.
   was recipient of a fellowship from MESR.}},
Cited-References = {{Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887.
   Bylesjo M, 2007, PLANT J, V52, P1181, DOI 10.1111/j.1365-313X.2007.03293.x.
   Clodfelter KH, 2007, PHYSIOL GENOMICS, V31, P63, DOI 10.1152/physiolgenomics.00055.2007.
   Currie RA, 2005, TOXICOL SCI, V86, P453, DOI 10.1093/toxsci/kfi207.
   Dejean S, 2007, EURASIP J Bioinform Syst Biol, P70561.
   Dumas ME, 2002, ANAL CHEM, V74, P2261, DOI 10.1021/ac0156870.
   Fan LQ, 2004, TOXICOLOGY, V204, P109, DOI 10.1016/j.tox.2004.06.018.
   Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200.
   Goodwin B, 2002, ANNU REV PHARMACOL, V42, P1, DOI 10.1146/annurev.pharmtox.42.111901.111051.
   Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x.
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040.
   Hatch EE, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-27.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2008, INT J ANDROL, V31, P112, DOI 10.1111/j.1365-2605.2007.00844.x.
   Hurst CH, 2004, TOXICOL APPL PHARM, V199, P266, DOI 10.1016/j.taap.2003.11.028.
   Inoue K, 2002, CLIN CHIM ACTA, V325, P157, DOI 10.1016/S0009-8981(02)00291-7.
   Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019.
   Ito Y, 2008, PPAR RES, DOI 10.1155/2008/759716.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8.
   Kroetz DL, 1998, J BIOL CHEM, V273, P31581, DOI 10.1074/jbc.273.47.31581.
   Lapinskas PJ, 2005, TOXICOLOGY, V207, P149, DOI 10.1016/j.tox.2004.09.008.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638.
   Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Martin PGP, 2007, HEPATOLOGY, V45, P767, DOI 10.1002/hep.21510.
   Martin PGP, 2005, GENE EXPRESSION, V12, P177, DOI 10.3727/000000005783992098.
   Meeker JD, 2009, J ANDROL, V30, P287, DOI 10.2164/jandrol.108.006403.
   Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M51713200.
   Mnif W, 2007, TOXICOL LETT, V170, P19, DOI 10.1016/j.toxlet.2006.11.016.
   Modigh CM, 2002, SCAND J WORK ENV HEA, V28, P418.
   Moreau A, 2008, MOL PHARM, V5, P35, DOI 10.1021/mp700103m.
   NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004.
   Ohashi Atsushi, 2005, J Artif Organs, V8, P252, DOI 10.1007/s10047-005-0307-y.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5.
   Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1.
   Urbanczyk-Wochniak E, 2003, EMBO REP, V4, P989, DOI 10.1038/sj.embor.embor944.
   Wei P, 2000, NATURE, V407, P920.
   Wyde ME, 2005, TOXICOL SCI, V86, P281, DOI 10.1093/toxsci/kfi204.
   Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179.
   YUDKOFF M, 1981, METABOLISM, V30, P1096, DOI 10.1016/0026-0495(81)90054-8.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{16}},
Journal-ISO = {{Toxicol. Appl. Pharmacol.}},
Doc-Delivery-Number = {{436QQ}},
Wos-Id = {{ISI:000265430100004}},
}

@article{ ISI:000264634900012,
Author = {Adibi, Jennifer J. and Hauser, Russ and Williams, Paige L. and Whyatt,
   Robin M. and Calafat, Antonia M. and Nelson, Heather and Herrick, Robert
   and Swan, Shanna H.},
Title = {{Maternal Urinary Metabolites of Di-(2-Ethylhexyl) Phthalate in Relation
   to the Timing of Labor in a US Multicenter Pregnancy Cohort Study}},
Journal = {{AMERICAN JOURNAL OF EPIDEMIOLOGY}},
Year = {{2009}},
Volume = {{169}},
Number = {{8}},
Pages = {{1015-1024}},
Month = {{APR 15}},
Abstract = {{Di-(2-ethylhexyl) phthalate (DEHP) is a plasticizer used in consumer and
   medical products that can cross the placenta, disrupt steroid hormone
   synthesis, and activate peroxisome proliferator-activated receptor
   gamma. The authors examined DEHP exposure in relation to the timing of
   labor in a pregnancy cohort study of 283 women recruited in 4 US states
   (California, Iowa, Minnesota, and Missouri) between 2000 and 2004. The
   authors estimated associations between concentrations of DEHP
   metabolites and gestational age at delivery using linear regression
   models and associations between DEHP metabolites and clinical outcomes
   using logistic regression models. After covariate adjustment, women at
   the 75th percentile of DEHP metabolite concentrations had a 2-day-longer
   mean length of gestation than women at the 25th percentile (95\%
   confidence interval: 1.4, 3.3). Log-unit increases in mono-2-ethylhexyl
   phthalate and mono-2-ethyl-5-oxohexyl phthalate concentrations were
   associated with increased odds of cesarean section delivery (30\% and
   50\% increased odds, respectively), increased odds of delivering at 41
   weeks or later (100\% and 120\% increased odds), and reduced odds of
   preterm delivery (50\% and 60\% decreased odds). These data suggest that
   DEHP may interfere with signaling related to the timing of parturition.}},
Publisher = {{OXFORD UNIV PRESS INC}},
Address = {{JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Adibi, JJ (Reprint Author), Univ Calif San Francisco, Ctr Reprod Sci, Dept Obstet Gynecol \& Reprod Sci, 513 Parnassus Ave,Box 0556, San Francisco, CA 94143 USA.
   Adibi, Jennifer J.; Hauser, Russ; Nelson, Heather; Herrick, Robert, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Williams, Paige L., Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   Whyatt, Robin M., Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Swan, Shanna H., Univ Rochester, Med Ctr, Dept Obstet \& Gynecol, Rochester, NY 14642 USA.}},
DOI = {{10.1093/aje/kwp001}},
ISSN = {{0002-9262}},
Keywords = {{creatinine; diethylhexyl phthalate; endocrine disruptors; gestational
   age; parturition; placenta; PPAR gamma; pregnancy}},
Keywords-Plus = {{ACTIVATED-RECEPTOR-GAMMA; HUMAN EXPOSURE ASSESSMENT; SOLID-PHASE
   EXTRACTION; PPAR-GAMMA; MONO-(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL
   PHTHALATE; OXIDATIVE METABOLITES; POSTTERM DELIVERY; GRANULOSA-CELLS;
   HUMAN-PLACENTA}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{adibij@obgyn.ucsf.edu}},
Funding-Acknowledgement = {{Environmental Protection Agency {[}R-82943601-0]; National Institute of
   Environmental Health Sciences {[}R01 ES013543)]; Harvard Education and
   Research Center for Occupational Safety and Health {[}T42 OH008416]}},
Funding-Text = {{This research was funded by the Environmental Protection Agency ( Star
   Grant R-82943601-0) and the National Institute of Environmental Health
   Sciences ( grant R01 ES013543). Jennifer Adibi's doctoral training was
   funded by the Harvard Education and Research Center for Occupational
   Safety and Health ( grant T42 OH008416).}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Agency for Toxic Substances and Disease Registry, 2002, TOX PROF DI2 ETH PHT.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Ananth CV, 2007, PAEDIATR PERINAT EP, V21, P22, DOI 10.1111/j.1365-3016.2007.00858.x.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   Calafat AM, 2008, INT J ANDROL, V31, P139, DOI 10.1111/j.1365-2605.2007.00826.x.
   Cunningham F, 2005, WILLIAMS OBSTET.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Dietz PM, 2007, PAEDIATR PERINAT EP, V21, P62, DOI 10.1111/j.1365-3016.2007.00862.x.
   Dunn-Albanese LR, 2004, AM J OBSTET GYNECOL, V190, P809, DOI 10.1016/j.ajog2003.09.052.
   Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200.
   FOURNETDULGUEROV N, 1987, J CLIN ENDOCR METAB, V65, P757.
   Fournier T, 2007, PLACENTA, V28, P65, DOI 10.1016/j.placenta.2006.04.009.
   Froment P, 2006, J ENDOCRINOL, V189, P199, DOI 10.1677/joe.1.06667.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hediger ML, 2007, PAEDIATR PERINAT EP, V21, P1, DOI 10.1111/j.1365-3016.2007.00855.x.
   Hilder L, 1998, BRIT J OBSTET GYNAEC, V105, P169, DOI 10.1111/j.1471-0528.1998.tb10047.x.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2006, ANAL CHEM, V78, P6651, DOI 10.1021/ac0608220.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Kennare R, 2007, OBSTET GYNECOL, V109, P270, DOI 10.1097/01.AOG.0000250469.23047.73.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Lovekamp-Swan T, 2003, MOL CELL ENDOCRINOL, V201, P133, DOI 10.1016/S0303-7207(02)00423-9.
   Makrides M, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003402.PUB2.
   Mose T, 2007, REPROD TOXICOL, V23, P83, DOI 10.1016/j.reprotox.2006.08.006.
   National Center for Health Statistics Centers for Disease Control and Prevention, 2006, NAT HLTH NUTR EX SUR.
   Olesen AW, 2003, AM J OBSTET GYNECOL, V189, P222, DOI 10.1067/mob.2003.446.
   Olsen SF, 2007, EUR J CLIN NUTR, V61, P976, DOI 10.1038/sj.ejcn.1602609.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   POOLE CF, 1977, J CHROMATOGR, V132, P511, DOI 10.1016/S0021-9673(00)82915-5.
   Qin C, 2007, PAEDIATR PERINAT EP, V21, P41, DOI 10.1111/j.1365-3016.2007.00860.x.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601.
   Schaiff WT, 2006, MOL CELL ENDOCRINOL, V249, P10, DOI 10.1016/j.mce.2006.02.009.
   Schaiff WT, 2007, ENDOCRINOLOGY, V148, P3625, DOI 10.1210/en.2007-0211.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Schisterman EF, 2005, ENVIRON HEALTH PERSP, V113, P853, DOI 10.1289/ehp.7640.
   Shea KM, 1998, EPIDEMIOLOGY, V9, P199, DOI 10.1097/00001648-199803000-00017.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Szajewska H, 2006, AM J CLIN NUTR, V83, P1337.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   Xu Y, 2005, TOXICOL SCI, V84, P287, DOI 10.1093/toxsci/kfi083.
   {*}NAT CTR HLTH STAT, 2007, CONT NHANES WEB TUT.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{24}},
Journal-ISO = {{Am. J. Epidemiol.}},
Doc-Delivery-Number = {{425KH}},
Wos-Id = {{ISI:000264634900012}},
}

@article{ ISI:000263628200002,
Author = {Latini, Giuseppe and Wittassek, Matthias and Del Vecchio, Antonio and
   Presta, Giuseppe and De Felice, Claudio and Angerer, Jurgen},
Title = {{Lactational exposure to phthalates in Southern Italy}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2009}},
Volume = {{35}},
Number = {{2}},
Pages = {{236-239}},
Month = {{FEB}},
Abstract = {{Background: Phthalates, reproductive toxicants in animals, are synthetic
   chemicals with ubiquitous human exposures because of their extensive
   use, with potential detrimental health effects. Infants are considered
   to represent a population at increased risk, as they are exposed early
   in life to several different sources of exposure to phthalates.
   Objectives and methods: Little information exists on phthalate exposure
   through breast milk from different geographic areas. By means of a
   LC/LC-MS/MS method we tested the presence of several different phthalate
   metabolites in breast milk from 62 healthy mothers living in Southern
   Italy.
   Results: The simple monoesters mono-isobutyl phthalate (MiBP) (median
   18.8 mu g/1) and mono(2-ethylhexyl) phthalate (MEHP) (median 8.4 mu g/1)
   were present in all milk samples, whereas mono-n-butyl phthalate (MnBP)
   (median 1.5 mu g/1) and mono-benzyl phthalate (MBzP) (median <03 mu g/1)
   were found in 64.5\% and 43.5\% of the samples, respectively. Among the
   oxidative metabolites of DEHP and DiNP only
   mono(2-ethyl-5-carboxypentyl) phthalate (5cx-MEPP) and monoisononyl
   phthalate with one hydroxyl group (OH-MiNP) were detectable in one and
   13 samples (21\%), respectively.
   Conclusions: These findings indicate that exposure to phthalates through
   breast milk in Southern Italian infants is comparable to that of other
   countries, thus confirming that human milk may represent an additional
   potential source of phthalate exposure in a population at increased
   risk. However, different milk concentrations of MiBP may suggest a
   different pattern of usage of di-iso-butyl phthalate in Europe, as
   compared to USA, whereas for the first time, we detected an oxidative
   DiNP metabolite, whose significance remains unclear. (C) 2008 Elsevier
   Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Latini, G (Reprint Author), Perrino Hosp, Div Neonatol, SS 7 Mesagne, I-72100 Brindisi, Italy.
   Latini, Giuseppe; Del Vecchio, Antonio, Perrino Hosp, Div Neonatol, I-72100 Brindisi, Italy.
   Latini, Giuseppe, CNR, Inst Clin Physiol, IFC CNR, Pisa, Italy.
   Wittassek, Matthias; Angerer, Jurgen, Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, Erlangen, Germany.
   Presta, Giuseppe, Azienda Osped Cardinal Panico, Neonatal Intens Care Unit, Lecce, Italy.
   De Felice, Claudio, Azienda Osped Univ Senese, Neonatal Intens Care Unit, Siena, Italy.}},
DOI = {{10.1016/j.envint.2008.06.002}},
ISSN = {{0160-4120}},
Keywords = {{Breast milk; Phthalates; Environmental hazards; Lactational exposure}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; HUMAN BREAST-MILK; POLYBROMINATED DIPHENYL
   ETHERS; DEUTERIUM-LABELED DEHP; INTENSIVE-CARE-UNIT; FETAL-RAT TESTIS;
   HUMAN URINE; DI(2-ETHYLHEXYL)PHTHALATE DEHP; IN-UTERO; DI-(2-ETHYLHEXYL)
   PHTHALATE}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{gilatini@tin.it}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   Dalsenter PR, 2006, HUM EXP TOXICOL, V25, P297, DOI 10.1191/0960327105ht624oa.
   ECB, 2004, EUR UN RISK ASS REP.
   European Chemicals Bureau European Chemicals Bureau (ECB), 2004, R0420402ENVHH46 ECB.
   FDA. US Food and Drug Administration, 2001, SAF ASS DI 2 ETH PHT.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   FREDRICSSON B, 1993, PHARMACOL TOXICOL, V72, P128.
   FURUYA S, 1978, ARCH ANDROLOGY, V1, P211.
   Grande SW, 2006, TOXICOL SCI, V91, P247, DOI 10.1093/toxsci/kfj128.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Hoyer PB, 2001, BIOCHEM PHARMACOL, V62, P1557, DOI 10.1016/S0006-2952(01)00814-0.
   Johnson-Restrepo B, 2007, J ENVIRON MONITOR, V9, P1205, DOI 10.1039/b711409p.
   Jorissen Joanne, 2007, Adv Neonatal Care, V7, P230.
   Kalantzi OI, 2004, ENVIRON HEALTH PERSP, V112, P1085, DOI 10.1289/ehp.6991.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Kunisue Tatsuya, 2007, Environ Int, V33, P1048, DOI 10.1016/j.envint.2007.06.006.
   Latini G, 2004, REPROD TOXICOL, V19, P27, DOI 10.1016/j.reprotox.2004.05.011.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Latini G, 2006, TOXICOLOGY, V226, P90, DOI 10.1016/j.tox.2006.07.011.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   Needham LL, 2002, J TOXICOL ENV HEAL A, V65, P1893, DOI 10.1080/00984100290071784.
   Nickerson K, 2006, J MIDWIFERY WOM HEAL, V51, P26, DOI 10.1016/j.jmwh.2005.09.006.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Rossi DT, 1997, J PHARMACEUT BIOMED, V15, P495, DOI 10.1016/S0731-7085(96)01880-8.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wittassek M, 2008, INT J ANDROL, V31, P131, DOI 10.1111/j.1365-2605.2007.00837.x.
   Wong JS, 2002, TOXICOL APPL PHARM, V185, P180, DOI 10.1006/taap.2002.9540.
   Zhu JP, 2006, ENVIRON SCI TECHNOL, V40, P5276, DOI 10.1021/es060356w.
   {*}ECB, 2006, R3180601ENVHH ECB EU.
   2003, EUROPEAN UN IN PRESS.}},
Number-of-Cited-References = {{53}},
Times-Cited = {{23}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{411DM}},
Wos-Id = {{ISI:000263628200002}},
}

@article{ ISI:000263628200018,
Author = {Berman, Tamar and Hochner-Celnikier, Drorit and Calafat, Antonia M. and
   Needham, Larry L. and Amitai, Yona and Wormser, Uri and Richter, Elihu},
Title = {{Phthalate exposure among pregnant women in Jerusalem, Israel: Results of
   a pilot study}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2009}},
Volume = {{35}},
Number = {{2}},
Pages = {{353-357}},
Month = {{FEB}},
Abstract = {{Background: Phthalates can disrupt endocrine function and induce
   reproductive and developmental toxicity in laboratory animals. Few
   studies have evaluated exposure to phthalates in pregnant women, despite
   the potential sensitivity of the developing fetus to adverse effects of
   phthalates.
   Methods: We measured urinary concentrations of 11 phthalate metabolites
   in 19 pregnant women, recruited in Jerusalem, Israel in 2006, and
   collected questionnaire data on demographic factors and consumer habits
   from these women. We compared geometric mean concentrations in subgroups
   and used the Mann-Whitney U-test for independent samples to determine
   significant differences between groups.
   Results: Nine metabolites were detected in at least 95\% of the samples:
   mono(2-ethyl-5-carboxypentyl) phthalate, mono(2-ethyl-5-hydroxyhexyl)
   phthalate, mono(2-ethyl-5-oxohexyl) phthalate, mono(3-carboxypropyl)
   phthalate, mono(n-butyl) phthalate, monobenzyl phthalate (MBzP),
   monoethyl phthalate (MEP), mono(2-ethylhexyl) phthalate and monoisobutyl
   phthalate. Phthalate metabolite concentrations in these pregnant women
   were remarkably similar to those in the general United States female
   population. MBzP geometric mean concentrations were higher in women
   living in buildings existing 40 years or more (P=0.04). In women who
   used four or more personal care products (perfume, deodorant lipstick,
   nail polish, or hand/face cream) in the 48 h prior to providing the
   urine sample, geometric mean MEP concentrations were more than 4 times
   higher than concentrations in women using only two or three of the
   aforementioned products (P=0.07).
   Conclusions: Pregnant women in Jerusalem are exposed to a wide range of
   phthalates. Building materials used in old constructions may be a source
   of exposure to benzylbutyl phthalate, the parent compound of MBzP.
   Personal care products may be sources of exposure to diethyl phthalate,
   the parent compound of MER (C) 2008 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Berman, T (Reprint Author), Hebrew Univ Jerusalem, Dept Pharmacol, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel.
   Berman, Tamar; Wormser, Uri, Hebrew Univ Jerusalem, Dept Pharmacol, Sch Pharm, Fac Med, IL-91120 Jerusalem, Israel.
   Hochner-Celnikier, Drorit, Hadassah Hosp Mt Scopus, Dept Obstet \& Gynecol, Jerusalem, Israel.
   Calafat, Antonia M.; Needham, Larry L., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Richter, Elihu, Hadassah Sch Publ Hlth \& Community Med, Jerusalem, Israel.}},
DOI = {{10.1016/j.envint.2008.08.010}},
ISSN = {{0160-4120}},
Keywords = {{Biomonitoring; Exposure; Phthalates; Pregnancy; Urinary metabolites}},
Keywords-Plus = {{NURSERY-SCHOOL CHILDREN; INTERNAL EXPOSURE; METABOLITES; URINE;
   MONOESTERS; DEHP; CONTAMINATION; POPULATION; TEACHERS; HORMONES}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{tamar.berman@mail.huji.ac.il}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{ADIBI JJ, 2008, ENV HLTH PERSPECT, DOI DOI 10.1289/EHP.10749.
   Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Centers for Disease Control and Prevention, 2005, 3 NAT REP HUM EXP EN.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   HOGBERG J, 2007, ENV HLTH PERSPECT, DOI DOI 10.1289/EHP.10788.
   Houlihan J., 2002, NOT TOO PRETTY PHTHA.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   MUSE T, 2007, REPROD TOXICOL, V23, P83.
   MUSZKAT L, 1993, WATER SCI TECHNOL, V27, P203.
   Muszkat L, 1997, B ENVIRON CONTAM TOX, V58, P348, DOI 10.1007/s001289900341.
   PANKRATOV I, 2005, GEOL SOC AM ANN M 16.
   SATHYANARAYANA S, 2008, PEDIATRICS, V21, pE260.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Zhu JP, 2006, ENVIRON SCI TECHNOL, V40, P5276, DOI 10.1021/es060356w.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{29}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{411DM}},
Wos-Id = {{ISI:000263628200018}},
}

@article{ ISI:000262970700025,
Author = {Hernandez-Diaz, Sonia and Mitchell, Allen A. and Kelley, Katherine E.
   and Calafat, Antonia M. and Hauser, Russ},
Title = {{Medications as a Potential Source of Exposure to Phthalates in the US
   Population}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2009}},
Volume = {{117}},
Number = {{2}},
Pages = {{185-189}},
Month = {{FEB}},
Abstract = {{BACKGROUND: Widespread human exposure to phthalates, some of which are
   developmental and reproductive toxicants in experimental animals, raises
   concerns about potential human health risks. Underappreciated sources of
   exposure include phthalates in the polymers coating some oral
   medications.
   OBJECTIVE: The objective of this study was to evaluate whether users of
   phthalate-containing medications have higher urinary concentrations of
   phthalate metabolites than do nonusers.
   METHODS: We used publically available files from the National Health and
   Nutrition Examination Survey for the years 1999-2004. For certain survey
   periods, participants were asked to recall use of prescription
   medication during the past 30 days, and for a subsample of individuals,
   the urinary concentrations of phthalate metabolites were measured. We a
   priori identified medications potentially containing phthalates as
   inactive ingredients and then compared the mean urinary concentration of
   phthalate metabolites between users and nonusers of those medications.
   RESULTS: Of the 7,999 persons with information on urinary phthalate
   concentrations, 6 reported using mesalamine formulations, some of which
   may include dibutyl phthalate (DBP); the mean urinary concentration of
   monobutyl phthalate, the main DBP metabolite, among these mesalamine
   users was 50 times higher than the mean for nonusers (2,257 mu g/L vs.
   46 mu g/L; p < 0.0001). Users of didanosine, omeprazole, and
   theophylline products, some of which may contain diethyl phthalate
   (DEP), had mean urinary concentrations of monoethyl phthalate, the main
   DEP metabolite, significantly higher than the mean for nonusers.
   CONCLUSION: Select medications might be a source of high exposure to
   some phthalates, one of which, DBP, shows adverse developmental and
   reproductive effects in laboratory animals. These results raise concern
   about potential human health risks, specifically among vulnerable
   segments of the general population and particularly pregnant women and
   children.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hernandez-Diaz, S (Reprint Author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Pharmacoepidemiol Program, Boston, MA 02115 USA.
   Hernandez-Diaz, Sonia, Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Pharmacoepidemiol Program, Boston, MA 02115 USA.
   Mitchell, Allen A.; Kelley, Katherine E., Boston Univ, Slone Epidemiol Ctr, Boston, MA 02215 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth Occupat \& Environm Med, Boston, MA 02115 USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth, Program Epidemiol, Boston, MA 02115 USA.}},
DOI = {{10.1289/ehp.11766}},
ISSN = {{0091-6765}},
Keywords = {{coating; didanosine; medications; mesalamine; omeprazole; phthalates;
   theophylline}},
Keywords-Plus = {{DIETHYLHEXYL PHTHALATE; SEXUAL-DIFFERENTIATION; ANOGENITAL DISTANCE;
   MALE INFANTS; HUMAN URINE; MALE-RAT; METABOLITES}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{shernan@hsph.harvard.edu}},
Funding-Acknowledgement = {{Harvard's National Institute of Environmental Health Sciences Center in
   Environmental Health {[}ES00002];  {[}ES009718];  {[}OH008578]}},
Funding-Text = {{This work was Supported by a pilot project grant from Harvard's National
   Institute of Environmental Health Sciences Center in Environmental
   Health (ES00002) and by grants ES009718 and OH008578.}},
Cited-References = {{Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   CDC, 2005, 3 CDCP NAT CTR ENV H.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch H, 2005, UMWELTMED FORSCH PRA, V10, P144.
   Koch H.M., 2003, INT J HYG ENVIR HEAL, V206, P1.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   McDowell A, 1981, VITAL HLTH STAT, V1, P1.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Saillenfait AM, 1998, TOXICOL SCI, V45, P212, DOI 10.1093/toxsci/45.2.212.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   THOMSON PDR, 2006, 2006 RED BOOK PHARM, P40.
   {*}AG TOX SUBST DIS, 2001, DI N BUTYL PHTHAL.
   {[}Anonymous], 2008, NAT HLTH NUTR EX SUR.
   {*}NCHS, 2007, CONT NHANES WEB TUT.
   {*}NCHS, 1994, VITAL HLTH STAT, V1, P1.
   {*}NHANES, 2005, NHANES 1999 2000 DAT.
   {*}NHANES, 2008, DAT SETS REL DOC.
   {*}US EPA, 2008, 84742 CASRN US EPA.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{28}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{401VO}},
Wos-Id = {{ISI:000262970700025}},
}

@article{ ISI:000262798100012,
Author = {Clewell, Rebecca A. and Kremer, John J. and Williams, Carla C. and
   Campbell, Jerry L. and Sochaski, Mark A. and Andersen, Melvin E. and
   Borghoff, Susan J.},
Title = {{Kinetics of selected di-n-butyl phthalate metabolites and fetal
   testosterone following repeated and single administration in pregnant
   rats}},
Journal = {{TOXICOLOGY}},
Year = {{2009}},
Volume = {{255}},
Number = {{1-2}},
Pages = {{80-90}},
Month = {{JAN 8}},
Abstract = {{Human exposure to phthalic acid diesters occurs through a variety of
   pathways as a result of their widespread use in consumer products and
   plastics. Repeated doses of di-n-butyl phthalate (DBP) from gestation
   day (GD) 12 to 19 disrupt testosterone synthesis and male sexual
   development in the fetal rat. Currently little is known about the
   disposition of DBP metabolites, such as monobutyl phthalate (MBP) and
   its glucuronide conjugate (MBP-G), during gestation after repeated
   exposure to DBP. In order to gain a better understanding of the effect
   of repeated dosing on maternal and fetal metabolism and distribution,
   pregnant Sprague-Dawley rats were given a single dose of 500 mg/kg DBP
   on GD 19 or daily doses of 50, 100, and 500 mg/(kg day) from GD 12 to 19
   via corn oil gavage. Dose-response evaluation revealed a nonlinear
   increase in maternal and fetal plasma concentrations of MBP. Maternal
   and fetal MBP levels were slightly lower in animals after 8 days of
   dosing at 500 mg/(kg day). Fetal plasma MBP levels closely followed
   maternal plasma, while the appearance and elimination of MBP-G in fetal
   plasma were significantly delayed. MBP-G accumulated over time in the
   amniotic fluid. Inhibition of testosterone was rapid in fetal testes
   when exposed to DBP (500 mg/(kg day)) on GD 19. Within 24 h, the level
   of inhibition in the fetus was similar between animals exposed to a
   single or multiple daily doses of 500 mg/(kg day). Examination of
   testosterone time-course data indicates a rapid recovery to normal
   levels within 24 h post-dosing at DBP doses of 50 and 100 mg/(kg day),
   with a rebound to higher than normal concentrations at later
   time-points. MBP kinetics in fetal testes allows direct comparison of
   active metabolite concentrations and testosterone response in the fetal
   testes. (C) 2008 Elsevier Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Clewell, RA (Reprint Author), Hamner Inst Hlth Sci, 6 Davis Dr, Res Triangle Pk, NC 27709 USA.
   Clewell, Rebecca A.; Kremer, John J.; Williams, Carla C.; Campbell, Jerry L.; Sochaski, Mark A.; Andersen, Melvin E.; Borghoff, Susan J., Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA.
   Clewell, Rebecca A., Univ N Carolina, Chapel Hill, NC 27599 USA.}},
DOI = {{10.1016/j.tox.2008.10.010}},
ISSN = {{0300-483X}},
Keywords = {{Phthalate; DBP; Testosterone; Gestation; Kinetics}},
Keywords-Plus = {{MALE REPRODUCTIVE DEVELOPMENT; DOSE-DEPENDENT ALTERATIONS; IN-UTERO
   EXPOSURE; DI(N-BUTYL) PHTHALATE; DI(2-ETHYLHEXYL) PHTHALATE;
   SEXUAL-DIFFERENTIATION; DI-(2-ETHYLHEXYL) PHTHALATE; DEVELOPMENTAL
   TOXICITY; DIETHYLHEXYL PHTHALATE; TESTICULAR DYSGENESIS}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{rclewell@thehamner.org}},
Funding-Acknowledgement = {{Long-Range Research Initiative of the American Chemistry Council
   (ACC-LRI); National Institute of Environmental Health Sciences (NIEHS)
   through a Ruth L. Kirschstein National Research Service Award (NRSA)}},
Funding-Text = {{The authors express their gratitude to the Animal Care and Necropsy
   staff at The Hamner Institutes and to Dr. Bruce Allen for assistance
   with statistical analyses. This study was funded by the Long-Range
   Research Initiative of the American Chemistry Council (ACC-LRI) and the
   National Institute of Environmental Health Sciences (NIEHS) through a
   Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral
   Fellowship (JJK).}},
Cited-References = {{Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   Ema M, 1998, TOXICOL LETT, V98, P87, DOI 10.1016/S0378-4274(98)00107-6.
   Ema M, 2000, TOXICOL LETT, V111, P271, DOI 10.1016/S0378-4274(99)00192-7.
   Fennell TR, 2004, TOXICOL SCI, V82, P407, DOI 10.1093/toxsci/kfh294.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   FOSTER PM, 1982, DRUG METAB DISPOS, V11, P59.
   FURUTA T, 1990, J CHROMATOGR-BIOMED, V525, P15, DOI 10.1016/S0378-4347(00)83376-9.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   HABERT R, 1984, J STEROID BIOCHEM, V21, P193, DOI 10.1016/0022-4731(84)90383-2.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Kessler W, 2004, TOXICOL APPL PHARM, V195, P142, DOI 10.1016/j.taap.2003.11.014.
   Kim HS, 2004, J TOXICOL ENV HEAL A, V67, P2045, DOI 10.1080/15287390490514859.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Kremer JJ, 2005, TOXICOL LETT, V159, P144, DOI 10.1016/j.toxlet.2005.05.006.
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169.
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   OISHI S, 1980, TOXICOL LETT, V6, P239.
   OKITA JR, 1993, J BIOCHEM TOXICOL, V8, P135, DOI 10.1002/jbt.2570080305.
   OKITA RT, 1992, PHARMACEUT RES, V9, P1648, DOI 10.1023/A:1015837113683.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Payan JP, 2001, DRUG METAB DISPOS, V29, P843.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P246, DOI 10.1016/0041-008X(85)90346-1.
   Saillenfait AM, 1998, TOXICOL SCI, V45, P212, DOI 10.1093/toxsci/45.2.212.
   Seo KW, 2004, FOOD CHEM TOXICOL, V42, P107, DOI 10.1016/j.fct.2003.08.010.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   SJOBERG P, 1985, ARCH TOXICOL, V58, P78, DOI 10.1007/BF00348313.
   TANAKA A, 1978, TOXICOLOGY, V9, P109, DOI 10.1016/0300-483X(78)90036-7.
   TEIRLYNCK OA, 1985, ARCH TOXICOL, V57, P226, DOI 10.1007/BF00324782.
   WHITE RD, 1980, FOOD COSMET TOXICOL, V18, P383, DOI 10.1016/0015-6264(80)90194-7.
   WISHART GJ, 1978, BIOCHEM J, V174, P485.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Wyde ME, 2005, TOXICOL SCI, V86, P281, DOI 10.1093/toxsci/kfi204.
   {*}AG TOX DIS REG, 2001, TOX PROF DI N BUTYL.
   {*}NIEHS, 1994, PREST TOX STUD REP D.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{12}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{399KF}},
Wos-Id = {{ISI:000262798100012}},
}

@article{ ISI:000262329300001,
Author = {Hines, Cynthia J. and Hopf, Nancy B. Nilsen and Deddens, James A. and
   Calafat, Antonia M. and Silva, Manori J. and Grote, Ardith A. and
   Sammons, Deborah L.},
Title = {{Urinary Phthalate Metabolite Concentrations among Workers in Selected
   Industries: A Pilot Biomonitoring Study}},
Journal = {{ANNALS OF OCCUPATIONAL HYGIENE}},
Year = {{2009}},
Volume = {{53}},
Number = {{1}},
Pages = {{1-17}},
Month = {{JAN}},
Abstract = {{Phthalates are used as plasticizers and solvents in industrial, medical
   and consumer products; however, occupational exposure information is
   limited. We sought to obtain preliminary information on occupational
   exposures to diethyl phthalate (DEP), di-n-butyl phthalate (DBP) and
   di(2-ethylhexyl) phthalate (DEHP) by analyzing for their metabolites in
   urine samples collected from workers in a cross-section of industries.
   We also obtained data on metabolites of dimethyl phthalate (DMP),
   benzylbutyl phthalate (BzBP), di-isobutyl phthalate and di-isononyl
   phthalate. We recruited 156 workers in 2003-2005 from eight industry
   sectors. We assessed occupational contribution by comparing end-shift
   metabolite concentrations to the US general population. Evidence of
   occupational exposure to DEHP was strongest in polyvinyl chloride (PVC)
   film manufacturing, PVC compounding and rubber boot manufacturing where
   geometric mean (GM) end-shift concentrations of DEHP metabolites
   exceeded general population levels by 8-, 6- and 3-fold, respectively.
   Occupational exposure to DBP was most evident in rubber gasket,
   phthalate (raw material) and rubber hose manufacturing, with DBP
   metabolite concentrations exceeding general population levels by 26-,
   25- and 10-fold, respectively, whereas DBP exposure in nail-only salons
   (manicurists) was only 2-fold higher than in the general population.
   Concentrations of DEP and DMP metabolites in phthalate manufacturing
   exceeded general population levels by 4- and > 1000-fold, respectively.
   We also found instances where GM end-shift concentrations of some
   metabolites exceeded general population concentrations even when no
   workplace use was reported, e.g. BzBP in rubber hose and rubber boot
   manufacturing. In summary, using urinary metabolites, we successfully
   identified workplaces with likely occupational phthalate exposure.
   Additional work is needed to distinguish occupational from
   non-occupational sources in low-exposure workplaces.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hines, CJ (Reprint Author), NIOSH, Ctr Dis Control \& Prevent, Cincinnati, OH 45226 USA.
   Hines, Cynthia J.; Hopf, Nancy B. Nilsen; Deddens, James A.; Grote, Ardith A.; Sammons, Deborah L., NIOSH, Ctr Dis Control \& Prevent, Cincinnati, OH 45226 USA.
   Deddens, James A., Univ Cincinnati, Dept Math Sci, Cincinnati, OH 45221 USA.
   Calafat, Antonia M.; Silva, Manori J., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.}},
DOI = {{10.1093/annhyg/men066}},
ISSN = {{0003-4878}},
Keywords-Plus = {{HUMAN EXPOSURE ASSESSMENT; DEUTERIUM-LABELED DEHP; DI(2-ETHYLHEXYL)
   PHTHALATE; OCCUPATIONAL-EXPOSURE; REPRODUCTIVE DEVELOPMENT; OXIDATIVE
   METABOLITES; BIOMARKERS; ESTERS; POPULATION; HEALTH}},
Research-Areas = {{Public, Environmental \& Occupational Health; Toxicology}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Toxicology}},
Author-Email = {{chines@cdc.gov}},
Funding-Acknowledgement = {{National Institute for Occupational Safety and Health}},
Funding-Text = {{Intramural research program of National Institute for Occupational
   Safety and Health.}},
Cited-References = {{ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   BUTTE W, 2004, HDB PLASTICIZERS, P568.
   Centers for Disease Control and Prevention - CDC, 2005, 3 CDCP.
   CLARK K, 2003, PHTHALATE ESTERS, P125.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395.
   Gaudin R, 2008, INT ARCH OCC ENV HEA, V81, P959, DOI 10.1007/s00420-007-0289-6.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Heudorf U, 2007, INT J HYG ENVIR HEAL, V210, P623, DOI 10.1016/j.ijheh.2007.07.011.
   Hubinger JC, 2006, J COSMET SCI, V57, P127.
   Ioku T, 1976, YAKURI TO CHIRYO, V4, P510.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Kwapniewski R, 2008, J OCCUP ENVIRON MED, V50, P705, DOI 10.1097/JOM.0b013e3181651571.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381.
   Martens E., 2002, ACTA CLIN BELG     S, V1, P16.
   Matsumoto M, 2008, REGUL TOXICOL PHARM, V50, P37, DOI 10.1016/j.yrtph.2007.09.004.
   National Center for Health Statistics (NCHS), 2008, NAT HLTH NUTR EX SUR.
   NIELSEN J, 1985, AM IND HYG ASSOC J, V46, P643, DOI 10.1202/0002-8894(1985)046<0643:PEEALA>2.3.CO;2.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   STANLEY MK, 2003, PHTHALATE ESTERS, P1.
   Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1.
   Thierry-Mieg J, 2006, J HIGH ENERGY PHYS.
   US EPA, 2007, TOX REL INV PROGR.
   VAINIOTALO S, 1990, ANN OCCUP HYG, V34, P585, DOI 10.1093/annhyg/34.6.585.
   Vermeulen R, 2005, INT ARCH OCC ENV HEA, V78, P663, DOI 10.1007/s00420-005-0017-z.
   WYPYCH G, 2004, HDB PLASTICIZERS, P1.
   {*}US NLM, 2002, HAZ SUBST DAT BANK.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{16}},
Journal-ISO = {{Ann. Occup. Hyg.}},
Doc-Delivery-Number = {{392VC}},
Wos-Id = {{ISI:000262329300001}},
}

@article{ ISI:000262218500003,
Author = {Huang, Po-Chin and Kuo, Pao-Lin and Chou, Yen-Yin and Lin, Shio-Jean and
   Lee, Ching-Chang},
Title = {{Association between prenatal exposure to phthalates and the health of
   newborns}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2009}},
Volume = {{35}},
Number = {{1}},
Pages = {{14-20}},
Month = {{JAN}},
Abstract = {{Phthalates are developmental and reproductive toxicants for the fetus in
   pregnant rodents, and the ability of phthalates to penetrate the
   placenta have been reported. The aims of this study were to evaluate the
   association between maternal urine excretion, the exposure of fetus to
   phthalates in amniotic fluid, and the health of newborns. Amniotic fluid
   and urine samples from pregnant women were collected to measure five
   phthalate monoesters using liquid chromatography/tandem mass
   spectrometry (LC/MS-MS) and the newborns birth weight. gestational age,
   and anogenital distance (AGD) were collected. The median levels of three
   phthalate monoesters in urine and amniotic fluid were 78.4 and 85.2
   ng/mL monobutyl phthalate (MBP); 24.9 and 22.8 ng/mL mono-(2-ethylhexyl)
   phthalate (MEHP): 19.8 and Not Detected monoethyl phthalate (MEP). We
   found a significant positive correlation only between creatinine
   adjusted urinary MBP and amniotic fluid MBP (R(2) =0.156, p < 0.05) in
   all infants and, only in female infants, a significantly negative
   correlation between amniotic fluid MBP, AGD (R=-0.31, p < 0.06), and the
   anogenital index adjusted by birth weight (AGI-W) (R=-0.32, p < 0.05).
   Although the influence of prenatal di-n-butyl phthalate (DBP) exposure
   on the endocrinology and physiology of the fetus is still a puzzle, our
   data clearly show that in utero exposure to phthalates in general has
   anti-androgenic effects on the fetus. (C) 2008 Elsevier Ltd. All rights
   reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lee, CC (Reprint Author), Natl Cheng Kung Univ, Coll Med, Dept Environm \& Occupat Hlth, Tainan 70101, Taiwan.
   Huang, Po-Chin; Lee, Ching-Chang, Natl Cheng Kung Univ, Coll Med, Dept Environm \& Occupat Hlth, Tainan 70101, Taiwan.
   Kuo, Pao-Lin, Natl Cheng Kung Univ Med Coll \& Hosp, Dept Obstet \& Gynecol, Tainan, Taiwan.
   Chou, Yen-Yin; Lin, Shio-Jean, Natl Cheng Kung Univ Med Coll \& Hosp, Dept Pediat, Tainan, Taiwan.
   Lee, Ching-Chang, Natl Cheng Kung Univ, Sustainable Environm Res Ctr, Tainan 70101, Taiwan.}},
DOI = {{10.1016/j.envint.2008.05.012}},
ISSN = {{0160-4120}},
Keywords = {{Prenatal exposure; Phthalate monoesters; Newborns; Anogenital distance;
   Amniotic fluid; Urine}},
Keywords-Plus = {{N-BUTYL PHTHALATE; SEXUALLY DIMORPHIC NUCLEUS; IN-UTERO EXPOSURE; MALE
   REPRODUCTIVE DEVELOPMENT; ANOGENITAL DISTANCE; DI(N-BUTYL) PHTHALATE;
   BENZYL PHTHALATE; PITUITARY-RESPONSIVENESS; LATE-GESTATION; MALE-RAT}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{cclee@mail.ncku.edu.tw}},
ResearcherID-Numbers = {{Huang, Po-Chin/I-5844-2012}},
Funding-Acknowledgement = {{National Science Council, Taiwan {[}NSC 93-2621-Z-006-005, NSC
   94-2621-Z-006-005, NSC 95-2621-Z-006-005]}},
Funding-Text = {{We are grateful to the pregnant women who participated in this study We
   are also greatly indebted to the gynecologists in the Department of
   Obstetrics and Gynecology, pediatricians in the Division of Genetics and
   Metabolism, Department of Pediatrics, National Cheng Kung University
   Hospital, and our colleagues at the Sustainable Environment Research
   Center, National Cheng Kung University, Tainan, Taiwan, for the sampling
   support. We are also grateful for the instrument support of the
   Livestock Research Institute, Taiwan Council of Agriculture. This work
   was supported by grants NSC 93-2621-Z-006-005, NSC 94-2621-Z-006-005,
   and NSC 95-2621-Z-006-005 from the National Science Council, Taiwan.}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   ANDRADE AJ, 2006, TOXICOLOGY, V27, P185.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050.
   CHAN PKL, 1994, ENVIRON CARCIN ECO R, V12, P257.
   CLEMENS LG, 1978, HORM BEHAV, V10, P40, DOI 10.1016/0018-506X(78)90023-5.
   Dallaire F, 2003, ENVIRON HEALTH PERSP, V111, P1660, DOI 10.1289/ehp.6269.
   DIGANGI J, 2002, PRETTY NASTY PHTHALA.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Ema M, 2003, REPROD TOXICOL, V17, P407, DOI 10.1016/S0890-6238(03)00037-6.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   Ema M, 2001, REPROD TOXICOL, V15, P261, DOI 10.1016/S0890-6238(01)00131-9.
   FABER KA, 1991, REPROD TOXICOL, V5, P363, DOI 10.1016/0890-6238(91)90095-W.
   FABER KA, 1992, BIOL REPROD, V46, P101, DOI 10.1095/biolreprod46.1.101.
   FABER KA, 1991, BIOL REPROD, V45, P649, DOI 10.1095/biolreprod45.4.649.
   Gallavan RH, 1999, REPROD TOXICOL, V13, P383, DOI 10.1016/S0890-6238(99)00036-2.
   GOOMER N, 1977, J REPROD FERTIL, V50, P239.
   GRANDE SW, 2006, TOXICOLOGY, V229, P114.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hotchkiss AK, 2007, TOXICOL SCI, V96, P335, DOI 10.1093/toxsci/kfm002.
   Houlihan J., 2002, NOT TOO PRETTY PHTHA.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Jiang JT, 2007, TOXICOLOGY, V232, P286, DOI 10.1016/j.tox.2007.01.018.
   KAVLOCK R, 2006, NTP CHRHR EXPERT PAN.
   Kavlock R, 2002, REPROD TOXICOL, V16, P453, DOI 10.1016/S0890-6238(02)00029-1.
   Kerin TK, 2003, PHYSIOL BEHAV, V78, P697, DOI 10.1016/S0031-9384(03)00054-4.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013.
   LEWIS M, 1992, PEDIATRICS, V89, P1010.
   Longnecker MP, 2007, AM J EPIDEMIOL, V165, P1015, DOI 10.1093/aje/kwk109.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   MOORE K, 1998, DEV HUMAN CLINICALLY.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   PALANZA P, 1995, PHYSIOL BEHAV, V58, P827, DOI 10.1016/0031-9384(95)00107-T.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Parks LG, 1999, BIOL REPROD, V60, P153.
   Risk Assessment Forum US Environmental Protection Agency, 1996, FED REG, V61, P56274.
   Salazar-Martinez Eduardo, 2004, Environ Health, V3, P8, DOI 10.1186/1476-069X-3-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   Steer PJ, 2005, HIGH RISK PREGNANCY.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   TARTTELIN MF, 1988, BRAIN RES, V456, P271, DOI 10.1016/0006-8993(88)90227-2.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   VANDENBERGH JG, 1995, LAB ANIM SCI, V45, P567.
   Wang SL, 2005, ENVIRON HEALTH PERSP, V113, P1645, DOI 10.1289/ehp.7994.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   Yuan SY, 2002, CHEMOSPHERE, V49, P1295, DOI 10.1016/S0045-6535(02)00495-2.
   Zehr JL, 2001, DEV PSYCHOBIOL, V38, P229, DOI 10.1002/dev.1017.
   {*}ATSDR, 2002, TOX PROF 2 ETH PHTH.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.}},
Number-of-Cited-References = {{64}},
Times-Cited = {{60}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{391FF}},
Wos-Id = {{ISI:000262218500003}},
}

@article{ ISI:000262483900034,
Author = {Hines, Erin P. and Calatat, Antonia M. and Silva, Manori J. and Mendola,
   Pauline and Fenton, Suzanne E.},
Title = {{Concentrations of Phthalate Metabolites in Milk, Urine, Saliva, and
   Serum of Lactating North Carolina Women}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2009}},
Volume = {{117}},
Number = {{1}},
Pages = {{86-92}},
Month = {{JAN}},
Abstract = {{BACKGROUND: Phthalates are ubiquitous in the environment, but
   concentrations in multiple media from breast-feeding U.S. women have not
   been evaluated.
   OBJECTIVES: The objective of this study was to accurately measure and
   compare the concentrations of oxidative monoester phthalate metabolites
   in milk and surrogate fluids (serum, saliva, and urine) of 33 lactating
   North Carolina women.
   METHODS: We analyzed serum, saliva, urine, and milk for the oxidative
   phthalate metabolites mono (3-carboxypropyl) phthalate, mono
   (2-ethyl-5-carboxypentyl) phthalate (MECPP), mono(2ethyl-5-hydroxyhexyl)
   phthalate, and mono(2-ethyl-5-oxohexyl) phthalate using isotope-dilution
   high-performance liquid chromatography tandem mass spectroscopy. Because
   only urine lacks esterases, we analyzed it for the hydrolytic phthalate
   monoesters.
   RESULTS: We detected phthalate metabolites in few milk (10\%) and saliva
   samples. MECPP was detected in > 80\% of serum samples, but other
   metabolites were less common (3-22\%). Seven of the 10 urinary
   metabolites were detectable in >= 85\% of samples. Monoethyl phthalate
   had the highest mean concentration in urine. Metabolite concentrations
   differed by body fluid (urine > serum > milk and saliva). Questionnaire
   data suggest that frequent nail polish use, immunoglobulin A, and
   fasting serum glucose and triglyceride levels were increased among women
   with higher concentrations of urinary and/or serum phthalate
   metabolites; motor vehicle age was inversely correlated with certain
   urinary phthalate concentrations.
   CONCLUSIONS: Our data suggest that phthalate metabolites are most
   frequently detected in urine of lactating women and are less often
   detected in serum, milk, or saliva. Urinary phthalate concentrations
   reflect maternal exposure and do not represent the concentrations of
   oxidative metabolites in other body fluids, especially milk.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fenton, SE (Reprint Author), US EPA, ORD, NHEERS, Reprod Toxicol Div,Dev Biol Branch, 2525 Hwy 54,MD-67, Res Triangle Pk, NC 27711 USA.
   Hines, Erin P.; Fenton, Suzanne E., US EPA, ORD, NHEERS, Reprod Toxicol Div,Dev Biol Branch, Res Triangle Pk, NC 27711 USA.
   Calatat, Antonia M.; Silva, Manori J., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA USA.
   Mendola, Pauline, US Dept Hlth \& Human Serv, Ctr Dis Control \& Prevent, Natl Ctr Hlth Stat, Hyattsville, MD USA.}},
DOI = {{10.1289/ehp.11610}},
ISSN = {{0091-6765}},
Keywords = {{biomonitoring; breast milk; lactation; MAMA study; phthalates; saliva;
   serum; urine}},
Keywords-Plus = {{SOLID-PHASE EXTRACTION; HUMAN BREAST-MILK; DI-(2-ETHYLHEXYL)-PHTHALATE;
   DIETHYL PHTHALATE; QUANTITATIVE-ANALYSIS; MALE RATS; EXPOSURE; ESTERS;
   BIOMARKERS; CHILDREN}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{fenton.suzanne@epa.gov}},
Cited-References = {{Adibi JJ, 2008, ENVIRON HEALTH PERSP, V116, P467, DOI 10.1289/ehp.10749.
   Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Baccarelli A, 2005, CHEMOSPHERE, V60, P898, DOI 10.1016/j.chemosphere.2005.01.055.
   BIZZARI SN, 2000, CHEM EC HDB.
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2.
   BRUNSWELLER E, 1999, PHTHALSAUREESTER ALS.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   de Wildt SN, 1999, CLIN PHARMACOKINET, V36, P439, DOI 10.2165/00003088-199936060-00005.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   DOELMAN CJA, 1990, LANCET, V335, P725, DOI 10.1016/0140-6736(90)90839-W.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Ferrari M, 2008, INT ARCH OCC ENV HEA, V81, P1021, DOI 10.1007/s00420-007-0295-8.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   HATCH EE, 2008, ENV HLTH, V7, P1.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hines EP, 2007, J HUM LACT, V23, P144, DOI 10.1177/0890334407300334.
   Hogberg J, 2008, ENVIRON HEALTH PERSP, V116, P334, DOI 10.1289/ehp.10788.
   Houlihan J., 2002, NOT TOO PRETTY PHTHA.
   Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7.
   Hubinger JC, 2006, J COSMET SCI, V57, P127.
   Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188.
   JANJUA NR, 2008, INT J ANDROL, V31, P116.
   KAMRIN MA, 1991, J CLIN PHARMACOL, V31, P484.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Landrigan PJ, 2006, PEDIATRICS, V118, P2173, DOI 10.1542/peds.2006-0360.
   Latini G, 2003, PEDIATR RES, V54, P564.
   Lim SY, 2005, J AUTOIMMUN, V25, P33, DOI 10.1016/j.jaut.2005.04.002.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Mapuskar K, 2007, PESTIC BIOCHEM PHYS, V87, P156, DOI 10.1016/j.pestbp.2006.07.005.
   Mendell MJ, 2007, INDOOR AIR, V17, P259, DOI 10.1111/j.1600-0668.2007.00478.x.
   Mocchiutti NO, 1997, FOOD CHEM TOXICOL, V35, P1017, DOI 10.1016/S0278-6915(97)87270-5.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Pereira C, 2006, REGUL TOXICOL PHARM, V45, P169, DOI 10.1016/j.yrtph.2006.04.006.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   SAS Institute Inc, 2006, SAS ENT GUID 4 1 4 1.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Silva MJ, 2005, J ANAL TOXICOL, V29, P819.
   Silva MJ, 2005, ARCH TOXICOL, V79, P647, DOI 10.1007/s00204-005-0674-4.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   TAKATORI S, 2007, BUNSEKI KAGAKU, V56, P225.
   Valles EG, 2003, TOXICOLOGY, V191, P211, DOI 10.1016/S0300-483X(03)00260-9.
   WOLFF MS, 2008, ENV HLTH PERSPECT, DOI DOI 10.1289/EHP.11007.
   Wolff MS, 2007, ENVIRON HEALTH PERSP, V115, P116, DOI 10.1289/ehp.9488.
   Zhu JP, 2006, ENVIRON SCI TECHNOL, V40, P5276, DOI 10.1021/es060356w.
   {*}NAT CHILDR STUD, 2008, NAT CHILDR STUD HOM.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{33}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{394WN}},
Wos-Id = {{ISI:000262483900034}},
}

@article{ ISI:000266231000008,
Author = {Yan, Xiaoyong and Calafat, Antonia and Lashley, Susan and Smulian, John
   and Ananth, Cande and Barr, Dana and Silva, Manori and Ledoux, Thomas
   and Hore, Paromita and Robson, Mark G.},
Title = {{Phthalates Biomarker Identification and Exposure Estimates in a
   Population of Pregnant Women}},
Journal = {{HUMAN AND ECOLOGICAL RISK ASSESSMENT}},
Year = {{2009}},
Volume = {{15}},
Number = {{3}},
Pages = {{565-578}},
Abstract = {{Phthalates are known reproductive and developmental toxicants in
   experimental animals. However, in humans, there are few data on the
   exposure of pregnant women that can be used to assess the potential
   developmental exposure experienced by the fetus. We measured several
   phthalate metabolites in maternal urine, maternal serum, and cord serum
   samples collected at the time of delivery from 150 pregnant women from
   central New Jersey. The urinary concentrations of most metabolites were
   comparable to or less than among the U.S. general population, except for
   mono(2-ethylhexyl) phthalate (MEHP), mono(2-ethyl-5-hydroxyhexyl)
   phthalate (MEHHP), and mono(2-ethyl-5-oxohexyl) phthalate (MEOHP), three
   metabolites of di(2-ethylhexyl) phthalate (DEHP). The median urinary
   concentrations of MEHHP (109 g/l) and MEOHP (95.1 g/l) were more than 5
   times their population-based concentrations, whereas the median urinary
   concentration of MEHP was more than 20 times higher. High concentration
   of MEHP may indicate a recent exposure to the parent chemical DEHP in
   the hospital shortly before the collection of the samples. Calculation
   of daily intakes using the urinary biomarker data reveals that none of
   the pregnant women tested had integrated exposures to DEHP greater than
   the Agency for Toxic Substances and Disease Registry's minimal risk
   levels (MRLs chronic 60, intermediate 100 g/kg/day). No abnormal birth
   outcomes (e.g., birth weight, Apgar Score, and gestational age) were
   noted in those newborns whose mothers had relatively greater exposure to
   DEHP during the perinatal period than others in this study.
   Significantly greater concentrations and detection frequencies in
   maternal urine than in maternal serum and cord serum suggest that the
   urinary concentrations of the phthalate metabolites may be more reliable
   biomarkers of exposure than their concentrations in other biological
   specimens.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Robson, MG (Reprint Author), NJAES Rutgers, 88 Lipman Dr,Martin Hall,Site 104, New Brunswick, NJ 08901 USA.
   Yan, Xiaoyong; Robson, Mark G., Rutgers State Univ, Joint Grad Program Toxicol, UMDNJ, Piscataway, NJ USA.
   Lashley, Susan, Univ Virginia, Dept Obstet Gynecol \& Reprod Sci, Charlottesville, VA USA.
   Smulian, John, Lehigh Valley Hosp, Dept Obstet \& Gynecol, Allentown, PA USA.
   Ananth, Cande, UMDNJ Robert Wood Johnson Med Sch, Dept Obstet Gynecol \& Reprod Sci, Div Epidemiol \& Biostat, New Brunswick, NJ USA.
   Calafat, Antonia; Barr, Dana; Silva, Manori, Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Ledoux, Thomas, New Jersey Dept Environm Protect, Div Sci Res \& Technol, Risk Assessment \& Toxicol Sect, Trenton, NJ USA.
   Hore, Paromita; Robson, Mark G., UMDNJ Sch Publ Hlth, Dept Environm \& Occupat Hlth, Piscataway, NJ USA.
   Robson, Mark G., Rutgers State Univ, New Jersey Agr Expt Stn, New Brunswick, NJ 08903 USA.}},
DOI = {{10.1080/10807030902892554}},
ISSN = {{1080-7039}},
Keywords = {{phthalates; metabolites; daily intake; risk assessment; women; children}},
Keywords-Plus = {{BUTYL BENZYL PHTHALATE; ALTERS SEXUAL-DIFFERENTIATION; MALE REPRODUCTIVE
   DEVELOPMENT; DI(N-BUTYL) PHTHALATE; HUMAN URINE; MALE-RAT;
   DI(2-ETHYLHEXYL)PHTHALATE DEHP; DIETHYLHEXYL PHTHALATE; ANOGENITAL
   DISTANCE; INTERNAL EXPOSURE}},
Research-Areas = {{Biodiversity \& Conservation; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Biodiversity Conservation; Environmental Sciences}},
Author-Email = {{robson@aesop.rutgers.edu}},
Funding-Acknowledgement = {{New Jersey Department of Environmental Protection {[}DEP SR02-038,
   SR04-058, SR05-042]; NIEHS {[}P30ES005022, 5T32ES07148]}},
Funding-Text = {{We thank Dr. Jack Reidy, Jim Preau, and Arnetra Herbert for their
   assistance in the phthalate analytical measurements. We also thank Dr.
   Kenneth R. Reuhl in the Department of Pharmacology and Toxicology,
   Rutgers University/UMDNJ, Piscataway, NJ, for his assistance. This work
   was supported by grants from New Jersey Department of Environmental
   Protection (DEP SR02-038, SR04-058, SR05-042) and the NIEHS P30ES005022
   and NIEHS 5T32ES07148.}},
Cited-References = {{AGARWAL DK, 1985, TOXICOLOGY, V35, P189, DOI 10.1016/0300-483X(85)90015-0.
   Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Calafat AM, 2008, INT J ANDROL, V31, P139, DOI 10.1111/j.1365-2605.2007.00826.x.
   CARPENTER CP, 1953, AMA ARCH IND HYG OCC, V8, P219.
   Centers for Disease Control and Prevention, 2005, 3 NAT REP HUM EXP EN.
   Crisp TM, 1998, ENVIRON HEALTH PERSP, V106, P11, DOI 10.2307/3433911.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Ema M, 2003, REPROD TOXICOL, V17, P407, DOI 10.1016/S0890-6238(03)00037-6.
   Ema M, 1998, REPROD TOXICOL, V12, P127, DOI 10.1016/S0890-6238(97)00127-5.
   Ema M, 2002, REPROD TOXICOL, V16, P71, DOI 10.1016/S0890-6238(01)00200-3.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Hotchkiss AK, 2004, BIOL REPROD, V71, P1852, DOI 10.1095/biolreprod.104.031674.
   Jacobs D.S., 2001, LAB TEST HDB.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch H.M., 2003, INT J HYG ENVIR HEAL, V206, P1.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Tietz NW, 1990, CLIN GUIDE LAB TESTS.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 1997, TOX PROF DI N OCT PH.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}CERHR, 2005, NTP CERHR EXP PAN UP.
   {*}CERHR, 2000, NTP CERHR EXP PAN RE.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{6}},
Journal-ISO = {{Hum. Ecol. Risk Assess.}},
Doc-Delivery-Number = {{447ZN}},
Wos-Id = {{ISI:000266231000008}},
}

@article{ ISI:000263960200011,
Author = {Chou, Yen-Yin and Huang, Po-Chin and Lee, Ching-Chang and Wu, Meng-Hsing
   and Lin, Shio-Jean},
Title = {{Phthalate Exposure in Girls During Early Puberty}},
Journal = {{JOURNAL OF PEDIATRIC ENDOCRINOLOGY \& METABOLISM}},
Year = {{2009}},
Volume = {{22}},
Number = {{1}},
Pages = {{69-77}},
Month = {{JAN}},
Abstract = {{The aim of this study was to determine the levels of phthalate ester
   metabolites in girls in early puberty, and the associated environmental
   factors for phthalate exposure. A case-control study was conducted in
   which we recruited girls in early puberty, including 30 girls with
   premature thelarche (PT) and 26 with central precocious puberty (CPP),
   and 33 normal controls. The mean urine levels of monomethyl phthalate
   (MMP) were significantly higher in the PT group (96.5 +/- 134.0 ng/ml)
   than in the control group (26.4 +/- 30.0 ng/ml; p = 0.005). The levels
   of monobutyl phthalate (MBuP) correlated with the intake of seafood,
   drink and the use of plastic cups. The levels of mono-(2-ethylhexyl)
   phthalate (MEHP) correlated with the intake of seafood and meat and
   exposure plastic handi-wrap. Significantly higher MMP in the PT girls
   revealed that phthalate may be one of the environmental causes of early
   puberty in Taiwanese girls.}},
Publisher = {{FREUND PUBLISHING HOUSE LTD}},
Address = {{PO BOX 35010, TEL AVIV 61350, ISRAEL}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lin, SJ (Reprint Author), Natl Cheng Kung Univ, Med Coll \& Hosp, Dept Pediat, 138 Sheng Li Rd, Tainan 70101, Taiwan.
   Chou, Yen-Yin; Lin, Shio-Jean, Natl Cheng Kung Univ, Med Coll \& Hosp, Dept Pediat, Tainan 70101, Taiwan.
   Chou, Yen-Yin, Natl Cheng Kung Univ, Med Coll \& Hosp, Inst Clin Med, Tainan 70101, Taiwan.
   Huang, Po-Chin; Lee, Ching-Chang, Natl Cheng Kung Univ, Med Coll \& Hosp, Dept Environm \& Occupat Hlth, Tainan 70101, Taiwan.
   Wu, Meng-Hsing, Natl Cheng Kung Univ, Med Coll \& Hosp, Dept Obstet \& Gynecol, Tainan 70101, Taiwan.}},
ISSN = {{0334-018X}},
Keywords = {{phthalates; endocrine-disrupting chemicals; environmental exposure;
   precocious puberty}},
Keywords-Plus = {{IN-VITRO; ESTERS; IDENTIFICATION; PLASTICIZERS; METABOLITES; POPULATION;
   TOXICITY; RECEPTOR; OVARIAN; ALPHA}},
Research-Areas = {{Endocrinology \& Metabolism; Pediatrics}},
Web-of-Science-Categories  = {{Endocrinology \& Metabolism; Pediatrics}},
Author-Email = {{yenyin@mail.ncku.edu.tw}},
ResearcherID-Numbers = {{Huang, Po-Chin/I-5844-2012}},
Funding-Acknowledgement = {{National Science Council in Taiwan {[}NSC93-2621-Z-006-006]}},
Funding-Text = {{This study was funded by the National Science Council in Taiwan
   (NSC93-2621-Z-006-006).}},
Cited-References = {{Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   BRADY AM, 1998, TOXICOLOGIST, V42, P176.
   Centers for Disease Control and Prevention National Center for Health Statistics. NHANES 2001-2002, NHANES 2001 2002.
   CLARK K, 2003, HDB ENV CHEM Q, V3, P22.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   FINCH CE, 1984, ENDOCR REV, V5, P467.
   Howdeshell KL, 1999, NATURE, V401, P763.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Kanno J, 2003, ENVIRON HEALTH PERSP, V111, P1550, DOI 10.1289/ehp.5870.
   Kaplowitz P, 2006, CURR OPIN OBSTET GYN, V18, P487, DOI 10.1097/01.gco.0000242949.02373.09.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P3, DOI 10.2307/3429377.
   Kusu R, 2007, ENVIRON TOXICOL PHAR, V24, P311, DOI 10.1016/j.etap.2007.08.002.
   Lovekamp-Swan T, 2003, MOL CELL ENDOCRINOL, V201, P133, DOI 10.1016/S0303-7207(02)00423-9.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Ma MY, 2006, TOXICOL SCI, V93, P164, DOI 10.1093/toxsci/kfl036.
   Massart F, 2006, Minerva Pediatr, V58, P247.
   McKee RH, 2004, ENVIRON HEALTH PERSP, V112, pA541.
   MCLACHLAN JA, 1985, ESTROGENS ENV, V2.
   Moore NP, 2000, REPROD TOXICOL, V14, P183, DOI 10.1016/S0890-6238(00)00068-X.
   Okamoto Y, 2006, CHEMOSPHERE, V64, P1785, DOI 10.1016/j.chemosphere.2005.12.046.
   Picard K, 2001, TOXICOL APPL PHARM, V172, P108, DOI 10.1006/taap.2001.9141.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Takeuchi S, 2005, TOXICOLOGY, V210, P223, DOI 10.1016/j.tox.2005.02.002.
   WAMS TJ, 1987, SCI TOTAL ENVIRON, V66, P1, DOI 10.1016/0048-9697(87)90072-6.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   WU ZF, 1998, TOXICOL SCI, V42, P176.
   Zacharewski TR, 1998, TOXICOL SCI, V46, P282, DOI 10.1093/toxsci/46.2.282.
   {*}ENV PROT ADM TAIW, 2002, ENV PROT ADM TAIW AN.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{20}},
Journal-ISO = {{J. Pediatr. Endocrinol. Metab.}},
Doc-Delivery-Number = {{415UD}},
Wos-Id = {{ISI:000263960200011}},
}

@article{ ISI:000271435300025,
Author = {Kwack, Seung Jun and Kim, Kyu Bong and Kim, Hyung Sik and Lee, Byung Mu},
Title = {{Comparative Toxicological Evaluation of Phthalate Diesters and
   Metabolites in Sprague-Dawley Male Rats for Risk Assessment}},
Journal = {{JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES}},
Year = {{2009}},
Volume = {{72}},
Number = {{21-22}},
Pages = {{1446-1454}},
Abstract = {{In order to comparatively assess the systemic toxicity and sperm
   parameters, nine phthalate diesters, including di(2-ethylhexyl)
   phthalate (DEHP), di(n-butyl) phthalate (DBP), di-n-octyl phthalate
   (DnOP), diethyl phthalate (DEP), butylbenzyl phthalate (BBP), dimethyl
   phthalate (DMP), di-isodecyl phthalate (DIDP), diundecyl phthalate
   (DUP), and di-isononyl phthalate (DINP), and five phthalate monoesters,
   including mono(2-ethylhexyl) phthalate (MEHP), monobutyl phthalate
   (MBuP), monobenzyl phthalate (MBeP), monoethyl phthalate (MEP),
   monomethyl phthalate (MMP), and phthalic acid (PA) were administered
   orally to Sprague-Dawley male rats at 250 (phthalate monoesters and PA)
   or 500 mg/kg body weight (bw)/d (phthalate diesters) for 4 wk. Liver
   weights were significantly increased in groups treated with DEHP, DBP,
   BBP, DIDP, DINP, MEHP, and MBuP compared to the control. Testes weights
   were significantly reduced only in DEHP, DBP, and MEHP-treated groups
   compared to the control. Significant decreases in red blood cell (RBC)
   and hematocrit (Ht) levels were observed in DEHP-treated rats, whereas
   significant increases in mean corpuscular hemoglobin (MCH), mean
   corpuscular hemoglobin concentration (MCHC), and platelet (PLT) levels
   were found in the DEHP-treated group. Hemoglobin (Hb) level was reduced
   only in the DMP group. Similar to effects on testis and epididymal
   weights, DEHP and MEHP significantly reduced sperm numbers and motility.
   In particular, DnOP, DBP, BBP, MEP, MBuP, DUP, DINP, and MBeP
   significantly lowered the sperm counts and sperm motility of epididymal
   sperm, detected by a change in the sperm motion parameters. The
   strongest to the weakest adverse effects for sperm motility were as
   follows: DEHP > DBP > DnOP > DUP > DIDP > BBP among diesters and MBuP >
   MEP > MEHP among monoesters, respectively. These results suggest that
   the adverse effects of phthalate esters (PEs) on sperm parameters in
   male rats are greater with phthalate diesters than monoesters, which may
   be useful for the risk assessment of phthalates.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lee, BM (Reprint Author), Sungkyunkwan Univ, Div Toxicol, Coll Pharm, Suwon 440746, Kyeonggi Do, South Korea.
   Lee, Byung Mu, Sungkyunkwan Univ, Div Toxicol, Coll Pharm, Suwon 440746, Kyeonggi Do, South Korea.
   Kwack, Seung Jun; Kim, Kyu Bong, Natl Inst Toxicol Res, Dept Toxicol Res, Seoul, South Korea.
   Kim, Hyung Sik, Pusan Natl Univ, Div Mol Toxicol, Coll Pharm, Pusan 609735, South Korea.}},
DOI = {{10.1080/15287390903212923}},
ISSN = {{1528-7394}},
Keywords-Plus = {{BUTYL BENZYL PHTHALATE; REPRODUCTIVE-TRACT DEVELOPMENT; IN-VITRO;
   DI(2-ETHYLHEXYL) PHTHALATE; MONO-(2-ETHYLHEXYL) PHTHALATE;
   DI-(2-ETHYLHEXYL) PHTHALATE; TESTICULAR TOXICITY; ESTROGENIC ACTIVITY;
   CELL-PROLIFERATION; ESTERS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{bmlee@skku.ac.kr}},
Cited-References = {{ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050.
   Coldham NG, 1997, ENVIRON HEALTH PERSP, V105, P734, DOI 10.1289/ehp.97105734.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   EIGENBERG DA, 1986, J TOXICOL ENV HEALTH, V17, P445.
   Ema M, 2002, REPROD TOXICOL, V16, P71, DOI 10.1016/S0890-6238(01)00200-3.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387.
   Gotz F, 2001, FOLIA HISTOCHEM CYTO, V39, P40.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gray T J, 1980, Arch Toxicol Suppl, V4, P452.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   HORIMOTO M, 2000, REPROD TOXICOL, V14, P53.
   Hossaini A, 2003, REPROD TOXICOL, V17, P607, DOI 10.1016/j.reprotox.2003.05.001.
   Kim HS, 2004, J TOXICOL ENV HEAL A, V67, P2045, DOI 10.1080/15287390490514859.
   LHUGUENOT JC, 1985, TOXICOL APPL PHARM, V80, P11, DOI 10.1016/0041-008X(85)90096-1.
   Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972.
   Long GG, 1998, TOXICOL PATHOL, V26, P316.
   Nativelle C, 1999, FOOD CHEM TOXICOL, V37, P905, DOI 10.1016/S0278-6915(99)00071-X.
   Okubo T, 2003, BIOL PHARM BULL, V26, P1219.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PECK CC, 1981, TRANSFUSION, V21, P163, DOI 10.1046/j.1537-2995.1981.21281178151.x.
   Picard K, 2001, TOXICOL APPL PHARM, V172, P108, DOI 10.1006/taap.2001.9141.
   Piersma AH, 2000, REPROD TOXICOL, V14, P417, DOI 10.1016/S0890-6238(00)00100-3.
   POLLACK GM, 1989, J PHARMACOL EXP THER, V248, P176.
   Rhee GS, 2002, TOXICOL IN VITRO, V16, P443.
   Ryu JY, 2007, J TOXICOL ENV HEAL A, V70, P1296, DOI 10.1080/15287390701432160.
   Saillenfait AM, 2003, REPROD TOXICOL, V17, P575, DOI 10.1016/S0890-6238(03)00102-3.
   SCHLEDE E, 1995, ARCH TOXICOL, V69, P659, DOI 10.1007/s002040050229.
   SHAFFER CB, 1945, J IND HYG TOXICOL, V27, P130.
   Shono T, 2003, UROL RES, V31, P293, DOI 10.1007/s00240-003-0330-5.
   SINGH AR, 1972, J PHARM SCI, V61, P51, DOI 10.1002/jps.2600610107.
   SJOBERG P, 1986, ENVIRON HEALTH PERSP, V65, P237, DOI 10.2307/3430188.
   SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.2307/3432519.
   TANAKA A, 1978, TOXICOLOGY, V9, P109, DOI 10.1016/0300-483X(78)90036-7.
   TEIRLYNCK O, 1988, TOXICOL LETT, V40, P85, DOI 10.1016/0378-4274(88)90186-5.
   THOMAS JA, 1978, TOXICOL APPL PHARM, V45, P1, DOI 10.1016/0041-008X(78)90024-8.
   Tsutsumi T, 2004, REPROD TOXICOL, V18, P35, DOI 10.1016/j.reprotox.2003.08.004.
   Waterman SJ, 2000, REPROD TOXICOL, V14, P21, DOI 10.1016/S0890-6238(99)00067-2.
   Zacharewski T, 1998, ENVIRON HEALTH PERSP, V106, P577, DOI 10.2307/3433808.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{12}},
Journal-ISO = {{J. Toxicol. Env. Health Part A}},
Doc-Delivery-Number = {{514ZI}},
Wos-Id = {{ISI:000271435300025}},
}

@article{ ISI:000260660000021,
Author = {Sathyanarayana, S. and Calafat, A. M. and Liu, F. and Swan, S. H.},
Title = {{Maternal and infant urinary phthalate metabolite concentrations: Are
   they related?}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2008}},
Volume = {{108}},
Number = {{3}},
Pages = {{413-418}},
Month = {{NOV}},
Abstract = {{Background: Phthalates are synthetic chemicals that are ubiquitous in
   our society and may have adverse health effects in humans. Detectable
   concentrations of phthalate metabolites have been found in adults and
   children, but no studies have examined the relationship between maternal
   and infant phthalate metabolite concentrations.
   Objective: We investigated the relationship between maternal and infant
   urinary phthalate metabolite concentrations.
   Methods: We measured nine phthalate metabolites in urine samples from
   210 mother/infant pairs collected on the same study visit day
   (1999-2005) and obtained demographic history from questionnaires. Using
   multivariate linear regression analyses, we examined the degree to which
   maternal urine phthalate metabolite concentration predicted infant
   phthalate metabolite concentration. All analyses were adjusted for
   infant age, creatinine concentration, and race.
   Results: Correlation coefficients between phthalate metabolite
   concentrations in the urine of mothers and their infants were generally
   low but increased with decreasing age of infant. In multivariate
   analyses, mother's phthalate metabolite concentrations were
   significantly associated with infants' concentrations for six phthalate
   metabolites: monobenzyl phthalate, monoethyl phthalate, monoisobutyl
   phthalate, and three metabolites of di(2-ethylhexyl) phthalate:
   mono(2-ethyl hexyl) phthalate, mono(2-ethyl-5-hydroxy-hexyl) phthalate,
   and mono(2-ethyl-5-oxo-hexyl) phthalate (p-values for all coefficients <
   0.05).
   Discussion: Mother's urine phthalate metabolite concentration is
   significantly associated with infant urine phthalate metabolite
   concentration for six phthalate metabolites. It is plausible that shared
   exposures to phthalates in the immediate surrounding environment
   accounted for these relationships, but other unidentified sources may
   also contribute to infants' phthalate exposures. This study indicates
   the importance of further identifying infant phthalate exposures that
   may be distinct from maternal exposures in order to decrease overall
   infant phthalate exposures. (C) 2008 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sathyanarayana, S (Reprint Author), Univ Washington, Dept Pediat, 325 9th Ave, Seattle, WA 98104 USA.
   Sathyanarayana, S., Univ Washington, Dept Pediat, Seattle, WA 98104 USA.
   Calafat, A. M., Ctr Dis Control \& Prevent, Atlanta, GA USA.
   Liu, F.; Swan, S. H., Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, Rochester, NY 14642 USA.}},
DOI = {{10.1016/j.envres.2008.07.002}},
ISSN = {{0013-9351}},
Keywords = {{Phthalate; infant; Maternal; Environmental health}},
Keywords-Plus = {{IN-UTERO EXPOSURE; HOUSE DUST; INDOOR AIR; ASSOCIATION; CHILDREN;
   ESTERS; DEHP; PRODUCTS; PVC; AGE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{sathyana@u.washington.edu}},
Cited-References = {{Afshari A, 2004, INDOOR AIR, V14, P120, DOI 10.1046/j.1600-0668.2003.00220.x.
   Barlow NJ, 2004, TOXICOL PATHOL, V32, P79, DOI 10.1080/01926230490265894.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050.
   CASTLE L, 1988, FOOD ADDIT CONTAM, V5, P9.
   Fromme H, 2007, ENVIRON INT, V33, P1012, DOI 10.1016/j.envint.2007.05.006.
   Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1046/j.1600-0668.2003.00223.x.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   HORNUNG RW, 1990, APPL OCCUP ENV HYG, V5.
   Jacobs D.S., 2001, LAB TEST HDB.
   KAREN WRC, 2006, J MED TOXICOL, V2.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch HM, 2006, INT J ANDROL, V29, P181.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Sathyanarayana S, 2008, PEDIATRICS, V121, pE260, DOI 10.1542/peds.2006-3766.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P1478, DOI 10.1289/ehp.6417.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Uhde E, 2001, INDOOR AIR, V11, P150, DOI 10.1034/j.1600-0668.2001.011003150.x.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}HLTH CAR HARM, 2002, P NAST PHTHAL EUR CO.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{10}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{368YR}},
Wos-Id = {{ISI:000260660000021}},
}

@article{ ISI:000261089000008,
Author = {Xu, Y. and Agrawal, S. and Cook, T. J. and Knipp, G. T.},
Title = {{Maternal Di-(2-ethylhexyl)-phthalate Exposure Influences Essential Fatty
   Acid Homeostasis in Rat Placenta}},
Journal = {{PLACENTA}},
Year = {{2008}},
Volume = {{29}},
Number = {{11}},
Pages = {{962-969}},
Month = {{NOV}},
Abstract = {{Maintaining essential fatty acid (EFA) homeostasis during pregnancy is
   critical for fetal development. As the organ that controls the
   maternal-to-fetal Supply of nutrients, the placenta plays a significant
   role in guiding EFA transfer to the fetus. Many EFA homeostasis proteins
   are regulated by peroxisome Proliferator-activated receptors (PPARs).
   The metabolites of di-(2-ethylhexyl)-phthalate (DEHP), a ubiquitous
   environmental contaminant, might influence EFA homeostasis via
   trans-activation of PPARs with subsequent downstream effects on EFA
   transporters and enzymes. To investigate DEHP's effect on
   placental/fetal EFA homeostasis, female Sprague-Dawley rats were orally
   gavaged with either vehicle OF DEHP at 750 or 1500 mg/kg/day from
   gestational day (GD) 0 to GD 19. Changes in the expression of several
   EFA homeostasis regulating proteins were determined in the junctional
   (JXN) and labyrinthine (LAB) zones of the placenta, including PPAR
   isoforms (alpha, beta and gamma), fatty acid translocase (FAT/CD36),
   fatty acid transport protein 1 (FATP1), plasma membrane fatty acid
   binding protein (FABPpm), heart cytoplasmic fatty acid binding protein
   (HFABP), cytochrome P450 (CYP) 4A1, and cyclooxygenase (COX)-1 and -2.
   Additionally, effects of DEHP maternal exposure on the placental
   transfer and fetal distribution of representative EFAs, arachidonic acid
   (AA) and docosahexaenoic acid (DHA), and the placental production of
   prostaglandins (PGs) were investigated. Expression of PPAR alpha, PPAR
   gamma, FAT/CD36, FATP1, HFABP and CYP4A1 was up-regulated in JXN and/or
   LAB while COX-2 was down-regulated in JXN. PPAR beta, FABPpm, and COX-1
   demonstrated variable expression. Reduced directional maternal-to-fetal
   placental transfer and altered fetal distribution of AA and DHA were
   observed in concordance with a decreased total placental PG production,
   These results correlate with previous in vitro data, Suggesting that
   DEHP could influence placental EFA homeostasis with potential downstream
   effects in the developing fetus. (C) 2008 Elsevier Ltd. All rights
   reserved.}},
Publisher = {{W B SAUNDERS CO LTD}},
Address = {{32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Knipp, GT (Reprint Author), Purdue Univ, Sch Pharm, Dept Ind \& Phys Pharm, 1205 Kent Ave, W Lafayette, IN 47906 USA.
   Knipp, G. T., Purdue Univ, Sch Pharm, Dept Ind \& Phys Pharm, W Lafayette, IN 47906 USA.
   Xu, Y.; Agrawal, S., Rutgers State Univ, Dept Pharmaceut, Piscataway, NJ 08854 USA.
   Cook, T. J., Touro Coll Pharm, Dept Pharmaceut \& Biomed Sci, New York, NY 10027 USA.}},
DOI = {{10.1016/j.placenta.2008.08.011}},
ISSN = {{0143-4004}},
Keywords = {{DEHP; Rat; Placenta; Fatty acid; Transport; Metabolism; PPAR}},
Keywords-Plus = {{PROLIFERATOR-ACTIVATED RECEPTOR; PPAR-GAMMA; DI(2-ETHYLHEXYL) PHTHALATE;
   ARACHIDONIC-ACID; DEVELOPMENTAL TOXICITY; EXPRESSION; ALPHA; PREGNANCY;
   CYCLOOXYGENASE-2; METABOLITES}},
Research-Areas = {{Developmental Biology; Obstetrics \& Gynecology; Reproductive Biology}},
Web-of-Science-Categories  = {{Developmental Biology; Obstetrics \& Gynecology; Reproductive Biology}},
Author-Email = {{gknipp@pharmacy.purdue.edu}},
Funding-Acknowledgement = {{National Alliance for Autism Research; NIH {[}R01GM065448, R03CA105465,
   R03CA121403]}},
Funding-Text = {{This study was Supported by the following funding sources: a grant from
   the National Alliance for Autism Research (T.J.C. and G.T.K.) and NIH
   grants R01GM065448 (G.T.K.), R03CA105465 (T.J.C.), and R03CA121403
   (T.J.C.).}},
Cited-References = {{Amusquivar E, 2000, J NUTR, V130, P2855.
   Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299.
   Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9.
   BELL FP, 1982, ENVIRON HEALTH PERSP, V45, P41, DOI 10.2307/3429382.
   Dutta-Roy AK, 2000, AM J CLIN NUTR, V71, p315S.
   Dzhekova-Stojkova S, 2001, CLIN CHEM LAB MED, V39, P468, DOI 10.1515/CCLM.2001.076.
   Fournier T, 2007, PLACENTA, V28, P65, DOI 10.1016/j.placenta.2006.04.009.
   Haggarty P, 2004, EUR J CLIN NUTR, V58, P1559, DOI 10.1038/sj.ejcn.1602016.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Innis SM, 2003, J PEDIATR, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2.
   Inoue H, 2000, J BIOL CHEM, V275, P28028.
   Johnson EF, 2002, TOXICOLOGY, V181, P203, DOI 10.1016/S0300-483X(02)00282-2.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kawai S, 1998, INFLAMM RES, V47, pS102.
   KIHLSTROM I, 1983, ACTA PHARMACOL TOX, V53, P23.
   Kim HS, 2004, J VET MED SCI, V66, P1119, DOI 10.1292/jvms.66.1119.
   Knipp GT, 1999, ADV DRUG DELIVER REV, V38, P41, DOI 10.1016/S0169-409X(99)00005-8.
   Kniss DA, 1999, J SOC GYNECOL INVEST, V6, P285, DOI 10.1016/S1071-5576(99)00034-9.
   Kretschmer XC, 2005, CHEM-BIOL INTERACT, V155, P111, DOI 10.1016/j.cbi.2005.06.003.
   Latini G, 2003, BIOL NEONATE, V83, P22, DOI 10.1159/000067012.
   Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809.
   Michalik L, 2002, INT J DEV BIOL, V46, P105.
   Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710.
   NAROTSKY MG, 1995, FUND APPL TOXICOL, V27, P203, DOI 10.1006/faat.1995.1125.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   SOARES MJ, 1997, NESTLE NUTR WORKSHOP, V39, P31.
   Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701.
   Subbaramaiah K, 2001, J BIOL CHEM, V276, P12440, DOI 10.1074/jbc.M007237200.
   Tapiero H, 2002, BIOMED PHARMACOTHER, V56, P215, DOI 10.1016/S0753-3322(02)00193-2.
   Uauy R, 2001, LIPIDS, V36, P885, DOI 10.1007/s11745-001-0798-1.
   Wong JS, 2002, TOXICOL APPL PHARM, V185, P180, DOI 10.1006/taap.2002.9540.
   Xu Y, 2007, J PHARM SCI-US, V96, P2582, DOI 10.1002/jps.20973.
   XU Y, 2005, PLACENTA, V26, P2218.
   Xu Y, 2005, MOL PHARMACEUT, V2, P481, DOI 10.1021/mp0500519.
   Xu Y, 2005, TOXICOL SCI, V84, P287, DOI 10.1093/toxsci/kfi083.
   Xu Y, 2007, ARCH TOXICOL, V81, P57, DOI 10.1007/s00204-006-0143-8.
   Yaghi A, 2001, J PHARMACOL EXP THER, V297, P479.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{13}},
Journal-ISO = {{Placenta}},
Doc-Delivery-Number = {{375BW}},
Wos-Id = {{ISI:000261089000008}},
}

@article{ ISI:000260132400007,
Author = {Swan, Shanna H.},
Title = {{Environmental phthalate exposure in relation to reproductive outcomes
   and other health endpoints in humans}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2008}},
Volume = {{108}},
Number = {{2}},
Pages = {{177-184}},
Month = {{OCT}},
Note = {{Workshop on Plastic World, Erice, ITALY, AUG 19-24, 2006}},
Organization = {{World Federat Scientists}},
Abstract = {{After briefly discussing human exposure to phthalates-diesters of
   1,2-benzenedicarboxylic acid (phthalic acid)-this article first presents
   recent findings from the Study for Future Families, a multi-center
   pregnancy study in which the human analogue of the phthalate syndrome
   was first identified. This is one of an increasing number of studies
   that have investigated human endpoints in relation to environmental
   exposure to these ubiquitous compounds. This literature, which includes
   a range of human health endpoints following prenatal, neonatal,
   childhood, and adult exposures, is then summarized. At least one
   significant association has been reported for urinary metabolites of
   di-n-butyl phthalate (DBP), butylbenzyl phthalate (BzBP), diethyl
   phthlate (DEP), and di-isononyl phthalate (DINP) and for three of the
   urinary metabolites of di(2-ethylhexyl) phthalate (DEHP). Many of the
   findings reported in humans-most of which have been in males-are
   consistent with the anti-androgenic action that has been demonstrated
   for several phthalates. Replication of the results described here and
   further mechanistic studies are needed to strengthen links between
   phthalates and adverse health outcomes. (C) 2008 Elsevier Inc. All
   rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Swan, SH (Reprint Author), Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, 601 Elmwood Ave,Box 668, Rochester, NY 14642 USA.
   Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, Rochester, NY 14642 USA.}},
DOI = {{10.1016/j.envres.2008.08.007}},
ISSN = {{0013-9351}},
Keywords = {{Phthalates; Genital dysmorphology; Anogenital distance; Phthalate
   syndrome}},
Keywords-Plus = {{THYROID-HORMONE LEVELS; IN-UTERO EXPOSURE; MALE-RAT; URINARY
   CONCENTRATIONS; SEMEN QUALITY; DI(2-ETHYLHEXYL) PHTHALATE;
   SEXUAL-DIFFERENTIATION; OXIDATIVE METABOLITES; TEMPORAL VARIABILITY;
   ANOGENITAL DISTANCE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{shanna\_swan@urmc.rochester.edu}},
Cited-References = {{Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   BORCH J, 2004, REPROD TOXICOL.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   CALLEGARI C, 1987, J PEDIATR, V111, P240, DOI 10.1016/S0022-3476(87)80075-6.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Hotchkiss AK, 2005, CONTEMP TOP LAB ANIM, V44, P46.
   HOWDESHELL K, 2008, ENV RES.
   HOWDESHELL KL, 2008, TOXICOL SCI.
   Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797.
   Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188.
   Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Kolarik B, 2008, ENVIRON HEALTH PERSP, V116, P98, DOI 10.1289/ehp.10498.
   Lee BM, 2007, J TOXICOL ENV HEAL A, V70, P1365, DOI 10.1080/15287390701432285.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   McKee RH, 2004, ENVIRON HEALTH PERSP, V112, pA541.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Phillip M, 1996, J PEDIATR ENDOCR MET, V9, P175.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Salazar-Martinez Eduardo, 2004, Environ Health, V3, P8, DOI 10.1186/1476-069X-3-8.
   SATHYANARAYANA S, 2008, PEDIATRICS, V121, P8.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P414, DOI 10.1289/ehp.5927.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Teitelbaum SL, 2008, ENVIRON RES, V106, P257, DOI 10.1016/j.envres.2007.09.010.
   vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713.
   Welsh M, 2008, J CLIN INVEST, V118, P1479, DOI 10.1172/JCI34241.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   Wilson VS, 2008, INT J ANDROL, V31, P178, DOI 10.1111/j.1365-2605.2007.00861.x.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Zhang YH, 2006, BIOMED ENVIRON SCI, V19, P205.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.
   {*}CDC, 2003, 2 NAT REP HUM EXP EN.
   {*}FDA, 2001, FDA TOT DIET STUD SU.}},
Number-of-Cited-References = {{57}},
Times-Cited = {{137}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{361MS}},
Wos-Id = {{ISI:000260132400007}},
}

@article{ ISI:000260132400018,
Author = {Ye, Xibiao and Pierik, Frank H. and Hauser, Russ and Duty, Susan and
   Angerer, Juergen and Park, Melissa M. and Burdorf, Alex and Hofman,
   Albert and Jaddoe, Vincent W. V. and Mackenbach, Johan P. and Steegers,
   Eric A. P. and Tiemeier, Henning and Longnecker, Matthew P.},
Title = {{Urinary metabolite concentrations of organophosphorous pesticides,
   bisphenol A, and phthalates among pregnant women in Rotterdam, the
   Netherlands: The Generation R study}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2008}},
Volume = {{108}},
Number = {{2}},
Pages = {{260-267}},
Month = {{OCT}},
Abstract = {{Concern about potential health impacts of low-level exposures to organ
   ophosphorus (OP) pesticides, bisphenol A (BPA), and phthalates among the
   general population is increasing. We measured levels of six dialkyl
   phosphate (DAP) metabolites of OP pesticides, a chlorpyrifos-specific
   metabolite (3,5,6-trichloro-2-pyridinol, TCPy), BPA, and 14 phthalate
   metabolites in urine samples of 100 pregnant women from the Generation R
   study, the Netherlands. The unadjusted and creatinine-adjusted
   concentrations were reported, and compared to National Health and
   Nutrition Examination Survey and other studies. In general, these
   metabolites were detectable in the urine of the women from the
   Generation R study and compared with other groups, they had relatively
   high-level exposures to OP pesticides and several phthalates but similar
   exposure to BPA. The median concentrations of total dimethyl (DM)
   metabolites was 264.0 nmol/g creatinine (Cr) and of total DAP was 316.0
   nmol/g Cr. The median concentration of mono-ethyl phthalate (MEP) was
   222.0 mu g/g Cr: the median concentrations of mono-isobutyl phthalate
   (MiBP) and mono-n-butyl phthalate (MnBP) were above 50 mu g/g Cr. The
   median concentrations of the three secondary metabolites of
   di-2-ethylhexyl phthalate (DEHP) were greater than 20 mu g/g Cr. The
   data indicate that the Generation R study population provides a wide
   distribution of selected environmental exposures. Reasons for the
   relatively high levels and possible health effects need investigation.
   (C) 2008 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Longnecker, MP (Reprint Author), NIEHS, Epidemiol Branch, NIH, DHHS, MD A3-05,POB 12233, Res Triangle Pk, NC 27709 USA.
   Ye, Xibiao; Park, Melissa M.; Longnecker, Matthew P., NIEHS, Epidemiol Branch, NIH, DHHS, Res Triangle Pk, NC 27709 USA.
   Pierik, Frank H., TNO Netherlands Org Appl Sci Res, Dept Environm \& Hlth, NL-2600 AA Delft, Netherlands.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Duty, Susan, Simmons Coll, Sch Hlth Studies, Dept Nursing, Boston, MA 02115 USA.
   Angerer, Juergen, Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, D-8520 Erlangen, Germany.
   Park, Melissa M., Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC 27599 USA.
   Pierik, Frank H.; Burdorf, Alex; Mackenbach, Johan P., Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands.
   Hofman, Albert; Jaddoe, Vincent W. V., Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands.
   Jaddoe, Vincent W. V., Univ Med Ctr Rotterdam, Erasmus MC, Generat R Study Grp, NL-3000 CA Rotterdam, Netherlands.
   Jaddoe, Vincent W. V., Univ Med Ctr Rotterdam, Erasmus MC, Dept Pediat, NL-3000 CA Rotterdam, Netherlands.
   Steegers, Eric A. P., Univ Med Ctr Rotterdam, Erasmus MC, Dept Obstet \& Gynecol, NL-3000 CA Rotterdam, Netherlands.
   Tiemeier, Henning, Univ Med Ctr Rotterdam, Erasmus MC, Dept Child \& Adolescent Psychiat, NL-3000 CA Rotterdam, Netherlands.}},
DOI = {{10.1016/j.envres.2008.07.014}},
ISSN = {{0013-9351}},
Keywords = {{Organophosphorus (OP) pesticides; Bisphenol A (BPA); Phthalates;
   Prenatal exposure; Biological monitoring}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; DIALKYL PHOSPHATE METABOLITES; HUMAN EXPOSURE;
   ANOGENITAL DISTANCE; BIOMONITORING DATA; INTERNAL EXPOSURE; US
   POPULATION; MALE INFANTS; HUMAN HEALTH; CHILDREN}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{longnec1@niehs.nih.gov}},
ResearcherID-Numbers = {{Burdorf, Alex/A-2226-2008}},
Funding-Acknowledgement = {{Intramural Research Program; NIEHS; Harvard NIEHS Environmental Health
   Center {[}P30ES000002]}},
Funding-Text = {{Funding source: This study was supported by the Intramural Research
   Program, NIEHS and the Harvard NIEHS Environmental Health Center Pilot
   Project Grant P30ES000002. This study was approved by ethical committees
   in National Institutes of Health (NIH) and Erasmus MC.}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Barr DB, 2006, ENVIRON HEALTH PERSP, V114, P1763, DOI 10.1289/ehp.9062.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Barr DB, 2004, ENVIRON HEALTH PERSP, V112, P186, DOI 10.1289/ehp.6503.
   Barr DB, 2002, J CHROMATOGR B, V778, P5, DOI 10.1016/S1570-0232(02)00035-1.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Berkowitz GS, 2003, ENVIRON HEALTH PERSP, V111, P79, DOI 10.1289/ehp.5619.
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2.
   Bradman A, 2005, ENVIRON HEALTH PERSP, V113, P1802, DOI 10.1289/ehp.7894.
   Bravo R, 2004, J EXPO ANAL ENV EPID, V14, P249, DOI 10.1038/sj.jea.7500322.
   {[}Centers for Disease Control and Prevention National Center for Health Statistics], NAT HLTH NUTR EX SUR.
   CHERRY S, 1991, COMPLICATIONS PREGNA, P1249.
   DIGANGI J, 2002, PRETTY NASTY PHTHALA.
   Duggan A, 2003, REGUL TOXICOL PHARM, V37, P382, DOI 10.1016/S0273-2300(03)00031-X.
   Engel SM, 2007, AM J EPIDEMIOL, V165, P1397, DOI 10.1093/aje/kwm029.
   Eskenazi B, 2007, ENVIRON HEALTH PERSP, V115, P792, DOI 10.1289/ehp.9828.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Huang PC, 2007, HUM REPROD, V22, P2715, DOI 10.1093/humrep/dem205.
   Jaddoe VWV, 2006, EUR J EPIDEMIOL, V21, P475, DOI 10.1007/s10654-006-9022-0.
   Jaddoe VWV, 2007, EUR J EPIDEMIOL, V22, P917, DOI 10.1007/s10654-007-9209-z.
   Kang JH, 2006, TOXICOLOGY, V226, P79, DOI 10.1016/j.tox.2006.06.009.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2006, INT J ANDROL, V29, P181.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2001, J CHROMATOGR B, V759, P43, DOI 10.1016/S0378-4347(01)00209-2.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   LARSEN K, 1972, CLIN CHIM ACTA, V38, P475.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Lu CS, 2006, ENVIRON HEALTH PERSP, V114, P260, DOI 10.1289/ehp.8418.
   MAIKRANZ P, 1989, KIDNEY INT, V36, P108, DOI 10.1038/ki.1989.168.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   Morgan MK, 2005, J EXPO ANAL ENV EPID, V15, P297, DOI 10.1038/sj.jea.7500406.
   National Research Council, 1993, PEST DIETS INF CHILD.
   National Toxicology Program, 2007, NTP CERHR EXP PAN RE.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Tsai WT, 2006, J ENVIRON SCI HEAL C, V24, P225, DOI 10.1080/10590500600936482.
   vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005.
   Wessels D, 2003, ENVIRON HEALTH PERSP, V111, P1939, DOI 10.1289/ehp.6179.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wolff MS, 2007, PEDIATR RES, V61, P243, DOI 10.1203/pdr.0b013e31802d77f0.
   Yang M, 2006, ENVIRON MOL MUTAGEN, V47, P571, DOI 10.1002/em.20230.
   {*}EUR COMM, 2007, ANN EU WID PEST RES.
   {*}FDA, 2005, PEST RES MON PROGR 2.}},
Number-of-Cited-References = {{50}},
Times-Cited = {{72}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{361MS}},
Wos-Id = {{ISI:000260132400018}},
}

@article{ ISI:000260196000008,
Author = {Silva, Manori J. and Preau, Jr., James L. and Needham, Larry L. and
   Calafat, Antonia M.},
Title = {{Cross validation and ruggedness testing of analytical methods used for
   the quantification of urinary phthalate metabolites}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES}},
Year = {{2008}},
Volume = {{873}},
Number = {{2}},
Pages = {{180-186}},
Month = {{OCT 1}},
Abstract = {{Since the publication of our first analytical method in 2000 to detect
   and quantify phthalate metabolites in human urine. we have modified the
   method several times to improve Performance, reduce the volume of matrix
   and solvents used, and to increase the number of analytes in one
   analytical run. We performed cross method validation and ruggedness
   testing after each modification to ensure that the analytical method
   adopted is robust and produces accurate and reproducible data when
   compared to the previously used method. Here. we present the results
   from the evaluation of the ruggedness of our analytical approach under
   variable experimental conditions, using the current analytical method.
   Minor deviations of the standard experimental conditions, i.e., pH,
   incubation time, amount of deconjugation enzyme, and incubation
   temperature, had no effect on final analyte concentrations. Furthermore,
   we validated the method to ensure accuracy at concentrations beyond the
   highest calibration standard. The concentrations obtained by using a
   lower volume of urine agreed well with original levels, suggesting broad
   linear calibration range as well as complete hydrolysis of the
   glucuronide conjugates with the standard amount of beta-glucuronidase
   used for deglucuronidation: also, the time of incubation (90 min) was
   adequate regardless of the amount of glucuronide present. We also
   summarize the precision of concentration data acquired by the five
   different analytical approaches we have used since 2000. The correlation
   plots of concentration data for each analyte obtained from split sample
   analysis, using three of these approaches, produced linear curves (R-2 >
   0.98) with slopes and intercepts that were not statistically different
   (p > 0.05) from I and 0, respectively. These results suggest that the
   data are reproducible and accurate, regardless of the analytical method
   used. Furthermore, analysis of quality control urine samples made over
   the years confirmed the stability of the phthalate metabolites in urine
   at -70 degrees C for several years and the consistency of the analytical
   measurements obtained by using various methodological approaches over
   time. Published by Elsevier B.V.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Mailstop F53,4770 Buford Highway NE, Atlanta, GA 30341 USA.
   Silva, Manori J.; Preau, James L., Jr.; Needham, Larry L.; Calafat, Antonia M., Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.}},
DOI = {{10.1016/j.jchromb.2008.08.017}},
ISSN = {{1570-0232}},
Keywords = {{Analytical method validation; Ruggedness resting; Phthalate metabolites;
   Cross method validation; HPLC-MS/MS}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; DI(2-ETHYLHEXYL) PHTHALATE; QUANTITATIVE
   DETECTION; OCCUPATIONAL-EXPOSURE; HUMAN SERUM; RATS; POLYVINYLCHLORIDE;
   IDENTIFICATION; PESTICIDES; VEGETABLES}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{zca2@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   Barr DB, 2007, ANAL BIOANAL CHEM, V389, P811, DOI 10.1007/s00216-007-1463-0.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Botitsi H, 2007, ANAL BIOANAL CHEM, V389, P1685, DOI 10.1007/s00216-007-1452-3.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Calafat AM, 2006, INT J ANDROL, V29, P166, DOI 10.1111/j.1365-2605.2005.00570.x.
   Chen Q, 2007, BIOPHARM DRUG DISPOS, V28, P439, DOI 10.1002/bdd.567.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P3, DOI 10.2307/3429377.
   Koch HM, 2005, INT J HYG ENVIR HEAL, V208, P489, DOI 10.1016/j.ijheh.2005.07.001.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381.
   Nativelle C, 1999, FOOD CHEM TOXICOL, V37, P905, DOI 10.1016/S0278-6915(99)00071-X.
   NIELSEN J, 1985, AM IND HYG ASSOC J, V46, P643, DOI 10.1202/0002-8894(1985)046<0643:PEEALA>2.3.CO;2.
   Otake T, 2004, J EXPO ANAL ENV EPID, V14, P524, DOI 10.1038/sj.jea.7500352.
   Paglia G, 2007, J CHROMATOGR B, V860, P153, DOI 10.1016/j.jchromb.2007.10.025.
   Silva MJ, 2005, J ANAL TOXICOL, V29, P819.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2007, J CHROMATOGR B, V860, P106, DOI 10.1016/j.jchromb.2007.10.023.
   Silva MJ, 2007, ENVIRON SCI TECHNOL, V41, P7576, DOI 10.1021/es071142x.
   Simonelli A, 2007, J CHROMATOGR B, V860, P26, DOI 10.1016/j.jchromb.2007.10.001.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Wang LX, 2007, CHINESE J ANAL CHEM, V35, P1559.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{12}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{362KG}},
Wos-Id = {{ISI:000260196000008}},
}

@article{ ISI:000259279600012,
Author = {Ljungvall, Karl and Veeramachaneni, D. N. Rao and Hou, Mi and Hulten,
   Fredrik and Magnusson, Ulf},
Title = {{Morphology and morphometry of the reproductive organs in prepubertal and
   postpubertal male pigs exposed to di(2-ethylhexyl) phthalate before
   puberty: Precocious development of bulbourethral glands}},
Journal = {{THERIOGENOLOGY}},
Year = {{2008}},
Volume = {{70}},
Number = {{6}},
Pages = {{984-991}},
Month = {{OCT 1}},
Abstract = {{In a split-litter design experiment, male piglets were exposed orally
   three times weekly to 300 mg/kg of di(2-ethylhexyl) phthalate (DEHP) or
   placebo between three and seven weeks of age. The effects on the
   reproductive organs were examined immediately after the exposure at
   seven weeks of age in one sub-group, and postpuberally at nine months of
   age in the other. Morphological features of testes were unaffected at
   either age group; there were no differences (p > 0.05) between the
   treatments in number of Sertoli cells (as identified by immunostaining
   with GATA-4 antibodies), percent area of Leydig cells (as detected by 3
   beta-hydroxysteroid dehydrogenase histochemistry), or incidence of
   germinal epithelial lesions (histopathology of H\&E-stained (hematoxylin
   and eosin) sections). Three of the seven DEHP-treated animals in
   seven-week-old group had bulbourethral glands at a stage of maturation
   far more advanced than that of controls. While there were no obvious
   differences in the cellular composition between the treatment groups in
   nine-month-old animals, the bulbourethral glands were heavier (p < 0.05)
   in DEHP-treated boars. Collectively, these features indicate that
   adolescent exposure to DEHP induces precocious maturity of bulbourethral
   glands in pigs with persistent effects lasting into adulthood. (c) 2008
   Elsevier Inc. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Magnusson, U (Reprint Author), Swedish Univ Agr Sci SLU, Dept Clin Sci, Div Reprod, POB 7054, SE-75007 Uppsala, Sweden.
   Ljungvall, Karl; Magnusson, Ulf, Swedish Univ Agr Sci, Dept Clin Sci, SE-75007 Uppsala, Sweden.
   Ljungvall, Karl; Magnusson, Ulf, Swedish Univ Agr Sci, Ctr Reprod Biol, SE-75007 Uppsala, Sweden.
   Veeramachaneni, D. N. Rao, Colorado State Univ, Dept Biomed Sci, Anim Reprod \& Biotechnol Lab, Ft Collins, CO 80523 USA.
   Hou, Mi, Karolinska Univ Hosp, Dept Woman \& Child Hlth, SE-17176 Stockholm, Sweden.
   Hulten, Fredrik, Swedish Med Prod Agcy, SE-75103 Uppsala, Sweden.}},
DOI = {{10.1016/j.theriogenology.2008.05.061}},
ISSN = {{0093-691X}},
Keywords = {{pig; phthalates; testes; bulbourthral glands}},
Keywords-Plus = {{MALE-RAT; DI-(2-ETHYLHEXYL) PHTHALATE; SEXUAL-DIFFERENTIATION;
   TESTOSTERONE SYNTHESIS; IN-UTERO; BOAR; TESTIS; RECEPTORS; TOXICITY;
   PLASMA}},
Research-Areas = {{Reproductive Biology; Veterinary Sciences}},
Web-of-Science-Categories  = {{Reproductive Biology; Veterinary Sciences}},
Author-Email = {{ulf.magnusson@kv.slu.se}},
Funding-Acknowledgement = {{Swedish EPA}},
Funding-Text = {{The ReproSafe program of the Swedish EPA for financial Support,
   Professor Heriberto Rodriguez-Martinez and Dr Linda Spjuth for technical
   assistance as well as for reading this manuscript, Professor Stig
   Einarsson for reading the manuscript, the late Ms angstrom sa Jansson
   and Dr Mimmi Winskog for technical assistance.}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Awal MA, 2005, TISSUE CELL, V37, P167, DOI 10.1016/j.tice.2004.12.005.
   Badia E, 2005, EUR J HISTOCHEM, V49, P131.
   COOKE PS, 1987, ENDOCRINOLOGY, V121, P2153.
   COOKE PS, 1990, PROSTATE, V17, P145, DOI 10.1002/pros.2990170208.
   DANZO BJ, 1983, MOL CELL ENDOCRINOL, V33, P197, DOI 10.1016/0303-7207(83)90167-3.
   DESCHAMPS JC, 1987, AM J VET RES, V48, P137.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   Franca LR, 2000, BIOL REPROD, V63, P1629, DOI 10.1095/biolreprod63.6.1629.
   Gaido KW, 2007, TOXICOL SCI, V97, P491, DOI 10.1093/toxsci/kfm049.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Higuchi TT, 2003, TOXICOL SCI, V72, P301, DOI 10.1093/toxsci/kfg036.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kim HS, 2003, ARCH TOXICOL, V77, P446, DOI 10.1007/s00204-003-0466-7.
   LARSSON K, 1976, ACTA VET SCAND, V17, P83.
   Ljungvall K, 2005, THERIOGENOLOGY, V64, P1170, DOI 10.1016/j.theriogenology.2005.02.003.
   Ljungvall K, 2006, REPROD TOXICOL, V21, P160, DOI 10.1016/j.reprotox.2005.07.012.
   McCoard SA, 2001, BIOL REPROD, V64, P689, DOI 10.1095/biolreprod64.2.689.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PARROTT RF, 1984, J REPROD FERTIL, V71, P453.
   PAYNE AH, 1980, ENDOCRINOLOGY, V106, P1424.
   SJOBERG P, 1985, ACTA PHARMACOL TOX, V56, P30.
   Wilson VS, 2008, INT J ANDROL, V31, P178, DOI 10.1111/j.1365-2605.2007.00861.x.
   Wilson VS, 2007, TOXICOL LETT, V170, P177, DOI 10.1016/j.toxlet.2007.03.004.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{2}},
Journal-ISO = {{Theriogenology}},
Doc-Delivery-Number = {{349KL}},
Wos-Id = {{ISI:000259279600012}},
}

@article{ ISI:000259751900001,
Author = {Boberg, Julie and Metzdorff, Stine and Wortziger, Rasmus and Axelstad,
   Marta and Brokken, Leon and Vinggaard, Anne Marie and Dalgaard, Majken
   and Nellemann, Christine},
Title = {{Impact of diisobutyl phthalate and other PPAR agonists on
   steroidogenesis and plasma insulin and leptin levels in fetal rats}},
Journal = {{TOXICOLOGY}},
Year = {{2008}},
Volume = {{250}},
Number = {{2-3}},
Pages = {{75-81}},
Month = {{SEP 4}},
Abstract = {{Endocrine disrupting chemicals can induce malformations and impairment
   of reproductive function in experimental animals and may have similar
   effects in humans. Recently, the environmental obesogen hypothesis was
   proposed, suggesting that environmental chemicals contribute to the
   development of obesity and insulin resistance. These effects could be
   related to chemical interaction with nuclear receptors such as the
   peroxisome proliferator activated receptors (PPARs). As several
   testosterone-reducing drugs are PPAR activators, we aimed to examine
   whether four PPAR agonists were able to affect fetal testosterone
   production and masculinization of rats. Additionally, we wished to
   examine whether these chemicals affected fetal plasma levels of insulin
   and leptin, which play important roles in the developmental programming
   of the metabolic system.
   Pregnant Wistar rats were exposed from gestation day (GD) 7-21 to
   diisobutyl phthalate (DiBP), butylparaben, perfluorooctanoate, or
   rosiglitazone (600, 100, 20, or 1 mg/kg bw/day, respectively). Endocrine
   endpoints were studied in offspring at GD 19 or 21.
   DiBP, butylparaben and rosiglitazone reduced plasma leptin levels in
   male and female offspring. DiBP and rosiglitazone additionally reduced
   fetal plasma insulin levels. In mates, DiBP reduced anogenital
   testosterone production and testicular expression of Insl-3 and genes
   related to steroidogenesis. distance, PPAR alpha mRNA levels were
   reduced by DiBP at GD 19 in testis and liver. In females, DiBP increased
   anogenital distance and increased ovarian aromatase mRNA levels. This
   study reveals new targets for phthalates and parabens in fetal male and
   female rats and contributes to the increasing concern about adverse
   effects of human exposure to these compounds. (C) 2008 Elsevier Ireland
   Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Boberg, J (Reprint Author), Tech Univ Denmark, Natl Food Inst, Morkhoj Bygade 19, DK-2860 Soborg, Denmark.
   Boberg, Julie; Metzdorff, Stine; Wortziger, Rasmus; Axelstad, Marta; Vinggaard, Anne Marie; Dalgaard, Majken; Nellemann, Christine, Tech Univ Denmark, Natl Food Inst, DK-2860 Soborg, Denmark.
   Brokken, Leon, Univ Turku, Dept Physiol, Inst Biomed, FIN-20520 Turku, Finland.}},
DOI = {{10.1016/j.tox.2008.05.020}},
ISSN = {{0300-483X}},
Keywords = {{diisobutyl phthalate; paraben; perfluorooctaonate; rosiglitazone;
   prenatal; steroidogenesis; testis; rat; insulin; leptin}},
Keywords-Plus = {{POLYCYSTIC-OVARY-SYNDROME; TESTICULAR DYSGENESIS SYNDROME; MALE
   REPRODUCTIVE-SYSTEM; N-BUTYL PHTHALATE; DI(N-BUTYL) PHTHALATE;
   GENE-EXPRESSION; AMMONIUM PERFLUOROOCTANOATE; ENVIRONMENTAL OBESOGENS;
   DIETHYLHEXYL PHTHALATE; TESTOSTERONE SYNTHESIS}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{jubo@food.dtu.dk}},
ResearcherID-Numbers = {{Kransler, Kevin/A-9662-2009}},
Funding-Acknowledgement = {{Nordic Council of Ministers; Danish Medical Council {[}22-03-0198,
   2107-04-0006]}},
Funding-Text = {{Nordic Council of Ministers and Danish Medical Council (grant no.
   22-03-0198 and 2107-04-0006).}},
Cited-References = {{Azziz R, 2001, J CLIN ENDOCR METAB, V86, P1626, DOI 10.1210/jc.86.4.1626.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   BIEGEL LB, 1995, TOXICOL APPL PHARM, V134, P18, DOI 10.1006/taap.1995.1164.
   Bloomgarden Z T, 2001, Endocr Pract, V7, P279.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   COOK JC, 1992, TOXICOL APPL PHARM, V113, P209, DOI 10.1016/0041-008X(92)90116-A.
   Corton JC, 2005, TOXICOL SCI, V83, P4, DOI 10.1093/toxsci/kfi011.
   Dalgaard M, 2003, REPROD TOXICOL, V17, P163, DOI 10.1016/S0890-6238(02)00149-1.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Grun F, 2006, ENDOCRINOLOGY, V147, pS50.
   Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x.
   Holemans K, 2003, J PHYSIOL-LONDON, V547, P11, DOI 10.1113/jphysiol.2002.036582.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Kersten S, 2000, NATURE, V405, P421.
   Korhonen S, 2003, HUM REPROD, V18, P540, DOI 10.1093/humrep/deg128.
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169.
   Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026.
   Lovekamp-Swan T, 2003, MOL CELL ENDOCRINOL, V201, P133, DOI 10.1016/S0303-7207(02)00423-9.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Newbold RR, 2007, MOL NUTR FOOD RES, V51, P912, DOI 10.1002/mnfr.200600259.
   Oishi S, 2002, FOOD CHEM TOXICOL, V40, P1807, DOI 10.1016/S0278-6915(02)00204-1.
   Oishi S, 2001, TOXICOL IND HEALTH, V17, P31, DOI 10.1191/0748233701th093oa.
   Olsen GW, 2005, ENVIRON HEALTH PERSP, V113, P539, DOI 10.1289/ehp.7544.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Seidlova-Wuttke D, 2005, TOXICOLOGY, V213, P13, DOI 10.1016/j.tox.2005.05.001.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   Silva MJ, 2005, ARCH TOXICOL, V79, P647, DOI 10.1007/s00204-005-0674-4.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Taxvig C, 2007, TOXICOL SCI, V100, P464, DOI 10.1093/toxsci/kfm227.
   Thompson CJ, 2004, ENDOCRINOLOGY, V145, P1227, DOI 10.1210/en.2003-1475.
   Toruner F, 2004, HORM METAB RES, V36, P226.
   Vickers Mark H, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P17, DOI 10.1097/MED.0b013e328013da48.
   Vierhapper H, 2003, METABOLISM, V52, P230, DOI 10.1053/meta.2003.50028.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   Xita N, 2006, J CLIN ENDOCR METAB, V91, P1660, DOI 10.1210/jc.2005-2757.
   Ye XY, 2006, ENVIRON HEALTH PERSP, V114, P1843, DOI 10.1289/ehp.9413.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{35}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{356AU}},
Wos-Id = {{ISI:000259751900001}},
}

@article{ ISI:000259547300016,
Author = {Kusu, Rena and Oishi, Ami and Kakizawa, Kimi and Kimura, Tomomi and
   Toda, Chitose and Hashizume, Kiyomatsu and Ueda, Koji and Kojima, Nakao},
Title = {{Effects of phthalate ester derivatives including oxidized metabolites on
   coactivator recruiting by PPAR alpha and PPAR gamma}},
Journal = {{TOXICOLOGY IN VITRO}},
Year = {{2008}},
Volume = {{22}},
Number = {{6}},
Pages = {{1534-1538}},
Month = {{SEP}},
Abstract = {{Phthalate esters (PEs), a group of environmental chemicals, affect
   biological systems via endocrine and lipid metabolism modulations. These
   effects are believed to be mediated in part by peroxisome
   proliferator-activated receptors (PPARs). Evaluations of PE activities
   as ligands toward PPARs have been investigated in many studies on their
   primary metabolites, monoesters. However, the activities of various
   other metabolites, including oxidized derivatives, remain to be
   determined. Here, we have evaluated the PPAR ligand activities of these
   PE derivatives by in vitro coactivator recruiting assay.
   Mono(2-ethyl-5-hydroxyhexyl)phthalate, the most abundant metabolite of
   di-(2-ethylhexyl)phthalate (DEHP), was less active than
   mono(2-ethylhexyl)phthalate (MEHP) as a PPAR ligand. Other derivatives
   oxidized at the alkyl group and benzene ring of DEHP, MEHP dibutyl
   phthalate and its monoester were also investigated and some affected
   PPAR activities. Unexpectedly, MEHP as well as its further oxidized
   metabolite did not show clear activity for PPAR alpha, although MEHP is
   believed to interact with PPAR alpha. This might imply indirect
   PPAR-mediated mechanisms that lead to observed biological effects such
   as peroxisome proliferation. (C) 2008 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kojima, N (Reprint Author), Meijo Univ, Fac Pharm, Tempaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.
   Kusu, Rena; Oishi, Ami; Kakizawa, Kimi; Kimura, Tomomi; Toda, Chitose; Hashizume, Kiyomatsu; Ueda, Koji; Kojima, Nakao, Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan.}},
DOI = {{10.1016/j.tiv.2008.05.010}},
ISSN = {{0887-2333}},
Keywords = {{phthalate ester; DEHP; MEHP; oxidized metabolite; PPAR; peroxisome
   proliferator; coactivator}},
Keywords-Plus = {{ACTIVATED-RECEPTOR-ALPHA; ACID-BINDING PROTEIN; ACYL-COA OXIDASE;
   DI(2-ETHYLHEXYL)PHTHALATE DEHP; HUMAN URINE; X-RECEPTOR; ADIPOCYTE
   DIFFERENTIATION; PEROXISOME PROLIFERATORS; HUMAN EXPOSURE; FATTY-ACIDS}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{kojiman@ccmfs.meijo-u.ac.jp}},
Funding-Acknowledgement = {{Research Institute of Meijo University; Scientific Frontier Research
   Project; Ministry of Education, Culture, Sports, Science and Technology
   of Japan}},
Funding-Text = {{We thank Ms. Y. Tozuka and Mr. A. Suzuki for their help in MS analysis
   and chemical synthesis. This research was supported by the bounty for
   academic research from the Research Institute of Meijo University and by
   the Scientific Frontier Research Project from the Ministry of Education,
   Culture, Sports, Science and Technology of Japan.}},
Cited-References = {{ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   BARBER ED, 1987, TOXICOL IND HEALTH, V3, P7.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   BELL DR, 1991, BIOCHEM J, V280, P249.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   CARTER JE, 1977, J PHARM SCI, V66, P546, DOI 10.1002/jps.2600660422.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   FOSTER PM, 1982, DRUG METAB DISPOS, V11, P59.
   Gilsing HD, 2002, MONATSH CHEM, V133, P1147, DOI 10.1007/s007060200084.
   Haishima Y, 2004, INT J PHARM, V274, P119, DOI 10.1016/j.ijpharm.2004.01.009.
   Hashizume K, 2002, BIOL PHARM BULL, V25, P209, DOI 10.1248/bpb.25.209.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019.
   Kanayama T, 2003, J BIOCHEM, V133, P791, DOI 10.1093/jb/mvg101.
   Kanayama T, 2005, MOL PHARMACOL, V67, P766, DOI 10.1124/mol.104.008409.
   KANDA T, 1990, BIOCHEM BIOPH RES CO, V168, P1053, DOI 10.1016/0006-291X(90)91136-G.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   KAWASHIMA Y, 1983, BIOCHIM BIOPHYS ACTA, V754, P21, DOI 10.1016/0005-2760(83)90077-2.
   Kaya T, 2006, CHEM RES TOXICOL, V19, P999, DOI 10.1021/tx050301s.
   Koch HM, 2005, ARCH TOXICOL, V79, P689, DOI 10.1007/s00204-005-0004-x.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Lapinskas PJ, 2005, TOXICOLOGY, V207, P149, DOI 10.1016/j.tox.2004.09.008.
   MITCHELL AM, 1985, TOXICOL APPL PHARM, V80, P23, DOI 10.1016/0041-008X(85)90097-3.
   MUERHOFF AS, 1992, J BIOL CHEM, V267, P19051.
   Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0.
   Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Simonson G. D., 2006, CURRENT OPINION ENDO, V13, P162, DOI 10.1097/01.med.0000216965.36504.be.
   TANAKA A, 1978, TOXICOLOGY, V9, P109, DOI 10.1016/0300-483X(78)90036-7.
   Toda C, 2004, ARCH BIOCHEM BIOPHYS, V431, P16, DOI 10.1016/j.abb.2004.07.028.
   Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120.
   TUGWOOD JD, 1992, EMBO J, V11, P433.
   Venkata NG, 2006, TOXICOL LETT, V163, P224, DOI 10.1016/j.toxlet.2005.11.001.
   Ward JM, 1998, TOXICOL PATHOL, V26, P240.
   Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898.
   Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0.
   Xu Y, 2005, TOXICOL SCI, V84, P287, DOI 10.1093/toxsci/kfi083.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{7}},
Journal-ISO = {{Toxicol. Vitro}},
Doc-Delivery-Number = {{353DW}},
Wos-Id = {{ISI:000259547300016}},
}

@article{ ISI:000258270200032,
Author = {Wolff, Mary S. and Engel, Stephanie M. and Berkowitz, Gertrud S. and Ye,
   Xiaoyun and Silva, Manori J. and Zhu, Chenbo and Wetmur, James and
   Calafat, Antonia M.},
Title = {{Prenatal phenol and phthalate exposures and birth outcomes}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2008}},
Volume = {{116}},
Number = {{8}},
Pages = {{1092-1097}},
Month = {{AUG}},
Abstract = {{BACKGROUND: Many phthalates and phenols are hormonally active and are
   suspected to alter the course of development.
   OBJECTIVE: We investigated prenatal exposures to phthalate and phenol
   metabolites and their associations with body size measures of the
   infants at birth.
   METHODS: We measured 5 phenol and 10 phthalate urinary metabolites in a
   multiethnic cohort of 404 women in New York City during their third
   trimester of pregnancy and recorded size of infants at birth.
   RESULTS: Median urinary concentrations were > 10 mu g/L for 2 of 5
   phenols and 6 of 10 phthalate monoester metabolites. Concentrations of
   low-molecular-weight phthalate monoesters (low-MWP) were approximately
   5-fold greater than those of high-molecular-weight metabolites. Low-MWP
   metabolites had a positive association with gestational age {[}0.97 day
   gestational age per ln-biomarker; 95\% confidence interval (CI),
   0.07-1.9 days, multivariate adjusted] and with head circumference.
   Higher prenatal exposures to 2,5-dichlorophenol (2,5-DCP) predicted
   lower birth weight in boys (-210 g average birth weight difference
   between the third tertile and first tertile of 2,5-DCP; 95\% CI, 71-348
   g). Higher maternal benzophenone-3 (BP3) concentrations were associated
   with a similar decrease in birth weight among girls but with greater
   birth weight in boys.
   CONCLUSIONS: We observed a range of phthalate and phenol exposures
   during pregnancy in our population, but few were associated with birth
   size. The association of 2,5-DCP and BP3 with reduced or increased birth
   weight could be important in very early or small-size births. In
   addition, positive associations of urinary metabolites with some
   outcomes may be attributable partly to unresolved confounding with
   maternal anthropometric factors.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wolff, MS (Reprint Author), Mt Sinai Sch Med, Dept Community \& Prevent Med, 1 Gustave L Levy Pl,Box 10571, New York, NY 10029 USA.
   Wolff, Mary S.; Engel, Stephanie M.; Berkowitz, Gertrud S.; Zhu, Chenbo, Mt Sinai Sch Med, Dept Community \& Prevent Med, New York, NY 10029 USA.
   Ye, Xiaoyun; Silva, Manori J.; Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Wetmur, James, Mt Sinai Sch Med, Dept Microbiol \& Genet \& Genom Sci, New York, NY 10029 USA.}},
DOI = {{10.1289/ehp.11007}},
ISSN = {{0091-6765}},
Keywords = {{2,5-DCP; birth length; birth weight; BMI; creatinine; phenols;
   phthalates; pregnancy; urinary biomarker}},
Keywords-Plus = {{NUTRITION EXAMINATION SURVEY; IN-UTERO EXPOSURE; BISPHENOL-A;
   BIS(2-ETHYLHEXYL) PHTHALATE; PESTICIDE EXPOSURE; AGRICULTURAL
   POPULATION; LIQUID-CHROMATOGRAPHY; ESTROGENIC ACTIVITIES;
   MASS-SPECTROMETRY; METABOLITE LEVELS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{mary.wolff@mssm.edu}},
Cited-References = {{Apelberg BJ, 2007, ENVIRON SCI TECHNOL, V41, P3891, DOI 10.1021/es0700911.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Berkowitz GS, 2004, ENVIRON HEALTH PERSP, V112, P388, DOI 10.1289/ehp.6414.
   Bernstein IM, 2005, OBSTET GYNECOL, V106, P986, DOI 10.1097/01.AOG.0000182580.78402.d2.
   BORNATOWICZ N, 1994, WIEN KLIN WOCHENSCHR, V106, P345.
   Bradman A, 2003, ENVIRON HEALTH PERSP, V111, P1779, DOI 10.1289/ehp.6259.
   Bradman A, 2005, ENVIRON HEALTH PERSP, V113, P1802, DOI 10.1289/ehp.7894.
   Carrieri M, 2001, INT ARCH OCC ENV HEA, V74, P63.
   Centers for Disease Control and Prevention National Center for Environmental Health Division of Laboratory Sciences, 2005, NCEH PUB.
   Chen JG, 2007, TOXICOL APPL PHARM, V221, P278, DOI 10.1016/j.taap.2007.03.015.
   Dalgaard M, 2003, REPROD TOXICOL, V17, P163, DOI 10.1016/S0890-6238(02)00149-1.
   Elliott L, 2006, ENVIRON HEALTH PERSP, V114, P1210, DOI 10.1289/ehp.9019.
   Engel SM, 2006, REPROD TOXICOL, V21, P110, DOI 10.1016/j.reprotox.2005.07.007.
   Eskenazi B, 2004, ENVIRON HEALTH PERSP, V112, P1116, DOI 10.1289/ehp.6789.
   Fang H, 2000, ENVIRON HEALTH PERSP, V108, P723, DOI 10.1289/ehp.00108723.
   Fenster L, 2006, ENVIRON HEALTH PERSP, V114, P597, DOI 10.1289/ehp.8423.
   Ferguson SA, 2000, NEUROTOXICOL TERATOL, V22, P583, DOI 10.1016/S0892-0362(00)00071-4.
   Ge RS, 2007, J ANDROL, V28, P513, DOI 10.2164/jandrol.106.001909.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   HILL RH, 1995, ARCH ENVIRON HEALTH, V50, P277.
   Holmes TJ, 2001, LIFE SCI, V69, P2975, DOI 10.1016/S0024-3205(01)01406-0.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hoshino Nobuhito, 2005, Journal of Toxicological Sciences, V30, P79.
   Hsieh MH, 2007, J UROLOGY, V178, P1637, DOI 10.1016/j.juro.2007.03.190.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kuklenyik Z, 2003, ANAL CHEM, V75, P6820, DOI 10.1021/ac0303158.
   Latendresse JR, 2001, TOXICOL SCI, V62, P140, DOI 10.1093/toxsci/62.1.140.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Latini G, 2006, CURR MED CHEM, V13, P2527, DOI 10.2174/092986706778201666.
   Lee Chae-Kwan, 2005, J Prev Med Public Health, V38, P330.
   Liu ZS, 2005, J CHROMATOGR B, V819, P155, DOI 10.1016/j.jchromb.2005.02.005.
   Longnecker MP, 1999, ARCH ENVIRON HEALTH, V54, P110.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Marsman D, 1995, TOXIC REP SER, V30, P1.
   Matsumoto A, 2003, ENVIRON HEALTH PERSP, V111, P101, DOI 10.1289/ehp.5512.
   Muckle G, 2001, ENVIRON HEALTH PERSP, V109, P1291, DOI 10.2307/3454753.
   Ogawa Y, 2006, FOOD ADDIT CONTAM, V23, P422, DOI {[}10.1080/02652030500482671, 10.1080/02652030500482371].
   Oken Emily, 2003, BMC Pediatr, V3, P6, DOI 10.1186/1471-2431-3-6.
   Ouchi K, 2002, J CHROMATOGR B, V780, P365, DOI 10.1016/S1570-0232(02)00547-0.
   Paris F, 2002, MOL CELL ENDOCRINOL, V193, P43, DOI 10.1016/S0303-7207(02)00094-1.
   Savabieasfahani M, 2006, ENDOCRINOLOGY, V147, P5956, DOI 10.1210/en.2006-0805.
   Seidlova-Wuttke D, 2005, TOXICOLOGY, V213, P13, DOI 10.1016/j.tox.2005.05.001.
   Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Tanaka T, 2003, FOOD CHEM TOXICOL, V41, P1429, DOI 10.1016/S0278-6915(03)00162-5.
   Tanaka T, 2002, FOOD CHEM TOXICOL, V40, P1499, DOI 10.1016/S0278-6915(02)00073-X.
   Tanaka T, 2005, FOOD CHEM TOXICOL, V43, P581, DOI 10.1016/j.fct.2005.01.001.
   TEITELBAUM SL, 2007, ENV RES.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   van Meeuwen JA, 2007, FOOD CHEM TOXICOL, V45, P2319, DOI 10.1016/j.fct.2007.06.011.
   Wolff MS, 2007, PEDIATR RES, V61, P243, DOI 10.1203/pdr.0b013e31802d77f0.
   Wolff MS, 2007, ENVIRON HEALTH PERSP, V115, P116, DOI 10.1289/ehp.9488.
   Ye XY, 2005, ANAL BIOANAL CHEM, V383, P638, DOI 10.1007/s00216-005-0019-4.
   {*}NAT TOX PROGR, 2005, 106467 CAS NAT TOX P.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{72}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{335DE}},
Wos-Id = {{ISI:000258270200032}},
}

@article{ ISI:000256317800003,
Author = {Gaudin, R. and Marsan, P. and Robert, A. and Ducos, P. and Pruvost, A.
   and Levi, M. and Bouscaillou, P.},
Title = {{Biological monitoring of occupational exposure to di(2-ethylhexyl)
   phthalate: survey of workers exposed to plastisols}},
Journal = {{INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH}},
Year = {{2008}},
Volume = {{81}},
Number = {{8}},
Pages = {{959-966}},
Month = {{AUG}},
Abstract = {{Objective The aim of this study was to perform a biological monitoring
   survey of workers exposed to di(2-ethylhexyl)phthalate (DEHP) in a
   factory using polyvinyl chloride plastisols and to contribute additional
   occupational data of exposure particularly sparse in the industrial
   sectors where this plasticizer is used.
   Method Three urinary metabolites of DEHP, mono(2-ethylhexyl)phthalate
   (MEHP), mono(5-carboxy-2-ethylpentyl)phthalate (MCEPP) and
   2-ethylhexanoic acid (2-EHA) were quantified in five workers using a
   plastisol (containing 33\% of DEHP) and in five unexposed workers
   (controls), during 5 days with pre- and post-shift sampling. Analyses
   were performed by high-performance liquid chromatography with tandem
   mass spectrometry (HPLC-MS/MS) with on-line extraction.
   Results Median concentrations of pre- and post-shift urinary samples in
   the exposed workers (n = 25) were 16.1 and 55.9 mu g/l for MEHP, 37.6
   and 103.7 mu g/l for MCEPP and 46.3 and 72.1 mu g/l for 2-EHA,
   respectively. In the controls (n = 19), the corresponding values were
   12.0 and 10.4 mu g/l for MEHP, 38.1 and 11.4 mu g/l for MCEPP and 31.9
   and 46.0 mu g/l for 2-EHA, respectively. There is a significant increase
   (Mann-Whitney U-test, P < 0.05) of post-shift excretion in the exposed
   workers versus unexposed controls and in post-shift versus pre-shift
   concentrations only in the exposed workers.
   Conclusion MEHP and MCEPP are shown to be suitable biomarkers to assess
   DEHP exposure while 2-EHA, less specific but classified in the category
   3 of the European Union (EU) reproductive toxicants, is also an
   interesting biomarker. There is clear evidence of occupational exposure
   of workers in this factory.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING ST, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gaudin, R (Reprint Author), Inst Natl Rech \& Secur, Dept Polluants \& Sante, BP 27, F-54501 Vandoeuvre Les Nancy, France.
   Gaudin, R.; Marsan, P.; Robert, A.; Ducos, P., Inst Natl Rech \& Secur, Dept Polluants \& Sante, F-54501 Vandoeuvre Les Nancy, France.
   Pruvost, A., CEA Saclay, DSV iBiTec S SPI, CEA, Lab Etude Metab Medicaments, F-91191 Gif Sur Yvette, France.
   Levi, M., SPI BIO, F-78180 Montigny Le Bretonneux, France.}},
DOI = {{10.1007/s00420-007-0289-6}},
ISSN = {{0340-0131}},
Keywords = {{DEHP; biological monitoring; metabolites; occupational exposure}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; DEUTERIUM-LABELED DEHP; HUMAN URINE;
   PLASTICIZER DI(2-ETHYLHEXYL)PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE;
   METABOLITES; BIOMARKERS; POLYVINYLCHLORIDE; POPULATION; SECONDARY}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{rene.gaudin@inrs.fr}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   ALBRO PW, 1981, DRUG METAB DISPOS, V9, P223.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   CADOGAN D, 2006, EUROPEAN COUNCIL PLA.
   Centers for Disease Control and Prevention, 2005, 3 NAT REP HUM EXP EN.
   CIPPOLA C, 1999, MED LAV, V90, P513.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   DOELMAN CJA, 1990, LANCET, V335, P725, DOI 10.1016/0140-6736(90)90839-W.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J LIQ CHROMATOGR R T, V26, P2167, DOI 10.1081/JLC-120022401.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381.
   Melnick RL, 2001, ENVIRON HEALTH PERSP, V109, P437, DOI 10.2307/3454700.
   Milkov L E, 1973, Environ Health Perspect, V3, P175, DOI 10.2307/3428045.
   NIELSEN J, 1985, AM IND HYG ASSOC J, V46, P643, DOI 10.1202/0002-8894(1985)046<0643:PEEALA>2.3.CO;2.
   Nuti F, 2005, BIOORGAN MED CHEM, V13, P3461, DOI 10.1016/j.bmc.2005.03.005.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   THIESS AM, 1978, ZBL ARBEITSMED, V12, P351.
   Wahl HG, 2001, J CHROMATOGR B, V758, P213.
   {*}CDCP, 2003, 2 NAT REP HUM EXP EN.
   {*}EU, 2001, RISK ASS BIS 2 ETH P.
   {*}IARC, 2000, MON EV CARC RISKS HU, P41.
   {*}NTP CERHR, 2000, EXP PAN REP 2 ETH PH.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{8}},
Journal-ISO = {{Int. Arch. Occup. Environ. Health}},
Doc-Delivery-Number = {{307KM}},
Wos-Id = {{ISI:000256317800003}},
}

@article{ ISI:000257560300002,
Author = {Hatch, Elizabeth E. and Nelson, Jessica W. and Qureshi, M. Mustafa and
   Weinberg, Janice and Moore, Lynn L. and Singer, Martha and Webster,
   Thomas F.},
Title = {{Association of urinary phthalate metabolite concentrations with body
   mass index and waist circumference: a cross-sectional study of NHANES
   data, 1999-2002}},
Journal = {{ENVIRONMENTAL HEALTH}},
Year = {{2008}},
Volume = {{7}},
Month = {{JUN 3}},
Abstract = {{Background: Although diet and activity are key factors in the obesity
   epidemic, laboratory studies suggest that endocrine disrupting chemicals
   may also affect obesity.
   Methods: We analyzed associations between six phthalate metabolites
   measured in urine and body mass index (BMI) and waist circumference (WC)
   in National Health and Nutrition Examination Survey (NHANES)
   participants aged 6-80. We included 4369 participants from NHANES
   1999-2002, with data on mono-ethyl (MEP), mono-2-ethylhexyl (MEHP),
   mono-n-butyl (MBP), and mono-benzyl (MBzP) phthalate; 2286 also had data
   on mono-2-ethyl-5-hydroxyhexyl (MEHHP) and mono-2-ethyl-5-oxohexyl
   (MEOHP) phthalate (2001-2002). Using multiple regression, we computed
   mean BMI and WC within phthalate quartiles in eight age/gender specific
   models.
   Results: The most consistent associations were in males aged 20-59; BMI
   and WC increased across quartiles of MBzP (adjusted mean BMI = 26.7,
   27.2, 28.4, 29.0, p-trend = 0.0002), and positive associations were also
   found for MEOHP, MEHHP, MEP, and MBP. In females, BMI and WC increased
   with MEP quartile in adolescent girls (adjusted mean BMI = 22.9, 23.8,
   24.1, 24.7, p-trend = 0.03), and a similar but less strong pattern was
   seen in 20 59 year olds. In contrast, MEHP was inversely related to BMI
   in adolescent girls (adjusted mean BMI = 25.4, 23.8, 23.4, 22.9, p-trend
   = 0.02) and females aged 20-59 (adjusted mean BMI = 29.9, 29.9, 27.9,
   27.6, p-trend = 0.02). There were no important associations among
   children, but several inverse associations among 60-80 year olds.
   Conclusion: This exploratory, cross-sectional analysis revealed a number
   of interesting associations with different phthalate metabolites and
   obesity outcomes, including notable differences by gender and age
   subgroups. Effects of endocrine disruptors, such as phthalates, may
   depend upon endogenous hormone levels, which vary dramatically by age
   and gender. Individual phthalates also have different biologic and
   hormonal effects. Although our study has limitations, both of these
   factors could explain some of the variation in the observed
   associations. These preliminary data support the need for prospective
   studies in populations at risk for obesity.}},
Publisher = {{BIOMED CENTRAL LTD}},
Address = {{236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hatch, EE (Reprint Author), Boston Univ, Sch Publ Hlth, Dept Epidemiol, 715 Albany St, Boston, MA 02118 USA.
   Hatch, Elizabeth E., Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA.
   Nelson, Jessica W.; Webster, Thomas F., Boston Univ, Sch Publ Heal, Dept Environm Hlth, Boston, MA 02118 USA.
   Qureshi, M. Mustafa; Moore, Lynn L.; Singer, Martha, Boston Univ, Sch Med, Prevent Med \& Epidemiol Sect, Boston, MA 02118 USA.
   Weinberg, Janice, Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA.}},
DOI = {{10.1186/1476-069X-7-27}},
Article-Number = {{27}},
ISSN = {{1476-069X}},
Keywords-Plus = {{ENDOCRINE-DISRUPTING CHEMICALS; OXIDATIVE METABOLITES; OBESITY EPIDEMIC;
   RECEPTORS PPARS; HUMAN EXPOSURE; UNITED-STATES; US POPULATION; MALE-RAT;
   HEALTH; MONOESTERS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{eehatch@bu.edu
   jwnelson@bu.edu
   mustafaq@bu.edu
   janicew@bu.edu
   llmoore@bu.edu
   msinger@bu.edu
   twebster@bu.edu}},
Cited-References = {{Ahima RS, 2000, TRENDS ENDOCRIN MET, V11, P327, DOI 10.1016/S1043-2760(00)00301-5.
   ATSDR, 2001, TOX PROF DI N BUT PH.
   Barak Y, 2007, PPAR RES, DOI 10.1155/2007/12781.
   Barber TM, 2006, CLIN ENDOCRINOL, V65, P137, DOI 10.1111/j.1365-2265.2006.02587.x.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253.
   Breous E, 2005, MOL CELL ENDOCRINOL, V244, P75, DOI 10.1016/j.mce.2005.06.009.
   Cooke PS, 2004, EXP BIOL MED, V229, P1127.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2.
   Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Graubard BL, 1999, J NATL CANCER I, V91, P1005, DOI 10.1093/jnci/91.12.1005.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Grun F, 2006, ENDOCRINOLOGY, V147, pS50.
   HASTIE TJ, 1990, GEN ADDITIVE MODELS, P29.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Heindel JJ, 2003, TOXICOL SCI, V76, P247, DOI 10.1093/toxsci/kfg255.
   Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Ishihara A, 2003, GEN COMP ENDOCR, V134, P36, DOI 10.1016/S0016-6480(03)00197-7.
   Janssen I, 2004, AM J CLIN NUTR, V79, P379.
   Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   KORN EL, 1991, AM J PUBLIC HEALTH, V81, P1166, DOI 10.2105/AJPH.81.9.1166.
   Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357.
   Lampen A, 2003, TOXICOL APPL PHARM, V188, P14, DOI 10.1016/S0041-008X(03)00014-0.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809.
   Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x.
   Meeker JD, 2007, ENVIRON HEALTH PERSP, V115, P1029, DOI 10.1289/ehp.9852.
   NCHS, NAT HLTH NUTR EX SUR.
   Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   ROLLANDCACHERA MF, INT J OBES, V30, pS11.
   Shimada N, 2004, J ENDOCRINOL, V183, P627, DOI 10.1677/joe.1.05893.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882.
   Sugiyama S, 2005, TOXICOL SCI, V88, P367, DOI 10.1093/toxsci/kfi330.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   U.S. Department of Agriculture, FOOD GUID PYR.
   Wenzel A, 2005, MOL CELL ENDOCRINOL, V244, P63, DOI 10.1016/j.mce.2005.02.008.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   Zhang Q, 2004, SOC SCI MED, V58, P1171, DOI 10.1016/S0277-9536(03)00288-0.
   {*}ATSDR, 2001, TOX PROF DI 2 ETH PH.
   {*}CDCP, 2005, 3 ANT REP HUM EXP EN.
   {*}CDCP NCHS, NAT HLTH NUTR EX SUR.}},
Number-of-Cited-References = {{55}},
Times-Cited = {{64}},
Journal-ISO = {{Environ. Health}},
Doc-Delivery-Number = {{325AK}},
Wos-Id = {{ISI:000257560300002}},
}

@article{ ISI:000256056800008,
Author = {Culty, Martine and Thuillier, Raphael and Li, Wenping and Wang, Yan and
   Martinez-Arguelles, Daniel B. and Benjamin, Carolina Gesteira and
   Triantafilou, Kostantinos M. and Zirkin, Barry R. and Papadopoulos,
   Vassilios},
Title = {{In utero exposure to di-(2-ethylhexyl) phthalate exerts both short-term
   and long-lasting suppressive effects on testosterone production in the
   rat}},
Journal = {{BIOLOGY OF REPRODUCTION}},
Year = {{2008}},
Volume = {{78}},
Number = {{6}},
Pages = {{1018-1028}},
Month = {{JUN}},
Abstract = {{We examined the effects of fetal exposure to a wide range of
   di-(2-ethylhexyl) phthalate (DEHP) doses on fetal, neonatal, and adult
   testosterone production. Pregnant rats were administered DEHP from
   Gestational Day (GD) 14 to the day of parturition (Postnatal Day 0).
   Exposure to between 234 and 1250 mg/kg/day of DEHP resulted in increases
   in the absolute volumes of Leydig cells per adult testis. Despite this,
   adult serum testosterone levels were reduced significantly compared to
   those of controls at all DEHP doses. Organ cultures of testes from GD20
   rats exposed in utero to DEHP showed dose-dependent reductions in basal
   testosterone production. Surprisingly, however, no significant effect of
   DEHP was found on hCG-induced testosterone production by GD20 testes,
   suggesting that the inhibition of basal steroidogenesis resulted from
   the alteration of molecular events upstream of the steroidogenic
   enzymes. Reduced fetal and adult testosterone production in response to
   in utero DEHP exposure appeared to be unrelated to changes in
   testosterone metabolism. in view of the DEHP-induced reductions in adult
   testosterone levels, a decrease in the expression of
   steroidogenesis-related genes was anticipated. Surprisingly, however,
   significant increases were seen in the expression of Cyp11a1, Cy17a1,
   Star, and Tspo transcripts, suggesting that decreased testosterone
   production after birth could not be explained by decreases in
   steroidogenic enzymes as seen at GD20. These changes may reflect an
   increased number of Leydig cells in adult testes exposed in utero to
   DEHP rather than increased gene expression in individual Leydig cells,
   but this remains uncertain. Taken together, these results demonstrate
   that in utero DEHP exposure exerts both short-term and long-lasting
   effects on testicular steroidogenesis that might involve distinct
   molecular targets in fetal and adult Leydig cells.}},
Publisher = {{SOC STUDY REPRODUCTION}},
Address = {{1603 MONROE ST, MADISON, WI 53711-2021 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Papadopoulos, V (Reprint Author), McGill Univ, Ctr Hlth, Res Inst, 2155 Guy St,5th Floor, Montreal, PQ H3H 2R9, Canada.
   Culty, Martine; Martinez-Arguelles, Daniel B.; Papadopoulos, Vassilios, McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3H 2R9, Canada.
   Culty, Martine; Martinez-Arguelles, Daniel B.; Papadopoulos, Vassilios, McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada.
   Culty, Martine; Thuillier, Raphael; Li, Wenping; Wang, Yan; Martinez-Arguelles, Daniel B.; Benjamin, Carolina Gesteira; Triantafilou, Kostantinos M.; Papadopoulos, Vassilios, Georgetown Univ, Med Ctr, Dept Biochem \& Mol \& Cellular Biol, Washington, DC 20057 USA.
   Zirkin, Barry R., Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Div Reprod Biol, Dept Biochem \& Mol Biol, Baltimore, MD 21205 USA.}},
DOI = {{10.1095/biolreprod.107.065649}},
ISSN = {{0006-3363}},
Keywords = {{endocrine disruptors; Leydig cells; phthalates; testosterone; toxicology}},
Keywords-Plus = {{GROWTH-FACTOR-I; LEYDIG-CELL FUNCTION; N-BUTYL PHTHALATE;
   GENE-EXPRESSION; DI(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL PHTHALATE;
   SEXUAL-DIFFERENTIATION; DI(N-BUTYL) PHTHALATE; TESTICULAR DYSGENESIS;
   ESTROGEN EXPOSURE}},
Research-Areas = {{Reproductive Biology}},
Web-of-Science-Categories  = {{Reproductive Biology}},
Author-Email = {{vassilios.papadopouios@mcgill.ca}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Andersson AM, 2004, J CLIN ENDOCR METAB, V89, P3161, DOI 10.1210/jc.2003-031786.
   ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.neuro.7.1.413.
   Balvers M, 1998, ENDOCRINOLOGY, V139, P2960, DOI 10.1210/en.139.6.2960.
   Blount B. C., 2000, ENV HLTH PERSPECT, V108, P972.
   Borch J, 2006, TOXICOLOGY, V223, P144, DOI 10.1016/j.tox.2006.03.015.
   CAILLEAU J, 1990, MOL CELL ENDOCRINOL, V69, P79, DOI 10.1016/0303-7207(90)90091-L.
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   de Kretser DM, 2004, J CLIN ENDOCR METAB, V89, P3158, DOI 10.1210/jc.2004-0741.
   Dees JH, 2001, REPROD TOXICOL, V15, P171, DOI 10.1016/S0890-6238(01)00110-1.
   Douglas GC, 2004, ENDOCRINOLOGY, V145, P4703, DOI 10.1210/en.2004-0443.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   El-Gehani F, 1998, BIOL REPROD, V58, P116, DOI 10.1095/biolreprod58.1.116.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Gazouli M, 2002, ENDOCRINOLOGY, V143, P2571, DOI 10.1210/en.143.7.2571.
   Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103.
   GRASSO P, 1993, BIOL REPROD, V48, P454, DOI 10.1095/biolreprod48.3.454.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Habert R, 2001, MOL CELL ENDOCRINOL, V179, P47, DOI 10.1016/S0303-7207(01)00461-0.
   Hansson V, 1975, Curr Top Mol Endocrinol, V2, P323.
   Hauet T, 2005, MOL ENDOCRINOL, V19, P540, DOI 10.1210/me.2004-0307.
   Hines M, 2006, EUR J ENDOCRINOL, V155, pS115, DOI 10.1530/eje.1.02236.
   Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005.
   JONES HB, 1993, EXP MOL PATHOL, V58, P179, DOI 10.1006/exmp.1993.1016.
   KAVLOCK R, 2005, NTP CERHR EXPERT PAN.
   Latini G, 2003, BIOL NEONATE, V83, P22, DOI 10.1159/000067012.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Li H, 2003, BIOL REPROD, V69, P1964, DOI 10.1095/biolreprod.103.018895.
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Mendis-Handagama SMLC, 2001, BIOL REPROD, V65, P660, DOI 10.1095/biolreprod65.3.660.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Nalbant D, 1998, ENDOCRINOLOGY, V139, P272, DOI 10.1210/en.139.1.272.
   NITTA H, 1993, ENDOCRINOLOGY, V132, P1396, DOI 10.1210/en.132.3.1396.
   O'Shaughnessy PJ, 2002, BIOL REPROD, V66, P966, DOI 10.1095/biolreprod66.4.966.
   OISHI S, 1980, TOXICOL LETT, V6, P239.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Papadopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P402, DOI 10.1016/j.tips.2006.06.005.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Rouiller-Fabre V, 1998, ENDOCRINOLOGY, V139, P2926, DOI 10.1210/en.139.6.2926.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Thuillier R, 2003, BIOL REPROD, V68, P867, DOI 10.1095/biolreprod.102.009605.
   TSAIMORRIS CH, 1985, ENDOCRINOLOGY, V116, P38.
   Wang GM, 2004, BIOL REPROD, V70, P632, DOI 10.1095/biolreprod.103.022590.
   Wang Y, 2004, BIOL REPROD, V71, P1652, DOI 10.1095/biolreprod.104.030205.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   ZAKERI Z, 1992, MOL REPROD DEV, V33, P373, DOI 10.1002/mrd.1080330403.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{33}},
Journal-ISO = {{Biol. Reprod.}},
Doc-Delivery-Number = {{303QY}},
Wos-Id = {{ISI:000256056800008}},
}

@article{ ISI:000256742100013,
Author = {Kwapniewski, Rachel and Kozaczka, Sarah and Hauser, Russ and Silva,
   Manori J. and Calafat, Antonia M. and Susan, Duty},
Title = {{Occupational exposure to dibutyl phthalate among manicurists}},
Journal = {{JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE}},
Year = {{2008}},
Volume = {{50}},
Number = {{6}},
Pages = {{705-711}},
Month = {{JUN}},
Abstract = {{Objective: To measure manicurists' exposure to dibutyl phthalate (DBP)
   at work and to determine whether workplace characteristics influence
   this exposure. DBP is a reproductive and developmental toxicant in rats
   and is used in nail polish to hold color and prevent chipping. Methods:
   Pre- and postshift spot urine samples were collected from 40
   manicurists. Linear regression compared the relationship between the log
   of the cross-shift differences in urinary phthalate monoester metabolite
   concentrations and use Of workplace exposure control methods. Results:
   There was a statistically significant cross-shift increase of 17.4 ng/mL
   in the urinary concentration of mono-n-butyl phthalate, the major
   metabolite of DBP. Use of gloves reduced, mono-n-butyl phthalate
   concentrations by 15.1 ng/mL below the preshift concentration compared
   with a 20.5 ng/mL increase if gloves were, not worn. Conclusions:
   Manicurists are occupationally exposed to DBP and glove use may minimize
   this exposure.}},
Publisher = {{LIPPINCOTT WILLIAMS \& WILKINS}},
Address = {{530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Susan, D (Reprint Author), Simmons Coll, Dept Nursing, Sch Hlth Studies, 300 Fenway, Boston, MA 02115 USA.
   Kwapniewski, Rachel; Kozaczka, Sarah; Susan, Duty, Simmons Coll, Dept Nursing, Sch Hlth Studies, Boston, MA 02115 USA.
   Hauser, Russ; Susan, Duty, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Silva, Manori J.; Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.}},
DOI = {{10.1097/JOM.0b013e3181651571}},
ISSN = {{1076-2752}},
Keywords-Plus = {{DI(N-BUTYL) PHTHALATE; DEVELOPMENTAL TOXICITY; URINARY CONCENTRATIONS;
   RATS; METABOLITES; TESTOSTERONE; RECRUITMENT; MONOESTERS; GONOCYTES;
   CELLS}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{duty@simmons.edu}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   ATSDR, 1995, TOX PROF DIETH.
   Barata PC, 2006, SOC SCI MED, V62, P479, DOI 10.1016/j.socscimed.2005.06.012.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2.
   Brown BA, 2000, WOMEN HEALTH, V31, P153.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   ELSISI AE, 1989, FUND APPL TOXICOL, V12, P70, DOI 10.1016/0272-0590(89)90063-8.
   Ema M, 2000, REPROD TOXICOL, V14, P13, DOI 10.1016/S0890-6238(99)00066-0.
   Ema M, 1998, TOXICOL LETT, V98, P87, DOI 10.1016/S0378-4274(98)00107-6.
   Ema M, 1999, J APPL TOXICOL, V19, P357, DOI 10.1002/(SICI)1099-1263(199909/10)19:5<357::AID-JAT589>3.0.CO;2-X.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Houlihan J., 2002, NOT TOO PRETTY PHTHA.
   Hubinger JC, 2006, J COSMET SCI, V57, P127.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   KOCH HM, 2006, EPIDEMIOLOGY, pS300.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Marquez MA, 2003, J BONE MINER RES, V18, P3, DOI 10.1359/jbmr.2003.18.1.3.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Nails Magazine, 2006, NAILS MAGAZINE.
   National Institutes of Health National Institutes of Health (US), 2002, OUTR NOT INCL RECR R.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Saillenfait AM, 1998, TOXICOL SCI, V45, P212, DOI 10.1093/toxsci/45.2.212.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   TREMAINE LM, 1985, TOXICOL APPL PHARM, V77, P165, DOI 10.1016/0041-008X(85)90277-7.
   Wine RN, 1997, ENVIRON HEALTH PERSP, V105, P102, DOI 10.1289/ehp.97105102.
   {*}ATSDR, 2001, TOX PROF DI N PHTH.
   {*}ATSDR, 2002, TOX PROF DI PHTH.
   {*}CERHR, 2000, NTP CERHR EXP PAN RE.
   {*}CRD, 2006, MAIL LIST PROF LIC S.
   {*}EWG, 2000, BEAUT SECR.
   {*}MBRC, 2005, DIV PROF LIC.
   {*}NIOSH, 1992, 90048 NIOSH.
   {*}NIOSH, 1992, 92128 NIOSH.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{11}},
Journal-ISO = {{J. Occup. Environ. Med.}},
Doc-Delivery-Number = {{313LM}},
Wos-Id = {{ISI:000256742100013}},
}

@article{ ISI:000257293700004,
Author = {Wirth, Julia J. and Rossano, Mary G. and Potter, Rachel and Puscheck,
   Elizabeth and Daly, Douglas C. and Paneth, Nigel and Krawetz, Stephen A.
   and Protas, Bridget M. and Diamond, Michael P.},
Title = {{A pilot study associating urinary concentrations of phthalate
   metabolites and semen quality}},
Journal = {{SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE}},
Year = {{2008}},
Volume = {{54}},
Number = {{3}},
Pages = {{143-154}},
Month = {{MAY-JUN}},
Abstract = {{Phthalates are ubiquitous industrial chemicals that are reported to
   adversely affect human reproductive outcomes, Divergent effects on semen
   quality have been reported in a limited number of studies. To assess the
   possible contribution of regional differences in phthalate exposure to
   these results, we wished to determine if ambient phthalate exposure of
   men from the Great Lakes region was associated with human sperm
   parameters. Male partners (N = 45) of subfertile couples presenting to a
   Michigan infertility clinic were recruited. Urinary concentrations of
   several phthalate metabolites were measured in these men. Semen
   parameters, measured according to the World Health Organization WHO
   19991 protocols, were divided into those at or above WHO cutoffs for
   motility (50\% motile), concentration (20 million/mL) and morphology
   (4\% normal) and those below. Phthalate metabolite concentrations were
   divided into those concentrations above the median and those at or below
   the median. Specific gravity was used as a covariate in the regression
   models to adjust for urine dilution. Low sperm concentration was
   significantly associated with above median concentrations of monoethyl
   phthalate (MEP) (OR= 6.5, 95\% CI: 1.0-43.6) and low morphology with
   above median concentrations of mono-3-carboxypropyl phthalate (OR = 7.6,
   95\% CI: 1.7-33.3). Increased odds for low concentration and above
   median concentrations of metabolites of di(2-ethylhexyl) phthalate
   (DEHP) (OR= 5.4, 95\% CI: 0.9-30.8) and low morphology and above median
   concentrations of MEP (OR= 3.4, 95\% CI: 0.9-13.8) were also found. A
   significant trend was observed for tertiles of MEP and low sperm
   concentration (p = 0.05). Results suggest that ambient phthalate
   metabolite concentrations may adversely affect human semen quality.}},
Publisher = {{INFORMA HEALTHCARE}},
Address = {{TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wirth, JJ (Reprint Author), Michigan State Univ, Dept Epidemiol, A632 W Fee Hall, E Lansing, MI 48823 USA.
   Wirth, Julia J.; Paneth, Nigel; Protas, Bridget M., Michigan State Univ, Dept Epidemiol, E Lansing, MI 48823 USA.
   Rossano, Mary G., Univ Kentucky, Dept Anim \& Food Sci, Lexington, KY USA.
   Potter, Rachel, Michigan Dept Community Hlth, Lansing, MI USA.
   Puscheck, Elizabeth; Krawetz, Stephen A.; Diamond, Michael P., Wayne State Univ, Dept Obstet \& Gynecol, Detroit, MI USA.
   Daly, Douglas C., Grand Rapids Fertil, Grand Rapids, MI USA.
   Daly, Douglas C., IVF, Grand Rapids, MI USA.}},
DOI = {{10.1080/19396360802055921}},
ISSN = {{1939-6368}},
Keywords = {{biomonitoring; exposure; Great Lakes; phthalate; sperm}},
Keywords-Plus = {{N-OCTYL PHTHALATE; DI(2-ETHYLHEXYL) PHTHALATE; SEXUAL-DIFFERENTIATION;
   TESTOSTERONE SYNTHESIS; DI(N-BUTYL) PHTHALATE; GENE-EXPRESSION; US
   POPULATION; MALE-RAT; EXPOSURE; ESTERS}},
Research-Areas = {{Endocrinology \& Metabolism; Reproductive Biology}},
Web-of-Science-Categories  = {{Andrology; Reproductive Biology}},
Author-Email = {{wirthj@msu.edu}},
Cited-References = {{Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395.
   Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1046/j.1600-0668.2003.00223.x.
   Fuji Sakiko, 2005, Journal of Toxicological Sciences, V30, P97.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Higuchi TT, 2003, TOXICOL SCI, V72, P301, DOI 10.1093/toxsci/kfg036.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   JONES HB, 1993, EXP MOL PATHOL, V58, P179, DOI 10.1006/exmp.1993.1016.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169.
   LI LH, 1998, TOXICOL APPL PHARM, V153, P288.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   MANN AH, 1985, TOXICOL APPL PHARM, V77, P116, DOI 10.1016/0041-008X(85)90273-X.
   MURATURE DA, 1987, BIOMED ENVIRON MASS, V14, P473, DOI 10.1002/bms.1200140815.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3.
   Schisterman EF, 2005, ENVIRON HEALTH PERSP, V113, P853, DOI 10.1289/ehp.7640.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   TEASS AW, 1998, NIOSH MANUAL ANAL ME, P52.
   World Health Organization, 1999, WHO LAB MAN EX HUM S.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Zavos PM, 2006, ASIAN J ANDROL, V8, P337, DOI 10.1111/j.1745-7262.2006.00128.x.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}CDC, 2005, 3 NATL REP HUM EXP E.
   {*}FOOD DRUG ADM, 2000, IND FOOD ADD ADH COM.
   {*}NTP CERHR, 080805 NTPCERHR.
   {*}NTP CERHR, 2000, NTPCERHRBBP00.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{18}},
Journal-ISO = {{Syst. Biol. Reprod. Med.}},
Doc-Delivery-Number = {{321GW}},
Wos-Id = {{ISI:000257293700004}},
}

@article{ ISI:000254566500027,
Author = {Adibi, Jennifer J. and Whyatt, Robin M. and Williams, Paige L. and
   Calafat, Antonia M. and Camann, David and Herrick, Robert and Nelson,
   Heather and Bhat, Hari K. and Perera, Frederica A. and Silva, Manori J.
   and Hauser, Russ},
Title = {{Characterization of phthalate exposure among pregnant women assessed by
   repeat air and urine samples}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2008}},
Volume = {{116}},
Number = {{4}},
Pages = {{467-473}},
Month = {{APR}},
Abstract = {{BACKGROUND: Although urinary concentrations of phthalate metabolites are
   frequently used as biomarkers in epidemiologic studies, variability
   during pregnancy has not been characterized.
   METHODS: We measured phthalate metabolite concentrations in spot urine
   samples collected from 246 pregnant Dominican and African-American
   women. Twenty-eight women had repeat urine samples collected over a
   6-week period. We also analyzed 48-hr personal air samples (n = 96
   women) and repeated indoor air samples (n = 32 homes) for five
   plithalate diesters. Mixed-effects models were fit to evaluate
   reproducibility via intraclass correlation coefficients (ICC). We
   evaluated the sensitivity and specificity of using a single specimen
   versus repeat samples to classify a woman's exposure in the low or high
   category.
   RESULTS: Plithalates were detected in 85-100\% of air and urine samples.
   ICCs for the unadjusted urinary metabolite concentrations ranged from
   0.30 for mono-ethyl plithalate to 0.66 for monobenzyl plithalate. For
   indoor air, ICCs ranged from 0.48 {[}di-2-ethylhexyl phthalate (DEHP)]
   to 0.83 {[}butylbenzyl phthalate (BBzP)]. Air levels of plithalate
   diesters correlated with their respective urinary metabolite
   concentrations for BBzP (r = 0.71), di-isobutyl plithalate (r = 0.44),
   and diethyl plithalate (DEP; r = 0.39). In women sampled late in
   pregnancy, specific gravity appeared to be more effective than
   creatinine in adjusting for urine dilution.
   CONCLUSIONS: urinary concentrations of DEP and DEHP metabolites in
   pregnant women showed lower reproducibility than metabolites for
   di-n-butyl phthalate and BBzP. A single indoor air sample may be
   sufficient to characterize phthalate exposure in the home, whereas
   urinary phthalate biomarkers should be sampled longitudinally during
   pregnancy to minimize exposure misclassification.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Whyatt, RM (Reprint Author), Columbia Univ, Joseph L Mailman Sch Publ Hlth, Dept Environm Hlth Sci, 60 Haven Ave,B-109, New York, NY 10032 USA.
   Adibi, Jennifer J.; Herrick, Robert; Nelson, Heather; Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Whyatt, Robin M.; Bhat, Hari K.; Perera, Frederica A., Columbia Univ, Mailman Sch Publ Hlth, Columbia Ctr Childrens Environm Hlth, New York, NY USA.
   Williams, Paige L., Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   Calafat, Antonia M.; Silva, Manori J., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Herrick, Robert, SW Res Inst, San Antonio, TX USA.}},
DOI = {{10.1289/ehp.10749}},
ISSN = {{0091-6765}},
Keywords = {{creatinine; indoor air; personal air; phthalates; pregnancy; specific
   gravity; urinary metabolites; variability}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; SOLID-PHASE EXTRACTION; NEW-YORK-CITY;
   QUANTITATIVE DETECTION; OXIDATIVE METABOLITES; INDOOR-AIR; VARIABILITY;
   POPULATION; PESTICIDES; BIOMARKERS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{rmw5@columbia.edu}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   DEKLERK NH, 1989, INT J EPIDEMIOL, V18, P705.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2006, ANAL CHEM, V78, P6651, DOI 10.1021/ac0608220.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Mose T, 2007, REPROD TOXICOL, V23, P83, DOI 10.1016/j.reprotox.2006.08.006.
   Perera F, 2006, ANN NY ACAD SCI, V1076, P15, DOI 10.1196/annals.1371.018.
   Rosner B, 2000, FUNDAMENTALS BIOSTAT.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Saillenfait AM, 1998, TOXICOL SCI, V45, P212, DOI 10.1093/toxsci/45.2.212.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   TEITEBAUM SL, 2007, ENVIRON RES, V106, P257.
   Whyatt RM, 2003, ENVIRON HEALTH PERSP, V111, P749, DOI 10.1289/ehp.5768.
   Whyatt RM, 2007, ENVIRON HEALTH PERSP, V115, P383, DOI 10.1289/ehp.9546.
   WILLIAMS J, 2005, WILLIAMS OBSTETRICS.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}CDC NCHS, 2001, NHANES 2001 2002.
   {*}CDC NCHS, 1999, NHANES 1999 2000.
   {*}NCHS, 2007, CONT NHANES WEB TUT.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{69}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{282KL}},
Wos-Id = {{ISI:000254566500027}},
}

@article{ ISI:000253710200008,
Author = {Hauser, Russ},
Title = {{Urinary phthalate metabolites and semen quality: a review of a potential
   biomarker of susceptibility}},
Journal = {{INTERNATIONAL JOURNAL OF ANDROLOGY}},
Year = {{2008}},
Volume = {{31}},
Number = {{2}},
Pages = {{112-116}},
Month = {{APR}},
Note = {{4th Copenhagen Workshop on Endocrine Disrupters, Copenhagen Univ Hosp,
   Copenhagen, DENMARK, MAY 28-31, 2007}},
Abstract = {{Phthalates are a class of chemicals with widespread general population
   exposure. Some phthalates are reproductive and developmental toxicants
   in laboratory animals. Advances in the field of phthalate research in
   humans are dependent on the development and implementation of biomarkers
   to assess exposure and outcome, as well as potential markers that may be
   indicative of increased susceptibility. Recently, we incorporated a
   novel biomarker of potential `susceptibility' into our study on the
   relationship of phthalates with semen quality and sperm DNA damage among
   men recruited from an infertility clinic. We measured urinary
   concentrations of three di(2-ethylhexyl) phthalate (DEHP) metabolites,
   mono(2-ethylhexyl) phthalate (MEHP) and two oxidative metabolites,
   mono-(2-ethyl-5-hydroxylhexyl) phthalate (MEHHP) and
   mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP). We calculated the percent
   of DEHP excreted as the hydrolytic monoester (i.e., MEHP). We referred
   to this as \%MEHP and considered it a phenotypic marker of the
   proportion of DEHP excreted in the urine as MEHP. In our sperm DNA
   study, we found novel results for the DEHP metabolites. Although MEHP
   was positively correlated with the oxidative metabolites, the
   association of sperm DNA damage with MEHP, as compared to MEHHP and
   MEOHP, were in opposite directions. We hypothesized that MEHP is the
   bioactive toxicant and further metabolism to MEHHP/MEOHP may lower
   internal burden of MEHP and thus be protective from sperm DNA damage. An
   alternative explanation may include that the relative percentage of DEHP
   excreted as MEHP was a surrogate for the function of phase I enzymes.
   Men with high \%MEHP may have higher levels of sperm DNA damage because
   of poor metabolism (detoxification) of other genotoxic chemicals. Our
   hypothesis that \%MEHP may represent a phenotypic marker of metabolism
   is novel but requires further exploration to confirm.}},
Publisher = {{BLACKWELL PUBLISHING}},
Address = {{9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Hauser, R (Reprint Author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, 665 Huntington Ave,Bldg 1,Room 1405, Boston, MA 02115 USA.
   Hauser, Russ, Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Hauser, Russ, Harvard Univ, Massachusetts Gen Hosp, Sch Med, Fertil Ctr,Vincent Mem Obstet \& Gynecol Serv, Boston, MA 02115 USA.}},
DOI = {{10.1111/j.1365-2605.2007.00844.x}},
ISSN = {{0105-6263}},
Keywords = {{phthalates; semen quality; sperm DNA damage; susceptibility}},
Keywords-Plus = {{DEUTERIUM-LABELED DEHP; DI(2-ETHYLHEXYL) PHTHALATE; OXIDATIVE
   METABOLITES; HUMAN SPERM; DNA-DAMAGE; EXPOSURES; MONOESTER; SERUM; DUST}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{hauser@hohp.harvard.edu}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   David R. M., 2001, PATTYS TOXICOLOGY, P635.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Singh NP, 1998, MUTAGENESIS, V13, P75, DOI 10.1093/mutage/13.1.75.
   {*}ATSDR, 2002, TOX PROF 2 ETH PHTHA.
   {*}ATSDR, 2001, TOX PROF DINB PHTHAL.}},
Number-of-Cited-References = {{17}},
Times-Cited = {{25}},
Journal-ISO = {{Int. J. Androl.}},
Doc-Delivery-Number = {{270GW}},
Wos-Id = {{ISI:000253710200008}},
}

@article{ ISI:000253710200010,
Author = {Janjua, Nadeem Rezaq and Frederiksen, Hanne and Skakkebaek, Niels E. and
   Wulf, Hans Christian and Andersson, Anna-Maria},
Title = {{Urinary excretion of phthalates and paraben after repeated whole-body
   topical application in humans}},
Journal = {{INTERNATIONAL JOURNAL OF ANDROLOGY}},
Year = {{2008}},
Volume = {{31}},
Number = {{2}},
Pages = {{118-129}},
Month = {{APR}},
Note = {{4th Copenhagen Workshop on Endocrine Disrupters, Copenhagen Univ Hosp,
   Copenhagen, DENMARK, MAY 28-31, 2007}},
Abstract = {{Diethyl phthalate (DEP), dibutyl phthalate (DBP) and butyl paraben (BP)
   are man-made chemicals used in personal care products, such as lotions
   and creams. Exposure to these chemicals causes a variety of adverse
   reproductive outcomes in animal studies. Humans can be exposed to these
   chemicals through dermal absorption, but there are no published data on
   absorption, metabolism, and excretion after dermal application. This
   study investigates urinary concentrations of BP and metabolites of DEP
   and DBP after topical application. In a 2-week single-blinded study, 26
   healthy Caucasian male subjects were given a whole body topical
   application of basic cream 2 mg/cm(2) (control week) and then a cream
   containing 2\% (w/w) of DEP, DBP and BP each (treatment week) daily.
   Twenty-four-hour urine samples were collected. Urinary total, and
   unconjugated BP, monoethyl phthalate (MEP) and monobutyl phthalate (MBP)
   metabolites were analysed by Liquid Chromatography-Tandem Mass
   Spectroscopy (LC-MS/MS). All 26 subjects showed increased excretion of
   MEP, MBP and BP following topical application. Total MEP, MBP and BP
   (mean +/- SEM) excreted in urine in the treatment week were,
   respectively, 41 +/- 1.9, 11.8 +/- 0.6 and 2.6 +/- 0.1 mg/24 h. On
   average 5.79, 1.82 and 0.32\%, respectively, of the applied DEP, DBP and
   BP could be recovered in urine as MEP, MBP and BP. The concentration of
   the compounds peaked in urine 8-12 h after application. The fractions of
   unconjugated MEP, MBP, and BP were 78, 8.0 and 2.1\%, respectively.
   Absorption of DEP, DBP and BP through skin could potentially contribute
   to adverse health effects. The three chemicals are systemically
   absorbed, metabolized and excreted in urine following application on the
   skin in a cream preparation. More DEP than DBP was absorbed, presumably
   because of a faster absorption rate for DEP.}},
Publisher = {{BLACKWELL PUBLISHING}},
Address = {{9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Janjua, NR (Reprint Author), Bispebjerg Hosp, Dept Dermatol D92, Bispebjerg Bakke 23, DK-2400 Copenhagen, Denmark.
   Janjua, Nadeem Rezaq; Frederiksen, Hanne; Skakkebaek, Niels E.; Andersson, Anna-Maria, Univ Copenhagen Hosp, Rigshosp, Dept Growth \& Reprod, DK-2100 Copenhagen, Denmark.
   Janjua, Nadeem Rezaq; Wulf, Hans Christian, Univ Copenhagen Hosp, Bispebjerg Hosp, Dept Dermatol, DK-2100 Copenhagen, Denmark.}},
DOI = {{10.1111/j.1365-2605.2007.00841.x}},
ISSN = {{0105-6263}},
Keywords = {{butyl paraben; human; mono-butyl phthalate; mono-ethyl phthalate;
   urinary excretion; whole-body topical application}},
Keywords-Plus = {{N-BUTYL PHTHALATE; TESTICULAR DYSGENESIS; ANOGENITAL DISTANCE; DIBUTYL
   PHTHALATE; HUMAN EXPOSURE; CELL FUNCTION; MALE INFANTS; RATS;
   METABOLITES; ESTERS}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{nrjanjua@hotmail.com}},
Cited-References = {{Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   BENOWITZ NL, 1986, ANNU REV MED, V37, P21, DOI 10.1146/annurev.med.37.1.21.
   Calafat AM, 2006, INT J ANDROL, V29, P166, DOI 10.1111/j.1365-2605.2005.00570.x.
   Centers for Disease Control and Prevention, 2005, 3 NAT REP HUM EXP EN.
   Darbre PD, 2004, J APPL TOXICOL, V24, P5, DOI 10.1002/jat.958.
   DIGANGI J, 2002, PRETTY NASTY PHTHALA.
   DUBOIS D, 1989, NUTRITION, V5, P303.
   ELSISI AE, 1989, FUND APPL TOXICOL, V12, P70, DOI 10.1016/0272-0590(89)90063-8.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P116, DOI 10.1016/0041-008X(92)90374-2.
   Houlihan J., 2002, NOT TOO PRETTY PHTHA.
   Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kavlock R, 2002, REPROD TOXICOL, V16, P489, DOI 10.1016/S0890-6238(02)00033-3.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Lenz TL, 2004, SPORTS MED, V34, P293, DOI 10.2165/00007256-200434050-00002.
   Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Marsman D, 1995, TOXIC REP SER, V30, P1.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Oishi S, 2001, TOXICOL IND HEALTH, V17, P31, DOI 10.1191/0748233701th093oa.
   Paluska Scott A, 2003, Curr Sports Med Rep, V2, P213, DOI 10.1007/s11932-003-0008-3.
   PARK CM, 2000, KIRK OTHMER ENCY CHE, V18, P991.
   RASTOGI SC, 1995, CONTACT DERMATITIS, V32, P28, DOI 10.1111/j.1600-0536.1995.tb00836.x.
   Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   SCOTT RC, 1987, ENVIRON HEALTH PERSP, V74, P223, DOI 10.2307/3430452.
   SHARPE RM, 2006, CLIN ENDOCRINOLOGY M, V20, P91.
   SHIRREFFS SM, 2006, CURRENT SPORTS MED S, V5, P195.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Soni MG, 2005, FOOD CHEM TOXICOL, V43, P985, DOI 10.1016/j.fct.2005.01.020.
   Swan SH, 2006, ENVIRON HEALTH PERSP, V114, pA88.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Williams K, 2000, MOL CELL ENDOCRINOL, V164, P117, DOI 10.1016/S0303-7207(00)00231-8.
   Ye XY, 2006, ENVIRON HEALTH PERSP, V114, P1843, DOI 10.1289/ehp.9413.
   {*}ATSDR, 2001, TOX PROF DINB PHTHAL.
   {*}NTP, 2005, 94268 CAS NTP.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{42}},
Journal-ISO = {{Int. J. Androl.}},
Doc-Delivery-Number = {{270GW}},
Wos-Id = {{ISI:000253710200010}},
}

@article{ ISI:000253710200012,
Author = {Wittassek, Matthias and Angerer, Juergen},
Title = {{Phthalates: metabolism and exposure}},
Journal = {{INTERNATIONAL JOURNAL OF ANDROLOGY}},
Year = {{2008}},
Volume = {{31}},
Number = {{2}},
Pages = {{131-136}},
Month = {{APR}},
Note = {{4th Copenhagen Workshop on Endocrine Disrupters, Copenhagen Univ Hosp,
   Copenhagen, DENMARK, MAY 28-31, 2007}},
Abstract = {{In human metabolism studies we found that after oral application of
   di(2-ethylhexyl) phthalate (DEHP), diisononyl phthalate (DiNP) and
   di(2-propylheptyl) phthalate (DPHP), at least 74, 44 and 34\%,
   respectively, are excreted via urine. In contrast to the short chain
   phthalates, their oxidized products, not the simple monoesters, were
   found to be the main metabolites. Based on urinary phthalate metabolite
   concentrations we estimated in 102 German subjects between 6 and 80
   years of age median daily intakes (mu g/kg/day) of 2.7 for DEHP, 2.1 for
   di-n-butyl phthalate, 1.5 for diisobutyl phthalate, 0.6 for DiNP, and
   0.3 for butylbenzyl phthalate. In general, children have higher
   exposures compared to adults and seem to have a more effective oxidative
   metabolism of phthalates. For individual phthalates tolerable daily
   intake (TDI) values have been deduced. However, in rats some phthalates
   have been shown to act as endocrine disrupters via a common mechanism of
   action in a dose-additive manner. Therefore, the concept of a cumulative
   TDI value may be more appropriate for the consideration of the overall
   exposure and the potential human health risks resulting from everyday
   and simultaneous exposure to several phthalates.}},
Publisher = {{BLACKWELL PUBLISHING}},
Address = {{9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Angerer, J (Reprint Author), Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, Schillerstr 25-29, D-91054 Erlangen, Germany.
   Wittassek, Matthias; Angerer, Juergen, Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, D-91054 Erlangen, Germany.}},
DOI = {{10.1111/j.1365-2605.2007.00837.x}},
ISSN = {{0105-6263}},
Keywords = {{biomonitoring; cumulative TDI; human exposure; human metabolism;
   phthalates}},
Keywords-Plus = {{DEUTERIUM-LABELED DEHP; N-BUTYL PHTHALATE; DI(2-ETHYLHEXYL)PHTHALATE
   DEHP; HUMAN URINE; INTERNAL EXPOSURE; MALE-RAT; POPULATION; CHILDREN;
   DINP; HEALTH}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{juergen.angerer@ipasum.imed.uni-erlangen.de}},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011.
   BORCH J, 2006, TOXICOL LETT, V163, P186.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   EFSA, 2005, EFSA J, V244, P77.
   EFSA, 2005, EFSA J, V243, P1.
   EFSA, 2005, STAT SCI PAN FOOD AD.
   EFSA (European Food Safety Authority), 2005, EFSA J, V241, P1.
   EFSA (European Food Safety Authority), 2005, EFSA J, V242, P1.
   Gray Jr L. E., 2006, INT J ANDROL, V29, P105.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Howdeshell KL, 2007, TOXICOL SCI, V99, P190, DOI 10.1093/toxsci/kfm069.
   Kessler W, 2004, TOXICOL APPL PHARM, V195, P142, DOI 10.1016/j.taap.2003.11.014.
   Koch H, 2005, UMWELTMED FORSCH PRA, V10, P144.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   KOCH HM, 2005, 15 ANN C INT SOC EXP.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013.
   Saillenfait AM, 2006, TOXICOL LETT, V165, P39, DOI 10.1016/j.toxlet.2006.01.013.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wolfe GW, 2003, MULTIGENERATION REPR.
   {*}AGPU, 2006, PLAST MARK DAT.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{52}},
Journal-ISO = {{Int. J. Androl.}},
Doc-Delivery-Number = {{270GW}},
Wos-Id = {{ISI:000253710200012}},
}

@article{ ISI:000253670600030,
Author = {Hogberg, Johan and Hanberg, Annika and Berglund, Marika and Skerfving,
   Staffan and Remberger, Mikael and Calafat, Antonia M. and Filipsson,
   Agneta Falk and Jansson, Bo and Johansson, Niklas and Appelgren, Malin
   and Hakansson, Helen},
Title = {{Phthalate diesters and their metabolites in human breast milk, blood or
   serum, and urine as biomarkers of exposure in vulnerable populations}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2008}},
Volume = {{116}},
Number = {{3}},
Pages = {{334-339}},
Month = {{MAR}},
Abstract = {{BACKGROUND: Phthalates may pose a risk for perinatal developmental
   effects. An important question relates to the choice of suitable
   biological matrices for assessing exposure during this period.
   OBJECTIVES: This study was designed to measure the concentrations of
   phthalate diesters or their metabolites in breast milk, blood or serum,
   and urine and to evaluate their suitability for assessing perinatal
   exposure to phthalates.
   METHODS: In 2001, 2-3 weeks after delivery, 42 Swedish primipara
   provided breast milk, blood, and urine samples at home. Special care was
   taken to minimize contamination with phthalates (e.g., use of a special
   breast milk pump, heat treatment of glassware and needles, addition of
   phosphoric acid).
   RESULTS: Phthalate diesters and metabolites in milk and blood or serum,
   if detected, were present at concentrations close to the limit of
   detection. By contrast, most phthalate metabolites were detectable in
   urine at concentrations comparable to those from the general population
   in the United States and in Germany. No correlations existed between
   urine concentrations and those found in milk or blood/serum for single
   phthalate metabolites. Our data are at odds with a previous study
   documenting frequent detection and comparatively high concentrations of
   phthalate metabolites in Finnish and Danish mothers' milk.
   CONCLUSIONS: Concentrations of phthalate metabolites in urine are more
   informative than those in milk or serum. Furthermore, collection of milk
   or blood may be associated with discomfort and potential technical
   problems such as contamination (unless oxidative metabolites are
   measured). Although urine is a suitable matrix for health-related
   phthalate monitoring, urinary concentrations in nursing mothers cannot
   be used to estimate exposure to phthalates through milk ingestion by
   breast-fed infants.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hogberg, J (Reprint Author), Karolinska Inst, Inst Environm Med, Nobels Vag 13, S-10401 Stockholm, Sweden.
   Hogberg, Johan; Hanberg, Annika; Berglund, Marika; Filipsson, Agneta Falk; Johansson, Niklas; Appelgren, Malin; Hakansson, Helen, Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.
   Skerfving, Staffan, Univ Lund Hosp, Sect Occupat \& Environm Med, Lund, Sweden.
   Remberger, Mikael, IVL Swedish Environm Res Inst Ltd, Stockholm, Sweden.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA USA.
   Jansson, Bo, Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden.
   Johansson, Niklas, Swedish Environm Protect Agcy, Stockholm, Sweden.}},
DOI = {{10.1289/ehp.10788}},
ISSN = {{0091-6765}},
Keywords = {{biomonitoring; blood; breast milk; metabolites; perinatal; phthalates;
   urine}},
Keywords-Plus = {{IN-UTERO EXPOSURE; TANDEM MASS-SPECTROMETRY; SOLID-PHASE EXTRACTION;
   DEUTERIUM-LABELED DEHP; INTENSIVE-CARE-UNIT; N-BUTYL PHTHALATE;
   DI(2-ETHYLHEXYL)PHTHALATE DEHP; DI-(2-ETHYLHEXYL) PHTHALATE;
   GENERAL-POPULATION; DI(N-BUTYL) PHTHALATE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{johan.hogberg@ki.se}},
Cited-References = {{Anderson GD, 2005, J WOMENS HEALTH, V14, P19, DOI 10.1089/jwh.2005.14.19.
   Andrade AJM, 2006, TOXICOLOGY, V225, P64, DOI 10.1016/j.tox.2006.05.007.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   DAVID F, 2001, ECPI200110 RES I CHR.
   Ellison S. L. R., 2000, EURACHEM CITAC GUID.
   Fabjan E, 2006, CRIT REV TOXICOL, V36, P695, DOI 10.1080/10408440600894914.
   Frederiksen H, 2007, MOL NUTR FOOD RES, V51, P899, DOI 10.1002/mnfr.20060243.
   Ge RS, 2007, REPROD TOXICOL, V23, P366, DOI 10.1016/j.reprotox.2006.12.006.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Hallmark N, 2007, ENVIRON HEALTH PERSP, V115, P390, DOI 10.1289/ehp.9490.
   Hauser R, 2006, SEMIN REPROD MED, V24, P156, DOI 10.1055/s-2006-944422.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   HOWDESHELL KL, 2007, TOXICOL SCI.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   KOCH HM, 2006, J EXPO SCI ENV EPID, V17, P378.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Lahousse SA, 2006, TOXICOL SCI, V91, P255, DOI 10.1093/toxsci/kfj135.
   Latini G, 2004, REPROD TOXICOL, V19, P27, DOI 10.1016/j.reprotox.2004.05.011.
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404.
   Mahood IK, 2006, INT J ANDROL, V29, P148, DOI 10.1111/j.1365-2605.2005.00574.x.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   McKinnell C, 2005, ENDOCRINOLOGY, V146, P4536, DOI 10.1210/en.2005-0676.
   Metzdorff SB, 2007, TOXICOL SCI, V98, P87, DOI 10.1093/toxsci/kfm079.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   Pflieger-Bruss S, 2004, ANDROLOGIA, V36, P337, DOI 10.1111/j.1439-0272.2004.00641.x.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Scientific Committee for Toxicity Ecotoxicity and the Environment (CSTEE), 1998, OP PHTHAL MIGR SOFT.
   Sharpe RM, 2005, ENVIRON HEALTH PERSP, V113, pA504.
   Sharpe RM, 2006, BEST PRACT RES CL EN, V20, P91, DOI 10.1016/j.beem.2005.09.005.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Takatori S, 2004, J CHROMATOGR B, V804, P397, DOI 10.1016/j.jchromb.2004.01.056.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   WOLD S, 1984, MULTIVARIATE DATA AN.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}AG TOX SUBST DIS, 2002, TOX PROF DI 2 ETH PH.
   {*}AG TOX SUBST DIS, 2001, TOX PROF DI N BUT PH.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{57}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{269SN}},
Wos-Id = {{ISI:000253670600030}},
}

@article{ ISI:000253618800014,
Author = {Teitelbaum, S. L. and Britton, J. A. and Calafat, A. M. and Ye, X. and
   Silva, M. J. and Reidy, J. A. and Galvez, M. P. and Brenner, B. L. and
   Wolff, M. S.},
Title = {{Temporal variability in urinary concentrations of phthalate metabolites,
   phytoestrogens and phenols among minority children in the United States}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2008}},
Volume = {{106}},
Number = {{2}},
Pages = {{257-269}},
Month = {{FEB}},
Abstract = {{Background: Exposure to endocrine disruptors (EDs), including some
   phthalates, phytoestrogens and phenols can be quantified using
   biomarkers of exposure. However, reliability, in the use of these
   biomarkers requires an understanding of the timeframe of exposure
   represented by one measurement. Data on the temporal variability of ED
   biomarkers are sparse, especially among children.
   Objective: To evaluate intraindividual temporal variability in 19
   individual urinary biomarkers (eight phthalate metabolites from six
   phthalate diesters, six phytoestrogens (two lignans and four
   isoflavones) and five phenols) among New York City children.
   Methods: Healthy Hispanic and Black children (N = 35; 6-10 years old)
   donated several urine samples over 6 months. To assess temporal
   variability we used three statistical methods: intraclass correlation
   coefficient (ICC), Spearman correlation coefficients (SCC) between
   concentrations measured at different timepoints, and surrogate category
   analysis to determine how well the tertile categories based on a single
   measurement represented a 6-month average concentration.
   Results: Surrogate category analysis indicated that a single sample
   provides reliable ranking for all analytes; at least three of four
   surrogate samples predicted the 6-month mean concentration. Of the 19
   analytes, the ICC was > 0.2 for 18 analytes and > 0.3 for 10 analytes.
   Correlations among sample concentrations throughout the 6-month period
   were observed for all analytes; 14 analyte concentrations were
   correlated at 16 weeks.
   Conclusions: The, reasonable degree of temporal reliability and the wide
   range of concentrations of phthalate metabolites, phytoestrogens and
   phenols suggest that these biomarkers are appropriate for use in
   epidemiologic studies of environmental exposures in relation to health
   outcomes in children. (c) 2007 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Teitelbaum, SL (Reprint Author), Mt Sinai Sch Med, Dept Community \& Prevent Med, 1 Gustave Levy Pl,POB 1043, New York, NY 10029 USA.
   Teitelbaum, S. L.; Britton, J. A.; Galvez, M. P.; Brenner, B. L.; Wolff, M. S., Mt Sinai Sch Med, Dept Community \& Prevent Med, New York, NY 10029 USA.
   Calafat, A. M.; Ye, X.; Silva, M. J.; Reidy, J. A., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA USA.
   Galvez, M. P., Mt Sinai Sch Med, Dept Pediat, New York, NY USA.}},
DOI = {{10.1016/j.envres.2007.09.010}},
ISSN = {{0013-9351}},
Keywords = {{endocrine disruptor; biomarker; urine; children; reproducibility of
   results; phthalates; phytoestrogens; Phenols; bisphenol A; isoflavones;
   ligans; time factors}},
Keywords-Plus = {{BISPHENOL-A; ANDROGEN RECEPTOR; AUTOMATED ONLINE; UV SCREENS; IN-VITRO;
   EXPOSURE; POPULATION; ESTROGEN; ISOFLAVONES; ENDOCRINE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{susan.teitelbaum@mssrr.edu}},
Cited-References = {{Adgate JL, 2001, ENVIRON HEALTH PERSP, V109, P583, DOI 10.2307/3455032.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Branca F, 2005, FORUM NUTR, V57, P100, DOI 10.1159/000083773.
   Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391.
   Centers for Disease Control and Prevention, 2005, 3 NAT REP HUM EXP EN.
   Doerge DR, 2002, J CHROMATOGR B, V777, P269, DOI 10.1016/S1570-0232(02)00214-3.
   Foran CM, 2000, MAR ENVIRON RES, V50, P153, DOI 10.1016/S0141-1136(00)00080-5.
   Gomez E, 2005, J TOXICOL ENV HEAL A, V68, P239, DOI 10.1080/15287390590895054.
   GRAY LE, 2007, J SOC TOXICOL, V96, P385.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   HOWDESHELL KL, 2007, TOXICOL SCI.
   Joskow R, 2006, J AM DENT ASSOC, V137, P353.
   Karmaus W, 2002, J PEDIATR, V140, P33, DOI 10.1067/mpd.2002.120764.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch D, 2002, ENVIRON HEALTH PERSP, V110, P829.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Lee BM, 2007, J TOXICOL ENV HEAL A, V70, P1365, DOI 10.1080/15287390701432285.
   Kuklenyik Z, 2004, J CHROMATOGR SCI, V42, P495.
   Macintosh DL, 2001, J EXPO ANAL ENV EPID, V11, P279, DOI 10.1038/sj.jea.7500167.
   Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033.
   Matsumoto A, 2003, ENVIRON HEALTH PERSP, V111, P101, DOI 10.1289/ehp.5512.
   Nesbitt PD, 1999, AM J CLIN NUTR, V69, P549.
   Remer T, 2002, AM J CLIN NUTR, V75, P561.
   Rosner B, 2000, FUNDAMENTALS BIOSTAT.
   Schlumpf M, 2001, ENVIRON HEALTH PERSP, V109, P239, DOI 10.2307/3434691.
   Schreurs RHMM, 2005, TOXICOL SCI, V83, P264, DOI 10.1093/toxsci/kfi035.
   Sexton K, 2006, ENVIRON HEALTH PERSP, V114, P453, DOI 10.1289/ehp.8324.
   Takeuchi S, 2005, TOXICOLOGY, V210, P223, DOI 10.1016/j.tox.2005.02.002.
   Willett W., 1998, NUTR EPIDEMIOLOGY.
   WOLFF MS, 2006, ENV HLTH PERSPECT.
   Ye XY, 2005, ANAL CHEM, V77, P5407, DOI 10.1021/ac050390d.
   Zeleniuch-Jacquotte A, 1998, CANCER EPIDEM BIOMAR, V7, P885.
   Zheng W, 1999, CANCER EPIDEM BIOMAR, V8, P35.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{78}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{268ZI}},
Wos-Id = {{ISI:000253618800014}},
}

@article{ ISI:000252877600043,
Author = {Sathyanarayana, Sheela and Karr, Catherine J. and Lozano, Paula and
   Brown, Elizabeth and Calafat, Antonia M. and Liu, Fan and Swan, Shanna
   H.},
Title = {{Baby care products: Possible sources of infant phthalate exposure}},
Journal = {{PEDIATRICS}},
Year = {{2008}},
Volume = {{121}},
Number = {{2}},
Pages = {{E260-E268}},
Month = {{FEB}},
Abstract = {{OBJECTIVES. Phthalates are man-made chemicals found in personal care and
   other products. Recent studies suggest that some phthalates can alter
   human male reproductive development, but sources of infant exposure have
   not been well characterized. We investigated the relationship between
   phthalate metabolite concentrations in infant urine and maternal
   reported use of dermally applied infant care products.
   METHODS. We measured 9 phthalate metabolites in 163 infants who were
   born in 2000-2005. An infant was considered to have been exposed to any
   infant care product that the mother reported using on her infant within
   24 hours of urine collection. Results of multiple linear regression
   analyses are reported as the ratio of metabolite concentrations (with
   95\% confidence intervals) in exposed and unexposed infants. We
   standardized concentrations by forming z scores and examined combined
   exposure to multiple metabolites.
   RESULTS. In most (81\%) infants, >= 7 phthalate metabolites were above
   the limit of detection. Exposure to lotion was predictive of monoethyl
   phthalate and monomethyl phthalate concentrations, powder of
   monoisobutyl phthalate, and shampoo of monomethyl phthalate. Z scores
   increased with number of products used. Most associations were stronger
   in younger infants.
   CONCLUSIONS. Phthalate exposure is widespread and variable in infants.
   Infant exposure to lotion, powder, and shampoo were significantly
   associated with increased urinary concentrations of monoethyl phthalate,
   monomethyl phthalate, and monoisobutyl phthalate, and associations
   increased with the number of products used. This association was
   strongest in young infants, who may be more vulnerable to developmental
   and reproductive toxicity of phthalates given their immature metabolic
   system capability and increased dosage per unit body surface area.}},
Publisher = {{AMER ACAD PEDIATRICS}},
Address = {{141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Sathyanarayana, S (Reprint Author), Univ Washington, Inst Child Hlth, Div Gen Pediat, Dept Occupat \& Environm Hlth Sci, Bldg 296200,NE 74th St, Seattle, WA 98115 USA.
   Sathyanarayana, Sheela; Karr, Catherine J., Univ Washington, Inst Child Hlth, Div Gen Pediat, Dept Occupat \& Environm Hlth Sci, Seattle, WA 98115 USA.
   Sathyanarayana, Sheela; Karr, Catherine J.; Lozano, Paula, Univ Washington, Inst Child Hlth, Div Gen Pediat, Dept Pediat, Seattle, WA 98115 USA.
   Brown, Elizabeth, Univ Washington, Inst Child Hlth, Div Gen Pediat, Dept Biostat, Seattle, WA 98115 USA.
   Calafat, Antonia M., Ctr Dis Control \& Prevent, Atlanta, GA USA.
   Liu, Fan; Swan, Shanna H., Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, Rochester, NY 14642 USA.}},
DOI = {{10.1542/peds.2006-3766}},
ISSN = {{0031-4005}},
Keywords = {{phthalate; infant; environmental exposure; baby care product}},
Keywords-Plus = {{DI-N-BUTYLPHTHALATE; REPRODUCTIVE HEALTH; RISK-ASSESSMENT; METABOLITES;
   ESTERS; CHILDREN; URINE; MONOESTERS; RATS; BUTYLBENZYLPHTHALATE}},
Research-Areas = {{Pediatrics}},
Web-of-Science-Categories  = {{Pediatrics}},
Author-Email = {{sathyana@u.washington.edu}},
ResearcherID-Numbers = {{Brown, Elizabeth/A-8984-2008}},
Cited-References = {{Afshari A, 2004, INDOOR AIR, V14, P120, DOI 10.1046/j.1600-0668.2003.00220.x.
   Barlow NJ, 2004, TOXICOL PATHOL, V32, P79, DOI 10.1080/01926230490265894.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050.
   CASTLE L, 1988, FOOD ADDIT CONTAM, V5, P9.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   ELSISI AE, 1989, FUND APPL TOXICOL, V12, P70, DOI 10.1016/0272-0590(89)90063-8.
   Fujii M, 2003, ATMOS ENVIRON, V37, P5495, DOI 10.1016/j.atmosenv.2003.09.026.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   HORNUNG RW, 1990, APPL OCCUP ENV HYG, V5.
   Houlihan J., 2002, NOT TOO PRETTY PHTHA.
   Hubinger JC, 2006, J COSMET SCI, V57, P127.
   Janjua NR, 2007, ENVIRON SCI TECHNOL, V41, P5564, DOI 10.1021/es0628755.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Koch HM, 2007, J EXPO SCI ENV EPID, V17, P378, DOI 10.1038/sj.jes.7500526.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Lottrup G, 2006, INT J ANDROL, V29, P181.
   Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   Grandjean P, 2006, INT J ANDROL, V29, P181, DOI 10.1111/j.1365-2605.2005.00679.x.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P1478, DOI 10.1289/ehp.6417.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Wilkinson CF, 1999, REGUL TOXICOL PHARM, V30, P140, DOI 10.1006/rtph.1999.1338.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}COMM ENV PUBL HLT, 546712005C6009220051.
   {*}HLTH CAR HARM WOM, 2002, PRETT NAST PHTH EUR.
   {*}US CONS PROD SAF, 1998, RISK TOX ASS EXP DII.
   {*}US EPA NCFEA, 2000, CHILD SPEC EXP FACT.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{43}},
Journal-ISO = {{Pediatrics}},
Doc-Delivery-Number = {{258OQ}},
Wos-Id = {{ISI:000252877600043}},
}

@article{ ISI:000252604900010,
Author = {Chen, Mei-Lien and Chen, Jing-Shieng and Tang, Chia-Ling and Mao, I-Fang},
Title = {{The internal exposure of Taiwanese to phthalate - An evidence of
   intensive use of plastic materials}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2008}},
Volume = {{34}},
Number = {{1}},
Pages = {{79-85}},
Month = {{JAN}},
Abstract = {{Phthalates are widely used in industry and consumer products.
   Di-(2-ethylhexyl) phthalate (DEHP) and di-n-butylphthalate (DBP) show
   the greatest potency of reproductive toxicants among phthalates. The
   purposes of this study are to examine the migration level of phthalate
   from PVC films by simulating food handling and to reveal the body burden
   of phthalate for Taiwanese. In order to estimate a worst-case of
   phthalate migration, food was covered with polyvinyl chloride (PVC)
   films and then microwave heated. Results show that DEHP level in food
   increased significantly after heating for 3 min. Under the heating
   condition, the calculated intake of phthalate and the percentage of the
   tolerable daily intake (TDI, based on body weight of 60 kg) from eating
   one 400-g meal were 1705.6 mu g and 92.2\% for DEHP. Determination of
   urinary metabolites from 60 subjects reveals more than 90\% of samples
   were detectable for mono-methyl phthalate (MMP), mono-butyl phthalate
   (MBP) and mono-ethythexyl phthalate (MEHP). Notably, the median value of
   estimated daily intake of DEHP had reached 91.6\% of TDI established by
   the European Union Scientific Committee for Toxicity, Ecotoxicity and
   the Environment (CSTEE) (1998). Thirty-seven percent of the study
   population exceeded the TDI and 85\% exceeded the reference dose (RfD)
   of the US EPA. We conclude that the body burden of DEHP for Taiwanese
   reflects the intensives use of plastic materials in the region. The
   regulation of PVC for food preparation is necessary. (C) 2007 Elsevier
   Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mao, IF (Reprint Author), Natl Yang Ming Univ, Coll Med, Inst Environm \& Occupat Hlth Sci, Taipei 112, Taiwan.
   Chen, Mei-Lien; Chen, Jing-Shieng; Tang, Chia-Ling; Mao, I-Fang, Natl Yang Ming Univ, Coll Med, Inst Environm \& Occupat Hlth Sci, Taipei 112, Taiwan.
   Mao, I-Fang, Chung Shan Med Univ, Dept Occupat Safety \& Hlth, Taichung, Taiwan.}},
DOI = {{10.1016/j.envint.2007.07.004}},
ISSN = {{0160-4120}},
Keywords = {{phthalate; exposure assessment; biomonitoring; endocrine disruptor; PVC
   film}},
Keywords-Plus = {{HYG. ENVIRON. HEALTH; IN-UTERO EXPOSURE; DI(2-ETHYL HEXYL)PHTHALATE;
   GENERAL-POPULATION; HUMAN-REPRODUCTION; DIET SAMPLES; NTP CENTER;
   ESTERS; DI-(2-ETHYLHEXYL)PHTHALATE; DI(2-ETHYLHEXYL)PHTHALATE}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{ifmao@ym.edu.tw}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Balafas D, 1999, FOOD CHEM, V65, P279, DOI 10.1016/S0308-8146(98)00240-4.
   BIEGEL LB, 1995, TOXICOL APPL PHARM, V134, P18, DOI 10.1006/taap.1995.1164.
   Blount B. C., 2000, ENV HLTH PERSPECT, V108, P972.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   CASTLE L, 1994, FOOD ADDIT CONTAM, V11, P79.
   CHANG BF, 2000, P C ENDOCRINE DISRUP.
   CHEN CF, 2002, THESIS NATL YANGMING.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   David RM, 2004, INT J HYG ENVIR HEAL, V207, P75, DOI 10.1078/1438-4639-00271.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Harper H.A., 1977, REV PHYSL CHEM.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hirayama K, 2001, FOOD ADDIT CONTAM, V18, P357, DOI 10.1080/02652030010021459.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   Inoue K, 2001, FOOD ADDIT CONTAM, V18, P157, DOI 10.1080/02652030010018930.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P77, DOI 10.1078/1438-4639-00272.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Kurata Y, 1998, TOXICOL SCI, V42, P49, DOI 10.1093/toxsci/42.1.49.
   Latini G, 2003, BIOL NEONATE, V83, P22, DOI 10.1159/000067012.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   McKee RH, 2004, REPROD TOXICOL, V18, P1, DOI 10.1016/j.reprotox.2003.09.002.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   MURPHY JS, 2001, ADDITIVES PLASTIC HD.
   PAGE BD, 1992, FOOD ADDIT CONTAM, V9, P197.
   PARK YK, 2000, MENSAGEM DOCE, V58, P2.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Rahman M, 2004, PROG POLYM SCI, V29, P1223, DOI 10.1016/j.progpolymsci.2004.10.001.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   Steiner I, 1998, FOOD ADDIT CONTAM, V15, P812.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P569, DOI 10.1080/02652030010028344.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474.
   {*}ATSDR, 2002, TOX PROF 2 ETH PHTH.
   {*}CDC, 2003, 2 NAT REP HUM EXP EN, P81.
   {*}CSTEE, 1998, OP PHTH MIGR SOFT PV.
   {*}FIRDI, 2001, FOOD INT DAT.
   {*}ITIS, 2004, REV PROSP PLAST DEM.
   {*}NTP CERHR, 2003, CTR CHRHR EXP PAN RE.
   {*}SAS I INC, 2005, SAS PROC GUID VERS 9.
   {*}WHO, 1997, ENV HLTH CRIT 131 DI.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{26}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{254RE}},
Wos-Id = {{ISI:000252604900010}},
}

@article{ ISI:000251217000009,
Author = {Johnson, Kamin J. and Hensley, Janan B. and Kelso, Michael D. and
   Wallace, Duncan G. and Gaido, Kevin W.},
Title = {{Mapping gene expression changes in the fetal rat testis following acute
   dibutyl phthalate exposure defines a complex temporal cascade of
   responding cell types}},
Journal = {{BIOLOGY OF REPRODUCTION}},
Year = {{2007}},
Volume = {{77}},
Number = {{6}},
Pages = {{978-989}},
Month = {{DEC}},
Abstract = {{Phthalates are chemical plasticizers used in a variety of consumer
   products; in rodents, they alter testicular development, leading to
   decreased testosterone synthesis and maldevelopment of the reproductive
   tract. Here, our goals were to discover a set of biomarker genes that
   respond early after relatively low-dose-level dibutyl phthalate (DBP)
   exposure and map the responding testicular cell types. To identify
   testicular phthalate biomarker genes, 34 candidate genes were examined
   by quantitative PCR at 1, 2, 3, or 6 h after exposure of Gestational Day
   19 rats to DBP dose levels ranging from 0.1 to 500 mg/kg body weight.
   Twelve genes (Ctgf, Cxcl10, Dusp6, Edn1, Egr1, Fos, Ier3, junb, Nr4a1,
   Stc1, Thbs1, and Tnfrsf12a) were identified with increased expression by
   1-3 h at 100 or 500 mg/kg DBP, and 7 of these 12 genes had increased
   expression by 6 h at 10 mg/kg DBP. Using in situ hybridization of fetal
   testis cryosections from DBP-exposed rats, the temporal cellular
   expression of 10 biomarker genes was determined. Genes with a robust
   response at 1 h (Dusp6, Egr1, Fos, and Thbs1) were induced in
   peritubular myoid cells. For Egr1 and Fos, the interstitial compartment
   also showed increased expression at 1 h. Cxcl10 and Nr4a1 were induced
   by 1-3 h in both sparsely located interstitial cells and peritubular
   myoid cells. By 3 h, Stc1 was induced in Leydig cells, and Edn1, ler3,
   and Tnfrsf12a were increased in Sertoli cells. These data reveal a
   complex early cascade of phthalate-induced cellular responses in the
   fetal testis, and for the first time suggest that peritubular myoid
   cells are an important proximal phthalate target cell.}},
Publisher = {{SOC STUDY REPRODUCTION}},
Address = {{1603 MONROE ST, MADISON, WI 53711-2021 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Johnson, KJ (Reprint Author), Alfred I duPont Hosp Children, 1600 Rockland Rd, Wilmington, DE 19803 USA.
   Alfred I duPont Hosp Children, Wilmington, DE 19803 USA.
   The Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA.}},
DOI = {{10.1095/biolreprod.107.062950}},
ISSN = {{0006-3363}},
Keywords = {{fetal; gene expression; Leydig; Leydig cells; peritubular myoid;
   phthalate; rat; Sertoli; Sertoli cells; testis; toxicology}},
Keywords-Plus = {{N-BUTYL PHTHALATE; IN-UTERO EXPOSURE; MONO-(2-ETHYLHEXYL) PHTHALATE;
   DI(N-BUTYL) PHTHALATE; SERTOLI-CELLS; LEYDIG-CELLS; TESTOSTERONE
   SYNTHESIS; OXIDATIVE METABOLITES; TESTICULAR DYSGENESIS; URINARY LEVELS}},
Research-Areas = {{Reproductive Biology}},
Web-of-Science-Categories  = {{Reproductive Biology}},
Author-Email = {{johnson@medsci.udel.edu}},
Cited-References = {{Blanco-Colio LM, 2007, FRONT BIOSCI, V12, P3648, DOI 10.2741/2340.
   BOEKELHEIDE K, 2005, SERTOLI CELL TOXICAN.
   Boekelheide K, 2004, TOXICOL SCI, V81, P1, DOI 10.1093/toxsci/kfh196.
   CREASY DM, 1987, EXP MOL PATHOL, V46, P357, DOI 10.1016/0014-4800(87)90056-6.
   ERGUL A, 1993, ENDOCRINOLOGY, V132, P598, DOI 10.1210/en.132.2.598.
   Fennell TR, 2004, TOXICOL SCI, V82, P407, DOI 10.1093/toxsci/kfh294.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Gaido KW, 2007, TOXICOL SCI, V97, P491, DOI 10.1093/toxsci/kfm049.
   Ge RS, 2006, P NATL ACAD SCI USA, V103, P2719, DOI 10.1073/pnas.0507692103.
   GE RS, 2007, J ANDROL, V58, P513.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Hallmark N, 2007, ENVIRON HEALTH PERSP, V115, P390, DOI 10.1289/ehp.9490.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hiscott P, 2006, PROG RETIN EYE RES, V25, P1, DOI 10.1016/j.preteyeres.2005.05.001.
   HUTSON JC, 1990, BIOL REPROD, V43, P885, DOI 10.1095/biolreprod43.5.885.
   Johnson KJ, 2002, BIOL REPROD, V66, P983, DOI 10.1095/biolreprod66.4.983.
   JONES HB, 1993, EXP MOL PATHOL, V58, P179, DOI 10.1006/exmp.1993.1016.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Lahousse SA, 2006, TOXICOL SCI, V93, P369, DOI 10.1093/toxsci/kfl049.
   Lahousse SA, 2006, TOXICOL SCI, V91, P255, DOI 10.1093/toxsci/kfj135.
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7.
   LLOYD SC, 1988, TOXICOL APPL PHARM, V95, P484, DOI 10.1016/0041-008X(88)90366-3.
   Luo CW, 2004, MOL ENDOCRINOL, V18, P2085, DOI 10.1210/me.2004-0066.
   Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Manna PR, 2004, MOL ENDOCRINOL, V18, P558, DOI 10.1210/me.2003-0223.
   Martineau J, 1997, CURR BIOL, V7, P958, DOI 10.1016/S0960-9822(06)00415-5.
   McKinnell C, 2005, ENDOCRINOLOGY, V146, P4536, DOI 10.1210/en.2005-0676.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Nagpal ML, 2004, J ENDOCRINOL, V183, P585, DOI 10.1677/joe.1.05795.
   ORTH JM, 1988, ENDOCRINOLOGY, V122, P787.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P45.
   Richburg JH, 1996, TOXICOL APPL PHARM, V137, P42, DOI 10.1006/taap.1996.0055.
   Robert NM, 2006, BIOL REPROD, V74, P322, DOI 10.1095/biolreprod.105.044560.
   Romano F, 2005, CONTRACEPTION, V72, P294, DOI 10.1016/j.contraception.2005.03.009.
   Scott HM, 2007, ENDOCRINOLOGY, V148, P2027, DOI 10.1210/en.2006-1622.
   Shea-Eaton W, 2002, MOL CELL ENDOCRINOL, V188, P161, DOI 10.1016/S0303-7207(01)00715-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Thompson CJ, 2005, BIOL REPROD, V73, P908, DOI 10.1095/biolreprod.105.042382.
   VOMSAAL FS, 1990, BIOL REPROD, V43, P751, DOI 10.1095/biolreprod43.5.751.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   Wu MX, 2003, APOPTOSIS, V8, P11, DOI 10.1023/A:1021688600370.
   Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441.
   Zhang CX, 2006, P NATL ACAD SCI USA, V103, P17718, DOI 10.1073/pnas.0608556103.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{14}},
Journal-ISO = {{Biol. Reprod.}},
Doc-Delivery-Number = {{235ET}},
Wos-Id = {{ISI:000251217000009}},
}

@article{ ISI:000251852500015,
Author = {Silva, Manori J. and Samandar, Ella and Preau, Jr., James L. and Reidy,
   John A. and Needham, Larry L. and Calafat, Antonia M.},
Title = {{Quantification of 22 phthalate metabolites in human urine}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES}},
Year = {{2007}},
Volume = {{860}},
Number = {{1}},
Pages = {{106-112}},
Month = {{DEC 1}},
Abstract = {{Phthalates are ubiquitous industrial chemicals with high potential for
   human exposure. Validated analytical methods to measure trace
   concentrations of phthalate metabolites in humans are essential for
   assessing exposure to phthalates. Previously, we developed a sensitive
   and accurate automated analytical method for measuring up to 16
   phthalate metabolites in human urine by using on-line solid phase
   extraction coupled with isotope dilution-high performance liquid
   chromatography (HPLC)-electrospray ionization-tandem mass spectrometry.
   To include the measurement of seven additional analytes, including
   oxidative metabolites of diisononyl and diisodecyl phthalates, two
   chemicals used extensively in numerous consumer products. we used a
   novel nontraditional HPLC solvent gradient program. With this approach,
   we achieved adequate resolution and sensitivity for all 22 analytes with
   limits of detection in the low ng/mL range, without increasing the
   analytical run time. The method also has high accuracy with automatic
   recovery correction, high precision, and excellent sample throughput
   with minimal matrix effects. Although it is possible to measure these 22
   phthalate metabolites with adequate precision and accuracy at
   sub-parts-per-bill ion levels, additional information, including
   toxicokinetic data. is needed to demonstrate the usefulness of these
   phthalate metabolites for exposure assessment purposes. Published by
   Elsevier B.V.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, 4770 Buford Hwy Mailstop F53, Atlanta, GA 30341 USA.
   Silva, Manori J.; Samandar, Ella; Preau, James L., Jr.; Reidy, John A.; Needham, Larry L.; Calafat, Antonia M., Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.}},
DOI = {{10.1016/j.jchromb.2007.10.023}},
ISSN = {{1570-0232}},
Keywords = {{reverse HPLC gradient; phthalate metabolites; phthalates; biomonitoring;
   exposure assessment; diisodecyl phthalate; diisononyl phthalate;
   phthalate analysis}},
Keywords-Plus = {{OXIDATIVE METABOLITES; HUMAN EXPOSURE; DI(2-ETHYLHEXYL) PHTHALATE;
   QUANTITATIVE DETECTION; MASS-SPECTROMETRY; MALE-RATS; BIOMARKERS;
   MONOESTER; PERFORMANCE; ESTERS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{zca2@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{AGARWAL DK, 1986, ENVIRON HEALTH PERSP, V65, P343, DOI 10.2307/3430202.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   CALAFAT AM, 2006, TOXICOL ENV HLTH A, V69, P215.
   David R. M., 2001, PATTYS TOXICOLOGY, P635.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Hauser R, 2007, HUM REPROD, V22, P688, DOI 10.1093/humrep/del428.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P129, DOI 10.2307/3429396.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2007, BIOMARKERS, V12, P133, DOI 10.1080/13547500601066915.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Taylor J. K., 1987, QUALITY ASSURANCE CH.
   {*}ATSDR, 2001, TOX PRF PHTH DBP.
   {*}ATSDR, 1997, TOX PRF PHTH DNOP.
   {*}ATSDR, 2002, TOX PROF.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{58}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{244FT}},
Wos-Id = {{ISI:000251852500015}},
}

@article{ ISI:000251358800008,
Author = {Mazzeo, Pietro and Di Pasquale, Dorina and Ruggieri, Fabrizio and
   Fanelli, Maria and D'Archivio, Angelo Antonio and Carlucci, Giuseppe},
Title = {{HPLC with diode-array detection for the simultaneous determination of
   di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate in seminal
   plasma}},
Journal = {{BIOMEDICAL CHROMATOGRAPHY}},
Year = {{2007}},
Volume = {{21}},
Number = {{11}},
Pages = {{1166-1171}},
Month = {{NOV}},
Abstract = {{A high-performance liquid chromatographic method for the simultaneous
   determination of di(2-ethylhexyl)phthalate (DEHP) and its major
   metabolite mono(2-ethylhexyl)phthalate (MEHP) in seminal plasma was
   developed and validated. The method involves liquid-liquid extraction
   followed by isocratic reversed-phase chromatography with diode-array
   detection. The recovery, selectivity, linearity, precision and accuracy
   of the method were evaluated from the analysis of spiked seminal plasma
   samples. The effect of mobile-phase composition and pH on the retention
   of the target analytes was investigated. The limits of detection were
   0.010 and 0.015 mu g/mL, for DEHP and MEHP, respectively. This method
   was used to analyze real samples in support of clinical studies on these
   potential endocrine disruptors. Copyright (c) 2007 John Wiley \& Sons,
   Ltd.}},
Publisher = {{JOHN WILEY \& SONS LTD}},
Address = {{THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mazzeo, P (Reprint Author), Univ Aquila, Dipartimento Chim Ingn Chim \& Mat, I-67010 Coppito, Italy.
   Univ Aquila, Dipartimento Chim Ingn Chim \& Mat, I-67010 Coppito, Italy.
   Univ G dAnnunzio, Fac Farm, Dipartimento Sci Farm, I-66100 Chieti, Italy.}},
DOI = {{10.1002/bmc.870}},
ISSN = {{0269-3879}},
Keywords = {{phthalates; HPLC-DAD; human seminal plasma}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; HUMAN URINE; PHTHALATE;
   METABOLITES; EXPOSURE; RATS; TESTES; DI-(2-ETHYLHEXYL)PHTHALATE;
   PARAMETERS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Biochemistry \& Molecular Biology;
   Chemistry, Analytical; Pharmacology \& Pharmacy}},
Author-Email = {{mazzeo@univaq.it}},
Cited-References = {{Bauer MJ, 1997, SCI TOTAL ENVIRON, V208, P49, DOI 10.1016/S0048-9697(97)00272-6.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   Dalgaard M, 2001, TOXICOL LETT, V122, P69, DOI 10.1016/S0378-4274(01)00348-4.
   DAVIES AG, 1957, J CHEM SOC, P3148, DOI 10.1039/jr9570003148.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   FREDRICSSON B, 1993, PHARMACOL TOXICOL, V72, P128.
   GRIFFITHS WC, 1985, ANN CLIN LAB SCI, V15, P140.
   Ichimura T, 2003, TOXICOLOGY, V194, P35, DOI 10.1016/j.tox.2003.07.003.
   Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019.
   Ito R, 2005, J PHARMACEUT BIOMED, V39, P1036, DOI 10.1016/j.jpba.2005.06.016.
   Keys DA, 1999, TOXICOL SCI, V49, P172, DOI 10.1093/toxsci/49.2.172.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Latini Giuseppe, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P37, DOI 10.2174/1568008043340017.
   Ljungstrom AM, 2002, J LIGHTWAVE TECHNOL, V20, P78, DOI 10.1109/50.974821.
   Paris I, 2003, ANAL LETT, V36, P2649, DOI 10.1081/AL-120024639.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Richburg JH, 1996, TOXICOL APPL PHARM, V137, P42, DOI 10.1006/taap.1996.0055.
   Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   SHIOTA K, 1985, ARCH TOXICOL, V56, P263, DOI 10.1007/BF00295165.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   SJOBERG P, 1991, BIOCHEM PHARMACOL, V41, P1493, DOI 10.1016/0006-2952(91)90566-N.
   Skakkebaek NE, 2002, HORM RES, V57, P43, DOI 10.1159/000058100.
   THYSEN B, 1990, TOXICOL APPL PHARM, V106, P154, DOI 10.1016/0041-008X(90)90115-B.
   {*}ATSDR, 2002, TOXICOLOGICAL PROFIL.
   {*}ICH, 2001, INT C HARM GUID BIOA.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{5}},
Journal-ISO = {{Biomed. Chromatogr.}},
Doc-Delivery-Number = {{237FE}},
Wos-Id = {{ISI:000251358800008}},
}

@article{ ISI:000250697000002,
Author = {Fromme, Hermann and Gruber, Ludwig and Schlurnmer, Martin and Wz, Gerd
   and Boehmer, Sigrun and Angerer, Juergen and Mayer, Richard and Liebl,
   Bernhard and Bolte, Gabriele},
Title = {{Intake of phthalates and di(2-ethylhexyl)adipate: Results of the
   Integrated Exposure Assessment Survey based on duplicate diet samples
   and biomonitoring data}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2007}},
Volume = {{33}},
Number = {{8}},
Pages = {{1012-1020}},
Month = {{NOV}},
Abstract = {{Phthalates are ubiquitous environmental chemicals with potential
   detrimental health effects. The purpose of our study was to quantify
   dietary intake of phthalates and of DEHA (Di-ethylhexyl adipate) using
   duplicate diet samples and to compare these data with the calculated
   data based on urinary levels of primary and secondary phthalate
   metabolites. 27 female and 23 male healthy subjects aged 14-60 years
   collected daily duplicate diet samples over 7 consecutive days. Overall,
   I I phthalates were measured in the duplicates by GC/MS and LC/MS
   methods. Urinary levels of primary and secondary phthalate metabolites
   are also available. The median (95th percentile) daily intake via food
   was 2.4 (4.0) mu g/kg b.w. (Di-2-ethylhexyl phthalate, DEHP), 0.3 (1.4)
   mu g/kg b.w. (Di-n-butyl phthalate, DnBP), 0.6 (2.1) mu g/kg b.w.
   (Di-isobutyl phthalate, DiBP) and 0.7 (2.2) mu g/kg b.w. for DEHA. MEPH
   (Mono-2-ethxylhexyl phthalate) was detectable only in minor
   concentrations in the samples, thus conversion of DEHP to MEHP and
   dietary intake of MEHP were negligible. When comparing back-calculated
   intake data of the DEHP metabolites with dietary DEHP intake from the
   day before significant correlations were observed for most of the
   metabolites. No correlation was found for DnBP and only a weak but
   significant correlation for DiBP The median and 95th percentile daily
   dietary intake of all target analytes did not exceed the recommended
   tolerable daily intake. Our data indicated that food was the predominant
   intake source of DEHP whilst other sources considerably contributed to
   the daily intake of DnBP and DiBP in an adult population. (C) 2007
   Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fromme, H (Reprint Author), Bavarian Hlth \& Food Safety Author, Dept Environm Hlth, Vet Str 2, D-85764 Oberschleissheim, Germany.
   Bavarian Hlth \& Food Safety Author, Dept Environm Hlth, D-85764 Oberschleissheim, Germany.
   Fraunhofer Inst Prco Engn \& Packaging, Dept Prod Safety \& Anal, D-85354 Freising Weihenstephan, Germany.
   Univ Erlangen Nurnberg, Inst Occupat Social \& Environm Med, D-91054 Erlangen, Germany.
   Univ Erlangen Nurnberg, Outpatient Clin Occupat Social \& Environm Med, D-91054 Erlangen, Germany.
   Bavarian State Minist Environm Publ Hlth \& Consum, D-81925 Munich, Germany.}},
DOI = {{10.1016/j.envint.2007.05.006}},
ISSN = {{0160-4120}},
Keywords = {{DEHP; DnBP; DiNP; phthalates; MEHP; DEHA; total diet study; duplicate;
   dietary intake; biomonitoring}},
Keywords-Plus = {{DI-2-(ETHYLHEXYL) ADIPATE DEHA; ISO-NONYLPHTHALATE DINP;
   DEUTERIUM-LABELED DEHP; N-BUTYL PHTHALATE; HUMAN URINE; DEVELOPMENTAL
   TOXICITY; ENVIRONMENTAL EXPOSURE; ANOGENITAL DISTANCE;
   GENERAL-POPULATION; RISK-ASSESSMENT}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{hennann.fromme@lgl.bayem.de}},
ResearcherID-Numbers = {{Gruber, Ludwig/G-1310-2010
   Schlummer, Martin/B-1101-2013}},
ORCID-Numbers = {{Gruber, Ludwig/0000-0001-9198-4786
   }},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Andrade AJM, 2006, TOXICOLOGY, V225, P64, DOI 10.1016/j.tox.2006.05.007.
   Angerer J, 2006, TOXICOL SCI, V93, P3, DOI 10.1093/toxsci/kfl042.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Bosgra S, 2005, REGUL TOXICOL PHARM, V43, P104, DOI 10.1016/j.yrtph.2005.06.008.
   Calafat AM, 2006, ENVIRON HEALTH PERSP, V114, P1783, DOI 10.1289/ehp.9059.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   CHAN PKL, 1994, ENVIRON CARCIN ECO R, V12, P257.
   CLARK K, 2003, HDB ENV CHEM PHTHALA.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   EFSA (European Food Safety Authority), 2005, EFSA J, V242, P1.
   Franco A, 2007, ENVIRON INT, V33, P283, DOI 10.1016/j.envint.2006.10.001.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P345, DOI 10.1016/j.ijheh.2007.01.026.
   Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1046/j.1600-0668.2003.00223.x.
   GRUBERL, INTEGRATED EXPOSURE.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   KOCH HM, 2006, ISEE ISEA C SEPT.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koch HM, 2007, J CHROMATOGR B, V847, P114, DOI 10.1016/j.jchromb.2006.09.044.
   Koch HM, 2007, INT J HYG ENVIR HEAL, V210, P9, DOI 10.1016/j.ijheh.2006.11.008.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   KOO HJ, 2005, J TOXICOL ENV HEAL A, V68, P1392.
   Kroes R, 2002, FOOD CHEM TOXICOL, V40, P327, DOI 10.1016/S0278-6915(01)00113-2.
   Kuchen Arnold, 1999, Mitteilungen aus Lebensmitteluntersuchung und Hygiene, V90, P78.
   Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013.
   LOFTUS NJ, 1993, FOOD CHEM TOXICOL, V31, P609, DOI 10.1016/0278-6915(93)90042-W.
   LOFTUS NJ, 1994, FOOD CHEM TOXICOL, V32, P1, DOI 10.1016/0278-6915(84)90029-2.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   PFANNHAUSER W, 1995, OSTERREICHISCHES BUN.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Thomas KW, 1997, J EXPO ANAL ENV EPID, V7, P17.
   Tsamura Y., 2001, FOOD ADDIT CONTAM, V18, P449.
   Wensing M, 2005, SCI TOTAL ENVIRON, V339, P19, DOI 10.1016/j.scitotenv.2004.10.028.
   WHO, 1985, GUID STUD DIET INT C.
   WOLFE GW, 2003, 7244200 TRC.
   WOOLLEN BH, 1998, CTLR1372 CENTR TOX L.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}BUA, 1996, 196.
   {*}CERHR, 2005, NAT TOX PROG CERHR E.
   {*}CERHR, 2000, NAT TOX PROGR CERHR.
   {*}DEHRM, 2003, MEAS BIOV HUM DIET I.
   {*}ECB, 2004, EUR UN RISK.
   {*}ECB, 2003, EUR UN RISK ASS REP, V30.
   {*}ECB, 2003, EUR UN RISK ASS REP, V29.
   {*}EFSA, 2005, STAT SCI PLAN FOOD A.
   {*}FDA, 2001, SAF ASS DIETH.
   {*}MAFF, 1987, 21 FOOD SURV.
   {*}MAFF, 1996, PHTHAL FOOD FOOD SUR.
   {*}SCF, 1997, REP SCI COMM FOOD DI.
   {*}WHO, 2004, BACKGR DOC DEV WHO G.}},
Number-of-Cited-References = {{62}},
Times-Cited = {{54}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{227ZQ}},
Wos-Id = {{ISI:000250697000002}},
}

@article{ ISI:000250556100063,
Author = {Silva, Manori J. and Samandar, Ella and Reidy, John A. and Hauser, Russ
   and Needham, Larry L. and Calafat, Antonia M.},
Title = {{Metabolite profiles of di-n-butyl phthalate in humans and rats}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2007}},
Volume = {{41}},
Number = {{21}},
Pages = {{7576-7580}},
Month = {{NOV 1}},
Abstract = {{Di-n-butyl phthalate (DBP) is widely used in consumer products. In
   humans and in rats, DBP is metabolized to mono-n-butyl phthalate (MBP).
   MBP may also further oxidize to other metabolites of DBP. We studied the
   metabolic profiles of DBP in rats and humans to evaluate the
   similarities between the two species and between different exposure
   scenarios. In rats administered DBP by oral gavage, we identified MBP
   and three urinary oxidative metabolites of DBP: mono-3-oxo-n-butyl
   phthalate, mono-3-hydroxy-n-butyl phthalate (MHBP), and
   mono-3-carboxypropyl phthalate (MCPP). MBP, MHBP, and MCPP were also
   present in serum, albeit at lower levels than in urine. Statistically
   significant correlations (p < 0.01) existed between the concentrations
   of MBP and the concentrations of MHBP (Pearson correlation coefficient r
   = 0.82 {[}urine] and r = 0.96 {[}serum]) and MCPP (r = 0.77 {[}urine]
   and r = 0.97 {[}serum]). However, the concentrations of these
   metabolites in urine collected 6 h after dosing and in serum 24 h after
   dosing were not correlated, suggesting continuous metabolism of DBP
   and/or individual differences among rats. Serum DBP metabolite
   concentrations increased with the dose, whereas urinary concentrations
   did not. We also identified MBP, MHBP, and MCPP in the urine of four men
   exposed to DBP by taking a prescription medication containing DBP, and
   MBP and MCPP in 94 adults with no documented exposure to DBP. In the
   human samples, we observed statistically significant correlations (p <
   0.01) among the urinary concentrations of MBP and MCPP, although the
   correlation was stronger for the four exposed men (r = 0.99) than for
   the adults without a documented exposure to DBP (r = 0.70). Our results
   suggest that regardless of species and exposure scenario, MBP, the major
   DBP metabolite, is an optimal biomarker of exposure to DBP. In addition
   to MBP, MCPP and MHBP may be adequate biomarkers of exposure to DBP in
   occupational settings or in potential high-exposure scenarios.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.
   Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.}},
DOI = {{10.1021/es071142x}},
ISSN = {{0013-936X}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; OXIDATIVE METABOLITES; DI(2-ETHYLHEXYL)
   PHTHALATE; OCTYL PHTHALATE; HUMAN EXPOSURE; URINARY; SERUM; POPULATION;
   BIOMARKERS; MONOESTERS}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{zca2@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   Fennell TR, 2004, TOXICOL SCI, V82, P407, DOI 10.1093/toxsci/kfh294.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kim HS, 2004, J TOXICOL ENV HEAL A, V67, P2045, DOI 10.1080/15287390490514859.
   Koch H, 2005, UMWELTMED FORSCH PRA, V10, P144.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013.
   Silva MJ, 2005, J ANAL TOXICOL, V29, P819.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2005, TOXICOLOGY, V210, P123, DOI 10.1016/j.tox2005.01.012.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2007, BIOMARKERS, V12, P133, DOI 10.1080/13547500601066915.
   Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   TANAKA A, 1978, TOXICOLOGY, V9, P109, DOI 10.1016/0300-483X(78)90036-7.
   {*}ATSDR, 2007, TOX PORF DI N BUT PH.
   {*}CDC, 3 CDCP NAT CTR ENV H.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{21}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{225ZE}},
Wos-Id = {{ISI:000250556100063}},
}

@article{ ISI:000250382700021,
Author = {Huang, Po-Chin and Kuo, Pao-Lin and Guo, Yue-Liang and Liao, Pao-Chi and
   Lee, Ching-Chang},
Title = {{Associations between urinary phthalate monoesters and thyroid hormones
   in pregnant women}},
Journal = {{HUMAN REPRODUCTION}},
Year = {{2007}},
Volume = {{22}},
Number = {{10}},
Pages = {{2715-2722}},
Month = {{OCT}},
Abstract = {{Background: Maternal hypothyroidism during pregnancy can cause adverse
   effects in the fetus. Scientific evidence has shown that probable
   thyroid- like function of some phthalates in vitro and in vivo, and
   phthalates exposure, can begin in utero. This study investigated the
   association between phthalate exposure and thyroid hormones in pregnant
   women. Methods: Serum and spot urine samples were collected from 76
   Taiwanese pregnant women at second trimester. Thyroid hormones,
   including thyroid- stimulating hormone (TSH), triiodothyronine (T3),
   thyroxine (T4) and free T4 (FT4) were analysed in serum samples, and
   five urinary phthalate monoesters, including mono butyl phthalate (MBP),
   monoethyl phthalate (MEP) and mono ethylhexyl phthalate (MEHP), were
   measured. Results: Urinary MBP, MEP and MEHP, the median levels of which
   were 81.8, 27.7 and 20.6 ng/ml, respectively, were the predominant
   substances in the urinary phthalate monoesters. Significant mild
   negative correlations were found between T4 and urinary MBP (R = 20.248,
   P < 0.05), and between FT4 and urinary MBP (R = 20.368, P < 0.05). After
   adjusting for age, BMI and gestation, urinary MBP levels showed negative
   associations with FT4 and T4 (FT4: b = 20.110, P < 0.001; T4: b520.112,
   P = 0.003). Conclusions: Exposure to di- n- butyl phthalate (DBP) may
   affect thyroid activity in pregnant women, but how DBP affects thyroid
   function is unclear. Further studies are needed to elucidate the
   mechanism of action and to investigate whether any other factors related
   to DBP exposure alter the thyroid function.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Lee, CC (Reprint Author), Natl Cheng Kung Univ, Coll Med, Dept Environm \& Occupat Hlth, Tainan 70101, Taiwan.
   Natl Cheng Kung Univ, Coll Med, Dept Environm \& Occupat Hlth, Tainan 70101, Taiwan.
   Natl Cheng Kung Univ Hosp, Dept Obstet \& Gynecol, Tainan 70428, Taiwan.
   Natl Taiwan Univ, Coll Med, Dept Environm \& Occupat Med, Taipei, Taiwan.}},
DOI = {{10.1093/humrep/dem205}},
ISSN = {{0268-1161}},
Keywords = {{pregnant women; urinary phthalate monoesters; thyroid hormones.}},
Keywords-Plus = {{N-BUTYL PHTHALATE; EXPERT PANEL REPORT; IN-UTERO EXPOSURE;
   DI(2-ETHYLHEXYL)PHTHALATE DEHP; DEVELOPMENTAL TOXICITY; ENVIRONMENTAL
   EXPOSURE; HUMAN-REPRODUCTION; DIETHYL PHTHALATE; AMNIOTIC-FLUID;
   FREE-THYROXINE}},
Research-Areas = {{Obstetrics \& Gynecology; Reproductive Biology}},
Web-of-Science-Categories  = {{Obstetrics \& Gynecology; Reproductive Biology}},
Author-Email = {{cclee@mail.ncku.edu.tw}},
ResearcherID-Numbers = {{Huang, Po-Chin/I-5844-2012}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   BALL R, 1989, CLIN CHEM, V35, P1891.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Breous E, 2005, MOL CELL ENDOCRINOL, V244, P75, DOI 10.1016/j.mce.2005.06.009.
   BURROW GN, 1993, ENDOCR REV, V14, P194, DOI 10.1210/er.14.2.194.
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   CHAN PKL, 1994, ENVIRON CARCIN ECO R, V12, P257.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   CUNNINGHAM FG, 2006, WILLIAMS OBSTETRICS.
   de Escobar GM, 2004, BEST PRACT RES CL EN, V18, P225, DOI 10.1016/j.beem.2004.03.012.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   Glinoer D, 1997, ENDOCR REV, V18, P404, DOI 10.1210/er.18.3.404.
   Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   Hashimoto KI, 2006, ENDOCR J, V53, P593, DOI 10.1507/endocrj.K06-055.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hume R, 2004, J CLIN ENDOCR METAB, V89, P4097, DOI 10.1210/jc.2004-0573.
   Kavlock R, 2002, REPROD TOXICOL, V16, P489, DOI 10.1016/S0890-6238(02)00033-3.
   KAVLOCK R, 2006, NTP CHRHR EXPERT PAN.
   Kavlock R, 2002, REPROD TOXICOL, V16, P453, DOI 10.1016/S0890-6238(02)00029-1.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   KUHLBACK B, 1966, SCAND J CLIN LAB INV, V18, P654, DOI 10.3109/00365516609049049.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Netto Lino Sieiro, 2004, Arq Bras Endocrinol Metabol, V48, P493, DOI 10.1590/S0004-27302004000400009.
   Pereira C, 2007, ACTA HISTOCHEM, V109, P29, DOI 10.1016/j.acthis.2006.09.008.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Pop VJ, 1999, CLIN ENDOCRINOL, V50, P149, DOI 10.1046/j.1365-2265.1999.00639.x.
   Poppe K, 2003, HUM REPROD UPDATE, V9, P149, DOI 10.1093/humupd/dmg012.
   PRICE SC, 1988, TOXICOL LETT, V40, P37, DOI 10.1016/0378-4274(88)90181-6.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Steer PJ, 2005, HIGH RISK PREGNANCY.
   Sugiyama S, 2005, TOXICOL SCI, V88, P367, DOI 10.1093/toxsci/kfi330.
   Takser L, 2005, ENVIRON HEALTH PERSP, V113, P1039, DOI 10.1289/ehp.7685.
   Wang SL, 2005, ENVIRON HEALTH PERSP, V113, P1645, DOI 10.1289/ehp.7994.
   Wolff J, 1998, PHARMACOL REV, V50, P89.
   Yuan SY, 2002, CHEMOSPHERE, V49, P1295, DOI 10.1016/S0045-6535(02)00495-2.
   Zoeller RT, 2004, J NEUROENDOCRINOL, V16, P809, DOI 10.1111/j.1365-2826.2004.01243.x.
   {*}ATSDR, 2002, TOX PROF DI PHTH.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{55}},
Journal-ISO = {{Hum. Reprod.}},
Doc-Delivery-Number = {{223OZ}},
Wos-Id = {{ISI:000250382700021}},
}

@article{ ISI:000251062600021,
Author = {Heudorf, Ursel and Mersch-Sundermann, Volker and Angerer, Juergen},
Title = {{Phthalates: Toxicology and exposure}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2007}},
Volume = {{210}},
Number = {{5}},
Pages = {{623-634}},
Month = {{OCT}},
Note = {{International Workshop on Childrens Environment in Central Europe -
   Threats and Chances, Osnabruck, GERMANY, NOV 21-24, 2006}},
Organization = {{DAKJ, Commiss Environm Issues; Kinderumwelt GmbH}},
Abstract = {{Phthalates are used as plasticizers in PVC plastics. As the phthalate
   plasticizers are not chemically bound to PVC, they can leach, migrate or
   evaporate into indoor air and atmosphere, foodstuff, other materials,
   etc. Consumer products containing phthalates can result in human
   exposure through direct contact and use, indirectly through leaching
   into other products, or general environmental contamination. Humans are
   exposed through ingestion, inhalation, and dermal exposure during their
   whole lifetime, including intrauterine development.
   This paper presents an overview on current risk assessments done by
   expert panels as well as on exposure assessment data, based on ambient
   and on current human biomonitoring results. Some phthalates are
   reproductive and developmental toxicants in animals and suspected
   endocrine disruptors in humans. Exposure assessment via modelling
   ambient data give hints that the exposure of children to phthalates
   exceeds that in adults. Current human biomonitoring data prove that the
   tolerable intake of children is exceeded to a considerable degree, in
   some instances up to 20-fold. Very high exposures to phthalates can
   occur via medical treatment, i.e. via use of medical devices containing
   DEHP or medicaments containing DBP phthalate in their coating.
   Because of their chemical properties exposure to phthalates does not
   result in bioaccumulation. However, health concern is raised regarding
   the developmental and/or reproductive toxicity of phthalates, even in
   environmental concentrations. (C) 2007 Elsevier GmbH. All rights
   reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Heudorf, U (Reprint Author), Dept Publ Hlth, Frankfurt, Germany.
   Dept Publ Hlth, Frankfurt, Germany.
   Univ Giessen, Dept Indoor \& Environm Toxicol, D-35390 Giessen, Germany.
   Univ Erlangen Nurnberg, Optpatient Clin Occupat Social \& Environm Med, D-8520 Erlangen, Germany.}},
DOI = {{10.1016/j.ijheh.2007.07.011}},
ISSN = {{1438-4639}},
Keywords = {{phthalates; toxicology; exposure assessment; human biomonitoring}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; NURSERY-SCHOOL CHILDREN;
   DI(2-ETHYLHEXYL)PHTHALATE DEHP; DIET SAMPLES; HUMAN URINE; ANOGENITAL
   DISTANCE; INTERNAL EXPOSURE; MALE INFANTS; METABOLITES; POPULATION}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{Ursel.heudorf@stadt-frankfurt.de}},
Cited-References = {{ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   ATSDR, 1995, TOX PROF DIETH.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   BECKER K, 2002, P 9 INT C IND AIR QU, V4, P883.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   CADOGAN DF, 2004, COMMUNICATION    MAR.
   Calafat AM, 2004, PEDIATRICS, V113, P429.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   EFSA (European Food Safety Authority), 2004, STAT SCI PAN FOOD AD.
   Fromme H, 2007, INT J HYG ENVIR HEAL, V210, P21, DOI 10.1016/j.ijheh.2006.09.005.
   Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1046/j.1600-0668.2003.00223.x.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   HOLSTRUP O, 2001, ENDOCRIN WIRKSAME XE.
   Karle VA, 1997, CRIT CARE MED, V25, P696, DOI 10.1097/00003246-199704000-00023.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   KERSTEN NE, 2003, GEFAHRST REINHALT L, V63, P85.
   Koch H, 2005, UMWELTMED FORSCH PRA, V10, P144.
   Koch HM, 2005, INT J HYG ENVIR HEAL, V208, P489, DOI 10.1016/j.ijheh.2005.07.001.
   Koch HM, 2006, INT J ANDROL, V29, P181.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   Koch HM, 2005, ARCH TOXICOL, V79, P689, DOI 10.1007/s00204-005-0004-x.
   KOCH HM, 2004, ARCH TOXICOL, V78, P120.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Latini G, 2004, REPROD TOXICOL, V19, P27, DOI 10.1016/j.reprotox.2004.05.011.
   Marsee K, 2006, ENVIRON HEALTH PERSP, V114, P805, DOI 10.1289/ehp.8663.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   NTP-CERHR, 2000, NTP CERHR EXP PAN RE.
   PAGE BD, 1995, FOOD ADDIT CONTAM, V12, P129.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   POHNER A, 1998, Z UMWELTMED, V6, P337.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Rais-Bahrami K, 2004, ENVIRON HEALTH PERSP, V112, P1339, DOI 10.1289/ehp.6901.
   Rao P R, 1997, Pharm Acta Helv, V72, P47, DOI 10.1016/S0031-6865(96)00060-X.
   REGNIER J, 2004, OFFICIAL J SOC TOXIC, V78, pS1.
   Grandjean P, 2006, INT J ANDROL, V29, P181, DOI 10.1111/j.1365-2605.2005.00679.x.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   SHELDON L, 1993, P IND AIR 93, V3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   SILVA MJ, 2006, TOXICOLOGY, V15, P219.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Tsumura Y, 2003, FOOD ADDIT CONTAM, V20, P317, DOI 10.1080/0265203031000122021.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474.
   WAMS TJ, 1987, SCI TOTAL ENVIRON, V66, P1, DOI 10.1016/0048-9697(87)90072-6.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P319, DOI 10.1016/j.ijheh.2007.01.037.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}ATSDR, 1997, TOX PROF DI N OCT PH.
   {*}ATSDR, 2002, TOX PROF DI PHTH.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}CDC, 2003, 020716 NCEH PUB.
   {*}COM, 1999, OFFICIAL J L, V315, P46.
   {*}CSTEE, 1998, 6 CSTEE PLEN M BURSS.
   {*}CSTEE, 1998, CSTEE 3 PLEN M BRUSS.
   {*}CSTEE, 2004, 41 PLEN M 8 JAN 2004.
   {*}ECB, 2004, R0420402ENVHH46.
   {*}ECCHCPD, 2002, OP MED DEV CONT DEHP.
   {*}HLTH CAN, 1994, PRIOR SUBST LIST.
   {*}HLTH CAN, 2002, DEHP MED EV EXP TOX.
   {*}IARC, 2000, IARC MON EV CARC RIS, V77, P41.
   {*}NTP CERHR, 2003, 034487 NIH PUBL NTP.
   {*}NTP CERHR, 2003, 034485 NIH PUBL NTP.
   {*}NTP CERHR, 2003, 034489 NIH PUBL NTP.
   {*}NTP CERHR, 2003, 034488 NIH PUBL NTP.
   {*}NTP CERHR, 2005, EXP PAN REEV DEHP M.
   {*}NTP CERHR, 2003, 034484 NIH PUBL NTP.
   {*}NTP CERHR, 2003, 034486 NIH PUBL NTP.
   {*}US EPA IRIS, 1993, BUT BENZ PHTH.
   {*}US EPA IRIS, 1990, DIB PHTH.
   {*}US EPA IRIS, 1993, DIET PHTH.
   {*}US EPA IRIS, 1991, DI PHTH.
   {*}US FDA, 2002, SAF ASS DI PHTH DEHP.
   {*}US FDA, 2000, IND FOOD ADD ADH COM.
   {*}US FDA, 2003, INACT INGR SEARCH AP.}},
Number-of-Cited-References = {{84}},
Times-Cited = {{174}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{233AK}},
Wos-Id = {{ISI:000251062600021}},
}

@article{ ISI:000248343600057,
Author = {Janjua, Nadeem Rezaq and Mortensen, Gerda Krogh and Andersson,
   Anna-Maria and Kongshoj, Brian and Skakkebaek, Niels E. and Wulf, Hans
   Christian},
Title = {{Systemic uptake of diethyl phthalate, dibutyl phthalate, and butyl
   paraben following whole-body topical application and reproductive and
   thyroid hormone levels in humans}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2007}},
Volume = {{41}},
Number = {{15}},
Pages = {{5564-5570}},
Month = {{AUG 1}},
Abstract = {{In vitro and animal studies have reported endocrine-disrupting activity
   of chemicals used commonly as additives in cosmetics and skin care
   products. We investigated whether diethyl phthalate (DEP), dibutyl
   phthalate (DBP), and butyl paraben (BP) were systemically absorbed and
   influenced endogenous reproductive and thyroid hormone levels in humans
   after topical application. In a two-week single-blinded study, 26
   healthy young male volunteers were assigned to daily whole-body topical
   application of 2 mg/cm(2) basic cream formulation each without (week
   one) and with (week two) the three 2\% (w/w) compounds. The
   concentrations of BP and the main phthalate metabolites monoethyl (MEP)
   and monobutyl phthalate (MBP) were measured in serum together with the
   following reproductive hormones: follicle stimulating hormone (FSH),
   lutenising hormone (LH), testosterone, estradiol, and inhibin B and
   thyroid hormones (thyroid stimulating hormone (TSH), free thyroxine
   (FT4), total triiodothyroxine (T3), and total thyroxine (T4)). MEP, MBP,
   and BP peaked in serum a few hours after application, reaching mean +/-
   SEM levels of 1001 +/- 81 mu g/L, 51 +/- 6 mu g/L, and 135 +/- 11 mu
   g/L, respectively. Only MEP was detectable in serum before treatment.
   Minor differences in inhibin B, LH, estradiol, T4, FT4, and TSH were
   observed between the two weeks, but these were not related to exposure.
   We demonstrated for the first time that DEP, DBP, and BP could be
   systemically absorbed in man after topical application. The systemic
   absorption of these compounds did not seem to have any short-term
   influence on the levels of reproductive and thyroid hormones in the
   examined young men.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Janjua, NR (Reprint Author), Bispebjerg Hosp, Dept Dermatol, DK-2400 Copenhagen, Denmark.
   Bispebjerg Hosp, Dept Dermatol, DK-2400 Copenhagen, Denmark.
   Univ Copenhagen Hosp, Rigshosp, Dept Growth \& Reprod, DK-2100 Copenhagen, Denmark.}},
DOI = {{10.1021/es0628755}},
ISSN = {{0013-936X}},
Keywords-Plus = {{IN-UTERO EXPOSURE; DEVELOPMENTAL TOXICITY; DI(N-BUTYL) PHTHALATE;
   TESTICULAR DYSGENESIS; ESTROGENIC ACTIVITY; RATS; VITRO; VIVO;
   ABSORPTION; ESTERS}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{nrjanjua@hotmail.com}},
Cited-References = {{Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   BENOWITZ NL, 1986, ANNU REV MED, V37, P21, DOI 10.1146/annurev.med.37.1.21.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   DUBOIS D, 1989, NUTRITION, V5, P303.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   ELSISI AE, 1989, FUND APPL TOXICOL, V12, P70, DOI 10.1016/0272-0590(89)90063-8.
   EMA M, 1995, TOXICOL LETT, V78, P101, DOI 10.1016/0378-4274(94)03241-X.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   HAGEDORNLEWEKE U, 1995, PHARMACEUT RES, V12, P1354.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   HAUSER R, 2005, OCCUP ENV MED, V62.
   Hong EJ, 2005, J REPROD DEVELOP, V51, P253, DOI 10.1262/jrd.16075.
   HOULIHAN J, 2002, BCSB NOT TOO PRETTY.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kang KS, 2002, J VET MED SCI, V64, P227, DOI 10.1292/jvms.64.227.
   Kavlock R, 2002, REPROD TOXICOL, V16, P489, DOI 10.1016/S0890-6238(02)00033-3.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   KROSCHWITZ JI, 1996, KIRKOTHMER ENCY CHEM, P991.
   Lenz TL, 2004, SPORTS MED, V34, P293, DOI 10.2165/00007256-200434050-00002.
   Mahood IK, 2006, INT J ANDROL, V29, P148, DOI 10.1111/j.1365-2605.2005.00574.x.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Marqusee E, 2000, J CLIN ENDOCR METAB, V85, P4407, DOI 10.1210/jc.85.11.4407.
   Shirreffs Susan M, 2006, Curr Sports Med Rep, V5, P192, DOI 10.1007/s11932-006-0046-8.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   O'Connor JC, 2002, TOXICOL SCI, V69, P92, DOI 10.1093/toxsci/69.1.92.
   Oishi S, 2001, TOXICOL IND HEALTH, V17, P31, DOI 10.1191/0748233701th093oa.
   Oishi S, 2002, ARCH TOXICOL, V76, P423, DOI 10.1007/s00204-002-0360-8.
   Paluska Scott A, 2003, Curr Sports Med Rep, V2, P213, DOI 10.1007/s11932-003-0008-3.
   RASTOGI SC, 1995, CONTACT DERMATITIS, V32, P28, DOI 10.1111/j.1600-0536.1995.tb00836.x.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   SCOTT RC, 1987, ENVIRON HEALTH PERSP, V74, P223, DOI 10.2307/3430452.
   Soni MG, 2005, FOOD CHEM TOXICOL, V43, P985, DOI 10.1016/j.fct.2005.01.020.
   Sugiyama S, 2005, TOXICOL SCI, V88, P367, DOI 10.1093/toxsci/kfi330.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Zacharewski T, 1998, ENVIRON HEALTH PERSP, V106, P577, DOI 10.2307/3433808.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}CDC, 2005, 2 NAT REP HUM EXP EN.
   {*}NTP, 2005, BUT PAR REV TOX LIT.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{58}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{194KP}},
Wos-Id = {{ISI:000248343600057}},
}

@article{ ISI:000247657800009,
Author = {Spjuth, L. and Johannisson, A. and Lundeheim, N. and Rodriguez-Martinez,
   H.},
Title = {{Early pre-pubertal exposure to low-dose oral di(2-ethylhexyl) phthalate
   does not affect sperm plasma membrane stability, acrosomal integrity or
   chromatin structure in the post-pubertal}},
Journal = {{THERIOGENOLOGY}},
Year = {{2007}},
Volume = {{68}},
Number = {{2}},
Pages = {{186-195}},
Month = {{JUL 15}},
Abstract = {{This study aimed to determine whether pre-pubertal exposure in boars to
   di(2-ethylhexyl) phthalate (DEHP), a plasticizer reported to have toxic
   effects on rodent reproduction, would affect the sperm ability to
   undergo capacitation and acrosome reaction (AR) in vitro or give rise to
   a higher degree of chromatin instability associated with acid-induced
   denaturation. Spermatozoa were collected from 16 boars (n = 8/group) 8-9
   months of age, exposed to 300 mg/kg body weight of DEHP or placebo per
   os three times a week, from 3 to 7 weeks of age. The spermatozoa were
   cryopreserved and examined post-thaw by flow cytometry for their ability
   to capacitate in vitro when exposed to the effector bicarbonate and to
   acrosome-react when exposed to calcium ionophores, using the lipid stain
   Merocyanine-540 (m-540), and peanut agglutinin-fluorescein
   isothiocyanate, respectively, as probes. The ability of the DNA to
   sustain denaturation in vitro was tested using a sperm chromatin
   structure assay (SCSA). No significant differences between the
   DEHP-exposed group and controls were found for any of the sperm
   attributes examined. Frozen-thawed spermatozoa showed similar rates of
   non-capacitated cells between groups, and were capacitated at similar
   rates. Rates of induced ARs were also similar. Values of DNA
   denaturation were low and showed no differences between groups. In
   conclusion, pre-pubertal exposure to DEHP does not seem, under the
   conditions of the present experiment, to affect the ability of
   frozen-thawed spermatozoa collected post-puberty to capacitate or
   acrosome-react (the main requisites for fertilization) or to present
   damage in their nuclear genome. (c) 2007 Elsevier Inc. All rights
   reserved.}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Spjuth, L (Reprint Author), Swedish Univ Agr Sci, Dept Anat \& Physiol, Box 7011, S-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Anat \& Physiol, S-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Anat \& Physiol, S-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Anim Breeding \& Genet, S-75007 Uppsala, Sweden.}},
DOI = {{10.1016/j.theriogenology.2007.04.051}},
ISSN = {{0093-691X}},
Keywords = {{di(2-ethylhexyl) phthalate (DEHP); boar spermatozoa; capacitation;
   acrosome reaction (AR); chromatin stability}},
Keywords-Plus = {{FLOW-CYTOMETRIC EVALUATION; STRUCTURE ASSAY; SEMEN QUALITY;
   DI-2-ETHYLHEXYL PHTHALATE; URINARY CONCENTRATIONS; OXIDATIVE
   METABOLITES; GENERAL-POPULATION; INTERNAL EXPOSURE; DNA FRAGMENTATION;
   BOAR SPERMATOZOA}},
Research-Areas = {{Reproductive Biology; Veterinary Sciences}},
Web-of-Science-Categories  = {{Reproductive Biology; Veterinary Sciences}},
Author-Email = {{Linda.Spjuth@kv.slu.se}},
ResearcherID-Numbers = {{Rodriguez-Martinez, Heriberto/G-2675-2012}},
ORCID-Numbers = {{Rodriguez-Martinez, Heriberto/0000-0002-5194-2124}},
Cited-References = {{AGARWAL DK, 1986, ENVIRON HEALTH PERSP, V65, P343, DOI 10.2307/3430202.
   Aitken RJ, 2006, INT J ANDROL, V29, P69, DOI 10.1111/j.1365-2605.2005.00630.x.
   Biscardi D, 2003, SCI TOTAL ENVIRON, V302, P101, DOI 10.1016/S0048-9697(02)00349-2.
   Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Casajuana N, 2003, CHROMATOGRAPHIA, V57, P649, DOI 10.1007/BF02491744.
   Dalgaard M, 2001, TOXICOL LETT, V122, P69, DOI 10.1016/S0378-4274(01)00348-4.
   Damgaard IN, 2002, BEST PRACT RES CL EN, V16, P289, DOI 10.1053/beem.2002.0205.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Evenson Donald, 2000, Methods in Cell Science, V22, P169, DOI 10.1023/A:1009844109023.
   EVENSON DP, 1980, SCIENCE, V210, P1131, DOI 10.1126/science.7444440.
   Evenson DP, 2002, J ANDROL, V23, P25.
   Evenson DP, 2006, THERIOGENOLOGY, V65, P979, DOI 10.1016/j.theriogenology.2005.09.011.
   EVENSON DP, 1994, THERIOGENOLOGY, V41, P637, DOI 10.1016/0093-691X(94)90174-H.
   Fraser L., 2004, Polish Journal of Veterinary Sciences, V7, P311.
   Fromme H, 2002, WATER RES, V36, P1429, DOI 10.1016/S0043-1354(01)00367-0.
   Gillan L, 2005, THERIOGENOLOGY, V63, P445, DOI 10.1016/j.theriogenology.2004.09.024.
   Harrison RAP, 2005, THERIOGENOLOGY, V63, P342, DOI 10.1016/j.theriogenology.2004.09.016.
   Harrison RAP, 1996, REPROD FERT DEVELOP, V8, P581, DOI 10.1071/RD9960581.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hernandez M, 2006, INT J ANDROL, V29, P583, DOI 10.1111/j.1365-2605.2006.00699.x.
   Inoue K, 2005, CLIN CHIM ACTA, V358, P159, DOI 10.1016/j.cccn.2005.02.019.
   Januskauskas A, 2005, THERIOGENOLOGY, V63, P160, DOI 10.1016/j.theriogenology.2004.04.002.
   Januskauskas A, 2001, THERIOGENOLOGY, V55, P947, DOI 10.1016/S0093-691X(01)00456-3.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kessler W, 2004, TOXICOL APPL PHARM, V195, P142, DOI 10.1016/j.taap.2003.11.014.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   LANGNER M, 1993, BIOCHIM BIOPHYS ACTA, V1149, P175, DOI 10.1016/0005-2736(93)90038-2.
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381.
   Ljungvall K, 2006, REPROD TOXICOL, V21, P160, DOI 10.1016/j.reprotox.2005.07.012.
   Ljungvall K, 2004, ARCH TOXICOL, V78, P384, DOI 10.1007/s00204-004-0558-z.
   LJUNGVALL K, 2006, THESIS SWEDISH U AGR.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   Maxwell WMC, 1997, THERIOGENOLOGY, V48, P209, DOI 10.1016/S0093-691X(97)84068-X.
   Ohl Dana A., 1996, Frontiers in Bioscience (online), V1, pE96.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PARMAR D, 1986, TOXICOLOGY, V42, P47, DOI 10.1016/0300-483X(86)90091-0.
   Peris SI, 2004, J ANDROL, V25, P224.
   Pugh G, 2000, TOXICOL SCI, V56, P181, DOI 10.1093/toxsci/56.1.181.
   RHODES C, 1986, ENVIRON HEALTH PERSP, V65, P299, DOI 10.2307/3430197.
   RODRIGUEZMARTINEZ H, 1990, J REPROD FERTIL, V89, P591.
   Rybar R., 2004, VET MED, V1, P1.
   Silva PFN, 2006, THERIOGENOLOGY, V65, P958, DOI 10.1016/j.theriogenology.2005.09.010.
   SMISTAD G, 1989, ACTA PHARM NORDICA, V1, P287.
   Smith AC, 2006, ILAR J, V47, P358.
   Spano M, 2000, FERTIL STERIL, V73, P43, DOI 10.1016/S0015-0282(99)00462-8.
   Spjuth L, 2006, INT J ANDROL, V29, P534, DOI 10.1111/j.1365-2605.2006.00693.x.
   Spjuth L, 2006, ANDROLOGIA, V38, P186, DOI 10.1111/j.1439-0272.2006.00737.x.
   STAHR B, 2000, P 14 INT C ANT RES I.
   Swindle M M, 1988, J Invest Surg, V1, P65, DOI 10.3109/08941938809141077.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P569, DOI 10.1080/02652030010028344.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474.
   Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3.
   Weuve J, 2006, ENVIRON HEALTH PERSP, V114, P1424, DOI 10.1289/ehp.8926.
   WILLIAMSON P, 1983, BIOCHIM BIOPHYS ACTA, V732, P387, DOI 10.1016/0005-2736(83)90055-X.
   Zhang YH, 2006, BIOMED ENVIRON SCI, V19, P205.}},
Number-of-Cited-References = {{60}},
Times-Cited = {{6}},
Journal-ISO = {{Theriogenology}},
Doc-Delivery-Number = {{184QW}},
Wos-Id = {{ISI:000247657800009}},
}

@article{ ISI:000247716100028,
Author = {Meeker, John D. and Calafat, Antonia M. and Hauser, Russ},
Title = {{Di(2-ethylhexyl) phthalate metabolites may alter thyroid hormone levels
   in men}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2007}},
Volume = {{115}},
Number = {{7}},
Pages = {{1029-1034}},
Month = {{JUL}},
Abstract = {{BACKGROUND: Phthalates are used extensively in many personal-care and
   consumer products, resulting in widespread nonoccupational human
   exposure through multiple routes and media. A limited number of animal
   studies suggest that exposure to phthalates may be associated with
   altered thyroid function, but human data are lacking.
   METHODS: Concurrent samples of urine and blood were collected from 408
   men. We measured urinary concentrations of mono (2-ethylhexyl) phthalate
   (MEHP), the hydrolytic metabolite of di(2-ethylhexyl) phthalate (DEHP),
   and other phthalate monoester metabolites, along with serum levels of
   free thyroxine (T-4), total triiodothyronine (T-3), and
   thyroid-stimulating hormone (TSH). Oxidative metabolites of DEHP were
   measured in urine from only 208 of the men.
   RESULTS: We found an inverse association between MEHP urinary
   concentrations and free T-4 and T-3 serum levels, although the
   relationships did not appear to be linear when MEHP concentrations were
   categorized by quintiles. There was evidence of a plateau at the fourth
   quintile, which was associated with a 0.11 ng/dL decrease in free T-4
   {[}95\% confidence interval (CI), -0.18 to -0-03] and a 0.05 ng/mL
   decrease in T-3 (95\% CI, -0.10 to 0.01) compared with the first
   (lowest) MEHP quintile. The inverse relationship between MEHP and free
   T-4 remained when we adjusted for oxidative metabolite concentrations;
   this simultaneously demonstrated a suggestive positive association with
   free T-4.
   CONCLUSIONS: Urinary MEHP concentrations may be associated with altered
   free T-4 and/or total T-3 levels in adult men, but additional study is
   needed to confirm the observed findings. Future studies must also
   consider oxidative DEHP metabolites relative to MEHP as a potential
   marker of metabolic susceptibility to DEHP exposure.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Meeker, JD (Reprint Author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, 6635 SPH Tower,109 S Observ St, Ann Arbor, MI 48109 USA.
   Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.
   Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA.
   Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv, Androl Lab \& In Vitro Fertilizat Unit, Boston, MA 02114 USA.}},
DOI = {{10.1289/ehp.9852}},
ISSN = {{0091-6765}},
Keywords = {{biomarkers; endocrine disruption; epidemiology; hormone; phthalates;
   thyroid; urinary metabolites}},
Keywords-Plus = {{ENDOCRINE-DISRUPTING CHEMICALS; HUMAN URINE; DI-(2-ETHYLHEXYL)
   PHTHALATE; ENVIRONMENTAL CHEMICALS; QUANTITATIVE DETECTION; OXIDATIVE
   METABOLITES; HEXYL) PHTHALATE; SEMEN QUALITY; MALE RATS; EXPOSURE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{meekerj@umich.edu}},
Cited-References = {{Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Bernal CA, 2002, FOOD ADDIT CONTAM, V19, P1091, DOI 10.1080/02652030210157709.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Boas M, 2006, EUR J ENDOCRINOL, V154, P599, DOI 10.1530/eje.1.02128.
   Boelaert K, 2005, J ENDOCRINOL, V187, P1, DOI 10.1677/joe.1.06131.
   Breous E, 2005, MOL CELL ENDOCRINOL, V244, P75, DOI 10.1016/j.mce.2005.06.009.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Gayathri NS, 2004, INDIAN J MED RES, V119, P139.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356.
   Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7.
   Ishihara A, 2003, GEN COMP ENDOCR, V134, P36, DOI 10.1016/S0016-6480(03)00197-7.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kleinbaum DG, 1998, APPL REGRESSION ANAL, P386.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   MURATURE DA, 1987, BIOMED ENVIRON MASS, V14, P473, DOI 10.1002/bms.1200140815.
   Nussey S.S, 2001, ENDOCRINOLOGY INTEGR.
   O'Connor JC, 2002, TOXICOL SCI, V69, P92, DOI 10.1093/toxsci/69.1.92.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   PRICE SC, 1988, TOXICOL LETT, V40, P37, DOI 10.1016/0378-4274(88)90181-6.
   Qatanani M, 2005, ENDOCRINOLOGY, V146, P995, DOI 10.1210/en.2004-1350.
   Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3.
   Shimada N, 2004, J ENDOCRINOL, V183, P627, DOI 10.1677/joe.1.05893.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Surks MI, 2004, JAMA-J AM MED ASSOC, V291, P228, DOI 10.1001/jama.291.2.228.
   TEASS AW, 1998, NIOSH MANUAL ANAL ME, P52.
   U.S. Environmental Protection Agency, 1997, EPA630R96012.
   VANDER A, 1998, HUMAN PHYSL MECHANIS.
   Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494.
   Wenzel A, 2005, MOL CELL ENDOCRINOL, V244, P63, DOI 10.1016/j.mce.2005.02.008.
   Zoeller RT, 2005, MOL CELL ENDOCRINOL, V242, P10, DOI 10.1016/j.mce.2005.07.006.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{66}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{185MW}},
Wos-Id = {{ISI:000247716100028}},
}

@article{ ISI:000247782500018,
Author = {Itoh, Hiroaki and Yoshida, Kikuo and Masunaga, Shigeki},
Title = {{Quantitative identification of unknown exposure pathways of phthalates
   based on measuring their metaholites in human urine}},
Journal = {{ENVIRONMENTAL SCIENCE \& TECHNOLOGY}},
Year = {{2007}},
Volume = {{41}},
Number = {{13}},
Pages = {{4542-4547}},
Month = {{JUL 1}},
Abstract = {{Humans are exposed to ubiquitous phthalates via multiple pathways.
   Exposures to phthalates have been estimated in some previous risk
   assessments in Japan based on point-of-contact measurement or scenario
   evaluation approaches. While the Japanese national government has
   regulated the use of di(2-ethyl hexyl)phtha late (DEHP) and excluded
   several other phthalates from its regulation based on some of them, it
   is unclear whether such past exposure assessment studies fully assessed
   total human exposure to phthalates. In the present study,we measured
   their urinary metabolites, which show direct evidence of human exposure
   to phthalates. We recruited voluntary participants (N = 36) who agreed
   to donate urine samples, and measured the urinary concentrations of
   phthalate metabolites using enzymatic deconjugation, solid-phase
   extraction, and high-performance liquid-chromatography isotope-dilution
   tandem mass spectrometry. We then derived the daily intakes of their
   respective phthalates based on steady state assumption and finally
   compared them with the corresponding estimated daily intakes of each
   phthalate via diet and air derived from previous exposure or risk
   assessments in Japan. These comparisons showed that exposures to
   dimethyl phthalate, diethyl phthalate, and di-n-butyl phthalate via diet
   and air accounted for less than half of their respective total
   exposures. On the other hand, it appears that dietary intake was more
   predictive for the total exposure to n-butyl-benzyl phthalate and DEHP.
   The probabilities that the lognormal distribution of each phthalate
   daily intake estimated from the present study exceeds the corresponding
   tolerable daily intake were estimated to be less than 10(-4).}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Itoh, H (Reprint Author), Yokohama Natl Univ, Grad Sch Environm \& Informat Sci, Hodogaya Ku, Tokiwadai 79-7, Yokohama, Kanagawa 2408501, Japan.
   Yokohama Natl Univ, Grad Sch Environm \& Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 2408501, Japan.
   Natl Adv Ind Sci \& Technol, Res Ctr Chem Risk \& Management, Tsukuba, Ibaraki 3058569, Japan.
   Natl Canc Ctr, Res Ctr Canc Prevent \& Screening, Epidemiol \& Prevent Div, Tokyo 104, Japan.}},
DOI = {{10.1021/es062926y}},
ISSN = {{0013-936X}},
Keywords-Plus = {{HUMAN REFERENCE POPULATION; DI(2-ETHYLHEXYL)PHTHALATE DEHP; BIOMARKER
   APPROACH; METABOLITES; SAMPLES; ESTERS; JAPAN}},
Research-Areas = {{Engineering; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Engineering, Environmental; Environmental Sciences}},
Author-Email = {{itoh-hiroaki@umin.ac.jp}},
ResearcherID-Numbers = {{Masunaga, Shigeki/F-1315-2011}},
ORCID-Numbers = {{Masunaga, Shigeki/0000-0003-0608-2337}},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Barrett JR, 2005, ENVIRON HEALTH PERSP, V113, pA24.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   HASEGAWA A, 2003, P GEN M SOC INDOOR E, P140.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Itoh H, 2005, INT J HYG ENVIR HEAL, V208, P237, DOI 10.1016/j.ijheh.2005.02.004.
   Kawasaki T, 1991, Nihon Koshu Eisei Zasshi, V38, P567.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Scientific Committee on Toxicity Ecotoxicity and the Environment, 1998, 6 CSTEE PLEN M BRUSS.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   TAKAHASHI K, 2001, MIYAGI PREFECTURAL I, V19, P77.
   Trapp S, 1998, CHEMODYNAMICS ENV MO.
   Tsumura Y, 2003, FOOD ADDIT CONTAM, V20, P317, DOI 10.1080/0265203031000122021.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474.
   YOSHIDA K, 2005, RISK ASSESMENT DIPHT.
   {*}MIN ENV, 2002, IN ASS ENV RISK CHEM.
   {*}MIN ENV, 2004, IN ASS ENV RISK CHEM.
   {*}MIN HLTH LAB WELF, 2002, REP PARTIAL REV STAN.
   {*}MIN HLTH WELF, 2000, REP CONCL JOINT M TO.
   {*}NAT I ADV IND SCI, 2003, NAT I ADV IND SCI TE.
   {*}NAT I HLTH NUTR, 2004, NAT NUTR SURV.
   {*}SCI COMM TOX EC E, 2004, 41 CSTEE PLEN M 8 JA.
   {*}TOK METR GOV, 2001, REP RES FIELD SURV E.
   {*}TOK METR GOV, 2002, REP MON SURV HAZ AIR.
   {*}US EPA, 1992, FED REG 22888, V57.
   {*}US EPA, 1993, 84662 CASRN.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{24}},
Journal-ISO = {{Environ. Sci. Technol.}},
Doc-Delivery-Number = {{186MJ}},
Wos-Id = {{ISI:000247782500018}},
}

@article{ ISI:000247355200012,
Author = {Kato, Kayoko and Silva, Manori J. and Wolf, Cynthia and Gray, L. Earl
   and Needham, Larry L. and Calafat, Antonia M.},
Title = {{Urinary metabolites of diisodecyl phthalate in rats}},
Journal = {{TOXICOLOGY}},
Year = {{2007}},
Volume = {{236}},
Number = {{1-2}},
Pages = {{114-122}},
Month = {{JUL 1}},
Abstract = {{Diisodecyl phthalate (DiDP) is an isomeric mixture of phthalates with
   predominantly 10-carbon branched-dialkyl chains, widely used as a
   plasticizer for polyvinyl chloride. The extent of human exposure to LIMP
   is unknown in part because adequate biomarkers of exposure to DiDP are
   not available. We identified several major metabolites of DiDP in urine
   of adult female Sprague-Dawley rats after a single oral administration
   of DiDP (300 mg/kg). These metabolites can potentially be used as
   biomarkers of exposure to DiDp. The metabolites extracted from urine
   were chromatographically resolved and identified by their
   chromatographic behavior and full scan negative ion electrospray
   ionization mass spectrum. The identity of metabolites with similar
   molecular weights was further examined in accurate mass mode. For some
   metabolites, unequivocal identification was done using authentic
   standards. Among these were the hydrolytic monoester of DiDP,
   monoisoclecyl phthalate (NIMP), detected as a minor metabolite, and one
   W oxidation product of MiDP, mono(carboxy-isononyl) phthalate (MCNP),
   which was the most abundant urinary metabolite. We also tentatively
   identified other secondary metabolites of MiDP, mono(hydroxy-isodecyl)
   phthalate, mono(oxo-isodecyl) phthalate, mono(carboxy-isoheptyl)
   phthalate, mono(carboxy-isohexyl) phthalate, mono(carboxy-isopentyl)
   phthalate, mono(carboxy-isobutyl) phthalate, and mono(carboxy-ethyl)
   phthalate. Oxidative metabolites of diisoundecyl phthalate (DiUdP) and
   diisononyl phthalate (DiNP) were also detected suggesting the presence
   of DiUdP and DiNP in the DiDP formulation. The urinary concentrations of
   all these metabolites gradually decreased in the 4 days following the
   administration of DiDR MCiNP and other DiDl? secondary metabolites are
   more abundant in urine than MiDP, suggesting that these oxidative
   products are better biomarkers for DiDP exposure assessment than MiDP.
   Additional research on the toxicokinetics of these metabolites is needed
   to understand the extent of human exposure to DiDP from the urinary
   concentrations of MCiNP and other DiDP secondary metabolites. (c) 2007
   Elsevier Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Lab Sci, 4770 Buford Hwy,Mailstop F-53, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Lab Sci, Atlanta, GA 30341 USA.
   US Environm Protect Agcy, Reprod Toxicol Div, Endocrinol Branch, Natl Hlth \& Environm Effects Res Lab, Durham, NC 27705 USA.}},
DOI = {{10.1016/j.tox.2007.04.009}},
ISSN = {{0300-483X}},
Keywords = {{phthalates; biomonitoring; exposure; diisodecyl phthalate; oxidative
   metabolism; secondary metabolites; DiDP}},
Keywords-Plus = {{DI-ISONONYL PHTHALATE; JUNCTIONAL INTERCELLULAR COMMUNICATION;
   SUBCUTANEOUS INJECTION MODEL; HUMAN EXPOSURE ASSESSMENT;
   DEUTERIUM-LABELED DEHP; N-OCTYL PHTHALATE; DI(2-ETHYLHEXYL)PHTHALATE
   DEHP; OXIDATIVE METABOLITES; ISODECYL PHTHALATE; PEROXISOME
   PROLIFERATION}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{ACalafat@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   Angerer J, 2006, TOXICOL SCI, V93, P3, DOI 10.1093/toxsci/kfl042.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   Hellwig J, 1997, FOOD CHEM TOXICOL, V35, P501, DOI 10.1016/S0278-6915(97)00008-2.
   Hushka LJ, 2001, REPROD TOXICOL, V15, P153, DOI 10.1016/S0890-6238(01)00109-5.
   Jepsen KF, 2004, TOXICOL IN VITRO, V18, P265, DOI 10.1016/j.tiv.2003.09.008.
   Kamendulis LM, 2002, J TOXICOL ENV HEAL A, V65, P569, DOI 10.1080/152873902317349736.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kaufmann W, 2002, REGUL TOXICOL PHARM, V36, P175, DOI 10.1066/rtph.2002.1575.
   Kavlock R, 2002, REPROD TOXICOL, V16, P655, DOI 10.1016/S0890-6238(02)00068-0.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Larsen ST, 2002, PHARMACOL TOXICOL, V91, P264, DOI 10.1034/j.1600-0773.2002.910508.x.
   Larsen ST, 2001, TOXICOLOGY, V169, P37, DOI 10.1016/S0300-483X(01)00484-X.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   McKee RH, 2000, J APPL TOXICOL, V20, P491, DOI 10.1002/1099-1263(200011/12)20:6<491::AID-JAT724>3.0.CO;2-H.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2005, TOXICOLOGY, V210, P123, DOI 10.1016/j.tox2005.01.012.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Silva MJ, 2007, BIOMARKERS, V12, P133, DOI 10.1080/13547500601066915.
   Smith JH, 2000, TOXICOL SCI, V54, P312, DOI 10.1093/toxsci/54.2.312.
   Stringer R, 2000, ENVIRON SCI POLLUT R, V7, P27, DOI 10.1065/espr199910.007.
   Waterman SJ, 1999, REPROD TOXICOL, V13, P131, DOI 10.1016/S0890-6238(99)00002-7.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}CERHR, 2000, NTP CERHR EXP PAN RE.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{9}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{180IB}},
Wos-Id = {{ISI:000247355200012}},
}

@article{ ISI:000247046600012,
Author = {Larsen, Soren Thor and Hansen, Jitka Stilund and Hansen, Erik Wind and
   Clausen, Per Axel and Nielsen, Gunnar Damgard},
Title = {{Airway inflammation and adjuvant effect after repeated airborne
   exposures to di-(2-ethylhexyl)phthalate and ovalbumin in BALB/c mice}},
Journal = {{TOXICOLOGY}},
Year = {{2007}},
Volume = {{235}},
Number = {{1-2}},
Pages = {{119-129}},
Month = {{JUN 3}},
Abstract = {{Background: Epidemiological studies have suggested an association
   between exposure to phthalate plasticizers, including
   di(2-ethylhexyl)phthalate (DEHP), and increased prevalence of asthma,
   rhinitis or wheezing. Furthermore, studies in mice have demonstrated an
   adjuvant effect from DEHP after parenteral administration with the model
   allergen ovalbumin (OVA).
   Objective: Exposures to DEHP were investigated for adjuvant effects and
   airway inflammation in a mouse inhalation model.
   Methods: BALB/cJ mice were exposed to aerosols of 0.022-13 mg/m(3) DEHP
   and 0. 14 mg/m(3) OVA 5 days/week for 2 weeks and thereafter weekly for
   12 weeks. Mice exposed to OVA alone or OVA + Al(OH)(3) served as control
   groups. Finally, all groups were exposed to a nebulized 1\% OVA solution
   on three consecutive days. Serum, bronchoalveolar lavage (BAL) fluid,
   and draining lymph nodes were collected 24 h later.
   Results: In the OVA + AI(OH)3 group, significantly increased levels of
   OVA-specific IgE and IgG I in serum as well as of eosinophils in BAL
   fluid were observed. DEHP affected OVA-specific IgG I production in a
   concentration-dependent manner, whereas little effect was seen on IgE
   and IgG2a. Dose-dependent increases in inflammatory cells were observed
   in BAL fluids, leading to significantly higher lymphocyte, neutrophil
   and eosinophil numbers in the OVA + 13 mg/m(3) DEHP group. Ex vivo
   cytokine secretion by cultures of draining lymph nodes suggested that
   DEHP has a mixed Th1r/Th2 cytokine profile.
   Conclusion: Airborne DEHP is able to increase serum IgG 1 and lung
   inflammatory cell levels, but only at very high concentrations.
   Realistic DEHP levels do not have an adjuvant effect or induce allergic
   lung inflammation in the present mouse model. (C) 2007 Elsevier Ireland
   Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Larsen, ST (Reprint Author), Natl Res Ctr Working Environm, Airway Allergy \& Irritat Grp, Lerso Parkallee 105, DK-2100 Copenhagen O, Denmark.
   Natl Res Ctr Working Environm, Airway Allergy \& Irritat Grp, DK-2100 Copenhagen O, Denmark.
   Univ Copenhagen, Fac Pharmaceut Sci, DK-1168 Copenhagen, Denmark.}},
DOI = {{10.1016/j.tox.2007.03.010}},
ISSN = {{0300-483X}},
Keywords = {{di-(2-ethylhexyl)phthalate; adjuvant effect; airway inflammation;
   inhalation; BALB/c mice}},
Keywords-Plus = {{SUBCUTANEOUS INJECTION MODEL; INTERIOR SURFACE MATERIALS;
   RESPIRATORY-TRACT; INDOOR AIR; MONO-2-ETHYLHEXYL PHTHALATE; ALVEOLAR
   MACROPHAGES; DENDRITIC CELLS; MURINE MODELS; IN-VIVO; DUST}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{stl@nrcwe.dk}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Alarie Y, 1998, ARCH TOXICOL, V72, P277, DOI 10.1007/s002040050502.
   BALLY MB, 1980, TOXICOLOGY, V18, P49, DOI 10.1016/0300-483X(80)90037-2.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Butala JH, 2004, TOXICOLOGY, V201, P77, DOI 10.1016/j.tox.2004.04.004.
   CADOGAN DF, 1996, ENCY CHEM TECHNOLOGY, P258.
   Clark RB, 2002, J LEUKOCYTE BIOL, V71, P388.
   CLAUSEN PA, 1999, P 8 INT C IND AIR QU, V2, P434.
   CLAUSEN PA, 1997, J HIGH RES CHROMATOG, V20, P99, DOI 10.1002/jhrc.1240200210.
   Clausen PA, 2004, ENVIRON SCI TECHNOL, V38, P2531, DOI 10.1021/es0347944.
   Clausen SK, 2003, TOXICOLOGY, V184, P51, DOI 10.1016/S0300-483X(02)00583-8.
   Despopoulos A, 1986, COLOR ATLAS PHYSL.
   Ejrnaes AM, 2006, CLIN EXP ALLERGY, V36, P273, DOI 10.1111/j.1365-2222.2006.02442.x.
   Finkelman FD, 2005, J ALLERGY CLIN IMMUN, V115, P449, DOI 10.1016/j.jaci.2004.12.1125.
   Francis JN, 2005, CURR OPIN ALLERGY CL, V5, P537, DOI 10.1097/01.all.0000191234.97760.88.
   Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1046/j.1600-0668.2003.00223.x.
   Glue C, 2005, BASIC CLIN PHARMACOL, V96, P140, DOI 10.1111/j.1742-7843.2005.pto960208.x.
   Granum B, 2002, TOXICOL SCI, V65, P7, DOI 10.1093/toxsci/65.1.7.
   Hansen JS, 2007, J TOXICOL ENV HEAL A, V70, P128, DOI 10.1080/15287390600755083.
   Hansen JS, 2007, TOXICOLOGY, V232, P79, DOI 10.1016/j.tox.2006.12.011.
   Herz U, 2004, METHODS, V32, P271, DOI 10.1016/j.ymeth.2003.08.013.
   HOLT PG, 1993, J EXP MED, V177, P397, DOI 10.1084/jem.177.2.397.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   Jaakkola JJK, 2006, AM J EPIDEMIOL, V164, P742, DOI 10.1093/aje/kwj249.
   Jaakkola JJK, 2004, AM J PUBLIC HEALTH, V94, P560, DOI 10.2105/AJPH.94.4.560.
   Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188.
   Kimber I, 2003, ENVIRON HEALTH PERSP, V111, P227, DOI 10.1289/ehp.5703.
   LAKE BG, 1987, TOXICOL IND HEALTH, V3, P165.
   Lambrecht BN, 2005, ALLERGY, V60, P271, DOI 10.1111/j.1398-9995.2005.00708.x.
   LARSEN N, 2007, TOXICOL LETT.
   Larsen ST, 2001, TOXICOL LETT, V125, P11.
   Larsen ST, 2004, HUM EXP TOXICOL, V23, P537, DOI 10.1191/0960327104ht486oa.
   Larsen ST, 2002, PHARMACOL TOXICOL, V91, P264, DOI 10.1034/j.1600-0773.2002.910508.x.
   Larsen ST, 2003, FOOD CHEM TOXICOL, V41, P439, DOI 10.1016/S0278-6915(02)00248-X.
   Larsen ST, 2000, HUM EXP TOXICOL, V19, P457, DOI 10.1191/096032700682694233.
   MCMENAMIN C, 1994, SCIENCE, V265, P1869, DOI 10.1126/science.7916481.
   NIELSEN GD, IN PRESS INDOOR AIR.
   Nielsen GD, 1999, HUM EXP TOXICOL, V18, P400, DOI 10.1191/096032799678840246.
   Oshiba A, 1996, J CLIN INVEST, V97, P1398, DOI 10.1172/JCI118560.
   Otake T, 2004, J EXPO ANAL ENV EPID, V14, P524, DOI 10.1038/sj.jea.7500352.
   Otake T, 2001, ENVIRON SCI TECHNOL, V35, P3099, DOI 10.1021/es001914o.
   PHALEN RF, 2007, CLIN OCCUP ENV MED, V5, P773.
   PURKERSON J, 1992, FASEB J, V6, P3245.
   Raabe O.G., 1988, ANN OCCUP HYG     S1, V32, P53.
   Robinson MK, 1996, FUND APPL TOXICOL, V34, P15, DOI 10.1006/faat.1996.0171.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Rudel RA, 2001, J AIR WASTE MANAGE, V51, P499.
   SHELDON L, 1992, PTEAM MONITORING PHT.
   SHERTZER HG, 1985, ARCH ENVIRON CON TOX, V14, P605.
   Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575.
   Taube C, 2004, INT ARCH ALLERGY IMM, V135, P173, DOI 10.1159/000080899.
   VIJAYARAGHAVAN R, 1994, ARCH TOXICOL, V68, P490, DOI 10.1007/s002040050101.
   von Garnier C, 2000, EUR J IMMUNOL, V30, P1638, DOI 10.1002/1521-4141(200006)30:6<1638::AID-IMMU1638>3.0.CO;2-R.
   Weschler CJ, 2003, ATMOS ENVIRON, V37, P5455, DOI 10.1016/j.atmosenv.2003.09.022.
   WONG KL, 1982, TOXICOL APPL PHARM, V63, P72, DOI 10.1016/0041-008X(82)90028-X.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   Yanagisawa R, 2006, CLIN EXP ALLERGY, V36, P386, DOI 10.1111/j.1365-2222.2006.02452.x.
   {*}COUNC EUR, 2005, BIOL TESTS 2 6 14 BA, P164.
   {*}WHO, 1983, GUID STUD ENV EP.}},
Number-of-Cited-References = {{59}},
Times-Cited = {{37}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{175XF}},
Wos-Id = {{ISI:000247046600012}},
}

@article{ ISI:000247280200032,
Author = {Stahlhut, Richard W. and van Wijngaarden, Edwin and Dye, Timothy D. and
   Cook, Stephen and Swan, Shanna H.},
Title = {{Concentrations of urinary phthalate metabolites are associated with
   increased waist circumference and insulin resistance in adult US males}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2007}},
Volume = {{115}},
Number = {{6}},
Pages = {{876-882}},
Month = {{JUN}},
Abstract = {{BACKGROUND: Phthalates impair rodent testicular function and have been
   associated with anti-androgenic effects in humans, including decreased
   testosterone levels. Low testosterone in adult human males has been
   associated with increased prevalence of obesity, insulin resistance, and
   diabetes.
   OBJECTIVES: Our objective in this study was to investigate phthalate
   exposure and its associations with abdominal obesity and insulin
   resistance.
   METHODS: Subjects were adult U.S. male participants in the National
   Health and Nutrition Examination Survey (NHANES) 1999-2002. We modeled
   six phthalate metabolites with prevalent exposure and known or suspected
   antiandrogenic activity as predictors of waist circumference and
   log-transformed homeostatic model assessment (HOMA; a measure of insulin
   resistance) using multiple linear regression, adjusted for age,
   race/ethnicity, fiat and total calorie consumption, physical activity
   level, serum cotinine, and urine creatinine (model 1); and adjusted for
   model 1 covariates plus measures of renal and hepatic function (model
   2). Metabolites were mono-butyl plithalates (MBP), mono-ethyl plithalate
   (MEP), mono- (2-ethyl) - h exyl plithalate (MEHP), mono-benzyl phthatate
   (MBzP), mono- (2-ethyl-5-hydroxyhexyl) plithalate (MEHHP), and
   mono-(2-ethyl-5oxohexyl) plithalate (MEOHP).
   RESULTS: In model 1, four metabolites were associated with increased
   waist circumference (MBzP, MEHHP, MEOHP, and MEP; p-values <= 0.0 13)
   and three with increased HOMA (MBP, MBzP, and MEP; p-values <= 0.0 11).
   When we also adjusted for renal and hepatic function, parameter
   estimates declined but all significant results remained so except
   HOMA-MBP.
   CONCLUSIONS: In this national cross-section of U.S. men, concentrations
   of several prevalent plithalate metabolites showed statistically
   significant correlations with abdominal obesity and insulin resistance.
   If confirmed by longitudinal studies, our findings would suggest that
   exposure to these plithalates may contribute to the population burden of
   obesity, insulin resistance, and related clinical disorders.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Stahlhut, RW (Reprint Author), Dept Commun \& Prevent Med, 601 Elmwood Ave,Box 644, New York, NY 14642 USA.
   Univ Rochester, Sch Med \& Dent, Dept Commun \& Prevent Med, Rochester, NY USA.
   Axios Int, Dept Res \& Evaluat, Paris, France.
   Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, Rochester, NY USA.}},
DOI = {{10.1289/ehp.9882}},
ISSN = {{0091-6765}},
Keywords = {{androgens; homeostatic model assessment; insulin resistance; obesity;
   plithalates}},
Keywords-Plus = {{NUTRITION EXAMINATION SURVEY; ENDOGENOUS SEX-HORMONES;
   ANDROGEN-DEPRIVATION THERAPY; DEUTERIUM-LABELED DEHP; 3RD
   NATIONAL-HEALTH; BETA-CELL FUNCTION; BODY-MASS INDEX; IN-VIVO;
   DI(2-ETHYLHEXYL)PHTHALATE DEHP; TESTOSTERONE SYNTHESIS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{richard\_stahlhut@urmc.rochester.edu}},
Cited-References = {{Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643.
   Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI 10.1289/ehp.8451.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   BELL FP, 1982, ENVIRON HEALTH PERSP, V45, P41, DOI 10.2307/3429382.
   Bhattacharya N, 2005, BIOL REPROD, V72, P745, DOI 10.1095/biolreprod.104.031583.
   Braga-Basaria M, 2006, J CLIN ONCOL, V24, P3979, DOI 10.1200/JCO.2006.05.9741.
   Corton JC, 2005, TOXICOL SCI, V83, P4, DOI 10.1093/toxsci/kfi011.
   Ding EL, 2006, JAMA-J AM MED ASSOC, V295, P1288, DOI 10.1001/jama.295.11.1288.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Ebbeling CB, 2002, LANCET, V360, P473, DOI 10.1016/S0140-6736(02)09678-2.
   Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025.
   Farin HMF, 2006, AM J CLIN NUTR, V83, P47.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Fujimoto Wilfred Y., 2000, American Journal of Medicine, V108, p9S.
   Gayathri NS, 2004, INDIAN J MED RES, V119, P139.
   Graubard BI, 1996, AM J EPIDEMIOL, V144, P102.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340.
   Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404.
   Rylander Lars, 2005, Environ Health, V4, P28, DOI 10.1186/1476-069X-4-28.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hauser R, 2005, ENVIRON HEALTH PERSP, V113, P425, DOI 10.1289/ehp.7305.
   Hauser R, 2006, EPIDEMIOLOGY, V17, P682, DOI 10.1097/01.ede.0000235996.89953.d7.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Hotchkiss AK, 2004, BIOL REPROD, V71, P1852, DOI 10.1095/biolreprod.104.031674.
   Isidori AM, 2005, CLIN ENDOCRINOL, V63, P280, DOI 10.1111/j.1365-2265.2005.02339.x.
   Janssen I, 2004, AM J CLIN NUTR, V79, P379.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kalish GM, 2003, J CLIN ENDOCR METAB, V88, P1646, DOI 10.1210/jc.2002-021375.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Lapinskas PJ, 2005, TOXICOLOGY, V207, P149, DOI 10.1016/j.tox.2004.09.008.
   Latini G, 2005, CLIN CHIM ACTA, V361, P20, DOI 10.1016/j.cccn.2005.05.003.
   Lawlor DA, 2005, AM J EPIDEMIOL, V161, P1081, DOI 10.1093/aje/kwi125.
   Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc05-0543.
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169.
   Levey AS, 1999, ANN INTERN MED, V130, P461.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Marin P, 1996, J CLIN ENDOCR METAB, V81, P1018, DOI 10.1210/jc.81.3.1018.
   MARIN P, 1992, INT J OBESITY, V16, P991.
   Marin P, 1995, OBES RES, V3, pS609.
   Mårin P, 1993, Obes Res, V1, P245.
   MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883.
   Oh JY, 2002, DIABETES CARE, V25, P55, DOI 10.2337/diacare.25.1.55.
   Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Phillips GB, 2003, METABOLISM, V52, P784, DOI 10.1016/S0026-0495(03)00072-6.
   Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016.
   Rajapakse N, 2002, ENVIRON HEALTH PERSP, V110, P917.
   REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595.
   Rusyn I, 2006, CRIT REV TOXICOL, V36, P459, DOI 10.1080/10408440600779065.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Selvin E, 2007, DIABETES CARE, V30, P234, DOI 10.2337/dc06-1579.
   Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003.
   Sharifi N, 2005, JAMA-J AM MED ASSOC, V294, P238, DOI 10.1001/jama.294.2.238.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Sugiyama S, 2005, TOXICOL SCI, V88, P367, DOI 10.1093/toxsci/kfi330.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Takano H, 2006, ENVIRON HEALTH PERSP, V114, P1266, DOI 10.1289/ehp.8985.
   Travison TG, 2007, J CLIN ENDOCR METAB, V92, P196, DOI 10.1210/jc.2006-1375.
   Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487.
   Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494.
   Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a.
   {*}CDC, 2005, 3 NATL REPORT HUMAN.
   {*}NCHS, 2006, CURR NHANES WEB TUT.
   {*}NCHS, 2006, NOT CORR SER CREAT N.
   {*}NCHS, 2006, NAT HLTHH NUTR EX SU.}},
Number-of-Cited-References = {{71}},
Times-Cited = {{139}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{179HK}},
Wos-Id = {{ISI:000247280200032}},
}

@article{ ISI:000246930700007,
Author = {Pereira, Contzen and Mapuskar, Kranti and Rao, C. Vaman},
Title = {{A two generation chronic mixture toxicity study of Clophen A60 and
   diethyl phthalate after gestational and lactational exposure in female
   Wistar rats}},
Journal = {{PESTICIDE BIOCHEMISTRY AND PHYSIOLOGY}},
Year = {{2007}},
Volume = {{88}},
Number = {{2}},
Pages = {{156-166}},
Month = {{JUN}},
Abstract = {{Polychlorinated biphenyls and diethyl phthalate are both lipophilic in
   nature and are likely to be present in the same environmental
   compartment or bioaccumalate over a period of time, thus a mixture
   toxicity study was undertaken to evaluate the type of interaction
   between polychlorinated biphenyls (Clophen A60) and diethyl phthalate
   over two generations in female Wistar rats. Healthy male and female
   albino rats of Wistar strain weighing 75-100 g (6-7 weeks old) were
   randomly assigned to four groups of six each. Group I male and female
   rats were fed on normal diet and water ad libitum. Group II male and
   female rats were maintained on normal diet mixed with corn oil as oil
   control. GroupS III and IV male and female rats were given Clophen A60
   and diethyl phthalate dissolved in corn oil mixed with the diet at
   50mg/kg of the diet individually to each group. Group V male and female
   rats received a mixture of diethyl phthalate and Clophen A60, each
   dissolved in corn oil mixed with the diet at 50 mg/kg of the diet.
   Hundred days after the treatment, females were mated with the males in
   each group for 10 days. Exposure to diethyl phthalate and Clophen A60
   was continued throughout mating, gestation until termination at weaning,
   which was 150 days of total treatment period of the parental generation
   female rats. Treatment for F1 generation male and female pups (6 males
   \& 6 females) with Clophen A60 and diethyl phthalate individually and in
   mixture was continued at doses reduced to 25 mg/kg of the diet after
   they reached 75-100 g in weight. The treatment was carried out similar
   to the parental generation for a period of 150 days. Liver and serum
   aspartate aminotransferase, liver cholesterol and glycogen were
   significantly increased in the F1 generation Clophen A60 + diethyl
   phthalate treated group, whereas serum cholesterol, liver glutathione
   and glutathione reductase showed a significant decrease in the F1
   generation Clophen A60 + diethyl phthalate treated group as compared to
   the parental generation mixture and individually treated groups as well
   as the individually treated F1 generation groups. A significant increase
   was observed in the liver and serum aspartate aminotransferase activity
   of Clophen A60 and serum aspartate aminotransferase levels of diethyl
   phthalate treated F1 generation rats as compared to the parental
   generation Clophen A60 and diethyl phthalate individually and mixture
   treated rats. Liver glutathione levels were significantly decreased in
   the F1 generation Clophen A60 and diethyl phthalate individually treated
   rats which was similar to the parental generation individually treated
   rats as compared to the controls. Liver glutathione reductase level was
   also significantly declined in the diethyl phthalate treated F1
   individual group as compared to diethyl phthalate individually treated
   parental generation rats. Histology of the liver showed fatty
   degeneration in the mixture treated F1 generation rats as compared to
   Clophen A60 and diethyl phthalate individually treated F1 rats and
   parental generation Clophen A60 and diethyl phthalate individually and
   mixture treated rats. Thus, in spite of dose reduction and continuous
   exposure over two generation's to a mixture of diethyl phthalate and
   Clophen A60 exposed through gestation, lactation and diet leads to a
   synergistic toxic effect in the F1 generation. (c) 2006 Elsevier Inc.
   All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rao, CV (Reprint Author), St Xavier Coll, Dept Zool, Bombay 400001, Maharashtra, India.
   St Xavier Coll, Dept Zool, Bombay 400001, Maharashtra, India.}},
DOI = {{10.1016/j.pestbp.2006.10.008}},
ISSN = {{0048-3575}},
Keywords = {{diethyl phthalate (DEP); Clophen A60; polychlorinated biphenyls (PCBs);
   liver; serum; enzymes; histology; generation; mixture}},
Keywords-Plus = {{POLYCHLORINATED-BIPHENYLS PCBS; REACTIVE OXYGEN; HEALTH;
   3,3',4,4'-TETRACHLOROBIPHENYL; INACTIVATION; ACCUMULATION; PLASTICIZERS;
   GLUTATHIONE; METABOLITES; NUTRITION}},
Research-Areas = {{Biochemistry \& Molecular Biology; Entomology; Physiology}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Entomology; Physiology}},
Author-Email = {{contzen@rediffmail.com
   lilo7@rediffmail.com
   vaman.rao@gmail.com}},
Cited-References = {{Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Bernt E., 1974, METHOD ENZYMAT AN, V4, P1643.
   BRAY TM, 1993, CAN J PHYSIOL PHARM, V71, P746.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   GIAM CS, 1987, J FOOD PROTECT, V50, P769.
   Guvenius DM, 2003, ENVIRON HEALTH PERSP, V111, P1235, DOI 10.1289/ehp.5946.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hauser R, 2005, ENVIRON HEALTH PERSP, V113, P425, DOI 10.1289/ehp.7305.
   Jacobson JL, 1996, NEW ENGL J MED, V335, P783, DOI 10.1056/NEJM199609123351104.
   KAMRIN MA, 1991, J CLIN PHARMACOL, V31, P484.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   KORRICK SA, 2001, PCBS.
   Korrick SA, 2000, J EXPO ANAL ENV EPID, V10, P743.
   Lowry O.H., 1951, J BIOL CHEM, V193, P275.
   MARSEE K, 2006, IN PRESS ENV HLTH PE.
   MCGOVERN V, 2006, HLTH PERSPECT, V114, pA368.
   MEISTER A, 1985, CURR TOP CELL REGUL, V26, P383.
   PAEXUS N, 1992, SWEDEN WATER SCI TEC, V25, P249.
   PARKINSON A, 1983, J BIOL CHEM, V258, P5967.
   PEREIRA C, 2006, ENV TOXICOL PHAR, V22, P93.
   POUL JM, 1991, ARCH ENVIRON CON TOX, V21, P528.
   Reitman S., 1957, AM J CLIN PATHOL, V28, P53.
   Ross G, 2004, ECOTOX ENVIRON SAFE, V59, P275, DOI 10.1016/j.ecoenv.2004.06.003.
   Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3.
   Ruder AM, 2006, ENVIRON HEALTH PERSP, V114, P18, DOI 10.1289/ehp.8253.
   Sanderson T, 2003, PURE APPL CHEM, V75, P1957, DOI 10.1351/pac200375111957.
   SANGER DB, 1987, B ENVIRON CONTAM TOX, V38, P946.
   Schantz SL, 2001, ENVIRON HEALTH PERSP, V109, P605, DOI 10.2307/3455035.
   Schlezinger JJ, 2000, COMP BIOCHEM PHYS C, V125, P273, DOI 10.1016/S0742-8413(99)00112-7.
   Schlezinger JJ, 1999, MOL PHARMACOL, V56, P588.
   SEIFTER S, 1950, ARCH BIOCHEM, V25, P191.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   Sonde V, 2000, TOXICOLOGY, V147, P23, DOI 10.1016/S0300-483X(00)00164-5.
   Sudaryanto A, 2006, ENVIRON POLLUT, V139, P107, DOI 10.1016/j.envpol.2005.04.028.
   Suk WA, 2002, ENVIRON HEALTH PERSP, V110, P891.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   TAKAGI Y, 1987, ARCH ENVIRON CON TOX, V16, P375.
   VODICNIK MJ, 1980, TOXICOL APPL PHARM, V54, P293, DOI 10.1016/0041-008X(80)90199-4.
   Wahl HG, 1999, J CHROMATOGR A, V847, P1, DOI 10.1016/S0021-9673(99)00138-7.
   WYBENGA DR, 1970, CLIN CHEM, V16, P980.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{2}},
Journal-ISO = {{Pest. Biochem. Physiol.}},
Doc-Delivery-Number = {{174GR}},
Wos-Id = {{ISI:000246930700007}},
}

@article{ ISI:000247178200026,
Author = {Gaido, Kevin W. and Hensley, Janan B. and Liu, Delong and Wallace,
   Duncan G. and Borghoff, Susan and Johnson, Kamin J. and Hall, Susan J.
   and Boekelheide, Kim},
Title = {{Fetal mouse phthalate exposure shows that gonocyte multinucleation is
   not associated with decreased testicular testosterone}},
Journal = {{TOXICOLOGICAL SCIENCES}},
Year = {{2007}},
Volume = {{97}},
Number = {{2}},
Pages = {{491-503}},
Month = {{JUN}},
Abstract = {{The rat has been explored in detail for its in utero susceptibility to
   male reproductive tract malformation following phthalate exposure. Few
   other species have been studied in detail, and it is important for both
   mechanistic and risk assessment purposes to understand the species
   specificity of this response. We investigated the response of the fetal
   mouse testis to phthalate exposure and compared these results with those
   previously obtained from the rat. Initial experiments using a variety of
   phthalate congeners (monobutyl phthalate, di-(n-butyl) phthalate, or
   mono (2-ethylhexyl) phthalate) and exposure paradigms did not reduce
   fetal mouse testis testosterone levels. Pharmacokinetic data after a
   single 500 mg/kg di-(n-butyl)-phthalate (DBP) exposure on mouse
   gestation day (gd) 18 demonstrated that the concentrations and kinetics
   of the active metabolite monobutyl phthalate (MBP) in fetal and maternal
   plasma were similar to the rat. After a single 500 mg/kg or multiple day
   250 mg/kg fetal mouse DBP exposure, rapid and dynamic changes in testis
   gene expression were observed, including induction of immediate early
   genes. Unlike the rat, expression of genes involved in cholesterol
   homeostasis and steroidogenesis were not decreased and were increased in
   a few cases. Similar to the rat, however, a 250- or 500-mg DBP/kg/day
   mouse exposure from gd 16 through 18 significantly increased
   seminiferous cord diameter, the number of multinucleated gonocytes per
   cord, and the number of nuclei per multinucleated gonocyte. Together,
   these results demonstrate that fetal mouse and rat phthalate exposure
   both induce, immediate early gene expression and disrupt seminiferous
   cord and gonocyte development. This response in the mouse occurs without
   a measurable decrease in testicular testosterone, suggesting that
   altered seminiferous cord formation and gonocyte multinucleation may not
   be mechanistically linked to lowered testosterone.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gaido, KW (Reprint Author), Ctr Hlth Sci, Hamner Inst Hlth Sci, POB 12137, Res Triangle Pk, NC 27709 USA.
   Ctr Hlth Sci, Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA.
   Brown Univ, Providence, RI 02912 USA.
   Integrated Lab Syst, Res Triangle Pk, NC 27709 USA.}},
DOI = {{10.1093/toxsci/kfm049}},
ISSN = {{1096-6080}},
Keywords = {{phthalate; di(n-butyl); in utero exposure; male reproductive
   development; antiandrogen; molecular mechanisms; steroidogenesis}},
Keywords-Plus = {{IN-UTERO EXPOSURE; REPRODUCTIVE-TRACT LESIONS; DI(N-BUTYL) PHTHALATE;
   GENE-EXPRESSION; GERM-CELLS; SEXUAL-DIFFERENTIATION; UROGENITAL
   DEVELOPMENT; TESTIS DEVELOPMENT; SERTOLI-CELLS; LEYDIG-CELLS}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{gaido@thechamner.org}},
Cited-References = {{BARDIN CW, 1989, ANN NY ACAD SCI, V564, P10, DOI 10.1111/j.1749-6632.1989.tb25884.x.
   BARLO, OI.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335.
   Barlow NJ, 2004, TOXICOL PATHOL, V32, P79, DOI 10.1080/01926230490265894.
   Barsoum I, 2006, TRENDS ENDOCRIN MET, V17, P223, DOI 10.1016/j.tem.2006.06.009.
   Cariou B, 2004, FRONT BIOSCI, V9, P1626, DOI 10.2741/1228.
   CHENG CY, 1989, J BIOL CHEM, V264, P21386.
   Chu TM, 2002, MATH BIOSCI, V176, P35, DOI 10.1016/S0025-5564(01)00107-9.
   CURTO KA, 1982, TOXICOL APPL PHARM, V62, P121, DOI 10.1016/0041-008X(82)90108-9.
   DAFAU ML, 1989, J STEROID BIOCHEM, V34, P205.
   Dennis Jr G., 2003, GENOME BIOL, V4, P3, DOI DOI 10.1186/GB-2003-4-5-P3.
   El-Gehani F, 2001, BIOL REPROD, V65, P595, DOI 10.1095/biolreprod65.2.595.
   Ferrara D, 2006, ENDOCRINOLOGY, V147, P5352, DOI 10.1210/en.2006-0527.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P48, DOI 10.1191/074823399678846646.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9.
   Grima J, 1997, J BIOL CHEM, V272, P6499.
   Habert R, 2001, MOL CELL ENDOCRINOL, V179, P47, DOI 10.1016/S0303-7207(01)00461-0.
   Hirai K, 2004, EXP CELL RES, V294, P77, DOI 10.1016/j.yexer.2003.11.012.
   Kasus-Jacobi A, 1998, J BIOL CHEM, V273, P26026, DOI 10.1074/jbc.273.40.26026.
   Kleymenova E, 2005, BIOL REPROD, V73, P482, DOI 10.1095/biolreprod.104.037184.
   Kremer JJ, 2005, TOXICOL LETT, V159, P144, DOI 10.1016/j.toxlet.2005.05.006.
   Lahousse SA, 2006, TOXICOL SCI, V93, P369, DOI 10.1093/toxsci/kfl049.
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404.
   Livera G, 2006, CELL TISSUE RES, V324, P507, DOI 10.1007/s00441-006-0167-7.
   Ludbrook LM, 2004, TRENDS ENDOCRIN MET, V15, P116, DOI 10.1016/j.tem.2004.02.002.
   Luo CW, 2004, MOL ENDOCRINOL, V18, P2085, DOI 10.1210/me.2004-0066.
   MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0.
   McIntyre BS, 2002, TOXICOL SCI, V65, P62, DOI 10.1093/toxsci/65.1.62.
   Meeks JJ, 2003, DEVELOPMENT, V130, P1029, DOI 10.1242/dev.00316.
   Migrenne S, 2001, MOL CELL ENDOCRINOL, V172, P193, DOI 10.1016/S0303-7207(00)00339-7.
   Mu XY, 2006, J BIOCHEM MOL TOXIC, V20, P7, DOI 10.1002/jbt.200110.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059.
   O'Shaughnessy PJ, 2006, INT J ANDROL, V29, P90, DOI 10.1111/j.1365-2605.2005.00555.x.
   Ozkurkcugil C, 2004, BJU INT, V93, P1094, DOI 10.1111/j.1464-410X.2004.04787.x.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Staack A, 2003, DIFFERENTIATION, V71, P402, DOI 10.1046/j.1432-0436.2003.7107004.x.
   Stasko SE, 2001, DEV DYNAM, V220, P49, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1086>3.0.CO;2-5.
   TAHRIJOUTEI A, 1991, MOL CELL ENDOCRINOL, V79, pR21, DOI 10.1016/0303-7207(91)90113-7.
   Thompson CJ, 2004, ENDOCRINOLOGY, V145, P1227, DOI 10.1210/en.2003-1475.
   VOMSAAL FS, 1990, BIOL REPROD, V43, P751, DOI 10.1095/biolreprod43.5.751.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{42}},
Journal-ISO = {{Toxicol. Sci.}},
Doc-Delivery-Number = {{177UO}},
Wos-Id = {{ISI:000247178200026}},
}

@article{ ISI:000245143200009,
Author = {Pereira, Contzen and Mapuskar, Kranti and Rao, C. Vaman},
Title = {{Chronic toxicity of diethyl phthalate - A three generation lactational
   and gestational exposure study on male Wistar rats}},
Journal = {{ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY}},
Year = {{2007}},
Volume = {{23}},
Number = {{3}},
Pages = {{319-327}},
Month = {{MAY}},
Abstract = {{Diethyl phthalate (DEP) is widely used in the perfume industry as a
   vehicle for fragrances and in personal care products making human
   exposure of DEP significant to adults as well as neonatals, as confirmed
   by levels recorded in blood as well as breast milk samples of human
   Populations in some parts of the world. Therefore. a Study was
   undertaken to understand the toxic effect of DEP over three generations
   in male Wistar rats. Healthy male and female albino rats of Wistar
   strain weighing 75-100 g (6-7 weeks old) were randomly assigned to two
   groups of six each. Group I (Control) male and female rats were fed on
   normal diet and water ad libitum. Group II (DEP) male and female rats
   were given DEP dissolved in corn oil mixed with the diet at 50 mg/kg of
   the diet/day. Hundred days after the treatment, females were mated with
   males for 10 days. Exposure to DEP was continued throughout mating,
   gestation until termination at weaning, which was 150 days of total
   treatment period of the parental generation. The F1 and F2 generation
   pups Were then segregated on the basis of their sex and six male and
   female pups of both generations were allowed to grow till they were
   75-100 g in weight. The treatment was then carried out similar to the
   parental generation but with reduced dose of 25 mg/kg of the diet/day
   for F1 generation and 10 mg/kg of the diet/day for F2 generation.
   Hundred days after the treatment, females were mated with males for 10
   days. Exposure to DEP was continued throughout mating, gestation (21
   days) until termination at weaning (21 days), which was 150 days of
   total treatment period of the F1 and F2 generation. Liver and serum ALT,
   AST and triglycerides were significantly increased over the three
   generations, which was much more significant in the F2 generation DEP
   treated group. The serum cholesterol and liver glutathione and
   glutathione reductase showed a significant decrease over the three
   generations, which was much more significant in the F2 generation DEP
   treated group as compared to the parental and F1 generation DEP treated
   rats. Histology of the liver showed remarkably enhanced fatty
   degeneration in the F2 generation DEP treated rats as compared to
   parental and F1 generation DEP treated rats. Vacuolations were much more
   significant in the F1 generation DEP treated rats as compared to the
   controls and F2 generation DEP treated rats. It can be concluded from
   this study, that continuous exposure through food, gestation and
   lactation over three generation's inspite of dose reduction of DEP leads
   to an enhanced toxic effect in the latter generations. (c) 2007 Elsevier
   B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rao, CV (Reprint Author), St Xavier Coll, Dept Zool, Bombay 400001, Maharashtra, India.
   St Xavier Coll, Dept Zool, Bombay 400001, Maharashtra, India.}},
DOI = {{10.1016/j.etap.2006.12.005}},
ISSN = {{1382-6689}},
Keywords = {{diethyl phthalate (DEP); serum enzymes histology}},
Keywords-Plus = {{EXPERT PANEL REPORT; DEVELOPMENTAL TOXICITY; HUMAN-REPRODUCTION;
   PPAR-ALPHA; NTP CENTER; PLASTICIZERS; RISKS; GLUTATHIONE; METABOLITES;
   POPULATION}},
Research-Areas = {{Environmental Sciences \& Ecology; Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{contzen@rediffmail.com
   lilo7@rediffmail.com
   vaman.rao@gmail.com}},
Cited-References = {{Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Bernt E., 1974, METHOD ENZYMAT AN, V4, P1643.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   BRAY TM, 1993, CAN J PHYSIOL PHARM, V71, P746.
   BROWN D, 1978, FOOD COSMET TOXICOL, V16, P415, DOI 10.1016/S0015-6264(78)80258-2.
   Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   FRINGS CS, 1972, CLIN CHEM, V18, P673.
   GIAM CS, 1987, J FOOD PROTECT, V50, P769.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hurst CH, 2003, TOXICOL SCI, V74, P297, DOI 10.1093/toxsci/kfg145.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kavlock R, 2002, REPROD TOXICOL, V16, P679, DOI 10.1016/S0890-6238(02)00034-5.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kavlock R, 2002, REPROD TOXICOL, V16, P721, DOI 10.1016/S0890-6238(02)00031-X.
   LOWRY OH, 1951, J BIOL CHEM, V193, P265.
   Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809.
   MEISTER A, 1985, CURR TOP CELL REGUL, V26, P383.
   National Center for Health Statistics, 2001, NAT HLTH NUTR EX SUR.
   Perivoliotis MC, 2005, TEXT HIST, V36, P1, DOI 10.1179/174329505X37103.
   Reitman S., 1957, AM J CLIN PATHOL, V28, P53.
   Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   Sonde V, 2000, TOXICOLOGY, V147, P23, DOI 10.1016/S0300-483X(00)00164-5.
   Wahl HG, 1999, J CHROMATOGR A, V847, P1, DOI 10.1016/S0021-9673(99)00138-7.
   WYBENGA DR, 1970, CLIN CHEM, V16, P980.
   YU K, 1995, J BIOL CHEM, V270, P23975.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.
   {*}CIR, 1985, J AM COLL TOXICOL, V4, P267.
   {*}EPA, 1981, EPA440481020.
   {*}EPA, 1987, PB89120158 EPA NTIS.
   {*}NTP, 1984, NTP84262 US DEP HHS.
   {*}SCCNFP, 2002, 20 PLEN M 4 JUN 2002.
   {*}SCCNFP, 2003, 26 PLEN M 9 DEC 2003.
   {*}US EPA, 1993, 84662 US EPA CASRN.
   {[}WHO] World Health Organisation, 2003, 52 WHO.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{8}},
Journal-ISO = {{Environ. Toxicol. Pharmacol.}},
Doc-Delivery-Number = {{149JM}},
Wos-Id = {{ISI:000245143200009}},
}

@article{ ISI:000246907000013,
Author = {Wittassek, Matthias and Wiesmueller, Gerhard Andreas and Koch, Holger
   Martin and Eckard, Rolf and Dobler, Lorenz and Mueller, Johannes and
   Angerer, Juergen and Schlueter, Christoph},
Title = {{Internal phthalate exposure over the last two decades - A retrospective
   human biomonitoring study}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2007}},
Volume = {{210}},
Number = {{3-4}},
Pages = {{319-333}},
Month = {{MAY}},
Abstract = {{In a retrospective human biomonitoring study we analyzed 24h urine
   samples taken from the German Environmental Specimen Bank for Human
   Tissues (ESBHum), which were collected from 634 subjects (predominantly
   students, age range 20-29 years, 326 females, 308 males) in 9 years
   between 1988 and 2003 (each n,>= 60), for the concentrations of primary
   and/or secondary metabolites of di-n-butyl phthalate (DnBP),
   di-iso-butyl phthalate (DiBP), butylbenzyl phthalate (BBzP),
   di(2-ethylhexyl) phthalate (DEHP) and di-iso-nonyl phthalate (DiNP).
   Based on the urinary metabolite excretion we estimated daily intakes of
   the parent phthalates and investigated the chronological course of the
   phthalate exposure. In over 98\% of the urine samples metabolites of all
   five phthalates were detectable indicating a ubiquitous exposure of the
   German population to all five phthalates throughout the last 20 years.
   The median daily intakes in the subsets between 1988 and 1993 were quite
   constant for DnBP (approx. 7 mu g/kg bw/d) and DEHP (approx. 4 mu g/kg
   bw/d). However, from 1996 the median levels of both phthalates decreased
   continuously until 2003 (DnBP 1.9 mu g/kg bw/d; DEHP 2.4 mu g/kg bw/d).
   By contrast, the daily intake values for DiBP were slightly increasing
   over the whole time frame investigated (median 1988: 1.1 mu g/kg bw/d;
   median 2003: 1.4 mu g/kg bw/d), approximating the levels for DnBP and
   DEHP. For BBzP we observed slightly decreasing values, even though the
   medians as of 1998 levelled off at around 0.2 mu g/kg bw/d. Regarding
   daily DiNP exposure we found continuously increasing values, with the
   lowest median being 0.20 mu g/kg bw/d for the subset of 1988 and the
   highest median for 2003 being twice as high. The trends observed in
   phthalate exposure may be associated with a change in production and
   usage pattern. Female subjects exhibited significantly higher daily
   intakes for the dibutyl phthalates (DnBP p = 0.0 13; DiBP p = 0.004).
   Compared to data from US National Health and Nutrition Examination
   Surveys (NHANES) exposure levels of the dibutyl phthalates were
   generally higher in our German study population, while levels of BBzP
   were somewhat lower. Overall, for a considerable 14\% of the subjects we
   observed daily DnBP intakes above the tolerable daily intake (TDI)
   value-deduced by the European Food Safety Authority (EFSA) (10 mu g/kg
   bw/d). However, the frequency of exceedance decreased during the years
   and was beneath 2\% in the 2003 subset. Even though transgressions of
   the exposure limit values of the EFSA and the US Environmental
   Protection Agency (US EPA) occurred only in a relatively small share of
   the subjects, one has to take into account the cumulative exposure to
   all phthalates investigated and possible dose-additive endocrine effects
   of these phthalates. (C) 2007 Elsevier GmbH. All rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Schluter, C (Reprint Author), Fed Environm Agcy Umweltbundesamt, Dessau, Germany.
   Fed Environm Agcy Umweltbundesamt, Dessau, Germany.
   German Envirnm Specimen Bank Human Tissues, ESBHum, Munster, Germany.
   Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, Erlangen, Germany.}},
DOI = {{10.1016/j.ijheh.2007.01.037}},
ISSN = {{1438-4639}},
Keywords = {{phthalates; di-n-butyl phthalate; di-iso-butyl phthalate; butylbenzyl
   phthalate; di(2-ethylhexyl) phthalatel; di-iso-nonyl phthalate;
   biomonitoring; daily intake}},
Keywords-Plus = {{N-BUTYL PHTHALATE; IN-UTERO EXPOSURE; MALE REPRODUCTIVE DEVELOPMENT;
   TANDEM MASS-SPECTROMETRY; DEUTERIUM-LABELED DEHP; FETAL-RAT TESTIS;
   DI(2-ETHYLHEXYL)PHTHALATE DEHP; HUMAN URINE; SEXUAL-DIFFERENTIATION;
   DIETHYLHEXYL PHTHALATE}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{christoph.schlueter@uba.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011.
   Borch J, 2006, TOXICOL LETT, V163, P183, DOI 10.1016/j.toxlet.2005.10.020.
   CADOGAN D, 2006, PLASTICISERS 2006 BR.
   CARPENTER CP, 1953, AMA ARCH IND HYG OCC, V8, P219.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   EFSA, 2005, EFSA J, V244, P77.
   EFSA, 2005, EFSA J, V243, P1.
   EFSA (European Food Safety Authority), 2005, EFSA J, V241, P1.
   EFSA (European Food Safety Authority), 2005, EFSA J, V242, P1.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   FOSTER PMD, 2000, FOOD CHEM TOXICOL, V38, P97.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395.
   Gray Jr L. E., 2006, INT J ANDROL, V29, P105.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hoppin JA, 2003, EPIDEMIOLOGY, V14, P259, DOI 10.1097/00001648-200305000-00002.
   Koch H, 2005, UMWELTMED FORSCH PRA, V10, P144.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   KOCH HM, 2007, INT J HYG ENV HLTH.
   KOCH HM, 2007, J EXPO SCI ENV EPIDE.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   KOCH HM, 2007, J CHROMATOGR B.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   LARSEN K, 1972, CLIN CHIM ACTA, V41, P209, DOI 10.1016/0009-8981(72)90513-X.
   Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013.
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404.
   Lorz P. M., 2002, ULLMANNS ENCY IND CH.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Saillenfait AM, 2006, TOXICOL LETT, V165, P39, DOI 10.1016/j.toxlet.2006.01.013.
   Grandjean P, 2006, INT J ANDROL, V29, P181, DOI 10.1111/j.1365-2605.2005.00679.x.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Shelby MD, 2002, REPROD TOXICOL, V16, P451, DOI 10.1016/S0890-6238(02)00045-X.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   SILVA MJ, 2006, HLTH PERSPECT, V114, P1158.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   Wittassek M, 2007, INT J HYG ENVIR HEAL, V210, P35, DOI 10.1016/j.ijheh.2006.11.009.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   WOLFE GW, 2003, 7244200 TRC.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}AGPU, 2006, PLAST MARK DAT.
   {*}ECB, 2004, R0420402ENVHH46 EUR.
   {*}ECB, 2004, EUR UN RISK ASS REP.
   {*}ECB, 2006, R3180601ENVHH EUR CH.
   {*}ECB, 2003, EUR UN RISK ASS REP.
   {*}EPA, 1993, 85687 CASRN.
   {*}EPA, 1991, 11781 CASRN.
   {*}EPA, 1990, 84742 CASRN.
   {*}FDA, 2006, IN INGR SEARCH APPR.
   {*}FDA, 2001, SAF ASS 2 ETH PHT DE.
   2002, HLTH CANADA.}},
Number-of-Cited-References = {{78}},
Times-Cited = {{86}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{173XY}},
Wos-Id = {{ISI:000246907000013}},
}

@article{ ISI:000245866400014,
Author = {Jiang, JunTao and Ma, Long and Yuan, Lin and Wang, XinRu and Zhang, Wei},
Title = {{Study on developmental abnormalities in hypospadiac male rats induced by
   maternal exposure to di-n-butyl phthalate (DBP)}},
Journal = {{TOXICOLOGY}},
Year = {{2007}},
Volume = {{232}},
Number = {{3}},
Pages = {{286-293}},
Month = {{APR 11}},
Abstract = {{The objective of this study was to establish a hypospadiac rat model by
   maternal exposure to di-n-butyl phthalate (DBP) and to evaluate the
   developmental abnormalities of hypospadiac male rats. Timed-pregnant
   rats were given DBP by gastric intubation at doses of 0, 250, 500, 750
   or 1000 mg/kg body weight (bw)/day from gestation day (GD) 14 to 18 to
   establish a hypospadiac rat model. The hypospadias was observerd in the
   500 and 750 mg/kg bw/day groups, the incidence of which was 6.8 and
   41.3\%, respectively. Transverse serial histological analysis of
   genitalia of hypospadiac male rats confirmed the malformation. With
   exposed dose increasing, the serum testosterone (T) levels of male rats
   inversely decreased, and in the same dosage group the serum T levels of
   hypospadiac rats were significantly lower than the levels of
   nonhypospadiac counterparts. The other reproductive lesions such as
   cryptorchidism and decreased ratio of anogenital distance/body weight
   (AGD/bw) were also observed. Autopsy analysis revealed the development
   of reproductive organs (prostate, testes, epididynnis, pituitary gland)
   and nonreproductive organs (adrenal gland, liver, kidney, heart, spleen)
   of hypospadiac rats and nonhypospadiac counterparts. The results
   indicated that the reproductive system and developmental condition of
   hypospadiac male offspring were damaged severely by DBP. (c) 2007
   Elsevier Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Zhang, W (Reprint Author), Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, 300 Guangzhou Rd, Nanjing 210029, Peoples R China.
   Nanjing Med Univ, Affiliated Hosp 1, Dept Urol, Nanjing 210029, Peoples R China.
   Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Urol, Shanghai 200080, Peoples R China.
   TCM, Jiangsu Province Hosp, Dept Urol, Nanjing 210029, Peoples R China.
   Nanjing Med Univ, Inst Toxicol, Nanjing 210029, Peoples R China.}},
DOI = {{10.1016/j.tox.2007.01.018}},
ISSN = {{0300-483X}},
Keywords = {{hypospadias; di-n-butyl phthalate; hypospadiac rat; genitalia; serum
   testosterone}},
Keywords-Plus = {{IN-UTERO EXPOSURE; EXTERNAL GENITALIA DEVELOPMENT; MALE REPRODUCTIVE
   DEVELOPMENT; DI(N-BUTYL) PHTHALATE; SPRAGUE-DAWLEY;
   SEXUAL-DIFFERENTIATION; LACTATIONAL EXPOSURE; LATE PREGNANCY;
   LATE-GESTATION; NTP CENTER}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{zhangwei\_njmu@hotmail.com}},
Cited-References = {{Andrade AJM, 2006, TOXICOLOGY, V228, P85, DOI 10.1016/j.tox.2006.08.020.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335.
   Baskin LS, 2000, J UROLOGY, V163, P951, DOI 10.1016/S0022-5347(05)67861-5.
   Baskin LS, 2001, ENVIRON HEALTH PERSP, V109, P1175, DOI 10.1289/ehp.011091175.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Booker SM, 2001, ENVIRON HEALTH PERSP, V109, pA260, DOI 10.1289/ehp.109-a260.
   Canning D A, 1999, J Urol, V161, P366.
   Ema M, 1997, J APPL TOXICOL, V17, P223, DOI 10.1002/(SICI)1099-1263(199707)17:4<223::AID-JAT433>3.0.CO;2-H.
   Ema M, 1998, TOXICOL LETT, V98, P87, DOI 10.1016/S0378-4274(98)00107-6.
   EMA M, 1993, TOXICOL LETT, V69, P197.
   EMA M, 1994, TOXICOLOGY, V86, P163, DOI 10.1016/0300-483X(94)90002-7.
   Ema M, 2000, TOXICOL LETT, V111, P271, DOI 10.1016/S0378-4274(99)00192-7.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P48, DOI 10.1191/074823399678846646.
   Haraguchi R, 2001, DEVELOPMENT, V128, P4241.
   HARRIS EL, 1990, EPIDEMIOL REV, V12, P29.
   KALLOO NB, 1993, J CLIN ENDOCR METAB, V77, P692, DOI 10.1210/jc.77.3.692.
   Kavlock R, 2002, REPROD TOXICOL, V16, P489, DOI 10.1016/S0890-6238(02)00033-3.
   Klonisch T, 2004, DEV BIOL, V270, P1, DOI 10.1016/j.ydbio.2004.02.018.
   Manson JM, 2003, BIRTH DEFECTS RES A, V67, P825, DOI 10.1002/bdra.10084.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Nakahara Hiroyuki, 2003, Fukuoka Acta Medica, V94, P331.
   PAGE LA, 1979, PEDIATRICS, V63, P788.
   Pan GW, 2006, ENVIRON HEALTH PERSP, V114, P1643, DOI 10.1289/ehp.9016.
   Paulozzi LJ, 1997, PEDIATRICS, V100, P831, DOI 10.1542/peds.100.5.831.
   Paulozzi LJ, 1999, ENVIRON HEALTH PERSP, V107, P297, DOI 10.2307/3434597.
   Perriton CL, 2002, DEV BIOL, V247, P26, DOI 10.1006/dbio.2002.0668.
   Renfree MB, 2002, NOVART FDN SYMP, V244, P136.
   Rozati R, 2000, ASIAN J ANDROL, V2, P263.
   Sharpe RM, 2003, INT J ANDROL, V26, P2, DOI 10.1046/j.1365-2605.2003.00367.x.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   WILSON JD, 1995, RECENT PROG HORM RES, V50, P349.
   WILSON JD, 1993, ENDOCR REV, V14, P577, DOI 10.1210/er.14.5.577.
   Wine RN, 1997, ENVIRON HEALTH PERSP, V105, P102, DOI 10.1289/ehp.97105102.
   Yamada G, 2003, DIFFERENTIATION, V71, P445, DOI 10.1046/j.1432-0436.2003.7108001.x.
   You L, 1998, TOXICOL SCI, V45, P162, DOI 10.1093/toxsci/45.2.162.
   Zhang YH, 2004, REPROD TOXICOL, V18, P669, DOI 10.1016/j.reprotox.2004.04.009.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{25}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{159LE}},
Wos-Id = {{ISI:000245866400014}},
}

@article{ ISI:000245369400001,
Author = {Franco, Amaya and Prevedouros, Konstantinos and Alli, Rebecca and
   Cousins, Ian T.},
Title = {{Comparison and analysis of different approaches for estimating the human
   exposure to phthalate esters}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2007}},
Volume = {{33}},
Number = {{3}},
Pages = {{283-291}},
Month = {{APR}},
Abstract = {{The human exposure estimates for dibutyl (DBP) and bis(2-ethylhexyl)
   phthalate (DEHP) made by two models EUSES and ACC-Human, and by an
   estimation approach which utilized measured concentrations in exposure
   media, were compared. The approach which utilized the latest monitoring
   data for important exposure media, yielded median daily intakes for
   adult humans for DBP and DEHP of 2.7 and 5.6 mu g/kg body weight per
   day, respectively, which were in the same range as previous estimates
   based on back-calculation from urinary metabolites. FUSES estimated
   average daily intakes of DBP and DEHP for humans that were between 8 and
   13 times lower. ACC-Human does not estimate average daily intakes, but
   ACC-Human-estimated human milk concentrations/fugacities were more than
   a thousand times lower than measured concentrations/fugacities in human
   milk. It was concluded that the two models underestimate human exposure
   to phthalate esters because they consider only a few key pathways that
   are known to be important for other, more persistent, hydrophobic
   organic compounds. Further, it was shown that there are differences
   between the two models on the methodology for estimating concentrations
   in exposure media such as vegetation, milk, beef and fish. ACC-Human
   uses a mechanistic approach for estimating transfer through aquatic and
   terrestrial food chains that are known to be important for human
   exposure to persistent, hydrophobic organics and can, unlike EUSES,
   account for food chain metabolism. It proved difficult, however, to
   obtain organism metabolism rates needed as model inputs to ACC-Human. If
   exposure estimates of phthalate esters are needed, it is recommended to
   use an estimation approach based on high quality monitoring data as
   presented here and/or back-calculate daily intake from concentrations of
   metabolites in human urine samples from the general population. (c) 2006
   Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Cousins, IT (Reprint Author), Stockholm Univ, Dept Appl Environm Sci, ITM, SE-10691 Stockholm, Sweden.
   Stockholm Univ, Dept Appl Environm Sci, ITM, SE-10691 Stockholm, Sweden.
   Univ Santiago de Compostela, Dept Chem Engn, Santiago De Compostela 15782, Spain.}},
DOI = {{10.1016/j.envint.2006.10.001}},
ISSN = {{0160-4120}},
Keywords = {{phthalate esters; human exposure; fate and exposure models; doses;
   FUSES; ACC-Human}},
Keywords-Plus = {{PHYSICAL-CHEMICAL PROPERTIES; EVALUATIVE FATE; HYDROPHOBIC CHEMICALS;
   ORGANIC-CHEMICALS; TOXIC POLLUTANTS; INTAKE FRACTION; MODEL;
   BIOCONCENTRATION; BIOACCUMULATION; UNCERTAINTY}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Author-Email = {{ian.cousins@itm.su.se}},
ResearcherID-Numbers = {{Cousins, Ian/A-6944-2008}},
ORCID-Numbers = {{Cousins, Ian/0000-0002-7035-8660}},
Cited-References = {{Vermeire T, 2005, CHEMOSPHERE, V59, P473, DOI 10.1016/j.chemosphere.2005.01.062.
   Bennett DH, 2002, RISK ANAL, V22, P905, DOI 10.1111/1539-6924.00260.
   CLARK K, 2004, REPORT UPDATE PHTHAL.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P125.
   CONNELL DW, 1988, ECOTOX ENVIRON SAFE, V16, P242, DOI 10.1016/0147-6513(88)90054-1.
   Cousins I, 2000, CHEMOSPHERE, V41, P1389, DOI 10.1016/S0045-6535(00)00005-9.
   Cousins IT, 2003, HANDB ENVIRON CHEM, V3, P179.
   Cousins IT, 2001, CHEMOSPHERE, V44, P643, DOI 10.1016/S0045-6535(00)00514-2.
   Cousins IT, 2003, HANDB ENVIRON CHEM, V3, P57.
   Czub G, 2004, ENVIRON TOXICOL CHEM, V23, P2356, DOI 10.1897/03-317.
   Czub G, 2004, ENVIRON SCI TECHNOL, V38, P2406, DOI 10.1021/es034871v.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   Den Hollander H., 2004, 601200003 RIVM.
   Gobas FAPC, 2003, HANDB ENVIRON CHEM, V3, P201.
   Hertwich EG, 1999, RISK ANAL, V19, P1193, DOI 10.1023/A:1007094930671.
   Hertwich EG, 2000, RISK ANAL, V20, P439, DOI 10.1111/0272-4332.204043.
   Huijbregts MAJ, 2005, ENVIRON TOXICOL CHEM, V24, P486, DOI 10.1897/04-001R.1.
   Huijbregts MAJ, 2003, CHEMOSPHERE, V51, P501, DOI 10.1016/S0045-6535(02)00856-1.
   KARICKHOFF SW, 1981, CHEMOSPHERE, V10, P833, DOI 10.1016/0045-6535(81)90083-7.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   LOWENBACH WA, 1995, MODEL ESTIMATING BEE.
   Mackay D., 2001, MULTIMEDIA ENV MODEL.
   Gobas FAPC, 2000, HANDBOOK OF PROPERTY ESTIMATION METHODS FOR CHEMICALS, P189.
   MADDALENA RL, 1995, CHEMOSPHERE, V30, P869, DOI 10.1016/0045-6535(94)00447-3.
   MCKONE TE, 1993, UCRLCR111456PTIIV L.
   McLachlan MS, 1996, ENVIRON SCI TECHNOL, V30, P252, DOI 10.1021/es9502738.
   OLIVER BG, 1985, ENVIRON SCI TECHNOL, V19, P842, DOI 10.1021/es00139a013.
   Peijnenburg WJGM, 2006, ECOTOX ENVIRON SAFE, V63, P204, DOI 10.1016/j.ecoenv.2005.07.023.
   Staples Charles A., 1997, Environmental Toxicology and Chemistry, V16, P875, DOI 10.1897/1551-5028(1997)016<0875:ATOEPE>2.3.CO;2.
   Stanley MK, 2003, HANDB ENVIRON CHEM, V3, P1.
   Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1.
   TRAPP S, 1995, ENVIRON SCI TECHNOL, V29, P2333, DOI 10.1021/es00009a027.
   TRAVIS CC, 1988, ENVIRON SCI TECHNOL, V22, P271, DOI 10.1021/es00168a005.
   VEITH GD, 1979, J FISH RES BOARD CAN, V36, P1040.
   Wormuth M, 2006, RISK ANAL, V26, P803, DOI 10.1111/j.1539-6924.2006.00770.x.
   {*}EMBSI, 2000, EV PROD CONS END US.
   {*}EUR CHEM BUR, 1997, EUSES DOC EUR UN SYS.
   {*}RIVM ECPI, 2000, ECPI200014 RIVM.
   {*}RIVM ECPI, 2000, ECPI200007 RIVM.
   1967, OFF J EUR COMMUNITIE, P196.
   1993, OFF J EUR COMMUNITIE.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{16}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{152NT}},
Wos-Id = {{ISI:000245369400001}},
}

@article{ ISI:000244350500003,
Author = {Silva, M. J. and Reidy, J. A. and Kato, K. and Preau, Jr., J. L. and
   Needham, L. L. and Calafat, A. M.},
Title = {{Assessment of human exposure to di-isodecyl phthalate using oxidative
   metabolites as biomarkers}},
Journal = {{BIOMARKERS}},
Year = {{2007}},
Volume = {{12}},
Number = {{2}},
Pages = {{133-144}},
Month = {{MAR-APR}},
Abstract = {{Di-isodecyl phthalate (DiDP), primarily used as a plasticiser, is a
   mixture of isomers with predominantly ten-carbon branched side chains.
   Assessment of DiDP exposure has not been conducted before because
   adequate biomarkers were lacking. In 129 adult volunteers with no known
   exposure to DiDP, the urinary concentrations of three oxidative
   metabolites of DiDP: monocarboxyisononyl phthalate (MCiNP),
   monooxoisodecyl phthalate (MOMP) and monohydroxyisoclecyl phthalate
   (MHiDP), previously identified in DiDP-dosed rats, were estimated by
   solid-phase extraction coupled to high-performance liquid
   chromatography-tandem mass spectrometry (HPLC-MS/MS) using the
   respective oxidative metabolites of di(2-ethylhexyl)phthalate since
   authentic standards of the DiDP oxidative metabolites were unavailable.
   Interestingly, the hydrolytic monoester of DiDP, monoisoclecyl phthalate
   (MiDP), was not detected in any of the samples, while MCiNP, MHiDP and
   MOMP were detected in 98\%, 96\% and 85\%, respectively, of the samples
   tested. MCiNP was excreted predominantly in its free form, whereas MOMP
   was excreted as its glucuronide. MCiNP, MHiDP and MOMP eluted as
   clusters of multiple peaks from the HPLC column probably due to the
   presence of numerous structurally similar isomers present in commercial
   DiDP formulations. The urinary concentrations of these oxidative
   metabolites correlated significantly (p < 0.0001) with each other, thus
   confirming a common precursor. The urinary concentrations of these DiDP
   oxidative metabolites also correlated significantly (p < 0.0001) with
   oxidative metabolites of di-isononyl phthalate (DiNP) suggesting the
   potential presence of DiNP isomers in commercial DiDP or simultaneous
   use of DiDP and DiNP in consumer products. The concentrations presented
   are semiquantitative estimates and should be interpreted cautiously.
   Nevertheless, the higher frequency of detection and higher urinary
   concentrations of MCiNP, MHiDP and MOMP than of MOP suggest that these
   oxidative metabolites are better biomarkers for DiDP exposure assessment
   than MiDP These data also suggest that unless oxidative metabolites are
   measured, the prevalence of exposure to DiDP will probably be
   underestimated.}},
Publisher = {{TAYLOR \& FRANCIS LTD}},
Address = {{4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, 4770 Buford Hwy NE,Mailstop F-53, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.}},
DOI = {{10.1080/13547500601066915}},
ISSN = {{1354-750X}},
Keywords = {{DiDP; MiDP; di-isodecyl phthalate; monoisodecyl phthalate; oxidative
   metabolite; oxidative metabolism; biomonitoring}},
Keywords-Plus = {{DEUTERIUM-LABELED DEHP; DI(2-ETHYLHEXYL)PHTHALATE DEHP; HUMAN URINE;
   DEVELOPMENTAL TOXICITY; ISONONYL PHTHALATE; INTERNAL EXPOSURE; RATS;
   CHILDREN; SERUM}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Toxicology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Toxicology}},
Author-Email = {{zca2@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{ALBRO PW, 1983, BIOCHIM BIOPHYS ACTA, V760, P283, DOI 10.1016/0304-4165(83)90175-7.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Calafat AM, 2004, PEDIATRICS, V113, P429.
   Gilsing HD, 2005, MONATSH CHEM, V136, P795, DOI 10.1007/s00706-004-0267-6.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kavlock R, 2002, REPROD TOXICOL, V16, P655, DOI 10.1016/S0890-6238(02)00068-0.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, ARCH TOXICOL, V79, P689, DOI 10.1007/s00204-005-0004-x.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   McKee RH, 2000, J APPL TOXICOL, V20, P491, DOI 10.1002/1099-1263(200011/12)20:6<491::AID-JAT724>3.0.CO;2-H.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2005, TOXICOLOGY, V210, P123, DOI 10.1016/j.tox2005.01.012.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Waterman SJ, 1999, REPROD TOXICOL, V13, P131, DOI 10.1016/S0890-6238(99)00002-7.
   {*}CERHR, 2000, NTP CERHR EXP PAN RE.
   {*}EXX CHEM CO EXX E, 1997, 2 GEN REPR TOX STUD.}},
Number-of-Cited-References = {{23}},
Times-Cited = {{10}},
Journal-ISO = {{Biomarkers}},
Doc-Delivery-Number = {{138GG}},
Wos-Id = {{ISI:000244350500003}},
}

@article{ ISI:000245011700008,
Author = {Hauser, R. and Meeker, J. D. and Singh, N. P. and Silva, M. J. and Ryan,
   L. and Duty, S. and Calafat, A. M.},
Title = {{DNA damage in human sperm is related to urinary levels of phthalate
   monoester and oxidative metabolites}},
Journal = {{HUMAN REPRODUCTION}},
Year = {{2007}},
Volume = {{22}},
Number = {{3}},
Pages = {{688-695}},
Month = {{MAR}},
Abstract = {{BACKGROUND: The ubiquitous use of phthalate esters in plastics, personal
   care products and food packaging materials results in widespread general
   population exposure. In this report, we extend our preliminary study on
   the relationship between urinary concentrations of phthalate metabolites
   and sperm DNA damage among a larger sample of men and include
   measurements of mono-(2-ethyl-5-hydroxyhexyl) phthalate (MEHAIR) and
   mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP), two oxidative metabolites
   of di-(2-ethylhexyl) phthalate (DEHP). METHODS: Among 379 men from an
   infertility clinic, urinary concentrations of phthalate metabolites were
   measured using isotope-dilution high-performance liquid
   chromatography-tandem mass spectrometry. Sperm DNA damage measurements,
   assessed with the neutral comet assay, included comet extent (CE),
   percentage of DNA in tail (Tail\%) and tail distributed moment (TDM).
   RESULTS: Monoethyl phthalate (MEP), a metabolite of diethyl phthalate,
   was associated with increased DNA damage, confirming our previous
   findings. Mono-(2-ethylhexyl) phthalate (MERP), a metabolite of DEHP,
   was associated with DNA damage after adjustment for the oxidative DEHP
   metabolites. After adjustment for MEHHP, for an interquartile range
   increase in urinary MEHP, CE increased 17.3\% {[}95\% confidence
   interval (CI) = 8.7-25.7\%], TDM increased 14.3\% (95\% CI = 6.8-21.7\%)
   and Tail\% increased 17.5\% (95\% CI = 3.5-31.5\%). CONCLUSIONS: Sperm
   DNA damage was associated with MEP and with MEHP after adjusting for
   DEHP oxidative metabolites, which may serve as phenotypic markers of
   DEHP metabolism to `less toxic' metabolites. The urinary levels of
   phthalate metabolites among these men were similar to those reported for
   the US general population, suggesting that exposure to some phthalates
   may affect the population distribution of sperm DNA damage.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hauser, R (Reprint Author), Harvard Univ, Sch Med, Dept Environm Hlth, Occupat Hlth Program, Bldg 1,Room 1405,665 Huntington Ave, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Dept Environm Hlth, Occupat Hlth Program, Boston, MA 02115 USA.
   Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv, Androl Lab, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, In Vitro Fertilizat Unit, Boston, MA 02114 USA.
   Univ Michigan, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Simmons Coll, Dept Nursing, Sch Hlth Studies, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.}},
DOI = {{10.1093/humrep/del428}},
ISSN = {{0268-1161}},
Keywords = {{phthalates; urinary metabolites; DNA damage; comet assay; human sperm}},
Keywords-Plus = {{EJACULATED HUMAN SPERMATOZOA; COMET ASSAY; DI(2-ETHYLHEXYL) PHTHALATE;
   TESTICULAR TOXICITY; EMBRYO DEVELOPMENT; BUTYL-PHTHALATE; HUMAN
   EXPOSURE; STRAND BREAKS; DEHP; APOPTOSIS}},
Research-Areas = {{Obstetrics \& Gynecology; Reproductive Biology}},
Web-of-Science-Categories  = {{Obstetrics \& Gynecology; Reproductive Biology}},
Author-Email = {{rhauser@hohp.harvard.edu}},
ResearcherID-Numbers = {{Ryan, Louise/A-4562-2009}},
Cited-References = {{Agarwal A, 2004, Minerva Ginecol, V56, P235.
   AGARWAL DK, 1985, TOXICOLOGY, V35, P189, DOI 10.1016/0300-483X(85)90015-0.
   Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   Aitken RJ, 2001, REPRODUCTION, V122, P497, DOI 10.1530/rep.0.1220497.
   Anderson D, 1999, TERATOGEN CARCIN MUT, V19, P275, DOI 10.1002/(SICI)1520-6866(1999)19:4<275::AID-TCM4>3.0.CO;2-1.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Barroso G, 2000, HUM REPROD, V15, P1338, DOI 10.1093/humrep/15.6.1338.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Borini A, 2006, HUM REPROD, V21, P2876, DOI 10.1093/humrep/del251.
   Bradbury J, 1996, LANCET, V347, P1541, DOI 10.1016/S0140-6736(96)90681-9.
   Duran EH, 2002, HUM REPROD, V17, P3122, DOI 10.1093/humrep/17.12.3122.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Duty SM, 2002, HUM REPROD, V17, P1274, DOI 10.1093/humrep/17.5.1274.
   Fraga CG, 1996, MUTAT RES-FUND MOL M, V351, P199, DOI 10.1016/0027-5107(95)00251-0.
   GORCZYCA W, 1993, EXP CELL RES, V207, P202, DOI 10.1006/excr.1993.1182.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Hosmer D, 1989, APPL LOGISTIC REGRES, P82.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254.
   Kleinsasser NH, 2000, ENVIRON MOL MUTAGEN, V35, P9, DOI 10.1002/(SICI)1098-2280(2000)35:1<9::AID-EM2>3.0.CO;2-1.
   Kleinsasser NH, 2001, TERATOGEN CARCIN MUT, V21, P189, DOI 10.1002/tcm.1007.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   MANICARDI GC, 1995, BIOL REPROD, V52, P864, DOI 10.1095/biolreprod52.4.864.
   MCKELVEYMARTIN VJ, 1993, MUTAT RES, V288, P47, DOI 10.1016/0027-5107(93)90207-V.
   MCPHERSON S, 1993, EUR J HISTOCHEM, V37, P109.
   Meeker JD, 2004, HUM REPROD, V19, P2573, DOI 10.1093/humrep/deh444.
   Moller P, 2000, CANCER EPIDEM BIOMAR, V9, P1005.
   Morris ID, 2002, HUM REPROD, V17, P990, DOI 10.1093/humrep/17.4.990.
   Moustafa MH, 2004, HUM REPROD, V19, P129, DOI 10.1093/humrep/deh024.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   Ollero M, 2001, HUM REPROD, V16, P1912, DOI 10.1093/humrep/16.9.1912.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PARMAR D, 1986, TOXICOLOGY, V42, P47, DOI 10.1016/0300-483X(86)90091-0.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Sakkas D, 2002, BIOL REPROD, V66, P1061, DOI 10.1095/biolreprod66.4.1061.
   Sakkas D, 1999, REV REPROD, V4, P31, DOI 10.1530/ror.0.0040031.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Singh NP, 1997, MUTAT RES-DNA REPAIR, V383, P167, DOI 10.1016/S0921-8777(96)00056-0.
   Singh NP, 1998, MUTAGENESIS, V13, P75, DOI 10.1093/mutage/13.1.75.
   SINGH NP, 2003, FERTIL STERIL, V18, P1420.
   SRIVASTAVA SP, 1990, ARCH TOXICOL, V64, P148, DOI 10.1007/BF01974401.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Sun JG, 1997, BIOL REPROD, V56, P602, DOI 10.1095/biolreprod56.3.602.
   Undeger U, 1999, J OCCUP ENVIRON MED, V41, P693.
   Zar J. H., 1984, BIOSTAT ANAL, P239.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 2001, DI N BUT PHTHAL.
   {*}CDCP NAT CTR ENV, 2005, 3 NAT REP HUM EXP EN.}},
Number-of-Cited-References = {{57}},
Times-Cited = {{93}},
Journal-ISO = {{Hum. Reprod.}},
Doc-Delivery-Number = {{147OG}},
Wos-Id = {{ISI:000245011700008}},
}

@article{ ISI:000243467000012,
Author = {Grande, Simone W. and Andrade, Anderson J. M. and Talsness, Chris E. and
   Grote, Konstanze and Golombiewski, Andrea and Sterner-Kock, Anja and
   Chahoud, Ibrahim},
Title = {{A dose-response study following in utero and lactational exposure to
   di-(2-ethylhexyl) phthalate (DEHP): Reproductive effects on adult female
   offspring rats}},
Journal = {{TOXICOLOGY}},
Year = {{2007}},
Volume = {{229}},
Number = {{1-2}},
Pages = {{114-122}},
Month = {{JAN 5}},
Abstract = {{Di(2-ethylhexyl) phthalate (DEHP) is used in numerous consumer products,
   mainly imparting flexibility and durability to polyvinyl chloride (PVC)
   based plastics. It is a known reproductive and developmental toxicant in
   male rodents. However, data regarding effects of DEHP on female
   reproductive health are particularly sparse. We performed an extensive
   dose-response study following developmental exposure to DEHP and
   evaluated the effects on adult female reproductive function. Two wide
   ranges of doses, low and high, were tested. Female Wistar rats were
   treated daily with DEHP and peanut oil (vehicle control) by gavage from
   gestation day 6 to lactation day 21. The low doses were: 0.015, 0.045,
   0.135, 0.405 and 1.215 mg DEHP/kg/bw/day and the high doses were: 5, 15,
   45, 135 and 405 mg DEHP/kg/bw/day. At the doses tested, no effects on
   organ (liver, kidney, spleen, thymus, thyroid, ovary and uterus) or body
   weights were detected. Female offspring presented a normal pattern of
   estrous cyclicity with no hormonal alterations (serum estradiol and
   progesterone). A statistically significant increase in tertiary atretic
   follicles was observed at the highest dose (405 mg DEHP/kg/day).
   Morphometric analysis indicated that uterus and vagina luminal
   epithelial cell height were unaffected by treatment. An increase in the
   number of ovarian atretic tertiary follicles was the only effect
   observed in adult female offspring exposed in utero and during lactation
   to DEHP. (c) 2006 Elsevier Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chahoud, I (Reprint Author), Charite Univ Med Sch Berlin, Inst Clin Pharmacol \& Toxicol, Dept Toxicol, Campus Benjamin Franklin,Gary Str 5, D-14195 Berlin, Germany.
   Charite Univ Med Sch Berlin, Inst Clin Pharmacol \& Toxicol, Dept Toxicol, D-14195 Berlin, Germany.
   Free Univ Berlin, Dept Vet Pathol, D-1000 Berlin, Germany.}},
DOI = {{10.1016/j.tox.2006.10.005}},
ISSN = {{0300-483X}},
Keywords = {{di-(2-ethylhexyl) phthalate; dose-response; female offspring; endocrine
   disruptors}},
Keywords-Plus = {{ACTIVATED RECEPTOR-GAMMA; DI(2-ETHYLHEXYL) PHTHALATE;
   MONO-(2-ETHYLHEXYL) PHTHALATE; TESTICULAR TOXICITY; GENE-EXPRESSION;
   GRANULOSA-CELLS; APOPTOSIS; OOCYTES; ATRESIA; TESTIS}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{ibrahim.chahoud@charite.de}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Andrade AJM, 2006, TOXICOLOGY, V225, P64, DOI 10.1016/j.tox.2006.05.007.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Andrade AJM, 2006, TOXICOLOGY, V228, P85, DOI 10.1016/j.tox.2006.08.020.
   Atarod EB, 2004, FREE RADICAL BIO MED, V37, P36, DOI 10.1016/j.freeradbiomed.2004.04.015.
   Baldridge Monika G., 2003, Reproductive Toxicology, V17, P567, DOI 10.1016/S0890-6238(03)00095-9.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Bhattacharya N, 2005, BIOL REPROD, V72, P745, DOI 10.1095/biolreprod.104.031583.
   Borgeest C, 2002, TOXICOL SCI, V68, P473, DOI 10.1093/toxsci/68.2.473.
   Boutin EL, 1997, DIFFERENTIATION, V62, P171.
   Brevini TAL, 2005, REPROD DOMEST ANIM, V40, P291, DOI 10.1111/j.1439-0531.2005.00592.x.
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   Chahoud I., 1977, Methods in prenatal toxicology. Evaluation of embryotoxic effects in experimental animals. Teratology workshop April 1977, Berlin., P78.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   Cummings Audrey M, 2004, J Toxicol Sci, V29, P167, DOI 10.2131/jts.29.167.
   Dalgaard M, 2001, TOXICOL LETT, V122, P69, DOI 10.1016/S0378-4274(01)00348-4.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Devine PJ, 2000, BIOL REPROD, V63, P1245, DOI 10.1095/biolreprod63.5.1245.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395.
   Giammona CJ, 2002, TOXICOL APPL PHARM, V185, P119, DOI 10.1006/taap.2002.9536.
   Grande SW, 2006, TOXICOL SCI, V91, P247, DOI 10.1093/toxsci/kfj128.
   Hasmall SC, 2000, ARCH TOXICOL, V74, P85, DOI 10.1007/s002040050657.
   Hirosawa N, 2006, PROTEOMICS, V6, P958, DOI 10.1002/pmic.200401344.
   HSUEH AJW, 1994, ENDOCR REV, V15, P707, DOI 10.1210/er.15.6.707.
   Kijima K, 2004, TOXICOL APPL PHARM, V200, P103, DOI 10.1016/j.taap.2004.03.015.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Komar CM, 2003, BIOL REPROD, V69, P549, DOI 10.1095/biolreprod.102.012831.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   Lovekamp-Swan T, 2005, MOL CELL ENDOCRINOL, V233, P15, DOI 10.1016/mce.2005.01.011.
   Lovekamp-Swan T, 2003, MOL CELL ENDOCRINOL, V201, P133, DOI 10.1016/S0303-7207(02)00423-9.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Nephew KP, 2000, P SOC EXP BIOL MED, V223, P288, DOI 10.1046/j.1525-1373.2000.22341.x.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PEDERSEN T, 1968, J REPROD FERTIL, V17, P555.
   PLOWCHALK DR, 1993, METHODS TOXICOL B, V3, P57.
   Rais-Bahrami K, 2004, ENVIRON HEALTH PERSP, V112, P1339, DOI 10.1289/ehp.6901.
   Reddy BS, 2006, BJOG-INT J OBSTET GY, V113, P515, DOI 10.1111/j.1471-0528.2006.00925.x.
   Richburg JH, 2000, ENDOCRINOLOGY, V141, P787, DOI 10.1210/en.141.2.787.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Timchalk C, 2004, TOXICOLOGY, V200, P1, DOI 10.1016/j.tox.2004.03.005.
   {*}US EPA, 1996, GUID REPR TOX RISK A, P163.
   {*}WHO, 2002, GLOB ASS STAT SCI EN, P180.
   2005, NATL TOXICOLOGY PROG.
   1998, TIERSCHUTZGESETZ.}},
Number-of-Cited-References = {{49}},
Times-Cited = {{27}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{125TZ}},
Wos-Id = {{ISI:000243467000012}},
}

@article{ ISI:000243299200043,
Author = {Wolff, Mary S. and Teitelbaum, Susan L. and Windham, Gayle and Pinney,
   Susan M. and Britton, Julie A. and Chelimo, Carol and Godbold, James and
   Biro, Frank and Kushi, Lawrence H. and Pfeiffer, Christine M. and
   Calafat, Antonia M.},
Title = {{Pilot study of urinary biomarkers of phytoestrogens, phthalates, and
   phenols in girls}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2007}},
Volume = {{115}},
Number = {{1}},
Pages = {{116-121}},
Month = {{JAN}},
Abstract = {{BACKGROUND: Hormonally active environmental agents have been measured
   among U.S. children using exposure biomarkers in urine. However, little
   is known about their variation by race, age, sex, and geography, and no
   data exist for newly developed biomarkers.
   OBJECTIVE: Our goal was to characterize relevant, prevalent exposures
   for a study of female pubertal development. METHODS: In a pilot study
   among 90 girls from New York City, New York, Cincinnati, Ohio, and
   northern California, we measured 25 urinary analytes representing 22
   separate agents from three chemical families: phytoestrogens,
   plithalates, and phenols. Exposures occur chiefly from the diet and from
   household or personal care products.
   RESULTS: Participants represented four racial/ethnic groups (Asian,
   black, Hispanic, white), with mean age of 7.77 years. Most analytes were
   detectable in > 94\% of samples. The highest median concentrations for
   individual analytes in each family were for enterolactone (298 mu g/L),
   monoethylplithalate (MEP; 83.2 mu g/L), and benzophenone-3 (BP3; 14.7 mu
   g/L). Few or no data have been reported previously for four metabolites:
   mono (2-ethyl-5-carboxypentyl) plithalate, triclosan, bisphenol A (BPA),
   and BP3; these were detected in 67-100\% of samples with medians of
   1.8-53.2 mu g/L. After multivariate adjustment, two analytes,
   enterolactone and BPA, were higher among girls with body mass index <
   85th reference percentile than those at of above the 85th percentile.
   Three phthalate metabolites differed by race/ethnicity {[}MEP, mono
   (2-ethylhexyl) phthalate, and mono-3-carboxypropylphthalate].
   CONCLUSIONS: A wide spectrum of hormonally active exposure biomarkers
   were detectable and variable among young girls, with high maximal
   concentrations (> 1,000 mu g/L) found for several analytes. They varied
   by characteristics that may be relevant to development.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wolff, MS (Reprint Author), CUNY Mt Sinai Sch Med, Dept Community \& Prevent Med, Div Environm Hlth Sci, 1 Gustave L Levy Pl,Box 1057, New York, NY 10029 USA.
   CUNY Mt Sinai Sch Med, Dept Community \& Prevent Med, Div Environm Hlth Sci, New York, NY 10029 USA.
   Calif Dept Hlth Serv, Div Environm \& Occupat Dis Control, Oakland, CA USA.
   Univ Cincinnati, Coll Med, Dept Environm Med, Cincinnati, OH 45221 USA.
   Cincinnati Childrens Hosp, Med Ctr, Div Adolescent Med, Cincinnati, OH USA.
   Kaiser Permanente, Div Res, Oakland, CA USA.
   Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA USA.}},
DOI = {{10.1289/ehp.9488}},
ISSN = {{0091-6765}},
Keywords = {{biomarkers; children; exposure; phenols; phthalates; phytoestrogen;
   urine}},
Keywords-Plus = {{BISPHENOL-A; MASS-SPECTROMETRY; AUTOMATED ONLINE; METABOLITES;
   QUANTIFICATION; EXPOSURE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{mary.wolff@mssm.edu}},
Cited-References = {{Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   FENTON SE, 2006, ENDOCRINOLOGY S, V147, pS18, DOI DOI 10.1210/en.2005-1131.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505.
   HIMES JH, 1994, AM J CLIN NUTR, V59, P307.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   KOCH HM, 2006, INT J ANDROL, V1, P155.
   Kuklenyik Z, 2004, J CHROMATOGR SCI, V42, P495.
   Miller RC, 2004, CLIN CHEM, V50, P924, DOI 10.1373/clinchem.2004.032292.
   Norrgran J, 2006, J CHROMATOGR B, V830, P185, DOI 10.1016/j.jchromb.2005.10.041.
   Rajapakse N, 2002, ENVIRON HEALTH PERSP, V110, P917.
   RYBAK ME, 2006, 54 ASMS C MASS SPECT.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Sohoni P, 1998, J ENDOCRINOL, V158, P327, DOI 10.1677/joe.0.1580327.
   vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713.
   Wolff MS, 2005, ENVIRON HEALTH PERSP, V113, P739, DOI 10.1289/ehp.7694.
   Ye XY, 2005, ANAL BIOANAL CHEM, V383, P638, DOI 10.1007/s00216-005-0019-4.
   Ye XY, 2005, ANAL CHEM, V77, P5407, DOI 10.1021/ac050390d.
   {*}CDC, 2000, CDC GROWTHS CHARTS.
   {*}CDC, 2005, NAT REP HUM EXP ENV.}},
Number-of-Cited-References = {{22}},
Times-Cited = {{86}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{123ME}},
Wos-Id = {{ISI:000243299200043}},
}

@article{ ISI:000244592600003,
Author = {Fromme, Hermann and Bolte, Gabriele and Koch, Holger M. and Angerer,
   Juergen and Boehmer, Sigrun and Drexler, Hans and Mayer, Richard and
   Liebl, Bernhard},
Title = {{Occurrence and daily variation of phthalate metabolites in the urine of
   an adult population}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2007}},
Volume = {{210}},
Number = {{1}},
Pages = {{21-33}},
Month = {{JAN}},
Abstract = {{Phthalates like di-(2-ethylhexyl) phthalate (DEHP) are commonly used as
   plasticizers and their metabolites are suspect of especially
   reproductive toxicity.
   The aim of our study was to assess phthalate exposure in adults by
   measuring urinary phthalate metabolite levels and to explore individual
   temporal variability. Urine samples were collected by 27 women and 23
   men aged 14 60 years during 8 consecutive days. We quantified four
   monoesters, four oxidative DEHP metabolites, and two secondary
   metabolites of di-isononyl phthalate (DiNP) by a LC/LC-MS/MS method.
   If we analyzed all 399 available samples independent of classification,
   the highest median values of primary metabolites in this study were
   found for mono-n-butyl phthalate (MnBP: 49.6 mu g/l), followed by
   mono-isobutyl phthalate (MiBP: 44.9 mu g/l), mono-benzyl phthalate
   (MBzP: 7.2 mu g/l), and mono-:2-ethylhexyl phthalate (MEHP: 4.9 mu g/l).
   The median concentrations of the oxidized metabolites of DEHP were 8.3
   mu g/l for mono-(2-carboxymethylbexyl) phthalate (2cx-MMHP), 19.2 mu g/l
   for mono-(2-ethyl-5-hydroxyhexyl) phthalate (50H-MEHP), 14.7 mu g/l for
   mono-(2-ethyl-5-oxohexyl) phthalate (5oxo-MEHP), and 26.2 mu g/l for
   mono-(2-ethyl-5-carboxypentyl) phthalate (5cx-MEPP). The concentrations
   of the two DiNP secondary metabolites mono (oxoisononyl) phthalate
   (oxo-MiNP) and mono(hydroxyisononyl) phthalate (OH-MiNP) ranged from <
   LOD to 304 mu g/l (median: 3.0 mu g/l, 2.9 mu g/g creatinine) and < LOD
   to 698 mu g/l (median: 5.5 mu g/l, 5.2 mu g/g creatinine), respectively.
   Phthalate metabolite levels did not consistently differ by sex or age.
   There was substantial day-to-day variation of urinary levels with
   considerable within-subject variability. Intraclass correlation
   coefficients adjusted for sex and age ranged between 0.21 and 0.48 for
   unadjusted metabolite levels and between 0.20 and 0.57 for
   creatinine-adjusted levels.
   The secondary metabolites of DiNP were detectable in nearly all samples
   and were therefore sensitive biomarkers of DiNP exposure. Our results of
   within-subject variability suggest that exposure assessment should not
   be based on a single urine measurement. (c) 2006 Elsevier GmbH. All
   rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fromme, H (Reprint Author), Bavarian Hlth \& Food Safety Author, Dept Environm Hlth, Vet Str 2, D-85764 Oberschleissheim, Germany.
   Bavarian Hlth \& Food Safety Author, Dept Environm Hlth, D-85764 Oberschleissheim, Germany.
   Univ Erlangen Nurnberg, Inst Outpatient Clin Occupat Social \& Environm Me, D-91054 Erlangen, Germany.
   Bavarian State Minist Environm Publ Hlth \& Consum, D-81925 Munich, Germany.}},
DOI = {{10.1016/j.ijheh.2006.09.005}},
ISSN = {{1438-4639}},
Keywords = {{DEHP; DNP; DiNP; MiBP MEHP; MiNP; phthalates; urine; metabolites;
   biomarkers}},
Keywords-Plus = {{DI-ISONONYL PHTHALATE; HUMAN EXPOSURE ASSESSMENT; DI(2-ETHYLHEXYL)
   PHTHALATE; MONO(2-ETHYLHEXYL) PHTHALATE; OXIDATIVE METABOLITES;
   MASS-SPECTROMETRY; INTERNAL EXPOSURE; DEHP; RATS; BIOMARKERS}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{hermann.fromme@lgl.bayern.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   CLARK K, 2003, HDB ENV CHEM.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   ECPI, 2006, PHTHAL INF CTR.
   Fromme H, 2004, INDOOR AIR, V14, P188, DOI 10.1046/j.1600-0668.2003.00223.x.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Itoh H, 2005, INT J HYG ENVIR HEAL, V208, P237, DOI 10.1016/j.ijheh.2005.02.004.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kessler W, 2004, TOXICOL APPL PHARM, V195, P142, DOI 10.1016/j.taap.2003.11.014.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   KOCH HM, 2005, UMWELTMED FORSCH PRA, V10, P318.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Ljungvall K, 2004, ARCH TOXICOL, V78, P384, DOI 10.1007/s00204-004-0558-z.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   NCEH. National Center for Environmental Health, 2005, 3 NAT REP HUM EXP EN.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Pugh G, 2000, TOXICOL SCI, V56, P181, DOI 10.1093/toxsci/56.1.181.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, ENVIRON HEALTH PERSP, V114, P1158, DOI 10.1289/ehp.8865.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Smith JH, 2000, TOXICOL SCI, V54, P312, DOI 10.1093/toxsci/54.2.312.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Waterman SJ, 1999, REPROD TOXICOL, V13, P131, DOI 10.1016/S0890-6238(99)00002-7.
   Waterman SJ, 2000, REPROD TOXICOL, V14, P21, DOI 10.1016/S0890-6238(99)00067-2.
   Wensing M, 2005, SCI TOTAL ENVIRON, V339, P19, DOI 10.1016/j.scitotenv.2004.10.028.
   {*}CERHR, 2005, NAT TOX PROGR CERHR.
   {*}CERHR, 2000, NAT TOX PROGR CERHR.
   {*}ECB, 2003, EUR UN RISK ASS REP, V30.
   {*}FDA, 2001, SAF ASS DI 2 ETH PHT.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{61}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{141QA}},
Wos-Id = {{ISI:000244592600003}},
}

@article{ ISI:000244592600004,
Author = {Wittassek, Matthias and Heger, Wolfgang and Koch, Holger M. and Becker,
   Kerstin and Angerer, Juergen and Kolossa-Gehring, Marike},
Title = {{Daily intake of di(2-ethylhexyl)phthalate (DEHP) by German children - A
   comparison of two estimation models based on urinary DEHP metabolite
   levels}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2007}},
Volume = {{210}},
Number = {{1}},
Pages = {{35-42}},
Month = {{JAN}},
Abstract = {{Di(2-ethylhexyl)phthalate (DEHP) is a general-purpose plasticizer for
   polyvinyl chloride (PVC) and has become a ubiquitous environmental
   contaminant. It is suspected to be an endocrine disruptin/modulating
   substance in humans. Children are of special concern due to their
   developmental state. In our study we estimated the daily DEHP intake of
   239 children aged 2-14 years by extrapolating from their urinary levels
   of the DEHP metabolites mono-(2-ethyl-5-hyd roxyhexyl)phthalate
   (50H-MEHP), mono-(2-ethyl-5-oxohexyl)phthalate (5oxo-MEHP) and
   mono-(2-ethylhexyl)phthalate (MEHP). We applied two calculation models
   based upon the volume and the creatinine-related urinary metabolite
   concentrations. Applying the volume- or the creatinine-based calculation
   model we determined a median daily DEHP intake of 7.8 or 4.3 mu g/kg
   body weight (bw)/day and a 95th percentile of 25.2 or 15.2 mu g/kg
   bw/day. Three children (1\%) exceeded the value of the tolerable daily
   intake (TDI) of the European Food Safety Authority of 50 mu g/ kg
   bw/day, while 7.5\% or 3\% (depending on the calculation model) exceeded
   the reference dose (RfD) of 20 mu g/kg bw/day of the US Environmental
   Protection Agency. In general, DEHP exposure was decreasing with
   increasing age and boys had higher exposures than girls. Our findings
   suggest that the majority of the children in the general population is
   exposed to quantities of DEHP below the TDI and the RfD. However, many
   children scoop out the preventive limit values to a considerable degree
   and in individual cases we observed substantial transgressions. Younger
   children seem to be more severely burdened, which may be due to a higher
   food consumption related to their bw, mouthing behaviour and/or playing
   near the ground. (c) 2006 Elsevier GmbH. All rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kolossa-Gehring, M (Reprint Author), Fed Environm Agcy Umweltbundesamt, Correns Pl 1, D-14195 Berlin, Germany.
   Fed Environm Agcy Umweltbundesamt, D-14195 Berlin, Germany.
   Univ Erlangen Nurnberg, Inst Outpatient Clin Occupat Social \& Environm Me, D-8520 Erlangen, Germany.
   Inst Ruhr Univ Bochum, BGFA, Bochum, Germany.}},
DOI = {{10.1016/j.ijheh.2006.11.009}},
ISSN = {{1438-4639}},
Keywords = {{di(2-ethylhexyl)phthalate (DEHP); daily intake; biomonitoring}},
Keywords-Plus = {{DEUTERIUM-LABELED DEHP; IN-UTERO EXPOSURE; PHTHALATE-ESTERS;
   REPRODUCTIVE DEVELOPMENT; DEVELOPMENTAL TOXICITY; GENERAL-POPULATION;
   INTERNAL EXPOSURE; MALE-RAT; HEALTH; DI-(2-ETHYLHEXYL)PHTHALATE}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{marike.kolossa@uba.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   ANGERER J, 2002, BIOL MONITORING PROS.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   CARPENTER CP, 1953, AMA ARCH IND HYG OCC, V8, P219.
   Centers for Disease Control and Prevention, 2005, 3 NAT REP HUM EXP EN.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   EFSA, 2005, EFSA J, V243, P1.
   EFSA (European Food Safety Authority), 2005, EFSA J, V242, P1.
   European Chemicals Bureau European Chemicals Bureau (ECB), 2004, R0420402ENVHH46 ECB.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395.
   Gray Jr L. E., 2006, INT J ANDROL, V29, P105.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Greim H, 2002, GESUNDHEITSSCHADLICH, P35.
   Heudorf U, 2001, ENVIRON RES, V86, P80, DOI 10.1006/enrs.2001.4237.
   Hileman B, 2005, CHEM ENG NEWS, V83, P32, DOI 10.1021/cen-v083n038.p032.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kavlock R, 2006, REPROD TOXICOL, V22, P291, DOI 10.1016/j.reprotox.2006.04.007.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   KOCH HM, 2006, J EXPO SCI ENV EPIDE.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   LORZ PM, 2002, ULLMANNS ENCY IND CH, DOI DOI 10.1002/14356007.A20181.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   REGNIER J, 2004, TOXICOLOGIST CD OFFI, V78, P187.
   Remer T, 2002, AM J CLIN NUTR, V75, P561.
   Grandjean P, 2006, INT J ANDROL, V29, P181, DOI 10.1111/j.1365-2605.2005.00679.x.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Scientific Committee for Toxicity Ecotoxicity and the Environment (CSTEE), 1998, OP PHTHAL MIGR SOFT.
   Sharpe RM, 2005, ENVIRON HEALTH PERSP, V113, pA504.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Stroheker T, 2006, FOOD CHEM TOXICOL, V44, P2064, DOI 10.1016/j.fct.2006.07.007.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   WOLFE GW, 2003, TRC STUDY.
   {*}CHIB GEIG AG, 1977, WISS TAB GEIG TEILB.
   {*}US EPA, 1991, 117817 US EPA CASRN.
   {*}US FDA, 2001, SAF ASS DI 2 ETH PHT.}},
Number-of-Cited-References = {{57}},
Times-Cited = {{31}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{141QA}},
Wos-Id = {{ISI:000244592600004}},
}

@article{ ISI:000243772800009,
Author = {Mose, Tina and Mortensen, Gerda K. and Hedegaard, Morten and Knudsen,
   Lisbeth E.},
Title = {{Phthalate monoesters in perfusate from a dual placenta perfusion system,
   the placenta tissue and umbilical cord blood}},
Journal = {{REPRODUCTIVE TOXICOLOGY}},
Year = {{2007}},
Volume = {{23}},
Number = {{1}},
Pages = {{83-91}},
Month = {{JAN}},
Abstract = {{Fetal exposure to phthalates may be associated with adverse reproductive
   effects, including cryptorchidism and decreased semen quality.
   Information about human placental transfer is needed to qualify the
   hypotheses. A dual recirculating placenta perfusion system to monitor
   concentrations of eight phthalate monoesters in fetal and maternal
   perfusates was established. In addition to perfusate background measures
   of phthalate monoesters, the concentrations in umbilical cord plasma and
   placenta tissue were measured. Monomethyl phthalate (mMP), monoethyl
   phthalate (mEP), monobutyl phthalate (mBP), and mono (2-ethyl-hexyl)
   phthalate (mEHP) were detected in both maternal and fetal perfusate,
   demonstrating a release of compounds from tissue or blood to perfusates.
   The distribution of compounds between perfusate, umbilical cord plasma,
   and tissue was in accordance with the physical-chemical properties of
   the compounds. Results from the present study of compounds residing in
   the tissue are essential before studying human transplacental transfer,
   storage, and metabolism of selected phthalate monoesters. (c) 2006
   Elsevier Inc. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mose, T (Reprint Author), Oester Farimagsgade 5A, DK-1014 Copenhagen K, Denmark.
   Univ Copenhagen, Dept Environm \& Occupat Hlth, Inst Publ Hlth, Copenhagen, Denmark.
   Copenhagen Univ Hosp, Dept Growth \& Reprod, Copenhagen, Denmark.
   Copenhagen Univ Hosp, Clin Obstet, Copenhagen, Denmark.}},
DOI = {{10.1016/j.reprotox.2006.08.006}},
ISSN = {{0890-6238}},
Keywords = {{placenta perfusion; phthalate monoesters; plasticizers; pregnancy; fetal
   exposure}},
Keywords-Plus = {{N-BUTYL PHTHALATE; TANDEM MASS-SPECTROMETRY; PREGNANT RATS;
   DI(2-ETHYLHEXYL) PHTHALATE; TESTICULAR DYSGENESIS; ANOGENITAL DISTANCE;
   AMNIOTIC-FLUID; EXPOSURE; METABOLITES; PHARMACOKINETICS}},
Research-Areas = {{Reproductive Biology; Toxicology}},
Web-of-Science-Categories  = {{Reproductive Biology; Toxicology}},
Author-Email = {{t.d.mikkelsen@pubhealth.ku.dk}},
Cited-References = {{ADIBI JJ, 2003, POLAND ENV HLTH PERS, V111, P1719.
   Anderson WAC, 2002, ANALYST, V127, P1193, DOI 10.1039/b200487a.
   BARR DB, 2003, ENV HLTH PERSPECT, V11, P1148.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Borch J, 2005, REPROD TOXICOL, V19, P517, DOI 10.1016/j.reprotox.2004.11.004.
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Ema M, 2003, REPROD TOXICOL, V17, P407, DOI 10.1016/S0890-6238(03)00037-6.
   Ema M, 2001, REPROD TOXICOL, V15, P261, DOI 10.1016/S0890-6238(01)00131-9.
   Fennell TR, 2004, TOXICOL SCI, V82, P407, DOI 10.1093/toxsci/kfh294.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   KIHLSTROM L, 1983, ACTA PHARMACOL TOX, V53, P23.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P3, DOI 10.2307/3429377.
   Kremer JJ, 2005, TOXICOL LETT, V159, P144, DOI 10.1016/j.toxlet.2005.05.006.
   LASHLEY S, 2004, AM J OBSTET GYNECO S, V191, P141.
   Latini G, 2003, BIOL NEONATE, V83, P22, DOI 10.1159/000067012.
   Lottrup G, 2006, INT J ANDROL, V29, P172, DOI 10.1111/j.1365-2605.2005.00642.x.
   Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   Mose T., 2006, ALTEX-ALTERN TIEREXP, V23, P358.
   MULLER K, 2003, HUMAN EXPOSURE SELEC.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Myllynen PK, 2003, EUR J CLIN PHARMACOL, V58, P677, DOI 10.1007/s00228-002-0544-4.
   POOLE CF, 1977, J CHROMATOGR, V132, P511, DOI 10.1016/S0021-9673(00)82915-5.
   PREUSS R, 2004, J CHROMATOGR B, V816, P269.
   Saillenfait AM, 1998, TOXICOL SCI, V45, P212, DOI 10.1093/toxsci/45.2.212.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   TOMITA I, 1986, ENVIRON HEALTH PERSP, V65, P249, DOI 10.2307/3430190.
   {*}NAT CTR ENV HLTH, 2005, 3 NAT REP HUM EXP EN, V3, P1.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{27}},
Journal-ISO = {{Reprod. Toxicol.}},
Doc-Delivery-Number = {{130BA}},
Wos-Id = {{ISI:000243772800009}},
}

@article{ ISI:000242456100014,
Author = {Stroheker, Thomas and Regnier, Jean-Francois and Lassurguere, Julie and
   Chagnon, Marie-Christine},
Title = {{Effect of in utero exposure to di-(2-ethylhexyl)phthalate: Distribution
   in the rat fetus and testosterone production by rat fetal testis in
   culture}},
Journal = {{FOOD AND CHEMICAL TOXICOLOGY}},
Year = {{2006}},
Volume = {{44}},
Number = {{12}},
Pages = {{2064-2069}},
Month = {{DEC}},
Abstract = {{DEHP is known to cause reproductive toxicity in rats, particularly
   during the neonatal period. Pregnant and brood rats were treated by
   gavage with 750 mg/kg b.w./day DEHP starting on GD14 within PND4. Two
   hours after C-14-DEHP administration on GD15, GD18, GD21 and PND4, the
   radioactivity content was measured in the dams blood and in the liver,
   gonads and carcass of the offspring. The radioactivity concentration
   recovered in the fetuses was one or two order of magnitude lower than
   the concentration found in the dam plasma. A low proportion of
   radioactivity was present in fetal gonads, ca. 2\%, 5\% and 3.6\% on
   GD18, GD21 and PND4, respectively. The effect on testosterone production
   of DEHP and its metabolites (MEHP, metabolites VI and IX) was assessed
   in fetal testis cultures using a dose-range which included the maximal
   exposure observed in vivo. None of the compounds affected testosterone
   production. Thus, DEHP and/or its metabolites appear to cross the
   placental barrier, reach the fetal gonads. In vitro, neither DEHP nor
   its main metabolites decreased the testosterone production. (c) 2006
   Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chagnon, MC (Reprint Author), ENSBANA, UMR 1234 Toxicol Alimentaire, 1 Esplanade Erasme, F-21000 Dijon, France.
   ENSBANA, UMR 1234 Toxicol Alimentaire, F-21000 Dijon, France.
   Univ Rennes 1, GERHM, INSERM, U625, F-35042 Rennes, France.}},
DOI = {{10.1016/j.fct.2006.07.007}},
ISSN = {{0278-6915}},
Keywords = {{DEHP; fetus; testis; placental transfer; testosterone production}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL PHTHALATE;
   SEXUAL-DIFFERENTIATION; MONO-(2-ETHYLHEXYL) PHTHALATE; DI(N-BUTYL)
   PHTHALATE; LACTATIONAL EXPOSURE; CELL-PROLIFERATION; REPRODUCTIVE-TRACT;
   NEONATAL-RATS; METABOLISM}},
Research-Areas = {{Food Science \& Technology; Toxicology}},
Web-of-Science-Categories  = {{Food Science \& Technology; Toxicology}},
Author-Email = {{mcchagn@u-bourgogne.fr}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   ALBRO PW, 1983, BIOCHIM BIOPHYS ACTA, V760, P283, DOI 10.1016/0304-4165(83)90175-7.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   ASTILL BD, 1989, DRUG METAB REV, V21, P35, DOI 10.3109/03602538909029954.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   CARLSEN E, 1992, BRIT MED J, V305, P609.
   DEAN ME, 1975, DRUG METAB DISPOS, V3, P325.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GUENTHNER TM, 1977, BIOCHEM PHARMACOL, V26, P577, DOI 10.1016/0006-2952(77)90027-2.
   JONES HB, 1993, EXP MOL PATHOL, V58, P179, DOI 10.1006/exmp.1993.1016.
   Kang KS, 2002, J TOXICOL ENV HEAL A, V65, P447, DOI 10.1080/15287390252808109.
   Karle VA, 1997, CRIT CARE MED, V25, P696, DOI 10.1097/00003246-199704000-00023.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Lassurguere J, 2003, TOXICOL SCI, V73, P160, DOI 10.1093/toxsci/kfg065.
   LHUGUENOT JC, 1985, TOXICOL APPL PHARM, V80, P11, DOI 10.1016/0041-008X(85)90096-1.
   Li H, 2003, BIOL REPROD, V69, P1964, DOI 10.1095/biolreprod.103.018895.
   Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972.
   LINDGREN A, 1982, TOXICOLOGY, V23, P149, DOI 10.1016/0300-483X(82)90094-4.
   McKee RH, 2004, REPROD TOXICOL, V18, P1, DOI 10.1016/j.reprotox.2003.09.002.
   MITCHELL AM, 1985, TOXICOL APPL PHARM, V80, P23, DOI 10.1016/0041-008X(85)90097-3.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   NAKAJIMA T, 1992, J PHARMACOL EXP THER, V261, P869.
   NEALE MG, 1973, BIOCHEM PHARMACOL, V22, P1451, DOI 10.1016/0006-2952(73)90323-7.
   PARKHIE MR, 1982, ENVIRON HEALTH PERSP, V45, P89, DOI 10.2307/3429389.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Picard K, 2001, TOXICOL APPL PHARM, V172, P108, DOI 10.1006/taap.2001.9141.
   POOLE CF, 1977, J CHROMATOGR, V132, P511, DOI 10.1016/S0021-9673(00)82915-5.
   SCHILLING K, 1999, DI 2 ETHYLHEXYL PHTH.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SHAKKEBAEK NE, 2001, HUMAN REPROD, V16, P972.
   Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228, DOI 10.1289/ehp.971051228.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   WOLFE GW, 2003, TOXICOLOGIST, V66, P234.
   Zacharewski TR, 1998, TOXICOL SCI, V46, P282, DOI 10.1093/toxsci/46.2.282.
   {*}NCI, 2002, SEER.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{10}},
Journal-ISO = {{Food Chem. Toxicol.}},
Doc-Delivery-Number = {{111ML}},
Wos-Id = {{ISI:000242456100014}},
}

@article{ ISI:000242135900010,
Author = {Andrade, Anderson J. M. and Grande, Simone W. and Talsness, Chris E. and
   Gericke, Christine and Grote, Konstanze and Golombiewski, Andrea and
   Sterner-Kock, Anja and Chahoud, Ibrahim},
Title = {{A dose response study following in utero and lactational exposure to
   di-(2-ethylhexyl) phthalate (DEHP): Reproductive effects on adult male
   offspring rats}},
Journal = {{TOXICOLOGY}},
Year = {{2006}},
Volume = {{228}},
Number = {{1}},
Pages = {{85-97}},
Month = {{NOV 10}},
Abstract = {{The reproductive effects of in utero and lactational exposure to
   di-(2-ethylhexyl) phthalate (DEHP) in adult male offspring rats were
   investigated. The selected endpoints included reproductive organ
   weights, testicular function, hormonal status, sexual behaviour and
   fertility. Two wide ranges of doses, low and high, were tested. Female
   Wistar rats were treated daily with DEHP and peanut oil (vehicle
   control) by gavage from gestation day 6 to lactation day 21. The
   low-doses were 0.015, 0.045, 0.135, 0.405 and 1.215 mg DEHP/kg body
   weight (bw)/day, and the high-doses were 5, 15, 45, 135 and 405 mg
   DEHP/kg bw/day. A reduction in daily sperm production of 19-25\% in
   relation to control was observed in animals exposed to 15, 45, 135 and
   405 mg/kg/day. Quantitation of specific cell types shows that the
   observed effects in daily sperm production are not related to changes in
   the number of Sertoli cells or their capability to support early stages
   spermatocytes. A low incidence of cryptorchidism was observed in DEHP
   exposed groups with a lowest observed adverse effect level of 5
   mg/kg/day. Serum testosterone concentration was similar to control at
   most doses but was significantly increased at 0.045, 0.405 and 405 mg
   DEHP/kg/day. In spite of this effect, the weight of seminal vesicle with
   coagulating glands was significantly reduced at 405 mg/kg/day. Testis,
   epididymis and prostate weights were similar among groups. Fertility and
   sexual behaviour were not affected by DEHP treatment at any dose.
   Overall, our results show that in utero and lactational DEHP exposure
   reduces daily sperm production and has the potential to induce
   reproductive tract abnormalities (of which cryptorchidism seems to be
   the most sensitive in our rat strain) in male offspring rats. The lowest
   observed adverse effect levels (LOAELs) for these effects were 15 and 5
   mg/kg/day, respectively. Therefore, the no observed adverse effect level
   (NOAEL) for this study can be set at 1.215 mg/kg/day. (c) 2006 Elsevier
   Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chahoud, I (Reprint Author), Charite Univ Med Berlin, Sch Med, Inst Clin Pharmacol \& Toxicol, Dept Toxicol, Campus Benjamin Franklin,Garystr 5, D-14195 Berlin, Germany.
   Charite Univ Med Berlin, Sch Med, Inst Clin Pharmacol \& Toxicol, Dept Toxicol, D-14195 Berlin, Germany.
   Free Univ Berlin, Dept Vet Pathol, D-1000 Berlin, Germany.}},
DOI = {{10.1016/j.tox.2006.08.020}},
ISSN = {{0300-483X}},
Keywords = {{di-(2-ethylhexyl) phthalate (DEHP); male offspring rats; dose response;
   development; reproductive effects; endocrine disruptors}},
Keywords-Plus = {{TESTICULAR DYSGENESIS SYNDROME; DI(2-ETHYLHEXYL) PHTHALATE; DI(N-BUTYL)
   PHTHALATE; SEXUAL-BEHAVIOR; SEMEN QUALITY; TESTIS; POPULATION; HEALTH;
   CRYPTORCHIDISM; DISRUPTION}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{ibrahim.chahoud@charite.de}},
Cited-References = {{Abercrombie M., 1946, ANAT REC, V49, P238.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   AMANN RP, 1986, FUND APPL TOXICOL, V7, P244, DOI 10.1016/0272-0590(86)90154-5.
   Andrade AJM, 2006, TOXICOLOGY, V225, P64, DOI 10.1016/j.tox.2006.05.007.
   Andrade AJM, 2006, TOXICOLOGY, V227, P185, DOI 10.1016/j.tox.2006.07.022.
   Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335.
   Bonde JPE, 1998, LANCET, V352, P1172, DOI 10.1016/S0140-6736(97)10514-1.
   Chahoud I, 1998, REPROD TOXICOL, V12, P667, DOI 10.1016/S0890-6238(98)00051-3.
   Cruz-Orive L.M., 1990, AM J PHYSIOL, V258, P148.
   Dalsenter PR, 2006, HUM EXP TOXICOL, V25, P297, DOI 10.1191/0960327105ht624oa.
   EFSA, 2005, EFSA J, V243, P1.
   EPA US Environmental Protection Agency, 1996, EPA630R96009.
   Faqi AS, 1997, HUM EXP TOXICOL, V16, P505.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x.
   Grande SW, 2006, TOXICOL SCI, V91, P247, DOI 10.1093/toxsci/kfj128.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005.
   HOCHEREAUDEREVIERS MT, 1978, J REPROD FERTIL, V54, P209.
   Hutson JM, 1997, ENDOCR REV, V18, P259, DOI 10.1210/er.18.2.259.
   Irvine S, 1996, BRIT MED J, V312, P467.
   Jarfelt K, 2005, REPROD TOXICOL, V19, P505, DOI 10.1016/j.reprotox.2004.11.005.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Koch HM, 2006, INT J ANDROL, V29, P155, DOI 10.1111/j.1365-2605.2005.00607.x.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Lephart ED, 1996, BRAIN RES REV, V22, P1.
   MESITRICH ML, 1982, J ANDROL, V3, P58.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Neves ES, 2002, BIOL REPROD, V67, P247, DOI 10.1095/biolreprod67.1.247.
   Paulozzi LJ, 1999, ENVIRON HEALTH PERSP, V107, P297, DOI 10.2307/3434597.
   ROBB GW, 1978, J REPROD FERTIL, V54, P103.
   Russell LD, 1990, HISTOLOGICAL HISTOPA.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Shirota Mariko, 2005, Journal of Toxicological Sciences, V30, P175, DOI 10.2131/jts.30.175.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Slama R, 2002, HUM REPROD, V17, P503, DOI 10.1093/humrep/17.2.503.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   WORKING PK, 1988, ENVIRON HEALTH PERSP, V77, P37, DOI 10.2307/3430627.
   Zenic H, 1989, PRINCIPLES METHODS T, P275.
   ZENICK H, 1988, PHYSL TOXICOLOGY MAL, P179.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{36}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{106XS}},
Wos-Id = {{ISI:000242135900010}},
}

@article{ ISI:000241822300022,
Author = {Pan, Guowei and Hanaoka, Tomoyuki and Yoshimura, Mariko and Zhang,
   Shujuan and Wang, Ping and Tsukino, Hiromasa and Inoue, Koichi and
   Nakazawa, Hiroyuki and Tsugane, Shoichiro and Takahashi, Ken},
Title = {{Decreased serum free testosterone in workers exposed to high levels of
   di-n-butyl phthalate (DBP) and di-2-ethylhexyl phthalate (DEHP): A
   cross-sectional study in China}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2006}},
Volume = {{114}},
Number = {{11}},
Pages = {{1643-1648}},
Month = {{NOV}},
Abstract = {{BACKGROUND: Observations of adverse developmental and reproductive
   effects in laboratory animals and wildlife have fueled increasing public
   concern regarding the potential for various chemicals to impair human
   fertility.
   OBJECTIVE: Our objective in this study was to assess the effect of
   occupational exposure to high levels of phthallate esters on the balance
   of gonadotropin and gonadal hormones including luteinizing hormone,
   follicle-stimulating hormone, free testosterone (fT), and estradiol.
   METHODS: We examined urine and blood samples of 74 male workers at a
   factory producing unfoamed polyvinyl chloride flooring exposed to
   di-n-butyl phthalate (DBP) and di-2-ethythexyl phthalate (DEHP) and
   compared them with samples from 63 male workers from a construction
   company, group matched for age and smoking status.
   RESULTS: Compared to the unexposed workers, the exposed workers had
   substantially and significantly elevated concentrations of mono-n-butyl
   phthalate (MBP; 644.3 vs. 129.6 mu g/g creatinine, p < 0.001) and
   mono-2-ethylhexyl phthalate (MEHP; 565.7 vs. 5.7 mu g/g creatinine, p <
   0.001). fT was significantly lower (8.4 vs. 9.7 mu g/g creatinine, p =
   0.019) in exposed workers than in unexposed workers. fT was negatively
   correlated to MBP (r = -0.25, p = 0.03) and MEHP (r = -0.19, p = 0.095)
   in the exposed worker group. Regression analyses revealed that fT
   decreases significantly with increasing total phthalate ester score (the
   sum of quartiles of MBP and MEHP; r = -0.26, p = 0.002).
   CONCLUSION: We observed a modest and significant reduction of serum fT
   in workers with higher levels of urinary MBP and MEHP compared with
   unexposed workers.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Takahashi, K (Reprint Author), Univ Occupat \& Environm Hlth, Dept Environm Epidemiol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.
   Univ Occupat \& Environm Hlth, Dept Environm Epidemiol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan.
   Liaoning Prov Ctr Dis Prevent \& Control, Dept Environm Epidemiol, Shenyang, Peoples R China.
   Natl Canc Ctr, Epidemiol \& Prevent Div, Res Ctr Canc Prevent \& Screening, Tokyo 104, Japan.
   Showa Univ, Sch Med, Dept Hyg \& Prevent Med, Tokyo 142, Japan.
   Shenyang Municipal Ctr Dis Prevent \& Control, Dept Infect Dis, Shenyang, Peoples R China.
   Hoshi Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Tokyo 142, Japan.}},
DOI = {{10.1289/ehp.9016}},
ISSN = {{0091-6765}},
Keywords = {{di-n-butyl phthalate (DBP); di-2-ethylhexyl phthalate (DEHP); free
   testosterone (fT); mono-n-butyl phthalate (MBP); mono-2-ethylhexyl
   phthalate (MEHP); occupational exposure}},
Keywords-Plus = {{ENDOCRINE-DISRUPTING CHEMICALS; REPRODUCTIVE HORMONES; DI(N-BUTYL)
   PHTHALATE; TESTICULAR DYSGENESIS; GENERAL-POPULATION; HUMAN URINE;
   METABOLITES; RATS; MEN; INFANTS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{ktaka@med.uoeh-u.ac.jp}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890.
   Cooper RL, 1997, J ENDOCRINOL, V152, P159, DOI 10.1677/joe.0.1520159.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Emanuele MA, 1998, ALCOHOL HEALTH RES W, V22, P195.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hoppin JA, 2003, EPIDEMIOLOGY, V14, P259, DOI 10.1097/00001648-200305000-00002.
   HU XY, 2003, CHINESE J HLTH LAB T, V13, P9.
   JONES HB, 1993, EXP MOL PATHOL, V58, P179, DOI 10.1006/exmp.1993.1016.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kavlock RJ, 1999, CHEMOSPHERE, V39, P1227, DOI 10.1016/S0045-6535(99)00190-3.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Kumar S, 2004, J OCCUP HEALTH, V46, P1, DOI 10.1539/joh.46.1.
   Liao EY, 2001, ENDOCRINOLOGY, P619.
   MA R, 2004, ZHUANGHUE LAO NIAN Y, V23, P549.
   Mahood IK, 2005, ENDOCRINOLOGY, V146, P613, DOI 10.1210/en.2004-0671.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Mantovani A, 1999, CHEMOSPHERE, V39, P1293, DOI 10.1016/S0045-6535(99)00197-6.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   PARK YK, 2000, MENSAGEM DOCE, V58, P2.
   Plant TM, 2001, ENDOCR REV, V22, P764, DOI 10.1210/er.22.6.764.
   Rais-Bahrami K, 2004, ENVIRON HEALTH PERSP, V112, P1339, DOI 10.1289/ehp.6901.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Takahashi Ken, 2004, Journal of UOEH, V26, P23.
   Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709.
   WANG B, 2005, ZHONGHUA YU FANG YI, V39, P179.
   World Medical Association, 2004, DECL HELS ETH PRINC.
   YIN XH, 1998, ZHONGHUA YU FANG YI, V32, P42.
   ZHNAG YH, 2003, ZHONGHUA YU FANG YI, V37, P429.
   {*}COMM TOX EC ENV, 1998, OP PHTHAL MIGR SOFT.
   {*}WHO, 1992, DIETH PHTHAL ENV HLT.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{91}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{102OS}},
Wos-Id = {{ISI:000241822300022}},
}

@article{ ISI:000241822300043,
Author = {Calafat, Antonia M. and McKee, Richard H.},
Title = {{Integrating biomonitoring exposure data into the risk assessment
   process: Phthalates {[}diethyl phthalate and di(2-ethylhexyl) phthalate]
   as a case study}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2006}},
Volume = {{114}},
Number = {{11}},
Pages = {{1783-1789}},
Month = {{NOV}},
Abstract = {{The probability of nonoccupational exposure to phthalates is high given
   their use in a vast range of consurnables, including personal care
   products (e.g., perfumes, lotions, cosmetics), paints, industrial
   plastics, and certain medical devices and pharmaceuticals. Phthalates
   are of high interest because of their potential for human exposure and
   because animal toxicity studies suggest that some phthalates affect male
   reproductive development apparently via inhibition of androgen
   biosynthesis. In humans, phthalates are rapidly metabolized to their
   monoesters, which can be further transformed to oxidative products,
   conjugated, and eliminated. Phthalate metabolites have been used as
   biomarkers of exposure. Using urinary phthalate metabolite
   concentrations allows accurate assessments of human exposure because
   these concentrations represent an integrative measure of exposure to
   phthalates from multiple sources and routes. However, the health
   significance of this exposure is unknown. To link biomarker measurements
   to exposure, internal dose, or health outcome, additional information
   (e.g., toxicolkinetics, inter- and intraindividual differences) is
   needed. We present a case study using diethyl phthalate and
   di(2-ethylhexyl) plithalate as examples to illustrate scientific
   approaches and their limitations, identify data gaps, and outline
   research needs for using biomonitoring data in the context of human
   health risk assessment, with an emphasis on exposure and dose. Although
   the vast and growing literature on phthalates research could not be
   covered comprehensively in this article, we made every attempt to
   include the most relevant publications as of the end of 2005.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, 4770 Buford Highway,Mailstop F17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.
   Amer Chem Council, Toxicol Res Task Grp, Arlington, VA USA.}},
DOI = {{10.1289/ehp.9059}},
ISSN = {{0091-6765}},
Keywords = {{biomarkers; biomonitoring; DEHP; DEP; exposure; human; phthalate; urine}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; MALE REPRODUCTIVE-TRACT; SOLID-PHASE
   EXTRACTION; PROLIFERATOR-ACTIVATED RECEPTORS; DEUTERIUM-LABELED DEHP;
   N-BUTYL PHTHALATE; IN-UTERO EXPOSURE; HUMAN URINE; QUANTITATIVE
   DETECTION; DI(N-BUTYL) PHTHALATE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{acalafat@cdc.gov}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Awal MA, 2004, INT J TOXICOL, V23, P349, DOI 10.1080/10915810490901985.
   Barber ED, 2000, J APPL TOXICOL, V20, P69, DOI 10.1002/(SICI)1099-1263(200001/02)20:1<69::AID-JAT630>3.0.CO;2-2.
   Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335.
   Barlow NJ, 2004, TOXICOL PATHOL, V32, P79, DOI 10.1080/01926230490265894.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Bosgra S, 2005, REGUL TOXICOL PHARM, V43, P104, DOI 10.1016/j.yrtph.2005.06.008.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Calafat AM, 2004, PEDIATRICS, V113, P429.
   Carruthers CM, 2005, BIRTH DEFECTS RES B, V74, P277, DOI 10.1002/bdrb.20050.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   Corton JC, 2005, TOXICOL SCI, V83, P4, DOI 10.1093/toxsci/kfi011.
   David RM, 2001, PATTYS TOXICOLOGY, V6, P635.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Ema M, 2003, REPROD TOXICOL, V17, P407, DOI 10.1016/S0890-6238(03)00037-6.
   Ema M, 2001, REPROD TOXICOL, V15, P261, DOI 10.1016/S0890-6238(01)00131-9.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   FOSTER PMD, 2000, FOOD CHEM TOXICOL, V38, P97.
   Foster PMD, 2005, CRIT REV TOXICOL, V35, P713, DOI 10.1080/10408440591007395.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1984, FOOD CHEM TOXICOL, V22, P123, DOI 10.1016/0278-6915(84)90092-9.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P116, DOI 10.1016/0041-008X(92)90374-2.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   Jacobs D.S., 2001, LAB TEST HDB.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kato K, 2003, J CHROMATOGR B, V788, P407, DOI 10.1016/S1570-0232(03)00041-2.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kato K, 2003, J LIQ CHROMATOGR R T, V26, P2167, DOI 10.1081/JLC-120022401.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kessler W, 2001, ARCH TOXICOL, V75, P62, DOI 10.1007/s002040000198.
   Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/10408440390250154.
   Koch H, 2005, UMWELTMED FORSCH PRA, V10, P144.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2005, INT J HYG ENVIR HEAL, V208, P489, DOI 10.1016/j.ijheh.2005.07.001.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch H.M., 2003, INT J HYG ENVIR HEAL, V206, P1.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, ARCH TOXICOL, V79, P689, DOI 10.1007/s00204-005-0004-x.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Li H, 2003, BIOL REPROD, V69, P1964, DOI 10.1095/biolreprod.103.018895.
   Medeiros AM, 1999, CONTACT DERMATITIS, V41, P287, DOI 10.1111/j.1600-0536.1999.tb06163.x.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   Mortensen GK, 2005, ANAL BIOANAL CHEM, V382, P1084, DOI 10.1007/s00216-005-3218-0.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Saillenfait AM, 2001, PHARMACOL TOXICOL, V89, P104, DOI 10.1034/j.1600-0773.2001.d01-143.x.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2005, ARCH TOXICOL, V79, P647, DOI 10.1007/s00204-005-0674-4.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Silverman WK, 2005, CHILD ADOL PSYCH CL, V14, P819, DOI 10.1016/j.chc.2005.05.004.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Takatori S, 2004, J CHROMATOGR B, V804, P397, DOI 10.1016/j.jchromb.2004.01.056.
   Tietz NW, 1990, CLIN GUIDE LAB TESTS.
   Ward JM, 1998, TOXICOL PATHOL, V26, P240.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.
   {*}CERHR, 2005, NTP CERHR EXP PAN UP.
   {*}CSTEE, 1998, 6 CSTEE PLEN M 26 27.
   {*}IARC, 2000, IARC MON EV CARC RIS, V77, P41.
   {*}US EPA, 2002, BIS 2 ETH PHTH DEHP.
   {*}US EPA, 1993, 84662 US EPA CASRN.
   {*}US EPA, 1993, 117817 US EPA CASRN.
   {*}US FDA, 2001, SAF ASS DI 2 ETH PHT.}},
Number-of-Cited-References = {{97}},
Times-Cited = {{50}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{102OS}},
Wos-Id = {{ISI:000241822300043}},
}

@article{ ISI:000241405800014,
Author = {Hauser, Russ and Meeker, John D. and Duty, Susan and Silva, Manori J.
   and Calafat, Antonia M.},
Title = {{Altered semen quality in relation to urinary concentrations of phthalate
   monoester and oxidative metabolites}},
Journal = {{EPIDEMIOLOGY}},
Year = {{2006}},
Volume = {{17}},
Number = {{6}},
Pages = {{682-691}},
Month = {{NOV}},
Abstract = {{Background: Phthalates are multifunctional chemicals used in a variety
   of consumer, medical, and personal care products. Previously, we
   reported dose-response associations of decreased semen quality with
   urinary concentrations of monobutyl phthalate (MBP) and monobenzyl
   (MBzP) phthalate, which are metabolites of dibutyl phthalate and
   butylbenzyl phthalate, respectively. The present study extends our work
   in a larger sample of men and includes measurements of di(2-ethylhexyl)
   phthalate (DEHP) oxidative metabolites.
   Methods: Between January 2000 and May 2004, we recruited 463 male
   partners of subfertile couples who presented for semen analysis to the
   Massachusetts General Hospital. Semen parameters were dichotomized based
   on World Health Organization reference values for sperm concentration
   (<20 million/mL) and motility (<50\% motile) and the Tygerberg Kruger
   Strict criteria for morphology (<4\% normal). The comparison group was
   men with all 3 semen parameters above the reference values. In a single
   spot urine sample from each man, phthalate metabolites were measured
   using solid- phase extraction coupled to high-performance liquid
   chromatography isotope-dilution tandem mass spectrometry.
   Results: There were dose-response relationships of MBP with low sperm
   concentration (odds ratio per quartile adjusted for age, abstinence
   time, and smoking status = 1.00, 3.1, 2.5, 3.3; P for trend = 0.04) and
   motility (1.0, 1.5, 1.5, 1.8; P for trend = 0.04). There was suggestive
   evidence of an association between the highest MBzP quartile and low
   sperm concentration (1.00, 1.1, 1.1, 1.9; P for trend = 0.13). There
   were no relationships of monoethyl phthalate, monomethyl phthalate, and
   the DEHP metabolites with these semen parameters.
   Conclusion: The present study confirms previous results on the
   relationship of altered semen quality with exposure to MBP at general
   population levels. We did not find associations between semen parameters
   and 3 DEHP metabolites.}},
Publisher = {{LIPPINCOTT WILLIAMS \& WILKINS}},
Address = {{530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hauser, R (Reprint Author), Harvard Univ, Sch Publ Hlth, Occupat Hlth Program, Bldg 1,Room 1405,665 Huntington Ave, Boston, MA 02115 USA.
   Harvard Univ, Massachusetts Gen Hosp, Sch Publ Hlth, Boston, MA 02115 USA.
   Simmons Coll, Boston, MA 02115 USA.
   Ctr Dis Control \& Prevent, Atlanta, GA USA.}},
DOI = {{10.1097/01.ede.0000235996.89953.d7}},
ISSN = {{1044-3983}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; HUMAN EXPOSURE ASSESSMENT; DEUTERIUM-LABELED
   DEHP; DI(2-ETHYLHEXYL) PHTHALATE; TESTICULAR TOXICITY; DI-(2-ETHYLHEXYL)
   PHTHALATE; QUANTITATIVE DETECTION; NEONATAL-RATS; BIOMARKERS;
   DISPOSITION}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{rhauser@hohp.harvard.edu}},
Cited-References = {{AGARWAL DK, 1985, TOXICOLOGY, V35, P189, DOI 10.1016/0300-483X(85)90015-0.
   Agency for Toxic Substances and Disease Registry, 1995, TOX PROF DIETH PHTH.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Hauser R, 2005, ENVIRON HEALTH PERSP, V113, P425, DOI 10.1289/ehp.7305.
   HAUSER R, 2005, HUM REPROD, V20, P2679.
   Higuchi TT, 2003, TOXICOL SCI, V72, P301, DOI 10.1093/toxsci/kfg036.
   Hosmer D. W., 1989, APPL LOGISTIC REGRES.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kato K, 2005, J CHROMATOGR B, V814, P355, DOI 10.1016/j.jchromb.2004.10.056.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   KRUGER TF, 1988, FERTIL STERIL, V49, P112.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PARMAR D, 1986, TOXICOLOGY, V42, P47, DOI 10.1016/0300-483X(86)90091-0.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   SJOBERG P, 1986, ENVIRON HEALTH PERSP, V65, P237, DOI 10.2307/3430188.
   SRIVASTAVA SP, 1990, ARCH TOXICOL, V64, P148, DOI 10.1007/BF01974401.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   TEASS AW, 1998, NIOSH MANUAL ANAL ME.
   World Health Organization, 1999, WHO LAB MAN EX HUM S.
   {*}AG TOX SUBST DIS, 2002, TOX PROF DI 2 ETH PH.
   {*}AG TOX SUBST DIS, 2001, TOX PROF DI N BUT PH.
   {*}CDCP NAT CTR ENV, 2005, 3 CDCP NAT CTR ENV H.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{117}},
Journal-ISO = {{Epidemiology}},
Doc-Delivery-Number = {{096VV}},
Wos-Id = {{ISI:000241405800014}},
}

@article{ ISI:000240401700005,
Author = {Spjuth, L. and Saravia, F. and Johannisson, A. and Lundeheim, N. and
   Rodriguez-Martinez, H.},
Title = {{Effects of exposure of pre-pubertal boars to di(2-ethylhexyl) phthalate
   on their frozen-thawed sperm viability post-puberty}},
Journal = {{ANDROLOGIA}},
Year = {{2006}},
Volume = {{38}},
Number = {{5}},
Pages = {{186-194}},
Month = {{OCT}},
Abstract = {{Late effects of pre-pubertal oral exposure to di(2-ethylhexyl) phthalate
   (DEHP), a plastic softener used in, for example, polyvinyl
   chloride-products, on semen quality in young boars have not been
   clear-cut. The aim of this study was to determine whether stress imposed
   on spermatozoa would reveal such effects. Semen was collected from
   post-pubertal boars (8-9 months of age), which had been exposed to 300
   mg kg(-1) body weight of DEHP per os three times a week from 3 to 7
   weeks of age and from control siblings given placebo (water). The semen
   was cryopreserved and examined for plasma membrane integrity post-thaw
   using the short hypo-osmotic swelling test and flow cytometry (propidium
   iodide /SYBR-14). Sperm motility was assessed by computer-assisted sperm
   analysis. No significant difference in plasma membrane integrity could
   be found between the groups. The DEHP-exposed group had a significantly
   lower percentage of linearly motile spermatozoa at 30 min (P < 0.05) and
   120 min (P < 0.001) after thawing, and a larger amplitude of lateral
   displacement of the head 120 min after thawing (P < 0.05), compared with
   controls. In summary, spermatozoa from boars pre-pubertally exposed to
   low doses of DEHP, showed kinematic deviations post-thaw that could be
   related to DEHP exposure.}},
Publisher = {{WILEY-BLACKWELL PUBLISHING, INC}},
Address = {{COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Spjuth, L (Reprint Author), Swedish Univ Agr Sci, Dept Clin Sci, Div Comparat Reprod, Box 7054, S-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Clin Sci, Div Comparat Reprod, S-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Anat \& Physiol, S-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Anim Breeding \& Genet, S-75007 Uppsala, Sweden.
   Ctr Reprod Biol Uppsala, CRU, Uppsala, Sweden.}},
DOI = {{10.1111/j.1439-0272.2006.00737.x}},
ISSN = {{0303-4569}},
Keywords = {{boar; di(2-ethylhexyl) phthalate; frozen-thawed; sperm motility; sperm
   viability}},
Keywords-Plus = {{DI-2-ETHYLHEXYL PHTHALATE; TESTICULAR DEVELOPMENT; QUIESCENT PERIOD;
   SERTOLI-CELLS; NEONATAL-RATS; IN-VITRO; SEMEN; FERTILITY; DEHP; TOXICITY}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{linda.spjuth@kv.slu.se}},
ResearcherID-Numbers = {{Rodriguez-Martinez, Heriberto/G-2675-2012}},
ORCID-Numbers = {{Rodriguez-Martinez, Heriberto/0000-0002-5194-2124}},
Cited-References = {{AGARWAL DK, 1986, ENVIRON HEALTH PERSP, V65, P343, DOI 10.2307/3430202.
   Al-Qarawi AA, 2002, ANIM REPROD SCI, V74, P1, DOI 10.1016/S0378-4320(02)00163-X.
   BANE A, 1952, CORNELL VET, V42, P518.
   Biscardi D, 2003, SCI TOTAL ENVIRON, V302, P101, DOI 10.1016/S0048-9697(02)00349-2.
   Bornehag CG, 2005, ENVIRON HEALTH PERSP, V113, P1399, DOI 10.1289/ehp.7809.
   BWANGA CO, 1991, ACTA VET SCAND, V32, P431.
   CARLSEN E, 1992, BRIT MED J, V305, P609.
   Casajuana N, 2003, CHROMATOGRAPHIA, V57, P649, DOI 10.1007/BF02491744.
   Chemes HE, 2001, INT J ANDROL, V24, P2, DOI 10.1046/j.1365-2605.2001.00260.x.
   Comhaire F, 1995, INT J ANDROL, V18, P1.
   Dalgaard M, 2001, TOXICOL LETT, V122, P69, DOI 10.1016/S0378-4274(01)00348-4.
   Damgaard IN, 2002, BEST PRACT RES CL EN, V16, P289, DOI 10.1053/beem.2002.0205.
   DUTY SM, 2002, EPIDEMIOLOGY, V13, P197.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Eriksson BM, 2000, ANIM REPROD SCI, V63, P205, DOI 10.1016/S0378-4320(00)00171-8.
   Fromme H, 2002, WATER RES, V36, P1429, DOI 10.1016/S0043-1354(01)00367-0.
   Giwercman A, 1998, ENDOCRIN METAB CLIN, V27, P807, DOI 10.1016/S0889-8529(05)70042-6.
   Harrison PTC, 1997, SCI TOTAL ENVIRON, V205, P97, DOI 10.1016/S0048-9697(97)00212-X.
   Hirano Y, 2001, J ASSIST REPROD GEN, V18, P213.
   Holt WV, 2000, ANIM REPROD SCI, V62, P3, DOI 10.1016/S0378-4320(00)00152-4.
   Irvine S, 1996, BRIT MED J, V312, P467.
   JEYENDRAN RS, 1984, J REPROD FERTIL, V70, P219.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kessler W, 2004, TOXICOL APPL PHARM, V195, P142, DOI 10.1016/j.taap.2003.11.014.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972.
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381.
   Ljungvall K, 2004, ARCH TOXICOL, V78, P384, DOI 10.1007/s00204-004-0558-z.
   LJUNGVALL K, 2006, THESIS SWEDISH U AGR.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   ORTH JM, 1988, ENDOCRINOLOGY, V122, P787.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PARMAR D, 1986, TOXICOLOGY, V42, P47, DOI 10.1016/0300-483X(86)90091-0.
   Perez-Llano B, 2001, THERIOGENOLOGY, V56, P387, DOI 10.1016/S0093-691X(01)00571-4.
   Pugh G, 2000, TOXICOL SCI, V56, P181, DOI 10.1093/toxsci/56.1.181.
   Rettenmeier AW, 1997, NIEREN HOCHDRUCK, V26, pS2.
   Rey R, 1999, HISTOL HISTOPATHOL, V14, P991.
   REY RA, 1993, J CLIN ENDOCR METAB, V76, P1325, DOI 10.1210/jc.76.5.1325.
   RHODES C, 1986, ENVIRON HEALTH PERSP, V65, P299, DOI 10.2307/3430197.
   Rodriguez-Martinez H, 2001, ARCH TIERZUCHT, V44, P102.
   RODRIGUEZMARTIN.H, 2000, RECENT ADV VET MED I.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Spjuth L, 2006, INT J ANDROL, V29, P534, DOI 10.1111/j.1365-2605.2006.00693.x.
   Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055.
   Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228, DOI 10.1289/ehp.971051228.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P569, DOI 10.1080/02652030010028344.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474.
   Watson PF, 2000, ANIM REPROD SCI, V60, P481, DOI 10.1016/S0378-4320(00)00099-3.
   Zhang BR, 1999, INT J ANDROL, V22, P253, DOI 10.1046/j.1365-2605.1999.00178.x.
   Zhang BR, 1998, INT J ANDROL, V21, P207.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{2}},
Journal-ISO = {{Andrologia}},
Doc-Delivery-Number = {{082QK}},
Wos-Id = {{ISI:000240401700005}},
}

@article{ ISI:000240318600006,
Author = {Spjuth, Linda and Ljungvall, Karl and Saravia, Fernando and Lundeheim,
   Nils and Magnusson, Ulf and Hulten, Fredrik and Rodriguez-Martinez,
   Heriberto},
Title = {{Does exposure to di(2-ethylhexyl) phthalate in pre-pubertal boars affect
   semen quality post-puberty?}},
Journal = {{INTERNATIONAL JOURNAL OF ANDROLOGY}},
Year = {{2006}},
Volume = {{29}},
Number = {{5}},
Pages = {{534-542}},
Month = {{OCT}},
Abstract = {{Di(2-ethylhexyl) phthalate (DEHP), a plastic softener used in polyvinyl
   chloride (PVC) products, has been ascribed to have toxic effects on
   animal reproduction. The present study aimed at determining potential
   late effects of pre-pubertal oral exposure to DEHP on semen quality in
   young pigs. Ten pairs of cross-bred male siblings were used. One brother
   in each pair became, at random, the test animal while the other acted as
   control. Test males were exposed to 300 mg/kg body weight (bw) of DEHP
   administered orally three times a week from 3 to 7 weeks of age. The
   control group was given placebo (water). Semen analyses started when the
   boars reached 6 months of age, with semen collected twice weekly, until
   animals were 9 months of age. Semen was evaluated for ejaculate volume,
   sperm concentration, total sperm count, sperm motility, sperm morphology
   (including presence of cells other than spermatozoa) and sperm plasma
   membrane integrity. Total sperm motility tended to be lower while local
   motility was higher in the DEHP-exposed group compared with controls (p
   = 0.07) when assessed by computer-assisted sperm analysis. The
   DEHP-exposed group had a significantly (p < 0.05) lower percentage of
   spermatozoa with tailless, defective heads (at 7-8 months of age) and
   double-folded tails (at 6-7, 7-8 and 6-9 months of age), compared with
   controls (albeit always under 5\%). In summary, there were no obvious
   adverse effects of early oral exposure to 300 mg/kg bw of DEHP on sperm
   output and sperm quality in post-pubertal young boars.}},
Publisher = {{WILEY-BLACKWELL PUBLISHING, INC}},
Address = {{COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Spjuth, L (Reprint Author), Swedish Univ Agr Sci, Dept Clin Sci, Div Comparat Reprod Obset \& Udder Hlth, Box 7054, SE-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Clin Sci, Div Comparat Reprod Obset \& Udder Hlth, SE-75007 Uppsala, Sweden.
   CRU, Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Anim Breeding \& Genet, S-75007 Uppsala, Sweden.}},
DOI = {{10.1111/j.1365-2605.2006.00693.x}},
ISSN = {{0105-6263}},
Keywords = {{boar; di(2-ethylhexyl) phthalate; male reproduction; phthalates; semen
   quality}},
Keywords-Plus = {{DI-2-ETHYLHEXYL PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; TESTICULAR
   DEVELOPMENT; ENDOCRINE DISRUPTERS; CELL-PROLIFERATION;
   GENERAL-POPULATION; QUIESCENT PERIOD; SERTOLI-CELLS; NEONATAL-RATS; DEHP}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{linda.spjuth@kv.slu.se}},
ResearcherID-Numbers = {{Rodriguez-Martinez, Heriberto/G-2675-2012}},
ORCID-Numbers = {{Rodriguez-Martinez, Heriberto/0000-0002-5194-2124}},
Cited-References = {{AGARWAL DK, 1986, ENVIRON HEALTH PERSP, V65, P343, DOI 10.2307/3430202.
   BANE A, 1952, CORNELL VET, V42, P518.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Biscardi D, 2003, SCI TOTAL ENVIRON, V302, P101, DOI 10.1016/S0048-9697(02)00349-2.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Casajuana N, 2003, CHROMATOGRAPHIA, V57, P649, DOI 10.1007/BF02491744.
   Chemes HE, 2001, INT J ANDROL, V24, P2, DOI 10.1046/j.1365-2605.2001.00260.x.
   Comhaire F, 1995, INT J ANDROL, V18, P1.
   Dalgaard M, 2001, TOXICOL LETT, V122, P69, DOI 10.1016/S0378-4274(01)00348-4.
   Damgaard IN, 2002, BEST PRACT RES CL EN, V16, P289, DOI 10.1053/beem.2002.0205.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   Franca LR, 2000, BIOL REPROD, V63, P1629, DOI 10.1095/biolreprod63.6.1629.
   Franca LR, 2005, THERIOGENOLOGY, V63, P300, DOI 10.1016/j.theriogenology.2004.09.014.
   Fromme H, 2002, WATER RES, V36, P1429, DOI 10.1016/S0043-1354(01)00367-0.
   Giwercman A, 1998, ENDOCRIN METAB CLIN, V27, P807, DOI 10.1016/S0889-8529(05)70042-6.
   Hallap T, 2004, INT J ANDROL, V27, P166, DOI 10.1111/j.1365-2605.2004.00470.x.
   Harrison PTC, 1997, SCI TOTAL ENVIRON, V205, P97, DOI 10.1016/S0048-9697(97)00212-X.
   Hill SS, 2003, BIOMED CHROMATOGR, V17, P250, DOI 10.1002/bmc.231.
   IKEDA GJ, 1980, FOOD COSMET TOXICOL, V18, P637, DOI 10.1016/S0015-6264(80)80012-5.
   Irvine S, 1996, BRIT MED J, V312, P467.
   JEYENDRAN RS, 1984, J REPROD FERTIL, V70, P219.
   Kambia K, 2001, INT J PHARM, V229, P139, DOI 10.1016/S0378-5173(01)00840-7.
   Kessler W, 2004, TOXICOL APPL PHARM, V195, P142, DOI 10.1016/j.taap.2003.11.014.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   LI H, 2003, BIOL REPROD, V69, P1965.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972.
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381.
   Ljungvall K, 2006, REPROD TOXICOL, V21, P160, DOI 10.1016/j.reprotox.2005.07.012.
   LJUNGVALL K, 2006, THESIS.
   Ljungvall K, 2004, ARCH TOXICOL, V78, P384, DOI 10.1007/s00204-004-0558-z.
   Mettang T, 1996, PERITON DIALYSIS INT, V16, P58.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   ORTH JM, 1988, ENDOCRINOLOGY, V122, P787.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PARMAR D, 1986, TOXICOLOGY, V42, P47, DOI 10.1016/0300-483X(86)90091-0.
   Perez-Llano B, 2001, THERIOGENOLOGY, V56, P387, DOI 10.1016/S0093-691X(01)00571-4.
   Pugh G, 2000, TOXICOL SCI, V56, P181, DOI 10.1093/toxsci/56.1.181.
   Rettenmeier AW, 1997, NIEREN HOCHDRUCK, V26, pS2.
   Rey R, 1999, HISTOL HISTOPATHOL, V14, P991.
   REY RA, 1993, J CLIN ENDOCR METAB, V76, P1325, DOI 10.1210/jc.76.5.1325.
   RHODES C, 1986, ENVIRON HEALTH PERSP, V65, P299, DOI 10.2307/3430197.
   SHAKKEBAEK NE, 2001, HUMAN REPROD, V16, P972.
   Sharpe RM, 2003, PURE APPL CHEM, V75, P2023, DOI 10.1351/pac200375112023.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   SIMONSSON A, 1994, SLU INFO RAPPORTER, V75.
   Skakkebaek Niels E., 2003, Hormone Research (Basel), V60, P49, DOI 10.1159/000074499.
   Skakkebaek NE, 2002, HORM RES, V57, P43, DOI 10.1159/000058100.
   Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055.
   Swan SH, 1997, ENVIRON HEALTH PERSP, V105, P1228, DOI 10.1289/ehp.971051228.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P569, DOI 10.1080/02652030010028344.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474.
   WALLGREN M, 2000, 14 INT C AN REPR STO, V1, P102.
   Williams W, 1920, CORNELL VET, V10, P87.
   {*}FDA, 2001, SAF ASS DI 2 ETHYLH.}},
Number-of-Cited-References = {{59}},
Times-Cited = {{5}},
Journal-ISO = {{Int. J. Androl.}},
Doc-Delivery-Number = {{081LH}},
Wos-Id = {{ISI:000240318600006}},
}

@article{ ISI:000240495800049,
Author = {Kato, Kayoko and Silva, Manori J. and Needham, Larry L. and Calafat,
   Antonia M.},
Title = {{Quantifying phthalate metabolites in human meconium and semen using
   automated off-line solid-phase extraction coupled with on-line SPE and
   isotope-dilution high-performance liquid chromatography-tandem mass
   spectrometry}},
Journal = {{ANALYTICAL CHEMISTRY}},
Year = {{2006}},
Volume = {{78}},
Number = {{18}},
Pages = {{6651-6655}},
Month = {{SEP 15}},
Abstract = {{We developed an analytical method using off-line solid-phase extraction
   (SPE) coupled with on-line SPE and isotope-dilution high-performance
   liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) to determine
   the concentrations of phthalate metabolites in human meconium and in
   semen. First, we used off-line SPE to remove interfering proteins and
   other biomolecules from the samples. Then, we preconcentrated the
   phthalate metabolites in the extract using on-line SPE before measuring
   them by HPLC-MS/MS. For most of the analytes, the limits of detection
   ranged between 0.2 and 0.7 ng/g for meconium and between 0.3 and 0.7
   ng/mL for semen. The recovery after off-line SPE varied for most
   analytes between 65 and 99\% at concentrations ranging from 3.0 to 30.0
   ng/mL in semen and between 67 and 103\% at concentrations ranging from
   2.0 to 10.0 ng/mL in meconium. Precision measured by the relative
   standard deviation ranged from 3.2 to 19.1\% for intraday and from 3.9
   to 18.6\% for interday. We validated this novel approach-which is
   applicable to other biological matrixes, including serum and breast
   milk-on spiked samples and on five meconium samples and one pooled semen
   sample from people with no known occupational exposure to phthalates.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.}},
DOI = {{10.1021/ac0608220}},
ISSN = {{0003-2700}},
Keywords-Plus = {{DECREASED ANOGENITAL DISTANCE; BUTYL BENZYL PHTHALATE; MALE-RAT;
   DI(2-ETHYLHEXYL)PHTHALATE DEHP; SEXUAL-DIFFERENTIATION;
   QUANTITATIVE-ANALYSIS; MONOBENZYL PHTHALATE; UNDESCENDED TESTES;
   EXPOSURE; VALIDATION}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Author-Email = {{ACalafat@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   Bearer CF, 2005, J PEDIATR-US, V146, P824, DOI 10.1016/j.jpeds.2005.01.048.
   Bielawski D, 2005, CHROMATOGRAPHIA, V62, P623, DOI 10.1365/s10337-005-0668-7.
   Bornehag CG, 2004, ENVIRON HEALTH PERSP, V112, P1393, DOI 10.1289/ehp.7187.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Chan D, 2004, CLIN BIOCHEM, V37, P429, DOI 10.1016/j.clinbiochem.2004.01.01.
   Coles R, 2005, J ANAL TOXICOL, V29, P522.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Ema M, 2003, REPROD TOXICOL, V17, P407, DOI 10.1016/S0890-6238(03)00037-6.
   Ema M, 2003, TOXICOL SCI, V72, P274.
   Ema M, 2002, REPROD TOXICOL, V16, P71, DOI 10.1016/S0890-6238(01)00200-3.
   Gareri J, 2006, CLIN CHIM ACTA, V366, P101, DOI 10.1016/j.cca.2005.10.028.
   Gray LE, 2003, TOXICOL SCI, V72, P283.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2005, Occup Environ Med, V62, P806, DOI 10.1136/oem.2004.017590.
   Hauser R, 2005, ENVIRON HEALTH PERSP, V113, P425, DOI 10.1289/ehp.7305.
   Jonsson BAG, 2005, EPIDEMIOLOGY, V16, P487, DOI 10.1097/01.ede.0000164555.19041.01.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Klemmt L, 2005, BIRTH DEFECTS RES B, V74, P119, DOI 10.1002/bdrb.20031.
   Koch HM, 2005, INT J HYG ENVIR HEAL, V208, P489, DOI 10.1016/j.ijheh.2005.07.001.
   Koch H.M., 2003, INT J HYG ENVIR HEAL, V206, P1.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Le NL, 2005, J ANAL TOXICOL, V29, P54.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PICHINI S, 1994, CLIN PHARMACOKINET, V26, P356.
   Pichini S, 2005, FORENSIC SCI INT, V153, P59, DOI 10.1016/j.forsciint.2005.04.013.
   Pichini S, 2003, J CHROMATOGR B, V794, P281, DOI 10.1016/S1570-0232(03)00478-1.
   Pichini S, 2004, ANAL CHEM, V76, P2124, DOI 10.1021/ac035419x.
   Silva MJ, 2005, J ANAL TOXICOL, V29, P819.
   Silva MJ, 2005, ARCH TOXICOL, V79, P647, DOI 10.1007/s00204-005-0674-4.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   SJOBERG P, 1986, ENVIRON HEALTH PERSP, V65, P237, DOI 10.2307/3430188.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Taylor J. K., 1987, QUALITY ASSURANCE CH.
   Whyatt RM, 2001, ENVIRON HEALTH PERSP, V109, P417, DOI 10.2307/3454902.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 1997, TOX PROF DI N OCT PH.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{23}},
Journal-ISO = {{Anal. Chem.}},
Doc-Delivery-Number = {{083YO}},
Wos-Id = {{ISI:000240495800049}},
}

@article{ ISI:000240755700043,
Author = {Weuve, Jennifer and Sanchez, Brisa N. and Calafat, Antonia M. and
   Schettler, Ted and Green, Ronald A. and Hu, Howard and Hauser, Russ},
Title = {{Exposure to phthalates in neonatal intensive care unit infants: Urinary
   concentrations of monoesters and oxidative metabolites}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2006}},
Volume = {{114}},
Number = {{9}},
Pages = {{1424-1431}},
Month = {{SEP}},
Abstract = {{OBJECTIVE: We previously demonstrated that among 54 infants in neonatal
   intensive care units, exposure to polyvinyl chloride plastic medical
   devices containing the plasticizer di(2-ethylhexyl) phthalate (DEHP) is
   associated with urinary concentrations of mono(2-ethylhexyl) phthalate
   (MEHP), a DEHP metabolite. In this follow-up report, we studied the
   neonates' exposure to DEHP-containing devices in relation to urinary
   concentrations of two other DEHP metabolites, and to urinary
   concentrations of metabolites of dibutyl phthalate (DBP) and benzylbutyl
   phthalate (BzBP), phthalates found in construction materials and
   personal care products.
   MEASUREMENTS: A priori, we classified the intensiveness of these 54
   infants' exposure to DEHP-containing medical products. We measured three
   metabolites of DEHP in infants' urine: MEHP and two of its oxidative
   metabolites, mono (2-ethyl-5-hydroxylhexyl) phthalate (MEHHP) and
   mono(2-ethyl-5-oxohexyl) phthalate (MEOHP). We also measured monobutyl
   phthalate (MBP), a metabolite of DBP, and monobenzyl phthalate (MBzP), a
   metabolite of BzBP.
   RESULTS: Intensiveness of DEHP-containing product use was monotonically
   associated with all three DEHP metabolites. Urinary concentrations of
   MEHHP and MEOHP among infants in the high-DEHP-intensiveness group were
   13-14 times the concentrations among infants in the low-intensiveness
   group (p <= 0.007). Concentrations of MBP were somewhat higher in the
   medium and high-DEHP-intensiveness group; MBzP did not vary by product
   use group. Incorporating all phthalate data into a structural equation
   model confirmed the specific monotonic association between intensiveness
   of product use and biologic measures of DEHP.
   CONCLUSION: Inclusion of the oxidative metabolites MEHHP and MEOHP
   strengthened the association between intensiveness of product use and
   biologic indices of DEHP exposure over that observed with MEHP alone.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Weuve, J (Reprint Author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Landmark Ctr E 3,401 Pk Dr, Boston, MA 02215 USA.
   Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Landmark Ctr E 3,401 Pk Dr, Boston, MA 02215 USA.
   Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.
   Ctr Dis Control \& Prevent, Atlanta, GA USA.
   Sci \& Environm Hlth Network, Boston, MA USA.
   Harvard Univ, Sch Med, Brigham \& Womens Hosp, Channing Lab,Dept Med, Boston, MA USA.}},
DOI = {{10.1289/ehp.8926}},
ISSN = {{0091-6765}},
Keywords = {{di(2-ethylhexyl) phthalate (DEHP); infants; mono(2-ethylhexyl) phthalate
   (MEHP); mono(2-ethyl5-hydroxylhexyl) phthalate (MEHHP); mono
   (2-ethyl-5-oxohexyl) phthalate (MEOHP); monobenzyl phthalate (MBzP);
   monobutyl phthalate (MBP); neonatal intensive care unit (NICU);
   phthalate; structural equation model}},
Keywords-Plus = {{NURSERY-SCHOOL CHILDREN; DEUTERIUM-LABELED DEHP; DI(2-ETHYLHEXYL)
   PHTHALATE; GENERAL-POPULATION; INTERNAL EXPOSURE; PLASTICIZER;
   BIOMARKERS; PRODUCTS; TEACHERS; TOXICITY}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{jweuve@hsph.harvard.edu}},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Budtz-Jørgensen Esben, 2002, Environ Health, V1, P2, DOI 10.1186/1476-069X-1-2.
   Calafat AM, 2004, PEDIATRICS, V113, P429.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   HAMOSH M, 1990, NUTRITION, V6, P421.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Hutson JM, 1997, ENDOCR REV, V18, P259, DOI 10.1210/er.18.2.259.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kim HS, 2004, J TOXICOL ENV HEAL A, V67, P2045, DOI 10.1080/15287390490514859.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Latini G, 1999, ACTA PAEDIATR, V88, P1174, DOI 10.1080/08035259950168333.
   Leeder JS, 1997, PEDIATR CLIN N AM, V44, P55, DOI 10.1016/S0031-3955(05)70463-6.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Main KM, 2006, ENVIRON HEALTH PERSP, V114, P270, DOI 10.1289/ehp.8075.
   Marcel Y L, 1973, Environ Health Perspect, V3, P119, DOI 10.2307/3428037.
   Muthen L. K., 1999, MPLUS USERS GUIDE.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Rais-Bahrami K, 2004, ENVIRON HEALTH PERSP, V112, P1339, DOI 10.1289/ehp.6901.
   ROCK G, 1984, TRANSFUSION, V24, P493, DOI 10.1046/j.1537-2995.1984.24685066808.x.
   Sanchez BN, 2005, J AM STAT ASSOC, V100, P1443, DOI 10.1198/0162145050000001005.
   Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   Tietz NW, 1990, CLIN GUIDE LAB TESTS.
   {*}ATSDR, 2001, TOX PROF DINBUT PHTH.
   {*}ATSDR, 2002, TOX PROF DI2 ETHYLB.
   {*}CDC, 2003, 2 NAT REP HUM EXP EN.
   {*}NTP CERHR, 2005, NTP CERHR EXP PAN UP.
   {*}NTP CERHR, 2000, MON POT HUM REPRO DE.
   {*}NTP CERHR, 2000, EXP PAN REP DEHP.
   {*}NTP CERHR, 2003, MON POT HUM REPR DEV.
   {*}US EPA, 2000, TECHN TRANSF NETW BI.
   {*}US FOOD DRUG ADM, 2002, SAF ASS DI2 ETH REL.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{39}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{087PZ}},
Wos-Id = {{ISI:000240755700043}},
}

@article{ ISI:000239839500018,
Author = {Ma, Mingyue and Kondo, Tomoko and Ban, Susumu and Umemura, Tomohiro and
   Kurahashi, Norie and Takeda, Makoto and Kishi, Reiko},
Title = {{Exposure of prepubertal female rats to inhaled di(2-ethylhexyl)phthalate
   affects the onset of puberty and postpubertal reproductive functions}},
Journal = {{TOXICOLOGICAL SCIENCES}},
Year = {{2006}},
Volume = {{93}},
Number = {{1}},
Pages = {{164-171}},
Month = {{SEP}},
Abstract = {{We evaluated the effects of inhaled di(2-ethylhexyl)phthalate (DEHP) on
   the onset of puberty and on postpubertal reproductive functions in
   prepubertal female rats. DEHP was administered by inhalation at doses of
   0, 5, and 25 mg/m(3) to groups of female rats for 6 h/day, 5 contiguous
   days/week from postnatal days (PNDs) 22 to 41 and to PND 84. The onset
   of puberty was determined by daily examination for vaginal opening (VO)
   and first estrous cycle. Reproductive function was evaluated by
   observing estrous cyclicity from PNDs 49 to 84. Upon completion of
   exposure, the rats were sacrificed at PND 42 and PNDs 85-88 during the
   diestrous stage. DEHP exposure advanced the age of VO and first estrous
   cycle, and serum cholesterol, luteinizing hormone, and estradiol levels
   were significantly elevated in the 25-mg/m(3) DEHP group. Irregular
   estrous cycles were observed more frequently in DEHP-exposed rats, and
   serum cholesterol decreased in DEHP-exposed rats in adulthood; RT-PCR
   showed that the expression of aromatase mRNA, encoding a rate-limiting
   enzyme that catalyzes the conversion of testosterone to estradiol, was
   elevated in the 25-mg/m(3) DEHP group. These data suggest that inhaled
   DEHP may advance the onset of puberty and alter postpubertal
   reproductive functions.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ma, MY (Reprint Author), Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.
   Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Kita Ku, Sapporo, Hokkaido 0608638, Japan.}},
DOI = {{10.1093/toxsci/kfl036}},
ISSN = {{1096-6080}},
Keywords = {{DEHP; female; reproductive functions; inhalation}},
Keywords-Plus = {{PHTHALATE SUPPRESSES ESTRADIOL; SUBCHRONIC ORAL TOXICITY;
   DI-(2-ETHYLHEXYL) PHTHALATE; DI-2-ETHYLHEXYL PHTHALATE; INDOOR
   ENVIRONMENT; GRANULOSA-CELLS; ESTERS; DEHP; SERUM; ACID}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{mamingy@med.hokudai.ac.jp}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Aldyreva MV, 1975, GIG TR PROF ZABOL, V19, P25.
   American Conference of Governmental Industrial Hygienists (ACGIH, 2001, DOC THRESH LIM VAL B.
   BELL FP, 1977, LIPIDS, V12, P581, DOI 10.1007/BF02533385.
   BELL FP, 1978, LIPIDS, V13, P66, DOI 10.1007/BF02533369.
   Biegel LB, 1998, TOXICOL SCI, V44, P143, DOI 10.1006/toxs.1998.2469.
   Chance GW, 1998, CAN J PUBLIC HEALTH, V89, pS9.
   Clausen PA, 2004, ENVIRON SCI TECHNOL, V38, P2531, DOI 10.1021/es0347944.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Dalgaard M, 2000, PHARMACOL TOXICOL, V86, P92, DOI 10.1034/j.1600-0773.2000.d01-17.x.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   DOCKE F, 1979, ZBL GYNAKOL, V101, P1082.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   Everett J W, 1989, Monogr Endocrinol, V32, P1.
   Goldman JM, 2000, CRIT REV TOXICOL, V30, P135, DOI 10.1080/10408440091159185.
   Grande SW, 2006, TOXICOL SCI, V91, P247, DOI 10.1093/toxsci/kfj128.
   Hirosawa N, 2006, PROTEOMICS, V6, P958, DOI 10.1002/pmic.200401344.
   Ishikawa J, 1994, Jikken Dobutsu, V43, P535.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Juberg DR, 1998, FOOD CHEM TOXICOL, V36, P429, DOI 10.1016/S0278-6915(97)00168-3.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   KLIMISCH HJ, 1992, FOOD CHEM TOXICOL, V30, P915, DOI 10.1016/0278-6915(92)90175-K.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Kurahashi N, 2005, J OCCUP HEALTH, V47, P437, DOI 10.1539/joh.47.437.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   MANGHAM BA, 1981, TOXICOL APPL PHARM, V61, P205, DOI 10.1016/0041-008X(81)90410-5.
   Parent AS, 2003, ENDOCR REV, V24, P668, DOI 10.1210/er.2002-0019.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P246, DOI 10.1016/0041-008X(85)90346-1.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Rais-Bahrami Khodayar, 2004, Pediatr Nurs, V30, P433.
   Uhde E, 2001, INDOOR AIR, V11, P150, DOI 10.1034/j.1600-0668.2001.011003150.x.
   WENSING M, 2005, P 8 INT C IND AIR CL, V5, P87.
   Wensing M, 2005, SCI TOTAL ENVIRON, V339, P19, DOI 10.1016/j.scitotenv.2004.10.028.
   XU Y, 2005, ARCH TOXICOL, V23, P1.
   Xu Y, 2005, TOXICOL SCI, V84, P287, DOI 10.1093/toxsci/kfi083.
   Zacharewski TR, 1998, TOXICOL SCI, V46, P282, DOI 10.1093/toxsci/46.2.282.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{16}},
Journal-ISO = {{Toxicol. Sci.}},
Doc-Delivery-Number = {{074VI}},
Wos-Id = {{ISI:000239839500018}},
}

@article{ ISI:000239468000035,
Author = {Silva, Manori J. and Reidy, John A. and Preau, Jr., James L. and
   Needham, Larry L. and Calafat, Antonia M.},
Title = {{Oxidative metabolites of diisononyl phthalate as biomarkers for human
   exposure assessment}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2006}},
Volume = {{114}},
Number = {{8}},
Pages = {{1158-1161}},
Month = {{AUG}},
Abstract = {{Diisononyl plithalate (DINP) is a complex mixture of predominantly
   nine-carbon branched-chain dialkyl phthalate isomers. Similar to
   di(2-ethylhexyl) phthalate, a widely used phthalate, DINP causes
   antiandrogenic effects on developing rodent male fetuses. Traditionally,
   assessment of human exposure to DINP has been done using monoisononyl
   phthalate (MINP), the hydrolytic metabolite of DINP, as a biomarker.
   However, MINP is only a minor urinary metabolite of DINP. Oxidative
   metabolites, including mono (carboxyisooctyl) phthalate (MCIOP),
   mono(oxoisononyl) plithalate (MOINP), and mono (hydroxyisononyl)
   phthalate (MHINP) are the major urinary metabolites in DINP-dosed rats.
   The urinary concentrations of MINP, MCIOP, MOINP, and MHINP were
   measured in 129 adult anonymous human volunteers with no known exposure
   to DINP. Although MINP was not present at detectable levels in any of
   the samples analyzed, MCIOP, MHINP, and MOINP were detected in 97, 100,
   and 87\% of the urine samples at geometric mean levels equal to 8.6,
   11.4, and 1.2 ng/mL, respectively. The concentrations of all three
   oxidative metabolites were highly correlated with each other (p <
   0.0001), which confirms a common precursor. MCIOP was excreted
   predominantly as a free species, whereas MOINP was excreted mostly in
   its glucuronidated form. The percentage of MHINP excreted either
   glucuronidated or in its free form was similar. The significantly higher
   frequency of detection and urinary concentrations of oxidative
   metabolites than of MINP suggest that these oxidative metabolites are
   better biomarkers of exposure assessment of DINP than is MINP.
   Therefore, we concluded that the prevalence of human exposure to DINP is
   underestimated by using MINP as the sole DINP urinary biomarker.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Div Lab Sci, Natl Ctr Environm Hlth, CDC, 4770 Buford Hwy NE,Mailstop F17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Div Lab Sci, Natl Ctr Environm Hlth, CDC, Atlanta, GA 30341 USA.}},
DOI = {{10.1289/ehp.8865}},
ISSN = {{0091-6765}},
Keywords = {{biomarkers; diisononyl phthalate; DINP; MINP; monoisononyl phthalate;
   oxidative metabolites}},
Keywords-Plus = {{DI-ISONONYL PHTHALATE; DEUTERIUM-LABELED DEHP; N-OCTYL PHTHALATE; HUMAN
   URINE; DI(2-ETHYLHEXYL)PHTHALATE DEHP; QUANTITATIVE DETECTION; RATS;
   ABSORPTION; SERUM}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{zca2@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{Abe Y, 2003, J FOOD HYG SOC JPN, V44, P168.
   ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kaufmann W, 2002, REGUL TOXICOL PHARM, V36, P175, DOI 10.1066/rtph.2002.1575.
   Kavlock R, 2002, REPROD TOXICOL, V16, P679, DOI 10.1016/S0890-6238(02)00034-5.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P689, DOI 10.1007/s00204-005-0004-x.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   McKee RH, 2000, J APPL TOXICOL, V20, P491, DOI 10.1002/1099-1263(200011/12)20:6<491::AID-JAT724>3.0.CO;2-H.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2006, TOXICOLOGY, V223, P101, DOI 10.1016/j.tox.2006.03.005.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2005, TOXICOLOGY, V210, P123, DOI 10.1016/j.tox2005.01.012.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   Silva MJ, 2006, BIOMARKERS, V11, P1, DOI 10.1080/13547500500382868.
   {*}CERHR, 2000, NTP CERHR EXP PAN RE.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{32}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{069SH}},
Wos-Id = {{ISI:000239468000035}},
}

@article{ ISI:000238004800025,
Author = {Marsee, K and Woodruff, TJ and Axelrad, DA and Calafat, AM and Swan, SH},
Title = {{Estimated daily phthalate exposures in a population of mothers of male
   infants exhibiting reduced anogenital distance}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2006}},
Volume = {{114}},
Number = {{6}},
Pages = {{805-809}},
Month = {{JUN}},
Abstract = {{Phthalate diesters have been shown to be developmental and reproductive
   toxicants in animal studies. A recent epidemiologic study showed certain
   phthalates to be significantly associated with reduced anogenital
   distance in human male infants, the first evidence of subtle
   developmental effects in human male infants exposed prenatally to
   phthalates. We used two previously published methods to estimate the
   daily phthalate exposures for the four phthalates whose urinary
   metabolites were statistically significantly associated with
   developmental effects in the 214 mother-infant pairs {[}di-n-butyl
   phthalate (DnBP), diethyl phthalate (DEP), butylbenzyl phthalate (BBzP),
   diisobutyl phthalate (DiBP)] and for another important phthalate
   {[}di-2-ethylhexyl phthalate (DEHP)]. We estimated the median and 95th
   percentile of daily exposures to DBP to be 0.99 and 2.68 mu g/kg/day,
   respectively; for DEP, 6.64 and 112.3 mu g/kg/day; for 13130, 0.50 and
   2.47 mu g/kg/day; and for DEHP, 1.32 and 9.32 mu g/kg/day. The U.S.
   Environmental Protection Agency (EPA) reference doses for these
   chemicals are 100 (DBP), 800 (DEP), 200 (BBzP), and 20 (DEHP) mu
   g/kg/day. The median and 95th percentile exposure estimates for the
   phthalates associated with reduced anogenital distance in the study
   population are substantially lower than current U.S. EPA reference doses
   for these chemicals and could be informative to any updates of the
   hazard assessments and risk assessments for these chemicals.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Woodruff, TJ (Reprint Author), Univ Calif San Francisco, Inst Hlth Policy Studies, 3333 Calif St,Suite 265, San Francisco, CA 94118 USA.
   Univ Calif Berkeley, Joint Med Program, Sch Publ Hlth, Berkeley, CA 94720 USA.
   US EPA, Off Policy Econ \& Innovat, San Francisco, CA USA.
   US EPA, Off Policy Econ \& Innovat, Washington, DC 20460 USA.
   Ctr Dis Control \& Prevent, Div Lab Sci, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Univ Rochester, Dept Obstet \& Gynecol, Rochester, NY 14627 USA.}},
DOI = {{10.1289/ehp.8663}},
ISSN = {{0091-6765}},
Keywords = {{anogenitall distance; butyl-benzyl phthalate; di(2-ethylhexyl)
   phthalate; dibutyl phthalate; diethyl plithalate; diisobutyl phthalate;
   exposure estimates; reference dose}},
Keywords-Plus = {{DOSE-DEPENDENT ALTERATIONS; HYG. ENVIRON. HEALTH; DI(N-BUTYL) PHTHALATE;
   DI(2-ETHYLHEXYL)PHTHALATE DEHP; REPRODUCTIVE DEVELOPMENT;
   SEXUAL-DIFFERENTIATION; TESTOSTERONE SYNTHESIS; GENERAL-POPULATION;
   HUMAN URINE; MALE-RAT}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{tracey.woodruff@ucsf.edu}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   David RM, 2004, INT J HYG ENVIR HEAL, V207, P75, DOI 10.1078/1438-4639-00271.
   Duty SM, 2005, ENVIRON HEALTH PERSP, V113, P1530, DOI 10.1289/ehp.8083.
   Ema M, 2003, REPROD TOXICOL, V17, P407, DOI 10.1016/S0890-6238(03)00037-6.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   EPA, 2005, INT RISK INF SYST.
   FOSTER PMD, 2000, FOOD CHEM TOXICOL, V38, P97.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gray LE, 2006, INT J ANDROL, V29, P96, DOI 10.1111/j.1365-2605.2005.00636.x.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P77, DOI 10.1078/1438-4639-00272.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 2000, TOXICOL APPL PHARM, V168, P174, DOI 10.1006/taap.2000.9032.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   {*}ATSDR, 2003, TOX PROF DH2 ETH.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.
   {*}ATSDR, 2001, TOX PROF DI PHTH.
   {*}NAT CTR ENV HLTH, 2005, 3 NAT REP HUM EXP EN.
   {*}US EPA, 2005, INT RISK INF SYST BU.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{74}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{049GS}},
Wos-Id = {{ISI:000238004800025}},
}

@article{ ISI:000238522900004,
Author = {Lee, HC and Yamanouchi, K and Nishihara, M},
Title = {{Effects of perinatal exposure to phthalate/adipate esters on
   hypothalamic gene expression and sexual behavior in rats}},
Journal = {{JOURNAL OF REPRODUCTION AND DEVELOPMENT}},
Year = {{2006}},
Volume = {{52}},
Number = {{3}},
Pages = {{343-352}},
Month = {{JUN}},
Abstract = {{Our previous research has identified the granulin (grn) and p130 genes
   as sex steroid-regulated genes in the neonatal rat hypothalamus that
   might be involved in sexual differentiation of the brain. Since
   phthalate/adipate esters such as di-n-butyl phthalate (DBP), diisononyl
   phthalate (DINP), and di-2-ethylhexyl adipate (DEHA) are suspected to
   interfere with the endocrine system as environmental endocrine
   disruptors having estrogenic or antiandrogenic properties, these
   chemicals may affect sexual differentiation of the brain. The present
   study assessed the effects of perinatal exposure to DBP, DINP, and DEHA
   on grn and p130 mRNA expressions in the hypothalamus on postnatal day
   (PND) 7 and sexual behaviors after maturation in rats. Maternal rats
   were given a phytoestrogen-free diet containing different doses of DBP
   (20, 200, 2,000, and 10,000 ppm), DINP (40, 400, 4,000, and 20,000 ppm)
   and DEHA (480, 2,400, and 12,000 ppm) from gestational day 15 to the day
   of weaning (PND 21). DBP and DINP exposure during the perinatal period
   resulted in an increase in hypothalamic grn and p130 mRNA levels in
   females and males, respectively, but DEHA exposure decreased expression
   levels of grn in males and p130 in females, although the effects were
   not dose-dependent. After maturation, male rats that were exposed to
   several doses of DBP, DINP, and DEHA displayed decreased copulatory
   behavior. The lordosis quotient was decreased in females perinatally
   exposed to DBP, DINP, and DEHA at all the doses used. On the other hand,
   serum levels of LH and FSH in both sexes and the estrous cycles in
   females were not affected by the treatments. These results suggest that
   inappropriate expression of grn and/or p130 genes in the brains of male
   and female neonatal rats by perinatal exposure to these chemicals may
   exert permanent effects on the hypothalamus, thereby decreasing sexual
   behavior after maturation.}},
Publisher = {{JAPANESE SOC ANIMAL REPRODUCTION}},
Address = {{C/O I P E C, INC, 1-24-11 SUGAMO, TOSHIMA-KU, TOKYO, 170-0002, JAPAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Nishihara, M (Reprint Author), Univ Tokyo, Dept Vet Physiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.
   Univ Tokyo, Dept Vet Physiol, Bunkyo Ku, Tokyo 1138657, Japan.}},
DOI = {{10.1262/jrd.17096}},
ISSN = {{0916-8818}},
Keywords = {{adipate; granulin; hypothalamus; p130; phthalate; sexual behavior}},
Keywords-Plus = {{MALE REPRODUCTIVE DEVELOPMENT; GRANULIN PRECURSOR GENE;
   STEROID-INDUCIBLE GENE; SPRAGUE-DAWLEY RATS; IN-UTERO EXPOSURE;
   DI(N-BUTYL) PHTHALATE; DIETHYLHEXYL PHTHALATE; DISRUPTING CHEMICALS;
   DIISONONYL PHTHALATE; LACTATIONAL EXPOSURE}},
Research-Areas = {{Agriculture; Reproductive Biology}},
Web-of-Science-Categories  = {{Agriculture, Dairy \& Animal Science; Reproductive Biology}},
Author-Email = {{amnishi@mail.ecc.u-tokyo.ac.jp}},
Cited-References = {{Andersen HR, 1999, ENVIRON HEALTH PERSP, V107, P89, DOI 10.2307/3434476.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335.
   Barlow S, 1999, TERATOLOGY, V60, P365, DOI 10.1002/(SICI)1096-9926(199912)60:6<365::AID-TERA9>3.0.CO;2-6.
   BARRACLOUGH C, 1961, ENDOCRINOLOGY, V68, P68.
   Caraty A, 1998, ENDOCRINOLOGY, V139, P1752, DOI 10.1210/en.139.4.1752.
   CLARK RL, 1999, EVALUATION INTERPRET, P10.
   COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890.
   DORNAN WA, 1990, BRAIN RES BULL, V25, P791, DOI 10.1016/0361-9230(90)90061-4.
   Gray LE, 2001, HUM REPROD UPDATE, V7, P248, DOI 10.1093/humupd/7.3.248.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   HEINRICHS WL, 1985, REPROD TOXICOL, P95.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Lington AW, 1997, FUND APPL TOXICOL, V36, P79, DOI 10.1006/faat.1997.2286.
   MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211.
   Masutomi N, 2003, TOXICOLOGY, V192, P149, DOI 10.1016/S0300-483X(03)00269-5.
   MATSUMOTO A, 1983, ENDOCRINOL JAPON, V30, P277.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   NISHIZUKA M, 1983, EXP BRAIN RES, V49, P462.
   PAGE BD, 1995, FOOD ADDIT CONTAM, V12, P129.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Petersen JH, 1998, FOOD ADDIT CONTAM, V15, P600.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   Suzuki M, 2000, PHYSIOL BEHAV, V68, P707, DOI 10.1016/S0031-9384(99)00241-3.
   Suzuki M, 2001, NEUROSCI LETT, V297, P199, DOI 10.1016/S0304-3940(00)01699-2.
   Suzuki M, 2002, MOL GENET METAB, V75, P31, DOI 10.1006/mgme.2001.3274.
   Suzuki M, 1998, NEUROSCI LETT, V242, P127, DOI 10.1016/S0304-3940(98)00008-1.
   WALDRON AC, 1974, POULTRY SCI, V53, P1428.
   Wine RN, 1997, ENVIRON HEALTH PERSP, V105, P102, DOI 10.1289/ehp.97105102.
   WISE LD, 1991, TERATOLOGY, V44, P507, DOI 10.1002/tera.1420440505.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   Yonehara K, 2002, ENDOCR J, V49, P131, DOI 10.1507/endocrj.49.131.
   Yonehara K, 2002, NEUROSCI LETT, V334, P107, DOI 10.1016/S0304-3940(02)01114-X.
   Zacharewski TR, 1998, TOXICOL SCI, V46, P282, DOI 10.1093/toxsci/46.2.282.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{12}},
Journal-ISO = {{J. Reprod. Dev.}},
Doc-Delivery-Number = {{056KY}},
Wos-Id = {{ISI:000238522900004}},
}

@article{ ISI:000238346300011,
Author = {Silva, MJ and Kato, K and Wolf, C and Samandar, E and Silva, SS and
   Gray, EL and Needham, LL and Calafat, AM},
Title = {{Urinary biomarkers of di-isononyl phthalate in rats}},
Journal = {{TOXICOLOGY}},
Year = {{2006}},
Volume = {{223}},
Number = {{1-2}},
Pages = {{101-112}},
Month = {{JUN 1}},
Abstract = {{Commercial di-isononyl phthalate (DiNP) is a mixture of various
   branched-chain dialkyl phthalates mainly containing nine-carbon alkyl
   isomers. At high doses in rodents, DiNP is a carcinogen, and a
   developmental toxicant. After exposure, the diester isomers are
   de-esterified to form hydrolytic monoesters, monoisononyl phthalates
   (MiNP), which subsequently metabolize to form oxidative metabolites.
   These metabolites can be excreted in urine or feces. The urinary
   excretion of DiNP metabolites was monitored in adult female
   Sprague-Dawley rats after oral administration of a single dose (300
   mg/kg) of commercial DiNP. The metabolites were extracted from urine,
   resolved with high performance liquid chromatography, analyzed by mass
   spectrometry, and tentatively identified based on their chromatographic
   separation and mass spectrometric fragmentation pattern. Because DiNP is
   an isomeric mixture, its metabolites were also isomeric mixtures that
   eluted from the HPLC column with close retention times.
   Mono(carboxyisooctyl)phthalate (MCiOP) was identified as the major
   metabolite of DiNP; in addition, mono(hydroxy-isononyl)phthalate (MHiNP)
   and mono(oxo-isononyl)phthalate (MOiNP) were present. Furthermore,
   metabolites of di-isooctyl phthalate (DiOP) and di-isodecyl phthalate
   (DiDP) were also detected. Excretion toxicokinetics of the DiNP
   metabolites in urine followed a biphasic pattern with initial rapid
   decay in concentration. Despite potential differences in the metabolism
   of DiNP among species, MCiOP, MHiNP and MONP were detected in humans
   with no known exposure to DiNP at levels significantly higher than MiNP
   suggesting that these oxidative metabolites may be better urinary
   biomarkers of human exposure to DiNP than is MiNP. Published by Elsevier
   Ireland Ltd.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Div Lab Sci, Natl Ctr Environm Hlth, Mailstop F53,4770 Buford Hwy NE, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Div Lab Sci, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.
   US EPA, Reprod Toxicol Div, Endocrinol Branch, Natl Hlth \& Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.}},
DOI = {{10.1016/j.tox.2006.03.005}},
ISSN = {{0300-483X}},
Keywords = {{di-isononyl phthalate; DiNP; monoisononyl phthalate; biomonitoring;
   plasticizer; biomarkers; exposure; oxidative metabolism}},
Keywords-Plus = {{DEUTERIUM-LABELED DEHP; N-OCTYL PHTHALATE; DIISONONYL PHTHALATE;
   RISK-ASSESSMENT; DI(2-ETHYLHEXYL)PHTHALATE DEHP; CHILDRENS PRODUCTS;
   ORAL-EXPOSURE; METABOLITES; TOXICITY; ABSORPTION}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{zca2@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   Babich MA, 2004, REGUL TOXICOL PHARM, V40, P151, DOI 10.1016/j.yrtph.2004.06.005.
   BABICH MA, 1998, RISK CHRONIC TOXICIT.
   Babich MA, 2003, TOXICOL SCI, V72, P392.
   Calafat AM, 2006, J TOXICOL ENV HEAL A, V69, P215, DOI 10.1080/15287390500227381.
   Center for Disease Control (CDC), 2005, 3 NAT REP HUM EXP EN.
   CPSC (Consumer Product Safety Commission), 2001, REP US CONS PROD SAF.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hellwig J, 1997, FOOD CHEM TOXICOL, V35, P501, DOI 10.1016/S0278-6915(97)00008-2.
   Kavlock R, 2002, REPROD TOXICOL, V16, P679, DOI 10.1016/S0890-6238(02)00034-5.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   Lington AW, 1997, FUND APPL TOXICOL, V36, P79, DOI 10.1006/faat.1997.2286.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   Shaw D, 2002, ARCH TOXICOL, V76, P344, DOI 10.1007/s00204-002-0342-x.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   SILVA MJ, 2006, HLTH PERSPECT.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2005, TOXICOLOGY, V210, P123, DOI 10.1016/j.tox2005.01.012.
   Silva MJ, 2006, TOXICOLOGY, V219, P22, DOI 10.1016/j.tox.2005.10.018.
   SILVA MJ, 2006, MEASUREMENT 8 URINAR.
   Smith JH, 2000, TOXICOL SCI, V54, P312, DOI 10.1093/toxsci/54.2.312.
   Wilkinson CF, 1999, REGUL TOXICOL PHARM, V30, P140, DOI 10.1006/rtph.1999.1338.
   {*}CERHR, 2000, NTP CERHR EXP PAN RE.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{26}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{053ZY}},
Wos-Id = {{ISI:000238346300011}},
}

@article{ ISI:000235299700003,
Author = {Silva, MJ and Samandar, E and Preau, JL and Needham, LL and Calafat, AM},
Title = {{Urinary oxidative metabolites of di(2-ethylhexyl) phthalate in humans}},
Journal = {{TOXICOLOGY}},
Year = {{2006}},
Volume = {{219}},
Number = {{1-3}},
Pages = {{22-32}},
Month = {{FEB 15}},
Abstract = {{Di(2-ethylhexyl) phthalate (DEHP) is added to polyvinyl chloride (PVC)
   plastics used widely in medical devices and toys to impart flexibility
   and durability. DEHP produces reproductive and development toxicities in
   rodents. Initial metabolism of DEHP in animals and humans results in
   mono(2-ethylhexyl) phthalate (MEHP), which subsequently metabolizes to a
   wide range of oxidative metabolites before being excreted in urine and
   feces. We investigated the metabolism of DEHP in humans by identifying
   urinary oxidative metabolites of DEHP from individuals with urinary MEHP
   concentrations about 100 times higher than the median concentration in
   the general US population. In addition to the previously identified DEHP
   metabolites MEHP, mono(2-ethyl-5-oxohexyl) phthalate (MEOHP),
   mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP),
   mono(2-ethyl-5-carboxypentyl) phthalate (MECPP), and
   mono(2-carboxymethylhexyl) phthalate (MCMHP), we also identified for the
   first time in humans three additional oxidative metabolites,
   mono(2-ethyl-3-carboxypropyl) phthalate (MECPrP),
   mono(2-ethyl-4-carboxybutyl) phthalate (MECBP), and
   mono(2-(1-oxoethyl)hexyl) phthalate (MOEHP) based on their
   chromatographic behavior and mass spectrometric fragmentation patterns.
   We also tentatively identified metabolites with two functional groups in
   the side alkyl chain as isomers of mono(2-hydroxyethyl-4-carboxybutyl)
   phthalate (MHECBP), mono(2-ethyl-4-oxo-5-carboxypentyl) phthalate
   (MEOCPP), and mono(2-ethyl-4-hydroxy-5-carboxypentyl) phthalate
   (MEHCPP). We report the presence of urinary DEHP metabolites in humans
   that have fewer than eight carbons in the alkyl chain. These metabolites
   were previously identified in rodents. Although quantitative information
   is not available, our findings suggest that, despite potential
   differences among species, the oxidative metabolism of DEHP in humans
   and rodents results in similar urinary metabolic products. Published by
   Elsevier Ireland Ltd.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Mailstop F17,4770 Buford Hwy NE, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.}},
DOI = {{10.1016/j.tox.2005.10.018}},
ISSN = {{0300-483X}},
Keywords = {{di(2-ethylhexyl) phthalate; DEHP; oxidative metabolism; phthalates;
   biomonitoring; plasticizers}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; DI-(2-ETHYLHEXYL) PHTHALATE; QUANTITATIVE
   DETECTION; INTERNAL EXPOSURE; AMNIOTIC-FLUID; MALE-RAT; DEHP;
   POPULATION; IDENTIFICATION; ABSORPTION}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{zca2@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{ALBRO PW, 1983, BIOCHIM BIOPHYS ACTA, V760, P283, DOI 10.1016/0304-4165(83)90175-7.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   ALBRO PW, 1981, DRUG METAB DISPOS, V9, P223.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Calafat AM, 2006, TOXICOLOGY, V217, P22, DOI 10.1016/j.tox.2005.08.013.
   Gray LE, 2003, TOXICOL SCI, V72, P283.
   Gray LE, 2004, BIOL REPROD, P113.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   KOCH HM, 2005, ARCH TOXICOL.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2005, TOXICOLOGY, V210, P123, DOI 10.1016/j.tox2005.01.012.
   SILVA MJ, 2005, IN PRESS BIOMARKERS.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Wester RC, 1998, TOXICOL APPL PHARM, V151, P159, DOI 10.1006/taap.1998.8434.
   {*}ATSDR, 2004, AG TOX SUBS DIS REG.
   {*}FDA, 2001, CTR DEV RAD HLTH.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{38}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{011WQ}},
Wos-Id = {{ISI:000235299700003}},
}

@article{ ISI:000237487200007,
Author = {Luisi, S and Latini, G and De Felice, C and Sanseverino, F and Di
   Pasquale, D and Mazzeo, P and Petraglia, F},
Title = {{Low serum concentrations of di-(2-ethylhexyl)phthalate in women with
   uterine fibromatosis}},
Journal = {{GYNECOLOGICAL ENDOCRINOLOGY}},
Year = {{2006}},
Volume = {{22}},
Number = {{2}},
Pages = {{92-95}},
Month = {{FEB}},
Abstract = {{Di-(2-ethylhexyl)phthalate (DEHP) is the most commonly used plasticizer
   in flexible polyvinylchloride formulations, and is a widespread
   ubiquitous environmental contaminant. A potential role of exposure to
   DEHP and its primary metabolite, monoethylhexylphthalate (MEHP), on
   women's reproductive function is suggested in the current study. The aim
   of the study was to test serum concentrations of DEHP and/or MEHP in
   women with uterine fibromatosis. Two groups of women were enrolled in
   the study: (i) women with uterine fibromatosis undergoing surgical
   menopause (n = 15) and (ii) healthy women (n = 20). Serum DEHP and MEHP
   concentrations were measured by high-performance liquid chromatography.
   Serum MEHP distribution was found to be non-Gaussian (p = 0.001) while
   serum DEHP distribution was compatible with a normal curve (p = 0.141).
   Patients with uterine fibromatosis showed significantly lower serum MEHP
   concentrations (median {[}interquartile range]: 0 {[}0-0] mu g/ml,
   range: 0-0.57 mu g/ml) than controls (0.42 {[}0-0.51] mu g/ml, range:
   0-1.20 mu g/ml, z = -2.93, p = 0.0034). Likewise, serum DEHP
   concentrations in women with fibromatosis were found to be significantly
   lower than in controls (patients: 0.27 +/- 0.096 mu g/ml (mean +/-
   standard deviation (SD)), range: 0.14-0.59 mu g/ml vs. controls: 0.30
   +/- 0.14 mu g/ml (mean +/- SD), range: 0-0.63 mu g/ml; t = 3.212, df =
   33, difference: -0.325 (95\% confidence interval: -0.5309, -0.1191), p =
   0.0029). In conclusion, the present findings indicate for the first time
   that serum DEHP and MEHP concentration are lower in women with uterine
   fibromatosis, suggesting a possible correlation between phthalate esters
   and fibromatosis pathology.}},
Publisher = {{PARTHENON PUBLISHING GROUP}},
Address = {{RICHMOND HOUSE, WHITE CROSS, SOUTH ROAD, LANCASTER LA1 4XQ, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Petraglia, F (Reprint Author), Univ Siena, Policlin S Maria Scotte, Dept Pediat Obstet \& Reprod Med, Chair Obstet \& Gynecol, Viale Bracci, I-53100 Siena, Italy.
   Univ Siena, Policlin S Maria Scotte, Dept Pediat Obstet \& Reprod Med, Chair Obstet \& Gynecol, I-53100 Siena, Italy.
   Perrino Hosp, Div Neonatol, Brindisi, Italy.
   Natl Res Council Italy, Lecce Sect, CNR, IFC,Clin Physiol Inst, Lecce, Italy.
   Azienda Osped Univ Senese, Neonatal Intens Care Unit, Siena, Italy.
   Univ Aquila, Dept Chem Chem Engn \& Mat, I-67100 Laquila, Italy.}},
DOI = {{10.1080/09513590600551312}},
ISSN = {{0951-3590}},
Keywords = {{di-(2-ethylhexyl)phthalate; monoethylhexylphthalate; uterine
   fibromatosis; environmental hazards}},
Keywords-Plus = {{EXPOSURE; PREGNANCY; DI-(2-ETHYLHEXYL)-PHTHALATE; IDENTIFICATION;
   PLASTICIZER; TISSUES; PLASMA; BLOOD}},
Research-Areas = {{Endocrinology \& Metabolism; Obstetrics \& Gynecology}},
Web-of-Science-Categories  = {{Endocrinology \& Metabolism; Obstetrics \& Gynecology}},
Author-Email = {{petraglia@unisi.it}},
Cited-References = {{Aldyreva MV, 1975, GIG TR PROF ZABOL, V19, P25.
   AUTIAN J, 1972, TOXICITY HLTH THREAT.
   Blount B. C., 2000, ENV HLTH PERSPECT, V108, P972.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Center for the Evaluation of Risks to Human Reproduction, 2000, NTP CERHR EXP PAN RE.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Greenberg MD, 1995, OBSTET GYN CLIN N AM, V22, P625.
   Gross KL, 2004, GENE CHROMOSOME CANC, V41, P183, DOI 10.1002/gcc.20079.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   Hoyer PB, 2001, BIOCHEM PHARMACOL, V62, P1557, DOI 10.1016/S0006-2952(01)00814-0.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   Latini G, 2003, BIOL NEONATE, V83, P22, DOI 10.1159/000067012.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Okubo T, 2003, BIOL PHARM BULL, V26, P1219.
   Paris I, 2003, ANAL LETT, V36, P2649, DOI 10.1081/AL-120024639.
   Tabacova S, 1999, EPIDEMIOLOGY, V10, pS127.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   {*}US FDA, 2001, SAF ASS DI 2 ETH PHT.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{7}},
Journal-ISO = {{Gynecol. Endocrinol.}},
Doc-Delivery-Number = {{041WM}},
Wos-Id = {{ISI:000237487200007}},
}

@article{ ISI:000236542000033,
Author = {Foster, PMD},
Title = {{Disruption of reproductive development in male rat offspring following
   in utero exposure to phthalate esters}},
Journal = {{INTERNATIONAL JOURNAL OF ANDROLOGY}},
Year = {{2006}},
Volume = {{29}},
Number = {{1}},
Pages = {{140-147}},
Month = {{FEB}},
Note = {{3rd Copenhagen Workshop on Environment Reproductive Health and
   Fertility, Copenhagen, DENMARK, JAN 15-18, 2005}},
Abstract = {{Certain Phthalate esters have been shown to produce reproductive
   toxicity in male rodents with an age dependent sensitivity in effects
   with foetal animals being more sensitive than neonates which are in turn
   more sensitive than pubertal and adult animals. While the testicular
   effects of phthalates in rats have been known for more than 30 years,
   recent attention has been focused on the ability of these agents to
   produce effects on reproductive development in male offspring after in
   utero exposure. These esters and in particular di-butyl,
   di-(2-ethylhexyl) and butyl benzyl phthalates have been shown to produce
   a syndrome of reproductive abnormalities characterized by malformations
   of the epididymis, vas deferens, seminal vesicles, prostate, external
   genitalia (hypospadias), cryptorchidism and testicular injury together
   with permanent changes (feminization) in the retention of
   nipples/areolae (sexually dimorphic structures in rodents) and
   demasculinization of the growth of the perineum resulting in a reduced
   anogenital distance (AGD). Critical to the induction of these effects is
   a marked reduction in foetal testicular testosterone production at the
   critical window for the development of the reproductive tract normally
   under androgen control. A second Leydig cell product, insl3, is also
   significantly down regulated and is likely responsible for the
   cryptorchidism commonly seen in these phthalate-treated animals. The
   testosterone decrease is mediated by changes in gene expression of a
   number of enzymes and transport proteins involved in normal testosterone
   biosynthesis and transport in the foetal Leydig cell. Alterations in the
   foetal seminiferous cords are also noted after in utero phthalate
   treatment with the induction of multinucleate gonocytes that contribute
   to lowered spermatocyte numbers in postnatal animals. The phthalate
   syndrome of effects on reproductive development has parallels with the
   reported human testicular dysgenesis syndrome, although no cause and
   effect relationship exists after exposure of humans to phthalate esters.
   However humans are exposed to and produce the critical phthalate
   metabolites that have been detected in blood of the general population,
   in children and also human amniotic fluid.}},
Publisher = {{BLACKWELL PUBLISHING}},
Address = {{9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Foster, PMD (Reprint Author), NIEHS, POB 12233 MD E1-06, Res Triangle Pk, NC 27709 USA.
   NIEHS, Res Triangle Pk, NC 27709 USA.}},
DOI = {{10.1111/j.1365-2605.2005.00563.x}},
ISSN = {{0105-6263}},
Keywords = {{androgen-mediated; cryptorchidism; development; di-(2-ethylhexyl)
   phthalate; di-n-butyl phthalate; endocrine disruption; hypospadias;
   phthalates}},
Keywords-Plus = {{EXPERT PANEL REPORT; TESTICULAR DYSGENESIS SYNDROME; N-BUTYL PHTHALATE;
   DOSE-DEPENDENT ALTERATIONS; GERM-CELL NEOPLASIA; DI(N-BUTYL) PHTHALATE;
   NTP CENTER; SEXUAL-DIFFERENTIATION; DIBUTYL PHTHALATE; PENTYL PHTHALATE}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{foster2@niehs.nih.gov}},
Cited-References = {{Adham IM, 2000, MOL CELL ENDOCRINOL, V160, P11, DOI 10.1016/S0303-7207(99)00188-4.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335.
   Barlow NJ, 2004, TOXICOL PATHOL, V32, P79, DOI 10.1080/01926230490265894.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   CREASY DM, 1987, EXP MOL PATHOL, V46, P357, DOI 10.1016/0014-4800(87)90056-6.
   CREASY DM, 1983, J PATHOL, V139, P309, DOI 10.1002/path.1711390307.
   EMA M, 1993, TOXICOL LETT, V69, P197.
   FIELD EA, 1989, NTP89246.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   FOSTER PMD, 1981, CHEM-BIOL INTERACT, V34, P233, DOI 10.1016/0009-2797(81)90134-4.
   FOSTER PMD, 1982, TOXICOL APPL PHARM, V63, P120, DOI 10.1016/0041-008X(82)90031-X.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   GEORGE FW, 1989, ENDOCRINOLOGY, V124, P727.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9.
   HEINDEL JJ, 1989, TOXICOL APPL PHARM, V97, P377.
   Hellwig J, 1997, FOOD CHEM TOXICOL, V35, P501, DOI 10.1016/S0278-6915(97)00008-2.
   Higuchi TT, 2003, TOXICOL SCI, V72, P301, DOI 10.1093/toxsci/kfg036.
   Holm M, 2003, J PATHOL, V199, P378, DOI 10.1002/path.1309.
   Hughes IA, 2001, ENDOCRINOLOGY, V142, P3281, DOI 10.1210/en.142.8.3281.
   IMPERATOMCGINLEY J, 1986, ENDOCRINOLOGY, V118, P132.
   IMPERATOMCGINLEY J, 1985, ENDOCRINOLOGY, V116, P807.
   IMPERATOMCGINLEY J, 1992, ENDOCRINOLOGY, V131, P1149, DOI 10.1210/en.131.3.1149.
   Ivell R, 2003, MOL HUM REPROD, V9, P175, DOI 10.1093/molehr/gag025.
   IZQUIERDO MA, 1995, J PATHOL, V177, P253, DOI 10.1002/path.1711770307.
   JONES HB, 1993, EXP MOL PATHOL, V58, P179, DOI 10.1006/exmp.1993.1016.
   Kavlock R, 2002, REPROD TOXICOL, V16, P679, DOI 10.1016/S0890-6238(02)00034-5.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kavlock R, 2002, REPROD TOXICOL, V16, P489, DOI 10.1016/S0890-6238(02)00033-3.
   Kavlock R, 2002, REPROD TOXICOL, V16, P453, DOI 10.1016/S0890-6238(02)00029-1.
   LAKE BG, 1976, TOXICOLOGY, V6, P341, DOI 10.1016/0300-483X(76)90038-X.
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169.
   Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972.
   LLOYD SC, 1988, TOXICOL APPL PHARM, V95, P484, DOI 10.1016/0041-008X(88)90366-3.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364.
   Nef S, 2000, DEV BIOL, V224, P354, DOI 10.1006/dbio.2000.9785.
   Ohtani H, 2000, ENVIRON HEALTH PERSP, V108, P1189, DOI 10.2307/3434832.
   Oosterhuis W, 1998, APMIS, V106, P204.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Paust HJ, 2002, EXP GERONTOL, V37, P1461, DOI 10.1016/S0531-5565(02)00098-0.
   RajpertDeMeyts E, 1996, VIRCHOWS ARCH, V428, P133.
   Rajpert-De Meyts E, 1998, APMIS, V106, P198.
   Richburg JH, 1999, TOXICOL APPL PHARM, V160, P271, DOI 10.1006/taap.1999.8786.
   SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E.
   Sharpe RM, 2003, INT J ANDROL, V26, P2, DOI 10.1046/j.1365-2605.2003.00367.x.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   SJOBERG P, 1986, ENVIRON HEALTH PERSP, V65, P237, DOI 10.2307/3430188.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Skakkebaek NE, 2002, HORM RES, V57, P43, DOI 10.1159/000058100.
   SKAKKEBAEK NE, 1987, INT J ANDROL, V10, P19, DOI 10.1111/j.1365-2605.1987.tb00161.x.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   Waterman SJ, 1999, REPROD TOXICOL, V13, P131, DOI 10.1016/S0890-6238(99)00002-7.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   Wine RN, 1997, ENVIRON HEALTH PERSP, V105, P102, DOI 10.1289/ehp.97105102.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {*}NTP, 1991, T0035C NTP.}},
Number-of-Cited-References = {{66}},
Times-Cited = {{166}},
Journal-ISO = {{Int. J. Androl.}},
Doc-Delivery-Number = {{029EN}},
Wos-Id = {{ISI:000236542000033}},
}

@article{ ISI:000236542000037,
Author = {Koch, HM and Preuss, R and Angerer, J},
Title = {{Di(2-ethylhexyl)phthalate (DEHP): human metabolism and internal exposure
   - an update and latest results}},
Journal = {{INTERNATIONAL JOURNAL OF ANDROLOGY}},
Year = {{2006}},
Volume = {{29}},
Number = {{1}},
Pages = {{155-165}},
Month = {{FEB}},
Note = {{3rd Copenhagen Workshop on Environment Reproductive Health and
   Fertility, Copenhagen, DENMARK, JAN 15-18, 2005}},
Abstract = {{Di(2-ethylhexyl)phthalate (DEHP) is a reproductive and developmental
   toxicant in animals and a suspected endocrine modulator in humans. There
   is widespread exposure to DEHP in the general population. Patients can
   be additionally exposed through DEHP-containing medical devices.
   Toxicokinetic and metabolic knowledge on DEHP in humans is vital not
   only for the toxicological evaluation of DEHP but also for exposure
   assessments based on human biomonitoring data. Secondary oxidized DEHP
   metabolites like mono-(2-ethyl-5-hydroxyhexyl) phthalate (5OH-MEHP),
   mono-(2-ethyl-5-oxohexyl)phthalate (5oxo-MEHP),
   mono-(2-ethyl-5-carboxypentyl)phthalate (5cx-MEPP) and
   mono-{[}2-(carboxymethyl)hexyl]phthalate (2cx-MMHP) are most valuable
   biomarkers of DEHP exposure. They represent the major share of DEHP
   metabolites excreted in urine (about 70\% for these four oxidized
   metabolites vs. about 6\% for MEHP); they are immune to external
   contamination and possibly the ultimate developmental toxicants. Long
   half-times of elimination make 5cx-MEPP and 2cx-MMHP excellent
   parameters to measure the time-weighted body burden to DEHP. 5OH-MEHP
   and 5oxo-MEHP more reflect the short-term exposure. We calculated the
   daily DEHP intake for the general population (n = 85) and for children
   (n = 254). Children were significantly higher exposed to DEHP than
   adults. Exposures at the 95th percentile (21 and 25 mu g/kg/day,
   respectively) scooped out limit values like the Reference Dose (RfD, 20
   mu g/kg/day) and the Tolerable Daily Intake (TDI, 20-48 mu g/kg/day) to
   a considerable degree. Up to 20-fold oversteppings for some children
   give cause for concern. We also detected significant DEHP exposures for
   voluntary platelet donors (n = 12, 38 mu g/kg/apheresis, dual-needle
   technique). Premature neonates (n = 45) were exposed to DEHP up to 100
   times above the limit values depending on the intensity of medical care
   (median: 42 mu g/kg/day; 95th percentile: 1780 mu g/kg/day).}},
Publisher = {{BLACKWELL PUBLISHING}},
Address = {{9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Angerer, J (Reprint Author), Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, Schillerstr 25-29, D-91054 Erlangen, Germany.
   Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, D-91054 Erlangen, Germany.}},
DOI = {{10.1111/j.1365-2605.2005.00607.x}},
ISSN = {{0105-6263}},
Keywords = {{biological monitoring; di(2-ethylhexyl)phthalat (DEHP); exposure;
   metabolism; neonates; platelet donors}},
Keywords-Plus = {{URINARY PHTHALATE METABOLITES; TANDEM MASS-SPECTROMETRY; NURSERY-SCHOOL
   CHILDREN; DEUTERIUM-LABELED DEHP; HYG. ENVIRON. HEALTH;
   GENERAL-POPULATION; MAJOR METABOLITES; BIS(2-ETHYLHEXYL) PHTHALATE;
   REPRODUCTIVE HEALTH; DI-(2-ETHYLHEXYL)PHTHALATE}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
Author-Email = {{juergen.angerer@ipasum.imed.uni-erlangen.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Angerer J, 2002, BIOLOGICAL MONITORING, P5, DOI 10.1002/9783527621026.ch2.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   BRUDER A, 1999, SWISS PLAST, V21, P5.
   Calafat AM, 2004, PEDIATRICS, V113, P429.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   CSTEE (Scientific Committee on Toxicity Ecotoxicity and the Environment), 1998, 6 CSTEE PLEN M BRUSS.
   DAVID R, 2003, INT J HYGIENE ENV HL, V206, P77.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   David RM, 2004, INT J HYG ENVIR HEAL, V207, P75, DOI 10.1078/1438-4639-00271.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Environmental Protection Agency (EPA), 1999, INT RISK INF SYST IR.
   European Chemicals Bureau European Chemicals Bureau (ECB), 2004, R0420402ENVHH46 ECB.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Gilsing HD, 2003, MONATSH CHEM, V134, P1207, DOI 10.1007/s00706-003-0044-y.
   Gilsing HD, 2005, MONATSH CHEM, V136, P795, DOI 10.1007/s00706-004-0267-6.
   Gilsing HD, 2002, MONATSH CHEM, V133, P1147, DOI 10.1007/s007060200084.
   GREIM H, 2002, GESUNDHEITSSCHADLICH, V35.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2005, ANAL CHEM, V77, P2985, DOI 10.1021/ac0481248.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Koch HM, 2004, REPROD TOXICOL, V18, P759, DOI 10.1016/j/reprotox.2004.05.003.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P77, DOI 10.1078/1438-4639-00272.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   KOCH HM, 2005, ARCH TOXICOLOGY 0730.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   KOCH HM, 2005, INT J HYGIENE E 0815.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Lorz P. M., 2002, ULLMANNS ENCY IND CH.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   REGNIER J, 2004, TOXICOLOGIST CD OFFI, V78, P187.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Sharpe RM, 2005, ENVIRON HEALTH PERSP, V113, pA504.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Swan SH, 2005, ENVIRON HEALTH PERSP, V113, P1056, DOI 10.1289/ehp.8100.
   WOLFE GW, 2003, 7244200 TRC.
   {*}CSTEE, 2004, 41 PLEN M 8 JAN 2004.
   {*}ECPI, 2004, COMMUNICATION.
   {*}EPA, 2001, SAF ASS DI 2 ETH PHT.
   {*}SANCO, 2002, OP MED DEV CONT DEHP.}},
Number-of-Cited-References = {{58}},
Times-Cited = {{110}},
Journal-ISO = {{Int. J. Androl.}},
Doc-Delivery-Number = {{029EN}},
Wos-Id = {{ISI:000236542000037}},
}

@article{ ISI:000235147600002,
Author = {Calafat, AM and Silva, MJ and Reidy, JA and Gray, LE and Samandar, E and
   Preau, JL and Herbert, AR and Needham, LL},
Title = {{Mono-(3-carboxypropyl) phthalate, a metabolite of di-n-octyl phthalate}},
Journal = {{JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES}},
Year = {{2006}},
Volume = {{69}},
Number = {{3}},
Pages = {{215-227}},
Month = {{FEB}},
Abstract = {{Di-n-octyl phthalate (DnOP) is found as a component of mixed C6-C10
   linear-chain phthalates used as plasticizers in various polyvinyl
   chloride applications, including flooring and carpet tiles. Following
   exposure and absorption, DnOP is metabolized to its hydrolytic
   monoester, mono-n-octyl phthalate (MnOP), and other oxidative products.
   The urinary levels of one of these oxidative metabolites, mono(
   3-carboxypropyl) phthalate (MCPP), were about 560-fold higher than MnOP
   in Sprague-Dawley rats dosed with DnOP by gavage. Furthermore, MCPP was
   also found in the urine of rats dosed with diisooctyl phthalate (DiOP),
   di-isononyl phthalate (DiNP), di-isodecyl phthalate (DiDP),
   di-(2-ethylhexyl) phthalate, and di- n-butyl phthalate (DBP), although
   at concentrations considerably lower than in rats given similar
   concentrations of DnOP. The comparatively much higher urinary
   concentrations of MCPP than of the hydrolytic monoesters of the
   high-molecular-weight phthalates DiOP, DiNP, and DiDP in the exposed
   rats suggest that these monoesters may be poor biomarkers of exposure to
   their precursor phthalates and may explain the relatively low frequency
   of detection of these monoester metabolites in human populations. MCPP
   and MnOP were also measured in 267 human urine samples. The frequent
   detection and higher urinary concentrations of MCPP than MnOP suggest
   that exposure to DnOP might be higher than previously thought based on
   the measurements of MnOP alone. However, because MCPP is also a minor
   metabolite of DBP and other phthalates in rats, and the metabolism of
   phthalates in rodents and humans may differ, additional data on the
   absorption, distribution, metabolism, and elimination of MCPP are needed
   to completely understand the extent of human exposure to DnOP from the
   urinary concentrations of MCPP.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, 4770 Buford Hwy NE,Mailstop F17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.
   US EPA, Reprod Toxicol Div, Endocrinol Branch, Natl Hlth \& Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.}},
DOI = {{10.1080/15287390500227381}},
ISSN = {{1528-7394}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; HUMAN URINE; DI(2-ETHYLHEXYL)PHTHALATE DEHP;
   DI-(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL PHTHALATE;
   SEXUAL-DIFFERENTIATION; INTERNAL EXPOSURE; MALE-RAT; POPULATION;
   MALFORMATIONS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{ACalafat@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   BIZZARI S, 2003, CHEM INT HDB.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   David R. M., 2001, PATTYS TOXICOLOGY, P635.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Ema M, 2001, REPROD TOXICOL, V15, P261, DOI 10.1016/S0890-6238(01)00131-9.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kelada SN, 2003, ENVIRON HEALTH PERSP, V111, P1055, DOI 10.1289/ehp.6065.
   Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/10408440390250154.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   Melnick RL, 2001, ENVIRON HEALTH PERSP, V109, P437, DOI 10.2307/3454700.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}ATSDR, 1997, TOX PROF DI N OCTYL.
   {*}CDCP, 2003, 2 NAT REP HUM EXP EN.
   {*}CERHR, 2000, NTP CERHR EXP PAN RE.
   {*}FOOD DRUG ADM, 2000, IND FOOD ADD ADH COM.
   {*}IARC, 2000, IARC MON EV CARC RIS, V77, P41.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{21}},
Journal-ISO = {{J. Toxicol. Env. Health Part A}},
Doc-Delivery-Number = {{009XT}},
Wos-Id = {{ISI:000235147600002}},
}

@article{ ISI:000235120600004,
Author = {Ljungvall, K and Spjuth, L and Hulten, F and Einarsson, S and
   Rodriguez-Martinez, H and Andersson, K and Magnusson, U},
Title = {{Early post-natal exposure to low dose oral di(2ethylhexyl) phthalate
   affects the peripheral LH-concentration in plasma, but does not affect
   mating behavior in the post-pubertal boar}},
Journal = {{REPRODUCTIVE TOXICOLOGY}},
Year = {{2006}},
Volume = {{21}},
Number = {{2}},
Pages = {{160-166}},
Month = {{FEB}},
Abstract = {{In a split-litter design experiment, boars were exposed orally three
   times weekly to 300 mg/kg of di(2-ethylhexyl) phthalate (DEHP) between 3
   and 7 weeks of age. Post-puberty, i.e. at 6 months of age the effects on
   endocrinology and mating behavior were examined. The response to
   stimulation with a synthetic GnRH-analogue at 9 months of age resulted
   initially in lower concentration of LH in the exposed animals, compared
   to the control animals. We did not find any effects of DEHP on the
   mating behavior. Also, the effects of DEHP during the treatment period
   on the plasma concentrations of testosterone, oestradiol and LH were
   examined. During the exposure period there was a transient decrease in
   plasma concentrations of LH in the control group, which did not occur in
   the boars exposed to DEHR The data suggest that DEHP in low repeated
   oral doses causes lasting effects on the hypothalamus-pituitary-gonadal
   axis. (c) 2005 Elsevier Inc. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ljungvall, K (Reprint Author), Swedish Univ Agr Sci, Fac Vet Med \& Anim Sci, Dept Clin Sci, Box 7054, S-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Fac Vet Med \& Anim Sci, Dept Clin Sci, S-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Anim Breeding \& Genet, S-75007 Uppsala, Sweden.}},
DOI = {{10.1016/j.reprotox.2005.07.012}},
ISSN = {{0890-6238}},
Keywords = {{endocrine disruption; DEHP; male; domestic pig; mating; behavior;
   testosterone; LH}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; MALE-RATS; SEXUAL-DIFFERENTIATION; IN-UTERO;
   SPERM; TESTOSTERONE; METHOXYCHLOR; METABOLITE; MORPHOLOGY; KINETICS}},
Research-Areas = {{Reproductive Biology; Toxicology}},
Web-of-Science-Categories  = {{Reproductive Biology; Toxicology}},
Author-Email = {{karl.ljungvall@kv.slu.se}},
ResearcherID-Numbers = {{Rodriguez-Martinez, Heriberto/G-2675-2012}},
ORCID-Numbers = {{Rodriguez-Martinez, Heriberto/0000-0002-5194-2124}},
Cited-References = {{AGARWAL DK, 1986, ENVIRON HEALTH PERSP, V65, P343, DOI 10.2307/3430202.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Andersson H, 1998, ANIM REPROD SCI, V54, P121, DOI 10.1016/S0378-4320(98)00149-3.
   ARKINS S, 1988, ANIM REPROD SCI, V16, P277, DOI 10.1016/0378-4320(88)90021-8.
   Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011.
   Chahoud I, 1998, REPROD TOXICOL, V12, P667, DOI 10.1016/S0890-6238(98)00051-3.
   CHRISTENSEN NO, 1953, SVENSKA SVINAVELSFOR, P5.
   Eroschenko VP, 2002, NEUROTOXICOL TERATOL, V24, P29, DOI 10.1016/S0892-0362(01)00194-5.
   Federman DD, 2004, NEW ENGL J MED, V350, P323, DOI 10.1056/NEJMp038175.
   FORSBERG M, 1993, ACTA VET SCAND, V34, P255.
   Franca LR, 2000, BIOL REPROD, V63, P1629, DOI 10.1095/biolreprod63.6.1629.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Halldin K, 2003, ARCH TOXICOL, V77, P116, DOI 10.1007/s00204-002-0417-8.
   Higuchi TT, 2003, TOXICOL SCI, V72, P301, DOI 10.1093/toxsci/kfg036.
   Hutchison JB, 1999, J STEROID BIOCHEM, V69, P85, DOI 10.1016/S0960-0760(99)00057-6.
   Kim HS, 2003, ARCH TOXICOL, V77, P446, DOI 10.1007/s00204-003-0466-7.
   Ljungvall K, 2005, THERIOGENOLOGY, V64, P1170, DOI 10.1016/j.theriogenology.2005.02.003.
   Ljungvall K, 2004, ARCH TOXICOL, V78, P384, DOI 10.1007/s00204-004-0558-z.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Ostrer H, 2000, SEMIN REPROD MED, V18, P41, DOI 10.1055/s-2000-13474.
   Palanza P, 2002, NEUROTOXICOL TERATOL, V24, P55, DOI 10.1016/S0892-0362(01)00191-X.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P246, DOI 10.1016/0041-008X(85)90346-1.
   Romeo RD, 2003, J NEUROENDOCRINOL, V15, P1185, DOI 10.1111/j.1365-2826.2003.01106.x.
   SCHWARZENBERGER F, 1993, ACTA ENDOCRINOL-COP, V128, P173.
   SIROIS J, 1990, ENDOCRINOLOGY, V127, P916.
   TAYLOR GT, 1991, J MED, V22, P29.
   Wang XQ, 2002, PHYSIOL BEHAV, V75, P689, DOI 10.1016/S0031-9384(02)00673-X.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{5}},
Journal-ISO = {{Reprod. Toxicol.}},
Doc-Delivery-Number = {{009OC}},
Wos-Id = {{ISI:000235120600004}},
}

@article{ ISI:000234666700003,
Author = {Calafat, AM and Brock, JW and Silva, MJ and Gray, LE and Reidy, JA and
   Barr, DB and Needham, LL},
Title = {{Urinary and amniotic fluid levels of phthalate monoesters in rats after
   the oral administration of di(2-ethylhexyl) phthalate and di-n-butyl
   phthalate}},
Journal = {{TOXICOLOGY}},
Year = {{2006}},
Volume = {{217}},
Number = {{1}},
Pages = {{22-30}},
Month = {{JAN 5}},
Abstract = {{Two studies were designed to examine amniotic fluid and maternal urine
   concentrations of the di(2-ethylhexyl) phthalate (DEHP) metabolite
   mono(2-ethylhexyl) phthalate (MEHP) and the di-n-butyl phthalate (DBP)
   metabolite monobutyl phthalate (MBP) after administration of DEHP and
   DBP during pregnancy. In the first study, pregnant Sprague-Dawley rats
   were administered 0, 11, 33, 100, or 300 mg DEHP/kg/day by oral gavage
   starting on gestational day (GD) 7. In the second study, DBP was
   administered by oral gavage to pregnant Sprague-Dawley rats at doses of
   0, 100, or 250 mg/kg/day starting on GD 13. Maternal urine and amniotic
   fluid were collected and analyzed to determine the free and
   glucuronidated levels of MEHP and MBP. In urine, MEHP and MBP were
   mostly glucuronidated. By contrast, free MEHP and free MBP predominated
   in amniotic fluid. Statistically significant correlations were found
   between maternal DEHP dose and total maternal urinary MEHP (p = 0.0117),
   and between maternal DEHP dose and total amniotic fluid MEHP levels (p =
   0.0021). Total maternal urinary MEHP and total amniotic fluid MEHP
   levels were correlated (Pearson correlation coefficient = 0.968).
   Statistically significant differences were found in amniotic MBP levels
   between animals within the same DBP dose treatment group (p<0.0001) and
   between animals in different dose treatment groups (P<0.0001). Amniotic
   fluid MBP levels increased with increasing DBP doses, and high
   variability in maternal urinary levels of MBP between rats was observed.
   Although no firm conclusions could be drawn from the urinary MBP data,
   the MEHP results suggest that maternal urinary MEHP levels may be useful
   surrogate markers for fetal exposure to DEHR Published by Elsevier
   Ireland Ltd.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, 4770 Buford Hwy NE,Mailstop F17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.
   US EPA, Reprod Toxicol Div, Endocrinol Branch, Natl Hlth \& Environm Effects Res Lab, Res Triangle Pk, NC 27705 USA.}},
DOI = {{10.1016/j.tox.2005.08.013}},
ISSN = {{0300-483X}},
Keywords = {{di(2-ethylhexyl) phthalate; di-n-butyl phthalate; DEHP; DBP; exposure;
   biomonitoring}},
Keywords-Plus = {{MALE REPRODUCTIVE DEVELOPMENT; IN-UTERO EXPOSURE; PROLIFERATOR-ACTIVATED
   RECEPTORS; DOSE-DEPENDENT ALTERATIONS; DEUTERIUM-LABELED DEHP;
   INTENSIVE-CARE-UNIT; DI(N-BUTYL) PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE;
   DIETHYLHEXYL PHTHALATE; SEXUAL-DIFFERENTIATION}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{ACalafat@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011
   Barr, Dana/E-6369-2011
   Barr, Dana/E-2276-2013}},
Cited-References = {{ALBRO PW, 1982, J CHROMATOGR, V244, P65, DOI 10.1016/S0021-9673(00)80123-5.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   ASTILL BD, 1989, DRUG METAB REV, V21, P35, DOI 10.3109/03602538909029954.
   Awal MA, 2004, INT J TOXICOL, V23, P349, DOI 10.1080/10915810490901985.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335.
   Bility MT, 2004, TOXICOL SCI, V82, P170, DOI 10.1093/toxsci/kfh253.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011.
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Corton JC, 2005, TOXICOL SCI, V83, P4, DOI 10.1093/toxsci/kfi011.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   de Wildt SN, 1999, CLIN PHARMACOKINET, V36, P439, DOI 10.2165/00003088-199936060-00005.
   Egestad B, 1996, J CHROMATOGR B, V677, P99, DOI 10.1016/0378-4347(95)00439-4.
   Ema M, 2003, REPROD TOXICOL, V17, P407, DOI 10.1016/S0890-6238(03)00037-6.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   Ema M, 2002, REPROD TOXICOL, V16, P71, DOI 10.1016/S0890-6238(01)00200-3.
   Fennell TR, 2004, TOXICOL SCI, V82, P407, DOI 10.1093/toxsci/kfh294.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   FOSTER PM, 1982, DRUG METAB DISPOS, V11, P59.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Foster PMD, 2000, FOOD CHEM TOXICOL, V38, pS97, DOI 10.1016/S0278-6915(99)00128-3.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   Gray LE, 2003, TOXICOL SCI, V72, P283.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1984, FOOD CHEM TOXICOL, V22, P123, DOI 10.1016/0278-6915(84)90092-9.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Green R, 2005, ENVIRON HEALTH PERSP, V113, P1222, DOI 10.1289/chp.7932.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P116, DOI 10.1016/0041-008X(92)90374-2.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P3, DOI 10.2307/3429377.
   Koch H, 2005, UMWELTMED FORSCH PRA, V10, P144.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch H.M., 2003, INT J HYG ENVIR HEAL, V206, P1.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, ARCH TOXICOL, V79, P367, DOI 10.1007/s00204-004-0642-4.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Lehmann KP, 2004, TOXICOL SCI, V81, P60, DOI 10.1093/toxsci/kfh169.
   Li H, 2003, BIOL REPROD, V69, P1964, DOI 10.1095/biolreprod.103.018895.
   Liu KJ, 2005, BIOL REPROD, V73, P180, DOI 10.1095/biolreprod.104.039404.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   MOORE KL, 2004, DEV HUMAN CLIN ORIEN.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Payan JP, 2001, DRUG METAB DISPOS, V29, P843.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Saillenfait AM, 2001, PHARMACOL TOXICOL, V89, P104, DOI 10.1034/j.1600-0773.2001.d01-143.x.
   Saillenfait AM, 1998, TOXICOL SCI, V45, P212, DOI 10.1093/toxsci/45.2.212.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   SJOBERG P, 1986, ENVIRON HEALTH PERSP, V65, P237, DOI 10.2307/3430188.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   TAYLOR JK, 1987, QUALTIY ASSURANCE CH.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {*}ATSDR, 2002, TOX PROF DI2 ETHYL.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}FDA, 2001, SAF ASS DI2 ETH DEHP.}},
Number-of-Cited-References = {{70}},
Times-Cited = {{44}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{003FI}},
Wos-Id = {{ISI:000234666700003}},
}

@article{ ISI:000235278000001,
Author = {Silva, MJ and Reidy, A and Preau, JL and Samandar, E and Needham, LL and
   Calafat, AM},
Title = {{Measurement of eight urinary metabolites of di(2-ethylhexyl) phthalate
   as biomarkers for human exposure assessment}},
Journal = {{BIOMARKERS}},
Year = {{2006}},
Volume = {{11}},
Number = {{1}},
Pages = {{1-13}},
Month = {{JAN-FEB}},
Abstract = {{Human metabolism of di(2-ethylhexyl) phthalate ( DEHP) is complex and
   yields mono(2-ethylhexyl) phthalate ( MEHP) and numerous oxidative
   metabolites. The oxidative metabolites, mono(2-ethyl-5-oxohexyl)
   phthalate (MEOHP), mono(2-ethyl-5-hydroxyhexyl) phthalate (MEHHP),
   mono(2-ethyl-5-carboxypentyl) phthalate (MECPP) and
   mono(2-carboxymethylhexyl) phthalate (MCMHP), have been considered to be
   better biomarkers for DEHP exposure assessment than MEHP because urinary
   levels of these metabolites are generally higher than MEHP, and their
   measurements are not subject to contamination. The urinary levels of the
   above metabolites, and of three other recently identified DEHP oxidative
   metabolites, mono(2-ethyl-3-carboxypropyl) phthalate (MECPrP),
   mono-2-(1-oxoethylhexyl) phthalate (MOEHP), and
   mono(2-ethyl-4-carboxybutyl) phthalate (MECBP), were measured in 129
   adults. MECPP, MCMHP and MEHHP were present in all the samples analysed.
   MEHP and the other oxidative metabolites were detected less frequently:
   MEOHP (99\%), MECBP (88\%), MECPrP (84\%), MEHP (83\%) and MOEHP (77\%).
   The levels of all DEHP metabolites were highly correlated (pB/0.0001)
   with each other, confirming a common parent. The v and omega-1 oxidative
   metabolites ( MECPP, MCMHP, MEHHP and MEOHP) comprised 87.1\% of all
   metabolites measured, and thus are most likely the best biomarkers for
   DEHP exposure assessment. The percentage of the unglucuronidated free
   form excreted in urine was higher for the ester linkage carboxylated
   DEHP metabolites compared with alcoholic and ketonic DEHP metabolites.
   The percentage of the unglucuronidated free form excreted in urine was
   higher for the DEHP metabolites with a carboxylated ester side-chain
   compared with alcoholic and ketonic metabolites. Further, differences
   were found between the DEHP metabolite profile between this adult
   population and that of six neonates exposed to high doses of DEHP
   through extensive medical treatment. In the neonates, MEHP represented
   0.6\% and MECPP 65.5\% of the eight DEHP metabolites measured compared
   to 6.6\% ( MEHP) and 31.8\% ( MECPP) in the adults. Whether the observed
   differences reflect differences in route/duration of the exposure, age
   and/or health status of the individuals is presently unknown.}},
Publisher = {{TAYLOR \& FRANCIS LTD}},
Address = {{4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, A770 Buford Highway NE,Mailstop F17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.}},
DOI = {{10.1080/13547500500382868}},
ISSN = {{1354-750X}},
Keywords = {{DEHP; MEHP; Di(2-ethylhexyl) phthalate; biomonitoring; phthalates}},
Keywords-Plus = {{SOLID-PHASE EXTRACTION; DI-(2-ETHYLHEXYL) PHTHALATE; DEHP; CHILDREN;
   RAT; PLASTICIZER; POPULATION; PARAMETERS; MONOESTERS; OXIDATION}},
Research-Areas = {{Biotechnology \& Applied Microbiology; Toxicology}},
Web-of-Science-Categories  = {{Biotechnology \& Applied Microbiology; Toxicology}},
Author-Email = {{zca2@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   ALBRO PW, 1983, BIOCHIM BIOPHYS ACTA, V760, P283, DOI 10.1016/0304-4165(83)90175-7.
   ALBRO PW, 1984, DRUG METAB DISPOS, V12, P742.
   ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   ALBRO PW, 1987, BIOCHIM BIOPHYS ACTA, V923, P196, DOI 10.1016/0304-4165(87)90004-3.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   CDC, 2005, 3 CDCP NAT CTR ENV H.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, ARCH TOXICOL, V79, P689, DOI 10.1007/s00204-005-0004-x.
   OCH HM, 2005, ARCH TOXICOL, V79, P367.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   ROTH B, 1988, EUR J PEDIATR, V147, P41, DOI 10.1007/BF00442609.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2005, ARCH TOXICOL, V79, P647, DOI 10.1007/s00204-005-0674-4.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2005, TOXICOLOGY, V210, P123, DOI 10.1016/j.tox2005.01.012.
   SILVA MJ, 2003, J CHROMATOGR B, V759, P393.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   SILVA MJ, 2006, IN PRESS TOXICOLOGY.
   SJOBERG P, 1986, ENVIRON HEALTH PERSP, V65, P237, DOI 10.2307/3430188.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{53}},
Journal-ISO = {{Biomarkers}},
Doc-Delivery-Number = {{011ON}},
Wos-Id = {{ISI:000235278000001}},
}

@article{ ISI:000241582000004,
Author = {Sircar, Debajit and Albazi, Sargon J. and Atallah, Yousef and Pizzi,
   William},
Title = {{Unified reversed-phase method for the determination of Di (2-ethylhexyl)
   phthalate and its major metabolite, mono (2-ethylhexyl) phthalate, in
   biological samples}},
Journal = {{JOURNAL OF LIQUID CHROMATOGRAPHY \& RELATED TECHNOLOGIES}},
Year = {{2006}},
Volume = {{29}},
Number = {{20}},
Pages = {{2931-2942}},
Abstract = {{A UV detector at 235 nm and an Alltech Altima C-18 column (150 x 4.6 mm
   and 5 micron) were used to develop a high performance liquid
   chromatographic method to determine Di (2-ethylhexyl) phthalate {[}DEHP]
   and its metabolite mono (2-ethylhexyl) phthalate {[}MEHP] in biological
   samples. A gradient time of 8 min and a gradient range of 60 - 100\%
   acetonitrile (ACN) at pH 3.0, with a segmented flow rate gradient, were
   found to be optimum conditions. These conditions resulted in retention
   times of 4.2 and 7.1 min for MEHP and DEHP, respectively. The estimated
   limits of detection (LOD) and quantitation (LOQ) for DEHP were 1.37 and
   4.8 mu g/mL, respectively. For MEHP, LOD, and LOQ were 0.57 and 2.4 mu
   g/mL, respectively. The developed method was applied to determine DEHP
   and its metabolite MEHP in blood plasma, liver, kidney, brain, and
   testis samples.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Albazi, SJ (Reprint Author), NE Illinois Univ, Dept Chem, Chicago, IL 60625 USA.
   NE Illinois Univ, Dept Chem, Chicago, IL 60625 USA.
   NE Illinois Univ, Dept Psychol, Chicago, IL 60625 USA.}},
DOI = {{10.1080/10826070600980993}},
ISSN = {{1082-6076}},
Keywords = {{DEHP; MEHP; HPLC-UV; biological samples}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; BLOOD PRODUCTS; DIETHYLHEXYL PHTHALATE; PVC
   GLOVES; PLASTICIZERS; EXPOSURE; PLASMA; DEHP; CONTAMINATION; BEHAVIOR}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{s-albazi@neiu.edu}},
Cited-References = {{ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   CHING NPH, 1981, J CHROMATOGR, V222, P171, DOI 10.1016/S0378-4347(00)81050-6.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P227.
   Clark K, 2003, HANDB ENVIRON CHEM, V3, P125.
   COLE RS, 1981, VOX SANG, V40, P317.
   Dalgaard M, 2000, PHARMACOL TOXICOL, V86, P92, DOI 10.1034/j.1600-0773.2000.d01-17.x.
   Demore B, 2002, J CLIN PHARM THER, V27, P139, DOI 10.1046/j.1365-2710.2002.00395.x.
   Hanawa T, 2003, INT J PHARM, V267, P141, DOI 10.1016/j.ijpharm.2003.08.009.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   Kambia K, 2001, J CHROMATOGR B, V755, P297, DOI 10.1016/S0378-4347(01)00125-6.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   MANGHAM BA, 1981, TOXICOL APPL PHARM, V61, P205, DOI 10.1016/0041-008X(81)90410-5.
   MANN AH, 1985, TOXICOL APPL PHARM, V77, P116, DOI 10.1016/0041-008X(85)90273-X.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   Shintani H, 2000, CHROMATOGRAPHIA, V52, P721, DOI 10.1007/BF02490995.
   SJOBERG P, 1985, J CHROMATOGR, V344, P167, DOI 10.1016/S0378-4347(00)82017-4.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P569, DOI 10.1080/02652030010028344.
   Tsumura Y, 2003, FOOD ADDIT CONTAM, V20, P317, DOI 10.1080/0265203031000122021.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{1}},
Journal-ISO = {{J. Liq. Chromatogr. Relat. Technol.}},
Doc-Delivery-Number = {{099GT}},
Wos-Id = {{ISI:000241582000004}},
}

@article{ ISI:000233718800001,
Author = {Koch, HM and Bolt, HM and Preuss, R and Eckstein, R and Weisbach, V and
   Angerer, J},
Title = {{Intravenous exposure to di(2-ethylhexyl)phthalate (DEHP): metabolites of
   DEHP in urine after a voluntary platelet donation}},
Journal = {{ARCHIVES OF TOXICOLOGY}},
Year = {{2005}},
Volume = {{79}},
Number = {{12}},
Pages = {{689-693}},
Month = {{DEC}},
Abstract = {{In this study we investigated human metabolism and excretion of DEHP
   after intravenous exposure. For this purpose we determined the five
   major DEHP metabolites in urine samples of a volunteer before and after
   a platelet donation (dual-needle technique). Plateletpheresis procedures
   are known to cause a significant DEHP exposure. We observed a sharp
   increase in urinary DEHP metabolite concentrations after the procedure.
   Maximum concentrations of 5OH-MEHP, 5oxo-MEHP, 5cx-MEPP and MEHP
   observed 4 h after the procedure were 822, 729, 577 and 388 mu g/l
   respectively. 2cx-MMHP was excreted at highest concentrations after 8 h
   (201 mu g/l). Due to longer elimination half-times, 5cx-MEPP and
   2cx-MMHP were the major metabolites excreted in urine 24 h after the
   exposure. The 24-h-cumulative excretion of 363 mu g 5cx-MEPP, 353 mu g
   5OH-MEHP, 309 mu g 5oxo-MEHP, 178 mu g MEHP and 133 mu g 2cx-MMHP
   indicates an absolute exposure of our volunteer of about 2.6 mg DEHP.
   Related to the body weight this equals a dose of 31.6 mu g/kg body
   weight/day. This indicates that current risk or preventive limit values
   for DEHP such as the RfD of the US EPA (20 mu g/kg/day) and the TDI of
   the European Union (20-48 mu g/kg/day) can be exceeded on the day of the
   plateletpheresis. The amount of the dose excreted in urine, distribution
   of the metabolites in urine and all other elimination characteristics
   after intravenous DEHP exposure are comparable to oral exposure. There
   are no indications that toxicokinetic behaviour and the toxicity of DEHP
   are fundamentally different after the two routes of exposure. Therefore,
   toxicological endpoints observed for DEHP after oral application should
   also be considered relevant for medical procedures causing intravenous
   DEHP exposure, like apheresis procedures. Especially women in their
   reproductive age need to be protected from DEHP exposures exceeding the
   above mentioned preventive limit values.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING STREET, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Angerer, J (Reprint Author), Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, Schillerstr 25-29, D-91054 Erlangen, Germany.
   Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, D-91054 Erlangen, Germany.
   Univ Dortmund, Inst Occupat Physiol, Leibniz Res Ctr Working Environm \& Human Factors, D-44139 Dortmund, Germany.
   Univ Hosp Erlangen Nuremberg, Dept Transfus Med \& Haemostaseol, D-91054 Erlangen, Germany.}},
DOI = {{10.1007/s00204-005-0004-x}},
ISSN = {{0340-5761}},
Keywords = {{metabolism; human; intravenous; exposure; apheresis; plateletpheresis;
   di(2-ethylhexyl)phthalate (DEHP); mono(2-ethyl-5-hydroxyhexyl)phthalate
   (5OH-MEHP); mono(2-ethyl-5-oxo-hexyl)phthalate (5oxo-MEHP);
   mono(2-ethyl-5-carboxypropyl)phthalate (5cx-MEPP);
   mono{[}2-(carboxymethyl)hexyl]phthalate (2cx-MMHP);
   mono(2-ethylhexyl)phthalate (MEHP)}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; MAJOR METABOLITES; PLASTICIZER
   DI(2-ETHYLHEXYL)PHTHALATE; BIS(2-ETHYLHEXYL) PHTHALATE; REPRODUCTIVE
   HEALTH; INTERNAL EXPOSURE; DI-(2-ETHYLHEXYL)PHTHALATE; BIOMARKERS;
   SECONDARY; CHILDREN}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{Juergen.Angerer@ipasum.imed.uni-erlangen.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Buchta C, 2003, TRANSFUSION, V43, P1115, DOI 10.1046/j.1537-2995.2003.00479.x.
   CSTEE (Scientific Committee on Toxicity Ecotoxicity and the Environment), 1998, 6 CSTEE PLEN M BRUSS.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Environmental Protection Agency (EPA), 1999, INT RISK INF SYST IR.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Gilsing HD, 2003, MONATSH CHEM, V134, P1207, DOI 10.1007/s00706-003-0044-y.
   Gilsing HD, 2005, MONATSH CHEM, V136, P795, DOI 10.1007/s00706-004-0267-6.
   Gilsing HD, 2002, MONATSH CHEM, V133, P1147, DOI 10.1007/s007060200084.
   Hoppin JA, 2003, EPIDEMIOLOGY, V14, P259, DOI 10.1097/00001648-200305000-00002.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   KOCH HM, IN PRESS INT J HYG E.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   KOCH HM, 2005, ARCH TOXICOL    0208.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   REGNIER J, 2004, TOXICOLOGIST CD OFFI, V78, P187.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   WOLFE GW, 2003, 7244200 TRC.
   {*}ADVAMED, 2001, 11947 ADVAMED.
   {*}CSTEE, 2004, CSTEE 41 PLEN M 8 JA.
   {*}DFG, 2002, GESUNDHEITSSCHADLICH.
   {*}DG SANCO, 2002, OP MED DEV CONT DEHP.
   {*}FED MED COUNC P E, 2001, GUID COLL BLOOD BLOO.
   {*}HLTH CAN, 2002, DEHP MED DEV EXP TOX.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{18}},
Journal-ISO = {{Arch. Toxicol.}},
Doc-Delivery-Number = {{990BS}},
Wos-Id = {{ISI:000233718800001}},
}

@article{ ISI:000233248400004,
Author = {Silva, MJ and Reidy, JA and Samandar, E and Herbert, AR and Needham, LL
   and Calafat, AM},
Title = {{Detection of phthalate metabolites in human saliva}},
Journal = {{ARCHIVES OF TOXICOLOGY}},
Year = {{2005}},
Volume = {{79}},
Number = {{11}},
Pages = {{647-652}},
Month = {{NOV}},
Abstract = {{In assessment of exposure to environmental contaminants, the use of
   unconventional matrices is becoming an increasingly important area of
   research. Saliva is one of the most promising alternative matrices
   because its collection is easy, noninvasive, and inexpensive. In this
   study, we measured the salivary concentrations of 14 phthalate
   metabolites in 39 anonymous adult volunteers using isotope-dilution,
   automated solid phase extraction-high performance liquid
   chromatography-tandem mass spectrometry. Seven phthalate metabolites
   were detected at the concentrations ranging from below the limit of
   detection (< 1 ng/mL) to 10.6 ng/mL for phthalic acid, 3.1 ng/mL for
   monomethyl phthalate (MMP), 91.4 ng/mL for monoethyl phthalate (MEP),
   65.8 ng/mL for mono-n-butyl phthalate (MBP), 17.9 ng/mL for
   mono-iso-butyl phthalate, 353.6 ng/mL for monobenzyl phthalate, and 6.8
   ng/mL for mono-2-ethylhexyl phthalate (MEHP). The frequency of detection
   was highest for MBP (85\%) and lowest for MMP (8\%). The median salivary
   MBP level in this group of adults was higher than the median serum MBP
   level in another non-occupationally exposed human adult population in
   the United States, whereas, the median salivary levels of MEP and MEHP
   were lower than the corresponding median serum levels. The frequency of
   detection and the salivary levels of each phthalate monoester in this
   study population were lower than the frequency of detection and urinary
   level of the same monoester in the general US population. Although urine
   is preferred for exposure assessment to non-persistent chemicals such as
   phthalates, the similar levels in serum and saliva suggest that saliva
   could be used as a surrogate matrix for measuring the bioavailable dose
   of phthalates in biomonitoring studies.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING STREET, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, 4770 Buford Highway NE,Mail Stop F-17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.}},
DOI = {{10.1007/s00204-005-0674-4}},
ISSN = {{0340-5761}},
Keywords-Plus = {{MALE REPRODUCTIVE DEVELOPMENT; TANDEM MASS-SPECTROMETRY; ASSESSING HUMAN
   EXPOSURE; NURSERY-SCHOOL CHILDREN; SOLID-PHASE EXTRACTION; BUTYL BENZYL
   PHTHALATE; DI(N-BUTYL) PHTHALATE; HUMAN URINE; ENVIRONMENTAL CHEMICALS;
   SEXUAL-DIFFERENTIATION}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{zca2@cdc.gov}},
Cited-References = {{Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   CALAFAT AM, 2005, IN PRESS J TOXICOL A.
   David R. M., 2001, PATTYS TOXICOLOGY, P635.
   Ema M, 2003, REPROD TOXICOL, V17, P407, DOI 10.1016/S0890-6238(03)00037-6.
   Ema M, 2001, REPROD TOXICOL, V15, P261, DOI 10.1016/S0890-6238(01)00131-9.
   Ema M, 2002, REPROD TOXICOL, V16, P71, DOI 10.1016/S0890-6238(01)00200-3.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1984, FOOD CHEM TOXICOL, V22, P123, DOI 10.1016/0278-6915(84)90092-9.
   HOLD KM, 1995, INT J DRUG TEST, V1, P1.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   KATO K, 2003, J ANAL TOXICOL, V27, pA15.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kidwell DA, 1998, J CHROMATOGR B, V713, P111, DOI 10.1016/S0378-4347(97)00572-0.
   Kintz P, 2002, THER DRUG MONIT, V24, P239, DOI 10.1097/00007691-200204000-00006.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   KOCH HM, 2005, IN PRESS ARCH TOXICO.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Koch HM, 2005, INT ARCH OCC ENV HEA, V78, P223, DOI 10.1007/s00420-004-0570-x.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Needham LL, 2005, ANAL BIOANAL CHEM, V381, P397, DOI 10.1007/s00216-004-2975-5.
   Needham LL, 2000, J EXPO ANAL ENV EPID, V10, P611.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Rivier L, 2000, BEST PRACT RES CL EN, V14, P147, DOI 10.1053/beem.2000.0060.
   SCHRAMM W, 1992, J ANAL TOXICOL, V16, P1.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   SILVA MJ, TOXICOLOGY, V210, P123.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 1997, TOX PROF DI N OCT PH.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}CDC, 2003, 2 CDC NAT CTR ENV HL.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{33}},
Journal-ISO = {{Arch. Toxicol.}},
Doc-Delivery-Number = {{983QY}},
Wos-Id = {{ISI:000233248400004}},
}

@article{ ISI:000232965600003,
Author = {Latini, G},
Title = {{Monitoring phthalate exposure in humans}},
Journal = {{CLINICA CHIMICA ACTA}},
Year = {{2005}},
Volume = {{361}},
Number = {{1-2}},
Pages = {{20-29}},
Month = {{NOV}},
Abstract = {{The dialkyl- or alkyl/aryl esters of 1,2-benzenedicarboxylic acid,
   commonly known as phthalates, are high-production-volume synthetic
   chemicals and ubiquitous environmental contaminants because of their use
   in plastics and other common consumer products. Di-(2-ethylhexyl)
   phthalate (DEHP) is the most abundant phthalate in the environment.
   Humans are exposed to these compounds through ingestion, inhalation, and
   dermal exposure for their whole lifetime, since the intrauterine life.
   Public and scientific concern has increased in recent years about the
   potential health risks associated with exposure to phthalates. The main
   focus has moved away from the hepatotoxic effects to the endocrine
   disrupting potency of these chemicals. To date, although the consistent
   toxicologic data on phthalates is suggestive, information on sources and
   pathways of human exposure to phthalates is limited. Recently, exposure
   to phthalates has been assessed by analyzing urine for their
   metabolites. This approach is contrary to the determination of the
   parent phthalates in air, water and foodstuff and not subject to
   contamination. Furthermore, these metabolites and the parent phthalates
   are considered the toxic species. However, accurate methods and models
   for measuring the amount of phthalates absorbed by the various pathways
   of exposure have to be developed. In fact, a frequent biological
   monitoring of phthalates in body fluids and tissues would be highly
   advisable, both in helping physicians to perform health risk assessments
   for exposure in the general population and in guiding governments to
   provide regulations concerning the maximum allowed concentrations in the
   environment, plasticized products, medications and medical equipment.
   (c) 2005 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Latini, G (Reprint Author), Perrino Hosp, Div Neonatol, Brindisi, Italy.
   Perrino Hosp, Div Neonatol, Brindisi, Italy.
   CNR, IFC, Inst Clin Physiol, Natl Res Council Italy,Lecce Sect, Lecce, Italy.}},
DOI = {{10.1016/j.cccn.2005.05.003}},
ISSN = {{0009-8981}},
Keywords = {{human biological monitoring; general population; phthalates; primary and
   secondary phthalate metabolites; endocrine disruptor; fertility;
   reproduction}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; SOLID-PHASE EXTRACTION; POLY(VINYL CHLORIDE)
   FORMULATIONS; LIQUID-CHROMATOGRAPHY; HUMAN URINE; DI-(2-ETHYLHEXYL)
   PHTHALATE; DI(2-ETHYLHEXYL) PHTHALATE; DI(N-BUTYL) PHTHALATE;
   MONO(2-ETHYLHEXYL) PHTHALATE; DI-2-ETHYLHEXYL PHTHALATE}},
Research-Areas = {{Medical Laboratory Technology}},
Web-of-Science-Categories  = {{Medical Laboratory Technology}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ANDERER J, 2002, BIOL MONITORING PROS.
   ATSDR, 1995, TOX PROF DIETH.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount B. C., 2000, ENV HLTH PERSPECT, V108, P972.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   Cobellis L, 2003, HUM REPROD, V18, P1512, DOI 10.1093/humrep/deg254.
   CSTEE (Scientific Committee on Toxicity Ecotoxicity and the Environment), 1998, 6 CSTEE PLEN M BRUSS.
   Damstra T, 2004, GLOBAL ASSESSMENT ST.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Ema M, 2001, REPROD TOXICOL, V15, P261, DOI 10.1016/S0890-6238(01)00131-9.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   Ferruti P, 2003, BIOMACROMOLECULES, V4, P181, DOI 10.1021/bm020115q.
   FISHER JS, 2003, HUM REPROD, V7, P1383.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   HEINDEL JJ, 1989, TOXICOL APPL PHARM, V97, P377.
   Hill SS, 2001, CLIN CHIM ACTA, V304, P1, DOI 10.1016/S0009-8981(00)00411-3.
   Holm A, 2004, ANAL BIOANAL CHEM, V378, P1762, DOI 10.1007/s00216-003-2488-7.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Hoyer PB, 2001, BIOCHEM PHARMACOL, V62, P1557, DOI 10.1016/S0006-2952(01)00814-0.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   IARC, 2000, IARC MON EV CARC RIS.
   Kambia K, 2003, INT J PHARM, V262, P83, DOI 10.1016/S0378-5173(03)00335-1.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J CHROMATOGR B, V788, P407, DOI 10.1016/S1570-0232(03)00041-2.
   Kato K, 2005, J CHROMATOGR B, V814, P355, DOI 10.1016/j.jchromb.2004.10.056.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Keys DA, 2000, TOXICOL SCI, V53, P173, DOI 10.1093/toxsci/53.2.173.
   Keys DA, 1999, TOXICOL SCI, V49, P172, DOI 10.1093/toxsci/49.2.172.
   Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/10408440390250154.
   Koch HM, 2004, REPROD TOXICOL, V18, P759, DOI 10.1016/j/reprotox.2004.05.003.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   KOCH HM, 2005, IN PRESS ARCH TOXICO.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Lakshmi S, 1998, ARTIF ORGANS, V22, P222, DOI 10.1046/j.1525-1594.1998.06124.x.
   Latini G, 2004, CANCER, V101, P210, DOI 10.1002/cncr.20357.
   Latini G, 2004, REPROD TOXICOL, V19, P27, DOI 10.1016/j.reprotox.2004.05.011.
   Latini Giuseppe, 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P37, DOI 10.2174/1568008043340017.
   Latini G, 1999, ACTA PAEDIATR, V88, P1174, DOI 10.1080/08035259950168333.
   Latini G, 2003, BIOL NEONATE, V83, P22, DOI 10.1159/000067012.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   Lee JH, 1999, J BIOMED MATER RES, V48, P328, DOI 10.1002/(SICI)1097-4636(1999)48:3<328::AID-JBM18>3.0.CO;2-L.
   Lin ZP, 2003, ENVIRON SCI TECHNOL, V37, P2100, DOI 10.1021/es026361r.
   Lorz P. M., 2002, ULLMANNS ENCY IND CH.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Magliozzi R, 2003, HISTOCHEM CELL BIOL, V120, P41, DOI 10.1007/s00418-003-0543-2.
   Mc Neal T.P., 1998, ANN M AM CHEM SOC AU.
   MES J, 1974, B ENVIRON CONTAM TOX, V12, P721.
   Mettang T, 2000, PERITON DIALYSIS INT, V20, P80.
   Mihovec-Grdic M, 2002, CROAT MED J, V43, P493.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Niino T, 2002, J CHROMATOGR B, V780, P35, DOI 10.1016/S1570-0232(02)00413-0.
   Nilsson S, 2002, CRIT REV EUKAR GENE, V12, P237, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i4.10.
   Otake T, 2001, ENVIRON SCI TECHNOL, V35, P3099, DOI 10.1021/es001914o.
   OVERTURF ML, 1979, B ENVIRON CONTAM TOX, V22, P536.
   Paris I, 2003, ANAL LETT, V36, P2649, DOI 10.1081/AL-120024639.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   Psillakis E, 2004, CHEMOSPHERE, V54, P849, DOI 10.1016/j.chemosphere.2003.09.039.
   REGNIER J, 2004, J SOC TOXICOL, V78, P187.
   ROCK G, 1990, TRANSFUSION, V30, P767, DOI 10.1046/j.1537-2995.1990.30891020345.x.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   SMITH MD, 1995, J BIOMAT SCI-POLYM E, V7, P453.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   Suzuki T, 2001, ENVIRON SCI TECHNOL, V35, P3757, DOI 10.1021/es001860i.
   Templeton DM, 2000, PURE APPL CHEM, V72, P1453, DOI 10.1351/pac200072081453.
   Valles EG, 2003, TOXICOLOGY, V191, P211, DOI 10.1016/S0300-483X(03)00260-9.
   Vikelsoe J, 2002, SCI TOTAL ENVIRON, V296, P105, DOI 10.1016/S0048-9697(02)00063-3.
   Weidenhoffer Z, 1996, Cent Eur J Public Health, V4, P11.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   YAKUBOVICH M, 2000, MED DEVICE TECHNOL, V11, P18.
   {[}Anonymous], 2002, FIN REP.
   {*}ATSDR, 2001, TOX PROF DINB.
   {*}ATSDR, 2002, TOX PROF DI2ETH DEHP.
   {*}ATSDR, 1997, TOX PROF DIN.
   {*}CTR DEV RAD HLTH, 2001, SAF ASS DI2 DEHP.
   {*}CTR EV RISKS HUM, 2000, NTCERHR EXP PAN REP.
   {*}NAT TOX PROGR CTR, 2003, NTPCERHR EXP PAN REP.
   {*}UK MIN AGR FISH F, 1998, 168 UK MIN AGR FISH.}},
Number-of-Cited-References = {{100}},
Times-Cited = {{96}},
Journal-ISO = {{Clin. Chim. Acta}},
Doc-Delivery-Number = {{979SR}},
Wos-Id = {{ISI:000232965600003}},
}

@article{ ISI:000232916700034,
Author = {Duty, SM and Ackerman, RM and Calafat, AM and Hauser, R},
Title = {{Personal care product use predicts urinary concentrations of some
   phthalate monoesters}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2005}},
Volume = {{113}},
Number = {{11}},
Pages = {{1530-1535}},
Month = {{NOV}},
Abstract = {{Phthalates are multifunctional chemicals used in a variety of
   applications, including personal care products. The present study
   explored the relationship between patterns of personal care product use
   and urinary levels of several phthalate metabolites. Subjects include
   406 men who participated in an ongoing semen quality study at the
   Massachusetts General Hospital Andrology Laboratory between January 2000
   and February 2003. A nurse-administered questionnaire was used to
   determine use of personal care products, including cologne, aftershave,
   lotions, hair products, and deodorants. Phthalate monoester
   concentrations were measured in a single spot urine sample by isotope
   dilution-high-performance liquid chromatography coupled to tandem mass
   spectrometry. Men who used cologne or aftershave within 48 hr before
   urine collection had higher median levels of monoethyl phthalate (MEP)
   (265 and 266 ng/mL, respectively) than those who did not use cologne or
   aftershave (108 and 133 ng/mL, respectively). For each additional type
   of product used, MEP increased 33\% (95\% confidence interval, 14-53\%).
   The use of lotion was associated with lower urinary levels of monobutyl
   phthalate (MBP) (14.9 ng/mL), monobenzyl phthalate (MBzP) (6.1 ng/mL),
   and mono(2-ethylhexyl) phthalate (MEHP) (4.4 ng/mL) compared with men
   who did not use lotion (MBP, 16.8 ng/mL; MBzP, 8.6 ng/mL; MEHP, 7.2
   ng/mL). The identification of personal care products as contributors to
   phthalate body burden is an important step in exposure.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hauser, R (Reprint Author), Harvard Univ, Occupat Hlth Program, Dept Environm Hlth, Sch Publ Hlth, Bldg 1,Room 1405,665 Huntington Ave, Boston, MA 02115 USA.
   Harvard Univ, Occupat Hlth Program, Dept Environm Hlth, Sch Publ Hlth, Boston, MA 02115 USA.
   Simmons Coll, Sch Hlth Studies, Dept Nursing, Boston, MA 02115 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv, Androl Lab, Boston, MA USA.
   Massachusetts Gen Hosp, In Vitro Fertilizat Unit, Boston, MA USA.}},
DOI = {{10.1289/ehp.8083}},
ISSN = {{0091-6765}},
Keywords = {{environment; personal care products; phthalates; urinary metabolites}},
Keywords-Plus = {{PERCUTANEOUS-ABSORPTION; HUMAN SKIN; IN-VIVO; QUANTITATIVE DETECTION;
   DIETHYL PHTHALATE; METABOLITES; EXPOSURE; INVITRO; RATS; POPULATION}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{rhauser@hohp.harvard.edu}},
Cited-References = {{Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   BARBER ED, 1992, FUND APPL TOXICOL, V19, P493, DOI 10.1016/0272-0590(92)90086-W.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Deisinger PJ, 1998, FOOD CHEM TOXICOL, V36, P521, DOI 10.1016/S0278-6915(98)00015-5.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   ELSISI AE, 1989, FUND APPL TOXICOL, V12, P70, DOI 10.1016/0272-0590(89)90063-8.
   HAGEDORNLEWEKE U, 1995, PHARMACEUT RES, V12, P1354.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Houlihan J., 2002, NOT TOO PRETTY PHTHA.
   HOWARD J, 2001, TOXICOLOGY TUTOR 2 T.
   Koo HJ, 2004, J TOXICOL ENV HEAL A, V67, P1901, DOI 10.1080/15287390490513300.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   MELNICK RL, 1987, TOXICOL IND HEALTH, V3, P99.
   MINT A, 1994, TOXICOL IN VITRO, V8, P251, DOI 10.1016/0887-2333(94)90190-2.
   MORRIS P, 2004, INGREDIENTS CIGARETT.
   NG KME, 1992, TOXICOL APPL PHARM, V115, P216, DOI 10.1016/0041-008X(92)90326-N.
   PARK YK, 2000, MENSAGEM DOCE, V58, P2.
   SCOTT RC, 1987, ENVIRON HEALTH PERSP, V74, P223, DOI 10.2307/3430452.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   SWAN SH, 2005, ENV HLTH PERSPECT.
   Wester RC, 1998, TOXICOL APPL PHARM, V151, P159, DOI 10.1006/taap.1998.8434.
   {*}ATSDR, 1995, TOX PROF DIET PHTH.
   {*}ATSDR, 2003, TOX PROF DI 2 ETHY P.
   {*}ATSOR, 2001, TOX PROF DI N BUTYL.
   {*}CDC, 2003, SEC NAT REP HUM EXP.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{71}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{979BI}},
Wos-Id = {{ISI:000232916700034}},
}

@article{ ISI:000233448800010,
Author = {Silva, MJ and Samandar, E and Preau, JL and Reidy, JA and Needham, LL
   and Calafat, AM},
Title = {{Automated solid-phase extraction and quantitative analysis of 14
   phthalate metabolites in human serum using isotope
   dilution-high-performance liquid chromatography-tandem mass spectrometry}},
Journal = {{JOURNAL OF ANALYTICAL TOXICOLOGY}},
Year = {{2005}},
Volume = {{29}},
Number = {{8}},
Pages = {{819-824}},
Month = {{NOV-DEC}},
Publisher = {{PRESTON PUBLICATIONS INC}},
Address = {{7800 MERRIMAC AVE PO BOX 48312, NILES, IL 60648 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Mailstop F17,4770 Buford Hwy NE, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.}},
ISSN = {{0146-4760}},
Keywords-Plus = {{HUMAN URINE; SEXUAL-DIFFERENTIATION; INTERNAL EXPOSURE; MALE-RAT; DEHP;
   POPULATION; DI(2-ETHYLHEXYL)PHTHALATE; MALFORMATIONS; BIOMARKERS;
   PARAMETERS}},
Research-Areas = {{Chemistry; Toxicology}},
Web-of-Science-Categories  = {{Chemistry, Analytical; Toxicology}},
Author-Email = {{zca2@cdc.gov}},
Cited-References = {{ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   David R. M., 2001, PATTYS TOXICOLOGY, P635.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Ema M, 2001, REPROD TOXICOL, V15, P261, DOI 10.1016/S0890-6238(01)00131-9.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Kuklenyik Z, 2004, ENVIRON SCI TECHNOL, V38, P3698, DOI 10.1021/es040332u.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Silva MJ, 2005, TOXICOLOGY, V210, P123, DOI 10.1016/j.tox2005.01.012.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   Takatori S, 2004, J CHROMATOGR B, V804, P397, DOI 10.1016/j.jchromb.2004.01.056.
   {*}AG TOX SUBST DIS, 1995, TOX PROF DIETH PHTHA.
   {*}AG TOX SUBST DIS, 2001, TOX PROF DI N BUT PH.
   {*}AG TOX SUBST DIS, 1997, TOX PROF DI N OCT.
   {*}AG TOX SUBST DIS, 2002, TOX PROF DI2 ETH DEH.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{17}},
Journal-ISO = {{J. Anal. Toxicol.}},
Doc-Delivery-Number = {{986KP}},
Wos-Id = {{ISI:000233448800010}},
}

@article{ ISI:000231967900012,
Author = {Ljungvall, K and Karlsson, P and Hulten, F and Madej, A and Norrgren, L
   and Einarsson, S and Rodriguez-Martinez, H and Magnusson, U},
Title = {{Delayed effects on plasma concentration of testosterone and testicular
   morphology by intramuscular low-dose di(2-ethylhexyl)phthalate or
   oestradiol benzoate in the prepubertal boar}},
Journal = {{THERIOGENOLOGY}},
Year = {{2005}},
Volume = {{64}},
Number = {{5}},
Pages = {{1170-1184}},
Month = {{SEP 15}},
Abstract = {{The immediate and delayed effects of prepubertal exposure to
   di(2-ethylhexyl)phthalate (DERP) or oestradiol benzoate on the plasma
   concentrations of testosterone, oestradiol and LH, as well as testicular
   morphology were examined in prepubertal boars. In a split litter design
   experiment, prepubertal boars were intramuscularly exposed to DEHP,
   oestradiol or vehicle during five weeks, starting at six weeks of age.
   The dose of DEHP was 50 mg/kg of bodyweight twice weekly, which is in
   the same range as recently used oral doses in rodents.
   Oestradiol-benzoate was administered at 0.25 mg/kg of bodyweight twice
   weekly. One set of animals was examined immediately after the exposure,
   and the other set was examined at an age of 7.5 months. During the
   exposure period concentrations of LH in plasma were lower (p = 0.02) in
   the oestradiol-treated animals than in the control group. In the group
   exposed to oestradiol, the relative to the body weight of the testicles
   tended to be lower (p = 0.07) than control immediately after five weeks
   of exposure, and the relative to the body weight of the seminal vesicles
   tended to be lower (p = 0.05) than control at 7.5 months of age. In the
   DEHP-exposed group an elevated (p = 0.005) concentration of testosterone
   and increased (p = 0.04) area of the Leydig cells in the testicles
   compared to the control group were seen at 7.5 months of age. These data
   suggest that DEHP early in life causes delayed effects on the
   reproductive system in the adult. (c) 2005 Elsevier Inc. All rights
   reserved.}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ljungvall, K (Reprint Author), Swedish Univ Agr Sci, Dept Clin Sci, Box 7039,Ulls Vag 12, S-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Clin Sci, S-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Ctr Image Anal, S-75237 Uppsala, Sweden.
   Uppsala Univ, S-75237 Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Anat \& Physiol, S-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Biomed Sci \& Vet Publ Hlth, S-75007 Uppsala, Sweden.
   Ctr Reprod Biol Uppsala, Uppsala, Sweden.}},
DOI = {{10.1016/j.theriogenology.2005.02.003}},
ISSN = {{0093-691X}},
Keywords = {{developmental biology; phthalates; male reproductive tract; luteinizing
   hormone; testosterone}},
Keywords-Plus = {{ADULT-RATS; MALE PIGS; PHTHALATE; DEHP; KINETICS; SPERMATOGENESIS;
   PROLIFERATION; METABOLITE; TOXICITY; EXPOSURE}},
Research-Areas = {{Reproductive Biology; Veterinary Sciences}},
Web-of-Science-Categories  = {{Reproductive Biology; Veterinary Sciences}},
Author-Email = {{karl.ljungvall@kv.slu.se}},
ResearcherID-Numbers = {{Rodriguez-Martinez, Heriberto/G-2675-2012}},
ORCID-Numbers = {{Rodriguez-Martinez, Heriberto/0000-0002-5194-2124}},
Cited-References = {{AGARWAL DK, 1986, TOXICOL APPL PHARM, V84, P12, DOI 10.1016/0041-008X(86)90412-6.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Andersson H, 1998, ANIM REPROD SCI, V51, P31, DOI 10.1016/S0378-4320(98)00054-2.
   Bielli A, 1999, ANIM REPROD SCI, V56, P93, DOI 10.1016/S0378-4320(99)00027-5.
   Blom A, 1998, ARCH ENVIRON CON TOX, V34, P306.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Bogh IB, 2001, THERIOGENOLOGY, V55, P131, DOI 10.1016/S0093-691X(00)00451-9.
   Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011.
   BROOKS RV, 1974, J PHYSIOL-LONDON, V239, pP54.
   Cammack JN, 2003, INT J TOXICOL, V22, P159, DOI 10.1080/10915810390201136.
   CARLSEN E, 1992, BRIT MED J, V305, P609.
   Dalgaard M, 2001, TOXICOL LETT, V122, P69, DOI 10.1016/S0378-4274(01)00348-4.
   Foote RH, 2000, REPROD TOXICOL, V14, P477, DOI 10.1016/S0890-6238(00)00101-5.
   GLASBEY CA, 1993, CVGIP-GRAPH MODEL IM, V55, P532.
   GRAY LE, 1998, TOXICOL LETT, V28, P102.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Guillette LJ, 2001, REPRODUCTION, V122, P857, DOI 10.1530/rep.0.1220857.
   KITTLER J, 1986, PATTERN RECOGN, V19, P41, DOI 10.1016/0031-3203(86)90030-0.
   Ljungvall K, 2004, ARCH TOXICOL, V78, P384, DOI 10.1007/s00204-004-0558-z.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Malmgren L, 1996, J VET MED A, V43, P169.
   Melnick RL, 2001, ENVIRON HEALTH PERSP, V109, P437, DOI 10.2307/3454700.
   PARMAR D, 1986, TOXICOLOGY, V42, P47, DOI 10.1016/0300-483X(86)90091-0.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P246, DOI 10.1016/0041-008X(85)90346-1.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Roselli CE, 2001, J STEROID BIOCHEM, V79, P247, DOI 10.1016/S0960-0760(01)00141-8.
   RUENMBERT I, 2004, AM J PHYSL RENAL PHY.
   Safe SH, 1998, ENVIRON HEALTH PERSP, V106, P1051, DOI 10.2307/3434151.
   SCHWARZENBERGER F, 1993, ACTA ENDOCRINOL-COP, V128, P173.
   SIROIS J, 1990, ENDOCRINOLOGY, V127, P916.
   SJOBERG P, 1985, ACTA PHARMACOL TOX, V56, P30.
   SKAKKEBAECK NE, 1994, BRIT MED J, V19, P1316.
   SWIERSTR.EE, 1968, ANAT REC, V161, P171, DOI 10.1002/ar.1091610204.
   Wickman S, 2001, J CLIN ENDOCR METAB, V86, P4887, DOI 10.1210/jc.86.10.4887.
   {*}SAS I INC, 1989, SAS STAT US GUID VER, V2, P891.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{13}},
Journal-ISO = {{Theriogenology}},
Doc-Delivery-Number = {{965RL}},
Wos-Id = {{ISI:000231967900012}},
}

@article{ ISI:000231677700043,
Author = {Green, R and Hauser, R and Calafat, AM and Weuve, J and Schettler, T and
   Ringer, S and Huttner, K and Hu, H},
Title = {{Use of di(2-ethylhexyl) phthalate-containing medical products and
   urinary levels of mono(2-ethylhexyl) phthalate in neonatal intensive
   care unit infants}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2005}},
Volume = {{113}},
Number = {{9}},
Pages = {{1222-1225}},
Month = {{SEP}},
Abstract = {{OBJECTIVE: Di(2-ethylhexyl) phthalate (DEHP) is a plasticizer used in
   medical products made with polyvinyl chloride (PVC) plastic and may be
   toxic to humans. DEHP is lipophilic and binds non-covalently to PVC,
   allowing it to leach from these products. Medical devices containing
   DEHP are used extensively in neonatal intensive care units (NICUs).
   Among neonates in NICUs, we studied exposure to DEHP-containing medical
   devices in relation to urinary levels of mono(2-ethylhexyl) phthalate
   (MEHP), a metabolite of DEHP.
   DESIGN: We used a cross-sectional design for this study.
   PARTICIPANTS: We studied 54 neonates admitted to either of two level III
   hospital NICUs for at least 3 days between 1 March and 36 April 2003.
   MEASUREMENTS: A priori, we classified the infants' exposures to DEHP
   based on medical products used: The low-DEHP exposure group included
   infants receiving primarily bottle and/or gavage feedings; the medium
   exposure group included infants receiving enteral feedings, intravenous
   hyperalimentation, and/or nasal continuous positive airway pressure; and
   the high exposure group included infants receiving umbilical vessel
   catheterization, endotracheal intubation, intravenous hyperalimentation,
   and indwelling gavage tube. We measured MEHP in the infants' urine using
   automated solid-phase extraction/isotope dilution/high-performance
   liquid chromatography/tandem mass spectrometry.
   RESULTS: Urinary MEHP levels increased monotonically with DEHP exposure.
   For the low-, medium-, and high-DEHP exposure groups, median
   (interquartile range) MEHP levels were 4 (18), 28 (58), and 86 ng/mL
   (150), respectively (p = 0.004). After adjustment for institution and
   sex, urinary MEHP levels among infants in the high exposure group were
   5.1 times those among infants in the low exposure group (p = 0.03).
   CONCLUSION: Intensive use of DEHP-containing medical devices in NICU
   infants results in higher exposure to DEHP as reflected by elevated
   urinary levels of MEHP.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hu, H (Reprint Author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Landmark Ctr E 3-110A,401 Pk Dr, Boston, MA 02215 USA.
   Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02215 USA.
   Ctr Dis Control \& Prevent, Atlanta, GA USA.
   Sci \& Environm Hlth Network, Boston, MA USA.
   Harvard Univ, Sch Med, Brigham \& Womens Hosp, Neonatol Unit, Boston, MA USA.
   Harvard Univ, Sch Med, Massachusetts Gen Hosp, Neonatol Unit, Boston, MA USA.
   Harvard Univ, Sch Med, Brigham \& Womens Hosp, Dept Med,Channing Lab, Boston, MA USA.}},
DOI = {{10.1289/chp.7932}},
ISSN = {{0091-6765}},
Keywords = {{di(2-ethylhexyl) phthalate; hospital equipment and supplies; mono
   (2-ethylhexyl) phthallate; neonatal intensive care units; newborn
   infants}},
Keywords-Plus = {{PLASTICIZER; EXPOSURE; CELLS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{lihu@hsph.harvard.edu}},
Cited-References = {{Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   CDC, 2003, NCEH PUB.
   GRAY TJB, 1984, FOOD CHEM TOXICOL, V22, P123, DOI 10.1016/0278-6915(84)90092-9.
   Jaeger R J, 1973, Environ Health Perspect, V3, P95, DOI 10.2307/3428035.
   Karle VA, 1997, CRIT CARE MED, V25, P696, DOI 10.1097/00003246-199704000-00023.
   Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1257/jep.15.4.143.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Latini G, 1999, ACTA PAEDIATR, V88, P1174, DOI 10.1080/08035259950168333.
   Leeder JS, 1997, PEDIATR CLIN N AM, V44, P55, DOI 10.1016/S0031-3955(05)70463-6.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   Marcel Y L, 1973, Environ Health Perspect, V3, P119, DOI 10.2307/3428037.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Rais-Bahrami K, 2004, ENVIRON HEALTH PERSP, V112, P1339, DOI 10.1289/ehp.6901.
   ROCK G, 1984, TRANSFUSION, V24, P493, DOI 10.1046/j.1537-2995.1984.24685066808.x.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   {*}ATSDR, 2002, TOX PROF DI2 ETH DEH.
   {*}NAT TOX PROGR, 2000, EXP PAN REP DEHP.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{59}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{961QU}},
Wos-Id = {{ISI:000231677700043}},
}

@article{ ISI:000232779200008,
Author = {Vermeulen, R and Jonsson, BAG and Lindh, CH and Kromhout, H},
Title = {{Biological monitoring of carbon disulphide and phthalate exposure in the
   contemporary rubber industry}},
Journal = {{INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH}},
Year = {{2005}},
Volume = {{78}},
Number = {{8}},
Pages = {{663-669}},
Month = {{SEP}},
Abstract = {{Objectives: We studied the range in urinary levels of
   2-thiothiazolidine-4-carboxyl acid (TTCA), a metabolite of CS, and
   phthalic acid (PA), a common metabolite of phthalates, across factories
   and departments in the contemporary rubber manufacturing industry.
   Methods: Spot urine samples from 101 rubber workers employed in nine
   different factories were collected on Sunday and during the workweek on
   Tuesday, Wednesday and Thursday at similar to 4 pm. In total, 386 urine
   samples were successfully analyzed. Results: Levels of both biomarkers
   increased significantly by a factor 2 (paired t-test P-value < 0.05)
   during the working week as compared to the Sunday biomarker levels with
   absolute increases of approximately 70 mu g/l and 5 mu mol/mol
   creatinine for PA and TTCA, respectively. Levels in both biomarkers did
   not differ markedly between working days. Increases seemed to be
   restricted to specific factories and/or departments (e.g. molding and
   curing). Conclusions: The results of this study demonstrate that rubber
   workers in the contemporary rubber industry are exposed to phthalates
   and low levels Of CS2 (similar to 0.05 ppm) as measured by PA and TTCA,
   respectively. Exposures to both compounds are largely driven by specific
   circumstances in Factories. Therefore, when estimating exposures to
   phthalates and CS2 detailed information should be collected on the type
   and amount of phthalate containing ester plasticizers, dithlocarbamates
   and thiurams used. Preferably, personal exposure data should be
   collected. In this case, biological monitoring seems a reasonable
   approach. However, in the case of PA attention should be given to
   individual background levels as this could lead to a substantial
   overestimation of the Occupational contribution to total phthalate
   exposure.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING STREET, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Vermeulen, R (Reprint Author), NCI, Div Canc Epidemiol \& Genet, Occupat \& Environm Epidemiol Branch, NIH,DHHS, 6120 Execut Blvd, Rockville, MD 20852 USA.
   NCI, Div Canc Epidemiol \& Genet, Occupat \& Environm Epidemiol Branch, NIH,DHHS, Rockville, MD 20852 USA.
   Univ Utrecht, Inst Risk Assessment Sci, Div Environm \& Occupat Hlth, Utrecht, Netherlands.
   Univ Lund Hosp, Dept Occupat \& Environm Med, S-22185 Lund, Sweden.}},
DOI = {{10.1007/s00420-005-0017-z}},
ISSN = {{0340-0131}},
Keywords = {{rubber industry; carbon disulphide; phthalates; biomonitoring}},
Keywords-Plus = {{MANUFACTURING-INDUSTRY; POPULATION; CHROMATOGRAPHY; METABOLITES; URINE}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{vermeulr@mail.nih.gov}},
ResearcherID-Numbers = {{Kromhout, Hans/A-9159-2008
   Vermeulen, Roel/F-8037-2011}},
ORCID-Numbers = {{Vermeulen, Roel/0000-0003-4082-8163}},
Cited-References = {{ALBRO PW, 1984, ANAL CHEM, V56, P247, DOI 10.1021/ac00266a029.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   DANILENKO LP, 1989, VRACHEBNOE DELO, V3, P109.
   Delpech Auguste L., 1863, ANN HYG PUBL MED LEG, V19, P65.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   FIGATALAMANCA I, 1984, INT ARCH OCC ENV HEA, V54, P163, DOI 10.1007/BF00378519.
   GRAHAM DG, 1995, CRIT REV TOXICOL, V25, P91, DOI 10.3109/10408449509021609.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Johnson DJ, 1996, CHEM RES TOXICOL, V9, P910, DOI 10.1021/tx960006v.
   Kato K, 2005, J CHROMATOGR B, V814, P355, DOI 10.1016/j.jchromb.2004.10.056.
   Kenny LC, 1997, ANN OCCUP HYG, V41, P135, DOI 10.1016/S0003-4878(96)00034-8.
   Kivisto H, 2000, INT ARCH OCC ENV HEA, V73, P263, DOI 10.1007/s004200050426.
   KROMHOUT H, 1994, ANN OCCUP HYG, V38, P3, DOI 10.1093/annhyg/38.1.3.
   MIKOCZY Z, 2004, MORTALITY CANC INCID.
   MIKOCZY Z, 2004, REPROD OUTCOME SWEDI.
   Roth VS, 1999, OCCUP MED, V14, P849.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Vermeulen R, 2000, CONTACT DERMATITIS, V42, P202, DOI 10.1034/j.1600-0536.2000.042004202.x.
   Vermeulen R, 2000, ANN OCCUP HYG, V44, P343, DOI 10.1016/S0003-4878(00)00020-X.
   Vermeulen R, 2001, MUTAT RES-GEN TOX EN, V490, P27, DOI 10.1016/S1383-5718(00)00147-9.
   {*}ACGIH, 2002, AM C GOV IND HYG.
   {*}NIOSH, 1977, MAN AN METH, pA77.}},
Number-of-Cited-References = {{22}},
Times-Cited = {{11}},
Journal-ISO = {{Int. Arch. Occup. Environ. Health}},
Doc-Delivery-Number = {{977CE}},
Wos-Id = {{ISI:000232779200008}},
}

@article{ ISI:000231001600018,
Author = {Inoue, K and Kawaguchi, M and Yamanaka, R and Higuchi, T and Ito, R and
   Saito, K and Nakazawa, H},
Title = {{Evaluation and analysis of exposure levels of di(2-ethylhexyl) phthalate
   from blood bags}},
Journal = {{CLINICA CHIMICA ACTA}},
Year = {{2005}},
Volume = {{358}},
Number = {{1-2}},
Pages = {{159-166}},
Month = {{AUG}},
Abstract = {{Background: The US FDA and The Ministry of Health, Labor and Welfare of
   Japan have indicated that the risk assessment of di(2-ethylhexyl)
   phthalate (DEHP) released from polyvinyl chloride (PVC) medical devices
   requires immediate attention. In particular, the analysis of the
   exposure to DEHP from blood bags is very important for medical
   treatment. However, human exposure to DEHP via blood transfusion remains
   poorly understood. We evaluated DEHP and mono(2-ethylhexyl) phthalate
   (MEHP) levels, migration patterns, and metabolism in blood products for
   the detailed assessment of exposure to DEHP.
   Methods: A method that is based on column-switching liquid
   chromatography-electrospray mass spectrometry (LC-MS) coupled with
   on-line extraction was used for the direct analysis of DEHP and MEHP in
   the blood products. From the Japanese Red Cross Society, 78 blood
   products (red blood cell concentrate: n = 18, irradiated red blood cell
   concentrate: n = 18, whole blood: n = 18, blood platelet: n = 18, and
   frozen plasma: n = 6) were sampled in January 2003 for use in this
   study.
   Results: The detection levels of DEHP and MEHP ranged from 1.8 to 83.2
   mu g/ml and from 0.1 to 9.7 mu g/ml, respectively. The levels of MEHP
   and DEHP in the blood products were increased with increasing storage
   time. In addition, whole blood products in PVC bags had the highest DEHP
   levels compared to the other blood products. Our results indicate that
   the maximum level of human exposure to DEHP released from blood bags is
   0.7 mg/kg weight/time.
   Conclusion: This first quantitative evidence may be useful for the risk
   assessment of DEHP released from blood bags. (c) 2005 Elsevier B.V. All
   rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Nakazawa, H (Reprint Author), Hoshi Univ, Dept Analyt Chem, Fac Pharmaceut Sci, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.
   Hoshi Univ, Dept Analyt Chem, Fac Pharmaceut Sci, Shinagawa Ku, Tokyo 1428501, Japan.
   Japanese Red Cross Soc, Blood Serv Dept, Minato Ku, Tokyo 1058521, Japan.}},
DOI = {{10.1016/j.cccn.2005.02.019}},
ISSN = {{0009-8981}},
Keywords = {{DEHP; MEHP; blood bag; exposure assessment; medical device}},
Keywords-Plus = {{DI-(2-ETHYLHEXYL) PHTHALATE; MASS-SPECTROMETRY; METABOLITES}},
Research-Areas = {{Medical Laboratory Technology}},
Web-of-Science-Categories  = {{Medical Laboratory Technology}},
Author-Email = {{nakazawa@hoshi.ac.jp}},
Cited-References = {{Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Hill SS, 2001, CLIN CHIM ACTA, V304, P1, DOI 10.1016/S0009-8981(00)00411-3.
   Inoue K, 2003, J PHARMACEUT BIOMED, V31, P1145, DOI 10.1016/S0731-7085(03)00019-0.
   Inoue K, 2002, CLIN CHIM ACTA, V325, P157, DOI 10.1016/S0009-8981(02)00291-7.
   Inoue K, 2003, ANAL BIOANAL CHEM, V375, P527, DOI 10.1007/s00216-002-1709-9.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kessler W, 2001, ARCH TOXICOL, V75, P62, DOI 10.1007/s002040000198.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   {*}HLTH CAN, 2002, HLTH CAN EXP ADV DEH.
   {*}MIN HLTH LAB WELF, 2002, PHARM MED DEV SAF IN.
   {*}US HLTH FDA, 2001, SAF ASS DI2 ETH PHTH.}},
Number-of-Cited-References = {{11}},
Times-Cited = {{31}},
Journal-ISO = {{Clin. Chim. Acta}},
Doc-Delivery-Number = {{952KE}},
Wos-Id = {{ISI:000231001600018}},
}

@article{ ISI:000230941100046,
Author = {Swan, SH and Main, KM and Liu, F and Stewart, SL and Kruse, RL and
   Calafat, AM and Mao, CS and Redmon, JB and Ternand, CL and Sullivan, S
   and Teague, JL and Study Future Families Res Team},
Title = {{Decrease in anogenital distance among male infants with prenatal
   phthalate exposure}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2005}},
Volume = {{113}},
Number = {{8}},
Pages = {{1056-1061}},
Month = {{AUG}},
Abstract = {{Prenatal phthalate exposure impairs testicular function and shortens
   anogenital distance (AGD) in male rodents. We present data from the
   first study to examine AGD, and other genital measurements in relation
   to prenatal phthalate exposure in humans. A standardized measure of AGD
   was obtained in 134 boys 2-36 months of age. AGD was significantly
   correlated with penile volume (R = 0.27, p = 0.001) and the proportion
   of boys with incomplete testicular descent (R = 0.20, p = 0.02). We
   defined the anogenital index (AGI) as AGD divided by weight at
   examination {[}AGI = AGD/weight (mm/kg)] and calculated the age-adjusted
   AGI by regression analysis. We examined nine phthallate monoester
   metabolites, measured in prenatal urine samples, as predictors of
   age-adjusted AGI in regression and categorical analyses that included
   all participants with prenatal urine samples (n = 85). Urinary
   concentrations of four phthalate metabolites {[}monoethyl phthalate
   (MEP), mono-n-butyl phthalate (MBP), monobenzyl phthalate (MBzP), and
   monoisobutyl phthalate (MiBP)] were inversely related to AGI. After
   adjusting for age at examination, p-values for regression coefficients
   ranged from 0.007 to 0.097. Comparing boys with prenatal MBP
   concentration in the highest quartile with those in the lowest quartile,
   the odds ratio for a shorter than expected AGI was 10.2 (95\% confidence
   interval, 2.5 to 42.2). The corresponding odds ratios for MEP, MBzP, and
   MiBP were 4.7, 3.8, and 9.1, respectively (all p-values < 0.05). We
   defined a summary phthalate score to quantify joint exposure to these
   four phthalate metabolites. The age-adjusted AGI decreased significantly
   with increasing phthalate score (p-value for slope = 0.009). The
   associations between male genital development and phthallate exposure
   seen here are consistent with the phthalate-related syndrome of
   incomplete virilization that has been reported in prenatally exposed
   rodents. The median concentrations of phthalate metabolites that are
   associated with short AGI and incomplete testicular descent are below
   those found in one-quarter of the female population of the United
   States, based on a nationwide sample. These data support the hypothesis
   that prenatal phthalate exposure at environmental levels can adversely
   affect male reproductive development in humans.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Swan, SH (Reprint Author), Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, 601 Elmwood Ave,Box 668, Rochester, NY 14642 USA.
   Univ Rochester, Sch Med \& Dent, Dept Obstet \& Gynecol, Rochester, NY 14642 USA.
   Univ Copenhagen, Dept Growth \& Reprod, Copenhagen, Denmark.
   Univ Missouri, Dept Family \& Community Med, Columbia, MO USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA USA.
   Harbor UCLA Med Ctr, Dept Pediat, Div Endocrinol, Los Angeles Biomed Res Inst, Los Angeles, CA USA.
   Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA.
   Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.
   Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.
   Univ Missouri, Dept Urol Surg, Columbia, MO USA.
   Univ Missouri, Dept Child Hlth, Columbia, MO 65201 USA.}},
DOI = {{10.1289/ehp.8100}},
ISSN = {{0091-6765}},
Keywords = {{anogenital distance; benzylbutyl phthalate; dibutyl phthalate; diethyl
   phthalate; monobenzyl phthalate; monoethyl plathalate; monoisobutyl
   phthalate; mono-n-butyl phthalate; phthalates; prenatal exposure}},
Keywords-Plus = {{BUTYL BENZYL PHTHALATE; IN-UTERO EXPOSURE; TESTICULAR DYSGENESIS
   SYNDROME; REPRODUCTIVE-TRACT LESIONS; MALE-RAT; DI(N-BUTYL) PHTHALATE;
   SEXUAL-DIFFERENTIATION; SEMEN QUALITY; METABOLITES; ADVERSE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{shanna\_swan@urmc.rochester.edu}},
Cited-References = {{Barlow NJ, 2003, TOXICOL PATHOL, V31, P397, DOI 10.1080/01926230390202335.
   Barlow NJ, 2004, TOXICOL PATHOL, V32, P79, DOI 10.1080/01926230490265894.
   Bowman CJ, 2003, TOXICOL SCI, V74, P393, DOI 10.1093/toxsci/kfg128.
   CALLEGARI C, 1987, J PEDIATR, V111, P240, DOI 10.1016/S0022-3476(87)80075-6.
   CLARK RL, 1990, TERATOLOGY, V42, P91, DOI 10.1002/tera.1420420111.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2005, HUM REPROD, V20, P604, DOI 10.1093/humrep/deh656.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Ema M, 2003, REPROD TOXICOL, V17, P407, DOI 10.1016/S0890-6238(03)00037-6.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   FOSTER PMD, 1981, CHEM-BIOL INTERACT, V34, P233, DOI 10.1016/0009-2797(81)90134-4.
   FOSTER PMD, 2000, FOOD CHEM TOXICOL, V38, P97.
   Foster PMD, 2002, TOXICOL PATHOL, V30, P59, DOI 10.1080/01926230252824716.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gray LE, 2003, PURE APPL CHEM, V75, P2125, DOI 10.1351/pac200375112125.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   McIntyre BS, 2001, TOXICOL SCI, V62, P236, DOI 10.1093/toxsci/62.2.236.
   McKee RH, 2004, ENVIRON HEALTH PERSP, V112, pA541.
   MURATURE DA, 1987, BIOMED ENVIRON MASS, V14, P473, DOI 10.1002/bms.1200140815.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2.
   Nakahara Hiroyuki, 2003, Fukuoka Acta Medica, V94, P331.
   Neumann F., 1976, ENV QUAL SAF S, P253.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Phillip M, 1996, J PEDIATR ENDOCR MET, V9, P175.
   Rhees RW, 1997, DEV NEUROSCI-BASEL, V19, P430, DOI 10.1159/000111240.
   Salazar-Martinez Eduardo, 2004, Environ Health, V3, P8, DOI 10.1186/1476-069X-3-8.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Swan SH, 2003, ENVIRON HEALTH PERSP, V111, P414, DOI 10.1289/ehp.5927.
   Tyl RW, 2004, REPROD TOXICOL, V18, P241, DOI 10.1016/j.reprotox.2003.10.006.
   VANDENBERGH JG, 1995, LAB ANIM SCI, V45, P567.
   White CR, 2005, J EXP BIOL, V208, P1611, DOI 10.1242/jeb.01501.
   {*}CDC, 2003, 2 NAT REP HUM EXP EN.}},
Number-of-Cited-References = {{41}},
Times-Cited = {{533}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{951OV}},
Wos-Id = {{ISI:000230941100046}},
}

@article{ ISI:000230722700001,
Author = {Koch, HM and Bolt, HM and Preuss, R and Angerer, J},
Title = {{New metabolites of di(2-ethylhexyl)phthalate (DEHP) in human urine and
   serum after single oral doses of deuterium-labelled DEHP}},
Journal = {{ARCHIVES OF TOXICOLOGY}},
Year = {{2005}},
Volume = {{79}},
Number = {{7}},
Pages = {{367-376}},
Month = {{JUL}},
Abstract = {{The metabolism of di(2-ethylhexyl)phthalate (DEHP) in humans was studied
   after three doses of 0.35 mg (4.7 mu g/kg), 2.15 mg (28.7 mu g/kg) and
   48.5 mg (650 mu g/kg) of D4-ring-labelled DEHP were administered orally
   to a male volunteer. Two new metabolites,
   mono(2-ethyl-5-carboxypentyl)phthalate (5cx-MEPP) and
   mono{[}2-(carboxymethyl)hexyl]phthalate (2cx-MMHP) were monitored for 44
   h in urine and for 8 h in serum for the high-dose case, in addition to
   the three metabolites previously analysed:
   mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP),
   mono(2-ethyl-5-oxohexyl)phthalate (5oxo-MEHP) and
   mono(2-ethylhexyl)phthalate (MEHP). For the medium- and low-dose cases,
   24 h urine samples were analysed. Up to 12 h after the dose, 5OH-MEHP
   was the major urinary metabolite, after 12 h it was 5cx-MEPP, and after
   24 h it was 2cx-MMHP. The elimination half-lives of 5cx-MEHP and
   2cx-MMHP were between 15 and 24 h. After 24 h 67.0\% (range:
   65.8-70.5\%) of the DEHP dose was excreted in urine, comprising 5OH-MEHP
   (23.3\%), 5cx-MEPP (18.5\%), 5oxo-MEHP (15.0\%), MEHP (5.9\%) and
   2cx-MMHP (4.2\%). An additional 3.8\% of the DEHP dose was excreted on
   the second day, comprising 2cx-MMHP (1.6\%), 5cx-MEPP (1.2\%), 5OH-MEHP
   (0.6\%) and 5oxo-MEHP (0.4\%). In total about 75\% of the administered
   DEHP dose was excreted in urine after two days. Therefore, in contrast
   to previous studies, most of the orally administered DEHP is
   systemically absorbed and excreted in urine. No dose dependency in
   metabolism and excretion was observed. The secondary metabolites of DEHP
   are superior biomonitoring markers compared to any other parameters,
   such as MEHP in urine or blood. 5OH-MEHP and 5oxo-MEHP in urine reflect
   short-term and 5cx-MEHP and 2cx-MMHP long-term exposure. All secondary
   metabolites are unsusceptible to contamination. Furthermore, there are
   strong hints that the secondary oxidised DEHP metabolites-not DEHP or
   MEHP-are the ultimate developmental toxicants.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING STREET, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Angerer, J (Reprint Author), Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, Schillerstr 25-29, D-91054 Erlangen, Germany.
   Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, D-91054 Erlangen, Germany.
   Univ Dortmund, Leibniz Res Ctr Working Environm \& Human Factors, Inst Occupat Physiol, D-44139 Dortmund, Germany.}},
DOI = {{10.1007/s00204-004-0642-4}},
ISSN = {{0340-5761}},
Keywords = {{metabolism; human; urine; serum; di(2-ethylhexyl)phthalate (DEHP);
   mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP);
   mono(2-ethyl-5-oxo-hexyl)phthalate (5oxo-MEHP);
   mono(2-ethyl-5-carboxypropyl)phthalate (5cx-MEPP);
   mono{[}2-(carboxymethyl)hexyl]phthalate (2cx-MMHP);
   mono(2-ethylhexyl)phthalate (MEHP)}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; PHTHALATE METABOLITES; MAJOR METABOLITES;
   REPRODUCTIVE HEALTH; GENERAL-POPULATION; INTERNAL EXPOSURE; BIOMARKERS;
   SECONDARY; TOXICITY; CHILDREN}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{Juergen.Angerer@ipasum.imed.uni-erlangen.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{Agency for Toxic Substances and Disease Registry (ATSDR), 1993, ATSDRTP9205 US DEP H.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   GILSING HD, 2005, IN PRESS MONATSH CHE.
   Gilsing HD, 2003, MONATSH CHEM, V134, P1207, DOI 10.1007/s00706-003-0044-y.
   Gilsing HD, 2002, MONATSH CHEM, V133, P1147, DOI 10.1007/s007060200084.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kessler W, 2004, TOXICOL APPL PHARM, V195, P142, DOI 10.1016/j.taap.2003.11.014.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P77, DOI 10.1078/1438-4639-00272.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   KOCH HM, 2004, INT J HYG ENVIR HEAL, V207, P75.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   Ljungvall K, 2004, ARCH TOXICOL, V78, P384, DOI 10.1007/s00204-004-0558-z.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Moore C, 2001, J COGN DEV, V2, P109, DOI 10.1207/S15327647JCD0202\_1.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   REGNIER J, 2004, TOXICOLOGIST CD OFFI, V78, P187.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Scientific Committee for Toxicity Ecotoxicity and the Environment (CSTEE), 1998, OP PHTHAL MIGR SOFT.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Silva MJ, 2004, B ENVIRON CONTAM TOX, V72, P1226, DOI 10.1007/s00128-004-0374-4.
   WOLFE GW, 2003, 7244200 TRC.
   {*}CSTEE, 2004, OP RES 2 RISK ASS BI.
   {*}DFG, 2002, GES ARB TOX ARB BEGR, V35.
   {*}EPA, 1999, INT RISK INF SYST DI.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{115}},
Journal-ISO = {{Arch. Toxicol.}},
Doc-Delivery-Number = {{948NM}},
Wos-Id = {{ISI:000230722700001}},
}

@article{ ISI:000230068000009,
Author = {Jonsson, BAG and Richthoff, J and Rylander, L and Giwercman, A and
   Hagmar, L},
Title = {{Urinary phthalate metabolites and biomarkers of reproductive function in
   young men}},
Journal = {{EPIDEMIOLOGY}},
Year = {{2005}},
Volume = {{16}},
Number = {{4}},
Pages = {{487-493}},
Month = {{JUL}},
Abstract = {{Background: High exposure to phthalates, which are ubiquitous
   contaminants, has been shown in animal studies to produce detrimental
   effects on male reproductive functions. A recent study in humans
   reported dose-response relations between low phthalate levels in urine
   and human semen parameters, which raises the question whether humans are
   more sensitive to phthalate exposure than animals.
   Methods: Urine, serum, and semen samples were collected from 234 young
   Swedish men at the time of their medical conscript examination. Semen
   volume, sperm concentration, and motility were measured, together with
   sperm chromatin integrity (sperm chromatin structure assay) and
   biochemical markers of epididymal and prostatic function. We analyzed
   reproductive hormones in serum, and mono ethyl phthalate (MEP), mono
   ethylhexyl phthaltale (MEHP), mono benzyl phthalate (MBzP), mono butyl
   phthalate (MBP), and phthalic acid in urine.
   Results: For MBP, MBzP, and MEHP, no clear pattern of associations were
   observed with any of the reproductive biomarkers. Subjects within the
   highest quartile for MEP had fewer motile sperm (mean difference =
   8.8\%; 95\% confidence interval = 0.8-17), more immotile sperms (8.9\%;
   0.3-18), and lower luteinizing hormone values (0.7 IU/L; 0.1-1.2), but
   there was no suggestion of harmful effects for most other endpoints.
   Phthalic acid actually was associated with improved function, as
   measured by several markers.
   Conclusions: The observed weak associations between I phthalate
   biomarker and impairment of a few aspects of reproductive function
   biomarkers were not consistent with results from a recent U.S. study.}},
Publisher = {{LIPPINCOTT WILLIAMS \& WILKINS}},
Address = {{530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Jonsson, BAG (Reprint Author), Univ Lund Hosp, Dept Occupat \& Environm Med, Inst Lab Med, SE-22185 Lund, Sweden.
   Univ Lund Hosp, Dept Occupat \& Environm Med, Inst Lab Med, SE-22185 Lund, Sweden.
   Malmo Univ Hosp, Fertil Ctr, Malmo, Sweden.}},
DOI = {{10.1097/01.ede.0000164555.19041.01}},
ISSN = {{1044-3983}},
Keywords-Plus = {{SEX GLAND-FUNCTION; GENERAL-POPULATION; EXPOSURE; RATS; PARAMETERS;
   GONOCYTES; IMPACT; CELLS; DEHP}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Author-Email = {{Bo.Jonsson@ymed.lu.se}},
Cited-References = {{Andersen AG, 2000, HUM REPROD, V15, P366, DOI 10.1093/humrep/15.2.366.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   DUTY SM, 2003, ENV HLTH PERSPECT, V11, P1164.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Elzanaty S, 2002, HUM REPROD, V17, P2904, DOI 10.1093/humrep/17.11.2904.
   Evenson Donald, 2000, Methods in Cell Science, V22, P169, DOI 10.1023/A:1009844109023.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   GIWERCMAN A, 1993, ENVIRON HEALTH PERSP, V101, P65, DOI 10.2307/3431378.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Groome NP, 1996, J CLIN ENDOCR METAB, V81, P1401, DOI 10.1210/jc.81.4.1401.
   Heite H., 1976, AKTUEL DERMATOL, V2, P239.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Larsen L, 2000, HUM REPROD, V15, P1562, DOI 10.1093/humrep/15.7.1562.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   MAKINO T, 1982, CLIN CHIM ACTA, V120, P127.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2.
   Richthoff J, 2002, HUM REPROD, V17, P2468, DOI 10.1093/humrep/17.9.2468.
   Richthoff J, 2003, ENVIRON HEALTH PERSP, V111, P409, DOI 10.1289/ehp.5767.
   Richthoff J, 2002, HUM REPROD, V17, P3162, DOI 10.1093/humrep/17.12.3162.
   SHAKKEBAEK NE, 2001, HUMAN REPROD, V16, P972.
   Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055.
   Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709.
   World Health Organization, 1999, WHO LAB MAN EX HUM S.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{84}},
Journal-ISO = {{Epidemiology}},
Doc-Delivery-Number = {{939JF}},
Wos-Id = {{ISI:000230068000009}},
}

@article{ ISI:000230257200008,
Author = {Carruthers, CM and Foster, PMD},
Title = {{Critical window of male reproductive tract development in rats following
   gestational exposure to di-n-butyl phthalate}},
Journal = {{BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY}},
Year = {{2005}},
Volume = {{74}},
Number = {{3}},
Pages = {{277-285}},
Month = {{JUN}},
Abstract = {{BACKGROUND: Gestational exposure to di-n-butyl phthalate (DBP), a
   ubiquitous environmental contaminant, has been shown to interfere with
   the development of the male reproductive tract by acting as an
   antiandrogen. This study was conducted to identify the critical days for
   the abnormal development of the male reproductive tract, specifically
   the testis and epididymis. METHODS: Timed-pregnant Sprague-Dawley rats
   were dosed with DBP at 500 mg/kg/day on gestation day (GD) 14 and 15, 15
   and 16, 16 and 17,17 and 18, 18 and 19, or 19 and 20 (GD 0 = plug day).
   Anogenital distance (AGD) was measured on postnatal day (PND) 1 and 13,
   while areloa number was recorded on PND 13 only. After weaning, males
   were allowed to mature to PND 90 at which time they were necropsied.
   Areloa number and AGD were recorded and testes, epididymides, seminal
   vesicles, prostate gland, kidneys, and liver weighed. Blood serum was
   collected and assayed for total testosterone concentration. RESULTS:
   There were no observable effects on litter size, sex ratio, serum
   testosterone concentration, or mortality of pups. Statistically
   significant permanent reductions in AGD were seen in males exposed
   prenatally to DBP on GD 15 and 16 or GD 18 and 19. On PND 13, areola
   were present in males exposed to DBP on GD 15 and 16, 16 and 17, 17 and
   18, and 19 and 20. However, permanent retention occurred only ill males
   after DBP exposure on GD 16 and 17. Exposure to DBP on only GD 17 and 18
   elicited a reduction in epididymal weights; while exposure on only GD 16
   and 17 caused a significant increase in the weights of the testes due to
   edema. In this study, epididymal and testicular malformations were most
   prevalent after exposure to DBP on any gestational day. Epididymal
   malformations, characterized by agenesis of various regions and small or
   flaccid testes were significantly increased in DBP-exposed males only on
   GD 16 and 17. CONCLUSIONS: These findings suggest that 2-day DBP
   exposure is highly detrimental to the developing reproductive tract of
   the male fetus and the critical window for abnormal development is GD
   16-18.}},
Publisher = {{WILEY-LISS}},
Address = {{DIV JOHN WILEY \& SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Carruthers, CM (Reprint Author), NIEHS, NIH, Dept Hlth \& Human Serv, POB 12233, Res Triangle Pk, NC 27709 USA.
   NIEHS, NIH, Dept Hlth \& Human Serv, Res Triangle Pk, NC 27709 USA.}},
DOI = {{10.1002/bdrb.20050}},
ISSN = {{1542-9733}},
Keywords = {{phthalate; DBP; testes; epididymis; anogenital distance; development;
   malformations}},
Keywords-Plus = {{ALTERS SEXUAL-DIFFERENTIATION; FALLING SPERM QUALITY; DI(N-BUTYL)
   PHTHALATE; SEMEN QUALITY; INSL3 GENE; TESTICULAR CANCER; CRYPTORCHIDISM;
   TESTIS; MALFORMATIONS; ANTIANDROGENS}},
Research-Areas = {{Oncology; Genetics \& Heredity; Toxicology}},
Web-of-Science-Categories  = {{Oncology; Genetics \& Heredity; Toxicology}},
Author-Email = {{carruth1@niehs.nih.gov}},
Cited-References = {{Baker LA, 2002, J UROLOGY, V167, P2534, DOI 10.1016/S0022-5347(05)65029-X.
   Barlow NJ, 2004, TOXICOL PATHOL, V32, P79, DOI 10.1080/01926230490265894.
   BENDVOLD E, 1989, INT J FERTIL, V34, P401.
   BOSTOFTE E, 1983, INT J FERTIL, V28, P91.
   BOYLE P, 1987, EUR J CANCER CLIN ON, V23, P827, DOI 10.1016/0277-5379(87)90286-0.
   CARLSEN E, 1992, BRIT MED J, V305, P609.
   Coleman M P, 1993, IARC Sci Publ, P1.
   Ema M, 2000, TOXICOL LETT, V111, P271, DOI 10.1016/S0378-4274(99)00192-7.
   FARROW S, 1994, BRIT MED J, V309, P1.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Ghirri P, 2002, J ENDOCRINOL INVEST, V25, P709.
   Gray LE, 2001, HUM REPROD UPDATE, V7, P248, DOI 10.1093/humupd/7.3.248.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hotchkiss AK, 2004, BIOL REPROD, V71, P1852, DOI 10.1095/biolreprod.104.031674.
   Huyghe E, 2003, J UROLOGY, V170, P5, DOI 10.1097/01.ju.0000053866.68623.da.
   IRVINE DS, 1994, BRIT MED J, V309, P476.
   JACKSON MB, 1988, HORM RES, V30, P153, DOI 10.1159/000181052.
   JAMES WH, 1980, ANDROLOGIA, V12, P381.
   Jorgensen N, 2001, HUM REPROD, V16, P1012, DOI 10.1093/humrep/16.5.1012.
   Kavlock R, 2002, REPROD TOXICOL, V16, P489, DOI 10.1016/S0890-6238(02)00033-3.
   Koskimies P, 2000, PEDIATR RES, V47, P538, DOI 10.1203/00006450-200004000-00020.
   Kubota Y, 2001, J UROLOGY, V165, P1673, DOI 10.1016/S0022-5347(05)66389-6.
   Kumagai J, 2002, J BIOL CHEM, V277, P31283, DOI 10.1074/jbc.C200398200.
   Lim HN, 2001, EUR J ENDOCRINOL, V144, P129, DOI 10.1530/eje.0.1440129.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972.
   Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709.
   Wilson VS, 2004, TOXICOL LETT, V146, P207, DOI 10.1016/j.toxlet.2003.09.012.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{44}},
Journal-ISO = {{Birth Defects Res. Part B-Dev. Reprod. Toxicol.}},
Doc-Delivery-Number = {{942BF}},
Wos-Id = {{ISI:000230257200008}},
}

@article{ ISI:000228873200003,
Author = {Silva, MJ and Kato, K and Gray, EL and Wolf, C and Needham, LL and
   Calafat, AM},
Title = {{Urinary metabolites of di-n-octyl phthalate in rats}},
Journal = {{TOXICOLOGY}},
Year = {{2005}},
Volume = {{210}},
Number = {{2-3}},
Pages = {{123-133}},
Month = {{JUN 1}},
Abstract = {{Di-n-octyl phthalate (DnOP) is a plasticizer used in polyvinyl chloride
   plastics, cellulose esters, and polystyrene resins. The metabolism of
   DnOPresults in the hydrolysis of one ester linkage to produce
   mono-n-octyl phthalate (MnOP), which subsequently metabolizes to form
   oxidative metabolites, We investigated the toxicokinetics of DnOP in
   adult female Sprague-Dawley rats by monitoring the excretion of DnOP
   metabolites in urine after oral administration of DnOP (300 mg/kg). By
   using authentic standards, the presence of urinary phthalic acid (PA),
   MnOP, and the major DnOP metabolite, mono-(3-carboxypropyl) phthalate
   (MCPP) was clearly established. Furthermore, we identified five
   additional urinary DnOP oxidative metabolites based on their
   chromatographic behavior and mass spectrometric fragmentation pattern.
   These DnOP oxidative metabolites, are postulated to be
   mono-carboxymethyl phthalate (MCMP), mono-(5-carboxy-n-pentyl) phthalate
   (MCPcP),mono-(7-carboxy-n-heptyl) phthalate (MCHpP), and isomers of
   mono-hydroxy-n-octyl phthalate (MHOP) (e.g., mono-(7-hydroxy-n-octyl)
   phthalate) and of mono-oxo-n-octyl phthalate (MOOP) (e.g., mono-
   (7-oxo-n-octyl) phthalate). The urinary excretion of DnOP metabolites
   followed a biphasic excretion pattern. The metabolite levels decreased
   significantly after the first day of DnOP administration although MCPP,
   MCHpR MHOP, and MOOP were detectable after 4 days. We also studied the
   in vitro metabolism of DnOP and MnOP by rat liver microsomes. DnOP
   produced MnOP, MHOP, and PA in vitro whereas, MnOP produced MHOP and PA
   in vitro at detectable levels. Published by Elsevier Ireland Ltd.}},
Publisher = {{ELSEVIER IRELAND LTD}},
Address = {{ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Mailstop F17,4770 Buford Hwy NE, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.
   US EPA, Natl Hlth \& Environm Effects Res Lab, Endocrinol Branch, Reprod Toxicol Div, Durham, NC 27705 USA.}},
DOI = {{10.1016/j.tox2005.01.012}},
ISSN = {{0300-483X}},
Keywords = {{di-n-octyl phthalate; mono-n-octyl phthalate; mono-3-carboxypropyl
   phthalate; mono-(7-carboxy-n-heptyl) phthalates;
   mono-(7hydroxy-n-octyl)phthalate; mono-(7-oxo-n-octyl) phthalates;
   oxidative metabolisms; phthalates}},
Keywords-Plus = {{EXPERT PANEL REPORT; DI(2-ETHYLHEXYL) PHTHALATE; DEVELOPMENTAL TOXICITY;
   HUMAN-REPRODUCTION; HUMAN EXPOSURE; NTP CENTER; IN-VITRO; ESTERS;
   BIOMARKERS; RISKS}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{zca2@cdc.gov}},
Cited-References = {{ALBRO PW, 1983, BIOCHIM BIOPHYS ACTA, V760, P283, DOI 10.1016/0304-4165(83)90175-7.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   David RM, 2001, PATTYS TOXICOLOGY, V6, P635.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kavlock R, 2002, REPROD TOXICOL, V16, P721, DOI 10.1016/S0890-6238(02)00031-X.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1.
   Zacharewski TR, 1998, TOXICOL SCI, V46, P282, DOI 10.1093/toxsci/46.2.282.}},
Number-of-Cited-References = {{15}},
Times-Cited = {{16}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{922XM}},
Wos-Id = {{ISI:000228873200003}},
}

@article{ ISI:000229136100016,
Author = {Nuti, F and Hildenbrand, S and Chelli, M and Wodarz, R and Papini, AM},
Title = {{Synthesis of DEHP metabolites as biomarkers for GC-MS evaluation of
   phthalates as endocrine disrupters}},
Journal = {{BIOORGANIC \& MEDICINAL CHEMISTRY}},
Year = {{2005}},
Volume = {{13}},
Number = {{10}},
Pages = {{3461-3465}},
Month = {{MAY 16}},
Abstract = {{Phthalates are used primarily as plasticizers to make polyvinyl chloride
   (PVC) soft and flexible. In recent years the phthalate esters have
   attracted increasing attention as environmental and biomedical
   pollutants and, because of their toxicological characteristics. In
   particular, they are more and more recognized as endocrine disrupters.
   In this context, we describe herein an efficient synthetic pathway
   leading to a series of metabolites of di(2-ethylhexyl) phthalate (DEHP).
   Mono(2-ethylhexenyl) phthalate was used as starting material to obtain
   these products in good yield, large scale and GC-MS purity. The
   metabolites of DEHP were synthesized, for the first time, as biomarkers
   to verify their quantitative determination in human urine and serum by
   GC-MS analysis for studying the exposure to phthalates and establishing
   reference values. \&COPY; 2005 Elsevier Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hildenbrand, S (Reprint Author), Univ Tubingen, Dept Occupat \& Social Med, Wilhelmstr 27, D-72074 Tubingen, Germany.
   Univ Tubingen, Dept Occupat \& Social Med, D-72074 Tubingen, Germany.
   Univ Florence, Dept Organ Chem, Lab Peptide \& Prot Chem \& Biol, I-50019 Florence, Italy.
   CNR, ICCOM, I-50019 Florence, Italy.}},
DOI = {{10.1016/j.bmc.2005.03.005}},
ISSN = {{0968-0896}},
Keywords = {{DEHP metabolites; phthalates; GC-MS analytes; endocrine disrupters;
   plasticizers}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL
   PHTHALATE; EXCHANGE-TRANSFUSION; NEWBORN-INFANTS; HUMAN URINE; EXPOSURE;
   RATS; CHROMATOGRAPHY; OXIDATION}},
Research-Areas = {{Biochemistry \& Molecular Biology; Pharmacology \& Pharmacy; Chemistry}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic}},
Author-Email = {{sibylle.hildenbrand@med.uni-tuebingen.de
   annamaria.papini@unifi.it}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   Albro P.W., 1987, REV BIOCHEM TOXICOL, V8, P73.
   ARBIN A, 1980, J CHROMATOGR, V193, P405, DOI 10.1016/S0021-9673(00)87740-7.
   Baczko K, 2000, J CHEM SOC PERK T 2, P521, DOI 10.1039/a907987d.
   de Boer T. J., 1956, ORG SYNTH, V36, P16.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Eisenbraun E. J., 1973, ORG SYNTH, V5, P310.
   EMA M, 1995, TOXICOL LETT, V78, P101, DOI 10.1016/0378-4274(94)03241-X.
   Gilsing HD, 2003, MONATSH CHEM, V134, P1207, DOI 10.1007/s00706-003-0044-y.
   HILDENBRAND S, 2002, PERSPEKTIVEN KLIN AR, P535.
   Kambia K, 2001, INT J PHARM, V229, P139, DOI 10.1016/S0378-5173(01)00840-7.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972.
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381.
   Meinwald J., 1973, ORG SYNTH, V5, P866.
   Mettang T, 1996, PERITON DIALYSIS INT, V16, P58.
   Mettang T, 1996, NEPHROL DIAL TRANSPL, V11, P2439.
   MORIARTY RM, 1989, ORG SYNTH, V68, P175.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x.
   SUZUKI T, 2001, ENVIRON SCI TECHNOL, V35, P3563.
   TSUJI J, 1984, SYNTHESIS-STUTTGART, P369.
   WAMS TJ, 1987, SCI TOTAL ENVIRON, V66, P1, DOI 10.1016/0048-9697(87)90072-6.
   WARD JM, 1986, ENVIRON HEALTH PERSP, V65, P279, DOI 10.2307/3430195.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{9}},
Journal-ISO = {{Bioorg. Med. Chem.}},
Doc-Delivery-Number = {{926PW}},
Wos-Id = {{ISI:000229136100016}},
}

@article{ ISI:000228877500052,
Author = {Kato, K and Silva, MJ and Needham, LL and Calafat, AM},
Title = {{Determination of 16 phthalate metabolites in urine using automated
   sample preparation and on-line preconcentration/high-performance liquid
   chromatography/tandem mass spectrometry}},
Journal = {{ANALYTICAL CHEMISTRY}},
Year = {{2005}},
Volume = {{77}},
Number = {{9}},
Pages = {{2985-2991}},
Month = {{MAY 1}},
Abstract = {{We developed an on-line solid-phase extraction (SPE) method, coupled
   with isotope dilution high-performance liquid chromatography/tandem mass
   spectrometry (HPLC/MS/MS) and with automated sample preparation, to
   simultaneously quantify 16 phthalate metabolites in human urine. The
   method requires a silica-based monolithic column for the initial
   preconcentration of the phthalate metabolites from the urine and a
   silica-based conventional analytical column for the chromatographic
   separation of the analytes of interest. It uses small amounts of urine
   (100 \&mu; L), is sensitive (limits of detection range from 0.11 to 0.90
   ng/mL), accurate (spiked recoveries are \&SIM; 100\%), and precise (the
   inter- and intraday coefficients of variation are \&LT; 10\%). The
   method is not labor intensive, and, because pretreatment of the urine
   samples was performed automatically using an HPLC autosampler, involves
   minimal sample handling, thus minimizing exposure to hazardous
   chemicals. The method was validated on spiked, pooled urine samples and
   on urine samples from 43 adults with no known exposure to phthalates.
   The high sensitivity and high throughput (HPLC run time, including the
   preconcentration step, is 27 min) of this analytical method combined
   with the ease of use and effective automated sample preparation
   procedure make it suitable for large epidemiological studies to evaluate
   the prevalence of human exposure to phthalates.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Natl Ctr Environm Hlth, Ctr Dis Control \& Prevent, Div Sci Lab, 4770 Buford Hwy,Mailstop F17, Atlanta, GA 30341 USA.
   Natl Ctr Environm Hlth, Ctr Dis Control \& Prevent, Div Sci Lab, Atlanta, GA 30341 USA.}},
DOI = {{10.1021/ac0481248}},
ISSN = {{0003-2700}},
Keywords-Plus = {{SOLID-PHASE EXTRACTION; MONOLITHIC SILICA COLUMNS; QUANTITATIVE
   DETECTION; SEXUAL-DIFFERENTIATION; EXPOSURE ASSESSMENT; INTERNAL
   EXPOSURE; MALE-RAT; DEHP; SEPARATIONS; POPULATION}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Author-Email = {{Acalafat@cdc.gov}},
Cited-References = {{Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Cabrera K, 2000, HRC-J HIGH RES CHROM, V23, P93.
   Cai YQ, 2003, ANAL SCI, V19, P1491, DOI 10.2116/analsci.19.1491.
   Calafat AM, 2004, J CHROMATOGR B, V805, P49, DOI {[}10.1016/j.jchromb.2004.02.006, 10.1016/j.chromb.2004.02.006].
   Cespedes R, 2004, ANAL BIOANAL CHEM, V378, P697, DOI 10.1007/s00216-003-2303-5.
   DAVID RM, 2001, PATTYS TOXICOLOGY, pCH80.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Ema M, 2003, TOXICOL SCI, V72, P274.
   Ema M, 2002, REPROD TOXICOL, V16, P71, DOI 10.1016/S0890-6238(01)00200-3.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Jonsson S, 2002, J CHROMATOGR A, V963, P393, DOI 10.1016/S0021-9673(02)00647-7.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kato K, 2003, J CHROMATOGR B, V788, P407, DOI 10.1016/S1570-0232(03)00041-2.
   Kato K, 2003, J LIQ CHROMATOGR R T, V26, P2167, DOI 10.1081/JLC-120022401.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Lim LW, 2004, J CHROMATOGR A, V1033, P205, DOI 10.1016/j.chroma.2004.01.045.
   Lopez-Roldan P, 2004, ANAL BIOANAL CHEM, V378, P599, DOI 10.1007/s00216-003-2187-4.
   Miller S, 2004, ANAL CHEM, V76, p99A, DOI 10.1021/ac041522q.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PREUSS R, 2005, J CHROMATOGR B.
   Quirino JP, 2001, ANAL CHEM, V73, P5557, DOI 10.1021/ac0155299.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Tanaka N, 2002, J CHROMATOGR A, V965, P35, DOI 10.1016/S0021-9673(01)01582-5.
   Tanaka N., 2001, ANAL CHEM, V73, P420.
   Tanaka N, 2000, HRC-J HIGH RES CHROM, V23, P111.
   Taylor J. K., 1987, QUALITY ASSURANCE CH.
   {*}ATSDR, 2002, TOX PROF DI2 ETH PHT.
   {*}ATSDR, 2001, TOX PROF DINB PHTHAL.
   {*}ATSDR, 1997, TOX PROF DIN PHTHAL.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{94}},
Journal-ISO = {{Anal. Chem.}},
Doc-Delivery-Number = {{922ZD}},
Wos-Id = {{ISI:000228877500052}},
}

@article{ ISI:000229548700002,
Author = {Lee, SK and Owens, GA and Veeramachaneni, DN},
Title = {{Exposure to low concentrations of di-n-butyl phthalate during
   embryogenesis reduces survivability and impairs development of Xenopus
   laevis frogs}},
Journal = {{JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES}},
Year = {{2005}},
Volume = {{68}},
Number = {{10}},
Pages = {{763-772}},
Month = {{MAY}},
Abstract = {{Di-n-butyl phthalate (DBP) appears to be a ubiquitous environmental
   contaminant, as indicated by its presence in air, water, and soil
   worldwide (Giam et al., 1980; ATSDR, 2001; Peterson \& Freeman, 1982)
   and the presence of its major metabolite, monobutyl phthalate (MBP), in
   random human urine samples (Blount et al., 2000). Studies indicate that
   exposure to a variety of endocrine-disrupting chemicals, such as DBP,
   may be partially responsible for reported global amphibian declines; if
   so, amphibians may serve as ecological harbingers for the future of
   human health. Therefore, this study was undertaken to investigate the
   effects of environmentally relevant concentrations of DBP on development
   in Xenopus laevis African clawed frogs. Developmental effects of DBP on
   Xenopus embryos were determined using the 96-h frog embryo teratogenesis
   assay - Xenopus (FETAX). Embryos ( n = 300/group) were exposed from
   gastrulation ( stage 8 - 11) through primary organogenesis ( stage 46)
   to 0.1, 0.5, 1, 5, 10, or 15 ppm DBP dissolved in 0.01\% dimethyl
   sulfoxide ( DMSO), vehicle alone ( 0.01\% DMSO; solvent control), or
   FETAX culture medium only ( control; n = 600). At 96 h, mortalities for
   control, solvent control, and 0.1, 0.5, 1, 5, 10, and 15 ppm DBP were 5,
   4, 6, 5, 5, 9, 18, and 52\%, respectively; the incidence of
   developmental malformations in the surviving tadpoles was 7, 9, 15, 37,
   51, 53, 90, and 100\%. The average length of embryos was significantly
   lower in all DBP treatment groups. Thus, DBP significantly affected
   development of Xenopus embryos at low, environmentally relevant
   concentrations.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Veeramachaneni, DN (Reprint Author), Colorado State Univ, Anim Reprod \& Biotechnol Lab, Ft Collins, CO 80523 USA.
   Colorado State Univ, Anim Reprod \& Biotechnol Lab, Ft Collins, CO 80523 USA.}},
DOI = {{10.1080/15287390590930243}},
ISSN = {{1528-7394}},
Keywords-Plus = {{EMBRYO TERATOGENESIS ASSAY; METABOLIC-ACTIVATION SYSTEM; INTERLABORATORY
   VALIDATION; DIBUTYL PHTHALATE; PHASE-III; ENVIRONMENTAL ESTROGENS;
   DI(N-BUTYL) PHTHALATE; FETAX; RATS; ESTERS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{rao@colostate.edu}},
Cited-References = {{ASTM, 1998, ANN BOOK ASTM STAND, V03.01.
   Bantle JA, 1999, J APPL TOXICOL, V19, P447, DOI 10.1002/(SICI)1099-1263(199911/12)19:6<447::AID-JAT601>3.3.CO;2-W.
   Bantle JA, 1998, ATLAS ABNORMALITIES.
   BANTLE JA, 1994, ENVIRON TOXICOL CHEM, V13, P1629, DOI 10.1897/1552-8618(1994)13{[}1629:FIVSPI]2.0.CO;2.
   Bantle JA, 1996, J APPL TOXICOL, V16, P517, DOI 10.1002/(SICI)1099-1263(199611)16:6<517::AID-JAT385>3.3.CO;2-I.
   BANTLE JA, 1994, J APPL TOXICOL, V14, P213, DOI 10.1002/jat.2550140312.
   Bevan CL, 2003, ENVIRON HEALTH PERSP, V111, P488, DOI 10.1289/ehp.5500.
   Blount B. C., 2000, ENV HLTH PERSPECT, V108, P972.
   BRANDT K, 1985, J AM COLL TOXICOL, V4, P267.
   Burkhart JG, 1998, ENVIRON HEALTH PERSP, V106, P841, DOI 10.2307/3434128.
   Coady KK, 2004, J TOXICOL ENV HEAL A, V67, P941, DOI 10.1080/15287390490443722.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   CUMMINGS AM, 1987, TOXICOL LETT, V39, P43, DOI 10.1016/0378-4274(87)90255-4.
   DAWSON DA, 1989, DRUG CHEM TOXICOL, V12, P67, DOI 10.3109/01480548908999144.
   DRESSER TH, 1992, J APPL TOXICOL, V12, P49, DOI 10.1002/jat.2550120111.
   ELSISI AE, 1989, FUND APPL TOXICOL, V12, P70, DOI 10.1016/0272-0590(89)90063-8.
   Ema M, 2001, REPROD TOXICOL, V15, P261, DOI 10.1016/S0890-6238(01)00131-9.
   Ema M, 1998, TOXICOL LETT, V98, P87, DOI 10.1016/S0378-4274(98)00107-6.
   EMA M, 1993, TOXICOL LETT, V69, P197.
   Fort DJ, 1998, DRUG CHEM TOXICOL, V21, P1, DOI 10.3109/01480549809017846.
   Fort DJ, 2000, TERATOGEN CARCIN MUT, V20, P87, DOI 10.1002/(SICI)1520-6866(2000)20:2<87::AID-TCM4>3.0.CO;2-6.
   GIAM CS, 1980, ATMOS ENVIRON, V14, P65, DOI 10.1016/0004-6981(80)90108-0.
   HARDIN BD, 1987, TERATOGEN CARCIN MUT, V7, P29, DOI 10.1002/tcm.1770070106.
   Hayes T, 2003, ENVIRON HEALTH PERSP, V111, P568, DOI 10.1289/ehp.5932.
   Hayes TB, 2002, P NATL ACAD SCI USA, V99, P5476, DOI 10.1073/pnas.082121499.
   HIGUCHI T, 2000, BIOL REPROD S1, V62.
   Higuchi TT, 2003, TOXICOL SCI, V72, P301, DOI 10.1093/toxsci/kfg036.
   Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052.
   KLEEREKOPER H, 1976, J FISH RES BOARD CAN, V33, P2036.
   Kloas W, 1999, SCI TOTAL ENVIRON, V225, P59, DOI 10.1016/S0048-9697(98)00332-5.
   Levy G, 2004, ENVIRON RES, V94, P102, DOI 10.1016/S0013-9351(03)00086-0.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Nieuwkoop P. D., 1967, NORMAL TABLE XENOPUS.
   Ohtani H, 2000, ENVIRON HEALTH PERSP, V108, P1189, DOI 10.2307/3434832.
   PAGE BD, 1992, FOOD ADDIT CONTAM, V9, P197.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   PETERSON JC, 1982, ENVIRON SCI TECHNOL, V16, P464, DOI 10.1021/es00102a007.
   Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3.
   Saillenfait AM, 1998, TOXICOL SCI, V45, P212, DOI 10.1093/toxsci/45.2.212.
   SHIOTA K, 1980, ENVIRON RES, V22, P245, DOI 10.1016/0013-9351(80)90136-X.
   SINGH AR, 1972, J PHARM SCI, V61, P51, DOI 10.1002/jps.2600610107.
   THUREN A, 1991, B ENVIRON CONTAM TOX, V46, P159.
   WEBER N, 2004, J TOXICOL ENV HEAL A, V67, P1.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {*}AG TOX SUBST DIS, 2001, TOX PROF DI N BUT PH.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{11}},
Journal-ISO = {{J. Toxicol. Env. Health Part A}},
Doc-Delivery-Number = {{932IZ}},
Wos-Id = {{ISI:000229548700002}},
}

@article{ ISI:000229478200015,
Author = {Gilsing, HD and Angerer, J and Prescher, D},
Title = {{Convenient and high-yielding preparations of
   mono(5-carboxy-2-ethylpentyl) phthalate and its ring-deuterated isomer -
   The ``third{''} major metabolite of bis(2-ethylhexyl) phthalate}},
Journal = {{MONATSHEFTE FUR CHEMIE}},
Year = {{2005}},
Volume = {{136}},
Number = {{5}},
Pages = {{795-801}},
Month = {{MAY}},
Abstract = {{The synthesis of an oxidative major metabolite of bis(2-ethylhexyl)
   phthalate is described. The target molecule and its ring-deuterated
   isomer were obtained via acylation of the appropriate omega-hydroxy
   benzyl ester or the corresponding carboxylate with phthalic anhydride or
   phthalic anhydride-d(4). All transformation steps proceed with high
   yields.}},
Publisher = {{SPRINGER WIEN}},
Address = {{SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gilsing, HD (Reprint Author), Inst Dunnschichttechnol \& Mikrosensor eV, D-14513 Teltow, Germany.
   Inst Dunnschichttechnol \& Mikrosensor eV, D-14513 Teltow, Germany.
   Univ Erlangen Nurnberg, Inst \& Poliklin Arbeits Sozial \& Umweltmed, D-91054 Erlangen, Germany.}},
DOI = {{10.1007/s00706-004-0267-6}},
ISSN = {{0026-9247}},
Keywords = {{bis(2-ethylhexyl) phthalate; oxidative metabolites; carboxylic acids;
   protecting groups; ozonolysis}},
Keywords-Plus = {{DI(2-ETHYLHEXYL)PHTHALATE DEHP; PEROXISOME PROLIFERATION; TISSUE
   DISTRIBUTION; GENERAL-POPULATION; HUMAN EXPOSURE; HUMAN URINE; ESTERS;
   RAT; MECHANISMS; MONOESTERS}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
Author-Email = {{gilsing@idm-teltow.de}},
Cited-References = {{ALBRO PW, 1983, BIOCHIM BIOPHYS ACTA, V760, P283, DOI 10.1016/0304-4165(83)90175-7.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1987, BIOCHIM BIOPHYS ACTA, V923, P196, DOI 10.1016/0304-4165(87)90004-3.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   CHU I, 1978, DRUG METAB DISPOS, V6, P146.
   CLARK RD, 1976, J ORG CHEM, V41, P1396, DOI 10.1021/jo00870a023.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   DENMARK SE, 1990, J AM CHEM SOC, V112, P3466, DOI 10.1021/ja00165a034.
   DIRVEN HAAM, 1993, BIOCHEM PHARMACOL, V45, P2425, DOI 10.1016/0006-2952(93)90223-J.
   ELCOMBE CR, 1986, ENVIRON HEALTH PERSP, V70, P211, DOI 10.2307/3430357.
   Gilsing HD, 2002, MONATSH CHEM, V133, P1147, DOI 10.1007/s007060200084.
   Gomez-Bengoa E, 1998, J AM CHEM SOC, V120, P7649, DOI 10.1021/ja980499l.
   GOTO G, 1985, CHEM PHARM BULL, V33, P4422.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Griesbeck AG, 1999, J ORG CHEM, V64, P5213, DOI 10.1021/jo990390b.
   HORIGUCHI Y, 1986, TETRAHEDRON LETT, V27, P4025, DOI 10.1016/S0040-4039(00)84901-1.
   Hum G, 2000, CAN J CHEM, V78, P642, DOI 10.1139/cjc-78-5-642.
   Kanemitsu T, 2002, J AM CHEM SOC, V124, P3591, DOI 10.1021/ja0167396.
   KAULEN J, 1982, TETRAHEDRON, V38, P3299, DOI 10.1016/0040-4020(82)80110-5.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   KOCH HM, 2003, UMWELTMED FORSCH PRA, V8, P15.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   KOCIENSKI PJ, 2004, PROTECTING GROUPS, P409.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   LHUGUENOT JC, 1985, TOXICOL APPL PHARM, V80, P11, DOI 10.1016/0041-008X(85)90096-1.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   MACDONALD RT, 1995, MACROMOLECULES, V28, P73, DOI 10.1021/ma00105a008.
   Melnick RL, 2001, ENVIRON HEALTH PERSP, V109, P437, DOI 10.2307/3454700.
   Muszkat L, 1997, B ENVIRON CONTAM TOX, V58, P348, DOI 10.1007/s001289900341.
   Nakamura E., 1994, ORGANOCOPPER REAGENT, P129.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   STEGLICH W, 1978, ANGEW CHEM, V90, P602.
   Suzuki T, 2001, ENVIRON SCI TECHNOL, V35, P3757, DOI 10.1021/es001860i.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{7}},
Journal-ISO = {{Mon. Chem.}},
Doc-Delivery-Number = {{931IE}},
Wos-Id = {{ISI:000229478200015}},
}

@article{ ISI:000228395600023,
Author = {Buchta, C and Bittner, C and Heinzl, H and Hocker, P and Macher, M and
   Mayerhofer, M and Schmid, R and Seger, C and Dettke, M},
Title = {{Transfusion-related exposure to the plasticizer
   di(2-ethylhexyl)phthalate in patients receiving plateletpheresis
   concentrates}},
Journal = {{TRANSFUSION}},
Year = {{2005}},
Volume = {{45}},
Number = {{5}},
Pages = {{798-802}},
Month = {{MAY}},
Abstract = {{BACKGROUND: Di(2-ethylhexyl)phthalate (DEHP) is a plasticizer that can
   leach from medical devices including storage bags for plateletpheresis
   concentrates (PCs). In this study, the DEHP exposure to patients
   receiving PCs was determined and several variables were evaluated to
   reduce DEHP load to PC recipients.
   STUDY DESIGN AND METHODS: In 12 patients, serum DEHP was assessed before
   and after PC transfusion. For in vitro investigations, PCs were produced
   either with donor plasma or with 65 percent additive solution (AS;
   T-Sol) and stored for 5 days. Washing of PCs was performed according to
   AABB standards. DEHP levels were determined by gas chromatography-mass
   spectrometry.
   RESULTS: Transfusion of PCs led to a significant increase in serum DEHP.
   DEHP levels in the PCs continuously increased during storage, although
   the accumulation of DEHP was less in PCs stored in the AS, T-Sol, than
   when stored in plasma. Storage-related accumulation of DEHP contributed
   to a major part of the total DEHP load in PCs stored for 5 days. Washing
   of PCs led to a reduction of DEHP load.
   CONCLUSION: Recipients of PCs are exposed to DEHP, although the total
   amount represents only a small percentage of the defined tolerable
   intake. Reduction of storage time, the storage of PC in T-Sol, or the
   exchange of the storage medium before transfusion are practicable means
   to reduce the DEHP load in PC.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{111 RIVER ST, HOBOKEN 07030-5774, NJ USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Buchta, C (Reprint Author), Med Univ Vienna, Dept Blood Grp Serol \& Transfus Med, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.
   Med Univ Vienna, Dept Blood Grp Serol \& Transfus Med, A-1090 Vienna, Austria.
   Med Univ Vienna, Inst Med \& Chem Lab Diagnost, Vienna, Austria.
   Med Univ Vienna, Core Unit Med Stat \& Informat, Vienna, Austria.
   Med Univ Vienna, Dept Internal Med 1, Vienna, Austria.
   Univ Innsbruck, Dept Pharmacognosy, Inst Pharm, A-6020 Innsbruck, Austria.}},
DOI = {{10.1111/j.1537-2995.2005.04380.x}},
ISSN = {{0041-1132}},
Keywords-Plus = {{MONO-2-ETHYLHEXYL PHTHALATE MEHP; DI-(2-ETHYLHEXYL) PHTHALATE;
   DI-2-ETHYLHEXYL PHTHALATE; EXCHANGE-TRANSFUSION; POLYVINYL-CHLORIDE;
   NEWBORN-INFANTS; WHOLE-BLOOD; DEHP; RATS; BAGS}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Author-Email = {{christoph.buchta@meduniwien.ac.at}},
Cited-References = {{ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   BARRY YA, 1989, J THORAC CARDIOV SUR, V97, P900.
   Buchta C, 2003, TRANSFUSION, V43, P1115, DOI 10.1046/j.1537-2995.2003.00479.x.
   CHAWLA AS, 1991, BIOMAT ARTIF CELL IM, V19, P761.
   Chen CY, 2004, APPL SURF SCI, V231, P447, DOI 10.1016/j.apsusc.2004.03.168.
   COLE RS, 1981, VOX SANG, V40, P317.
   CONTRERA.TJ, 1974, TRANSFUSION, V14, P34.
   David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195.
   DIGANGI J, 1999, PHTHALATES VINYL MED.
   GOLLAMUDI R, 1983, J TOXICOL ENV HEALTH, V12, P623.
   Hanawa T, 2000, INT J PHARM, V210, P109, DOI 10.1016/S0378-5173(00)00578-0.
   HOGMAN CF, 1994, TRANSFUS SCI, V15, P351, DOI 10.1016/0955-3886(94)90167-8.
   JACOBSON MS, 1977, J LAB CLIN MED, V89, P1066.
   JAGER RJ, 1972, NEW ENGL J MED, V287, P1114.
   LABOW RS, 1986, J TOXICOL ENV HEALTH, V19, P591.
   Lantos P R, 1988, J Biomater Appl, V2, P358.
   Latini G, 1999, ACTA PAEDIATR, V88, P1174, DOI 10.1080/08035259950168333.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   LUNDBURG G, 1994, 1294 SWED NAT CHEM I.
   Marcel Y L, 1973, Environ Health Perspect, V3, P119, DOI 10.2307/3428037.
   PECK CC, 1979, TRANSFUSION, V19, P137, DOI 10.1046/j.1537-2995.1979.19279160282.x.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   ROCK G, 1986, ENVIRON HEALTH PERSP, V65, P309, DOI 10.2307/3430198.
   SCHNEIDER B, 1989, NEW ENGL J MED, V320, P1563.
   SCHWETZ BA, 2001, SAFETY ASSESSMENT DE.
   SJOBERG P, 1985, ARCH TOXICOL, V58, P78, DOI 10.1007/BF00348313.
   SJOBERG P, 1991, BIOCHEM PHARMACOL, V41, P1493, DOI 10.1016/0006-2952(91)90566-N.
   SJOBERG P, 1985, ACTA PHARMACOL TOX, V56, P30.
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x.
   TOMITA I, 1986, ENVIRON HEALTH PERSP, V65, P249, DOI 10.2307/3430190.
   {*}AABB, 1999, AABB STAND.
   {*}AABB, 1996, AABB TECHN MAN.
   {*}AABB, 1999, AABB TECHN MAN.
   {*}EUR DIR QUAL MED, 2002, EUR PHARM.
   {*}FDA, 2002, FDA PUBL HLTH NOT PV.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{16}},
Journal-ISO = {{Transfusion}},
Doc-Delivery-Number = {{916OS}},
Wos-Id = {{ISI:000228395600023}},
}

@article{ ISI:000227973900011,
Author = {Xu, Y and Cook, TJ and Knipp, GT},
Title = {{Effects of di-(2-ethylhexyl)-phthalate (DEHP) and its metabolites on
   fatty acid homeostasis regulating proteins in rat placental HRP-1
   trophoblast cells}},
Journal = {{TOXICOLOGICAL SCIENCES}},
Year = {{2005}},
Volume = {{84}},
Number = {{2}},
Pages = {{287-300}},
Month = {{APR}},
Abstract = {{Di-(2-ethylhexyl)-phthalate (DEHP) is a widely used plasticizer and
   ubiquitous environmental contaminant. The potential health hazards,
   including teratogenicity, from exposure to DEHP may be related to the
   role of DEHP or its metabolites in the trans-activation of peroxisome
   proliferator-activated receptors (PPARs). Fetal essential fatty acid
   (EFA) homeostasis is controlled by directional transfer across the
   placenta through a highly regulated process, including PPAR activation.
   Using HRP-1 rat trophoblastic cells, the effects of DEHP and two of its
   metabolites, mono-(2-ethylhexyl)-phthalate (MEHP) and 2-ethylhexanoic
   acid (EHA), on the mRNA and protein expression of the three known PPAR
   isoforms (alpha, beta, and gamma), fatty acid transport protein 1
   (FATP1), plasma membrane fatty acid binding protein (FABPpm), and the
   heart cytoplasmic fatty acid binding protein (HFABP) were investigated.
   This study also investigated the functional effects of exposure on the
   uptake and transport of six long chain fatty acids (LCFAs): arachidonic
   acid (AA), docosahexaenoic acid (DHA), linoleic acid (LA),
   alpha-linolenic acid (ALA), oleic acid (OA), and stearic acid (SA). In
   the presence of DEHP, MEHP, and EHA, the expression of PPAR alpha, PPAR
   gamma, FATP1, and HFABP were up-regulated in a dose- and time- dependent
   manner, while PPAR beta and FABPpm demonstrated variable expression. The
   uptake rates of EFAs (AA, DHA, LA, ALA) increased significantly upon
   exposure, and the transport of AA (omega-6) and DHA (omega-3) were
   directionally induced. These results suggest that DEHP, MEHP, and EHA
   can influence EFA transfer across HRP-1 cells, implying that these
   compounds may alter placental EFA homeostasis and potentially result in
   abnormal fetal development.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Knipp, GT (Reprint Author), Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, 160 Frelinghuysen Rd, Piscataway, NJ 08854 USA.
   Rutgers State Univ, Ernest Mario Sch Pharm, Dept Pharmaceut, Piscataway, NJ 08854 USA.}},
DOI = {{10.1093/toxsci/kfi083}},
ISSN = {{1096-6080}},
Keywords = {{phthalates; rat; placenta; HRP-1; fatty acid; transport; PPAR}},
Keywords-Plus = {{ACTIVATED RECEPTOR-ALPHA; PPAR-GAMMA; DI(2-ETHYLHEXYL) PHTHALATE;
   TRANSPORT; EXPOSURE; DIFFERENTIATION; TERATOGENESIS; PERMEABILITY;
   EXPRESSION; PHYSIOLOGY}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{gknipp@rci.rutgers.edu}},
Cited-References = {{ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   Asano T, 2000, BBA-MOL CELL RES, V1497, P148, DOI 10.1016/S0167-4889(00)00054-9.
   Barak Y, 2002, P NATL ACAD SCI USA, V99, P303, DOI 10.1073/pnas.012610299.
   Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9.
   Benassayag C, 1997, J LIPID RES, V38, P276.
   Bocher V, 2002, ANN NY ACAD SCI, V967, P7.
   Cammack JN, 2003, INT J TOXICOL, V22, P159, DOI 10.1080/10915810390201136.
   Campbell FM, 1997, J LIPID RES, V38, P2558.
   Das UG, 1998, AM J PHYSIOL-REG I, V274, pR339.
   Dutta-Roy AK, 2000, AM J CLIN NUTR, V71, p315S.
   Giammona CJ, 2002, TOXICOL APPL PHARM, V185, P119, DOI 10.1006/taap.2002.9536.
   Guay DRP, 2002, CARDIOVASC DRUG REV, V20, P281.
   HAGGARTY P, 2002, PLACENTA, V23, pW28.
   Innis SM, 2003, J PEDIATR, V143, pS1, DOI 10.1067/S0022-3476(03)00396-2.
   JUCHAU MR, 1992, DRUG METAB REV, V24, P195, DOI 10.3109/03602539208996293.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   KLHLSTROM I, 1983, ACTA PHARM TOXICOL C, V53, P23.
   Knipp GT, 1999, ADV DRUG DELIVER REV, V38, P41, DOI 10.1016/S0169-409X(99)00005-8.
   Knipp GT, 2000, PLACENTA, V21, P367, DOI 10.1053/plac.1999.0484.
   Lampen A, 2003, TOXICOL APPL PHARM, V188, P14, DOI 10.1016/S0041-008X(03)00014-0.
   Latini G, 2003, BIOL NEONATE, V83, P22, DOI 10.1159/000067012.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   Lemberger T, 1996, ANNU REV CELL DEV BI, V12, P335, DOI 10.1146/annurev.cellbio.12.1.335.
   Magliozzi R, 2003, HISTOCHEM CELL BIOL, V120, P41, DOI 10.1007/s00418-003-0543-2.
   Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809.
   Moore C, 2001, J COGN DEV, V2, P109, DOI 10.1207/S15327647JCD0202\_1.
   Motojima K, 1998, J BIOL CHEM, V273, P16710, DOI 10.1074/jbc.273.27.16710.
   Novak D, 2001, AM J PHYSIOL-CELL PH, V281, pC1014.
   Peters JM, 1997, TERATOLOGY, V56, P311, DOI 10.1002/(SICI)1096-9926(199711)56:5<311::AID-TERA4>3.0.CO;2-\#.
   Richburg JH, 2000, ENDOCRINOLOGY, V141, P787, DOI 10.1210/en.141.2.787.
   Shi FL, 1997, EXP CELL RES, V234, P147, DOI 10.1006/excr.1997.3603.
   Simpson AECM, 1997, GEN PHARMACOL, V28, P351, DOI 10.1016/S0306-3623(96)00246-7.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   SOARES MJ, 1987, DEV BIOL, V124, P134, DOI 10.1016/0012-1606(87)90466-0.
   Storey KB, 2003, ADV EXP MED BIOL, V543, P21.
   Uauy R, 1999, EUR J CLIN NUTR, V53, pS66, DOI 10.1038/sj.ejcn.1600745.
   Wang Q, 2002, PLACENTA, V23, P661, DOI 10.1053/plac.2002.0855.
   XU Y, 2004, IN PRESS METHODS MOL.
   Yokoyama Y, 2003, TOXICOL LETT, V144, P371, DOI 10.1016/S0378-4274(03)00256-X.
   Youdim KA, 2003, DRUG DISCOV TODAY, V8, P997, DOI 10.1016/S1359-6446(03)02873-3.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{26}},
Journal-ISO = {{Toxicol. Sci.}},
Doc-Delivery-Number = {{911AQ}},
Wos-Id = {{ISI:000227973900011}},
}

@article{ ISI:000227129300006,
Author = {Duty, SM and Calafat, AM and Silva, MJ and Ryan, L and Hauser, R},
Title = {{Phthalate exposure and reproductive hormones in adult men}},
Journal = {{HUMAN REPRODUCTION}},
Year = {{2005}},
Volume = {{20}},
Number = {{3}},
Pages = {{604-610}},
Month = {{MAR}},
Abstract = {{BACKGROUND: Phthalates are used in personal and consumer products, food
   packaging materials, and polyvinyl chloride plastics and have been
   measured in the majority of the general population of the USA.
   Consistent experimental evidence shows that some phthalates are
   developmental and reproductive toxicants in animals. This study explored
   the association between environmental levels of phthalates and altered
   reproductive hormone levels in adult men. METHODS: Between 1999 and
   2003, 295 men were recruited from Massachusetts General Hospital.
   Selected phthalate metabolites were measured in urine. Linear regression
   models explored the relationship between specific gravity-adjusted
   urinary phthalate monoester concentrations and serum levels of
   reproductive hormones, including FSH, LH, sex hormone-binding globulin,
   testosterone, and inhibin B. RESULTS: An interquartile range (IQR)
   change in monobenzyl phthalate (MBzP) exposure was significantly
   associated with a 10\% {[}95\% confidence interval (CI): -16, -4.0]
   decrease in FSH concentration. Additionally, an IQR change in monobutyl
   phthalate (MBP) exposure was associated with a 4.8\% (95\% CI: 0, 10)
   increase in inhibin B but this was of borderline significance.
   CONCLUSIONS: Although we found associations between MBP and MBzP urinary
   concentrations and altered levels of inhibin B and FSH, the hormone
   concentrations did not change in the expected patterns. Therefore, it is
   unclear whether these associations represent physiologically relevant
   alterations in these hormones, or whether they represent associations
   found as a result of conducting multiple comparisons.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hauser, R (Reprint Author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Occupat Hlth Program, 665 Huntington Ave, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Occupat Hlth Program, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   Simmons Coll, Sch Hlth Studies, Dept Nursing, Boston, MA 02115 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.
   Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA.
   Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv, Androl Lab, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, In Vitro Fertilizat Unit, Boston, MA 02114 USA.}},
DOI = {{10.1093/humrep/deh656}},
ISSN = {{0268-1161}},
Keywords = {{environmental; epidemiology; hormones; human; phthalates}},
Keywords-Plus = {{SEXUAL-DIFFERENTIATION; MALE-RATS; DIETHYLHEXYL PHTHALATE; QUANTITATIVE
   DETECTION; INHIBIN-B; METABOLITES; TESTOSTERONE; MALFORMATIONS;
   POPULATION; PARAMETERS}},
Research-Areas = {{Obstetrics \& Gynecology; Reproductive Biology}},
Web-of-Science-Categories  = {{Obstetrics \& Gynecology; Reproductive Biology}},
ResearcherID-Numbers = {{Ryan, Louise/A-4562-2009}},
Cited-References = {{AGARWAL DK, 1985, TOXICOLOGY, V35, P189, DOI 10.1016/0300-483X(85)90015-0.
   Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   BAIN PA, 1987, HORM BEHAV, V21, P430, DOI 10.1016/0018-506X(87)90002-X.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Groome NP, 1996, J CLIN ENDOCR METAB, V81, P1401, DOI 10.1210/jc.81.4.1401.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hosmer D, 1989, APPL LOGISTIC REGRES, P82.
   Jensen TK, 1997, J CLIN ENDOCR METAB, V82, P4059, DOI 10.1210/jc.82.12.4059.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P133.
   SCHRADER SM, 1993, J OCCUP ENVIRON MED, V35, P574, DOI 10.1097/00043764-199306000-00013.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   TEASS AW, 1998, NIOSH MANUAL ANAL ME, P52.
   Uhler ML, 2003, FERTIL STERIL, V79, P1535, DOI 10.1016/S0015-0282(03).
   VERMEULEN A, 1992, J CLIN ENDOCR METAB, V74, P939, DOI 10.1210/jc.74.4.939.
   WILKE TJ, 1987, CLIN CHEM, V33, P1372.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 1997, TOX PROF DINOCTYL PH.
   {*}ATSDR, 2001, TOX PROF DINBUTYL PH.
   {*}CDC, 2003, 2 CDCP.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{69}},
Journal-ISO = {{Hum. Reprod.}},
Doc-Delivery-Number = {{899FC}},
Wos-Id = {{ISI:000227129300006}},
}

@article{ ISI:000226879800034,
Author = {Preuss, R and Koch, HM and Angerer, J},
Title = {{Biological monitoring of the five major metabolites of
   di-(2-ethylhexyl)phthalate (DEHP) in human urine using column-switching
   liquid chromatography-tandem mass spectrometry}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES}},
Year = {{2005}},
Volume = {{816}},
Number = {{1-2}},
Pages = {{269-280}},
Month = {{FEB 25}},
Abstract = {{We present a fast and reliable on-line clean-up HPLC-method for the
   simultaneous determination of the five major urinary metabolites of
   di-(2-ethylhexyl)phthalate (DEHP) namely
   mono-(2-ethyl-5-carboxypentyl)phthalate (5carboxy-MEPP), mono-
   {[}2-(carboxymethyl)hexyl]phthalate (2carboxy-MMHP),
   mono-(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP),
   mono-(2-ethyl-5-oxohexyl)phthalate (5oxo-MEHP) and
   mono-(2-ethylhexyl)phthalate (MEHP). These metabolites represent about
   70\% of an oral DEHP dose. We for the first time succeeded to reliably
   quantify 5carboxy-MEPP and to identify 2carboxy-MMHP as major
   metabolites in native urines of the general population. The analytical
   procedure consists of an enzymatic hydrolysis, on-line extraction of the
   analytes from urinary matrix by a restricted access material column
   (RAM), back-flush transfer onto the analytical column (betasil
   phenylhexyl), detection by ESI-tandem mass spectrometry and
   quantification by isotope dilution (limit of detection (LOD) 0.25
   mug/l). Median concentrations of a small collective taken from the
   general population (n = 19) were 85.5 mug/l (5carboxy-MEPP), 47.5 mug/l
   (5OH-MEHP), 39.7 mug/l (5oxo-MEHP), 9.8 mug/l (MEHP) and about 37 mug/l
   (2carboxy-MMHP). The presented method can provide insights into the
   actual internal burden of the general population and certain risk
   groups. It will help to further explore the human metabolism of DEHP-an
   occupational and environmental toxicant of great concern. (C) 2004
   Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Angerer, J (Reprint Author), Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, Schillerstr 25, D-91054 Erlangen, Germany.
   Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, D-91054 Erlangen, Germany.}},
DOI = {{10.1016/j.jchromb.2004.11.048}},
ISSN = {{1570-0232}},
Keywords = {{DEHP; phthalates; urine; plasticizer; metabolites; biological monitoring}},
Keywords-Plus = {{TESTICULAR DYSGENESIS SYNDROME; SOLID-PHASE EXTRACTION; DI(2-ETHYLHEXYL)
   PHTHALATE; HUMAN EXPOSURE; MALE-RATS; DIETHYLHEXYL PHTHALATE;
   SEXUAL-DIFFERENTIATION; GENERAL-POPULATION; INTERNAL EXPOSURE; ONLINE
   CLEANUP}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{Juergen.Angerer@ipasum.imed.uni-erlangen.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   ANGERER J, 2002, PROSPECTS OCCUPATION.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Boos KS, 1999, TRAC-TREND ANAL CHEM, V18, P175, DOI 10.1016/S0165-9936(98)00102-2.
   Borch J, 2004, REPROD TOXICOL, V18, P53, DOI 10.1016/j.reprotox.2003.10.011.
   Calafat AM, 2004, PEDIATRICS, V113, P429.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   DIRVEN HAAM, 1993, BIOCHEM PHARMACOL, V45, P2425, DOI 10.1016/0006-2952(93)90223-J.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Gilsing HD, 2003, MONATSH CHEM, V134, P1207, DOI 10.1007/s00706-003-0044-y.
   GILSING HD, IN PRESS MONATSH CHE.
   Gilsing HD, 2002, MONATSH CHEM, V133, P1147, DOI 10.1007/s007060200084.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hoppin JA, 2003, EPIDEMIOLOGY, V14, P259, DOI 10.1097/00001648-200305000-00002.
   IARC, 1982, IARC MON EV CARC RIS, V29, P416.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   KOCH HM, IN PRESS ARCH TOXICO.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   KOCH HM, 2003, J ANGERER UMWELTMED, V8, P15.
   LARSEN K, 1972, CLIN CHIM ACTA, V41, P209, DOI 10.1016/0009-8981(72)90513-X.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Preuss R, 2004, J CHROMATOGR B, V801, P307, DOI 10.1016/j.jchromb.2003.11.032.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   SJOBERG P, 1985, ARCH TOXICOL, V58, P78, DOI 10.1007/BF00348313.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   Skakkebaek NE, 2002, HORM RES, V57, P43, DOI 10.1159/000058100.
   Souverain S, 2004, J CHROMATOGR B, V801, P141, DOI 10.1016/j.jchromb.2003.11.043.
   {*}ATSDR, 1993, ATDRTP9205 US DEP HH, P171.
   {*}DFG, 2002, GESUNDHEITSSCHADLICH.
   {*}ECPI, 2004, COMMUNICATION.
   {*}FDA, 2001, US FOOD DRUG ADM SAF.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{63}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{895RD}},
Wos-Id = {{ISI:000226879800034}},
}

@article{ ISI:000226438400020,
Author = {Kato, K and Silva, MJ and Needham, LL and Calafat, AM},
Title = {{Determination of total phthalates in urine by isotope-dilution liquid
   chromatography-tandem mass spectrometry}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES}},
Year = {{2005}},
Volume = {{814}},
Number = {{2}},
Pages = {{355-360}},
Month = {{JAN 25}},
Abstract = {{Diesters, of 1,2-benzenedicarboxylic acid are a family of industrial
   compounds called ``phthalates{''}. The physical and chemical properties
   of these diesters, and therefore their potential uses, depend on the
   structure of the dialkyl or alkyl/aryl side chain. The urinary
   concentrations of phthalate monoesters, which are metabolites, have been
   used as biomarkers of human exposure to specific phthalates. However,
   several phthalates, particularly those with side chains of eight or more
   carbon atoms, are complex mixtures of isomers. For these, the phthalate
   metabolites to be used as biomarkers of exposure have not been
   unequivocally identified. We developed a method for assessing total
   exposure to phthalates, including the isomeric mixtures of high
   molecular weight phthalates, by measuring the concentration of phthalic
   acid (PA) in human urine after acid hydrolysis of the phthalate
   metabolites to PA. The present method accurately assesses total exposure
   to phthalates without noticeable contamination from the ubiquitous
   phthalates in the environment, but it gives no information about the
   parent phthalate. (C) 2004 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.}},
DOI = {{10.1016/j.jchromb.2004.10.056}},
ISSN = {{1570-0232}},
Keywords = {{phthalic acid; acid hydrolysis; phthalates; total exposure; body burden}},
Keywords-Plus = {{SEXUAL-DIFFERENTIATION; INTERNAL EXPOSURE; MALE-RAT; METABOLITES;
   POPULATION; DEHP; MALFORMATIONS; PARAMETERS; CHILDREN; DINP}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{acalafat@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   ALBRO PW, 1984, ANAL CHEM, V56, P247, DOI 10.1021/ac00266a029.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   David R. M., 2001, PATTYS TOXICOLOGY, P635.
   Duty SM, 2004, J ANDROL, V25, P293.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Ema M, 2001, REPROD TOXICOL, V15, P261, DOI 10.1016/S0890-6238(01)00131-9.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hoppin JA, 2004, ENVIRON HEALTH PERSP, V112, P571.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   IARC, 2000, IARC MON EV CARC RIS.
   Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/10408440390250154.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   {*}ATSDR, 2001, US DEP HHS PUBL HLTH.
   {*}ATSDR, 1997, US DEP HHS PUBL HLTH.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.
   {*}ATSDR, 2002, DEHP US DEP HHS PUBL.
   {*}CDC, 2003, CDCP NAT CTR ENV HLT.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{15}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{889JD}},
Wos-Id = {{ISI:000226438400020}},
}

@article{ ISI:000225960500026,
Author = {Chandrasekaran, Y and Richburg, JH},
Title = {{The p53 protein influences the sensitivity of testicular germ cells to
   mono-(2-ethyl hexyl) phthalate-induced apoptosis by increasing the
   membrane levels of fas and DR5 and decreasing the intracellular amount
   of c-FLIP}},
Journal = {{BIOLOGY OF REPRODUCTION}},
Year = {{2005}},
Volume = {{72}},
Number = {{1}},
Pages = {{206-213}},
Month = {{JAN}},
Abstract = {{The consequence of mono-(2-ethylhexyl) phthalate (MEHP)induced injury of
   testicular Sertoli cells is the Fas-dependent apoptotic elimination of
   germ cells. In addition to the well-known ability of p53 to regulate the
   transcription of various apoptosis-associated proteins, p53 also has
   been implicated in mediating the localization of Fas to the plasma
   membrane of various cell types in a transcription-independent manner. To
   resolve the role of p53 in MEHP-mediated testicular toxicity, we used
   wild-type (p53(+/+)) and p53 knockout (p53(-/-)) mice. A significantly
   lower incidence of TUNEL-positive germ cells was observed in p53(-/-)
   mice compared to p53(+/+) mice at 1, 1.5, and 24 h after MEHP exposure.
   In these same mice, an induction of Fas and death receptor-5 (DR5) in
   testicular membrane preparations was observed only in p53(+/+) mice.
   Analyses of mRNA levels in testes of p53(+/+) and p53(-/-) mice by
   reverse transcription-polymerase chain reaction revealed that increases
   in membrane levels of Fas occurred in the absence of their
   transcriptional up-regulation. Processing of procaspase-8 was observed
   only in MEHP-treated p53(+/+) mice, and this correlated with the
   observed incidence of germ cell apoptosis. Interestingly, the p53 status
   of mice also influenced the stability of c-FLIP (L), a caspase-8
   inhibitory protein, that was measured at levels approximately two- to
   fivefold higher in p53(-/-) mice after MEHP-exposure compared to those
   in p53(+/+) mice. Taken together, these data suggest that MEHP-induced
   germ cell apoptosis is dependent, in part, on the p53 protein and on its
   abilities to increase the localization of Fas and DR5 on the germ cell
   membrane as well as to decrease the cellular levels of c-FLIP (L).}},
Publisher = {{SOC STUDY REPRODUCTION}},
Address = {{1603 MONROE ST, MADISON, WI 53711-2021 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Richburg, JH (Reprint Author), Univ Texas, Coll Pharm, Dept Pharmacol \& Toxicol, PHR 5-218,1 Univ Stn,A1915, Austin, TX 78712 USA.
   Univ Texas, Coll Pharm, Dept Pharmacol \& Toxicol, Austin, TX 78712 USA.}},
DOI = {{10.1095/biolreprod.104.030858}},
ISSN = {{0006-3363}},
Keywords = {{apoptosis; Sertoli cells; signal transduction; testis; toxicology}},
Keywords-Plus = {{DEATH RECEPTOR; MOUSE TESTIS; SIGNALING COMPLEX; DI-(2-ETHYLHEXYL)
   PHTHALATE; P53-MEDIATED APOPTOSIS; CELLULAR FLIP; SERTOLI-CELL; LIGAND;
   SYSTEM; EXPRESSION}},
Research-Areas = {{Reproductive Biology}},
Web-of-Science-Categories  = {{Reproductive Biology}},
Author-Email = {{john\_richburg@mail.utexas.edu}},
Cited-References = {{Almasan A, 2003, CYTOKINE GROWTH F R, V14, P337, DOI 10.1016/S1359-6101(03)00029-7.
   Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9.
   Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305.
   Beltinger C, 1999, P NATL ACAD SCI USA, V96, P8699, DOI 10.1073/pnas.96.15.8699.
   Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290.
   Bratton SB, 2000, EXP CELL RES, V256, P27, DOI 10.1006/excr.2000.4835.
   CHAPIN RE, 1988, TOXICOL APPL PHARM, V92, P467, DOI 10.1016/0041-008X(88)90186-X.
   CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3.
   CREASY DM, 1988, TOXICOL IN VITRO, V2, P83, DOI 10.1016/0887-2333(88)90018-5.
   D'Alessio A, 2001, P NATL ACAD SCI USA, V98, P3316, DOI 10.1073/pnas.051566098.
   DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0.
   Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489.
   ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P.
   Embree-Ku M, 2002, BIOL REPROD, V66, P1456, DOI 10.1095/biolreprod66.5.1456.
   Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673.
   Giammona CJ, 2002, TOXICOL APPL PHARM, V185, P119, DOI 10.1006/taap.2002.9536.
   Giampietri C, 2003, CELL DEATH DIFFER, V10, P175, DOI 10.1038/sj.cdd.4401137.
   Grataroli R, 2002, BIOL REPROD, V66, P1707, DOI 10.1095/biolreprod66.6.1707.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710.
   Irmler M, 1997, NATURE, V388, P190.
   Jo M, 2000, NAT MED, V6, P564.
   Koji T, 2001, BIOL REPROD, V64, P946, DOI 10.1095/biolreprod64.3.946.
   Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200.
   Lee J, 1999, ENDOCRINOLOGY, V140, P852, DOI 10.1210/en.140.2.852.
   Lee JW, 1997, ENDOCRINOLOGY, V138, P2081, DOI 10.1210/en.138.5.2081.
   Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794.
   MIYASHITA T, 1995, CELL, V80, P293.
   Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033.
   Munsch D, 2000, J BIOL CHEM, V275, P3867, DOI 10.1074/jbc.275.6.3867.
   Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0.
   Nesterov A, 2002, ONCOGENE, V21, P1135, DOI 10.1038/sj.onc.1205151.
   Ogi S, 1998, UROL RES, V26, P17.
   OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032.
   Pentikainen V, 1999, AM J PHYSIOL-ENDOC M, V276, pE310.
   Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186.
   Peter ME, 2000, CELL DEATH DIFFER, V7, P759, DOI 10.1038/sj.cdd.4400735.
   Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525.
   Richburg JH, 2000, ENDOCRINOLOGY, V141, P787, DOI 10.1210/en.141.2.787.
   Richburg JH, 1999, TOXICOL APPL PHARM, V160, P271, DOI 10.1006/taap.1999.8786.
   Seaman F, 2003, APOPTOSIS, V8, P101, DOI 10.1023/A:1021734604913.
   TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1.
   THOMAS JA, 1984, CRC CR REV TOXICOL, V13, P283, DOI 10.3109/10408448409023761.
   THOMAS JA, 1978, TOXICOL APPL PHARM, V45, P1, DOI 10.1016/0041-008X(78)90024-8.
   Van de Craen M, 1998, J MOL BIOL, V284, P1017, DOI 10.1006/jmbi.1998.2226.
   Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072.
   Wu GS, 1999, ONCOGENE, V18, P6411, DOI 10.1038/sj.onc.1203025.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{18}},
Journal-ISO = {{Biol. Reprod.}},
Doc-Delivery-Number = {{882TF}},
Wos-Id = {{ISI:000225960500026}},
}

@article{ ISI:000231016100002,
Author = {Itoh, H and Yoshida, K and Masunaga, S},
Title = {{Evaluation of the effect of governmental control of human exposure to
   two phthalates in Japan using a urinary biomarker approach}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2005}},
Volume = {{208}},
Number = {{4}},
Pages = {{237-245}},
Abstract = {{In Japan, the use of certain phthalates has been regulated. We analyzed
   the effectiveness of these measures using an analytical biomarker
   approach. We measured two phthalate metabolites, mono-n-butyl phthalate
   (MBP) and mono-2ethylhexyl phthalate (MEHP) in urine samples from 36
   participants using enzymatic deconjugation, offline solid phase
   extraction, and HPLC-ESI-MS/MS. From the levels measured and individual
   values of creatinine excretion rate the daily intake was determined and
   compared to each corresponding tolerable daily intake (TDI). The levels
   of urinary MBP and MEHP were < 1.8-280 and 0.76-25 mu g/l, respectively.
   The ranges of the estimated daily intake of di-n-butyl phthalate (DBP)
   and cli-2-ethylhexyl phthalate (DEHP) from 35 adult urine samples were
   0.22-4.5 and 0.37-7.3 mu g/kg/day, respectively. These values were lower
   than the corresponding TDIs. After comparing these values to previous
   exposure assessment data on DEHP in Japan, it could be seen that the
   DEHP intake dropped over the period from 1998 to 2001.
   Children were not covered in the present study, so the results may only
   be applicable to adults, not to the Japanese population at large. Even
   so, the small number of people in one specific geographic area cannot be
   considered representative of the adult Japanese population.
   In addition to MEHP, the secondary metabolites of DEHP, which are more
   suitable biomarkers should be measured in the future. (c) 2005 Elsevier
   GmbH. All rights reserved.}},
Publisher = {{URBAN \& FISCHER VERLAG}},
Address = {{BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Itoh, H (Reprint Author), Yokohama Natl Univ, Grad Sch Environm \& Informat Sci, Yokohama, Kanagawa 240, Japan.
   Yokohama Natl Univ, Grad Sch Environm \& Informat Sci, Yokohama, Kanagawa 240, Japan.}},
DOI = {{10.1016/j.ijheh.2005.02.004}},
ISSN = {{1438-4639}},
Keywords = {{risk reduction; policy analysis; exposure pathway; biomarker; risk
   management; metabolites; phthalates; reconstruction}},
Keywords-Plus = {{HUMAN REFERENCE POPULATION; SOLID-PHASE EXTRACTION;
   DI(2-ETHYLHEXYL)PHTHALATE DEHP; GENERAL-POPULATION; METABOLITES;
   MONOESTERS; ESTERS}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{itoh-hiroaki@umin.ac.jp}},
ResearcherID-Numbers = {{Masunaga, Shigeki/F-1315-2011}},
ORCID-Numbers = {{Masunaga, Shigeki/0000-0003-0608-2337}},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Borjanovic SS, 1999, J OCCUP HEALTH, V41, P27, DOI 10.1539/joh.41.27.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kawasaki T, 1991, Nihon Koshu Eisei Zasshi, V38, P567.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   MHLW, 2003, PRACT WORKSH HLTH MA, P57.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SHIMURA T, 2000, ANAL PHTHALIC ACID M, P142.
   Silva MJ, 2004, J CHROMATOGR B, V805, P161, DOI 10.1016/j.jchromb.2004.02.038.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Suzuki T, 2001, ENVIRON SCI TECHNOL, V35, P3757, DOI 10.1021/es001860i.
   TAKADA K, 2002, BASIC CLIN PHARM, P230.
   Trapp S, 1998, CHEMODYNAMICS ENV MO.
   USEPA, 1992, FED REGISTER, V104, P22888.
   YASUGI R, 1998, IWANAMI DICT BIOL SC.
   YOSHIDA K, 2003, 16 ANN M SOC RISK AN.
   YOSHIDA K, 2005, RISK ASSESSMENT DI 2.
   {*}AIST, 2003, NATL I ADV IND SCI T.
   {*}CHEM DAIL CO LTD, 2000, CHEM DAIL.
   {*}CSTEE, 1998, OP PHTH MIGR SOFT PV.
   {*}CSTEE, 2004, OP RES 2 RISK ASS BI.
   {*}MHLW, 2002, REP PART REV STAND F.
   {*}MIN ENV, 2002, DIET SURV CONC END D.
   {*}MIN HLTH WELF, 2000, REP CONCL JOINT M TO.
   {*}NATL I HLTH NUTR, NATL NUTR SURV HLTH.
   {*}WHO, 1992, DIETHYLH PHTH, V131, P49.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{12}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{952OT}},
Wos-Id = {{ISI:000231016100002}},
}

@article{ ISI:000233911200007,
Author = {Koch, HM and Angerer, J and Drexler, H and Eckstein, R and Weisbach, V},
Title = {{Di(2-ethylhexyl)phthalate (DEHP) exposure of voluntary plasma and
   platelet donors}},
Journal = {{INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH}},
Year = {{2005}},
Volume = {{208}},
Number = {{6}},
Pages = {{489-498}},
Abstract = {{Each year thousands of healthy volunteers undergo apheresis procedures
   to donate blood components and safe lives. However, many disposables
   used in apheresis contain di(2-ethylhexyl)phthalate (DEHP). This way,
   donors are exposed to DEHP, which is a reproductive and developmental
   toxicant in animals and a suspected endocrine modulator in humans.
   We quantified the DEHP exposure of six plasma donors, six
   discontinuous-flow platelet donors and six continuous-flow platelet
   donors by determining three specific metabolites in urine (5OH-MEHP:
   mono(2-ethyl-5-hydroxyhexyl)phthalate; 5oxo-MEHP:
   mono(2-ethyl-5-oxo-hexyl)phthalate and MEHP:
   mono(2-ethylhexyl)phthalate).
   We found maximum concentrations in urine samples after the
   discontinuous-flow plateletpheresis procedure with 826 mu g/l for
   5OH-MEHP, 774 mu g/l for 5oxo-MEHP and 266 mu g/l for MEHP (mean of the
   six volunteers). Metabolite excretions were found to be significantly
   (p<0.0001) higher for both plateletpheresis techniques compared to
   plasmapheresis and controls. Continuous-flow plateletpheresis led to
   significantly higher (p<0.0001) excretions than discontinuous-flow
   plateletpheresis.
   Mean absolute DEHP exposures were 1.2 mg for discontinuous- and 2.1 mg
   for continuous-flow plateletpheresis. Exposure for plasmapheresis (0.37
   mg) was in the range of the controls (0.41 mg). Mean DEHP doses for both
   plateletpheresis techniques (18.1 and 32.3 mu g/kg/day) were close to or
   exceeded the reference dose (RfD) of the US EPA and tolerable daily
   intake (TDI) value of the EU on the day of the apheresis. Therefore,
   margins of safety might be insufficient to protect especially young men
   and women in their reproductive age from effects on reproductivity. At
   present, discontinuous-flow devices should be preferred to avert
   conceivable health risks from plateletpheresis donors. Strategies to
   avoid DEHP exposure of donors during apheresis need to be developed. (C)
   2005 Elsevier GmbH. All rights reserved.}},
Publisher = {{ELSEVIER GMBH, URBAN \& FISCHER VERLAG}},
Address = {{OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Angerer, J (Reprint Author), Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, Schillerstr 25-29, D-91054 Erlangen, Germany.
   Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, D-91054 Erlangen, Germany.
   Univ Hosp Erlangen Nuremberg, Dept Transfus Med \& Haemostaseol, Erlangen, Germany.}},
DOI = {{10.1016/j.ijheh.2005.07.001}},
ISSN = {{1438-4639}},
Keywords = {{apheresis; plateletpheresis; plasmapheresis; di(2-ethylhexyl)phthalate;
   DEHP; phthalate; plasticizer; urine; biomarker; internal exposure;
   biological monitoring}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; PHTHALATE METABOLITES; HUMAN URINE;
   DI-(2-ETHYLHEXYL) PHTHALATE; REPRODUCTIVE HEALTH; GENERAL-POPULATION;
   INTERNAL EXPOSURE; SERUM; BIOMARKERS; SECONDARY}},
Research-Areas = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health; Infectious Diseases}},
Author-Email = {{Juergen.Angerer@ipasum.imed.uni-erlangen.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{Akingbemi BT, 2004, P NATL ACAD SCI USA, V101, P775, DOI 10.1073/pnas.0305977101.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Becker K, 2004, INT J HYG ENVIR HEAL, V207, P409, DOI 10.1078/1438-4639-00309.
   BRUDER A, 1999, SWISS PLAST, V21, P5.
   Buchta C, 2003, TRANSFUSION, V43, P1115, DOI 10.1046/j.1537-2995.2003.00479.x.
   Calafat AM, 2004, PEDIATRICS, V113, pE429, DOI 10.1542/peds.113.5.e429.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Fisher JS, 2004, REPRODUCTION, V127, P305, DOI 10.1530/rep.1.00025.
   Greim H, 2002, GESUNDHEITSSCHADLICH, P35.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P751, DOI 10.1289/ehp.6804.
   Hauser R, 2004, ENVIRON HEALTH PERSP, V112, P1734, DOI 10.1289/ehp.7212.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hoppin JA, 2003, EPIDEMIOLOGY, V14, P259, DOI 10.1097/00001648-200305000-00002.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Koch H, 2005, UMWELTMED FORSCH PRA, V10, P144.
   Koch HM, 2004, REPROD TOXICOL, V18, P759, DOI 10.1016/j/reprotox.2004.05.003.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P77, DOI 10.1078/1438-4639-00272.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, ARCH TOXICOL, V78, P123, DOI 10.1007/00204-003-0522-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   KOCH HM, 2005, ARCH TOXICOL.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Latini G, 2003, ENVIRON HEALTH PERSP, V111, P1783, DOI 10.1289/ehp.6202.
   LIU K, 2005, BIOL REPROD     0223.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Preuss R, 2005, J CHROMATOGR B, V816, P269, DOI 10.1016/j.jchromb.2004.11.048.
   REGNIER J, 2004, TOXICOLOGIST CD OFFI, V78, P187.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Sharpe RM, 2004, BRIT MED J, V328, P447, DOI 10.1136/bmj.328.7437.447.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Stroheker T, 2005, TOXICOLOGY, V208, P115, DOI 10.1016/j.tox.2004.11.013.
   SWAN SH, 2005, ENV HLTH PERSPE 0527.
   US Environmental Protection Agency, 1999, INT RISK INF SYST IR.
   Wilson N, 2004, TOB CONTROL, V13, P3, DOI 10.1136/tc.2003.006635.
   WOLFE GW, 2003, 7244200 TRC.
   Zimmermann R, 1997, TRANSFUSION, V37, P1075, DOI 10.1046/j.1537-2995.1997.371098016449.x.
   {*}ADVAMED, 2001, 11974 ADVAMED.
   {[}Anonymous], 2002, FDA PUBL HLTH NOT PV.
   {*}CSTEE SCI COMM TO, 1998, 6 CSTEE PLEN M BRUSS.
   {*}CSTEE SCI COMM TO, 2004, EC ENV OP RES 2 RISK.
   {*}DG SANCO EUR COMM, 2002, OP MED DEV CONT DEHP.
   {*}ECB, 2004, RISK ASS REP BIS2 ET.
   {*}FED MED COUNC P E, 2001, GUID COLL BLOOD BLOO.
   {*}HLTH CAN, 2002, DEHP MED DEV EXP TOX.
   {*}US FDA, 2001, SAF ASS DI2 ETH PHTH.}},
Number-of-Cited-References = {{51}},
Times-Cited = {{31}},
Journal-ISO = {{Int. J. Hyg. Environ. Health.}},
Doc-Delivery-Number = {{992VD}},
Wos-Id = {{ISI:000233911200007}},
}

@article{ ISI:000225781300052,
Author = {Hauser, R and Meeker, JD and Park, S and Silva, MJ and Calafat, AM},
Title = {{Temporal variability of urinary phthalate metabolite levels in men of
   reproductive age}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2004}},
Volume = {{112}},
Number = {{17}},
Pages = {{1734-1740}},
Month = {{DEC}},
Abstract = {{Phthalates are a family of multifunctional chemicals widely used in
   personal care and other consumer products. The ubiquitous use of
   phthalates results in human exposure through multiple sources and
   routes, including dietary ingestion, dermal absorption, inhalation, and
   parenteral exposure from medical devices containing phthalates. We
   explored the temporal variability over 3 months in urinary phthalate
   metabolite levels among 11 men who collected up to nine urine samples
   each during this time period. Eight phthalate metabolites were measured
   by solid-phase extraction-high-performance liquid chromatography-tandem
   mass spectrometry. Statistical analyses were performed to determine the
   between- and within-subject variance apportionment, and the sensitivity
   and specificity of a single urine sample to classify a subject's 3-month
   average exposure. Five of the eight phthalates were frequently detected.
   Monoethyl phthalate (MEP) was detected in 100\% of samples; monobutyl
   phthalate, monobenzyl phthalate, mono-2-ethylhexyl phthalate (MEHP), and
   monomethyl phthalate were detected in > 90\% of samples. Although we
   found both substantial day-to-day and month-to-month variability in each
   individual's urinary phthalate metabolite levels, a single urine sample
   was moderately predictive of each subject's exposure over 3 months. The
   sensitivities ranged from 0.56 to 0.74. Both the degree of between- and
   within-subject variance and the predictive ability of a single urine
   sample differed among phthalate metabolites. In particular, a single
   urine sample was most predictive for MEP and least predictive for MEHP.
   These results suggest that the most efficient exposure assessment
   strategy for a particular study may depend on the phthalates of
   interest.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hauser, R (Reprint Author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Occupat Hlth Program, Bldg 1,Room 1405,665 Huntington Ave, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Occupat Hlth Program, Boston, MA 02115 USA.
   Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv, Androl Lab, Boston, MA USA.
   Massachusetts Gen Hosp, In Vitro Fertilizat Unit, Boston, MA USA.
   Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.}},
DOI = {{10.1289/ehp.7212}},
ISSN = {{0091-6765}},
Keywords = {{biomarkers; human; phthalates; reliability; urine}},
Keywords-Plus = {{HUMAN SEMEN PARAMETERS; DI(2-ETHYLHEXYL) PHTHALATE; QUANTITATIVE
   DETECTION; EXPOSURE; POPULATION; RATS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{rhauser@hohp.harvard.edu}},
Cited-References = {{Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2.
   Box G. E. P., 1978, STAT EXPT.
   Bradbury J, 1996, LANCET, V347, P1541, DOI 10.1016/S0140-6736(96)90681-9.
   Carroll RJ, 1995, MEASUREMENT ERROR NO.
   CASTLE L, 1990, FOOD ADDIT CONTAM, V7, P779.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Hauser R, 2003, ENVIRON HEALTH PERSP, V111, P1505, DOI 10.1289/ehp.6175.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   JAAKOALA JJ, 1999, AM J PUBLIC HEALTH, V2, P188.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   OISHI S, 1986, ARCH TOXICOL, V59, P290, DOI 10.1007/BF00290553.
   PAGE BD, 1995, FOOD ADDIT CONTAM, V12, P129.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Peck JD, 2003, AM J EPIDEMIOL, V157, P258, DOI 10.1093/aje/kwf183.
   Rosner B., 1999, FUNDAMENTALS BIOSTAT.
   ROSNER B, 1992, AM J EPIDEMIOL, V136, P1400.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   SJOBERG P, 1986, ENVIRON HEALTH PERSP, V65, P237, DOI 10.2307/3430188.
   TEASS AW, 1998, NIOSH MANUAL ANAL ME, P52.
   TREMAINE LM, 1985, TOXICOL APPL PHARM, V77, P165, DOI 10.1016/0041-008X(85)90277-7.
   Willett W., 1998, NUTR EPIDEMIOLOGY.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.
   {*}ATSDR, 2002, TOX PROF DIL2 ETH DE.
   {*}CDC, 2003, 2 NAT REP HUM EXP EN.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{99}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{880ID}},
Wos-Id = {{ISI:000225781300052}},
}

@article{ ISI:000225105900012,
Author = {Kim, HS and Kim, TS and Shin, JH and Moon, HJ and Kang, IH and Kim, IY
   and Oh, JY and Han, SY},
Title = {{Neonatal exposure to di(n-butyl) phthalate (DBP) alters male
   reproductive-tract development}},
Journal = {{JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES}},
Year = {{2004}},
Volume = {{67}},
Number = {{23-24}},
Pages = {{2045-2060}},
Month = {{DEC}},
Abstract = {{The purpose of this study was to evaluate male reproductive-organ
   development in early postnatal male rats following neonatal exposure to
   di(n-butyl) phthalate (DBP) and identify a mechanism of action. Neonatal
   male rats were injected subcutaneously from d 5 to 74 after birth with
   corn oil (control) and DBP (5, 10, or 20 mg/animal). Animals were killed
   at postnatal day (PND) 31 and PND 42, respectively, and testes,
   epididymis, seminal vesicles, ventral prostate, levator ani plus
   bulbocavernosus muscles (LABC), and Cowper's glands were weighed. In
   addition, the expressions of androgen receptor (AR), estrogen receptors
   (ERs), and steroidogenic factor-1 (SF-1) were also examined in the
   testes. Total body weights gains were significantly reduced at PND
   29-31, but gradually recovered on PND 42. However, DBP (20 mg/animal)
   significantly reduced the weights of testes and accessory sex organs
   (seminal vesicles, LABC, and Cowper's glands), but not of the
   epididymis. These adverse effects persisted through puberty at PND 42.
   Serum testosterone levels did not show any significant changes in the
   control and DBP treatment groups. Histomorphological examination showed
   mild diffuse Leydig-cell hyperplasia in the interstitium of severely
   affected tubules on PND 31. Only a few multinuclear germ cells were
   observed. DBP (20 mg/animal) significantly decreased the expression of
   AR, whereas ER expression and SF-I expression were increased in a
   dose-dependent manner on PND 31 in the rat testes. On PND 42, DBP (20
   mg/animal) significantly inhibited ER expression in the testes, but not
   AR, ER, and ST-1. These results demonstrate that neonatal exposure to
   DBP produces permanent changes in the endocrine system and leads to
   abnormal male reproductive-tract development until puberty. Thus our
   data suggest that DBP is likely to exert its antiandrogenic actions
   through disruption of AR or ER expression during the early neonatal
   stage.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Han, SY (Reprint Author), Korea Food \& Drug Adm, Natl Inst Toxicol Res, 5 Nokbun Dong, Seoul 122704, South Korea.
   Korea Food \& Drug Adm, Natl Inst Toxicol Res, Seoul 122704, South Korea.
   Pusan Natl Univ, Coll Pharm, Mol Toxicol Lab, Pusan 609735, South Korea.}},
DOI = {{10.1080/15287390490514859}},
ISSN = {{1528-7394}},
Keywords-Plus = {{IN-UTERO EXPOSURE; N-BUTYL PHTHALATE; FETAL-RAT TESTES; TESTICULAR
   ATROPHY; ENVIRONMENTAL ANTIANDROGENS; SEXUAL-DIFFERENTIATION;
   DIETHYLHEXYL PHTHALATE; LACTATIONAL EXPOSURE; RECEPTOR EXPRESSION;
   GENE-EXPRESSION}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health;
   Toxicology}},
Author-Email = {{soonyoungh@kfda.go.kr}},
Cited-References = {{BARLOW NJ, 2003, TOXICOL PATHOL, V34, P319.
   Barlow NJ, 2003, TOXICOL SCI, V73, P431, DOI 10.1093/toxsci/kfg087.
   Barlow NJ, 2004, TOXICOL PATHOL, V32, P79, DOI 10.1080/01926230490265894.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   BRANDT K, 1985, J AM COLL TOXICOL, V4, P267.
   Cammack JN, 2003, INT J TOXICOL, V22, P159, DOI 10.1080/10915810390201136.
   CLARK JDA, 1992, CLIN ENDOCRINOL, V36, P481, DOI 10.1111/j.1365-2265.1992.tb02249.x.
   CREASY DM, 1983, J PATHOL, V139, P309, DOI 10.1002/path.1711390307.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   FOSTER PMD, 1983, DRUG METAB DISPOS, V11, P59.
   FUKUOKA M, 1995, J APPL TOXICOL, V15, P379, DOI 10.1002/jat.2550150507.
   Gray LE, 2001, HUM REPROD UPDATE, V7, P248, DOI 10.1093/humupd/7.3.248.
   GROUP EF, 1986, ENVIRON HEALTH PERSP, V65, P337, DOI 10.2307/3430201.
   Higuchi TT, 2003, TOXICOL SCI, V72, P301, DOI 10.1093/toxsci/kfg036.
   Kassim NM, 1997, J ANAT, V190, P577, DOI 10.1046/j.1469-7580.1997.19040577.x.
   Kavlock R, 2002, REPROD TOXICOL, V16, P721, DOI 10.1016/S0890-6238(02)00031-X.
   Kelce WR, 1997, J MOL MED-JMM, V75, P198, DOI 10.1007/s001090050104.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Maness SC, 1998, TOXICOL APPL PHARM, V151, P135, DOI 10.1006/taap.1998.8431.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2000, TOXICOL APPL PHARM, V168, P174, DOI 10.1006/taap.2000.9032.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Ohsako S, 2003, J REPROD DEVELOP, V49, P275.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Prins GS, 1997, ENDOCRINOLOGY, V138, P1801, DOI 10.1210/en.138.5.1801.
   Regadera J, 2001, J CLIN ENDOCR METAB, V86, P413, DOI 10.1210/jc.86.1.413.
   REJFER J, 1977, J UROLOGY, V118, P985.
   RULLI SB, 1995, J ANDROL, V16, P225.
   Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   TEIRLYNCK O, 1988, TOXICOL LETT, V40, P85, DOI 10.1016/0378-4274(88)90186-5.
   Tsai EM, 2001, CANCER RES, V61, P8390.
   Wellejus A, 2002, J TOXICOL ENV HEAL A, V65, P813, DOI 10.1080/00984100290071126.
   Williams K, 2001, HUM REPROD UPDATE, V7, P236, DOI 10.1093/humupd/7.3.236.
   Wine RN, 1997, ENVIRON HEALTH PERSP, V105, P102, DOI 10.1289/ehp.97105102.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {*}DEP HHS, 2003, NCEH PUB.}},
Number-of-Cited-References = {{40}},
Times-Cited = {{36}},
Journal-ISO = {{J. Toxicol. Env. Health Part A}},
Doc-Delivery-Number = {{871CC}},
Wos-Id = {{ISI:000225105900012}},
}

@article{ ISI:000224504200017,
Author = {Okamoto, Y and Okajima, K and Toda, C and Ueda, K and Hashizume, K and
   Itoh, K and Kojima, N},
Title = {{Novel estrogenic microsomal metabolites from phthalate esters}},
Journal = {{JOURNAL OF HEALTH SCIENCE}},
Year = {{2004}},
Volume = {{50}},
Number = {{5}},
Pages = {{556-560}},
Month = {{OCT}},
Abstract = {{Many researchers have found evidence of the estrogenic effects of
   phthalate esters (PEs), but the disruption mechanism is not fully
   elucidated. Once PEs are hydroxylated at the ring 4-position, the
   resulting compounds exhibit unequivocal binding affinity for human
   estrogen receptors. In this study, we first succeeded to demonstrate the
   generation of potent estrogenic metabolite from PEs. We used rat liver
   microsomes and dimethyl phthalate (DMP) as a representative for the
   metabolism of PEs. Among the metabolites detected by HPLC, one of them
   was consistent with an authentic compound, 4-hydroxylated DMP (DMP-40H)
   on their HPLC profiles. Together with the UV (lambdamax = 257 nm) and MS
   (m/z 210) data, the metabolite was concluded to be DMP-40H. We propose
   that this ring-hydroxylated metabolite could be a key active species in
   the endocrine disrupting processes of PEs.}},
Publisher = {{PHARMACEUTICAL SOC JAPAN}},
Address = {{2-12-15-201 SHIBUYA, SHIBUYA-KU, TOKYO, 150, JAPAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kojima, N (Reprint Author), Meijo Univ, Fac Pharm, Tempaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.
   Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan.}},
DOI = {{10.1248/jhs.50.556}},
ISSN = {{1344-9702}},
Keywords = {{phthalate ester; estrogenic activity; metabolic activation;
   ring-hydroxylation; microsome; endocrine disrupting chemical}},
Keywords-Plus = {{ENDOCRINE-DISRUPTING COMPOUNDS; RECEPTOR; EXPOSURE; POPULATION; WATER;
   URINE}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{kojiman@ccmfs.meijo-u.ac.jp}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1981, DRUG METAB DISPOS, V9, P223.
   Asai D, 2000, TOXICOL LETT, V118, P1, DOI 10.1016/S0378-4274(00)00253-8.
   Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645.
   CARTER JE, 1977, J PHARM SCI, V66, P546, DOI 10.1002/jps.2600660422.
   Casajuana N, 2003, CHROMATOGRAPHIA, V57, P649, DOI 10.1007/BF02491744.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   Fang H, 2001, CHEM RES TOXICOL, V14, P280, DOI 10.1021/tx000208y.
   Hashizume K, 2002, BIOL PHARM BULL, V25, P209, DOI 10.1248/bpb.25.209.
   Inoue K, 2002, CLIN CHIM ACTA, V325, P157, DOI 10.1016/S0009-8981(02)00291-7.
   Kambia K, 2003, INT J PHARM, V262, P83, DOI 10.1016/S0378-5173(03)00335-1.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Nakai M, 1999, BIOCHEM BIOPH RES CO, V254, P311, DOI 10.1006/bbrc.1998.9928.
   OKAMOTO Y, 2003, J RES I MEIJO U, V2, P45.
   Paganetto G, 2000, PHARMACOL TOXICOL, V86, P24.
   Pike ACW, 1999, EMBO J, V18, P4608, DOI 10.1093/emboj/18.17.4608.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Watanabe H, 2003, J MOL ENDOCRINOL, V30, P347, DOI 10.1677/jme.0.0300347.}},
Number-of-Cited-References = {{22}},
Times-Cited = {{5}},
Journal-ISO = {{J. Health Sci.}},
Doc-Delivery-Number = {{862PW}},
Wos-Id = {{ISI:000224504200017}},
}

@article{ ISI:000224354300023,
Author = {Wahl, HG and Hong, QF and Hildenbrand, S and Risler, T and Luft, D and
   Liebich, H},
Title = {{4-heptanone is a metabolite of the plasticizer di(2-ethylhexyl)
   phthalate (DEHP) in haemodialysis patients}},
Journal = {{NEPHROLOGY DIALYSIS TRANSPLANTATION}},
Year = {{2004}},
Volume = {{19}},
Number = {{10}},
Pages = {{2576-2583}},
Month = {{OCT}},
Abstract = {{Background. There is an ongoing discussion about the risks of
   di(2-ethylhexyl) plithalate (DEHP) exposure for the general population
   as well as for specific subgroups in various medical settings.
   Haemodialysis patients certainly belong to the group with the highest
   exposure taking into account the repeated treatments over a long period
   of time. Many studies have shown that DEHP metabolites are more active
   with regard to cellular responses than DEHP itself. Although 4-heptanone
   has been shown to be a DEHP metabolite in rats, this has never been
   tested in humans. On the other hand, 4-heptanone was reported to be
   associated with diabetes mellitus.
   Methods. After establishing analytical methods for all postulated
   metabolites, we analysed (i) plasma samples from 50 patients on
   haemodialysis and 50 controls; (ii) urine samples from 100 diabetic
   patients and 100 controls; and (iii) urine samples from 10 controls
   receiving DEHP intravenously.
   Results. 4-Heptanone concentrations in urine did not differ between
   controls (128.6 +/- 11.4 mug/l, mean +/- SEM) and diabetic patients
   (131.2 +/- 11.6 mug/l) but were significantly elevated in plasma from
   haemodialysis patients (95.9 +/- 9.6 mug/l) compared with controls (10.4
   +/- 0.5 mug/l). Exposure to DEHP led to a significant increase (P <
   0.001) of the metabolite 4-heptanone and all the proposed intermediates
   in urine of healthy persons within 24 h.
   Conclusions. These studies show that 4-heptanone is not associated with
   diabetes but is a major DEHP metabolite in humans. Studies concerning
   the toxicity of DEHP in haemodialysis patients and other highly exposed
   groups should therefore include 4-heptanone together with DEHP and its
   primary metabolites mono(2-ethylhexyl) phthalate (MEHP) and
   2-ethylhexanol.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wahl, HG (Reprint Author), Klinikum Philipps Univ Marburg, Dept Clin Chem \& Mol Diagnost, D-35033 Marburg, Germany.
   Klinikum Philipps Univ Marburg, Dept Clin Chem \& Mol Diagnost, D-35033 Marburg, Germany.
   Internal Med Univ Klinikum Tubigen, Dept Endocrinol Metab \& Clin Chem, Tubingen, Germany.
   Internal Med Univ Klinikum Tubigen, Inst Occupat \& Social Med, Tubingen, Germany.
   Internal Med Univ Klinikum Tubigen, Dept Nephrol, Tubingen, Germany.}},
DOI = {{10.1093/ndt/gfh425}},
ISSN = {{0931-0509}},
Keywords = {{DEHP; diabetes mellitus; haemodialysis; 4-heptanone; in vivo metabolism}},
Keywords-Plus = {{CHROMATOGRAPHY-MASS SPECTROMETRY; GAS-CHROMATOGRAPHY; 2-ETHYLHEXANOIC
   ACID; HUMAN URINE; IDENTIFICATION; PRODUCTS; EXPOSURE; PROFILE; SERUM;
   BAGS}},
Research-Areas = {{Transplantation; Urology \& Nephrology}},
Web-of-Science-Categories  = {{Transplantation; Urology \& Nephrology}},
Author-Email = {{hg.wahl@med.uni-marburg.de}},
Cited-References = {{ALBRO PW, 1975, XENOBIOTICA, V5, P625.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Ferruti P, 2003, BIOMACROMOLECULES, V4, P181, DOI 10.1021/bm020115q.
   JAEGER RJ, 1970, LANCET, V2, P151.
   LIEBICH HM, 1975, J CHROMATOGR, V112, P539, DOI 10.1016/S0021-9673(00)99983-7.
   LIEBICH HM, 1977, J CHROMATOGR, V142, P505, DOI 10.1016/S0021-9673(01)92063-1.
   Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809.
   Melnick RL, 2001, ENVIRON HEALTH PERSP, V109, P437, DOI 10.2307/3454700.
   Mettang T, 2000, PERITON DIALYSIS INT, V20, P80.
   Mettang T, 1996, NEPHROL DIAL TRANSPL, V11, P2439.
   Mettang T, 1997, PERITON DIALYSIS INT, V17, pS31.
   MITCHELL AM, 1985, TOXICOL APPL PHARM, V80, P23, DOI 10.1016/0041-008X(85)90097-3.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   Rothenbacher KP, 1998, HUM EXP TOXICOL, V17, P336, DOI 10.1191/096032798678908873.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Wahl Hans Guenther, 2002, Nephrology Dialysis Transplantation, V17, P292.
   Wahl H. G., 1997, Nephrology Dialysis Transplantation, V12, pA6.
   Wahl HG, 1999, J CHROMATOGR A, V847, P1, DOI 10.1016/S0021-9673(99)00138-7.
   Wahl HG, 2001, J CHROMATOGR B, V758, P213.
   Wahl HG, 1999, J CHROMATOGR A, V847, P117, DOI 10.1016/S0021-9673(99)00017-5.
   Walker V, 2001, CLIN CHIM ACTA, V306, P51, DOI 10.1016/S0009-8981(01)00390-4.
   ZLATKIS A, 1973, ANAL CHEM, V45, P763, DOI 10.1021/ac60326a036.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{13}},
Journal-ISO = {{Nephrol. Dial. Transplant.}},
Doc-Delivery-Number = {{860PA}},
Wos-Id = {{ISI:000224354300023}},
}

@article{ ISI:000224528900014,
Author = {Colon, I and Dimandja, JMD},
Title = {{High-throughput analysis of phthalate esters in human serum by direct
   immersion SPME followed by isotope dilution-fast GC/MS}},
Journal = {{ANALYTICAL AND BIOANALYTICAL CHEMISTRY}},
Year = {{2004}},
Volume = {{380}},
Number = {{2}},
Pages = {{275-283}},
Month = {{SEP}},
Abstract = {{Solid-phase microextraction (SPME) coupled to gas chromatography/mass
   spectrometry (GC/MS) was applied to the determination of phthalate
   esters in human serum. The present method decreased the sample
   preparation time by a factor of 50 by using direct immersion SPME with
   an 85-mum polyacrylate fiber to extract phthalate esters from the
   matrix. The use of fast GC/MS further improves total analysis time when
   compared to other techniques. Isotope dilution was successfully applied
   to improve the precision, reproducibility, and repeatability of the SPME
   method. The linear dynamic range spans several orders of magnitude from
   low ppb to ppm levels, and the LOD for the method is 15 pg muL(-1) on
   average with RSDs less than 4\% for the six phthalate esters included in
   this study.}},
Publisher = {{SPRINGER HEIDELBERG}},
Address = {{TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dimandja, JMD (Reprint Author), Spelman Coll, Dept Chem, 350 W Spelman Lane SW Box 279, Atlanta, GA 30314 USA.
   Spelman Coll, Dept Chem, Atlanta, GA 30314 USA.
   Pfizer Global R\&D, Groton, CT USA.}},
DOI = {{10.1007/s00216-004-2743-6}},
ISSN = {{1618-2642}},
Keywords = {{solid-phase microextraction; SPME; phthalate esters; isotope dilution;
   serum analysis}},
Keywords-Plus = {{SOLID-PHASE MICROEXTRACTION; PERFORMANCE LIQUID-CHROMATOGRAPHY;
   PLASTICIZER DI(2-ETHYLHEXYL)PHTHALATE; DI-2-ETHYLHEXYL PHTHALATE;
   HEMODIALYSIS-PATIENTS; URINE SAMPLES; METABOLITES; EXPOSURE; CHEMICALS;
   WATER}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{Jdimandja@spelman.edu}},
Cited-References = {{ARTHUR CL, 1992, ANAL CHEM, V64, P1960, DOI 10.1021/ac00041a034.
   Asaoka K, 2000, B ENVIRON CONTAM TOX, V64, P679.
   Baltussen E, 1999, J MICROCOLUMN SEP, V11, P737, DOI 10.1002/(SICI)1520-667X(1999)11:10<737::AID-MCS7>3.0.CO;2-4.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   BROTONS JA, 1995, ENVIRON HEALTH PERSP, V103, P608, DOI 10.2307/3432439.
   CARO DA, 1990, THESIS U PUERTO RICO.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   COLON I, 1999, THESIS U PUERTO RICO.
   Dimandja JMD, 2000, J EXPO ANAL ENV EPID, V10, P761.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Egestad B, 1996, J CHROMATOGR B, V677, P99, DOI 10.1016/0378-4347(95)00439-4.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   GIUST JA, 1990, J AGR FOOD CHEM, V38, P415, DOI 10.1021/jf00092a016.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   Huang GL, 1999, B ENVIRON CONTAM TOX, V63, P759.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Kamendulis LM, 2002, J TOXICOL ENV HEAL A, V65, P569, DOI 10.1080/152873902317349736.
   Kataoka H, 2002, J SEP SCI, V25, P77, DOI 10.1002/1615-9314(20020101)25:1/2<77::AID-JSSC77>3.0.CO;2-3.
   KHALIQ MA, 1992, B ENVIRON CONTAM TOX, V48, P572.
   LEIBOWITZ JN, 1995, J AOAC INT, V78, P730.
   LEUNG SC, 1993, B ENVIRON CONTAM TOX, V50, P528.
   LOPEZAVILA V, 1990, J ASSOC OFF ANA CHEM, V73, P709.
   MALIK S, 1993, TOXICOL ENVIRON CHEM, V37, P133, DOI 10.1080/02772249309357862.
   MARCEL YL, 1973, ENV HLTH PERSPECT, V81, P1199.
   PATTERSON DG, 1997, ORGANOHALOGEN COMPD, V31, P193.
   Penalver A, 2001, J CHROMATOGR A, V922, P377, DOI 10.1016/S0021-9673(01)00920-7.
   Penalver A, 2000, J CHROMATOGR A, V872, P191, DOI 10.1016/S0021-9673(99)01284-4.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   Poon KF, 1999, ANAL CHIM ACTA, V396, P303, DOI 10.1016/S0003-2670(99)00447-X.
   Rastogi SC, 1998, CHROMATOGRAPHIA, V47, P724, DOI 10.1007/BF02467461.
   SCHULZ CO, 1989, DRUG METAB REV, V21, P111, DOI 10.3109/03602538909029958.
   SOMMER W, 1985, PLASTIC ADDITIVES HD.
   Theodoridis G, 2000, J CHROMATOGR B, V745, P49, DOI 10.1016/S0378-4347(00)00203-6.
   WALISZEWSKI SM, 1990, ANDROLOGIA, V22, P69.
   ZHANG ZY, 1994, ANAL CHEM, V66, pA844, DOI 10.1021/ac00089a001.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{9}},
Journal-ISO = {{Anal. Bioanal. Chem.}},
Doc-Delivery-Number = {{862ZB}},
Wos-Id = {{ISI:000224528900014}},
}

@article{ ISI:000224547000037,
Author = {Rais-Bahrami, K and Nunez, S and Revenis, ME and Luban, NLC and Short,
   BL},
Title = {{Follow-up study of adolescents exposed to di(2-ethylhexyl) phthalate
   (DEHP) as neonates on extracorporeal membrane oxygenation (ECMO) support}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2004}},
Volume = {{112}},
Number = {{13}},
Pages = {{1339-1340}},
Month = {{SEP}},
Abstract = {{Di(2-ethylhexyl) plithalate (DEHP) is used to make polyvinyl chloride
   (PVC) plastic tubing soft and flexible. Animal data show that adverse
   effects of DEHP exposure may include reduced fertility, reduced sperm
   production in males, and ovarian dysfunction in females. Known
   treatments that involve high DEHP exposures are blood exchange
   transfusions, extracorporeal membrane oxygenation (ECMO), and
   cardiovascular surgery. Although potential exposure to DEHP in ECMO
   patients is significant, the exposure has not been associated with
   short-term toxicity. To evaluate long-term toxicity, we undertook a
   study of neonatal ECMO survivors to assess their onset of puberty and
   sexual maturity. We evaluated 13 male and 6 female subjects at 14-16
   years of age who had undergone ECMO as neonates. All subjects had a
   complete physical examination including measurements for height, weight,
   head circumference, and pubertal assessment by Tanner staging. The
   testicular volume and the phallic length were measured in male
   participants. Laboratory tests included thyroid, liver, and renal
   function as well as measurements of luteinizing hormone,
   follicle-stimulating hormone, testosterone for males, and estradiol for
   females. Except for one patient with Marfan syndrome, the rest had
   normal growth percentile for age and sex. All had normal values for
   thyroid, liver, and renal functions. Sexual hormones were appropriate
   for the stage of pubertal maturity. Our results indicate that
   adolescents exposed to significant quantities of DEHP as neonates showed
   no significant adverse effects on their physical growth and pubertal
   maturity. Thyroid, liver, renal, and male and female gonadal functions
   tested were within normal range for age and sex distribution.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rais-Bahrami, K (Reprint Author), Childrens Natl Med Ctr, Dept Neonatol, 111 Michigan Ave NW, Washington, DC 20010 USA.
   Childrens Natl Med Ctr, Dept Neonatol, Washington, DC 20010 USA.
   Childrens Natl Med Ctr, Dept Endocrinol, Washington, DC 20010 USA.
   Childrens Natl Med Ctr, Dept Transfus Med, Washington, DC 20010 USA.
   Univ Washington, Sch Med, Washington, DC USA.}},
DOI = {{10.1289/ehp.6901}},
ISSN = {{0091-6765}},
Keywords-Plus = {{DI-2-ETHYLHEXYL PHTHALATE; PLASTICIZER; RATS; TOXICITY; INFANTS;
   DI-(2-ETHYLHEXYL)-PHTHALATE; TRANSFUSION; BLOOD; RISK; BAGS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{Kraisbah@CNMC.org}},
Cited-References = {{CROCKER JFS, 1988, J TOXICOL ENV HEALTH, V23, P433.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   Karle VA, 1997, CRIT CARE MED, V25, P696, DOI 10.1097/00003246-199704000-00023.
   KEVY SV, 1982, ENVIRON HEALTH PERSP, V45, P57, DOI 10.2307/3429384.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   LEWANDOWSKI M, 1980, TOXICOL APPL PHARM, V54, P141, DOI 10.1016/0041-008X(80)90014-9.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   MORRIS NM, 1980, J YOUTH ADOLESCENCE, V9, P271, DOI 10.1007/BF02088471.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   ROCK G, 1987, NEW ENGL J MED, V316, P1218.
   ROTH B, 1988, EUR J PEDIATR, V147, P41, DOI 10.1007/BF00442609.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   SHNEIDER B, 1989, NEW ENGL J MED, V320, P1563.
   Tanner JM, 1975, ENDOCRINE GENETIC DI, P14.
   THOMAS JA, 1979, TOXICOL APPL PHARM, V51, P523, DOI 10.1016/0041-008X(79)90377-6.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Ward JM, 1998, TOXICOL PATHOL, V26, P240.}},
Number-of-Cited-References = {{22}},
Times-Cited = {{27}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{863FS}},
Wos-Id = {{ISI:000224547000037}},
}

@article{ ISI:000224015700009,
Author = {Butala, JH and David, RM and Gans, G and McKee, RH and Guo, TL and
   Peachee, VL and White, KL},
Title = {{Phthalate treatment does not influence levels of IgE or Th-2 cytokines
   in B6C3F1 mice}},
Journal = {{TOXICOLOGY}},
Year = {{2004}},
Volume = {{201}},
Number = {{1-3}},
Pages = {{77-85}},
Month = {{SEP 1}},
Abstract = {{Bronchial asthma is mediated, in part, by the immunoregulatory cytokines
   interleukins 4 and 13 (IL-4 and IL-13). These cytokines stimulate IgE
   synthesis that in turn is associated with airway hyper-responsiveness.
   Compounds that stimulate IgE synthesis and elicit bronchial reactivity
   are generally considered to be respiratory sensitizers. Recently, it has
   been hypothesized that exposure to phthalates may contribute to
   childhood asthma. To address this question, di-(2-ethylhexyl) phthalate
   (DEHP) was tested using a protocol adapted from work by Dearman that
   involves topical application (and challenge) of test substances to mice
   followed by measurements of total serum IgE. In addition, auricular
   lymph nodes were harvested for measurement of IL-4 and IL-13 proteins
   and their corresponding messenger RNAs. Because skin absorption of high
   molecular weight phthalates is limited, liver weight increase, a measure
   of peroxisomal proliferation, was monitored to assure that internal
   dosing had been achieved. ELISA and RNAse protection assays demonstrated
   that DEHP treatment did not significantly affect IgE, IL-4, or IL-13
   levels. Similarly, IL-4 and IL-13 mRNA levels were not elevated. In
   contrast, all of these were significantly elevated by trimellitic
   anhydride (TMA), a respiratory sensitizer used as the positive control
   in this assay. Liver weights were significantly elevated by DEHP,
   providing evidence of sufficient percutaneous absorption to induce
   physiological responses.
   To extend these observations, three other commercial phthalate ester
   plasticizers, di-isononyl phthalate (DINP), di-isohexyl phthalate
   (DIHP), and butyl benzyl phthalate (BBP), were assessed using the same
   protocol. As above, ELISA and RNAse protection assays showed that IgE,
   IL-4, and IL-13 proteins, and IL-4 and IL-13 mRNAs in the
   phthalate-treated animals were all at levels similar to that of control
   values. The positive control, TMA, produced large, statistically
   significant increases in all parameters, demonstrating responsiveness of
   the assay. Another control, dinitrochlorobenzene (DNCB), a contact
   sensitizer, also responded as expected, producing smaller but
   statistically significant increases in IgE and in mRNA for IL-4 and
   IL-13 but not in the levels of these cytokines. In summary, treatment
   with DEHP, DINP, DIHP, and BBP did not result in significant elevations
   in total serum IgE, IL-4, or IL-13. As such it is unlikely that these
   substances would produce antibody-mediated respiratory allergy. (C) 2004
   Elsevier Ireland Ltd. All rights reserved.}},
Publisher = {{ELSEVIER SCI IRELAND LTD}},
Address = {{CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{McKee, RH (Reprint Author), ExxonMobil Biomed Sci, Dept Toxicol, 1545 Route 22 E,POB 971, Annandale, NJ 08801 USA.
   ExxonMobil Biomed Sci, Dept Toxicol, Annandale, NJ 08801 USA.
   Eastman Chem Co, Kingsport, TN USA.
   BASF AG, Washington, DC USA.
   Virginia Commonwealth Univ, Dept Pharmacol \& Toxicol, Richmond, VA USA.
   ImmunoTox Inc, Richmond, VA USA.}},
DOI = {{10.1016/j.tox.2004.04.004}},
ISSN = {{0300-483X}},
Keywords = {{phthalates; respiratory allergy; DEHP; MEHP; DINP; BBP; DIHP}},
Keywords-Plus = {{SUBCUTANEOUS INJECTION MODEL; BETA-OXIDATION PBOX; DIFFERENTIAL
   STIMULATION; CHEMICAL ALLERGENS; YOUNG-CHILDREN; DNA-SYNTHESIS; BALB/C
   MICE; ADJUVANT; ASTHMA; MOUSE}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{richard.h.mckee@exxonmobil.com}},
Cited-References = {{ASHBY J, 1994, HUM EXP TOXICOL, V13, pS1.
   BARTLETT M. S., 1937, J. Roy. Statist. Soc. 1937., (Suppl.), V4, P131.
   Dearman RJ, 2003, TOXICOL SCI, V71, P137, DOI 10.1093/toxsci/71.2.137.
   DEARMAN RJ, 1992, J APPL TOXICOL, V12, P317, DOI 10.1002/jat.2550120505.
   DEARMAN RJ, 1992, TOXICOL APPL PHARM, V112, P190, DOI 10.1016/0041-008X(92)90187-W.
   Dearman RJ, 2000, J APPL TOXICOL, V20, P221, DOI 10.1002/(SICI)1099-1263(200005/06)20:3<221::AID-JAT651>3.3.CO;2-R.
   Dearman RJ, 1998, TOXICOL METHOD, V8, P69.
   DEARMAN RJ, 1991, IMMUNOLOGY, V72, P563.
   DUNNETT CW, 1955, J AM STAT ASSOC, V50, P1096, DOI 10.2307/2281208.
   ELSISI AE, 1989, FUND APPL TOXICOL, V12, P70, DOI 10.1016/0272-0590(89)90063-8.
   FINKELMAN FD, 1988, J IMMUNOL, V141, P2335.
   GROSS AJ, 1975, SURVIVAL DISTRIBUTIO, P120.
   Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261.
   Guo TL, 2002, J APPL TOXICOL, V22, P397, DOI 10.1002/jat.876.
   HAMMOND BG, 1987, TOXICOL IND HEALTH, V3, P79.
   Isenberg JS, 2001, TOXICOL SCI, V64, P192, DOI 10.1093/toxsci/64.2.192.
   Isenberg JS, 2000, TOXICOL SCI, V56, P73, DOI 10.1093/toxsci/56.1.73.
   Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797.
   Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188.
   Kanerva L, 1997, CONTACT DERMATITIS, V37, P301, DOI 10.1111/j.1600-0536.1997.tb02474.x.
   Klaunig JE, 2003, CRIT REV TOXICOL, V33, P655, DOI 10.1080/10408440390250154.
   KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.2307/2280779.
   Larsen ST, 2001, TOXICOL LETT, V125, P11.
   Larsen ST, 2002, PHARMACOL TOXICOL, V91, P264, DOI 10.1034/j.1600-0773.2002.910508.x.
   Larsen ST, 2003, FOOD CHEM TOXICOL, V41, P439, DOI 10.1016/S0278-6915(02)00248-X.
   MALLETTE FS, 1952, AMA ARCH IND HYG OCC, V6, P231.
   Medeiros AM, 1999, CONTACT DERMATITIS, V41, P287, DOI 10.1111/j.1600-0536.1999.tb06163.x.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   SHAFFER CB, 1945, J IND HYG TOXICOL, V27, P130.
   Smith JH, 2000, TOXICOL SCI, V54, P312, DOI 10.1093/toxsci/54.2.312.
   Tekkanat KK, 2001, J IMMUNOL, V166, P3542.
   Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258.
   {*}NRC, 1996, GUID CAR US LAB AN.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{15}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{856AJ}},
Wos-Id = {{ISI:000224015700009}},
}

@article{ ISI:000222967400010,
Author = {Kicheva, YI and Richter, H and Popova, E},
Title = {{Evaluation of the effect of the concentration of plasticizer
   di(2-ethylhexyl) phthalate on the quantity of residual monomer vinyl
   chloride in PVC chest drainage tubes}},
Journal = {{JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE}},
Year = {{2004}},
Volume = {{15}},
Number = {{8}},
Pages = {{909-914}},
Month = {{AUG}},
Abstract = {{The effect of amount of plasticizer di(2-ethylhexyl) phthalate (DEHP)
   amount on the amount of residual monomer vinyl chloride WC) was
   determined in samples of plasticised polyvinyl chloride (PVC) with
   different concentration of plasticiser (22.32-33.05\%), before and after
   sterilisation by a titrimetric method. The titrimetric method was used
   to determine the VC concentration in a KMnO4 solution where the samples
   were kept immersed under the same conditions for 2 h.
   The influence of PVC film extracts with different amounts of DEHP on
   mouse fibroblast cells L-929 in a culture medium was evaluated by using
   quantitative tests: the amount of cells ( protein determination),
   viability (MTT test) and proliferation (incorporation of
   bromodeoxyuridine (BrDU). The amount of vinyl chloride before and after
   heat sterilisation at 120 degreesC for 30 min was found to be almost the
   same for all samples and without any dependence on the concentration of
   DEHP. The extracts of the PVC films which were tested have no toxic
   effect on cells in a culture medium. (C) 2004 Kluwer Academic
   Publishers.}},
Publisher = {{KLUWER ACADEMIC PUBL}},
Address = {{VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kicheva, YI (Reprint Author), Univ Med, Dept Phys \& Biophys, Plovdiv, Bulgaria.
   Univ Med, Dept Phys \& Biophys, Plovdiv, Bulgaria.
   Rhein Westfal TH Aachen, Inst Pathol, Aachen, Germany.
   Med Univ, Fac Stomatol, Dept Periodontol \& Oral Mucosal Dis, Plovdiv, Bulgaria.}},
DOI = {{10.1023/B:JMSM.0000036279.97458.8e}},
ISSN = {{0957-4530}},
Keywords-Plus = {{POLYVINYL-CHLORIDE; INFUSION SOLUTIONS; CONTAINERS; BLOOD; BAGS;
   COMPATIBILITY; COMPONENTS; EXTRACTION; SORPTION; EXPOSURE}},
Research-Areas = {{Engineering; Materials Science}},
Web-of-Science-Categories  = {{Engineering, Biomedical; Materials Science, Biomaterials}},
Author-Email = {{icomp@plovdiv.techno-link.com}},
Cited-References = {{AIRAUDO CB, 1992, CLIN THER, V14, P192.
   ANGYOZOVA E, 1985, COLLECTION SCI WORKS.
   ANGYOZOVA M, 1983, 8 NAT S INT PART POL, V83, P13.
   BARDOV VG, 1991, VRACHEBNOE DELO, V5, P84.
   BIANCHI C, 1992, J CLIN PHARM THER, V17, P223.
   BOSSELI PM, 1991, B CHIM FARM, V130, P213.
   BRANGER B, 1990, INT J ARTIF ORGANS, V13, P693.
   DAVIES MFP, 1990, BRIT J IND MED, V47, P65.
   DESINGER PI, 1998, FOOD CHEM TOXICOL, V36, P521.
   FARBE T, 1998, J BIOMED MATER RES, V39, P637.
   Horn KD, 1999, AM J CLIN PATHOL, V111, P99.
   JEONG OK, 1990, MED TEXTILES IMPLANT, P18.
   KIM SW, 1976, J PHARM SCI, V65, P670, DOI 10.1002/jps.2600650510.
   Lakshmi S, 1998, ARTIF ORGANS, V22, P222, DOI 10.1046/j.1525-1594.1998.06124.x.
   LANINA SY, 1992, MED PROG TECHNOL, V18, P19.
   MARDIROSSJAN Z, 1991, STOM, V73, P50.
   MAZUR HI, 1989, JPEN-PARENTER ENTER, V13, P59, DOI 10.1177/014860718901300159.
   Melnick RL, 2001, ENVIRON HEALTH PERSP, V109, P437, DOI 10.2307/3454700.
   NG TP, 1991, SCAND J WORK ENV HEA, V17, P53.
   Nosko M, 1989, Probl Khig, V14, P103.
   OKITA N, 1991, J PROSTHET DENT, V66, P656, DOI 10.1016/0022-3913(91)90448-6.
   PEARSON SD, 1993, AM J HOSP PHARM, V50, P1405.
   SANCHEZ RB, 1989, MED CLIN, V96, P129.
   Sano Masashi, 1999, Journal of Toxicological Sciences, V24, P177.
   SHIMIZU T, 1989, TRANSFUSION, V29, P292, DOI 10.1046/j.1537-2995.1989.29489242792.x.
   VALDOR M, 1992, FLOW CYT TOOL BIOC T.
   VANDOOREN AA, 1991, PHARM WEEKBLAD, V13, P109.
   WAUGH WN, 1991, AM J HOSP PHARM, V48, P1520.
   WEIL PH, 1981, AM J SURG, V142, P692, DOI 10.1016/0002-9610(81)90313-5.
   WENZ LM, 1990, J BIOMED MATER RES, V24, P207, DOI 10.1002/jbm.820240207.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{1}},
Journal-ISO = {{J. Mater. Sci.-Mater. Med.}},
Doc-Delivery-Number = {{841YB}},
Wos-Id = {{ISI:000222967400010}},
}

@article{ ISI:000223017800004,
Author = {Ljungvall, K and Tienpont, B and David, F and Magnusson, U and Torneke,
   K},
Title = {{Kinetics of orally administered di(2-ethylhexyl) phthalate and its
   metabolite, mono(2-ethylhexyl) phthalate, in male pigs}},
Journal = {{ARCHIVES OF TOXICOLOGY}},
Year = {{2004}},
Volume = {{78}},
Number = {{7}},
Pages = {{384-389}},
Month = {{JUL}},
Abstract = {{Di(2-ethylhexyl) phthalate (DEHP) is used as a plastic softener in the
   polymer industry and is widespread in medical devices. DEHP has been
   incriminated as an endocrine-disrupting chemical, and the effects of
   DEHP in various species have included disturbances in the reproductive
   system. The effects of the chemical have varied, depending upon exposure
   routes and species. This study was performed in order to characterise
   the kinetics of DEHP and its metabolite mono(2-ethylhexyl) phthalate
   (MEHP) in the young male pig, an omnivore model-species for research in
   reproductive toxicology. Eight pigs were given 1000 mg DEHP/kg
   bodyweight by oral gavage. The concentrations of DEHP and MEHP were then
   measured in the plasma and tissues of the pigs at different time points
   after administration. There was no consistent rise above contamination
   levels of concentrations of DEHP in the plasma of the pigs. However, the
   metabolite MEHP reached the systemic blood circulation. The half-life of
   MEHP in the systemic blood circulation was calculated to be 6.3 h.
   Absorption from the intestine was biphasic in six of the eight pigs and
   the mono-exponential elimination-phase started 16 h after the after the
   administration of DEHP. To conclude, MEHP consistently reaches the
   systemic circulation in the pig when DEHP is administered orally. The
   kinetic pattern of the parent substance on the other hand is more
   difficult to characterise.}},
Publisher = {{SPRINGER}},
Address = {{233 SPRING STREET, NEW YORK, NY 10013 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Ljungvall, K (Reprint Author), Swedish Univ Agr Sci, Dept Obstet \& Gynaecol, Ctr Reprod Biol Uppsala, Box 7039, S-75007 Uppsala, Sweden.
   Swedish Univ Agr Sci, Dept Obstet \& Gynaecol, Ctr Reprod Biol Uppsala, S-75007 Uppsala, Sweden.
   Res Inst Cromatog, B-8500 Kortrijk, Belgium.
   Swedish Univ Agr Sci, Dept Biomed Sci \& Vet Publ Hlth, Div Pathol Pharmacol \& Toxicol, S-75007 Uppsala, Sweden.}},
DOI = {{10.1007/s00204-004-0558-z}},
ISSN = {{0340-5761}},
Keywords = {{di(2-ethylhexyl) phthalate (DEHP); oral administration; Sus scrofa
   domestica; pharmacokinetics; chromatography}},
Keywords-Plus = {{DI-(2-ETHYLHEXYL) PHTHALATE; DI-2-ETHYLHEXYL PHTHALATE;
   MONO-(2-ETHYLHEXYL) PHTHALATE; RATS; DEHP; DISPOSITION; EXCRETION;
   PHARMACOKINETICS; ELIMINATION; ABSORPTION}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{Karl.Ljungvall@og.slu.se}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   Almond GW, 1996, VET CLIN N AM-FOOD A, V12, P707.
   GAUNT IF, 1982, FOOD CHEM TOXICOL, V20, P215, DOI 10.1016/S0278-6915(82)80252-4.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   IKEDA GJ, 1980, FOOD COSMET TOXICOL, V18, P637, DOI 10.1016/S0015-6264(80)80012-5.
   Jarosova A, 1999, VET MED-CZECH, V44, P61.
   Kessler W, 2001, ARCH TOXICOL, V75, P62, DOI 10.1007/s002040000198.
   Keys DA, 1999, TOXICOL SCI, V49, P172, DOI 10.1093/toxsci/49.2.172.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   OISHI S, 1982, ARCH TOXICOL, V51, P149, DOI 10.1007/BF00302755.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P246, DOI 10.1016/0041-008X(85)90346-1.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Pugh G, 2000, TOXICOL SCI, V56, P181, DOI 10.1093/toxsci/56.1.181.
   RHODES C, 1986, ENVIRON HEALTH PERSP, V65, P299, DOI 10.2307/3430197.
   Safe SH, 1998, ENVIRON HEALTH PERSP, V106, P1051, DOI 10.2307/3434151.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   SJOBERG P, 1985, ACTA PHARMACOL TOX, V56, P30.
   TANAKA A, 1975, TOXICOLOGY, V4, P253, DOI 10.1016/0300-483X(75)90105-5.
   TEIRLYNCK OA, 1985, ARCH TOXICOL, V57, P226, DOI 10.1007/BF00324782.
   WHITE RD, 1980, FOOD COSMET TOXICOL, V18, P383, DOI 10.1016/0015-6264(80)90194-7.
   {*}EASTM KOD CO, 1983, 0206634 TSCATS OTS E.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{19}},
Journal-ISO = {{Arch. Toxicol.}},
Doc-Delivery-Number = {{842QA}},
Wos-Id = {{ISI:000223017800004}},
}

@article{ ISI:000222427700086,
Author = {Chen, CY and Ghule, AV and Chen, WY and Wang, CC and Chiang, YS and
   Ling, YC},
Title = {{Rapid identification of phthalates in blood bags and food packaging
   using ToF-SIMS}},
Journal = {{APPLIED SURFACE SCIENCE}},
Year = {{2004}},
Volume = {{231}},
Number = {{SI}},
Pages = {{447-451}},
Month = {{JUN 15}},
Note = {{14th International Conference on Secondary Ion Mass Spectrometry (SIMS
   14), San Diego, CA, SEP 14-19, 2003}},
Abstract = {{ToF-SLMS with Ga- ion as primary source is used to analyze plasticizers
   like bis(2-ethylhexyl) phthalate (DEHP) from the inner surface of the
   blood bags and their migration into the blood. Food packing materials
   were also analyzed for the presence of DEHP. The simplicity of using
   ToF-SIMS with high mass resolution as an aid in the identification and
   analysis are discussed. The ToF-SIMS results, the fragmentation pattern,
   and the ratio of ions were comparable to those obtained from traditional
   GCMS analysis. This indicates that ToF-SIMS could be a promising
   technique for direct detection of DEHP (and phthalates in general) in
   blood bags and food packaging polymeric materials. (C) 2004 Elsevier
   B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Ling, YC (Reprint Author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan.
   Natl Tsing Hua Univ, Dept Chem, Hsinchu 300, Taiwan.}},
DOI = {{10.1016/j.apsusc.2004.03.168}},
ISSN = {{0169-4332}},
Keywords = {{DEHP; plasticizer; poly(vinylchloride); ToF-SIMS; blood bag; food
   packing material}},
Keywords-Plus = {{MIGRATION; CONTAMINATION; PLASTICIZER; DEHP}},
Research-Areas = {{Chemistry; Materials Science; Physics}},
Web-of-Science-Categories  = {{Chemistry, Physical; Materials Science, Coatings \& Films; Physics,
   Applied; Physics, Condensed Matter}},
Author-Email = {{ycling@mx.nthu.edu.tw}},
Cited-References = {{BENNINGHOVEN A, 1994, ANGEW CHEM INT EDIT, V33, P1023, DOI 10.1002/anie.199410231.
   CASTLE L, 1990, FOOD ADDIT CONTAM, V7, P591.
   Kim JH, 2003, B KOR CHEM SOC, V24, P345.
   Lau OW, 2000, J CHROMATOGR A, V882, P255, DOI 10.1016/S0021-9673(00)00356-3.
   PAGE BD, 1992, FOOD ADDIT CONTAM, V9, P197.
   PETERSEN JH, 1991, FOOD ADDIT CONTAM, V8, P701.
   RHODES C, 1986, ENVIRON HEALTH PERSP, V65, P299, DOI 10.2307/3430197.
   Tomiyasu B, 2003, APPL SURF SCI, V203, P775, DOI 10.1016/S0169-4332(02)00815-2.
   {*}ASTM, 1986, F96396 ASTM.
   {*}US EPA, MAX CONT LEV MCLS RE.}},
Number-of-Cited-References = {{10}},
Times-Cited = {{12}},
Journal-ISO = {{Appl. Surf. Sci.}},
Doc-Delivery-Number = {{834RG}},
Wos-Id = {{ISI:000222427700086}},
}

@article{ ISI:000221310200022,
Author = {Silva, MJ and Slakman, AR and Reidy, JA and Preau, JL and Herbert, AR
   and Samandar, E and Needham, LL and Calafat, AM},
Title = {{Analysis of human urine for fifteen phthalate metabolites using
   automated solid-phase extraction}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES}},
Year = {{2004}},
Volume = {{805}},
Number = {{1}},
Pages = {{161-167}},
Month = {{JUN 5}},
Abstract = {{We improved our previous analytical method to measure phthalate
   metabolites in urine as biomarkers for phthalate exposure by automating
   the solid-phase extraction (SPE) procedure and expanding the analytical
   capability to quantify four additional metabolites: phthalic acid,
   mono-3-carboxypropyl phthalate, mono-isobutyl phthalate (miBP), and
   monomethyl isoplithalate. The method, which involves automated SPE
   followed by isotope dilution-high performance liquid chromatography
   (HPLC)-electrospray ionization (ESI)-tandem mass spectrometry (MS).
   allows for the quantitative measurement of 15 phthalate metabolites in
   urine with detection limits in the low ng/ml range. SPE automation
   allowed for the unattended sequential extraction of up to 100 samples at
   a time, and resulted in an increased sample throughput, lower solvent
   use. and better reproducibility than the manual SPE. Furthermore, the
   modified method permitted for the first time, the separation and
   quantification of mono-n-butyl phthalate (mBP) and its structural isomer
   miBP. The method was validated on spiked pooled urine samples and on
   pooled urine samples from persons with no known exposure to phthalates.
   (C) 2004 Elsevier B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, 4770 Buford Hwy,Mailstop F17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.}},
DOI = {{10.1016/j.jchromb.2004.02.038}},
ISSN = {{1570-0232}},
Keywords = {{phthalate metabolites}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; QUANTITATIVE DETECTION; INTERNAL EXPOSURE;
   MALE-RATS; POPULATION; PERFORMANCE; MONOESTERS; BIOMARKERS; SECONDARY;
   CHILDREN}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{acalafat@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{AGARWAL DK, 1986, ENVIRON HEALTH PERSP, V65, P343, DOI 10.2307/3430202.
   Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   David R. M., 2001, PATTYS TOXICOLOGY, P635.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P129, DOI 10.2307/3429396.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2004, INT J HYG ENVIR HEAL, V207, P15, DOI 10.1078/1438-4639-00270.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 1997, TOX PROF DI N OCT PH.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}CDC, 2003, 2 NAT REP HUM EXP EN.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{86}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{819JC}},
Wos-Id = {{ISI:000221310200022}},
}

@article{ ISI:000221646500020,
Author = {Silva, MJ and Reidy, JA and Herbert, AR and Preau, JL and Needham, LL
   and Calafat, AM},
Title = {{Detection of phthalate metabolites in human amniotic fluid}},
Journal = {{BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY}},
Year = {{2004}},
Volume = {{72}},
Number = {{6}},
Pages = {{1226-1231}},
Month = {{JUN}},
Publisher = {{SPRINGER-VERLAG}},
Address = {{175 FIFTH AVE, NEW YORK, NY 10010 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), CDC, Ctr Dis Control \& Prevent, NCEH, Div Sci Lab, 4770 Buford Highway NE,Mailstop F-17, Atlanta, GA 30341 USA.
   CDC, Ctr Dis Control \& Prevent, NCEH, Div Sci Lab, Atlanta, GA 30341 USA.}},
DOI = {{10.1007/s00128-004-0374-4}},
ISSN = {{0007-4861}},
Keywords-Plus = {{LACTATIONAL EXPOSURE; GLUCURONIDATION; MONOESTERS; URINARY; RATS}},
Research-Areas = {{Environmental Sciences \& Ecology; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Toxicology}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   COUGHTRIE MWH, 1988, MOL PHARMACOL, V34, P729.
   Foster W, 2000, J CLIN ENDOCR METAB, V85, P2954, DOI 10.1210/jc.85.8.2954.
   KATO K, 2003, IN PRESS MONO 2 EHTY.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Persaud T.V.N., 1998, DEV HUMAN CLIN ORIEN.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   {*}ATSDR, 1995, TOX PROF DIETHYL PHT.
   {*}ATSDR, 2002, TOX PROF DI 2 ETHYL.
   {*}ATSDR, 2001, TOX PROF DI N BUTYL.
   {*}CDC, 2003, 2 NAT REP HUM EXP EN.}},
Number-of-Cited-References = {{14}},
Times-Cited = {{83}},
Journal-ISO = {{Bull. Environ. Contam. Toxicol.}},
Doc-Delivery-Number = {{823XD}},
Wos-Id = {{ISI:000221646500020}},
}

@article{ ISI:000221008600018,
Author = {Takatori, S and Kitagawa, Y and Kitagawa, M and Nakazawa, H and Hori, S},
Title = {{Determination of di(2-ethylhexyl)phthalate and
   mono(2-ethylhexyl)phthalate in human serum using liquid
   chromatography-tandem mass spectrometry}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES}},
Year = {{2004}},
Volume = {{804}},
Number = {{2}},
Pages = {{397-401}},
Month = {{MAY 25}},
Abstract = {{Concentrations of mono(2-ethylhexyl)phthalate (MEHP), and
   di(2-ethylhexyl)phthalate (DEHP), in serum of healthy volunteers were
   determined by high performance liquid chromatography (HPLC) with tandem
   mass spectrometry (LC/MS/MS). The serum was extracted with acetone,
   followed by hexane extraction under acidic conditions, and then applied
   to the LC/MS/MS. Recoveries of 20 ng/ml of MEHP and DEHP were 101 +/-
   5.7 (n = 6) and 102 +/- 6.5\% (n = 6), respectively. The limits of
   quantification (LOQ) of MEHP and DEHP in the method were 5.0 and 14.0
   ng/ml, respectively. The concentration of MEHP in the serum was at or
   less than the LOQ. The concentration of DEHP in the serum was less than
   the LOQ. Contaminations of MEHP and DEHP from experimental reagents,
   apparatus and air during the procedure were less than the LOQ and were
   estimated to be <1.0 and 2.2 +/- 0.6 ng/ml, respectively. After
   subtraction of the contamination, the net concentrations of MEHP and
   DEHP in the serum were estimated at or <5 and <2 ng/ml, respectively. To
   decrease contamination by DEHP, the cleanup steps and the apparatus and
   solvent usage were minimized in the sample preparation procedures. The
   high selectivity of LC/MS/MS is the key for obtaining reliable
   experimental data from in the matrix-rich analytical samples and for
   maintaining a low level contamination of MEHP and DEHP in this
   experimental system. This method would be a useful tool for the
   detection of MEHP and DEHP in serum. (C) 2004 Elsevier B.V. All rights
   reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Takatori, S (Reprint Author), Osaka Prefectural Inst Publ Hlth, Higashinari Ku, 3-69,1 Chome,Nakamichi, Osaka 5370025, Japan.
   Osaka Prefectural Inst Publ Hlth, Higashinari Ku, Osaka 5370025, Japan.
   Hoshi Univ, Fac Pharmaceut Sci, Shinagawa Ku, Tokyo 1428501, Japan.}},
DOI = {{10.1016/j.jchromb.2004.01.056}},
ISSN = {{1570-0232}},
Keywords = {{di(2-ethylhexyl)phthalate; mono(2-ethylhexyl)phthalate}},
Keywords-Plus = {{MONO-(2-ETHYLHEXYL) PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL
   PHTHALATE; PLASTICIZER EXTRACTION; PARENTERAL-NUTRITION; INFUSION
   SOLUTIONS; RELEASE BEHAVIOR; HEMODIALYSIS; RATS; INJECTION}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{takatori@iph.pref.osaka.jp}},
Cited-References = {{ALBRO PW, 1989, TOXICOL APPL PHARM, V100, P193, DOI 10.1016/0041-008X(89)90305-0.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V360, P380.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   DINE T, 1991, BIOMED CHROMATOGR, V5, P94, DOI 10.1002/bmc.1130050211.
   Faouzi MA, 1999, J PHARMACEUT BIOMED, V21, P923, DOI 10.1016/S0731-7085(99)00204-6.
   FLAMINIO LM, 1988, INT J ARTIF ORGANS, V11, P428.
   FLAMINIO LM, 1988, INT J ARTIF ORGANS, V11, P435.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Hanawa T, 2003, INT J PHARM, V267, P141, DOI 10.1016/j.ijpharm.2003.08.009.
   Hanawa T, 2000, INT J PHARM, V210, P109, DOI 10.1016/S0378-5173(00)00578-0.
   Inoue K, 2003, ANAL BIOANAL CHEM, V375, P527, DOI 10.1007/s00216-002-1709-9.
   Kambia K, 2001, J CHROMATOGR B, V755, P297, DOI 10.1016/S0378-4347(01)00125-6.
   Kambia K, 2001, INT J PHARM, V229, P139, DOI 10.1016/S0378-5173(01)00840-7.
   Kambia K, 2003, INT J PHARM, V262, P83, DOI 10.1016/S0378-5173(03)00335-1.
   Kessler W, 2001, ARCH TOXICOL, V75, P62, DOI 10.1007/s002040000198.
   KOCH HM, IN PRESS ARCH TOXICO.
   LAKE BG, 1977, TOXICOL APPL PHARM, V39, P239, DOI 10.1016/0041-008X(77)90157-0.
   MAZUR HI, 1989, JPEN-PARENTER ENTER, V13, P59, DOI 10.1177/014860718901300159.
   Mitani K, 2003, J PHARMACEUT BIOMED, V32, P469, DOI 10.1016/S0731-7085(03)00221-8.
   MOSS EJ, 1988, TOXICOL LETT, V40, P77, DOI 10.1016/0378-4274(88)90185-3.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P246, DOI 10.1016/0041-008X(85)90346-1.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   RATHINAM K, 1990, J APPL TOXICOL, V10, P39, DOI 10.1002/jat.2550100107.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   Suzuki T, 2001, ENVIRON SCI TECHNOL, V35, P3757, DOI 10.1021/es001860i.
   TEIRLYNCK OA, 1985, ARCH TOXICOL, V57, P226, DOI 10.1007/BF00324782.
   WAUGH WN, 1991, AM J HOSP PHARM, V48, P1520.
   {*}CASTEE, 2002, 29 CASTEE PLEN M BRU.
   {*}IARC, 2000, IARC MON EV CARC RIS, V77, P41.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{39}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{814XY}},
Wos-Id = {{ISI:000221008600018}},
}

@article{ ISI:000221514400042,
Author = {Hauser, R and Duty, S and Godfrey-Bailey, L and Calafat, AM},
Title = {{Medications as a source of human exposure to phthalates}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2004}},
Volume = {{112}},
Number = {{6}},
Pages = {{751-753}},
Month = {{MAY}},
Abstract = {{Phthalates are a group of multifunctional chemicals used in consumer and
   personal care products, plastics, and medical devices. Laboratory
   studies show that some plathalates are reproductive and developmental
   toxicants. Recently, human studies have shown measurable levels of
   several phthalates in most of the U.S. general population. Despite their
   widespread use and the consistent toxicologic data on phthalates,
   information is limited on sources and pathways of human exposure to
   phthalates. One potential source of exposure is medications. The need
   for site-specific dosage medications has led to the use of enteric
   coatings that allow the release of the active ingredients into the small
   intestine or in the colon. The enteric coatings generally consist of
   various polymers that contain plasticizers, including triethyl citrate,
   dibutyl sebacate, and phthalates such as diethyl phthalate (DEP) and
   dibutyl plathalate (DBP). In this article we report on medications as a
   potential source of exposure to DBP in a man who took Asacol {[}active
   ingredient mesalamine (mesalazine)] for the treatment of ulcerative
   colitis. In a spot urine sample from this man collected 3 months after
   he started taking Asacol, the concentration of monobutyl phthalate, a
   DBP metabolite, was 16,868 ng/mL (6,180 mug/g creatinine). This
   concentration was more than two orders of magnitude higher than the 95th
   percentile for males reported in the 1999-2000 National Health and
   Nutrition Examination Survey (NHANES). The patient's urinary
   concentrations of monoethyl phthalate (443.7 ng/mL, 162.6 mug/g
   creatinine), mono-2-ethythexyl plathalate (3.0 ng/mL, 1.1 mug/g
   creatinine), and monobenzyl phthalate (9.3 ng/mL, 3.4 mug/g creatinine)
   were unremarkable compared with the NHANES 1999-2000 values. Before this
   report, the highest estimated human exposure to DBP was more than two
   orders of magnitude lower than the no observable adverse effect level
   from animal studies. Further research is necessary to determine the
   proportional contribution of medications, as well as personal care and
   consumer products, to a person's total phthalate burden.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hauser, R (Reprint Author), Harvard Univ, Sch Publ Hlth, Occupat Hlth Program, Dept Environm Hlth, 665 Huntington Ave,Bldg 1,Room 1405, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Occupat Hlth Program, Dept Environm Hlth, Boston, MA 02115 USA.
   Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv, Androl Lab, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv, Androl Lab, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, In Vitro Fertilizat Unit, Boston, MA 02114 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.}},
DOI = {{10.1289/ehp.6804}},
ISSN = {{0091-6765}},
Keywords = {{biomarkers; environmental health; medications; phthalates; reproductive
   health}},
Keywords-Plus = {{MALE REPRODUCTIVE DEVELOPMENT; DI(N-BUTYL) PHTHALATE; DI(2-ETHYLHEXYL)
   PHTHALATE; QUANTITATIVE DETECTION; DELIVERY SYSTEMS; LATE-GESTATION;
   RATS; METABOLITES; PLASTICIZERS; GONOCYTES}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{rhauser@hohp.harvard.edu}},
Cited-References = {{AGARWAL DK, 1985, TOXICOLOGY, V35, P189, DOI 10.1016/0300-483X(85)90015-0.
   Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   ASHFORD M, 1994, J DRUG TARGET, V2, P241, DOI 10.3109/10611869408996806.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   CASTLE L, 1990, FOOD ADDIT CONTAM, V7, P779.
   CATER BR, 1977, TOXICOL APPL PHARM, V41, P609, DOI 10.1016/S0041-008X(77)80014-8.
   CDC, 2003, NCEH PUB.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   Frohoff-Hulsmann MA, 1999, INT J PHARM, V177, P69, DOI 10.1016/S0378-5173(98)00327-5.
   HARRIS MR, 1989, AQUEOUS POLYM COATIN, P81.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Marvola M, 1999, EUR J PHARM SCI, V7, P259, DOI 10.1016/S0928-0987(98)00032-3.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   National Center for Health Statistics, 2003, NAT HLTH NUTR EX SUR.
   PAGE BD, 1995, FOOD ADDIT CONTAM, V12, P129.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Rao P R, 1997, Pharm Acta Helv, V72, P47, DOI 10.1016/S0031-6865(96)00060-X.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   SCHROEDER KW, 2002, SCAND J GASTROENTE S, V236, P42.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   SJOBERG P, 1986, ENVIRON HEALTH PERSP, V65, P237, DOI 10.2307/3430188.
   {*}ATSDR, 2000, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}PROCT GAMBL PHARM, 2000, AS MES DEL REL TABL.
   {*}US FDA, 2003, IN INGR SEARCH APPR.
   {*}US FDA, 2000, INDR FOOD ADD ADH CO.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{79}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{822DD}},
Wos-Id = {{ISI:000221514400042}},
}

@article{ ISI:000221169200061,
Author = {Calafat, AM and Needham, LL and Silva, MJ and Lambert, G},
Title = {{Exposure to di-(2-ethylhexyl) phthalate among premature neonates in a
   neonatal intensive care unit}},
Journal = {{PEDIATRICS}},
Year = {{2004}},
Volume = {{113}},
Number = {{5}},
Pages = {{E429-E434}},
Month = {{MAY}},
Abstract = {{Objective. Premature neonates who spend time in a neonatal intensive
   care unit may be at increased risk of adverse health effects from
   exposure to di-(2-ethylhexyl) phthalate ( DEHP) because of their
   increased risk of high exposure, their small body size, and their
   physical condition. DEHP, a reproductive toxicant in animals, is a major
   component in polyvinyl chloride ( PVC) plastics, which are frequently
   used in medical tubing and blood storage bags. DEHP is not covalently
   bound to PVC, and it may be easily released from the PVC medical
   devices. The objective of this study was to determine whether premature
   infants who undergo medical procedures, such as blood transfusions,
   intravenous therapy, enteral and parenteral nutrition support, and
   dialysis, are at increased risk of exposure to DEHP than the general
   population. Because of their smaller size, children and especially
   premature and small infants may receive a larger dose of DEHP on a
   milligram per kilogram basis than adults when the same-size medical
   device is used for all ages.
   Methods. Premature neonates who seemed to have the potential to be on
   intravenous infusion for > 2 weeks and were expected to survive were
   eligible for enrollment in the study. We assessed exposure to DEHP in 6
   premature newborns by measuring in 41 urine samples the levels of 3 DEHP
   metabolites: mono-(2-ethylhexyl) phthalate (mEHP),
   mono-(2-ethyl-5-hydroxyhexyl) phthalate (mEHHP), and
   mono-(2-ethyl-5-oxohexyl) phthalate (mEOHP).
   Results. mEHHP and mEOHP were detected in all 41 urine samples, and mEHP
   was detected in 33. Because only 33 of the samples had detectable
   amounts for all 3 metabolites, statistical analyses were limited to
   those 33. The levels of all 3 DEHP metabolites varied widely, and the
   urinary mean and median concentrations of mEOHP and mEHHP were 1 order
   of magnitude higher than those for mEHP. Furthermore, the geometric mean
   urinary concentrations of mEOHP ( 1617 ng/mL), mEHHP ( 2003 ng/mL), and
   mEHP ( 100 ng/mL) in these 6 premature infants who underwent intensive
   therapeutic interventions were found to be severalfold higher than in
   the US general population ( for mEHP, geometric mean in those 6 years
   and older was 3.43 ng/mL).
   Conclusions. This study provides the first quantitative evidence
   confirming that newborns who undergo intensive therapeutic medical
   interventions are exposed to higher concentrations of DEHP than the
   general population. Although the overall benefits of medical procedures
   using PVC devices outweigh the risks associated with exposure to DEHP,
   more research is needed to determine whether infants and children who
   undergo intensive therapeutic interventions using DEHP-containing
   devices are at higher risk for altered health outcomes than infants and
   children who undergo similar treatments but are not potentially exposed
   to DEHP.}},
Publisher = {{AMER ACAD PEDIATRICS}},
Address = {{141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, 4770 Buford Hwy,Mailstop F17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.
   Univ Med \& Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Ctr Childhood Neurotoxicol \& Exposure Assessment, Piscataway, NJ 08854 USA.}},
DOI = {{10.1542/peds.113.5.e429}},
ISSN = {{0031-4005}},
Keywords = {{DEHP; phthalate; plasticizer; urine; biomarker}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL-PHTHALATE;
   SEXUAL-DIFFERENTIATION; QUANTITATIVE DETECTION; GENERAL-POPULATION;
   MASS-SPECTROMETRY; YOUNG-CHILDREN; MALE-RATS; METABOLITES; URINE}},
Research-Areas = {{Pediatrics}},
Web-of-Science-Categories  = {{Pediatrics}},
Author-Email = {{ACalafat@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{AGARWAL DK, 1986, ENVIRON HEALTH PERSP, V65, P343, DOI 10.2307/3430202.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   ALBRO PW, 1981, DRUG METAB DISPOS, V9, P223.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1984, FOOD CHEM TOXICOL, V22, P123, DOI 10.1016/0278-6915(84)90092-9.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   HAMOSH M, 1990, NUTRITION, V6, P421.
   Hu YA, 2000, J EXPO ANAL ENV EPID, V10, P703.
   JACKSON S, 1966, HEALTH PHYS, V12, P843, DOI 10.1097/00004032-196606000-00014.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   Kambia K, 2003, INT J PHARM, V262, P83, DOI 10.1016/S0378-5173(03)00335-1.
   Kato K, 2004, ENVIRON HEALTH PERSP, V112, P327, DOI 10.1289/ehp.6663.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Leeder JS, 1997, PEDIATR CLIN N AM, V44, P55, DOI 10.1016/S0031-3955(05)70463-6.
   Loff S, 2002, JPEN-PARENTER ENTER, V26, P305, DOI 10.1177/0148607102026005305.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   Needham LL, 2000, J EXPO ANAL ENV EPID, V10, P611.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   Shea KM, 2003, PEDIATRICS, V111, P1467, DOI 10.1542/peds.111.6.1467.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2004, ENVIRON HEALTH PERSP, V112, P331, DOI 10.1289/ehp.6723.
   Tietz NW, 1990, CLIN GUIDE LAB TESTS.
   Wahl HG, 1999, J CHROMATOGR A, V847, P1, DOI 10.1016/S0021-9673(99)00138-7.
   WHO, 1996, BIOL MON CHEM EXP WO.
   {*}ATSDR, TOX PROF DI2 ETH PHT.
   {*}CDC, 2 NAT REP HUM EXP EN.
   {*}CERHR, NTP CERHR EXP PAN RE.
   {*}EPA, BIS2 ETH PHTH DEHP.
   {*}FDA, SAF ASS DI2 ETH PHTH.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{59}},
Journal-ISO = {{Pediatrics}},
Doc-Delivery-Number = {{817HS}},
Wos-Id = {{ISI:000221169200061}},
}

@article{ ISI:000220837400010,
Author = {Haishima, Y and Matsuda, R and Hayashi, Y and Hasegawa, C and Yagami, T
   and Tsuchiya, T},
Title = {{Risk assessment of di(2-ethylhexyl)phthalate released from PVC blood
   circuits during hemodialysis and pump-oxygenation therapy}},
Journal = {{INTERNATIONAL JOURNAL OF PHARMACEUTICS}},
Year = {{2004}},
Volume = {{274}},
Number = {{1-2}},
Pages = {{119-129}},
Month = {{APR 15}},
Abstract = {{This study deals with in vitro investigation of the release of
   di(2-ethylhexyl)phthalate (DEHP) during hemodialysis and
   pump-oxygenation therapy using medical grade PVC tubing. High resolution
   GC-MS analysis showed that the release of DEHP was time-dependently
   increased by circulation of bovine blood into a major system for the
   hemodialysis that is used in Japan, and the amount of DEHP released into
   the blood had reached 7.3 mg by 4 h of circulation. No significant
   difference was observed in the release patterns of DEHP under the
   conditions with and without fluid removal treatment during hemodialysis,
   indicating that the treatment seems not to be effective for eliminating
   DEHP from the blood through the hemodialysis membrane.
   Mono(2-ethylhexyl)phthalate (MEHP) analysis revealed that a small amount
   of DEHP (3-4\%) was converted to MEHP by hydrolysis during the
   circulation of blood. A considerable amount of DEHP was also released
   from the PVC circuit mimicking the pump-oxygenation system, and 7.5-12.1
   mg of DEHP had migrated into bovine blood from the circuit by 6 h. It
   was noticed, however, that the release was obviously suppressed by
   covalently coating the inner surface of the PVC tubing with heparin,
   though this effect was not observed with ionic bond type-heparin
   coating. Covalent bond type-heparin coating of PVC tubing seems to offer
   the advantage of decreasing the amount of DEHP exposure to patients
   during treatment using a PVC circuit. (C) 2004 Elsevier B.V. All rights
   reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Haishima, Y (Reprint Author), Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.
   Natl Inst Hlth Sci, Div Med Devices, Setagaya Ku, Tokyo 1588501, Japan.
   Natl Inst Hlth Sci, Div Foods, Setagaya Ku, Tokyo 1588501, Japan.
   Natl Inst Hlth Sci, Div Safety Informat Drug Food \& Chem, Setagaya Ku, Tokyo 1588501, Japan.}},
DOI = {{10.1016/j.ijpharm.2004.01.009}},
ISSN = {{0378-5173}},
Keywords = {{DEHP; MEHP; hemodialysis; pump-oxygenator; PVC tubing; blood circuit}},
Keywords-Plus = {{GERM-CELL APOPTOSIS; SERTOLI-CELL; MONO(2-ETHYLHEXYL) PHTHALATE;
   DI-(2-ETHYLHEXYL) PHTHALATE; DI-2-ETHYLHEXYL PHTHALATE;
   LIQUID-CHROMATOGRAPHY; MEDICAL DEVICES; BISPHENOL-A; IN-VITRO; RAT}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Author-Email = {{haishima@nihs.go.jp}},
Cited-References = {{ALLWOOD MC, 1986, INT J PHARM, V29, P233, DOI 10.1016/0378-5173(86)90120-1.
   David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   FLAMINIO LM, 1988, INT J ARTIF ORGANS, V11, P428.
   GRASSO P, 1993, BIOL REPROD, V48, P454, DOI 10.1095/biolreprod48.3.454.
   Haishima Y, 2001, J BIOMED MATER RES, V58, P209, DOI 10.1002/1097-4636(2001)58:2<209::AID-JBM1009>3.0.CO;2-7.
   Hanawa T, 2000, INT J PHARM, V210, P109, DOI 10.1016/S0378-5173(00)00578-0.
   HAYASHI Y, 1994, ANAL CHEM, V66, P2874, DOI 10.1021/ac00090a013.
   Hayashi Y, 2002, J PHARMACEUT BIOMED, V28, P421, DOI 10.1016/S0731-7085(01)00698-7.
   Hayashi Y, 1996, ANALYST, V121, P591, DOI 10.1039/an9962100591.
   HEINDEL JJ, 1989, TOXICOL APPL PHARM, V97, P377.
   Inoue K, 2003, J PHARMACEUT BIOMED, V31, P1145, DOI 10.1016/S0731-7085(03)00019-0.
   Inoue K, 2003, ANAL BIOANAL CHEM, V375, P527, DOI 10.1007/s00216-002-1709-9.
   KAMBIA K, 2001, INT J PHARM, V23, P139.
   Karle VA, 1997, CRIT CARE MED, V25, P696, DOI 10.1097/00003246-199704000-00023.
   KOIZUMI M, 2000, JPN J FOOD CHEM, V7, P65.
   LAKE BG, 1977, TOXICOL APPL PHARM, V39, P239, DOI 10.1016/0041-008X(77)90157-0.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   Lamba NMK, 2000, BIOMATERIALS, V21, P89, DOI 10.1016/S0142-9612(99)00145-3.
   Lee J, 1999, ENDOCRINOLOGY, V140, P852, DOI 10.1210/en.140.2.852.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Mejak BL, 2000, PERFUSION-UK, V15, P51.
   MURAMATSU E, 2000, JPN J HOSP PHARM, V26, P471.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   RHODES C, 1986, ENVIRON HEALTH PERSP, V65, P299, DOI 10.2307/3430197.
   Richburg JH, 1996, TOXICOL APPL PHARM, V137, P42, DOI 10.1006/taap.1996.0055.
   Richburg JH, 2000, ENDOCRINOLOGY, V141, P787, DOI 10.1210/en.141.2.787.
   TANAKA M, 2001, JPN J HLTH CARE SCI, V27, P132.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   TYL RW, 1988, FUND APPL TOXICOL, V10, P395, DOI 10.1016/0272-0590(88)90286-2.
   WOODWARD KN, 1988, PHTHALATE ESTERS TOX, V2.
   Zacharewski TR, 1998, TOXICOL SCI, V46, P282, DOI 10.1093/toxsci/46.2.282.
   {*}CTR DEV RAD HLTH, 2001, SAF ASS DI2 DEHP REL.
   {*}ICH, 1996, VAL AN PROD METH.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{20}},
Journal-ISO = {{Int. J. Pharm.}},
Doc-Delivery-Number = {{812KC}},
Wos-Id = {{ISI:000220837400010}},
}

@article{ ISI:000220458400016,
Author = {Holm, A and Solbu, K and Molander, P and Lundanes, E and Greibrokk, T},
Title = {{Sensitive biomonitoring of phthalate metabolites in human urine using
   packed capillary column switching liquid chromatography coupled to
   electrospray ionization ion-trap mass spectrometry}},
Journal = {{ANALYTICAL AND BIOANALYTICAL CHEMISTRY}},
Year = {{2004}},
Volume = {{378}},
Number = {{7}},
Pages = {{1762-1768}},
Month = {{APR}},
Abstract = {{A rapid and sensitive method for the determination of the phthalate
   monoesters monoethyl phthalate (MEP), monobutyl phthalate (MBP),
   monobenzyl phthalate (MBzP) and monoethylhexyl phthalate (MEHP), in
   human urine, using packed capillary column liquid chromatography coupled
   to electrospray quadrupole-ion trap mass spectrometry (ESI-QITMS(n)) has
   been developed. Sample volumes of 200 muL of deconjugated and diluted
   urine were loaded onto a precolumn of 30 mmx0.32 mm I.D. packed with
   Hypercarb 5 mum particles, using a sample carrier consisting of
   acetonitrile/water (15/85, v/v, adjusted to pH 2 using HCl) with a flow
   rate of 20 muL/min. Backflushed elution onto a 100 mmx0.32 mm I.D.
   analytical column packed with 5 mum Hypercarb particles was conducted
   using a tetrahydrofuran/water gradient where both solvents contained 10
   mM ammonium acetate, at a flow rate of 4 muL/min. Determination of the
   monophthalates was achieved within 8 min. Ionization was performed in
   the negative mode and the analytes were observed as {[}M-H](-) at
   m/z=193.1, 221.1, 255.1 and 277.0 for MEP, MBP, MBzP and MEHP,
   respectively. Quantification was performed in the multiple reaction
   monitoring (MRM) mode monitoring the fragments at m/z=121.1, 177.0,
   183.0 and 233.0 for MEP, MBP, MBzP and MEHP, respectively. The method
   was validated over the concentration range 2.5-125 ng/mL in pretreated
   urine samples, corresponding to 25-1250 ng/mL untreated urine, yielding
   correlation coefficients in the range 0.996-0.999. The within-assay
   (n=6) and between-assay (n=6) repeatabilities were in the range 4.0-18\%
   and 4.8-15\% RSD, respectively. The mass limits of detection were in the
   range 32-70 pg, corresponding to concentration limits of detection of
   1.6-3.5 ng/mL of untreated urine.}},
Publisher = {{SPRINGER-VERLAG HEIDELBERG}},
Address = {{TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Holm, A (Reprint Author), Univ Oslo, Dept Chem, POB 1033, N-0315 Blindern, Norway.
   Univ Oslo, Dept Chem, N-0315 Blindern, Norway.
   Natl Inst Occupat Hlth, N-0033 Oslo, Norway.}},
DOI = {{10.1007/s00216-003-2488-7}},
ISSN = {{1618-2642}},
Keywords = {{capillary liquid chromatography; column switching; porous graphitic
   carbon; biomonitoring; phthalates}},
Keywords-Plus = {{EVAPORATIVE LIGHT-SCATTERING; DI(2-ETHYLHEXYL) PHTHALATE; GRAPHITIC
   CARBON; DI-(2-ETHYLHEXYL) PHTHALATE; MONO-(2-ETHYLHEXYL) PHTHALATE;
   DI-2-ETHYLHEXYL PHTHALATE; STATIONARY-PHASE; INORGANIC ANIONS; EXPOSURE;
   PLASTICIZERS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Author-Email = {{anders.holm@kjemi.uio.no}},
ResearcherID-Numbers = {{Molander, Paal/C-9477-2009}},
Cited-References = {{ALBRO PW, 1982, J ENVIRON SCI HEAL B, V17, P701, DOI 10.1080/03601238209372351.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   CHU I, 1978, DRUG METAB DISPOS, V6, P146.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   DIRVEN HAAM, 1993, BIOCHEM PHARMACOL, V45, P2425, DOI 10.1016/0006-2952(93)90223-J.
   DOELMAN CJA, 1990, LANCET, V335, P725, DOI 10.1016/0140-6736(90)90839-W.
   Elfakir C, 1998, J CHROMATOGR A, V829, P193, DOI 10.1016/S0021-9673(98)00843-7.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   Harnisch JA, 2001, ANALYST, V126, P1841, DOI 10.1039/b105249g.
   HARVAN DJ, 1980, BIOMED MASS SPECTROM, V7, P242, DOI 10.1002/bms.1200070604.
   Hellwig J, 1997, FOOD CHEM TOXICOL, V35, P501, DOI 10.1016/S0278-6915(97)00008-2.
   Hill SS, 2001, CLIN CHIM ACTA, V304, P1, DOI 10.1016/S0009-8981(00)00411-3.
   Holm A, 2003, J CHROMATOGR B, V794, P175, DOI 10.1016/S1570-0232(03)00427-6.
   Holm A, 2003, J CHROMATOGR A, V983, P43, DOI 10.1016/S0021-9673(02)01693-X.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   Inoue K, 2003, ANAL BIOANAL CHEM, V375, P527, DOI 10.1007/s00216-002-1709-9.
   Kambia K, 2001, INT J PHARM, V229, P139, DOI 10.1016/S0378-5173(01)00840-7.
   Kessler W, 2001, ARCH TOXICOL, V75, P62, DOI 10.1007/s002040000198.
   Knox JH, 1997, ADV CHROMATOGR, V37, P73.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Konermann L, 2001, ANAL CHEM, V73, P4836, DOI 10.1021/ac010545r.
   KRIZ J, 1994, J CHROMATOGR A, V663, P151.
   Liu SY, 2003, ANAL CHEM, V75, P1022, DOI 10.1021/ac026066p.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   LUSTER MI, 1978, CLIN CHEM, V24, P429.
   Mercier JP, 1999, J CHROMATOGR A, V849, P197, DOI 10.1016/S0021-9673(99)00556-7.
   MOCKEL HJ, 1991, J LIQ CHROMATOGR, V14, P2477, DOI 10.1080/01483919108049334.
   Molander P, 2001, J SEP SCI, V24, P947, DOI 10.1002/1615-9314(20011201)24:12<947::AID-JSSC947>3.0.CO;2-7.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   PAGE BD, 1987, ACS SYM SER, V365, P118.
   Peters JM, 1997, TERATOLOGY, V56, P311, DOI 10.1002/(SICI)1096-9926(199711)56:5<311::AID-TERA4>3.0.CO;2-\#.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   Rezai MA, 1996, J CHROMATOGR A, V742, P69, DOI 10.1016/0021-9673(96)00240-3.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x.
   Takeuchi T, 2000, HRC-J HIGH RES CHROM, V23, P590, DOI 10.1002/1521-4168(20001001)23:10<590::AID-JHRC590>3.0.CO;2-C.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Tornkvist A, 2003, ANALYST, V128, P844, DOI 10.1039/b303076h.
   Van Tongeren M, 2002, ANN OCCUP HYG, V46, P465, DOI 10.1093/annhyg/mef053.
   Vissers JPC, 1999, J CHROMATOGR A, V856, P117, DOI 10.1016/S0021-9673(99)00692-5.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {*}EUR COUNC PLAST I, 2003, ANN REP.
   {*}NCEH, 2004, WEBS GEN INF PHTHAL.
   {*}THERM EL CORP, 2004, WEBS DESCR HYP.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{14}},
Journal-ISO = {{Anal. Bioanal. Chem.}},
Doc-Delivery-Number = {{806UI}},
Wos-Id = {{ISI:000220458400016}},
}

@article{ ISI:000220770400044,
Author = {Hoppin, JA and Ulmer, R and London, SJ},
Title = {{Phthalate exposure and pulmonary function}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2004}},
Volume = {{112}},
Number = {{5}},
Pages = {{571-574}},
Month = {{APR}},
Abstract = {{Exposure to phthalates is widespread because of their use in plastics,
   cosmetics, and other consumer products. Phthalate exposure has been
   associated with adverse respiratory outcomes in children. With urinary
   phthalate measures, we assessed the association between phthalate
   exposure and four pulmonary function parameters {[}forced vital capacity
   (FVC), forced expiratory volume at 1 sec (FEV1), peak expiratory flow
   (PEF), and maximum mid-expiratory flow] among the 240 adult Third
   National Health and Nutrition Examination Survey (NHANES III)
   participants with urinary phthalate data. Linear regression models
   controlled for race, age, age squared, standing height, body mass index,
   cumulative smoking, and current smoking. Monobutyl phthalate (MBP) was
   significantly associated with decrements in three measures of pulmonary
   function (FVC, FEV1, PEF) in males but not in females. For a change from
   the 25th to the 75th percentile in MBP level among men, FEV1 decreased
   112 mL (SE = 51, p = 0.03). Monoethyl phthalate (MEP) was associated
   with lower FVC and FEV1 values in men. Monoethythexyl phthalate (MEHP),
   the metabolite of the plasticizer commonly used in medical tubing, was
   not adversely associated with any of the pulmonary function parameters
   evaluated. Our results suggest that MBP and MEP, but not MEHP, may
   influence pulmonary function among adult males.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hoppin, JA (Reprint Author), NIEHS, Epidemiol Branch, NIH, Dept Hlth \& Human Serv, MD A3-05,POB 12233, Res Triangle Pk, NC 27709 USA.
   NIEHS, Epidemiol Branch, NIH, Dept Hlth \& Human Serv, Res Triangle Pk, NC 27709 USA.
   WESTAT Corp, Res Triangle Pk, NC USA.}},
ISSN = {{0091-6765}},
Keywords = {{monobutyl phthalate; pulmonary function; urine samples}},
Keywords-Plus = {{RESPIRATORY SYMPTOMS; YOUNG-CHILDREN; LUNG-FUNCTION; METABOLITES;
   HEALTH; DUST; POPULATION; SAMPLES; ASTHMA; HOME}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{hoppin1@niehs.nih.gov}},
Cited-References = {{Beach JR, 2001, INT ARCH OCC ENV HEA, V74, P489, DOI 10.1007/s004200100245.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Centers for Disease Control, 2003, NAT REP HUM EXP ENV.
   Eisner MD, 2002, ENVIRON HEALTH PERSP, V110, P765.
   Gardiner K, 2001, OCCUP ENVIRON MED, V58, P496, DOI 10.1136/oem.58.8.496.
   Hollund BE, 2001, OCCUP ENVIRON MED, V58, P780, DOI 10.1136/oem.58.12.780.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Iwatsubo Y, 2003, OCCUP ENVIRON MED, V60, P831, DOI 10.1136/oem.60.11.831.
   Jaakkola JJK, 2000, AM J PUBLIC HEALTH, V90, P797, DOI 10.2105/AJPH.90.5.797.
   Jaakkola JJK, 1999, AM J PUBLIC HEALTH, V89, P188, DOI 10.2105/AJPH.89.2.188.
   Latini G, 1999, ACTA PAEDIATR, V88, P1174, DOI 10.1080/08035259950168333.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   Ponsonby AL, 2003, EPIDEMIOLOGY, V14, P37, DOI 10.1097/00001648-200301000-00012.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Rudel RA, 2001, J AIR WASTE MANAGE, V51, P499.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Ulvestad B, 2000, THORAX, V55, P277, DOI 10.1136/thorax.55.4.277.
   Wang XR, 2003, OCCUP ENVIRON MED, V60, P115, DOI 10.1136/oem.60.2.115.
   {*}CERHR, 2000, NTP CEHRH EXP PAN RE.
   {*}CERHR, 2000, NAT TOX PROGR NTP CE.
   {*}CERHR, 2000, NTP CERHR EXP PAN RE.
   {*}NCHS, 2001, 3 NAT HLTH NUTR E 11.}},
Number-of-Cited-References = {{23}},
Times-Cited = {{40}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{811KI}},
Wos-Id = {{ISI:000220770400044}},
}

@article{ ISI:000221317300005,
Author = {Gayathri, NS and Dhanya, CR and Indu, AR and Kurup, PA},
Title = {{Changes in some hormones by low doses of di(2-ethyl hexyl) phthalate
   (DEHP), a commonly used plasticizer in PVC blood storage bags \& medical
   tubing}},
Journal = {{INDIAN JOURNAL OF MEDICAL RESEARCH}},
Year = {{2004}},
Volume = {{119}},
Number = {{4}},
Pages = {{139-144}},
Month = {{APR}},
Abstract = {{Background \& objectives: Di (2-ethyl hexyl) phthalate (DEHP), a
   plasticizer commonly used in PVC blood storage bags leaches out in
   significant amounts into blood during storage. In view of many reports
   on the toxicity of this compound, it was considered necessary to
   investigate the effect of DEHP at the low level solubilized in blood on
   some important hormones in rats and in human blood stored in DEHP
   plasticized blood bags.
   Methods: Rats were administered DEHP at a low level of 750 mug/100 g
   body weight on alternate days for 14 clays. Changes in the serum
   insulin, blood glucose, liver glycogen level and T-3, T-4 and thyroid
   stimulating hormone (TSH) as well as cortisol in the serum were studied.
   Changes in the hormones were also studied in blood stored in DEHP
   plasticized PVC bags.
   Results: The results indicated decrease in serum insulin, cortisol and
   liver glycogen, and increase in blood glucose, serum T 3 and T 4 in rats
   receiving DEHP. These changes were reversed when administration of DEHP
   was stopped. Similar changes in hormones were also observed in the blood
   stored in DEHP plasticized blood bags.
   Interpretation \& conclusion: The results indicated that administration
   of DEHP at low levels to rats caused symptoms of diabetes, thyroid and
   adrenocortical dysfunction. Though the results obtained in rats cannnot
   be extrapolated to human, the fact that similar hormonal changes seen in
   human blood stored in DEHP plasticized blood bags may suggest
   possibility of DEHP Causing similar changes in human. The fact that
   these changes were reversed in rats when DEHP administration was
   stopped, indicates that transfusion of a few units of blood to a
   recipient may not be harmful, but it may pose a problem during repeated
   transfusions such as in thalassaemia patients.}},
Publisher = {{INDIAN COUNCIL MEDICAL RES}},
Address = {{PO BOX 4911 ANSARI NAGAR, NEW DELHI 110029, INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kurup, PA (Reprint Author), Terumo Penpol Ltd, Dept Biol Sci Res \& Dev, TC 16-1653, Thiruvananthapuram 695014, Kerala, India.
   Terumo Penpol Ltd, Dept Biol Sci Res \& Dev, Thiruvananthapuram 695014, Kerala, India.}},
ISSN = {{0971-5916}},
Keywords = {{blood transfusion; cortisol; DEHP; thyroid hormones}},
Keywords-Plus = {{DI-2-ETHYLHEXYL PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; MALE RATS;
   ESTERS; LIVER; TOXICITY; GLYCOGEN}},
Research-Areas = {{Immunology; General \& Internal Medicine; Research \& Experimental
   Medicine}},
Web-of-Science-Categories  = {{Immunology; Medicine, General \& Internal; Medicine, Research \&
   Experimental}},
Author-Email = {{tplrd@asianetindia.com}},
Cited-References = {{BENNET CA, 1967, STAT ANAL CHEM CHEM, P105.
   CARROLL NV, 1956, J BIOL CHEM, V220, P583.
   CONWAY JG, 1989, CARCINOGENESIS, V10, P513, DOI 10.1093/carcin/10.3.513.
   David RM, 2001, TOXICOL PATHOL, V29, P430, DOI 10.1080/01926230152500040.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387.
   HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356.
   Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   MANN AH, 1985, TOXICOL APPL PHARM, V77, P116, DOI 10.1016/0041-008X(85)90273-X.
   MATTINGLY D, 1962, J CLIN PATHOL, V15, P374, DOI 10.1136/jcp.15.4.374.
   MUSHTAQ M, 1980, TOXICOLOGY, V16, P153, DOI 10.1016/0300-483X(80)90045-1.
   Nair K. G. Padmakumaran, 1998, Indian Journal of Experimental Biology, V36, P264.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PECK CC, 1979, TRANSFUSION, V19, P137, DOI 10.1046/j.1537-2995.1979.19279160282.x.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   PRICE SC, 1988, TOXICOL LETT, V40, P37, DOI 10.1016/0378-4274(88)90181-6.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   SETH PK, 1982, ENVIRON HEALTH PERSP, V45, P27, DOI 10.2307/3429380.
   TAKAGI A, 1992, J ENVIRON PATHOL TOX, V11, P149.
   VANDOOREN AA, 1991, PHARM WEEKBLAD, V13, P109.
   WALKER RH, 1993, BLOOD COMPONENTS PRE, P57.
   WALKER RH, 1993, BLOOD COMPONENTS PRE, P51.
   {*}US EPA OFF TOX SU, 1992, SUBCH 13 WEEK DIET O.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{19}},
Journal-ISO = {{Indian J. Med. Res.}},
Doc-Delivery-Number = {{819LV}},
Wos-Id = {{ISI:000221317300005}},
}

@article{ ISI:000220298700001,
Author = {Koch, HM and Bolt, HM and Angerer, J},
Title = {{Di(2-ethylhexyl)phthalate (DEHP) metabolites in human urine and serum
   after a single oral dose of deuterium-labelled DEHP}},
Journal = {{ARCHIVES OF TOXICOLOGY}},
Year = {{2004}},
Volume = {{78}},
Number = {{3}},
Pages = {{123-130}},
Month = {{MAR}},
Abstract = {{Human metabolism of di(2-ethylhexyl)phthalate (DEHP) was studied after a
   single oral dose of 48.1 mg to a male volunteer. To avoid interference
   by background exposure the D4-ring-labelled DEHP analogue was dosed.
   Excretion of three metabolites, mono(2-ethyl-5-hydroxyhexyl)phthalate
   (5OH-MEHP), mono(2-ethyl-5-oxohexyl)phthalate (5oxo-MEHP) and
   mono(2-ethylhexyl)phthalate (MEHP), was monitored for 44 h in urine and
   for 8 h in serum. Peak concentrations of all metabolites were found in
   serum after 2 h and in urine after 2 h (MEHP) and after 4 h (5OH-MEHP
   and 5oxo-MEHP). While the major metabolite in serum was MEHP, the major
   metabolite in urine was 5OH-MEHP, followed by 5oxo-MEHP and MEHP.
   Excretion in urine followed a multi-phase elimination model. After an
   absorption and distribution phase of 4 to 8 h, half-life times of
   excretion in the first elimination phase were approximately 2 h with
   slightly higher half-life times for 5OH- and 5oxo-MEHP. Half-life times
   in the second phase-beginning 14 to 18 h post dose-were 5 h for MEHP and
   10 h for 5OH-MEHP and 5oxo-MEHP. In the time window 36 to 44 h, no
   decrease in excreted concentrations of 5OH- and 5oxo-MEHP was observed.
   In the first elimination phase (8 to 14 h post dose), mean excretion
   ratios of MEHP to 5oxo-MEHP and MEHP to 5OH-MEHP were 1 to 1.8 and 1 to
   3.1. In the second elimination phase up to 24 h post dose mean excretion
   ratios of MEHP to 5oxo-MEHP to 5OH-MEHP were 1 to 5.0 to 9.3. The
   excretion ratio of 5OH-MEHP to 5oxo-MEHP remained constant through time
   at 1.7 in the mean. After 44 h, 47\% of the DEHP dose was excreted in
   urine, comprising MEHP (7.3\%), 5OH-MEHP (24.7\%) and 5oxo-MEHP
   (14.9\%).}},
Publisher = {{SPRINGER-VERLAG}},
Address = {{175 FIFTH AVE, NEW YORK, NY 10010 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Angerer, J (Reprint Author), Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Enviornm, Schillerstr 25-29, D-91054 Erlangen, Germany.
   Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Enviornm, D-91054 Erlangen, Germany.
   Univ Dortmund, Inst Occupat Physiol, Leibniz Res Ctr Working Enviornm \& Human Factors, D-44139 Dortmund, Germany.}},
DOI = {{10.1007/00204-003-0522-3}},
ISSN = {{0340-5761}},
Keywords = {{metabolism; urine; serum; di(2-ethylhexyl)phthalate (DEHP);
   mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP);
   mono(2-ethyl-5-oxohexyl)phthalate (5oxo-MEHP);
   mono(2-ethylhexyl)phthalate (MEHP)}},
Keywords-Plus = {{TESTICULAR DYSGENESIS SYNDROME; SEXUAL-DIFFERENTIATION; PHTHALATE
   METABOLITES; GENERAL-POPULATION; MALE-RAT; EXPOSURE; TOXICITY;
   CHEMICALS; SECONDARY; SAMPLES}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Author-Email = {{Juergen.Angerer@ipasum.imed.uni-erlangen.de}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Butte W, 2001, GEFAHRST REINHALT L, V61, P19.
   Cammack JN, 2003, INT J TOXICOL, V22, P159, DOI 10.1080/10915810390201136.
   Centers for Disease Control and Prevention, 2003, NCEH PUB, V020716.
   CSTEE (Scientific Committee on Toxicity Ecotoxicity and the Environment), 1998, 6 CSTEE PLEN M BRUSS.
   Dalgaard M, 2001, TOXICOL LETT, V122, P69, DOI 10.1016/S0378-4274(01)00348-4.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Fisher JS, 2003, HUM REPROD, V18, P1383, DOI 10.1093/humrep/deg273.
   Gilsing HD, 2002, MONATSH CHEM, V133, P1147, DOI 10.1007/s007060200084.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   Lorz P. M., 2002, ULLMANNS ENCY IND CH.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   Moore C, 2001, J COGN DEV, V2, P109, DOI 10.1207/S15327647JCD0202\_1.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   RIPPEN G, 2000, HDB UMWELTCHEMIKAL S, V51.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   SJOBERG P, 1985, ARCH TOXICOL, V58, P78, DOI 10.1007/BF00348313.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   Skakkebaek NE, 2002, HORM RES, V57, P43, DOI 10.1159/000058100.
   {*}ATSDR, 1993, ATDRTP9205 US DEP HH, P171.
   {*}DFG, 2002, GESUNDHEITSSCHADLICH.
   {*}EUR COMM EU, 2002, SANCOSCMPMD20020010F.
   {*}FDA, 2001, SAF ASS DI 2 ETHYLH.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{108}},
Journal-ISO = {{Arch. Toxicol.}},
Doc-Delivery-Number = {{804KX}},
Wos-Id = {{ISI:000220298700001}},
}

@article{ ISI:000220047700031,
Author = {Kato, K and Silva, MJ and Reidy, JA and Hurtz, D and Malek, NA and
   Needham, LL and Nakazawa, H and Barr, DB and Calafat, AM},
Title = {{Mono(2-ethyl-5-hydroxyhexyl) phthalate and mono-(2-ethyl-5-oxohexyl)
   phthalate as biomarkers for human exposure assessment to
   di-(2-ethylhexyl) phthalate}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2004}},
Volume = {{112}},
Number = {{3}},
Pages = {{327-330}},
Month = {{MAR}},
Abstract = {{Exposure to di-(2-ethylhexyl) phthalate (DEHP) is prevalent based on the
   measurement of its hydrolytic metabolite mono-(2-ethylhexyl) phthalate
   (MEHP) in the urine of 78\% of the general U.S. population studied in
   the 1999-2000 National Health and Nutrition Examination Survey (NHANES).
   However, despite the high level of production and use of DEHP, the
   urinary MEHP levels in the NHANES samples were lower than the monoester
   metabolites of phthalates less commonly used than DEHP, suggesting
   metabolic differences between phthalates. We measured MEHP and two
   oxidative DEHP metabolites, mono-(2-ethyl-5-oxohexyl) phthalate (MEOHP)
   and mono (2-ethyl-5-hydroxyhexyl) phthalate (MEHHP) to verify whether
   these other metabolites account for a greater proportion of DEHP
   metabolic products in 127 paired human urine and serum samples. We found
   that the urinary levels of MEHHP and MEOHP were 10-fold higher than
   levels of MEHP; concentrations of urinary MEOHP and MEHHP were strongly
   correlated (r = 0.928). We also found that the serum levels of MEOHP and
   MEHHP were comparatively lower than those in urine. Furthermore, the
   glucuronide-bound conjugates of the oxidative metabolites were the
   predominant form in both urine and serum. MEOHP and MEHHP cannot be
   formed by serum enzymes from the hydrolysis of any contamination from
   DEHP potentially introduced during blood collection and storage.
   Therefore, concentrations of MEHHP and MEOHP in serum may be a more
   selective measure of DEHP exposure than is MEHP. However, additional
   data on the absorption, distribution, metabolism, and elimination of
   these oxidative metabolites are needed to completely understand the
   extent of DEHP exposure from the serum concentrations of oxidative DEHP
   metabolites.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, 4770 Buford Highway NE,Mailstop F17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.
   Hoshi Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Tokyo 142, Japan.}},
DOI = {{10.1289/ehp.6663}},
ISSN = {{0091-6765}},
Keywords = {{DEHP; MEHHP; MEHP; MEOHP; phthalate metabolites; phthalates}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; QUANTITATIVE DETECTION; DI-2-ETHYLHEXYL
   PHTHALATE; DIETHYLHEXYL PHTHALATE; HUMAN SERUM; METABOLITES; RAT;
   URINARY; CHROMATOGRAPHY; PESTICIDES}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{zca2@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011
   Barr, Dana/E-6369-2011
   Barr, Dana/E-2276-2013}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   ALBRO PW, 1984, ANAL CHEM, V56, P247, DOI 10.1021/ac00266a029.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Barr DB, 2002, J CHROMATOGR B, V778, P99, DOI 10.1016/S0378-4347(01)00444-3.
   Barr DB, 1999, TOXICOL IND HEALTH, V15, P168, DOI 10.1191/074823399678846556.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   HINTON RH, 1986, ENVIRON HEALTH PERSP, V70, P195, DOI 10.2307/3430356.
   Kato K, 2003, J ANAL TOXICOL, V27, P284.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P129, DOI 10.2307/3429396.
   LUSTER MI, 1978, CLIN CHEM, V24, P429.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   ONO K, 1975, JAMA-J AM MED ASSOC, V234, P948, DOI 10.1001/jama.234.9.948.
   PECK CC, 1979, TRANSFUSION, V19, P137, DOI 10.1046/j.1537-2995.1979.19279160282.x.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   Taylor J. K., 1987, QUALITY ASSURANCE CH.
   WHITE RD, 1980, FOOD COSMET TOXICOL, V18, P383, DOI 10.1016/0015-6264(80)90194-7.
   WILLIAMS DT, 1975, J AGR FOOD CHEM, V23, P854, DOI 10.1021/jf60201a047.
   WILLIAMS DT, 1974, B ENVIRON CONTAM TOX, V11, P371.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}CDC, 2003, SEC NAT REP HUM EXP.
   {*}IARC, 2000, IARC MON EV CARC RIS, V77, P41.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{101}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{800SJ}},
Wos-Id = {{ISI:000220047700031}},
}

@article{ ISI:000220047700032,
Author = {Silva, MJ and Barr, DB and Reidy, JA and Malek, NA and Hodge, CC and
   Caudill, SP and Brock, JW and Needham, LL and Calafat, AM},
Title = {{Urinary levels of seven phthalate metabolites in the US population from
   the National Health and Nutrition Examination Survey (NHANES) 1999-2000}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2004}},
Volume = {{112}},
Number = {{3}},
Pages = {{331-338}},
Month = {{MAR}},
Abstract = {{We measured the urinary monoester metabolites of seven commonly used
   phthalates in approximately 2,540 samples collected from participants of
   the National Health and Nutrition Examination Survey (NHANES),
   1999-2000, who were greater than or equal to 6 years of age. We found
   detectable levels of metabolites monoethyl phthalate (MEP), monobutyl
   phthalate (MBP), monobenzyl phthalate (MBzP), and mono-(2-ethylhexyl)
   phthalate (MEHP) in > 75\% of the samples, suggesting widespread
   exposure in the United States to diethyl phthalate, dibutyl phthalate or
   diisobutylphthalate, benzylbutyl phthalate, and di-(2-ethylhexyl)
   phthalate, respectively. We infrequently detected monoisononyl
   phthalate, mono-cyclohexyl phthalate, and mono-n-octyl phthalate,
   suggesting that human exposures to di-isononyl phthalate,
   dioctylphthalate, and dicyclohexyl phthalate, respectively, are lower
   than those listed above, or the pathways, routes of exposure, or
   pharmacokinetic factors such as absorption, distribution, metabolism,
   and elimination are different. Non-Hispanic blacks had significantly
   higher concentrations of MEP than did Mexican Americans and non-Hispanic
   whites. Compared with adolescents and adults, children had significantly
   higher levels of MBP, MBzP, and MEHP but had significantly lower
   concentrations of MEP. Females had significantly higher concentrations
   of MEP and MBzP than did males, but similar MEHP levels. Of particular
   interest, females of all ages had significantly higher concentrations of
   the reproductive toxicant MBP than did males of all ages; however, women
   of reproductive age (i.e., 20-39 years of age) had concentrations
   similar to adolescent girls and women greater than or equal to 40 years
   of age. These population data on exposure to phthalates will serve an
   important role in public health by helping to set research priorities
   and by establishing a nationally representative baseline of exposure
   with which population levels can be compared.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Calafat, AM (Reprint Author), Ctr Dis Control \& Prevent, Dis Lab Sci, Natl Ctr Environm Hlth, 4770 Buford Hwy NE,Mailstop F17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Dis Lab Sci, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.}},
DOI = {{10.1289/ehp.6723}},
ISSN = {{0091-6765}},
Keywords = {{mono-(2-ethylhexyl) phthalate; monobenzyl phthalate; monobutyl
   phthalate; monoethyl phthalate; NHANES; phthalate exposure}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; QUANTITATIVE DETECTION; HEMODIALYSIS-PATIENTS;
   MONOBUTYL PHTHALATE; REPRODUCTIVE-TRACT; EXPOSURE; RATS;
   DI(2-ETHYLHEXYL)PHTHALATE; MALFORMATIONS; MONOESTERS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Author-Email = {{Acalafat@cdc.gov}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011
   Barr, Dana/E-6369-2011
   Barr, Dana/E-2276-2013}},
Cited-References = {{Adibi JJ, 2003, ENVIRON HEALTH PERSP, V111, P1719, DOI 10.1289/ehp.6235.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Barr DB, 2003, ENVIRON HEALTH PERSP, V111, P1148, DOI 10.1289/ehp.6074.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   CDC, 2001, NAT REP HUM EXP ENV.
   CHING NPH, 1981, J CHROMATOGR, V225, P196, DOI 10.1016/S0378-4347(00)80260-1.
   David RM, 2001, PATTYS TOXICOLOGY, V6, P635.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   Duty SM, 2003, ENVIRON HEALTH PERSP, V111, P1164, DOI 10.1289/ehp.5756.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   Ema M, 2001, REPROD TOXICOL, V15, P261, DOI 10.1016/S0890-6238(01)00131-9.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hornung RW, 1990, APPL OCCUP ENV HYG, V5, P46.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   JACKSON S, 1966, HEALTH PHYS, V12, P843, DOI 10.1097/00004032-196606000-00014.
   Koch HM, 2003, ENVIRON RES, V93, P177, DOI 10.1016/S0013-9351(03)00083-3.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   McKee RH, 2002, J APPL TOXICOL, V22, P293, DOI 10.1002/jat.861.
   Mettang T, 1996, NEPHROL DIAL TRANSPL, V11, P2439.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   National Center for Health Statistics, 2003, NAT HLTH NUTR EX SUR.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   Rudel RA, 2003, ENVIRON SCI TECHNOL, V37, P4543, DOI 10.1021/es0264596.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Silva MJ, 2003, ARCH TOXICOL, V77, P561, DOI 10.1007/s00204-003-0486-3.
   {*}ATSDR, 2002, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 1997, TOX PROF DI N OCT PH.
   {*}ATSDR, 2001, TOX PROF DI N BUT PH.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.
   {*}CDC, 2003, SEC NAT REP HUM EXP.}},
Number-of-Cited-References = {{36}},
Times-Cited = {{271}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{800SJ}},
Wos-Id = {{ISI:000220047700032}},
}

@article{ ISI:000189382200020,
Author = {Duty, SM and Calafat, AM and Silva, MJ and Brock, JW and Ryan, L and
   Chen, ZY and Overstreet, J and Hauser, R},
Title = {{The relationship between environmental exposure to phthalates and
   computer-aided sperm analysis motion parameters}},
Journal = {{JOURNAL OF ANDROLOGY}},
Year = {{2004}},
Volume = {{25}},
Number = {{2}},
Pages = {{293-302}},
Month = {{MAR-APR}},
Abstract = {{The general population is exposed to phthalates through consumer
   products, diet, and medical devices. The present study explored whether
   phthalates, reproductive toxins in laboratory animals, were associated
   with altered sperm movement characteristics in men. Two-hundred twenty
   subjects provided a semen sample for computer-aided sperm analysis
   (CASA) and a urine sample for measurement of phthalate monoesters,
   monoethyl (MEP), monobenzyl (MBzP), mono-n-butyl (MBIP),
   mono-2-ethylhexyl (MEHP), and monomethyl (MMP). Three CASA parameters,
   straight-line velocity (VSL), curvilinear velocity (VCL), and linearity
   (LIN), were used as measures of sperm progression, sperm vigor, and
   swimming pattern, respectively. There were suggestive dose-response
   relationships (shown as the predicted change in mean sperm motion
   parameter for the second and third tertiles compared with the first
   tertile; P value for trend) for MBzP with VSL (-2.36 mum/s, -2.81 mum/s;
   P = .09) and VCL (-1.67 mum/s, -2.45 mum/s; P =.4). There were
   suggestive negative associations between MBP and VSL (-3.07 mum/s, -2.87
   mum/ s; P = .08) and VCL (-3.25 mum/s; -3.46 mum/s; P = .2), and between
   MEHP with VSL (-1.09 mum/s, -2.73 mum/s; P = .1) and VCL (-0.29 mum/s,
   -2.93 mum/s; P = .3). In contrast to the other phthalates, MEP was
   positively associated with VSL and VCL but negatively associated with
   LIN. No consistent relationship was found for MMP and any sperm motion
   parameter. Although we did not find statistically significant
   associations, trends between CASA parameters, sperm velocity, and
   forward progression, and increased urinary levels of MBP, MBzP, and MEHP
   warrant further follow-up.}},
Publisher = {{AMER SOC ANDROLOGY, INC}},
Address = {{C/O ALLEN PRESS, INC PO BOX 368, LAWRENCE, KS 66044 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hauser, R (Reprint Author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Occupat Hlth Program, Bldg 1,Room 1405,665 Huntington Ave, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Occupat Hlth Program, Boston, MA 02115 USA.
   Simmons Coll, Sch Hlth Studies, Nursing Programs, Boston, MA 02115 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA.
   Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv Androl Lab, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, In Vitro Fertilizat Unit, Boston, MA 02114 USA.
   Univ Calif Davis, Sch Med, Dept Obstet \& Gynecol, Div Reprod Biol \& Med, Davis, CA 95616 USA.}},
ISSN = {{0196-3635}},
Keywords = {{environment; epidemiology; human phthalate}},
Keywords-Plus = {{ASSISTED SEMEN ANALYSIS; QUANTITATIVE DETECTION; ALPHA-CHLOROHYDRIN;
   HUMAN SPERMATOZOA; PREDICTIVE VALUE; ADULT-RATS; QUALITY; MEN;
   METABOLITES; FERTILITY}},
Research-Areas = {{Endocrinology \& Metabolism}},
Web-of-Science-Categories  = {{Andrology}},
ResearcherID-Numbers = {{Ryan, Louise/A-4562-2009}},
Cited-References = {{AGARWAL DK, 1985, TOXICOLOGY, V35, P189, DOI 10.1016/0300-483X(85)90015-0.
   AITKEN RJ, 1982, FERTIL STERIL, V38, P212.
   Aitken RJ, 1997, MOL HUM REPROD, V3, P169, DOI 10.1093/molehr/3.3.169.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Armstrong JS, 1999, FREE RADICAL BIO MED, V26, P869, DOI 10.1016/S0891-5849(98)00275-5.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2.
   Calabrese EJ, 2001, ANNU REV PUBL HEALTH, V22, P15, DOI 10.1146/annurev.publhealth.22.1.15.
   CARLSEN E, 1992, BRIT MED J, V305, P609.
   Comhaire F, 1996, ANDROLOGIA, V28, P300.
   DAVIS RO, 1992, FERTIL STERIL, V57, P648.
   Duty SM, 2003, EPIDEMIOLOGY, V14, P269, DOI 10.1097/00001648-200305000-00005.
   Barratt CLR, 1996, HUM REPROD, V11, P1463.
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gyllenborg J, 1999, INT J ANDROL, V22, P28.
   Hosmer D, 1989, APPL LOGISTIC REGRES, P82.
   Kraemer M, 1998, HUM REPROD, V13, P611, DOI 10.1093/humrep/13.3.611.
   KRUGER TF, 1988, FERTIL STERIL, V49, P112.
   Larsen L, 2000, HUM REPROD, V15, P1562, DOI 10.1093/humrep/15.7.1562.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   MACLEOD IC, 1995, HUM REPROD, V10, P580.
   Mortimer D, 1995, REPROD FERT DEVELOP, V7, P951, DOI 10.1071/RD9950951.
   MURATURE DA, 1987, BIOMED ENVIRON MASS, V14, P473, DOI 10.1002/bms.1200140815.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   PARMAR D, 1986, TOXICOLOGY, V42, P47, DOI 10.1016/0300-483X(86)90091-0.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Perreault SD, 2001, REPRODUCTION, V121, P207, DOI 10.1530/rep.0.1210207.
   REEL JR, 1984, DIETHYLHEXYL PHTHALA.
   Rozati R, 2002, FERTIL STERIL, V78, P1187, DOI 10.1016/S0015-0282(02)04389-3.
   Selevan SG, 2000, ENVIRON HEALTH PERSP, V108, P887, DOI 10.2307/3434998.
   SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Slott VL, 1997, J ANDROL, V18, P708.
   Slott VL, 1995, J ANDROL, V16, P523.
   SRIVASTAVA S, 1990, INDIAN J EXP BIOL, V28, P67.
   Storey BT, 1997, MOL HUM REPROD, V3, P203, DOI 10.1093/molehr/3.3.203.
   Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055.
   TEASS AW, 1998, NIOSH MANUAL ANAL ME, P52.
   Wine RN, 1997, ENVIRON HEALTH PERSP, V105, P102, DOI 10.1289/ehp.97105102.
   World Health Organization, 1999, WHO LAB MAN EX HUM S.
   {*}AG TOX SUBST DIS, DI N BUT PHTH 1999.
   {*}CDCP, NCEH PUBL.
   National Center for Health Statistics, NAT HLTH NUTR EX SUR.
   {*}US DEP HHS CTR EV, 2000, NAT TOX PROGR NTP CE.
   {*}US DEP HHS PUBL H, 1997, NAT TOX TOX CARC STU.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{56}},
Journal-ISO = {{J. Androl.}},
Doc-Delivery-Number = {{780LM}},
Wos-Id = {{ISI:000189382200020}},
}

@article{ ISI:000220094500002,
Author = {Kessler, W and Numtip, W and Grote, K and Csanady, GA and Chahoud, I and
   Filser, JG},
Title = {{Blood burden of di(2-ethylhexyl) phthalate and its primary metabolite
   mono (2-ethylhexyl) phthalate in pregnant and nonpregnant rats and
   marmosets}},
Journal = {{TOXICOLOGY AND APPLIED PHARMACOLOGY}},
Year = {{2004}},
Volume = {{195}},
Number = {{2}},
Pages = {{142-153}},
Month = {{MAR 1}},
Abstract = {{A comparison of the dose-dependent blood burden of di(2-ethylhexyl)
   phthalate (DEHP) and mono(2-ethylhexyl) phthalate (MEHP) in pregnant and
   nonpregnant rats and marmosets is presented. Sprague-Dawley rats and
   marmosets were treated orally with 30 or 500 mg DEHP/kg per day,
   nonpregnant animals on 7 (rats) and 29 (marmosets) consecutive days,
   pregnant animals on gestation days 14-19 (rats) and 96-124 (marmosets).
   In addition, rats received a single dose of 1000 mg DEHP/kg. Blood was
   collected up to 48 It after dosing. Concentrations of DEHP and MEHP in
   blood were determined by GC/MS. In rats, normalized areas under the
   concentration-time curves (AUCs) of DEHP were two orders of magnitude
   smaller than the normalized AUCs of the first metabolite MEHP.
   Metabolism of MEHP was saturable. Repeated DEHP treatment and pregnancy
   had only little influence on the normalized AUC of MEHP In mannosets,
   most of MEHP concentration-time courses oscillated. Normalized AUCs of
   DEHP were at least one order of magnitude smaller than those of MEHP. In
   pregnant marmosets, normalized AUCs of MEHP were similar to those in
   nonpregnant animals with the exception that at 500 mg DEHP/kg per day,
   the normalized AUCs determined on gestation days 103, 117, and 124 were
   distinctly smaller. The maximum concentrations of MEHP in blood of
   mannosets were up to 7.5 times and the normalized AUCs up to 16 times
   lower than in rats receiving the same daily oral DEHP dose per kilogram
   of body weight. From this toxicokinetic comparison, DEHP can be expected
   to be several times less effective in the offspring of marmosets than in
   that of rats if the blood burden by MEHP in dams can be regarded as a
   dose surrogate for the MEHP burden in their fetuses. (C) 2004 Elsevier
   Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Filser, JG (Reprint Author), GSF, Natl Res Ctr Environm \& Hlth, Inst Toxicol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
   GSF, Natl Res Ctr Environm \& Hlth, Inst Toxicol, D-85764 Neuherberg, Germany.
   Charite Univ Med Berlin, Dept Toxicol, Inst Clin Pharmacol \& Toxicol, D-14195 Berlin, Germany.}},
DOI = {{10.1016/j.taap.2003.11.014}},
ISSN = {{0041-008X}},
Keywords = {{di(2-ethylhexyl) phthalate; mono(2-ethylhexyl) phthalate; rat; marmoset;
   kinetics; blood; oral; pregnancy}},
Keywords-Plus = {{DE-ESTERIFIED METABOLITE; DI-(2-ETHYLHEXYL) PHTHALATE;
   MONO-(2-ETHYLHEXYL) PHTHALATE; SEXUAL-DIFFERENTIATION;
   MONO(2-ETHYLHEXYL) PHTHALATE; DIETHYLHEXYL PHTHALATE; TESTICULAR
   TOXICITY; GAS-CHROMATOGRAPHY; TESTIS; CLOFIBRATE}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Author-Email = {{johannes.filser@gsf.de}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   ALBRO PW, 1984, DRUG METAB DISPOS, V12, P742.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   Dalgaard M, 2001, TOXICOL LETT, V122, P69, DOI 10.1016/S0378-4274(01)00348-4.
   David RM, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440a.
   David RM, 2000, TOXICOL SCI, V55, P433, DOI 10.1093/toxsci/55.2.433.
   DIRVEN HAAM, 1990, TOXICOLOGY, V65, P199, DOI 10.1016/0300-483X(90)90089-Y.
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRIFFITHS WC, 1988, ENVIRON HEALTH PERSP, V77, P151, DOI 10.2307/3430640.
   Hall Michael, 1999, Journal of Toxicological Sciences, V24, P237.
   HEGER W, 1988, NONHUMAN PRIMATES DE, P71.
   Howarth JA, 2001, TOXICOL LETT, V121, P35, DOI 10.1016/S0378-4274(01)00313-7.
   JACKH R, 1984, FOOD CHEM TOXICOL, V22, P151, DOI 10.1016/0278-6915(84)90096-6.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kessler W, 2001, ARCH TOXICOL, V75, P62, DOI 10.1007/s002040000198.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Kurata Y, 1998, TOXICOL SCI, V42, P49, DOI 10.1093/toxsci/42.1.49.
   LAKE BG, 1984, ACTA PHARMACOL TOX, V54, P167.
   Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   Moore C, 2001, J COGN DEV, V2, P109, DOI 10.1207/S15327647JCD0202\_1.
   NTP-CERHR, 2000, NTP CERHR EXP PAN RE.
   OISHI S, 1990, ARCH TOXICOL, V64, P143, DOI 10.1007/BF01974400.
   OISHI S, 1989, ARCH TOXICOL, V63, P289, DOI 10.1007/BF00278642.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P246, DOI 10.1016/0041-008X(85)90346-1.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   Pugh G, 2000, TOXICOL SCI, V56, P181, DOI 10.1093/toxsci/56.1.181.
   RHODES C, 1986, ENVIRON HEALTH PERSP, V65, P299, DOI 10.2307/3430197.
   Richburg JH, 1996, TOXICOL APPL PHARM, V137, P42, DOI 10.1006/taap.1996.0055.
   Richburg JH, 2002, TOXICOL LETT, V135, P167, DOI 10.1016/S0378-4274(02)00254-0.
   ROWLAND IR, 1974, FOOD COSMET TOXICOL, V12, P292.
   SHARMA R, 1988, BIOCHEM PHARMACOL, V37, P1203, DOI 10.1016/0006-2952(88)90771-X.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   SJOBERG P, 1985, ACTA PHARMACOL TOX, V56, P30.
   SJOBERG P, 1985, J CHROMATOGR, V344, P167, DOI 10.1016/S0378-4347(00)82017-4.
   SJOBERG P, 1986, ENVIRON HEALTH PERSP, V65, P237, DOI 10.2307/3430188.
   TEIRLYNCK O, 1988, TOXICOL LETT, V40, P85, DOI 10.1016/0378-4274(88)90186-5.
   TEIRLYNCK OA, 1985, ARCH TOXICOL, V57, P226, DOI 10.1007/BF00324782.
   TEIRLYNCK OA, 1985, J CHROMATOGR, V342, P399, DOI 10.1016/S0378-4347(00)84534-X.
   Tomonari Y, 2003, TOXICOL SCI, V72, P385.
   WHITE RD, 1980, FOOD COSMET TOXICOL, V18, P383, DOI 10.1016/0015-6264(80)90194-7.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {*}EU, 2001, RISK ASS BIS 2 ETH P.
   {*}IARC, 2000, IARC MON EV CARC RIS, V77, P41.}},
Number-of-Cited-References = {{46}},
Times-Cited = {{31}},
Journal-ISO = {{Toxicol. Appl. Pharmacol.}},
Doc-Delivery-Number = {{801KJ}},
Wos-Id = {{ISI:000220094500002}},
}

@article{ ISI:000188067200012,
Author = {Barlow, NJ and McIntyre, BS and Foster, PMD},
Title = {{Male reproductive tract lesions at 6, 12, and 18 months of age following
   in utero exposure to di(n-butyl) phthalate}},
Journal = {{TOXICOLOGIC PATHOLOGY}},
Year = {{2004}},
Volume = {{32}},
Number = {{1}},
Pages = {{79-90}},
Month = {{JAN-FEB}},
Abstract = {{In utero exposure of male rats to the antiandrogen di(n-butyl) phthalate
   (DBP) leads to decreased anogenital distance (AGD) on postnatal day
   (PND) 1, increased areolae retention on PND 13, malformations in the
   male reproductive tract, and histologic testicular lesions including
   marked seminiferous epithelial degeneration and a low incidence of
   Leydig cell (LC) adenomas on PND 90. One objective of this study was to
   determine the incidence and persistence of decreased AGD, increased
   areolae retention, and LC adenomas in adult rats following in utero DBP
   exposure. A second objective was to determine whether AGD and areolae
   retention during the early postnatal period are associated with lesions
   in the male reproductive tract. Pregnant Crl:CD(SD) BR rats were gavaged
   with corn oil or DBP at 100 or 500 mg/kg/day, 10 dams per group. Three
   replicates of rats (n=30 rats per replicate) were exposed from gestation
   day 12 to 21 and the male offspring allowed to mature to 6, 12, or 18
   months of age. Gross malformations in the male reproductive tract and
   histologic lesions in the testes were similar to those previously
   described. However, testicular dysgenesis, a lesion of proliferating LCs
   and aberrant tubules that has not been previously described in
   DBP-exposed testes, was diagnosed. The incidence of this lesion was
   approximately 20\% unilateral and 7-18\% bilateral in the high-dose
   group and was similar among all ages examined, implicating a
   developmental alteration rather than an age-related change. AGD and
   areolae retention were found to be permanent changes following in utero
   exposure to 500 mg/kg/day of DBP. Decreased AGD was a sensitive
   predictor of lesions in the male reproductive tract, relatively small
   changes in AGD were associated with a significant incidence of male
   reproductive malformations. In utero DBP exposure induced proliferative
   developmental lesions, some of which would have been diagnosed as LC
   adenomas by the morphological criteria set forth by the Society of
   Toxicologic Pathology. However, these lesions were dissimilar to
   traditional LC adenomas as the LCs were poorly differentiated and the
   lesions contained aberrant seminiferous tubules. While the morphology
   and incidence of this DBP-induced testicular developmental lesion has
   been fully characterized by this study, the detailed pathogenesis
   warrants further investigation.}},
Publisher = {{TAYLOR \& FRANCIS INC}},
Address = {{325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Foster, PMD (Reprint Author), NIEHS, POB 12233 MD E1-06, Res Triangle Pk, NC 27709 USA.
   NIEHS, Res Triangle Pk, NC 27709 USA.
   CIIT Ctr Hlth Res, Res Triangle Pk, NC USA.
   Aventis Inc, Bridgewater, NJ USA.
   Schering Plough Corp, Res Inst, Lafayette, NJ USA.}},
DOI = {{10.1080/01926230490265894}},
ISSN = {{0192-6233}},
Keywords = {{di(n-butyl); phthalate; in utero exposure; male reproductive
   development; testes; Leydig cell adenoma; testicular dysgenesis}},
Keywords-Plus = {{PROLIFERATIVE LESIONS; DEVELOPMENTAL EXPOSURE; ANOGENITAL DISTANCE;
   NIPPLE RETENTION; LATE-GESTATION; URINARY-TRACT; MALE-RAT; MICE;
   DIETHYLSTILBESTROL; MALFORMATIONS}},
Research-Areas = {{Pathology; Toxicology}},
Web-of-Science-Categories  = {{Pathology; Toxicology}},
Author-Email = {{foster2@niehs.nih.gov}},
Cited-References = {{BARLOW NJ, 2003, IN PRESS TOXICOL PAT, V31.
   Boorman G., 1990, PATHOLOGY FISCHER RA.
   HANLEY JA, 1982, RADIOLOGY, V143, P29.
   HERBST AL, 1972, NEW ENGL J MED, V287, P1259, DOI 10.1056/NEJM197212212872501.
   IMPERATOMCGINLEY J, 1986, ENDOCRINOLOGY, V118, P132.
   Lambright CR, 2003, TOXICOL SCI, V72, P272.
   Lanning LL, 2002, TOXICOL PATHOL, V30, P507, DOI 10.1080/01926230290105695.
   LARSSON PA, 1989, UROL INT, V44, P210.
   Latendresse JR, 2002, TOXICOL PATHOL, V30, P524, DOI 10.1080/01926230290105721.
   MCCONNELL RF, 1992, PROLIFERATIVE LESION.
   McIntyre BS, 2001, TOXICOL SCI, V62, P236, DOI 10.1093/toxsci/62.2.236.
   McIntyre BS, 2002, TOXICOL SCI, V65, P62, DOI 10.1093/toxsci/65.1.62.
   MCMARTIN DN, 1992, TOXICOL PATHOL, V20, P212.
   MITSUMORI K, 1988, ENVIRON HEALTH PERSP, V77, P11, DOI 10.2307/3430623.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Neumann F, 1970, Recent Prog Horm Res, V26, P337.
   NEWBOLD R, 1995, ENVIRON HEALTH PERSP, V103, P83, DOI 10.2307/3432514.
   Newbold RR, 2002, TOXICOL PATHOL, V30, P611, DOI 10.1080/01926230290105839.
   Newbold RR, 2001, CANCER RES, V61, P4325.
   Newbold RR, 2000, CARCINOGENESIS, V21, P1355, DOI 10.1093/carcin/21.7.1355.
   QURESHI SR, 1991, TOXICOL PATHOL, V19, P280.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   TAKEUCHI H, 1991, UROL RES, V19, P305.
   Turner KJ, 2002, TOXICOL SCI, V68, P174, DOI 10.1093/toxsci/68.1.174.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {[}Anonymous], 1992, SPONTANEOUS NEOPLAST.
   {*}NAT RES COUNC, 1996, GUID CAR US LAB.
   {*}WHO, 1997, WHO ENV HLTH CRIT, V189.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{64}},
Journal-ISO = {{Toxicol. Pathol.}},
Doc-Delivery-Number = {{763GU}},
Wos-Id = {{ISI:000188067200012}},
}

@article{ ISI:000186449600023,
Author = {Adibi, JJ and Perera, FP and Jedrychowski, W and Camann, DE and Barr, D
   and Jacek, R and Whyatt, RM},
Title = {{Prenatal exposures to phthalates among women in New York City and
   Krakow, Poland}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2003}},
Volume = {{111}},
Number = {{14}},
Pages = {{1719-1722}},
Month = {{NOV}},
Abstract = {{Experimental evidence has shown that certain phthalates can disrupt
   endocrine function and induce reproductive and developmental toxicity.
   However, few data are available on the extent of human exposure to
   phthalates during pregnancy. As part of the research being conducted by
   the Columbia Center for Children's Environmental Health, we have
   measured levels of phthalates in 48-hr personal air samples collected
   from parallel cohorts of pregnant women in New York, New York, (n = 30)
   and in Krakow, Poland (n = 30). Spot urine samples were collected during
   the same 48-hr period from the New York women (n = 25). The following
   four phthalates or their metabolites were measured in both personal air
   and urine: diethyl phthalate (DEP), dibutyl phthalate (DBP),
   diethylhexyl phthalate (DEHP), and butyl benzyl phthalate (BBzP). All
   were present in 100\% of the air and urine samples. Ranges in personal
   air samples were as follows: DEP (0.26-7-12 mug/m(3)), DBP (0.11-14.76
   mug/m(3)), DEHP (0.05-1.08 mug/m(3)), and BBzP (0.00-0.63 mug/m(3)). The
   mean personal air concentrations of DBP, di-isobutyl phthalate, and DEHP
   are higher in Krakow, whereas the mean personal air concentration of DEP
   is higher in New York. Statistically significant correlations between
   personal air and urinary levels were found for DEP and monoethyl
   phthalate (r = 0.42, p < 0.05), DBP and monobutyl phthalate (r = 0.58, p
   < 0.01), and BBzP and monobenzyl phthalate (r = 0.65, p < 0.01). These
   results demonstrate considerable phthalate exposures during pregnancy
   among women in these two cohorts and indicate that inhalation is an
   important route of exposure.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Adibi, JJ (Reprint Author), Columbia Univ, Mailman Sch Publ Hlth, Environm Hlth Sci Div, Columbia Ctr Childrens Environm Hlth, 60 Haven Ave,B-1, New York, NY 10032 USA.
   Columbia Univ, Mailman Sch Publ Hlth, Environm Hlth Sci Div, Columbia Ctr Childrens Environm Hlth, New York, NY 10032 USA.
   Jagiellonian Univ, Coll Med, Krakow, Poland.
   SW Res Inst, San Antonio, TX USA.
   Ctr Dis Control \& Prevent, Atlanta, GA USA.}},
DOI = {{10.1289/ehp.6235}},
ISSN = {{0091-6765}},
Keywords = {{endocrine disruption; exposure assessment; internal dose; personal air
   monitoring; phthalates; prenatal exposures; urban; urinary metabolites}},
Keywords-Plus = {{RAT GRANULOSA-CELLS; SUPPRESSES ESTRADIOL; METABOLITES; TOXICITY; ESTERS}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Cai LQ, 1996, J CLIN ENDOCR METAB, V81, P1730, DOI 10.1210/jc.81.5.1730.
   CDC, 2003, NCEH PUB.
   Corton JC, 1997, BIOCHIMIE, V79, P151, DOI 10.1016/S0300-9084(97)81508-8.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   DIGANGI J, 2002, AGGREGATE EXPOSURES.
   Ema M, 2000, REPROD TOXICOL, V14, P13, DOI 10.1016/S0890-6238(99)00066-0.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   HEINDEL JJ, 1989, FUND APPL TOXICOL, V12, P508, DOI 10.1016/0272-0590(89)90024-9.
   HOULIHAN J, 2000, BEAUTY SECRETS DOES.
   KATZ MD, 1995, J CLIN ENDOCR METAB, V80, P3160, DOI 10.1210/jc.80.11.3160.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P2255.
   Lovekamp TN, 2001, TOXICOL APPL PHARM, V172, P217, DOI 10.1006/taap.2001.9156.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   SCCNFP, 2002, OP SCI COMM COSM PRO.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   Whyatt RM, 2002, ENVIRON HEALTH PERSP, V110, P507.
   Woodward KN, 1988, PHTHALATE ESTERS TOX, VI.
   {*}ATSDR, 1999, DRAFT PUBL COMM TOX.
   {*}CERHR, 2000, NTPCERHRDEHP00.
   {*}CERHR, 2000, NTPCERHRDBP00.
   {*}CERHR, 2000, NTPCERHRBBP00 EXP PA.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{99}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{741GD}},
Wos-Id = {{ISI:000186449600023}},
}

@article{ ISI:000186449600034,
Author = {Latini, G and De Felice, C and Presta, G and Del Vecchio, A and Paris, I
   and Ruggieri, F and Mazzeo, P},
Title = {{In utero exposure to di-(2-ethylhexyl)phthalate and duration of human
   pregnancy}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2003}},
Volume = {{111}},
Number = {{14}},
Pages = {{1783-1785}},
Month = {{NOV}},
Abstract = {{Di-(2-ethylhexyl)phthalate (DEHP), the most commonly used plasticizer in
   flexible polyvinylchloride formulations, is a ubiquitous environmental
   contaminant. To date, no information exists on the potential health
   hazards from exposure to DEHP and/or its main metabolite,
   mono-(2-ethylhexyl)phthalate (MEHP), in high-risk conditions, such as
   pregnancy and during the neonatal period. The aim of this study was to
   evaluate prenatal exposure to DEHP and/or MEHP and its possible biologic
   effects. We measured serum DEHP and MEHP concentrations in the cord
   blood of 84 consecutive newborns by high-performance liquid
   chromatography. Relationships between DEHP/MEHP and infant
   characteristics were tested using Fisher's exact test, impaired t-tests,
   and univariate linear regression analyses, and significant differences
   on univariate analysis were evaluated using multiple logistic regression
   analysis. We found detectable cord blood DEHP and/or MEHP concentrations
   in 88.1\% of the samples. Either DEHP or MEHP was present in 65 of 84
   (77.4\%) of the examined samples. Mean concentrations of DEHP and MEHP
   were 1.19 +/- 1.15 mug/mL {[}95\% confidence interval (CI), 0.93-1.44,
   range = 0-4.71] and 0.52 +/- 0.61 mug/mL (95\% CI, 0.39-0.66, range =
   0-2.94), respectively. MEHP-positive newborns showed a significantly
   lower gestational age compared with MEHP-negative infants (p = 0.033).
   Logistic regression analysis results indicated a positive correlation
   between absence of MEHP in cord blood and gestational age at delivery
   (odds ratio = 1.50, 95\% CI, 1.013-2.21; p = 0.043). These findings
   confirm that human exposure to DEHP can begin in utero and suggest that
   phthalate exposure is significantly associated with a shorter pregnancy
   duration.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Latini, G (Reprint Author), Perrino Hosp, Div Paediat, Neonatal Intens Care Unit, SS 7 Mesagne, I-72100 Brindisi, Italy.
   Perrino Hosp, Div Paediat, Neonatal Intens Care Unit, I-72100 Brindisi, Italy.
   CNR, IFC, Lecce Sect, Lecce, Italy.
   Univ Siena, Dept Paediat Obstet \& Reprod Med, Neonatal Intens Care Unit, I-53100 Siena, Italy.
   Univ Aquila, Dept Chem Chem Engn \& Mat, I-67100 Laquila, Italy.}},
DOI = {{10.1289/ehp.6202}},
ISSN = {{0091-6765}},
Keywords = {{di-(2-ethylhexyl)phthalate; environmental hazards; gestational age;
   mono-(2-ethylhexyl)phthalate; prenatal exposure}},
Keywords-Plus = {{PHTHALATE-ESTERS; DI(2-ETHYLHEXYL) PHTHALATE; DI-2-ETHYLHEXYL PHTHALATE;
   SMALL THYMUS; MALE RATS; PLASTICIZERS; INFANTS;
   DI-(2-ETHYLHEXYL)-PHTHALATE; CATHETERS; BIRTH}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   Bauer MJ, 1997, SCI TOTAL ENVIRON, V208, P49, DOI 10.1016/S0048-9697(97)00272-6.
   Bradbury J, 1996, LANCET, V347, P1541, DOI 10.1016/S0140-6736(96)90681-9.
   CALO L, 1993, CLIN NEPHROL, V40, P57.
   De Felice C, 2002, EUR J PEDIATR, V161, P362, DOI 10.1007/s00431-002-0948-2.
   De Felice C, 1999, J PEDIATR, V135, P384, DOI 10.1016/S0022-3476(99)70140-X.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   GIAM CS, 1978, SCIENCE, V199, P419, DOI 10.1126/science.199.4327.419-a.
   Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRIFFITHS WC, 1985, ANN CLIN LAB SCI, V15, P140.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   Latini G, 1999, ACTA PAEDIATR, V88, P1174, DOI 10.1080/08035259950168333.
   Latini G, 2003, BIOL NEONATE, V83, P22, DOI 10.1159/000067012.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   Loch-Caruso R, 2002, INT J HYG ENVIR HEAL, V205, P121, DOI 10.1078/1438-4639-00137.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   MAROZIENE L, 2002, ENV HLTH, V9, P6.
   MAYER FL, 1972, NATURE, V238, P411, DOI 10.1038/238411a0.
   MES J, 1974, B ENVIRON CONTAM TOX, V12, P721.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   PARIS I, 2003, ANAL LETT, V36, P2645.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   ROTH B, 1988, EUR J PEDIATR, V147, P41, DOI 10.1007/BF00442609.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   TANDON R, 1991, Indian Journal of Experimental Biology, V29, P1044.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Tsai ML, 1997, BIOL REPROD, V56, P341, DOI 10.1095/biolreprod56.2.341.
   Wong JS, 2002, TOXICOL APPL PHARM, V185, P180, DOI 10.1006/taap.2002.9540.
   Yang Q, 2000, CLIN EXP IMMUNOL, V122, P219, DOI 10.1046/j.1365-2249.2000.01367.x.
   {*}CTR DEV RAD HLTH, 2001, SAF ASS DI 2 ETH DEH.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{158}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{741GD}},
Wos-Id = {{ISI:000186449600034}},
}

@article{ ISI:000186094100003,
Author = {Silva, MJ and Barr, DB and Reidy, JA and Kato, K and Malek, NA and
   Hodge, CC and Hurtz, D and Calafat, AM and Needham, LL and Brock, JW},
Title = {{Glucuronidation patterns of common urinary and serum monoester phthalate
   metabolites}},
Journal = {{ARCHIVES OF TOXICOLOGY}},
Year = {{2003}},
Volume = {{77}},
Number = {{10}},
Pages = {{561-567}},
Month = {{OCT}},
Abstract = {{Metabolism of most diesters of phthalic acid in humans occurs by an
   initial phase I biotransformation in which phthalate monoesters are
   formed, followed by a phase II biotransformation in which phthalate
   monoesters react with glucuronic acid to form their respective
   glucuronide conjugates. The phase II conjugation increases water
   solubility and facilitates urinary excretion of phthalate, and reduces
   the potential biological activity because the putative biologically
   active species is the monoester metabolite. In this study, we report
   percentages of glucuronidation of four common phthalate monoesters,
   monoethyl (mEP), monobutyl (mBP), monobenzyl (mBzP), and
   mono-2-ethylhexyl phthalate (mEHP) in a subset of urine (mEP n=262, mBP
   n=283, mBzP n=328, mEHP n=119) and serum (mEP n=93, mBP n=149, mEHP
   n=141) samples from the general US population. The percentages of free
   and conjugated monoester excreted in urine differed for the various
   phthalates. For the more lipophilic monoesters (i.e., mBP, mBzP, and
   mEHP), the geometric mean of free monoester excretion ranged from 6 to
   16\%. The contrary was true for the most hydrophilic monoester, mEP, for
   which about 71\% was excreted in urine as its free monoester.
   Furthermore, percentages of free and conjugated monoesters were similar
   for mEP, mBP and mEHP among serum and urine samples. Serum mBzP was
   largely below the method limit of detection. Interestingly, the serum
   mEP and mBP levels were less than 3\% and 47\%, respectively, of their
   urinary levels, whereas the level of mEHP was similar both in urine and
   serum.}},
Publisher = {{SPRINGER-VERLAG}},
Address = {{175 FIFTH AVE, NEW YORK, NY 10010 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, 4770 Buford Hwy NE,Mailstop F17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.
   Battelle Mem Inst, Edgewood Operat, Bel Air, MD 21015 USA.}},
DOI = {{10.1007/s00204-003-0486-3}},
ISSN = {{0340-5761}},
Keywords = {{serum phthalates; urinary phthalates; monoethyl phthalate; monobuty
   phthalate; monobenzylphthalate; mono-2-ethylhexyl phthalate; phthalate
   metabolism; phthalate glucuronidation}},
Keywords-Plus = {{QUANTITATIVE DETECTION; DI(2-ETHYLHEXYL)PHTHALATE; EXPOSURE; DEHP}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011
   Barr, Dana/E-6369-2011
   Barr, Dana/E-2276-2013}},
Cited-References = {{ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   AUTIAN J, 1982, ENVIRON HEALTH PERSP, V45, P115, DOI 10.2307/3429393.
   BANERJEE S, 2002, BIOL REPROD, V66, P254.
   BARR DB, 2003, ENV HLTH PERSPE 0224.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   DOUGLAS GR, 1986, ENVIRON HEALTH PERSP, V65, P255, DOI 10.2307/3430191.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   DUTY SM, 2002, EPIDEMIOLOGY, V13, P657.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P116, DOI 10.1016/0041-008X(92)90374-2.
   KATO K, 2003, IN PRESS J ANAL TOXI.
   Mettang T, 1996, NEPHROL DIAL TRANSPL, V11, P2439.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   {*}ATSDR, 1997, TOX PROF DI N OCT PH.
   {*}ATSDR, 1999, TOX PROF DI N BUT UP.
   {*}ATSDR, 2000, TOX PROF DI 2 ETH PH.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.
   {*}CDC, 2001, NCEH PUB.}},
Number-of-Cited-References = {{23}},
Times-Cited = {{71}},
Journal-ISO = {{Arch. Toxicol.}},
Doc-Delivery-Number = {{735CD}},
Wos-Id = {{ISI:000186094100003}},
}

@article{ ISI:000185509800009,
Author = {Koch, HM and Rossbach, B and Drexler, H and Angerer, J},
Title = {{Internal exposure of the general population to DEHP and other phthalates
   - determination of secondary and primary phthalate monoester metabolites
   in urine}},
Journal = {{ENVIRONMENTAL RESEARCH}},
Year = {{2003}},
Volume = {{93}},
Number = {{2}},
Pages = {{177-185}},
Month = {{OCT}},
Abstract = {{A number of phthalates and their metabolites are suspected of having
   teratogenic and endocrine disrupting effects. Especially the
   developmental and reproductive effects of di(2-ethythexyl)phthalate
   (DEHP) are under scrutiny. In this study we determined the
   concentrations of the secondary, chain oxidized monoester metabolites of
   DEHP, mono(2-ethyl-5-hydroxyhexyl)phthalate (5OH-MEHP) and
   mono(2-ethyl-5-oxo-hexyl)phthalate (5oxo-MEHP) in urine samples from the
   general population. The utilization of the secondary metabolites
   minimized any risk of contamination by the ubiquitously present
   phthalate parent compounds. Included in the method were also the simple
   monoester metabolites of DEHP, dioctylphthalate (DOP),
   di-n-butylphthalate (DnBuP), butylbenzylphthalate (BBzP) and
   diethylphthalate (DEP). Automated sample preparation was performed
   applying a column switching liquid chromatography system enabling online
   extraction of the urine on a restricted access material (RAM) and
   separation on a reversed phase analytical column. Detection was
   performed by negative ESI-tandem mass spectrometry in multiple reaction
   monitoring mode and quantification by isotope dilution. The excretion of
   DEHP and the other phthalates was studied by analyzing first morning
   urine samples from 53 women and 32 men aged 7-64 years (median: 34.2
   years) living in northern Bavaria (Germany) who were not occupationally
   exposed to phthalates. Phthalate metabolites, secondary and primary
   ones, were detected in all specimens. Concentrations were found to vary
   strongly from phthalate to phthalate and subject to subject with
   differences spanning more than three orders of magnitude. Median
   concentrations for excretion of DEHP metabolites were 46.8 mug/L for
   5OH-MEHP (range 0.5-818 mug/L), 36.5 mug/L for 5oxo-MEHP (range 0.5-544
   mug/L), and 10.3 mug/L for MEHP (range:<0.5 (limit of quantification,
   LOQ) to 177 mug/L). A strong correlation was found between the excretion
   of 5OH-MEHP and 5oxo-MEHP with a correlation coefficient of r = 0.991,
   indicating close metabolic proximity of those two parameters but also
   the absence of any contaminating interference. Median concentrations for
   the other monoester metabolites were for mono-n-butylphthalate (MnBuP)
   181 mug/L, for monobenzylphthalate (MBzP) 21.0 mug/L, for
   monoethylphthalate, (MEP) 90.2 mug/L and for mono-n-octylphthalate (MOP)
   < 1.0 mug/L (LOQ). These results will help to perform health risk
   assessments for the phthalate exposure of the general population. (C)
   2003 Elsevier Inc. All rights reserved.}},
Publisher = {{ACADEMIC PRESS INC ELSEVIER SCIENCE}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Angerer, J (Reprint Author), Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, Schillerstr 25-29, D-91054 Erlangen, Germany.
   Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, D-91054 Erlangen, Germany.
   Univ Mainz, Inst Occupat Social \& Environm Med, D-55131 Mainz, Germany.}},
DOI = {{10.1016/S0013-9351(03)00083-3}},
ISSN = {{0013-9351}},
Keywords = {{human biological monitoring; general population; phthalates; urine;
   primary and secondary phthalate metabolites}},
Keywords-Plus = {{TANDEM MASS-SPECTROMETRY; DI(2-ETHYLHEXYL) PHTHALATE; QUANTITATIVE
   DETECTION; 2-ETHYLHEXANOIC ACID; GAS-CHROMATOGRAPHY; ORAL TOXICITY; NTP
   CENTER; ESTERS; RATS; MONO(2-ETHYLHEXYL)PHTHALATE}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{ALBRO PW, 1982, J CHROMATOGR, V244, P65, DOI 10.1016/S0021-9673(00)80123-5.
   ALBRO PW, 1984, ANAL CHEM, V56, P247, DOI 10.1021/ac00266a029.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   ANGERER J, 2001, BIOL MONITORING, P5.
   ANGERER J, 1998, ENCY ENV ANAL REMEDI, P702.
   Angerer J, 1996, Ann Ist Super Sanita, V32, P199.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   Asaoka K, 2000, B ENVIRON CONTAM TOX, V64, P679.
   BARR DB, 2003, IN PRESS ENV HLTH PE.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   BOHME C, 1998, BUNDESGESUNDHBL, V41, P340.
   Booker SM, 2001, ENVIRON HEALTH PERSP, V109, pA260, DOI 10.1289/ehp.109-a260.
   Butte W, 2001, GEFAHRST REINHALT L, V61, P19.
   CDC, 2003, NCEH PUB.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Dalgaard M, 2001, TOXICOL LETT, V122, P69, DOI 10.1016/S0378-4274(01)00348-4.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   DIRVEN HAAM, 1993, BIOCHEM PHARMACOL, V45, P2425, DOI 10.1016/0006-2952(93)90223-J.
   DRAVIAM EJ, 1982, ANAL LETT PT B, V15, P1729.
   FROMME H, 1999, PRAKTISCHE UMWELTM 4.
   Gilsing HD, 2002, MONATSH CHEM, V133, P1147, DOI 10.1007/s007060200084.
   Kambia K, 2001, J CHROMATOGR B, V755, P297, DOI 10.1016/S0378-4347(01)00125-6.
   Kavlock R, 2002, REPROD TOXICOL, V16, P529, DOI 10.1016/S0890-6238(02)00032-1.
   Kessler W, 2001, ARCH TOXICOL, V75, P62, DOI 10.1007/s002040000198.
   Kleinsasser NH, 2000, ENVIRON MOL MUTAGEN, V35, P9, DOI 10.1002/(SICI)1098-2280(2000)35:1<9::AID-EM2>3.0.CO;2-1.
   Kleinsasser NH, 2001, TERATOGEN CARCIN MUT, V21, P189, DOI 10.1002/tcm.1007.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   LARSEN K, 1972, CLIN CHIM ACTA, V41, P209, DOI 10.1016/0009-8981(72)90513-X.
   LEISEWITZ A, 1998, UMWELTBUNDESAMT.
   LEISEWITZ A, 1999, ATV SCHRIFTENREIHE, V15, P22.
   LORZ PM, 2003, ULLMANNS ENCY IND CH.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   Mettang T, 2000, PERITON DIALYSIS INT, V20, P80.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   PIRKLE JL, 1995, ENVIRON HEALTH PERSP, V103, P45, DOI 10.2307/3432559.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   POLLACK GM, 1984, J CHROMATOGR, V311, P101, DOI 10.1016/S0378-4347(00)84695-2.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   RIPPEN G, 2000, HDB UMWELTCHEMIKALIE.
   SAMPSON EJ, 1994, CLIN CHEM, V40, P1376.
   SCHAFER WR, 1996, UMWELTMED, V1, P35.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Wahl HG, 2001, J CHROMATOGR B, V758, P213.
   {*}ATSDR, 1993, ATDRTP9205 US DEP HH, P171.
   {*}CSTEE, 1998, 6 CSTEE PLEN M 26 27.
   {*}IARC, 1982, IARC MON EV CARC RIS, P416.}},
Number-of-Cited-References = {{52}},
Times-Cited = {{142}},
Journal-ISO = {{Environ. Res.}},
Doc-Delivery-Number = {{724WN}},
Wos-Id = {{ISI:000185509800009}},
}

@article{ ISI:000185768700005,
Author = {Gilsing, HD and Angerer, J and Prescher, D},
Title = {{(2-Ethyl-5-oxo-hexyl) methylthiomethyl phthalate as by-product of the
   Swern oxidation: Improved synthesis of ring-deuterated major metabolites
   of bis(2-ethylhexyl) phthalate}},
Journal = {{MONATSHEFTE FUR CHEMIE}},
Year = {{2003}},
Volume = {{134}},
Number = {{9}},
Pages = {{1207-1213}},
Month = {{SEP}},
Abstract = {{Two ring-deuterated major metabolites of bis(2-ethylhexyl) phthalate
   were obtained in excellent yields by means of an improved oxidation
   procedure. The by-product of their interconversion by Swern oxidation is
   elucidated and a possible mechanism of its formation is proposed.}},
Publisher = {{SPRINGER-VERLAG WIEN}},
Address = {{SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gilsing, HD (Reprint Author), Inst Dunnschichttechnol \& Mikrosensorik EV, D-14513 Teltow, Germany.
   Inst Dunnschichttechnol \& Mikrosensorik EV, D-14513 Teltow, Germany.
   Univ Erlangen Nurnberg, Inst \& Poliklin Arbeits Sozial \& Umweltmed, D-91054 Erlangen, Germany.}},
DOI = {{10.1007/s00706-003-0044-y}},
ISSN = {{0026-9247}},
Keywords = {{bis(2-ethylhexyl) phthalate; metabolites; isotopic labelling;
   oxidations; methylthiomethyl esters}},
Keywords-Plus = {{ACTIVATED DIMETHYL-SULFOXIDE; ACETIC-ANHYDRIDE; ENVIRONMENTAL
   CONTAMINANT; DI-2-ETHYLHEXYL PHTHALATE; PUMMERER REACTIONS;
   CARBOXYLIC-ACIDS; OXALYL CHLORIDE; HUMAN URINE; ESTERS; ALCOHOLS}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
Author-Email = {{gilsing@idm-teltow.de}},
Cited-References = {{ALBRO PW, 1982, J ENVIRON SCI HEAL B, V17, P701, DOI 10.1080/03601238209372351.
   Allen B, 1999, GREEN CHEM, V1, pG102, DOI 10.1039/a906799j.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Butte W, 2001, GEFAHRST REINHALT L, V61, P19.
   CRONHOLM T, 1988, SYNTHESIS APPL ISOTO, P1.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   DOSSENA A, 1981, J CHEM SOC PERK T 1, P2737, DOI 10.1039/p19810002737.
   DOSSENA A, 1984, INT J PEPT PROT RES, V23, P198.
   DOSSENA A, 1979, J CHEM SOC CHEM COMM, P370, DOI 10.1039/c39790000370.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   GERDES JM, 1979, TETRAHEDRON LETT, P689.
   Gilsing HD, 2002, MONATSH CHEM, V133, P1147, DOI 10.1007/s007060200084.
   GRIFFITHS WC, 1985, ANN CLIN LAB SCI, V15, P140.
   HERDEWIJN P, 1982, CAN J CHEM, V60, P2903, DOI 10.1139/v82-416.
   HO TL, 1979, SYNTHETIC COMMUN, V9, P267, DOI 10.1080/00397917908064150.
   HO TL, 1973, J CHEM SOC CHEM COMM, P224, DOI 10.1039/c39730000224.
   HUSSEY AS, 1960, J ORG CHEM, V25, P1434, DOI 10.1021/jo01078a602.
   ITOH O, 1983, B CHEM SOC JPN, V56, P266, DOI 10.1246/bcsj.56.266.
   JOHNSON CR, 1969, J AM CHEM SOC, V91, P682, DOI 10.1021/ja01031a028.
   Kambia K, 2001, INT J PHARM, V229, P139, DOI 10.1016/S0378-5173(01)00840-7.
   KIM S, 1991, TETRAHEDRON LETT, V32, P3099, DOI 10.1016/0040-4039(91)80699-7.
   Koch HM, 2003, J CHROMATOGR B, V784, P169, DOI 10.1016/S1570-0232(02)00785-7.
   Koch HM, 2003, INT J HYG ENVIR HEAL, V206, P77, DOI 10.1078/1438-4639-00205.
   KUKLA MJ, 1982, TETRAHEDRON LETT, V23, P4539, DOI 10.1016/S0040-4039(00)85647-6.
   LERCH U, 1971, J ORG CHEM, V36, P3391.
   LIU JS, 1992, TETRAHEDRON, V48, P6793, DOI 10.1016/S0040-4020(01)89869-0.
   LOWE G, 1983, J CHEM SOC CHEM COMM, P1279, DOI 10.1039/c39830001279.
   MANCUSO AJ, 1981, SYNTHESIS-STUTTGART, P165.
   MANCUSO AJ, 1978, J ORG CHEM, V43, P2480, DOI 10.1021/jo00406a041.
   MARX M, 1984, J ORG CHEM, V49, P788, DOI 10.1021/jo00179a009.
   METHCOHN O, 1982, J CHEM SOC CHEM COMM, P90, DOI 10.1039/c39820000090.
   MORA N, 1993, TETRAHEDRON LETT, V34, P2461, DOI 10.1016/S0040-4039(00)60441-0.
   OAE S, 1983, B CHEM SOC JPN, V56, P270, DOI 10.1246/bcsj.56.270.
   OMURA K, 1978, TETRAHEDRON, V34, P1651, DOI 10.1016/0040-4020(78)80197-5.
   PARHAM WE, 1965, J ORG CHEM, V30, P728, DOI 10.1021/jo01014a016.
   PARHAM WE, 1963, J ORG CHEM, V28, P2686, DOI 10.1021/jo01045a046.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   POHL LR, 1985, DRUG METAB REV, V15, P1335.
   PYRON KH, 1997, J ANAL TOXICOL, V21, P363.
   ROBERTS SM, 1981, J CHEM SOC PERK T 1, P1729, DOI 10.1039/p19810001729.
   SIEKMANN L, 1989, MASS SPECTROMETRY, P648.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   TIDWELL TT, 1990, SYNTHESIS-STUTTGART, P857.
   Tidwell T.T., 1990, ORG REACTIONS, V39, P297.
   TOLGYESSY J, 1972, ISOTOPE DILUTION ANA, P155.
   TOMITA I, 1977, ECOTOX ENVIRON SAFE, V1, P275, DOI 10.1016/0147-6513(77)90043-4.
   WADE LG, 1978, TETRAHEDRON LETT, P731.
   WAMS TJ, 1987, SCI TOTAL ENVIRON, V66, P1, DOI 10.1016/0048-9697(87)90072-6.
   WOODWARD KN, 1986, REV TOXICITY ESTERS, P159.
   WOODWARD KN, 1988, PHTHALATE ESTERS TOX, V1, P47.
   WOODWARD KN, 1990, HUM EXP TOXICOL, V9, P397.
   YOSHIOKA H, 1995, ENCY ANAL SCI, V4, P2399.}},
Number-of-Cited-References = {{53}},
Times-Cited = {{8}},
Journal-ISO = {{Mon. Chem.}},
Doc-Delivery-Number = {{729HX}},
Wos-Id = {{ISI:000185768700005}},
}

@article{ ISI:000184418100019,
Author = {Buchta, C and Bittner, C and Hocker, P and Macher, M and Schmid, R and
   Seger, C and Dettke, M},
Title = {{Donor exposure to the plasticizer di(2-ethylhexyl)phthalate during
   plateletpheresis}},
Journal = {{TRANSFUSION}},
Year = {{2003}},
Volume = {{43}},
Number = {{8}},
Pages = {{1115-1120}},
Month = {{AUG}},
Abstract = {{BACKGROUND: Di(2-ethylhexyl)phthalate (DEHP) is a plasticizer that is
   contained in most PVC devices, including apheresis disposables. Because
   DEHP can be extracted from apheresis disposables as the blood passes
   through the apheresis device, DEHP exposure was determined in healthy
   donors undergoing plateletpheresis performed with commercially available
   apheresis systems.
   STUDY DESIGN AND METHODS: The study population consisted of 36 healthy
   PLT donors undergoing plateletpheresis with either continuous or
   discontinuous apheresis devices. Serum concentrations of DEHP were
   determined from peripheral blood obtained before and after
   plateletpheresis, with gas chromatographymass spectroscopy.
   RESULTS: Plateletpheresis performed with standard collection disposables
   resulted in a median increase of 232 percent of serum DEHP compared to
   levels before apheresis, corresponding to a total amount of DEHP exposed
   during a single apheresis of a median of 6.46 (range, 1.8-20.3) mug per
   kg of body weight. Endogenous levels of triglycerides showed a positive
   correlation with the amount of DEHP released. Increase in serum DEHP was
   short-term as serum DEHP rapidly returned to levels obtained before
   apheresis within 3 hours after completion of the apheresis course. Donor
   exposure to DEHP led to no variation in liver cell function within 48
   hours after plateletpheresis.
   CONCLUSION: Commercial plateletpheresis disposables release considerable
   amounts of DEHP during the apheresis procedure, but the total dose of
   DEHP retained by the donor is within the normal range of DEHP exposure
   of the general population.}},
Publisher = {{WILEY-BLACKWELL}},
Address = {{COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dettke, M (Reprint Author), Univ Vienna, Sch Med, Vienna Gen Hosp, Dept Blood Grp Serol \& Transfus Med, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.
   Univ Vienna, Sch Med, Vienna Gen Hosp, Dept Blood Grp Serol \& Transfus Med, A-1090 Vienna, Austria.
   Univ Vienna, Sch Med, Vienna Gen Hosp, Inst Med \& Chem Lab Diagnost, A-1090 Vienna, Austria.
   Univ Innsbruck, Dept Pharmacognosy, A-6020 Innsbruck, Austria.}},
DOI = {{10.1046/j.1537-2995.2003.00479.x}},
ISSN = {{0041-1132}},
Keywords-Plus = {{PHTHALATE ESTER PLASTICIZER; DI-2-ETHYLHEXYL PHTHALATE;
   POLYVINYL-CHLORIDE; HUMAN-PLASMA; BLOOD BAGS; TRANSFUSION; ACID;
   HEMODIALYSIS; DEHP; DI-(2-ETHYLHEXYL)-PHTHALATE}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Author-Email = {{markus.dettke@univie.ac.at}},
Cited-References = {{ALBRO PW, 1978, TRANSFUSION, V18, P750, DOI 10.1046/j.1537-2995.1978.18679077962.x.
   BARRY YA, 1989, J THORAC CARDIOV SUR, V97, P900.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   Hanawa T, 2000, INT J PHARM, V210, P109, DOI 10.1016/S0378-5173(00)00578-0.
   HAUGHEY DB, 1988, PHARMACEUT RES, V5, P10, DOI 10.1023/A:1015872309411.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   JACOBSON MS, 1977, J LAB CLIN MED, V89, P1066.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   KEVY SV, 1982, ENVIRON HEALTH PERSP, V45, P57, DOI 10.2307/3429384.
   KHALIQ MA, 1992, B ENVIRON CONTAM TOX, V48, P572.
   KLUWE WM, 1982, J TOXICOL ENV HEALTH, V10, P797.
   Lantos P R, 1988, J Biomater Appl, V2, P358.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   Loff S, 2000, J PEDIATR SURG, V35, P1775, DOI 10.1053/jpsu.2000.19249.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   REDDY JK, 1984, CRC CRIT R TOXICOL, V12, P1.
   ROCK G, 1984, TRANSFUSION, V24, P493, DOI 10.1046/j.1537-2995.1984.24685066808.x.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   SCHNEIDER B, 1989, NEW ENGL J MED, V320, P1563.
   SCWETZ BA, 2001, SAFETY ASSESSMENT DE.
   SHINTANI H, 1985, J CHROMATOGR, V337, P279, DOI 10.1016/0378-4347(85)80041-4.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Van den Munckhof RJM, 1998, HISTOCHEM J, V30, P339, DOI 10.1023/A:1003232427793.
   WAMS TJ, 1987, SCI TOTAL ENVIRON, V66, P1, DOI 10.1016/0048-9697(87)90072-6.
   Willhite CC, 2001, TOXICOLOGY, V160, P219, DOI 10.1016/S0300-483X(00)00451-0.
   {*}CTR DEV RAD HLTH, FDN PUBL HLTH NOT PV.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{22}},
Journal-ISO = {{Transfusion}},
Doc-Delivery-Number = {{705WC}},
Wos-Id = {{ISI:000184418100019}},
}

@article{ ISI:000184992700025,
Author = {Duty, SM and Singh, NP and Silva, MJ and Barr, DB and Brock, JW and
   Ryan, L and Herrick, RF and Christiani, DC and Hauser, R},
Title = {{The relationship between environmental exposures to phthalates and DNA
   damage in human sperm using the neutral comet assay}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2003}},
Volume = {{111}},
Number = {{9}},
Pages = {{1164-1169}},
Month = {{JUL}},
Abstract = {{Phthalates are industrial chemicals widely used in many commercial
   applications. The general population is exposed to phthalates through
   consumer products as well as through diet and medical treatments. To
   determine whether environmental levels of phthalates are associated with
   altered DNA integrity in human sperm, we selected a population without
   identified sources of exposure to phthalates. One hundred sixty-eight
   subjects recruited from the Massachusetts General Hospital Andrology
   Laboratory provided a semen and a urine sample. Eight phthalate
   metabolites were measured in urine by using high-performance liquid
   chromatography and tandem mass spectrometry;, data were corrected for
   urine dilution by adjusting for specific gravity. The neutral
   single-cell microgel electrophoresis assay (comet assay) was used to
   measure DNA integrity in sperm. VisComet image analysis software was
   used to measure comet extent, a measure of total comet length
   (micrometers); percent DNA in tail (tail\%), a measure of the proportion
   of total DNA present in the comet tail; and tail distributed moment
   (TDM), an integrated measure of length and intensity (micrometers). For
   an interquartile range increase in specific gravity-adjusted monoethyl
   phthalate (MEP) level, the comet extent increased significantly by 3.6
   mum {[}95\% confidence interval (95\% CI), 0.74-6.47]; the TDM also
   increased 1.2 mum (95\% CI, -0.05 to 2.38) but was of borderline
   significance. Monobutyl, monobenzyl, monomethyl, and mono-2-ethylhexyl
   phthalates were not significantly associated with comet assay
   parameters. In conclusion, this study represents the first human data to
   demonstrate that urinary MEP, at environmental levels, is associated
   with increased DNA damage in sperm.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hauser, R (Reprint Author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Occupat Hlth Program, Bldg 1,Rm 1405,665 Huntington Ave, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Occupat Hlth Program, Boston, MA 02115 USA.
   Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA.}},
DOI = {{10.1289/ehp.5756}},
ISSN = {{0091-6765}},
Keywords = {{comet assay; DNA damage; environmental; human sperm; phthalates; urinary
   metabolites}},
Keywords-Plus = {{HUMAN REFERENCE POPULATION; GEL-ELECTROPHORESIS ASSAY; CHROMATIN
   STRUCTURE ASSAY; DOUBLE-STRAND BREAKS; MUCOSAL CELLS; IN-VITRO;
   GENOTOXICITY; METABOLITES; ESTERS; REPRODUCIBILITY}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
ResearcherID-Numbers = {{Ryan, Louise/A-4562-2009
   Barr, Dana/E-6369-2011
   Barr, Dana/E-2276-2013}},
Cited-References = {{Agency for Toxic Substances and Disease Registry (ATSDR), 1995, TOX PROF DIETH PHTHA.
   Anderson D, 1999, TERATOGEN CARCIN MUT, V19, P275, DOI 10.1002/(SICI)1520-6866(1999)19:4<275::AID-TCM4>3.0.CO;2-1.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2.
   Bradbury J, 1996, LANCET, V347, P1541, DOI 10.1016/S0140-6736(96)90681-9.
   CDC, 2001, NAT REP HUM EXP ENV.
   Duty SM, 2002, HUM REPROD, V17, P1274, DOI 10.1093/humrep/17.5.1274.
   Evenson DP, 1999, HUM REPROD, V14, P1039, DOI 10.1093/humrep/14.4.1039.
   EVENSON DP, 1991, REPROD TOXICOL, V5, P115, DOI 10.1016/0890-6238(91)90039-I.
   Fraga CG, 1996, MUTAT RES-FUND MOL M, V351, P199, DOI 10.1016/0027-5107(95)00251-0.
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hosmer D, 1989, APPL LOGISTIC REGRES, P82.
   Hughes CM, 1997, MUTAT RES-FUND MOL M, V374, P261, DOI 10.1016/S0027-5107(96)00241-2.
   Kleinsasser NH, 2000, ENVIRON MOL MUTAGEN, V35, P9, DOI 10.1002/(SICI)1098-2280(2000)35:1<9::AID-EM2>3.0.CO;2-1.
   Kleinsasser NH, 2000, EUR ARCH OTO-RHINO-L, V257, P337, DOI 10.1007/s004059900220.
   Kleinsasser NH, 2001, TERATOGEN CARCIN MUT, V21, P189, DOI 10.1002/tcm.1007.
   Koo JW, 2002, ENVIRON HEALTH PERSP, V110, P405.
   LAHDETIE J, 1996, ENVIRON HEALTH PER S, V104, P620.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   MARTIN RH, 1993, REPROD TOXICOL, V7, P47, DOI 10.1016/0890-6238(93)90068-I.
   MCKELVEYMARTIN VJ, 1993, MUTAT RES, V288, P47, DOI 10.1016/0027-5107(93)90207-V.
   Moller P, 2000, CANCER EPIDEM BIOMAR, V9, P1005.
   Nakai M, 1999, BIOCHEM BIOPH RES CO, V254, P311, DOI 10.1006/bbrc.1998.9928.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   National Center for Health Statistics, 2001, NAT HLTH NUTR EX SUR.
   NTP, 2000, NTP CERHR EXP PAN RE, P1.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P133.
   Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610.
   Singh NP, 1997, MUTAT RES-DNA REPAIR, V383, P167, DOI 10.1016/S0921-8777(96)00056-0.
   Singh NP, 1998, MUTAGENESIS, V13, P75, DOI 10.1093/mutage/13.1.75.
   Singh NP, 2001, BIOGERONTOLOGY, V2, P261, DOI 10.1023/A:1013262327193.
   SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0.
   SINGH NP, 1989, EXP CELL RES, V184, P461, DOI 10.1016/0014-4827(89)90344-3.
   Sun JG, 1997, BIOL REPROD, V56, P602, DOI 10.1095/biolreprod56.3.602.
   TEASS AW, 1998, NIOSH MANUAL ANAL ME, P52.
   THOMAS JA, 1982, ENVIRON HEALTH PERSP, V45, P85, DOI 10.2307/3429388.
   TREMAINE LM, 1985, TOXICOL APPL PHARM, V77, P165, DOI 10.1016/0041-008X(85)90277-7.
   Undeger U, 1999, J OCCUP ENVIRON MED, V41, P693.
   World Health Organization, 1999, WHO LAB MAN EX HUM S.
   Zar J. H., 1984, BIOSTAT ANAL, P239.
   {*}ATSDR, 1999, DINBUTYL PHTHALATE.
   {*}ATSDR, 2000, TOX PROF DI 2 ETH PH.}},
Number-of-Cited-References = {{47}},
Times-Cited = {{120}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{715VH}},
Wos-Id = {{ISI:000184992700025}},
}

@article{ ISI:000184144900024,
Author = {Cobellis, L and Latini, G and DeFelice, C and Razzi, S and Paris, I and
   Ruggieri, F and Mazzeo, P and Petraglia, F},
Title = {{High plasma concentrations of di-(2-ethylhexyl)-phthalate in women with
   endometriosis}},
Journal = {{HUMAN REPRODUCTION}},
Year = {{2003}},
Volume = {{18}},
Number = {{7}},
Pages = {{1512-1515}},
Month = {{JUL}},
Abstract = {{BACKGROUND: Emerging evidence suggests a potential role for ubiquitous
   environmental contaminants in the physiopathology of endometriosis.
   Di-(2-ethylhexyl)-phthalate (DEHP), the most commonly used plasticizer
   in flexible polyvinylchloride (PVC) formulations, is a widespread
   environmental contaminant with potentially adverse effects on fertility
   in animal models. In the present study, we tested the hypothesis that
   DEHP and/or and its main metabolite, mono-ethylhexyl phthalate (MEHP),
   play a role in the pathogenesis of endometriosis. METHODS: Specimens of
   blood and peritoneal fluid were collected in a group of women with
   endometriosis (n = 55), and in age-matched control women (n = 24).
   Concentrations of DEHP and MEHP were measured in plasma and peritoneal
   fluid by using high performance liquid chromatography (HPLC).
   Differences between groups were tested using the Fisher's exact test,
   Wilcoxon-test, and Kruskal-Wallis analysis of variance. RESULTS:
   Endometriotic women showed significantly higher plasma DEHP
   concentrations than controls (median 0.57 mug/ml, interquartile range:
   0.06-1.23; values range: 0-3.24 versus median 0.18 mug/ml, interquartile
   range: 0-0.44; values range: 0-1.03; P = 0.0047) and 92.6\% of them had
   detectable DEHP and/or MEHP in the peritoneal fluid. No significant
   differences in either the DEHP/MEHP plasma concentrations (P greater
   than or equal to 0.31) or DEHP/MEHP peritoneal fluid concentrations (P
   greater than or equal to 0.66) were observed in the endometriotic
   patients as a function of the disease stage at the time of diagnosis.
   CONCLUSIONS: The present findings showed for the first time an
   association between DEHP plasma concentrations and endometriosis,
   suggesting a possible role for phthalate esters in the pathogenesis.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Petraglia, F (Reprint Author), Univ Siena, Policlin Le Scotte, Dept Pediat Obstet \& Reprod Med, Chair Obstet \& Gynecol, Viale Bracci, I-53100 Siena, Italy.
   Univ Siena, Policlin Le Scotte, Dept Pediat Obstet \& Reprod Med, Chair Obstet \& Gynecol, I-53100 Siena, Italy.
   CNR, IFC,Clin Physiol Inst,Perrino Hosp, Div Paediat,Neonatal Intens Care Unit, Lecce Sect, Brindisi, Italy.
   Univ Siena, Dept Pediat Obstet \& Reprod Med, Neonatal Intens Care Unit, I-53100 Siena, Italy.
   Univ Aquila, Dept Chem Chem Engn \& Mat, I-67100 Laquila, Italy.}},
DOI = {{10.1093/humrep/deg254}},
ISSN = {{0268-1161}},
Keywords = {{di-(2-ethylhexyl)-phthalate endometriosis; environmental hazards;
   mono-ethylhexyl phthalate; plasticizers}},
Keywords-Plus = {{DI-2-ETHYLHEXYL PHTHALATE DEHP; CYCLING RATS; DI(2-ETHYLHEXYL)
   PHTHALATE; REPRODUCTIVE-PERFORMANCE; TESTICULAR TOXICITY; NEONATAL RATS;
   ACID ESTERS; DI-(2-ETHYLHEXYL)PHTHALATE; EXPOSURE; CULTURE}},
Research-Areas = {{Obstetrics \& Gynecology; Reproductive Biology}},
Web-of-Science-Categories  = {{Obstetrics \& Gynecology; Reproductive Biology}},
Cited-References = {{AGARWAL DK, 1989, J TOXICOL ENV HEALTH, V26, P39.
   AGARWAL DK, 1986, ENVIRON HEALTH PERSP, V65, P343, DOI 10.2307/3430202.
   AGARWAL DK, 1985, J TOXICOL ENV HEALTH, V16, P71.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   Bauer MJ, 1997, SCI TOTAL ENVIRON, V208, P49, DOI 10.1016/S0048-9697(97)00272-6.
   BERMAN E, 1993, REPROD TOXICOL, V7, P349, DOI 10.1016/0890-6238(93)90024-2.
   Dalgaard M, 2001, TOXICOL LETT, V122, P69, DOI 10.1016/S0378-4274(01)00348-4.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   GIAM CS, 1978, SCIENCE, V199, P419, DOI 10.1126/science.199.4327.419-a.
   GRIFFITHS WC, 1985, ANN CLIN LAB SCI, V15, P140.
   Hoyer PB, 2001, BIOCHEM PHARMACOL, V62, P1557, DOI 10.1016/S0006-2952(01)00814-0.
   Kim EJ, 2002, ENVIRON INT, V28, P359, DOI 10.1016/S0160-4120(02)00058-2.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   LASKEY JW, 1993, REPROD TOXICOL, V7, P25, DOI 10.1016/0890-6238(93)90006-S.
   Latini G, 1999, ACTA PAEDIATR, V88, P1174, DOI 10.1080/08035259950168333.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Lovekamp-Swan T, 2003, ENVIRON HEALTH PERSP, V111, P139.
   Mayani A, 1997, HUM REPROD, V12, P373, DOI 10.1093/humrep/12.2.373.
   MAYER FL, 1972, NATURE, V238, P411, DOI 10.1038/238411a0.
   OLIVE DL, 1993, NEW ENGL J MED, V328, P1759, DOI 10.1056/NEJM199306173282407.
   Osteen KG, 1997, SEMIN REPROD ENDOCR, V15, P301, DOI 10.1055/s-2008-1068760.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   PARMAR D, 1986, TOXICOLOGY, V42, P47, DOI 10.1016/0300-483X(86)90091-0.
   Pauwels A, 2001, HUM REPROD, V16, P2050, DOI 10.1093/humrep/16.10.2050.
   Rier S, 2002, TOXICOL SCI, V70, P161, DOI 10.1093/toxsci/70.2.161.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   The American Fertility Society, 1985, FERTIL STERIL, V43, P351.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   {*}HLTH CAN EXP ADV, 2002, FIN REP 2002 JAN 11.
   {*}US FDA, 2001, SAF ASS DI 2 ETH PHT.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{67}},
Journal-ISO = {{Hum. Reprod.}},
Doc-Delivery-Number = {{701BD}},
Wos-Id = {{ISI:000184144900024}},
}

@article{ ISI:000184365000004,
Author = {Kato, K and Silva, MJ and Brock, JW and Reidy, JA and Malek, NA and
   Hodge, CC and Nakazawa, H and Needham, LL and Barr, DB},
Title = {{Quantitative detection of nine phthalate metabolites in human serum
   using reversed-phase high-performance liquid chromatography-electrospray
   ionization-tandem mass Spectrometry}},
Journal = {{JOURNAL OF ANALYTICAL TOXICOLOGY}},
Year = {{2003}},
Volume = {{27}},
Number = {{5}},
Pages = {{284-289}},
Month = {{JUL-AUG}},
Publisher = {{PRESTON PUBLICATIONS INC}},
Address = {{7800 MERRIMAC AVE PO BOX 48312, NILES, IL 60648 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Mail Stop F17,4770 Buford Hwy NE, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Sci Lab, Atlanta, GA 30341 USA.
   Hoshi Univ, Dept Analyt Chem, Fac Pharmaceut Sci, Tokyo 142, Japan.}},
ISSN = {{0146-4760}},
Keywords-Plus = {{N-BUTYL PHTHALATE; DIETHYLHEXYL PHTHALATE; RATS; MALFORMATIONS; DIBUTYL;
   ESTERS; URINE}},
Research-Areas = {{Chemistry; Toxicology}},
Web-of-Science-Categories  = {{Chemistry, Analytical; Toxicology}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011
   Barr, Dana/E-6369-2011
   Barr, Dana/E-2276-2013}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   Ema M, 2001, REPROD TOXICOL, V15, P189, DOI 10.1016/S0890-6238(01)00111-3.
   EMA M, 1993, TOXICOL LETT, V69, P197.
   EMA M, 1995, ARCH ENVIRON CON TOX, V28, P223.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   RHODES JE, 1995, ENVIRON TOXICOL CHEM, V14, P1569.
   SCMID P, 1985, XENOBIOTICA, V15, P251.
   SHIOTA K, 1980, ENVIRON RES, V22, P245, DOI 10.1016/0013-9351(80)90136-X.
   Silva MJ, 2003, J CHROMATOGR B, V789, P393, DOI 10.1016/S1570-0232(03)00164-8.
   Taylor J. K., 1987, QUALITY ASSURANCE CH.
   Uhde E, 2001, INDOOR AIR, V11, P150, DOI 10.1034/j.1600-0668.2001.011003150.x.
   WESTGARD JO, MULTIRULE WESTGARD R.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {*}CDCP, 2 NAT REP HUM EXP EN.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{41}},
Journal-ISO = {{J. Anal. Toxicol.}},
Doc-Delivery-Number = {{704WW}},
Wos-Id = {{ISI:000184365000004}},
}

@article{ ISI:000182941700020,
Author = {Silva, MJ and Malek, NA and Hodge, CC and Reidy, JA and Kato, K and
   Barr, DB and Needham, LL and Brock, JW},
Title = {{Improved quantitative detection of 11 urinary phthalate metabolites in
   humans using liquid chromatography-atmospheric pressure chemical
   ionization tandem mass spectrometry}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES}},
Year = {{2003}},
Volume = {{789}},
Number = {{2}},
Pages = {{393-404}},
Month = {{JUN 15}},
Abstract = {{Phthalates are widely used as industrial solvents and plasticizers, with
   global use exceeding four million tons per year. We improved our
   previously developed high-performance liquid chromatography-atmospheric
   pressure chemical ionization-tandem mass spectrometric (HPLC-APCI-MS/MS)
   method to measure urinary phthalate metabolites by increasing the
   selectivity and the sensitivity by better resolving them from the
   solvent front, adding three more phthalate metabolites, monomethyl
   phthalate (mMP), mono-(2-ethyl-5-oxohexyl)phthalate (mEOHP) and mono-
   (2-ethyl-5 -hydroxyhexyl)phthalate (mEHHP); increasing the sample
   throughput; and reducing the solvent usage. Furthermore, this improved
   method enabled us to analyze free un-conjugated mono-2-ethylhexyl
   phthalate (mEHP) by eliminating interferences derived from coelution of
   the glucuronide-bound, or conjugated form, of the mEHP on measurements
   of the free mEHP. This method for measuring phthalate metabolites in
   urine involves solid-phase extraction followed by reversed-phase
   HPLC-APCI-MS/MS using isotope dilution with C-13(4) internal standards.
   We further evaluated the ruggedness and the reliability of the method by
   comparing measurements made by multiple analysts at different extraction
   settings on multiple instruments. We observed mMP. monoethyl phthalate
   (mEP), mono-n-butyl phthalate (mBP), monobenzyl phthalate (mBzP), mEHP,
   mEHHP and mEOHP in the majority of urine specimens analyzed with
   DEHP-metabolites mEHHP and mEOHP present in significantly higher amounts
   than mEHP. (C) 2003 Elsevier Science B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Silva, MJ (Reprint Author), Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, 4770 Buford Hwy NE,Mailstop F17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Div Sci Lab, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.}},
DOI = {{10.1016/S1570-0232(03)00164-8}},
ISSN = {{1570-0232}},
Keywords = {{phthalates}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; RATS; EXPOSURE; MS/MS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011
   Barr, Dana/E-6369-2011
   Barr, Dana/E-2276-2013}},
Cited-References = {{ALBRO PW, 1989, TOXICOL APPL PHARM, V100, P193, DOI 10.1016/0041-008X(89)90305-0.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1984, ANAL CHEM, V56, P247, DOI 10.1021/ac00266a029.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   CDC, 2002, NAT REP HUM EXP ENV.
   CHING NPH, 1981, J CHROMATOGR, V225, P196, DOI 10.1016/S0378-4347(00)80260-1.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Ema M, 1996, REPROD TOXICOL, V10, P365, DOI 10.1016/0890-6238(96)00082-2.
   Imajima T, 1997, J PEDIATR SURG, V32, P18, DOI 10.1016/S0022-3468(97)90083-X.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   PIRKLE JL, 1995, ENVIRON HEALTH PERSP, V103, P45, DOI 10.2307/3432559.
   SAMPSON EJ, 1994, CLIN CHEM, V40, P1376.
   SCHMID P, 1985, XENOBIOTICA, V15, P151.
   Valentin-Blasini L, 2000, J EXPO ANAL ENV EPID, V10, P799.
   WARD JM, 1986, ENVIRON HEALTH PERSP, V65, P279, DOI 10.2307/3430195.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{81}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{679VB}},
Wos-Id = {{ISI:000182941700020}},
}

@article{ ISI:000183040200022,
Author = {Barlow, NJ and Phillips, SL and Wallace, DG and Sar, M and Gaido, KW and
   Foster, PMD},
Title = {{Quantitative changes in gene expression in fetal rat testes following
   exposure to Di(n-butyl) phthalate}},
Journal = {{TOXICOLOGICAL SCIENCES}},
Year = {{2003}},
Volume = {{73}},
Number = {{2}},
Pages = {{431-441}},
Month = {{JUN}},
Abstract = {{Di(n-butyl) phthalate (DBP) alters male reproductive development by
   decreasing testicular testosterone (T) production when fetuses are
   exposed on. gestation days (GD) 12-21. Previous studies have shown
   altered gene expression for enzymes in the T biosynthetic pathway
   following exposure to DBP. The objectives of this study were to develop
   a more detailed understanding of the effect of DBP on steroidogenesis,
   using a robust study design with increased numbers of dams and fetuses,
   compared with previous studies, and to explore messenger RNA (mRNA)
   expression for other critical genes involved in androgen biosynthesis
   and signaling. Additionally, immunohistochemical localization of protein
   expression for several key genes was performed to further confirm mRNA
   changes. Fetal Leydig cell lipid levels were also examined
   histochemically, using oil red O. Six to seven pregnant Crl:CD(SD)BR
   rats per group were gavaged with corn oil or DBP at 500 mg/kg/day on GD
   12-19. Testicular RNA isolated from three randomly selected GD 19
   fetuses per litter was used for real-time RT-PCR for the following
   genes: scavenger receptor class B-1 (SRB1), steroidogenic acute
   regulatory protein (StAR), P450 side-chain cleavage enzyme (P450scc),
   3beta-hydroxysteroid dehydrogenase (3beta-HSD), P450c17,
   17beta-hydroxysteroid dehydrogenase (17beta-HSD), androgen receptor
   (AR), luteinizing hormone receptor (LHR), follicle-stimulating hormone
   receptor (FSHR), stem cell factor tyrosine kinase receptor (c-kit), stem
   cell factor (SCF), proliferating cell nuclear antigen (PCNA), and
   testosterone-repressed prostate message-2 (TRPM-2). mRNA expression was
   downregulated for SRB1, StAR, P450scc, 3beta-HSD, P450c17, and c-kit
   following DBP exposure, and TRPM-2 was upregulated. 17beta-HSD, AR, LHR,
   FSHR, and PCNA were not significantly changed. Immunohistochemical
   staining for c-kit was seen in fetal Leydig cells, which has not been
   previously reported. Downregulation of most of the genes in the T
   biosynthetic pathway confirms and extends previous findings. Diminished
   Leydig cell lipid content and alteration of cholesterol transport genes
   also support altered cholesterol metabolism and transport as a potential
   mechanism for decreased T synthesis following exposure to DBP.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Foster, PMD (Reprint Author), NIEHS, POB 12233 MD E1-06, Res Triangle Pk, NC 27709 USA.
   NIEHS, Res Triangle Pk, NC 27709 USA.
   CIIT Ctr Hlth Res, Res Triangle Pk, NC 27709 USA.}},
DOI = {{10.1093/toxsci/kfg087}},
ISSN = {{1096-6080}},
Keywords = {{di(n-butyl); phthalate; steroidogenesis; male reproductive development;
   gene expression; fetal testes; litter variability; c-kit}},
Keywords-Plus = {{STEM-CELL FACTOR; MALE REPRODUCTIVE DEVELOPMENT; C-KIT; LEYDIG-CELLS;
   VENTRAL PROSTATE; LATE-GESTATION; BLOOD-FLOW; RECEPTOR; HORMONE; MICE}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Cited-References = {{ANDERSEN JM, 1978, J BIOL CHEM, V253, P9024.
   BARLOW NJ, 2003, TOXICOL PATHOL, V31.
   BELL FP, 1982, ENVIRON HEALTH PERSP, V45, P41, DOI 10.2307/3429382.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   BRANNAN CI, 1992, GENE DEV, V6, P1832, DOI 10.1101/gad.6.10.1832.
   BUELKESAM J, 1982, TERATOLOGY, V26, P279, DOI 10.1002/tera.1420260310.
   Cao GQ, 1999, MOL ENDOCRINOL, V13, P1460, DOI 10.1210/me.13.9.1460.
   CLARK MM, 1993, PHYSIOL BEHAV, V53, P1183, DOI 10.1016/0031-9384(93)90377-R.
   El-Gehani F, 1998, BIOL REPROD, V58, P116, DOI 10.1095/biolreprod58.1.116.
   Elswick BA, 2000, REPROD TOXICOL, V14, P359, DOI 10.1016/S0890-6238(00)00092-7.
   EVEN MD, 1992, J REPROD FERTIL, V96, P709.
   EVEN MD, 1994, J REPROD FERTIL, V102, P245.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   Fox RA, 2000, J ANDROL, V21, P579.
   Hasegawa T, 2000, MOL ENDOCRINOL, V14, P1462, DOI 10.1210/me.14.9.1462.
   HASEMAN JK, 1975, TERATOLOGY, V12, P165, DOI 10.1002/tera.1420120209.
   HUHTANIEMI I, 1992, P SOC EXP BIOL MED, V201, P125.
   KOHN MC, 2000, ENV HLTH PERSPECT, V108, P440.
   Lakins J, 1998, J BIOL CHEM, V273, P27887, DOI 10.1074/jbc.273.43.27887.
   Lambright CR, 2003, TOXICOL SCI, V72, P272.
   LEGER JG, 1987, BIOCHEM BIOPH RES CO, V147, P196, DOI 10.1016/S0006-291X(87)80106-7.
   Loveland KL, 1997, J ENDOCRINOL, V153, P337, DOI 10.1677/joe.0.1530337.
   Manna PR, 2001, J STEROID BIOCHEM, V76, P167, DOI 10.1016/S0960-0760(00)00156-4.
   MANOVA K, 1990, DEVELOPMENT, V110, P1057.
   MILLER WL, 1988, ENDOCR REV, V9, P295.
   Miyake H, 2000, CANCER RES, V60, P170.
   Miyake H, 2000, CLIN CANCER RES, V6, P1655.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2002, REPROD TOXICOL, V16, P19, DOI 10.1016/S0890-6238(01)00201-5.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   NONNEMAN DJ, 1992, BIOL REPROD, V47, P723, DOI 10.1095/biolreprod47.5.723.
   NOUMURA T, 1966, ENDOCRINOLOGY, V78, P245.
   OMURA T, 1995, J STEROID BIOCHEM, V53, P19, DOI 10.1016/0960-0760(95)00036-Y.
   Orth JM, 1996, MOL REPROD DEV, V45, P123, DOI 10.1002/(SICI)1098-2795(199610)45:2<123::AID-MRD3>3.0.CO;2-V.
   O'Shaughnessy PJ, 1998, ENDOCRINOLOGY, V139, P1141, DOI 10.1210/en.139.3.1141.
   PEARSE AGE, 1996, HISTOTECHNOLOGY SELF.
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, P2002, DOI DOI 10.1093/NAR/29.9.E45.
   Sar M, 1999, ENDOCRINOLOGY, V140, P963, DOI 10.1210/en.140.2.963.
   SHIRLEY EAC, 1981, BIOMETRICS, V37, P819, DOI 10.2307/2530164.
   Shultz VD, 2001, TOXICOL SCI, V64, P233, DOI 10.1093/toxsci/64.2.233.
   TAPANAINEN J, 1984, BIOL REPROD, V31, P1027, DOI 10.1095/biolreprod31.5.1027.
   Thompson C, 2003, TOXICOL SCI, V72, P273.
   Trigatti B, 2000, CURR OPIN LIPIDOL, V11, P123, DOI 10.1097/00041433-200004000-00004.
   WILLIAMS DA, 1975, BIOMETRICS, V31, P949, DOI 10.2307/2529820.
   Wine RN, 1997, ENVIRON HEALTH PERSP, V105, P102, DOI 10.1289/ehp.97105102.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   WONG P, 1993, J BIOL CHEM, V268, P5021.
   Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172.
   ZHANG FP, 1994, ENDOCRINOLOGY, V134, P2206, DOI 10.1210/en.134.5.2206.
   ZSEBO KM, 1990, CELL, V63, P213, DOI 10.1016/0092-8674(90)90302-U.
   {*}INT PROGR CHEM SA, 1992, ENV HLTH CRIT, V131.
   {*}IPCS, 1997, ENV HLTH CRIT, V189.
   {*}NAT RES COUNC, 1996, GUID CAR US LAB.
   {*}NAT TOX PROGR, 1991, DI N BUT PHTHAL REPR.}},
Number-of-Cited-References = {{54}},
Times-Cited = {{122}},
Journal-ISO = {{Toxicol. Sci.}},
Doc-Delivery-Number = {{681MP}},
Wos-Id = {{ISI:000183040200022}},
}

@article{ ISI:000182488900022,
Author = {Kato, K and Shoda, S and Takahashi, M and Doi, N and Yoshimura, Y and
   Nakazawa, H},
Title = {{Determination of three phthalate metabolites in human urine using
   on-line solid-phase extraction-liquid chromatography-tandem mass
   spectrometry}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES}},
Year = {{2003}},
Volume = {{788}},
Number = {{2}},
Pages = {{407-411}},
Month = {{MAY 25}},
Abstract = {{An on-line solid-phase extraction-liquid chromatography-tandem mass
   spectrometry (on-line SPE-HPLC-MS/MS) method was developed for the
   analysis of metabolites of three phthalate esters in human urine at the
   low nanogram per milliliter level. The recoveries were above 84.3\% and
   relative standard deviations varied from 0.8 to 4.8\%. The compounds
   along with their deuterated internal standards were detected in the
   negative ion mode by selective reaction monitoring and the accuracy of
   the method was improved by isotope dilution. Monobutyl phthalate was
   detected with median level of 22.5 ng/ml. The median levels for
   monobenzyl phthalate and monoethylhexyl phthalate were less than the
   limit of quantitation (LOQ). The on-line SPE-HPLC-MS/MS method allowed
   the possibility of determining these metabolites within a short time,
   with increased sensitivity and by using decreased amounts of sample and
   solvent. (C) 2003 Elsevier Science B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Nakazawa, H (Reprint Author), Hoshi Univ, Fac Pharmaceut Sci, Dept Anal Chem, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.
   Hoshi Univ, Fac Pharmaceut Sci, Dept Anal Chem, Shinagawa Ku, Tokyo 1428501, Japan.
   GL Sci Inc, Iruma, Saitama 3580032, Japan.}},
DOI = {{10.1016/S1570-0232(03)00041-2}},
ISSN = {{1570-0232}},
Keywords = {{on-line solid-phase extraction; phthalate monoester}},
Keywords-Plus = {{RATS; EXPOSURE; SAMPLES}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Cited-References = {{Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   BOUMA K, 2002, J FOOD ADDIT CONTAM, V19, P602.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Fromme H, 2002, WATER RES, V36, P1429, DOI 10.1016/S0043-1354(01)00367-0.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Kawaguchi M, 2002, J NEUROENDOCRINOL, V14, P486, DOI 10.1046/j.1365-2826.2002.00804.x.
   Moore RW, 2001, ENVIRON HEALTH PERSP, V109, P229, DOI 10.2307/3434690.
   Brossa L, 2002, J CHROMATOGR A, V963, P287, DOI 10.1016/S0021-9673(02)00224-8.
   RHEE GS, 2002, IN VITRO, V16, P443.
   Wang LS, 2002, CANCER LETT, V186, P177, DOI 10.1016/S0304-3835(02)00324-5.
   Wellejus A, 2002, J TOXICOL ENV HEAL A, V65, P813, DOI 10.1080/00984100290071126.
   Woodfine D, 2002, ENVIRON POLLUT, V119, P341, DOI 10.1016/S0269-7491(01)00344-X.}},
Number-of-Cited-References = {{14}},
Times-Cited = {{29}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{671WX}},
Wos-Id = {{ISI:000182488900022}},
}

@article{ ISI:000183393100005,
Author = {Duty, SM and Silva, MJ and Barr, DB and Brock, JW and Ryan, L and Chen,
   ZY and Herrick, RF and Christiani, DC and Hauser, R},
Title = {{Phthalate exposure and human semen parameters}},
Journal = {{EPIDEMIOLOGY}},
Year = {{2003}},
Volume = {{14}},
Number = {{3}},
Pages = {{269-277}},
Month = {{MAY}},
Abstract = {{Background. There is scientific and public concern about commonly used
   chemicals, including phthalates, that are associated with reproductive
   toxicity in laboratory animals and are hormonally active. People are
   exposed to phthalates through diet, consumer products and medical
   devices. The present study explored whether environmental levels of
   phthalates are associated with altered semen quality in humans.
   Methods. We recruited 168 men who were part of subfertile couples and
   who presented to the Massachusetts General Hospital andrology laboratory
   for semen analysis between January 2000 and April 2001. Semen parameters
   were dichotomized based on 1999 World Health Organization reference
   values for sperm concentration (<20 million/ml) and motility (<50\%
   motile), as well as Tygerberg Strict criteria for morphology (<4\%
   normal). The comparison group was men for whom these semen parameters
   were all above the reference values. In urine, eight phthalate
   metabolites were measured with high-performance liquid chromatography
   and tandem mass spectrometry. Specific gravity-adjusted phthalate
   metabolite levels were categorized into tertiles.
   Results. There was a dose-response relation between tertiles of
   mono-butyl phthalate and sperm motility (odds ratio per tertile = 1.0,
   1.8, 3.0; P-value for trend 0.02) and sperm concentration (1.0, 1.4,
   3.3; P-value for trend 0.07). In addition, there was a dose-response
   relation between tertiles of monobenzyl phthalate and sperm
   concentration (1.0, 1.4, 5.5; P-value for trend = 0.02).
   Conclusions. There were dose-response relations for monobutyl phthalate
   and monobenzyl phthalate with one or more semen parameters, and
   suggestive evidence for monomethyl phthalate with sperm morphology. The
   lack of a relation for other phthalates may indicate a difference in
   spermatotoxicity among phthalates.}},
Publisher = {{LIPPINCOTT WILLIAMS \& WILKINS}},
Address = {{530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hauser, R (Reprint Author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Occupat Hlth Program, Boston, MA 02115 USA.
   Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Occupat Hlth Program, Boston, MA 02115 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA USA.
   Harvard Univ, Sch Publ Hlth, Dept Biostat, Cambridge, MA 02138 USA.
   Dana Farber Canc Inst, Dept Biostat Sci, Boston, MA 02115 USA.
   Massachusetts Gen Hosp, Vincent Mem Obstet \& Gynecol Serv Androl Lab, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, In Vitro Fertilizat Unit, Boston, MA 02114 USA.
   Harvard Univ, Sch Med, Dept Med, Boston, MA USA.}},
DOI = {{10.1097/00001648-200305000-00005}},
ISSN = {{1044-3983}},
Keywords = {{semen quality; phthalate; urine; environment; human; epidemiology}},
Keywords-Plus = {{BUTYL BENZYL PHTHALATE; SEXUAL-DIFFERENTIATION; MALE-RAT; DIETHYLHEXYL
   PHTHALATE; REPRODUCTIVE-TRACT; QUALITY; SPERM; ESTERS; MEN; METABOLITES}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
ResearcherID-Numbers = {{Ryan, Louise/A-4562-2009
   Barr, Dana/E-6369-2011
   Barr, Dana/E-2276-2013}},
Cited-References = {{AGARWAL DK, 1985, TOXICOLOGY, V35, P189, DOI 10.1016/0300-483X(85)90015-0.
   Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Andersen AG, 2000, HUM REPROD, V15, P366, DOI 10.1093/humrep/15.2.366.
   BLACKWELL JM, 1992, FERTIL STERIL, V58, P798.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2.
   Bonde JP, 1996, OCCUP ENVIRON MED, V53, P511.
   Bonde JPE, 1998, LANCET, V352, P1172, DOI 10.1016/S0140-6736(97)10514-1.
   CARLSEN E, 1992, BRIT MED J, V305, P609.
   Comhaire F, 1996, ANDROLOGIA, V28, P300.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   Gyllenborg J, 1999, INT J ANDROL, V22, P28.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P116, DOI 10.1016/0041-008X(92)90374-2.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Hosmer D, 1989, APPL LOGISTIC REGRES, P82.
   Jensen TK, 2000, EUR J ENDOCRINOL, V142, P47, DOI 10.1530/eje.0.1420047.
   Kidd SA, 2001, FERTIL STERIL, V75, P237, DOI 10.1016/S0015-0282(00)01679-4.
   KRUGER TF, 1988, FERTIL STERIL, V49, P112.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   MURATURE DA, 1987, BIOMED ENVIRON MASS, V14, P473, DOI 10.1002/bms.1200140815.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   Nagao T, 2000, REPROD TOXICOL, V14, P513, DOI 10.1016/S0890-6238(00)00105-2.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   National Center for Health Statistics, 2001, NAT HLTH NUTR EX SUR.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Rothman KJ, 1998, MODERN EPIDEMIOLOGY, P133.
   Schrader S M, 1988, Reprod Toxicol, V2, P183, DOI 10.1016/0890-6238(88)90020-2.
   SHARPE RM, 1993, LANCET, V341, P1392, DOI 10.1016/0140-6736(93)90953-E.
   Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610.
   Swan SH, 2000, ENVIRON HEALTH PERSP, V108, P961, DOI 10.2307/3435055.
   TEASS AW, 1998, NIOSH MANUAL ANAL ME, P52.
   TREMAINE LM, 1985, TOXICOL APPL PHARM, V77, P165, DOI 10.1016/0041-008X(85)90277-7.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   World Health Organization, 1999, WHO LAB MAN EX HUM S.
   {*}ATSDR, 1999, DINB PHTHAL.
   {*}CDC, 2001, NCEH PUB.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{158}},
Journal-ISO = {{Epidemiology}},
Doc-Delivery-Number = {{687TM}},
Wos-Id = {{ISI:000183393100005}},
}

@article{ ISI:000181931200017,
Author = {Higuchi, TT and Palmer, JS and Gray, LE and Veeramachaneni, DNR},
Title = {{Effects of dibutyl phthalate in male rabbits following in utero,
   adolescent, or postpubertal exposure}},
Journal = {{TOXICOLOGICAL SCIENCES}},
Year = {{2003}},
Volume = {{72}},
Number = {{2}},
Pages = {{301-313}},
Month = {{APR}},
Abstract = {{We evaluated sequelae in male rabbits following exposure to dibutyl
   phthalate (DBP) at a dose level known to adversely affect testicular
   function in rodents without causing systemic toxicity. Because rabbits
   have a relatively long phase of reproductive development simulating
   better than rodents the reproductive development of humans, and because
   the use of rabbits facilitates multiple evaluations of mating ability
   and seminal quality, we used this animal model. Rabbits were exposed to
   0 or 400 mg DBP/kg/day in utero (gestation days {[}GD] 15-29) or during
   adolescence (postnatal weeks {[}PNW] 4-12), and male offspring were
   examined at 6, 12, and 25 weeks of age. Another group was exposed after
   puberty (for 12 weeks) and examined at the conclusion of exposure. The
   most pronounced reproductive effects were in male rabbits exposed in
   utero. Male offspring in this group exhibited reduction in numbers of
   ejaculated sperm (down 43 h; p < 0.01), in weights of testes (at 12
   weeks, down 23\%; p < 0.05) and in accessory sex glands (at 12 and 25
   weeks, down 36\%; p < 0.01 and down 27\%; p < 0.05, respectively). Serum
   testosterone levels were down (at 6 weeks, 32 /c; p < 0.05); a slight
   increase in histological alterations of the testis (p < 0.05) and a
   doubling in the percentage (from 16 to 30\%, p < 0.01) of abnormal
   sperm; and 1/17 males manifesting hypospadias, hypoplastic prostate, and
   cryptorchid testes with carcinoma in situ-like cells. In the DBP group
   exposed during adolescence, basal serum testosterone levels were reduced
   at 6 weeks (p < 0.01) while at 12 weeks, testosterone production in vivo
   failed to respond normally, to a GnRH challenge (p < 0.01). In addition,
   weight of accessory sex glands was reduced at 12 weeks but not at 25
   weeks after a recovery period; there was a slight increase in the
   percentage of abnormal sperm in the ejaculate; and 1/11 males was
   unilaterally cryptorchid. In both of these DBP-treated groups, daily,
   sperm production, epididymal sperm counts, mating ability, and weights
   of body, and nonreproductive organs were unaffected. Thus, DBP induces
   lesions in the reproductive system of the rabbit, with the intrauterine
   period being the most sensitive stage of life.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Veeramachaneni, DNR (Reprint Author), Colorado State Univ, Anim Reprod \& Biotechnol Lab, Ft Collins, CO 80523 USA.
   Colorado State Univ, Anim Reprod \& Biotechnol Lab, Ft Collins, CO 80523 USA.
   US EPA, Natl Hlth \& Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA.}},
DOI = {{10.1093/toxsci/kfg036}},
ISSN = {{1096-6080}},
Keywords = {{DBP; reproductive toxicity; abnormal male sexual differentiation;
   ejaculated sperm counts; atypical germ cells; semen quality;
   testosterone}},
Keywords-Plus = {{CARCINOMA-IN-SITU; MALE REPRODUCTIVE DEVELOPMENT; INDUCED TESTICULAR
   ATROPHY; N-PENTYL PHTHALATE; SEXUAL-DIFFERENTIATION; DI(N-BUTYL)
   PHTHALATE; MALE-RAT; DIETHYLHEXYL PHTHALATE; OCCUPATIONAL EXPOSURE;
   POLYVINYL-CHLORIDE}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   AMANN RP, 1974, J DAIRY SCI, V57, P93.
   Amann R P, 1982, Fundam Appl Toxicol, V2, P13, DOI 10.1016/S0272-0590(82)80059-6.
   AMANN RP, 1969, J ANIM SCI, V28, P369.
   Aurela B, 1999, FOOD ADDIT CONTAM, V16, P571, DOI 10.1080/026520399283713.
   AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   BERNDTSO.WE, 1974, J REPROD FERTIL, V39, P115.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   BOVE JL, 1978, INT J ENVIRON AN CH, V5, P189, DOI 10.1080/03067317808071144.
   CATER BR, 1977, TOXICOL APPL PHARM, V41, P609, DOI 10.1016/S0041-008X(77)80014-8.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   CREASY DM, 1987, EXP MOL PATHOL, V46, P357, DOI 10.1016/0014-4800(87)90056-6.
   CREASY DM, 1983, J PATHOL, V139, P309, DOI 10.1002/path.1711390307.
   DEKKER I, 1992, CANCER, V69, P993, DOI 10.1002/1097-0142(19920215)69:4<993::AID-CNCR2820690427>3.0.CO;2-8.
   Dieckmann KP, 1999, INT J CANCER, V83, P815, DOI 10.1002/(SICI)1097-0215(19991210)83:6<815::AID-IJC21>3.0.CO;2-Z.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   DUTY SM, 2002, ENV HLTH PERSPECT.
   EMA M, 1993, TOXICOL LETT, V69, P197.
   EMA M, 1994, TOXICOLOGY, V86, P163, DOI 10.1016/0300-483X(94)90002-7.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   FOSTER PMD, 1983, DRUG METAB DISPOS, V11, P59.
   GIAM CS, 1980, ATMOS ENVIRON, V14, P65, DOI 10.1016/0004-6981(80)90108-0.
   GONDOS B, 1973, AM J ANAT, V136, P427, DOI 10.1002/aja.1001360404.
   GONDOS B, 1973, AM J ANAT, V136, P23, DOI 10.1002/aja.1001360104.
   GONDOS B, 1976, AM J ANAT, V145, P167, DOI 10.1002/aja.1001450203.
   Gray LE, 2001, HUM REPROD UPDATE, V7, P248, DOI 10.1093/humupd/7.3.248.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9.
   Hansen J, 1999, INT J CANCER, V82, P911, DOI 10.1002/(SICI)1097-0215(19990909)82:6<911::AID-IJC23>3.0.CO;2-O.
   Hardell L, 1997, INT J CANCER, V73, P828, DOI 10.1002/(SICI)1097-0215(19971210)73:6<828::AID-IJC10>3.0.CO;2-0.
   HEINDEL JJ, 1989, TOXICOL APPL PHARM, V97, P377.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P116, DOI 10.1016/0041-008X(92)90374-2.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Li LH, 2000, TOXICOL APPL PHARM, V166, P222, DOI 10.1006/taap.2000.8972.
   Looijenga LHJ, 1999, REV REPROD, V4, P90, DOI 10.1530/revreprod/4.2.90.
   MOSS GE, 1980, J ANIM SCI, V50, P496.
   MURATURE DA, 1987, BIOMED ENVIRON MASS, V14, P473, DOI 10.1002/bms.1200140815.
   MYICHREEST E, 2002, REPROD TOXICOL, V16, P19.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Mylchreest E, 2000, TOXICOL SCI, V55, P143, DOI 10.1093/toxsci/55.1.143.
   NETT TM, 1977, ENDOCRINOLOGY, V101, P1135.
   NIELSEN H, 1974, ACTA PATH MICRO IM A, VA 82, P235.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   PERWACK J, 1981, EPA440481020 OFF WAT.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   SKAKKEBA.NE, 1972, LANCET, V2, P516.
   Veeramachaneni DNR, 2001, HUM REPROD, V16, P979, DOI 10.1093/humrep/16.5.979.
   VEERAMACHANENI DNR, 2001, J ANDROL S.
   VEERAMACHANENI DNR, 1986, AM J VET RES, V47, P1988.
   Veeramachaneni DNR, 1999, INT J ANDROL, V22, P97.
   Veeramachaneni DNR, 2000, ANIM REPROD SCI, V60, P121, DOI 10.1016/S0378-4320(00)00113-5.
   VEERAMACHANENI DNR, 1993, J EQUINE VET SCI, V13, P207.
   VEERAMACHANENI DNR, 2000, BIOL REPROD, V62, P354.
   Wine RN, 1997, ENVIRON HEALTH PERSP, V105, P102, DOI 10.1289/ehp.97105102.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {*}WHO, 1992, B WHO, V131.}},
Number-of-Cited-References = {{59}},
Times-Cited = {{58}},
Journal-ISO = {{Toxicol. Sci.}},
Doc-Delivery-Number = {{662DP}},
Wos-Id = {{ISI:000181931200017}},
}

@article{ ISI:000181211600001,
Author = {Pietrogrande, MC and Rossi, D and Paganetto, G},
Title = {{Gas chromatographic-mass spectrometric analysis of di(2-ethylhexyl)
   phthalate and its metabolites in hepatic microsomal incubations}},
Journal = {{ANALYTICA CHIMICA ACTA}},
Year = {{2003}},
Volume = {{480}},
Number = {{1}},
Pages = {{1-10}},
Month = {{MAR 17}},
Abstract = {{A method is reported for the determination of di(2-ethylhexyl) phthalate
   (DEHP) and its metabolites in in vitro metabolism studies. Gas
   chromatography-mass spectrometry (GC-MS) analysis allows separation of
   18 by-products of DEHP metabolism. On the basis of retention time and
   specific mass spectra m/z values, three classes of compounds can be
   identified: (i) alcohols as hydrolysis product; (ii) acids produced by
   alcohol oxidation; (iii) compounds retaining phthalic moiety. The
   chromatogram can also be acquired in SIM mode at m/z 149 resulting in 13
   well-separated chromatographic peaks: from retention time and mass
   spectra it can be inferred that the main peaks correspond to
   mono(2-ethylhexyl) phthalate (MEHP) and (omega-1)-hydroxyl-MEHP. The
   kinetics of DEHP metabolism was studied using an S9 Aroclor-induced
   liver fraction as in vitro model and following incubation assay after
   20, 40, 60 and 90 min. The composition of incubation mixtures can be
   quantitatively evaluated from selected ion monitoring chromatograms at
   m/z 149: the by-product concentration increases during the incubation
   time, as a consequence of DEHP degradation. During the incubation test a
   significant conversion of DEHP into MEHP is observed: a conversion yield
   of 10, 13, 16 and 20\% of the original DEHP is obtained after 20, 40, 60
   and 90 min, respectively. The metabolic conversion of DEHP to MEHP
   explains the endocrine-disrupting activity of the original DEHP;
   moreover, it has been demonstrated that MEHP and its (omega-1)-oxidation
   metabolite induce peroxisome proliferation. This result strengthens the
   suggestion that the study of DEHP metabolic pathway is fundamental to
   better understanding its toxicological behavior. (C) 2003 Elsevier
   Science B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Pietrogrande, MC (Reprint Author), Univ Ferrara, Dept Chem, Via L Borsari 46, I-44100 Ferrara, Italy.
   Univ Ferrara, Dept Chem, I-44100 Ferrara, Italy.
   CAT Grp srl, I-44030 Ferrara, Italy.}},
DOI = {{10.1016/S0003-2670(02)01652-5}},
ISSN = {{0003-2670}},
Keywords = {{di(2-ethylhexyl) phthalate; GC-MS analysis; in vitro oxidative
   metabolism; hepatic microsomal incubations}},
Keywords-Plus = {{SOLID-PHASE MICROEXTRACTION; LIQUID-CHROMATOGRAPHY; ESTERS; RATS; ACID;
   EXTRACTION; MONOESTER; PRODUCTS; DIESTER; URINE}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Cited-References = {{Adas F, 1998, J CHROMATOGR B, V714, P133, DOI 10.1016/S0378-4347(98)00244-8.
   ALBRO PW, 1982, J CHROMATOGR, V244, P65, DOI 10.1016/S0021-9673(00)80123-5.
   ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   ATLAS E, 1995, MASS SPECTROMETRY EN, P341.
   AUSTIN J, 1973, ENV HLTH PERSPECT, V4, P3.
   Baltes MRH, 1998, J CHROMATOGR B, V706, P201, DOI 10.1016/S0378-4347(97)00565-3.
   BOWER RK, 1970, J PHARMACOL EXP THER, V171, P314.
   BRIDGES JW, 1988, TOXIC HAZARD ASSESSM, P233.
   CASTLE L, 1987, FOOD ADDIT CONTAM, V4, P399.
   Di Bella G, 1999, J AGR FOOD CHEM, V47, P1009, DOI 10.1021/jf980735b.
   DIRVEN HAAM, 1992, BIOCHEM PHARMACOL, V43, P2621, DOI 10.1016/0006-2952(92)90151-8.
   DIRVEN HAAM, 1993, BIOCHEM PHARMACOL, V45, P2425, DOI 10.1016/0006-2952(93)90223-J.
   Egestad B, 1996, J CHROMATOGR B, V677, P99, DOI 10.1016/0378-4347(95)00439-4.
   Ema M, 1997, TOXICOL LETT, V93, P109, DOI 10.1016/S0378-4274(97)00078-7.
   GROUP EF, 1986, ENVIRON HEALTH PERSP, V65, P337, DOI 10.2307/3430201.
   GUENGERICH FP, 1992, FRONTIERS MOL TOXICO, P99.
   GUESS WL, 1967, AM J HOSP PHARM, V24, P494.
   HABERMAN S, 1968, SPE J, V24, P62.
   HARRIS CA, 1997, ENV HLTH PERSPECT, V105, P8.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   Jonsson S, 2002, J CHROMATOGR A, V963, P393, DOI 10.1016/S0021-9673(02)00647-7.
   Kelly MT, 1999, J CHROMATOGR A, V841, P177, DOI 10.1016/S0021-9673(99)00282-4.
   LAURENCE WH, 1978, CLIN TOXICOL, V13, P89.
   LAW RJ, 1991, WATER SCI TECHNOL, V24, P127.
   LEIBOWITZ JN, 1995, J AOAC INT, V78, P3.
   Luks-Betlej K, 2001, J CHROMATOGR A, V938, P93, DOI 10.1016/S0021-9673(01)01363-2.
   Niino T, 2002, J CHROMATOGR B, V780, P35, DOI 10.1016/S1570-0232(02)00413-0.
   Paganetto G, 2000, PHARMACOL TOXICOL, V86, P24.
   Penalver A, 2000, J CHROMATOGR A, V872, P191, DOI 10.1016/S0021-9673(99)01284-4.
   ROCK G, 1986, ENVIRON HEALTH PERSP, V65, P309, DOI 10.2307/3430198.
   RUSSELL DJ, 1985, J ENVIRON SCI HEAL A, V20, P927.
   SINGH AR, 1972, J PHARM SCI, V61, P51, DOI 10.1002/jps.2600610107.
   TSUTSUI T, 1993, CARCINOGENESIS, V14, P611, DOI 10.1093/carcin/14.4.611.
   YAGI Y, 1980, J ENVIRON PATHOL TOX, V4, P533.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{5}},
Journal-ISO = {{Anal. Chim. Acta}},
Doc-Delivery-Number = {{649MB}},
Wos-Id = {{ISI:000181211600001}},
}

@article{ ISI:000181861200011,
Author = {Gourlay, T and Samartzis, I and Stefanou, D and Taylor, K},
Title = {{Inflammatory response of rat and human neutrophils exposed to
   di-(2-ethyl-hexyl)-phthalate-plasticized polyvinyl chloride}},
Journal = {{ARTIFICIAL ORGANS}},
Year = {{2003}},
Volume = {{27}},
Number = {{3}},
Pages = {{256-260}},
Month = {{MAR}},
Abstract = {{A series of in vitro studies were designed to determine whether
   di-(2-ethyl-hexyl)-phthalate (DEHP)-plasticized polyvinyl chloride (PVC)
   and DEHP itself initiated an inflammatory response in both human and rat
   blood. Additionally, the effect of methanol washing of the PVC on the
   inflammatory response was studied in both blood types. Blood from both
   species was exposed to first, no material; second, ground
   DEHP-plasticized PVC; third, methanol-washed ground DEHP-plasticized
   PVC; and fourth, known concentrations of DEHP. The expression of the
   integrin CD11b was employed as a marker of the inflammatory response.
   After 20 minutes' exposure to PVC, CD11b expression increased to 210 +/-
   32\% of baseline in human blood and to 238 +/- 21.7\% in rodent blood.
   Both blood types showed an increase in CD11b expression with increasing
   concentrations of DEHP (214 +/- 40.8\% of baseline levels in human blood
   and 237 +/- 14.5\% in rodent blood at the highest concentration).
   Methanol washing resulted in a significant moderation in CD11b
   upregulation in both blood types; 117 +/- 27\% of baseline in human and
   150 +/- 14.7\% in rodent. These results support the hypothesis that
   DEHP-plasticized PVC and DEHP itself are proinflammatory in blood from
   both species, and suggest that the rodent is an appropriate model for
   studies of this nature.}},
Publisher = {{BLACKWELL PUBLISHING INC}},
Address = {{350 MAIN ST, MALDEN, MA 02148 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gourlay, T (Reprint Author), Hammersmith Hosp, Imperial Coll Fac Med, NHLI, Dept Cardiac Surg, 2nd Floor B Block,DuCane Rd, London W12 ONN, England.
   Hammersmith Hosp, Imperial Coll Fac Med, NHLI, Dept Cardiac Surg, London W12 ONN, England.}},
DOI = {{10.1046/j.1525-1594.2003.07107.x}},
ISSN = {{0160-564X}},
Keywords-Plus = {{CARDIOPULMONARY BYPASS; RECIRCULATION MODEL; EXPRESSION; CONTACT; BLOOD}},
Research-Areas = {{Engineering; Transplantation}},
Web-of-Science-Categories  = {{Engineering, Biomedical; Transplantation}},
Cited-References = {{Asimakopoulos G, 1999, PERFUSION-UK, V14, P269.
   Asimakopoulos G, 2000, ANN THORAC SURG, V69, P1192, DOI 10.1016/S0003-4975(99)01553-2.
   Borgdorff P, 2000, J THORAC CARDIOV SUR, V120, P12, DOI 10.1067/mtc.2000.105454.
   BUTLER J, 1993, ANN THORAC SURG, V55, P552.
   David RM, 2001, TOXICOL PATHOL, V29, P430, DOI 10.1080/01926230152500040.
   Gourlay T, 2002, ARTIF ORGANS, V26, P5, DOI 10.1046/j.1525-1594.2002.06730.x.
   Gourlay T, 2001, ARTIF ORGANS, V25, P475, DOI 10.1046/j.1525-1594.2001.025006475.x.
   Gourlay T, 2001, PERFUSION-UK, V16, P381.
   HILL GE, 1994, ANAESTH ANALG, V79, P1201.
   MATHEW JP, 1995, J THORAC CARDIOV SUR, V109, P448, DOI 10.1016/S0022-5223(95)70275-X.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.
   Zhao XB, 1999, ARTIF ORGANS, V23, P104, DOI 10.1046/j.1525-1594.1999.06267.x.}},
Number-of-Cited-References = {{13}},
Times-Cited = {{30}},
Journal-ISO = {{Artif. Organs}},
Doc-Delivery-Number = {{660XV}},
Wos-Id = {{ISI:000181861200011}},
}

@article{ ISI:000181659600010,
Author = {Inoue, K and Kawaguchi, M and Okada, F and Yoshimura, Y and Nakazawa, H},
Title = {{Column-switching high-performance liquid chromatography electrospray
   mass spectrometry coupled with on-line of extraction for the
   determination of mono- and di-(2-ethylhexyl) phthalate in blood samples}},
Journal = {{ANALYTICAL AND BIOANALYTICAL CHEMISTRY}},
Year = {{2003}},
Volume = {{375}},
Number = {{4}},
Pages = {{527-533}},
Month = {{FEB}},
Abstract = {{A novel method based on column-switching high-performance liquid
   chromatography-electrospray mass spectrometry (LC-MS) coupled with an
   on-line extraction column containing conjugated avidin has been
   developed for direct injection analysis of di(2-ethylhexyl) phthalate
   (DEHP) and its metabolite, mono(2-ethylhexyl) phthalate (MEHP), in blood
   samples. The sample preparation for on-line extraction involved the
   mixing of blood samples with internal standards, DEHP-d(4) and
   MEHP-d(4), in LC glass vials. A linear response was found for
   column-switching LC-MS when tests were conducted within the validated
   range of 25 to 1000 ng mL(-1) for DEHP and 5 to 1000 ng mL-1 for MEHP,
   with correlation coefficients (r) greater than 0.999. In addition, the
   recoveries of DEHP and MEHP from human plasma were calculated by using
   this method with on-line extraction, yielding recoveries of up to 91.2\%
   (RSD<5\%). We measured the background levels of DEHP and MEHP in six
   human plasma samples from healthy volunteers and three fetal bovine
   serum samples for cell-line culture. DEHP and MEHP were not detected in
   all human plasma samples (N.D. is <25 ng mL(-1) for DEHP, and N.D. is
   <5.0 ng mL(-1) for MEHP). In contrast, high DEHP contamination of
   commercially available fetal bovine serum samples was found by this
   method.}},
Publisher = {{SPRINGER-VERLAG BERLIN}},
Address = {{HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Nakazawa, H (Reprint Author), Hoshi Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.
   Hoshi Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Shinagawa Ku, Tokyo 1428501, Japan.}},
DOI = {{10.1007/s00216-002-1709-9}},
ISSN = {{1618-2642}},
Keywords = {{di(2-ethylhexyl) phthalate, DEHP; mono(2-ethylhexyl) phthalate, MEHP;
   LC-MS; column switching; on-line extraction; blood}},
Keywords-Plus = {{SOLID-PHASE EXTRACTION; DIRECT-INJECTION; DI(2-ETHYLHEXYL) PHTHALATE;
   CONJUGATED COLUMN; DRUG ENANTIOMERS; RIVER WATER; PLASMA; METABOLITES;
   URINE; PLASTICIZERS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Cited-References = {{Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   Egestad B, 1996, J CHROMATOGR B, V677, P99, DOI 10.1016/0378-4347(95)00439-4.
   Fischer FP, 1998, PERITON DIALYSIS INT, V18, P620.
   FUNG YS, 1994, FRESEN J ANAL CHEM, V12, P721.
   Guo XJ, 2002, ANALYST, V127, P480, DOI 10.1039/b111053p.
   Hanawa T, 2000, INT J PHARM, V210, P109, DOI 10.1016/S0378-5173(00)00578-0.
   Hashizume K, 2002, BIOL PHARM BULL, V25, P209, DOI 10.1248/bpb.25.209.
   Hill SS, 2001, CLIN CHIM ACTA, V304, P1, DOI 10.1016/S0009-8981(00)00411-3.
   Inoue K, 2002, CLIN CHIM ACTA, V325, P157, DOI 10.1016/S0009-8981(02)00291-7.
   Kambia K, 2001, J CHROMATOGR B, V755, P297, DOI 10.1016/S0378-4347(01)00125-6.
   Kessler W, 2001, ARCH TOXICOL, V75, P62, DOI 10.1007/s002040000198.
   KOIZUMI M, 2000, JPN J FOOD CHEM, V7, P65.
   KOIZUMI M, 2001, JPN J FOOD CHEM, V8, P1.
   LUKS BK, 2001, J CHROMATOGR A, V938, P93.
   METTANG T, 1997, PERIT DIAL INT S2, V17.
   Molander P, 2002, ANALYST, V127, P892, DOI 10.1039/b201651f.
   ODA Y, 1992, J PHARM SCI, V81, P1227, DOI 10.1002/jps.2600811221.
   ODA Y, 1991, J CHROMATOGR-BIOMED, V572, P133, DOI 10.1016/0378-4347(91)80478-U.
   ODA Y, 1992, J LIQ CHROMATOGR, V15, P2997, DOI 10.1080/10826079208016366.
   Saito Y, 2002, ANAL BIOANAL CHEM, V373, P81, DOI 10.1007/s00216-002-1270-6.
   Saito Y, 2002, ANAL BIOANAL CHEM, V372, P164, DOI 10.1007/s00216-001-1126-5.
   Suzuki T, 2001, ENVIRON SCI TECHNOL, V35, P3757, DOI 10.1021/es001860i.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Trittler R, 2002, J CHROMATOGR B, V775, P127, DOI 10.1016/S1570-0232(02)00298-2.
   YAKUBOVICH M, 2000, MED DEVICE TECHNOL, V11, P18.
   2002, HLTH CANADA EXPERT A.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{18}},
Journal-ISO = {{Anal. Bioanal. Chem.}},
Doc-Delivery-Number = {{657HD}},
Wos-Id = {{ISI:000181659600010}},
}

@article{ ISI:000180412800019,
Author = {Koch, HM and Gonzalez-Reche, LM and Angerer, J},
Title = {{On-line clean-up by multidimensional liquid chromatography-electrospray
   ionization tandem mass spectrometry for high throughput quantification
   of primary and secondary phthalate metabolites in human urine}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES}},
Year = {{2003}},
Volume = {{784}},
Number = {{1}},
Pages = {{169-182}},
Month = {{JAN 25}},
Abstract = {{We developed a new and fast multidimensional on-line HPLC-method for the
   quantitative determination of the secondary, chain oxidized monoester
   metabolites of diethylhexylphthalate (DEHP),
   5-hydroxy-mono-(2-ethylhexyl)-phthalate (5OH-MEHP) and
   5-oxo-mono-(2-ethylhexyl)-phthalate (5oxo-MEHP) in urine samples from
   the general population. Also included in the method were the simple
   monoester metabolites of DEHP, dioctylphthalate (DOP), dibutylphthalate
   (DBP), butylbenzylphthalate (BBzP) and diethylphthalate (DEP). Except
   for enzymatic hydrolysis for deconjugation of the metabolites no further
   sample pre-treatment step is necessary. The phthalate metabolites are
   stripped from urinary matrix by on-line extraction on a restricted
   access material (LiChrospher(R) ADS-8) precolumn, transferred in
   backflush-mode and chromatographically resolved by reversed-phase HPLC.
   Eluting metabolites are detected by ESI-tandem mass spectrometry in
   negative ionization mode and quantified by isotope dilution. Within a
   total run time of 25 min we can selectively and sensitively quantify
   seven urinary metabolites of six commonly occurring phthalate diesters
   including the controversial di(2-ethylhexyl)phthalate (DEHP). The
   detection limits for all analytes are in the low ppb range (0.5-2.0
   mug/l urine). First results on a small non-exposed group (n = 8) ranged
   for 5OH-MEHP from 0.59 to 124 mug/l, for 5oxo-MEHP from <LOQ to 73.0
   \&mu;g/l, and for MEHP from <LOQ to 41.1 mug/l. The other short chain
   monoester metabolites were detectable in every sample with mean
   concentrations for MnBuP of 36.5 mug/l, for MBzP of 7.19 mug/l and MEP
   of 1.0 mg/l. With this rapid and economic method we can determine the
   internal exposure of the general population to DEHP and other phthalates
   as well as the body burden of occupationally and medically exposed
   subjects. The results can help to rank the risks of phthalates in the
   areas of carcinogenesis, peroxisome proliferation and endocrine
   disruption. Since secondary, functionalized metabolites of DEHP are
   included in the method an enduring problem of the past is excluded:
   sample contamination in the pre-analytical and analytical phase by both
   di- and monoesters. (C) 2002 Elsevier Science B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Angerer, J (Reprint Author), Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, Schillerstr 25-29, D-91054 Erlangen, Germany.
   Univ Erlangen Nurnberg, Inst \& Outpatient Clin Occupat Social \& Environm, D-91054 Erlangen, Germany.}},
DOI = {{10.1016/S1570-0232(02)00785-7}},
ISSN = {{1570-0232}},
Keywords = {{biological monitoring; plasticizers; phthalates}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; DI-2-ETHYLHEXYL PHTHALATE; EXPOSURE; PLASMA;
   PLASTICIZERS; SAMPLES; HEALTH}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
ResearcherID-Numbers = {{Koch, Holger/B-3277-2011}},
ORCID-Numbers = {{Koch, Holger/0000-0002-8328-2837}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   ANGERER J, 2001, BIOL MONITORING HEUT.
   ANGERER J, 1998, ENCY ENV ANAL REMEDI, P702.
   Angerer J, 1996, Ann Ist Super Sanita, V32, P199.
   ANGERER J, 1985, SCAND J WORK ENV HEA, V11, P45.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   BOHME C, 1998, BUNDESGESUNDHBL, V41, P340.
   Butte W, 2001, GEFAHRST REINHALT L, V61, P19.
   David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   DIRVEN HAAM, 1993, BIOCHEM PHARMACOL, V45, P2425, DOI 10.1016/0006-2952(93)90223-J.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   FROMME H, 1999, PRAKTISCHE UMWELTM 4.
   Gilsing HD, 2002, MONATSH CHEM, V133, P1147, DOI 10.1007/s007060200084.
   Hellwig J, 1997, FOOD CHEM TOXICOL, V35, P501, DOI 10.1016/S0278-6915(97)00008-2.
   Hoyer PB, 2001, BIOCHEM PHARMACOL, V62, P1557, DOI 10.1016/S0006-2952(01)00814-0.
   Huber WW, 1996, CRIT REV TOXICOL, V26, P365, DOI 10.3109/10408449609048302.
   Kambia K, 2001, J CHROMATOGR B, V755, P297, DOI 10.1016/S0378-4347(01)00125-6.
   Kambia K, 2001, INT J PHARM, V229, P139, DOI 10.1016/S0378-5173(01)00840-7.
   Kleinsasser NH, 2001, TERATOGEN CARCIN MUT, V21, P189, DOI 10.1002/tcm.1007.
   LARSEN K, 1972, CLIN CHIM ACTA, V41, P209, DOI 10.1016/0009-8981(72)90513-X.
   LEISEWITZ A, 1997, 10601076 BUND UMW NA.
   LEISEWITZ A, 1999, ATV SCHRIFTENREIHE, V15, P22.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   PIRKLE JL, 1995, ENVIRON HEALTH PERSP, V103, P45, DOI 10.2307/3432559.
   RIPPEN G, 2000, HDB UMWELTCHEMIKAL S.
   SAMPSON EJ, 1994, CLIN CHEM, V40, P1376.
   SCHAFER WR, 1996, UMWELTMED, V1, P35.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SJOBERG P, 1985, J CHROMATOGR, V344, P167, DOI 10.1016/S0378-4347(00)82017-4.
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Youssef J, 1998, CRIT REV TOXICOL, V28, P1, DOI 10.1080/10408449891344182.
   {*}BER UMW ALTL, 1986, 4 BUA.
   {*}BER UMW ALTL, 1987, 22 BUA.
   {*}BER UMW ALTL, 1993, 114 BUA.
   {*}DTSCH FORSCH, 2001, TOX ARB BEGR MAK WER.
   {*}EUR COMM, 2000, GREEN PAP ENV ISS PV.
   {*}INT AG RES CANC, 1982, IARC MON EV CARC RIS, V29, P416.
   {*}US DEP HHS, 1993, TOX PROF DI 2 ETH PH, P171.}},
Number-of-Cited-References = {{43}},
Times-Cited = {{93}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{635RK}},
Wos-Id = {{ISI:000180412800019}},
}

@article{ ISI:000185668000008,
Author = {Paris, I and Ruggieri, F and Mazzeo, P and Carlucci, G},
Title = {{Simultaneous determination of di(2-ethylhexyl)phthalate and
   mono(2-ethylhexyl)phthalate in human plasma by high-performance liquid
   chromatography}},
Journal = {{ANALYTICAL LETTERS}},
Year = {{2003}},
Volume = {{36}},
Number = {{12}},
Pages = {{2649-2658}},
Abstract = {{A method for the simultaneous determination of di(2-ethylhexyl)phthalate
   and its major metabolite mono(2-ethylhexyl)phthalate in human plasma by
   high-performance liquid chromatography is described. The procedure,
   linear in the concentration range 0.05-5.0 ppm, is simple and rapid and
   allows accurate and precise results. The limits of detection for
   di(2-ethylhexyl)phthalate and mono(2-ethylhexyl)phthalate were 0.05 ppm.}},
Publisher = {{MARCEL DEKKER INC}},
Address = {{270 MADISON AVE, NEW YORK, NY 10016 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mazzeo, P (Reprint Author), Univ Aquila, Dipartimento Chim Ingn Chim \& Mat, Via Vetoio, I-67010 Coppito, Laquila, Italy.
   Univ Aquila, Dipartimento Chim Ingn Chim \& Mat, I-67010 Coppito, Laquila, Italy.
   Univ G DAnnunzio, Fac Farm, Dipartimento Sci Farm, Chieti, Italy.}},
DOI = {{10.1081/AL-120024639}},
ISSN = {{0003-2719}},
Keywords = {{di(2-ethylhexyl)phthalate; mono(ethylhexyl)phthalate; simultaneous
   determination; human plasma; HPLC}},
Keywords-Plus = {{DI-(2-ETHYLHEXYL) PHTHALATE; ENVIRONMENTAL CONTAMINANT; CONJUGATED
   METABOLITES; EXCHANGE-TRANSFUSION; INFUSION SOLUTIONS;
   MASS-SPECTROMETRY; NEWBORN-INFANTS; COMPATIBILITY; CONTAINERS;
   EXTRACTION}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Cited-References = {{ALBRO PW, 1982, J CHROMATOGR, V244, P65, DOI 10.1016/S0021-9673(00)80123-5.
   AMUNDSON SC, 1978, J CHROMATOGR SCI, V16, P170.
   BARTHES DMC, 1994, AM J HOSP PHARM, V51, P2706.
   BHUJLE VV, 1984, ANALYST, V109, P177, DOI 10.1039/an9840900177.
   Boselli P M, 1991, Boll Chim Farm, V130, P213.
   COHEN H, 1991, ARCH ENVIRON CON TOX, V20, P437.
   Craig SB, 1997, J PHARMACEUT BIOMED, V16, P199, DOI 10.1016/S0731-7085(97)00022-8.
   DAVIES AG, 1957, J CHEM SOC, P3148, DOI 10.1039/jr9570003148.
   DINE T, 1991, BIOMED CHROMATOGR, V5, P94, DOI 10.1002/bmc.1130050211.
   EGESTAD B, 1988, BIOMED ENVIRON MASS, V16, P151, DOI 10.1002/bms.1200160126.
   Egestad B, 1996, J CHROMATOGR B, V677, P99, DOI 10.1016/0378-4347(95)00439-4.
   FAOUZI ME, 1995, J PHARMACEUT BIOMED, V13, P1363, DOI 10.1016/0731-7085(95)01553-W.
   GANNING AE, 1984, HEPATOLOGY, V4, P541, DOI 10.1002/hep.1840040331.
   GRIFFITHS WC, 1985, ANN CLIN LAB SCI, V15, P140.
   KLUWE WM, 1982, J TOXICOL ENV HEALTH, V10, P797.
   LAKE BG, 1975, TOXICOL APPL PHARM, V32, P355, DOI 10.1016/0041-008X(75)90226-4.
   Morelli-Cardoso MHW, 1999, HRC-J HIGH RES CHROM, V22, P70.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   POLLACK GM, 1984, J CHROMATOGR, V311, P101, DOI 10.1016/S0378-4347(00)84695-2.
   SHINTANI H, 1985, J CHROMATOGR, V337, P279, DOI 10.1016/0378-4347(85)80041-4.
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x.
   Steiner I, 1998, FOOD ADDIT CONTAM, V15, P812.
   WAMS TJ, 1987, SCI TOTAL ENVIRON, V66, P1, DOI 10.1016/0048-9697(87)90072-6.
   YOSHIKAWA K, 1983, FOOD CHEM TOXICOL, V21, P221, DOI 10.1016/0278-6915(83)90239-9.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{4}},
Journal-ISO = {{Anal. Lett.}},
Doc-Delivery-Number = {{727PU}},
Wos-Id = {{ISI:000185668000008}},
}

@article{ ISI:000180909800005,
Author = {Latini, G and De Felice, C and Presta, G and Del Vecchio, A and Paris, I
   and Ruggieri, F and Mazzeo, P},
Title = {{Exposure to Di(2-ethyl hexyl)phthalate in humans during pregnancy - A
   preliminary report}},
Journal = {{BIOLOGY OF THE NEONATE}},
Year = {{2003}},
Volume = {{83}},
Number = {{1}},
Pages = {{22-24}},
Abstract = {{Background. Di(2-ethylhexyl)phthalate (DEHP), the most commonly used
   plasticizer, is a widespread ubiquitous environmental contaminant. The
   potential health hazards from exposure to DEHP and its main metabolite,
   mono(2-ethylhexyl)phthalate (MEHP), have been well documented. Exposure
   to DEHP and MEHP in humans at risk, such as pregnant women and human
   fetuses, has not been tested. Methods: Plasma DEHP and MEHP
   concentrations were measured in a total of 24 consecutive mother-infant
   pairs by high performance liquid chromatography. Associations between
   DEHP/MEHP and infant characteristics were tested using Fisher's exact
   test, unpaired t tests and univariate linear regression analysis.
   Results: Measurable DEHP and MEHP concentrations were found in 17/24
   (70.8\%) and 18/24 (75\%) maternal plasmas, respectively, and in 11/25
   (44\%) and 18/25 (72.0\%) cord samples, respectively. Either DEHP or
   MEHP were detectable in 21/24 (87.5\%) maternal plasmas and 19/25 (76\%)
   cord samples. The mean DEHP concentrations in maternal and cord plasmas
   were 1.15 +/- 0.81 and 2.05 +/- 1.47 mug/ml, respectively. The mean MEHP
   concentrations were 0.68 +/- 0.85 and 0.68 +/- 1.03 mug/ml,
   respectively. No significant correlations were found between maternal
   and cord blood DEHP, maternal and cord blood MEHP, maternal DEHP and
   cord blood MEHP, or maternal MEHP and cord blood DEHP plasma
   concentrations. Conclusion: Although the effects of perinatal exposure
   to phthalates need further research, our findings: (i) confirm the high
   frequency of DEHP and/or MEHP exposure in human pregnancies; (ii)
   indicate that the exposure to these environmental contaminants begins
   during intrauterine life, and (iii) suggest that fetal exposure is
   closely related to the maternal exposure. Copyright (C) 2003 S. Karger
   AG, Basel.}},
Publisher = {{KARGER}},
Address = {{ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Latini, G (Reprint Author), Azienda Osped A Di Summa, Perrino Hosp,Div Pediat, Clin Physiol Inst,Natl Res Council Italy, Lecce Sect,Neonatal Intens Care Unit, Piazza Antonio Di Summa, I-72100 Brindisi, Italy.
   Azienda Osped A Di Summa, Perrino Hosp,Div Pediat, Clin Physiol Inst,Natl Res Council Italy, Lecce Sect,Neonatal Intens Care Unit, I-72100 Brindisi, Italy.
   Univ Siena, Neonatal Intens Care Unit, Dept Pediat Obstet \& Reprod Med, I-53100 Siena, Italy.
   Univ Aquila, Dept Chem Chem Engn \& Mat, Coppito, Italy.}},
DOI = {{10.1159/000067012}},
ISSN = {{0006-3126}},
Keywords = {{Di(2-ethylhexyl)phthalate; mono(2-ethylhexyl)phthalate; prenatal
   exposure; environmental hazards}},
Keywords-Plus = {{SEXUAL-DIFFERENTIATION; MALE-RAT; DIETHYLHEXYL PHTHALATE; MALFORMATIONS;
   DEHP}},
Research-Areas = {{Pediatrics}},
Web-of-Science-Categories  = {{Pediatrics}},
Cited-References = {{Akingbemi BT, 2001, BIOL REPROD, V65, P1252, DOI 10.1095/biolreprod65.4.1252.
   Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   Barrett JR, 2001, ENVIRON HEALTH PERSP, V109, pA524, DOI 10.1289/ehp.109-a524a.
   DAVIES AG, 1957, J CHEM SOC, P3148, DOI 10.1039/jr9570003148.
   DELVECCHIO A, 2001, PEDIATR RES, V50, pA283.
   Foster PMD, 2001, HUM REPROD UPDATE, V7, P231, DOI 10.1093/humupd/7.3.231.
   GIAM CS, 1978, SCIENCE, V199, P419, DOI 10.1126/science.199.4327.419-a.
   Gray LE, 2000, TOXICOL SCI, V58, P350, DOI 10.1093/toxsci/58.2.350.
   GRIFFITHS WC, 1985, ANN CLIN LAB SCI, V15, P140.
   Kambia K, 2001, J CHROMATOGR B, V755, P297, DOI 10.1016/S0378-4347(01)00125-6.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   MAYER FL, 1972, NATURE, V238, P411, DOI 10.1038/238411a0.
   Parks LG, 2000, TOXICOL SCI, V58, P339, DOI 10.1093/toxsci/58.2.339.
   Sharpe RM, 2001, TOXICOL LETT, V120, P221, DOI 10.1016/S0378-4274(01)00298-3.
   SINGH AR, 1975, J PHARM SCI, V64, P1347, DOI 10.1002/jps.2600640819.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   TOMITA I, 1986, ENVIRON HEALTH PERSP, V65, P249, DOI 10.2307/3430190.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {*}US FDA, 2001, SAF ASS DI2 ETH PHTH.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{35}},
Journal-ISO = {{Biol. Neonate}},
Doc-Delivery-Number = {{644GP}},
Wos-Id = {{ISI:000180909800005}},
}

@article{ ISI:000184426800011,
Author = {Kato, K and Yamauchi, T and Higashiyama, K and Nakazawa, H},
Title = {{High throughput analysis of di-(2-ethylhexyl)phthalate metabolites in
   urine for exposure assessment}},
Journal = {{JOURNAL OF LIQUID CHROMATOGRAPHY \& RELATED TECHNOLOGIES}},
Year = {{2003}},
Volume = {{26}},
Number = {{13}},
Pages = {{2167-2176}},
Abstract = {{In order to assess exposure, we developed high throughput analysis of
   di(2-ethylhexyl)phthalate (DEHP) metabolites in urine using an on-line
   solid phase extraction-liquid chromatography/tandem mass spectrometry
   (on-line SPE-HPLC-MS/MS) method. The metabolites were detected in the
   negative mode by select reaction monitoring at low nanogram per
   milliliter levels. Repeatability and reproducibility of the methods was
   checked by analyzing spiked urine. The results, expressed as relative
   standard deviation (RSD\%), varied from 0.8 to 6.9. The recoveries were
   above 85.8\%. Three metabolites of DEHP were detected with the levels
   from 9.5 to 320.8 ng mL(-1) for mono-(2-ethyl-5-hydroxyhexyl)phthatate
   (VI), from 13.9 to 187.5 ng mL(-1) for
   mono-(5carboxy-2-ethylpentyl)phthalate (IX), and from ND to 13.9 ng
   mL(-1) for mono-(2-ethylhexyl)phthalate (MEHP). The concentration levels
   of VI and IX were detected higher than MEHP. The frequencies of VI and
   IX were 100\%. The proposed method introduces the possibility of
   determining these metabolites within 8 min (including sample preparation
   time), while also increasing sensitivity and reducing amounts of sample
   and solvent required.}},
Publisher = {{MARCEL DEKKER INC}},
Address = {{270 MADISON AVE, NEW YORK, NY 10016 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Nakazawa, H (Reprint Author), Hoshi Univ, Dept Analyt Chem, Fac Pharmaceut Sci, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.
   Hoshi Univ, Dept Analyt Chem, Fac Pharmaceut Sci, Shinagawa Ku, Tokyo 1428501, Japan.
   Hoshi Univ, Inst Med Chem, Tokyo 1428501, Japan.}},
DOI = {{10.1081/JLC-120022401}},
ISSN = {{1082-6076}},
Keywords = {{DEHP metabolites; HPLC-MS/MS; exposure assesment}},
Keywords-Plus = {{DIETHYLHEXYL-PHTHALATE; DI(2-ETHYLHEXYL)PHTHALATE; APOPTOSIS; RATS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   Anderson WAC, 2001, FOOD ADDIT CONTAM, V18, P1068, DOI 10.1080/02652030110050113.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Brock JW, 2002, B ENVIRON CONTAM TOX, V68, P309, DOI {[}10.1007/s00128-001-0255-z, 10.1007/s001280255].
   DRIVEN HAA, 1993, INT ARCH OCC ENV HEA, V64, P555.
   Elcombe CR, 2002, ENVIRON HEALTH PERSP, V110, P363.
   Hoppin JA, 2002, ENVIRON HEALTH PERSP, V110, P515.
   Kang KS, 2002, J TOXICOL ENV HEAL A, V65, P447, DOI 10.1080/15287390252808109.
   Kasahara E, 2002, BIOCHEM J, V365, P849, DOI 10.1042/BJ20020254.
   KAYOKO K, 2003, J CHROMATOGR B, V788, P407.
   Loff S, 2002, JPEN-PARENTER ENTER, V26, P305, DOI 10.1177/0148607102026005305.
   Mettang T, 1996, NEPHROL DIAL TRANSPL, V11, P2439.
   Norback D, 2000, INT J TUBERC LUNG D, V4, P1016.
   Park JD, 2002, TOXICOLOGY, V171, P105, DOI 10.1016/S0300-483X(01)00567-4.}},
Number-of-Cited-References = {{15}},
Times-Cited = {{6}},
Journal-ISO = {{J. Liq. Chromatogr. Relat. Technol.}},
Doc-Delivery-Number = {{705ZH}},
Wos-Id = {{ISI:000184426800011}},
}

@article{ ISI:000180151700026,
Author = {Fukuwatari, T and Suzuki, Y and Sugimoto, E and Shibata, K},
Title = {{Identification of a toxic mechanism of the plasticizers, phtahlic acid
   esters, which are putative endocrine disrupters: Time-dependent increase
   in quinolinic acid and its metabolites in rats fed
   di(2-ethylhexyl)phthalate}},
Journal = {{BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY}},
Year = {{2002}},
Volume = {{66}},
Number = {{12}},
Pages = {{2687-2691}},
Month = {{DEC}},
Abstract = {{We have reported that the administration of di(2-ethylhexyl)phthalate
   (DEHP) increased the formations of quinolinic acid (QA) and its lower
   metabolites on the tryptophan-niacin pathway. To discover the mechanism
   involved in disruption of the tryptophan-niacin pathway by DEHP, we
   assessed the daily urinary excretion of QA and its lower metabolites,
   and enzyme activities on the tryptophan-niacin pathway. Rats were fed
   with a niacin-free, 20\% casein diet or the same diet supplemented with
   0.1\% DEHP or 0.043\% phthalic acid and 0.067\% 2-ethylhexanol added for
   21 days. Feeding of DEHP increased the urinary excretions of QA and its
   lower metabolites in a time-dependent manner, and the increase of these
   excretions reached a peak at 11 days, but feeding of phthalic acid and
   2-ethylhexanol had no effect. Feeding of DEHP, however, did not affect
   any enzyme activity including
   alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase
   (ACMSD), affecting the formation of QA, on the tryptophan-niacin
   pathway.}},
Publisher = {{JAPAN SOC BIOSCI BIOTECHN AGROCHEM}},
Address = {{JAPAN ACAD SOC CTR BLDG, 2-4-6 YAYOI BUNKYO-KU, TOKYO, 113, JAPAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fukuwatari, T (Reprint Author), Univ Shiga Prefecture, Sch Human Cultures, Dept Life Style Studies, Lab Food Sci \& Nutr, Shiga 5228533, Japan.
   Univ Shiga Prefecture, Sch Human Cultures, Dept Life Style Studies, Lab Food Sci \& Nutr, Shiga 5228533, Japan.}},
ISSN = {{0916-8451}},
Keywords = {{phthalate ester; di(2-ethylhexyl)phthalate; quinolinic acid; endocrine
   disrupters; tryptophan metabolism}},
Keywords-Plus = {{PERFORMANCE LIQUID-CHROMATOGRAPHY; TRYPTOPHAN-NIACIN METABOLISM;
   3-HYDROXYANTHRANILIC ACID; MICRO-DETERMINATION; CONVERSION RATIO;
   PHTHALATE DEHP; NICOTINAMIDE; URINE; LIVER}},
Research-Areas = {{Biochemistry \& Molecular Biology; Biotechnology \& Applied
   Microbiology; Chemistry; Food Science \& Technology}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Biotechnology \& Applied
   Microbiology; Chemistry, Applied; Food Science \& Technology}},
Cited-References = {{Egashira Y, 1997, J NUTR SCI VITAMINOL, V43, P233.
   Fukuwatari T, 2001, BIOSCI BIOTECH BIOCH, V65, P2154, DOI 10.1271/bbb.65.2154.
   Fukuwatari T, 2002, BIOSCI BIOTECH BIOCH, V66, P705.
   HAYAISHI O, 1965, VITAMINS, V31, P107.
   ICHIYAMA A, 1965, J BIOL CHEM, V240, P740.
   IKEDA M, 1965, J BIOL CHEM, V240, P1395.
   Isenberg JS, 2000, TOXICOL SCI, V56, P73, DOI 10.1093/toxsci/56.1.73.
   KLUWE WM, 1982, J TOXICOL ENV HEALTH, V10, P797.
   LAKE BG, 1977, TOXICOL APPL PHARM, V39, P239, DOI 10.1016/0041-008X(77)90157-0.
   MAWATARI K, 1995, ANAL CHIM ACTA, V302, P179, DOI 10.1016/0003-2670(94)00493-6.
   PULLMAN ME, 1954, J BIOL CHEM, V206, P121.
   Saito K, 2000, AM J PHYSIOL-RENAL, V279, pF565.
   Shibata K, 2000, J CHROMATOGR B, V749, P281, DOI 10.1016/S0378-4347(00)00406-0.
   SHIBATA K, 1992, BIOSCI BIOTECH BIOCH, V56, P974.
   SHIBATA K, 1988, J CHROMATOGR-BIOMED, V424, P23, DOI 10.1016/S0378-4347(00)81072-5.
   SHIBATA K, 1994, BIOSCI BIOTECH BIOCH, V58, P1757.
   SHIBATA K, 1987, AGR BIOL CHEM TOKYO, V51, P811.
   SHIBATA K, 1988, J CHROMATOGR-BIOMED, V430, P376, DOI 10.1016/S0378-4347(00)83173-4.
   SHIBATA K, 1987, Vitamins (Kyoto), V61, P599.
   Shibata K, 2001, J NUTR SCI VITAMINOL, V47, P263.
   SHIBATA K, 1982, J NUTR SCI VITAMINOL, V28, P173.
   SHIBATA K, 1991, AGR BIOL CHEM TOKYO, V55, P143.
   Shin M, 1999, TOXICOL APPL PHARM, V158, P71, DOI 10.1006/taap.1999.8683.
   THOMAS JA, 1982, ENVIRON HEALTH PERSP, V45, P85, DOI 10.2307/3429388.
   Ward JM, 1998, TOXICOL PATHOL, V26, P240.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{13}},
Journal-ISO = {{Biosci. Biotechnol. Biochem.}},
Doc-Delivery-Number = {{631DG}},
Wos-Id = {{ISI:000180151700026}},
}

@article{ ISI:000179497700008,
Author = {Watanabe, N and Shimizu, M and Matsumoto, Y and Fukuoka, M},
Title = {{Testicular toxicity of mono-n-butyl phthalate and related phthalates on
   bound iron in rat red blood cells}},
Journal = {{JOURNAL OF HEALTH SCIENCE}},
Year = {{2002}},
Volume = {{48}},
Number = {{6}},
Pages = {{527-533}},
Month = {{DEC}},
Abstract = {{It was previously reported that free iron was released from rat red
   blood cells in both an in vitro study with a metabolite,
   mono-n-butylphthalate (MBP), of di-n-butylphthalate (DBP) and an in vivo
   study with oral DBP, inducing rat testicular atrophy in hypoxic
   conditions due to MBP-induced hemoglobin deprivation. This study
   investigated whether mono-n-alkylphthalates (alkyl-carbon C-4-C-6 ;
   MAP), which result in rat testicular damage, induce iron release from
   hemoglobin by incubation with rat red blood cells. Iron release was
   observed with C-3-C-6 MAP incubation at lower doses and with C-1 and C-2
   MAP incubation at higher doses, but not with C-7, C-8, and C-4(6) MAP.}},
Publisher = {{PHARMACEUTICAL SOC JAPAN}},
Address = {{2-12-15-201 SHIBUYA, SHIBUYA-KU, TOKYO, 150, JAPAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fukuoka, M (Reprint Author), Showa Pharmaceut Univ, Dept Clin Pharmacol \& Toxicol, Higashi Tamagawagakuen 3-3165, Machida, Tokyo 1948543, Japan.
   Showa Pharmaceut Univ, Dept Clin Pharmacol \& Toxicol, Machida, Tokyo 1948543, Japan.}},
DOI = {{10.1248/jhs.48.527}},
ISSN = {{1344-9702}},
Keywords = {{di-n-butylphthalate; mono-n-alkylphthalate; testicular damage;
   hemoglobin; hypoxia}},
Keywords-Plus = {{LIPID-PEROXIDATION; GERM-CELLS; HEMOGLOBIN; MECHANISM; TRANSFERRIN;
   DEPLETION; FERRITIN; STORAGE; SERTOLI; ACID}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Cited-References = {{Arun P, 1999, VOX SANG, V76, P220, DOI 10.1159/000031055.
   Bieber E, 2001, J REPROD MED, V46, P521.
   BONAFE CFS, 1991, J BIOL CHEM, V266, P13210.
   CICCOLI L, 1994, EXP MOL PATHOL, V60, P108, DOI 10.1006/exmp.1994.1010.
   COHN VH, 1966, ANAL BIOCHEM, V14, P434, DOI 10.1016/0003-2697(66)90286-7.
   DAUGHERTY MA, 1994, BIOCHEMISTRY-US, V33, P10345, DOI 10.1021/bi00200a015.
   Deepa Devi K. V., 1998, Vox Sanguinis, V75, P198, DOI 10.1159/000030987.
   FERRALI M, 1992, BIOCHEM J, V285, P295.
   Foster PMD, 2000, FOOD CHEM TOXICOL, V38, pS97, DOI 10.1016/S0278-6915(99)00128-3.
   FUKUOKA M, 1993, J APPL TOXICOL, V13, P241, DOI 10.1002/jat.2550130406.
   FUKUOKA M, 1995, J APPL TOXICOL, V15, P379, DOI 10.1002/jat.2550150507.
   FUKUOKA M, 1994, BIOL PHARM BULL, V17, P1609.
   GAD SC, 1982, PRINCIPLES METHODS T, P273.
   GOGGANS JF, 1939, J AM CHEM SOC, V61, P2909, DOI 10.1021/ja01265a094.
   IARC, 2000, MONOGR EVAL CARCINOG, V77, P41.
   Manojkumar V, 1999, INDIAN J MED RES, V109, P157.
   MCNEIL TL, 1968, ANAL BIOCHEM, V22, P431, DOI 10.1016/0003-2697(68)90285-6.
   Moulton DP, 1996, BIOCHEM BIOPH RES CO, V226, P309, DOI 10.1006/bbrc.1996.1352.
   OISHI S, 1980, TOXICOLOGY, V15, P197, DOI 10.1016/0300-483X(80)90053-0.
   PENNINGTON R, 1961, BIOCHEM J, V80, P649.
   Romero PJ, 1999, CELL CALCIUM, V26, P131, DOI 10.1054/ceca.1999.0063.
   Safo MK, 2001, PROTEIN SCI, V10, P951, DOI 10.1110/ps.50601.
   SETCHELL BP, 1981, J ENDOCRINOL, V91, P245, DOI 10.1677/joe.0.0910245.
   SPAGNUOLO C, 1994, J BIOL CHEM, V269, P20441.
   TELEN MJ, 1993, VINTROBES CLIN HEMAT, V1, P101.
   WATANABE N, 2002, J HEALTH SCI, P503.
   ZHOU Y, 1990, J APPL TOXICOL, V10, P447, DOI 10.1002/jat.2550100612.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{0}},
Journal-ISO = {{J. Health Sci.}},
Doc-Delivery-Number = {{619VG}},
Wos-Id = {{ISI:000179497700008}},
}

@article{ ISI:000179132200004,
Author = {Kim, EJ and Kim, JW and Lee, SK},
Title = {{Inhibition of oocyte development in Japanese medaka (Oryzias latipes)
   exposed to di-2-ethylhexyl phthalate}},
Journal = {{ENVIRONMENT INTERNATIONAL}},
Year = {{2002}},
Volume = {{28}},
Number = {{5}},
Pages = {{359-365}},
Month = {{NOV}},
Abstract = {{Di-2-ethylhexyl phthalate (DEHP) is a widely used plasticizer known to
   be a suspected endocrine disrupter, but its precise effects on aquatic
   organisms are not yet known, When Japanese medaka (Oryzias latipes) were
   exposed from the time of hatching to 3 months of age to an aqueous DEHP
   solution at nominal concentrations of 1, 10, and 50 mug/l, DEHP-treated
   female fish showed distinct reproductive effects as follows. First,
   blood vitellogenin levels in all treated test subjects markedly
   decreased. Second, Gonado Somatic Index (GSI) decreased to 33\% and 38\%
   of the control GSI in 10 mug/l and 50 mug/l treated female fish,
   respectively. Third, 54\% of female fish in the control treatment had
   completely matured oocytes in their ovaries, but only 37\%, 0\% and 22\%
   of female fish matured to the last stage in the 1, 10 and 50 mug/l
   treated test subjects, respectively. Unlike female fish, no change or
   adverse effects were observed in the male fish. In summary, DEHP hinders
   the development of reproductive organs in the female Japanese medaka. In
   this work, the possibility of anti-estrogenic activity of DEHP is
   proposed as the cause. (C) 2002 Elsevier Science Ltd. All rights
   reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kim, EJ (Reprint Author), Pohang Univ Sci \& Technol, Digital Informat Ctr Environm Res, Nam Gu, Hyoja Dong,San 31, Pohang 790784, South Korea.
   Korea Res Inst Chem Technol, Environm Toxicol Team, Yusung Gu, Taejon 305600, South Korea.
   Seoul Natl Univ, Sch Environm Studies, Dept Environm Planning, Kwanank Gu, Seoul 151742, South Korea.}},
DOI = {{10.1016/S0160-4120(02)00058-2}},
ISSN = {{0160-4120}},
Keywords = {{di-2-ethylhexyl phthalate; Japanese medaka (Oryzias latipes);
   vitellogenin; oocyte development; reproduction disorder}},
Keywords-Plus = {{IN-VITRO; VITELLOGENIN PRODUCTION; TESTIS-OVA; ESTERS; ESTRADIOL;
   VETULUS; CELLS; CARP}},
Research-Areas = {{Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Environmental Sciences}},
Cited-References = {{Anderson MJ, 1996, AQUAT TOXICOL, V34, P327, DOI 10.1016/0166-445X(95)00047-8.
   CHEN TT, 1986, CAN J FISH AQUAT SCI, V43, P169, DOI 10.1139/f86-019.
   CHEN TT, 1978, J BIOL CHEM, V253, P5325.
   GIAM CS, 1978, SCIENCE, V199, P419, DOI 10.1126/science.199.4327.419-a.
   Gimeno S, 1996, NATURE, V384, P221, DOI 10.1038/384221a0.
   Giam C.S., 1984, Handbook of Environmental Chemistry, V3C, P67.
   GRAHAM PR, 1973, ENV HLTH PERSPECT, V1, P3.
   Gray MA, 1999, ENVIRON TOXICOL CHEM, V18, P1835, DOI 10.1897/1551-5028(1999)018<1835:FATDOT>2.3.CO;2.
   Gray MA, 1997, ENVIRON TOXICOL CHEM, V16, P1082, DOI 10.1897/1551-5028(1997)016<1082:IOTOIJ>2.3.CO;2.
   GUILLETTE LJ, 1994, ENVIRON HEALTH PERSP, V102, P680, DOI 10.2307/3432198.
   HAMAZAKI TS, 1987, J EXP ZOOL, V242, P333, DOI 10.1002/jez.1402420312.
   Hansen PD, 1998, TRAC-TREND ANAL CHEM, V17, P448, DOI 10.1016/S0165-9936(98)00020-X.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   JOHNSON LL, 1991, J EXP MAR BIOL ECOL, V152, P161, DOI 10.1016/0022-0981(91)90213-G.
   KERCHEN RV, 1976, JAPANESE MEDAKA ITS.
   Lomax DP, 1998, COMP BIOCHEM PHYS B, V121, P425, DOI 10.1016/S0305-0491(98)10125-6.
   MAYER FL, 1972, NATURE, V238, P411, DOI 10.1038/238411a0.
   MORRIS RJ, 1970, NATURE, V227, P1264, DOI 10.1038/2271264a0.
   Panter GH, 1999, CHEMOSPHERE, V38, P3579, DOI 10.1016/S0045-6535(98)00572-4.
   Smeets JMW, 1999, TOXICOL APPL PHARM, V157, P68, DOI 10.1006/taap.1999.8663.
   Steinmetz R, 1996, CANCER RES, V56, P5403.
   TAN GH, 1995, B ENVIRON CONTAM TOX, V54, P171.
   {*}OECD ENV DIR, 2001, 2000 OECD LIST HIGH.
   {*}US EPA, 1986, 8060 US EPA.
   {*}US EPA, 1973, EPA440580067.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{28}},
Journal-ISO = {{Environ. Int.}},
Doc-Delivery-Number = {{613KV}},
Wos-Id = {{ISI:000179132200004}},
}

@article{ ISI:000179163600012,
Author = {Bernal, CA and Martinelli, MI and Mocchiutti, NO},
Title = {{Effect of the dietary exposure of rat to di(2-ethyl hexyl) phthalate on
   their metabolic efficiency}},
Journal = {{FOOD ADDITIVES AND CONTAMINANTS}},
Year = {{2002}},
Volume = {{19}},
Number = {{11}},
Pages = {{1091-1096}},
Month = {{NOV}},
Abstract = {{The nutritional impact of di(2-ethyl hexyl) phthalate (DEHP),
   specifically its energy efficiency and nitrogen utilization, was studied
   in the experimental rat. Groups of male Wistar rats were fed over 21
   days with a standard diet alone or a standard diet supplemented with 2\%
   (w/w) DEHP. Food intake, body weight and nitrogen compounds excretion
   were measured daily. The composition and energetic content of the
   carcass were determined in animals of both dietary groups after the
   feeding period, as well as in a separate group on day 0. The food and
   energy intakes were similar in both groups, however, the efficiencies of
   energy and nitrogen use were significantly reduced in the DEHP-fed rat.
   These alterations were reflected by a reduction of 31\% on carcass
   energy retention and a decrease of 26\% on cumulative nitrogen balance,
   without changes in the body composition. The increase of urinary
   nitrogen excretion, mainly as urea compound, is the major contributing
   factor to the lower nitrogen retention. These results indicate that DEHP
   decreases energy efficiency and nitrogen utilization, leading to a
   pronounced reduction in body weight gain. In addition, this study
   provides a possible conceptual framework that could explain the
   metabolic changes induced by DEHP and related compounds in experimental
   animals.}},
Publisher = {{TAYLOR \& FRANCIS LTD}},
Address = {{4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mocchiutti, NO (Reprint Author), Univ Nacl Litoral, Fac Bioquim \& Ciencias Biol, Dept Ciencias Biol, Santa Fe, Argentina.
   Univ Nacl Litoral, Fac Bioquim \& Ciencias Biol, Dept Ciencias Biol, Santa Fe, Argentina.
   Consejo Nacl Invest Cient \& Tecn, Santa Fe, Argentina.}},
DOI = {{10.1080/02652030210157709}},
ISSN = {{0265-203X}},
Keywords = {{di(2-ethyl hexyl)phthalate; metabolic efficiency; rats}},
Keywords-Plus = {{DOSE-RESPONSE; INDUCTION; LIVER; DI-(2-ETHYLHEXYL)PHTHALATE;
   DI(2-ETHYLHEXYL)PHTHALATE; PLASTICIZERS; OXIDATION; TOXICITY; GROWTH;
   ESTERS}},
Research-Areas = {{Chemistry; Food Science \& Technology; Toxicology}},
Web-of-Science-Categories  = {{Chemistry, Applied; Food Science \& Technology; Toxicology}},
Cited-References = {{BADR MZ, 1992, J PHARMACOL EXP THER, V263, P1105.
   CANOLTY NL, 1976, J NUTR, V106, P1202.
   CUNNIFF P, 1999, OFF METH AN ASS OFF.
   DANIEL JW, 1978, CLIN TOXICOL, V13, P257.
   David RM, 2000, TOXICOL SCI, V55, P433, DOI 10.1093/toxsci/55.2.433.
   DeGroot MH, 1975, PROBABILITY STAT.
   DOSTAL LA, 1987, TOXICOL APPL PHARM, V87, P81, DOI 10.1016/0041-008X(87)90086-X.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Dzhekova-Stojkova S, 2001, CLIN CHEM LAB MED, V39, P468, DOI 10.1515/CCLM.2001.076.
   Hasmall SC, 2000, ARCH TOXICOL, V74, P85, DOI 10.1007/s002040050657.
   Kleiber M., 1975, FIRE LIFE.
   Latini G, 2000, BIOL NEONATE, V78, P269, DOI 10.1159/000014278.
   MANN AH, 1985, TOXICOL APPL PHARM, V77, P116, DOI 10.1016/0041-008X(85)90273-X.
   MEEK ME, 1994, ENVIRON CARCIN ECO R, V12, P179.
   MITCHELL AM, 1985, TOXICOL APPL PHARM, V80, P23, DOI 10.1016/0041-008X(85)90097-3.
   MITCHELL FE, 1985, TOXICOL APPL PHARM, V81, P371, DOI 10.1016/0041-008X(85)90409-0.
   MITCHELL FE, 1986, BIOCHEM PHARMACOL, V35, P2941, DOI 10.1016/0006-2952(86)90490-9.
   Mocchiutti NO, 1997, FOOD CHEM TOXICOL, V35, P1017, DOI 10.1016/S0278-6915(97)87270-5.
   Moore NP, 2000, REPROD TOXICOL, V14, P183, DOI 10.1016/S0890-6238(00)00068-X.
   NAIR N, 1986, BIOCHEM PHARMACOL, V35, P3441, DOI 10.1016/0006-2952(86)90610-6.
   OKITA RT, 1992, PHARMACEUT RES, V9, P1648, DOI 10.1023/A:1015837113683.
   OSUMI T, 1978, J BIOCHEM-TOKYO, V83, P1361.
   Petersen JH, 2000, FOOD ADDIT CONTAM, V17, P133, DOI 10.1080/026520300283487.
   PRICE SC, 1988, TOXICOL LETT, V40, P37, DOI 10.1016/0378-4274(88)90181-6.
   Rao KN, 1997, GASTROENTEROLOGY, V113, P238, DOI 10.1016/S0016-5085(97)70101-X.
   REUBSAET FAG, 1991, INT J BIOCHEM, V23, P961, DOI 10.1016/0020-711X(91)90086-3.
   REUBSAET FAG, 1990, BIOCHIM BIOPHYS ACTA, V1047, P264, DOI 10.1016/0005-2760(90)90525-3.
   SHARMA R, 1988, BIOCHEM PHARMACOL, V37, P1203, DOI 10.1016/0006-2952(88)90771-X.
   THOMAS DA, 1978, POLYM BLENDS, V2, P1.
   {*}ATSDR, 1993, TOX PROF DI 2 ETH UP.
   {*}CEPA, 1994, PRIOR SUBST LIST ASS.
   {*}CEPA, 1993, PRIOR SUBST LIST SUP.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{13}},
Journal-ISO = {{Food Addit. Contam.}},
Doc-Delivery-Number = {{614AA}},
Wos-Id = {{ISI:000179163600012}},
}

@article{ ISI:000176661000010,
Author = {Gal, JF and Maria, PC and Decouzon, M},
Title = {{Adduct formation between phthalate esters and Li+ in the gas phase: a
   thermochemical study by FT-ICR mass spectrometry}},
Journal = {{INTERNATIONAL JOURNAL OF MASS SPECTROMETRY}},
Year = {{2002}},
Volume = {{217}},
Number = {{1-3}},
Pages = {{75-79}},
Month = {{JUN 1}},
Abstract = {{The lithium-cation basicity (LCB = Gibbs energy of adduct dissociation)
   of methyl benzoate, and the three isomeric dimethyl phthalates
   (phthalate, iso- and tere-phthalate) has been determined by Fourier
   transform ion cyclotron resonance (FT-ICR), using the kinetic method.
   The dimethyl phthalate ester appears to be a relatively strong base
   toward Li+, as compared to the other isomers and to methyl benzoate.
   This is attributed to the chelation effect of the two carboxyl groups.
   The previously unknown protonic gas-phase basicity of dimethyl phthalate
   was also determined. Chelation makes also dimethyl phthalate a much
   stronger base than the two other isomers toward H+, but its protonated
   form decomposes readily by loss of a methanol molecule. (C) 2002
   Elsevier Science B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Gal, JF (Reprint Author), Univ Nice, Fac Sci Chim Mat Organ \& Metall, F-06108 Nice 2, France.
   Univ Nice, Fac Sci Chim Mat Organ \& Metall, F-06108 Nice 2, France.}},
ISSN = {{1387-3806}},
Keywords = {{adduct; lithium cation; phthalate; FT-ICR; basicity}},
Keywords-Plus = {{ION-CYCLOTRON RESONANCE; PROTON AFFINITIES; LITHIUM-CATION; BASICITY}},
Research-Areas = {{Physics; Spectroscopy}},
Web-of-Science-Categories  = {{Physics, Atomic, Molecular \& Chemical; Spectroscopy}},
Cited-References = {{Aue D. H., 1979, GAS PHASE ION CHEM, V2.
   BERTHELOT M, 1991, J ORG CHEM, V56, P4490, DOI 10.1021/jo00014a031.
   Buncel E, 1997, J AM SOC MASS SPECTR, V8, P262, DOI 10.1016/S1044-0305(96)00255-3.
   Burk P, 2000, J PHYS CHEM A, V104, P2824, DOI 10.1021/jp9931399.
   COOKS RG, 1994, MASS SPECTROM REV, V13, P287.
   Decouzon M, 1998, INT J MASS SPECTROM, V175, P27, DOI 10.1016/S0168-1176(98)00108-6.
   DECOUZON M, 1994, J PHYS ORG CHEM, V7, P615, DOI 10.1002/poc.610071105.
   Decouzon M, 1996, RAPID COMMUN MASS SP, V10, P242, DOI 10.1002/(SICI)1097-0231(19960131)10:2<242::AID-RCM473>3.0.CO;2-6.
   DECOUZON M, 1991, J ORG CHEM, V56, P3669, DOI 10.1021/jo00011a041.
   DECOUZON M, 1989, SPECTRA 2000, V17, P51.
   Herreros M, 1999, EUR MASS SPECTROM, V5, P259, DOI 10.1255/ejms.282.
   HILEMAN B, 2000, CHEM ENG NEWS   0807, P52.
   HUNTER EP, 2000, NIST CHEM WEBBOOK NI.
   Hunter EPL, 1998, J PHYS CHEM REF DATA, V27, P413.
   Kleinsasser NH, 2000, ENVIRON MOL MUTAGEN, V35, P9, DOI 10.1002/(SICI)1098-2280(2000)35:1<9::AID-EM2>3.0.CO;2-1.
   MARIA PC, 1995, B SOC CHIM FR, V132, P394.
   Morelli-Cardoso MHW, 1999, HRC-J HIGH RES CHROM, V22, P70.
   Penalver A, 2001, J CHROMATOGR A, V922, P377, DOI 10.1016/S0021-9673(01)00920-7.
   Raczynska ED, 2001, J PHYS ORG CHEM, V14, P25, DOI 10.1002/1099-1395(200101)14:1<25::AID-POC332>3.0.CO;2-E.
   Staples CA, 2000, CHEMOSPHERE, V40, P885, DOI 10.1016/S0045-6535(99)00315-X.
   STARECZEK T, 1999, INT POLYM SCI TECHN, V26, pT97.
   Taft RW, 1987, PROG PHYS ORG CHEM, V16, P1, DOI 10.1002/9780470171950.ch1.
   TAFT RW, 1990, PURE APPL CHEM, V62, P17, DOI 10.1351/pac199062010017.
   Tienpont B, 2000, J MICROCOLUMN SEP, V12, P194, DOI 10.1002/(SICI)1520-667X(2000)12:4<194::AID-MCS4>3.0.CO;2-U.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{7}},
Journal-ISO = {{Int. J. Mass Spectrom.}},
Doc-Delivery-Number = {{570MA}},
Wos-Id = {{ISI:000176661000010}},
}

@article{ ISI:000175626400027,
Author = {Hoppin, JA and Brock, JW and Davis, BJ and Baird, DD},
Title = {{Reproducibility of urinary phthalate metabolites in first morning urine
   samples}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2002}},
Volume = {{110}},
Number = {{5}},
Pages = {{515-518}},
Month = {{MAY}},
Abstract = {{Phthalates are ubiquitous in our modern environment because of their use
   in plastics and cosmetic products. Phthalate monoesters-primarily
   monoethylhexyl phthalate and monobutyl phthalateare reproductive and
   developmental toxicants in animals. Accurate measures of phthalate
   exposure a-re needed to assess their human health effects. Phthalate
   monoesters have a biologic half-life of approximately 12 hr, and little
   is known about the temporal variability and daily reproducibility of
   urinary measures in humans. To explore these aspects, we measured seven
   phthalate monoesters and creatinine concentration in two consecutive
   first-morning urine specimens from 46 African-American women, ages 35-49
   years, residing in the Washington, DC, area in 1996-1997. We measured
   phthalate monoesters using high-pressure liquid chromatography followed
   by tandem mass spectrometry on a triple quadrupole instrument using
   atmospheric pressure chemical ionization. We detected four phthalate
   monoesters in all subjects, with median levels of 31 ng/mL for
   monobenzyl phthalate (mBzP), 53 ng/mL for monobutyl phthalate (mBP), 211
   ng/mL for monoethyl phthalate (mEP), and 7.3 ng/mL for monoethylhexyl
   phthalate (mEHP). These were similar to concentrations reported for
   other populations using spot urine specimens. Phthalate levels did not
   differ between the two sampling days. The Pearson correlation
   coefficient between the concentrations on the 2 days was 0.8 for mBP,
   0.7 for mEHP, 0.6 for mEP, and 0.5 for mBzP. These results suggest that
   even with the short half-lives of phthalates, women's patterns of
   exposure may be sufficiently stable to assign an exposure level based on
   a single first morning void urine measurement.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Hoppin, JA (Reprint Author), NIEHS, Epidemiol Branch, MD A3-05,POB 12233, Res Triangle Pk, NC 27709 USA.
   NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA.
   Ctr Dis Control \& Prevent, Atlanta, GA USA.
   NIEHS, Lab Womens Hlth, Res Triangle Pk, NC 27709 USA.}},
ISSN = {{0091-6765}},
Keywords = {{biologic markers; environmental exposure; phthalates; reliability;
   urine; women's health}},
Keywords-Plus = {{BUTYL BENZYL PHTHALATE; RATS; DI(2-ETHYLHEXYL)PHTHALATE; WOMEN}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Cited-References = {{ALBRO PW, 1986, ENVIRON HEALTH PERSP, V65, P293, DOI 10.2307/3430196.
   Api AM, 2001, FOOD CHEM TOXICOL, V39, P97, DOI 10.1016/S0278-6915(00)00124-1.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   CADOGAN DF, 1999, KIRK CTHMER CONCISE, P1577.
   CDC, 2001, NAT REP HUM EXP ENV.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   EMA M, 1992, J APPL TOXICOL, V12, P179, DOI 10.1002/jat.2550120305.
   Ema M, 2000, REPROD TOXICOL, V14, P13, DOI 10.1016/S0890-6238(99)00066-0.
   Fleiss J.L., 1986, DESIGN ANAL CLIN EXP.
   Gammon MD, 1997, CANCER EPIDEM BIOMAR, V6, P327.
   Gunter EW, 1996, LAB METHODS USED 3 N.
   HANKINSON SE, 1995, CANCER EPIDEM BIOMAR, V4, P649.
   HEE SSQ, 1993, BIOL MONITORING INTR, P139.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P116, DOI 10.1016/0041-008X(92)90374-2.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381.
   Moorman WJ, 2000, REPROD TOXICOL, V14, P293, DOI 10.1016/S0890-6238(00)00089-7.
   NTP-CERHR, 2000, NTP CERHR EXP PAN RE.
   Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.0.CO;2-Q.
   Uriu-Adams JY, 2001, TOXICOLOGY, V159, P55, DOI 10.1016/S0300-483X(00)00403-0.
   WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51.
   ZACHAREWSKI TR, 1998, TOXICOL SCI, V46, P280.
   {*}ATSDR, 1993, TOX PROF DI 2 ETH UP.
   {*}ATSDR, 1999, TOX PROF DI N BUT UP.
   {*}ATSDR, 1995, TOX PROF DIETH PHTH.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{85}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{552NL}},
Wos-Id = {{ISI:000175626400027}},
}

@article{ ISI:000176073100023,
Author = {Kato, K and Yoshimura, Y and Nakazawa, H and Ito, Y and Oka, H},
Title = {{Preparation of samples for gas chromatography/mass spectrometry analysis
   of phthalate and adipate esters in plasma and beverages by steam
   distillation and extraction}},
Journal = {{JOURNAL OF AOAC INTERNATIONAL}},
Year = {{2002}},
Volume = {{85}},
Number = {{3}},
Pages = {{719-723}},
Month = {{MAY-JUN}},
Abstract = {{Phthalate and adipate esters are present in relatively large amounts in
   the environment, resulting in their large blank values at analysis and
   making precise analysis difficult. We developed a highly sensitive
   analytical method for phthalate and adipate esters in plasma and
   beverages by lowering the blank values that interfere with analysis. The
   method uses a closed distillation cleanup system in which steam
   distillation and extraction are performed simultaneously. The recoveries
   from beverages and plasma were both satisfactory, ranging from 90.2 to
   118.3\%, relative standard deviation (RSD) = 2.8-5.3\%, and
   96.2-134.4\%, RSD 2.2-6.5\%, respectively. The detection limits of
   dibutyl phthalate and di-2-ethyl hexyl phthalate were 5 ng/mL, and those
   of diethyl phthalate, butyl benzyl phthalate, and di-2-ethyl hexyl
   adipate were 10 ng/mL in rabbit plasma and beverages.}},
Publisher = {{AOAC INTERNATIONAL}},
Address = {{481 NORTH FREDRICK AVE, STE 500, GAITHERSBURG, MD 20877-2504 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Nakazawa, H (Reprint Author), Hoshi Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.
   Hoshi Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Shinagawa Ku, Tokyo 1428501, Japan.
   Aichi Prefectural Inst Publ Hlth, Dept Chem, Kita Ku, Nagoya, Aichi 4628576, Japan.}},
ISSN = {{1060-3271}},
Keywords-Plus = {{ENVIRONMENTAL-SAMPLES; ELECTRON-CAPTURE; MIGRATION; BUTTER; FOOD}},
Research-Areas = {{Chemistry; Food Science \& Technology}},
Web-of-Science-Categories  = {{Chemistry, Analytical; Food Science \& Technology}},
Cited-References = {{Hammarling L, 1998, FOOD ADDIT CONTAM A, V15, P203.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   HIRANO K, 1971, BUNSEKI KAGAKU, V20, P364.
   LEUNG SC, 1993, B ENVIRON CONTAM TOX, V50, P528.
   Matsumoto H., 1975, Journal of the Food Hygienic Society of Japan, V16, P165.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Nilsson R, 2000, TOXICOL PATHOL, V28, P420, DOI 10.1177/019262330002800311.
   OBER AG, 1987, B ENVIRON CONTAM TOX, V38, P404.
   PAGE BD, 1987, J ASSOC OFF ANA CHEM, V70, P446.
   PAGE BD, 1992, FOOD ADDIT CONTAM, V9, P197.
   Piergiovanni L, 1999, FOOD ADDIT CONTAM, V16, P353, DOI 10.1080/026520399283920.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   SHINTANI H, 1985, J CHROMATOGR, V337, P279, DOI 10.1016/0378-4347(85)80041-4.
   Veningerova M, 1997, J CHROMATOGR A, V774, P333, DOI 10.1016/S0021-9673(97)00359-2.}},
Number-of-Cited-References = {{14}},
Times-Cited = {{6}},
Journal-ISO = {{J. AOAC Int.}},
Doc-Delivery-Number = {{560FY}},
Wos-Id = {{ISI:000176073100023}},
}

@article{ ISI:000174975900029,
Author = {Koo, JW and Parham, F and Kohn, MC and Masten, SA and Brock, JW and
   Needham, LL and Portier, CJ},
Title = {{The association between biomarker-based exposure estimates for
   phthalates and demographic factors in a human reference population}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2002}},
Volume = {{110}},
Number = {{4}},
Pages = {{405-410}},
Month = {{APR}},
Abstract = {{Population-based estimates of environmental exposures using biomarkers
   can be difficult to obtain for a variety of reasons, including problems
   with limits of detection, undersampling of key strata, time between
   exposure and sampling, variation across individuals, variation within
   individuals, and the ability to find and interpret a given biomarker. In
   this article, we apply statistical likelihoods, weighted sampling, and
   regression methods for censored data to the analysis of biomarker data.
   Urinary metabolites for seven phthalates, reported by Blount et al., are
   analyzed using these methods. In the case of the phthalates data, we
   assumed the underlying model to be a log-normal distribution with the
   mean of the distribution defined as a function of a number of
   demographic variables that might affect phthalate levels in individuals.
   Included as demographic variables were age, sex, ethnicity, residency,
   family income, and education level. We conducted two analyses: an
   unweighted analysis where phthalate distributions were estimated with
   changes in the means of these distributions as a function of demographic
   variables, and a weighted prediction for the general population in which
   weights were assigned for a subset of the population depending on the
   frequency of their demographic variables in the general U.S. population.
   We used statistical tests to determine whether any of the demographic
   variables affected mean phthalate levels. Individuals with only a high
   school education had higher levels of di-n-butyl phthalate than
   individuals with education beyond high school. Subjects who had family
   income less than \$1,500 in the month before sampling and/or only high
   school education had higher levels of n-buryl. benzyl phthalate levels
   than other groupings. Di(2-ethylhexyl) phthalate was higher in males
   and/or in urban populations and/or in people who had family income less
   than \$1,500 per month. Our findings suggest that there may be
   significant demographic variations in exposure and/or metabolism of
   phthalates and that health-risk assessments for phthalate exposure in
   humans should consider different potential risk groups.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Portier, CJ (Reprint Author), Natl Inst Environm Hlth Sci, Environm Toxicol Program, Res Triangle Pk, NC 27709 USA.
   Natl Inst Environm Hlth Sci, Environm Toxicol Program, Res Triangle Pk, NC 27709 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.}},
ISSN = {{0091-6765}},
Keywords = {{demographic factors; phthalates; risk assessment}},
Keywords-Plus = {{BUTYL BENZYL PHTHALATE; TESTICULAR ATROPHY; RAT-LIVER; METABOLISM;
   ESTERS; EXCRETION; IDENTIFICATION; DIBUTYL}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
ResearcherID-Numbers = {{Portier, Christopher/A-3160-2010
   Needham, Larry/E-4930-2011}},
Cited-References = {{AITIO A, 1978, ARCH INT PHARMACOD T, V235, P187.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   BELL FP, 1978, LIPIDS, V13, P66, DOI 10.1007/BF02533369.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Burmaster DE, 2000, RISK ANAL, V20, P261, DOI 10.1111/0272-4332.202025.
   CASTIE L, COMMUNICATION.
   CREASY DM, 1983, J PATHOL, V139, P309, DOI 10.1002/path.1711390307.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   EIGENBERG DA, 1986, J TOXICOL ENV HEALTH, V17, P445.
   EMA M, 1993, TOXICOLOGY, V79, P11, DOI 10.1016/0300-483X(93)90202-4.
   Ema M, 1996, TOXICOL LETT, V86, P19.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   FOSTER PMD, 1983, DRUG METAB DISPOS, V11, P59.
   FURTMANN RNK, 1996, PHTHALATES AQUATIC E.
   GRAY TJB, 1984, FOOD CHEM TOXICOL, V22, P123, DOI 10.1016/0278-6915(84)90092-9.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P116, DOI 10.1016/0041-008X(92)90374-2.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P3, DOI 10.2307/3429377.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P129, DOI 10.2307/3429396.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   LEYDER F, 1983, B ENVIRON CONTAM TOX, V30, P152.
   Lindsey JK, 2000, BIOMETRICS, V56, P81, DOI 10.1111/j.0006-341X.2000.00081.x.
   MATTHEWS HB, 1975, DRUG METAB DISPOS, V3, P211.
   MOODY DE, 1978, TOXICOL APPL PHARM, V45, P497, DOI 10.1016/0041-008X(78)90111-4.
   Nativelle C, 1999, FOOD CHEM TOXICOL, V37, P905, DOI 10.1016/S0278-6915(99)00071-X.
   OISHI S, 1983, TOXICOL APPL PHARM, V70, P43, DOI 10.1016/0041-008X(83)90177-1.
   OISHI S, 1982, TOXICOL LETT, V14, P79.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   PIRKLE JL, 1995, ENVIRON HEALTH PERSP, V103, P45, DOI 10.2307/3432559.
   PITTMAN KA, 1976, DRUG METAB DISPOS, V4, P288.
   REDDY JK, 1976, LIFE SCI, V18, P941, DOI 10.1016/0024-3205(76)90412-4.
   REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0.
   ROZMAN T, 1981, DRUG CHEM TOXICOL, V4, P251, DOI 10.3109/01480548109018132.
   SHIOTA K, 1980, ENVIRON RES, V22, P245, DOI 10.1016/0013-9351(80)90136-X.
   TANAKA A, 1978, TOXICOLOGY, V9, P109, DOI 10.1016/0300-483X(78)90036-7.
   TANAKA A, 1975, TOXICOLOGY, V4, P253, DOI 10.1016/0300-483X(75)90105-5.
   TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382.
   TSAY JY, 1979, CLIN CHEM, V25, P2011.
   US Census Bureau, 2001, STAT ABSTR US 2000.
   VLACHONIKOLIS IG, 1995, FOOD ADDIT CONTAM, V12, P637.
   WALSETH F, 1982, ARCH TOXICOL, V50, P1, DOI 10.1007/BF00569231.
   WILLIAMS DT, 1975, J AGR FOOD CHEM, V23, P854, DOI 10.1021/jf60201a047.
   WILLIAMS DT, 1974, B ENVIRON CONTAM TOX, V11, P371.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.
   {*}DEP HHS NAT CTR H, 1996, 76200 DEP HHS NAT CT.
   {*}ECPI, 1996, PHTHAL EST US PVC AS.
   {*}NTP, 2001, CTR EV RISK HUM REPR.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{39}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{541GB}},
Wos-Id = {{ISI:000174975900029}},
}

@article{ ISI:000173967000001,
Author = {Brock, JW and Caudill, SP and Silva, MJ and Needham, LL and Hilborn, ED},
Title = {{Phthalate monoesters levels in the urine of young children}},
Journal = {{BULLETIN OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY}},
Year = {{2002}},
Volume = {{68}},
Number = {{3}},
Pages = {{309-314}},
Month = {{MAR}},
Publisher = {{SPRINGER-VERLAG}},
Address = {{175 FIFTH AVE, NEW YORK, NY 10010 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Brock, JW (Reprint Author), Warren Wilson Coll, POB 9000, Asheville, NC 28815 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Div Lab Sci, Atlanta, GA 30341 USA.
   US EPA, NHEERL, Off Res \& Dev, Chapel Hill, NC 27599 USA.}},
DOI = {{10.1007/s00128-001-0255-z}},
ISSN = {{0007-4861}},
Keywords-Plus = {{METABOLITES; DI(2-ETHYLHEXYL)PHTHALATE}},
Research-Areas = {{Environmental Sciences \& Ecology; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Toxicology}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   Blount BC, 2000, ANAL CHEM, V72, P4127, DOI 10.1021/ac000422r.
   Burtis CA, 1999, TIETZ TXB CLIN CHEM.
   Chance GW, 1998, CAN J PUBLIC HEALTH, V89, pS9.
   David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   GREENE MG, 1991, HARRIET LANE HDB MAN.
   Gunter EW, 1996, LAB METHODS USED 3 N.
   MYLECREEST E, 1998, TOXICOL SCI, V43, P47.
   Simcox NJ, 1995, ENVIRON HEALTH PERSP, V103, P1126, DOI 10.2307/3432609.}},
Number-of-Cited-References = {{12}},
Times-Cited = {{66}},
Journal-ISO = {{Bull. Environ. Contam. Toxicol.}},
Doc-Delivery-Number = {{523QT}},
Wos-Id = {{ISI:000173967000001}},
}

@article{ ISI:000174603600006,
Author = {Martens, F and Martens, M},
Title = {{Analysis of the monoester metabolites of butylbenzyl phthalate by GC-MS
   in urine of exposed workers}},
Journal = {{ACTA CLINICA BELGICA}},
Year = {{2002}},
Volume = {{57}},
Number = {{1}},
Pages = {{16-23}},
Note = {{2nd Meeting of the Internationales-de-Toxicologie-Hospitaliere, LIEGE,
   BELGIUM, OCT 25-26, 2001}},
Organization = {{Merck eurolab; Agilent Technologies; Bruker; Abbott Diagnost Div; Van
   der Heyden; Dade Behring; Ulti Med; Baxter; Micromass; Waters}},
Abstract = {{A method of analysis was developed to determine free and glueuronated
   monobutyl plithalate (BuP) and monobenzyl phthalate (BeP) in urine for
   the assessment of exposure of man to butylbenzyl phthalate (BBP) in the
   workplace and in the environment. This method has also been applied in
   pharmacokinetic studies in experimental animals and the determination in
   urine of exposed workers.}},
Publisher = {{ACTA CLINICA BELGICA}},
Address = {{UNIV HOSPITAL GENT, DE PINTELAAN 185, RENAL DIVISION, B-9000 GHENT,
   BELGIUM}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Martens, F (Reprint Author), Az Groeninge, Dept Toxicol, Houtmarkt 33, B-8500 Kortrijk, Belgium.
   Az Groeninge, Dept Toxicol, B-8500 Kortrijk, Belgium.}},
ISSN = {{0001-5512}},
Keywords = {{butylbenzylphthatate; monobenzylphthalate; monobutylphthalate; GCMS;
   urine extraction; exposure; workplace}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Medicine, General \& Internal}},
Cited-References = {{ANGELA B, 2000, TOX SUBST MECH, V19, P1.
   MARTENS FK, 2000, P 38 INT M TIAFT 200.
   Nativelle C, 1999, FOOD CHEM TOXICOL, V37, P905, DOI 10.1016/S0278-6915(99)00071-X.}},
Number-of-Cited-References = {{3}},
Times-Cited = {{0}},
Journal-ISO = {{Acta Clin. Belg.}},
Doc-Delivery-Number = {{534TV}},
Wos-Id = {{ISI:000174603600006}},
}

@article{ ISI:000172238300003,
Author = {Anderson, WAC and Castle, L and Scotter, MJ and Massey, RC and
   Springall, C},
Title = {{A biomarker approach to measuring human dietary exposure to certain
   phthalate diesters}},
Journal = {{FOOD ADDITIVES AND CONTAMINANTS}},
Year = {{2001}},
Volume = {{18}},
Number = {{12}},
Pages = {{1068-1074}},
Month = {{DEC}},
Note = {{1st Symposium on Risk Assessment and Communication for Food Safety,
   YORK, ENGLAND, JUN, 2000}},
Organization = {{Cent Sci Lab; Joint Inst Food Safety \& Appl Nutr}},
Abstract = {{Three groups of eight volunteers were administered stable
   isotope-labelled phthalate diesters in a single dose and the amount of
   the corresponding phthalate monoesters excreted in the urine was
   measured. Amongst the phthalates administered were the symmetrical
   dibutyl-, di-2-ethyl- and diisooctyl- phthalates along with the
   unsymmetrical benzylbutylphthalate. The control group received no dose,
   the low dose group received 168-255 mug of each phthalate and the high
   dose group received 336 to 510 mug of each phthalate. The excreted
   phthalate monoesters were measured by LC-MS following hydrolysis of
   conjugates. The bulk of phthalate monoester was excreted in the first 24
   hour period following the dose. For dibutylphthalate, 64\% and 73\% on a
   mole basis of the low and high dose respectively was excreted as
   monobutylphthalate. For dioctlyphthalate (sum of the 2-ethylhexyl and
   the isooctyl species) the yield was 14 and 12\% of the low and high dose
   excreted as monooctylphthalate. For benzylbutylphthalate, 67\% and 78\%
   was eliminated as monobenzylphthalate and only 6\% (measured for the
   high dose only) was eliminated as monobutylphthalate. These conversion
   factors can be used in future studies to assess exposure to phthalate
   esters via measuring urinary levels of the monoester metabolites.}},
Publisher = {{TAYLOR \& FRANCIS LTD}},
Address = {{11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{Castle, L (Reprint Author), MAFF, Cent Sci Lab, York, N Yorkshire, England.
   MAFF, Cent Sci Lab, York, N Yorkshire, England.
   TNO BIBRA Int Ltd, Surrey, England.}},
DOI = {{10.1080/02652030110050113}},
ISSN = {{0265-203X}},
Keywords = {{phthalates; monoesters; urinary metabolites; exposure; LC-MS}},
Keywords-Plus = {{PLASTICIZER DI(2-ETHYLHEXYL)PHTHALATE; DIETHYLHEXYL PHTHALATE; URINE
   SAMPLES; METABOLITES; ESTERS}},
Research-Areas = {{Chemistry; Food Science \& Technology; Toxicology}},
Web-of-Science-Categories  = {{Chemistry, Applied; Food Science \& Technology; Toxicology}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   AYESH R, 1997, 31011 TNO BIBRA.
   BARRETT GFC, 1996, ADDITIVES PLASTICISE, P297.
   BERG JD, 1985, ANN CLIN BIOCHEM, V22, P586.
   Blount BC, 2000, ENVIRON HEALTH PERSP, V108, P979, DOI 10.1289/ehp.00108979.
   CASTLE L, 1987, FOOD ADDIT CONTAM, V5, P9.
   Colon I, 2000, ENVIRON HEALTH PERSP, V108, P895, DOI 10.2307/3434999.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   EGESTAD B, 1992, DRUG METAB DISPOS, V20, P470.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   IKEDA GJ, 1980, FOOD COSMET TOXICOL, V18, P637, DOI 10.1016/S0015-6264(80)80012-5.
   Kohn MC, 2000, ENVIRON HEALTH PERSP, V108, pA440, DOI 10.1289/ehp.108-a440b.
   PAGE BD, 1995, FOOD ADDIT CONTAM, V12, P129.
   PIRKLE JL, 1995, ENVIRON HEALTH PERSP, V103, P45, DOI 10.2307/3432559.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610.
   THOMAS JA, 1982, J TOXICOL ENV HEALTH, V9, P141.
   Tsumura Y, 2001, FOOD ADDIT CONTAM, V18, P449, DOI 10.1080/02652030010024474.
   TSUMURA Y, 2001, FOOD ADDIT CONTAM, V218, P569.
   {*}MAFF, 1996, 82 MAFF.
   {*}MAFF, 1987, 21 MAFF.
   {*}MRC, 1995, ASS ENV OESTR CONS H.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{88}},
Journal-ISO = {{Food Addit. Contam.}},
Doc-Delivery-Number = {{493RY}},
Wos-Id = {{ISI:000172238300003}},
}

@article{ ISI:000169712400011,
Author = {Wahl, HG and Hong, QF and Stube, D and Maier, ME and Haring, HU and
   Liebich, HM},
Title = {{Simultaneous analysis of the di(2-ethylhexyl)phthalate metabolites
   2-ethylhexanoic acid, 2-ethyl-3-hydroxyhexanoic acid and
   2-ethyl-3-oxohexanoic acid in urine by gas chromatography-mass
   spectrometry}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B}},
Year = {{2001}},
Volume = {{758}},
Number = {{2}},
Pages = {{213-219}},
Month = {{JUL 15}},
Abstract = {{A gas chromatographic-mass spectrometric method was developed for the
   quantitative analysis of the three Di(2-ethylhexyl)phthalate (DEHP)
   metabolites, 2-ethylhexanoic acid, 2-ethyl-3-hydroxyhexanoic acid and
   2-ethyl-3-oxohexanoic acid in urine. After oximation with
   O-(2,3,4,5,6-pentafluorobenzyl)-hydroxylamine hydrochloride and sample
   clean-up with Chromosorb P filled glass tubes, all three organic acids
   were converted to their tert.-butyldimethyfsilyl derivatives.
   Quantitation was done with trans-cinnamic acid as internal standard and
   CC-MS analysis in the selected ion monitoring mode (SIM). Calibration
   curves for all three acids in the range from 20 to 1000 mug/l showed
   correlation coefficients from 0.9972 to 0.9986. The relative standard
   deviation (RSD) values determined in the observed concentration range
   were between 1.3 and 8.9\% for all three ac ids. Here we report for the
   first time the identification of 2-ethyl-3-hydroxyhexanoic acid and
   2-ethyl-3-oxohexanoic acid in human urine next to the known DEHP
   metabolite 2-ethylhexanoic acid. In 28 urine samples from healthy
   persons we found all three acids with mean concentrations of 56.1 +/-
   13.5 mug/l for 2-ethylhexanoic acid, 104.8 +/- 80.6 mug/l for
   2-ethyl-3-hydroxyhexanoic acid and 482.2 +/- 389.5 mug/l for
   2-erhyl-3-oxohexanoic acid. (C) 2001 Elsevier Science B.V. All rights
   reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Wahl, HG (Reprint Author), Klinikum Fulda, Inst Lab Med, D-36043 Fulda, Germany.
   Med Univ Klin Abt 4, D-72076 Tubingen, Germany.
   Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany.}},
ISSN = {{0378-4347}},
Keywords = {{di(2-ethylhexyl)phthalate; 2-ethylhexanoic acid;
   2-ethyl-3-hydroxyhexanoic acid; 2-ethyl-3-oxohexanoic acid}},
Keywords-Plus = {{ORGANIC-ACIDS; PHTHALATE; RAT; DI-(2-ETHYLHEXYL)PHTHALATE;
   DI-(2-ETHYLHEXYL)-PHTHALATE; IDENTIFICATION; HEMODIALYSIS; DERIVATIVES;
   EXPOSURE; PRODUCTS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Cited-References = {{ALBRO PW, 1983, BIOCHIM BIOPHYS ACTA, V760, P283, DOI 10.1016/0304-4165(83)90175-7.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1975, XENOBIOTICA, V5, P625.
   BERMAN E, 1995, J TOXICOL ENV HEALTH, V45, P127.
   CIMINI AM, 1994, CELL MOL BIOL, V40, P1063.
   DEISINGER PJ, 1994, XENOBIOTICA, V24, P429.
   DIMEANA CP, 1991, OFFICIAL J EUROPEAN, P4.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Fischer FP, 1998, PERITON DIALYSIS INT, V18, P620.
   FLAMINIO LM, 1988, INT J ARTIF ORGANS, V11, P435.
   GORSKI T, 1990, J CHROMATOGR, V509, P383, DOI 10.1016/S0021-9673(01)93096-1.
   FROSTICK FC, 1949, J AM CHEM SOC, V71, P1350, DOI 10.1021/ja01172a060.
   HOFFMANN GF, 1991, CLIN CHIM ACTA, V199, P237, DOI 10.1016/0009-8981(91)90117-U.
   KEITH Y, 1992, ARCH TOXICOL, V66, P321, DOI 10.1007/BF01973626.
   KIM KR, 1992, J CHROMATOGR, V605, P241, DOI 10.1016/0021-9673(92)85242-L.
   Kim KR, 1997, J CHROMATOGR B, V701, P1, DOI 10.1016/S0378-4347(97)00358-7.
   KROGER S, 1989, ANALYST, V114, P1647, DOI 10.1039/an9891401647.
   LIEBICH HM, 1986, J CHROMATOGR, V379, P347, DOI 10.1016/S0378-4347(00)80689-1.
   LIEBICH HM, 1975, J CHROMATOGR, V112, P539, DOI 10.1016/S0021-9673(00)99983-7.
   Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809.
   Mettang T, 1997, PERITON DIALYSIS INT, V17, pS31.
   Noah V A, 1994, J Intraven Nurs, V17, P210.
   PENNANEN S, 1991, J CHROMATOGR-BIOMED, V568, P125, DOI 10.1016/0378-4347(91)80346-E.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   RHODES G, 1982, EXPERIENTIA, P75.
   Rothenbacher KP, 1998, HUM EXP TOXICOL, V17, P336, DOI 10.1191/096032798678908873.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   WAHL HG, 1996, 18 INT S CAP CHROM R, P681.
   Wahl HG, 1999, J CHROMATOGR A, V847, P117, DOI 10.1016/S0021-9673(99)00017-5.
   {*}AM COUNC SCI HLTH, 1999, REV CONS STAT SCI EV.
   {*}NAT TOX PROGR, 1982, TECH REP SER, P217.
   {*}US EPA, 1996, FED REGISTER, V61, P17960.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{14}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{449XL}},
Wos-Id = {{ISI:000169712400011}},
}

@article{ ISI:000168423600034,
Author = {Kambia, K and Dine, T and Gressier, B and Germe, AF and Luyckx, M and
   Brunet, C and Michaud, L and Gottrand, F},
Title = {{High-performance liquid chromatographic method for the determination of
   di(2-ethylhexyl) phthalate in total parenteral nutrition and in plasma}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B}},
Year = {{2001}},
Volume = {{755}},
Number = {{1-2}},
Pages = {{297-303}},
Month = {{MAY 5}},
Abstract = {{A simple, rapid and sensitive reversed-phase high-performance liquid
   chromatographic method with UV detection was developed for the
   quantification of di(2-ethylhexyl) phthalate (DEHP) in parenteral
   nutrition admixtures containing fat emulsion and in plasma samples of
   children daily treated by total parenteral nutrition. The analyte and
   the internal standard, di-n-heptyl phthalate, were extracted twice using
   hexane and the organic layer separated and dried under nitrogen. The
   residues were reconstituted with acetonitrile and 20 mul was injected
   into a Waters Spherisorb C-18 column, the UV detector was set at 202 nm.
   The mobile phase was acetonitrile-aqueous buffer (triethylamine 0.08\%
   adjusted to pH 2.8 with 1 M phosphoric acid) mixture (88:12, v/v) and it
   was pumped at 1 ml/min. Average recoveries were 97\% or greater. This
   method was successfully used to investigate the amounts of DEHP which
   can leach from bags and tubing into fat emulsion and which could
   contaminate children under long-term parenteral nutrition. On the other
   hand, the circulating DEHP concentrations were estimated in four
   children under regular long-term, parenteral nutrition. (C) 2001
   Elsevier Science B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dine, T (Reprint Author), Fac Sci Pharmaceut \& Biol, Lab Pharmacol Pharmacocinet \& Pharm Clin, 3 Rue Professeur Laguesse,BP 83, F-59006 Lille, France.
   Fac Sci Pharmaceut \& Biol, Lab Pharmacol Pharmacocinet \& Pharm Clin, F-59006 Lille, France.
   Ctr Hosp Reg \& Univ Lille, F-59037 Lille, France.
   Hop Jean Flandre, Unite Gastroenterol Hepatol \& Nutr Pediat, F-59006 Lille, France.}},
DOI = {{10.1016/S0378-4347(01)00125-6}},
ISSN = {{0378-4347}},
Keywords = {{di(2-ethylhexyl) phthalate}},
Keywords-Plus = {{PLASTICIZER EXTRACTION; INFUSION SOLUTIONS; CONTAINERS; COMPATIBILITY;
   STABILITY; INJECTION; PLATELETS; BAGS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Cited-References = {{ALBRO PW, 1978, TRANSFUSION, V18, P750, DOI 10.1046/j.1537-2995.1978.18679077962.x.
   ALLWOOD MC, 1986, INT J PHARM, V29, P233, DOI 10.1016/0378-5173(86)90120-1.
   ARBIN A, 1980, J CHROMATOGR, V193, P405, DOI 10.1016/S0021-9673(00)87740-7.
   DINE T, 1991, BIOMED CHROMATOGR, V5, P94, DOI 10.1002/bmc.1130050211.
   FAOUZI ME, 1995, J PHARMACEUT BIOMED, V13, P1363, DOI 10.1016/0731-7085(95)01553-W.
   MAZUR HI, 1989, JPEN-PARENTER ENTER, V13, P59, DOI 10.1177/014860718901300159.
   RACZ Z, 1995, VOX SANG, V68, P197.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   Steiner I, 1998, FOOD ADDIT CONTAM, V15, P812.
   TURNER VS, 1995, VOX SANG, V69, P195.
   VENTAKATARAMANA.R, 1986, AM J HOSP PHARM, V43, P2800.
   WAUGH WN, 1991, AM J HOSP PHARM, V48, P1520.}},
Number-of-Cited-References = {{12}},
Times-Cited = {{56}},
Journal-ISO = {{J. Chromatogr. B}},
Doc-Delivery-Number = {{427UJ}},
Wos-Id = {{ISI:000168423600034}},
}

@article{ ISI:000168058600008,
Author = {Kessler, W and Phokha, W and Csanady, GA and Filser, JG},
Title = {{No background concentrations of di(2-ethylhexyl) phthalate and
   mono(2-ethylhexyl) phthalate in blood of rats}},
Journal = {{ARCHIVES OF TOXICOLOGY}},
Year = {{2001}},
Volume = {{75}},
Number = {{1}},
Pages = {{62-64}},
Month = {{MAR}},
Abstract = {{We measured the background levels of di(2-ethylhexyl) phthalate (DEHP)
   and its hydrolytic metabolite mono(2-ethylhexyl) phthalate (MEHP) in
   blood from naive female Sprague-Dawley rats and in de-ionized
   charcoal-purified water using an analytical procedure that is based on
   sample treatment with acetonitrile, n-hexane extraction and analysis by
   gas chromatography. In blood, blank values of 91.3 +/- 34.7 mug DEHP/1
   (n=31) and 30.1 +/- 13.1 mug MEHP/1 (n=20) were obtained, and in water,
   values of 91.6 +/- 44.2 mug DEHP/1 (n = 26) and 26.7 +/- 10.4 mug MEHP/1
   (n = 15) were found. Since there is no difference between the background
   valves obtained from blood of naive rats and water, we conclude that
   DEHP and MEHP result from contamination during the analytical procedure.}},
Publisher = {{SPRINGER-VERLAG}},
Address = {{175 FIFTH AVE, NEW YORK, NY 10010 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Filser, JG (Reprint Author), GSF Forschungszentrum Umwelt \& Gesundheit, Inst Toxikol, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
   GSF Forschungszentrum Umwelt \& Gesundheit, Inst Toxikol, D-85764 Neuherberg, Germany.
   Tech Univ Munich, Inst Toxikol \& Umwelthyg, Munich, Germany.}},
DOI = {{10.1007/s002040000198}},
ISSN = {{0340-5761}},
Keywords = {{di(2-ethylhexyl) phthalate; mono(2-ethylhexyl) phthalate; rat; blood}},
Keywords-Plus = {{GAS-CHROMATOGRAPHY; DI-(2-ETHYLHEXYL) PHTHALATE; ELECTRON-CAPTURE;
   ESTERS; PLASMA; DISPOSITION; HYDROLYSIS; KINETICS}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Cited-References = {{ALBRO PW, 1989, TOXICOL APPL PHARM, V100, P193, DOI 10.1016/0041-008X(89)90305-0.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Fay M, 1999, TOXICOL IND HEALTH, V15, P651, DOI 10.1177/074823379901500801.
   LAKE BG, 1977, TOXICOL APPL PHARM, V39, P239, DOI 10.1016/0041-008X(77)90157-0.
   LEE DF, 1966, NATURE, V211, P521, DOI 10.1038/211521b0.
   OISHI S, 1990, ARCH TOXICOL, V64, P143, DOI 10.1007/BF01974400.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P246, DOI 10.1016/0041-008X(85)90346-1.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   RITSEMA R, 1989, CHEMOSPHERE, V18, P2161.
   ROWLAND IR, 1977, FOOD COSMET TOXICOL, V15, P17, DOI 10.1016/S0015-6264(77)80257-5.
   SCHAFER WR, 1997, UMWELTMED FORSCH PRA, V2, P281.
   SJOBERG P, 1985, ACTA PHARMACOL TOX, V56, P30.
   SJOBERG P, 1985, J CHROMATOGR, V344, P167, DOI 10.1016/S0378-4347(00)82017-4.
   TEIRLYNCK OA, 1985, ARCH TOXICOL, V57, P226, DOI 10.1007/BF00324782.
   TEIRLYNCK OA, 1985, J CHROMATOGR, V342, P399, DOI 10.1016/S0378-4347(00)84534-X.
   VESSMAN J, 1974, J CHROMATOGR, V100, P153, DOI 10.1016/S0021-9673(00)86049-5.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{14}},
Journal-ISO = {{Arch. Toxicol.}},
Doc-Delivery-Number = {{421HH}},
Wos-Id = {{ISI:000168058600008}},
}

@article{ ISI:000172385800001,
Author = {Kuhn-Velten, WN and Kramer, U and Susanto, F and Schram, J and Reinauer,
   H},
Title = {{Differential contribution of albumin and lipids to the hydrophobic
   extraction of bis-(2-ethylhexyl) phthalate from hemodialysis tubing by
   human serum: Analysis by gas chromatography - Stable isotope dilution
   mass spectrometry}},
Journal = {{INTERNATIONAL JOURNAL OF ENVIRONMENTAL ANALYTICAL CHEMISTRY}},
Year = {{2001}},
Volume = {{80}},
Number = {{4}},
Pages = {{245-256}},
Abstract = {{A method is presented which allows quantitative assignment of
   hydrophobic human serum components to the extraction of
   bis-(2-ethylhexyl) phthalate (DEHP) from medical tubing. Under optimized
   conditions (sample pH 5.5; fluid-fluid extraction with ethyl acetate +
   tert-butyl methyl ether I + I v/v; DEMP-ring-D4 as internal standard
   with ratios of endogenous (m/z = 149) and added deuterated DEHP (m/Z
   similar or equal to 153) adjusted to around 1.0; equilibration of added
   internal standard with the hydrophobic sample for 24 hours), a high
   precision can be achieved with an intra-assay coefficient of variation
   of 1.5\% (n = 7) for sample DEHP quantification. Phthalate migration
   from hemodialysis tubing wa. quantified by use of a peristaltic pump and
   recirculation (200 minutes) of serum with different degrees of
   hypertriglyceridemia (range from 2.26 to 14.5 g/L) or solutions of human
   albumin (10 to 50 g/L). Only DEHP, but no other phthalates are detected
   in the extracts. There exist linear relations between DEHP extraction
   and triglyceride content (increase by 1.01 mug DEHP / g tubing material
   per g triglyceride / L serum) as well as between DEHP extraction and
   albumin content (0.59 mug DEHP / g tubing material per g albumin / L).
   Under physiological conditions, the total amount of albumin extracts
   17.7-fold more DEHP than the total triglyceride amount in human serum.
   The suitability of the proposed method as a candidate reference method
   as well as consequences for dyslipidemic and hypalbuminemic patients on
   hemodialysis schemes are discussed.}},
Publisher = {{GORDON BREACH PUBLISHING, TAYLOR \& FRANCIS GROUP}},
Address = {{325 CHESTNUT ST, 8TH FL, PHILADELPHIA, PA 19106 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Susanto, F (Reprint Author), Univ Dusseldorf, German Diabet Res Inst, Dept Clin Biochem, Hennekamp 65, D-40225 Dusseldorf, Germany.
   Univ Dusseldorf, German Diabet Res Inst, Dept Clin Biochem, D-40225 Dusseldorf, Germany.
   Univ Appl Sci, Dept Instrumental \& Environm Analyt, D-47798 Krefeld, Germany.}},
DOI = {{10.1080/03067310108044361}},
ISSN = {{0306-7319}},
Keywords = {{isotope dilution mass spectrometry; hemodialysis; diabetes mellitus;
   phthalates; albumin; triglycerides}},
Keywords-Plus = {{DI(2-ETHYLHEXYL)PHTHALATE; PLASTICIZER; CHEMICALS; PRODUCTS; ALPHA}},
Research-Areas = {{Chemistry; Environmental Sciences \& Ecology}},
Web-of-Science-Categories  = {{Chemistry, Analytical; Environmental Sciences}},
Cited-References = {{Brucker-Davis F, 1998, THYROID, V8, P827, DOI 10.1089/thy.1998.8.827.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   Gray Leon Earl Jr., 1998, Toxicology Letters (Shannon), V102-103, P331, DOI 10.1016/S0378-4274(98)00327-0.
   Karle VA, 1997, CRIT CARE MED, V25, P696, DOI 10.1097/00003246-199704000-00023.
   KUHN WN, 2000, BIOL CHEM S, V381, pS124.
   Maloney EK, 1999, TOXICOL APPL PHARM, V161, P209, DOI 10.1006/taap.1999.8809.
   Mylchreest E, 1999, TOXICOL APPL PHARM, V156, P81, DOI 10.1006/taap.1999.8643.
   Peters JM, 1997, TERATOLOGY, V56, P311, DOI 10.1002/(SICI)1096-9926(199711)56:5<311::AID-TERA4>3.0.CO;2-\#.
   Quaschning T, 1999, J AM SOC NEPHROL, V10, P332.
   Ritz E, 1999, J INTERN MED, V245, P111, DOI 10.1046/j.1365-2796.1999.00411.x.
   Rothenbacher KP, 1998, HUM EXP TOXICOL, V17, P336, DOI 10.1191/096032798678908873.
   Susanto F, 1997, FRESEN J ANAL CHEM, V357, P338, DOI 10.1007/s002160050164.
   Thienpont LM, 1999, SCAND J CLIN LAB INV, V59, P535, DOI 10.1080/00365519950185300.
   Wahl HG, 1999, J CHROMATOGR A, V847, P1, DOI 10.1016/S0021-9673(99)00138-7.}},
Number-of-Cited-References = {{16}},
Times-Cited = {{0}},
Journal-ISO = {{Int. J. Environ. Anal. Chem.}},
Doc-Delivery-Number = {{496FP}},
Wos-Id = {{ISI:000172385800001}},
}

@article{ ISI:000166274600006,
Author = {Shintani, H},
Title = {{Pretreatment and chromatographic analysis of phthalate esters, and their
   biochemical behavior in blood products}},
Journal = {{CHROMATOGRAPHIA}},
Year = {{2000}},
Volume = {{52}},
Number = {{11-12}},
Pages = {{721-726}},
Month = {{DEC}},
Abstract = {{A method combining pretreatment by automated solid-phase extraction
   (SPE) with high-performance liquid chromatography (HPLC) has been
   developed for analysis of the endocrine disrupters mono-(2-ethylhexyl)
   phthalate (MEHP) and di-(2-ethylhexyl) phthalate (DEHP) in blood
   products. For successful analysis it was necessary to use acidified
   blood and acidified SPE eluent to suppress the ionization of MEHP and
   phthalic acid (PA). The amounts of PA, MEHP, and DEHP migrating into
   blood products from flexible blood bags made from poly(vinyl chloride)
   (PVC) was determined. By addition of inhibitors of endogenous blood
   lipase and esterase to blood it was shown that most of the MEHP detected
   in human plasma is not derived directly from flexible PVC bags but is
   produced by the action of these enzymes on DEHP. Esterase hydrolytic
   activity was greater than lipase activity.}},
Publisher = {{VIEWEG}},
Address = {{ABRAHAM-LINCOLN-STRABE 46, POSTFACH 15 47, D-65005 WIESBADEN, GERMANY}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Shintani, H (Reprint Author), Minist Hlth \& Welf, Natl Inst Hlth Sci, 1-18-1 Kamiyoga, Tokyo 158, Japan.
   Minist Hlth \& Welf, Natl Inst Hlth Sci, Tokyo 158, Japan.}},
DOI = {{10.1007/BF02490995}},
ISSN = {{0009-5893}},
Keywords = {{column liquid chromatography; solid-phase extraction; plasticizer;
   endocrine disrupter}},
Keywords-Plus = {{SOLID-PHASE EXTRACTION; DIETHYLHEXYL PHTHALATE; ARTIFACT FORMATION;
   METABOLISM}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   CHU I, 1978, DRUG METAB DISPOS, V6, P146.
   DRAVIAM EJ, 1980, ANAL LETT PT B, V13, P1137.
   PEACK CC, 1981, TRANSFUSION, V21, P163.
   ROBINSON JL, 1987, J CHROMATOGR, V402, P201, DOI 10.1016/0021-9673(87)80018-3.
   ROCK G, 1978, FED PROC, V27, P442.
   Shintani H, 1998, J LIQ CHROMATOGR R T, V21, P2297, DOI 10.1080/10826079808000539.
   SHINTANI H, 1984, BUNSEKI KAGAKU, V33, P314.
   SHINTANI H, 1995, J LIQ CHROMATOGR, V18, P2167, DOI 10.1080/10826079508010262.
   SHINTANI H, 1993, J ANAL TOXICOL, V17, P73.
   SHINTANI H, 1998, ADSORPTION ITS APPL, V120.
   Shintani H, 1996, J CHROMATOGR SCI, V34, P92.
   SHINTANI H, 1995, J LIQ CHROMATOGR, V16, P813.
   THOMAS JA, 1982, J TOXICOL ENV HEALTH, V9, P141.
   VESSMAN J, 1974, J CHROMATOGR, V100, P153, DOI 10.1016/S0021-9673(00)86049-5.
   WOODWARD K, 1988, PHTHALATE ESTERS TOX.}},
Number-of-Cited-References = {{16}},
Times-Cited = {{6}},
Journal-ISO = {{Chromatographia}},
Doc-Delivery-Number = {{390BQ}},
Wos-Id = {{ISI:000166274600006}},
}

@article{ ISI:000090093000026,
Author = {Blount, BC and Silva, MJ and Caudill, SP and Needham, LL and Pirkle, JL
   and Sampson, EJ and Lucier, GW and Jackson, RJ and Brock, JW},
Title = {{Levels of seven urinary phthalate metabolites in a human reference
   population}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2000}},
Volume = {{108}},
Number = {{10}},
Pages = {{979-982}},
Month = {{OCT}},
Abstract = {{Using a novel and highly selective technique, we measured monoester
   metabolites of seven commonly used phthalates in urine samples from a
   reference population of 289 adult humans. This analytical approach
   allowed us to directly measure the individual phthalate metabolites
   responsible for the animal reproductive and developmental toxicity while
   avoiding contamination from the ubiquitous parent compounds. The
   monoesters with the highest urinary levels found were monoethyl
   phthalate (95th percentile, 3,750 ppb, 2,610 mug/g creatinine),
   monobutyl phthalate (95th percentile, 294 ppb, 162 mug/g creatinine),
   and monobenzyl phthalate (95th percentile, 137 ppb, 92 mug/g
   creatinine), reflecting exposure to diethyl phthalate, dibutyl
   phthalate, and benzyl butyl phthalate. Women of reproductive age (20-40
   years) were found to have significantly higher levels of monobutyl
   phthalate, a reproductive and developmental toxicant in rodents, than
   other age/gender groups (p < 0.005). Current scientific and regulatory
   attention on phthalates has focused almost exclusively on health risks
   from exposure to only two phthalates, di-(2-ethylhexyl) phthalate and
   di-isononyl phthalate. Our findings strongly suggest that health-risk
   assessments for phthalate exposure in humans should include diethyl,
   dibutyl, and benzyl butyl phthalates.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Brock, JW (Reprint Author), Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, 4770 Buford Highway MS F-17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.
   NIEHS, Natl Toxicol Program, Res Triangle Pk, NC 27709 USA.}},
DOI = {{10.1289/ehp.00108979}},
ISSN = {{0091-6765}},
Keywords = {{exposure; glucuronidase; human; metabolism; phthalates; urine}},
Keywords-Plus = {{BUTYL BENZYL PHTHALATE; PLASTICIZER DI(2-ETHYLHEXYL)PHTHALATE; RATS;
   EXCRETION; EXPOSURE; SAMPLES}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1984, ANAL CHEM, V56, P247, DOI 10.1021/ac00266a029.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   BLOUNT BC, 2000, IN PRESS ANAL CHEM.
   Brock JW, 1996, J ANAL TOXICOL, V20, P528.
   CHING NPH, 1981, J CHROMATOGR, V225, P196, DOI 10.1016/S0378-4347(00)80260-1.
   David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   ELSISI AE, 1989, FUND APPL TOXICOL, V12, P70, DOI 10.1016/0272-0590(89)90063-8.
   EMA M, 1993, TOXICOLOGY, V79, P11, DOI 10.1016/0300-483X(93)90202-4.
   EMA M, 1993, TOXICOL LETT, V69, P197.
   Ema M, 1996, TOXICOL LETT, V86, P19.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   FOSTER PMD, 1983, DRUG METAB DISPOS, V11, P59.
   GRAY TJB, 1984, FOOD CHEM TOXICOL, V22, P123, DOI 10.1016/0278-6915(84)90092-9.
   Gunter EW, 1996, LAB METHODS USED 3 N.
   GUSTAFSSON JEC, 1978, CLIN CHIM ACTA, V90, P249, DOI 10.1016/0009-8981(78)90264-4.
   HARVAN DJ, 1980, BIOMED MASS SPECTROM, V7, P242, DOI 10.1002/bms.1200070604.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P118.
   LUSTER MI, 1978, CLIN CHEM, V24, P429.
   PIRKLE JL, 1995, ENVIRON HEALTH PERSP, V103, P45, DOI 10.2307/3432559.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SHIOTA K, 1980, ENVIRON RES, V22, P245, DOI 10.1016/0013-9351(80)90136-X.
   WARD JM, 1986, ENVIRON HEALTH PERSP, V65, P279, DOI 10.2307/3430195.
   Gray LE, 1999, TOXICOL IND HEALTH, V15, P94, DOI 10.1191/074823399678846664.}},
Number-of-Cited-References = {{29}},
Times-Cited = {{291}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{367ZP}},
Wos-Id = {{ISI:000090093000026}},
}

@article{ ISI:000089178600031,
Author = {Blount, BC and Milgram, KE and Silva, MJ and Malek, NA and Reidy, JA and
   Needham, LL and Brock, JW},
Title = {{Quantitative detection of eight phthalate metabolites in human urine
   using HPLC-APCI-MS/MS}},
Journal = {{ANALYTICAL CHEMISTRY}},
Year = {{2000}},
Volume = {{72}},
Number = {{17}},
Pages = {{4127-4134}},
Month = {{SEP 1}},
Abstract = {{Because of the ubiquity of phthalates and their potential role in
   increasing risk for cancer and reproductive dysfunction, the need for
   human exposure assessment studies is urgent. In response to this need,
   we developed a high-throughput, robust, sensitive, accurate, and precise
   assay for simultaneous measurement of trace levels of eight phthalate
   metabolites in human urine by HPLC-MS/MS. Human urine samples were
   processed using enzymatic deconjugation of the glucuronides followed by
   solid-phase ex-traction. The eluate was concentrated, and the phthalate
   metabolites were chromatographically resolved by reversed-phase HPLC,
   detected by APCI-tandem mass spectrometry, and quantified by isotope
   dilution. This selective analytical method permits rapid detection (7.7
   min total run time) of eight urinary metabolites of the most commonly
   used phthalates with detection limits in the low nanagram per milliliter
   range. Assay precision Was improved by incorporating C-13(4)-labeled
   internal standards for each of the eight analytes, as well as a
   conjugated internal standard to monitor deconjugation efficiency. This
   selective, sensitive, and rapid method will help elucidate potential
   associations (if any) between human exposure to phthalates and adverse
   health effects.}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Brock, JW (Reprint Author), Ctr Dis Control \& Prevent, Div Lab Sci, Natl Ctr Environm Hlth, 4770 Buford Hwy NE,Mailstop F-17, Atlanta, GA 30341 USA.
   Ctr Dis Control \& Prevent, Div Lab Sci, Natl Ctr Environm Hlth, Atlanta, GA 30341 USA.}},
DOI = {{10.1021/ac000422r}},
ISSN = {{0003-2700}},
Keywords-Plus = {{PLASTICIZER DI(2-ETHYLHEXYL)PHTHALATE; MONO-(2-ETHYLHEXYL) PHTHALATE;
   EXPOSURE; HEMODIALYSIS; SAMPLES; RATS}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
ResearcherID-Numbers = {{Needham, Larry/E-4930-2011}},
Cited-References = {{ALBRO PW, 1989, TOXICOL APPL PHARM, V100, P193, DOI 10.1016/0041-008X(89)90305-0.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1984, ANAL CHEM, V56, P247, DOI 10.1021/ac00266a029.
   ALBRO PW, 1982, J ENVIRON SCI HEAL B, V17, P701, DOI 10.1080/03601238209372351.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   Barr DB, 1998, J ANAL TOXICOL, V22, P96.
   BLOUNT BC, IN PRESS ENV HLTH PE.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P224, DOI 10.1006/taap.1994.1201.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   Ema M, 1996, REPROD TOXICOL, V10, P365, DOI 10.1016/0890-6238(96)00082-2.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   FOSTER PMD, 1983, DRUG METAB DISPOS, V11, P59.
   GUSTAFSSON JEC, 1978, CLIN CHIM ACTA, V90, P249, DOI 10.1016/0009-8981(78)90264-4.
   HARVAN DJ, 1980, BIOMED MASS SPECTROM, V7, P242, DOI 10.1002/bms.1200070604.
   Imajima T, 1997, J PEDIATR SURG, V32, P18, DOI 10.1016/S0022-3468(97)90083-X.
   LUSTER MI, 1978, CLIN CHEM, V24, P429.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   PIRKLE JL, 1995, ENVIRON HEALTH PERSP, V103, P45, DOI 10.2307/3432559.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   SAMPSON EJ, 1994, CLIN CHEM, V40, P1376.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x.
   Taylor J. K., 1987, QUALITY ASSURANCE CH.
   VALENTINBLASINI L, IN PRESS J EXPOSURE.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{155}},
Journal-ISO = {{Anal. Chem.}},
Doc-Delivery-Number = {{351VJ}},
Wos-Id = {{ISI:000089178600031}},
}

@article{ ISI:000089647400029,
Author = {Colon, I and Caro, D and Bourdony, CJ and Rosario, O},
Title = {{Identification of phthalate esters in the serum of young Puerto Rican
   girls with premature breast development}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{2000}},
Volume = {{108}},
Number = {{9}},
Pages = {{895-900}},
Month = {{SEP}},
Abstract = {{Premature breast development (thelarche) is the growth of mammary tissue
   in girls younger than 8 years of age without other manifestations of
   puberty. Puerto Rico has the highest known incidence of premature
   thelarche ever reported. In the last two decades since this serious
   public health anomaly has been observed, no explanation for this
   phenomenon has been found. Some organic pollutants, including pesticides
   and some plasticizers, can disrupt normal sexual development in
   wildlife, and many of these have been widely used in Puerto Rico. This
   investigation was designed to identify pollutants in the serum of Puerto
   Rican girls with premature thelarche. A method for blood serum analysis
   was optimized and validated using pesticides and phthalate esters as
   model compounds of endocrine-disrupting chemicals. Recovery was > 80\%
   for all compounds. We performed final detection by gas
   chromatography/mass spectrometry. We analyzed 41 serum samples from
   thelarche patients and 35 control samples. No pesticides or their
   metabolite residues were detected in the serum of the study or control
   subjects. Significantly high levels of phthalates {[}dimethyl, diethyl,
   dibutyl, and di-(2-ethylhexyl)] and its major metabolite
   mono-(2-ethylhexyl) phthalate were identified in 28 (68\%) samples from
   thelarche patients. Of the control samples analyzed, only one showed
   significant levels of di-isooctyl phthalate. The phthalates that we
   identified have been classified as endocrine disruptors. This study
   suggests a possible association between plasticizers with known
   estrogenic and antiandrogenic activity and the cause of premature breast
   development in a human female population.}},
Publisher = {{US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Rosario, O (Reprint Author), Univ Puerto Rico, Dept Chem, POB 23346, Rio Piedras, PR 00931 USA.
   Univ Puerto Rico, Dept Chem, Rio Piedras, PR 00931 USA.
   San Juan City Hosp, Pediat Endocrinol \& Diabet Div, San Juan, PR USA.
   Univ Puerto Rico, Sch Med, Dept Pediat, San Juan, PR 00936 USA.}},
DOI = {{10.1289/ehp.00108895}},
ISSN = {{0091-6765}},
Keywords = {{endocrine-disrupting chemicals; phthalate esters; premature thelarche}},
Keywords-Plus = {{BIS(2-ETHYLHEXYL) PHTHALATE; ORAL TOXICITY; IN-VITRO; EXPOSURE; RAT;
   PLASTICIZERS; THELARCHE; EPIDEMIC}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Cited-References = {{Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   BONGIOVANNI AM, 1983, J PEDIATR, V103, P245, DOI 10.1016/S0022-3476(83)80354-0.
   BOURDONY CJ, 1998, PREMATURE THELARCHE.
   COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890.
   Colborn T.C., 1992, WILDLIFE HUMAN CONNE.
   FREDRICSSON B, 1993, PHARMACOL TOXICOL, V72, P128.
   FRENITITULAER LW, 1986, AM J DIS CHILD, V140, P1263.
   GIUST JA, 1990, J AGR FOOD CHEM, V38, P415, DOI 10.1021/jf00092a016.
   GUILLETTE LJ, 1994, ENVIRON HEALTH PERSP, V102, P680, DOI 10.2307/3432198.
   Harris CA, 1997, ENVIRON HEALTH PERSP, V105, P802, DOI 10.1289/ehp.97105802.
   HermanGiddens ME, 1997, PEDIATRICS, V99, P505, DOI 10.1542/peds.99.4.505.
   Hileman B, 1996, CHEM ENG NEWS, V74, P28, DOI 10.1021/cen-v074n051.p028.
   Imajima T, 1997, J PEDIATR SURG, V32, P18, DOI 10.1016/S0022-3468(97)90083-X.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   Kavlock RJ, 1996, ENVIRON HEALTH PERSP, V104, P715, DOI 10.2307/3432708.
   Kulin H E, 1996, Pediatr Rev, V17, P75, DOI 10.1542/pir.17-3-75.
   LEUNG SC, 1993, B ENVIRON CONTAM TOX, V50, P528.
   LIWNICZ BH, 1989, CLIN CHEM THEORY ANA, P607.
   LOPEZAVILA V, 1990, J ASSOC OFF ANA CHEM, V73, P709.
   MALIK S, 1993, TOXICOL ENVIRON CHEM, V37, P333.
   Marin ML, 1998, B ENVIRON CONTAM TOX, V60, P68.
   Mocarelli P, 1996, LANCET, V348, P409, DOI 10.1016/S0140-6736(05)65030-1.
   MONTGOMERY EE, UNPUB.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   Patlak M, 1996, ENVIRON SCI TECHNOL, V30, pA540, DOI 10.1021/es962527a.
   PEREZCOMAS AP, 1982, LANCET, V1, P1299.
   Poon R, 1997, FOOD CHEM TOXICOL, V35, P225, DOI 10.1016/S0278-6915(96)00064-6.
   QUINONES A, 1992, THESIS PUERTO RICO U.
   Rastogi SC, 1998, CHROMATOGRAPHIA, V47, P724, DOI 10.1007/BF02467461.
   ROSS G, 1994, 1001 CHEM EVERYDAY P.
   Sáenz de Rodríguez C A, 1985, J Pediatr, V107, P393, DOI 10.1016/S0022-3476(85)80513-8.
   SAFE SH, 1995, ENVIRON HEALTH PERSP, V103, P346, DOI 10.2307/3432287.
   SATTIN RW, 1984, PUBLIC HEALTH REP, V99, P504.
   SIDDIQUI A, 1992, B ENVIRON CONTAM TOX, V48, P115.
   SIPPELL WG, 1994, HORM RES, V41, P14, DOI 10.1159/000183952.
   VANWINTER JT, 1990, J PEDIATR, V116, P278, DOI 10.1016/S0022-3476(05)82891-4.
   Vonier PM, 1996, ENVIRON HEALTH PERSP, V104, P1318, DOI 10.2307/3432968.
   WEISGLASKUPERUS N, 1995, PEDIATR RES, V38, P404, DOI 10.1203/00006450-199509000-00022.
   Zacharewski TR, 1998, TOXICOL SCI, V46, P282, DOI 10.1093/toxsci/46.2.282.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{246}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{360BW}},
Wos-Id = {{ISI:000089647400029}},
}

@article{ ISI:000085306200003,
Author = {Keys, DA and Wallace, DG and Kepler, TB and Conolly, RB},
Title = {{Quantitative evaluation of alternative mechanisms of blood disposition
   of di(n-butyl) phthalate and mono(n-butyl) phthalate in rats}},
Journal = {{TOXICOLOGICAL SCIENCES}},
Year = {{2000}},
Volume = {{53}},
Number = {{2}},
Pages = {{173-184}},
Month = {{FEB}},
Abstract = {{Phthalate esters are ubiquitous, low-level environmental contaminants
   that induce testicular toxicity in laboratory animals. The diester is
   rapidly metabolized in the gut to the monoester, which causes the
   testicular toxicity. Several physiologically based pharmacokinetic
   (PBPK) model structures have been evaluated for di(2-ethylhexyl)
   phthalate (DEHP) and mono(2-ethylhexyl) phthalate (MEHP), The objective
   of this study was to test these PBPK models for a less lipophilic
   phthalate diester, di(n-butyl) phthalate (DBP), and monoester,
   mono(n-butyl) phthalate (MBP). Alternate models describing enterohepatic
   circulation, diffusion limitation, tissue pH gradients (pH trapping),
   and a simpler, flow-limited model were evaluated. A combined
   diffusion-limited and pH trapping model was also tested. MBP
   tissue:blood partition coefficients were similar when determined either
   experimentally by a nonvolatile, vial equilibration technique or
   algorithmically. All other parameters were obtained from the literature
   or estimated from MBP blood concentrations following intravenous or oral
   exposure to DBP or MBP. A flow-limited model was unable to predict MBP
   blood levels, whereas each alternative model had statistically better
   predictions. The combined diffusion-limited and pH trapping model was
   the best overall, having the highest log-likelihood function value. This
   result is consistent with a previous finding that the pH trapping model
   was the best model for describing DEHP and MEHP blood dosimetry, though
   it was necessary to extend the model to include diffusion-limitation.
   The application of the pH trapping model is a step toward developing a
   generic model structure for all phthalate esters, though more work is
   required before a generic structure can be identified with confidence.
   Development of a PBPK model structure applicable to all phthalate esters
   would support more realistic assessments of risk to human health from
   exposure to one or more members of this class of compounds.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Conolly, RB (Reprint Author), Chem Ind Inst Toxicol, 6 Davis Dr,POB 12137, Res Triangle Pk, NC 27709 USA.
   Chem Ind Inst Toxicol, Res Triangle Pk, NC 27709 USA.
   N Carolina State Univ, Dept Stat, Biomath Grad Program, Raleigh, NC 27695 USA.}},
DOI = {{10.1093/toxsci/53.2.173}},
ISSN = {{1096-6080}},
Keywords = {{phthalates; DBP; MBP; PBPK; model; flow-limited; diffusion-limited; pH
   trapping; enterohepatic circulation; log-likelihood ratio test}},
Keywords-Plus = {{N-BUTYL PHTHALATE; TESTICULAR ATROPHY; PARTITION-COEFFICIENTS;
   ORGANIC-CHEMICALS; ESTERS; PHARMACOKINETICS; METABOLISM; TOXICITY;
   TESTOSTERONE; DIESTERS}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Cited-References = {{ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   ANDERSEN ME, 1993, RISK ANAL, V13, P25, DOI 10.1111/j.1539-6924.1993.tb00726.x.
   BAILEY JW, 1980, GROWTH, V44, P220.
   CATER BR, 1977, TOXICOL APPL PHARM, V41, P609, DOI 10.1016/S0041-008X(77)80014-8.
   CHUBB C, 1982, AM J ANAT, V165, P357, DOI 10.1002/aja.1001650402.
   FISEROVABERGERO.V, 1983, MODELING INHALATION, V1, P15.
   FOSTER PMD, 1981, CHEM-BIOL INTERACT, V34, P233, DOI 10.1016/0009-2797(81)90134-4.
   FOSTER PMD, 1983, DRUG METAB DISPOS, V11, P59.
   FUKUOKA M, 1989, J APPL TOXICOL, V9, P277, DOI 10.1002/jat.2550090413.
   FUKUOKA M, 1990, J APPL TOXICOL, V10, P285, DOI 10.1002/jat.2550100410.
   FUKUOKA M, 1993, J APPL TOXICOL, V13, P241, DOI 10.1002/jat.2550130406.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9.
   GUTHRIE FE, 1987, TXB MODERN TOXICOLOG, P123.
   Guyton AC, 1991, TXB MED PHYSL.
   KANESHIMA H, 1978, B ENVIRON CONTAM TOX, V19, P503.
   Keys DA, 1999, TOXICOL SCI, V49, P172, DOI 10.1093/toxsci/49.2.172.
   LONG G, 1997, ENV HLTH CRITERIA, V189.
   MURPHY JE, 1995, J APPL TOXICOL, V15, P147, DOI 10.1002/jat.2550150215.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   OFLAHERTY EJ, 1992, TOXICOL APPL PHARM, V112, P245, DOI 10.1016/0041-008X(92)90194-W.
   OISHI S, 1989, ARCH TOXICOL, V63, P289, DOI 10.1007/BF00278642.
   OISHI S, 1980, TOXICOLOGY, V15, P197, DOI 10.1016/0300-483X(80)90053-0.
   POULIN P, 1995, J TOXICOL ENV HEALTH, V46, P117.
   Poulin P, 1996, TOXICOL METHOD, V6, P117, DOI 10.3109/15376519609068458.
   RAMSEY JC, 1984, TOXICOL APPL PHARM, V73, P159, DOI 10.1016/0041-008X(84)90064-4.
   SJOBERG P, 1986, ENVIRON HEALTH PERSP, V65, P237, DOI 10.2307/3430188.
   SRIVASTAVA S, 1990, INDIAN J EXP BIOL, V28, P67.
   TABRIZCHI R, 1993, J PHARM PHARMACOL, V45, P151.
   TANAKA A, 1978, TOXICOLOGY, V9, P109, DOI 10.1016/0300-483X(78)90036-7.
   TANINO M, 1987, Jikeikai Medical Journal, V34, P245.
   WHITE RD, 1980, FOOD COSMET TOXICOL, V18, P383, DOI 10.1016/0015-6264(80)90194-7.
   WILLIAMS DT, 1975, J AGR FOOD CHEM, V23, P854, DOI 10.1021/jf60201a047.
   WILLIAMS HH, 1945, J BIOL CHEM, V161, P475.
   Wine RN, 1997, ENVIRON HEALTH PERSP, V105, P102, DOI 10.1289/ehp.97105102.
   {*}ATSDR, 1990, TP9010 US DEP HLTH H.
   {*}ILSI, 1994, PHYS PAR VAL PBPK MO.
   {*}NIEHS, 1995, TOX STUD REP TOX MET.
   {*}NIEHS, 1994, PREST TOX STUD REP D.
   {*}NRC, 1996, GUID CAR US LAB AN.
   {*}NTP, 1995, TOX SER US DEP HLTH, V30.
   {*}NTP, 1991, T0035C DEP COMM NAT.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{10}},
Journal-ISO = {{Toxicol. Sci.}},
Doc-Delivery-Number = {{283ZP}},
Wos-Id = {{ISI:000085306200003}},
}

@article{ ISI:000165527700001,
Author = {Latini, G},
Title = {{Potential hazards of exposure to di-(2-ethylhexyl)-phthalate in babies}},
Journal = {{BIOLOGY OF THE NEONATE}},
Year = {{2000}},
Volume = {{78}},
Number = {{4}},
Pages = {{269-276}},
Abstract = {{Many plastic items are made of polyvinylchloride (PVC) blended with
   plasticizers. The most frequently used plasticizer is
   di-(2-ethylhexyl)-phthalate (DEHP). DEHP migrates at a constant rate
   from plastics to the environment: it has been detected in water, soil
   and food and is therefore considered as a widespread environmental
   contaminant. Over the past several years, a number of publications
   concerning toxic effects of DEHP on animals and humans have been
   reported. Although DEHP is suggested to be of low acute toxicity,
   long-term exposure, especially in human beings at risk such as pregnant
   women and children, requires more in-depth studies. If DEHP toxicity in
   humans were to be confirmed, it would be advisable in the future to
   replace current PVC plasticizers, especially if they come into contact
   with babies, with better-quality materials. Copyright (C) 2000 S. Karger
   AG, Basel.}},
Publisher = {{KARGER}},
Address = {{ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND}},
Type = {{Review}},
Language = {{English}},
Affiliation = {{Latini, G (Reprint Author), Azienda Osped A Di Summa, Osped A Perrino, Div Pediat, Piazza Di Summa, I-72100 Brindisi, Italy.
   Azienda Osped A Di Summa, Osped A Perrino, Div Pediat, I-72100 Brindisi, Italy.}},
DOI = {{10.1159/000014278}},
ISSN = {{0006-3126}},
Keywords = {{polyvinylchloride; di-(2-ethylhexyl)-phthalate; medical device;
   pregnancy}},
Keywords-Plus = {{EXTRACORPOREAL MEMBRANE-OXYGENATION; PLASTICIZER DI(2-ETHYLHEXYL)
   PHTHALATE; ISCHEMIA-REPERFUSION INJURY; CHLORIDE BLOOD BAGS; STORED
   HUMAN BLOOD; POLYVINYL-CHLORIDE; IN-VITRO; MONO-(2-ETHYLHEXYL)
   PHTHALATE; BRONCHOPULMONARY DYSPLASIA; PEROXISOME PROLIFERATION}},
Research-Areas = {{Pediatrics}},
Web-of-Science-Categories  = {{Pediatrics}},
Cited-References = {{Arcadi FA, 1998, FOOD CHEM TOXICOL, V36, P963, DOI 10.1016/S0278-6915(98)00065-9.
   ARUN P, 1999, VOX SANG, V6, P220.
   BALLY MB, 1980, TOXICOLOGY, V18, P49, DOI 10.1016/0300-483X(80)90037-2.
   BARRY YA, 1990, TOXICOL APPL PHARM, V106, P48, DOI 10.1016/0041-008X(90)90104-3.
   BARRY YA, 1988, BLOOD, V72, P1438.
   BARRY YA, 1989, J THORAC CARDIOV SUR, V97, P900.
   Bauer MJ, 1997, SCI TOTAL ENVIRON, V208, P49, DOI 10.1016/S0048-9697(97)00272-6.
   Blass C R, 1992, Med Device Technol, V3, P32.
   Bradbury J, 1996, LANCET, V347, P1541, DOI 10.1016/S0140-6736(96)90681-9.
   BRUCK SD, 1982, INT J ARTIF ORGANS, V5, P85.
   CALO L, 1993, CLIN NEPHROL, V40, P57.
   CIMINI AM, 1994, CELL MOL BIOL, V40, P1063.
   Contreras M, 1996, CRIT CARE MED, V24, P29, DOI 10.1097/00003246-199601000-00008.
   CROCKER JFS, 1988, J TOXICOL ENV HEALTH, V23, P433.
   DABHOLKAR AS, 1988, ACTA ANAT, V131, P218.
   David RM, 1999, TOXICOL SCI, V50, P195, DOI 10.1093/toxsci/50.2.195.
   DAVIS BJ, 1994, TOXICOL APPL PHARM, V128, P216, DOI 10.1006/taap.1994.1200.
   Deepa Devi K. V., 1998, Vox Sanguinis, V75, P198, DOI 10.1159/000030987.
   DELRIO LA, 1992, FREE RADICAL BIO MED, V13, P557, DOI 10.1016/0891-5849(92)90150-F.
   Dickerson RN, 1997, NUTRITION, V13, P1010, DOI 10.1016/0899-9007(97)90962-X.
   DOELMAN CJA, 1990, LANCET, V335, P725, DOI 10.1016/0140-6736(90)90839-W.
   Doelman C J, 1990, Agents Actions Suppl, V31, P81.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   DOSTAL LA, 1987, TOXICOL APPL PHARM, V87, P81, DOI 10.1016/0041-008X(87)90086-X.
   Doull J, 1999, REGUL TOXICOL PHARM, V29, P327, DOI 10.1006/rtph.1999.1296.
   Faouzi MA, 1999, INT J PHARM, V180, P113, DOI 10.1016/S0378-5173(98)00411-6.
   Fischer FP, 1998, PERITON DIALYSIS INT, V18, P620.
   FREDRICSSON B, 1993, PHARMACOL TOXICOL, V72, P128.
   GIAM CS, 1978, SCIENCE, V199, P419, DOI 10.1126/science.199.4327.419-a.
   GRIFFITHS WC, 1985, ANN CLIN LAB SCI, V15, P140.
   GULATI S, 1993, BIOCHIM BIOPHYS ACTA, V1182, P291, DOI 10.1016/0925-4439(93)90071-8.
   Hasmall SC, 1999, ARCH TOXICOL, V73, P451, DOI 10.1007/s002040050634.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   Imajima T, 1997, J PEDIATR SURG, V32, P18, DOI 10.1016/S0022-3468(97)90083-X.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   Jayakrishnan K, 1998, NATURE, V396, P638.
   JONES C, 1989, INT J ARTIF ORGANS, V12, P466.
   Karle VA, 1997, CRIT CARE MED, V25, P696, DOI 10.1097/00003246-199704000-00023.
   KELLY FJ, 1993, BRIT MED BULL, V49, P668.
   KHALIQ MA, 1992, B ENVIRON CONTAM TOX, V48, P572.
   KICHEVA YI, 1995, BIOMATERIALS, V16, P575, DOI 10.1016/0142-9612(95)91132-I.
   KIM SW, 1976, J PHARM SCI, V65, P670, DOI 10.1002/jps.2600650510.
   LABOW RS, 1988, ENVIRON HEALTH PERSP, V78, P179, DOI 10.2307/3430519.
   Lamba NMK, 2000, BIOMATERIALS, V21, P89, DOI 10.1016/S0142-9612(99)00145-3.
   Lantos P R, 1988, J Biomater Appl, V2, P358.
   Latini G, 1999, ACTA PAEDIATR, V88, P1174, DOI 10.1080/08035259950168333.
   Li LH, 1998, TOXICOL APPL PHARM, V153, P258, DOI 10.1006/taap.1998.8550.
   Manojkumar V, 1998, VOX SANG, V75, P139, DOI 10.1159/000030975.
   Marin ML, 1998, B ENVIRON CONTAM TOX, V60, P68.
   MAYER FL, 1972, NATURE, V238, P411, DOI 10.1038/238411a0.
   Mettang T, 1999, ADV PERIT D, V15, P229.
   Mettang T, 1996, PERITON DIALYSIS INT, V16, P58.
   MEZ J, 1974, B ENVIRON CONTAM TOX, V12, P721.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   Nazir D J, 1973, Environ Health Perspect, V3, P141, DOI 10.2307/3428041.
   Noah V A, 1994, J Intraven Nurs, V17, P210.
   NOWICKI P, 1980, POL J PHARMACOL PHAR, V32, P77.
   Oie L, 1997, ENVIRON HEALTH PERSP, V105, P972, DOI 10.1289/ehp.97105972.
   OISHI S, 1985, ENVIRON RES, V36, P160, DOI 10.1016/0013-9351(85)90014-3.
   OLIVER JE, 1975, BRIT MED J, V2, P262.
   Ono K, 1976, Proc Eur Dial Transplant Assoc, V12, P571.
   ONO K, 1975, JAMA-J AM MED ASSOC, V234, P948, DOI 10.1001/jama.234.9.948.
   OSSENDORP BC, 1994, BIOCHEM BIOPH RES CO, V205, P1581, DOI 10.1006/bbrc.1994.2847.
   Papparella A, 1997, PEDIATR RES, V42, P180, DOI 10.1203/00006450-199708000-00009.
   Parke DV, 1984, TOXICOLOGY NEWBORN, P1.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   Peters JM, 1997, TERATOLOGY, V56, P311, DOI 10.1002/(SICI)1096-9926(199711)56:5<311::AID-TERA4>3.0.CO;2-\#.
   PIETARINEN P, 1995, AM J RESP CELL MOL, V13, P434.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   PRICE SC, 1988, TOXICOL LETT, V40, P37, DOI 10.1016/0378-4274(88)90181-6.
   Roberts RA, 1999, ARCH TOXICOL, V73, P413, DOI 10.1007/s002040050629.
   ROCK G, 1987, NEW ENGL J MED, V316, P1218.
   ROCK G, 1990, TRANSFUSION, V30, P767, DOI 10.1046/j.1537-2995.1990.30891020345.x.
   ROTH B, 1988, EUR J PEDIATR, V147, P41, DOI 10.1007/BF00442609.
   Rothenbacher KP, 1998, HUM EXP TOXICOL, V17, P336, DOI 10.1191/096032798678908873.
   RUBIN RJ, 1989, TRANSFUSION, V29, P358, DOI 10.1046/j.1537-2995.1989.29489242805.x.
   SAUGSTAD OD, 1990, ACTA PAEDIATR SCAND, V79, P881, DOI 10.1111/j.1651-2227.1990.tb11348.x.
   Saugstad OD, 1998, BIOL NEONATE, V74, P21, DOI 10.1159/000047031.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SHARMAN M, 1994, FOOD ADDIT CONTAM, V11, P375.
   SHERTZER HG, 1982, ARCH ENV CONTAM TOXI, V14, P605.
   SHNEIDER B, 1991, J PEDIATR GASTR NUTR, V13, P285, DOI 10.1097/00005176-199110000-00008.
   SHNEIDER B, 1989, NEW ENGL J MED, V320, P1563.
   SIOBERG POJ, 1985, TRANSFUSION, V25, P424.
   SJOBERG P, 1985, EUR J CLIN INVEST, V15, P430, DOI 10.1111/j.1365-2362.1985.tb00297.x.
   SJOBERG P, 1991, BIOCHEM PHARMACOL, V41, P1493, DOI 10.1016/0006-2952(91)90566-N.
   SJOBERG P, 1988, BIOL NEONATE, V53, P32.
   SMITH MD, 1995, J BIOMAT SCI-POLYM E, V7, P453.
   Stefanini S, 1995, BIOL CELL, V85, P167, DOI 10.1016/0248-4900(96)85277-4.
   Steiner I, 1998, FOOD ADDIT CONTAM, V15, P812.
   Toppari J, 1996, ENVIRON HEALTH PERSP, V104, P741, DOI 10.2307/3432709.
   Webb JS, 1999, APPL ENVIRON MICROB, V65, P3575.
   WOODWARD KN, 1990, HUM EXP TOXICOL, V9, P397.
   Zhao XB, 1999, ARTIF ORGANS, V23, P104, DOI 10.1046/j.1525-1594.1999.06267.x.
   1975, LANCET, V1, P1172.}},
Number-of-Cited-References = {{97}},
Times-Cited = {{54}},
Journal-ISO = {{Biol. Neonate}},
Doc-Delivery-Number = {{377RR}},
Wos-Id = {{ISI:000165527700001}},
}

@article{ ISI:000082765800012,
Author = {Nativelle, C and Picard, K and Valentin, I and Lhuguenot, JC and
   Chagnon, MC},
Title = {{Metabolism of n-butyl benzyl phthalate in the female Wistar rat.
   Identification of new metabolites}},
Journal = {{FOOD AND CHEMICAL TOXICOLOGY}},
Year = {{1999}},
Volume = {{37}},
Number = {{8}},
Pages = {{905-917}},
Month = {{AUG}},
Abstract = {{n-Butyl benzyl phthalate (BBP), a plasticizer used in polyvinylchloride
   (PVC) and other polymers, has been orally administered to female Wistar
   rats with four doses (150, 475, 780 and 1500 mg/kg body weight/day) for
   3 consecutive days. Metabolites recovered in urines were analysed by gas
   chromatography-mass spectrometry (GC-MS) after 24, 48 and 72 hours. Six
   metabolites were identified. Mono-n-butyl phthalate (MBuP) and
   mono-n-benzyl phthalate (MBeP) represented respectively 29-34\% and 7-12
   \% of the total recovered metabolites. Hippuric acid, the main
   metabolite of benzoic acid, represented the second major metabolite
   (51-56\%). Phthalic acid, benzoic acid and an omega-oxidized metabolite
   of MBuP were also recovered in urine but in small quantities. BBP was
   never identified in urines. Total urinary metabolites recovery
   represented 56\% of the dose administered in the first 24 hours.
   However, total recovery decreased when the dose increases (43\% at 780
   mg/kg body weight/day, only 30\% at 1500 mg/kg body weight/day).
   Whatever the time was, BBP metabolites recovered in urines were all
   present and in the same proportions for the two lowest doses.
   Discrepancy in metabolites quantities expressed as percentages of the
   dose observed in urine of rat treated with the highest BBP dose
   disappeared with time as MBuP, MBeP and hippuric acid recovery has
   significantly increased at day 3. Metabolic profile of BBP in female
   rats has been established. The aim of the present study is to identify
   further the active(s) agent(s) involved in the BBP malformations and
   teratogenic effects. (C) 1999 Elsevier Science Ltd. All rights reserved.}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Chagnon, MC (Reprint Author), ENSBANA, Toxicol Lab, 1 Esplanade Erasme, F-21000 Dijon, France.
   ENSBANA, Toxicol Lab, F-21000 Dijon, France.}},
DOI = {{10.1016/S0278-6915(99)00071-X}},
ISSN = {{0278-6915}},
Keywords = {{n-butyl benzyl phthalate; metabolism; metabolites; female rat}},
Keywords-Plus = {{DEVELOPMENTAL TOXICITY; PHARMACOKINETICS; ABSORPTION}},
Research-Areas = {{Food Science \& Technology; Toxicology}},
Web-of-Science-Categories  = {{Food Science \& Technology; Toxicology}},
Cited-References = {{AGARWAL DK, 1985, TOXICOLOGY, V35, P189, DOI 10.1016/0300-483X(85)90015-0.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V360, P380.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   BRIDGES JW, 1970, BIOCHEM J, V118, P47.
   BUDZIKIEWICZ H, 1967, MASS SPECTROMETRY OR, P35.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   DEBOER TJ, 1954, RECL TRAV CHIM PAY B, V73, P229.
   EIGENBERG DA, 1986, J TOXICOL ENV HEALTH, V17, P445.
   EMA M, 1992, J APPL TOXICOL, V12, P179, DOI 10.1002/jat.2550120305.
   EMA M, 1992, J APPL TOXICOL, V12, P57, DOI 10.1002/jat.2550120112.
   EMA M, 1995, TOXICOL LETT, V78, P101, DOI 10.1016/0378-4274(94)03241-X.
   EMA M, 1993, TOXICOLOGY, V79, P11, DOI 10.1016/0300-483X(93)90202-4.
   EMA M, 1994, TOXICOLOGY, V86, P163, DOI 10.1016/0300-483X(94)90002-7.
   EMA M, 1990, J APPL TOXICOL, V10, P339, DOI 10.1002/jat.2550100506.
   Ema M, 1996, TOXICOL LETT, V86, P19.
   Ema M, 1996, REPROD TOXICOL, V10, P365, DOI 10.1016/0890-6238(96)00082-2.
   EMA M, 1995, ARCH ENVIRON CON TOX, V28, P223.
   FIELD EA, 1989, 85687 CAS.
   HARVAN DJ, 1980, BIOMED MASS SPECTROM, V7, P242, DOI 10.1002/bms.1200070604.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P3, DOI 10.2307/3429377.
   LAKE BG, 1987, TOXICOL IND HEALTH, V3, P165.
   LHUGUENOT JC, 1988, TOXICOL IND HEALTH, V4, P431.
   MANNAERTS GP, 1993, BIOCHIMIE, V75, P147, DOI 10.1016/0300-9084(93)90072-Z.
   MULDER GJ, 1986, CHEM-BIOL INTERACT, V57, P1, DOI 10.1016/0009-2797(86)90044-X.
   PAITRY M, 1995, THESIS U BOURGOGNE.
   PRICE CJ, 1990, 90114 NTP.
   TANAKA A, 1978, TOXICOLOGY, V9, P109, DOI 10.1016/0300-483X(78)90036-7.
   TEUCHY H, 1971, ARCH INT PHYS BIOCH, V79, P573, DOI 10.3109/13813457109085340.
   TREMBLAY GC, 1993, PHARMACOL THERAPEUT, V60, P63, DOI 10.1016/0163-7258(93)90022-6.
   WHITE RD, 1983, FOOD CHEM TOXICOL, V21, P99, DOI 10.1016/0278-6915(83)90276-4.
   WILLIAMS DT, 1974, B ENVIRON CONTAM TOX, V12, P109.
   {*}IARC, 1982, IARC MON EV CARC RIS, V29, P193.}},
Number-of-Cited-References = {{33}},
Times-Cited = {{22}},
Journal-ISO = {{Food Chem. Toxicol.}},
Doc-Delivery-Number = {{239JW}},
Wos-Id = {{ISI:000082765800012}},
}

@article{ ISI:000083455100005,
Author = {Keys, DA and Wallace, DG and Kepler, TB and Conolly, RB},
Title = {{Quantitative evaluation of alternative mechanisms of blood and testes
   disposition of di(2-ethylhexyl) phthalate and mono(2-ethylhexyl)
   phthalate in rats}},
Journal = {{TOXICOLOGICAL SCIENCES}},
Year = {{1999}},
Volume = {{49}},
Number = {{2}},
Pages = {{172-185}},
Month = {{JUN}},
Abstract = {{Di(2-ethylhexyl) phthalate (DEHP), a commercially important plasticizer,
   induces testicular toxicity in laboratory animals at high doses. After
   oral exposure, most of the DEHP is rapidly metabolized in the gut to
   mono(2-ethylhexyl) phthalate (MEHP), which is the active metabolite for
   induction of testicular toxicity. To quantify the testes dose of MEHP
   with various routes of exposure and dose levels, we developed a
   physiologically based pharmacokinetic (PBPK) model for DEHP and MEHP in
   rats. Tissue:blood partition coefficients for DEHP were estimated from
   the n-octanol: water partition coefficient, while partition coefficients
   for MEHP were determined experimentally using a vial equilibration
   technique. All other parameters were either found in the literature or
   estimated from blood or tissue levels following oral or intravenous
   exposure to DEHP or MEHP. A flow-limited model failed to adequately
   simulate the available data. Alternative plausible mechanisms were
   explored, including diffusion-limited membrane transport, enterohepatic
   circulation, and MEHP ionization (pH-trapping model). In the pH-trapping
   model, only nonionized MEHP is free to become partitioned into the
   tissues, where it is equilibrated and trapped as ionized MEHP until it
   is deionized and released. All three alternative models significantly
   improved predictions of DEHP and MEHP blood concentrations over the
   flow-limited model predictions. The pH-trapping model gave the best
   predictions with the largest value of the log likelihood function.
   Predicted MEHP blood and testes concentrations were compared to measured
   concentrations in juvenile rats to validate the pH-trapping model. Thus,
   MEHP ionization may be an important mechanism of MEHP blood and testes
   disposition in rats.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Conolly, RB (Reprint Author), Chem Ind Inst Toxicol, 6 Davis Dr, Res Triangle Pk, NC 27709 USA.
   Chem Ind Inst Toxicol, Res Triangle Pk, NC 27709 USA.
   N Carolina State Univ, Dept Stat, Biomath Grad Program, Raleigh, NC 27695 USA.}},
DOI = {{10.1093/toxsci/49.2.172}},
ISSN = {{1096-6080}},
Keywords = {{phthalates; DEHP; MEHP; PBPK; model; flow-limited; diffusion-limited; pH
   trapping; enterohepatic circulation; log-likelihood ratio test}},
Keywords-Plus = {{CONTINUOUS BREEDING PROTOCOL; DE-ESTERIFIED METABOLITE; N-PENTYL
   PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; ACID ESTERS; PEROXISOME
   PROLIFERATION; PARTITION-COEFFICIENTS; REPRODUCTIVE TOXICITY; TESTICULAR
   ATROPHY; PHARMACOKINETICS}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Cited-References = {{ALBRO PW, 1984, DRUG METAB DISPOS, V12, P742.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ANDERSEN ME, 1993, RISK ANAL, V13, P25, DOI 10.1111/j.1539-6924.1993.tb00726.x.
   ASTILL BD, 1989, DRUG METAB REV, V21, P35, DOI 10.3109/03602538909029954.
   BAILEY JW, 1980, GROWTH, V44, P220.
   Bruijn JD, 1989, ENVIRON TOXICOL CHEM, V8, P499.
   CAFLISCH CR, 1994, J TOXICOL ENV HEALTH, V42, P323.
   CHUBB C, 1982, AM J ANAT, V165, P357, DOI 10.1002/aja.1001650402.
   CREASY DM, 1987, EXP MOL PATHOL, V46, P357, DOI 10.1016/0014-4800(87)90056-6.
   CREASY DM, 1983, J PATHOL, V139, P309, DOI 10.1002/path.1711390307.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   DIRVEN HAAM, 1992, BIOCHEM PHARMACOL, V43, P2621, DOI 10.1016/0006-2952(92)90151-8.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   FISEROVABERGERO.V, 1983, MODELING INHALATION, V1, P15.
   FOSTER PMD, 1982, TOXICOL APPL PHARM, V63, P120, DOI 10.1016/0041-008X(82)90031-X.
   Gray T J, 1980, Arch Toxicol Suppl, V4, P452.
   GRAY TJB, 1984, FOOD CHEM TOXICOL, V22, P123, DOI 10.1016/0278-6915(84)90092-9.
   GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9.
   GUYTON AC, 1991, TXB MED PHYSL, P331.
   HEINDEL JJ, 1989, FUND APPL TOXICOL, V12, P508, DOI 10.1016/0272-0590(89)90024-9.
   KLOPFFER W., 1994, ENVIRON SCI POLLUT R, V1, P108, DOI 10.1007/BF02986520.
   KRISHNAN K, 1997, FUNDAM APPL TOXICO S, V36, P28.
   LAKE BG, 1984, TOXICOL APPL PHARM, V72, P46, DOI 10.1016/0041-008X(84)90248-5.
   LAMB JC, 1987, TOXICOL APPL PHARM, V88, P255, DOI 10.1016/0041-008X(87)90011-1.
   Michnowska M, 1996, AM J NEPHROL, V16, P431, DOI 10.1159/000169037.
   MURPHY JE, 1995, J APPL TOXICOL, V15, P147, DOI 10.1002/jat.2550150215.
   Mylchreest E, 1998, TOXICOL SCI, V43, P47, DOI 10.1093/toxsci/43.1.47.
   OFLAHERTY EJ, 1992, TOXICOL APPL PHARM, V112, P245, DOI 10.1016/0041-008X(92)90194-W.
   OISHI S, 1989, TOXICOL LETT, V47, P271.
   OISHI S, 1990, ARCH TOXICOL, V64, P143, DOI 10.1007/BF01974400.
   OISHI S, 1989, ARCH TOXICOL, V63, P289, DOI 10.1007/BF00278642.
   OISHI S, 1982, ARCH TOXICOL, V51, P149, DOI 10.1007/BF00302755.
   OISHI S, 1985, ENVIRON RES, V36, P160, DOI 10.1016/0013-9351(85)90014-3.
   OISHI S, 1980, TOXICOLOGY, V15, P197, DOI 10.1016/0300-483X(80)90053-0.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P246, DOI 10.1016/0041-008X(85)90346-1.
   POULIN P, 1995, J TOXICOL ENV HEALTH, V46, P117.
   Poulin P, 1996, TOXICOL METHOD, V6, P117, DOI 10.3109/15376519609068458.
   RAMSEY JC, 1984, TOXICOL APPL PHARM, V73, P159, DOI 10.1016/0041-008X(84)90064-4.
   SAXENA D K, 1985, Industrial Health, V23, P191.
   Schulz C O, 1973, Environ Health Perspect, V3, P123, DOI 10.2307/3428038.
   SHORT RD, 1987, TOXICOL IND HEALTH, V3, P185.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   SJOBERG P, 1985, ARCH TOXICOL, V58, P72, DOI 10.1007/BF00348312.
   SJOBERG P, 1986, ENVIRON HEALTH PERSP, V65, P237, DOI 10.2307/3430188.
   TABRIZCHI R, 1993, J PHARM PHARMACOL, V45, P151.
   TEIRLYNCK O, 1988, TOXICOL LETT, V40, P85, DOI 10.1016/0378-4274(88)90186-5.
   TEIRLYNCK OA, 1985, ARCH TOXICOL, V57, P226, DOI 10.1007/BF00324782.
   WHITE RD, 1980, FOOD COSMET TOXICOL, V18, P383, DOI 10.1016/0015-6264(80)90194-7.
   WILLIAMS HH, 1945, J BIOL CHEM, V161, P475.
   Wine RN, 1997, ENVIRON HEALTH PERSP, V105, P102, DOI 10.1289/ehp.97105102.
   WOLFORD ST, 1986, J TOXICOL ENV HEALTH, V18, P161.
   {*}AG TOX SUBST DIS, 1993, NTIS PUBL.
   {[}Anonymous], 1994, PHYS PAR VAL PBPK MO.
   {*}NAT RES COUNC, 1996, GUID CAR US LAB.
   {*}NAT TOX PROGR, 1991, NTIS PUBL.}},
Number-of-Cited-References = {{55}},
Times-Cited = {{27}},
Journal-ISO = {{Toxicol. Sci.}},
Doc-Delivery-Number = {{251PY}},
Wos-Id = {{ISI:000083455100005}},
}

@article{ ISI:000080103700007,
Author = {Manojkumar, V and Deepadevi, KV and Arun, P and Nair, KGP and Lakshmi,
   LR and Kurup, PA},
Title = {{Changes in the composition of erythrocyte membrane during storage of
   blood in di-(2-ethyl hexyl) phthalate {[}DEHP] plasticized poly vinyl
   chloride (PVC) blood storage bags}},
Journal = {{INDIAN JOURNAL OF MEDICAL RESEARCH}},
Year = {{1999}},
Volume = {{109}},
Pages = {{157-163}},
Month = {{APR}},
Abstract = {{Very little information is available on the changes in the erythrocyte
   membrane composition during storage of blood at 4 degrees C,
   particularly with respect to the glycosaminoglycans and glycoproteins.
   In view of this, a detailed study was carried out on the changes in the
   membrane proteins, glycosaminoglycans (GAG), carbohydrate components of
   glycoproteins, cholesterol, phospholipids and vitamin E in blood stored
   in glass bottles and a di-(2-ethyl hexyl) phthalate (DEHP) plasticized
   PVC bag (Penpol blood bag). Blood was collected in CPDA solution in
   glass bottles and in Penpol blood bags and kept at 4+/-1 degrees C.
   Analysis was made immediately after blood collection and after 28 and 42
   days. Significant increase in the total protein in the erythrocyte
   membrane was observed during storage of whole blood in glass bottles and
   Penpol blood bag at 4 degrees C. This increase was progressively more
   with increase in storage time. Significant changes were also observed in
   GAG, carbohydrate components of glycoproteins, cholesterol,
   phospholipids and vitamin E in the erythrocyte membrane under these
   conditions. The protein : GAG ratio, protein : carbohydrate ratio,
   cholesterol : phospholipid ratio as well as protein : lipid ratio showed
   significant increase in the membrane. The extent of these changes was
   lower in the Penpol bag, indicating the stabilizing effect of DEHP on
   the erythrocyte membrane.}},
Publisher = {{INDIAN COUNCIL MEDICAL RES}},
Address = {{PO BOX 4911 ANSARI NAGAR, NEW DELHI 110029, INDIA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kurup, PA (Reprint Author), Peninsula Polymers Ltd, Dept Biol Sci, Thiruvananthapuram 695573, Kerala, India.
   Peninsula Polymers Ltd, Dept Biol Sci, Thiruvananthapuram 695573, Kerala, India.}},
ISSN = {{0971-5916}},
Keywords = {{blood; di-(2-ethyl hexyl) phthalate (DEHP); erythrocyte membrane;
   glycosaminoglycans; glycoproteins; vitamin E}},
Keywords-Plus = {{CELLS}},
Research-Areas = {{Immunology; General \& Internal Medicine; Research \& Experimental
   Medicine}},
Web-of-Science-Categories  = {{Immunology; Medicine, General \& Internal; Medicine, Research \&
   Experimental}},
Cited-References = {{AUBUCHON JP, 1988, BLOOD, V71, P448.
   BENNET CA, 1967, STAT ANAL CHEM CHEM, P105.
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7.
   COLIN G, 1983, J LIQ CHROMATOGR, V6, P1123.
   Deepa Devi K. V., 1998, Vox Sanguinis, V75, P198, DOI 10.1159/000030987.
   DISCHE Z, 1948, METHOD ENZYMOL, V8, P11.
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017.
   FOLCH J, 1957, J BIOL CHEM, V226, P497.
   HALBHUBER KJ, 1983, BIOMED BIOCHIM ACTA, V42, pS337.
   HOGMAN C F, 1980, Haematologia, V13, P135.
   HOROWITZ B, 1985, VOX SANG, V48, P150.
   JAYA P, 1986, J BIOSCIENCE, V10, P487, DOI 10.1007/BF02900510.
   KARP G, 1979, MEMBRANE STRUCTURE F, P214.
   LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882.
   MENON PVG, 1976, INDIAN J BIOCHEM BIO, V13, P390.
   PALMER DN, 1984, ANAL BIOCHEM, V140, P315, DOI 10.1016/0003-2697(84)90172-6.
   Racek J, 1997, VOX SANG, V72, P16, DOI 10.1046/j.1423-0410.1997.00016.x.
   ROBERT KM, 1996, HARPERS BIOCH, P733.
   ROCK G, 1984, TRANSFUSION, V24, P493, DOI 10.1046/j.1537-2995.1984.24685066808.x.
   RUMSBY MG, 1977, BIOCHEM SOC T, V5, P126.
   SCOT JE, 1960, METHOD BIOCHEM ANAL, V8, P154.
   Selvam S., 1995, Indian Journal of Physiology and Pharmacology, V39, P252.
   WAGH PV, 1973, ATHEROSCLEROSIS, V18, P83, DOI 10.1016/0021-9150(73)90119-6.
   WARREN L, 1959, J BIOL CHEM, V234, P1971.
   ZILVERSMIT DB, 1950, J LAB CLIN MED, V35, P155.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{6}},
Journal-ISO = {{Indian J. Med. Res.}},
Doc-Delivery-Number = {{192WX}},
Wos-Id = {{ISI:000080103700007}},
}

@article{ ISI:000079645800013,
Author = {Faouzi, MA and Dine, T and Gressier, B and Kambia, K and Luyckx, M and
   Pagniez, D and Brunet, C and Cazin, M and Belabed, A and Cazin, JC},
Title = {{Exposure of hemodialysis patients to di-2-ethylhexyl phthalate}},
Journal = {{INTERNATIONAL JOURNAL OF PHARMACEUTICS}},
Year = {{1999}},
Volume = {{180}},
Number = {{1}},
Pages = {{113-121}},
Month = {{MAR 25}},
Abstract = {{The migration of di-2-ethylhexyl phthalate (DEHP) from dialyzers was
   studied in 21 patients with chronic renal failure undergoing maintenance
   hemodialysis. The circulating concentrations of DEHP were measured by
   high performance liquid chromatography in blood of patients obtained
   from the inlet and the outlet of the dialyzer during a 4-h dialysis
   session. During treatment of renal failure using plasticized tubing, the
   plasma level of DEHP increased. On average, an estimated 75.2 mg of DEHP
   was extracted from the dialyzer during a single dialysis session, with a
   range of 44.3-197.1 mg. On the other hand, the total amount of DEHP
   retained by the patient during the dialysis session was evaluated by the
   difference between the AUC(out) and the AUC(in) and ranged from 3.6 to
   59.6 mg. The rate of extraction of DEHP from the dialyzer was correlated
   (r = 0.705, P < 0.05) with serum lipid content (cholesterol and
   triglyceride).
   So, we confirmed that patients on hemodialysis are always regularly
   exposed to considerable amounts of DEHP. However, several metabolic
   effects have been reported in various animal species following treatment
   with DEHP, such as changes in lipid metabolism and in hepatic microsomal
   drug-metabolizing enzyme activities. DEHP is now a well-known hepatic
   peroxisomal proliferator in rodents and an inducer of many peroxisomal
   and non-peroxisomal enzymes. So, lipid metabolism modifications and
   hepatic changes observed in hemodialysis patients could be explained
   from chronic exposition to DEHP. In the coming years, it seems necessary
   to reconsider the use of DEHP as a plasticizer in medical devices.
   Highly unacceptable amounts of DEHP leached during the dialysis session
   could be easily avoided by careful selection of hemodialysis tubing. (C)
   1999 Elsevier Science B.V. All rights reserved.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dine, T (Reprint Author), Fac Pharm, Lab Pharmacol Pharmacokinet \& Clin Pharm, 3 Rue Prof Laguesse,BP 83, F-59006 Lille, France.
   Fac Pharm, Lab Pharmacol Pharmacokinet \& Clin Pharm, F-59006 Lille, France.
   Calmette Hosp, Dept Nephrol, Lille, France.
   Fac Sci, Oujda, Morocco.}},
DOI = {{10.1016/S0378-5173(98)00411-6}},
ISSN = {{0378-5173}},
Keywords = {{hemodialysis; di-2-ethylhexyl phthalate; polyvinyl chloride tubing}},
Keywords-Plus = {{DI(2-ETHYLHEXYL) PHTHALATE; PEROXISOME PROLIFERATORS; PLASTICIZER
   DI(2-ETHYLHEXYL)PHTHALATE; EXCHANGE-TRANSFUSION; POSSIBLE MECHANISMS;
   INFUSION SOLUTIONS; ESTER PLASTICIZER; NEWBORN-INFANTS; URINE SAMPLES;
   DEHP}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Author-Email = {{tdine@phare.univ-lille2.fr}},
Cited-References = {{ALLWOOD MC, 1986, INT J PHARM, V29, P233, DOI 10.1016/0378-5173(86)90120-1.
   ARBIN A, 1986, INT J PHARM, V28, P211, DOI 10.1016/0378-5173(86)90247-4.
   BARRY YA, 1989, J THORAC CARDIOV SUR, V97, P900.
   BELL FP, 1978, LIPIDS, V13, P673, DOI 10.1007/BF02533744.
   BOJES HK, 1994, TOXICOL APPL PHARM, V126, P233, DOI 10.1006/taap.1994.1112.
   CHRISTENSSON A, 1991, INT J ARTIF ORGANS, V14, P407.
   CONWAY JG, 1989, DRUG METAB REV, V21, P65, DOI 10.3109/03602538909029956.
   CONWAY JG, 1989, CARCINOGENESIS, V10, P513, DOI 10.1093/carcin/10.3.513.
   DINE T, 1991, BIOMED CHROMATOGR, V5, P94, DOI 10.1002/bmc.1130050211.
   DIRVEN HAAM, 1992, BIOCHEM PHARMACOL, V43, P2621, DOI 10.1016/0006-2952(92)90151-8.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P549, DOI 10.1007/BF00517699.
   DIRVEN HAAM, 1993, INT ARCH OCC ENV HEA, V64, P555, DOI 10.1007/BF00517700.
   ELCOMBE CR, 1986, ENVIRON HEALTH PERSP, V70, P211, DOI 10.2307/3430357.
   FAOUZI ME, 1995, J PHARMACEUT BIOMED, V13, P1363, DOI 10.1016/0731-7085(95)01553-W.
   FLAMINIO LM, 1988, INT J ARTIF ORGANS, V11, P428.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   GROLIER P, 1993, BIOCHEM PHARMACOL, V45, P827, DOI 10.1016/0006-2952(93)90165-S.
   HAYASHI F, 1995, CANCER LETT, V92, P87, DOI 10.1016/0304-3835(95)03758-O.
   KEVY S, 1983, CONTRIB NEPHROL, V36, P82.
   KLUWE WM, 1982, J TOXICOL ENV HEALTH, V10, P797.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   Mettang T, 1996, PERITON DIALYSIS INT, V16, P58.
   Mettang T, 1996, NEPHROL DIAL TRANSPL, V11, P2439.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   OKITA RT, 1992, ARCH BIOCHEM BIOPHYS, V294, P475, DOI 10.1016/0003-9861(92)90714-8.
   PLONAIT SL, 1993, TRANSFUSION, V33, P598, DOI 10.1046/j.1537-2995.1993.33793325058.x.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   RACZ Z, 1995, VOX SANG, V68, P197.
   REDDY JK, 1990, BIOCHEM SOC T, V18, P92.
   ROBERTS BJ, 1995, XENOBIOTICA, V25, P469.
   SHARMA R, 1988, BIOCHEM PHARMACOL, V37, P1203, DOI 10.1016/0006-2952(88)90771-X.
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x.
   TOMITA I, 1982, ENVIRON HEALTH PERSP, V45, P71, DOI 10.2307/3429386.
   TURNER VS, 1995, VOX SANG, V69, P195.
   VENTAKATARAMANA.R, 1986, AM J HOSP PHARM, V43, P2800.
   WAUGH WN, 1991, AM J HOSP PHARM, V48, P1520.
   WINBERG LD, 1995, TOXICOL LETT, V76, P63, DOI 10.1016/0378-4274(94)03199-1.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{60}},
Journal-ISO = {{Int. J. Pharm.}},
Doc-Delivery-Number = {{185AK}},
Wos-Id = {{ISI:000079645800013}},
}

@article{ ISI:000076711500008,
Author = {Manojkumar, V and Nair, KGP and Santhosh, A and Deepadevi, KV and Arun,
   P and Lakshmi, LR and Kurup, PA},
Title = {{Decrease in the concentration of vitamin E in blood and tissues caused
   by di(2-ethylhexyl) phthalate, a commonly used plasticizer in blood
   storage bags and medical tubing}},
Journal = {{VOX SANGUINIS}},
Year = {{1998}},
Volume = {{75}},
Number = {{2}},
Pages = {{139-144}},
Abstract = {{Background and Objectives: Significant amounts of di(2-ethylhexyl)
   phthlate (DEHP) leach into blood stored in DEHP-plasticized PVC bags.
   The aim of this study was to find out whether DEHP at these low levels
   has any effect on the concentration of vitamin E, an antioxidant which
   affords protection against free radical damage. Materials and Methods:
   DEHP was administered in low doses (150-750 mu g/100 g body weight) to
   rats intraperitoneally and the concentration of vitamin E in the liver
   and testes was measured. Concentration of vitamin E was also measured in
   blood stored in glass bottles in the presence and absence of DEHP and in
   blood stored in DEHP-plasticized PVC bags. Results: A decrease in the
   concentration of vitamin E was observed in all cases. Administration of
   vitamin E to rats and incorporation of vitamin E in the additive
   solution in the case of blood prevented this decrease. Conclusion: DEHP
   even at very low doses caused a decrease in the concentration of vitamin
   E in liver and tests of rats given this substance. Blood stored in
   DEHP-plasticized bags also showed a decrease in the concentration of
   vitamin E.}},
Publisher = {{KARGER}},
Address = {{ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kurup, PA (Reprint Author), Peninsula Polymers Ltd Sasthamangalam, Dept Biol Sci, Trivandrum 695010, Kerala, India.
   Peninsula Polymers Ltd Sasthamangalam, Dept Biol Sci, Trivandrum 695010, Kerala, India.}},
DOI = {{10.1159/000030975}},
ISSN = {{0042-9007}},
Keywords-Plus = {{DI-(2-ETHYLHEXYL) PHTHALATE; WHOLE-BLOOD; ESTERS; ACCUMULATION; MEHP;
   RATS}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{BARRY YA, 1988, BLOOD, V72, P1438.
   BENNET CA, 1967, STAT ANAL CHEM CHEM, P105.
   BICHET N, 1990, TOXICOL APPL PHARM, V106, P509, DOI 10.1016/0041-008X(90)90345-U.
   Carmen Raleigh, 1993, Transfusion Medicine Reviews, V7, P1, DOI 10.1016/S0887-7963(93)70027-9.
   CONWAY JG, 1989, CARCINOGENESIS, V10, P513, DOI 10.1093/carcin/10.3.513.
   FOLCH J, 1957, J BIOL CHEM, V226, P497.
   FREDRICSSON B, 1993, PHARMACOL TOXICOL, V72, P128.
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387.
   GRAY TJB, 1983, TOXICOLOGY, V28, P167, DOI 10.1016/0300-483X(83)90115-4.
   JAEGER RJ, 1970, LANCET, V2, P151.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   MAXWELL SRJ, 1995, DRUGS, V49, P345, DOI 10.2165/00003495-199549030-00003.
   MITCHELL AM, 1984, TOXICOLOGIST, V4, P143.
   Packer L, 1994, SCI AM SCI MED, V1, P54.
   PECK CC, 1979, TRANSFUSION, V19, P137, DOI 10.1046/j.1537-2995.1979.19279160282.x.
   RAMMELL CG, 1983, J LIQ CHROMATOGR, V6, P1123, DOI 10.1080/01483918308076094.
   REDDY JK, 1984, CRC CRIT R TOXICOL, V12, P1.
   RICEEVANS CA, 1993, FREE RADICAL BIO MED, V15, P77, DOI 10.1016/0891-5849(93)90127-G.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   RUBIN RJ, 1989, TRANSFUSION, V29, P358, DOI 10.1046/j.1537-2995.1989.29489242805.x.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   SETH PK, 1982, ENVIRON HEALTH PERSP, V45, P27, DOI 10.2307/3429380.
   SJOBERG P, 1985, ACTA PHARMACOL TOX, V56, P30.
   SJOBERG P, 1985, ARCH TOXICOL, V58, P72, DOI 10.1007/BF00348312.
   TAKAGI A, 1992, J ENVIRON PATHOL TOX, V11, P149.
   THOMAS JA, 1984, CRC CR REV TOXICOL, V13, P283, DOI 10.3109/10408448409023761.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{13}},
Journal-ISO = {{Vox Sang.}},
Doc-Delivery-Number = {{133WX}},
Wos-Id = {{ISI:000076711500008}},
}

@article{ ISI:000077275200006,
Author = {Devi, KVD and Kumar, VM and Arun, P and Santhosh, A and Nair, KGP and
   Lakshmi, LR and Kurup, PA},
Title = {{Increased lipid peroxidation of erythrocytes in blood stored in
   polyvinyl chloride blood storage bags plasticized with di-{[}2-ethyl
   hexyl]phthalate and effect of antioxidants}},
Journal = {{VOX SANGUINIS}},
Year = {{1998}},
Volume = {{75}},
Number = {{3}},
Pages = {{198-204}},
Abstract = {{Background and Objectives: Previous work in this laboratory has shown
   significant decrease in vitamin E in erythrocytes in blood stored in
   polyvinyl chloride (PVC) bags plasticized with di-{[}2-ethyl hexyl]
   phthalate (DEHP), and in erythrocytes incubated in vitro with DEHP.
   Since vitamin E is a major antioxidant, a study was carried out to find
   out whether this decrease observed in vitamin E has an effect on lipid
   peroxidation in blood stored in DEHP-plasticized PVC blood bags.
   Materials and Methods: Blood was collected in Penpol blood storage bags
   (which is a DEHP-plasticized PVC bag) and parameters of lipid
   peroxidation, i.e. activity of superoxide dismutase (SOD), catalase,
   glutathione peroxidase, glutathione reductase, concentration of
   malondialdehyde (MDA), conjugated dienes, hydroperoxides, glutathione
   and vitamin E studied in erythrocytes after Various periods of storage
   as compared to glass bottles. Erythrocytes were also incubated in vitro
   with DEHP with and without vitamin E, and changes in lipid peroxidation
   studied. Results: Blood stored in Penpol bags showed increased lipid
   peroxidation in erythrocytes as compared to that stored in glass
   bottles, as is evident from a greater increase in MDA and a greater
   decrease in glutathione and a significant decrease in vitamin E. The
   addition of vitamin E decreased the formation of MDA and conjugated
   dienes and prevented the decrease in vitamin E. However in spite of
   increased lipid peroxidation in the presence of DEHP, the release-of K+
   and hemoglobin from erythrocytes was lower When there was an increase in
   DEHP taken up by erythrocytes, there was a corresponding decrease in
   vitamin E. More important, whenever there was an increase in vitamin E
   in erythrocytes (when RBCs in the presence of DEHP were incubated with
   vitamin E), there was a progressive decrease in DEHP. Conclusion: DEHP
   caused increased lipid peroxidation in erythrocytes. At the same time,
   it decreased the release of K+ and hemoglobin from erythrocytes. It is
   possible that the stabilizing effect of DEHP on the erythrocyte membrane
   may offset the detrimental effects of the increased lipid peroxidation
   it causes.}},
Publisher = {{KARGER}},
Address = {{ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Kurup, PA (Reprint Author), Peninsula Polymers Ltd, Dept Biol Sci, Trivandrum 695010, Kerala, India.
   Peninsula Polymers Ltd, Dept Biol Sci, Trivandrum 695010, Kerala, India.}},
ISSN = {{0042-9007}},
Keywords-Plus = {{PHTHALATE}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{AUBUCHON JP, 1988, BLOOD, V71, P448.
   BENNET CA, 1967, STAT ANAL CHEM CHEM, P105.
   BEUTLER E, 1963, J LAB CLIN MED, V61, P882.
   BRIEN PJO, 1969, CAN J BIOCHEM, V47, P485.
   COLIN G, 1983, J LIQ CHROMATOGR, V6, P1123.
   HORN HD, 1978, METHODS ENZYMATIC AN.
   KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   LOWRY OH, 1951, J BIOL CHEM, V193, P265.
   MAEHLY AC, 1954, METHOD BIOCHEM ANAL, V1, P357.
   MANOJKUMAR V, IN PRESS VOX SANG.
   Pagila D.E., 1967, J LAB CLIN MED, V70, P158.
   PECK CC, 1978, TRANSFUSION, V19, P137.
   Racek J, 1997, VOX SANG, V72, P16, DOI 10.1046/j.1423-0410.1997.00016.x.
   ROCK G, 1984, TRANSFUSION, V24, P493, DOI 10.1046/j.1537-2995.1984.24685066808.x.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   RUBY AJ, 1995, CANCER LETT, V94, P79, DOI 10.1016/0304-3835(95)03827-J.
   TAMURA H, 1990, CARCINOGENESIS, V11, P445.
   WILLS ED, 1969, BIOCHEM J, V113, P315.}},
Number-of-Cited-References = {{20}},
Times-Cited = {{6}},
Journal-ISO = {{Vox Sang.}},
Doc-Delivery-Number = {{143UJ}},
Wos-Id = {{ISI:000077275200006}},
}

@article{ ISI:000071082500020,
Author = {Dickerson, RN},
Title = {{Migration of a phthalate ester plasticizer from polyvinyl chloride blood
   bags into stored human blood and its localization in human tissues -
   Prospective overview - di(2-ethylhexyl)phthalate as a plasticizer for
   intravenous bags and tubing: A toxicological quandary}},
Journal = {{NUTRITION}},
Year = {{1997}},
Volume = {{13}},
Number = {{11-12}},
Pages = {{1010-1012}},
Month = {{NOV-DEC}},
Publisher = {{ELSEVIER SCIENCE INC}},
Address = {{655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Dickerson, RN (Reprint Author), Univ Tennessee, Dept Clin Pharm, Memphis, TN 38163 USA.
   Univ Tennessee, Dept Clin Pharm, Memphis, TN 38163 USA.}},
DOI = {{10.1016/0899-9007(97)90962-X}},
ISSN = {{0899-9007}},
Keywords-Plus = {{TOXICITY}},
Research-Areas = {{Nutrition \& Dietetics}},
Web-of-Science-Categories  = {{Nutrition \& Dietetics}},
ResearcherID-Numbers = {{Dickerson, Roland/C-5185-2008}},
Cited-References = {{ARGAWAL DK, 1989, J TOXICOL ENV HLTH, V26, P39.
   DANIEL JW, 1978, CLIN TOXICOL, V13, P257.
   EMA M, 1995, TOXICOL LETT, V78, P101, DOI 10.1016/0378-4274(94)03241-X.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   JONES HB, 1993, EXP MOL PATHOL, V58, P179, DOI 10.1006/exmp.1993.1016.
   KEVY SV, 1982, ENVIRON HEALTH PERSP, V45, P57, DOI 10.2307/3429384.
   MAZUR HI, 1989, JPEN-PARENTER ENTER, V13, P59, DOI 10.1177/014860718901300159.
   MYHRE BA, 1988, ANN CLIN LAB SCI, V18, P131.
   Selvam S., 1995, Indian Journal of Physiology and Pharmacology, V39, P252.
   WINBERG LD, 1995, TOXICOL LETT, V76, P63, DOI 10.1016/0378-4274(94)03199-1.}},
Number-of-Cited-References = {{12}},
Times-Cited = {{8}},
Journal-ISO = {{Nutrition}},
Doc-Delivery-Number = {{YM615}},
Wos-Id = {{ISI:000071082500020}},
}

@article{ ISI:A1997XQ87800035,
Author = {Singletary, K and MacDonald, C and Wallig, M},
Title = {{The plasticizer benzyl butyl phthalate (BBP) inhibits
   7,12-dimethylbenz{[}a]anthracene (DMBA)-induced rat mammary DNA adduct
   formation and tumorigenesis}},
Journal = {{CARCINOGENESIS}},
Year = {{1997}},
Volume = {{18}},
Number = {{8}},
Pages = {{1669-1673}},
Month = {{AUG}},
Abstract = {{Although the risk for cancer is multifactorial, a substantial portion of
   cancer incidence rates is related to environmental factors, including
   diet and environmental chemicals, The magnitude of the contribution to
   cancer of the breast from exposure to environmental chemicals remains
   unclear, The phthalate ester plasticizers are abundantly-produced
   industrial chemicals that have become widely-dispersed environmental
   pollutants, The present studies were conducted to determine the effect
   of the phthalate ester, benzyl butyl phthalate (BBP) on mammary gland
   carcinogenesis induced in the female rat by the polycyclic aromatic
   hydrocarbon (PAH) 7,12-dimethylbenz{[}a]anthracene (DMBA), Exposure to
   BBP (i.p. injection) at 100 and 500 mg/kg doses for 5 days resulted in a
   significant 72 and 92\% inhibition, respectively, in the in vivo
   formation of mammary DMBA-DNA adducts, compared to controls, Treatment
   with BBP (i.g. intubation) for 7 days resulted in a significant (48\%)
   inhibition in mammary DMBA-DNA adduct formation only for those animals
   receiving the 500 mg/kg dose, compared to controls, Administration of
   BBP (i.g.) at 500 mg/kg for 7 days also was associated with a
   significant 8.5-fold increase in the liver activity of
   7-ethoxyresorufin-O-deethylase. No change in liver
   glutathione-S-transferase activity was observed for animals treated with
   both BBP (i.g.) doses, Treatment with BBP (i.g.) at 250 and 500 mg/kg
   doses for 7 days prior to DMBA administration resulted in a significant
   37\% decrease in mammary tumor incidence for both doses, compared to
   controls, The number of mammary adenocarcinomas per rat was
   significantly inhibited by 60 and 70\% for rats exposed to BBP at the
   250 and 500 mg/kg doses, respectively, compared to controls, Therefore,
   the present studies indicate that BBP acts as a blocking agent toward
   DMBA-induced rat mammary DNA adduct formation and mammary
   carcinogenesis. This effect partly may be due to increased metabolism of
   BBP in the liver, These results underscore the need to further examine
   the effect of BBP and other phthalates on the various stages of mammary
   carcinogenesis, as web as on the metabolism of mammary carcinogens.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD, ENGLAND OX2 6DP}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{UNIV ILLINOIS,DEPT FOOD SCI \& HUMAN NUTR,URBANA,IL 61801.
   UNIV ILLINOIS,DEPT VET PATHOBIOL,URBANA,IL 61801.}},
DOI = {{10.1093/carcin/18.8.1669}},
ISSN = {{0143-3334}},
Keywords-Plus = {{ENVIRONMENTAL CONTAMINANT; PRENEOPLASTIC LESIONS;
   DI(2-ETHYLHEXYL)PHTHALATE; CARCINOGENESIS; CANCER; ESTERS; CELLS}},
Research-Areas = {{Oncology}},
Web-of-Science-Categories  = {{Oncology}},
Cited-References = {{BAKER H, 1979, LAB RAT BIOL DIS, V1, P361.
   DAVIS DL, 1993, ENVIRON HEALTH PERSP, V101, P372, DOI 10.2307/3431889.
   DEANGELO AB, 1986, TOXICOLOGY, V41, P279, DOI 10.1016/0300-483X(86)90182-4.
   DEANGELO AB, 1983, CANCER LETT, V20, P199, DOI 10.1016/0304-3835(83)90049-6.
   DIWAN BA, 1985, CARCINOGENESIS, V6, P343, DOI 10.1093/carcin/6.3.343.
   ELBAYOUMY K, 1992, CHEM RES TOXICOL, V5, P585, DOI 10.1021/tx00029a001.
   EMA M, 1992, TOXICOL LETT, V61, P1.
   EMA M, 1994, REPROD TOXICOL, V8, P231, DOI 10.1016/0890-6238(94)90007-8.
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387.
   HABIG WH, 1974, J BIOL CHEM, V249, P7130.
   HARRIS CC, 1987, CANCER RES, V47, P1.
   JOBLING S, 1995, ENVIRON HEALTH PERSP, V103, P582, DOI 10.2307/3432434.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P129, DOI 10.2307/3429396.
   McLachlan JA, 1996, AM SCI, V84, P452.
   MURATURE D, 1987, BIOMED ENVIRON MASS, V13, P473.
   POHL RJ, 1980, ANAL BIOCHEM, V107, P150, DOI 10.1016/0003-2697(80)90505-9.
   REDDY JK, 1983, CRC CR REV TOXICOL, V12, P1, DOI 10.3109/10408448309029317.
   Richmond RE, 1996, CARCINOGENESIS, V17, P1647, DOI 10.1093/carcin/17.8.1647.
   ROJANAPO W, 1993, CARCINOGENESIS, V14, P663, DOI 10.1093/carcin/14.4.663.
   SAFE SH, 1995, ENVIRON HEALTH PERSP, V103, P346, DOI 10.2307/3432287.
   Sharpe RM, 1995, ENVIRON HEALTH PERSP, V103, P1136, DOI 10.2307/3432610.
   SINGLETARY KW, 1990, CARCINOGENESIS, V11, P1959, DOI 10.1093/carcin/11.11.1959.
   {*}COMM DIET HLTH, 1989, DIET HLTH.
   {*}IARC, 1982, MON EV CARC RISK CHE, V29, P193.
   {*}MIN AGR FISH FOOD, 1987, 21 MIN AGR FISH FOOD.
   {*}MIN AGR FISH FOOD, 1990, 30 MIN AGR FISH FOOD.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{23}},
Journal-ISO = {{Carcinogenesis}},
Doc-Delivery-Number = {{XQ878}},
Wos-Id = {{ISI:A1997XQ87800035}},
}

@article{ ISI:A1997WW93000023,
Author = {Karle, VA and Short, BL and Martin, GR and Bulas, DI and Getson, PR and
   Luban, NLC and OBrien, AM and Rubin, RJ},
Title = {{Extracorporeal membrane oxygenation exposes infants to the plasticizer,
   di(2-ethylhexyl)phthalate}},
Journal = {{CRITICAL CARE MEDICINE}},
Year = {{1997}},
Volume = {{25}},
Number = {{4}},
Pages = {{696-703}},
Month = {{APR}},
Abstract = {{Objectives: To determine the exposure to, and evaluate the potential
   toxicity from, the plasticizer, di(2-ethylhexyl)phthalate (DEHP) during
   extracorporeal membrane oxygenation (ECMO) therapy.
   Design: Protocol 1 consisted of a prospective comparison of three ECMO
   circuit designs in vitro. Protocol 2 consisted of a prospective,
   comparative clinical study evaluating DEHP plasma concentrations in ECMO
   vs. non-ECMO patients with respiratory failure.
   Setting: Neonatal intensive care unit at The Children's National Medical
   Center, Washington, DC.
   Patients: In protocol 2, 28 consecutive term infants were referred for
   ECMO therapy. Eighteen infants required ECMO; ten control patients
   received conventional ventilation and improved without ECMO.
   Interventions: In protocol 1, three ECMO circuit designs were primed in
   vitro with normal saline, albumin, and human blood, which was maintained
   at 37 degrees C and recirculated at 400 mL/min far 48 hrs. Plasma
   samples were obtained at time 0, 1 hr, and every 6 hrs. In protocol 2,
   ventilatory and cardiovascular management of the patients in the study
   was conducted by the attending physician. Patients were placed on ECMO
   when they met the institutional criteria far ECMO therapy. Dairy plasma
   concentrations for DEHP were collected until 3 days after decannulation
   from bypass in the ECMO group. Control patients were sampled daily until
   extubation. Evidence of cardiac, liver, or lung toxicity was evaluated
   by Chest Radiographic Scores, liver function studies, and
   echocardiograms obtained on day 1, day 3, and the day of decannulation
   in the ECMO group, or at the time of extubation in the control group.
   Sedation, blood product transfusions as indicated, antibiotics, and
   hyperalimentation were administered to all patients.
   Measurements and Main Results: All DEHP plasma concentrations were
   measured by gas chromatography. In protocol 1, three circuits were
   studied: circuit A (small surface area); circuit B (larger surface
   area); and circuit C (surface area of A but with heparin-bonded tubing
   in the circuit). DEHP leached from circuit A at 0.32 +/- 0.12 mu
   g/mL/hr, compared with 0.57 +/- 0.14 mu g/mL/hr from circuit B (p <
   .05). This amount of DEHP extrapolates in the ECMO patient to a
   potential exposure of 20 to 70 times that exposure from other medical
   devices or procedures, such as transfusions, dialysis, or short-term
   cardiopulmonary bypass. Circuit C showed almost no leaching from the
   circuit; DEHP concentrations decreased at a rate of 0.2 +/- 0.04 mu
   g/mL/hr. In protocol 2, DEHP was undetected in the control patients.
   DEHP concentrations in ECMO patients were greater in the early course of
   ECMO. However, most patients cleared this compound from the plasma
   before decannulation. In contrast to the in vitro results in protocol 1,
   the average highest concentration at any time on bypass was 8.3 +/- 5.7
   mu g/mL or 2 mg/kg.
   Conclusions: DEHP teaches from ECMO circuits, with potential exposure
   concentrations related to the surface area of the tubing in the ECMO
   circuit. Heparin bonding of the tubing eliminates this risk. Although
   significant concentrations of DEHP leach from the nonheparin-bonded
   circuits over time, our in vivo studies showed that the DEHP plasma
   concentrations were less than the previously reported values and do not
   correlate with any observable short-term toxicity. This compound may be
   either efficiently metabolized by the newborn, or redistributed into
   various tissues. Although signs of toxicity were not found in this
   study, long term complications from chronic exposure to DEHP have not
   been determined.}},
Publisher = {{WILLIAMS \& WILKINS}},
Address = {{351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{GEORGE WASHINGTON UNIV,SCH MED,DEPT PEDIAT,WASHINGTON,DC 20052.
   CHILDRENS NATL MED CTR,WASHINGTON,DC 20010.
   JOHNS HOPKINS SCH HYG \& PUBL HLTH,DEPT ENVIRONM HLTH SCI,BALTIMORE,MD.}},
DOI = {{10.1097/00003246-199704000-00023}},
ISSN = {{0090-3493}},
Keywords = {{extracorporeal membrane oxygenation; plasticizer;
   di(2-ethylhexyl)phthalate; newborn; toxicity; phthalate}},
Keywords-Plus = {{CARDIOPULMONARY BYPASS; CARDIAC-PERFORMANCE; RESPIRATORY-FAILURE;
   TRIHEXYL-CITRATE; BLOOD BAGS; PHTHALATE; SURFACTANT; STORAGE;
   IDENTIFICATION; CONTAINER}},
Research-Areas = {{General \& Internal Medicine}},
Web-of-Science-Categories  = {{Critical Care Medicine}},
Cited-References = {{AGATA Y, 1991, J PEDIATR, V119, P441, DOI 10.1016/S0022-3476(05)82060-8.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V360, P380.
   ANDERSON HL, 1989, T AM SOC ART INT ORG, V35, P650.
   AVERY GB, 1987, NEONATOLOGY PATHOPHY, P557.
   AVERY GB, 1987, NEONATOLOGY PATHOPHY, P1353.
   BARRY YA, 1988, BLOOD, V72, P1438.
   BARRY YA, 1989, J THORAC CARDIOV SUR, V97, P900.
   BECK R, 1986, J PEDIATR SURG, V21, P297, DOI 10.1016/S0022-3468(86)80188-9.
   CARILLI AD, 1978, CHEST, V74, P310, DOI 10.1378/chest.74.3.310.
   EDWARDS DK, 1985, RADIOLOGY, V157, P329.
   GULLIKSSON H, 1991, VOX SANG, V61, P165.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   HOGMAN CF, 1991, TRANSFUSION, V31, P26, DOI 10.1046/j.1537-2995.1991.31191096180.x.
   JACOBSON MS, 1977, J LAB CLIN MED, V89, P1066.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   JAEGER RJ, 1970, LANCET, V2, P151.
   KARR SS, 1991, J PEDIATR, V118, P437, DOI 10.1016/S0022-3476(05)82164-X.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   LOTZE A, 1993, J PEDIATR, V122, P261, DOI 10.1016/S0022-3476(06)80131-9.
   LOTZE A, 1990, J PEDIATR, V116, P435, DOI 10.1016/S0022-3476(05)82839-2.
   LOTZE A, 1987, CRIT CARE MED, V15, P226, DOI 10.1097/00003246-198703000-00009.
   MARTIN GR, 1988, AM J CARDIOL, V62, P929, DOI 10.1016/0002-9149(88)90895-8.
   MITCHELL AM, 1985, TOXICOL APPL PHARM, V80, P23, DOI 10.1016/0041-008X(85)90097-3.
   MYHRE BA, 1988, ANN CLIN LAB SCI, V18, P131.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   PHANG PT, 1986, J THORAC CARDIOV SUR, V91, P248.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   ROWLAND IR, 1977, FOOD COSMET TOXICOL, V15, P17, DOI 10.1016/S0015-6264(77)80257-5.
   RUBIN RJ, 1978, TOXICOL APPL PHARM, V45, P230.
   RUBIN RJ, 1989, TRANSFUSION, V29, P358, DOI 10.1046/j.1537-2995.1989.29489242805.x.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   SCHULZ CO, 1975, TOXICOL APPL PHARM, V33, P514, DOI 10.1016/0041-008X(75)90077-0.
   SHNEIDER B, 1990, 6 ANN CHILDR NAT MED.
   SHNEIDER B, 1989, NEW ENGL J MED, V320, P1563.
   SHNEIDER B, 1989, J PEDIATR, V115, P462, DOI 10.1016/S0022-3476(89)80857-1.
   SHNEIDER B, 1990, 6 ANN CHILDR HOSP NA.
   SHORT BL, 1993, EXTRACORPOREAL LIFE, P195.
   SJOBERG P, 1975, EUR J CLIN INVEST, V15, P424.
   TAYLOR GA, 1986, AM J ROENTGENOL, V146, P1257.
   TAYLOR GA, 1986, RADIOLOGY, V161, P347.
   WOODWARD KN, 1988, PHTHALATE ESTERS TOX, V1, P104.
   WOODWARD KN, 1988, PHTHALATE ESTERS TOX, V1, P47.
   WOODWARD KN, 1988, PHTHALATE ESTERS TOX, V1, P143.
   WOODWARD KN, 1988, PHTHALATE ESTERS TOX, V1, P75.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{44}},
Journal-ISO = {{Crit. Care Med.}},
Doc-Delivery-Number = {{WW930}},
Wos-Id = {{ISI:A1997WW93000023}},
}

@article{ ISI:A1997WK62200015,
Author = {Nagini, S and Selvam, S},
Title = {{Biochemical indicators of membrane damage in the plasma and erythrocytes
   of rats fed the peroxisome proliferator di(2-ethylhexyl)phthalate}},
Journal = {{MEDICAL SCIENCE RESEARCH}},
Year = {{1997}},
Volume = {{25}},
Number = {{2}},
Pages = {{119-121}},
Month = {{FEB}},
Abstract = {{We examined the deleterious effects induced by the plasticiser
   di(2-ethylhexyl)phthalate (DEHP) in the plasma and erythrocytes of rats.
   Administration of DEHP for 24 weeks caused decreases in erythrocyte
   count and uric acid concentration and an increase in the levels of
   methaemoglobin. The increase in erythrocyte osmotic fragility, which is
   inversely related to erythrocyte survival, correlated well with a
   decrease in red cell Na+K+-ATPase activity. The release of the lysosomal
   enzyme acid phosphatase and the metal catalysts iron and calcium can
   account for the liver cell damage induced by DEHP.}},
Publisher = {{CHAPMAN HALL LTD}},
Address = {{2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Nagini, S (Reprint Author), ANNAMALAI UNIV,FAC SCI,DEPT BIOCHEM,ANNAMALAINAGAR 608002,TAMIL NADU,INDIA.}},
ISSN = {{0269-8951}},
Keywords = {{lipid peroxidation; plasticiser; di(2-ethylhexyl)phthalate;
   erythrocytes; membrane damage}},
Keywords-Plus = {{INDUCED LIPID-PEROXIDATION; HYDROGEN-PEROXIDE; URIC-ACID; COMPLEXES;
   RADICALS; LIVER}},
Research-Areas = {{Research \& Experimental Medicine}},
Web-of-Science-Categories  = {{Medicine, Research \& Experimental}},
Cited-References = {{Bentley P, 1987, Arch Toxicol Suppl, V10, P157.
   Bonting SL, 1970, MEMBRANES ION TRANSP, V1, P257.
   CARAWAY WJ, 1963, STANDARD METHODS CLI, P230.
   CHEN CC, 1985, BIOCHEM PHARMACOL, V34, P2335, DOI 10.1016/0006-2952(85)90791-9.
   CHOW CK, 1979, AM J CLIN NUTR, V32, P1066.
   COMPORTI M, 1985, LAB INVEST, V53, P599.
   CONWAY JG, 1989, CARCINOGENESIS, V10, P515.
   DAVIES KJA, 1986, BIOCHEM J, V235, P747.
   DODGE JF, 1968, ARCH BIOCHEM BIOPHYS, V100, P119.
   Drabkin DL, 1932, J BIOL CHEM, V98, P719.
   Evelyn KA, 1938, J BIOL CHEM, V126, P655.
   GOEL SK, 1986, CANCER RES, V46, P1324.
   Gowenlock A, 1988, VARLEYS PRACTICAL CL, P550.
   Gupta Meera, 1995, Indian Journal of Experimental Biology, V33, P342.
   Gutman EB, 1940, J BIOL CHEM, V136, P201.
   GUTTERIDGE JMC, 1992, BIOCHIM BIOPHYS ACTA, V1159, P248, DOI 10.1016/0167-4838(92)90052-F.
   HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1.
   HANSEN AJ, 1977, ACTA PHYSIOL SCAND, V99, P412, DOI 10.1111/j.1748-1716.1977.tb10394.x.
   HEBBEL RP, 1984, BLOOD, V64, P733.
   HOWELL RR, 1960, J BIOL CHEM, V235, P3544.
   JAIN SK, 1983, BRIT J HAEMATOL, V53, P247, DOI 10.1111/j.1365-2141.1983.tb02018.x.
   KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33.
   King EJ, 1934, CAN MED ASSOC J, V31, P376.
   King J., 1965, PRACTICAL CLIN ENZYM, P106.
   KO KM, 1990, MOL CELL BIOCHEM, V95, P125.
   LORENTZ K, 1982, CLIN CHIM ACTA, V126, P327, DOI 10.1016/0009-8981(82)90308-4.
   LOWRY OH, 1951, J BIOL CHEM, V193, P265.
   MANDAL TK, 1980, RADIAT RES, V83, P290, DOI 10.2307/3575280.
   MANJUNATH CK, 1979, BIOCHEM PHARMACOL, V28, P2929, DOI 10.1016/0006-2952(79)90588-4.
   MARSMAN DS, 1988, CANCER RES, V48, P6739.
   MAYNE PD, 1994, CLIN CHEM DIAGNOSIS.
   Mead J., 1976, FREE RADICAL BIO MED, V1, P51.
   OSCHSNER M, 1990, BIOCHEM PHARMACOL, V40, P2247.
   PARPART AK, 1946, J CLIN INVEST, V26, P636.
   PRICE SC, 1986, TOXICOLOGY, V41, P169, DOI 10.1016/0300-483X(86)90198-8.
   QUIST EE, 1980, BIOCHEM BIOPH RES CO, V92, P631, DOI 10.1016/0006-291X(80)90380-0.
   RAMSAY WNM, 1958, ADV CLIN CHEM.
   REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0.
   Selvam S., 1995, Indian Journal of Physiology and Pharmacology, V39, P252.
   SELVAM S, 1994, TRENDS LIFE SCI, V9, P1.
   SELVAM S, 1995, MED SCI RES, V22, P677.
   SELVAM S, 1995, MED SCI RES, V23, P203.
   SHERLOCK S, 1988, DISEASES LIVER BILIA.
   SHINAR E, 1989, BIOCHIM BIOPHYS ACTA, V1014, P66, DOI 10.1016/0167-4889(89)90241-3.
   SMITH RC, 1983, ARCH BIOCHEM BIOPHYS, V223, P166, DOI 10.1016/0003-9861(83)90582-9.
   TAMURA H, 1990, CARCINOGENESIS, V11, P445.
   TOMASZEWSKI KE, 1986, CARCINOGENESIS, V7, P1871, DOI 10.1093/carcin/7.11.1871.
   WAMS TJ, 1987, SCI TOTAL ENVIRON, V66, P1, DOI 10.1016/0048-9697(87)90072-6.}},
Number-of-Cited-References = {{48}},
Times-Cited = {{4}},
Journal-ISO = {{Med. Sci. Res.}},
Doc-Delivery-Number = {{WK622}},
Wos-Id = {{ISI:A1997WK62200015}},
}

@article{ ISI:A1996WD97200016,
Author = {Mettang, T and Thomas, S and Kiefer, T and Fischer, FP and Kuhlmann, U
   and Wodarz, R and Rettenmeier, AW},
Title = {{Uraemic pruritus and exposure to di(2-ethylhexyl)phthalate (DEHP) in
   haemodialysis patients}},
Journal = {{NEPHROLOGY DIALYSIS TRANSPLANTATION}},
Year = {{1996}},
Volume = {{11}},
Number = {{12}},
Pages = {{2439-2443}},
Month = {{DEC}},
Abstract = {{Uraemic pruritus is a frequent and disabling symptom in patients on
   dialysis. The pathogenesis of uraemic pruritus is nevertheless still
   obscure. We investigated whether di(2-ethylhexyl)phthalate (DEHP), the
   most commonly used plasticizer in polyvinylchloride (PVC) haemodialysis
   tubings, is a possible pathogenetic factor in uraemic pruritus. Serum
   concentrations of DEHP and its major derivatives
   mono-(2-ethylhexyl)phthalate (MEHP), 2-ethylhexanol (2-EH) and phthalic
   acid (PA) were determined in uraemic patients before and after a
   haemodialysis session and compared with the occurrence and intensity of
   pruritus in these patients. Twenty-one patients on regular haemodialysis
   for at least 6 months were examined. The severity of uraemic pruritus
   was assessed using a standard questionnaire (pruritus score). The
   quantitative analysis of DEHP and its derivatives was carried out by
   GC/selected ion monitoring mass spectrometry. Fourteen out of 21
   patients (66\%) complained about uraemic pruritus to a variable degree.
   The post-dialysis serum concentrations of DEHP, MEHP and 2-EH were
   significantly higher than the corresponding pre-dialysis values, whereas
   the postdialysis concentrations of PA (0.122 +/- 0.078 mu g/ml) were
   significantly lower than pre-dialysis levels (0.194 +/- 0.101 mu g/ml,
   P=0.00068). Neither pre- nor post-dialysis serum concentrations of DEHP,
   MEHP, PA or 2-EH were correlated with the severity of uraemic pruritus.
   Additionally, serum concentrations of DEHP and its metabolites did not
   differ significantly in patients with and without pruritus. These
   findings suggest that patients on haemodialysis are regularly exposed to
   considerable amounts of DEHP and metabolites. Phthalic acid, one of the
   presumed end products of DEHP metabolism, might be eliminated at least
   in part by haemodialysis. The exposition to DEHP and metabolites during
   haemodialysis, as assessed by measuring serum concentrations, bears no
   immediate relation to the occurrence or intensity of uraemic pruritus.}},
Publisher = {{OXFORD UNIV PRESS}},
Address = {{GREAT CLARENDON ST, OXFORD, ENGLAND OX2 6DP}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Mettang, T (Reprint Author), ROBERT BOSCH KRANKENHAUS,DEPT INTERNAL MED,DIV NEPHROL,AUERBACHSTR 110,D-70376 STUTTGART,GERMANY.
   UNIV TUBINGEN,DEPT OCCUPAT \& SOCIAL MED,TUBINGEN,GERMANY.}},
ISSN = {{0931-0509}},
Keywords = {{uraemia; pruritus; haemodialysis; plasticizer; DEHP; phthalates}},
Keywords-Plus = {{CHRONIC-RENAL-FAILURE; UREMIC PRURITUS; PLASMA HISTAMINE; HEMODIALYSIS;
   DIALYSIS; PLASTICIZER; PHTHALATE; PRODUCTS; THERAPY}},
Research-Areas = {{Transplantation; Urology \& Nephrology}},
Web-of-Science-Categories  = {{Transplantation; Urology \& Nephrology}},
Cited-References = {{ALTMEYER P, 1982, HAUTARZT, V33, P303.
   ANDERSEN LW, 1984, CLIN NEPHROL, V21, P355.
   BAECKDAHL M, 1988, KIDNEY INT, V33, P759.
   BENCINI PL, 1985, NEPHRON, V40, P316, DOI 10.1159/000183485.
   CARMICHAEL AJ, 1988, BRIT MED J, V296, P1575.
   CROCKER JFS, 1988, J TOXICOL ENV HEALTH, V23, P433.
   DEMARCHI S, 1992, NEW ENGL J MED, V326, P969.
   DUO LJ, 1987, NEPHRON, V47, P179, DOI 10.1159/000184487.
   FANTINI F, 1992, ACTA DERM-VENEREOL, V72, P102.
   FRACASSO A, 1988, PERITONEAL DIALYSIS, P57.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   GILL DS, 1991, J CLIN PATHOL, V44, P243, DOI 10.1136/jcp.44.3.243.
   GIOVANNETTI S, 1995, NEPHRON, V70, P193.
   HAMPERS CL, 1968, NEW ENGL J MED, V279, P695, DOI 10.1056/NEJM196809262791307.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   HIROSHIGE K, 1995, AM J KIDNEY DIS, V25, P413, DOI 10.1016/0272-6386(95)90102-7.
   LJUNGGREN L, 1984, ARTIF ORGANS, V8, P99, DOI 10.1111/j.1525-1594.1984.tb04251.x.
   MALLETTE FS, 1952, AMA ARCH IND HYG OCC, V6, P231.
   MASI CM, 1992, NEPHRON, V62, P257, DOI 10.1159/000187055.
   MASSRY SG, 1968, NEW ENGL J MED, V279, P697, DOI 10.1056/NEJM196809262791308.
   Mettang T, 1996, PERITON DIALYSIS INT, V16, P58.
   METTANG T, 1990, CLIN NEPHROL, V34, P136.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   NEUMULLER OA, 1985, ROMPPS CHEMIE LEXIKO, V4, P3200.
   NIELSEN T, 1980, DAN MED BULL, V27, P269.
   PEDERSON JA, 1989, ANN INTERN MED, V93, P446.
   Poignet J, 1989, ASAIO Trans, V35, P252, DOI 10.1097/00002480-198907000-00024.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   RUBIN RJ, 1978, TOXICOL APPL PHARM, V45, P230.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SNEDDON HB, 1972, CONTACT DERM NEWSL, P308.
   STOCKENHUBER F, 1990, CLIN SCI, V79, P477.
   TOMITA I, 1982, ENVIRON HEALTH PERSP, V45, P71, DOI 10.2307/3429386.
   VAHLQUIST A, 1982, EUR J CLIN INVEST, V12, P63, DOI 10.1111/j.1365-2362.1982.tb00940.x.
   YOUNG AW, 1973, NEW YORK STATE J MED, V73, P2670.}},
Number-of-Cited-References = {{35}},
Times-Cited = {{26}},
Journal-ISO = {{Nephrol. Dial. Transplant.}},
Doc-Delivery-Number = {{WD972}},
Wos-Id = {{ISI:A1996WD97200016}},
}

@article{ ISI:A1996VJ88500008,
Author = {Fukuoka, M and Niimi, S and Zhou, Y and Kobayashi, T and Hayakawa, T},
Title = {{Responsiveness of rat nonparenchymal liver cells and spleen cells to the
   decomposition of erythrocytes exposed to di-n-butyl phthalate and its
   metabolite}},
Journal = {{BIOLOGICAL \& PHARMACEUTICAL BULLETIN}},
Year = {{1996}},
Volume = {{19}},
Number = {{9}},
Pages = {{1154-1159}},
Month = {{SEP}},
Abstract = {{We have reported that di-II-butyl phthalate (DBP) caused the depletion
   of circulating iron, characterized by the release of iron from both
   haemoglobin (Hb) and transferrin (Tf). The present study investigated
   whether the erythrocytes from DBP-treated rats were destroyed by
   nonparenchymal liver cells (NPC, including Kupffer cells) or spleen
   cells (SC). In the in vivo study, there were observed depletions of Hb
   in the blood and of iron in the hepatic Tf fraction, as,yell as an
   accumulation of iron in the hepatic hemosiderin (Hs) and splenic Tf
   fractions. Tn the in vitro study, mono-butyl phthalate (MBP), a
   metabolite of DBP, caused a depletion of iron in the plasma Tf, although
   a direct release of iron from Tf was not detectable. When erythrocytes
   from DBP-treated rats and erythrocytes preincubated with MBP both were
   incubated with NPC, respectively, the Hb was decomposed and the iron
   also accumulated in the cell debris. However, when the two kinds of
   erythrocytes were incubated with SC, respectively, no decomposition of
   Hb was observed at low and medium doses, but the highest dose induced an
   accumulation of iron to Tf. Therefore, the NPC may contribute in part to
   the decomposition of DBP- or MBP-affected erythrocytes.}},
Publisher = {{PHARMACEUTICAL SOC JAPAN}},
Address = {{2-12-15-201 SHIBUYA, SHIBUYA-KU, TOKYO 150, JAPAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{Fukuoka, M (Reprint Author), NATL INST HLTH SCI,DIV BIOL CHEM,SETAGAYA KU,KAMIYOGA 1 CHOME,TOKYO 158,JAPAN.}},
ISSN = {{0918-6158}},
Keywords = {{phthalate; iron release; transferrin; haemoglobin; hemosiderin;
   nonparenchymal liver cell}},
Keywords-Plus = {{INDUCED TESTICULAR ATROPHY; PRIMARY CULTURES; IRON DEPLETION;
   GERM-CELLS; MECHANISM; TRANSFERRIN; SERTOLI; ESTERS; FERRITIN; ENZYMES}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Cited-References = {{BRIELAND JK, 1992, ARCH BIOCHEM BIOPHYS, V294, P265, DOI 10.1016/0003-9861(92)90167-U.
   Brunel RF, 1923, J AM CHEM SOC, V45, P1334, DOI 10.1021/ja01658a031.
   CALLEY D, 1966, J PHARM SCI, V55, P158, DOI 10.1002/jps.2600550206.
   CARVER FJ, 1978, BIOCHEMISTRY-US, V17, P167, DOI 10.1021/bi00594a024.
   CHAPIN RE, 1988, TOXICOL APPL PHARM, V92, P467, DOI 10.1016/0041-008X(88)90186-X.
   CREASY DM, 1983, J PATHOL, V139, P309, DOI 10.1002/path.1711390307.
   DOSTAL LA, 1988, TOXICOL APPL PHARM, V95, P104, DOI 10.1016/S0041-008X(88)80012-7.
   FOSTER PMD, 1982, TOXICOL APPL PHARM, V63, P120, DOI 10.1016/0041-008X(82)90031-X.
   FOSTER PMD, 1983, TOXICOL LETT, V15, P265, DOI 10.1016/0378-4274(83)90226-6.
   FUKUOKA M, 1989, J APPL TOXICOL, V9, P277, DOI 10.1002/jat.2550090413.
   FUKUOKA M, 1990, J APPL TOXICOL, V10, P285, DOI 10.1002/jat.2550100410.
   FUKUOKA M, 1993, J APPL TOXICOL, V13, P241, DOI 10.1002/jat.2550130406.
   FUKUOKA M, 1995, J APPL TOXICOL, V15, P379, DOI 10.1002/jat.2550150507.
   FUKUOKA M, 1994, BIOL PHARM BULL, V17, P1609.
   GAD SC, 1982, PRINCIPLES METHODS T, P273.
   GALLEMANN D, 1993, BIOL CHEM H-S, V374, P51, DOI 10.1515/bchm3.1993.374.1-6.51.
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387.
   GRAY TJB, 1984, FOOD CHEM TOXICOL, V22, P123, DOI 10.1016/0278-6915(84)90092-9.
   GRAY TJB, 1986, ENVIRON HEALTH PERSP, V65, P229, DOI 10.2307/3430187.
   GRAY TJB, 1977, FOOD COSMET TOXICOL, V14, P389.
   GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9.
   HARRIS DC, 1985, BIOCHIM BIOPHYS ACTA, V838, P295, DOI 10.1016/0304-4165(85)90226-0.
   HEMMAPLA.D, 1974, BIOCHIM BIOPHYS ACTA, V373, P84, DOI 10.1016/0005-2736(74)90108-4.
   KOJIMA N, 1979, J BIOL CHEM, V254, P8847.
   MISHELL RI, 1967, J EXP MED, V126, P423, DOI 10.1084/jem.126.3.423.
   Mitsumori Kunitoshi, 1994, Journal of Toxicological Sciences, V19, P141.
   NAUGHTON BA, 1990, J LAB CLIN MED, V116, P498.
   OISHI S, 1993, TOXICOL LETT, V66, P47, DOI 10.1016/0378-4274(93)90078-C.
   SETSUDA T, 1985, ACTA HAEMATOL JAPON, V48, P155.
   SHIMAOKA S, 1987, EXP CELL RES, V172, P228, DOI 10.1016/0014-4827(87)90109-1.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   THYSEN B, 1990, TOXICOL APPL PHARM, V106, P154, DOI 10.1016/0041-008X(90)90115-B.
   VIDNES A, 1973, BIOCHIM BIOPHYS ACTA, V328, P365, DOI 10.1016/0005-2795(73)90270-5.
   WALLACE WJ, 1974, BIOCHEM BIOPH RES CO, V57, P1104, DOI 10.1016/0006-291X(74)90810-9.
   WALLACE WJ, 1982, J BIOL CHEM, V257, P4966.
   ZAVODNIK I V, 1992, Molekulyarnaya Biologiya (Moscow), V26, P321.
   ZHOU Y, 1990, J APPL TOXICOL, V10, P447, DOI 10.1002/jat.2550100612.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{2}},
Journal-ISO = {{Biol. Pharmacol. Bull.}},
Doc-Delivery-Number = {{VJ885}},
Wos-Id = {{ISI:A1996VJ88500008}},
}

@article{ ISI:A1996TZ69600010,
Author = {Egestad, B and Green, G and Sjoberg, P and KlassonWehler, E and
   Gustafsson, J},
Title = {{Chromatographic fractionation and analysis by mass spectrometry of
   conjugated metabolites of bis(2-ethylhexyl)phthalate in urine}},
Journal = {{JOURNAL OF CHROMATOGRAPHY B-BIOMEDICAL APPLICATIONS}},
Year = {{1996}},
Volume = {{677}},
Number = {{1}},
Pages = {{99-109}},
Month = {{FEB 23}},
Abstract = {{Mono(2-ethylhexyl)phthalate (MEHP), the primary metabolite of the
   plasticizer bis(2-ethylhexyl)phthalate (DEHP), was given to guinea pigs
   and mice and the methods for the isolation, separation and analysis of
   its metabolites in urine were developed. Following solid-phase
   extraction with octadecylsilane-bonded silica, individual metabolites
   were purified and separated using a combination of ion-exchange
   chromatography on lipophilic gels and reversed-phase high-performance
   liquid chromatography. Analysis of intact conjugates, as well as
   nonconjugated metabolites, was performed by fast atom bombardment mass
   spectrometry (FAB-MS) and, after derivatization, by gas
   chromatography-mass spectrometry. Enzymatic methods were used for
   further characterization. The study confirms glucuronidation as the
   major conjugation pathway for MEHP in the investigated species. Although
   less important quantitatively, glucosidation is shown to be an
   alternative conjugation pathway in mice. The methods developed were
   applied to a sample of urine from a hyperbilirubinemic newborn infant
   subjected to DEHP-exposure in conjunction with an exchange transfusion.
   It was demonstrated that metabolites of DEHP were excreted in amounts
   which could be analyzed by FAB-MS.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{KAROLINSKA INST,DEPT MED BIOCHEM \& BIOPHYS,S-17177 STOCKHOLM,SWEDEN.
   MED PROD AGCY,DIV PHARMACOL,S-75103 UPPSALA,SWEDEN.
   UNIV STOCKHOLM,WALLENBERG LAB,S-10691 STOCKHOLM,SWEDEN.
   UNIV UPPSALA,CHILDRENS HOSP,DEPT PAEDIAT,S-75185 UPPSALA,SWEDEN.}},
DOI = {{10.1016/0378-4347(95)00439-4}},
ISSN = {{0378-4347}},
Keywords = {{mono(2-ethylhexyl)phthalate; bis(2-ethylhexyl)phthalate}},
Keywords-Plus = {{ION-EXCHANGE CHROMATOGRAPHY; DI(2-ETHYLHEXYL) PHTHALATE;
   MONO-(2-ETHYLHEXYL) PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE;
   ENVIRONMENTAL CONTAMINANT; LIQUID-CHROMATOGRAPHY; NEWBORN-INFANTS;
   SEPARATION; RATS; BILE}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Chemistry, Analytical}},
Cited-References = {{AHLMAN M, 1986, XENOBIOTICA, V16, P225.
   ALBRO PW, 1983, BIOCHIM BIOPHYS ACTA, V760, P283, DOI 10.1016/0304-4165(83)90175-7.
   ALBRO PW, 1982, J CHROMATOGR, V244, P65, DOI 10.1016/S0021-9673(00)80123-5.
   ALBRO PW, 1989, DRUG METAB REV, V21, P13, DOI 10.3109/03602538909029953.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   ALME B, 1977, J LIPID RES, V18, P339.
   AXELSON M, 1976, J CHROMATOGR, V126, P705, DOI 10.1016/S0021-9673(01)84113-3.
   BOYD RK, 1977, ORG MASS SPECTROM, V12, P163, DOI 10.1002/oms.1210120311.
   CALDWELL J, 1984, ADV GLUCURONIDE CONJ, P7.
   COMPERNOLLE F, 1978, BIOCHEM J, V171, P185.
   DEJONGH DC, 1969, J AM CHEM SOC, V91, P1728, DOI 10.1021/ja01035a022.
   EGESTAD B, 1992, DRUG METAB DISPOS, V20, P470.
   Egestad B, 1987, Biomed Chromatogr, V2, P120, DOI 10.1002/bmc.1130020308.
   EGESTAD B, 1988, BIOMED ENVIRON MASS, V16, P151, DOI 10.1002/bms.1200160126.
   EGESTAD B, 1993, RAPID COMMUN MASS SP, V7, P812, DOI 10.1002/rcm.1290070906.
   FAED EM, 1978, CLIN EXP PHARMACOL P, V5, P195, DOI 10.1111/j.1440-1681.1978.tb00671.x.
   FAED EM, 1979, CLIN EXP PHARMACOL P, V6, P267, DOI 10.1111/j.1440-1681.1979.tb01248.x.
   GANNING AE, 1984, HEPATOLOGY, V4, P541, DOI 10.1002/hep.1840040331.
   GANNING AE, 1991, PHARMACOL TOXICOL, V68, P392.
   GRIFFITHS WC, 1985, ANN CLIN LAB SCI, V15, P140.
   HARVAN DJ, 1980, BIOMED MASS SPECTROM, V7, P242, DOI 10.1002/bms.1200070604.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   MANN AH, 1985, TOXICOL APPL PHARM, V77, P116, DOI 10.1016/0041-008X(85)90273-X.
   MARSCHALL HU, 1988, J CHROMATOGR, V452, P459, DOI 10.1016/S0021-9673(01)81468-0.
   RHODES C, 1986, ENVIRON HEALTH PERSP, V65, P299, DOI 10.2307/3430197.
   SCHACKLETON CHL, 1980, CLIN CHIM ACTA, V107, P23.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SETCHELL KDR, 1976, J STEROID BIOCHEM, V7, P615, DOI 10.1016/0022-4731(76)90086-8.
   SINCLAIR KA, 1982, BIOCHEM PHARMACOL, V31, P953, DOI 10.1016/0006-2952(82)90326-4.
   SJOBERG P, 1985, EUR J CLIN INVEST, V15, P430, DOI 10.1111/j.1365-2362.1985.tb00297.x.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x.
   Sjövall J, 1984, J Pharm Biomed Anal, V2, P265, DOI 10.1016/0731-7085(84)80077-1.
   SJOVALL J, 1983, J CHROMATOGR, V276, P150, DOI 10.1016/S0378-4347(00)85075-6.
   SPIEGELHALDER B, 1976, J STEROID BIOCHEM, V7, P749, DOI 10.1016/0022-4731(76)90175-8.
   THOMAS JA, 1982, J TOXICOL ENV HEALTH, V9, P141.
   UUSIJARVI J, 1989, J CHROMATOGR-BIOMED, V488, P87, DOI 10.1016/S0378-4347(00)82941-2.
   WAMS TJ, 1987, SCI TOTAL ENVIRON, V66, P1, DOI 10.1016/0048-9697(87)90072-6.
   YANG Y, 1994, CARCINOGENESIS, V15, P681, DOI 10.1093/carcin/15.4.681.}},
Number-of-Cited-References = {{39}},
Times-Cited = {{16}},
Journal-ISO = {{J. Chromatogr. B-Biomed. Appl.}},
Doc-Delivery-Number = {{TZ696}},
Wos-Id = {{ISI:A1996TZ69600010}},
}

@article{ ISI:A1995RX41700005,
Author = {FUKUOKA, M and KOBAYASHI, T and HAYAKAWA, T},
Title = {{MECHANISM OF TESTICULAR ATROPHY INDUCED BY DI-N-BUTYL PHTHALATE IN RATS
   .5. TESTICULAR IRON DEPLETION AND LEVELS OF FERRITIN, HEMOGLOBIN AND
   TRANSFERRIN IN THE BONE-MARROW, LIVER AND SPLEEN}},
Journal = {{JOURNAL OF APPLIED TOXICOLOGY}},
Year = {{1995}},
Volume = {{15}},
Number = {{5}},
Pages = {{379-386}},
Month = {{SEP-OCT}},
Abstract = {{This study reports changes in levels of ferritin, haemoglobin and
   transferrin in the bone marrow, liver and spleen as an attempt to
   determine the causes of testicular iron depletion. A single oral dose of
   di-n-bntyl phthalate (DBP) to male rats caused a sloughing of the germ
   cells (at 6 h) prior to testicular atrophy, Before the sloughing it was
   observed that DBP induced decreases both in the iron levels in the
   blood, bone marrow and testis and in haemoglobin (Hb) levels in the
   blood, bone marrow and spleen. Decrease in transferrin (Tf) levels was
   observed in the liver. Significant increases in ferritin and
   haemosiderin (Hs) levels were observed in the spleen and in the liver
   and spleen, respectively.
   In vitro studies where mono-n-butyl phthalate (MBP) was incubated with
   liver homogenates, MBP caused both the decreases in Db and Tf-bound iron
   levels and increases in Hs and Hs-iron levels.
   The present study proposes that the mechanism of testicular atrophy by
   DBP might be associated with both the iron release from Db and/or Tf in
   the liver and spleen and the subsequent depletion of iron in the blood
   and testes.}},
Publisher = {{JOHN WILEY \& SONS LTD}},
Address = {{BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{FUKUOKA, M (Reprint Author), NATL INST HLTH SCI,DIV BIOL CHEM,SETAGAYA KU,KAMIYOGA-1-CHOME,TOKYO 158,JAPAN.}},
DOI = {{10.1002/jat.2550150507}},
ISSN = {{0260-437X}},
Keywords = {{DI-N-BUTYL PHTHALATE; RAT TESTICULAR ATROPHY; SERTOLI CELLS; SUCCINATE
   DEHYDROGENASE; IRON; TRANSFERRIN; FERRITIN; HEMOGLOBIN; HEMOSIDERIN;
   HEPATOTOXICITY; LIVER; SPLEEN; BONE MARROW}},
Keywords-Plus = {{BOUND IRON; RABBIT RETICULOCYTES; GERM-CELLS; TRANSPORT; SERTOLI;
   RELEASE; INVIVO; DI(2-ETHYLHEXYL)PHTHALATE; ENDOCYTOSIS; REDUCTION}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Cited-References = {{AISEN P, 1980, ANNU REV BIOCHEM, V49, P357, DOI 10.1146/annurev.bi.49.070180.002041.
   AUST SD, 1988, OXYGEN RADICALS BIOL, P137.
   BAIL PK, 1991, BIOCHEMISTRY-US, V30, P324.
   BEGUIN Y, 1989, J LAB CLIN MED, V113, P346.
   BRIELAND JK, 1992, ARCH BIOCHEM BIOPHYS, V294, P265, DOI 10.1016/0003-9861(92)90167-U.
   Brunel RF, 1923, J AM CHEM SOC, V45, P1334, DOI 10.1021/ja01658a031.
   CARVER FJ, 1978, BIOCHEMISTRY-US, V17, P167, DOI 10.1021/bi00594a024.
   CREASY DM, 1983, J PATHOL, V139, P309, DOI 10.1002/path.1711390307.
   DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258.
   ENTMAN SS, 1987, J IN VITRO FERTIL EM, V4, P98, DOI 10.1007/BF01555447.
   FOSTER PMD, 1982, TOXICOL APPL PHARM, V63, P120, DOI 10.1016/0041-008X(82)90031-X.
   FUKUOKA M, 1989, J APPL TOXICOL, V9, P277, DOI 10.1002/jat.2550090413.
   FUKUOKA M, 1990, J APPL TOXICOL, V10, P285, DOI 10.1002/jat.2550100410.
   FUKUOKA M, 1993, J APPL TOXICOL, V13, P241, DOI 10.1002/jat.2550130406.
   GAD SC, 1982, PRINCIPLES METHODS T, P273.
   GRAY TJB, 1984, FOOD CHEM TOXICOL, V22, P123, DOI 10.1016/0278-6915(84)90092-9.
   HARRIS DC, 1985, BIOCHIM BIOPHYS ACTA, V838, P295, DOI 10.1016/0304-4165(85)90226-0.
   HEMMAPLA.D, 1974, BIOCHIM BIOPHYS ACTA, V373, P84, DOI 10.1016/0005-2736(74)90108-4.
   IACOPETTA BJ, 1983, J BIOL CHEM, V258, P9108.
   IANCU TC, 1977, BRIT J HAEMATOL, V37, P527, DOI 10.1111/j.1365-2141.1977.tb01026.x.
   IDZERDA RL, 1986, P NATL ACAD SCI USA, V83, P3723, DOI 10.1073/pnas.83.11.3723.
   JEEJEEBHOY KN, 1975, BIOCHEM J, V146, P141.
   KISSINGER C, 1982, BIOL REPROD, V27, P223.
   KLAUSNER RD, 1983, P NATL ACAD SCI-BIOL, V80, P2263, DOI 10.1073/pnas.80.8.2263.
   KOJIMA N, 1979, J BIOL CHEM, V254, P8847.
   MORALES C, 1987, BIOL REPROD, V37, P995, DOI 10.1095/biolreprod37.4.995.
   MORGAN EH, 1988, BIOCHIM BIOPHYS ACTA, V943, P428, DOI 10.1016/0005-2736(88)90374-4.
   MORGAN EH, 1969, J BIOL CHEM, V244, P4193.
   POPP JA, 1987, TOXICOL IND HEALTH, V3, P151.
   RAO MS, 1990, J TOXICOL ENV HEALTH, V30, P85.
   SELDEN C, 1980, BRIT J HAEMATOL, V44, P593, DOI 10.1111/j.1365-2141.1980.tb08714.x.
   SETSUDA T, 1985, ACTA HAEMATOL JAPON, V48, P155.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   SKINNER MK, 1984, BIOCHEM J, V218, P313.
   THORSTENSEN K, 1990, BIOCHEM J, V271, P1.
   VIDNES A, 1973, BIOCHIM BIOPHYS ACTA, V328, P365, DOI 10.1016/0005-2795(73)90270-5.
   WEIN MP, 1985, BIOCHIM BIOPHYS ACTA, V828, P298.
   WRIGHT TL, 1988, J BIOL CHEM, V263, P1842.
   WRIGHT TL, 1986, J BIOL CHEM, V261, P909.
   XU B, 1991, Journal of Biological Chemistry, V266, P19965.
   ZHOU Y, 1990, J APPL TOXICOL, V10, P447, DOI 10.1002/jat.2550100612.
   1992, WHO ENV HLTH CRITERI, V131, P1.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{10}},
Journal-ISO = {{J. Appl. Toxicol.}},
Doc-Delivery-Number = {{RX417}},
Wos-Id = {{ISI:A1995RX41700005}},
}

@article{ ISI:A1995QX61400011,
Author = {KICHEVA, YI and KOSTOV, VD and CHICHOVSKA, M},
Title = {{IN-VITRO AND IN-VIVO STUDIES OF THE EFFECT OF THE CONCENTRATION OF
   PLASTICIZER DI(2-ETHYLHEXYL) PHTHALATE ON THE BLOOD COMPATIBILITY OF
   PLASTICIZED POLY(VINYL CHLORIDE) DRAIN TUBES}},
Journal = {{BIOMATERIALS}},
Year = {{1995}},
Volume = {{16}},
Number = {{7}},
Pages = {{575-579}},
Month = {{MAY}},
Abstract = {{Evaluation of the effect of the plasticizer di(2-ethylhexyl) phthalate
   (DEHP) has been carried out on the properties of blood compatibility of
   plasticized poly(vinyl chloride) (PVC) through an in vitro registering
   of the amount of total protein in relation to the amount of DEHP. The
   influence of DEHP on the properties of blood compatibility has also been
   evaluated in vivo by tracing through a modified method of Gott (LV Gott
   and A Peruse, Bull NY Acad Med 1972; 48(2): 482-491) the presence of a
   thrombus and the patency of tubes made from the material tested, as well
   as the patency of tubes made from the same material having surfaces
   coated with paraffin and complexone. For all implanted samples the
   changes in coagulation time and the amount of haemoglobin after their
   stay inside a blood vessel in the abdominal cavity of a dog have been
   registered.}},
Publisher = {{ELSEVIER SCI LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, OXON, ENGLAND OX5 1GB}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{KICHEVA, YI (Reprint Author), HIGHER MED INST,CENT CLIN LABS,15A VASSIL APRILOV ST,BU-4000 PLOVDIV,BULGARIA.
   HIGHER MED INST,DEPT PHYSIOL,BU-4000 PLOVDIV,BULGARIA.}},
DOI = {{10.1016/0142-9612(95)91132-I}},
ISSN = {{0142-9612}},
Keywords = {{BIOCOMPATIBILITY; HEMOCOMPATIBILITY; PROTEIN; BLOOD COAGULATION TIME;
   SURFACE; HEMOGLOBIN}},
Research-Areas = {{Engineering; Materials Science}},
Web-of-Science-Categories  = {{Engineering, Biomedical; Materials Science, Biomaterials}},
Cited-References = {{ANGYOZOVA E, 1985, COLLECTION SCI WORKS.
   ANGYOZOVA E, 1983, 8TH NAT S INT PART P.
   BAIER RE, 1972, B NY ACAD MED, V48, P2.
   Bruck S. D, 1977, J BIOMED MATER RES S, V8, P1.
   BRUCK SD, 1983, BIOMATER ARTIF CELL, V11, P271.
   BRUCK SD, 1982, MED PROG TECHNOL, V9, P1.
   BURTON NA, 1983, ANN THORAC SURG, V36, P78.
   CHAZOVA EIP, 1981, CURRENT PROBLEMS HEM, P310.
   DIDISHEIM P, 1989, SEMIN THROMB HEMOST, V15, P240, DOI 10.1055/s-2007-1002713.
   DUBECZ S, 1990, Acta Chirurgica Hungarica, V31, P333.
   FLAMINIO LM, 1988, INT J ARTIF ORGANS, V11, P435.
   GOODWIN MI, 1990, ANN ROY COLL SURG, V72, P125.
   GOTT VL, 1972, B NEW YORK ACAD MED, V48, P482.
   KAMENSKOL MA, 1974, EXPERIMENTAL PHYSL.
   LENINGER RY, 1966, TASAIO RES, V12, P151.
   MARTIN Y, 1988, EXP SURG CENT SURG B, V13, P1548.
   MOLLNES T E, 1991, Clinical and Experimental Immunology, V86, P21.
   RUIZ FB, 1991, MED CLIN-BARCELONA, V96, P129.
   STEEN JA, 1982, CRIT CARE MED, V10, P186, DOI 10.1097/00003246-198203000-00009.
   STEWART JW, 1969, LANCET, V340.
   THAMURA K, 1985, BIOMAT MED EV ARTIF, V13, P895.
   UYAMA Y, 1991, BIOMATERIALS, V12, P71, DOI 10.1016/0142-9612(91)90135-W.
   VANDOOREN AA, 1991, PHARM WEEKBLAD, V13, P109.
   1990, ASTR BIOM, V11, P135.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{12}},
Journal-ISO = {{Biomaterials}},
Doc-Delivery-Number = {{QX614}},
Wos-Id = {{ISI:A1995QX61400011}},
}

@article{ ISI:A1994PM11400031,
Author = {MALIK, S and KENNY, MA and BUCHWALD, DS},
Title = {{DI-2-ETHYLHEXYL PHTHALATE - A MEDICAL CONCERN AND A POSSIBLE MARKER FOR
   CHRONIC FATIGUE SYNDROME}},
Journal = {{PURE AND APPLIED CHEMISTRY}},
Year = {{1994}},
Volume = {{66}},
Number = {{10-11}},
Pages = {{2103-2106}},
Month = {{OCT-NOV}},
Note = {{19th International Symposium on the Chemistry of Natural Products,
   KARACHI, PAKISTAN, JAN 16-20, 1994}},
Organization = {{INT UNION PURE \& APPL CHEM, ORGANIC CHEM DIV; CHEM SOC PAKISTAN, H E J
   RES INST CHEM}},
Abstract = {{Di-2-ethylhexyl phthalate (DEHP) is a plasticizer which continuously
   leaches from some plastics into the environment.  It is on EPA's list of
   carcinogens but there are not extensive data on humans.  People who are
   more in contact with these plastic products are at greater risk of
   exposure.  Hospital patients with high exposure risk were evaluated and
   their tissues and blood DEHP levels are reported.  Elevated DEHP levels
   were also observed in chronic fatigue syndrome (CFS) patients.  A
   correlation is proposed between metal ions depletion and increased
   circulating DEHP in CFS patients.  It was also found that DEHP cross
   reacts with some antidigoxin polyclonal antibody preparations.  This can
   lead to false positive results in serum digoxin immunoassays and may
   indirectly endanger patients on digoxin therapy.}},
Publisher = {{BLACKWELL SCIENCE LTD}},
Address = {{OSNEY MEAD, OXFORD, OXON, ENGLAND OX2 0EL}},
Type = {{Article; Proceedings Paper}},
Language = {{English}},
Affiliation = {{MALIK, S (Reprint Author), UNIV WASHINGTON,DEPT LAB MED,DIV CHEM,SEATTLE,WA 98195, USA.
   UNIV WASHINGTON,DEPT MED,DIV CHEM,SEATTLE,WA 98195.}},
DOI = {{10.1351/pac199466102103}},
ISSN = {{0033-4545}},
Keywords-Plus = {{PLASTICIZERS}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Multidisciplinary}},
Cited-References = {{COX IM, 1991, LANCET, V337, P757, DOI 10.1016/0140-6736(91)91371-Z.
   Durlach J, 1992, Magnes Res, V5, P68.
   GACHTER R, 1985, PLASTICS ADDITIVES H, P255.
   GIAM CS, 1978, SCIENCE, V199, P419, DOI 10.1126/science.199.4327.419-a.
   HOLMES GP, 1988, ANN INTERN MED, V108, P387.
   KLUWE W, 1982, J TOXICOL ENV HLTH, P797.
   KROENKE K, 1988, JAMA-J AM MED ASSOC, V260, P929, DOI 10.1001/jama.260.7.929.
   MALIK S, 1993, TOXICOL ENVIRON CHEM, V37, P133, DOI 10.1080/02772249309357862.
   MOODY DE, 1978, TOXICOL APPL PHARM, V45, P497, DOI 10.1016/0041-008X(78)90111-4.
   REDDY JK, 1976, LIFE SCI, V18, P941, DOI 10.1016/0024-3205(76)90412-4.
   TANAKA A, 1975, TOXICOLOGY, V4, P253, DOI 10.1016/0300-483X(75)90105-5.
   WILLIAMS DT, 1974, B ENVIRON CONTAM TOX, V11, P371.
   1982, IAR MONOGRAPHS EVALU, V29, P269.
   1993, CIBA F S, V173.
   1982, NIH217 TECHN REP SER.
   1992, ENV HLTH CRITERIA, V131.
   1989, TOXICOLOGICAL EVALUA, P362.}},
Number-of-Cited-References = {{17}},
Times-Cited = {{1}},
Journal-ISO = {{Pure Appl. Chem.}},
Doc-Delivery-Number = {{PM114}},
Wos-Id = {{ISI:A1994PM11400031}},
}

@article{ ISI:A1994NL81200001,
Author = {ABERG, F and ZHANG, YY and APPELKVIST, EL and DALLNER, G},
Title = {{EFFECTS OF CLOFIBRATE, PHTHALATES AND PROBUCOL ON UBIQUINONE LEVELS}},
Journal = {{CHEMICO-BIOLOGICAL INTERACTIONS}},
Year = {{1994}},
Volume = {{91}},
Number = {{1}},
Pages = {{1-14}},
Month = {{APR}},
Abstract = {{Rats were exposed through their diet to clofibrate,
   di(2-ethylhexyl)phthalate or probucol for 6 weeks and the levels of
   ubiquinone (UQ), cholesterol and dolichol were monitored in liver,
   muscle, heart, brain and blood. The levels of UQ-9 and -10 were
   increased by clofibrate and, in particular by phthalate administration.
   With the latter agent this increase in liver was fourfold, in muscle was
   twofold and levels in the heart and blood increased by 20\%, whereas
   there was no change in the brain. Probucol led to a moderate decrease in
   the level of UQ in liver, muscle and blood, but not in heart or brain.
   The extent of reduction of UQ was not modified by any of the treatments
   employed. Probucol did not have any effect on tissue or}},
Publisher = {{ELSEVIER SCI IRELAND LTD}},
Address = {{CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{ABERG, F (Reprint Author), UNIV STOCKHOLM,DEPT BIOCHEM,S-10691 STOCKHOLM,SWEDEN.
   KAROLINSKA INST,CLIN RES CTR,HUDDINGE,SWEDEN.}},
DOI = {{10.1016/0009-2797(94)90002-7}},
ISSN = {{0009-2797}},
Keywords = {{PEROXISOMAL INDUCERS; MEVALONATE PATHWAY; RAT TISSUES}},
Keywords-Plus = {{RAT-LIVER; LIPID-PEROXIDATION; ALPHA-TOCOPHEROL; HUMAN-TISSUES;
   COENZYME-Q; VITAMIN-E; ANTIOXIDANT; BIOSYNTHESIS;
   DI(2-ETHYLHEXYL)PHTHALATE; MITOCHONDRIA}},
Research-Areas = {{Biochemistry \& Molecular Biology; Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Pharmacology \& Pharmacy; Toxicology}},
Cited-References = {{ABERG F, 1992, ARCH BIOCHEM BIOPHYS, V295, P230.
   APPELKVIST EL, 1991, BIOMED CLIN, V6, P141.
   BARNHART JW, 1970, AM J CLIN NUTR, V23, P1229.
   BARNHART RL, 1989, J LIPID RES, V30, P1703.
   BEYER RE, 1987, CHEM SCRIPTA, V27, P145.
   BEYER RE, 1991, BIOMED CLIN, V6, P501.
   Crane F.L., 1965, BIOCH QUINONES, P183.
   DELRIO LA, 1992, FREE RADICAL BIO MED, V13, P557, DOI 10.1016/0891-5849(92)90150-F.
   EDLUND C, 1986, CHEM-BIOL INTERACT, V57, P255, DOI 10.1016/0009-2797(86)90001-3.
   EGGENS I, 1990, J EXP PATHOL, V71, P219.
   ELMBERGER PG, 1989, LIPIDS, V24, P919, DOI 10.1007/BF02544535.
   ERNSTER L, 1991, BIOMED CLIN, V6, P45.
   Ernster L, 1977, BIOMEDICAL CLIN ASPE, P15.
   FORSMARK P, 1991, FEBS LETT, V285, P39, DOI 10.1016/0014-5793(91)80720-N.
   FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879.
   GANNING AE, 1983, BIOCHIM BIOPHYS ACTA, V763, P72, DOI 10.1016/0167-4889(83)90027-7.
   GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0.
   KAGAN V, 1990, BIOCHEM BIOPH RES CO, V169, P851, DOI 10.1016/0006-291X(90)91971-T.
   KALEN A, 1989, LIPIDS, V24, P579, DOI 10.1007/BF02535072.
   KALEN A, 1987, BIOCHIM BIOPHYS ACTA, V926, P70, DOI 10.1016/0304-4165(87)90183-8.
   KALEN A, 1990, CHEM-BIOL INTERACT, V73, P221, DOI 10.1016/0009-2797(90)90005-8.
   KELLER RK, 1986, J BIOL CHEM, V261, P2053.
   KUZUYA M, 1993, FREE RADICAL BIO MED, V14, P67, DOI 10.1016/0891-5849(93)90510-2.
   LANG JK, 1987, J CHROMATOGR, V385, P109, DOI 10.1016/S0021-9673(01)94626-6.
   LEMKE M, 1990, NEUROSCI LETT, V108, P201, DOI 10.1016/0304-3940(90)90731-N.
   LENAZ G, 1990, HIGHLIGHTS IN UBIQUINONE RESEARCH, P52.
   LENAZ G, 1985, COENZYME Q, P83.
   OLSSON JM, 1991, CANCER RES, V51, P3774.
   OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z.
   Ozawa T, 1985, COENZYME Q BIOCH BIO, P441.
   POTTER JER, 1981, J BIOL CHEM, V256, P2371.
   RAMASARMA T, 1985, COENZYME Q, P67.
   REDDY JK, 1983, CRC CR REV TOXICOL, V12, P1, DOI 10.3109/10408448309029317.
   REDDY JK, 1987, PEROXISOMES BIOL MED, P254.
   SODERBERG M, 1992, J NEUROCHEM, V59, P1646.
   STOCKER R, 1991, P NATL ACAD SCI USA, V88, P1646, DOI 10.1073/pnas.88.5.1646.
   SUGAWARA H, 1990, INT J BIOCHEM, V22, P477.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{27}},
Journal-ISO = {{Chem.-Biol. Interact.}},
Doc-Delivery-Number = {{NL812}},
Wos-Id = {{ISI:A1994NL81200001}},
}

@article{ ISI:A1993LM69100014,
Author = {PLONAIT, SL and NAU, H and MAIER, RF and WITTFOHT, W and OBLADEN, M},
Title = {{EXPOSURE OF NEWBORN-INFANTS TO DI-(2-ETHYLHEXYL)-PHTHALATE AND
   2-ETHYLHEXANOIC ACID FOLLOWING EXCHANGE-TRANSFUSION WITH
   POLYVINYLCHLORIDE CATHETERS}},
Journal = {{TRANSFUSION}},
Year = {{1993}},
Volume = {{33}},
Number = {{7}},
Pages = {{598-605}},
Month = {{JUL}},
Abstract = {{Infants in the neonatal intensive care unit are regularly exposed to the
   plasticizer di-(2-ethylhexyl)-phthalate (DEHP) following exchange
   transfusion or extracorporeal membrane oxygenation. Whether such
   exposure leads to increased morbidity is not known, although elevated
   levels of DEHP have been associated with necrotizing enterocolitis and
   cholestasis. The hypothesis that infants undergoing exchange transfusion
   are exposed to toxic levels of DEHP and the presumed metabolite
   2-ethylhexanoic acid (EHXA) was tested by measuring serum levels of DEHP
   in 16 newborn infants (gas-liquid-chromatography) and urine
   concentrations of EHXA in 6 of these infants (gas chromatography-mass
   spectrometry). DEHP levels were undetectable (<1 mug/mL) before exchange
   but ranged from 6.1 to 21.6 mug per mL of serum (average, 12.5 +/- 6.2
   mug/mL) after a single exchange transfusion. DEHP uptake did not result
   in cholestasis. EHXA peak levels were 127 to 416 ng per mL of urine,
   with a median of 174 ng per mL. Concentrations of EHXA were lower than
   anticipated, which indicates that EHXA is not a major metabolite in the
   neonatal infant.}},
Publisher = {{AMER ASSOC BLOOD BANKS}},
Address = {{8101 GLENBROOK RD, BETHESDA, MD 20814-2749}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{FREE UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,DEPT NEONATOL,HEUBNER WEG 6,W-1000 BERLIN 19,GERMANY.
   FREE UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,INST TOXICOL \& EMBRYOPHARMACOL,W-1000 BERLIN 19,GERMANY.}},
DOI = {{10.1046/j.1537-2995.1993.33793325058.x}},
ISSN = {{0041-1132}},
Keywords-Plus = {{EXTRACORPOREAL MEMBRANE-OXYGENATION; CHROMATOGRAPHY-MASS-SPECTROMETRY;
   DI-2-ETHYLHEXYL PHTHALATE; VALPROIC ACID; DI(2-ETHYLHEXYL) PHTHALATE;
   MONO-(2-ETHYLHEXYL) PHTHALATE; QUANTITATIVE-DETERMINATION; RED-CELLS;
   PLASTICIZER; BLOOD}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1975, XENOBIOTICA, V5, P625.
   ARONSON CE, 1978, TOXICOL APPL PHARM, V44, P155, DOI 10.1016/0041-008X(78)90295-8.
   AUBUCHON JP, 1988, BLOOD, V71, P448.
   BARRY YA, 1989, J THORAC CARDIOV SUR, V97, P900.
   BELL FP, 1979, LIPIDS, V14, P372, DOI 10.1007/BF02533420.
   CARTER JE, 1974, DRUG METAB DISPOS, V2, P341.
   COLE RS, 1981, VOX SANG, V40, P317.
   COLLINS MD, 1992, TOXICOL APPL PHARM, V112, P257, DOI 10.1016/0041-008X(92)90195-X.
   DABHOLKAR AS, 1988, ACTA ANAT, V131, P218.
   DINE T, 1991, BIOMED CHROMATOGR, V5, P94, DOI 10.1002/bmc.1130050211.
   DIRVEN HAAM, 1992, BIOCHEM PHARMACOL, V43, P2621, DOI 10.1016/0006-2952(92)90151-8.
   FISHER E, 1992, BIOMED CHROMATOGR, V6, P24, DOI 10.1002/bmc.1130060108.
   FISHER E, 1992, EPILEPSIA, V33, P165, DOI 10.1111/j.1528-1157.1992.tb02301.x.
   GANNING AE, 1984, HEPATOLOGY, V4, P541, DOI 10.1002/hep.1840040331.
   GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9.
   GRIMMER I, 1992, EARLY HUM DEV, V30, P221, DOI 10.1016/0378-3782(92)90071-N.
   HAUCK RS, 1989, TOXICOL LETT, V49, P41, DOI 10.1016/0378-4274(89)90099-4.
   HEINDEL JJ, 1992, TOXICOL APPL PHARM, V115, P116, DOI 10.1016/0041-008X(92)90374-2.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   HOGMAN CF, 1991, TRANSFUSION, V31, P26, DOI 10.1046/j.1537-2995.1991.31191096180.x.
   HOROWITZ B, 1985, VOX SANG, V48, P150.
   JACOBSON MS, 1977, J LAB CLIN MED, V89, P1066.
   JACOBSON MS, 1980, TRANSFUSION, V20, P443, DOI 10.1046/j.1537-2995.1980.20480260277.x.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   LUNDGREN B, 1988, CHEM-BIOL INTERACT, V68, P219, DOI 10.1016/0009-2797(88)90018-X.
   MYHRE BA, 1988, ANN CLIN LAB SCI, V18, P131.
   NAU H, 1981, J CHROMATOGR, V226, P69, DOI 10.1016/S0378-4347(00)84207-3.
   NEERGAARD J, 1971, Scandinavian Journal of Urology and Nephrology, V5, P141, DOI 10.3109/00365597109133592.
   PECK CC, 1979, TRANSFUSION, V19, P137, DOI 10.1046/j.1537-2995.1979.19279160282.x.
   POLLACK GM, 1985, TOXICOL APPL PHARM, V79, P257, DOI 10.1016/0041-008X(85)90347-3.
   REDDY JK, 1984, AM J PATHOL, V114, P171.
   RITTER EJ, 1987, TERATOLOGY, V35, P41, DOI 10.1002/tera.1420350107.
   ROCK G, 1984, TRANSFUSION, V24, P493, DOI 10.1046/j.1537-2995.1984.24685066808.x.
   ROCK G, 1987, NEW ENGL J MED, V316, P1218.
   RUBIN RJ, 1989, TRANSFUSION, V29, P358, DOI 10.1046/j.1537-2995.1989.29489242805.x.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SETH PK, 1982, ENVIRON HEALTH PERSP, V45, P27, DOI 10.2307/3429380.
   SHNEIDER B, 1991, J PEDIATR GASTR NUTR, V13, P285, DOI 10.1097/00005176-199110000-00008.
   SHNEIDER B, 1989, NEW ENGL J MED, V320, P1563.
   SJOBERG P, 1985, ARCH TOXICOL, V58, P78, DOI 10.1007/BF00348313.
   SJOBERG P, 1985, EUR J CLIN INVEST, V15, P430, DOI 10.1111/j.1365-2362.1985.tb00297.x.
   SJOBERG P, 1991, BIOCHEM PHARMACOL, V41, P1493, DOI 10.1016/0006-2952(91)90566-N.
   SJOBERG P, 1988, BIOL NEONATE, V53, P32.
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x.
   SNYDER EL, 1933, TRANSFUSION, V33, P515.
   SNYDER EL, 1992, TRANSFUSION, V32, P736, DOI 10.1046/j.1537-2995.1992.32893032101.x.
   SRIVASTAVA SP, 1978, TOXICOLOGY, V11, P271, DOI 10.1016/S0300-483X(78)91639-6.
   STERN IJ, 1977, TOXICOL APPL PHARM, V41, P507, DOI 10.1016/S0041-008X(77)80006-9.
   WILKS MF, 1992, OCT INT S BIOL MON S.
   1978, VOX SANG, V34, P244.
   1975, EUROPEAN PHARMACOPOE.}},
Number-of-Cited-References = {{55}},
Times-Cited = {{54}},
Journal-ISO = {{Transfusion}},
Doc-Delivery-Number = {{LM691}},
Wos-Id = {{ISI:A1993LM69100014}},
}

@article{ ISI:A1993LH30800013,
Author = {SNYDER, EL and HEDBERG, SL and NAPYCHANK, PA and ROBERTS, C and KAGEN, L
   and ASTER, RA and QUINLAN, K and STRUCALY, A and BUCHHOLZ, DH},
Title = {{STABILITY OF RED-CELL ANTIGENS AND PLASMA COAGULATION-FACTORS STORED IN
   A NON-DIETHYLHEXYL PHTHALATE-PLASTICIZED CONTAINER}},
Journal = {{TRANSFUSION}},
Year = {{1993}},
Volume = {{33}},
Number = {{6}},
Pages = {{515-519}},
Month = {{JUN}},
Abstract = {{Red cell antigen stability studies were performed to evaluate whether
   the storage of red cells in plastic segments made up of a new
   non-di-2(ethylhexyl)phthalate (DEHP)-plasticized material resulted in
   poststorage antigenic reactivity different from that seen in segments
   made from DEHP-containing plastic. Serial 1-in-2 dilutions of
   commercially available antisera were prepared and tested by using stored
   red cells obtained from segments on Days 0, 28, 42, and, in some
   instances, 49. Antigenic determinants tested included A, B, D, c, K,
   Le(a), Fy(a), Jk(a), M, and P1. To minimize variability, the same
   reagent lots were used throughout each study, and the same technologists
   performed the assays in each laboratory. No significant differences in
   titration scores were seen when cells stored in segments made of the
   test plastic were compared with cells obtained from the same donor and
   stored for the same length of time in segments made of control plastic.
   In addition, plasma coagulation factor stability was studied in
   fresh-frozen plasma and cryoprecipitate stored for up to 1 year in the
   non-DEHP-plasticized plastic containers. No significant differences were
   seen in prothrombin time, activated partial thromboplastin time,
   fibrinogen content, or factor V, VII, VIII, IX, or X activity as
   compared with plasma stored for equal periods of time in control plastic
   containers. It is concluded that the test plastic does not adversely
   affect red cell antigenic reactivity or plasma coagulation factor
   stability and that it is suitable for use in clinical transfusion
   practice.}},
Publisher = {{AMER ASSOC BLOOD BANKS}},
Address = {{8101 GLENBROOK RD, BETHESDA, MD 20814-2749}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{SNYDER, EL (Reprint Author), YALE UNIV,SCH MED,DEPT LAB MED,NEW HAVEN,CT 06510, USA.
   BLOOD CTR SE WISCONSIN INC,MILWAUKEE,WI.
   BAXTER HEALTHCARE CORP,FENWAL DIV,DEERFIELD,IL.}},
DOI = {{10.1046/j.1537-2995.1993.33693296816.x}},
ISSN = {{0041-1132}},
Keywords-Plus = {{WHOLE-BLOOD; DI-2-ETHYLHEXYL PHTHALATE; MONO-2-ETHYLHEXYL PHTHALATE;
   DI-(2-ETHYLHEXYL) PHTHALATE; TRIHEXYL-CITRATE; STORAGE; BAGS; DEHP;
   ACCUMULATION; PLATELETS}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{ALBRO PW, 1989, TOXICOL APPL PHARM, V100, P193, DOI 10.1016/0041-008X(89)90305-0.
   AUBUCHON JP, 1988, BLOOD, V71, P448.
   BUCHHOLZ D, 1989, TRANSFUSION S, V29, pS8.
   CONWAY JG, 1989, CARCINOGENESIS, V10, P513, DOI 10.1093/carcin/10.3.513.
   ESTEP TN, 1984, BLOOD, V64, P1270.
   GULLIKSSON H, 1991, VOX SANG, V61, P165.
   HOGMAN CF, 1991, TRANSFUSION, V31, P26, DOI 10.1046/j.1537-2995.1991.31191096180.x.
   HOROWITZ B, 1985, VOX SANG, V48, P150.
   HULL EH, 1990, JAN P SOC PLAST ENG, P1.
   JACOBSON MS, 1988, 20TH C INT SOC BLOOD, P235.
   JAEGER RJ, 1973, TRANSFUSION, V13, P107.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   KEVY SV, 1985, BLOOD S, V66, pA280.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P129, DOI 10.2307/3429396.
   KOOPTZOFF O, 1954, AUST J EXP BIOL MED, V32, P695, DOI 10.1038/icb.1954.72.
   LINNS I, 1959, CAN J MED TECHNOL, V21, P47.
   MARSH WL, 1972, TRANSFUSION, V12, P352.
   PECK CC, 1979, TRANSFUSION, V19, P137, DOI 10.1046/j.1537-2995.1979.19279160282.x.
   ROCK G, 1984, TRANSFUSION, V24, P493, DOI 10.1046/j.1537-2995.1984.24685066808.x.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   ROSENFIE.RE, 1971, TRANSFUSION, V11, P177.
   RUBIN RJ, 1989, TRANSFUSION, V29, P358, DOI 10.1046/j.1537-2995.1989.29489242805.x.
   SASAKAWA S, 1978, VOX SANG, V34, P81.
   SEIDL S, 1991, VOX SANG, V61, P8.
   SIMON TL, 1991, TRANSFUSION, V31, P335, DOI 10.1046/j.1537-2995.1991.31491213299.x.
   SNYDER EL, 1983, TRANSFUSION, V23, P165, DOI 10.1046/j.1537-2995.1983.23283172859.x.
   SNYDER EL, 1992, TRANSFUSION, V32, P736, DOI 10.1046/j.1537-2995.1992.32893032101.x.
   SNYDER EL, 1983, TRANSFUSION, V23, P49, DOI 10.1046/j.1537-2995.1983.23183147305.x.
   WARD JM, 1986, ENVIRON HEALTH PERSP, V65, P279, DOI 10.2307/3430195.
   WARREN JR, 1982, ENVIRON HEALTH PERSP, V45, P35, DOI 10.2307/3429381.}},
Number-of-Cited-References = {{30}},
Times-Cited = {{5}},
Journal-ISO = {{Transfusion}},
Doc-Delivery-Number = {{LH308}},
Wos-Id = {{ISI:A1993LH30800013}},
}

@article{ ISI:A1993LC69700003,
Author = {DIRVEN, HAAM and VANDENBROEK, PHH and ARENDS, AMM and NORDKAMP, HH and
   DELEPPER, AJGM and HENDERSON, PT and JONGENEELEN, FJ},
Title = {{METABOLITES OF THE PLASTICIZER DI(2-ETHYLHEXYL)PHTHALATE IN URINE
   SAMPLES OF WORKERS IN POLYVINYLCHLORIDE PROCESSING INDUSTRIES}},
Journal = {{INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH}},
Year = {{1993}},
Volume = {{64}},
Number = {{8}},
Pages = {{549-554}},
Month = {{MAY}},
Abstract = {{Little is known about occupational exposure to the plasticizer
   di(2-ethylhexyl)phthalate (CAS number 117-81-7), a compound widely used
   in polyvinylchloride (PVC) plastics. We have studied the uptake of DEHP
   in workers by determining the concentrations of four metabolites of DEHP
   in urine samples, i.e., mono(2-ethylhexyl)phthalate (MEHP),
   mono(5-carboxy-2-ethylpentyl)phthalate,
   mono(2-ethyl-5-oxohexyl)phthalate, and
   mono(2-ethyl-5-hydroxyhexyl)phthalate. In addition DEHP concentrations
   in the air were determined by personal air sampling. Nine workers in a
   PVC boot factory exposed to a maximum of 1.2 mg/m3 DEHP showed an
   increase in the urinary concentrations of all four metabolites over the
   workshift. These results were obtained on both the first and the last
   day of the workweek. With the exception of MEHP, the increases in the
   concentrations of the metabolites during a workday were statistically
   significant. Six workers from a PVC cable factory exposed to a maximum
   of 1.2 mg/m3 DEHP showed a one-to fourfold increase in the
   concentrations of the four metabolites over the workshift, but these
   increases were not statistically significant. These results indicate
   that measurement of DEHP metabolites in urine samples may be of use for
   monitoring the occupational exposure to DEHP.}},
Publisher = {{SPRINGER VERLAG}},
Address = {{175 FIFTH AVE, NEW YORK, NY 10010}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{DIRVEN, HAAM (Reprint Author), CATHOLIC UNIV NIJMEGEN,DEPT TOXICOL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.}},
DOI = {{10.1007/BF00517699}},
ISSN = {{0340-0131}},
Keywords = {{DI(2-ETHYLHEXYL)PHTHALATE; POLYVINYLCHLORIDE}},
Keywords-Plus = {{EXPOSURE; DEHP; DI(2-ETHYLHEXYL)-PHTHALATE; HEALTH; RISK}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Cited-References = {{ALBRO PW, 1986, REV BIOCHEM TOXICOL, V8, P73.
   ASTILL BD, 1989, DRUG METAB REV, V21, P35, DOI 10.3109/03602538909029954.
   Burg R V, 1988, J Appl Toxicol, V8, P75, DOI 10.1002/jat.2550080113.
   CONWAY JG, 1989, DRUG METAB REV, V21, P65, DOI 10.3109/03602538909029956.
   DEGROOT JLB, 1987, TNO18287 RAPP.
   DIEM K, 1976, WISSENSCHAFTLICHE TA, P546.
   ELSISI AE, 1989, FUND APPL TOXICOL, V12, P70, DOI 10.1016/0272-0590(89)90063-8.
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381.
   NIELSEN J, 1985, AM IND HYG ASSOC J, V46, P643, DOI 10.1202/0002-8894(1985)046<0643:PEEALA>2.3.CO;2.
   RAO MS, 1987, CARCINOGENESIS, V8, P631.
   RODRICKS JV, 1989, TOXICOL IND HLTH, V3, P197.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SCHULZ CO, 1989, DRUG METAB REV, V21, P111, DOI 10.3109/03602538909029958.
   STOTT WT, 1988, REGUL TOXICOL PHARM, V8, P125, DOI 10.1016/0273-2300(88)90026-8.
   THIESS AM, 1978, ZBL ARBEITSMED, V12, P351.
   TURNBULL D, 1985, J AM COLL TOXICOL, V4, P111.
   VAINIOTALO S, 1990, ANN OCCUP HYG, V34, P585, DOI 10.1093/annhyg/34.6.585.
   1987, IARC MONOGRAPHS EV S, V7.
   1977, NIOSH MANUAL ANAL ME, V3.
   1991, OCCUPATIONAL SAFETY, V37.
   1986, AM C GOVT IND HYGIEN, P223.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{51}},
Journal-ISO = {{Int. Arch. Occup. Environ. Health}},
Doc-Delivery-Number = {{LC697}},
Wos-Id = {{ISI:A1993LC69700003}},
}

@article{ ISI:A1993LC69700004,
Author = {DIRVEN, HAAM and VANDENBROEK, PHH and JONGENEELEN, FJ},
Title = {{DETERMINATION OF 4 METABOLITES OF THE PLASTICIZER
   DI(2-ETHYLHEXYL)PHTHALATE IN HUMAN URINE SAMPLES}},
Journal = {{INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH}},
Year = {{1993}},
Volume = {{64}},
Number = {{8}},
Pages = {{555-560}},
Month = {{MAY}},
Abstract = {{A method for biological monitoring of exposure to the plasticizer
   di(2-ethylhexyl)phthalate (DEHP) is described. In this method the four
   main metabolites of DEHP {[}i.e., mono(2-ethylhexyl)phthalate (MEHP),
   mono(5-carboxy-2-ethylpentyl)phthalate,
   mono(2-ethyl-5-oxohexyl)phthalate, and
   mono(2-ethyl-5-hydroxyhexyl)phthalate] are determined in urine samples.
   The procedure includes enzymatic hydrolysis, ether extraction, and
   derivatization with triethyloxonium tetrafluoroborate. Analysis is
   performed by gas chromatography-electron impact mass spectrometry. The
   detection limit for all four metabolites is less than 25 mug/l urine.
   The coefficient of variation based on duplicate determinations of urine
   samples of workers occupationally exposed to DEHP was 16\% for MEHP
   (mean concentration 0.157 mg/l) and 6\%-9\% for the other three
   metabolites (mean concentrations 0.130-0.175 mg/l). The method described
   here was used to study DEHP metabolism in man. Most persons excrete
   mono(2-ethyl-5-oxohexyl)phthalate and
   mono(2-ethyl-5-hydroxyhexyl)phthalate as a (glucuronide) conjugate.
   Mono(5-carboxy-2-ethylpentyl)phthalate is mainly excreted in free form,
   while for MEHP a large interindividual variation in conjugation status
   was observed. Of the four metabolites quantified, 52\% are products of a
   (omega-1)-hydroxylation reaction of MEHP {[}i.e.,
   mono(2-ethyl-5-oxohexyl)phthalate and
   mono(2-ethyl-5-hydroxyhexyl)phthalate], 22\% is the product of a
   omega-hydroxylation reaction of MEHP {[}i.e.,
   mono(5-carboxy-2-ethylpentyl)phthalate], and 26\% is not oxidized
   further (i.e., MEHP). A good correlation is obtained when the amount of
   MEHP (omega-hydroxylation products is compared with the amount of MEHP
   (omega-1)hydroxylation products in urine samples. When the internal dose
   of DEHP has to be established we recommend that the levels of all four
   metabolites of DEHP be studied in urine samples.}},
Publisher = {{SPRINGER VERLAG}},
Address = {{175 FIFTH AVE, NEW YORK, NY 10010}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{DIRVEN, HAAM (Reprint Author), CATHOLIC UNIV NIJMEGEN,DEPT TOXICOL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.}},
DOI = {{10.1007/BF00517700}},
ISSN = {{0340-0131}},
Keywords = {{DI(2-ETHYLHEXYL)PHTHALATE; URINE SAMPLING}},
Keywords-Plus = {{MONO-(2-ETHYLHEXYL) PHTHALATE; PEROXISOME PROLIFERATION;
   SPECIES-DIFFERENCES; POSSIBLE MECHANISMS; EXPOSURE; DEHP; PLASMA; MEHP}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Cited-References = {{ALBRO PW, 1984, DRUG METAB DISPOS, V12, P742.
   ALBRO PW, 1986, REV BIOCHEM TOXICOL, V8, P73.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   BARRY YA, 1989, J THORAC CARDIOV SUR, V97, P900.
   CONWAY JG, 1989, DRUG METAB REV, V21, P65, DOI 10.3109/03602538909029956.
   DIRVEN HAAM, 1992, BIOCHEM PHARMACOL, V43, P2621, DOI 10.1016/0006-2952(92)90151-8.
   DIRVEN HAAM, 1991, MUTAT RES, V260, P121, DOI 10.1016/0165-1218(91)90088-4.
   ELCOMBE CR, 1986, ENVIRON HEALTH PERSP, V70, P211, DOI 10.2307/3430357.
   FLAMINIO LM, 1988, INT J ARTIF ORGANS, V11, P428.
   LHUGUENOT JC, 1985, TOXICOL APPL PHARM, V80, P11, DOI 10.1016/0041-008X(85)90096-1.
   LISS GM, 1985, SCAND J WORK ENV HEA, V11, P381.
   NASSBERGER L, 1987, NEPHRON, V45, P286, DOI 10.1159/000184165.
   NIELSEN J, 1985, AM IND HYG ASSOC J, V46, P643, DOI 10.1202/0002-8894(1985)046<0643:PEEALA>2.3.CO;2.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   SHARMA R, 1988, BIOCHEM PHARMACOL, V37, P1193, DOI 10.1016/0006-2952(88)90770-8.
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x.
   TURNBULL D, 1985, J AM COLL TOXICOL, V4, P111.
   1987, IARC MONOGRAPHS EV S, V7.
   1982, NTP NIH821773 NAT TO.}},
Number-of-Cited-References = {{20}},
Times-Cited = {{50}},
Journal-ISO = {{Int. Arch. Occup. Environ. Health}},
Doc-Delivery-Number = {{LC697}},
Wos-Id = {{ISI:A1993LC69700004}},
}

@article{ ISI:A1993KX68200001,
Author = {MALIK, S and KENNY, M and AHMAD, S},
Title = {{A CONVENIENT METHOD TO MEASURE DI-2-ETHYLHEXYL PHTHALATE FROM THE SERUM
   OF HEMODIALYSIS-PATIENTS}},
Journal = {{TOXICOLOGICAL AND ENVIRONMENTAL CHEMISTRY}},
Year = {{1993}},
Volume = {{37}},
Number = {{3-4}},
Pages = {{133-137}},
Abstract = {{A simple and rapid method is developed to extract and quantify
   Di-2-ethylhexyl phthalate (DEHP) from the serum of hemodialysis
   patients. DEHP was measured in serum, before and after hemodialysis by
   high-performance liquid chromatography.}},
Publisher = {{GORDON BREACH SCI PUBL LTD}},
Address = {{C/O STBS LTD PO BOX 90, READING, BERKS, ENGLAND RG1 8JL}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{MALIK, S (Reprint Author), UNIV WASHINGTON,DEPT LAB MED,SB-10,SEATTLE,WA 98195, USA.
   UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195.}},
DOI = {{10.1080/02772249309357862}},
ISSN = {{0277-2248}},
Keywords = {{DI-2-ETHYLHEXYL PHTHALATE; CARCINOGEN; PLASTICIZER; QUANTIFICATION;
   HEMODIALYSIS; SERUM}},
Keywords-Plus = {{PLASTICIZERS; DI(2-ETHYLHEXYL); DEHP; RATS}},
Research-Areas = {{Environmental Sciences \& Ecology; Toxicology}},
Web-of-Science-Categories  = {{Environmental Sciences; Toxicology}},
Cited-References = {{CHRISTENSSON A, 1991, INT J ARTIF ORGANS, V14, P407.
   DINE T, 1991, BIOMED CHROMATOGR, V5, P94, DOI 10.1002/bmc.1130050211.
   GIAM CS, 1978, SCIENCE, V199, P419, DOI 10.1126/science.199.4327.419-a.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   JAEGER RJ, 1970, LANCET, V2, P151.
   KEVY SV, 1981, T AM SOC ART INT ORG, V27, P386.
   KLUWE WM, 1982, J TOXICOL ENV HEALTH, V10, P797.
   LEWIS LM, 1977, T AM SOC ART INT ORG, V23, P566.
   MARINOVICH M, 1988, INT J ARTIF ORGANS, V11, P428.
   MOODY DE, 1978, TOXICOL APPL PHARM, V45, P497, DOI 10.1016/0041-008X(78)90111-4.
   NAESSBERGER L, 1987, NEPHRON, V45, P286.
   PEAKALL D B, 1975, Residue Reviews, V54, P1.
   REDDY JK, 1983, CRC CR REV TOXICOL, V12, P1, DOI 10.3109/10408448309029317.
   REDDY JK, 1976, LIFE SCI, V18, P941, DOI 10.1016/0024-3205(76)90412-4.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   SJOBERG P, 1985, EUR J CLIN INVEST, V15, P430, DOI 10.1111/j.1365-2362.1985.tb00297.x.
   1982, IARC MONOGRAPHS EVAL, V29, P269.
   1982, TECHNICAL REPORT SER, V217.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{2}},
Doc-Delivery-Number = {{KX682}},
Wos-Id = {{ISI:A1993KX68200001}},
}

@article{ ISI:A1991FK36700016,
Author = {DIRVEN, HAAM and THEUWS, JLG and JONGENEELEN, FJ and BOS, RP},
Title = {{NON-MUTAGENICITY OF 4 METABOLITES OF DI(2-ETHYLHEXYL)PHTHALATE (DEHP)
   AND 3 STRUCTURALLY RELATED DERIVATIVES OF DI(2-ETHYLHEXYL)ADIPATE (DEHA)
   IN THE SALMONELLA MUTAGENICITY ASSAY}},
Journal = {{MUTATION RESEARCH}},
Year = {{1991}},
Volume = {{260}},
Number = {{1}},
Pages = {{121-130}},
Month = {{MAY}},
Abstract = {{Four metabolites of the rat liver carcinogen di(2-ethylhexyl)phthalate
   (DEHP) (mono-(2-ethylhexyl)-phthalate,
   mono-(2-ethyl-5-hydroxyhexyl)phthalate,
   mono-(2-ethyl-5-oxohexyl)phthalate, and
   mono-(5-carboxy-2-ethylpentyl)phthalate) and 3 structurally related
   derivatives of di(2-ethylhexyl)adipate (DEHA)
   (mono-(2-ethylhexyl)adipate, mono-(2-ethyl-5-hydroxyhexyl)adipate, and
   mono-(2-ethyl-5-oxohexyl)-adipate) were tested for mutagenicity in the
   Ames assay using Salmonella typhimurium strains TA97, TA98, TA100, and
   TA102, with and without a metabolic activation preparation.  Aroclor
   1254-induced rat liver S9 and DEHP-induced rat liver S9 were used. 
   Concentrations of these compounds up to 1000-mu-g/plate were negative
   with all tester strains in the presence or absence of metabolic
   activation.}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{DIRVEN, HAAM (Reprint Author), CATHOLIC UNIV NIJMEGEN,DEPT TOXICOL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.}},
DOI = {{10.1016/0165-1218(91)90088-4}},
ISSN = {{0921-8262}},
Keywords = {{DI(2-ETHYLHEXYL)PHTHALATE; DI(2-ETHYLHEXYL)ADIPATE; METABOLITES;
   MUTAGENICITY TESTING}},
Keywords-Plus = {{PHTHALATE DEHP; RATS; HEPATOCARCINOGENESIS; TYPHIMURIUM; INVITRO;
   ESTERS; INVIVO; URINE; MEHP}},
Research-Areas = {{Genetics \& Heredity; Toxicology}},
Web-of-Science-Categories  = {{Genetics \& Heredity; Toxicology}},
Cited-References = {{AGARWAL DK, 1985, J TOXICOL ENV HEALTH, V16, P61.
   ALBRO PW, 1981, DRUG METAB DISPOS, V9, P223.
   CONWAY JG, 1989, DRUG METAB REV, V21, P65, DOI 10.3109/03602538909029956.
   CORNU MC, 1988, ARCH TOXICOL S, V12, P265.
   DIVINCENZO GD, 1985, TOXICOLOGY, V34, P247, DOI 10.1016/0300-483X(85)90175-1.
   HAWKINS JM, 1987, DRUG METAB REV, V18, P441, DOI 10.3109/03602538708994130.
   KIRBY PE, 1983, ENV MUTAGEN, V5, P567.
   KLUWE WM, 1982, J TOXICOL ENV HEALTH, V10, P797.
   KOZUMBO WJ, 1982, ENVIRON HEALTH PERSP, V45, P103, DOI 10.2307/3429391.
   LEVIN DE, 1984, METHOD ENZYMOL, V105, P249.
   LHUGUENOT JC, 1985, TOXICOL APPL PHARM, V80, P11, DOI 10.1016/0041-008X(85)90096-1.
   MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9.
   RAO MS, 1987, CARCINOGENESIS, V8, P631.
   RUDDICK JA, 1981, B ENVIRON CONTAM TOX, V27, P181.
   SCHMEZER P, 1988, CARCINOGENESIS, V9, P37, DOI 10.1093/carcin/9.1.37.
   SCHMID P, 1985, XENOBIOTICA, V15, P251.
   Simmon V. F., 1977, PROGR GENETIC TOXICO, P249.
   SJOBERG P, 1986, ACTA PHARMACOL TOX, V58, P225.
   SMITHOLIVER T, 1987, MUTAT RES, V188, P21, DOI 10.1016/0165-1218(87)90110-8.
   TAKAHASHI T, 1981, TOXICOLOGY, V22, P223, DOI 10.1016/0300-483X(81)90085-8.
   TOMITA I, 1982, ENVIRON HEALTH PERSP, V45, P119, DOI 10.2307/3429394.
   YAGI Y, 1976, TERATOLOGY, V14, P259.
   YOSHIKAWA K, 1983, FOOD CHEM TOXICOL, V21, P221, DOI 10.1016/0278-6915(83)90239-9.
   ZEIGER E, 1985, ENVIRON MUTAGEN, V7, P213, DOI 10.1002/em.2860070209.
   ZEIGER E, 1982, ENVIRON HEALTH PERSP, V45, P99, DOI 10.2307/3429390.
   1982, TECHNICAL REPORT SER, V212.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{7}},
Doc-Delivery-Number = {{FK367}},
Wos-Id = {{ISI:A1991FK36700016}},
}

@article{ ISI:A1991FG20700010,
Author = {DINE, T and LUYCKX, M and CAZIN, M and BRUNET, C and CAZIN, JC and
   GOUDALIEZ, F},
Title = {{RAPID-DETERMINATION BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY OF
   DI-2-ETHYLHEXYL PHTHALATE IN PLASMA STORED IN PLASTIC BAGS}},
Journal = {{BIOMEDICAL CHROMATOGRAPHY}},
Year = {{1991}},
Volume = {{5}},
Number = {{2}},
Pages = {{94-97}},
Month = {{MAR}},
Abstract = {{A rapid sensitive technique was developed for the analysis of
   di-2-ethylhexyl phthalate (DEHP) in plasma stored in plastic bags by
   using high performance liquid chromatography (HPLC) with UV detection
   and a Hypersil ODS column.  The compound was easily and efficiently
   extracted with a mixture of sodium hydroxide and acetonitrile, which
   allowed the deproteinization of plasma samples.  The recovery was
   greater than 95\% and the intra- and inter-assay coefficients of
   variation were better than 6.5\%.  The results obtained showed that the
   amount of DEHP accumulated in plasma varied according to different
   parameters and depended on the storage conditions (time, temperature and
   shaking) and also on the lipid content of the stored plasma and the
   sterilization process of the PVC bags.}},
Publisher = {{JOHN WILEY \& SONS LTD}},
Address = {{BAFFINS LANE CHICHESTER, W SUSSEX, ENGLAND PO19 1UD}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{DINE, T (Reprint Author), FAC PHARM LILLE,PHARMACOL PHARMACOCINET \& PHARM CLIN,3 RUE PROFESSEUR LAGUESSE,F-59045 LILLE,FRANCE.
   MACO PHARMA,PHARMACEUT LABS,F-59338 TOURCOING,FRANCE.}},
DOI = {{10.1002/bmc.1130050211}},
ISSN = {{0269-3879}},
Keywords-Plus = {{MONO-(2-ETHYLHEXYL) PHTHALATE; DI-(2-ETHYLHEXYL) PHTHALATE; BLOOD}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry; Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Biochemistry \& Molecular Biology;
   Chemistry, Analytical; Pharmacology \& Pharmacy}},
Cited-References = {{ALBRO PW, 1978, TRANSFUSION, V18, P750, DOI 10.1046/j.1537-2995.1978.18679077962.x.
   ARBIN A, 1980, J CHROMATOGR, V193, P405, DOI 10.1016/S0021-9673(00)87740-7.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   FRIOCOURT MP, 1979, REV FRANCAISE TRANSF, V4, P343.
   GANGOLLI SD, 1975, TOXICOL APPL PHARM, V32, P355.
   GERLAI I, 1987, CHROMATOGRAPHIA, V24, P403, DOI 10.1007/BF02688515.
   Jaminet F, 1974, J Pharm Belg, V29, P393.
   LOVRIC VA, 1985, VOX SANG, V49, P181.
   OTSUKI A, 1977, J CHROMATOGR, V133, P402, DOI 10.1016/S0021-9673(00)83505-0.
   POLLACK GM, 1984, J CHROMATOGR, V311, P101, DOI 10.1016/S0378-4347(00)84695-2.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   SHINTANI H, 1985, J CHROMATOGR, V337, P279, DOI 10.1016/0378-4347(85)80041-4.
   SJOBERG POJ, 1985, TRANSFUSION, V25, P424, DOI 10.1046/j.1537-2995.1985.25586020115.x.
   TEIRLYNCK OA, 1985, J CHROMATOGR, V193, P405.
   Valeri C R, 1973, Environ Health Perspect, V3, P103, DOI 10.2307/3428036.
   VESSMAN J, 1974, J CHROMATOGR, V133, P402.}},
Number-of-Cited-References = {{16}},
Times-Cited = {{27}},
Journal-ISO = {{Biomed. Chromatogr.}},
Doc-Delivery-Number = {{FG207}},
Wos-Id = {{ISI:A1991FG20700010}},
}

@article{ ISI:A1991FW60500013,
Author = {TZAN, YL and LIN, SY and WENG, CN and LEE, CJ},
Title = {{PREPARATION OF ENTERIC COATED MICROSPHERES OF MYCOPLASMA-HYOPNEUMONIAE
   VACCINE WITH CELLULOSE-ACETATE PHTHALATE - THE EFFECT OF SWINE SERUM ON
   MICROMERITIC PROPERTIES}},
Journal = {{BIOTECHNOLOGY TECHNIQUES}},
Year = {{1991}},
Volume = {{5}},
Number = {{2}},
Pages = {{139-144}},
Month = {{MAR-APR}},
Abstract = {{Cellulose acetate phthalate was used to prepare the Mycoplasma
   hyopneumoniae vaccine (MHV) microspheres using a solvent evaporation
   method.  Swine serum was used as an additive in the antigen to form the
   core materials.  The addition of serum had a significant effect on
   surface topography of the MHV microspheres.  By using this modified
   solvent evaporation method, the recoveries of antigens in the MHV
   microspheres were generally over 90\% of the weight and antigenicity of
   antigens originally added in the formulation.}},
Publisher = {{CHAPMAN HALL LTD}},
Address = {{2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{NATL TSING HUA UNIV,DEPT CHEM ENGN,HSINCHU 300,TAIWAN.
   VET GEN HOSP,DEPT MED RES,TAIPEI,TAIWAN.
   PIG RES INST,DEPT PATHOL,CHU NAN,TAIWAN.}},
DOI = {{10.1007/BF00159986}},
ISSN = {{0951-208X}},
Keywords-Plus = {{ALBUMIN MICROSPHERES; AGENTS}},
Research-Areas = {{Biochemistry \& Molecular Biology; Biotechnology \& Applied Microbiology}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Biotechnology \& Applied Microbiology}},
Cited-References = {{BEYGER JW, 1986, J PHARM SCI, V75, P573, DOI 10.1002/jps.2600750610.
   BURGER JJ, 1985, INT J PHARM, V23, P333, DOI 10.1016/0378-5173(85)90160-7.
   CREMERS HFM, 1990, J CONTROL RELEASE, V11, P167, DOI 10.1016/0168-3659(90)90130-L.
   FRIIS NF, 1979, ACTA VET SCAND, V20, P607.
   GRAHAM DE, 1976, THEORY PRACTICE EMUL, P75.
   LEE TK, 1981, SCIENCE, V213, P223.
   LONGO WE, 1982, J PHARM SCI, V71, P1323, DOI 10.1002/jps.2600711205.
   MAHARAJ I, 1984, J PHARM SCI, V73, P39, DOI 10.1002/jps.2600730110.
   NOZAWA Y, 1976, J APPL POLYM SCI, V20, P3197, DOI 10.1002/app.1976.070201122.
   ROSS RF, 1984, AM J VET RES, V45, P1899.
   TORRADO JJ, 1989, INT J PHARM, V51, P85, DOI 10.1016/0378-5173(89)90079-3.
   TZAN Y L, 1989, Journal of the Chinese Society of Veterinary Science, V15, P193.
   TZAN Y L, 1989, Journal of the Chinese Society of Veterinary Science, V15, P199.}},
Number-of-Cited-References = {{13}},
Times-Cited = {{3}},
Journal-ISO = {{Biotechnol. Tech.}},
Doc-Delivery-Number = {{FW605}},
Wos-Id = {{ISI:A1991FW60500013}},
}

@article{ ISI:A1990ET81700015,
Author = {DIRVEN, HAAM and VANDENBROEK, PHH and JONGENEELEN, FJ},
Title = {{EFFECT OF DI(2-ETHYLHEXYL)PHTHALATE ON ENZYME-ACTIVITY LEVELS IN LIVER
   AND SERUM OF RATS}},
Journal = {{TOXICOLOGY}},
Year = {{1990}},
Volume = {{65}},
Number = {{1-2}},
Pages = {{199-207}},
Month = {{DEC 17}},
Abstract = {{In order to identify non-invasive, biochemical indicators of
   di(2-ethylhexyl)phthalate (DEHP) exposure, we have compared the effects
   in blood serum with biochemical effects in liver in rats fed a diet
   containing 0, 0.25, 0.75 and 2\% DEHP for 2 weeks.  After 3 days of
   treatment serum arylesterase activity levels and serum triglycerides
   were decreased to 60\% and 20\% of control values, respectively.  After
   a 2-week treatment with DEHP the effects were generally stronger. 
   Compared to a control group, serum arylesterase activity levels, serum
   triglycerides and serum cholesterol were decreased to 40\%, 20\% and
   50\%, respectively.  Serum cholinesterase activity levels and serum
   albumin concentrations were increased by the DEHP treatment to 290\% and
   135\% of control values, respectively.
   In the livers a hepatomegaly, an induction of cytochrome P-450 IVA1 and
   induction of the activity of palmitoyl-CoA oxidase and carnitine
   acetyl-CoA transferase was found to be 180\%, 1080\%, 1300\% and 1700\%
   of control values, respectively.  The liver is a more sensitive target
   for DEHP exposure compared to the biochemical effects in serum, but
   determination of the serum parameters can be used to determine early
   biological effects of exposure to DEHP.}},
Publisher = {{ELSEVIER SCI IRELAND LTD}},
Address = {{CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{DIRVEN, HAAM (Reprint Author), CATHOLIC UNIV NIJMEGEN,DEPT TOXICOL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.}},
DOI = {{10.1016/0300-483X(90)90089-Y}},
ISSN = {{0300-483X}},
Keywords = {{DI(2-ETHYLHEXYL)PHTHALATE (C.A.S. 117-81-7); SERUM CHOLINESTERASE; SERUM
   ARYLESTERASE; SERUM TRIGLYCERIDES; SERUM CHOLESTEROL; PEROXISOME
   PROLIFERATION}},
Keywords-Plus = {{ACYL-COA OXIDASE; PEROXISOME PROLIFERATORS; HYPOLIPIDEMIC AGENTS; MICE;
   ARYLESTERASE; CLOFIBRATE; INDUCTION; PHTHALATE; TISSUES; ACID}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Cited-References = {{ASHOUR MBA, 1987, TOXICOL APPL PHARM, V89, P361, DOI 10.1016/0041-008X(87)90155-4.
   BUTLER EG, 1988, RES COMMUN CHEM PATH, V60, P125.
   BUTLER EG, 1985, DRUG METAB DISPOS, V13, P640.
   GRAY TJB, 1982, TOXICOL LETT, V10, P273, DOI 10.1016/0378-4274(82)90087-X.
   HAWKINS JM, 1987, DRUG METAB REV, V18, P441, DOI 10.3109/03602538708994130.
   KITCHEN BJ, 1973, BIOCHEM J, V135, P93.
   LOWRY OH, 1951, J BIOL CHEM, V193, P265.
   LUNDGREN B, 1987, EUR J BIOCHEM, V163, P423, DOI 10.1111/j.1432-1033.1987.tb10815.x.
   MANN AH, 1985, TOXICOL APPL PHARM, V77, P116, DOI 10.1016/0041-008X(85)90273-X.
   OMURA T, 1964, J BIOL CHEM, V239, P2379.
   REDDY JK, 1976, LIFE SCI, V18, P941, DOI 10.1016/0024-3205(76)90412-4.
   REDDY JK, 1980, NATURE, V283, P397, DOI 10.1038/283397a0.
   REUBSAET FAG, 1988, BIOCHIM BIOPHYS ACTA, V958, P434, DOI 10.1016/0005-2760(88)90229-9.
   RODKEY FL, 1965, CLIN CHEM, V11, P478.
   SHARMA R, 1988, BIOCHEM PHARMACOL, V37, P1193, DOI 10.1016/0006-2952(88)90770-8.
   SIEDEL J, 1983, CLIN CHEM, V29, P1075.
   TOMASZEWSKI KE, 1987, TOXICOL LETT, V37, P203, DOI 10.1016/0378-4274(87)90133-0.
   WAHLEFELD AW, 1974, METHOD ENZYMAT AN, P1831.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{16}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{ET817}},
Wos-Id = {{ISI:A1990ET81700015}},
}

@article{ ISI:A1990EN44600010,
Author = {HAGIWARA, A and TAMANO, S and OGISO, T and ASAKAWA, E and FUKUSHIMA, S},
Title = {{PROMOTING EFFECT OF THE PEROXISOME PROLIFERATOR, CLOFIBRATE, BUT NOT
   DI(2-ETHYLHEXYL)PHTHALATE, ON URINARY-BLADDER CARCINOGENESIS IN F344
   RATS INITIATED BY N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE}},
Journal = {{JAPANESE JOURNAL OF CANCER RESEARCH}},
Year = {{1990}},
Volume = {{81}},
Number = {{12}},
Pages = {{1232-1238}},
Month = {{DEC}},
Abstract = {{The modifying potential of clofibrate and di(2-ethylhexyl)phthalate
   (DEHP) on second stage, N-butyl-N-(4-hydroxybutyl)nitrosamine
   (BBN)-initiated urinary bladder carcinogenesis was investigated in male
   F344 rats, using a uracil-accelerated transitional cell proliferation
   model.  Six-week-old animals received 0.05\% BBN in their drinking water
   for 4 weeks and then clofibrate (1.0, 0.5, and 0.25\%) and DEHP (1.2,
   0.6, and 0.3\%) were given during experimental weeks 5-8 and weeks
   12-20.  Uracil was administered during weeks 9-11 at a dietary level of
   3.0\%.  Control rats were treated with BBN and uracil without peroxisome
   proliferator.  Surviving animals were killed at the end of week 20 of
   the experiment, when the densities of putative preneoplastic, papillary
   or nodular (PN) hyperplasias (numbers per 10 cm of basement membrane)
   were significantly increased in all clofibrate-treated, but not the DEHP
   groups.  The incidences of PN hyperplasia were similar in both treated
   animals and controls.  In a second experiment, rats fed diets containing
   1.0\% clofibrate or 1.2\% DEHP were assessed for levels of DNA synthesis
   in urinary bladder epithelium by 5-bromo-2'-deoxyuridine
   immunohistochemistry.  Numbers of labeled nuclei remained within normal
   levels, and no proliferative changes were evident.  Thus, the present
   experiments indicated that while clofibrate, but not DEHP, exerts weak
   enhancing effects on BBN-initiated urinary bladder carcinogenesis in
   rats this is not associated with increased levels of DNA synthesis in
   the affected epithelium.}},
Publisher = {{JAPANESE CANCER ASSOCIATION}},
Address = {{EDITORIAL OFFICE 7TH FLOOR, JOHKOH BLDG 2-23-11, KOISHIKAWA, TOKYO 112,
   JAPAN}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{HAGIWARA, A (Reprint Author), NAGOYA CITY UNIV,SCH MED,DEPT PATHOL 1,1 KAWASUMI,MIZUHO CHO,MIZUHO KU,NAGOYA,AICHI 467,JAPAN.}},
ISSN = {{0910-5050}},
Keywords = {{PROMOTING EFFECT; PEROXISOME PROLIFERATOR; CLOFIBRATE;
   DI(2-ETHYLHEXYL)PHTHALATE; URINARY BLADDER CARCINOGENESIS}},
Keywords-Plus = {{URACIL-INDUCED UROLITHIASIS; DNA-SYNTHESIS; HEPATIC TUMORIGENESIS; LIVER
   CARCINOGENESIS; HEPATOCARCINOGENICITY; DIETHYLNITROSAMINE; PHTHALATE;
   WY-14,643; 2-STAGE; AGENTS}},
Research-Areas = {{Oncology}},
Web-of-Science-Categories  = {{Oncology}},
Cited-References = {{CATTLEY RC, 1987, CANCER LETT, V38, P15, DOI 10.1016/0304-3835(87)90195-9.
   CONWAY JG, 1989, CARCINOGENESIS, V10, P513, DOI 10.1093/carcin/10.3.513.
   DIWAN BA, 1985, CARCINOGENESIS, V6, P343, DOI 10.1093/carcin/6.3.343.
   FAHL WE, 1984, P NATL ACAD SCI-BIOL, V81, P7827, DOI 10.1073/pnas.81.24.7827.
   FUKUSHIMA S, 1980, CANCER RES, V40, P734.
   FUKUSHIMA S, 1982, ACTA PATHOL JAPON, V32, P243.
   FUKUSHIMA S, 1989, EXP PATHOL, V36, P1.
   FUKUSHIMA S, 1988, 47TH P JPN CANC ASS, P90.
   FUKUSHIMA S, 1983, FOOD CHEM TOXICOL, V21, P59, DOI 10.1016/0278-6915(83)90269-7.
   HAGIWARA A, 1989, FUND APPL TOXICOL, V13, P332, DOI 10.1016/0272-0590(89)90269-8.
   KASAI H, 1989, CANCER RES, V49, P2603.
   KURATA Y, 1986, CANCER LETT, V32, P125, DOI 10.1016/0304-3835(86)90110-2.
   KUROKAWA Y, 1988, CANCER LETT, V43, P145, DOI 10.1016/0304-3835(88)90227-3.
   MARSMAN DS, 1988, CANCER RES, V48, P6739.
   MASUI T, 1988, CARCINOGENESIS, V9, P1981, DOI 10.1093/carcin/9.11.1981.
   MOCHIZUKI Y, 1982, CARCINOGENESIS, V3, P1027, DOI 10.1093/carcin/3.9.1027.
   MOCHIZUKI Y, 1983, CANCER LETT, V19, P99, DOI 10.1016/0304-3835(83)90142-8.
   NUMOTO S, 1984, CARCINOGENESIS, V5, P1603, DOI 10.1093/carcin/5.12.1603.
   POPP JA, 1985, CARCINOGENESIS, V6, P141, DOI 10.1093/carcin/6.1.141.
   RAO MS, 1987, CARCINOGENESIS, V8, P631.
   REDDY JK, 1983, CRC CR REV TOXICOL, V12, P1, DOI 10.3109/10408448309029317.
   SAKATA T, 1988, CARCINOGENESIS, V9, P1271, DOI 10.1093/carcin/9.7.1271.
   SHIBATA MA, 1989, TOXICOL APPL PHARM, V99, P37, DOI 10.1016/0041-008X(89)90109-9.
   SHIRAI T, 1986, CANCER RES, V46, P2062.
   SHIRAI T, 1989, CANCER RES, V49, P373.
   SHIRAI T, 1987, CANCER RES, V47, P6726.
   WARD JM, 1983, CARCINOGENESIS, V4, P1021, DOI 10.1093/carcin/4.8.1021.
   WARD JM, 1986, ENVIRON HEALTH PERSP, V65, P279, DOI 10.2307/3430195.
   WARD JM, 1988, TOXICOL APPL PHARM, V96, P494, DOI 10.1016/0041-008X(88)90009-9.
   WILLIAMS GM, 1987, CARCINOGENESIS, V8, P875, DOI 10.1093/carcin/8.7.875.
   1987, IARC MONOGR, V1, P171.}},
Number-of-Cited-References = {{31}},
Times-Cited = {{10}},
Journal-ISO = {{Jpn. J. Cancer Res.}},
Doc-Delivery-Number = {{EN446}},
Wos-Id = {{ISI:A1990EN44600010}},
}

@article{ ISI:A1989U577900005,
Author = {SHIMIZU, T and KOUKETSU, K and MORISHIMA, Y and GOTO, S and HASEGAWA, I
   and KAMIYA, T and TAMURA, Y and KORA, S},
Title = {{A NEW POLYVINYLCHLORIDE BLOOD BAG PLASTICIZED WITH LESS-LEACHABLE
   PHTHALATE ESTER ANALOG, DI-N-DECYL PHTHALATE, FOR STORAGE OF PLATELETS}},
Journal = {{TRANSFUSION}},
Year = {{1989}},
Volume = {{29}},
Number = {{4}},
Pages = {{292-297}},
Month = {{MAY}},
Publisher = {{AMER ASSOC BLOOD BANKS}},
Address = {{8101 GLENBROOK RD, BETHESDA, MD 20814-2749}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{SHIMIZU, T (Reprint Author), JAPANESE RED CROSS BLOOD TRANSFUS SERV,AICHI CTR,5393 MINAMI,SETO,AICHI 489,JAPAN.
   TERUMO CORP,DIV TECH RES \& DEV,FUJI,SHIZUOKA,JAPAN.}},
DOI = {{10.1046/j.1537-2995.1989.29489242792.x}},
ISSN = {{0041-1132}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{CARMEN RA, 1982, TRANSFUSION, V22, P432.
   COLE RS, 1981, VOX SANG, V40, P317.
   FRATANTONI JC, 1984, THROMB RES, V33, P607, DOI 10.1016/0049-3848(84)90115-4.
   HEATON WAL, 1986, NEW FRONTIERS BLOOD, P89.
   ISHIKAWA Y, 1983, VOX SANG, V45, P68.
   ISHIKAWA Y, 1984, VOX SANG, V47, P330.
   KENNEY DM, 1988, VOX SANG, V54, P24.
   KILKSON H, 1984, BLOOD, V64, P406.
   KIM BK, 1974, TRANSFUSION, V14, P130.
   KOUKETSU K, 1988, CRYOBIOLOGY, V25, P440, DOI 10.1016/0011-2240(88)90051-X.
   KUNICKI TJ, 1975, TRANSFUSION, V15, P414, DOI 10.1046/j.1537-2995.1975.15576082215.x.
   LABOW RS, 1986, TRANSFUSION, V26, P351, DOI 10.1046/j.1537-2995.1986.26486262743.x.
   LAWRENCE WH, 1978, CLIN TOXICOL, V13, P89.
   MURPHY S, 1985, SEMIN HEMATOL, V22, P165.
   ROCK G, 1981, TRANSFUSION, V21, P167, DOI 10.1046/j.1537-2995.1981.21281178152.x.
   ROSE HG, 1965, J LIPID RES, V6, P428.
   SHIMIZU T, 1988, CRYOBIOLOGY, V25, P164, DOI 10.1016/0011-2240(88)90010-7.
   SHIMIZU T, 1988, JPN J PHARMACOL, V46, P147, DOI 10.1254/jjp.46.147.
   STRAUSS RG, 1987, TRANSFUSION, V27, P284, DOI 10.1046/j.1537-2995.1987.27387235642.x.
   Valeri C R, 1973, Environ Health Perspect, V3, P103, DOI 10.2307/3428036.
   WALKER WH, 1984, 18TH C INT SOC BLOOD, P125.}},
Number-of-Cited-References = {{21}},
Times-Cited = {{22}},
Journal-ISO = {{Transfusion}},
Doc-Delivery-Number = {{U5779}},
Wos-Id = {{ISI:A1989U577900005}},
}

@article{ ISI:A1988Q757200015,
Author = {LINDSTROM, P and HARRIS, M and ROSS, M and LAMB, JC and CHAPIN, RE},
Title = {{COMPARISON OF CHANGES IN SERUM ANDROGEN BINDING-PROTEIN WITH GERMINAL
   EPITHELIAL DAMAGE AND INFERTILITY INDUCED BY DI-NORMAL-PENTYL PHTHALATE}},
Journal = {{FUNDAMENTAL AND APPLIED TOXICOLOGY}},
Year = {{1988}},
Volume = {{11}},
Number = {{3}},
Pages = {{528-539}},
Month = {{OCT}},
Publisher = {{ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{LINDSTROM, P (Reprint Author), NIEHS,NATL TOXICOL PROGRAM,DEV \& REPROD TOXICOL GRP,POB 12233,RES TRIANGLE PK,NC 27709, USA.}},
DOI = {{10.1016/0272-0590(88)90117-0}},
ISSN = {{0272-0590}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Cited-References = {{ARMITAGE P, 1971, STAT METHODS MED RES, P362.
   AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   BARDIN CW, 1986, REPRODUCTIVE ENDOCRI, P177.
   Chapin R E, 1984, Toxicol Pathol, V12, P221.
   CHAPIN RE, 1985, FUND APPL TOXICOL, V5, P182, DOI 10.1016/0272-0590(85)90063-6.
   CREASY DM, 1987, EXP MOL PATHOL, V46, P357, DOI 10.1016/0014-4800(87)90056-6.
   CREASY DM, 1983, J PATHOL, V139, P309, DOI 10.1002/path.1711390307.
   DELIC JI, 1986, BRIT J CANCER, V53, P105.
   FISHER RB, 1969, BRIEF INTRO QUANTITA, P77.
   FOSTER PMD, 1987, TOXICOLOGIST, V7, P142.
   FOSTER PMD, 1982, ADV EXP MED BIOL, V136, P445.
   FOSTER PMD, 1983, TOXICOL LETT, V15, P265, DOI 10.1016/0378-4274(83)90226-6.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   FOSTER PMD, 1983, DRUG METAB DISPOS, V11, P59.
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387.
   Gray T J, 1980, Arch Toxicol Suppl, V4, P452.
   GRAY TJB, 1977, FOOD COSMET TOXICOL, V15, P389, DOI 10.1016/S0015-6264(77)80003-5.
   Gunsalus G. L., 1980, Testicular development, structure and function., P291.
   GUNSALUS GL, 1981, J STEROID BIOCHEM, V15, P99, DOI 10.1016/0022-4731(81)90263-6.
   GUNSALUS GL, 1985, BIOL REPROD, V33, P1057, DOI 10.1095/biolreprod33.5.1057.
   GUNSALUS GL, 1978, SCIENCE, V200, P65, DOI 10.1126/science.635573.
   HADLEY MA, 1987, ENDOCRINOLOGY, V120, P1097.
   HANSSON V, 1975, HDB PHYSIOLOGY     7, V5, P173.
   JANECKI A, 1987, ENDOCRINOLOGY, V120, P291.
   LEBLOND CP, 1952, ANN NY ACAD SCI, V55, P548, DOI 10.1111/j.1749-6632.1952.tb26576.x.
   LOBL TJ, 1979, BIOL REPROD S1, V20, P158.
   LOBL TJ, 1983, BIOL REPROD, V29, P697, DOI 10.1095/biolreprod29.3.697.
   LOBL TJ, 1981, ARCH ANDROLOGY, V7, P133.
   Lobl T. J., 1980, Testicular development, structure and function., P323.
   PARVINEN M, 1980, TESTICULAR DEV STRUC, P424.
   SEARLE S. R., 1971, LINEAR MODELS.
   SHAFFER CB, 1945, J IND HYG TOXICOL, V27, P130.
   SHIRLEY E, 1977, BIOMETRICS, V33, P386, DOI 10.2307/2529789.
   TANANISANTHONY CT, 1984, ENDOCRINOLOGY, V114, P1413.
   THOMAS JA, 1984, CRC CR REV TOXICOL, V13, P283, DOI 10.3109/10408448409023761.
   WILLIAMS DA, 1972, BIOMETRICS, V28, P519, DOI 10.2307/2556164.
   WILLIAMS DA, 1986, BIOMETRICS, V42, P183, DOI 10.2307/2531254.
   1985, SAS USERS GUIDE STAT.}},
Number-of-Cited-References = {{38}},
Times-Cited = {{11}},
Journal-ISO = {{Fundam. Appl. Toxicol.}},
Doc-Delivery-Number = {{Q7572}},
Wos-Id = {{ISI:A1988Q757200015}},
}

@article{ ISI:A1988N537300020,
Author = {GRIFFITHS, WC and CAMARA, PD and SARITELLI, A and GENTILE, J},
Title = {{THE INVITRO SERUM PROTEIN-BINDING CHARACTERISTICS OF BIS-(2-ETHYLHEXYL)
   PHTHALATE AND ITS PRINCIPAL METABOLITE, MONO-(2-ETHYLHEXYL) PHTHALATE}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{1988}},
Volume = {{77}},
Pages = {{151-156}},
Month = {{APR}},
Publisher = {{NATL INST ENVIRON HEALTH SCI}},
Address = {{PO BOX 12233, RES TRIANGLE PK, NC 27709}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{GRIFFITHS, WC (Reprint Author), BROWN UNIV,ROGER WILLIAMS GEN HOSP,DEPT PATHOL \& LAB MED,PROVIDENCE,RI 02908, USA.
   BROWN UNIV,DIV BIOL \& MED,PROVIDENCE,RI 02908.
   BROWN UNIV,MIRIAM HOSP,DIV NUTR \& METAB,PROVIDENCE,RI 02906.
   BROWN UNIV,DIV BIOL \& MED,PROVIDENCE,RI 02906.}},
DOI = {{10.2307/3430640}},
ISSN = {{0091-6765}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V360, P380.
   ALBRO PW, 1978, TRANSFUSION, V18, P750, DOI 10.1046/j.1537-2995.1978.18679077962.x.
   BELL FP, 1984, MEMBRANE FLUIDITY, P543.
   COLE RS, 1981, VOX SANG, V40, P317.
   CONTRERA.TJ, 1974, TRANSFUSION, V14, P34.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   GRIFFITHS WC, 1985, ANN CLIN LAB SCI, V15, P140.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   JAEGER RJ, 1970, LANCET, V2, P151.
   KLUWE WM, 1982, J TOXICOL ENV HEALTH, V10, P797.
   LUNDKATZ S, 1986, BIOCHEMISTRY-US, V25, P1562, DOI 10.1021/bi00355a016.
   LUSTER MI, 1978, CLIN CHEM, V24, P429.
   Marcel Y L, 1973, Environ Health Perspect, V3, P119, DOI 10.2307/3428037.
   MARCEL YL, 1970, LANCET, V1, P35.
   ONO K, 1975, JAMA-J AM MED ASSOC, V234, P948, DOI 10.1001/jama.234.9.948.
   PIKE E, 1981, CLIN PHARMACOKINET, V6, P367.
   POLLACK GM, 1984, J CHROMATOGR, V311, P101, DOI 10.1016/S0378-4347(00)84695-2.
   ROCK G, 1986, ENVIRON HEALTH PERSP, V65, P309, DOI 10.2307/3430198.
   SASAKAWA S, 1978, VOX SANG, V34, P91.
   TERPSTRA AHM, 1981, ANAL BIOCHEM, V111, P149, DOI 10.1016/0003-2697(81)90243-8.
   THOMAS JA, 1984, CRC CR REV TOXICOL, V13, P283, DOI 10.3109/10408448409023761.
   VESSMAN J, 1974, J CHROMATOGR, V100, P153, DOI 10.1016/S0021-9673(00)86049-5.}},
Number-of-Cited-References = {{24}},
Times-Cited = {{8}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{N5373}},
Wos-Id = {{ISI:A1988N537300020}},
}

@article{ ISI:A1988N008500006,
Author = {MYHRE, BA},
Title = {{TOXICOLOGICAL QUANDARY OF THE USE OF BIS (2-DIETHYLHEXYL) PHTHALATE
   (DEHP) AS A PLASTICIZER FOR BLOOD BAGS}},
Journal = {{ANNALS OF CLINICAL AND LABORATORY SCIENCE}},
Year = {{1988}},
Volume = {{18}},
Number = {{2}},
Pages = {{131-140}},
Month = {{MAR-APR}},
Publisher = {{INST CLINICAL SCIENCE INC}},
Address = {{1833 DELANCEY PLACE, PHILADELPHIA, PA 19103}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{MYHRE, BA (Reprint Author), UNIV CALIF LOS ANGELES,LOS ANGELES CTY HARBOR MED CTR,DEPT PATHOL,TORRANCE,CA 90509, USA.}},
ISSN = {{0091-7370}},
Research-Areas = {{Medical Laboratory Technology}},
Web-of-Science-Categories  = {{Medical Laboratory Technology}},
Cited-References = {{ALBRO PW, 1978, TRANSFUSION, V18, P750, DOI 10.1046/j.1537-2995.1978.18679077962.x.
   AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   CARMEN RA, 1982, TRANSFUSION, V22, P432.
   CARTER JE, 1974, DRUG METAB DISPOS, V2, P341.
   CONTRERA.TJ, 1974, TRANSFUSION, V14, P34.
   DEHAAN RL, 1971, NATURE-NEW BIOL, V231, P85.
   ESTEP TN, 1984, BLOOD, V64, P1270.
   Gesler R M, 1973, Environ Health Perspect, V3, P73, DOI 10.2307/3428032.
   GILBO CM, 1975, VOX SANG, V29, P242.
   GUESS WL, 1967, DRUG INTELL, V1, P120.
   HOGGE DE, 1986, TRANSFUSION, V26, P131, DOI 10.1046/j.1537-2995.1986.26286152900.x.
   HOROWITZ B, 1985, VOX SANG, V48, P150.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1973, TRANSFUSION, V13, P107.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   KAKAIYA RM, 1987, JAMA-J AM MED ASSOC, V257, P1176.
   Kendrick DB, 1964, BLOOD PROGRAM WORLD.
   KLUWE WM, 1982, J TOXICOL ENV HEALTH, V10, P797.
   LAKE BG, 1975, TOXICOL APPL PHARM, V32, P355, DOI 10.1016/0041-008X(75)90226-4.
   LAKE BG, 1976, TOXICOLOGY, V6, P341, DOI 10.1016/0300-483X(76)90038-X.
   Marcel Y L, 1973, Environ Health Perspect, V3, P119, DOI 10.2307/3428037.
   MIRIPOL JE, 1977, TRANSFUSION, V17, P71, DOI 10.1046/j.1537-2995.1977.17177128891.x.
   MIYAMOTO M, 1987, VOX SANG, V53, P19.
   MYHRE BA, 1983, TRANSFUSION, V23, P420.
   MYHRE BA, IN PRESS VOX SANG.
   NOWICKI P, 1980, POL J PHARMACOL PHAR, V32, P77.
   PECK CC, 1981, TRANSFUSION, V21, P163, DOI 10.1046/j.1537-2995.1981.21281178151.x.
   QUINN MA, 1986, PATHOLOGY, V18, P331.
   ROCK G, 1986, ENVIRON HEALTH PERSP, V65, P309, DOI 10.2307/3430198.
   ROCK G, 1984, TRANSFUSION, V24, P493, DOI 10.1046/j.1537-2995.1984.24685066808.x.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   RUBIN RJ, 1973, NEW ENGL J MED, V288, P915.
   Rubin R J, 1973, Environ Health Perspect, V3, P53, DOI 10.2307/3428030.
   Schulz C O, 1973, Environ Health Perspect, V3, P123, DOI 10.2307/3428038.
   SNYDER EL, 1983, TRANSFUSION, V23, P49, DOI 10.1046/j.1537-2995.1983.23183147305.x.
   STERN IJ, 1980, HEMOLYSIS STORED BLO.
   TAVARES IA, 1985, J PHARM PHARMACOL, V37, P67.
   THOMAS JA, 1984, CRC CR REV TOXICOL, V13, P283, DOI 10.3109/10408448409023761.
   THOMAS JA, 1980, TOXICOL APPL PHARM, V45, P1.
   TURNER JH, 1974, TRANSFUSION, V14, P560.
   VESSMAN J, 1978, VOX SANG, V35, P75.
   Wallin R F, 1974, Bull Parenter Drug Assoc, V28, P278.
   WALTER CW, 1984, VOX SANG, V47, P318.
   WIERDA D, 1987, TRANSFUSION, V27, P183, DOI 10.1046/j.1537-2995.1987.27287150196.x.
   1978, VOX SAND, V34, P244.}},
Number-of-Cited-References = {{45}},
Times-Cited = {{13}},
Journal-ISO = {{Ann. Clin. Lab. Sci.}},
Doc-Delivery-Number = {{N0085}},
Wos-Id = {{ISI:A1988N008500006}},
}

@article{ ISI:A1986C041200045,
Author = {ROCK, G and LABOW, RS and TOCCHI, M},
Title = {{DISTRIBUTION OF DI(2-ETHYLHEXYL) PHTHALATE AND PRODUCTS IN BLOOD AND
   BLOOD COMPONENTS}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{1986}},
Volume = {{65}},
Pages = {{309-316}},
Month = {{MAR}},
Publisher = {{US DEPT HEALTH HUMAN SERVICES PUBLIC HEALTH SERVICE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SERVICES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{ROCK, G (Reprint Author), CANADIAN RED CROSS,BLOOD TRANSFUS SERV,OTTAWA CTR,85 PLYMOUTH ST,OTTAWA K1S 3E2,ONTARIO,CANADA.
   UNIV OTTAWA,DEPT MED,OTTAWA K1N 6N5,ONTARIO,CANADA.}},
DOI = {{10.2307/3430198}},
ISSN = {{0091-6765}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Cited-References = {{ADAMS GA, 1983, CAN FED BIOL SCI JUN.
   CHU I, 1978, DRUG METAB DISPOS, V6, P146.
   COLE R, 1980, AUG INT SOC HEM INT.
   COLE RS, 1981, VOX SANG, V40, P317.
   COLE RS, 1979, OCT AM ASS BLOOD BAN.
   COLE RS, 1979, 11 INT C BIOCH.
   CONTRERA.TJ, 1974, TRANSFUSION, V14, P34.
   ESTEP TN, 1984, BLOOD, V6, P1270.
   FRATANTONI JC, 1984, THROMB RES, V33, P607, DOI 10.1016/0049-3848(84)90115-4.
   GILBO CM, 1975, VOX SANG, V29, P242.
   GUESS WL, 1967, DRUG INTELL, V1, P120.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1973, TRANSFUSION, V13, P107.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P129, DOI 10.2307/3429396.
   LABOW RS, 1984, 20TH INT SOC BLOOD T.
   LAWRENCE WH, 1978, CLIN TOXICOL, V13, P89.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   MARCEL YL, 1970, LANCET, V1, P35.
   PECK CC, 1979, TRANSFUSION, V19, P137, DOI 10.1046/j.1537-2995.1979.19279160282.x.
   ROCK G, 1984, TRANSFUSION, V24, P493, DOI 10.1046/j.1537-2995.1984.24685066808.x.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   ROCK GA, 1983, CAN MED ASSOC J, V128, P403.
   STERN IJ, 1980, AUG INT SOC HEM INT.
   Valeri C R, 1973, Environ Health Perspect, V3, P103, DOI 10.2307/3428036.
   VESSMAN J, 1978, VOX SANG, V35, P75.}},
Number-of-Cited-References = {{25}},
Times-Cited = {{27}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{C0412}},
Wos-Id = {{ISI:A1986C041200045}},
}

@article{ ISI:A1985AJG7500042,
Author = {DEANGELO, AB and GARRETT, CT and QUERAL, AE and IRWIN, D},
Title = {{PHOSPHORYLATION OF SPECIFIC RAT PLASMA-MEMBRANE PROTEINS DURING
   PROMOTION OF GAMMA-GLUTAMYL-TRANSFERASE TRANSPEPTIDASE-POSITIVE HEPATIC
   FOCI AND INHIBITION BY DI(2-ETHYLHEXYL)PHTHALATE}},
Journal = {{CANCER RESEARCH}},
Year = {{1985}},
Volume = {{45}},
Number = {{6}},
Pages = {{2654-2660}},
Publisher = {{AMER ASSOC CANCER RESEARCH}},
Address = {{PUBLIC LEDGER BLDG, SUITE 816, 150 S. INDEPENDENCE MALL W.,
   PHILADELPHIA, PA 19106}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{GEORGE WASHINGTON UNIV,MED CTR,DEPT PATHOL,WASHINGTON,DC 20037.}},
ISSN = {{0008-5472}},
Research-Areas = {{Oncology}},
Web-of-Science-Categories  = {{Oncology}},
Cited-References = {{APPELLA E, 1982, ADV VIRAL ONCOL, V2, P137.
   ASHENDEL CL, 1983, CANCER RES, V43, P4327.
   ASHENDEL CL, 1983, CANCER RES, V43, P4333.
   BANNASCH P, 1980, BIOCHIM BIOPHYS ACTA, V605, P217, DOI 10.1016/0304-419X(80)90005-0.
   BENCHIMOL S, 1982, EMBO J, V1, P1055.
   BLUMBERG PM, 1980, CRC CR REV TOXICOL, V8, P153, DOI 10.3109/10408448009037493.
   BURNETTE DM, 1971, J MEMBRANE BIOL, V5, P215.
   CASTAGNA M, 1982, J BIOL CHEM, V257, P7847.
   CHIANG TM, 1981, THROMB RES, V21, P611, DOI 10.1016/0049-3848(81)90262-0.
   COFFMAN RL, 1981, J EXP MED, V153, P269, DOI 10.1084/jem.153.2.269.
   COLEMAN R, 1967, BIOCHIM BIOPHYS ACTA, V135, P573, DOI 10.1016/0005-2736(67)90089-2.
   COOPER JA, 1983, CURR TOP MICROBIOL, V107, P125.
   CRAWFORD LV, 1981, P NATL ACAD SCI-BIOL, V78, P41, DOI 10.1073/pnas.78.1.41.
   DEANGELO AB, 1984, CANCER LETT, V23, P323, DOI 10.1016/0304-3835(84)90100-9.
   DEANGELO AB, 1983, CANCER LETT, V20, P199, DOI 10.1016/0304-3835(83)90049-6.
   DEANGELO AB, 1984, P AM ASSOC CANC RES, V25, P141.
   Diamond L, 1980, Adv Cancer Res, V32, P1, DOI 10.1016/S0065-230X(08)60360-7.
   EMMELOT P, 1964, BIOCHIM BIOPHYS ACTA, V90, P126, DOI 10.1016/0304-4165(64)90125-4.
   EMMELOT P, 1980, BIOCHIM BIOPHYS ACTA, V605, P247, DOI 10.1016/0304-419X(80)90006-2.
   ENAT R, 1984, P NATL ACAD SCI-BIOL, V81, P1411, DOI 10.1073/pnas.81.5.1411.
   FARBER E, 1980, BIOCHIM BIOPHYS ACTA, V605, P149, DOI 10.1016/0304-419X(80)90002-5.
   FARBER E, 1982, AM J PATHOL, V108, P270.
   FIALA S, 1980, J NATL CANCER I, V64, P267.
   Fiske CH, 1925, J BIOL CHEM, V66, P375.
   GOLDFARB S, 1973, CANCER RES, V33, P1119.
   GOLDSWORTHY T, 1984, CARCINOGENESIS, V5, P67, DOI 10.1093/carcin/5.1.67.
   HUBSCHER G, 1965, NATURE, V205, P799, DOI 10.1038/205799a0.
   HUNTER T, 1983, PROG NUCLEIC ACID RE, V29, P221, DOI 10.1016/S0079-6603(08)60450-X.
   IRWIN D, 1979, ANAL BIOCHEM, V92, P193, DOI 10.1016/0003-2697(79)90644-4.
   KAWAHARA Y, 1980, BIOCHEM BIOPH RES CO, V97, P309, DOI 10.1016/S0006-291X(80)80169-0.
   KING TE, 1967, METHOD ENZYMOL, V10, P332.
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0.
   LAKS MS, 1980, BIOCHEM BIOPH RES CO, V96, P697, DOI 10.1016/0006-291X(80)91411-4.
   LANFORD RE, 1980, VIROLOGY, V105, P314, DOI 10.1016/0042-6822(80)90033-1.
   LESKO L, 1973, BIOCHIM BIOPHYS ACTA, V311, P173, DOI 10.1016/0005-2736(73)90264-2.
   LOWRY OH, 1951, J BIOL CHEM, V193, P265.
   NAKAJO S, 1981, J BIOCHEM-TOKYO, V90, P23.
   NAKAYA K, 1983, CANCER RES, V43, P3778.
   PERAINO C, 1981, NATL CANCER I MONOGR, V58, P55.
   PERAINO C, 1977, CANCER RES, V37, P3623.
   PITOT HC, 1978, NATURE, V271, P456, DOI 10.1038/271456a0.
   PITOT HC, 1980, BIOCHIM BIOPHYS ACTA, V605, P191, DOI 10.1016/0304-419X(80)90004-9.
   PITOT HC, 1982, CANCER, V49, P1206, DOI 10.1002/1097-0142(19820315)49:6<1206::AID-CNCR2820490623>3.0.CO;2-7.
   RAY TK, 1970, BIOCHIM BIOPHYS ACTA, V196, P1, DOI 10.1016/0005-2736(70)90159-8.
   ROTTER V, 1983, P NATL ACAD SCI-BIOL, V80, P2613, DOI 10.1073/pnas.80.9.2613.
   ROY FV, 1984, MOL CELL BIOL, V4, P232.
   RUBIN RA, 1982, P NATL ACAD SCI-BIOL, V79, P776, DOI 10.1073/pnas.79.3.776.
   SELLS MA, 1979, BRIT J CANCER, V40, P274, DOI 10.1038/bjc.1979.176.
   SHINOZUKA H, 1979, CANCER RES, V39, P2515.
   SHINOZUKA H, 1980, CANCER RES, V40, P3846.
   SHINOZUKA H, 1983, ENVIRON HEALTH PERSP, V50, P163, DOI 10.2307/3429546.
   SHINOZUKA H, 1978, CANCER RES, V38, P1092.
   Snedecor GW, 1980, STAT METHODS, P215.
   STAUBLI W, 1984, CARCINOGENESIS, V5, P41, DOI 10.1093/carcin/5.1.41.
   TAKAI Y, 1981, BIOCHEM BIOPH RES CO, V101, P61, DOI 10.1016/S0006-291X(81)80010-1.
   TROSKO JE, 1981, SHORT TERM TESTS CHE, P421.
   WEBER A, 1983, EUR J BIOCHEM, V130, P447, DOI 10.1111/j.1432-1033.1983.tb07171.x.
   WEINSTEIN IB, 1978, CARCINOGENESIS, V2, P313.
   WEINSTEIN IB, 1983, NATURE, V302, P750, DOI 10.1038/302750a0.
   WILLIAMS GM, 1980, BIOCHIM BIOPHYS ACTA, V605, P167, DOI 10.1016/0304-419X(80)90003-7.
   WU BC, 1979, CANCER RES, V39, P116.
   YOTTI LP, 1979, SCIENCE, V206, P1089, DOI 10.1126/science.493994.
   SIGMA TECHNICAL B, V670, P1.}},
Number-of-Cited-References = {{63}},
Times-Cited = {{11}},
Journal-ISO = {{Cancer Res.}},
Doc-Delivery-Number = {{AJG75}},
Wos-Id = {{ISI:A1985AJG7500042}},
}

@article{ ISI:A1985AHS9900006,
Author = {HINTON, RH and PRICE, SC and MITCHELL, FE and MANN, A and HALL, DE and
   BRIDGES, JW},
Title = {{PLASMA-PROTEIN CHANGES IN RATS TREATED WITH HYPOLIPEMIC DRUGS AND WITH
   PHTHALATE-ESTERS}},
Journal = {{HUMAN TOXICOLOGY}},
Year = {{1985}},
Volume = {{4}},
Number = {{3}},
Pages = {{261-271}},
Publisher = {{STOCKTON PRESS LTD}},
Address = {{BRUNEL RD HOUNDMILLS, BASINGSTOKE,HAMPSHIRE, ENGLAND RG21 2XS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{HINTON, RH (Reprint Author), UNIV SURREY,ROBENS INST IND \& ENVIRONM HLTH \& SAFETY,GUILDFORD GU2 5XH,SURREY,ENGLAND.
   UNIV SURREY,DEPT BIOCHEM,GUILDFORD GU2 5XH,SURREY,ENGLAND.}},
ISSN = {{0144-5952}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Cited-References = {{AXELSEN N, 1973, MANUAL QUANTITATIVE.
   BARNARD SD, 1980, J TOXICOL ENV HEALTH, V6, P547.
   BAUMANN H, 1983, J BIOL CHEM, V258, P563.
   BLANE GF, 1980, NOUV PRESSE MED, V9, P3737.
   BLUMCKE S, 1983, ATHEROSCLEROSIS, V46, P105, DOI 10.1016/0021-9150(83)90169-7.
   COHEN AJ, 1981, FOOD COSMET TOXICOL, V19, P585, DOI 10.1016/0015-6264(81)90509-5.
   GRASSO P, 1977, TOXICOLOGY, V7, P327, DOI 10.1016/0300-483X(77)90051-8.
   GRAY TJB, 1982, TOXICOL LETT, V10, P273, DOI 10.1016/0378-4274(82)90087-X.
   HANEFELD M, 1980, ATHEROSCLEROSIS, V36, P159, DOI 10.1016/0021-9150(80)90225-7.
   HINTON RH, 1980, FEBS LETT, V112, P247, DOI 10.1016/0014-5793(80)80190-6.
   KAWAI T, 1973, PRACTICE CLIN IMMUNO, pCH21.
   KOJ A, 1974, STRUCTURE FUNCTION P, V1, P73.
   KUSHNER I, 1982, ANN NY ACAD SCI, V389, P39, DOI 10.1111/j.1749-6632.1982.tb22124.x.
   MANN AH, 1981, THESIS U SURREY GUIL.
   MILLER EC, 1981, CANCER, V47, P1055, DOI 10.1002/1097-0142(19810301)47:5+<1055::AID-CNCR2820471302>3.0.CO;2-3.
   MILLER LL, 1980, PLASMA PROTEIN METAB, P207.
   PRICE S C, 1982, Biochemical Society Transactions, V10, P244.
   REDDY JK, 1984, AM J PATHOL, V114, P171.
   REDDY JK, 1984, CRC CRIT R TOXICOL, V12, P1.
   RINKUS SJ, 1979, CANCER RES, V39, P3289.
   WILLIAMS CA, 1961, J EXP MED, V114, P311, DOI 10.1084/jem.114.3.311.
   1979, MONOGRAPH EVALUATION, V20.}},
Number-of-Cited-References = {{22}},
Times-Cited = {{5}},
Doc-Delivery-Number = {{AHS99}},
Wos-Id = {{ISI:A1985AHS9900006}},
}

@article{ ISI:A1985AVG1000017,
Author = {SJOBERG, P and BONDESSON, U},
Title = {{DETERMINATION OF DI(2-ETHYLHEXYL) PHTHALATE AND 4 OF ITS METABOLITES IN
   BLOOD-PLASMA BY GAS-CHROMATOGRAPHY MASS-SPECTROMETRY}},
Journal = {{JOURNAL OF CHROMATOGRAPHY}},
Year = {{1985}},
Volume = {{344}},
Number = {{NOV}},
Pages = {{167-175}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{SJOBERG, P (Reprint Author), NATL BOARD HLTH \& WELF,DEPT DRUGS,BOX 607,S-75125 UPPSALA,SWEDEN.
   ULLERAKER HOSP,PSYCHIAT RES CTR,UPPSALA,SWEDEN.
   ULLERAKER HOSP,HOSP PHARM,UPPSALA,SWEDEN.}},
DOI = {{10.1016/S0378-4347(00)82017-4}},
ISSN = {{0021-9673}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   BAKER RWR, 1978, TOXICOLOGY, V9, P319, DOI 10.1016/0300-483X(78)90015-X.
   BHUJLE VV, 1984, ANALYST, V109, P177, DOI 10.1039/an9840900177.
   BLAU K, 1978, HDB DERIVATIVES CHRO, P104.
   CHING NPH, 1981, J CHROMATOGR, V222, P171, DOI 10.1016/S0378-4347(00)81050-6.
   CHU I, 1978, DRUG METAB DISPOS, V6, P146.
   COLE RS, 1981, VOX SANG, V40, P317.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   DRAVIAM EJ, 1982, ANAL LETT PT B, V15, P1729.
   EASTERLI.RE, 1974, P SOC EXP BIOL MED, V147, P572.
   FAYZ S, 1977, J PHARM PHARMACOL, V29, P407.
   GANGOLLI SD, 1982, ENV HLTH PERSPECT, V45, P27.
   GRAY TJB, 1984, FOOD CHEM TOXICOL, V22, P123, DOI 10.1016/0278-6915(84)90092-9.
   HARVAN DJ, 1980, BIOMED MASS SPECTROM, V7, P242, DOI 10.1002/bms.1200070604.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   JENSEN L E, 1977, Archiv for Pharmaci og Chemi Scientific Edition, V5, P43.
   KLUWE WM, 1982, J TOXICOL ENV HEALTH, V10, P797.
   LAKE BG, 1975, TOXICOL APPL PHARM, V32, P355, DOI 10.1016/0041-008X(75)90226-4.
   LAWRENCE WH, 1979, CLIN TOXICOL, V15, P447.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   PECK CC, 1981, TRANSFUSION, V21, P163, DOI 10.1046/j.1537-2995.1981.21281178151.x.
   PIECHOCK.JT, 1973, CLIN CHIM ACTA, V48, P385, DOI 10.1016/0009-8981(73)90417-8.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   SASAKAWA S, 1978, VOX SANG, V34, P81.
   SETH PK, 1982, ENVIRON HEALTH PERSP, V45, P27, DOI 10.2307/3429380.
   SJOBERG P, 1985, ACTA PHARMACOL TOX, V56, P30.
   STJERNSTROM NE, COMMUNICATION.
   Thomas G H, 1973, Environ Health Perspect, V3, P23, DOI 10.2307/3428026.
   THOMAS JA, 1984, CRC CR REV TOXICOL, V13, P283, DOI 10.3109/10408448409023761.
   VESSMAN J, 1978, VOX SANG, V35, P75.
   VESSMAN J, 1974, J CHROMATOGR, V100, P153, DOI 10.1016/S0021-9673(00)86049-5.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{22}},
Doc-Delivery-Number = {{AVG10}},
Wos-Id = {{ISI:A1985AVG1000017}},
}

@article{ ISI:A1985ADU5600009,
Author = {SHINTANI, H},
Title = {{DETERMINATION OF PHTHALIC-ACID, MONO-(2-ETHYLHEXYL)PHTHALATE AND
   DI-(2-ETHYLHEXYL) PHTHALATE IN HUMAN-PLASMA AND IN BLOOD PRODUCTS}},
Journal = {{JOURNAL OF CHROMATOGRAPHY}},
Year = {{1985}},
Volume = {{337}},
Number = {{2}},
Pages = {{279-290}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{SHINTANI, H (Reprint Author), NATL INST HYG SCI,DEPT MED DEVICES,1-18-1 KAMIYOGA,SETAGAYA KU,TOKYO 158,JAPAN.}},
DOI = {{10.1016/0378-4347(85)80041-4}},
ISSN = {{0021-9673}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Cited-References = {{CHU I, 1978, DRUG METAB DISPOS, V6, P146.
   DRAVIAM EJ, 1980, ANAL LETT PT B, V13, P1137.
   PEACK CC, 1981, TRANSFUSION, V21, P163.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   SAIDO K, 1978, NIHON DAIGAKU YAKUGA, V18, P1.
   THOMAS JA, 1982, J TOXICOL ENV HEALTH, V9, P141.
   VESSMAN J, 1974, J CHROMATOGR, V100, P153, DOI 10.1016/S0021-9673(00)86049-5.
   YOSHIKAWA, 1983, FD CHEM TOXIC, V21, P221.}},
Number-of-Cited-References = {{8}},
Times-Cited = {{14}},
Doc-Delivery-Number = {{ADU56}},
Wos-Id = {{ISI:A1985ADU5600009}},
}

@article{ ISI:A1985ASX4100008,
Author = {LISS, GM and ALBRO, PW and HARTLE, RW and STRINGER, WT},
Title = {{URINE PHTHALATE DETERMINATIONS AS AN INDEX OF OCCUPATIONAL EXPOSURE TO
   PHTHALIC-ANHYDRIDE AND DI(2-ETHYLHEXYL)PHTHALATE}},
Journal = {{SCANDINAVIAN JOURNAL OF WORK ENVIRONMENT \& HEALTH}},
Year = {{1985}},
Volume = {{11}},
Number = {{5}},
Pages = {{381-387}},
Publisher = {{SCAND J WORK ENV HEALTH}},
Address = {{TOPELIUKSENKATU 41A, SF-00250 HELSINKI, FINLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{NIOSH,DIV SURVEILLANCE HAZARD EVALUAT \& FIELD STUDIES,CINCINNATI,OH 45226.
   NIEHS,MOLEC BIOPHYS LAB,RES TRIANGLE PK,NC 27709.}},
ISSN = {{0355-3140}},
Research-Areas = {{Public, Environmental \& Occupational Health}},
Web-of-Science-Categories  = {{Public, Environmental \& Occupational Health}},
Cited-References = {{ALBRO PW, 1984, ANAL CHEM, V56, P247, DOI 10.1021/ac00266a029.
   ALBRO PW, 1981, DRUG METAB DISPOS, V9, P223.
   ALBRO PW, 1978, TRANSFUSION, V18, P750, DOI 10.1046/j.1537-2995.1978.18679077962.x.
   AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   BERNSTEIN IL, 1981, CLIN CHEST MED, V2, P255.
   DRAVIAM EJ, 1980, ANAL LETT PT B, V13, P1137.
   DRAVIAM EJ, 1982, ANAL LETT PT B, V15, P1729.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   LAWRENCE WH, 1979, CLIN TOXICOL, V15, P447.
   LISS GM, 1983, HETA820321384 NAT I.
   MACCIA CA, 1976, AM REV RESPIR DIS, V113, P701.
   PECK CC, 1979, TRANSFUSION, V18, P53.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   RIBOLI E, 1983, SCAND J WORK ENV HEA, V9, P455.
   Thiess A M, 1978, Zentralbl Arbeitsmed Arbeitsschutz Prophyl, V28, P351.
   THOMAS JA, 1978, TOXICOL APPL PHARM, V45, P1, DOI 10.1016/0041-008X(78)90024-8.
   1982, IARC MONOGRAPHS EVAL, V29, P269.
   1977, DHEW NIOSH77157B PUB.
   1981, NTP DHHS NIH811773 P.
   1980, PROJECTED NUMBER OCC, P64.
   1977, DHEW NIOSH77157C PUB.
   1980, NATIONAL OCCUPATIONA.}},
Number-of-Cited-References = {{23}},
Times-Cited = {{28}},
Journal-ISO = {{Scand. J. Work Environ. Health}},
Doc-Delivery-Number = {{ASX41}},
Wos-Id = {{ISI:A1985ASX4100008}},
}

@article{ ISI:A1985AEL3500005,
Author = {BARBER, ED and DONISH, WH and MUELLER, KR and HAMILTON, ML and
   DIVINCENZO, GD},
Title = {{METHODS FOR MEASURING MUTAGENICITY IN URINE OF RATS DOSED WITH
   {[}C-14]DI(2-ETHYLHEXYL)PHTHALATE}},
Journal = {{TOXICOLOGY}},
Year = {{1985}},
Volume = {{34}},
Number = {{3}},
Pages = {{231-245}},
Publisher = {{ELSEVIER SCI IRELAND LTD}},
Address = {{CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{BARBER, ED (Reprint Author), EASTMAN KODAK CO,HLTH SAFETY \& HUMAN FACTORS LAB,ROCHESTER,NY 14650, USA.}},
DOI = {{10.1016/0300-483X(85)90174-X}},
ISSN = {{0300-483X}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Cited-References = {{AESCHBACHER HU, 1983, TERATOGEN CARCIN MUT, V3, P195, DOI 10.1002/1520-6866(1990)3:2<195::AID-TCM1770030212>3.0.CO;2-Q.
   AESCHBACHER HU, 1981, MUTAT RES, V89, P161, DOI 10.1016/0165-1218(81)90122-1.
   ALBRO PW, 1982, J CHROMATOGR, V244, P65, DOI 10.1016/S0021-9673(00)80123-5.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   AMES BN, 1975, MUTAT RES, V31, P347, DOI 10.1016/0165-1161(75)90046-1.
   AMMENHEUSER MM, 1979, MUTAT RES, V66, P241, DOI 10.1016/0165-1218(79)90084-3.
   BADEN JM, 1980, ANESTHESIOLOGY, V53, P195, DOI 10.1097/00000542-198009000-00003.
   BAKER R, 1982, CANCER LETT, V16, P81, DOI 10.1016/0304-3835(82)90094-5.
   BAKERMAN HA, 1951, J BIOL CHEM, V188, P117.
   BLUM A, 1978, SCIENCE, V201, P1020, DOI 10.1126/science.684422.
   BOS RP, 1980, TOXICOLOGY, V16, P113, DOI 10.1016/0300-483X(80)90042-6.
   COMMONER B, 1974, NATURE, V249, P850, DOI 10.1038/249850a0.
   CONNOR TH, 1977, CANCER RES, V37, P629.
   LEGATOR MS, 1974, MUTAT RES, V26, P456.
   DIVINCENZO GD, 1985, TOXICOLOGY, V34, P247, DOI 10.1016/0300-483X(85)90175-1.
   DOUGLAS JF, 1981, TOXICOLOGIST, V1, P129.
   DURSTON WE, 1974, P NATL ACAD SCI USA, V71, P737, DOI 10.1073/pnas.71.3.737.
   FONG LYY, 1979, INT J CANCER, V23, P542, DOI 10.1002/ijc.2910230416.
   FRIEDERICH U, 1982, MUTAT RES, V103, P133, DOI 10.1016/0165-7992(82)90018-5.
   GELBERT SM, 1980, LANCET          0426, P894.
   HODGSON JR, 1982, 13TH ANN M ENV MUT S.
   KIRBY PE, 1982, 13TH ANN M ENV MUT S.
   KOVACH PM, 1982, ANAL CHEM, V54, P217, DOI 10.1021/ac00239a016.
   LAMBOTTEVANDEPAER M, 1980, TOXICOLOGY, V16, P67, DOI 10.1016/0300-483X(80)90111-0.
   LEGATOR M, 1979, ENVIRON RES, V20, P99, DOI 10.1016/0013-9351(79)90089-6.
   LEGATOR MS, 1975, ANN NY ACAD SCI, V269, P16.
   LEGATOR MS, 1982, MUTAT RES, V98, P319, DOI 10.1016/0165-1110(82)90038-0.
   MINNICH V, 1976, CANCER, V38, P1253, DOI 10.1002/1097-0142(197609)38:3<1253::AID-CNCR2820380327>3.0.CO;2-6.
   MOLLER M, 1980, SCAND J WORK ENV HEA, V6, P216.
   OMORI Y, 1976, ENVIRON HEALTH PERSP, V17, P203, DOI 10.2307/3428627.
   PAK K, 1979, UROL RES, V7, P119.
   PHILLIPS BJ, 1982, MUTAT RES, V102, P297, DOI 10.1016/0165-1218(82)90139-2.
   PIETRZYK DJ, 1977, ANAL CHEM, V49, P757, DOI 10.1021/ac50014a022.
   PUTNAM DL, 1982, 13TH ANN M ENV MUT S.
   PUTZRATH RM, 1981, MUTAT RES, V85, P97, DOI 10.1016/0165-1161(81)90025-X.
   REDDY TV, 1980, MUTAT RES, V79, P307, DOI 10.1016/0165-1218(80)90154-8.
   RUBIN RJ, 1979, 18TH ANN M SOC TOX N.
   RUSHBROOK CJ, 1982, 13TH ANN M ENV MUT S.
   SALMEEN I, 1981, MUTAT RES, V84, P109.
   Simmon V. F., 1977, PROGR GENETIC TOXICO, V2, P249.
   SINGH AR, 1972, J PHARM SCI, V61, P51, DOI 10.1002/jps.2600610107.
   SPECK WT, 1976, J NATL CANCER I, V56, P283.
   STAIANO N, 1981, LANCET, V1, P615.
   SULING WJ, 1978, CANCER TREAT REP, V63, P1321.
   SWAMINATHAN S, 1981, CANCER RES, V41, P2648.
   TANAKA KI, 1980, MUTAT RES, V79, P173, DOI 10.1016/0165-1218(80)90086-5.
   TANAKA KI, 1981, INT ARCH OCC ENV HEA, V49, P177, DOI 10.1007/BF00377671.
   VANDOORN R, 1979, INT ARCH OCC ENV HEA, V43, P159.
   VOGEL HJ, 1956, J BIOL CHEM, V218, P97.
   WANG CY, 1977, J NATL CANCER I, V58, P871.
   YAGI Y, 1976, TERATOLOGY, V14, P259.
   YAMASAKI E, 1977, P NATL ACAD SCI USA, V74, P3555, DOI 10.1073/pnas.74.8.3555.
   1980, USITC US INT TRADE C, V1099.}},
Number-of-Cited-References = {{53}},
Times-Cited = {{2}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{AEL35}},
Wos-Id = {{ISI:A1985AEL3500005}},
}

@article{ ISI:A1985ASA9800007,
Author = {SJOBERG, POJ and BONDESSON, UG and SEDIN, EG and GUSTAFSSON, JP},
Title = {{EXPOSURE OF NEWBORN-INFANTS TO PLASTICIZERS - PLASMA-LEVELS OF
   DI-(2-ETHYLHEXYL) PHTHALATE AND MONO-(2-ETHYLHEXYL) PHTHALATE DURING
   EXCHANGE-TRANSFUSION}},
Journal = {{TRANSFUSION}},
Year = {{1985}},
Volume = {{25}},
Number = {{5}},
Pages = {{424-428}},
Publisher = {{AMER ASSOC BLOOD BANKS}},
Address = {{8101 GLENBROOK RD, BETHESDA, MD 20814-2749}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{SJOBERG, POJ (Reprint Author), ULLERAKER HOSP,HOSP PHARM \& PSYCHIAT RES CTR,NATL BOARD HLTH \& WELF,DEPT DRUGS,BOX 607,S-75125 UPPSALA,SWEDEN.
   UNIV UPPSALA,DEPT PEDIAT,S-75105 UPPSALA,SWEDEN.
   UNIV UPPSALA,DEPT PHARMACEUT BIOCHEM,S-75105 UPPSALA,SWEDEN.}},
DOI = {{10.1046/j.1537-2995.1985.25586020115.x}},
ISSN = {{0041-1132}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   CHU I, 1978, DRUG METAB DISPOS, V6, P146.
   COLE RS, 1981, VOX SANG, V40, P317.
   GANGOLLI SD, 1982, ENVIRON HEALTH PERSP, V45, P77, DOI 10.2307/3429387.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   JENSEN L E, 1977, Archiv for Pharmaci og Chemi Scientific Edition, V5, P43.
   KLINGER W, 1982, PHARMACOL THERAPEUT, V16, P377, DOI 10.1016/0163-7258(82)90007-9.
   LAKE BG, 1975, TOXICOL APPL PHARM, V32, P355, DOI 10.1016/0041-008X(75)90226-4.
   LAWRENCE WH, 1979, CLIN TOXICOL, V15, P447.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   OISHI S, 1980, TOXICOLOGY, V15, P197, DOI 10.1016/0300-483X(80)90053-0.
   PECK CC, 1977, TRANSFUSION, V17, P400, DOI 10.1046/j.1537-2995.1977.17477216873.x.
   PECK CC, 1979, TRANSFUSION, V19, P137, DOI 10.1046/j.1537-2995.1979.19279160282.x.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   SETH PK, 1982, ENVIRON HEALTH PERSP, V45, P27, DOI 10.2307/3429380.
   WARREN JR, 1982, ENVIRON HEALTH PERSP, V45, P35, DOI 10.2307/3429381.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{56}},
Journal-ISO = {{Transfusion}},
Doc-Delivery-Number = {{ASA98}},
Wos-Id = {{ISI:A1985ASA9800007}},
}

@article{ ISI:A1985APP8400007,
Author = {SIMON, J and BARLA, F},
Title = {{APPLICATION OF CAPILLARY GAS-CHROMATOGRAPHY IN THE STABILITY CONTROL OF
   PHTHALATE-ESTER-TYPE POLYVINYL-CHLORIDE) PLASTICIZERS TREATED WITH LIGHT
   AND PLASMA}},
Journal = {{JOURNAL OF CHROMATOGRAPHY}},
Year = {{1985}},
Volume = {{329}},
Number = {{3}},
Pages = {{389-394}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{SIMON, J (Reprint Author), HUNGARIAN OIL \& GAS RES INST,POB 167,VESZPREM,HUNGARY.
   COTTON WEAVING \& ARTIFICIAL LEATHER PROD FACTORY,GYOR,HUNGARY.}},
DOI = {{10.1016/S0021-9673(01)81945-2}},
ISSN = {{0021-9673}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Cited-References = {{BURNS DT, 1975, J CHROMATOGR, V103, P241.
   FRIOCOURT MP, 1979, J CHROMATOGR, V172, P261, DOI 10.1016/S0021-9673(00)90961-0.
   HAYES WP, 1977, J CHROMATOGR, V139, P395, DOI 10.1016/S0021-9673(00)89339-5.
   MORI S, 1976, J CHROMATOGR, V129, P53, DOI 10.1016/S0021-9673(00)87767-5.
   TAKESHITA R, 1977, J CHROMATOGR, V133, P303, DOI 10.1016/S0021-9673(00)83487-1.}},
Number-of-Cited-References = {{5}},
Times-Cited = {{1}},
Doc-Delivery-Number = {{APP84}},
Wos-Id = {{ISI:A1985APP8400007}},
}

@article{ ISI:A1984SB62900042,
Author = {ALBRO, PW and JORDAN, S and CORBETT, JT and SCHROEDER, JL},
Title = {{DETERMINATION OF TOTAL PHTHALATE IN URINE BY GAS-CHROMATOGRAPHY}},
Journal = {{ANALYTICAL CHEMISTRY}},
Year = {{1984}},
Volume = {{56}},
Number = {{2}},
Pages = {{247-250}},
Publisher = {{AMER CHEMICAL SOC}},
Address = {{1155 16TH ST, NW, WASHINGTON, DC 20036}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{ALBRO, PW (Reprint Author), NIEHS,POB 12233,RES TRIANGLE PK,NC 27709, USA.}},
DOI = {{10.1021/ac00266a029}},
ISSN = {{0003-2700}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Cited-References = {{ALBRO PW, 1982, J CHROMATOGR, V2, P130.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   BURNS BG, 1981, J ASSOC OFF ANA CHEM, V64, P282.
   FALES HM, 1973, ANAL CHEM, V45, P2302, DOI 10.1021/ac60335a020.
   FISCHER E, 1906, BER DTSCH CHEM GES, V39, P2896.
   FISHBEIN L, 1972, J CHROMATOGR, V70, P365, DOI 10.1016/S0021-9673(00)92702-X.
   FRIOCOURT MP, 1979, J CHROMATOGR, V172, P261, DOI 10.1016/S0021-9673(00)90961-0.
   GEE M, 1965, ANAL CHEM, V37, P926, DOI 10.1021/ac60226a038.
   GEHRKE CW, 1963, ANAL CHEM, V35, P76, DOI 10.1021/ac60194a025.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9.
   GREELEY RH, 1974, J CHROMATOGR, V88, P229.
   ISHIDA M, 1980, J CHROMATOGR, V189, P421, DOI 10.1016/S0021-9673(00)80323-4.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   KIM SW, 1976, J PHAM SCI, P670.
   KLUNE WM, 1982, EHP ENV HLTH PERSPEC, V45, P3.
   KLUWE WM, 1982, ENVIRON HEALTH PERSP, V45, P129, DOI 10.2307/3429396.
   KOVATS E, 1958, HELV CHIM ACTA, V41, P1915, DOI 10.1002/hlca.19580410703.
   MAMER OA, 1973, CLIN CHEM, V19, P1006.
   MARCEL YL, 1970, LANCET, V1, P35.
   MES J, 1974, B ENVIRON CONTAM TOX, V12, P721.
   MORRISON WR, 1964, J LIPID RES, V5, P600.
   MORTENSEN PB, 1982, BIOCHIM BIOPHYS ACTA, V710, P477, DOI 10.1016/0005-2760(82)90132-1.
   NAZIR DJ, 1971, BIOCHEMISTRY-US, V10, P4228, DOI 10.1021/bi00799a012.
   ONO K, 1975, JAMA-J AM MED ASSOC, V234, P948, DOI 10.1001/jama.234.9.948.
   PECK CC, 1982, ENVIRON HEALTH PERSP, V45, P11, DOI 10.2307/3429378.
   PIERCE RC, 1980, NRCC17583 CNRC ENV S.
   ROGOZINSKI M, 1964, J GAS CHROMATOGR, V2, P328.
   SHAFFER CB, 1945, J IND HYG, V2, P130.
   SIMMONDS PG, 1965, ANAL CHEM, V37, P302, DOI 10.1021/ac60221a041.
   TOMITA I, 1977, ECOTOX ENVIRON SAFE, V1, P275, DOI 10.1016/0147-6513(77)90043-4.
   Vorbruggen H., 1963, ANGEW CHEM INT EDIT, V2, P211, DOI 10.1002/anie.196302112.}},
Number-of-Cited-References = {{34}},
Times-Cited = {{27}},
Journal-ISO = {{Anal. Chem.}},
Doc-Delivery-Number = {{SB629}},
Wos-Id = {{ISI:A1984SB62900042}},
}

@article{ ISI:A1984TV35100019,
Author = {ESTEP, TN and PEDERSEN, RA and MILLER, TJ and STUPAR, KR},
Title = {{CHARACTERIZATION OF ERYTHROCYTE QUALITY DURING THE REFRIGERATED STORAGE
   OF WHOLE-BLOOD CONTAINING DI-(2-ETHYLHEXYL) PHTHALATE}},
Journal = {{BLOOD}},
Year = {{1984}},
Volume = {{64}},
Number = {{6}},
Pages = {{1270-1276}},
Publisher = {{W B SAUNDERS CO}},
Address = {{INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA
   19106-3399}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{ESTEP, TN (Reprint Author), TRAVENOL LABS RLT-14,FENWAL DIV,ROUTE 120 \& WILSON RD,ROUND LAKE,IL 60073, USA.}},
ISSN = {{0006-4971}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{ADAMS H, 1963, METHOD ENZYMAT AN, P539.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V360, P380.
   ALBRO PW, 1978, TRANSFUSION, V18, P750, DOI 10.1046/j.1537-2995.1978.18679077962.x.
   Bartlett G, 1974, HUMAN RED CELL IN VI, P5.
   Bessis M., 1973, LIVING BLOOD CELLS T.
   BEUTLER E, 1975, RED CELL METABOLISM, P42.
   BEUTLER E, 1969, TRANSFUSION, V9, P109.
   BREWER GJ, 1966, J LAB CLIN MED, V67, P726.
   BUCHER T, 1947, BIOCHIM BIOPHYS ACTA, V1, P292, DOI 10.1016/0006-3002(47)90143-1.
   CROSBY WH, 1956, BLOOD, V11, P380.
   DAWSON R B JR, 1969, Clinical Research, V17, P323.
   DERN RJ, 1966, J LAB CLIN MED, V67, P955.
   DERN RJ, 1967, J LAB CLIN MED, V69, P968.
   DEUTICKE B, 1968, BIOCHIM BIOPHYS ACTA, V163, P494, DOI 10.1016/0005-2736(68)90078-3.
   DRABKIN DL, 1949, AM J MED SCI, V217, P710.
   GEISSLER UC, 1978, TRANSFUSION, V18, P382.
   GILBO CM, 1975, VOX SANG, V29, P242.
   JACOBSON MS, 1980, TRANSFUSION, V20, P443, DOI 10.1046/j.1537-2995.1980.20480260277.x.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   JAEGER RJ, 1970, LANCET, V2, P151.
   KANDLER RL, 1982, BLOOD S1, V60, pA179.
   LAWRENCE WH, 1978, CLIN TOXICOL, V13, P89.
   LEAVITT RD, 1971, NOUV REV FR HEMATOL, V11, P331.
   LICHTMAN MA, 1972, NOUV REV FR HEMATOL, V12, P755.
   LOWRY OH, 1964, J BIOL CHEM, V239, P18.
   MARCEL YL, 1970, LANCET, V1, P35.
   MIRIPOL JE, 1977, TRANSFUSION, V17, P71, DOI 10.1046/j.1537-2995.1977.17177128891.x.
   MOORE GL, 1981, BIOCHEM MED METAB B, V26, P167, DOI 10.1016/0006-2944(81)90043-0.
   NELSON GJ, 1972, BLOOD LIPIDS LIPOPRO, P789.
   PECK CC, 1979, TRANSFUSION, V19, P137, DOI 10.1046/j.1537-2995.1979.19279160282.x.
   Ponder E., 1948, HEMOLYSIS RELATED PH.
   ROCK G, 1983, TRANSFUSION, V23, P426.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   SASAKAWA S, 1978, VOX SANG, V34, P81.
   SHOHET SB, 1972, NOUV REV FR HEMATOL, V12, P761.
   STERN IJ, 1980, 16TH P C INT SOC HEM, P151.
   THOMAS JA, 1978, TOXICOL APPL PHARM, V45, P1, DOI 10.1016/0041-008X(78)90024-8.
   Valeri C R, 1973, Environ Health Perspect, V3, P103, DOI 10.2307/3428036.
   VESSMAN J, 1978, VOX SANG, V35, P75.
   WALLAS CH, 1949, TRANSFUSION, V19, P210.
   WEED RI, 1973, RED CELL SHAPE PHYSL, P55.
   WHITE M, 1979, BIOCH SOC T, V7, P921.}},
Number-of-Cited-References = {{42}},
Times-Cited = {{34}},
Journal-ISO = {{Blood}},
Doc-Delivery-Number = {{TV351}},
Wos-Id = {{ISI:A1984TV35100019}},
}

@article{ ISI:A1984TV86700011,
Author = {POLLACK, GM and SLAUGHTER, RL and BUCHANAN, JF and SHEN, DD},
Title = {{HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC PROCEDURE FOR THE DETERMINATION
   OF DI-(2-ETHYLHEXYL)PHTHALATE IN HUMAN-BLOOD SPECIMENS - PROBLEMS OF
   VARIABLE-EXTRACTION YIELD AND THE USE OF STANDARD ADDITION FOR
   CALIBRATION}},
Journal = {{JOURNAL OF CHROMATOGRAPHY}},
Year = {{1984}},
Volume = {{311}},
Number = {{1}},
Pages = {{101-108}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{SUNY BUFFALO,SCH PHARM,DEPT PHARM,BUFFALO,NY 14260.
   SUNY BUFFALO,SCH PHARM,DEPT PHARMACEUT,BUFFALO,NY 14260.}},
DOI = {{10.1016/S0378-4347(00)84695-2}},
ISSN = {{0021-9673}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Cited-References = {{ALBRO PW, 1978, TRANSFUSION, V18, P750, DOI 10.1046/j.1537-2995.1978.18679077962.x.
   ANDERSON GD, UNPUB J PHARM SCI.
   CHING NPH, 1981, J CHROMATOGR, V222, P171, DOI 10.1016/S0378-4347(00)81050-6.
   DRAVIAM EJ, 1982, ANAL LETT PT B, V15, P1729.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   GULBRING B, 1964, VOX SANG, V9, P513.
   KLUWE WM, 1982, J TOXICOL ENV HEALTH, V10, P797.
   LAWRENCE WH, 1978, CLIN TOXICOL, V13, P89.
   LEWIS LM, 1977, T AM SOC ART INT ORG, V23, P566.
   MOTT GE, 1978, CLIN CHEM, V24, P354.
   PIECHOCK.JT, 1973, CLIN CHIM ACTA, V48, P385, DOI 10.1016/0009-8981(73)90417-8.
   PIKE E, 1981, CLIN PHARMACOKINET, V6, P367.
   POLLACK GM, UNPUB.
   VESSMAN J, 1974, J CHROMATOGR, V100, P153, DOI 10.1016/S0021-9673(00)86049-5.
   WARNICK GR, 1978, J LIPID RES, V19, P65.}},
Number-of-Cited-References = {{15}},
Times-Cited = {{15}},
Doc-Delivery-Number = {{TV867}},
Wos-Id = {{ISI:A1984TV86700011}},
}

@article{ ISI:A1984TP78300010,
Author = {OISHI, S},
Title = {{EFFECTS OF DI-2-ETHYLHEXYL PHTHALATE ON LIPID-COMPOSITION OF SERUM AND
   TESTIS IN RATS}},
Journal = {{TOXICOLOGY LETTERS}},
Year = {{1984}},
Volume = {{23}},
Number = {{1}},
Pages = {{67-72}},
Publisher = {{ELSEVIER SCI IRELAND LTD}},
Address = {{CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{OISHI, S (Reprint Author), TOKYO METROPOLITAN RES LAB PUBL HLTH,DEPT TOXICOL,3-24-1 HYAKUNINCHO,SHINJUKU KU,TOKYO 160,JAPAN.}},
ISSN = {{0378-4274}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Cited-References = {{Allen RJL, 1940, BIOCHEM J, V34, P858.
   BELL FP, 1982, ENVIRON HEALTH PERSP, V45, P41, DOI 10.2307/3429382.
   BETTGER WJ, 1979, J NUTR, V109, P480.
   BIERI JG, 1966, J NUTR, V89, P55.
   CLEJAN S, 1982, LIPIDS, V17, P129, DOI 10.1007/BF02535092.
   CONGLIO JG, 1977, LIPID METABOLISM MAM, V2, P83.
   DUCOMBE W, 1963, BIOCHEM J, V88, P7.
   FISHBEIN L, 1972, J CHROMATOGR, V70, P365, DOI 10.1016/S0021-9673(00)92702-X.
   FOLCH J, 1957, J BIOL CHEM, V226, P497.
   MCCREARY DK, 1979, J CHROMATOGR SCI, V16, P329.
   NAKAMURA M, 1968, ENDOCRINOLOGY, V82, P137.
   ODELL BL, 1977, J NUTR, V107, P1222.
   OISHI S, 1980, TOXICOLOGY, V15, P197, DOI 10.1016/0300-483X(80)90053-0.
   OISHI S, 1983, TOXICOL APPL PHARM, V70, P43, DOI 10.1016/0041-008X(83)90177-1.
   OISHI S, 1980, TOXICOL APPL PHARM, V53, P35, DOI 10.1016/0041-008X(80)90378-6.
   OISHI S, 1982, TOXICOL LETT, V14, P79.
   VANHANDEL E, 1957, J LAB CLIN MED, V50, P152.
   ZAK B, 1957, AM J CLIN PATHOL, V27, P583.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{3}},
Journal-ISO = {{Toxicol. Lett.}},
Doc-Delivery-Number = {{TP783}},
Wos-Id = {{ISI:A1984TP78300010}},
}

@article{ ISI:A1984SA85200012,
Author = {OISHI, S},
Title = {{TESTICULAR ATROPHY OF RATS INDUCED BY DI-2-ETHYLHEXYL PHTHALATE -
   EFFECTS OF VITAMIN-A AND ZINC CONCENTRATIONS IN THE TESTIS, LIVER AND
   SERUM}},
Journal = {{TOXICOLOGY LETTERS}},
Year = {{1984}},
Volume = {{20}},
Number = {{1}},
Pages = {{75-78}},
Publisher = {{ELSEVIER SCI IRELAND LTD}},
Address = {{CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{OISHI, S (Reprint Author), TOKYO METROPOLITAN RES LAB PUBL HLTH,DEPT TOXICOL,SHINJUKU KU,3-24-1 HYAKUNINCHO,TOKYO 160,JAPAN.}},
DOI = {{10.1016/0378-4274(84)90186-3}},
ISSN = {{0378-4274}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Cited-References = {{ABBASI AA, 1980, J LAB CLIN MED, V96, P544.
   AHLUWALIA B, 1971, Journal of Nutrition, V101, P141.
   AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   CHEN WS, 1979, ANAL LETT PT B, V12, P1517.
   COWARD WA, 1969, BRIT J NUTR, V23, P619, DOI 10.1079/BJN19690069.
   COWARD WA, 1966, J REPROD FERTIL, V12, P309.
   EVANS HM, 1922, ANAT REC, V23, P17.
   HOWELL JMG, J REPROD FERTIL, V5, P159.
   HUANG HFS, 1979, BIOL REPROD, V21, P891, DOI 10.1095/biolreprod21.4.891.
   ISHIDA M, 1980, J CHROMATOGR, V189, P421, DOI 10.1016/S0021-9673(00)80323-4.
   KRUEGER PM, 1974, ENDOCRINOLOGY, V95, P955.
   LAWRENCE WH, 1979, CLIN TOXICOL, V16, P53.
   MAI J, 1980, LIPID, V15, P961.
   Mason KE, 1933, AM J ANAT, V52, P153, DOI 10.1002/aja.1000520202.
   MES J, 1974, B ENVIRON CONTAM TOX, V12, P721.
   MILLAR MJ, 1960, CAN J BIOCHEM PHYS, V38, P1457.
   MILLAR MJ, 1958, CAN J BIOCHEM PHYS, V36, P557.
   OISHI S, 1980, TOXICOL APPL PHARM, V53, P35, DOI 10.1016/0041-008X(80)90378-6.
   OISHI S, 1983, TOXICOL APPL PHARM.
   OVERTURF ML, 1979, B ENVIRON CONTAM TOX, V22, P536.
   PRASAD AS, 1976, ZINC METABOLISM, P250.
   PRASAD AS, 1976, AM J DIS CHILD, V130, P359.
   RICH KA, 1977, ENDOCRINOLOGY, V101, P959.
   SMITH JC, 1973, SCIENCE, V181, P954, DOI 10.1126/science.181.4103.954.
   THOMAS JA, 1978, TOXICOL APPL PHARM, V45, P1, DOI 10.1016/0041-008X(78)90024-8.
   THOMAS JA, 1982, J TOXICOL ENV HEALTH, V9, P141.
   THOMPSON JN, 1971, BIOCHEM MED METAB B, V5, P67, DOI 10.1016/0006-2944(71)90076-7.
   UNDERWOOD EJ, TRACE ELEMENTS HUMAN, P208.}},
Number-of-Cited-References = {{28}},
Times-Cited = {{5}},
Journal-ISO = {{Toxicol. Lett.}},
Doc-Delivery-Number = {{SA852}},
Wos-Id = {{ISI:A1984SA85200012}},
}

@article{ ISI:A1984SY93300003,
Author = {ALBRO, PW and CORBETT, JT and MARBURY, D and PARKER, C},
Title = {{URINARY METABOLITES OF ORALLY-ADMINISTERED DI-(5-HEXENYL) PHTHALATE AND
   DI-(9-DECENYL) PHTHALATE IN THE RAT}},
Journal = {{XENOBIOTICA}},
Year = {{1984}},
Volume = {{14}},
Number = {{5}},
Pages = {{389-398}},
Publisher = {{TAYLOR \& FRANCIS LTD}},
Address = {{ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{ALBRO, PW (Reprint Author), NIEHS,POB 12233,RES TRIANGLE PK,NC 27709, USA.}},
ISSN = {{0049-8254}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Cited-References = {{ALBRO PW, 1983, BIOCHIM BIOPHYS ACTA, V760, P283, DOI 10.1016/0304-4165(83)90175-7.
   ALBRO PW, 1982, J CHROMATOGR, V244, P65, DOI 10.1016/S0021-9673(00)80123-5.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   ALBRO PW, 1975, XENOBIOTICA, V5, P625.
   ALBRO PW, 1981, DRUG METAB DISPOS, V9, P223.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V360, P380.
   ALBRO PW, 1982, ENVIRON HEALTH PERSP, V45, P19, DOI 10.2307/3429379.
   CHEN WS, 1979, ANAL LETT PT B, V12, P1517.
   CHEN WS, 1979, ANAL LETT PT B, V12, P1501.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   DEBOER TJ, 1954, RECL TRAV CHIM PAY B, V73, P229.
   FISHBEIN L, 1972, J CHROMATOGR, V70, P365, DOI 10.1016/S0021-9673(00)92702-X.
   FOSTER PM, 1982, DRUG METAB DISPOS, V11, P59.
   Gray T J, 1980, Arch Toxicol Suppl, V4, P452.
   GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9.
   HARVAN DJ, 1980, BIOMED MASS SPECTROM, V7, P242, DOI 10.1002/bms.1200070604.
   HORNING MG, 1968, ANAL BIOCHEM, V22, P284, DOI 10.1016/0003-2697(68)90318-7.
   KAGEURA M, 1980, JAP J LEGAL EED, V34, P626.
   KLUWE WM, 1982, J TOXICOL ENV HLTH, V10, P795.
   KOVATS E, 1958, HELV CHIM ACTA, V41, P1915, DOI 10.1002/hlca.19580410703.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   MES J, 1974, B ENVIRON CONTAM TOX, V12, P721.
   MIWA TK, 1963, J AM OIL CHEM SOC, V40, P309, DOI 10.1007/BF02633703.
   PECK CC, 1982, ENV HLTH PERSPECT, V45, P27.
   PIERCE RC, 1980, NRCC17583 CNRC.
   POOLE CF, 1977, J CHROMATOGR, V132, P511, DOI 10.1016/S0021-9673(00)82915-5.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{1}},
Journal-ISO = {{Xenobiotica}},
Doc-Delivery-Number = {{SY933}},
Wos-Id = {{ISI:A1984SY93300003}},
}

@article{ ISI:A1983PZ91900012,
Author = {FOSTER, PMD and COOK, MW and THOMAS, LV and WALTERS, DG and GANGOLLI, SD},
Title = {{DIFFERENCES IN URINARY METABOLIC PROFILE FROM DI-NORMAL-BUTYL
   PHTHALATE-TREATED RATS AND HAMSTERS - A POSSIBLE EXPLANATION FOR
   SPECIES-DIFFERENCES IN SUSCEPTIBILITY TO TESTICULAR ATROPHY}},
Journal = {{DRUG METABOLISM AND DISPOSITION}},
Year = {{1983}},
Volume = {{11}},
Number = {{1}},
Pages = {{59-61}},
Publisher = {{WILLIAMS \& WILKINS}},
Address = {{351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{FOSTER, PMD (Reprint Author), BRITISH IND BIOL RES ASSOC,WOODMANSTERNE RD,CARSHALTON SM5 4DS,SURREY,ENGLAND.}},
ISSN = {{0090-9556}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   CATER BR, 1977, TOXICOL APPL PHARM, V41, P609, DOI 10.1016/S0041-008X(77)80014-8.
   FISHMAN WH, 1974, METHOD ENZYMAT AN, P929.
   FOSTER PMD, 1981, CHEM-BIOL INTERACT, V34, P233, DOI 10.1016/0009-2797(81)90134-4.
   FOSTER PMD, 1980, TOXICOL APPL PHARM, V54, P392, DOI 10.1016/0041-008X(80)90165-9.
   GRAY TJB, 1982, TOXICOL LETT, V11, P141, DOI 10.1016/0378-4274(82)90119-9.
   HITES RA, 1973, ENV HLTH PERSPECT, V1, P17.
   KANESHIMA H, 1978, B ENVIRON CONTAM TOX, V19, P502.
   LAKE BG, 1977, TOXICOL APPL PHARM, V39, P239, DOI 10.1016/0041-008X(77)90157-0.
   MAYER FL, 1972, NATURE, V238, P411, DOI 10.1038/238411a0.
   PHILLIPS JC, 1980, FOOD COSMET TOXICOL, V18, P7, DOI 10.1016/0015-6264(80)90003-6.
   TANAKA A, 1978, TOXICOLOGY, V9, P109, DOI 10.1016/0300-483X(78)90036-7.
   THOMAS GH, 1973, ENV HLTH PERSPECT, V1, P23.
   WILLIAMS DT, 1975, J AGR FOOD CHEM, V23, P854, DOI 10.1021/jf60201a047.
   WILLIAMS DT, 1973, J AGR FOOD CHEM, V21, P1128, DOI 10.1021/jf60190a028.}},
Number-of-Cited-References = {{16}},
Times-Cited = {{20}},
Journal-ISO = {{Drug Metab. Dispos.}},
Doc-Delivery-Number = {{PZ919}},
Wos-Id = {{ISI:A1983PZ91900012}},
}

@article{ ISI:A1983QU84300010,
Author = {ISHIKAWA, Y and HONDA, K and SASAKAWA, S and HATADA, K and KOBAYASHI, H},
Title = {{PREVENTION OF LEAKAGE OF DI-(2-ETHYLHEXYL)PHTHALATE FROM BLOOD BAGS BY
   GLOW-DISCHARGE TREATMENT AND ITS EFFECT ON AGGREGABILITY OF STORED
   PLATELETS}},
Journal = {{VOX SANGUINIS}},
Year = {{1983}},
Volume = {{45}},
Number = {{1}},
Pages = {{68-76}},
Publisher = {{KARGER}},
Address = {{ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{ISHIKAWA, Y (Reprint Author), JAPANESE RED CROSS,CENT BLOOD CTR,4 HIROO,SHIBUYA BU,TOKYO 150,JAPAN.
   TORAY IND INC,FILMS \& FILM PROD RES LABS,OTSU,SHIGA,JAPAN.}},
ISSN = {{0042-9007}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{ASAI M, 1979, JPN J ARTIF ORGANS, V8, P389.
   AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   GRRASO P, 1973, FD COSMET TOXICOL, V11, P255.
   GUESS WL, 1967, DRUG INTELL, V1, P120.
   GUESS WL, 1965, J PHARM SCI, V54, P1545, DOI 10.1002/jps.2600541036.
   JACOBSON MS, 1974, RES COMMUN CHEM PATH, V9, P315.
   Jaeger R J, 1973, Environ Health Perspect, V3, P95, DOI 10.2307/3428035.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   JONES AE, 1975, TOXICOL APPL PHARM, V31, P283, DOI 10.1016/0041-008X(75)90163-5.
   KIM SW, 1976, J PHARM SCI, V65, P670, DOI 10.1002/jps.2600650510.
   MARCEL YL, 1970, LANCET, V1, P35.
   OZGE A, 1964, J LAB CLIN MED, V63, P378.
   PECK CC, 1977, TRANSFUSION, V17, P400, DOI 10.1046/j.1537-2995.1977.17477216873.x.
   RUBIN RJ, 1975, 6 P INT C PHARM HELS, V6, P205.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   SAJIKI J, 1976, IGAKU AYUMI, V99, P514.
   SASAKAWA S, UNPUB RESTORATION ST.
   SASAKAWA S, 1978, VOX SANG, V34, P81.
   STRUMIA MM, 1955, J LAB CLIN MED, V46, P225.
   THOMAS JA, 1978, TOXICOL APPL PHARM, V45, P1, DOI 10.1016/0041-008X(78)90024-8.
   TURNER JH, 1974, TRANSFUSION, V14, P560.
   WALL RL, 1953, J LAB CLIN MED, V42, P674.
   WORNER P, 1980, THROMB RES, V18, P439, DOI 10.1016/0049-3848(80)90339-4.}},
Number-of-Cited-References = {{23}},
Times-Cited = {{35}},
Journal-ISO = {{Vox Sang.}},
Doc-Delivery-Number = {{QU843}},
Wos-Id = {{ISI:A1983QU84300010}},
}

@article{ ISI:A1982NU14600001,
Author = {WALSETH, F and TOFTGARD, R and NILSEN, OG},
Title = {{PHTHALATE-ESTERS .1. EFFECTS ON CYTOCHROME-P-450 MEDIATED METABOLISM IN
   RAT-LIVER AND LUNG, SERUM ENZYMATIC-ACTIVITIES AND SERUM-PROTEIN LEVELS}},
Journal = {{ARCHIVES OF TOXICOLOGY}},
Year = {{1982}},
Volume = {{50}},
Number = {{1}},
Pages = {{1-10}},
Publisher = {{SPRINGER VERLAG}},
Address = {{175 FIFTH AVE, NEW YORK, NY 10010}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{WALSETH, F (Reprint Author), UNIV TRONDHEIM,REG HOSP,SCH MED,DEPT PHARMACOL \& TOXICOL,N-7000 TRONDHEIM,NORWAY.
   KAROLINSKA INST,DEPT PHARMACOL,S-10401 STOCKHOLM 60,SWEDEN.
   KAROLINSKA INST,DEPT MED NUTR,S-10401 STOCKHOLM 60,SWEDEN.}},
DOI = {{10.1007/BF00569231}},
ISSN = {{0340-5761}},
Research-Areas = {{Toxicology}},
Web-of-Science-Categories  = {{Toxicology}},
Cited-References = {{AITIO A, 1978, ARCH INT PHARMACOD T, V235, P187.
   ALBRO PW, 1973, BIOCH BIOPHYS ACTA, V36, P380.
   DANIEL JW, 1978, CLIN TOXICOL, V13, P257.
   DVOSKIN YG, 1969, GIG SANIT, V34, P8.
   GORNALL AG, 1949, J BIOL CHEM, V177, P715.
   INGELMANSUNDBER.M, 1980, DEV BIOCH, V13, P299.
   Jaeger R J, 1973, Environ Health Perspect, V3, P95, DOI 10.2307/3428035.
   JOHANNESEN K, 1977, BIOCHIM BIOPHYS ACTA, V496, P115, DOI 10.1016/0304-4165(77)90120-9.
   JOHANNESEN KAM, 1978, ANAL BIOCHEM, V86, P725, DOI 10.1016/0003-2697(78)90800-X.
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0.
   LAKE BG, 1975, TOXICOL APPL PHARM, V32, P355, DOI 10.1016/0041-008X(75)90226-4.
   LAKE BG, 1977, TOXICOL APPL PHARM, V39, P239, DOI 10.1016/0041-008X(77)90157-0.
   LOWRY OH, 1951, J BIOL CHEM, V193, P265.
   MAYER FL, 1972, NATURE, V238, P411, DOI 10.1038/238411a0.
   MEZ J, 1974, B ENVIRON CONTAM TOX, V12, P721.
   NAZIR DJ, 1971, BIOCHEMISTRY-US, V10, P4228, DOI 10.1021/bi00799a012.
   NILSEN OG, 1981, ACTA PHARMACOL TOX, V48, P369.
   NOSHIRO M, 1980, DEV BIOCH, V13, P351.
   OHYAMA T, 1977, TOXICOL APPL PHARM, V40, P355, DOI 10.1016/0041-008X(77)90107-7.
   OMURA T, 1964, J BIOL CHEM, V239, P2370.
   PATEL JM, 1979, TOXICOL APPL PHARM, V48, P337, DOI 10.1016/0041-008X(79)90040-1.
   PINNELL AE, 1978, CLIN CHEM, V24, P80.
   SRIVASTAVA SP, 1978, TOXICOLOGY, V11, P271, DOI 10.1016/S0300-483X(78)91639-6.
   TOFTGARD R, 1980, ACTA PHARMACOL TOX, V46, P353.
   VATSIS KP, 1980, DEV BIOCH, V13, P347.
   WILLIAMS CH, 1962, J BIOL CHEM, V237, P587.
   1974, SCAND J CLIN LAB INV, V33, P287.}},
Number-of-Cited-References = {{27}},
Times-Cited = {{18}},
Journal-ISO = {{Arch. Toxicol.}},
Doc-Delivery-Number = {{NU146}},
Wos-Id = {{ISI:A1982NU14600001}},
}

@article{ ISI:A1982PT96800009,
Author = {KEVY, SV and JACOBSON, MS},
Title = {{HEPATIC-EFFECTS OF A PHTHALATE ESTER PLASTICIZER LEACHED FROM
   POLYVINYL-CHLORIDE) BLOOD BAGS FOLLOWING TRANSFUSION}},
Journal = {{ENVIRONMENTAL HEALTH PERSPECTIVES}},
Year = {{1982}},
Volume = {{45}},
Number = {{NOV}},
Pages = {{57-64}},
Publisher = {{US DEPT HEALTH HUMAN SERVICES PUBLIC HEALTH SERVICE}},
Address = {{NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SERVICES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{KEVY, SV (Reprint Author), CHILDRENS HOSP MED CTR,DEPT MED,BOSTON,MA 02115, USA.
   HARVARD UNIV,SCH MED,BOSTON,MA 02115.}},
DOI = {{10.2307/3429384}},
ISSN = {{0091-6765}},
Research-Areas = {{Environmental Sciences \& Ecology; Public, Environmental \& Occupational
   Health}},
Web-of-Science-Categories  = {{Environmental Sciences; Public, Environmental \& Occupational Health}},
Cited-References = {{ALBRO PW, 1981, DRUG METAB DISPOS, V9, P223.
   BERMAN M, 1967, NIAMD NIH USPHS PUBL, V1703.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   HARPER PV, 1966, RADIOACTIVE PHARM, P335.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   INGELFINGER FJ, 1948, GASTROENTEROLOGY, V11, P646.
   JACOBSON MS, 1977, J LAB CLIN MED, V89, P1066.
   JACOBSON MS, 1974, RES COMMUN CHEM PATH, V9, P315.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   KEVY SV, 1975, TOXICOLOGY PLASTIC D.
   LEBENTHAL E, 1974, MAY GASTR SOC SAN FR.
   QUARFORD.SH, 1971, GASTROENTEROLOGY, V60, P246.
   RANKIN JG, 1961, J LAB CLIN MED, V58, P920.}},
Number-of-Cited-References = {{13}},
Times-Cited = {{36}},
Journal-ISO = {{Environ. Health Perspect.}},
Doc-Delivery-Number = {{PT968}},
Wos-Id = {{ISI:A1982PT96800009}},
}

@article{ ISI:A1982PB13200007,
Author = {ALBRO, PW and JORDAN, ST and SCHROEDER, JL and CORBETT, JT},
Title = {{CHROMATOGRAPHIC-SEPARATION AND QUANTITATIVE-DETERMINATION OF THE
   METABOLITES OF DI-(2-ETHYLHEXYL) PHTHALATE FROM URINE OF
   LABORATORY-ANIMALS}},
Journal = {{JOURNAL OF CHROMATOGRAPHY}},
Year = {{1982}},
Volume = {{244}},
Number = {{1}},
Pages = {{65-79}},
Publisher = {{ELSEVIER SCIENCE BV}},
Address = {{PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{ALBRO, PW (Reprint Author), NIEHS,POB 12233,RES TRIANGLE PK,NC 27709, USA.}},
DOI = {{10.1016/S0021-9673(00)80123-5}},
ISSN = {{0021-9673}},
Research-Areas = {{Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Analytical}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   ALBRO PW, 1981, DRUG METAB DISPOS, V9, P223.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V360, P380.
   BERTHEL G, 1974, J AM OIL CHEM SOC, V51, P540.
   DODGSON KS, 1953, BIOCHEM J, V53, P444.
   DOUGLAS JF, 1981, TOXICOLOGIST, V1, P129.
   FISHBEIN L, 1972, J CHROMATOGR, V70, P365, DOI 10.1016/S0021-9673(00)92702-X.
   FOLK JE, 1963, J BIOL CHEM, V238, P3884.
   FONES WS, 1953, J BIOL CHEM, V201, P847.
   GRAY TJB, 1977, FOOD COSMET TOXICOL, V15, P389, DOI 10.1016/S0015-6264(77)80003-5.
   HARVAN DJ, 1980, BIOMED MASS SPECTROM, V7, P242, DOI 10.1002/bms.1200070604.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   KEGLEVIC D, 1968, J CHEM SOC C, P511, DOI 10.1039/j39680000511.
   MAGNUSON JA, 1966, ANAL CHEM, V38, P1088, DOI 10.1021/ac60240a041.
   PECK CC, 1980, MICROAGGREGATES EXPT, P25.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   SRIVATAVA SP, 1976, CHEMOSPHERE, V3, P177.
   YANAGITA T, 1978, BIOCHEM PHARMACOL, V27, P2283, DOI 10.1016/0006-2952(78)90132-6.
   1981, JUL PHTH C NAT TOX P.
   1973, ENV HLTH PERSP   JAN.}},
Number-of-Cited-References = {{22}},
Times-Cited = {{39}},
Doc-Delivery-Number = {{PB132}},
Wos-Id = {{ISI:A1982PB13200007}},
}

@article{ ISI:A1981LR90100010,
Author = {ALBRO, PW and HASS, JR and PECK, CC and ODAM, DG and CORBETT, JT and
   BAILEY, FJ and BLATT, HE and BARRETT, BB},
Title = {{IDENTIFICATION OF THE METABOLITES OF DI-(2-ETHYLHEXYL) PHTHALATE IN
   URINE FROM THE AFRICAN-GREEN MONKEY}},
Journal = {{DRUG METABOLISM AND DISPOSITION}},
Year = {{1981}},
Volume = {{9}},
Number = {{3}},
Pages = {{223-225}},
Publisher = {{WILLIAMS \& WILKINS}},
Address = {{351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{ALBRO, PW (Reprint Author), NIEHS,ENVIRONM CHEM LAB,POB 12233,RES TRIANGLE PK,NC 27709, USA.
   LETTERMAN ARMY INST RES,DEPT SURG,DIV BLOOD RES,SAN FRANCISCO,CA 94129.}},
ISSN = {{0090-9556}},
Research-Areas = {{Pharmacology \& Pharmacy}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   ALBRO P W, 1970, Biochimica et Biophysica Acta, V219, P437, DOI 10.1016/0005-2736(70)90221-X.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   FISHBEIN L, 1972, J CHROMATOGR, V70, P365, DOI 10.1016/S0021-9673(00)92702-X.
   HARVAN DJ, 1980, BIOMED MASS SPECTROM, V7, P242, DOI 10.1002/bms.1200070604.
   PECK CC, 1978, CLIN RES, V26, pA101.
   PECK CC, 1979, TRANSFUSION, V19, P137, DOI 10.1046/j.1537-2995.1979.19279160282.x.
   PECK CC, 1976, TRANSFUSION, V16, P526.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.}},
Number-of-Cited-References = {{10}},
Times-Cited = {{48}},
Journal-ISO = {{Drug Metab. Dispos.}},
Doc-Delivery-Number = {{LR901}},
Wos-Id = {{ISI:A1981LR90100010}},
}

@article{ ISI:A1981LK81400005,
Author = {PECK, CC and ODOM, DG and ALBRO, PW and JESS, DA and BARRETT, BB},
Title = {{EFFECT OF HEAT ON THE CONVERSION OF DI-2-ETHYLHEXYL PHTHALATE TO
   MONO-2-ETHYLHEXYL PHTHALATE IN HUMAN-PLASMA}},
Journal = {{TRANSFUSION}},
Year = {{1981}},
Volume = {{21}},
Number = {{2}},
Pages = {{163-166}},
Publisher = {{AMER ASSOC BLOOD BANKS}},
Address = {{8101 GLENBROOK RD, BETHESDA, MD 20814-2749}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{USA,DIV CLIN PHARMACOL,SAN FRANCISCO,CA 94129.
   NIEHS,RES TRIANGLE PK,NC 27709.}},
DOI = {{10.1046/j.1537-2995.1981.21281178151.x}},
ISSN = {{0041-1132}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V360, P380.
   CONTRERA.TJ, 1974, TRANSFUSION, V14, P34.
   DEZEEUW RA, 1975, ANAL BIOCHEM, V67, P339, DOI 10.1016/0003-2697(75)90303-6.
   DIXON WJ, 1975, BIOMEDICAL COMPUTER.
   EASTERLI.RE, 1974, P SOC EXP BIOL MED, V147, P572.
   GUESS WL, 1967, DRUG INTELL, V1, P120.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1973, TRANSFUSION, V13, P107.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   JAEGER RJ, 1970, LANCET, V2, P151.
   MIRIPOL JE, 1975, NOIHB22990 CONTR, P2.
   MIRIPOL JE, 1975, COMMUNICATION.
   PECK CC, 1979, TRANSFUSION, V19, P137, DOI 10.1046/j.1537-2995.1979.19279160282.x.
   PECK CC, 1976, WORKSHOP ADENINE RED.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   RUBIN RJ, 1973, NEW ENGL J MED, V288, P915.
   SNEDECOR GW, 1967, STATISTICAL METHODS, P273.
   VESSMAN J, 1978, VOX SANG, V35, P75.
   WINER BJ, 1962, STATISTICAL PRINCIPL, P83.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{12}},
Journal-ISO = {{Transfusion}},
Doc-Delivery-Number = {{LK814}},
Wos-Id = {{ISI:A1981LK81400005}},
}

@article{ ISI:A1981LU01500002,
Author = {COLE, RS and TOCCHI, M and WYE, E and VILLENEUVE, DC and ROCK, G},
Title = {{CONTAMINATION OF COMMERCIAL BLOOD PRODUCTS BY DI-2-ETHYLHEXYL PHTHALATE
   AND MONO-2-ETHYLHEXYL PHTHALATE}},
Journal = {{VOX SANGUINIS}},
Year = {{1981}},
Volume = {{40}},
Number = {{5}},
Pages = {{317-322}},
Publisher = {{KARGER}},
Address = {{ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{CANADIAN RED CROSS,85 PLYMOUTH ST,OTTAWA K1S 3E2,ONTARIO,CANADA.
   CONNAUGHT LABS LTD,WILLOWDALE M2N 5T8,ONTARIO,CANADA.
   ENVIRONM HLTH DIRECTORATE,HLTH PROTECT BRANCH,OTTAWA,ONTARIO,CANADA.
   UNIV OTTAWA,FAC MED,OTTAWA K1N 6N5,ONTARIO,CANADA.}},
ISSN = {{0042-9007}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{ALBRO PW, 1978, TRANSFUSION, V18, P750, DOI 10.1046/j.1537-2995.1978.18679077962.x.
   COLE RS, 1979, 11TH INT C BIOCH TOR.
   CONTRERA.TJ, 1974, TRANSFUSION, V14, P34.
   GILBO CM, 1975, VOX SANG, V29, P242.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   Marcel Y L, 1973, Environ Health Perspect, V3, P119, DOI 10.2307/3428037.
   MARCEL YL, 1970, LANCET, V1, P35.
   PECK CC, 1979, TRANSFUSION, V19, P137, DOI 10.1046/j.1537-2995.1979.19279160282.x.
   ROCK G, 1978, TRANSFUSION, V18, P553, DOI 10.1046/j.1537-2995.1978.18579036383.x.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   Valeri C R, 1973, Environ Health Perspect, V3, P103, DOI 10.2307/3428036.
   VESSMAN J, 1978, VOX SANG, V35, P75.
   VESSMAN J, 1974, J CHROMATOGR, V100, P153, DOI 10.1016/S0021-9673(00)86049-5.
   VILLENEUVE DC, 1978, 17TH ANN M SAN FRANC.
   1980, EPA BARS MANUFACTURE.}},
Number-of-Cited-References = {{15}},
Times-Cited = {{36}},
Journal-ISO = {{Vox Sang.}},
Doc-Delivery-Number = {{LU015}},
Wos-Id = {{ISI:A1981LU01500002}},
}

@article{ ISI:A1980KQ29100004,
Author = {DRAVIAM, EJ and KERKAY, J and PEARSON, KH},
Title = {{SEPARATION AND QUANTITATION OF URINARY PHTHALATES BY HPLC}},
Journal = {{ANALYTICAL LETTERS PART B-CLINICAL AND BIOCHEMICAL ANALYSIS}},
Year = {{1980}},
Volume = {{13}},
Number = {{13}},
Pages = {{1137-1155}},
Publisher = {{MARCEL DEKKER INC}},
Address = {{270 MADISON AVE, NEW YORK, NY 10016}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{CLEVELAND STATE UNIV,DEPT CHEM,CLEVELAND,OH 44115.}},
ISSN = {{0003-2719}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Biochemistry \& Molecular Biology;
   Chemistry, Analytical}},
Cited-References = {{ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   CHEN WS, 1979, ANAL LETT PT B, V12, P1517.
   CHEN WS, 1979, ANAL LETT PT B, V12, P1501.
   CHU I, 1978, DRUG METAB DISPOS, V6, P146.
   EASTERLI.RE, 1974, P SOC EXP BIOL MED, V147, P572.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   JAEGER RJ, 1970, LANCET, V2, P151.
   Stalling D L, 1973, Environ Health Perspect, V3, P159, DOI 10.2307/3428044.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.
   TANAKA A, 1978, TOXICOLOGY, V9, P109, DOI 10.1016/0300-483X(78)90036-7.}},
Number-of-Cited-References = {{14}},
Times-Cited = {{12}},
Doc-Delivery-Number = {{KQ291}},
Wos-Id = {{ISI:A1980KQ29100004}},
}

@article{ ISI:A1980JU63300013,
Author = {LEWANDOWSKI, M and FERNANDES, J and CHEN, TS},
Title = {{ASSESSMENT OF THE TERATOGENIC POTENTIAL OF PLASMA-SOLUBLE EXTRACTS OF
   DIETHYLHEXYL PHTHALATE PLASTICIZED POLYVINYL-CHLORIDE PLASTICS IN RATS}},
Journal = {{TOXICOLOGY AND APPLIED PHARMACOLOGY}},
Year = {{1980}},
Volume = {{54}},
Number = {{1}},
Pages = {{141-147}},
Publisher = {{ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{TRAVENOL LABS INC,DEPT TOXICOL,MORTON GROVE,IL 60053.}},
DOI = {{10.1016/0041-008X(80)90014-9}},
ISSN = {{0041-008X}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Cited-References = {{Banerjee B N, 1973, Toxicology, V1, P151, DOI 10.1016/0300-483X(73)90028-0.
   CARPENTER CP, 1953, AMA ARCH IND HYG OCC, V8, P219.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   Dillingham E O, 1973, Environ Health Perspect, V3, P81, DOI 10.2307/3428033.
   FISBEIN L, 1972, J CHROMATOGR, V70, P365.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   JAGER RJ, 1972, NEW ENGL J MED, V287, P1114.
   NIKONORO.M, 1973, TOXICOL APPL PHARM, V26, P253, DOI 10.1016/0041-008X(73)90259-7.
   PERRAUD J, 1976, LAB ANIM SCI, V26, P293.
   Peters J W, 1973, Environ Health Perspect, V3, P91, DOI 10.2307/3428034.
   SINGH AR, 1974, TOXICOL APPL PHARM, V29, P35, DOI 10.1016/0041-008X(74)90159-8.
   SINGH AR, 1972, J PHARM SCI, V61, P51, DOI 10.1002/jps.2600610107.
   THOMAS JA, 1978, TOXICOL APPL PHARM, V45, P1, DOI 10.1016/0041-008X(78)90024-8.
   THOMAS JA, 1979, TOXICOL APPL PHARM, V51, P523, DOI 10.1016/0041-008X(79)90377-6.}},
Number-of-Cited-References = {{14}},
Times-Cited = {{20}},
Journal-ISO = {{Toxicol. Appl. Pharmacol.}},
Doc-Delivery-Number = {{JU633}},
Wos-Id = {{ISI:A1980JU63300013}},
}

@article{ ISI:A1979JC96500001,
Author = {CHEN, WS and KERKAY, J and PEARSON, KH and PAGANINI, EP and NAKAMOTO, S},
Title = {{DETERMINATION OF URINARY BIS-(2-ETHYLHEXYL)PHTHALATE LEVELS IN
   NON-UREMIC SUBJECTS BY GAS-CHROMATOGRAPHY}},
Journal = {{ANALYTICAL LETTERS PART B-CLINICAL AND BIOCHEMICAL ANALYSIS}},
Year = {{1979}},
Volume = {{12}},
Number = {{15}},
Pages = {{1501-1515}},
Publisher = {{MARCEL DEKKER INC}},
Address = {{270 MADISON AVE, NEW YORK, NY 10016}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{CLEVELAND STATE UNIV,DEPT CHEM,CLEVELAND,OH 44115.
   CLEVELAND CLIN EDUC FDN,DEPT HYPERTENS NEPHROL,CLEVELAND,OH 44106.}},
ISSN = {{0003-2719}},
Research-Areas = {{Biochemistry \& Molecular Biology; Chemistry}},
Web-of-Science-Categories  = {{Biochemical Research Methods; Biochemistry \& Molecular Biology;
   Chemistry, Analytical}},
Cited-References = {{CHEN WS, 1979, 9TH CLIN DIAL TRANSP.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   EASTERLI.RE, 1974, P SOC EXP BIOL MED, V147, P572.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1970, LANCET, V2, P151.
   LEWIS LM, 1978, CLIN CHEM, V24, P741.}},
Number-of-Cited-References = {{7}},
Times-Cited = {{5}},
Doc-Delivery-Number = {{JC965}},
Wos-Id = {{ISI:A1979JC96500001}},
}

@article{ ISI:A1979GZ24800015,
Author = {AHMAD, N and AHMAD, SA and KHAN, AA and SHOEB, A},
Title = {{ISOLATION OF DI-N-2-PROPYLPENTYL PHTHALATE FROM HUMAN-URINE}},
Journal = {{EXPERIENTIA}},
Year = {{1979}},
Volume = {{35}},
Number = {{6}},
Pages = {{736-737}},
Publisher = {{BIRKHAUSER VERLAG AG}},
Address = {{PO BOX 133 KLOSTERBERG 23, CH-4010 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{AHMAD, N (Reprint Author), ALIGARH MUSLIM UNIV,INST OPHTHALMOL,DIV BIOCHEM,ALIGARH 202001,UTTAR PRADESH,INDIA.
   CENT DRUG RES INST,LUCKNOW 226001,UTTAR PRADESH,INDIA.}},
DOI = {{10.1007/BF01968212}},
ISSN = {{0014-4754}},
Research-Areas = {{Science \& Technology - Other Topics}},
Web-of-Science-Categories  = {{Multidisciplinary Sciences}},
Cited-References = {{AGARWAL LP, 1962, 19 CONC OPHTH, P821.
   ASHTON N, 1962, 19 C OPHTH NEW DELH, P828.
   EALES H, 1880, BIRMINGHAM MED REV, V9, P262.
   EMERY EM, 1960, ANAL CHEM, V32, P1495, DOI 10.1021/ac60167a033.
   HUNNEMAN D. H., 1968, TETRAHEDRON LETT, V14, P1743.
   LOWRY OH, 1951, J BIOL CHEM, V193, P265.
   SHOEB A, COMMUNICATION.}},
Number-of-Cited-References = {{7}},
Times-Cited = {{0}},
Journal-ISO = {{Experientia}},
Doc-Delivery-Number = {{GZ248}},
Wos-Id = {{ISI:A1979GZ24800015}},
}

@article{ ISI:A1979HA20300003,
Author = {LAGENTE, M and LAFARGE, FD and VALDIGUIE, P},
Title = {{INFLUENCE OF PHTHALATE-ESTERS ON HUMAN-PLASMA LECITHIN-CHOLESTEROL
   ACYLTRANSFERASE}},
Journal = {{LIPIDS}},
Year = {{1979}},
Volume = {{14}},
Number = {{6}},
Pages = {{533-534}},
Publisher = {{AMER OIL CHEMISTS SOC}},
Address = {{1608 BROADMOOR DRIVE, CHAMPAIGN, IL 61821-0489}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{LAGENTE, M (Reprint Author), FAC MED RANGUEIL,BIOCHIM LAB,CHEMIN VALLON,F-31054 TOULOUSE,FRANCE.}},
DOI = {{10.1007/BF02533527}},
ISSN = {{0024-4201}},
Research-Areas = {{Biochemistry \& Molecular Biology; Nutrition \& Dietetics}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Nutrition \& Dietetics}},
Cited-References = {{ALCINDOR LG, 1977, CLIN CHIM ACTA, V81, P177, DOI 10.1016/0009-8981(77)90009-2.
   ALDYREVA MV, 1974, GIG T SOSTOYANIE SPE, P154.
   BELL FP, 1976, LIPIDS, V11, P769, DOI 10.1007/BF02533053.
   BELL FP, 1978, LIPIDS, V13, P66, DOI 10.1007/BF02533369.
   DILLINGHAM EO, 1973, ENV HLTH PERSPECTIVE, P81.
   EASTERLI.RE, 1974, P SOC EXP BIOL MED, V147, P572.
   FOLCH J, 1957, J BIOL CHEM, V226, P497.
   Shibko S. J., 1973, Environmental Health Perspectives, P131.
   STOKKE KT, 1971, SCAND J CLIN LAB INV, V27, P21, DOI 10.3109/00365517109080184.
   ZAREMBO OK, 1976, GIG SANIT, V5, P106.}},
Number-of-Cited-References = {{10}},
Times-Cited = {{10}},
Journal-ISO = {{Lipids}},
Doc-Delivery-Number = {{HA203}},
Wos-Id = {{ISI:A1979HA20300003}},
}

@article{ ISI:A1979GU42900006,
Author = {PECK, CC and ODOM, DG and FRIEDMAN, HI and ALBRO, PW and HASS, JR and
   BRADY, JT and JESS, DA},
Title = {{DI-2-ETHYLHEXYL PHTHALATE (DEHP) AND MONO-2-ETHYLHEXYL PHTHALATE (MEHP)
   ACCUMULATION IN WHOLE-BLOOD AND RED-CELL CONCENTRATES}},
Journal = {{TRANSFUSION}},
Year = {{1979}},
Volume = {{19}},
Number = {{2}},
Pages = {{137-146}},
Publisher = {{AMER ASSOC BLOOD BANKS}},
Address = {{8101 GLENBROOK RD, BETHESDA, MD 20814-2749}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{PECK, CC (Reprint Author), LETTERMAN ARMY INST RES,DEPT SURG,DIV BLOOD RES,SAN FRANCISCO,CA 94129, USA.
   NIEHS,RES TRIANGLE PK,NC 27709.
   CORNELL COLL,MT VERNON,IA 52314.
   UNIV ARIZONA,HLTH SCI CTR,DEPT SURG,TUCSON,AZ 85721.
   UNIV COLORADO,MED CTR,DENVER,CO 80220.}},
DOI = {{10.1046/j.1537-2995.1979.19279160282.x}},
ISSN = {{0041-1132}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1974, J CHROMATOGR, V94, P209, DOI 10.1016/S0021-9673(01)92368-4.
   AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   BROCKMAN HL, 1973, J BIOL CHEM, V248, P4965.
   CONTRERA.TJ, 1974, TRANSFUSION, V14, P34.
   DARBY TD, 1976, PHARMACOLOGIST, V18, P171.
   DIXON W.J., 1975, BMDP BIOMEDICAL COMP.
   DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330.
   FISHMAN WH, 1960, PLASMA PROTEINS, V2, P70.
   HOROWITZ DL, 1976, 25 NAV MED RES I REP.
   LAKE BG, 1975, TOXICOL APPL PHARM, V32, P355, DOI 10.1016/0041-008X(75)90226-4.
   MILLER WV, 1974, TECHNICAL METHODS PR.
   MIRIPOL JE, 1977, TRANSFUSION, V17, P71, DOI 10.1046/j.1537-2995.1977.17177128891.x.
   MIRIPOL JE, 1975, NOIHB22990 CONTR.
   PECK CC, 1976, S3021 LETT ARM I RES, P95.
   PECK CC, 1976, OCT P DEP HEW FOOD D.
   PETERSON RV, 1975, NIHNHLI732908B CONTR, P35.
   RUBIN RT, P DEP HEW FOOD DRUG.
   SUGIURA M, 1976, CHEM PHARM BULL, V24, P72.
   SWISHER SN, 1977, TRANSFUSION, V17, P309, DOI 10.1046/j.1537-2995.1977.17477216858.x.
   WINER BJ, 1962, STATISTICAL PRINCIPL, P518.
   1970, PHARMACOPEIA US AM 1, P47.}},
Number-of-Cited-References = {{22}},
Times-Cited = {{51}},
Journal-ISO = {{Transfusion}},
Doc-Delivery-Number = {{GU429}},
Wos-Id = {{ISI:A1979GU42900006}},
}

@article{ ISI:A1978ER16500005,
Author = {LUSTER, MI and ALBRO, PW and CHAE, K and CLARK, G and MCKINNEY, JD},
Title = {{RADIOIMMUNOASSAY FOR MONO-(2-ETHYLHEXYL) PHTHALATE IN UNEXTRACTED PLASMA}},
Journal = {{CLINICAL CHEMISTRY}},
Year = {{1978}},
Volume = {{24}},
Number = {{3}},
Pages = {{429-432}},
Publisher = {{AMER ASSOC CLINICAL CHEMISTRY}},
Address = {{2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{LUSTER, MI (Reprint Author), NIEHS,RES TRIANGLE PK,NC 27709, USA.}},
ISSN = {{0009-9147}},
Research-Areas = {{Medical Laboratory Technology}},
Web-of-Science-Categories  = {{Medical Laboratory Technology}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V360, P380.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   HUNTER W, 1973, HDB EXPT IMMUNOLOGY, P1.
   HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0.
   JAEGER R, 1972, N ENGL J MED, V278, P1114.
   KABAT EA, 1964, EXPT IMMUNOCHEMISTRY, P789.
   Krauskopf L G, 1973, Environ Health Perspect, V3, P61, DOI 10.2307/3428031.
   LAKE BG, 1975, TOXICOL APPL PHARM, V32, P355, DOI 10.1016/0041-008X(75)90226-4.
   MARCEL YL, 1970, LANCET, V1, P35.
   ROTTA J, 1971, J EXP MED, V134, P1298, DOI 10.1084/jem.134.5.1298.
   Shibko S I, 1973, Environ Health Perspect, V3, P131, DOI 10.2307/3428039.
   TABACHNICK M, 1960, J BIOL CHEM, V235, P1051.}},
Number-of-Cited-References = {{13}},
Times-Cited = {{10}},
Journal-ISO = {{Clin. Chem.}},
Doc-Delivery-Number = {{ER165}},
Wos-Id = {{ISI:A1978ER16500005}},
}

@article{ ISI:A1978EY40400001,
Author = {LEWIS, LM and FLECHTNER, TW and KERKAY, J and PEARSON, KH and NAKAMOTO,
   S},
Title = {{BIS(2-ETHYLHEXYL) PHTHALATE CONCENTRATIONS IN SERUM OF HEMODIALYSIS
   PATIENTS}},
Journal = {{CLINICAL CHEMISTRY}},
Year = {{1978}},
Volume = {{24}},
Number = {{5}},
Pages = {{741-746}},
Publisher = {{AMER ASSOC CLINICAL CHEMISTRY}},
Address = {{2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{CLEVELAND STATE UNIV,DEPT CHEM,CLEVELAND,OH 44115.
   CLEVELAND CLIN EDUC FDN,DEPT HYPERTENS \& NEPHROL,CLEVELAND,OH 44106.}},
ISSN = {{0009-9147}},
Research-Areas = {{Medical Laboratory Technology}},
Web-of-Science-Categories  = {{Medical Laboratory Technology}},
Cited-References = {{BELL FP, 1976, LIPIDS, V11, P216, DOI 10.1007/BF02532860.
   BELL FP, 1976, LIPIDS, V11, P769, DOI 10.1007/BF02533053.
   CHEN WK, UNPUBLISHED.
   Dillingham E O, 1973, Environ Health Perspect, V3, P81, DOI 10.2307/3428033.
   EASTERLI.RE, 1974, P SOC EXP BIOL MED, V147, P572.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   JAEGER R, 1971, THESIS J HOPKINS SCH.
   JAEGER RJ, 1970, LANCET, V2, P151.
   Krauskopf L G, 1973, Environ Health Perspect, V3, P61, DOI 10.2307/3428031.
   LAKE BG, 1975, TOXICOL APPL PHARM, V32, P355, DOI 10.1016/0041-008X(75)90226-4.
   MARCEL YL, 1973, ENVIRON HLTH PERSPEC, V3, P141.
   ONO K, 1975, JAMA-J AM MED ASSOC, V234, P948, DOI 10.1001/jama.234.9.948.
   PIECHOCKI J, 1973, THESIS U MARYLAND.
   REDDY JK, 1976, LIFE SCI, V18, P941, DOI 10.1016/0024-3205(76)90412-4.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   Schulz C O, 1973, Environ Health Perspect, V3, P123, DOI 10.2307/3428038.
   Stein M S, 1973, Environ Health Perspect, V3, P149, DOI 10.2307/3428042.
   1972, SIMULTANEOUS CHOLEST.}},
Number-of-Cited-References = {{18}},
Times-Cited = {{63}},
Journal-ISO = {{Clin. Chem.}},
Doc-Delivery-Number = {{EY404}},
Wos-Id = {{ISI:A1978EY40400001}},
}

@article{ ISI:A1978EL28900011,
Author = {BELL, FP and PATT, CS and BRUNDAGE, B and GILLIES, PJ and PHILLIPS, WA},
Title = {{STUDIES ON LIPID BIOSYNTHESIS AND CHOLESTEROL CONTENT OF LIVER AND
   SERUM-LIPOPROTEINS IN RATS FED VARIOUS PHTHALATE ESTERS}},
Journal = {{LIPIDS}},
Year = {{1978}},
Volume = {{13}},
Number = {{1}},
Pages = {{66-74}},
Publisher = {{AMER OIL CHEMISTS SOC}},
Address = {{1608 BROADMOOR DRIVE, CHAMPAIGN, IL 61821-0489}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{BELL, FP (Reprint Author), UPJOHN CO,DIABET \& ATHEROSCLEROSIS RES,KALAMAZOO,MI 49001, USA.}},
DOI = {{10.1007/BF02533369}},
ISSN = {{0024-4201}},
Research-Areas = {{Biochemistry \& Molecular Biology; Nutrition \& Dietetics}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Nutrition \& Dietetics}},
Cited-References = {{ABELL LL, 1952, J BIOL CHEM, V195, P357.
   BELL FP, 1976, LIPIDS, V11, P216, DOI 10.1007/BF02532860.
   BELL FP, 1977, LIPIDS, V12, P581, DOI 10.1007/BF02533385.
   BELL FP, 1976, LIPIDS, V11, P769, DOI 10.1007/BF02533053.
   BELL FP, 1975, P CAN FED BIOL SOC, V18, P57.
   BELL FP, 1976, ARTERY, V2, P384.
   BORREBAEK B, 1975, ACTA PHYSIOL SCAND, V95, P448, DOI 10.1111/j.1748-1716.1975.tb10073.x.
   CARPENTER CP, 1953, AMA ARCH IND HYG OCC, V8, P219.
   CHRISTIANSEN R, 1976, FEBS LETT, V62, P313, DOI 10.1016/0014-5793(76)80083-X.
   CONTRERA.TJ, 1974, TRANSFUSION, V14, P34.
   Dillingham E O, 1973, Environ Health Perspect, V3, P81, DOI 10.2307/3428033.
   EASTERLI.RE, 1974, P SOC EXP BIOL MED, V147, P572.
   FOLCH J, 1957, J BIOL CHEM, V226, P497.
   Graham P R, 1973, Environ Health Perspect, V3, P3, DOI 10.2307/3428023.
   HARRIS R S, 1956, AMA Arch Ind Health, V13, P259.
   Hatch F T, 1968, Adv Lipid Res, V6, P1.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1973, TRANSFUSION, V13, P107.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   JAEGER RJ, 1970, LANCET, V2, P151.
   KASUYA M, 1974, B ENVIRON CONTAM TOX, V12, P167.
   KASUYA M, 1973, JAP J HYG, V28, P248.
   LOPEZ A, 1971, CLIN CHEM, V17, P994.
   Marcel Y L, 1970, Chem Phys Lipids, V4, P417.
   MARX JL, 1972, SCIENCE, V178, P46, DOI 10.1126/science.178.4056.46.
   MAYER FL, 1972, NATURE, V238, P411, DOI 10.1038/238411a0.
   MCNAMARA DJ, 1972, BIOCH REGULATORY MEC, P205.
   MES J, 1974, B ENVIRON CONTAM TOX, V12, P721.
   NAZIR DJ, 1971, BIOCHEMISTRY, V10, P4428.
   PHILLIPS WA, 1973, P SOC EXP BIOL MED, V143, P733.
   PHILLIPS WA, 1954, J NUTR, V53, P481.
   PHILLIPS WA, 1977, LIPIDS, V12, P10, DOI 10.1007/BF02532965.
   REDDY JK, 1976, LIFE SCI, V18, P941, DOI 10.1016/0024-3205(76)90412-4.
   ROGERS AF, 1969, LANCET, V2, P1246.
   RUBIN RJ, 1973, NEW ENGL J MED, V288, P915.
   Rubin R J, 1973, Environ Health Perspect, V3, P53, DOI 10.2307/3428030.
   RUDEL LL, 1973, J LIPID RES, V14, P364.
   SCHURR PE, 1976, ATHEROSCLEROSIS DRUG, P215.
   SINGH AR, 1972, J PHARM SCI, V61, P51, DOI 10.1002/jps.2600610107.
   STEIN MS, 1974, J NUTR, V104, P187.
   SUGAWARA N, 1974, B ENVIRON CONTAM TOX, V12, P421.
   SUGAWARA N, 1974, TOXICOL APPL PHARM, V30, P87, DOI 10.1016/0041-008X(74)90249-X.
   WILLIAMS DT, 1973, J AGR FOOD CHEM, V21, P1128, DOI 10.1021/jf60190a028.}},
Number-of-Cited-References = {{44}},
Times-Cited = {{31}},
Journal-ISO = {{Lipids}},
Doc-Delivery-Number = {{EL289}},
Wos-Id = {{ISI:A1978EL28900011}},
}

@article{ ISI:A1978FU92200008,
Author = {BELL, FP and PATT, CS and GILLIES, PJ},
Title = {{EFFECT OF PHTHALATE ESTERS ON SERUM-CHOLESTEROL AND LIPID BIOSYNTHESIS
   IN LIVER, TESTES, AND EPIDIDYMAL FAT IN RAT AND RABBIT}},
Journal = {{LIPIDS}},
Year = {{1978}},
Volume = {{13}},
Number = {{10}},
Pages = {{673-678}},
Publisher = {{AMER OIL CHEMISTS SOC}},
Address = {{1608 BROADMOOR DRIVE, CHAMPAIGN, IL 61821-0489}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{BELL, FP (Reprint Author), UPJOHN CO,DIABET \& ATHEROSCLEROSIS RES,KALAMAZOO,MI 49001, USA.}},
DOI = {{10.1007/BF02533744}},
ISSN = {{0024-4201}},
Research-Areas = {{Biochemistry \& Molecular Biology; Nutrition \& Dietetics}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Nutrition \& Dietetics}},
Cited-References = {{BELL FP, 1976, LIPIDS, V11, P216, DOI 10.1007/BF02532860.
   BELL FP, 1977, LIPIDS, V12, P581, DOI 10.1007/BF02533385.
   BELL FP, 1976, LIPIDS, V11, P769, DOI 10.1007/BF02533053.
   Bell F P, 1970, Lipids, V5, P153, DOI 10.1007/BF02531115.
   BELL FP, 1978, LIPIDS, V13, P66, DOI 10.1007/BF02533369.
   BELL FP, 1976, EXP MOL PATHOL, V25, P279, DOI 10.1016/0014-4800(76)90038-1.
   FOLCH J, 1957, J BIOL CHEM, V226, P497.
   GIAM CS, 1978, SCIENCE, V199, P419, DOI 10.1126/science.199.4327.419-a.
   GLOMSET JA, 1970, AM J CLIN NUTR, V23, P1129.
   HERODEK S, 1972, LIPIDS, V7, P572, DOI 10.1007/BF02531958.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   JACOBSON MS, 1977, J LAB CLIN MED, V89, P1066.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   LAKE BG, 1975, TOXICOL APPL PHARM, V32, P355, DOI 10.1016/0041-008X(75)90226-4.
   LAKE BG, 1977, TOXICOL APPL PHARM, V39, P239, DOI 10.1016/0041-008X(77)90157-0.
   MAYER FL, 1972, NATURE, V238, P411, DOI 10.1038/238411a0.
   MES J, 1974, B ENVIRON CONTAM TOX, V12, P721.
   NAZIR DJ, 1971, BIOCHEMISTRY, V10, P4428.
   REDDY JK, 1976, LIFE SCI, V18, P941, DOI 10.1016/0024-3205(76)90412-4.
   RUBIN RJ, 1973, NEW ENGL J MED, V288, P915.
   RUDEL LL, 1973, J LIPID RES, V14, P364.
   SPERRY WM, 1950, J BIOL CHEM, V187, P97.
   TAKAHASHI T, 1977, BIOCHEM PHARMACOL, V26, P19.
   TANAKA A, 1975, TOXICOLOGY, V4, P253, DOI 10.1016/0300-483X(75)90105-5.
   WILLIAMS DT, 1973, J AGR FOOD CHEM, V21, P1128, DOI 10.1021/jf60190a028.
   WILLIAMS DT, 1974, B ENVIRON CONTAM TOX, V11, P371.}},
Number-of-Cited-References = {{26}},
Times-Cited = {{40}},
Journal-ISO = {{Lipids}},
Doc-Delivery-Number = {{FU922}},
Wos-Id = {{ISI:A1978FU92200008}},
}

@article{ ISI:A1978FC33400003,
Author = {BAKER, RWR},
Title = {{DIETHYLHEXYL PHTHALATE AS A FACTOR IN BLOOD-TRANSFUSION AND HEMODIALYSIS}},
Journal = {{TOXICOLOGY}},
Year = {{1978}},
Volume = {{9}},
Number = {{4}},
Pages = {{319-329}},
Publisher = {{ELSEVIER SCI IRELAND LTD}},
Address = {{CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE,
   IRELAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{BAKER, RWR (Reprint Author), GUYS HOSP,SCH MED,DEPT CHEM PATHOL,LONDON SE1 9RT,ENGLAND.}},
DOI = {{10.1016/0300-483X(78)90015-X}},
ISSN = {{0300-483X}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Cited-References = {{ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V306, P380, DOI 10.1016/0005-2760(73)90176-8.
   ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1975, XENOBIOTICA, V5, P625.
   BELL FP, 1977, LIPIDS, V12, P581, DOI 10.1007/BF02533385.
   CALLEY D, 1966, J PHARM SCI, V55, P158, DOI 10.1002/jps.2600550206.
   CARPENTER CP, 1953, AMA ARCH IND HYG OCC, V8, P219.
   CATER BR, 1976, BIOCHEM SOC T, V4, P652.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   DEHAAN RL, 1971, NATURE-NEW BIOL, V231, P85.
   Dillingham E O, 1973, Environ Health Perspect, V3, P81, DOI 10.2307/3428033.
   DUKE HN, 1968, LANCET, V2, P21.
   EASTERLI.RE, 1974, P SOC EXP BIOL MED, V147, P572.
   FAYZ S, 1977, J PHARM PHARMACOL, V29, P407.
   FISHBEIN L, 1972, J CHROMATOGR, V70, P365, DOI 10.1016/S0021-9673(00)92702-X.
   Gesler R M, 1973, Environ Health Perspect, V3, P73, DOI 10.2307/3428032.
   GIBSON TP, 1976, J LAB CLIN MED, V87, P519.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1973, TRANSFUSION, V13, P107.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   Stalling D L, 1973, Environ Health Perspect, V3, P159, DOI 10.2307/3428044.
   JONES AE, 1975, TOXICOL APPL PHARM, V31, P283, DOI 10.1016/0041-008X(75)90163-5.
   KIM SW, 1976, J PHARM SCI, V65, P670, DOI 10.1002/jps.2600650510.
   Krauskopf L G, 1973, Environ Health Perspect, V3, P61, DOI 10.2307/3428031.
   LAKE BG, 1975, TOXICOL APPL PHARM, V32, P355, DOI 10.1016/0041-008X(75)90226-4.
   LAKE BG, 1976, BIOCHEM SOC T, V4, P654.
   LAKE BG, 1976, TOXICOLOGY, V6, P341, DOI 10.1016/0300-483X(76)90038-X.
   LAWRENCE WH, 1975, ENVIRON RES, V9, P1, DOI 10.1016/0013-9351(75)90043-2.
   LEE H, 1974, EXPERIENTIA, V30, P800, DOI 10.1007/BF01924194.
   LINDNER A, 1974, NEW ENGL J MED, V290, P697, DOI 10.1056/NEJM197403282901301.
   Marcel Y L, 1973, Environ Health Perspect, V3, P119, DOI 10.2307/3428037.
   MARCEL YL, 1970, CHEM PHYS LIPIDS, V4, P418, DOI 10.1016/0009-3084(70)90040-X.
   Mayer F L Jr, 1973, Environ Health Perspect, V3, P153, DOI 10.2307/3428043.
   MAYER FL, 1972, NATURE, V238, P411, DOI 10.1038/238411a0.
   MELANCON MJ, 1976, DRUG METAB DISPOS, V4, P112.
   MEYLER FL, 1960, CIRC RES, V8, P44.
   MIRIPOL JE, 1975, NO1HP22990 CONTR.
   Nazir D J, 1973, Environ Health Perspect, V3, P141, DOI 10.2307/3428041.
   NAZIR DJ, 1971, BIOCHEMISTRY-US, V10, P4228, DOI 10.1021/bi00799a012.
   NEERGAARD J, 1971, Scandinavian Journal of Urology and Nephrology, V5, P141, DOI 10.3109/00365597109133592.
   OLEARY RK, 1968, J PHARM SCI, V57, P12, DOI 10.1002/jps.2600570102.
   ONO K, 1975, JAMA-J AM MED ASSOC, V234, P948, DOI 10.1001/jama.234.9.948.
   PATTY FA, 1962, IND HYGIENE TOXICOLO, V2, P1906.
   PEAKALL D B, 1975, Residue Reviews, V54, P1.
   POOLE CF, 1977, J CHROMATOGR, V132, P511, DOI 10.1016/S0021-9673(00)82915-5.
   RUBIN RJ, 1976, TRANSFUSION, V16, P330.
   SANDERS HO, 1973, ENVIRON RES, V6, P84, DOI 10.1016/0013-9351(73)90020-0.
   Schulz C O, 1973, Environ Health Perspect, V3, P123, DOI 10.2307/3428038.
   SHAFFER CB, 1945, J IND HYG TOXICOL, V27, P130.
   SINGH AR, 1974, TOXICOL APPL PHARM, V29, P35, DOI 10.1016/0041-008X(74)90159-8.
   SINGH AR, 1974, TOXICOL APPL PHARMAC, V32, P566.
   SINGH AR, 1972, J PHARM SCI, V61, P51, DOI 10.1002/jps.2600610107.
   SINGH AR, 1973, J PHARM SCI, V62, P1596, DOI 10.1002/jps.2600621004.
   SRIVASTAVA SP, 1975, ENVIRON PHYSIOL BIOC, V5, P178.
   STERN I, 1974, PHARMACOLOGIST, V16, P283.
   TANAKA A, 1975, TOXICOLOGY, V4, P253, DOI 10.1016/0300-483X(75)90105-5.
   Valeri C R, 1973, Environ Health Perspect, V3, P103, DOI 10.2307/3428036.
   VESSMAN J, 1974, J CHROMATOGR, V100, P153, DOI 10.1016/S0021-9673(00)86049-5.
   WADDELL WJ, 1977, TOXICOL APPL PHARM, V39, P339, DOI 10.1016/0041-008X(77)90167-3.
   WILLIAMS DT, 1976, J ASSOC OFF ANA CHEM, V59, P32.
   1975, LANCET, V1, P1172.
   1976, MODERN PLASTICS  MAR, P38.}},
Number-of-Cited-References = {{62}},
Times-Cited = {{36}},
Journal-ISO = {{Toxicology}},
Doc-Delivery-Number = {{FC334}},
Wos-Id = {{ISI:A1978FC33400003}},
}

@article{ ISI:A1978FC37100011,
Author = {VESSMAN, J and RIETZ, G},
Title = {{FORMATION OF MONO(ETHYLHEXYL)PHTHALATE FROM DI(ETHYLHEXYL)PHTHALATE IN
   HUMAN-PLASMA STORED IN PVC BAGS AND ITS PRESENCE IN FRACTIONATED
   PLASMA-PROTEINS}},
Journal = {{VOX SANGUINIS}},
Year = {{1978}},
Volume = {{35}},
Number = {{1-2}},
Pages = {{75-80}},
Publisher = {{KARGER}},
Address = {{ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{AB KABI,DEPT RES,ANALYT CHEM,S-10425 STOCKHOLM,SWEDEN.}},
ISSN = {{0042-9007}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{BJORLING H, 1972, VOX SANG, V23, P18.
   CARTER JE, 1974, DRUG METAB DISPOS, V2, P341.
   GILBO CM, 1975, VOX SANG, V29, P242.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   PETERSEN RV, 1977, J PHARM SCI, V66, P546.
   ROWLAND IR, 1977, FOOD COSMET TOXICOL, V15, P17, DOI 10.1016/S0015-6264(77)80257-5.
   SCHLENK H, 1960, ANAL CHEM, V32, P1412, DOI 10.1021/ac60167a011.
   VESSMAN J, 1974, J CHROMATOGR, V100, P153, DOI 10.1016/S0021-9673(00)86049-5.
   VESSMAN J, 1970, ACTA PHARM SUEC, V7, P363.}},
Number-of-Cited-References = {{9}},
Times-Cited = {{22}},
Journal-ISO = {{Vox Sang.}},
Doc-Delivery-Number = {{FC371}},
Wos-Id = {{ISI:A1978FC37100011}},
}

@article{ ISI:A1977CP73100003,
Author = {LEE, HY and AUSLANDER, SE and KALMUS, GW},
Title = {{TOXICITY OF DI(2-ETHYLHEXYL) PHTHALATE IN CHICK-EMBRYOS GEL
   ELECTROPHORETIC ANALYSIS OF SERUM-PROTEINS}},
Journal = {{COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-PHARMACOLOGY TOXICOLOGY \&
   ENDOCRINOLOGY}},
Year = {{1977}},
Volume = {{56}},
Number = {{1}},
Pages = {{9-12}},
Publisher = {{PERGAMON-ELSEVIER SCIENCE LTD}},
Address = {{THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{RUTGERS STATE UNIV,DEPT BIOL,CAMDEN,NJ 08102.}},
DOI = {{10.1016/0306-4492(77)90041-7}},
ISSN = {{0742-8413}},
Research-Areas = {{Biochemistry \& Molecular Biology; Endocrinology \& Metabolism;
   Toxicology; Zoology}},
Web-of-Science-Categories  = {{Biochemistry \& Molecular Biology; Endocrinology \& Metabolism;
   Toxicology; Zoology}},
Cited-References = {{BOWER RK, 1970, J PHARMACOL EXP THER, V171, P314.
   DEHAAN RL, 1971, NATURE-NEW BIOL, V231, P85.
   GRABOWSK.CT, 1966, DEV BIOL, V13, P199, DOI 10.1016/0012-1606(66)90064-9.
   GUESS W L, 1968, Journal of Biomedical Materials Research, V2, P313, DOI 10.1002/jbm.820020304.
   GUESS WL, 1967, DRUG INTELL, V1, P120.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   LEE HY, 1974, GROWTH, V38, P301.
   LEE H, 1974, EXPERIENTIA, V30, P800, DOI 10.1007/BF01924194.
   MACFARLANE RG, 1961, FUNCTION BLOOD.
   MARCEL YL, 1970, CHEM PHYS LIPIDS, V4, P418, DOI 10.1016/0009-3084(70)90040-X.
   MARCEL YL, 1970, LANCET, V1, P35.
   PEACOCK AC, 1965, SCIENCE, V147, P1451, DOI 10.1126/science.147.3664.1451.
   WELLER EM, 1962, DEV BIOL, V4, P517, DOI 10.1016/0012-1606(62)90055-6.}},
Number-of-Cited-References = {{14}},
Times-Cited = {{2}},
Journal-ISO = {{Comp. Biochem. Physiol. C-Pharmacol. Toxicol. Endocrinol.}},
Doc-Delivery-Number = {{CP731}},
Wos-Id = {{ISI:A1977CP73100003}},
}

@article{ ISI:A1977DY23000006,
Author = {STERN, IJ and MIRIPOL, JE and IZZO, RS and LUECK, JD},
Title = {{PHYSICOCHEMICAL ASPECTS OF EXTRACTION IN BLOOD AND DISPOSITION IN RATS
   OF DI-(2-ETHYLHEXYL) PHTHALATE PLASTICIZER}},
Journal = {{TOXICOLOGY AND APPLIED PHARMACOLOGY}},
Year = {{1977}},
Volume = {{41}},
Number = {{3}},
Pages = {{507-522}},
Publisher = {{ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{BAXTER TRAVENOL LABS,BIOCHEM SECT,MORTON GROVE,IL 60053.}},
DOI = {{10.1016/S0041-008X(77)80006-9}},
ISSN = {{0041-008X}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V360, P380.
   CONTRERA.TJ, 1974, TRANSFUSION, V14, P34.
   COOK CD, 1962, ANAL CHEM, V34, P1177, DOI 10.1021/ac60189a054.
   DANIEL C, 1971, FITTING EQUATIONS DA, P193.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   DARBY TD, 1973, N ENGL J MED, V290, P579.
   FISER RH, 1974, J NUTR, V104, P223.
   GILBO CM, 1975, VOX SANG, V29, P242.
   GUESS WL, 1967, DRUG INTELL, V1, P120.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   HILLYARD L. A., 1955, JOUR BIOL CHEM, V214, P79.
   Jaeger R J, 1973, Environ Health Perspect, V3, P95, DOI 10.2307/3428035.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   KELLNER A, 1951, J EXP MED, V93, P373, DOI 10.1084/jem.93.4.373.
   KEVY SV, 1975, PHS722968 NIH CONTR.
   LAWRENCE WH, 1975, ENVIRON RES, V9, P1, DOI 10.1016/0013-9351(75)90043-2.
   MAHIN DT, 1966, ANAL BIOCHEM, V16, P500, DOI 10.1016/0003-2697(66)90233-8.
   Marcel Y L, 1973, Environ Health Perspect, V3, P119, DOI 10.2307/3428037.
   MCNAIR HM, 1969, BASIC GAS CHROMATOGR, P150.
   MES J, 1974, B ENVIRON CONTAM TOX, V12, P721.
   MILLER LL, 1973, ISOLATED LIVER PERFU.
   MIRIPOL JE, 1977, TRANSFUSION, V17, P67.
   MIRIPOL JE, 1975, NO1HB22990 NIH CONTR.
   Notari RE, 1971, BIOPHARMACEUTICS PHA.
   PECK CC, 1976, PHARMACOLOGIST, V18, P195.
   ROWLAND IR, 1974, FOOD COSMET TOXICOL, V12, P293, DOI 10.1016/0015-6264(74)90001-7.
   RUBIN RJ, 1973, NEW ENGL J MED, V288, P915.
   Rubin R J, 1973, Environ Health Perspect, V3, P53, DOI 10.2307/3428030.
   SCHOTZ MC, 1957, AM J PHYSIOL, V188, P390.
   Schulz C O, 1973, Environ Health Perspect, V3, P123, DOI 10.2307/3428038.
   SCHULZ CO, 1975, TOXICOL APPL PHARM, V33, P514, DOI 10.1016/0041-008X(75)90077-0.
   SINGH AR, 1974, TOXICOL APPL PHARM, V29, P35, DOI 10.1016/0041-008X(74)90159-8.
   STERN I, 1974, PHARMACOLOGIST, V16, P283.
   SWINYARD EA, 1976, J PHARM SCI, V65, P733, DOI 10.1002/jps.2600650525.
   VESSMAN J, 1974, J CHROMATOGR, V100, P153, DOI 10.1016/S0021-9673(00)86049-5.
   Wallin R F, 1974, Bull Parenter Drug Assoc, V28, P278.}},
Number-of-Cited-References = {{37}},
Times-Cited = {{16}},
Journal-ISO = {{Toxicol. Appl. Pharmacol.}},
Doc-Delivery-Number = {{DY230}},
Wos-Id = {{ISI:A1977DY23000006}},
}

@article{ ISI:A1977CZ73100018,
Author = {WADDELL, WJ and MARLOWE, C and MIRIPOL, JE and GARVIN, PJ},
Title = {{DISTRIBUTION IN MICE OF INTRAVENOUSLY ADMINISTERED PLASMA SOLUTIONS OF
   {[}DI-2-ETHYLHEXYL-C-14] PHTHALATE DETERMINED BY WHOLE-BODY
   AUTORADIOGRAPHY}},
Journal = {{TOXICOLOGY AND APPLIED PHARMACOLOGY}},
Year = {{1977}},
Volume = {{39}},
Number = {{2}},
Pages = {{339-353}},
Publisher = {{ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS}},
Address = {{525 B ST, STE 1900, SAN DIEGO, CA 92101-4495}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{UNIV KENTUCKY,SCH MED,DEPT PHARMACOL,LEXINGTON,KY 40506.
   BAXTER TRAVENOL LABS,MORTON GROVE,IL.}},
DOI = {{10.1016/0041-008X(77)90167-3}},
ISSN = {{0041-008X}},
Research-Areas = {{Pharmacology \& Pharmacy; Toxicology}},
Web-of-Science-Categories  = {{Pharmacology \& Pharmacy; Toxicology}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   ALBRO PW, 1973, BIOCHIM BIOPHYS ACTA, V360, P380.
   AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   DANIEL JW, 1974, TOXICOLOGY, V2, P51, DOI 10.1016/0300-483X(74)90042-0.
   Jaeger R J, 1973, Environ Health Perspect, V3, P95, DOI 10.2307/3428035.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   KENNEDY JS, 1972, TOXICOL APPL PHARM, V22, P252, DOI 10.1016/0041-008X(72)90175-5.
   KLAASSEN CD, 1971, BRIT J PHARMACOL, V43, P161.
   ROBERTS RJ, 1967, P SOC EXP BIOL MED, V125, P313.
   RUBIN RJ, 1974, TOXICOL APPL PHARM, V29, P143.
   SCHMIDT JG, 1975, TOXICOL APPL PHARM, V33, P169.
   SCHULZ CO, 1974, FED PROC, V33, P234.
   Schulz C O, 1973, Environ Health Perspect, V3, P123, DOI 10.2307/3428038.
   ULLBERG S, 1954, ACTA RADIOL STOCKH S, P1.
   WILLIAMS RT, 1959, DETOXICATION MECHANI.}},
Number-of-Cited-References = {{16}},
Times-Cited = {{18}},
Journal-ISO = {{Toxicol. Appl. Pharmacol.}},
Doc-Delivery-Number = {{CZ731}},
Wos-Id = {{ISI:A1977CZ73100018}},
}

@article{ ISI:A1977CY47900016,
Author = {MIRIPOL, JE and STERN, IJ},
Title = {{DECREASED ACCUMULATION OF PHTHALATE PLASTICIZER DURING STORAGE OF BLOOD
   AS PACKED CELLS}},
Journal = {{TRANSFUSION}},
Year = {{1977}},
Volume = {{17}},
Number = {{1}},
Pages = {{71-72}},
Publisher = {{AMER ASSOC BLOOD BANKS}},
Address = {{8101 GLENBROOK RD, BETHESDA, MD 20814-2749}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{TRAVENOL LABS,BIOCHEM SECT,MORTON GROVE,IL 60053.}},
DOI = {{10.1046/j.1537-2995.1977.17177128891.x}},
ISSN = {{0041-1132}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{ALBRO PW, 1973, J CHROMATOGR, V76, P321, DOI 10.1016/S0021-9673(01)96915-8.
   AUTIAN J, 1973, NUTRITION REV, V31, P119.
   CONTRERA.TJ, 1974, TRANSFUSION, V14, P34.
   Jaeger R J, 1973, Environ Health Perspect, V3, P95, DOI 10.2307/3428035.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   MIRIPOL JE, 1975, NO1HB22990 CONTR.
   STERN I, 1974, PHARMACOLOGIST, V16, P283.
   Wallin R F, 1974, Bull Parenter Drug Assoc, V28, P278.
   1974, TECHNICAL METHODS PR, P180.}},
Number-of-Cited-References = {{9}},
Times-Cited = {{17}},
Journal-ISO = {{Transfusion}},
Doc-Delivery-Number = {{CY479}},
Wos-Id = {{ISI:A1977CY47900016}},
}

@article{ ISI:A1976BR50400010,
Author = {KIM, SW and PETERSEN, RV and LEE, ES},
Title = {{EFFECT OF PHTHALATE PLASTICIZER ON BLOOD COMPATIBILITY OF
   POLYVINYL-CHLORIDE}},
Journal = {{JOURNAL OF PHARMACEUTICAL SCIENCES}},
Year = {{1976}},
Volume = {{65}},
Number = {{5}},
Pages = {{670-673}},
Publisher = {{AMER PHARMACEUTICAL ASSN}},
Address = {{2215 CONSTITUTION AVE NW, WASHINGTON, DC 20037}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{UNIV UTAH,COLL PHARM,DEPT APPL PHARM SCI,SALT LAKE CITY,UT 84112.}},
DOI = {{10.1002/jps.2600650510}},
ISSN = {{0022-3549}},
Research-Areas = {{Pharmacology \& Pharmacy; Chemistry}},
Web-of-Science-Categories  = {{Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology \&
   Pharmacy}},
Cited-References = {{AUTIAN J, 1973, Environmental Health Perspectives, V4, P3, DOI 10.2307/3428178.
   EASTERLI.RE, 1974, P SOC EXP BIOL MED, V147, P572.
   GUESS W L, 1968, Journal of Biomedical Materials Research, V2, P313, DOI 10.1002/jbm.820020304.
   GUESS WL, 1967, DRUG INTELL, V1, P120.
   HILLMAN LS, 1975, NEW ENGL J MED, V292, P381, DOI 10.1056/NEJM197502202920801.
   JACOBS PWM, 1974, J SOLID STATE CHEM, V9, P315, DOI 10.1016/0022-4596(74)90089-9.
   Jaeger R J, 1973, Environ Health Perspect, V3, P95, DOI 10.2307/3428035.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1973, ENVIRON HLTH PERSPEC, V3, P53.
   JAEGER RJ, 1971, THESIS JOHNS HOPKINS.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   KIM SW, 1974, T AM SOC ART INT ORG, VB 20, P449.
   LEE RG, 1974, J BIOMED MATER RES, V8, P393, DOI 10.1002/jbm.820080607.
   LEE RG, 1974, THROMB RES, V4, P485, DOI 10.1016/0049-3848(74)90083-8.
   LEE RG, 1974, J BIOMED MATER RES, V8, P251, DOI 10.1002/jbm.820080507.
   MANNUCCI PM, 1972, PLATELET FUNCTION TH.
   MARCEL YL, 1970, CHEM PHYS LIPIDS, V4, P418, DOI 10.1016/0009-3084(70)90040-X.
   MASON RG, 1971, P SOC EXP BIOL MED, V137, P680.
   MCNAMARA JJ, 1970, ANN SURG, V172, P334, DOI 10.1097/00000658-197009000-00003.
   MES J, 1974, B ENVIRON CONTAM TOX, V12, P721.
   MOSELEY RV, 1970, ANN SURG, V171, P329, DOI 10.1097/00000658-197003000-00002.
   MUSTARD JF, 1967, FED PROC, V26, P106.
   PACKHAM MA, 1969, J LAB CLIN MED, V73, P686.
   SALZMAN EW, 1971, FED PROC, V30, P1503.
   Schulz C O, 1973, Environ Health Perspect, V3, P123, DOI 10.2307/3428038.
   SHERRY S, 1974, PLATELET THROMBOSIS.
   SOLIS RT, 1972, TRANSFUSION, V12, P245.
   TRIMBLE AS, 1966, SURGERY, V59, P857.
   VALERI CR, 1973, ENVIRON HLTH PERSPEC, V3, P102.
   VESSMAN J, 1974, 13TH INT C IABS    A, V27, P205.
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106.
   1971, CHEM ENG NEWS   0215, P12.}},
Number-of-Cited-References = {{32}},
Times-Cited = {{30}},
Journal-ISO = {{J. Pharm. Sci.}},
Doc-Delivery-Number = {{BR504}},
Wos-Id = {{ISI:A1976BR50400010}},
}

@article{ ISI:A1975AH76100002,
Author = {GILBO, CM and COLES, NW},
Title = {{DI(2-ETHYLHEXYL)PHTHALATE CONTENT OF PLASMA FRACTIONS PREPARED BY
   LOW-TEMPERATURE ETHANOL (COHN) FRACTIONATION}},
Journal = {{VOX SANGUINIS}},
Year = {{1975}},
Volume = {{29}},
Number = {{4}},
Pages = {{242-247}},
Publisher = {{KARGER}},
Address = {{ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND}},
Type = {{Article}},
Language = {{English}},
Affiliation = {{COMMONWEALTH SERUM LABS,45 POPLAR RD,PARKVILLE 3052,VICTORIA,AUSTRALIA.}},
ISSN = {{0042-9007}},
Research-Areas = {{Hematology}},
Web-of-Science-Categories  = {{Hematology}},
Cited-References = {{Blomback B., 1956, ARK KEMI, V10, P415.
   COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034.
   CONTRERA.TJ, 1974, TRANSFUSION, V14, P34.
   DEHAAN RL, 1971, NATURE-NEW BIOL, V231, P85.
   DUKE HN, 1968, LANCET, V2, P21.
   FISHBEIN L, 1972, J CHROMATOGR, V70, P365, DOI 10.1016/S0021-9673(00)92702-X.
   GESLER RM, 1970, LANCET, V1, P1227.
   HINK J H Jr, 1957, Vox Sang, V2, P174.
   JAEGER RJ, 1970, SCIENCE, V170, P460, DOI 10.1126/science.170.3956.460.
   JAEGER RJ, 1973, TRANSFUSION, V13, P107.
   JAEGER RJ, 1972, NEW ENGL J MED, V287, P1114, DOI 10.1056/NEJM197211302872203.
   LITTLE K, 1962, LANCET, V2, P857.
   LITTLE K, 1968, LANCET, V2, P351.
   MARCEL YL, 1973, ENV HLTH PERP EXP, P119.
   MARCEL YL, 1970, CHEM PHYS LIPIDS, V4, P418, DOI 10.1016/0009-3084(70)90040-X.
   MARCEL YL, 1970, LANCET, V1, P35.
   ONCLEY JL, 1949, J AM CHEM SOC, V71, P541, DOI 10.1021/ja01170a048.
   VESSMAN J, 1974, J CHROMATOGR, V100, P153, DOI 10.1016/S0021-9673(00)86049-5.
   1968, LANCET, V2, P34.}},
Number-of-Cited-References = {{19}},
Times-Cited = {{11}},
Journal-ISO = {{Vox Sang.}},
Doc-Delivery-Number = {{AH761}},
Wos-Id = {{ISI:A1975AH76100002}},
}
